Citrus Sinensis ID: 020657

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320---
Protein Sequence
MAVVKQRRQLNLRLPMPELSERCLRFPLALPPTAPNTNNNTTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSDC
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHccccccccEEEEEEEEcccccEEEEEEEEccccHHHHHHHHHHHHHHHHcccccEEEccEEEEcccccEEEEEEEcccccHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHccccccccccccEEEcccccccEEEcccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHccccccccccccccHHHHHHHHcccccccccccccHHHHHHHHHHHcccccccccHHHHHccHHHcccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEEccccHHHEEEEEEcccccEEEEEEEEccccccHHHHHHHHHHHHHHcccccEEEEEEEEEEcccEEEEEEEcccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEEEEcccccccccccccccccccccccccHHHHcccccccccccccEEHHHHHHHHHHHHccccccccccHHHHHHHHHccccccccEEccccccHHHHHHHHHHHcccHHHcccHHHHHccHHHHcccHccc
Coil and Loop (DISEMBL)
MAVVKQRRQlnlrlpmpelserclrfplalpptapntnnnttaTTAAIAYSDLEKLqvlghgnggtvYKVQHRCTHKIYALKvvhgdadptvRRQVFREMEilrrtdspfivqcfgifekpsgdIAILMEYmdsgtldtllnkngtfsepkLAHIASQILKGLSylhghkiihrdikpsnllvnnnnmqvkIADFGVSKIMCRSLDACnsyvgtcaymsperfdpdayggnyngyagdIWSLGLTLLELYLghfpflqpgqrpdwaTLMCAIcfgdppslpdgaspeFRSFIECCLQKEFSKRWTASQLlthpflcknrrsdc
Flexible Loop (DISEMBL)
mavvkqrrqlnlrlpmpelSERCLRFPLALpptapntnnNTTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYAlkvvhgdadptVRRQVFREMEilrrtdspfiVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSkrwtasqllthpflcknrrsdc
Low Complexity Region (SEG)
MAVVKQRRQLNLRLPMPELSERCLRFplalpptapntnnnttattaaIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDayggnyngyagDIWSlgltllelylGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSDC
Disordered region (IsUnstruct)
**********************CLRFPLAL***********TATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP********PEFRSFIECCLQKEFSKRWTASQLLTHPFLC*******
Disordered Region (DISOPRED)
***************************************************DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR****
Disordered Region (DISEMBL)
MAVVKQRRQLNLRLPMPELSERCLRFPLALPPTAPNTNNNTTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSDC
Disordered Region (DISPRO)
***********************************************IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MAVVKQRRQLNLRLPMPELSERCLRFPLALPPTAPNTNNNTTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSDC
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	323	2.2.26 [Sep-21-2011]
O80397	366	Mitogen-activated protein	no	no	0.941	0.830	0.492	5e-82
Q8RXG3	348	Mitogen-activated protein	no	no	0.835	0.775	0.530	2e-81
Q5QN75	355	Mitogen-activated protein	no	no	0.913	0.830	0.404	3e-55
Q9S7U9	363	Mitogen-activated protein	no	no	0.814	0.724	0.425	1e-54
Q9FJV0	356	Mitogen-activated protein	no	no	0.829	0.752	0.405	5e-53
Q94A06	354	Mitogen-activated protein	no	no	0.919	0.838	0.388	2e-52
Q24324	396	Dual specificity mitogen-	yes	no	0.814	0.664	0.405	1e-51
P33886	605	Protein kinase wis1 OS=Sc	yes	no	0.854	0.456	0.412	2e-49
Q05116	395	Dual specificity mitogen-	N/A	no	0.814	0.665	0.363	3e-49
Q02750	393	Dual specificity mitogen-	yes	no	0.804	0.661	0.371	5e-49

>sp|O80397|M2K4_ARATH Mitogen-activated protein kinase kinase 4 OS=Arabidopsis thaliana GN=MKK4 PE=1 SV=1

 Score =  304 bits (779), Expect = 5e-82,   Method: Compositional matrix adjust.
 Identities = 162/329 (49%), Positives = 221/329 (67%), Gaps = 25/329 (7%)

Query: 5   KQRRQLNLRLPMPELSERCLRFPLALPPTAPNTNNNTTATTA---------------AIA 49
           + RR+ +L LP+P+  +  L  PL LPPT+  +  ++ +  +               A  
Sbjct: 17  RPRRRPDLTLPLPQ-RDVSLAVPLPLPPTSGGSGGSSGSAPSSGGSASSTNTNSSIEAKN 75

Query: 50  YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSP 109
           YSDL +   +G G GGTVYKV HR + ++YALKV++G+ + TVRRQ+ RE+EILR  + P
Sbjct: 76  YSDLVRGNRIGSGAGGTVYKVIHRPSSRLYALKVIYGNHEETVRRQICREIEILRDVNHP 135

Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
            +V+C  +F++ +G+I +L+E+MD G+L+        + E +LA ++ QIL GL+YLH  
Sbjct: 136 NVVKCHEMFDQ-NGEIQVLLEFMDKGSLEGA----HVWKEQQLADLSRQILSGLAYLHSR 190

Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYG 229
            I+HRDIKPSNLL+N+    VKIADFGVS+I+ +++D CNS VGT AYMSPER + D   
Sbjct: 191 HIVHRDIKPSNLLINSAK-NVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNQ 249

Query: 230 GNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRP-DWATLMCAICFGDPPSLPDGASPEF 288
           G Y+GYAGDIWSLG+++LE YLG FPF  P  R  DWA+LMCAIC   PP  P  ASPEF
Sbjct: 250 GKYDGYAGDIWSLGVSILEFYLGRFPF--PVSRQGDWASLMCAICMSQPPEAPATASPEF 307

Query: 289 RSFIECCLQKEFSKRWTASQLLTHPFLCK 317
           R FI CCLQ+E  KR +A QLL HPF+ +
Sbjct: 308 RHFISCCLQREPGKRRSAMQLLQHPFILR 336

Involved in the second phase of hydrogen peroxide generation during hypersensitive response-like cell death. Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. Activates by phosphorylation the downstream MPK3 and MPK6.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 2EC: .EC: 2

>sp|Q8RXG3|M2K5_ARATH Mitogen-activated protein kinase kinase 5 OS=Arabidopsis thaliana GN=MKK5 PE=1 SV=2

 Score =  303 bits (775), Expect = 2e-81,   Method: Compositional matrix adjust.
 Identities = 147/277 (53%), Positives = 197/277 (71%), Gaps = 7/277 (2%)

Query: 41  TTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREM 100
           +T  +AA + S+LE++  +G G GGTVYKV H  T + +ALKV++G+ + TVRRQ+ RE+
Sbjct: 58  STNISAAKSLSELERVNRIGSGAGGTVYKVIHTPTSRPFALKVIYGNHEDTVRRQICREI 117

Query: 101 EILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQIL 160
           EILR  D P +V+C  +F+  +G+I +L+E+MD G+L+        + E +LA ++ QIL
Sbjct: 118 EILRSVDHPNVVKCHDMFDH-NGEIQVLLEFMDQGSLEGA----HIWQEQELADLSRQIL 172

Query: 161 KGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSP 220
            GL+YLH   I+HRDIKPSNLL+N+    VKIADFGVS+I+ +++D CNS VGT AYMSP
Sbjct: 173 SGLAYLHRRHIVHRDIKPSNLLINSAK-NVKIADFGVSRILAQTMDPCNSSVGTIAYMSP 231

Query: 221 ERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSL 280
           ER + D   G Y+GYAGD+WSLG+++LE YLG FPF    Q  DWA+LMCAIC   PP  
Sbjct: 232 ERINTDLNHGRYDGYAGDVWSLGVSILEFYLGRFPFAVSRQG-DWASLMCAICMSQPPEA 290

Query: 281 PDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK 317
           P  AS EFR F+ CCLQ +  KRW+A QLL HPF+ K
Sbjct: 291 PATASQEFRHFVSCCLQSDPPKRWSAQQLLQHPFILK 327

Involved in the second phase of hydrogen peroxide generation during hypersensitive response-like cell death. Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. Activates by phosphorylation the downstream MPK3 and MPK6.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q5QN75|M2K1_ORYSJ Mitogen-activated protein kinase kinase 1 OS=Oryza sativa subsp. japonica GN=MEK1 PE=1 SV=1

 Score =  216 bits (549), Expect = 3e-55,   Method: Compositional matrix adjust.
 Identities = 125/309 (40%), Positives = 184/309 (59%), Gaps = 14/309 (4%)

Query: 19  LSERCLRFPLALPPTAPNTNNNTTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKI 78
           L++R L+         P + N        ++  DLE +QV+G G+GG V  V+H+    +
Sbjct: 38  LNQRGLQLISEETADEPQSTN-LKVEDVQLSMDDLEMIQVIGKGSGGIVQLVRHKWVGTL 96

Query: 79  YALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLD 138
           YALK +  +    VR+Q+ +E++I + T +  IV C   F   +G I +++EYMD G+L 
Sbjct: 97  YALKGIQMNIQEAVRKQIVQELKINQATQNAHIVLCHQSFYH-NGVIYLVLEYMDRGSLA 155

Query: 139 TLLNKNGTFSEPKLAHIASQILKGLSYLHGHK-IIHRDIKPSNLLVNNNNMQVKIADFGV 197
            ++ +  T  EP LA +  Q+L+GL YLH  + +IHRDIKPSNLLVN    +VKI DFGV
Sbjct: 156 DIIKQVKTILEPYLAVLCKQVLEGLLYLHHERHVIHRDIKPSNLLVNRKG-EVKITDFGV 214

Query: 198 SKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFL 257
           S ++  S+   +++VGT  YM+PER      G +Y+ Y  DIWSLGL +LE  +G FP++
Sbjct: 215 SAVLASSMGQRDTFVGTYNYMAPERIS----GSSYD-YKSDIWSLGLVILECAIGRFPYI 269

Query: 258 QPGQRPDWAT---LMCAICFGDPPSLP-DGASPEFRSFIECCLQKEFSKRWTASQLLTHP 313
            P +   W +   L+ AI    PPS P D  SPEF +FI  C+QK+ ++R +AS+LL HP
Sbjct: 270 -PSEGEGWLSFYELLEAIVDQPPPSAPADQFSPEFCAFISSCIQKDPAERMSASELLNHP 328

Query: 314 FLCKNRRSD 322
           F+ K    D
Sbjct: 329 FIKKFEDKD 337

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q9S7U9|M2K2_ARATH Mitogen-activated protein kinase kinase 2 OS=Arabidopsis thaliana GN=MKK2 PE=1 SV=2

 Score =  213 bits (542), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 117/275 (42%), Positives = 167/275 (60%), Gaps = 12/275 (4%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           ++ SDL+ ++V+G G+ G V  VQH+ T + +ALKV+  + D  +R+ + +E++I + + 
Sbjct: 65  LSLSDLDMVKVIGKGSSGVVQLVQHKWTGQFFALKVIQLNIDEAIRKAIAQELKINQSSQ 124

Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
            P +V  +  F   +G I++++EYMD G+L   L       +  L+ I  Q+L+GL YLH
Sbjct: 125 CPNLVTSYQSFYD-NGAISLILEYMDGGSLADFLKSVKAIPDSYLSAIFRQVLQGLIYLH 183

Query: 168 GHK-IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPD 226
             + IIHRD+KPSNLL+N+   +VKI DFGVS +M  +    N++VGT  YMSPER    
Sbjct: 184 HDRHIIHRDLKPSNLLINHRG-EVKITDFGVSTVMTNTAGLANTFVGTYNYMSPERI--- 239

Query: 227 AYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWAT---LMCAICFGDPPSLPDG 283
              GN  G   DIWSLGL +LE   G FP+  P Q   W +   LM AI    PP+LP G
Sbjct: 240 --VGNKYGNKSDIWSLGLVVLECATGKFPYAPPNQEETWTSVFELMEAIVDQPPPALPSG 297

Query: 284 A-SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK 317
             SPE  SFI  CLQK+ + R +A +L+ HPFL K
Sbjct: 298 NFSPELSSFISTCLQKDPNSRSSAKELMEHPFLNK 332

May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Activates by phosphorylation the downstream MPK4 and MPK6.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q9FJV0|M2K6_ARATH Mitogen-activated protein kinase kinase 6 OS=Arabidopsis thaliana GN=MKK6 PE=1 SV=1

 Score =  208 bits (529), Expect = 5e-53,   Method: Compositional matrix adjust.
 Identities = 114/281 (40%), Positives = 174/281 (61%), Gaps = 13/281 (4%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           I   DLE ++V+G G+GG V  V+H+   K +A+KV+  +    +R+Q+ +E++I + + 
Sbjct: 65  ITAEDLETVKVIGKGSGGVVQLVRHKWVGKFFAMKVIQMNIQEEIRKQIVQELKINQASS 124

Query: 108 S-PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
             P +V C+  F   +G  ++++EYMD G+L  ++ +  T  EP LA +  Q+L GL YL
Sbjct: 125 QCPHVVVCYHSFYH-NGAFSLVLEYMDRGSLADVIRQVKTILEPYLAVVCKQVLLGLVYL 183

Query: 167 HGHK-IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDP 225
           H  + +IHRDIKPSNLLVN+   +VKI+DFGVS  +  S+   +++VGT  YMSPER   
Sbjct: 184 HNERHVIHRDIKPSNLLVNHKG-EVKISDFGVSASLASSMGQRDTFVGTYNYMSPERIS- 241

Query: 226 DAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQR---PDWATLMCAICFGDPPSLP- 281
              G  Y+ Y+ DIWSLG+++LE  +G FP+L+   +   P +  L+ AI    PP+ P 
Sbjct: 242 ---GSTYD-YSSDIWSLGMSVLECAIGRFPYLESEDQQNPPSFYELLAAIVENPPPTAPS 297

Query: 282 DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSD 322
           D  SPEF SF+  C+QK+   R ++  LL+HPF+ K    D
Sbjct: 298 DQFSPEFCSFVSACIQKDPPARASSLDLLSHPFIKKFEDKD 338

Involved in the regulation of plant cytokinesis during meiosis and mitosis. Activates MPK13 in vitro.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q94A06|M2K1_ARATH Mitogen-activated protein kinase kinase 1 OS=Arabidopsis thaliana GN=MKK1 PE=1 SV=2

 Score =  206 bits (523), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 123/317 (38%), Positives = 178/317 (56%), Gaps = 20/317 (6%)

Query: 11  NLRLPMPELSERCLRFPLALPPTAPNTNNNTTATTAAIAYSDLEKLQVLGHGNGGTVYKV 70
           +LR+    +    L  P A PP  P  N         ++ +DLE ++V+G G+ G V  V
Sbjct: 34  DLRVNKDGIQTVSLSEPGAPPPIEPLDNQ--------LSLADLEVIKVIGKGSSGNVQLV 85

Query: 71  QHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILME 130
           +H+ T + +ALKV+  + + +  R + +E+ I   +  P++V C+  F   +G ++I++E
Sbjct: 86  KHKLTQQFFALKVIQLNTEESTCRAISQELRINLSSQCPYLVSCYQSFYH-NGLVSIILE 144

Query: 131 YMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK-IIHRDIKPSNLLVNNNNMQ 189
           +MD G+L  LL K G   E  L+ I  ++L+GL Y+H  + IIHRD+KPSNLL+N+   +
Sbjct: 145 FMDGGSLADLLKKVGKVPENMLSAICKRVLRGLCYIHHERRIIHRDLKPSNLLINHRG-E 203

Query: 190 VKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLEL 249
           VKI DFGVSKI+  +    NS+VGT  YMSPER     Y         DIWSLGL LLE 
Sbjct: 204 VKITDFGVSKILTSTSSLANSFVGTYPYMSPERISGSLYSNK-----SDIWSLGLVLLEC 258

Query: 250 YLGHFPFLQPGQRPDWAT---LMCAICFGDPPSLPDGA-SPEFRSFIECCLQKEFSKRWT 305
             G FP+  P  +  W++   L+ AI    PP  P    SPEF SFI  C+QK+   R +
Sbjct: 259 ATGKFPYTPPEHKKGWSSVYELVDAIVENPPPCAPSNLFSPEFCSFISQCVQKDPRDRKS 318

Query: 306 ASQLLTHPFLCKNRRSD 322
           A +LL H F+     SD
Sbjct: 319 AKELLEHKFVKMFEDSD 335

May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Phosphorylates MPK4 in vitro.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q24324|DSOR1_DROME Dual specificity mitogen-activated protein kinase kinase dSOR1 OS=Drosophila melanogaster GN=Dsor1 PE=2 SV=2

 Score =  203 bits (516), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 120/296 (40%), Positives = 166/296 (56%), Gaps = 33/296 (11%)

Query: 46  AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRR 105
             ++  DLEKL  LG GNGG V KV+H  TH I A K++H +  P +++Q+ RE+++L  
Sbjct: 80  GELSDEDLEKLGELGSGNGGVVMKVRHTHTHLIMARKLIHLEVKPAIKKQILRELKVLHE 139

Query: 106 TDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
            + P IV  +G F    G+I+I MEYMD G+LD +L + G   E  L  I   +LKGLSY
Sbjct: 140 CNFPHIVGFYGAFYS-DGEISICMEYMDGGSLDLILKRAGRIPESILGRITLAVLKGLSY 198

Query: 166 LH-GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD 224
           L   H IIHRD+KPSN+LVN++  ++KI DFGVS  +  S+   NS+VGT +YMSPER  
Sbjct: 199 LRDNHAIIHRDVKPSNILVNSSG-EIKICDFGVSGQLIDSM--ANSFVGTRSYMSPERLQ 255

Query: 225 PDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQP----------------GQRPDWATL 268
                G +     DIWSLGL+L+E+ +G +P   P                GQ  D    
Sbjct: 256 -----GTHYSVQSDIWSLGLSLVEMAIGMYPIPPPNTATLESIFADNAEESGQPTDEPRA 310

Query: 269 MCAICFGD------PPSLPDGA-SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK 317
           M      D      PP L     S EF+ F++ CL+K+  +R     LL+HP++ K
Sbjct: 311 MAIFELLDYIVNEPPPKLEHKIFSTEFKDFVDICLKKQPDERADLKTLLSHPWIRK 366

Required downstream of Raf in the sevenless (sev), torso (tor), and Drosophila EGF receptor homolog (DER) signal transduction pathways. Involved in both positive regulation (at the posterior terminus) and negative regulation (at the anterior domain) of tll, as in other terminal class gene products, maybe via the ERK-A kinase.

Drosophila melanogaster (taxid: 7227)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|P33886|WIS1_SCHPO Protein kinase wis1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=wis1 PE=1 SV=1

 Score =  196 bits (497), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 120/291 (41%), Positives = 164/291 (56%), Gaps = 15/291 (5%)

Query: 39  NNTTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFR 98
           N ++ ++  I  S++ KL+ LG GN G VYK  H+ T    ALK +    +     Q+  
Sbjct: 306 NFSSGSSFRINMSEIIKLEELGKGNYGVVYKALHQPTGVTMALKEIRLSLEEATFNQIIM 365

Query: 99  EMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQ 158
           E++IL +  SP+IV  +G F    G + I MEYMD+G++D L    G   E  LA  A  
Sbjct: 366 ELDILHKAVSPYIVDFYGAFFV-EGSVFICMEYMDAGSMDKLY-AGGIKDEGVLARTAYA 423

Query: 159 ILKGLSYL-HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAY 217
           +++GL  L   H IIHRD+KP+N+LVN+N  QVK+ DFGVS  +  S+   N  +G  +Y
Sbjct: 424 VVQGLKTLKEEHNIIHRDVKPTNVLVNSNG-QVKLCDFGVSGNLVASISKTN--IGCQSY 480

Query: 218 MSPERFDPDAYGGNYNGY-----AGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAI 272
           M+PER      GG  NG        D+WSLGLT+LE+ LG +P+        +A L  AI
Sbjct: 481 MAPERIR---VGGPTNGVLTYTVQADVWSLGLTILEMALGAYPYPPESYTSIFAQL-SAI 536

Query: 273 CFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSDC 323
           C GDPPSLPD  SPE R F+  CL K  S R    +L  HP+L K + +D 
Sbjct: 537 CDGDPPSLPDSFSPEARDFVNKCLNKNPSLRPDYHELANHPWLLKYQNADV 587

Dosage-dependent regulator of mitosis with serine/ threonine protein kinase activity. May play a role in the integration of nutritional sensing with the control over entry into mitosis. It may interact with cdc25, wee1 and win1. May activate sty1.

Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q05116|MP2K1_XENLA Dual specificity mitogen-activated protein kinase kinase 1 OS=Xenopus laevis GN=map2k1 PE=1 SV=2

 Score =  195 bits (496), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 114/314 (36%), Positives = 166/314 (52%), Gaps = 51/314 (16%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
           D EK+  LG GNGG V+KV H+ T  I A K++H +  P +R Q+ RE+++L   +SP+I
Sbjct: 67  DFEKVSELGAGNGGVVFKVSHKPTSLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 126

Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL-HGHK 170
           V  +G F    G+I+I ME+MD G+LD +L K G   E  L  ++  ++KGL+YL   HK
Sbjct: 127 VGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGKIPEKILGKVSIAVIKGLTYLREKHK 185

Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGG 230
           I+HRD+KPSN+LVN+   ++K+ DFGVS  +  S+   NS+VGT +YMSPER       G
Sbjct: 186 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQ-----G 237

Query: 231 NYNGYAGDIWSLGLTLLELYLGHFPF---------------------------------- 256
            +     DIWS+GL+L+E+ +G +P                                   
Sbjct: 238 THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELIFGCSVERDPASSELAPRPRPPGR 297

Query: 257 ----LQPGQRPDWAT--LMCAICFGDPPSLPDGA-SPEFRSFIECCLQKEFSKRWTASQL 309
                 P  RP  A   L+  I    PP LP G    EF+ F+  CL K  ++R    QL
Sbjct: 298 PISSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLVKNPAERADLKQL 357

Query: 310 LTHPFLCKNRRSDC 323
           + H F+ ++   + 
Sbjct: 358 MVHSFIKQSELEEV 371

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates the MAPK/ERK cascade, ultimately leading to phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. Depending on the cellular context, this pathway mediates diverse biological functions such as cell growth, adhesion, survival and differentiation predominantly through the regulation of transcription, metabolism and cytoskeletal rearrangements.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q02750|MP2K1_HUMAN Dual specificity mitogen-activated protein kinase kinase 1 OS=Homo sapiens GN=MAP2K1 PE=1 SV=2

 Score =  195 bits (495), Expect = 5e-49,   Method: Compositional matrix adjust.
 Identities = 116/312 (37%), Positives = 168/312 (53%), Gaps = 52/312 (16%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
           D EK+  LG GNGG V+KV H+ +  + A K++H +  P +R Q+ RE+++L   +SP+I
Sbjct: 67  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 126

Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL-HGHK 170
           V  +G F    G+I+I ME+MD G+LD +L K G   E  L  ++  ++KGL+YL   HK
Sbjct: 127 VGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 185

Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGG 230
           I+HRD+KPSN+LVN+   ++K+ DFGVS  +  S+   NS+VGT +YMSPER       G
Sbjct: 186 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQ-----G 237

Query: 231 NYNGYAGDIWSLGLTLLELYLGHFPFLQP------------------------------- 259
            +     DIWS+GL+L+E+ +G +P   P                               
Sbjct: 238 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 297

Query: 260 -----GQRPDWAT--LMCAICFGDPPSLPDGA-SPEFRSFIECCLQKEFSKRWTASQLLT 311
                  RP  A   L+  I    PP LP G  S EF+ F+  CL K  ++R    QL+ 
Sbjct: 298 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 357

Query: 312 HPFLCKNRRSDC 323
           H F+   +RSD 
Sbjct: 358 HAFI---KRSDA 366

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2, leading to their activation and further transduction of the signal within the MAPK/ERK cascade. Depending on the cellular context, this pathway mediates diverse biological functions such as cell growth, adhesion, survival and differentiation, predominantly through the regulation of transcription, metabolism and cytoskeletal rearrangements. One target of the MAPK/ERK cascade is peroxisome proliferator-activated receptor gamma (PPARG), a nuclear receptor that promotes differentiation and apoptosis. MAP2K1/MEK1 has been shown to export PPARG from the nucleus. The MAPK/ERK cascade is also involved in the regulation of endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC), as well as in the fragmentation of the Golgi apparatus during mitosis.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	323
118489678	321	unknown [Populus trichocarpa x Populus d	0.981	0.987	0.751	1e-133
225456228	314	PREDICTED: mitogen-activated protein kin	0.962	0.990	0.754	1e-133
147770515	314	hypothetical protein VITISV_038954 [Viti	0.962	0.990	0.751	1e-132
108743310	325	mitogen-activated protein kinase kinase	0.981	0.975	0.700	1e-130
224125868	310	predicted protein [Populus trichocarpa]	0.959	1.0	0.730	1e-130
315258235	325	mitogen-activated protein kinase kinase	0.987	0.981	0.708	1e-128
449439485	320	PREDICTED: mitogen-activated protein kin	0.978	0.987	0.746	1e-128
449520938	320	PREDICTED: mitogen-activated protein kin	0.978	0.987	0.746	1e-128
356520673	318	PREDICTED: mitogen-activated protein kin	0.969	0.984	0.683	1e-128
290784293	327	mitogen-activated protein kinase kinase	0.981	0.969	0.704	1e-125

>gi|118489678|gb|ABK96640.1| unknown [Populus trichocarpa x Populus deltoides]

 Score =  480 bits (1235), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 242/322 (75%), Positives = 277/322 (86%), Gaps = 5/322 (1%)

Query: 1   MAVVKQRRQLNLRLPMPELSERCLRFPLALPPTAPNTNNNTTATTAAIAYSDLEKLQVLG 60
           MA+V++RRQ+NLRLP  ELS+R  RFPL L     +T NN    T+ I+ +D+EK+ VLG
Sbjct: 1   MALVRERRQVNLRLP--ELSDRRPRFPLPL--PPTSTINNNNNNTSTISCNDIEKIHVLG 56

Query: 61  HGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEK 120
           HGNGGTVYKV+H+   +IYALKVVHGD+DP VRRQ++RE+EILRRTDSP IV+C G++EK
Sbjct: 57  HGNGGTVYKVRHKRNSQIYALKVVHGDSDPLVRRQIYREIEILRRTDSPNIVKCHGVYEK 116

Query: 121 PSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSN 180
           PSGDIAI MEYMD GTLD+LL K+GTF+E KL+H+ASQ+L GLSYLH  KIIHRDIKPSN
Sbjct: 117 PSGDIAITMEYMDLGTLDSLLKKHGTFNESKLSHVASQVLNGLSYLHAQKIIHRDIKPSN 176

Query: 181 LLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIW 240
           LLVN + M+VKIADFGVSKIM R+LDACNSYVGTCAYMSPERFDPD YGGNYNGYA DIW
Sbjct: 177 LLVNKD-MEVKIADFGVSKIMHRTLDACNSYVGTCAYMSPERFDPDTYGGNYNGYAADIW 235

Query: 241 SLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEF 300
           SLGL LLELY+GHFPFL PGQRPDWATLMCAICFGDPPSLP+GAS EFR FI+CCLQKE 
Sbjct: 236 SLGLILLELYMGHFPFLPPGQRPDWATLMCAICFGDPPSLPEGASEEFRDFIQCCLQKES 295

Query: 301 SKRWTASQLLTHPFLCKNRRSD 322
            KRWTA+QLL HPF+CK  RSD
Sbjct: 296 GKRWTAAQLLAHPFVCKVPRSD 317

Source: Populus trichocarpa x Populus deltoides

Species: Populus trichocarpa x Populus deltoides

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225456228|ref|XP_002283080.1| PREDICTED: mitogen-activated protein kinase kinase 5 [Vitis vinifera]

 Score =  479 bits (1234), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 240/318 (75%), Positives = 272/318 (85%), Gaps = 7/318 (2%)

Query: 1   MAVVKQRRQLNLRLPMPELSERCLRFPLALPPTAPNTNNNTTATTAAIAYSDLEKLQVLG 60
           MAVV+ RRQLNLRLP+PE+SER  RFPL LPPT    ++   ATTAA    DLEK++V+G
Sbjct: 1   MAVVRDRRQLNLRLPLPEISERRPRFPLPLPPTNLPFSSG--ATTAA----DLEKIEVIG 54

Query: 61  HGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEK 120
           HGNGGTVYKVQH+ T   YALKVVHGD DPTVRRQV REMEILR TDSPF+VQC GIF+K
Sbjct: 55  HGNGGTVYKVQHKRTAANYALKVVHGDCDPTVRRQVLREMEILRFTDSPFVVQCHGIFQK 114

Query: 121 PSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSN 180
           PSGDIAILMEYMD+GTL TLL   GTFSE  LA +A Q+L GLSYLH HKIIHRDIKP+N
Sbjct: 115 PSGDIAILMEYMDAGTLKTLLETKGTFSEVDLAGVAGQVLNGLSYLHSHKIIHRDIKPAN 174

Query: 181 LLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIW 240
           LLVN N M+VKIADFGVSKIM R LD+CNSYVGTCAYMSPERFDPD++G NY+GY+GDIW
Sbjct: 175 LLVNGN-MEVKIADFGVSKIMRRMLDSCNSYVGTCAYMSPERFDPDSHGSNYDGYSGDIW 233

Query: 241 SLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEF 300
           SLGLTLLELY+GHFP L  GQ+PDWATLMCAICFG+ P+LP+G S EFR+FIECCLQK+ 
Sbjct: 234 SLGLTLLELYVGHFPLLPAGQKPDWATLMCAICFGEEPALPEGVSEEFRNFIECCLQKDS 293

Query: 301 SKRWTASQLLTHPFLCKN 318
           +KRWTA+QLL+HPF+CK 
Sbjct: 294 TKRWTAAQLLSHPFICKQ 311

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147770515|emb|CAN75681.1| hypothetical protein VITISV_038954 [Vitis vinifera]

 Score =  478 bits (1230), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 239/318 (75%), Positives = 272/318 (85%), Gaps = 7/318 (2%)

Query: 1   MAVVKQRRQLNLRLPMPELSERCLRFPLALPPTAPNTNNNTTATTAAIAYSDLEKLQVLG 60
           MAVV+ RRQLNLRLP+PE+S+R  RFPL LPPT    ++   ATTAA    DLEK++V+G
Sbjct: 1   MAVVRDRRQLNLRLPLPEISDRRPRFPLPLPPTNLPFSSG--ATTAA----DLEKIEVIG 54

Query: 61  HGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEK 120
           HGNGGTVYKVQH+ T   YALKVVHGD DPTVRRQV REMEILR TDSPF+VQC GIF+K
Sbjct: 55  HGNGGTVYKVQHKRTAANYALKVVHGDCDPTVRRQVLREMEILRFTDSPFVVQCHGIFQK 114

Query: 121 PSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSN 180
           PSGDIAILMEYMD+GTL TLL   GTFSE  LA +A Q+L GLSYLH HKIIHRDIKP+N
Sbjct: 115 PSGDIAILMEYMDAGTLKTLLETQGTFSEVDLAGVAGQVLNGLSYLHSHKIIHRDIKPAN 174

Query: 181 LLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIW 240
           LLVN N M+VKIADFGVSKIM R LD+CNSYVGTCAYMSPERFDPD++G NY+GY+GDIW
Sbjct: 175 LLVNGN-MEVKIADFGVSKIMRRMLDSCNSYVGTCAYMSPERFDPDSHGSNYDGYSGDIW 233

Query: 241 SLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEF 300
           SLGLTLLELY+GHFP L  GQ+PDWATLMCAICFG+ P+LP+G S EFR+FIECCLQK+ 
Sbjct: 234 SLGLTLLELYVGHFPLLPAGQKPDWATLMCAICFGEEPALPEGVSEEFRNFIECCLQKDS 293

Query: 301 SKRWTASQLLTHPFLCKN 318
           +KRWTA+QLL+HPF+CK 
Sbjct: 294 TKRWTAAQLLSHPFICKQ 311

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|108743310|dbj|BAE95414.1| mitogen-activated protein kinase kinase [Nicotiana benthamiana]

 Score =  470 bits (1210), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 227/324 (70%), Positives = 264/324 (81%), Gaps = 7/324 (2%)

Query: 1   MAVVKQRRQLNLRLPMPELSERCLRFPLALPPTA------PNTNNNTTATTAAIAYSDLE 54
           MA+V++RRQLNLRLP+PE SER  RFPL +PP++            TTA+T  I+ S+LE
Sbjct: 1   MALVRERRQLNLRLPLPEPSERRPRFPLPIPPSSICTTNSTANTATTTASTTTISISELE 60

Query: 55  KLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQC 114
           KL+VLGHGNGGTVY+V+H+ T  IYALKVVHGD+DP +RRQ+ RE+ ILRRTDSP++++C
Sbjct: 61  KLKVLGHGNGGTVYEVRHKRTSAIYALKVVHGDSDPEIRRQILREISILRRTDSPYVIKC 120

Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
            G+ + P GDI ILMEYM+ GTL++LL    TFSE  LA IA Q+L GL YLH HKIIHR
Sbjct: 121 HGVIDMPGGDIGILMEYMNVGTLESLLKSQATFSELSLAKIAKQVLSGLDYLHNHKIIHR 180

Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNG 234
           D+KPSNLLVN   M+VKIADFGVSKIMCR+LD CNSYVGTCAYMSPERFDP  YG NYNG
Sbjct: 181 DLKPSNLLVNRE-MEVKIADFGVSKIMCRTLDPCNSYVGTCAYMSPERFDPGTYGVNYNG 239

Query: 235 YAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIEC 294
           YA DIWSLGLTL+ELY+GHFPFL PGQRPDWATLMCAICFG+PPSLP+G S  FR FIEC
Sbjct: 240 YAADIWSLGLTLMELYIGHFPFLPPGQRPDWATLMCAICFGEPPSLPEGTSVNFRDFIEC 299

Query: 295 CLQKEFSKRWTASQLLTHPFLCKN 318
           CLQKE SKRW+A QLL HPF+  N
Sbjct: 300 CLQKESSKRWSAQQLLNHPFILSN 323

Source: Nicotiana benthamiana

Species: Nicotiana benthamiana

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224125868|ref|XP_002329737.1| predicted protein [Populus trichocarpa] gi|222870645|gb|EEF07776.1| predicted protein [Populus trichocarpa]

 Score =  470 bits (1209), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 230/315 (73%), Positives = 268/315 (85%), Gaps = 5/315 (1%)

Query: 1   MAVVKQRRQLNLRLPMPELSERCLRFPLALPPTAPNTNNNTTATTAAIAYSDLEKLQVLG 60
           MA+V++RRQ+NLRLP  ELS+   R    LP    +T   T+  ++ I+ +D+EK+ VLG
Sbjct: 1   MALVRERRQINLRLP--ELSD--CRPRFPLPLPPTSTTTTTSNNSSNISCNDIEKIHVLG 56

Query: 61  HGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEK 120
           HGNGGTVYKV+H+   +IYALKVVHGD+DP VRRQ++RE+EILRRTDSP+IVQC G +EK
Sbjct: 57  HGNGGTVYKVRHKRNSQIYALKVVHGDSDPLVRRQIYREIEILRRTDSPYIVQCHGSYEK 116

Query: 121 PSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSN 180
           PSGDI I+MEYM+ GTLD++L K G F E KL+H+A Q+L GLSYLHG KIIHRDIKPSN
Sbjct: 117 PSGDIGIVMEYMELGTLDSILQKYGAFDESKLSHVARQVLHGLSYLHGQKIIHRDIKPSN 176

Query: 181 LLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIW 240
           LLVN + M+VKIADFGVSKIM R+LDACNSYVGTCAYMSPERFDPD YG NY+GYAGDIW
Sbjct: 177 LLVNKD-MEVKIADFGVSKIMQRTLDACNSYVGTCAYMSPERFDPDTYGVNYDGYAGDIW 235

Query: 241 SLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEF 300
           SLGLTL+ELYLGHFPFL PGQRPDWATLMCAICFGDPPSLP+GAS EFR FI+CCLQKE 
Sbjct: 236 SLGLTLMELYLGHFPFLPPGQRPDWATLMCAICFGDPPSLPEGASEEFRDFIQCCLQKES 295

Query: 301 SKRWTASQLLTHPFL 315
           SKRWT SQLL+HPF+
Sbjct: 296 SKRWTTSQLLSHPFV 310

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|315258235|gb|ADT91696.1| mitogen-activated protein kinase kinase 1 [Nicotiana attenuata]

 Score =  463 bits (1191), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 231/326 (70%), Positives = 267/326 (81%), Gaps = 7/326 (2%)

Query: 1   MAVVKQRRQLNLRLPMPELSERCLRFPLALPPTA------PNTNNNTTATTAAIAYSDLE 54
           MA+V++RRQLNLRLP+PE SER  RFPL LPP++            TTA T  I+ S+LE
Sbjct: 1   MALVRERRQLNLRLPLPEPSERRPRFPLPLPPSSISTTNSAANTTTTTAPTTTISISELE 60

Query: 55  KLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQC 114
           KL+VLGHGNGGTVYKV+H+ T  IYALKVVHGD+DP +RRQV RE+ ILRRTDSP+I++C
Sbjct: 61  KLKVLGHGNGGTVYKVRHKRTSAIYALKVVHGDSDPEIRRQVLREISILRRTDSPYIIKC 120

Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
            G+ + P GDI ILMEYM+SGTL++LL  + TF+E  LA IA Q+L GL YLH HKIIHR
Sbjct: 121 HGVIDMPGGDIGILMEYMNSGTLESLLKSHATFTELSLAKIAKQVLSGLDYLHNHKIIHR 180

Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNG 234
           D+KPSNLLVN   M+VKIADFGVSKIMCR+LD CNSYVGTCAYMSPERFDPD YG NYNG
Sbjct: 181 DLKPSNLLVNRE-MEVKIADFGVSKIMCRTLDPCNSYVGTCAYMSPERFDPDTYGVNYNG 239

Query: 235 YAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIEC 294
           YA DIWSLGLTL+ELY+GHFPFL PGQRPDWATLMCAICFG+PPSLP+G S  F+ FIEC
Sbjct: 240 YAADIWSLGLTLMELYMGHFPFLPPGQRPDWATLMCAICFGEPPSLPEGTSGNFKDFIEC 299

Query: 295 CLQKEFSKRWTASQLLTHPFLCKNRR 320
           CLQKE SKRW+A QLL HPF+  N +
Sbjct: 300 CLQKESSKRWSAQQLLQHPFILSNLK 325

Source: Nicotiana attenuata

Species: Nicotiana attenuata

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449439485|ref|XP_004137516.1| PREDICTED: mitogen-activated protein kinase kinase 4-like [Cucumis sativus]

 Score =  462 bits (1190), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 242/324 (74%), Positives = 271/324 (83%), Gaps = 8/324 (2%)

Query: 1   MAVVKQRRQLNLRLPMPELSERCLRFPLALPPTAPNTNNNTTATTAAIAYSDLEKLQVLG 60
           MA+V+ RR LNLRLP  +LS+ C           P++     A  +AI+ SDL+KLQVLG
Sbjct: 1   MALVRDRRHLNLRLP--DLSD-CRPRFPLP--LPPSSAPPAPAAPSAISSSDLDKLQVLG 55

Query: 61  HGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEK 120
           HGNGGTVYKV+H+ T   YALKVVHGD DPTVRRQVFREMEILRRTDSP++VQC GIFEK
Sbjct: 56  HGNGGTVYKVRHKRTSTTYALKVVHGDCDPTVRRQVFREMEILRRTDSPYVVQCHGIFEK 115

Query: 121 PSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSN 180
           PSGD+ ILMEYMD G+LD+LL KN T SE  LAH++ Q+L GL YLH HKIIHRDIKPSN
Sbjct: 116 PSGDVTILMEYMDLGSLDSLLKKNSTLSEATLAHVSRQVLNGLHYLHSHKIIHRDIKPSN 175

Query: 181 LLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIW 240
           LLVN N M+VKIADFGVSKIMCR+LDACNSYVGTCAYMSPERFDP+ YGGNYNGYAGDIW
Sbjct: 176 LLVNKN-MEVKIADFGVSKIMCRTLDACNSYVGTCAYMSPERFDPETYGGNYNGYAGDIW 234

Query: 241 SLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEF 300
           SLGLTLLELYLGHFPFL  GQRPDWATLMCAICFG+PP LP+ AS EFRSF+ECCLQKE 
Sbjct: 235 SLGLTLLELYLGHFPFLPAGQRPDWATLMCAICFGEPPKLPEDASEEFRSFVECCLQKES 294

Query: 301 SKRWTASQLLTHPFLCK--NRRSD 322
           SKRWTA+QLLTHPF+C+  +R SD
Sbjct: 295 SKRWTAAQLLTHPFVCRESSRSSD 318

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449520938|ref|XP_004167489.1| PREDICTED: mitogen-activated protein kinase kinase 4-like [Cucumis sativus]

 Score =  462 bits (1190), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 242/324 (74%), Positives = 271/324 (83%), Gaps = 8/324 (2%)

Query: 1   MAVVKQRRQLNLRLPMPELSERCLRFPLALPPTAPNTNNNTTATTAAIAYSDLEKLQVLG 60
           MA+V+ RR LNLRLP  +LS+ C           P++     A  +AI+ SDL+KLQVLG
Sbjct: 1   MALVRDRRHLNLRLP--DLSD-CRPRFPLP--LPPSSAPPAPAAPSAISSSDLDKLQVLG 55

Query: 61  HGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEK 120
           HGNGGTVYKV+H+ T   YALKVVHGD DPTVRRQVFREMEILRRTDSP++VQC GIFEK
Sbjct: 56  HGNGGTVYKVRHKRTSATYALKVVHGDCDPTVRRQVFREMEILRRTDSPYVVQCHGIFEK 115

Query: 121 PSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSN 180
           PSGD+ ILMEYMD G+LD+LL KN T SE  LAH++ Q+L GL YLH HKIIHRDIKPSN
Sbjct: 116 PSGDVTILMEYMDLGSLDSLLKKNSTLSEATLAHVSRQVLNGLHYLHSHKIIHRDIKPSN 175

Query: 181 LLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIW 240
           LLVN N M+VKIADFGVSKIMCR+LDACNSYVGTCAYMSPERFDP+ YGGNYNGYAGDIW
Sbjct: 176 LLVNKN-MEVKIADFGVSKIMCRTLDACNSYVGTCAYMSPERFDPETYGGNYNGYAGDIW 234

Query: 241 SLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEF 300
           SLGLTLLELYLGHFPFL  GQRPDWATLMCAICFG+PP LP+ AS EFRSF+ECCLQKE 
Sbjct: 235 SLGLTLLELYLGHFPFLPAGQRPDWATLMCAICFGEPPKLPEDASEEFRSFVECCLQKES 294

Query: 301 SKRWTASQLLTHPFLCK--NRRSD 322
           SKRWTA+QLLTHPF+C+  +R SD
Sbjct: 295 SKRWTAAQLLTHPFVCRESSRSSD 318

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356520673|ref|XP_003528985.1| PREDICTED: mitogen-activated protein kinase kinase 4-like [Glycine max]

 Score =  462 bits (1189), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 218/319 (68%), Positives = 255/319 (79%), Gaps = 6/319 (1%)

Query: 1   MAVVKQRRQLNLRLPMPELSERCLRFPLALPPTAPNTNNNTTATTAAIAYSDLEKLQVLG 60
           MA+V+ RR  NLRLP+PE SER LRFPL LPPT         A+  AIA +DLEKL +LG
Sbjct: 1   MALVRHRRHPNLRLPLPEPSERRLRFPLPLPPT----TTAKPASGDAIAAADLEKLAILG 56

Query: 61  HGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRR-TDSPFIVQCFGIFE 119
           HGNGGTVYKV+H+ T   YALK++H D D T RR+   E  ILRR TD P +V+    FE
Sbjct: 57  HGNGGTVYKVRHKATSATYALKIIHSDTDATRRRRALSETSILRRVTDCPHVVRFHSSFE 116

Query: 120 KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPS 179
           KPSGD+AILMEYMD GTL+T L  +GTFSE +LA +A  +L+GL+YLH   I HRDIKP+
Sbjct: 117 KPSGDVAILMEYMDGGTLETALAASGTFSEERLAKVARDVLEGLAYLHARNIAHRDIKPA 176

Query: 180 NLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDI 239
           N+LVN+    VKIADFGVSK+MCRSL+ACNSYVGTCAYMSP+RFDP+AYGGNYNG+A DI
Sbjct: 177 NILVNSEG-DVKIADFGVSKLMCRSLEACNSYVGTCAYMSPDRFDPEAYGGNYNGFAADI 235

Query: 240 WSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKE 299
           WSLGLTL ELY+GHFPFLQ GQRPDWATLMCAICFGDPPSLP+ ASPEFR F+ECCL+KE
Sbjct: 236 WSLGLTLFELYVGHFPFLQAGQRPDWATLMCAICFGDPPSLPETASPEFRDFVECCLKKE 295

Query: 300 FSKRWTASQLLTHPFLCKN 318
             +RWT +QLLTHPF+C +
Sbjct: 296 SGERWTTAQLLTHPFVCND 314

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|290784293|gb|ADD62693.1| mitogen-activated protein kinase kinase [Capsicum annuum]

 Score =  453 bits (1165), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 229/325 (70%), Positives = 266/325 (81%), Gaps = 8/325 (2%)

Query: 1   MAVVKQRRQLNLRLPMPELSERCLRFPLALPPTAPNTNNNTTATTAA-------IAYSDL 53
           MA+V+ RRQLNLRLP+PE SER  RFPL LPP++ +T + TT TT         ++ S+L
Sbjct: 1   MALVRDRRQLNLRLPLPEPSERRPRFPLPLPPSSVSTVSTTTTTTTTTASTTTTMSISEL 60

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           EKL+VLGHGNGGTVYKV+H+ T  IYALKVVHGD+DP +RRQ+ RE+ ILRRTDSP++++
Sbjct: 61  EKLKVLGHGNGGTVYKVRHKRTSAIYALKVVHGDSDPEIRRQILREISILRRTDSPYVIK 120

Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
           C G+ + P GDI ILMEYM+SGTL+ LL    TFSE  LA IA Q+L GL YLH HKIIH
Sbjct: 121 CHGVIDMPGGDIGILMEYMNSGTLENLLKSQTTFSELCLAKIAKQVLSGLDYLHNHKIIH 180

Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYN 233
           RD+KPSNLLVN   M+VKIADFGVSKIMCR+LD CNSYVGTCAYMSPERFDPD YG NYN
Sbjct: 181 RDLKPSNLLVNRE-MEVKIADFGVSKIMCRTLDPCNSYVGTCAYMSPERFDPDTYGVNYN 239

Query: 234 GYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIE 293
           GYA DIWSLGLTL+ELY+GHFPFL PGQRPDWATLMCAICFG+PPSLP G S +F+ F+E
Sbjct: 240 GYAADIWSLGLTLMELYMGHFPFLPPGQRPDWATLMCAICFGEPPSLPKGTSEKFKDFME 299

Query: 294 CCLQKEFSKRWTASQLLTHPFLCKN 318
           CCLQKE SKRW+A QLL HPF+  N
Sbjct: 300 CCLQKESSKRWSAQQLLQHPFVRSN 324

Source: Capsicum annuum

Species: Capsicum annuum

Genus: Capsicum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	323
TAIR|locus:2206885	310	MKK9 "MAP kinase kinase 9" [Ar	0.944	0.983	0.613	2.1e-100
TAIR|locus:2014099	307	MKK7 "MAP kinase kinase 7" [Ar	0.934	0.983	0.582	6.3e-92
TAIR|locus:2017662	366	MKK4 "mitogen-activated protei	0.804	0.710	0.505	5.8e-66
TAIR|locus:2094761	348	MKK5 "MAP kinase kinase 5" [Ar	0.804	0.747	0.494	2.5e-65
TAIR|locus:2082390	293	MKK8 "MAP kinase kinase 8" [Ar	0.885	0.976	0.429	1.7e-59
TAIR|locus:2028301	305	MKK10 "MAP kinase kinase 10" [	0.938	0.993	0.401	3.8e-53
UNIPROTKB|Q5ZIF0	395	MAP2K1 "Uncharacterized protei	0.671	0.549	0.399	1.8e-46
UNIPROTKB|Q0VD16	393	MAP2K1 "MAP2K1 protein" [Bos t	0.681	0.559	0.389	6e-46
UNIPROTKB|Q02750	393	MAP2K1 "Dual specificity mitog	0.681	0.559	0.389	6e-46
RGD|70495	393	Map2k1 "mitogen activated prot	0.681	0.559	0.389	6e-46

TAIR|locus:2206885 MKK9 "MAP kinase kinase 9" [Arabidopsis thaliana (taxid:3702)]

 Score = 996 (355.7 bits), Expect = 2.1e-100, P = 2.1e-100
 Identities = 194/316 (61%), Positives = 229/316 (72%)

Query:     1 MAVVKQRRQLNLRLPMPELSERCLRFXXXXXXXXXXXXXXXXXXXXXIAYSDLEKLQVLG 60
             MA+V++RRQLNLRLP+P +S+R  RF                     I+  DLEKL VLG
Sbjct:     1 MALVRERRQLNLRLPLPPISDR--RFSTSSSSATTTTVAGCNG----ISACDLEKLNVLG 54

Query:    61 HGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEK 120
              GNGG VYKV+H+ T +IYALK V+GD DP   RQ+ REMEILRRTDSP++V+C GIFEK
Sbjct:    55 CGNGGIVYKVRHKTTSEIYALKTVNGDMDPIFTRQLMREMEILRRTDSPYVVKCHGIFEK 114

Query:   121 PS-GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPS 179
             P  G+++ILMEYMD GTL++L    G  +E KLA  A QILKGLSYLH  KI+HRDIKP+
Sbjct:   115 PVVGEVSILMEYMDGGTLESL---RGGVTEQKLAGFAKQILKGLSYLHALKIVHRDIKPA 171

Query:   180 NLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXXXXXDI 239
             NLL+N+ N +VKIADFGVSKI+ RSLD+CNSYVGTCAYMSPERFD +           DI
Sbjct:   172 NLLLNSKN-EVKIADFGVSKILVRSLDSCNSYVGTCAYMSPERFDSESSGGSSDIYAGDI 230

Query:   240 WSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKE 299
             WS          GHFP L PGQRPDWATLMCA+CFG+PP  P+G S EFRSF+ECCL+K+
Sbjct:   231 WSFGLMMLELLVGHFPLLPPGQRPDWATLMCAVCFGEPPRAPEGCSEEFRSFVECCLRKD 290

Query:   300 FSKRWTASQLLTHPFL 315
              SKRWTA QLL HPFL
Sbjct:   291 SSKRWTAPQLLAHPFL 306

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005739 "mitochondrion" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=IDA;TAS

GO:0009611 "response to wounding" evidence=IEP

GO:0009873 "ethylene mediated signaling pathway" evidence=IMP

GO:0009651 "response to salt stress" evidence=IMP

GO:0009693 "ethylene biosynthetic process" evidence=RCA;IDA

GO:0010120 "camalexin biosynthetic process" evidence=IDA

GO:0030295 "protein kinase activator activity" evidence=IDA

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=IEP

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0006569 "tryptophan catabolic process" evidence=RCA

GO:0009684 "indoleacetic acid biosynthetic process" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0019344 "cysteine biosynthetic process" evidence=RCA

TAIR|locus:2014099 MKK7 "MAP kinase kinase 7" [Arabidopsis thaliana (taxid:3702)]

 Score = 916 (327.5 bits), Expect = 6.3e-92, P = 6.3e-92
 Identities = 184/316 (58%), Positives = 220/316 (69%)

Query:     1 MAVVKQRRQLNLRLPMPELSERCLRFXXXXXXXXXXXXXXXXXXXXXIAYSDLEKLQVLG 60
             MA+V++RRQ+NLRLP+P LS     F                     I+ SD+EKL VLG
Sbjct:     1 MALVRKRRQINLRLPVPPLSVHLPWFSFASSTAPVINNG--------ISASDVEKLHVLG 52

Query:    61 HGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEK 120
              G+ G VYKV H+ T +IYALK V+GD  P   RQ+ REMEILRRTDSP++V+C GIFEK
Sbjct:    53 RGSSGIVYKVHHKTTGEIYALKSVNGDMSPAFTRQLAREMEILRRTDSPYVVRCQGIFEK 112

Query:   121 PS-GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPS 179
             P  G+++ILMEYMD G L++L    G  +E +LA  + QILKGLSYLH  KI+HRDIKP+
Sbjct:   113 PIVGEVSILMEYMDGGNLESL---RGAVTEKQLAGFSRQILKGLSYLHSLKIVHRDIKPA 169

Query:   180 NLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXXXXXDI 239
             NLL+N+ N +VKIADFGVSKI+ RSLD CNSYVGTCAYMSPERFD             DI
Sbjct:   170 NLLLNSRN-EVKIADFGVSKIITRSLDYCNSYVGTCAYMSPERFD-SAAGENSDVYAGDI 227

Query:   240 WSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKE 299
             WS          GHFP L  GQRPDWATLMC +CFG+PP  P+G S EFRSF++CCL+KE
Sbjct:   228 WSFGVMILELFVGHFPLLPQGQRPDWATLMCVVCFGEPPRAPEGCSDEFRSFVDCCLRKE 287

Query:   300 FSKRWTASQLLTHPFL 315
              S+RWTASQLL HPFL
Sbjct:   288 SSERWTASQLLGHPFL 303

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=TAS

GO:0009926 "auxin polar transport" evidence=IMP

GO:0002229 "defense response to oomycetes" evidence=IMP

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=IMP

GO:0042742 "defense response to bacterium" evidence=IMP

TAIR|locus:2017662 MKK4 "mitogen-activated protein kinase kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 671 (241.3 bits), Expect = 5.8e-66, P = 5.8e-66
 Identities = 136/269 (50%), Positives = 179/269 (66%)

Query:    50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSP 109
             YSDL +   +G G GGTVYKV HR + ++YALKV++G+ + TVRRQ+ RE+EILR  + P
Sbjct:    76 YSDLVRGNRIGSGAGGTVYKVIHRPSSRLYALKVIYGNHEETVRRQICREIEILRDVNHP 135

Query:   110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
              +V+C  +F++ +G+I +L+E+MD G+L+        + E +LA ++ QIL GL+YLH  
Sbjct:   136 NVVKCHEMFDQ-NGEIQVLLEFMDKGSLEGA----HVWKEQQLADLSRQILSGLAYLHSR 190

Query:   170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
              I+HRDIKPSNLL+N+    VKIADFGVS+I+ +++D CNS VGT AYMSPER + D   
Sbjct:   191 HIVHRDIKPSNLLINSAK-NVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNQ 249

Query:   230 XXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRP-DWATLMCAICFGDPPSLPDGASPEF 288
                     DIWS          G FPF  P  R  DWA+LMCAIC   PP  P  ASPEF
Sbjct:   250 GKYDGYAGDIWSLGVSILEFYLGRFPF--PVSRQGDWASLMCAICMSQPPEAPATASPEF 307

Query:   289 RSFIECCLQKEFSKRWTASQLLTHPFLCK 317
             R FI CCLQ+E  KR +A QLL HPF+ +
Sbjct:   308 RHFISCCLQREPGKRRSAMQLLQHPFILR 336

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009814 "defense response, incompatible interaction" evidence=RCA;IMP

GO:0005737 "cytoplasm" evidence=IDA

GO:2000037 "regulation of stomatal complex patterning" evidence=IGI

GO:2000038 "regulation of stomatal complex development" evidence=IGI

GO:0010227 "floral organ abscission" evidence=IMP

GO:0000165 "MAPK cascade" evidence=IC;RCA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0010229 "inflorescence development" evidence=IGI

GO:0004708 "MAP kinase kinase activity" evidence=ISS;IDA

TAIR|locus:2094761 MKK5 "MAP kinase kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 665 (239.2 bits), Expect = 2.5e-65, P = 2.5e-65
 Identities = 132/267 (49%), Positives = 175/267 (65%)

Query:    51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
             S+LE++  +G G GGTVYKV H  T + +ALKV++G+ + TVRRQ+ RE+EILR  D P 
Sbjct:    68 SELERVNRIGSGAGGTVYKVIHTPTSRPFALKVIYGNHEDTVRRQICREIEILRSVDHPN 127

Query:   111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
             +V+C  +F+  +G+I +L+E+MD G+L+        + E +LA ++ QIL GL+YLH   
Sbjct:   128 VVKCHDMFDH-NGEIQVLLEFMDQGSLEGA----HIWQEQELADLSRQILSGLAYLHRRH 182

Query:   171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
             I+HRDIKPSNLL+N+    VKIADFGVS+I+ +++D CNS VGT AYMSPER + D    
Sbjct:   183 IVHRDIKPSNLLINSAK-NVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHG 241

Query:   231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                    D+WS          G FPF    Q  DWA+LMCAIC   PP  P  AS EFR 
Sbjct:   242 RYDGYAGDVWSLGVSILEFYLGRFPFAVSRQG-DWASLMCAICMSQPPEAPATASQEFRH 300

Query:   291 FIECCLQKEFSKRWTASQLLTHPFLCK 317
             F+ CCLQ +  KRW+A QLL HPF+ K
Sbjct:   301 FVSCCLQSDPPKRWSAQQLLQHPFILK 327

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005739 "mitochondrion" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009814 "defense response, incompatible interaction" evidence=IMP

GO:2000037 "regulation of stomatal complex patterning" evidence=IGI

GO:0010227 "floral organ abscission" evidence=IMP

GO:0015824 "proline transport" evidence=RCA

GO:0010229 "inflorescence development" evidence=IGI

GO:0004708 "MAP kinase kinase activity" evidence=ISS

TAIR|locus:2082390 MKK8 "MAP kinase kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 610 (219.8 bits), Expect = 1.7e-59, P = 1.7e-59
 Identities = 133/310 (42%), Positives = 191/310 (61%)

Query:     1 MAVVKQRRQLNLRL-PM--PELSERCLRFXXXXXXXXXXXXXXXXXXXXXIAYSDLEKLQ 57
             M +V+  + LNL+L P+  P     C RF                     +A  +L+++ 
Sbjct:     1 MVMVRDNQFLNLKLSPIQAPTTIPPC-RFPIIPATKVSATVSSCASNTFSVA--NLDRIS 57

Query:    58 VLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGI 117
             VLG GNGGTV+KV+ + T +IYALK V  + D T      RE+EILR  +SP++ +C  I
Sbjct:    58 VLGSGNGGTVFKVKDKTTSEIYALKKVKENWDSTS----LREIEILRMVNSPYVAKCHDI 113

Query:   118 FEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIK 177
             F+ PSG+++ILM+YMD G+L++L    G  +E +LA ++ Q+L+G +YLH HKI+HRDIK
Sbjct:   114 FQNPSGEVSILMDYMDLGSLESL---RGV-TEKQLALMSRQVLEGKNYLHEHKIVHRDIK 169

Query:   178 PSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXX----XX 233
             P+NLL  ++  +VKIADFGVSKI+ RSL+ CNS+VGT AYMSPER D +           
Sbjct:   170 PANLL-RSSKEEVKIADFGVSKIVVRSLNKCNSFVGTFAYMSPERLDSEADGVTEEDKSN 228

Query:   234 XXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIE 293
                 DIWS          G++P L     PD A ++CA+CFG+PP  P+  S + +SF++
Sbjct:   229 VYAGDIWSFGLTMLEILVGYYPML-----PDQAAIVCAVCFGEPPKAPEECSDDLKSFMD 283

Query:   294 CCLQKEFSKR 303
             CCL+K+ S+R
Sbjct:   284 CCLRKKASER 293

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=TAS

TAIR|locus:2028301 MKK10 "MAP kinase kinase 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 550 (198.7 bits), Expect = 3.8e-53, P = 3.8e-53
 Identities = 129/321 (40%), Positives = 174/321 (54%)

Query:     1 MAVVKQRR-QLNLRLPMPELSERCLRFXXXXXXXXXXXXXXXXXXXXXIAYSDLEKLQVL 59
             M +V++RR Q  L L +P L      F                        +DLEKL VL
Sbjct:     1 MTLVRERRHQEPLTLSIPPLIYHGTAFSVASSSSSSPETSPIQTL------NDLEKLSVL 54

Query:    60 GHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFE 119
             G G+GGTVYK +HR T  +YALKV+     P +   V  E +IL+R +S FI++C+ +F 
Sbjct:    55 GQGSGGTVYKTRHRRTKTLYALKVLR----PNLNTTVTVEADILKRIESSFIIKCYAVFV 110

Query:   120 KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPS 179
                 D+  +ME M+ G+L   L     FSEP ++ +A++IL+GL YL    I+H DIKPS
Sbjct:   111 SLY-DLCFVMELMEKGSLHDALLAQQVFSEPMVSSLANRILQGLRYLQKMGIVHGDIKPS 169

Query:   180 NLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDX-XXXXXXXXXXD 238
             NLL+N    +VKIADFG S+I+       N   GTCAYMSPER D +            D
Sbjct:   170 NLLINKKG-EVKIADFGASRIVAGGDYGSN---GTCAYMSPERVDLEKWGFGGEVGFAGD 225

Query:   239 IWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQK 298
             +WS          G +P  + G +PDWATL CAIC  +   +P   S EFR F+  CL+K
Sbjct:   226 VWSLGVVVLECYIGRYPLTKVGDKPDWATLFCAICCNEKVDIPVSCSLEFRDFVGRCLEK 285

Query:   299 EFSKRWTASQLLTHPFLCKNR 319
             ++ KR T  +LL H F+ KNR
Sbjct:   286 DWRKRDTVEELLRHSFV-KNR 305

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=TAS

UNIPROTKB|Q5ZIF0 MAP2K1 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 419 (152.6 bits), Expect = 1.8e-46, Sum P(2) = 1.8e-46
 Identities = 91/228 (39%), Positives = 130/228 (57%)

Query:    52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
             D EK+  LG GNGG V+KV H+ +  I A K++H +  P +R Q+ RE+++L   +SP+I
Sbjct:    67 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 126

Query:   112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG-HK 170
             V  +G F    G+I+I ME+MD G+LD +L K G   E  L  ++  ++KGL+YL   HK
Sbjct:   127 VGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 185

Query:   171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
             I+HRD+KPSN+LVN+   ++K+ DFGVS  +  S+   NS+VGT +YMSPER        
Sbjct:   186 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQ-----G 237

Query:   231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPP 278
                    DIWS          G +P   P  +       C +  GD P
Sbjct:   238 THYSVQSDIWSMGLSLVEMAIGRYPIPPPDSKELELMFGCPV-EGDSP 284

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=IEA

GO:0004728 "receptor signaling protein tyrosine phosphatase activity" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0005886 "plasma membrane" evidence=IEA

GO:0007050 "cell cycle arrest" evidence=IEA

GO:0008285 "negative regulation of cell proliferation" evidence=IEA

GO:0030182 "neuron differentiation" evidence=IEA

GO:0030216 "keratinocyte differentiation" evidence=IEA

GO:0043539 "protein serine/threonine kinase activator activity" evidence=IEA

GO:0045597 "positive regulation of cell differentiation" evidence=IEA

GO:0048870 "cell motility" evidence=IEA

GO:0060674 "placenta blood vessel development" evidence=IEA

GO:0060711 "labyrinthine layer development" evidence=IEA

GO:0090398 "cellular senescence" evidence=IEA

UNIPROTKB|Q0VD16 MAP2K1 "MAP2K1 protein" [Bos taurus (taxid:9913)]

 Score = 415 (151.1 bits), Expect = 6.0e-46, Sum P(2) = 6.0e-46
 Identities = 90/231 (38%), Positives = 130/231 (56%)

Query:    52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
             D EK+  LG GNGG V+KV H+ +  + A K++H +  P +R Q+ RE+++L   +SP+I
Sbjct:    67 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 126

Query:   112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG-HK 170
             V  +G F    G+I+I ME+MD G+LD +L K G   E  L  ++  ++KGL+YL   HK
Sbjct:   127 VGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 185

Query:   171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
             I+HRD+KPSN+LVN+   ++K+ DFGVS  +  S+   NS+VGT +YMSPER        
Sbjct:   186 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQ-----G 237

Query:   231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLP 281
                    DIWS          G +P   P  +       C +  GD    P
Sbjct:   238 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV-EGDAAETP 287

GO:0090398 "cellular senescence" evidence=IEA

GO:0060711 "labyrinthine layer development" evidence=IEA

GO:0060674 "placenta blood vessel development" evidence=IEA

GO:0048870 "cell motility" evidence=IEA

GO:0045597 "positive regulation of cell differentiation" evidence=IEA

GO:0043539 "protein serine/threonine kinase activator activity" evidence=IEA

GO:0030216 "keratinocyte differentiation" evidence=IEA

GO:0030182 "neuron differentiation" evidence=IEA

GO:0008285 "negative regulation of cell proliferation" evidence=IEA

GO:0007050 "cell cycle arrest" evidence=IEA

GO:0005886 "plasma membrane" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0004728 "receptor signaling protein tyrosine phosphatase activity" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|Q02750 MAP2K1 "Dual specificity mitogen-activated protein kinase kinase 1" [Homo sapiens (taxid:9606)]

 Score = 415 (151.1 bits), Expect = 6.0e-46, Sum P(2) = 6.0e-46
 Identities = 90/231 (38%), Positives = 130/231 (56%)

Query:    52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
             D EK+  LG GNGG V+KV H+ +  + A K++H +  P +R Q+ RE+++L   +SP+I
Sbjct:    67 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 126

Query:   112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG-HK 170
             V  +G F    G+I+I ME+MD G+LD +L K G   E  L  ++  ++KGL+YL   HK
Sbjct:   127 VGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 185

Query:   171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
             I+HRD+KPSN+LVN+   ++K+ DFGVS  +  S+   NS+VGT +YMSPER        
Sbjct:   186 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQ-----G 237

Query:   231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLP 281
                    DIWS          G +P   P  +       C +  GD    P
Sbjct:   238 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV-EGDAAETP 287

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0003056 "regulation of vascular smooth muscle contraction" evidence=IEA

GO:0004728 "receptor signaling protein tyrosine phosphatase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005938 "cell cortex" evidence=IEA

GO:0006979 "response to oxidative stress" evidence=IEA

GO:0007067 "mitosis" evidence=IEA

GO:0008283 "cell proliferation" evidence=IEA

GO:0017016 "Ras GTPase binding" evidence=IEA

GO:0030216 "keratinocyte differentiation" evidence=IEA

GO:0030335 "positive regulation of cell migration" evidence=IEA

GO:0031435 "mitogen-activated protein kinase kinase kinase binding" evidence=IEA

GO:0032320 "positive regulation of Ras GTPase activity" evidence=IEA

GO:0032402 "melanosome transport" evidence=IEA

GO:0032839 "dendrite cytoplasm" evidence=IEA

GO:0032968 "positive regulation of transcription elongation from RNA polymerase II promoter" evidence=IEA

GO:0033267 "axon part" evidence=IEA

GO:0034111 "negative regulation of homotypic cell-cell adhesion" evidence=IEA

GO:0043204 "perikaryon" evidence=IEA

GO:0045597 "positive regulation of cell differentiation" evidence=IEA

GO:0046579 "positive regulation of Ras protein signal transduction" evidence=IEA

GO:0047496 "vesicle transport along microtubule" evidence=IEA

GO:0048313 "Golgi inheritance" evidence=IEA

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0048678 "response to axon injury" evidence=IEA

GO:0048870 "cell motility" evidence=IEA

GO:0051291 "protein heterooligomerization" evidence=IEA

GO:0051384 "response to glucocorticoid stimulus" evidence=IEA

GO:0060674 "placenta blood vessel development" evidence=IEA

GO:0060711 "labyrinthine layer development" evidence=IEA

GO:0005816 "spindle pole body" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005829 "cytosol" evidence=TAS

GO:0005634 "nucleus" evidence=TAS

GO:0000187 "activation of MAPK activity" evidence=TAS

GO:0032872 "regulation of stress-activated MAPK cascade" evidence=TAS

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=TAS

GO:0005769 "early endosome" evidence=TAS

GO:0005770 "late endosome" evidence=TAS

GO:2000641 "regulation of early endosome to late endosome transport" evidence=TAS

GO:0005794 "Golgi apparatus" evidence=TAS

GO:0090170 "regulation of Golgi inheritance" evidence=TAS

GO:0005739 "mitochondrion" evidence=TAS

GO:0005925 "focal adhesion" evidence=TAS

GO:0071902 "positive regulation of protein serine/threonine kinase activity" evidence=IDA

GO:0004708 "MAP kinase kinase activity" evidence=IDA

GO:0043539 "protein serine/threonine kinase activator activity" evidence=IDA

GO:0004672 "protein kinase activity" evidence=TAS

GO:0006928 "cellular component movement" evidence=TAS

GO:0006935 "chemotaxis" evidence=TAS

GO:0007165 "signal transduction" evidence=TAS

GO:0000165 "MAPK cascade" evidence=TAS

GO:0000186 "activation of MAPKK activity" evidence=TAS

GO:0002224 "toll-like receptor signaling pathway" evidence=TAS

GO:0002755 "MyD88-dependent toll-like receptor signaling pathway" evidence=TAS

GO:0002756 "MyD88-independent toll-like receptor signaling pathway" evidence=TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=TAS

GO:0007173 "epidermal growth factor receptor signaling pathway" evidence=TAS

GO:0007264 "small GTPase mediated signal transduction" evidence=TAS

GO:0007265 "Ras protein signal transduction" evidence=TAS

GO:0007411 "axon guidance" evidence=TAS

GO:0008063 "Toll signaling pathway" evidence=TAS

GO:0008286 "insulin receptor signaling pathway" evidence=TAS

GO:0008543 "fibroblast growth factor receptor signaling pathway" evidence=TAS

GO:0034130 "toll-like receptor 1 signaling pathway" evidence=TAS

GO:0034134 "toll-like receptor 2 signaling pathway" evidence=TAS

GO:0034138 "toll-like receptor 3 signaling pathway" evidence=TAS

GO:0034142 "toll-like receptor 4 signaling pathway" evidence=TAS

GO:0035666 "TRIF-dependent toll-like receptor signaling pathway" evidence=TAS

GO:0045087 "innate immune response" evidence=TAS

GO:0048011 "neurotrophin TRK receptor signaling pathway" evidence=TAS

GO:0051403 "stress-activated MAPK cascade" evidence=TAS

GO:0007050 "cell cycle arrest" evidence=IMP

GO:0008285 "negative regulation of cell proliferation" evidence=IDA

GO:0090398 "cellular senescence" evidence=IMP

GO:0005737 "cytoplasm" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

RGD|70495 Map2k1 "mitogen activated protein kinase kinase 1" [Rattus norvegicus (taxid:10116)]

 Score = 415 (151.1 bits), Expect = 6.0e-46, Sum P(2) = 6.0e-46
 Identities = 90/231 (38%), Positives = 130/231 (56%)

Query:    52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
             D EK+  LG GNGG V+KV H+ +  + A K++H +  P +R Q+ RE+++L   +SP+I
Sbjct:    67 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 126

Query:   112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG-HK 170
             V  +G F    G+I+I ME+MD G+LD +L K G   E  L  ++  ++KGL+YL   HK
Sbjct:   127 VGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 185

Query:   171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
             I+HRD+KPSN+LVN+   ++K+ DFGVS  +  S+   NS+VGT +YMSPER        
Sbjct:   186 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQ-----G 237

Query:   231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLP 281
                    DIWS          G +P   P  +       C +  GD    P
Sbjct:   238 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELLFGCQV-EGDAAETP 287

GO:0000165 "MAPK cascade" evidence=IMP

GO:0000187 "activation of MAPK activity" evidence=ISO;IDA;TAS

GO:0003056 "regulation of vascular smooth muscle contraction" evidence=IMP

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=ISO;IMP;IDA;TAS

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=TAS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0004728 "receptor signaling protein tyrosine phosphatase activity" evidence=IEA;ISO

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IDA

GO:0005634 "nucleus" evidence=TAS

GO:0005737 "cytoplasm" evidence=ISO

GO:0005739 "mitochondrion" evidence=TAS

GO:0005769 "early endosome" evidence=TAS

GO:0005770 "late endosome" evidence=TAS

GO:0005794 "Golgi apparatus" evidence=IDA;TAS

GO:0005816 "spindle pole body" evidence=IEA

GO:0005829 "cytosol" evidence=IDA;TAS

GO:0005886 "plasma membrane" evidence=ISO;IDA

GO:0005925 "focal adhesion" evidence=TAS

GO:0005938 "cell cortex" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=ISO;IDA;TAS

GO:0006979 "response to oxidative stress" evidence=IDA

GO:0007050 "cell cycle arrest" evidence=IEA;ISO

GO:0007067 "mitosis" evidence=IDA

GO:0007243 "intracellular protein kinase cascade" evidence=TAS

GO:0008283 "cell proliferation" evidence=IDA

GO:0008285 "negative regulation of cell proliferation" evidence=IEA;ISO

GO:0017016 "Ras GTPase binding" evidence=IPI

GO:0019901 "protein kinase binding" evidence=IPI

GO:0030182 "neuron differentiation" evidence=ISO;IMP

GO:0030216 "keratinocyte differentiation" evidence=IEA;ISO

GO:0030335 "positive regulation of cell migration" evidence=IMP

GO:0030425 "dendrite" evidence=IDA

GO:0031435 "mitogen-activated protein kinase kinase kinase binding" evidence=IDA;IPI

GO:0032320 "positive regulation of Ras GTPase activity" evidence=IMP

GO:0032402 "melanosome transport" evidence=IDA

GO:0032839 "dendrite cytoplasm" evidence=IDA

GO:0032872 "regulation of stress-activated MAPK cascade" evidence=TAS

GO:0032968 "positive regulation of transcription elongation from RNA polymerase II promoter" evidence=IMP

GO:0033267 "axon part" evidence=IDA

GO:0034111 "negative regulation of homotypic cell-cell adhesion" evidence=IMP

GO:0043204 "perikaryon" evidence=IDA

GO:0043539 "protein serine/threonine kinase activator activity" evidence=IEA;ISO

GO:0045597 "positive regulation of cell differentiation" evidence=IEA;ISO

GO:0046579 "positive regulation of Ras protein signal transduction" evidence=IMP

GO:0047496 "vesicle transport along microtubule" evidence=IDA

GO:0048313 "Golgi inheritance" evidence=IMP

GO:0048471 "perinuclear region of cytoplasm" evidence=IDA

GO:0048678 "response to axon injury" evidence=IMP

GO:0048812 "neuron projection morphogenesis" evidence=IMP

GO:0048870 "cell motility" evidence=IEA;ISO

GO:0051291 "protein heterooligomerization" evidence=IPI

GO:0051384 "response to glucocorticoid stimulus" evidence=IDA

GO:0060674 "placenta blood vessel development" evidence=IEA;ISO

GO:0060711 "labyrinthine layer development" evidence=IEA;ISO

GO:0071902 "positive regulation of protein serine/threonine kinase activity" evidence=ISO

GO:0090170 "regulation of Golgi inheritance" evidence=TAS

GO:0090398 "cellular senescence" evidence=IEA;ISO

GO:2000641 "regulation of early endosome to late endosome transport" evidence=TAS

GO:0005874 "microtubule" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.12.2	0.914
3rd Layer	2.7.12	0.921
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	323
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-149
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-129
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	7e-95
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-91
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-80
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-79
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-79
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-78
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-78
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-77
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	8e-75
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	8e-72
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-70
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-67
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-66
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-63
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-60
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	8e-60
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	6e-59
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	7e-59
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-58
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-57
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-55
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-55
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-55
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-55
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	8e-55
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	5e-54
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-52
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	8e-52
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-49
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-49
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-48
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-44
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	5e-44
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	6e-44
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-43
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-43
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	9e-43
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-42
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-42
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-41
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-41
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-41
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-41
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	6e-41
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-41
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	7e-41
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-40
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	5e-40
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-39
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-39
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-39
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	7e-39
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	9e-39
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-38
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-38
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-38
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-38
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	9e-38
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-37
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-36
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-35
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-35
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	4e-35
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-35
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	6e-35
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-34
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-34
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-33
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-33
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-33
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-33
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-33
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-33
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	8e-33
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-32
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-32
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-32
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-32
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-31
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-31
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-31
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-31
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-30
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-30
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-30
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-30
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-30
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-30
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-30
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	6e-30
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	7e-30
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-29
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-29
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-29
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-29
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-28
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-28
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-28
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	7e-28
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	8e-28
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-27
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-27
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-27
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-27
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-27
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-27
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-26
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-26
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-26
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-26
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-26
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-26
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-26
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-26
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-26
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	7e-26
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	7e-26
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	7e-26
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	8e-26
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-25
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-25
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-25
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-25
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-25
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-25
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-25
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-25
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-25
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-25
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	7e-25
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-24
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-24
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-24
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-24
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-24
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	6e-24
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	7e-24
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	7e-24
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	9e-24
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	9e-24
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-23
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-23
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-23
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-23
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-23
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-23
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	8e-23
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-22
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-22
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-22
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-22
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	6e-22
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	7e-22
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-21
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-21
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-21
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-21
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-21
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-21
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-21
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-21
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-21
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	6e-21
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	7e-21
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	7e-21
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	7e-21
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-20
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-20
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-20
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-20
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-20
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-20
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-20
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	5e-20
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	6e-20
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	8e-20
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	9e-20
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-19
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-19
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-19
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-19
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-19
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-19
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-19
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-19
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-19
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-19
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	5e-19
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	6e-19
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-18
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-18
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-18
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	4e-18
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-18
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	6e-18
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	8e-18
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	9e-18
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-17
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-17
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-17
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-17
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-17
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-17
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-17
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	4e-17
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	5e-17
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-17
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-17
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	8e-17
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	9e-17
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-16
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-16
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-16
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	4e-16
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-16
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-16
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-16
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	6e-16
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-15
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-15
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-15
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-15
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-15
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-15
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-15
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-15
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-15
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-15
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-15
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-15
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-15
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	9e-15
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-14
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-14
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-14
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-14
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-14
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-14
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-14
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-14
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-14
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-14
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	4e-14
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	6e-14
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	8e-14
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-13
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-13
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-13
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-13
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-13
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-13
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	7e-13
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	8e-13
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	9e-13
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	9e-13
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-12
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-12
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-12
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-12
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-12
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-12
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	6e-12
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	6e-12
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	7e-12
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-11
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-11
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-11
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-11
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	8e-11
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-10
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-10
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-10
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-10
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-10
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	5e-10
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	6e-10
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	7e-10
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	8e-10
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	8e-10
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	8e-10
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-09
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-09
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-09
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	5e-09
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	6e-09
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-08
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	3e-08
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	3e-08
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	9e-08
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	2e-07
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-07
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	4e-07
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-07
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	9e-07
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	3e-06
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	3e-06
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	4e-06
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	5e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	5e-06
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	1e-05
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-04
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	0.002
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	0.002

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  420 bits (1083), Expect = e-149
 Identities = 154/267 (57%), Positives = 193/267 (72%), Gaps = 10/267 (3%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           SDLE+++VLG G+ G VYKV+H+ T KIYALK +H D D   R+Q+ RE++ LR  +SP+
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60

Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG-H 169
           +V+C+G F K  G+I+I++EYMD G+L  LL K G   EP LA+IA QILKGL YLH   
Sbjct: 61  VVKCYGAFYKE-GEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR 119

Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYG 229
            IIHRDIKPSNLL+ N+  +VKIADFG+SK++  +LD CN++VGT  YMSPER   ++Y 
Sbjct: 120 HIIHRDIKPSNLLI-NSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESY- 177

Query: 230 GNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDG-ASPEF 288
                YA DIWSLGLTLLE  LG FPFL PGQ P +  LM AIC G PPSLP    SPEF
Sbjct: 178 ----SYAADIWSLGLTLLECALGKFPFLPPGQ-PSFFELMQAICDGPPPSLPAEEFSPEF 232

Query: 289 RSFIECCLQKEFSKRWTASQLLTHPFL 315
           R FI  CLQK+  KR +A++LL HPF+
Sbjct: 233 RDFISACLQKDPKKRPSAAELLQHPFI 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  372 bits (956), Expect = e-129
 Identities = 164/323 (50%), Positives = 226/323 (69%), Gaps = 18/323 (5%)

Query: 7   RRQLNLRLPMPELSERCLRFPLALPPTAP------NTNNNTTATTAAIAYSDLEKLQVLG 60
           RR+ +L LP+P+  +  L  PL LPP +       +++ + +A +AA + S+LE++  +G
Sbjct: 25  RRRPDLTLPLPQ-RDPSLAVPLPLPPPSSSSSSSSSSSASGSAPSAAKSLSELERVNRIG 83

Query: 61  HGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEK 120
            G GGTVYKV HR T ++YALKV++G+ + TVRRQ+ RE+EILR  + P +V+C  +F+ 
Sbjct: 84  SGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH 143

Query: 121 PSGDIAILMEYMDSGTLDTLLNKNGT--FSEPKLAHIASQILKGLSYLHGHKIIHRDIKP 178
            +G+I +L+E+MD G+L+      GT    E  LA +A QIL G++YLH   I+HRDIKP
Sbjct: 144 -NGEIQVLLEFMDGGSLE------GTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKP 196

Query: 179 SNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGD 238
           SNLL+N+    VKIADFGVS+I+ +++D CNS VGT AYMSPER + D   G Y+GYAGD
Sbjct: 197 SNLLINSAK-NVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGD 255

Query: 239 IWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQK 298
           IWSLG+++LE YLG FPF   G++ DWA+LMCAIC   PP  P  AS EFR FI CCLQ+
Sbjct: 256 IWSLGVSILEFYLGRFPF-GVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQR 314

Query: 299 EFSKRWTASQLLTHPFLCKNRRS 321
           E +KRW+A QLL HPF+ + +  
Sbjct: 315 EPAKRWSAMQLLQHPFILRAQPG 337

Length = 353

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  281 bits (722), Expect = 7e-95
 Identities = 123/271 (45%), Positives = 167/271 (61%), Gaps = 13/271 (4%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
            DLE L  LG GN G V KV HR T KI A+K +  + +  +++Q+ RE++IL + +SP+
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60

Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLH-G 168
           IV  +G F   +GDI+I MEYMD G+LD +L +  G   E  L  IA  +LKGL+YLH  
Sbjct: 61  IVGFYGAFYN-NGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119

Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAY 228
           HKIIHRD+KPSN+LVN+   Q+K+ DFGVS  +  SL    ++VGT +YM+PER   + Y
Sbjct: 120 HKIIHRDVKPSNILVNSRG-QIKLCDFGVSGQLVNSL--AKTFVGTSSYMAPERIQGNDY 176

Query: 229 GGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWA-TLMCAICFGDPPSLPDGA-SP 286
                    DIWSLGL+L+EL  G FP+      PD    L+  I    PP LP G  SP
Sbjct: 177 -----SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSP 231

Query: 287 EFRSFIECCLQKEFSKRWTASQLLTHPFLCK 317
           +F+ F+  CL K+  +R +  +LL HPF+ K
Sbjct: 232 DFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  271 bits (695), Expect = 5e-91
 Identities = 98/264 (37%), Positives = 138/264 (52%), Gaps = 13/264 (4%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           E L+ LG G+ G VY  + + T K+ A+KV+        R ++ RE++IL++   P IV+
Sbjct: 2   EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVR 61

Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
            + +FE     + ++MEY + G L  LL K G  SE +      QIL  L YLH   I+H
Sbjct: 62  LYDVFEDE-DKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVH 120

Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYN 233
           RD+KP N+L++ +   VK+ADFG+++ +    +   ++VGT  YM+PE      Y     
Sbjct: 121 RDLKPENILLDEDG-HVKLADFGLARQL-DPGEKLTTFVGTPEYMAPEVLLGKGY----- 173

Query: 234 GYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPD--GASPEFRSF 291
           G A DIWSLG+ L EL  G  PF  PG       L   I    PP  P     SPE +  
Sbjct: 174 GKAVDIWSLGVILYELLTGKPPF--PG-DDQLLELFKKIGKPKPPFPPPEWDISPEAKDL 230

Query: 292 IECCLQKEFSKRWTASQLLTHPFL 315
           I   L K+  KR TA + L HPF 
Sbjct: 231 IRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  244 bits (625), Expect = 5e-80
 Identities = 111/275 (40%), Positives = 156/275 (56%), Gaps = 20/275 (7%)

Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           + +L  LG G GG+V K + + T  I+ALK +  D +P +++Q+ RE+EI +   SP+IV
Sbjct: 3   IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIV 62

Query: 113 QCFGIF-EKPSGDIAILMEYMDSGTLDTL----LNKNGTFSEPKLAHIASQILKGLSYLH 167
           + +G F ++ S  I I MEY + G+LD++      + G   E  L  IA  +LKGLSYLH
Sbjct: 63  KYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH 122

Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDA 227
             KIIHRDIKPSN+L+     QVK+ DFGVS  +  SL    ++ GT  YM+PER     
Sbjct: 123 SRKIIHRDIKPSNILLTRKG-QVKLCDFGVSGELVNSLAG--TFTGTSFYMAPERIQ--- 176

Query: 228 YGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPG-QRPDWATLMCAICFGDPPSLPDGA-- 284
            G  Y+    D+WSLGLTLLE+    FPF   G        L+  I     P L D    
Sbjct: 177 -GKPYS-ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234

Query: 285 ----SPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
               S EF+ FI+ CL+K+ ++R T   +L HP++
Sbjct: 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  242 bits (621), Expect = 1e-79
 Identities = 92/269 (34%), Positives = 145/269 (53%), Gaps = 14/269 (5%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTDSPF 110
           +  + ++LG G+ G+VY    + T ++ A+K V            + RE+ IL     P 
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 111 IVQCFGIFEKPSGD-IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           IV+ +G       + + I +EY+  G+L +LL K G   EP +     QIL+GL+YLH +
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN 120

Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS--LDACNSYVGTCAYMSPERFDPDA 227
            I+HRDIK +N+LV+++   VK+ADFG +K +      +   S  GT  +M+PE    + 
Sbjct: 121 GIVHRDIKGANILVDSDG-VVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179

Query: 228 YGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAI-CFGDPPSLPDGASP 286
           Y     G A DIWSLG T++E+  G  P+    +  +    +  I   G+PP +P+  S 
Sbjct: 180 Y-----GRAADIWSLGCTVIEMATGKPPW---SELGNPMAALYKIGSSGEPPEIPEHLSE 231

Query: 287 EFRSFIECCLQKEFSKRWTASQLLTHPFL 315
           E + F+  CL+++  KR TA +LL HPFL
Sbjct: 232 EAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score =  243 bits (623), Expect = 2e-79
 Identities = 116/301 (38%), Positives = 166/301 (55%), Gaps = 43/301 (14%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
            D EKL  LG GNGG V KV HR +  I A K++H +  P +R Q+ RE+++L   +SP+
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60

Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG-H 169
           IV  +G F    G+I+I ME+MD G+LD +L K G   E  L  I+  +L+GL+YL   H
Sbjct: 61  IVGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH 119

Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYG 229
           KI+HRD+KPSN+LVN+   ++K+ DFGVS  +  S+   NS+VGT +YMSPER       
Sbjct: 120 KIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQ----- 171

Query: 230 GNYNGYAGDIWSLGLTLLELYLGHFP---------------FLQPGQRPDWAT------- 267
           G +     DIWSLGL+L+E+ +G +P                +  G+  +          
Sbjct: 172 GTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231

Query: 268 ----------LMCAICFGDPPSLPDGA-SPEFRSFIECCLQKEFSKRWTASQLLTHPFLC 316
                     L+  I    PP LP GA S EF+ F++ CL+K   +R    +L  HPF+ 
Sbjct: 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK 291

Query: 317 K 317
           +
Sbjct: 292 R 292

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  240 bits (614), Expect = 1e-78
 Identities = 104/267 (38%), Positives = 144/267 (53%), Gaps = 11/267 (4%)

Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHG-DADPTVRRQVFREMEILRRTDSPFI 111
            E L+ LG G+ GTVYK +H+ T KI A+K++          +   RE+ ILRR   P I
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
           V+    FE     + ++MEY + G L   L++ G  SE +   IA QIL+GL YLH + I
Sbjct: 61  VRLIDAFEDKD-HLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119

Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGN 231
           IHRD+KP N+L+ + N  VKIADFG++K + +S  +  ++VGT  YM+PE       GGN
Sbjct: 120 IHRDLKPENILL-DENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVL----LGGN 174

Query: 232 YNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPS---LPDGASPEF 288
             G   D+WSLG+ L EL  G  PF       D   L+  I               S E 
Sbjct: 175 GYGPKVDVWSLGVILYELLTGKPPF-SGENILDQLQLIRRILGPPLEFDEPKWSSGSEEA 233

Query: 289 RSFIECCLQKEFSKRWTASQLLTHPFL 315
           +  I+ CL K+ SKR TA ++L HP+ 
Sbjct: 234 KDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  239 bits (613), Expect = 1e-78
 Identities = 99/266 (37%), Positives = 150/266 (56%), Gaps = 16/266 (6%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
             E L+ +G G  G VYK +H+ T K  A+KV+        + ++  E++IL++   P I
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK-LESKEKKEKIINEIQILKKCKHPNI 59

Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLN-KNGTFSEPKLAHIASQILKGLSYLHGHK 170
           V+ +G + K   ++ I+ME+   G+L  LL   N T +E ++A++  ++LKGL YLH + 
Sbjct: 60  VKYYGSYLKK-DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG 118

Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGG 230
           IIHRDIK +N+L+ ++  +VK+ DFG+S  +  +    N+ VGT  +M+PE  +   Y  
Sbjct: 119 IIHRDIKAANILLTSDG-EVKLIDFGLSAQLSDTKA-RNTMVGTPYWMAPEVINGKPY-- 174

Query: 231 NYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDG--ASPEF 288
               Y  DIWSLG+T +EL  G  P+ +    P  A    A     PP L +    S EF
Sbjct: 175 ---DYKADIWSLGITAIELAEGKPPYSELP--PMKALFKIAT--NGPPGLRNPEKWSDEF 227

Query: 289 RSFIECCLQKEFSKRWTASQLLTHPF 314
           + F++ CLQK   KR TA QLL HPF
Sbjct: 228 KDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  237 bits (606), Expect = 3e-77
 Identities = 116/282 (41%), Positives = 162/282 (57%), Gaps = 19/282 (6%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
            DLE +  LG GNGG+V KV+H  T  + A KVVH  A  +VR+Q+ RE++I+    SP+
Sbjct: 5   EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPY 64

Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG-H 169
           IV  +G F     +I + ME+MD G+LD +  K G      L  IA  +++GL+YL+  H
Sbjct: 65  IVSFYGAFLN-ENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123

Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYG 229
           +I+HRDIKPSN+LVN+   Q+K+ DFGVS  +  S+   +++VGT  YMSPER      G
Sbjct: 124 RIMHRDIKPSNILVNSRG-QIKLCDFGVSGELINSI--ADTFVGTSTYMSPERIQ----G 176

Query: 230 GNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWAT-------LMCAICFGDPPSLPD 282
           G Y     D+WSLG++++EL LG FPF       D          L+  I    PP LP 
Sbjct: 177 GKYT-VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS 235

Query: 283 GASPE-FRSFIECCLQKEFSKRWTASQLL-THPFLCKNRRSD 322
              PE  R F++ CL K+ ++R T  QL    PF+   R S+
Sbjct: 236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASN 277

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  228 bits (584), Expect = 8e-75
 Identities = 90/256 (35%), Positives = 136/256 (53%), Gaps = 42/256 (16%)

Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIF 118
           LG G  GTVY  + + T K  A+K++  +   ++  ++ RE+EIL++ + P IV+ +G+F
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 119 EKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIK 177
           E     + ++MEY + G+L  LL +N G  SE ++  I  QIL+GL YLH + IIHRD+K
Sbjct: 61  EDE-NHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLK 119

Query: 178 PSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAG 237
           P N+L++++N +VK+ADFG+SK++        + VGT AYM+PE       G  Y     
Sbjct: 120 PENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLL----GKGYYSEKS 175

Query: 238 DIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQ 297
           DIWSLG+ L EL                                    PE +  I   LQ
Sbjct: 176 DIWSLGVILYEL------------------------------------PELKDLIRKMLQ 199

Query: 298 KEFSKRWTASQLLTHP 313
           K+  KR +A ++L H 
Sbjct: 200 KDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  223 bits (570), Expect = 8e-72
 Identities = 112/281 (39%), Positives = 158/281 (56%), Gaps = 18/281 (6%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
            ++E L  LG GN G+VYKV HR T    A+K +  + D +   Q+  E++IL +  SP+
Sbjct: 1   DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPY 60

Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLL---NKNGTFSEPKLAHIASQILKGLSYL- 166
           IV  +G F    G + + MEYMD+G+LD L           E  L  I   ++KGL +L 
Sbjct: 61  IVDFYGAFFI-EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK 119

Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPD 226
             H IIHRD+KP+N+LVN N  QVK+ DFGVS  +  SL   N  +G  +YM+PER    
Sbjct: 120 EEHNIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLVASLAKTN--IGCQSYMAPERIK-- 174

Query: 227 AYGGNYNGYA-----GDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLP 281
              G  N         D+WSLGL++LE+ LG +P+  P    +    + AI  GDPP+LP
Sbjct: 175 --SGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY-PPETYANIFAQLSAIVDGDPPTLP 231

Query: 282 DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSD 322
            G S + + F+  CL K  ++R T +QLL HP+L K + +D
Sbjct: 232 SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNAD 272

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  220 bits (562), Expect = 1e-70
 Identities = 113/269 (42%), Positives = 157/269 (58%), Gaps = 19/269 (7%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
           D++  ++LGHGNGGTVYK  H  T +I A+KV+  D    +++Q+  E+EIL + DSP+I
Sbjct: 2   DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYI 61

Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
           +  +G F   +  I+I  E+MD G+LD          E  L  IA  ++KGL+YL   KI
Sbjct: 62  IGFYGAFFVEN-RISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKI 116

Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGN 231
           +HRD+KPSN+LVN    QVK+ DFGVS  +  S+    +YVGT AYM+PER   + Y   
Sbjct: 117 LHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVNSI--AKTYVGTNAYMAPERISGEQY--- 170

Query: 232 YNGYAGDIWSLGLTLLELYLGHFPFLQ----PGQRPDWATLMCAICFGDPPSLPDGA-SP 286
             G   D+WSLG++ +EL LG FP+ Q     G       L C I   DPP LP G  S 
Sbjct: 171 --GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC-IVDEDPPVLPVGQFSE 227

Query: 287 EFRSFIECCLQKEFSKRWTASQLLTHPFL 315
           +F  FI  C++K+  +R     L+ HPF+
Sbjct: 228 KFVHFITQCMRKQPKERPAPENLMDHPFI 256

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  211 bits (540), Expect = 1e-67
 Identities = 103/269 (38%), Positives = 158/269 (58%), Gaps = 21/269 (7%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
             + L+ LG G+ G+VYK  H+ T ++ A+KVV  + D     ++ +E+ IL++ DSP+I
Sbjct: 4   VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ---EIIKEISILKQCDSPYI 60

Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLN-KNGTFSEPKLAHIASQILKGLSYLHGHK 170
           V+ +G + K + D+ I+MEY  +G++  ++   N T +E ++A I  Q LKGL YLH +K
Sbjct: 61  VKYYGSYFK-NTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK 119

Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGG 230
            IHRDIK  N+L+N    Q K+ADFGVS  +  ++   N+ +GT  +M+PE         
Sbjct: 120 KIHRDIKAGNILLNEEG-QAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEI---- 174

Query: 231 NYNGYAGDIWSLGLTLLELYLGHFPF--LQPGQRPDWATLMCAICFGDPPSL--PDGASP 286
            YN  A DIWSLG+T +E+  G  P+  + P         +  I    PP+L  P+  SP
Sbjct: 175 GYNNKA-DIWSLGITAIEMAEGKPPYSDIHP------MRAIFMIPNKPPPTLSDPEKWSP 227

Query: 287 EFRSFIECCLQKEFSKRWTASQLLTHPFL 315
           EF  F++ CL K+  +R +A QLL HPF+
Sbjct: 228 EFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  208 bits (532), Expect = 2e-66
 Identities = 89/267 (33%), Positives = 137/267 (51%), Gaps = 16/267 (5%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTDSPFIV 112
           E ++ +G G+ G VY V+ +   K+Y LK +   +     R     E++IL++ + P I+
Sbjct: 3   EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNII 62

Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNK----NGTFSEPKLAHIASQILKGLSYLHG 168
           + +  FE+  G + I+MEY D G L   + K       F E ++     Q+   L YLH 
Sbjct: 63  KYYESFEEK-GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS 121

Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAY 228
            KI+HRDIKP N+ + +N + VK+ DFG+SK++  ++D   + VGT  Y+SPE      Y
Sbjct: 122 RKILHRDIKPQNIFLTSNGL-VKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPY 180

Query: 229 GGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEF 288
                 Y  DIWSLG  L EL     PF    +  +   L   I  G  P +P   S E 
Sbjct: 181 -----NYKSDIWSLGCVLYELCTLKHPF----EGENLLELALKILKGQYPPIPSQYSSEL 231

Query: 289 RSFIECCLQKEFSKRWTASQLLTHPFL 315
           R+ +   LQK+  +R + +Q+L  PF+
Sbjct: 232 RNLVSSLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  201 bits (514), Expect = 2e-63
 Identities = 94/283 (33%), Positives = 144/283 (50%), Gaps = 33/283 (11%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
                L+ +G G+ G VYK   + T+++ A+KV+  +        + +E++ L +  SP+
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60

Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           I + +G F K S  + I+MEY   G+   LL K G   E  +A I  ++L GL YLH   
Sbjct: 61  ITKYYGSFLKGS-KLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLHEEG 118

Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGG 230
            IHRDIK +N+L++     VK+ADFGVS  +  ++   N++VGT  +M+PE         
Sbjct: 119 KIHRDIKAANILLSEEGD-VKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIK----QS 173

Query: 231 NYNGYAGDIWSLGLTLLELYLGHFP----------FLQPGQRPDWATLMCAICFGDPPSL 280
            Y+  A DIWSLG+T +EL  G  P          FL P                +PPSL
Sbjct: 174 GYDEKA-DIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN--------------NPPSL 218

Query: 281 PDGA-SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSD 322
                S  F+ F+  CL K+  +R +A +LL H F+ K +++ 
Sbjct: 219 EGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKTS 261

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  194 bits (494), Expect = 1e-60
 Identities = 91/271 (33%), Positives = 143/271 (52%), Gaps = 18/271 (6%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTDSPFIV 112
           ++   +G G  G VY   +  T ++ A+K +   D DP   +++  EM++L     P +V
Sbjct: 3   QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62

Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
           + +G+ E     + I MEY   GTL+ LL       E  +     Q+L+GL+YLH H I+
Sbjct: 63  KYYGV-EVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIV 121

Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC----NSYVGTCAYMSPERFDPDAY 228
           HRDIKP+N+ +++N + +K+ DFG +  +  +         S  GT AYM+PE       
Sbjct: 122 HRDIKPANIFLDHNGV-IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT---- 176

Query: 229 GGNYNGYAG--DIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPD--GA 284
           GG   G+    DIWSLG  +LE+  G  P+       ++  +M  +  G  P +PD    
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPW--SELDNEFQ-IMFHVGAGHKPPIPDSLQL 233

Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
           SPE + F++ CL+ +  KR TAS+LL HPF+
Sbjct: 234 SPEGKDFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score =  194 bits (494), Expect = 8e-60
 Identities = 115/313 (36%), Positives = 167/313 (53%), Gaps = 54/313 (17%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
           D EK+  LG GNGG V+KV H+ +  I A K++H +  P +R Q+ RE+++L   +SP+I
Sbjct: 6   DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65

Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL-HGHK 170
           V  +G F    G+I+I ME+MD G+LD +L K G   E  L  ++  ++KGL+YL   HK
Sbjct: 66  VGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 124

Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGG 230
           I+HRD+KPSN+LVN+   ++K+ DFGVS  +  S+   NS+VGT +YMSPER       G
Sbjct: 125 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQ-----G 176

Query: 231 NYNGYAGDIWSLGLTLLELYLGHFPF---------------------------------- 256
            +     DIWS+GL+L+E+ +G +P                                   
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR 236

Query: 257 ----LQPGQRPDWAT--LMCAICFGDPPSLPDGA-SPEFRSFIECCLQKEFSKRWTASQL 309
                 P  RP  A   L+  I    PP LP G    EF+ F+  CL K  ++R    QL
Sbjct: 237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQL 296

Query: 310 LTHPFLCKNRRSD 322
           + H F+   +RS+
Sbjct: 297 MVHAFI---KRSE 306

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  191 bits (486), Expect = 6e-59
 Identities = 102/269 (37%), Positives = 154/269 (57%), Gaps = 13/269 (4%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEI-LRRTDSPF 110
           DLE L  +G G  G VYK++ + T  + A+K +    +    +++  ++++ L+  D P+
Sbjct: 16  DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPY 75

Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYL-HG 168
           IV+C+G F   S D+ I ME M S  LD LL +  G   E  L  +   I+K L YL   
Sbjct: 76  IVKCYGYFITDS-DVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK 133

Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAY 228
           H +IHRD+KPSN+L++ +   VK+ DFG+S  +  S  A     G  AYM+PER DP   
Sbjct: 134 HGVIHRDVKPSNILLDASG-NVKLCDFGISGRLVDSK-AKTRSAGCAAYMAPERIDPPDP 191

Query: 229 GGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLP--DGASP 286
              Y+  A D+WSLG++L+EL  G FP+     + ++  ++  I   +PPSLP  +G SP
Sbjct: 192 NPKYDIRA-DVWSLGISLVELATGQFPY--KNCKTEF-EVLTKILQEEPPSLPPNEGFSP 247

Query: 287 EFRSFIECCLQKEFSKRWTASQLLTHPFL 315
           +F SF++ CL K+  KR    +LL HPF+
Sbjct: 248 DFCSFVDLCLTKDHRKRPKYRELLQHPFI 276

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  189 bits (482), Expect = 7e-59
 Identities = 95/267 (35%), Positives = 143/267 (53%), Gaps = 10/267 (3%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
            D E +Q +G G  G VYK +   T ++ A+KV+  +        + +E+ +L+    P 
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFE-IIQQEISMLKECRHPN 61

Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGH 169
           IV  FG + +    + I+MEY   G+L  +     G  SE ++A++  + LKGL+YLH  
Sbjct: 62  IVAYFGSYLR-RDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET 120

Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYG 229
             IHRDIK +N+L+  +   VK+ADFGVS  +  ++    S++GT  +M+PE    +  G
Sbjct: 121 GKIHRDIKGANILLTEDG-DVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKG 179

Query: 230 GNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA--SPE 287
           G Y+G   DIW+LG+T +EL     P       P  A  + +     PP L D    SP 
Sbjct: 180 G-YDGKC-DIWALGITAIELAELQPPMF--DLHPMRALFLISKSNFPPPKLKDKEKWSPV 235

Query: 288 FRSFIECCLQKEFSKRWTASQLLTHPF 314
           F  FI+ CL K+  KR TA++LL HPF
Sbjct: 236 FHDFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score =  188 bits (479), Expect = 4e-58
 Identities = 102/288 (35%), Positives = 155/288 (53%), Gaps = 35/288 (12%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPF 110
           DLE ++ LG G  G V K++H  T  I A+K +    +   ++++  +++I  R+ D P+
Sbjct: 2   DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPY 61

Query: 111 IVQCFG-IFEKPSGDIAILMEYMDSGTLDTL----LNKNGTFSEPKLAHIASQILKGLSY 165
            V  +G +F +  GD+ I ME MD+ +LD       +K  T  E  L  IA  I+K L Y
Sbjct: 62  TVTFYGALFRE--GDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEY 118

Query: 166 LHGH-KIIHRDIKPSNLLVNNNNMQVKIADFGVS----KIMCRSLDACNSYVGTCAYMSP 220
           LH    +IHRD+KPSN+L+N N  QVK+ DFG+S      + +++DA     G   YM+P
Sbjct: 119 LHSKLSVIHRDVKPSNVLINRNG-QVKLCDFGISGYLVDSVAKTIDA-----GCKPYMAP 172

Query: 221 ERFDPDAYGGNYNGY--AGDIWSLGLTLLELYLGHFPFLQPGQRPDWATL---MCAICFG 275
           ER +P+    N  GY    D+WSLG+T++EL  G FP+        W T    +  +   
Sbjct: 173 ERINPE---LNQKGYDVKSDVWSLGITMIELATGRFPYDS------WKTPFQQLKQVVEE 223

Query: 276 DPPSLP-DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSD 322
             P LP +  SPEF+ F+  CL+K + +R    +LL HPF   +   +
Sbjct: 224 PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKN 271

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  185 bits (473), Expect = 1e-57
 Identities = 89/263 (33%), Positives = 133/263 (50%), Gaps = 21/263 (7%)

Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR----QVFREMEILRRTDSPFIVQC 114
           LG G+ G V  V+ + T K+YA+KV+       ++R        E  IL R + PFIV+ 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKK--IIKRKEVEHTLTERNILSRINHPFIVKL 58

Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
              F+     + +++EY   G L + L+K G FSE +    A++I+  L YLH   II+R
Sbjct: 59  HYAFQTEE-KLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYR 117

Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNG 234
           D+KP N+L+ + +  +K+ DFG++K +       N++ GT  Y++PE      Y     G
Sbjct: 118 DLKPENILL-DADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY-----G 171

Query: 235 YAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIEC 294
            A D WSLG+ L E+  G  PF       D   +   I   DP   P+  SPE R  I  
Sbjct: 172 KAVDWWSLGVLLYEMLTGKPPFYA----EDRKEIYEKILK-DPLRFPEFLSPEARDLISG 226

Query: 295 CLQKEFSKRWT---ASQLLTHPF 314
            LQK+ +KR     A ++  HPF
Sbjct: 227 LLQKDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  181 bits (461), Expect = 1e-55
 Identities = 90/263 (34%), Positives = 139/263 (52%), Gaps = 18/263 (6%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALK--VVHGDADPTVRRQVFREMEILRRTDSPFIVQC 114
            ++G G  G VYK  +  T    A+K   +         + + +E+++L+    P IV+ 
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLKHPNIVKY 64

Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
            G   + S  + I++EY ++G+L  ++ K G F E  +A    Q+L+GL+YLH   +IHR
Sbjct: 65  IG-SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHR 123

Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNG 234
           DIK +N+L   + + VK+ADFGV+  +        S VGT  +M+PE         +   
Sbjct: 124 DIKAANILTTKDGV-VKLADFGVATKLNDVSKDDASVVGTPYWMAPE-----VIEMSGAS 177

Query: 235 YAGDIWSLGLTLLELYLGHFPF--LQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFI 292
            A DIWSLG T++EL  G+ P+  L P         +  I   D P LP+G SPE + F+
Sbjct: 178 TASDIWSLGCTVIELLTGNPPYYDLNP------MAALFRIVQDDHPPLPEGISPELKDFL 231

Query: 293 ECCLQKEFSKRWTASQLLTHPFL 315
             C QK+ + R TA QLL HP++
Sbjct: 232 MQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  180 bits (458), Expect = 3e-55
 Identities = 97/265 (36%), Positives = 145/265 (54%), Gaps = 14/265 (5%)

Query: 55  KLQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVR---RQVFREMEILRRTDSPF 110
           K ++LG G+ G+VY+  +      +A+K V   D   T +   +Q+ +E+ +L +   P 
Sbjct: 4   KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPN 63

Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           IVQ  G  E+   ++ I +E +  G+L  LL K G+F EP +     QIL GL YLH   
Sbjct: 64  IVQYLGT-EREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN 122

Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGG 230
            +HRDIK +N+LV+ N + VK+ADFG++K +        S+ G+  +M+PE        G
Sbjct: 123 TVHRDIKGANILVDTNGV-VKLADFGMAKQV-VEFSFAKSFKGSPYWMAPEVIAQQ---G 177

Query: 231 NYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
            Y G A DIWSLG T+LE+  G  P+    Q    A +       + P +PD  S E + 
Sbjct: 178 GY-GLAADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKIGRSKELPPIPDHLSDEAKD 233

Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
           FI  CLQ++ S R TA++LL HPF+
Sbjct: 234 FILKCLQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  180 bits (460), Expect = 4e-55
 Identities = 94/278 (33%), Positives = 142/278 (51%), Gaps = 24/278 (8%)

Query: 50  YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSP 109
           Y +LEK+   G G  G VYK   R T K  A+K +        +  +  E+ I++    P
Sbjct: 21  YKNLEKI---GEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHP 75

Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
            IV  +  +     ++ ++MEYMD G+L D +       +EP++A++  ++L+GL YLH 
Sbjct: 76  NIVDYYDSYLVG-DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS 134

Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAY 228
             +IHRDIK  N+L++ +   VK+ADFG +  + +     NS VGT  +M+PE      Y
Sbjct: 135 QNVIHRDIKSDNILLSKDG-SVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDY 193

Query: 229 GGNYNGYAGDIWSLGLTLLELYLGHFPFLQ-PGQRPDWATLMCAICFGDPPSLPDGA--S 285
           G        DIWSLG+  +E+  G  P+L+ P  R      +  I     P L +    S
Sbjct: 194 GPKV-----DIWSLGIMCIEMAEGEPPYLREPPLR-----ALFLITTKGIPPLKNPEKWS 243

Query: 286 PEFRSFIECCLQKEFSKRWTASQLLTHPFL---CKNRR 320
           PEF+ F+  CL K+  KR +A +LL HPFL   C    
Sbjct: 244 PEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPKEE 281

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score =  182 bits (462), Expect = 4e-55
 Identities = 110/308 (35%), Positives = 164/308 (53%), Gaps = 53/308 (17%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
           D E++  LG GNGG V KVQH+ +  I A K++H +  P +R Q+ RE+++L   +SP+I
Sbjct: 6   DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65

Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL-HGHK 170
           V  +G F    G+I+I ME+MD G+LD +L +     E  L  ++  +L+GL+YL   H+
Sbjct: 66  VGFYGAFYS-DGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ 124

Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGG 230
           I+HRD+KPSN+LVN+   ++K+ DFGVS  +  S+   NS+VGT +YMSPER       G
Sbjct: 125 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQ-----G 176

Query: 231 NYNGYAGDIWSLGLTLLELYLGHFPFLQP------------------------------- 259
            +     DIWS+GL+L+EL +G +P   P                               
Sbjct: 177 THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236

Query: 260 ---------GQRPDWAT--LMCAICFGDPPSLPDGA-SPEFRSFIECCLQKEFSKRWTAS 307
                      RP  A   L+  I    PP LP+G  +P+F+ F+  CL K  ++R    
Sbjct: 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLK 296

Query: 308 QLLTHPFL 315
            L+ H F+
Sbjct: 297 MLMNHTFI 304

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  183 bits (463), Expect = 8e-55
 Identities = 90/282 (31%), Positives = 133/282 (47%), Gaps = 26/282 (9%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSP-F 110
             L+ LG G+ G VY  +     K+ ALKV+            +  RE++IL   + P  
Sbjct: 3   RILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59

Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGT---FSEPKLAHIASQILKGLSYLH 167
           IV+ +  F+   G + ++MEY+D G+L+ LL K G     SE +   I +QIL  L YLH
Sbjct: 60  IVKLYDFFQDE-GSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA------CNSYVGTCAYMSPE 221
              IIHRDIKP N+L++ +   VK+ DFG++K++             ++ VGT  YM+PE
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178

Query: 222 RFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPP--- 278
                     Y   + DIWSLG+TL EL  G  PF         +  +  I     P   
Sbjct: 179 VLLG--LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236

Query: 279 -----SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
                S P+  S      ++  L K+   R ++S  L+H  L
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLL 278

Length = 384

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score =  177 bits (452), Expect = 5e-54
 Identities = 102/282 (36%), Positives = 150/282 (53%), Gaps = 32/282 (11%)

Query: 50  YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREME-ILRRTDS 108
             DL+ L  +G G  GTV K+ H+ +  I A+K +    D   ++++  +++ ++R +D 
Sbjct: 3   AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDC 62

Query: 109 PFIVQCFG-IFEKPSGDIAILMEYMDSGTLDTL-----LNKNGTFSEPKLAHIASQILKG 162
           P+IV+ +G +F +  GD  I ME MD  +LD               E  L  IA   +K 
Sbjct: 63  PYIVKFYGALFRE--GDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKA 119

Query: 163 LSYL-HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
           L+YL    KIIHRD+KPSN+L++ N   +K+ DFG+S  +  S+ A     G   YM+PE
Sbjct: 120 LNYLKEELKIIHRDVKPSNILLDRNG-NIKLCDFGISGQLVDSI-AKTRDAGCRPYMAPE 177

Query: 222 RFDPDAYGGNYNGY--AGDIWSLGLTLLELYLGHFPFLQPGQRPDWATL---MCAICFGD 276
           R DP A     +GY    D+WSLG+TL E+  G FP+      P W ++   +  +  GD
Sbjct: 178 RIDPSA----RDGYDVRSDVWSLGITLYEVATGKFPY------PKWNSVFDQLTQVVKGD 227

Query: 277 PPSLPDGA----SPEFRSFIECCLQKEFSKRWTASQLLTHPF 314
           PP L +      SP F +FI  CL K+ SKR    +LL HPF
Sbjct: 228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPF 269

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  173 bits (440), Expect = 3e-52
 Identities = 94/278 (33%), Positives = 144/278 (51%), Gaps = 27/278 (9%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRR-TDSPFIV 112
           E ++V+G G  G VYK +H+ T ++ A+K++    D     +   E  ILR+ ++ P I 
Sbjct: 9   ELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKE--EYNILRKYSNHPNIA 66

Query: 113 QCFGIFEKPSGDIA-----ILMEYMDSGT----LDTLLNKNGTFSEPKLAHIASQILKGL 163
             +G F K +         ++ME    G+    +  L  K     E  +A+I  + L+GL
Sbjct: 67  TFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGL 126

Query: 164 SYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE-- 221
           +YLH +K+IHRDIK  N+L+  N  +VK+ DFGVS  +  +L   N+++GT  +M+PE  
Sbjct: 127 AYLHENKVIHRDIKGQNILLTKNA-EVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVI 185

Query: 222 --RFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPS 279
                PDA    Y+    D+WSLG+T +EL  G  P       P  A  +  I    PP+
Sbjct: 186 ACDEQPDAS---YD-ARSDVWSLGITAIELADGKPPLCD--MHPMRA--LFKIPRNPPPT 237

Query: 280 L--PDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
           L  P+  S +F  FI  CL K + +R    +LL HPF+
Sbjct: 238 LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  171 bits (437), Expect = 8e-52
 Identities = 77/297 (25%), Positives = 131/297 (44%), Gaps = 51/297 (17%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVV---HGDADPTVRRQ-----VFREMEI 102
            D +  +++G G+  TV   + + T+K YA+K++          + ++     V  E E+
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQ------LIKEKKVKYVKIEKEV 54

Query: 103 LRR-TDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILK 161
           L R    P I++ +  F+    ++  ++EY  +G L   + K G+  E      A++IL 
Sbjct: 55  LTRLNGHPGIIKLYYTFQDEE-NLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILL 113

Query: 162 GLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA-------------- 207
            L YLH   IIHRD+KP N+L+ + +M +KI DFG +K++  +                 
Sbjct: 114 ALEYLHSKGIIHRDLKPENILL-DKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172

Query: 208 ------CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQ 261
                   S+VGT  Y+SPE            G + D+W+LG  + ++  G  PF     
Sbjct: 173 EKNRRRFASFVGTAEYVSPE-----LLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN- 226

Query: 262 RPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTAS----QLLTHPF 314
             ++ T    I   +  S P    P+ +  IE  L  +   R   +    +L  HPF
Sbjct: 227 --EYLT-FQKILKLE-YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  165 bits (421), Expect = 1e-49
 Identities = 91/279 (32%), Positives = 139/279 (49%), Gaps = 28/279 (10%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
            D E ++V+G G    VY       ++  A+K +  +   T   ++ +E++ + + + P 
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60

Query: 111 IVQCFGIF-EKPSGDIAILMEYMDSGTLDTLL---NKNGTFSEPKLAHIASQILKGLSYL 166
           +V+ +  F       + ++M Y+  G+L  ++      G   E  +A +  ++LKGL YL
Sbjct: 61  VVKYYTSFVVGDE--LWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118

Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVS----KIMCRSLDACNSYVGTCAYMSPER 222
           H +  IHRDIK  N+L+  +   VKIADFGVS        R+     ++VGT  +M+PE 
Sbjct: 119 HSNGQIHRDIKAGNILLGEDG-SVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177

Query: 223 FDPDAYGGNYNGY--AGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSL 280
            +        +GY    DIWS G+T +EL  G  P+    + P    LM  +   DPPSL
Sbjct: 178 MEQV------HGYDFKADIWSFGITAIELATGAAPY---SKYPPMKVLMLTL-QNDPPSL 227

Query: 281 PDGA-----SPEFRSFIECCLQKEFSKRWTASQLLTHPF 314
             GA     S  FR  I  CLQK+ SKR TA +LL H F
Sbjct: 228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKF 266

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  164 bits (417), Expect = 5e-49
 Identities = 87/275 (31%), Positives = 133/275 (48%), Gaps = 21/275 (7%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTDSPF 110
           D E L+ +G G+ GTV KV+ +   KI   K +  G+     ++Q+  E+ ILR    P 
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN 60

Query: 111 IVQCFG-IFEKPSGDIAILMEYMDSGTLDTLLNK----NGTFSEPKLAHIASQILKGLSY 165
           IV+ +  I ++ +  + I+MEY + G L  L+ K         E  +  I +Q+L  L  
Sbjct: 61  IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120

Query: 166 LH-----GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSP 220
            H     G+ ++HRD+KP+N+ ++ NN  VK+ DFG++KI+        +YVGT  YMSP
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANN-NVKLGDFGLAKILGHDSSFAKTYVGTPYYMSP 179

Query: 221 ERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSL 280
           E+ +  +Y         DIWSLG  + EL     PF    Q      L   I  G    +
Sbjct: 180 EQLNHMSYDE-----KSDIWSLGCLIYELCALSPPFTARNQ----LQLASKIKEGKFRRI 230

Query: 281 PDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
           P   S E    I+  L  +  KR +  +LL  P +
Sbjct: 231 PYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  163 bits (414), Expect = 2e-48
 Identities = 89/262 (33%), Positives = 145/262 (55%), Gaps = 14/262 (5%)

Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIF 118
           LG G  G VYK QH+ T    A K++  +++  +   +  E++IL     P IV  +  +
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV-EIDILSECKHPNIVGLYEAY 71

Query: 119 EKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILKGLSYLHGHKIIHRDIK 177
                 + IL+E+ D G LD+++ +     +EP++ ++  Q+L+ L++LH HK+IHRD+K
Sbjct: 72  FY-ENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLK 130

Query: 178 PSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAG 237
             N+L+  +   VK+ADFGVS     +L   ++++GT  +M+PE    + +  N   Y  
Sbjct: 131 AGNILLTLDG-DVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKA 189

Query: 238 DIWSLGLTLLELYLGHFPF--LQPGQRPDWATLMCAICFGDPPSL--PDGASPEFRSFIE 293
           DIWSLG+TL+EL     P   L P +      ++  I   +PP+L  P   S  F  F++
Sbjct: 190 DIWSLGITLIELAQMEPPHHELNPMR------VLLKILKSEPPTLDQPSKWSSSFNDFLK 243

Query: 294 CCLQKEFSKRWTASQLLTHPFL 315
            CL K+   R TA++LL HPF+
Sbjct: 244 SCLVKDPDDRPTAAELLKHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  152 bits (386), Expect = 2e-44
 Identities = 94/268 (35%), Positives = 149/268 (55%), Gaps = 16/268 (5%)

Query: 55  KLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQC 114
           KL+ +G G+ G V+K     T K+ A+K++  +        + +E+ +L + DSP++ + 
Sbjct: 8   KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 67

Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
           +G + K +  + I+MEY+  G+   LL + G   E ++A I  +ILKGL YLH  K IHR
Sbjct: 68  YGSYLKDT-KLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLDYLHSEKKIHR 125

Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNG 234
           DIK +N+L++ +  +VK+ADFGV+  +  +    N++VGT  +M+PE     AY      
Sbjct: 126 DIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK--- 181

Query: 235 YAGDIWSLGLTLLELYLGHFPF--LQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFI 292
              DIWSLG+T +EL  G  P   L P +      ++  I   +PP+L    S   + F+
Sbjct: 182 --ADIWSLGITAIELAKGEPPHSELHPMK------VLFLIPKNNPPTLEGNYSKPLKEFV 233

Query: 293 ECCLQKEFSKRWTASQLLTHPFLCKNRR 320
           E CL KE S R TA +LL H F+ +  +
Sbjct: 234 EACLNKEPSFRPTAKELLKHKFIVRFAK 261

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  151 bits (385), Expect = 5e-44
 Identities = 83/297 (27%), Positives = 134/297 (45%), Gaps = 48/297 (16%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD----PTVRRQVFREMEILRRTDSP 109
           EK+  +G G  G VYK +++ T ++ ALK +  + +    P       RE+++L++   P
Sbjct: 2   EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFP---ITAIREIKLLQKLRHP 58

Query: 110 FIVQCFGI-FEKPSGDIAILMEYMD---SGTLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
            IV+   I   K  G I ++ EYMD   +G LD   +    F+E ++     Q+L+GL Y
Sbjct: 59  NIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLD---SPEVKFTESQIKCYMKQLLEGLQY 115

Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA-CNSYVGTCAYMSPERFD 224
           LH + I+HRDIK SN+L+NN+ + +K+ADFG+++   +   A   + V T  Y  PE   
Sbjct: 116 LHSNGILHRDIKGSNILINNDGV-LKLADFGLARPYTKRNSADYTNRVITLWYRPPELL- 173

Query: 225 PDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAIC----------- 273
               G    G   D+WS+G  L EL+LG  P  Q     +    +  +C           
Sbjct: 174 ---LGATRYGPEVDMWSVGCILAELFLGK-PIFQGSTELEQLEKIFELCGSPTDENWPGV 229

Query: 274 ----FGDPPSLPDGA------------SPEFRSFIECCLQKEFSKRWTASQLLTHPF 314
               + +                     P     ++  L  +  KR +A Q L H +
Sbjct: 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  151 bits (383), Expect = 6e-44
 Identities = 88/261 (33%), Positives = 143/261 (54%), Gaps = 17/261 (6%)

Query: 55  KLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEIL---RRTDSPFI 111
           +L+++G G  G VY+ +H  T ++ ALK+++ D        + RE+ +L   R++  P I
Sbjct: 5   RLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNI 64

Query: 112 VQCFGIFEK-PSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
            + +G + K P   + I+MEY + G++ TL+ K G  +E  ++ I  ++L  L Y+H   
Sbjct: 65  TKYYGSYLKGPR--LWIIMEYAEGGSVRTLM-KAGPIAEKYISVIIREVLVALKYIHKVG 121

Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGG 230
           +IHRDIK +N+LV N    VK+ DFGV+ ++ ++    +++VGT  +M+PE        G
Sbjct: 122 VIHRDIKAANILVTNTG-NVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVI----TEG 176

Query: 231 NYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPD-GASPEFR 289
            Y     DIWSLG+T+ E+  G+ P+       D    M  I    PP L D G S   R
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPYSD----VDAFRAMMLIPKSKPPRLEDNGYSKLLR 232

Query: 290 SFIECCLQKEFSKRWTASQLL 310
            F+  CL +E  +R +A +LL
Sbjct: 233 EFVAACLDEEPKERLSAEELL 253

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  150 bits (381), Expect = 1e-43
 Identities = 94/265 (35%), Positives = 144/265 (54%), Gaps = 16/265 (6%)

Query: 55  KLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQC 114
           KL+ +G G+ G VYK     T ++ A+K++  +        + +E+ +L + DSP+I + 
Sbjct: 8   KLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRY 67

Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
           +G + K    + I+MEY+  G+   LL K G   E  +A I  +ILKGL YLH  + IHR
Sbjct: 68  YGSYLK-GTKLWIIMEYLGGGSALDLL-KPGPLEETYIATILREILKGLDYLHSERKIHR 125

Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNG 234
           DIK +N+L++     VK+ADFGV+  +  +    N++VGT  +M+PE     AY      
Sbjct: 126 DIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY-----D 179

Query: 235 YAGDIWSLGLTLLELYLGHFPF--LQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFI 292
           +  DIWSLG+T +EL  G  P   L P +      ++  I    PP+L    S  F+ F+
Sbjct: 180 FKADIWSLGITAIELAKGEPPNSDLHPMR------VLFLIPKNSPPTLEGQYSKPFKEFV 233

Query: 293 ECCLQKEFSKRWTASQLLTHPFLCK 317
           E CL K+   R TA +LL H F+ +
Sbjct: 234 EACLNKDPRFRPTAKELLKHKFITR 258

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  149 bits (378), Expect = 3e-43
 Identities = 94/266 (35%), Positives = 148/266 (55%), Gaps = 12/266 (4%)

Query: 55  KLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQC 114
           KL+ +G G+ G V+K     T ++ A+K++  +        + +E+ +L + DSP++ + 
Sbjct: 8   KLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 67

Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
           +G + K +  + I+MEY+  G+   LL + G F E ++A +  +ILKGL YLH  K IHR
Sbjct: 68  YGSYLKGT-KLWIIMEYLGGGSALDLL-RAGPFDEFQIATMLKEILKGLDYLHSEKKIHR 125

Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNG 234
           DIK +N+L++     VK+ADFGV+  +  +    N++VGT  +M+PE     AY      
Sbjct: 126 DIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK--- 181

Query: 235 YAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIEC 294
              DIWSLG+T +EL  G  P       P    ++  I   +PP+L    S  F+ FI+ 
Sbjct: 182 --ADIWSLGITAIELAKGEPP--NSDMHP--MRVLFLIPKNNPPTLTGEFSKPFKEFIDA 235

Query: 295 CLQKEFSKRWTASQLLTHPFLCKNRR 320
           CL K+ S R TA +LL H F+ KN +
Sbjct: 236 CLNKDPSFRPTAKELLKHKFIVKNAK 261

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  149 bits (376), Expect = 9e-43
 Identities = 91/264 (34%), Positives = 143/264 (54%), Gaps = 14/264 (5%)

Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIF 118
           LG G  G VYK +++ T  + A KV+   ++  +   +  E+EIL   + P+IV+  G F
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMV-EIEILATCNHPYIVKLLGAF 78

Query: 119 EKPSGDIAILMEYMDSGTLD-TLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIK 177
               G + I++E+   G +D  +L  +   +EP++  I  Q+L+ L YLH  KIIHRD+K
Sbjct: 79  YW-DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLK 137

Query: 178 PSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAG 237
             N+L+  +   +K+ADFGVS    ++L   +S++GT  +M+PE    +        Y  
Sbjct: 138 AGNVLLTLDG-DIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKA 196

Query: 238 DIWSLGLTLLELYLGHFPF--LQPGQRPDWATLMCAICFGDPPSL--PDGASPEFRSFIE 293
           DIWSLG+TL+E+     P   L P +      ++  I   +PP+L  P   S EFR F++
Sbjct: 197 DIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSEPPTLSQPSKWSMEFRDFLK 250

Query: 294 CCLQKEFSKRWTASQLLTHPFLCK 317
             L K    R +A+QLL HPF+  
Sbjct: 251 TALDKHPETRPSAAQLLEHPFVSS 274

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  147 bits (373), Expect = 2e-42
 Identities = 89/263 (33%), Positives = 142/263 (53%), Gaps = 10/263 (3%)

Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIF 118
           LG G  G VYK Q++ T  + A KV+   ++  +   +  E++IL   D P IV+    F
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMV-EIDILASCDHPNIVKLLDAF 71

Query: 119 EKPSGDIAILMEYMDSGTLDT-LLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIK 177
              + ++ IL+E+   G +D  +L      +EP++  +  Q L+ L+YLH +KIIHRD+K
Sbjct: 72  YYEN-NLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLK 130

Query: 178 PSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAG 237
             N+L   +   +K+ADFGVS    R++   +S++GT  +M+PE    +        Y  
Sbjct: 131 AGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKA 189

Query: 238 DIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSL--PDGASPEFRSFIECC 295
           D+WSLG+TL+E+         P    +   ++  I   +PP+L  P   S EF+ F++ C
Sbjct: 190 DVWSLGITLIEMA----QIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKC 245

Query: 296 LQKEFSKRWTASQLLTHPFLCKN 318
           L+K    RWT +QLL HPF+  N
Sbjct: 246 LEKNVDARWTTTQLLQHPFVTVN 268

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  146 bits (369), Expect = 4e-42
 Identities = 87/268 (32%), Positives = 135/268 (50%), Gaps = 16/268 (5%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTDSPF 110
           D E L  +G G+ G V+KV  +   ++YA+K +     +   R +   E  +L + DS +
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 111 IVQCFGIF-EKPSGDIAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLH 167
           I++ +  F +K  G + I+MEY ++G L  LL         E ++     QIL GL++LH
Sbjct: 61  IIRYYESFLDK--GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH 118

Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDA 227
             KI+HRDIK  NL ++  +  VKI D GV+K++  + +  N+ VGT  Y+SPE  +   
Sbjct: 119 SKKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKP 177

Query: 228 YGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPE 287
           Y         D+W+LG+ L E   G  PF    Q      L+  I  G  P +    S +
Sbjct: 178 YNEK-----SDVWALGVVLYECCTGKHPFDANNQ----GALILKIIRGVFPPVSQMYSQQ 228

Query: 288 FRSFIECCLQKEFSKRWTASQLLTHPFL 315
               I+ CL K++ +R    QLL +P L
Sbjct: 229 LAQLIDQCLTKDYRQRPDTFQLLRNPSL 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  145 bits (368), Expect = 1e-41
 Identities = 91/283 (32%), Positives = 144/283 (50%), Gaps = 31/283 (10%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQV-FREMEILRRTDSP 109
           S L+    +G G+ G V     + T +  A+K +  D     RR++ F E+ I+R    P
Sbjct: 19  SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFNEVVIMRDYQHP 76

Query: 110 FIVQCFGIFEKPSGD-IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
            IV+ +  +    GD + ++ME+++ G L T +  +   +E ++A +   +LK LS+LH 
Sbjct: 77  NIVEMYSSYL--VGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIATVCLAVLKALSFLHA 133

Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFG----VSKIMCRSLDACNSYVGTCAYMSPERFD 224
             +IHRDIK  ++L+ ++  +VK++DFG    VSK + R      S VGT  +M+PE   
Sbjct: 134 QGVIHRDIKSDSILLTSDG-RVKLSDFGFCAQVSKEVPRR----KSLVGTPYWMAPEVIS 188

Query: 225 PDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFL--QPGQRPDWATLMCAICFGDPPSL-- 280
              YG        DIWSLG+ ++E+  G  P+    P Q       M  I    PP L  
Sbjct: 189 RLPYGTEV-----DIWSLGIMVIEMVDGEPPYFNEPPLQA------MKRIRDNLPPKLKN 237

Query: 281 PDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSDC 323
               SP  RSF++  L ++ ++R TA++LL HPFL K      
Sbjct: 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSS 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  144 bits (365), Expect = 2e-41
 Identities = 92/274 (33%), Positives = 137/274 (50%), Gaps = 29/274 (10%)

Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVH---GDADPTVRRQVF-----REMEILRRTDSP 109
           ++G G+ G+VY   +  + ++ A+K V      A    R++       RE+ +L+     
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
            IVQ  G     +  + I +EY+  G++  LLN  G F E  + +   QILKGL+YLH  
Sbjct: 67  NIVQYLGS-SLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR 125

Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVS-KIMCRSLDACN-----SYVGTCAYMSPERF 223
            IIHRDIK +N+LV+N    +KI+DFG+S K+   SL         S  G+  +M+PE  
Sbjct: 126 GIIHRDIKGANILVDNKG-GIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVV 184

Query: 224 DPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD--PPSLP 281
              +Y         DIWSLG  ++E+  G  PF      PD   L      G+   P +P
Sbjct: 185 KQTSYTRK-----ADIWSLGCLVVEMLTGKHPF------PDCTQLQAIFKIGENASPEIP 233

Query: 282 DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
              S E   F+E   + + +KR TA++LL HPFL
Sbjct: 234 SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  144 bits (364), Expect = 3e-41
 Identities = 93/263 (35%), Positives = 132/263 (50%), Gaps = 14/263 (5%)

Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGI 117
           VLG G  G VY  +   T    A+K +  + D    + +  E+ +        IVQ  G 
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIP-ERDSRYVQPLHEEIALHSYLKHRNIVQYLGS 73

Query: 118 FEKPSGDIAILMEYMDSGTLDTLL-NKNGTFS--EPKLAHIASQILKGLSYLHGHKIIHR 174
             + +G   I ME +  G+L  LL +K G     E  +     QIL+GL YLH ++I+HR
Sbjct: 74  DSE-NGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHR 132

Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD--PDAYGGNY 232
           DIK  N+LVN  +  VKI+DFG SK +        ++ GT  YM+PE  D  P  YG   
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGA-- 190

Query: 233 NGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFI 292
                DIWSLG T++E+  G  PF++ G+ P  A     + F   P +P+  S E ++FI
Sbjct: 191 ---PADIWSLGCTIVEMATGKPPFIELGE-PQAAMFKVGM-FKIHPEIPESLSAEAKNFI 245

Query: 293 ECCLQKEFSKRWTASQLLTHPFL 315
             C + +  KR +A  LL  PFL
Sbjct: 246 LRCFEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  143 bits (363), Expect = 4e-41
 Identities = 87/272 (31%), Positives = 129/272 (47%), Gaps = 31/272 (11%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFR---EMEILRRTDSPFIV 112
           ++LG G  G VY      T +  A+K V      P  +++V     E+++L+      IV
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
           Q +G        ++I MEYM  G++   L   G  +E        QIL+G+ YLH + I+
Sbjct: 68  QYYGCLRDD-ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIV 126

Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSK---IMCRSLDACNSYVGTCAYMSPERFDPDAYG 229
           HRDIK +N+L ++    VK+ DFG SK    +C S     S  GT  +MSPE    + YG
Sbjct: 127 HRDIKGANILRDSAG-NVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYG 185

Query: 230 GNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATL--MCAICFG-----DPPSLPD 282
                   D+WS+G T++E+           ++P WA    M AI F        P LP 
Sbjct: 186 RK-----ADVWSVGCTVVEMLT---------EKPPWAEFEAMAAI-FKIATQPTNPQLPS 230

Query: 283 GASPEFRSFIECCLQKEFSKRWTASQLLTHPF 314
             SP+ R+F+     +   KR +A +LL H F
Sbjct: 231 HVSPDARNFLRRTFVENAKKRPSAEELLRHFF 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  143 bits (362), Expect = 6e-41
 Identities = 77/264 (29%), Positives = 115/264 (43%), Gaps = 14/264 (5%)

Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALK-VVHGDADPTVR-RQVFREMEILRRTDSPFIVQ 113
           L+V+G G  G V  VQ R T K++A+K +           R V  E  IL+  + PF+V 
Sbjct: 5   LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVN 64

Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
            +  F+    ++ ++++ +  G L   L++   FSE ++     +I+  L YLH   IIH
Sbjct: 65  LWYSFQD-EENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIH 123

Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYN 233
           RDIKP N+L++     V I DF ++  +        S  GT  YM+PE      Y     
Sbjct: 124 RDIKPDNILLDEQG-HVHITDFNIATKVTPDTLT-TSTSGTPGYMAPEVLCRQGY----- 176

Query: 234 GYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIE 293
             A D WSLG+T  E   G  P+   G        + A         P   S E    I 
Sbjct: 177 SVAVDWWSLGVTAYECLRGKRPY--RGHSRTIRDQIRAKQETADVLYPATWSTEAIDAIN 234

Query: 294 CCLQKEFSKRW--TASQLLTHPFL 315
             L+++  KR       L  HP+ 
Sbjct: 235 KLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  143 bits (362), Expect = 7e-41
 Identities = 78/268 (29%), Positives = 124/268 (46%), Gaps = 31/268 (11%)

Query: 65  GTVYKVQHRCTHKIYALKVVHGDADPTVRR----QVFREMEILRRTDSPFIVQCFGIFEK 120
           G V+  + + T  IYA+KV+       +R+    QV  E +IL +  SP++V+ +  F+ 
Sbjct: 7   GRVFLAKKKSTGDIYAIKVI--KKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG 64

Query: 121 PSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSN 180
              ++ ++MEY+  G L +LL   G+  E       ++I+  L YLH + IIHRD+KP N
Sbjct: 65  KK-NLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDN 123

Query: 181 LLVNNNNMQVKIADFGVSKI--------MCRSLDACNSYVGTCAYMSPERFDPDAYGGNY 232
           +L+++N   +K+ DFG+SK+        +          VGT  Y++PE      +    
Sbjct: 124 ILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH---- 178

Query: 233 NGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD--PPSLPDGASPEFRS 290
                D WSLG  L E  +G  PF   G+ P+       I  G    P   +  S E   
Sbjct: 179 -SKTVDWWSLGCILYEFLVGIPPF--HGETPE-EIFQ-NILNGKIEWPEDVE-VSDEAID 232

Query: 291 FIECCLQKEFSKR---WTASQLLTHPFL 315
            I   L  +  KR    +  ++  HPF 
Sbjct: 233 LISKLLVPDPEKRLGAKSIEEIKNHPFF 260

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  143 bits (363), Expect = 7e-41
 Identities = 77/295 (26%), Positives = 125/295 (42%), Gaps = 46/295 (15%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALK-VVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           +KL  +G G  G VYK + + T +I A+K +        + +   RE+++L+  + P I+
Sbjct: 2   QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNII 61

Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
           +   +F +  GD+ ++ E+MD+     + ++     E  +     Q+L+GL++ H H I+
Sbjct: 62  KLLDVF-RHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGIL 120

Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNY 232
           HRD+KP NLL+N     +K+ADFG+++     +     YV T  Y +PE       G   
Sbjct: 121 HRDLKPENLLINTEG-VLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELL----LGDKG 175

Query: 233 NGYAGDIWSLGLTLLELYLG--------------------------HFPFLQPGQR---- 262
                DIWS+G    EL                              +P      R    
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235

Query: 263 --PDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
             P  A +         P L   ASP+    +   L  +  KR TA Q L HP+ 
Sbjct: 236 SFPKKAGM-------PLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  140 bits (356), Expect = 4e-40
 Identities = 71/272 (26%), Positives = 116/272 (42%), Gaps = 34/272 (12%)

Query: 58  VLGHGNGGTVYK--VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQC 114
            LG G  G VYK  ++ +       A+K +  DA    R+   +E  ++++   P +V+ 
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61

Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLL---------NKNGTFSEPKLAHIASQILKGLSY 165
            G+  +    + +++EYM+ G L   L          +  T S   L   A QI KG+ Y
Sbjct: 62  LGVCTEE-EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA------YMS 219
           L   K +HRD+   N LV  +   VKI+DFG    + R +   + Y           +M+
Sbjct: 121 LASKKFVHRDLAARNCLVGEDL-VVKISDFG----LSRDVYDDDYYRKKTGGKLPIRWMA 175

Query: 220 PERFDPDAYGGNYNGYAGDIWSLGLTLLELY-LGHFPFLQPGQRPDWATLMCAICFGDPP 278
           PE        G +     D+WS G+ L E++ LG  P+  PG       ++  +  G   
Sbjct: 176 PESL----KDGIFT-SKSDVWSFGVLLWEIFTLGATPY--PGL--SNEEVLEYLRKGYRL 226

Query: 279 SLPDGASPEFRSFIECCLQKEFSKRWTASQLL 310
             P+    E    +  C Q +   R T S+L+
Sbjct: 227 PKPEYCPDELYELMLSCWQLDPEDRPTFSELV 258

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  141 bits (356), Expect = 5e-40
 Identities = 94/272 (34%), Positives = 146/272 (53%), Gaps = 16/272 (5%)

Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRR-TDSPFI 111
            E ++V+G+G  G VYK +H  T ++ A+KV+  D       ++  E+ +L++ +    I
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTEDEEEEIKLEINMLKKYSHHRNI 75

Query: 112 VQCFGIFEK--PSGD---IAILMEYMDSGTLDTLL--NKNGTFSEPKLAHIASQILKGLS 164
              +G F K  P G    + ++ME+  +G++  L+   K     E  +A+I  +IL+GL+
Sbjct: 76  ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA 135

Query: 165 YLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD 224
           +LH HK+IHRDIK  N+L+   N +VK+ DFGVS  + R++   N+++GT  +M+PE   
Sbjct: 136 HLHAHKVIHRDIKGQNVLL-TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 194

Query: 225 PDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
            D        Y  DIWSLG+T +E+  G  P       P  A  +  I    PP L    
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD--MHPMRALFL--IPRNPPPKLKSKK 250

Query: 285 -SPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
            S +F  FIE CL K +  R +  QLL HPF+
Sbjct: 251 WSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  141 bits (356), Expect = 1e-39
 Identities = 85/282 (30%), Positives = 138/282 (48%), Gaps = 30/282 (10%)

Query: 50  YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR--QVFREMEILRRTD 107
           ++DL ++   GHG+ G VY  +   T+++ A+K +      +  +   + +E+  L++  
Sbjct: 17  FTDLREI---GHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR 73

Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
            P  ++  G + +      ++MEY      D L        E ++A I    L+GL+YLH
Sbjct: 74  HPNTIEYKGCYLREH-TAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLH 132

Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE---RFD 224
            H+ IHRDIK  N+L+      VK+ADFG + ++  +    NS+VGT  +M+PE     D
Sbjct: 133 SHERIHRDIKAGNILLTEPG-TVKLADFGSASLVSPA----NSFVGTPYWMAPEVILAMD 187

Query: 225 PDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCA---ICFGDPPSL- 280
                G Y+G   D+WSLG+T +EL     P             M A   I   D P+L 
Sbjct: 188 E----GQYDGKV-DVWSLGITCIELAERKPPLFN-------MNAMSALYHIAQNDSPTLS 235

Query: 281 PDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSD 322
            +  S  FR+F++ CLQK    R ++ +LL H F+ + R   
Sbjct: 236 SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPT 277

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  138 bits (351), Expect = 3e-39
 Identities = 72/272 (26%), Positives = 108/272 (39%), Gaps = 31/272 (11%)

Query: 53  LEKLQVLGHGNGGTVYK----VQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS 108
           LE  + LG G  G VYK         T    A+K +   A    R +   E  I+++   
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60

Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQILKGLSYLH 167
           P IV+  G+  +    + I+ EYM  G L   L       +   L  +A QI KG+ YL 
Sbjct: 61  PNIVRLLGVCTQ-GEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119

Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSY-VGTCAY-----MSPE 221
               +HRD+   N LV  N   VKI+DFG    + R +   + Y            M+PE
Sbjct: 120 SKNFVHRDLAARNCLVTENL-VVKISDFG----LSRDIYEDDYYRKRGGGKLPIKWMAPE 174

Query: 222 RFDPDAYGGNYNGY--AGDIWSLGLTLLELY-LGHFPFLQPGQRPDWATLMCAICFGDPP 278
                        +    D+WS G+ L E++ LG  P+  PG       ++  +  G   
Sbjct: 175 SL-------KDGKFTSKSDVWSFGVLLWEIFTLGEQPY--PGM--SNEEVLELLEDGYRL 223

Query: 279 SLPDGASPEFRSFIECCLQKEFSKRWTASQLL 310
             P+    E    +  C   +   R T S+L+
Sbjct: 224 PRPENCPDELYELMLQCWAYDPEDRPTFSELV 255

Length = 258

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  138 bits (349), Expect = 5e-39
 Identities = 99/278 (35%), Positives = 157/278 (56%), Gaps = 28/278 (10%)

Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKV--VHGDADPTVRRQVFREMEILRR-TDSP 109
            E ++++G+G  G VYK +H  T ++ A+KV  V GD +  +++    E+ +L++ +   
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ----EINMLKKYSHHR 63

Query: 110 FIVQCFGIFEK--PSG---DIAILMEYMDSGTLDTLL--NKNGTFSEPKLAHIASQILKG 162
            I   +G F K  P G    + ++ME+  +G++  L+   K  T  E  +A+I  +IL+G
Sbjct: 64  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123

Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
           LS+LH HK+IHRDIK  N+L+   N +VK+ DFGVS  + R++   N+++GT  +M+PE 
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLL-TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 182

Query: 223 F----DPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPP 278
                +PDA    Y+ +  D+WSLG+T +E+  G  P       P  A  +  I     P
Sbjct: 183 IACDENPDA---TYD-FKSDLWSLGITAIEMAEGAPPLCD--MHPMRALFL--IPRNPAP 234

Query: 279 SLPDGA-SPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
            L     S +F+SFIE CL K  S+R T  QL+ HPF+
Sbjct: 235 RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  137 bits (348), Expect = 7e-39
 Identities = 79/272 (29%), Positives = 115/272 (42%), Gaps = 31/272 (11%)

Query: 53  LEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRTDS 108
           L   + LG G  G VYK          ++  A+K +  DA      +  RE  I+R+ D 
Sbjct: 1   LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60

Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLL--NKNGTFSEPKLAHIASQILKGLSYL 166
           P IV+  G+  +    + I+MEYM  G L   L  N+    S   L   A QI +G+ YL
Sbjct: 61  PNIVKLLGVCTEE-EPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119

Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA-----YMSPE 221
                IHRD+   N LV  N   VKI+DFG    + R L   + Y          +M+PE
Sbjct: 120 ESKNFIHRDLAARNCLVGENL-VVKISDFG----LSRDLYDDDYYKVKGGKLPIRWMAPE 174

Query: 222 RFDPDAYGGNYNGY--AGDIWSLGLTLLELY-LGHFPFLQPGQRPDWATLMCAICFGDPP 278
                        +    D+WS G+ L E++ LG  P+  PG     A ++  +  G   
Sbjct: 175 SL-------KEGKFTSKSDVWSFGVLLWEIFTLGEEPY--PG--MSNAEVLEYLKKGYRL 223

Query: 279 SLPDGASPEFRSFIECCLQKEFSKRWTASQLL 310
             P    PE    +  C  ++   R T S+L+
Sbjct: 224 PKPPNCPPELYKLMLQCWAEDPEDRPTFSELV 255

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  138 bits (348), Expect = 9e-39
 Identities = 90/286 (31%), Positives = 135/286 (47%), Gaps = 45/286 (15%)

Query: 55  KLQVLGHGNGGTVYKVQHRCTHKIYALKVV---------HGDADPTVRRQVFREMEILRR 105
           K +++G G  G VY   +  T ++ A+K V         H      + + +  E+E L+ 
Sbjct: 5   KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD 64

Query: 106 TDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
            D   IVQ  G FE     ++I +EY+  G++ + L   G F E  +     Q+L+GL+Y
Sbjct: 65  LDHLNIVQYLG-FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAY 123

Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD-----ACNSYVGTCAYMSP 220
           LH   I+HRD+K  NLLV+ + +  KI+DFG+SK   +S D        S  G+  +M+P
Sbjct: 124 LHSKGILHRDLKADNLLVDADGI-CKISDFGISK---KSDDIYDNDQNMSMQGSVFWMAP 179

Query: 221 ERFDPDAYGGNYNGYAG--DIWSLGLTLLELYLGHFPFLQPGQRPDWATL-MCAICF--G 275
           E     +      GY+   DIWSLG  +LE++         G+RP W+     A  F  G
Sbjct: 180 EVIHSYS-----QGYSAKVDIWSLGCVVLEMF--------AGRRP-WSDEEAIAAMFKLG 225

Query: 276 D-------PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPF 314
           +       PP +    SP    F+  C       R TA +LL HPF
Sbjct: 226 NKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  136 bits (346), Expect = 1e-38
 Identities = 79/271 (29%), Positives = 116/271 (42%), Gaps = 30/271 (11%)

Query: 53  LEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRTDS 108
           L   + LG G  G VYK          K+  A+K +  DA      +  RE  I+R+ D 
Sbjct: 1   LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60

Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLH 167
           P +V+  G+  +    + I+MEYM+ G L + L KN    S   L   A QI +G+ YL 
Sbjct: 61  PNVVKLLGVCTEE-EPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119

Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA-----YMSPER 222
               IHRD+   N LV  N   VKI+DFG    + R L   + Y          +M+PE 
Sbjct: 120 SKNFIHRDLAARNCLVGENL-VVKISDFG----LSRDLYDDDYYRKRGGKLPIRWMAPES 174

Query: 223 FDPDAYGGNYNGY--AGDIWSLGLTLLELY-LGHFPFLQPGQRPDWATLMCAICFGDPPS 279
                       +    D+WS G+ L E++ LG  P+  PG       ++  +  G    
Sbjct: 175 L-------KEGKFTSKSDVWSFGVLLWEIFTLGEQPY--PGM--SNEEVLEYLKNGYRLP 223

Query: 280 LPDGASPEFRSFIECCLQKEFSKRWTASQLL 310
            P    PE    +  C  ++   R T S+L+
Sbjct: 224 QPPNCPPELYDLMLQCWAEDPEDRPTFSELV 254

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  137 bits (346), Expect = 2e-38
 Identities = 75/269 (27%), Positives = 132/269 (49%), Gaps = 17/269 (6%)

Query: 55  KLQVLGHGNGGTVYKVQHRCTHKIYALKVV------HGDADPTVRRQVFREMEILRRTDS 108
           K Q LG G   + Y+ +   T  + A+K V        + +  V   + +E+ ++ R + 
Sbjct: 4   KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVE-ALRKEIRLMARLNH 62

Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           P I++  G   +      + +E+M  G++  LL+K G F E  + +   Q+L+GLSYLH 
Sbjct: 63  PHIIRMLGATCE-DSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHE 121

Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSY----VGTCAYMSPERFD 224
           ++IIHRD+K +NLL+++   +++IADFG +  +         +    +GT A+M+PE   
Sbjct: 122 NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181

Query: 225 PDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
            + Y     G + D+WS+G  ++E+     P+         A +         PS+P+  
Sbjct: 182 GEQY-----GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHL 236

Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHP 313
           SP  R     CL+ +   R  + +LL HP
Sbjct: 237 SPGLRDVTLRCLELQPEDRPPSRELLKHP 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  137 bits (348), Expect = 2e-38
 Identities = 86/259 (33%), Positives = 133/259 (51%), Gaps = 25/259 (9%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR-RQV---FREMEILRRT 106
            D E ++ LG G+ G V  V+H+ + K YALK++       V+ +QV     E  IL+  
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILS--KAKIVKLKQVEHVLNEKRILQSI 58

Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
             PF+V  +G F+  S ++ ++MEY+  G L + L K+G F EP     A+Q++  L YL
Sbjct: 59  RHPFLVNLYGSFQDDS-NLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYL 117

Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPD 226
           H   I++RD+KP NLL++++   +KI DFG +K   R      +  GT  Y++PE     
Sbjct: 118 HSLDIVYRDLKPENLLLDSDG-YIKITDFGFAK---RVKGRTYTLCGTPEYLAPEIILSK 173

Query: 227 AYGGNYNGYAGDIWSLGLTLLELYLGHFPF--LQPGQRPDWATLMCAICFGDPPSLPDGA 284
            Y     G A D W+LG+ + E+  G+ PF    P Q  +   L   + F      P   
Sbjct: 174 GY-----GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYE-KILEGKVRF------PSFF 221

Query: 285 SPEFRSFIECCLQKEFSKR 303
           SP+ +  I   LQ + +KR
Sbjct: 222 SPDAKDLIRNLLQVDLTKR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  135 bits (341), Expect = 5e-38
 Identities = 84/272 (30%), Positives = 130/272 (47%), Gaps = 24/272 (8%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTDSPF 110
           D + L+ LG G+ G+VYKV+    ++ YALK V  G      R     E+ IL   + P 
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 111 IVQCFGIFEKPSGDIAIL---MEYMDSGTLDTLLNKNGT----FSEPKLAHIASQILKGL 163
           I+     +++   D   L   MEY   G L   ++K         E ++  I  Q+L+GL
Sbjct: 61  IIS----YKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGL 116

Query: 164 SYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF 223
             LH  KI+HRD+K +N+L+  N+  VKI D G+SK++ +++    + +GT  YM+PE +
Sbjct: 117 QALHEQKILHRDLKSANILLVAND-LVKIGDLGISKVLKKNM--AKTQIGTPHYMAPEVW 173

Query: 224 DPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDG 283
               Y      Y  DIWSLG  L E+     PF    +      L   +  G  P +P  
Sbjct: 174 KGRPY-----SYKSDIWSLGCLLYEMATFAPPF----EARSMQDLRYKVQRGKYPPIPPI 224

Query: 284 ASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
            S + ++FI   LQ +   R    ++L  P +
Sbjct: 225 YSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  134 bits (340), Expect = 9e-38
 Identities = 70/207 (33%), Positives = 103/207 (49%), Gaps = 10/207 (4%)

Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFG 116
           LG G  G V  V+ +  ++ +ALK V      +   +  +F E EIL   + PFIV+ + 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 117 IFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDI 176
            F K    I +LMEY   G L T+L   G F E       + ++    YLH   II+RD+
Sbjct: 61  TF-KDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDL 119

Query: 177 KPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYA 236
           KP NLL+++N   VK+ DFG +K +        ++ GT  Y++PE      Y      ++
Sbjct: 120 KPENLLLDSNGY-VKLVDFGFAKKLKSGQKT-WTFCGTPEYVAPEIILNKGY-----DFS 172

Query: 237 GDIWSLGLTLLELYLGHFPFLQPGQRP 263
            D WSLG+ L EL  G  PF +  + P
Sbjct: 173 VDYWSLGILLYELLTGRPPFGEDDEDP 199

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  133 bits (338), Expect = 4e-37
 Identities = 88/292 (30%), Positives = 129/292 (44%), Gaps = 41/292 (14%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSPFIV 112
           EKL+ LG G  G VYK + + T +I ALK +  D +   +     RE+ +L+    P IV
Sbjct: 2   EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIV 61

Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKI 171
           +   +       + ++ EY D   L   L+K  G  S   +  I  Q+L+GL+Y H H+I
Sbjct: 62  KLLDVIHTERK-LYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRI 119

Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGN 231
           +HRD+KP N+L+N + + +K+ADFG+++     L      V T  Y +PE       G  
Sbjct: 120 LHRDLKPQNILINRDGV-LKLADFGLARAFGIPLRTYTHEVVTLWYRAPEIL----LGSK 174

Query: 232 YNGYAGDIWSLGLTLLELYLGHFPFLQPGQRP-DWATLMCAICFGDP--------PSLPD 282
           +   A DIWS+G    E+  G   F  PG    D    +  I  G P          LPD
Sbjct: 175 HYSTAVDIWSVGCIFAEMITGKPLF--PGDSEIDQLFKIFQIL-GTPTEESWPGVTKLPD 231

Query: 283 GASPEFRSFIECCLQKEFS-------------------KRWTASQLLTHPFL 315
              P F  F    L+K                      KR +A + L HP+ 
Sbjct: 232 Y-KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  132 bits (333), Expect = 2e-36
 Identities = 87/295 (29%), Positives = 134/295 (45%), Gaps = 49/295 (16%)

Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHG----DADPTVRRQVFREMEILRRTDSPFI 111
           L  +G G  G V+K + R T +  ALK V         P    Q  RE++ L+    P++
Sbjct: 5   LGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPN---QALREIKALQACQHPYV 61

Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
           V+   +F   SG   ++MEYM S   + L ++     E ++      +LKG++Y+H + I
Sbjct: 62  VKLLDVFPHGSG-FVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGI 120

Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSY---VGTCAYMSPERFDPDAY 228
           +HRD+KP+NLL++ + + +KIADFG++++   S +    Y   V T  Y +PE      Y
Sbjct: 121 MHRDLKPANLLISADGV-LKIADFGLARLF--SEEEPRLYSHQVATRWYRAPELL----Y 173

Query: 229 GGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAI-CFGDP--------PS 279
           G        D+W++G    EL L   P   PG   D   L       G P         S
Sbjct: 174 GARKYDPGVDLWAVGCIFAEL-LNGSPLF-PG-ENDIEQLAIVFRTLGTPNEETWPGLTS 230

Query: 280 LPD-------------------GASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
           LPD                    ASPE    ++  L  + SKR +A++ L HP+ 
Sbjct: 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  129 bits (324), Expect = 2e-35
 Identities = 90/267 (33%), Positives = 140/267 (52%), Gaps = 13/267 (4%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSP 109
           D E +Q +G G  G VYK ++  T ++ A+KV+  +   D  V +Q   E+ +++     
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ---EIIMMKDCKHS 66

Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
            IV  FG + +    + I ME+   G+L  + +  G  SE ++A+++ + L+GL YLH  
Sbjct: 67  NIVAYFGSYLR-RDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK 125

Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYG 229
             +HRDIK +N+L+ +N   VK+ADFGVS  +  ++    S++GT  +M+PE    +  G
Sbjct: 126 GKMHRDIKGANILLTDNG-HVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKG 184

Query: 230 GNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA--SPE 287
           G YN    DIW++G+T +EL     P       P  A  +       PP L D    S  
Sbjct: 185 G-YNQLC-DIWAVGITAIELAELQPPMFD--LHPMRALFLMTKSNFQPPKLKDKMKWSNS 240

Query: 288 FRSFIECCLQKEFSKRWTASQLLTHPF 314
           F  F++  L K   KR TA +LL HPF
Sbjct: 241 FHHFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  128 bits (325), Expect = 3e-35
 Identities = 84/293 (28%), Positives = 133/293 (45%), Gaps = 39/293 (13%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHG-DADPTVRRQVFREMEILRRTDSPFIV 112
           E L V+G G  G V K +++ T +I A+K     + D  V++   RE+++LR+     IV
Sbjct: 4   EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIV 63

Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
                F +  G + ++ EY++   L+ L    G      +     Q+L+ ++Y H H II
Sbjct: 64  NLKEAF-RRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNII 122

Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIM-CRSLDACNSYVGTCAYMSPERFDPDAYGGN 231
           HRDIKP N+LV+ + + +K+ DFG ++ +  R       YV T  Y +PE    D    N
Sbjct: 123 HRDIKPENILVSESGV-LKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT---N 178

Query: 232 YNGYAGDIWSLGLTLLELYLGHFPFLQPGQRP-DWATLMCAICFGDPPS----------- 279
           Y G   D+W++G  + EL  G   F  PG    D   L+       PPS           
Sbjct: 179 Y-GKPVDVWAIGCIMAELLDGEPLF--PGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235

Query: 280 ----LPDGASPEFR-------------SFIECCLQKEFSKRWTASQLLTHPFL 315
                P+ + PE                F++ CL+ +  +R T  +LL HP+ 
Sbjct: 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  128 bits (322), Expect = 4e-35
 Identities = 90/268 (33%), Positives = 138/268 (51%), Gaps = 22/268 (8%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVH----GDADPTVRRQVFREMEILRRTDSPFIV 112
           Q LG G+ GTVY V+ +       LKV+     G+ +P    Q  +E ++L + D P IV
Sbjct: 6   QRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65

Query: 113 QCFGIF-EKPSGDIAILMEYMDSGTLDTLL---NKNG-TFSEPKLAHIASQILKGLSYLH 167
           +    F E+ +    I+ EY +   LD  L      G T SE ++     Q+L G+ Y+H
Sbjct: 66  KFHASFLERDA--FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123

Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDA 227
             +I+HRD+K  N+ + NN   +KI DFGVS+++  S D   ++ GT  YMSPE      
Sbjct: 124 QRRILHRDLKAKNIFLKNN--LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQG 181

Query: 228 YGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPE 287
           Y         DIWSLG  L E+      F   GQ  ++ +++  I  G  PSLP+  S +
Sbjct: 182 YDSK-----SDIWSLGCILYEMCCLAHAFE--GQ--NFLSVVLRIVEGPTPSLPETYSRQ 232

Query: 288 FRSFIECCLQKEFSKRWTASQLLTHPFL 315
             S ++  L K+ S R +A+++L +PF+
Sbjct: 233 LNSIMQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  129 bits (327), Expect = 5e-35
 Identities = 86/298 (28%), Positives = 130/298 (43%), Gaps = 48/298 (16%)

Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALK-VVHGDADPTVRRQVFREMEILRRTDSPFIVQC 114
           L+ +G G  G V     + T +  A+K + +   D    +++ RE+++LR      I+  
Sbjct: 5   LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGL 64

Query: 115 FGIFEKPS----GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
             I   PS     D+ I+ E M++  L  ++      ++  + +   QIL+GL YLH   
Sbjct: 65  LDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN 123

Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN---SYVGTCAYMSPERFDPDA 227
           +IHRD+KPSN+LVN+N   +KI DFG+++ +    D       YV T  Y +PE      
Sbjct: 124 VIHRDLKPSNILVNSNC-DLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELL---- 178

Query: 228 YGGNYNGY--AGDIWSLGLTLLELYLGHFPFLQPGQ--------------RPDWATLMC- 270
              + + Y  A DIWS+G    EL L   P   PG+               P    L   
Sbjct: 179 --LSSSRYTKAIDIWSVGCIFAEL-LTRKPLF-PGRDYIDQLNLIVEVLGTPSEEDLKFI 234

Query: 271 ----AICF--GDPPSLP-------DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
               A  +    P            GASPE    +E  L  +  KR TA + L HP+L
Sbjct: 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  127 bits (320), Expect = 6e-35
 Identities = 83/263 (31%), Positives = 127/263 (48%), Gaps = 14/263 (5%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFR-EMEILRRTDSPFIV 112
           EK++V+G G  G V+  + +   K+  +K +  +      R   + E ++L+    P I+
Sbjct: 3   EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNII 62

Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHGHK 170
           + +  F +    + I+MEY   GTL   + K  N    E  + H   QIL  L ++H   
Sbjct: 63  EYYENFLEDKA-LMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL 121

Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGG 230
           I+HRD+K  N+L++ + M VKI DFG+SKI+  S     + VGT  Y+SPE  +    G 
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYTVVGTPCYISPELCE----GK 176

Query: 231 NYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
            YN    DIW+LG  L EL      F    +  +   L+  I  G    + D  SP+ R 
Sbjct: 177 PYN-QKSDIWALGCVLYELASLKRAF----EAANLPALVLKIMSGTFAPISDRYSPDLRQ 231

Query: 291 FIECCLQKEFSKRWTASQLLTHP 313
            I   L  + SKR   SQ++  P
Sbjct: 232 LILSMLNLDPSKRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  126 bits (317), Expect = 2e-34
 Identities = 92/274 (33%), Positives = 146/274 (53%), Gaps = 27/274 (9%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH---GDADPTVRRQVFREMEILRRTDS 108
           D E +Q +G G  G VYK ++  T ++ A+K++    GD    +++++F    +++    
Sbjct: 10  DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIF----MVKECKH 65

Query: 109 PFIVQCFGIF---EKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
             IV  FG +   EK    + I MEY   G+L  + +  G  SE ++A++  + L+GL+Y
Sbjct: 66  CNIVAYFGSYLSREK----LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAY 121

Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDP 225
           LH    +HRDIK +N+L+ +N   VK+ADFGV+  +  ++    S++GT  +M+PE    
Sbjct: 122 LHSKGKMHRDIKGANILLTDNG-DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAV 180

Query: 226 DAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQ---RPDWATLMCAICFGDPPSLPD 282
           +  GG YN    DIW++G+T +EL       LQP      P  A  + +     PP L D
Sbjct: 181 EKNGG-YNQLC-DIWAVGITAIEL-----AELQPPMFDLHPMRALFLMSKSNFQPPKLKD 233

Query: 283 GA--SPEFRSFIECCLQKEFSKRWTASQLLTHPF 314
               S  F +F++  L K   KR TA +LLTH F
Sbjct: 234 KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  125 bits (317), Expect = 4e-34
 Identities = 91/297 (30%), Positives = 145/297 (48%), Gaps = 54/297 (18%)

Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVF--------REMEILRR-T 106
           ++ LG G  G+VY  +++ T ++ A+K         ++++ +        RE++ LR+  
Sbjct: 4   IKQLGDGTFGSVYLARNKETGELVAIK--------KMKKKFYSWEECMNLREVKSLRKLN 55

Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLL--NKNGTFSEPKLAHIASQILKGLS 164
           + P IV+   +F + + ++  + EYM+ G L  L+   K   FSE  +  I  QIL+GL+
Sbjct: 56  EHPNIVKLKEVF-RENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLA 113

Query: 165 YLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD 224
           ++H H   HRD+KP NLLV+   + VKIADFG+++ + RS      YV T  Y +PE   
Sbjct: 114 HIHKHGFFHRDLKPENLLVSGPEV-VKIADFGLAREI-RSRPPYTDYVSTRWYRAPEILL 171

Query: 225 PDAYGGNYNGYAGDIWSLGLTLLELYLGH--FP--------FL------QPGQR--PDWA 266
                  Y+    DIW+LG  + ELY     FP        +        P ++  P+  
Sbjct: 172 RSTS---YSS-PVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGY 227

Query: 267 TLMCAICFGDPPS--------LPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
            L   + F  P          +P+ ASPE    I+  L+ +  KR TASQ L HP+ 
Sbjct: 228 KLASKLGFRFPQFAPTSLHQLIPN-ASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  125 bits (317), Expect = 2e-33
 Identities = 90/304 (29%), Positives = 137/304 (45%), Gaps = 57/304 (18%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQV--FR-EMEILRRTD 107
            D E ++V+G G  G V+ V+ + T ++YA+KV+   +D   R Q+   R E +IL   D
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLR-KSDMIKRNQIAHVRAERDILADAD 59

Query: 108 SPFIVQCFGIFEKPSGD---IAILMEYMDSGTLDTLLNKNGTFSEPKLA--HIASQILKG 162
           SP+IV+ +  F+    D   + ++MEYM  G L  LL +   F E + A  +IA  +L  
Sbjct: 60  SPWIVKLYYSFQ----DEEHLYLVMEYMPGGDLMNLLIRKDVFPE-ETARFYIAELVL-A 113

Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA--------------- 207
           L  +H    IHRDIKP N+L++ +   +K+ADFG+ K M ++ D                
Sbjct: 114 LDSVHKLGFIHRDIKPDNILIDADG-HIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172

Query: 208 --------------CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGH 253
                          NS VGT  Y++PE      YG        D WSLG+ L E+  G 
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLEC-----DWWSLGVILYEMLYGF 227

Query: 254 FPFLQPGQRPDWATLM-CAICFGDPPSLPDGASPEFRSFIE--CCLQKEFSKRWTASQLL 310
            PF     +  +  ++        PP      SPE    I    C  ++        ++ 
Sbjct: 228 PPFYSDTLQETYNKIINWKESLRFPPD--PPVSPEAIDLICRLLCDPEDRLGS--FEEIK 283

Query: 311 THPF 314
           +HPF
Sbjct: 284 SHPF 287

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  123 bits (311), Expect = 2e-33
 Identities = 81/266 (30%), Positives = 119/266 (44%), Gaps = 16/266 (6%)

Query: 54  EKLQVLGHGNGG--TVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
             ++VLG G  G  T+Y+ +      +   +V         RR    E+ IL     P I
Sbjct: 3   IPIRVLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61

Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGT-FSEPKLAHIASQILKGLSYLHGH 169
           +  +  F      + I MEY + GTL D ++ + G  F E  +     QI+  +SY+H  
Sbjct: 62  IAYYNHFMD-DNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120

Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYG 229
            I+HRDIK  N+ +    + +K+ DFG+SKI+        + VGT  YMSPE       G
Sbjct: 121 GILHRDIKTLNIFLTKAGL-IKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQ----G 175

Query: 230 GNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFR 289
             YN +  DIW+LG  L EL      F           L+  I  G+   +    S E  
Sbjct: 176 VKYN-FKSDIWALGCVLYELLTLKRTFDATNP----LNLVVKIVQGNYTPVVSVYSSELI 230

Query: 290 SFIECCLQKEFSKRWTASQLLTHPFL 315
           S +   LQ++  KR TA ++L  P L
Sbjct: 231 SLVHSLLQQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  123 bits (312), Expect = 2e-33
 Identities = 80/312 (25%), Positives = 128/312 (41%), Gaps = 76/312 (24%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALK--VVHGDAD--PTVRRQVFREMEILRRTDS- 108
           E+L  +G G  GTVYK +   T +  ALK   V    +  P       RE+ +L++ +S 
Sbjct: 2   EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPL---STLREIALLKQLESF 58

Query: 109 --PFIVQCFGIFEKPSGD----IAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQIL 160
             P IV+   +   P  D    + ++ E++D   L T L+K          +  +  Q+L
Sbjct: 59  EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLL 117

Query: 161 KGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSP 220
           +G+ +LH H+I+HRD+KP N+LV ++  QVKIADFG+++I    + A  S V T  Y +P
Sbjct: 118 RGVDFLHSHRIVHRDLKPQNILVTSDG-QVKIADFGLARIYSFEM-ALTSVVVTLWYRAP 175

Query: 221 ERFDPDAYGGNYNGYAGDIWSLGLTLLELYL----------------------------- 251
           E     +Y         D+WS+G    EL+                              
Sbjct: 176 EVLLQSSY-----ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEW 230

Query: 252 --------GHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKR 303
                     FP         + + +  IC        +G        ++  L     KR
Sbjct: 231 PRNVSLPRSSFP---SYTPRSFKSFVPEIC-------EEGL-----DLLKKMLTFNPHKR 275

Query: 304 WTASQLLTHPFL 315
            +A + L HP+ 
Sbjct: 276 ISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  123 bits (311), Expect = 2e-33
 Identities = 89/282 (31%), Positives = 139/282 (49%), Gaps = 31/282 (10%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTH---KIYALKVVHG--------DADPT-VRRQVFRE 99
           + E L+VLG G  G V+ V+    H   K+YA+KV+           A+ T   RQV   
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQV--- 57

Query: 100 MEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQI 159
           +E +RR   PF+V     F+  +  + ++++Y++ G L T L +   F+E ++    ++I
Sbjct: 58  LEAVRRC--PFLVTLHYAFQTDT-KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEI 114

Query: 160 LKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKI-MCRSLDACNSYVGTCAYM 218
           +  L +LH   II+RDIK  N+L+++    V + DFG+SK  +    +   S+ GT  YM
Sbjct: 115 VLALDHLHQLGIIYRDIKLENILLDSEG-HVVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173

Query: 219 SPE--RFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD 276
           +PE  R     +       A D WSLG+   EL  G  PF   G++   + +   I    
Sbjct: 174 APEVIRGGSGGHDK-----AVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK 228

Query: 277 PPSLPDGASPEFRSFIECCLQKEFSKRW---TASQLLTHPFL 315
           PP  P   S E R FI+  L+K+  KR     A ++  HPF 
Sbjct: 229 PP-FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  122 bits (308), Expect = 4e-33
 Identities = 76/259 (29%), Positives = 122/259 (47%), Gaps = 16/259 (6%)

Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVH--GDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           +G G    VYK       ++ ALK V      D   R+   +E+++L++ D P +++   
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 117 IFEKPSGDIAILMEYMDSGTLDTLL----NKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
            F + + ++ I++E  D+G L  ++     +     E  +     Q+   L ++H  +I+
Sbjct: 70  SFIE-NNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIM 128

Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNY 232
           HRDIKP+N+ +      VK+ D G+ +       A +S VGT  YMSPER     +   Y
Sbjct: 129 HRDIKPANVFITATG-VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI----HENGY 183

Query: 233 NGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLP-DGASPEFRSF 291
           N +  DIWSLG  L E+     PF   G + +  +L   I   D P LP D  S E R  
Sbjct: 184 N-FKSDIWSLGCLLYEMAALQSPFY--GDKMNLYSLCKKIEKCDYPPLPADHYSEELRDL 240

Query: 292 IECCLQKEFSKRWTASQLL 310
           +  C+  +  KR   S +L
Sbjct: 241 VSRCINPDPEKRPDISYVL 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  122 bits (308), Expect = 6e-33
 Identities = 80/267 (29%), Positives = 126/267 (47%), Gaps = 22/267 (8%)

Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQ----VFREMEILRRTDSPFIVQC 114
           LG G  G V   Q + T K+YA K +  D     +R+       E +IL +  S FIV  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKL--DKKRLKKRKGEQMALNEKKILEKVSSRFIVSL 58

Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGT--FSEPKLAHIASQILKGLSYLHGHKII 172
              FE    D+ ++M  M+ G L   +   G   F E +    A+QI+ GL +LH  +I+
Sbjct: 59  AYAFETKD-DLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIV 117

Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNY 232
           +RD+KP N+L++++   V+I+D G++  + +         GT  YM+PE    + Y    
Sbjct: 118 YRDLKPENVLLDDHG-NVRISDLGLAVEL-KGGKKIKGRAGTPGYMAPEVLQGEVY---- 171

Query: 233 NGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFI 292
             ++ D ++LG TL E+  G  PF Q  ++ +   L            PD  SPE +   
Sbjct: 172 -DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT-LEMAVEYPDKFSPEAKDLC 229

Query: 293 ECCLQKEFSKR-----WTASQLLTHPF 314
           E  LQK+  KR      +A ++  HP 
Sbjct: 230 EALLQKDPEKRLGCRGGSADEVREHPL 256

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  122 bits (306), Expect = 8e-33
 Identities = 91/272 (33%), Positives = 129/272 (47%), Gaps = 30/272 (11%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-PTVRRQVFR---EMEILRRTDSPFIV 112
           ++LG G  G VY      T +  A K V  D + P   ++V     E+++L+      IV
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67

Query: 113 QCFGIF-EKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
           Q +G   ++    + I MEYM  G++   L   G  +E        QIL+G+SYLH + I
Sbjct: 68  QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMI 127

Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSK---IMCRSLDACNSYVGTCAYMSPERFDPDAY 228
           +HRDIK +N+L ++    VK+ DFG SK    +C S     S  GT  +MSPE    + Y
Sbjct: 128 VHRDIKGANILRDSAG-NVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY 186

Query: 229 GGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATL--MCAI--CFGDP--PSLPD 282
                G   D+WSLG T++E+           ++P WA    M AI      P  P LP 
Sbjct: 187 -----GRKADVWSLGCTVVEMLT---------EKPPWAEYEAMAAIFKIATQPTNPQLPS 232

Query: 283 GASPEFRSFIECCLQKEFSKRWTASQLLTHPF 314
             S   R F+ C    E   R +A +LL HPF
Sbjct: 233 HISEHARDFLGCIFV-EARHRPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  121 bits (306), Expect = 1e-32
 Identities = 82/268 (30%), Positives = 133/268 (49%), Gaps = 18/268 (6%)

Query: 50  YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSP 109
           Y+  EK+   G G  GTVY      T +  A+K ++    P  +  +  E+ ++R    P
Sbjct: 21  YTRFEKI---GQGASGTVYTAIDVATGQEVAIKQMNLQQQPK-KELIINEILVMRENKHP 76

Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
            IV     +     ++ ++MEY+  G+L  ++ +     E ++A +  + L+ L +LH +
Sbjct: 77  NIVNYLDSY-LVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN 134

Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYG 229
           ++IHRDIK  N+L+  +   VK+ DFG    +       ++ VGT  +M+PE     AYG
Sbjct: 135 QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 193

Query: 230 GNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSL--PDGASPE 287
                   DIWSLG+  +E+  G  P+L   + P  A  + A      P L  P+  S  
Sbjct: 194 PKV-----DIWSLGIMAIEMVEGEPPYLN--ENPLRALYLIAT--NGTPELQNPEKLSAI 244

Query: 288 FRSFIECCLQKEFSKRWTASQLLTHPFL 315
           FR F+  CL+ +  KR +A +LL HPFL
Sbjct: 245 FRDFLNRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  121 bits (306), Expect = 2e-32
 Identities = 85/294 (28%), Positives = 135/294 (45%), Gaps = 45/294 (15%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH----GDADPTVRRQVFREMEILRRTDSP 109
           EK + LG G    VYK + + T +I A+K +      +A   +     RE+++L+    P
Sbjct: 3   EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHP 62

Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQILKGLSYLHG 168
            I+    +F   S +I ++ E+M++  L+ ++ +K+   +   +       L+GL YLH 
Sbjct: 63  NIIGLLDVFGHKS-NINLVFEFMET-DLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS 120

Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAY 228
           + I+HRD+KP+NLL+ ++   +K+ADFG+++            V T  Y +PE      +
Sbjct: 121 NWILHRDLKPNNLLIASDG-VLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELL----F 175

Query: 229 GGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRP-DWATLMCAICFGDP-----P---S 279
           G  + G   D+WS+G    EL L   PFL PG    D    +     G P     P   S
Sbjct: 176 GARHYGVGVDMWSVGCIFAELLLRV-PFL-PGDSDIDQLGKIFEA-LGTPTEENWPGVTS 232

Query: 280 LPDGASPEFRSFIECCLQKEFS-------------------KRWTASQLLTHPF 314
           LPD    EF+ F    L++ F                    KR TA Q L HP+
Sbjct: 233 LPDYV--EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  121 bits (305), Expect = 2e-32
 Identities = 83/281 (29%), Positives = 126/281 (44%), Gaps = 43/281 (15%)

Query: 53  LEKLQVLGHGNGGTVYKVQHRC----THKIYALKVVHGDADPTVRRQVFREMEILRRTDS 108
           L+ ++ LG G+ G V   ++      T +  A+K ++   +   R    RE+EILR  D 
Sbjct: 6   LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDH 65

Query: 109 PFIVQCFGIFEKPSGD-IAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYL 166
             IV+  G+ EKP G  + ++MEY+ SG+L   L ++    +  +L   +SQI KG+ YL
Sbjct: 66  ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYL 125

Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER-FDP 225
              + IHRD+   N+LV + +  VKI+DFG++K++    D    Y       SP   + P
Sbjct: 126 GSQRYIHRDLAARNILVESED-LVKISDFGLAKVLPEDKD---YYYVKEPGESPIFWYAP 181

Query: 226 DAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD--------- 276
           +    +    A D+WS G+TL EL+    P   P         M  I  G          
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF---LRMIGIAQGQMIVTRLLEL 238

Query: 277 ---------PPSLPD----------GASPEFR-SFIECCLQ 297
                    PPS PD           A P+ R SF +  L 
Sbjct: 239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILI 279

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =  120 bits (303), Expect = 3e-32
 Identities = 83/270 (30%), Positives = 129/270 (47%), Gaps = 23/270 (8%)

Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFR----EMEILRRTDSPFIVQC 114
           LG G  G V   Q R T K+YA K +  +     +R+ +     E  IL +  S FIV  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKL--NKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL 58

Query: 115 FGIFEKPSGDIAILMEYMDSGTLD----TLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
              F+  + D+ ++M  M+ G L      +  +N  F EP+     +QI+ GL +LH  +
Sbjct: 59  AYAFQTKT-DLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR 117

Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGG 230
           II+RD+KP N+L++N+   V+I+D G++  +         Y GT  +M+PE    + Y  
Sbjct: 118 IIYRDLKPENVLLDNDG-NVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEY-- 174

Query: 231 NYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
               ++ D ++LG+TL E+     PF   G++ +   L   I   D  + PD  SP  +S
Sbjct: 175 ---DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI-LNDSVTYPDKFSPASKS 230

Query: 291 FIECCLQKEFSKRW-----TASQLLTHPFL 315
           F E  L K+  KR          L THP  
Sbjct: 231 FCEALLAKDPEKRLGFRDGNCDGLRTHPLF 260

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  119 bits (300), Expect = 1e-31
 Identities = 83/293 (28%), Positives = 134/293 (45%), Gaps = 43/293 (14%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALK-VVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           EKL  +G G+ G V+K ++R T +I A+K  V  + DP +++   RE+ +L++   P +V
Sbjct: 4   EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLV 63

Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTL-LNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
               +F +    + ++ EY D   L+ L  N  G   E  +  I  Q L+ +++ H H  
Sbjct: 64  NLIEVFRR-KRKLHLVFEYCDHTVLNELEKNPRG-VPEHLIKKIIWQTLQAVNFCHKHNC 121

Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPD-AYGG 230
           IHRD+KP N+L+     Q+K+ DFG ++I+    D    YV T  Y +PE    D  YG 
Sbjct: 122 IHRDVKPENILITKQG-QIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGP 180

Query: 231 NYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATL---------------------- 268
                  D+W++G    EL  G  P L PG + D   L                      
Sbjct: 181 -----PVDVWAIGCVFAELLTGQ-P-LWPG-KSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232

Query: 269 -MCAICFGDPPSLPD------GASPEFRSFIECCLQKEFSKRWTASQLLTHPF 314
               +   +P +           S    SF++ CLQ + ++R +  +LL HP+
Sbjct: 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  118 bits (297), Expect = 2e-31
 Identities = 88/277 (31%), Positives = 144/277 (51%), Gaps = 26/277 (9%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT--VRRQVFREMEILRR-TDSPF 110
           E ++ +G G  G V+KV ++      A+K++    DP   +  ++  E  IL+  +D P 
Sbjct: 21  EIIETIGKGTYGKVFKVLNKKNGSKAAVKIL----DPIHDIDEEIEAEYNILKALSDHPN 76

Query: 111 IVQCFGIF---EKPSGD-IAILMEYMDSGTLDTL----LNKNGTFSEPKLAHIASQILKG 162
           +V+ +G++   +  +GD + +++E  + G++  L    L +     EP +A+I  + L G
Sbjct: 77  VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMG 136

Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
           L +LH +K IHRD+K +N+L+      VK+ DFGVS  +  +    N+ VGT  +M+PE 
Sbjct: 137 LQHLHVNKTIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 195

Query: 223 FDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPF--LQPGQRPDWATLMCAICFGDPPSL 280
              +    +      D+WSLG+T +EL  G  P   L P +       +  I    PP+L
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA------LFKIPRNPPPTL 249

Query: 281 --PDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
             P+  S EF  FI  CL K++ KR T S LL H F+
Sbjct: 250 HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  119 bits (299), Expect = 4e-31
 Identities = 83/270 (30%), Positives = 128/270 (47%), Gaps = 27/270 (10%)

Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQ----VFREMEILRRT---DSPFI 111
           +G G  G VY+V+ + T +IYA+KV+       V ++       E  IL RT   +SPFI
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVL--SKKEIVAKKEVAHTIGERNILVRTLLDESPFI 58

Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
           V     F+  S D+ ++ +YM  G L   L K G FSE +     ++++  L +LH + I
Sbjct: 59  VGLKFSFQTDS-DLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDI 117

Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGN 231
           ++RD+KP N+L++     + + DFG+SK         N++ GT  Y++PE    +     
Sbjct: 118 VYRDLKPENILLDATG-HIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEK---- 172

Query: 232 YNGYAG--DIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFR 289
             GY    D WSLG+ + E+  G  PF       D   +   I FG      +  S E R
Sbjct: 173 --GYTKHVDFWSLGVLVFEMCCGWSPFYA----EDTQQMYRNIAFGKVRFPKNVLSDEGR 226

Query: 290 SFIECCLQKEFSKRW----TASQLLTHPFL 315
            F++  L +    R      A +L  HPF 
Sbjct: 227 QFVKGLLNRNPQHRLGAHRDAVELKEHPFF 256

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  117 bits (294), Expect = 4e-31
 Identities = 82/280 (29%), Positives = 136/280 (48%), Gaps = 35/280 (12%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH---GDADPTVR--RQVFREMEILRRTDS 108
            K +VLG G  GTVY        ++ A+K V     +     +   ++  E+++L+    
Sbjct: 3   TKGEVLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61

Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
             IVQ  G     +  I+I ME++  G++ ++LN+ G   EP       QIL G++YLH 
Sbjct: 62  VNIVQYLGTCLDDN-TISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN 120

Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC------RSLDACNSYVGTCAYMSPER 222
           + ++HRDIK +N+++  N + +K+ DFG ++ +          +   S  GT  +M+PE 
Sbjct: 121 NCVVHRDIKGNNVMLMPNGI-IKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179

Query: 223 FDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATL--MCAICF-----G 275
            +   Y     G   DIWS+G T+ E+  G         +P  A++  + A+ +     G
Sbjct: 180 INESGY-----GRKSDIWSIGCTVFEMATG---------KPPLASMDRLAAMFYIGAHRG 225

Query: 276 DPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
             P LPD  S     F+  CL ++  +R +A QLL H FL
Sbjct: 226 LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  116 bits (294), Expect = 2e-30
 Identities = 80/304 (26%), Positives = 134/304 (44%), Gaps = 53/304 (17%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR--QVFREMEILRRTDS 108
              +K+++LG G+ G V+ V+ + T K++ALKV+         +  +V  E EIL   D 
Sbjct: 1   KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60

Query: 109 PFIVQCFGIFEKPSGD-IAILMEYMDSGTLDTLLNKN--GTFSEPKLAHIASQILKGLSY 165
           PF+   +  F+  +   + ++M+Y   G L  LL +      SE      A+++L  L Y
Sbjct: 61  PFLPTLYASFQ--TETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEY 118

Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-------------------------- 199
           LH   I++RD+KP N+L++ +   + ++DF +SK                          
Sbjct: 119 LHLLGIVYRDLKPENILLHESG-HIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177

Query: 200 ---IMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPF 256
                       NS+VGT  Y++PE        G+ +G A D W+LG+ L E+  G  PF
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPE-----VISGDGHGSAVDWWTLGILLYEMLYGTTPF 232

Query: 257 LQPGQRPDWATLMCAICFGDPPSLP--DGASPEFRSFIECCLQKEFSKR---WT-ASQLL 310
               +   ++ ++         + P     S   R  I   L K+ SKR      A+++ 
Sbjct: 233 KGSNRDETFSNIL-----KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIK 287

Query: 311 THPF 314
            HPF
Sbjct: 288 QHPF 291

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  115 bits (290), Expect = 2e-30
 Identities = 76/269 (28%), Positives = 130/269 (48%), Gaps = 26/269 (9%)

Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFR---EMEILR-RTDSPFI 111
           L+ +  G  G+VY  + R T   +A+KV+   +D   + QV     E  I+  + +SP++
Sbjct: 1   LKPISKGAFGSVYLAKKRSTGDYFAIKVLK-KSDMIAKNQVTNVKAERAIMMIQGESPYV 59

Query: 112 VQCFGIFEKPSGD-IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
            + +  F+  S D + ++MEY++ G   +L+   G   E       ++++ G+  LH   
Sbjct: 60  AKLYYSFQ--SKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG 117

Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGG 230
           IIHRDIKP NLL++     +K+ DFG+S+    +      +VGT  Y++PE        G
Sbjct: 118 IIHRDIKPENLLIDQTG-HLKLTDFGLSRNGLENKK----FVGTPDYLAPETIL-----G 167

Query: 231 NYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPD--WATLMCAICFGDPPSLPDGASPEF 288
             +    D WSLG  + E   G+ PF    + PD  +  ++       P  + +  SPE 
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFGYPPF--HAETPDAVFDNILSRR-INWPEEVKEFCSPEA 224

Query: 289 RSFIECCLQKEFSKRWTAS---QLLTHPF 314
              I   L  + +KR  A+   ++ +HPF
Sbjct: 225 VDLINRLLCMDPAKRLGANGYQEIKSHPF 253

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score =  116 bits (291), Expect = 2e-30
 Identities = 85/274 (31%), Positives = 139/274 (50%), Gaps = 20/274 (7%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRR-TDSPFIV 112
           E ++ +G G  G VYKV ++    + A+K++   +D  V  ++  E  IL+   + P +V
Sbjct: 25  EIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD--VDEEIEAEYNILQSLPNHPNVV 82

Query: 113 QCFGIFEKPS----GDIAILMEYMDSGTLDTL----LNKNGTFSEPKLAHIASQILKGLS 164
           + +G+F K      G + +++E  + G++  L    L       E  +++I    L GL 
Sbjct: 83  KFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQ 142

Query: 165 YLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD 224
           +LH ++IIHRD+K +N+L+      VK+ DFGVS  +  +    N+ VGT  +M+PE   
Sbjct: 143 HLHNNRIIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 201

Query: 225 PD-AYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSL--P 281
            +  Y  +Y+    D+WSLG+T +EL  G  P       P     +  I    PP+L  P
Sbjct: 202 CEQQYDYSYDARC-DVWSLGITAIELGDGDPPLFD--MHP--VKTLFKIPRNPPPTLLHP 256

Query: 282 DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
           +     F  FI  CL K+F  R + + LL HPF+
Sbjct: 257 EKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFI 290

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  115 bits (290), Expect = 3e-30
 Identities = 81/268 (30%), Positives = 134/268 (50%), Gaps = 18/268 (6%)

Query: 50  YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSP 109
           Y+  EK+   G G  GTVY      T +  A+K ++    P  +  +  E+ ++R   +P
Sbjct: 21  YTRFEKI---GQGASGTVYTAIDIATGQEVAIKQMNLQQQPK-KELIINEILVMRENKNP 76

Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
            IV     +     ++ ++MEY+  G+L  ++ +     E ++A +  + L+ L +LH +
Sbjct: 77  NIVNYLDSY-LVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSN 134

Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYG 229
           ++IHRDIK  N+L+  +   VK+ DFG    +       ++ VGT  +M+PE     AYG
Sbjct: 135 QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 193

Query: 230 GNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSL--PDGASPE 287
                   DIWSLG+  +E+  G  P+L   + P  A  + A      P L  P+  S  
Sbjct: 194 PKV-----DIWSLGIMAIEMVEGEPPYLN--ENPLRALYLIAT--NGTPELQNPERLSAV 244

Query: 288 FRSFIECCLQKEFSKRWTASQLLTHPFL 315
           FR F+  CL+ +  +R +A +LL HPFL
Sbjct: 245 FRDFLNRCLEMDVDRRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  115 bits (290), Expect = 3e-30
 Identities = 84/291 (28%), Positives = 133/291 (45%), Gaps = 39/291 (13%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKV-VHGDADPTVRRQVFREMEILRRTDSPFIV 112
           E L ++G G+ G V K +H+ T +I A+K  +  + D  V++   RE+ +L++     +V
Sbjct: 4   ENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLV 63

Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
               +F +    + ++ E++D   LD L        E ++     QIL+G+ + H H II
Sbjct: 64  NLIEVFRRKK-RLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNII 122

Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNY 232
           HRDIKP N+LV+ + + VK+ DFG ++ +    +    YV T  Y +PE    D     Y
Sbjct: 123 HRDIKPENILVSQSGV-VKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDT---KY 178

Query: 233 NGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAI-CFGD------------PP- 278
            G A DIW++G  + E+  G  P   PG   D   L   I C G+            P  
Sbjct: 179 -GRAVDIWAVGCLVTEMLTGE-PLF-PGDS-DIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234

Query: 279 ---SLPDGA------------SPEFRSFIECCLQKEFSKRWTASQLLTHPF 314
               LP+              S       + CL+ +   R ++SQLL H F
Sbjct: 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  115 bits (289), Expect = 4e-30
 Identities = 82/268 (30%), Positives = 135/268 (50%), Gaps = 18/268 (6%)

Query: 50  YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSP 109
           Y+  EK+   G G  GTV+      T +  A+K ++    P  +  +  E+ +++   +P
Sbjct: 21  YTRYEKI---GQGASGTVFTAIDVATGQEVAIKQINLQKQPK-KELIINEILVMKELKNP 76

Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
            IV     F     ++ ++MEY+  G+L  ++ +     E ++A +  + L+ L +LH +
Sbjct: 77  NIVNFLDSF-LVGDELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHAN 134

Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYG 229
           ++IHRDIK  N+L+  +   VK+ DFG    +       ++ VGT  +M+PE     AYG
Sbjct: 135 QVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 193

Query: 230 GNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSL--PDGASPE 287
                   DIWSLG+  +E+  G  P+L   + P  A  + A      P L  P+  SP 
Sbjct: 194 PKV-----DIWSLGIMAIEMVEGEPPYLN--ENPLRALYLIAT--NGTPELQNPEKLSPI 244

Query: 288 FRSFIECCLQKEFSKRWTASQLLTHPFL 315
           FR F+  CL+ +  KR +A +LL HPFL
Sbjct: 245 FRDFLNRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  115 bits (290), Expect = 4e-30
 Identities = 83/270 (30%), Positives = 131/270 (48%), Gaps = 21/270 (7%)

Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR--QVFREMEILRRTDSPFIVQ 113
           L  +GHG+ G VY   +  T+++ A+K +      T  +   + +E++ L++   P  ++
Sbjct: 26  LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85

Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
             G + K      ++MEY      D L        E ++A I    L+GL+YLH H +IH
Sbjct: 86  YKGCYLKEH-TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIH 144

Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE---RFDPDAYGG 230
           RDIK  N+L+     QVK+ADFG +          NS+VGT  +M+PE     D   Y G
Sbjct: 145 RDIKAGNILLTEPG-QVKLADFGSASKS----SPANSFVGTPYWMAPEVILAMDEGQYDG 199

Query: 231 NYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA-SPEFR 289
                  D+WSLG+T +EL     P           + +  I   D P+L     +  FR
Sbjct: 200 KV-----DVWSLGITCIELAERKPPLFNMNA----MSALYHIAQNDSPTLQSNEWTDSFR 250

Query: 290 SFIECCLQKEFSKRWTASQLLTHPFLCKNR 319
            F++ CLQK   +R  +++LL H F+ ++R
Sbjct: 251 GFVDYCLQKIPQERPASAELLRHDFVRRDR 280

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  114 bits (288), Expect = 6e-30
 Identities = 71/212 (33%), Positives = 111/212 (52%), Gaps = 20/212 (9%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR-----QVFREMEILRR 105
            DLE+++ +G G  G V+ V+ R +   YALKV+   A P V R      V  E  +L+ 
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVM---AIPEVIRLKQEQHVHNEKRVLKE 57

Query: 106 TDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
              PFI++ F   E     + +LMEY+  G L + L  +G FS       AS+I+  L Y
Sbjct: 58  VSHPFIIRLFWT-EHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEY 116

Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFD 224
           LH  +I++RD+KP N+L++     +K+ DFG +K +  R+   C    GT  Y++PE   
Sbjct: 117 LHSKEIVYRDLKPENILLDKEG-HIKLTDFGFAKKLRDRTWTLC----GTPEYLAPE--- 168

Query: 225 PDAYGGNYNGYAGDIWSLGLTLLELYLGHFPF 256
                   +  A D W+LG+ + E+ +G+ PF
Sbjct: 169 --VIQSKGHNKAVDWWALGILIYEMLVGYPPF 198

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  115 bits (291), Expect = 7e-30
 Identities = 84/306 (27%), Positives = 134/306 (43%), Gaps = 46/306 (15%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALK-VVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           + ++ +G G  G V       + K  A+K + H    PT+ ++  RE++ILR      I+
Sbjct: 8   KPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNII 67

Query: 113 QCFGIFEKPSG---DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
               I   P     D+ ++M+ M+S  L  +++ +   +E  + +   Q+L+GL Y+H  
Sbjct: 68  AIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA 126

Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS-LDACN---SYVGTCAYMSPE-RFD 224
            +IHRD+KPSNLLV N + +++I DFG+++ +  S  +       YV T  Y +PE    
Sbjct: 127 NVIHRDLKPSNLLV-NEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLS 185

Query: 225 PDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPP------ 278
              Y       A D+WS+G    E+ LG    L PG+       +     G P       
Sbjct: 186 LPEY-----TTAIDMWSVGCIFAEM-LGRRQ-LFPGKNYVHQLKLILSVLGSPSEEVLNR 238

Query: 279 -----------SLPD-----------GASPEFRSFIECCLQKEFSKRWTASQLLTHPFLC 316
                      +LP             ASPE    +   LQ +  +R T  Q L HPFL 
Sbjct: 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA 298

Query: 317 KNRRSD 322
           +    D
Sbjct: 299 QYHDPD 304

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  114 bits (287), Expect = 1e-29
 Identities = 86/276 (31%), Positives = 135/276 (48%), Gaps = 24/276 (8%)

Query: 50  YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH--GDADPTVRRQVFREMEILRRTD 107
           ++DL ++   GHG+ G VY  +   T+++ A+K +   G       + + +E++ L+R  
Sbjct: 27  FTDLREI---GHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK 83

Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
            P  ++  G + +      ++MEY      D L        E ++A I    L+GL+YLH
Sbjct: 84  HPNSIEYKGCYLREH-TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 142

Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE---RFD 224
            H +IHRDIK  N+L+     QVK+ADFG + I        NS+VGT  +M+PE     D
Sbjct: 143 SHNMIHRDIKAGNILLTEPG-QVKLADFGSASIA----SPANSFVGTPYWMAPEVILAMD 197

Query: 225 PDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
              Y G       D+WSLG+T +EL     P           + +  I   + P+L    
Sbjct: 198 EGQYDGKV-----DVWSLGITCIELAERKPPLFNMNA----MSALYHIAQNESPTLQSNE 248

Query: 285 -SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR 319
            S  FR+F++ CLQK    R T+ +LL H F+ + R
Sbjct: 249 WSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  113 bits (283), Expect = 2e-29
 Identities = 90/272 (33%), Positives = 129/272 (47%), Gaps = 30/272 (11%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFR----EMEILRRTDSPFIV 112
           ++LG G  G VY      T +  A+K V  D D     +       E+++L+      IV
Sbjct: 8   KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67

Query: 113 QCFGIFEKPS-GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
           Q +G    P    ++I +EYM  G++   L   G  +E        QIL+G+SYLH + I
Sbjct: 68  QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMI 127

Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSK---IMCRSLDACNSYVGTCAYMSPERFDPDAY 228
           +HRDIK +N+L ++    VK+ DFG SK    +C S     S  GT  +MSPE    + Y
Sbjct: 128 VHRDIKGANILRDSAG-NVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGY 186

Query: 229 GGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATL--MCAI--CFGDP--PSLPD 282
                G   D+WS+  T++E+           ++P WA    M AI      P  P LPD
Sbjct: 187 -----GRKADVWSVACTVVEMLT---------EKPPWAEYEAMAAIFKIATQPTKPMLPD 232

Query: 283 GASPEFRSFIECCLQKEFSKRWTASQLLTHPF 314
           G S   R F++    +E  +R TA  LL HPF
Sbjct: 233 GVSDACRDFLKQIFVEE-KRRPTAEFLLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  113 bits (284), Expect = 3e-29
 Identities = 80/270 (29%), Positives = 129/270 (47%), Gaps = 21/270 (7%)

Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR--QVFREMEILRRTDSPFIVQ 113
           L+ +GHG+ G VY  +     ++ A+K +      +  +   + +E+  L++   P  +Q
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79

Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
             G + +      ++MEY      D L        E ++A +    L+GL+YLH H +IH
Sbjct: 80  YRGCYLREH-TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIH 138

Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE---RFDPDAYGG 230
           RD+K  N+L++     VK+ DFG + IM  +    N +VGT  +M+PE     D   Y G
Sbjct: 139 RDVKAGNILLSEPG-LVKLGDFGSASIMAPA----NXFVGTPYWMAPEVILAMDEGQYDG 193

Query: 231 NYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA-SPEFR 289
                  D+WSLG+T +EL     P           + +  I   + P+L  G  S  FR
Sbjct: 194 KV-----DVWSLGITCIELAERKPPLFNMNA----MSALYHIAQNESPALQSGHWSEYFR 244

Query: 290 SFIECCLQKEFSKRWTASQLLTHPFLCKNR 319
           +F++ CLQK    R T+  LL H F+ + R
Sbjct: 245 NFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  112 bits (280), Expect = 7e-29
 Identities = 80/268 (29%), Positives = 132/268 (49%), Gaps = 18/268 (6%)

Query: 50  YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSP 109
           Y+  EK+   G G  GTVY      T +  A++ ++    P  +  +  E+ ++R   +P
Sbjct: 22  YTRFEKI---GQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNP 77

Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
            IV     +     ++ ++MEY+  G+L  ++ +     E ++A +  + L+ L +LH +
Sbjct: 78  NIVNYLDSY-LVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN 135

Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYG 229
           ++IHRDIK  N+L+  +   VK+ DFG    +       ++ VGT  +M+PE     AYG
Sbjct: 136 QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194

Query: 230 GNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSL--PDGASPE 287
                   DIWSLG+  +E+  G  P+L   + P  A  + A      P L  P+  S  
Sbjct: 195 PKV-----DIWSLGIMAIEMIEGEPPYLN--ENPLRALYLIAT--NGTPELQNPEKLSAI 245

Query: 288 FRSFIECCLQKEFSKRWTASQLLTHPFL 315
           FR F+  CL  +  KR +A +LL H FL
Sbjct: 246 FRDFLNRCLDMDVEKRGSAKELLQHQFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  110 bits (277), Expect = 1e-28
 Identities = 78/262 (29%), Positives = 121/262 (46%), Gaps = 13/262 (4%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
               L+V+G G+ G    VQH  + + YA+K +      +      +E  +L +   P I
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60

Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTL--DTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           V     FE   G + I+MEY D G L     L +   F E  +     Q+  G+ ++H  
Sbjct: 61  VAFKESFEA-DGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK 119

Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYG 229
           +++HRDIK  N+ +  N  +VK+ DFG ++++        +YVGT  Y+ PE ++   Y 
Sbjct: 120 RVLHRDIKSKNIFLTQNG-KVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYN 178

Query: 230 GNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFR 289
                   DIWSLG  L EL     PF    Q   W  L+  +C G    LP   S E R
Sbjct: 179 NK-----SDIWSLGCILYELCTLKHPF----QANSWKNLILKVCQGSYKPLPSHYSYELR 229

Query: 290 SFIECCLQKEFSKRWTASQLLT 311
           S I+   ++    R +A+ +L+
Sbjct: 230 SLIKQMFKRNPRSRPSATTILS 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  112 bits (281), Expect = 1e-28
 Identities = 80/270 (29%), Positives = 126/270 (46%), Gaps = 30/270 (11%)

Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGD---AD-----PTVRRQVFREMEILRRTDSP 109
           VLG G+ G V   + + T ++YA+KV+  D    D         ++V     +  +   P
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVL---ALAGK--HP 56

Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           F+ Q    F+     +  +MEY++ G L   + ++G F EP+    A++I+ GL +LH  
Sbjct: 57  FLTQLHSCFQTKD-RLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER 115

Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYG 229
            II+RD+K  N+L+++    +KIADFG+ K         +++ GT  Y++PE      Y 
Sbjct: 116 GIIYRDLKLDNVLLDSEG-HIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPY- 173

Query: 230 GNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFR 289
               G A D W+LG+ L E+  G  PF   G   D   L  +I   D    P   S E +
Sbjct: 174 ----GPAVDWWALGVLLYEMLAGQSPF--EGDDED--ELFQSI-LEDEVRYPRWLSKEAK 224

Query: 290 SFIECCLQKEFSKRWTASQ-----LLTHPF 314
           S ++  L K   KR          +  HPF
Sbjct: 225 SILKSFLTKNPEKRLGCLPTGEQDIKGHPF 254

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  109 bits (274), Expect = 3e-28
 Identities = 89/273 (32%), Positives = 130/273 (47%), Gaps = 30/273 (10%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-PTVRRQVFR---EMEILRRTDSPFIV 112
           ++LG G  G VY      T +  A+K V  D + P   ++V     E+++L+      IV
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67

Query: 113 QCFGIFEKP-SGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
           Q +G    P    ++I ME+M  G++   L   G  +E        QIL+G+SYLH + I
Sbjct: 68  QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMI 127

Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSK---IMCRSLDACNSYVGTCAYMSPERFDPDAY 228
           +HRDIK +N+L ++    VK+ DFG SK    +C S     S  GT  +MSPE    + Y
Sbjct: 128 VHRDIKGANILRDSVG-NVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGY 186

Query: 229 GGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATL--MCAI--CFGDP--PSLPD 282
                G   DIWS+G T++E+           ++P WA    M AI      P  P LP 
Sbjct: 187 -----GRKADIWSVGCTVVEMLT---------EKPPWAEFEAMAAIFKIATQPTNPVLPP 232

Query: 283 GASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
             S   R F++     E   R +A +LL H F+
Sbjct: 233 HVSDHCRDFLKRIFV-EAKLRPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  109 bits (275), Expect = 7e-28
 Identities = 74/266 (27%), Positives = 124/266 (46%), Gaps = 21/266 (7%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGD---ADPTVRRQVFREMEILRRTDSPFIVQ 113
           ++LG G  G V  V+ + T K YA+K++  +   A   V   +  E  +L+ T  PF+  
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTL-TESRVLQNTRHPFLTA 59

Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
               F+     +  +MEY + G L   L++   FSE +     ++I+  L YLH   +++
Sbjct: 60  LKYSFQT-HDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVY 118

Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYN 233
           RD+K  NL+++ +   +KI DFG+ K          ++ GT  Y++PE  + + Y     
Sbjct: 119 RDLKLENLMLDKDG-HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY----- 172

Query: 234 GYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIE 293
           G A D W LG+ + E+  G  PF       D   L   I   +    P   SPE +S + 
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYN----QDHEKLFELILMEE-IRFPRTLSPEAKSLLA 227

Query: 294 CCLQKEFSKRW-----TASQLLTHPF 314
             L+K+  +R       A +++ H F
Sbjct: 228 GLLKKDPKQRLGGGPEDAKEIMEHRF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score =  108 bits (273), Expect = 8e-28
 Identities = 72/299 (24%), Positives = 128/299 (42%), Gaps = 51/299 (17%)

Query: 38  NNNTTATTAAIAYSDLEKLQVLGHGNG--GTVYKVQHRCTHKIYALKVVHGDADPTVRRQ 95
           N + + +       + E ++ L   +G  G V  ++H+ T K++  K         ++ +
Sbjct: 1   NMDKSLSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQK--------IIKAK 52

Query: 96  VFREMEI----LRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPK 151
            F  +E     L + D+P  ++ +       G   ++M+Y+  G L  LL K G  SE +
Sbjct: 53  NFNAIEPMVHQLMK-DNPNFIKLYYSVTTLKG-HVLIMDYIKDGDLFDLLKKEGKLSEAE 110

Query: 152 LAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSY 211
           +  I  Q+++ L+ LH H IIH DIK  N+L +    ++ + D+G    +C+ +   + Y
Sbjct: 111 VKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYG----LCKIIGTPSCY 166

Query: 212 VGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPF------------LQP 259
            GT  Y SPE+      G NY+  + D W++G+   EL  G  PF            L  
Sbjct: 167 DGTLDYFSPEKIK----GHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLK 221

Query: 260 GQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTA-SQLLTHPFLCK 317
            Q+                      S     F++  L+   + R T  ++++ HPFL  
Sbjct: 222 RQQ-------------KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267

Length = 267

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  108 bits (273), Expect = 1e-27
 Identities = 84/291 (28%), Positives = 127/291 (43%), Gaps = 51/291 (17%)

Query: 59  LGHGNGGTVYKVQHRCTHKIYA---LKVVHGDADPTVRRQVFREMEILRR-TDSPFIVQ- 113
           +G G    V K Q R T K YA   +K      +        RE++ LRR +  P I++ 
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN---LREIQALRRLSPHPNILRL 63

Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
              +F++ +G +A++ E MD    + +  +     E ++     Q+LK L ++H + I H
Sbjct: 64  IEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFH 123

Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA---CNSYVGTCAYMSPERFDPDAYGG 230
           RDIKP N+L+ ++   +K+ADFG     CR + +      Y+ T  Y +PE    D Y  
Sbjct: 124 RDIKPENILIKDDI--LKLADFG----SCRGIYSKPPYTEYISTRWYRAPECLLTDGY-- 175

Query: 231 NYNGYAGDIWSLGLTLLELYLGHFPFLQPGQR--------------PDWATLM------- 269
            Y G   DIW++G    E+ L  FP L PG                PD   L        
Sbjct: 176 -Y-GPKMDIWAVGCVFFEI-LSLFP-LFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH 231

Query: 270 CAICF------GDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPF 314
               F      G    LP+ AS E    ++  L  +  +R TA Q L HP+
Sbjct: 232 MNYNFPSKKGTGLRKLLPN-ASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  108 bits (270), Expect = 1e-27
 Identities = 78/265 (29%), Positives = 127/265 (47%), Gaps = 13/265 (4%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFR-EMEILRRTDSPFIV 112
           E ++ +G G+ G +Y  + +   +   +K +     P   ++  + E+ +L +   P IV
Sbjct: 3   EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIV 62

Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHK 170
             F  F++ +G + I+MEY D G L   +N+     FSE ++     QI  GL ++H  K
Sbjct: 63  TFFASFQE-NGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK 121

Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGG 230
           I+HRDIK  N+ ++ N M  K+ DFG+++ +  S++   + VGT  Y+SPE      Y  
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNN 181

Query: 231 NYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                  DIWSLG  L EL     PF    +  +   L+  IC G    +    S + RS
Sbjct: 182 K-----TDIWSLGCVLYELCTLKHPF----EGNNLHQLVLKICQGYFAPISPNFSRDLRS 232

Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
            I    +     R + + +L  PFL
Sbjct: 233 LISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  107 bits (268), Expect = 2e-27
 Identities = 76/263 (28%), Positives = 123/263 (46%), Gaps = 13/263 (4%)

Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTDSPFIVQC 114
           ++V+G G+ G V  V+HR   K Y +K ++  +A    R+   +E ++L +   P IV  
Sbjct: 5   VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64

Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLL--NKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
              +E   G + I+M + + G L   L   K     E ++     QI   L YLH   I+
Sbjct: 65  RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHIL 124

Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNY 232
           HRD+K  N+ +   N+ +K+ D G+++++    D  ++ +GT  YMSPE F    Y    
Sbjct: 125 HRDLKTQNVFLTRTNI-IKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPY---- 179

Query: 233 NGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFI 292
             Y  D+W+LG  + E+      F       D  +L+  I  G  P +P   SPE    I
Sbjct: 180 -NYKSDVWALGCCVYEMATLKHAF----NAKDMNSLVYRIIEGKLPPMPKDYSPELGELI 234

Query: 293 ECCLQKEFSKRWTASQLLTHPFL 315
              L K   KR +   +L  P++
Sbjct: 235 ATMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  107 bits (269), Expect = 3e-27
 Identities = 81/274 (29%), Positives = 139/274 (50%), Gaps = 17/274 (6%)

Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQV-FREMEILRRTDSPFI 111
           LE    +G G+ G V   + + + +  A+K++  D     RR++ F E+ I+R      +
Sbjct: 23  LENYIKIGEGSTGIVCIAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQHQNV 80

Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
           V+ +  +     ++ +LME++  G L  ++++    +E ++A +   +L+ L YLH   +
Sbjct: 81  VEMYKSY-LVGEELWVLMEFLQGGALTDIVSQT-RLNEEQIATVCESVLQALCYLHSQGV 138

Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGN 231
           IHRDIK  ++L+  +  +VK++DFG    + + +    S VGT  +M+PE      YG  
Sbjct: 139 IHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTE 197

Query: 232 YNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA--SPEFR 289
                 DIWSLG+ ++E+  G  P+      P  A  M  +    PP L +    SP  R
Sbjct: 198 V-----DIWSLGIMVIEMVDGEPPYFS--DSPVQA--MKRLRDSPPPKLKNAHKISPVLR 248

Query: 290 SFIECCLQKEFSKRWTASQLLTHPFLCKNRRSDC 323
            F+E  L +E  +R TA +LL HPFL +    +C
Sbjct: 249 DFLERMLTREPQERATAQELLDHPFLLQTGLPEC 282

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  107 bits (270), Expect = 4e-27
 Identities = 74/233 (31%), Positives = 113/233 (48%), Gaps = 30/233 (12%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVV--HGDADPTVRRQVFREMEILRRTDS 108
            D E ++++ +G  G VY V+H+ T + +A+K +           +QVF E +IL   ++
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60

Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFS-EPKLAHIASQILKGLSYLH 167
           PF+V  F  FE     + ++MEY++ G   TLL   G    +    + A  +L  L YLH
Sbjct: 61  PFVVSMFCSFETKR-HLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVL-ALEYLH 118

Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSY---------------- 211
            + I+HRD+KP NLL+ +    +K+ DFG+SKI   SL   N Y                
Sbjct: 119 NYGIVHRDLKPDNLLITSMG-HIKLTDFGLSKIGLMSL-TTNLYEGHIEKDTREFLDKQV 176

Query: 212 VGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPD 264
            GT  Y++PE      YG        D W++G+ L E  +G  PF   G  P+
Sbjct: 177 CGTPEYIAPEVILRQGYGK-----PVDWWAMGIILYEFLVGCVPFF--GDTPE 222

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  107 bits (270), Expect = 5e-27
 Identities = 71/224 (31%), Positives = 105/224 (46%), Gaps = 20/224 (8%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD----ADPTVRRQVFREMEILRRT 106
            D + L  +G G  G V+  + + T +I ALK +        +    R V  E +IL  T
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNE--VRHVLTERDILTTT 58

Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
            S ++V+    F+     + + MEY+  G   TLLN  G  SE       +++ + +  L
Sbjct: 59  KSEWLVKLLYAFQDDE-YLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDAL 117

Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPD 226
           H    IHRD+KP N L++ +   +K+ DFG+SK     +   NS VG+  YM+PE     
Sbjct: 118 HELGYIHRDLKPENFLIDASG-HIKLTDFGLSK---GIVTYANSVVGSPDYMAPEVL--- 170

Query: 227 AYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPD--WATL 268
             G  Y+ +  D WSLG  L E   G  PF   G  P+  W  L
Sbjct: 171 -RGKGYD-FTVDYWSLGCMLYEFLCGFPPF--SGSTPNETWENL 210

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score =  106 bits (265), Expect = 1e-26
 Identities = 81/259 (31%), Positives = 132/259 (50%), Gaps = 31/259 (11%)

Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVV--------HGDADPTVRRQVFREMEILRRTDSP 109
           ++G G  G VY  +   T K+YA+K +         G+      R +   + ++   D P
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM---LSLVSTGDCP 57

Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           FIV     F  P   +  +++ M+ G L   L+++G FSE ++   A++I+ GL ++H  
Sbjct: 58  FIVCMTYAFHTPD-KLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR 116

Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR-SLDACNSYVGTCAYMSPERFDPDAY 228
            +++RD+KP+N+L++ +   V+I+D G++   C  S    ++ VGT  YM+PE       
Sbjct: 117 FVVYRDLKPANILLDEHG-HVRISDLGLA---CDFSKKKPHASVGTHGYMAPEVLQK--- 169

Query: 229 GGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRP----DWATLMCAICFGDPPSLPDGA 284
           G  Y+  A D +SLG  L +L  GH PF Q   +     D  TL   +       LPD  
Sbjct: 170 GTAYDSSA-DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNV------ELPDSF 222

Query: 285 SPEFRSFIECCLQKEFSKR 303
           SPE +S +E  LQ++ SKR
Sbjct: 223 SPELKSLLEGLLQRDVSKR 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  106 bits (267), Expect = 1e-26
 Identities = 80/269 (29%), Positives = 133/269 (49%), Gaps = 23/269 (8%)

Query: 56  LQVLGHGNGGTVY---KVQHRCTHKIYALKVVHGDADPTVRRQVFREME--ILRRTDSPF 110
           L+VLG G+ G V+   K+      ++YA+KV+   A   VR +V  +ME  IL   + PF
Sbjct: 1   LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLK-KATLKVRDRVRTKMERDILAEVNHPF 59

Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           IV+    F+   G + ++++++  G L T L+K   F+E  +    +++   L +LH   
Sbjct: 60  IVKLHYAFQTE-GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 118

Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGG 230
           II+RD+KP N+L++     +K+ DFG+SK          S+ GT  YM+PE  +   +  
Sbjct: 119 IIYRDLKPENILLDEEG-HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGH-- 175

Query: 231 NYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                + D WS G+ + E+  G  PF Q   R +  T++     G P  L    SPE +S
Sbjct: 176 ---TQSADWWSFGVLMFEMLTGSLPF-QGKDRKETMTMILKAKLGMPQFL----SPEAQS 227

Query: 291 FIECCLQKEFSKRWTAS-----QLLTHPF 314
            +    ++  + R  A      ++  HPF
Sbjct: 228 LLRALFKRNPANRLGAGPDGVEEIKRHPF 256

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  106 bits (266), Expect = 1e-26
 Identities = 90/318 (28%), Positives = 132/318 (41%), Gaps = 69/318 (21%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALK--VVHGDAD--PTVRRQVFREMEILRRT 106
            D E L  LG G  G VYK +   T ++ ALK  ++H + D  P       RE++IL++ 
Sbjct: 8   RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPIT---ALREIKILKKL 64

Query: 107 DSPFIVQCFG-IFEKPS------GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQI 159
             P +V       E+P       G + ++  YMD      L N +   +E ++     Q+
Sbjct: 65  KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQL 124

Query: 160 LKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC----------- 208
           L+G++YLH + I+HRDIK +N+L++N    +KIADFG++    R  D             
Sbjct: 125 LEGINYLHENHILHRDIKAANILIDNQG-ILKIADFGLA----RPYDGPPPNPKGGGGGG 179

Query: 209 ----NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPD 264
                + V T  Y  PE    +     Y   A DIW +G    E++    P LQ     D
Sbjct: 180 TRKYTNLVVTRWYRPPELLLGER---RY-TTAVDIWGIGCVFAEMFTRR-PILQGKSDID 234

Query: 265 WATLMCAICFGDPP--------SLPDGA--------------------SPEFRSFIECCL 296
              L+  +C G P         SLP G                      PE    +   L
Sbjct: 235 QLHLIFKLC-GTPTEETWPGWRSLP-GCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLL 292

Query: 297 QKEFSKRWTASQLLTHPF 314
             +  KR TAS  L HP+
Sbjct: 293 SLDPYKRLTASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  107 bits (268), Expect = 1e-26
 Identities = 66/215 (30%), Positives = 111/215 (51%), Gaps = 19/215 (8%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQ----VFREMEILRRTD 107
           D + ++V+G G  G V  V+H+ + ++YA+K++       ++R      + E +I+   +
Sbjct: 44  DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLL--SKFEMIKRSDSAFFWEERDIMAHAN 101

Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
           S +IVQ    F+     + ++MEYM  G L  L++ N    E       ++++  L  +H
Sbjct: 102 SEWIVQLHYAFQDDK-YLYMVMEYMPGGDLVNLMS-NYDIPEKWARFYTAEVVLALDAIH 159

Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA-----CNSYVGTCAYMSPER 222
               IHRD+KP N+L++ +   +K+ADFG     C  +DA     C++ VGT  Y+SPE 
Sbjct: 160 SMGFIHRDVKPDNMLLDKSG-HLKLADFGT----CMKMDANGMVRCDTAVGTPDYISPEV 214

Query: 223 FDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFL 257
                  G Y G   D WS+G+ L E+ +G  PF 
Sbjct: 215 LKSQGGDGYY-GRECDWWSVGVFLYEMLVGDTPFY 248

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  104 bits (261), Expect = 2e-26
 Identities = 67/265 (25%), Positives = 126/265 (47%), Gaps = 14/265 (5%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTDSPFIV 112
            K++ +G G+ G    V+ +   K Y +K ++     P  R +  +E+ +L     P IV
Sbjct: 3   VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIV 62

Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLN--KNGTFSEPKLAHIASQILKGLSYLHGHK 170
           Q    FE+ +G++ I+M+Y + G L   +N  +   F E ++     QI   L ++H  K
Sbjct: 63  QYQESFEE-NGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK 121

Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGG 230
           I+HRDIK  N+ +  +   +K+ DFG+++++  +++   + +GT  Y+SPE  +   Y  
Sbjct: 122 ILHRDIKSQNIFLTKDGT-IKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNN 180

Query: 231 NYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                  DIW+LG  L E+      F    +  +   L+  I  G  P +    S + R+
Sbjct: 181 K-----SDIWALGCVLYEMCTLKHAF----EAGNMKNLVLKIIRGSYPPVSSHYSYDLRN 231

Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
            +    ++    R + + +L   F+
Sbjct: 232 LVSQLFKRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  105 bits (265), Expect = 2e-26
 Identities = 80/270 (29%), Positives = 127/270 (47%), Gaps = 25/270 (9%)

Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQV------FREMEILRRTDSP 109
           L VLG G+ G V   +++ T ++YA+K +    D   R +V       R  E       P
Sbjct: 4   LAVLGRGHFGKVLLAEYKKTGELYAIKALKKG-DIIARDEVESLMCEKRIFETANSERHP 62

Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           F+V  F  F+     +  +MEY   G L   ++ +  FSEP+    A+ ++ GL YLH +
Sbjct: 63  FLVNLFACFQTED-HVCFVMEYAAGGDLMMHIHTD-VFSEPRAVFYAACVVLGLQYLHEN 120

Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYG 229
           KI++RD+K  NLL++     VKIADFG+ K      D  +++ GT  +++PE     +Y 
Sbjct: 121 KIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSY- 178

Query: 230 GNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFR 289
                 A D W LG+ + E+ +G  PF  PG   D   +  +I   D    P   S E  
Sbjct: 179 ----TRAVDWWGLGVLIYEMLVGESPF--PGD--DEEEVFDSI-VNDEVRYPRFLSREAI 229

Query: 290 SFIECCLQKEFSKRWTASQ-----LLTHPF 314
           S +   L++   +R  + +     +   PF
Sbjct: 230 SIMRRLLRRNPERRLGSGEKDAEDVKKQPF 259

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  106 bits (265), Expect = 2e-26
 Identities = 87/280 (31%), Positives = 140/280 (50%), Gaps = 28/280 (10%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTH---KIYALKVVHGDADPTVRRQVFRE--------M 100
           + E L+VLG G  G V+ V+    H   K+YA+KV+   A   V++    E        +
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAA--LVQKAKTVEHTRTERNVL 58

Query: 101 EILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQIL 160
           E +R+  SPF+V     F+  +  + ++++Y+  G + T L +   FSE ++   + +I+
Sbjct: 59  EHVRQ--SPFLVTLHYAFQTEA-KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEII 115

Query: 161 KGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMS 219
             L +LH   I++RDIK  N+L+++    V + DFG+SK  +    +   S+ GT  YM+
Sbjct: 116 LALEHLHKLGIVYRDIKLENILLDSEG-HVVLTDFGLSKEFLSEEKERTYSFCGTIEYMA 174

Query: 220 PERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPS 279
           PE       G   +G A D WSLG+ + EL  G  PF   G+R   + +   I   DPP 
Sbjct: 175 PEIIR----GKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPP- 229

Query: 280 LPDGASPEFRSFIECCLQKEFSKR-----WTASQLLTHPF 314
            P    PE +  +   L+K+  KR       AS++  HPF
Sbjct: 230 FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF 269

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  104 bits (260), Expect = 3e-26
 Identities = 70/252 (27%), Positives = 116/252 (46%), Gaps = 16/252 (6%)

Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVH--GDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           +G G    VY+          ALK V      D   R    +E+++L++ + P +++ + 
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69

Query: 117 IFEKPSGDIAILMEYMDSGTLDTLL----NKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
            F +   ++ I++E  D+G L  ++     +     E  +     Q+   L ++H  +++
Sbjct: 70  SFIE-DNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVM 128

Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNY 232
           HRDIKP+N+ +    + VK+ D G+ +       A +S VGT  YMSPER   + Y    
Sbjct: 129 HRDIKPANVFITATGV-VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY---- 183

Query: 233 NGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLP-DGASPEFRSF 291
             +  DIWSLG  L E+     PF   G + +  +L   I   D P LP D  S E R  
Sbjct: 184 -NFKSDIWSLGCLLYEMAALQSPFY--GDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQL 240

Query: 292 IECCLQKEFSKR 303
           +  C+  +  KR
Sbjct: 241 VNMCINPDPEKR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score =  104 bits (260), Expect = 5e-26
 Identities = 87/273 (31%), Positives = 138/273 (50%), Gaps = 30/273 (10%)

Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVF----REMEILRRT-DSPFIV 112
           ++G G  G VY  +   T K+YA+K +        + +      R M  L  T D PFIV
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
                F  P   ++ +++ M+ G L   L+++G FSE ++   A++I+ GL ++H   ++
Sbjct: 61  CMSYAFHTPD-KLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVV 119

Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCR-SLDACNSYVGTCAYMSPERFDPDAYGGN 231
           +RD+KP+N+L++ +   V+I+D G++   C  S    ++ VGT  YM+PE       G  
Sbjct: 120 YRDLKPANILLDEHG-HVRISDLGLA---CDFSKKKPHASVGTHGYMAPEVL---QKGVA 172

Query: 232 YNGYAGDIWSLGLTLLELYLGHFPFLQPGQRP----DWATLMCAICFGDPPSLPDGASPE 287
           Y+  A D +SLG  L +L  GH PF Q   +     D  TL  A        LPD  SPE
Sbjct: 173 YDSSA-DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA------VELPDSFSPE 225

Query: 288 FRSFIECCLQKEFSKR-----WTASQLLTHPFL 315
            RS +E  LQ++ ++R       A ++  HPF 
Sbjct: 226 LRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFF 258

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  104 bits (260), Expect = 7e-26
 Identities = 66/217 (30%), Positives = 108/217 (49%), Gaps = 35/217 (16%)

Query: 50  YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSP 109
           +  LEKL   G G   TVYK ++R T +I ALK +H DA+        RE+ +++     
Sbjct: 2   FKQLEKL---GEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHE 58

Query: 110 FIVQCFG----------IFEKPSGDIAILMEYMDS----GTLDTLLNKNGTFSEPKLAHI 155
            IV+             +FE    D   L +YMD+    G LD    K+ T+        
Sbjct: 59  NIVRLHDVIHTENKLMLVFEYMDKD---LKKYMDTHGVRGALDPNTVKSFTY-------- 107

Query: 156 ASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTC 215
             Q+LKG+++ H ++++HRD+KP NLL+N    ++K+ADFG+++     ++  ++ V T 
Sbjct: 108 --QLLKGIAFCHENRVLHRDLKPQNLLINKRG-ELKLADFGLARAFGIPVNTFSNEVVTL 164

Query: 216 AYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLG 252
            Y +P+       G      + DIWS+G  + E+  G
Sbjct: 165 WYRAPDVL----LGSRTYSTSIDIWSVGCIMAEMITG 197

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  103 bits (259), Expect = 7e-26
 Identities = 80/263 (30%), Positives = 138/263 (52%), Gaps = 19/263 (7%)

Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQV-FREMEILRRTDSPFIVQCFGI 117
           +G G+ G V     + + K+ A+K +  D     RR++ F E+ I+R      +V+ +  
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85

Query: 118 FEKPSGD-IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDI 176
           +    GD + ++ME+++ G L  ++      +E ++A +   +LK LS LH   +IHRDI
Sbjct: 86  YL--VGDELWVVMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLKALSVLHAQGVIHRDI 142

Query: 177 KPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYA 236
           K  ++L+ ++  +VK++DFG    + + +    S VGT  +M+PE      YG       
Sbjct: 143 KSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV---- 197

Query: 237 GDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPD--GASPEFRSFIEC 294
            DIWSLG+ ++E+  G  P+    + P  A  M  I    PP L +    SP  + F++ 
Sbjct: 198 -DIWSLGIMVIEMVDGEPPYFN--EPPLKAMKM--IRDNLPPKLKNLHKVSPSLKGFLDR 252

Query: 295 CLQKEFSKRWTASQLLTHPFLCK 317
            L ++ ++R TA++LL HPFL K
Sbjct: 253 LLVRDPAQRATAAELLKHPFLAK 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  104 bits (262), Expect = 7e-26
 Identities = 84/303 (27%), Positives = 131/303 (43%), Gaps = 60/303 (19%)

Query: 50  YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALK-VVHGDADPTVRRQVFREMEILRRTDS 108
           Y DL   Q +G G  G V   + + T +  A+K ++   + P + ++ +RE+++L+    
Sbjct: 12  YVDL---QPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
             I+    IF  P  DI  + E +    L  LL  +    +  + +   QIL+GL Y+H 
Sbjct: 69  ENIISLSDIFISPLEDIYFVTELL-GTDLHRLL-TSRPLEKQFIQYFLYQILRGLKYVHS 126

Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE------R 222
             ++HRD+KPSN+L+ N N  +KI DFG+++I    +     YV T  Y +PE      +
Sbjct: 127 AGVVHRDLKPSNILI-NENCDLKICDFGLARIQDPQM---TGYVSTRYYRAPEIMLTWQK 182

Query: 223 FDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAIC--FGDPP-- 278
           +D +           DIWS G    E+  G   F  PG+  D       I    G PP  
Sbjct: 183 YDVEV----------DIWSAGCIFAEMLEGKPLF--PGK--DHVNQFSIITDLLGTPPDD 228

Query: 279 ---------------SLP-----------DGASPEFRSFIECCLQKEFSKRWTASQLLTH 312
                          SLP             A P     +E  L  +  KR +A++ L H
Sbjct: 229 VINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288

Query: 313 PFL 315
           P+L
Sbjct: 289 PYL 291

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  105 bits (263), Expect = 8e-26
 Identities = 82/309 (26%), Positives = 138/309 (44%), Gaps = 56/309 (18%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFR---EMEILRRTD 107
            D E ++V+G G  G V  VQ + T  IYA+K +   ++   + QV     E +IL   D
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLR-KSEMLEKEQVAHVRAERDILAEAD 59

Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPK-LAHIASQILKGLSYL 166
           +P++V+ +  F+  +  + ++MEY+  G + TLL K  TF+E +   +IA  IL  +  +
Sbjct: 60  NPWVVKLYYSFQDEN-YLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETIL-AIDSI 117

Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK------------------------IMC 202
           H    IHRDIKP NLL++     +K++DFG+                           + 
Sbjct: 118 HKLGYIHRDIKPDNLLLDAKG-HIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFIS 176

Query: 203 RSLDACN--------------SYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLE 248
           + + +                S VGT  Y++PE F    Y         D WSLG+ + E
Sbjct: 177 KPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-----NKECDWWSLGVIMYE 231

Query: 249 LYLGHFPFLQPGQRPDWATLM-CAICFGDPPSLPDGASPEFRSFIE--CCLQKEFSKRWT 305
           + +G+ PF     +  +  ++        P  +P   SPE +  I+  CC  +       
Sbjct: 232 MLVGYPPFCSDNPQETYRKIINWKETLQFPDEVP--LSPEAKDLIKRLCCEAERRLGNNG 289

Query: 306 ASQLLTHPF 314
            +++ +HPF
Sbjct: 290 VNEIKSHPF 298

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  105 bits (262), Expect = 1e-25
 Identities = 67/214 (31%), Positives = 113/214 (52%), Gaps = 19/214 (8%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQ----VFREMEILRRTD 107
           D + ++V+G G  G V  V+H+ + K+YA+K++       ++R      + E +I+   +
Sbjct: 44  DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLL--SKFEMIKRSDSAFFWEERDIMAFAN 101

Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
           SP++VQ F  F+     + ++MEYM  G L  L++ N    E       ++++  L  +H
Sbjct: 102 SPWVVQLFCAFQDDK-YLYMVMEYMPGGDLVNLMS-NYDVPEKWAKFYTAEVVLALDAIH 159

Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA-----CNSYVGTCAYMSPER 222
              +IHRD+KP N+L++ +   +K+ADFG     C  +D      C++ VGT  Y+SPE 
Sbjct: 160 SMGLIHRDVKPDNMLLDKHG-HLKLADFGT----CMKMDETGMVRCDTAVGTPDYISPEV 214

Query: 223 FDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPF 256
                 G  Y G   D WS+G+ L E+ +G  PF
Sbjct: 215 LKSQG-GDGYYGRECDWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  104 bits (260), Expect = 1e-25
 Identities = 77/268 (28%), Positives = 127/268 (47%), Gaps = 23/268 (8%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGD---ADPTVRRQVFREMEILRRTDSPFIVQ 113
           ++LG G  G V  V+ + T + YA+K++  +   A   V   V  E  +L+ T  PF+  
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV-TESRVLQNTRHPFLTA 59

Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
               F+     +  +MEY + G L   L++   F+E +     ++I+  L YLH   +++
Sbjct: 60  LKYAFQT-HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVY 118

Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYN 233
           RDIK  NL+++ +   +KI DFG+ K          ++ GT  Y++PE  + + Y     
Sbjct: 119 RDIKLENLMLDKDG-HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY----- 172

Query: 234 GYAGDIWSLGLTLLELYLGHFPFL-QPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFI 292
           G A D W LG+ + E+  G  PF  Q  +R     LM  I F      P   SPE +S +
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF------PRTLSPEAKSLL 226

Query: 293 ECCLQKEFSKRW-----TASQLLTHPFL 315
              L+K+  +R       A +++ H F 
Sbjct: 227 AGLLKKDPKQRLGGGPSDAKEVMEHRFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  103 bits (258), Expect = 1e-25
 Identities = 85/301 (28%), Positives = 128/301 (42%), Gaps = 60/301 (19%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSPFIV 112
           +K++ +G G  G VYK +++ T ++ ALK +  D +   V     RE+ +L+  + P IV
Sbjct: 3   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 62

Query: 113 QC----------FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIAS---QI 159
           +           + +FE    D   L ++MD+  L          S   L  I S   Q+
Sbjct: 63  KLLDVIHTENKLYLVFEFLHQD---LKKFMDASPL----------SGIPLPLIKSYLFQL 109

Query: 160 LKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMS 219
           L+GL++ H H+++HRD+KP NLL+N     +K+ADFG+++     +      V T  Y +
Sbjct: 110 LQGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRA 168

Query: 220 PERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQR--------------PDW 265
           PE       G  Y   A DIWSLG    E+      F  PG                PD 
Sbjct: 169 PEIL----LGCKYYSTAVDIWSLGCIFAEMVTRRALF--PGDSEIDQLFRIFRTLGTPDE 222

Query: 266 ATLMCAICFGD-PPSLPDGASPEF-----------RSFIECCLQKEFSKRWTASQLLTHP 313
                     D  PS P  A  +F           R  +   L  + +KR +A   L HP
Sbjct: 223 VVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHP 282

Query: 314 F 314
           F
Sbjct: 283 F 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  102 bits (256), Expect = 2e-25
 Identities = 87/283 (30%), Positives = 141/283 (49%), Gaps = 27/283 (9%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTH---KIYALKVVHG-----DADPTVRRQVFRE-MEI 102
           + E L+VLG G  G V+ V+    H   K+YA+KV+        A  T   +  R+ +E 
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 103 LRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
           +R+  SPF+V     F+  +  + ++++Y++ G L T L++   F E ++   + +I+  
Sbjct: 61  IRQ--SPFLVTLHYAFQTDT-KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLA 117

Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPE 221
           L +LH   II+RDIK  N+L+++N   V + DFG+SK      ++   S+ GT  YM+  
Sbjct: 118 LEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKEFHEDEVERAYSFCGTIEYMA-- 174

Query: 222 RFDPDAYGGNYNGY--AGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPS 279
              PD   G   G+  A D WS+G+ + EL  G  PF   G++   A +   I   +PP 
Sbjct: 175 ---PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP- 230

Query: 280 LPDGASPEFRSFIECCLQKEFSKRW-----TASQLLTHPFLCK 317
            P   S   +  I+  L K+  KR       A ++  HPF  K
Sbjct: 231 YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  102 bits (256), Expect = 2e-25
 Identities = 81/261 (31%), Positives = 134/261 (51%), Gaps = 19/261 (7%)

Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQV-FREMEILRRTDSPFIVQCFGI 117
           +G G+ G V     + T K  A+K +  D     RR++ F E+ I+R      +V  +  
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87

Query: 118 FEKPSGD-IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDI 176
           +    GD + ++ME+++ G L  ++      +E ++A +   +L+ LSYLH   +IHRDI
Sbjct: 88  YL--VGDELWVVMEFLEGGALTDIVTHT-RMNEEQIATVCLSVLRALSYLHNQGVIHRDI 144

Query: 177 KPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYA 236
           K  ++L+ ++  ++K++DFG    + + +    S VGT  +M+PE      YG       
Sbjct: 145 KSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV---- 199

Query: 237 GDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDG--ASPEFRSFIEC 294
            DIWSLG+ ++E+  G  P+    + P  A  M  I    PP + D    S   R F++ 
Sbjct: 200 -DIWSLGIMVIEMIDGEPPYFN--EPPLQA--MRRIRDNLPPRVKDSHKVSSVLRGFLDL 254

Query: 295 CLQKEFSKRWTASQLLTHPFL 315
            L +E S+R TA +LL HPFL
Sbjct: 255 MLVREPSQRATAQELLQHPFL 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  103 bits (257), Expect = 2e-25
 Identities = 71/265 (26%), Positives = 126/265 (47%), Gaps = 19/265 (7%)

Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQV---FREMEILRRTDSPFIVQCF 115
           +G G+ G V +V+ R T +IYALK +   A    R +V     E  +L + + PFIV   
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIR-KAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK 59

Query: 116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRD 175
             F+ P   + +++ +++ G L   L + G F   +     +++L  L  LH   +I+RD
Sbjct: 60  FSFQSP-EKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRD 118

Query: 176 IKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGY 235
           +KP N+L++     + + DFG+ K+  +  D  N++ GT  Y++PE      Y       
Sbjct: 119 LKPENILLDYQG-HIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTK----- 172

Query: 236 AGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECC 295
           A D W+LG+ L E+  G  PF        +  ++      +P   PDG   + +  +   
Sbjct: 173 AVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL-----QEPLRFPDGFDRDAKDLLIGL 227

Query: 296 LQKEFSKRW---TASQLLTHPFLCK 317
           L ++ ++R     A ++  HPF  +
Sbjct: 228 LSRDPTRRLGYNGAQEIKNHPFFSQ 252

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  101 bits (254), Expect = 4e-25
 Identities = 84/291 (28%), Positives = 125/291 (42%), Gaps = 40/291 (13%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTDSPFIV 112
           EKL+ +G G  GTV+K ++R TH+I ALK V   D D  V     RE+ +L+      IV
Sbjct: 3   EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 62

Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
           + + +       + ++ EY D        + NG      +     Q+LKGL++ H H ++
Sbjct: 63  RLYDVLHSDK-KLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVL 121

Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSK---IMCRSLDACNSYVGTCAYMSPERFDPDAYG 229
           HRD+KP NLL+N N  ++K+ADFG+++   I  R   A    V T  Y  P+      +G
Sbjct: 122 HRDLKPQNLLINKNG-ELKLADFGLARAFGIPVRCYSA---EVVTLWYRPPDVL----FG 173

Query: 230 GNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP-----PS---LP 281
                 + D+WS G    EL     P L PG   D          G P     P    LP
Sbjct: 174 AKLYSTSIDMWSAGCIFAELANAGRP-LFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP 232

Query: 282 D------------------GASPEFRSFIECCLQKEFSKRWTASQLLTHPF 314
           D                    +   R  ++  L     +R +A + L HP+
Sbjct: 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  102 bits (257), Expect = 4e-25
 Identities = 88/303 (29%), Positives = 140/303 (46%), Gaps = 55/303 (18%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRR-TDSPF 110
           E LQ LG G  G V+K   R T ++ ALK +  DA  + T  ++ FRE+  L+   D P 
Sbjct: 10  EILQKLGKGAYGIVWKAIDRRTKEVVALKKIF-DAFRNATDAQRTFREIMFLQELGDHPN 68

Query: 111 IVQCFGIFEKPSG-DIAILMEYMDSGTLDTLLN---KNGTFSEPKLAHIASQILKGLSYL 166
           IV+   + +  +  DI ++ EYM+     T L+   +     +    +I  Q+LK L Y+
Sbjct: 69  IVKLLNVIKAENDKDIYLVFEYME-----TDLHAVIRANILEDVHKRYIMYQLLKALKYI 123

Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNS------YVGTCAYMSP 220
           H   +IHRD+KPSN+L+ N++ +VK+ADFG+++ +   L+          YV T  Y +P
Sbjct: 124 HSGNVIHRDLKPSNILL-NSDCRVKLADFGLARSLS-ELEENPENPVLTDYVATRWYRAP 181

Query: 221 ERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPG-------------------- 260
           E       G        D+WS+G  L E+ LG   F  PG                    
Sbjct: 182 EIL----LGSTRYTKGVDMWSVGCILGEMLLGKPLF--PGTSTLNQLEKIIEVIGPPSAE 235

Query: 261 -----QRPDWATLMCAICFGDPPSLPDG---ASPEFRSFIECCLQKEFSKRWTASQLLTH 312
                + P  AT++ ++       L +    AS +    ++  L    +KR TA + L H
Sbjct: 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295

Query: 313 PFL 315
           P++
Sbjct: 296 PYV 298

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  100 bits (252), Expect = 5e-25
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 27/211 (12%)

Query: 59  LGHGNGGTVYKVQHR---CTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           LGHGN G+V K  +          A+K +  +     +++  RE  ++ + D P IV+  
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRD 175
           G+ +     + ++ME    G L   L K        L  +A Q+  G++YL     +HRD
Sbjct: 63  GVCKGEP--LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRD 120

Query: 176 IKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYV-GTCA------YMSPERFDPDAY 228
           +   N+L+ N + Q KI+DFG+S    R+L A + Y   T A      + +PE       
Sbjct: 121 LAARNVLLVNRH-QAKISDFGMS----RALGAGSDYYRATTAGRWPLKWYAPECI----- 170

Query: 229 GGNYNGY--AGDIWSLGLTLLELY-LGHFPF 256
             NY  +    D+WS G+TL E +  G  P+
Sbjct: 171 --NYGKFSSKSDVWSYGVTLWEAFSYGAKPY 199

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  103 bits (257), Expect = 5e-25
 Identities = 68/210 (32%), Positives = 112/210 (53%), Gaps = 11/210 (5%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQ----VFREMEILRRTD 107
           D E ++V+G G  G V  V+H+ T K+YA+K++       ++R      + E +I+   +
Sbjct: 44  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL--SKFEMIKRSDSAFFWEERDIMAFAN 101

Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
           SP++VQ F  F+     + ++MEYM  G L  L++ N    E       ++++  L  +H
Sbjct: 102 SPWVVQLFYAFQDDRY-LYMVMEYMPGGDLVNLMS-NYDVPEKWARFYTAEVVLALDAIH 159

Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS-LDACNSYVGTCAYMSPERFDPD 226
               IHRD+KP N+L++ +   +K+ADFG    M +  +  C++ VGT  Y+SPE     
Sbjct: 160 SMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 218

Query: 227 AYGGNYNGYAGDIWSLGLTLLELYLGHFPF 256
             G  Y G   D WS+G+ L E+ +G  PF
Sbjct: 219 G-GDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  101 bits (254), Expect = 7e-25
 Identities = 72/215 (33%), Positives = 108/215 (50%), Gaps = 15/215 (6%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSP 109
           ++ EKL  +G G  G VY+ +   + +I ALK V  D +   +     RE+ +L     P
Sbjct: 7   TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHP 66

Query: 110 FIVQCFGIFEKPSGD-IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
            IV+   +      D I ++MEY +      L N    FSE ++  +  Q+L+GL YLH 
Sbjct: 67  NIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE 126

Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK---IMCRSLDACNSYVGTCAYMSPERFDP 225
           + IIHRD+K SNLL+ +    +KIADFG+++   +  + +      V T  Y +PE    
Sbjct: 127 NFIIHRDLKVSNLLLTDKGC-LKIADFGLARTYGLPAKPMTPK---VVTLWYRAPELL-- 180

Query: 226 DAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPG 260
              G      A D+W++G  L EL L H P L PG
Sbjct: 181 --LGCTTYTTAIDMWAVGCILAEL-LAHKPLL-PG 211

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  100 bits (251), Expect = 1e-24
 Identities = 72/273 (26%), Positives = 119/273 (43%), Gaps = 30/273 (10%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVV--------HGDADPTVRRQVFREMEILRRTDS 108
           +VLG G  G V   Q R T K+YA K +         G+A          E +IL + +S
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEA------MALNEKQILEKVNS 59

Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYL 166
            F+V     +E     + +++  M+ G L   +    N  F E +    A++I  GL  L
Sbjct: 60  RFVVSLAYAYETKDA-LCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDL 118

Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPD 226
           H  +I++RD+KP N+L+++    ++I+D G++ +     +     VGT  YM+PE    +
Sbjct: 119 HRERIVYRDLKPENILLDDYG-HIRISDLGLA-VEIPEGETIRGRVGTVGYMAPEVVKNE 176

Query: 227 AYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP 286
            Y      ++ D W LG  + E+  G  PF Q  ++     +   +   D     +  S 
Sbjct: 177 RY-----TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRV-KEDQEEYSEKFSE 230

Query: 287 EFRSFIECCLQKEFSKRW-----TASQLLTHPF 314
             RS     L K+   R       A ++  HPF
Sbjct: 231 AARSICRQLLTKDPGFRLGCRGEGAEEVKAHPF 263

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  101 bits (252), Expect = 1e-24
 Identities = 82/272 (30%), Positives = 125/272 (45%), Gaps = 27/272 (9%)

Query: 56  LQVLGHGNGGTVY---KVQHRCTHKIYALKVVHGDADPTVRRQ-----VFREMEILRRTD 107
           L+VLG G  G V+   KV    T KI+A+KV+       VR Q        E  IL    
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKAT--IVRNQKDTAHTKAERNILEAVK 58

Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
            PFIV     F+   G + +++EY+  G L   L + G F E       S+I   L +LH
Sbjct: 59  HPFIVDLIYAFQT-GGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLH 117

Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDA 227
              II+RD+KP N+L++     VK+ DFG+ K         +++ GT  YM+PE      
Sbjct: 118 QQGIIYRDLKPENILLDAQG-HVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSG 176

Query: 228 YGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPE 287
           +G      A D WSLG  + ++  G  PF    ++     ++         +LP   +PE
Sbjct: 177 HGK-----AVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL-----NLPPYLTPE 226

Query: 288 FRSFIECCLQKEFSKRW-----TASQLLTHPF 314
            R  ++  L++  S R       A+++ +HPF
Sbjct: 227 ARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPF 258

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  101 bits (253), Expect = 2e-24
 Identities = 83/305 (27%), Positives = 127/305 (41%), Gaps = 64/305 (20%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALK--------VVHGDADPTVRRQVFREMEILRR 105
           + L  +G G  G V       T +  A+K         +H        ++ +RE+ +L+ 
Sbjct: 18  QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHA-------KRTYRELRLLKH 70

Query: 106 TDSPFIVQCFGIFEKPSG-----DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQIL 160
            D   ++    +F   S      D+ ++   M +  L+ ++ K    S+  +  +  QIL
Sbjct: 71  MDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIV-KCQKLSDDHIQFLVYQIL 128

Query: 161 KGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA-CNSYVGTCAYMS 219
           +GL Y+H   IIHRD+KPSN+ V N + ++KI DFG    + R  D     YV T  Y +
Sbjct: 129 RGLKYIHSAGIIHRDLKPSNIAV-NEDCELKILDFG----LARHTDDEMTGYVATRWYRA 183

Query: 220 PERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRP-DWATLMCAICFGDPP 278
           PE         +YN    DIWS+G  + EL  G   F  PG    D    +  +  G P 
Sbjct: 184 PEIM---LNWMHYNQTV-DIWSVGCIMAELLTGKTLF--PGSDHIDQLKRIMNLV-GTPD 236

Query: 279 -----------------SLPD-----------GASPEFRSFIECCLQKEFSKRWTASQLL 310
                            SLP            GA+P     +E  L  +  KR TA++ L
Sbjct: 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEAL 296

Query: 311 THPFL 315
            HP+L
Sbjct: 297 AHPYL 301

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 99.9 bits (249), Expect = 3e-24
 Identities = 77/263 (29%), Positives = 127/263 (48%), Gaps = 18/263 (6%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA----DPTVRRQVFREMEILRRTDSPFIV 112
           +VLG G+ G V   + + T++ +A+K +  D     D      V R +  L   + PF+ 
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA-WEHPFLT 59

Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
             F  F+     +  +MEY++ G L   +  +G F E +    A++I+ GL +LH   II
Sbjct: 60  HLFCTFQTKE-HLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGII 118

Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNY 232
           +RD+K  N+L++ +   +KIADFG+ K         +++ GT  Y++PE       G  Y
Sbjct: 119 YRDLKLDNVLLDKDG-HIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILK----GQKY 173

Query: 233 NGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFI 292
           N  + D WS G+ L E+ +G  PF   G+  D   L  +I   D P  P   S E +  +
Sbjct: 174 N-ESVDWWSFGVLLYEMLIGQSPF--HGEDED--ELFDSILN-DRPHFPRWISKEAKDCL 227

Query: 293 ECCLQKEFSKRW-TASQLLTHPF 314
               +++ +KR      +  HPF
Sbjct: 228 SKLFERDPTKRLGVDGDIRQHPF 250

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  100 bits (249), Expect = 4e-24
 Identities = 76/268 (28%), Positives = 127/268 (47%), Gaps = 23/268 (8%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGD---ADPTVRRQVFREMEILRRTDSPFIVQ 113
           ++LG G  G V  V+ + + K YA+K++  +   A   V      E  +L+ T  PF+  
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVA-HTLTESRVLKNTRHPFLTS 59

Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
               F+     +  +MEY++ G L   L++   FSE +     ++I+  L YLH  KI++
Sbjct: 60  LKYSFQTKD-RLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVY 118

Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYN 233
           RD+K  NL+++ +   +KI DFG+ K          ++ GT  Y++PE  + + Y     
Sbjct: 119 RDLKLENLMLDKDG-HIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY----- 172

Query: 234 GYAGDIWSLGLTLLELYLGHFPFL-QPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFI 292
           G A D W LG+ + E+  G  PF  Q  ++     LM  I F      P   S + +S +
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKF------PRTLSADAKSLL 226

Query: 293 ECCLQKEFSKRW-----TASQLLTHPFL 315
              L K+ +KR       A +++ H F 
Sbjct: 227 SGLLIKDPNKRLGGGPDDAKEIMRHSFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 98.8 bits (247), Expect = 6e-24
 Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 17/203 (8%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVF-----REMEILRRTDS 108
           EKL  +  G  G VY+ + + T +I ALK +  + +    ++ F     RE+ IL +   
Sbjct: 8   EKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKE----KEGFPITSLREINILLKLQH 63

Query: 109 PFIVQCFGI-FEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQILKGLSYL 166
           P IV    +        I ++MEY++   L +L+      F + ++  +  Q+L G+++L
Sbjct: 64  PNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHL 122

Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPD 226
           H + I+HRD+K SNLL+NN    +KI DFG+++     L      V T  Y +PE     
Sbjct: 123 HDNWILHRDLKTSNLLLNNRG-ILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELL--- 178

Query: 227 AYGGNYNGYAGDIWSLGLTLLEL 249
             G      A D+WS+G    EL
Sbjct: 179 -LGAKEYSTAIDMWSVGCIFAEL 200

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 98.7 bits (246), Expect = 7e-24
 Identities = 89/305 (29%), Positives = 133/305 (43%), Gaps = 55/305 (18%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVF-----REMEILRRTDS 108
           + +  +G G  G VYK + + T ++ ALK V  D +    ++ F     RE++ILR+ + 
Sbjct: 10  DIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE----KEGFPITAIREIKILRQLNH 65

Query: 109 PFIVQCFGI---------FEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQI 159
             IV    I         F+K  G   ++ EYMD   +  L +    FSE  +     Q+
Sbjct: 66  RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL 125

Query: 160 LKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSY---VGTCA 216
           L+GL+Y H    +HRDIK SN+L+NN   Q+K+ADFG++++   + +    Y   V T  
Sbjct: 126 LEGLNYCHKKNFLHRDIKCSNILLNNKG-QIKLADFGLARLY--NSEESRPYTNKVITLW 182

Query: 217 YMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAIC-FG 275
           Y  PE       G    G A D+WS G  L EL+    P  Q  Q      L+  +C   
Sbjct: 183 YRPPELL----LGEERYGPAIDVWSCGCILGELFTKK-PIFQANQELAQLELISRLCGSP 237

Query: 276 DPPSLPDGAS-PEFRSF------------------------IECCLQKEFSKRWTASQLL 310
            P   PD    P F +                         ++  L  + SKR TA + L
Sbjct: 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEAL 297

Query: 311 THPFL 315
             P+L
Sbjct: 298 NSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 98.5 bits (246), Expect = 7e-24
 Identities = 77/299 (25%), Positives = 120/299 (40%), Gaps = 54/299 (18%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIV 112
           +K++ +G G  G VYK + + T +I ALK +  +  D  V     RE+ +L+  + P IV
Sbjct: 2   QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIV 61

Query: 113 QCFGI----------FEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
           +   +          FE    D   L +YMDS  L  L         P +     Q+L+G
Sbjct: 62  RLLDVVHSENKLYLVFEFLDLD---LKKYMDSSPLTGL-------DPPLIKSYLYQLLQG 111

Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
           ++Y H H+++HRD+KP NLL++     +K+ADFG+++     +      V T  Y +PE 
Sbjct: 112 IAYCHSHRVLHRDLKPQNLLIDREG-ALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 170

Query: 223 FDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQR--------------PDWATL 268
                 G        DIWS+G    E+ +   P L PG                PD    
Sbjct: 171 L----LGSRQYSTPVDIWSIGCIFAEM-VNRRP-LFPGDSEIDQLFRIFRTLGTPDEDVW 224

Query: 269 MCAICFGD---------PPSLPD---GASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
                  D            L         +    +   L  + +KR +A   L HP+ 
Sbjct: 225 PGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 99.1 bits (247), Expect = 9e-24
 Identities = 76/271 (28%), Positives = 122/271 (45%), Gaps = 9/271 (3%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVF--REMEILRRTDSP 109
           D +   ++G G+ G V  V+ + T  IYA+KV+            F   E +IL  ++SP
Sbjct: 2   DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSP 61

Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHG 168
           +I Q    F+    ++ ++MEY   G L +LLN+    F E       ++++  +  +H 
Sbjct: 62  WIPQLQYAFQD-KDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120

Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA-CNSYVGTCAYMSPERFDP-D 226
              +HRDIKP N+L++     +K+ADFG +  +  +        VGT  Y++PE     +
Sbjct: 121 MGYVHRDIKPENVLIDRTG-HIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMN 179

Query: 227 AYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP 286
             G    G   D WSLG+   E+  G  PF +      +  +M    F   P  P   S 
Sbjct: 180 GDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPK-VSS 238

Query: 287 EFRSFIECCLQKEFSKRWTASQLLTHPFLCK 317
           +F   I+  L  +  +R     L  HPF  K
Sbjct: 239 DFLDLIQSLLCGQ-KERLGYEGLCCHPFFSK 268

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 99.1 bits (247), Expect = 9e-24
 Identities = 84/307 (27%), Positives = 132/307 (42%), Gaps = 60/307 (19%)

Query: 56  LQVLGHGNGGTVYK-VQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQC 114
           L+ LG G+ G V+  V   C  ++   K+V    DP   +   RE++I+RR D   IV+ 
Sbjct: 10  LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVL--TDPQSVKHALREIKIIRRLDHDNIVKV 67

Query: 115 FGIFEKPSGD-------------IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILK 161
           + +      D             + I+ EYM++  L  +L + G  SE        Q+L+
Sbjct: 68  YEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQ-GPLSEEHARLFMYQLLR 125

Query: 162 GLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVG-------T 214
           GL Y+H   ++HRD+KP+N+ +N  ++ +KI DFG+++I+    D   S+ G       T
Sbjct: 126 GLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIV----DPHYSHKGYLSEGLVT 181

Query: 215 CAYMSPE-RFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPF---------------LQ 258
             Y SP     P+    NY   A D+W+ G    E+  G   F               + 
Sbjct: 182 KWYRSPRLLLSPN----NYTK-AIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236

Query: 259 PGQRPDWATLMCAI-----CFGDPPSLP-----DGASPEFRSFIECCLQKEFSKRWTASQ 308
             +  D   L+  I       G  P  P      G +PE   F+E  L      R TA +
Sbjct: 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEE 296

Query: 309 LLTHPFL 315
            L HP++
Sbjct: 297 ALMHPYM 303

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 98.0 bits (244), Expect = 1e-23
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 14/206 (6%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRR-TDSPFI 111
           EKL+ +G G  G VYK + + T K+ ALK    + D   +     RE+ +L+  ++S +I
Sbjct: 4   EKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYI 63

Query: 112 VQCFGI--FEKPSGDIAI--LMEYMDSGT---LDTLLNKNGTFSEPKLAH-IASQILKGL 163
           V+   +   E+ +G  ++  + EY+DS     +D+     G     K       Q+LKG+
Sbjct: 64  VRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123

Query: 164 SYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF 223
           ++ H H ++HRD+KP NLLV+     +KIAD G+ +     + +    + T  Y +PE  
Sbjct: 124 AHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVL 183

Query: 224 DPDAYGGNYNGYAGDIWSLGLTLLEL 249
                G  +     DIWS+G    E+
Sbjct: 184 ----LGSTHYSTPVDIWSVGCIFAEM 205

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 98.3 bits (245), Expect = 1e-23
 Identities = 75/265 (28%), Positives = 120/265 (45%), Gaps = 19/265 (7%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEIL-RRTDSPFIVQ 113
           +V+G G+ G V   +H+   K YA+KV+   A      ++ +  E  +L +    PF+V 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
               F+     +  +++Y++ G L   L +  +F EP+    A++I   L YLH   II+
Sbjct: 61  LHYSFQTAD-KLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIY 119

Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYN 233
           RD+KP N+L+++    V + DFG+ K         +++ GT  Y++PE      Y     
Sbjct: 120 RDLKPENILLDSQG-HVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPY----- 173

Query: 234 GYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIE 293
               D W LG  L E+  G  PF       D A +   I    P  L    S   R  +E
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYS----RDTAEMYDNI-LNKPLRLKPNISVSARHLLE 228

Query: 294 CCLQKEFSKRWTAS----QLLTHPF 314
             LQK+ +KR  A     ++  H F
Sbjct: 229 GLLQKDRTKRLGAKDDFLEIKNHVF 253

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 97.4 bits (242), Expect = 1e-23
 Identities = 67/252 (26%), Positives = 117/252 (46%), Gaps = 16/252 (6%)

Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVH--GDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           +G G    VY+       K  ALK V      D   R+   +E+++L++ + P +++   
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 117 IFEKPSGDIAILMEYMDSGTLDTLL----NKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
            F +   ++ I++E  D+G L  ++     +     E  +     Q+   + ++H  +++
Sbjct: 70  SFIE-DNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVM 128

Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNY 232
           HRDIKP+N+ +    + VK+ D G+ +       A +S VGT  YMSPER   + Y    
Sbjct: 129 HRDIKPANVFITATGV-VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY---- 183

Query: 233 NGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLP-DGASPEFRSF 291
             +  DIWSLG  L E+     PF   G + +  +L   I   D P LP +  S + R  
Sbjct: 184 -NFKSDIWSLGCLLYEMAALQSPFY--GDKMNLFSLCQKIEQCDYPPLPTEHYSEKLREL 240

Query: 292 IECCLQKEFSKR 303
           +  C+  +  +R
Sbjct: 241 VSMCIYPDPDQR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 97.6 bits (243), Expect = 3e-23
 Identities = 68/218 (31%), Positives = 105/218 (48%), Gaps = 12/218 (5%)

Query: 41  TTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQ--VFR 98
           T   T++   SD E  + LG G+ G V   +H+ T + YA+K +       +++   V +
Sbjct: 8   TKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQ 67

Query: 99  EMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQ 158
           E  IL     PFIV     F+     +  L+E++  G L T L K G F         ++
Sbjct: 68  EKSILMELSHPFIVNMMCSFQD-ENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAE 126

Query: 159 ILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYM 218
           ++    YLH   II+RD+KP NLL++N    VK+ DFG +K   +  D   +  GT  Y+
Sbjct: 127 LVLAFEYLHSKDIIYRDLKPENLLLDNKG-HVKVTDFGFAK---KVPDRTFTLCGTPEYL 182

Query: 219 SPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPF 256
           +PE      +G      A D W++G+ L E   G+ PF
Sbjct: 183 APEVIQSKGHGK-----AVDWWTMGVLLYEFIAGYPPF 215

Length = 329

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 97.0 bits (241), Expect = 4e-23
 Identities = 75/269 (27%), Positives = 128/269 (47%), Gaps = 24/269 (8%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGD---ADPTVRRQVFREMEILRRTDSPFIVQ 113
           ++LG G  G V  V+ + T + YA+K++  +   A   V      E  +L+ +  PF+  
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVA-HTLTENRVLQNSRHPFLTA 59

Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK-II 172
               F+     +  +MEY + G L   L++   FSE +     ++I+  L YLH  K ++
Sbjct: 60  LKYSFQT-HDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVV 118

Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNY 232
           +RD+K  NL+++ +   +KI DFG+ K   +      ++ GT  Y++PE  + + YG   
Sbjct: 119 YRDLKLENLMLDKDG-HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYG--- 174

Query: 233 NGYAGDIWSLGLTLLELYLGHFPFL-QPGQRPDWATLMCAICFGDPPSLPDGASPEFRSF 291
              A D W LG+ + E+  G  PF  Q  ++     LM  I F      P   SPE +S 
Sbjct: 175 --RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF------PRTLSPEAKSL 226

Query: 292 IECCLQKEFSKRW-----TASQLLTHPFL 315
           +   L+K+  +R       A +++ H F 
Sbjct: 227 LSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 97.1 bits (242), Expect = 4e-23
 Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 38/227 (16%)

Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVV---HGDADPTVRRQ----------VFREMEILRR 105
           LG G  G V K     T KI A+K V       D T  RQ            RE++I+  
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 106 TDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
                I+    ++ +    I ++M+ M S  L  ++++    +E ++  I  QIL GL+ 
Sbjct: 77  IKHENIMGLVDVYVE-GDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNV 134

Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVS---------------KIMCRSLDACNS 210
           LH    +HRD+ P+N+ +N+  +  KIADFG++               + M R  +   S
Sbjct: 135 LHKWYFMHRDLSPANIFINSKGI-CKIADFGLARRYGYPPYSDTLSKDETMQRREEM-TS 192

Query: 211 YVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGH--FP 255
            V T  Y +PE       G     +A D+WS+G    EL  G   FP
Sbjct: 193 KVVTLWYRAPELL----MGAEKYHFAVDMWSVGCIFAELLTGKPLFP 235

Length = 335

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 95.9 bits (239), Expect = 8e-23
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 18/217 (8%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALK-VVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           EKL  +G G  G V+K +H+ T +I ALK V+  +          RE++IL+      +V
Sbjct: 15  EKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVV 74

Query: 113 QCFGIFEKPS-------GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
               I    +       G   ++ E+ +      L NKN  F+  ++  +   +L GL Y
Sbjct: 75  NLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYY 134

Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL-DACNSY---VGTCAYMSPE 221
           +H +KI+HRD+K +N+L+  + + +K+ADFG+++    S     N Y   V T  Y  PE
Sbjct: 135 IHRNKILHRDMKAANILITKDGI-LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPE 193

Query: 222 RFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQ 258
               +    +Y G   D+W  G  + E++    P +Q
Sbjct: 194 LLLGER---DY-GPPIDMWGAGCIMAEMWTRS-PIMQ 225

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 95.5 bits (237), Expect = 1e-22
 Identities = 70/212 (33%), Positives = 111/212 (52%), Gaps = 13/212 (6%)

Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTDSPFI 111
            E L V+G G  G V K +H+ T +I A+K     + +  V+    RE+++LR      I
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62

Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEP-KLAHIASQILKGLSYLHGHK 170
           V+    F +  G + ++ EY++   L+ LL +      P K+     Q++K + + H + 
Sbjct: 63  VELKEAFRR-RGKLYLVFEYVEKNMLE-LLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND 120

Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA-CNSYVGTCAYMSPERFDPDAYG 229
           I+HRDIKP NLL+++N++ +K+ DFG ++ +    +A    YV T  Y SPE       G
Sbjct: 121 IVHRDIKPENLLISHNDV-LKLCDFGFARNLSEGSNANYTEYVATRWYRSPELL----LG 175

Query: 230 GNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQ 261
             Y G A D+WS+G  L EL  G   F  PG+
Sbjct: 176 APY-GKAVDMWSVGCILGELSDGQPLF--PGE 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 95.8 bits (239), Expect = 1e-22
 Identities = 69/218 (31%), Positives = 103/218 (47%), Gaps = 24/218 (11%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
              + L  +G G  G V    H+ T    A+K +      T  ++  RE++ILRR     
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64

Query: 111 IVQCFGIFEKPS----GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
           I+    I   PS     D+ I+ E M++     +  ++   S   + +   QIL+GL Y+
Sbjct: 65  IIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQH--LSNDHIQYFLYQILRGLKYI 122

Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNS-----YVGTCAYMSPE 221
           H   ++HRD+KPSNLL+ N N  +KI DFG+++I     D  ++     YV T  Y +PE
Sbjct: 123 HSANVLHRDLKPSNLLL-NTNCDLKICDFGLARIADPEHD--HTGFLTEYVATRWYRAPE 179

Query: 222 RFDPDAYGGNYNGY--AGDIWSLGLTLLELYLGH--FP 255
                    N  GY  A DIWS+G  L E+      FP
Sbjct: 180 IML------NSKGYTKAIDIWSVGCILAEMLSNRPLFP 211

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 93.1 bits (231), Expect = 4e-22
 Identities = 71/244 (29%), Positives = 120/244 (49%), Gaps = 19/244 (7%)

Query: 59  LGHGNGGTVYK--VQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCF 115
           LG GN GTV K   + + + K  A+K++  D  DP ++ ++ RE  ++++ D+P+IV+  
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRD 175
           GI E  S    ++ME  + G L+  L KN   +E  +  +  Q+  G+ YL     +HRD
Sbjct: 63  GICEAES--WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120

Query: 176 IKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER-FDPDAYGGNYNG 234
           +   N+L+   +   KI+DFG+SK +    D  N Y        P + + P+    NY  
Sbjct: 121 LAARNVLLVTQHY-AKISDFGLSKAL--GADE-NYYKAKTHGKWPVKWYAPECM--NYYK 174

Query: 235 YA--GDIWSLGLTLLELY-LGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSF 291
           ++   D+WS G+ + E +  G  P+   G + +  T M  I  G+    P    PE    
Sbjct: 175 FSSKSDVWSFGVLMWEAFSYGQKPYK--GMKGNEVTQM--IESGERMECPQRCPPEMYDL 230

Query: 292 IECC 295
           ++ C
Sbjct: 231 MKLC 234

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 94.2 bits (234), Expect = 5e-22
 Identities = 59/203 (29%), Positives = 105/203 (51%), Gaps = 10/203 (4%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA---DPTVRRQVFREMEILRRTDSPFIVQ 113
           +VLG G+ G V   + + + ++YA+KV+  D    D  V   +  +  +    + PF+ Q
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
            +  F+ P   +  +ME+++ G L   + K+  F E +    A++I   L +LH   II+
Sbjct: 61  LYCCFQTPD-RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIY 119

Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYN 233
           RD+K  N+L+++     K+ADFG+ K    +    +++ GT  Y++PE      Y     
Sbjct: 120 RDLKLDNVLLDHEG-HCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY----- 173

Query: 234 GYAGDIWSLGLTLLELYLGHFPF 256
           G + D W++G+ L E+  GH PF
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 92.8 bits (231), Expect = 6e-22
 Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 18/214 (8%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIY---ALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +V+G G  G V + + +   K     A+K +   +    R     E  I+ + D P I++
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKII 172
             G+  K S  + I+ EYM++G+LD  L +N G F+  +L  +   I  G+ YL     +
Sbjct: 70  LEGVVTK-SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYV 128

Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDAYGGN 231
           HRD+   N+LV N+N+  K++DFG+S    R L+   +   T     P R+  P+A    
Sbjct: 129 HRDLAARNILV-NSNLVCKVSDFGLS----RRLEDSEATYTTKGGKIPIRWTAPEAIAYR 183

Query: 232 YNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDW 265
               A D+WS G+ + E+       +  G+RP W
Sbjct: 184 KFTSASDVWSFGIVMWEV-------MSYGERPYW 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 93.7 bits (233), Expect = 7e-22
 Identities = 77/256 (30%), Positives = 117/256 (45%), Gaps = 17/256 (6%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA---DPTVRRQVFREMEILRRTDS 108
           D   L VLG G+ G V   + + T ++YA+K++  D    D  V      E  +L     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVE-CTMVEKRVLALPGK 59

Query: 109 P-FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
           P F+ Q    F+     +  +MEY++ G L   + + G F EP     A++I  GL +LH
Sbjct: 60  PPFLTQLHSCFQTMD-RLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH 118

Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDA 227
              II+RD+K  N++++     +KIADFG+ K          ++ GT  Y++PE      
Sbjct: 119 SKGIIYRDLKLDNVMLDAEG-HIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQP 177

Query: 228 YGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPE 287
           YG      + D W+ G+ L E+  G  PF   G+  D   L  +I      S P   S E
Sbjct: 178 YGK-----SVDWWAFGVLLYEMLAGQPPF--DGEDED--ELFQSI-MEHNVSYPKSLSKE 227

Query: 288 FRSFIECCLQKEFSKR 303
             S  +  L K  +KR
Sbjct: 228 AVSICKGLLTKHPAKR 243

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 92.8 bits (231), Expect = 1e-21
 Identities = 75/309 (24%), Positives = 124/309 (40%), Gaps = 66/309 (21%)

Query: 62  GNGGTVYKVQHRCTHKIYALKVVHGDADPTVR-RQVFREMEILRRTDSPFI---VQCFGI 117
            +   V+  +H+ T+ + A+K ++ D+      + + +E+   R+   P I   V  F +
Sbjct: 11  EDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV 70

Query: 118 FEKPSGDIAILMEYMDSGTLDTLLNKNGT--FSEPKLAHIASQILKGLSYLHGHKIIHRD 175
                 ++ ++   M  G+ + LL  +      E  +A I   +L  L Y+H    IHR 
Sbjct: 71  ----DSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRS 126

Query: 176 IKPSNLLVNNNNMQVKIADFGVSKIMCRS-------LDACNSYVGTCAYMSPERFDPDAY 228
           +K S++L++ +  +V ++    S  M +         D   S V    ++SPE    +  
Sbjct: 127 VKASHILLSGDG-KVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQ 185

Query: 229 GGNYNGYAGDIWSLGLTLLELYLGHFPF--LQPGQRPDWATLM-------CAICFGDPPS 279
           G  YN  + DI+S+G+T  EL  GH PF  +         T M          C  D  +
Sbjct: 186 G--YNEKS-DIYSVGITACELANGHVPFKDMPA-------TQMLLEKVRGTVPCLLDKST 235

Query: 280 LPDGA---------------------------SPEFRSFIECCLQKEFSKRWTASQLLTH 312
            P                              S  F  F+E CLQ++   R +ASQLL H
Sbjct: 236 YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295

Query: 313 PFL--CKNR 319
            F   CK R
Sbjct: 296 SFFKQCKRR 304

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 94.9 bits (236), Expect = 1e-21
 Identities = 53/165 (32%), Positives = 86/165 (52%), Gaps = 5/165 (3%)

Query: 62  GNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSPFIVQCFGIFE 119
           G  G VY  + +   K+YA+KVV      +  +  QV  E + L  + SPFIV  +   +
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74

Query: 120 KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPS 179
             + ++ ++MEY+  G + +LL+  G F E       S++   L YLH H IIHRD+KP 
Sbjct: 75  SAN-NVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPD 133

Query: 180 NLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD 224
           N+L++N    +K+ DFG+SK+     +     + T   M+  + D
Sbjct: 134 NMLISNEG-HIKLTDFGLSKVTLNR-ELNMMDILTTPSMAKPKND 176

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 91.3 bits (227), Expect = 3e-21
 Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 22/220 (10%)

Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRT 106
           ++LEK++VLG G  GTVYK   +      KI  A+KV+  +  P   +++  E  ++   
Sbjct: 7   TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV 66

Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSY 165
           D P +V+  GI    S  + ++ + M  G L   +  +        L +   QI KG+SY
Sbjct: 67  DHPHVVRLLGI--CLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY 124

Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA--YMSPERF 223
           L   +++HRD+   N+LV      VKI DFG++K++       ++  G     +M+ E  
Sbjct: 125 LEEKRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183

Query: 224 DPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRP 263
               Y      +  D+WS G+T+ EL      F   G +P
Sbjct: 184 LHRIY-----THKSDVWSYGVTVWEL----MTF---GAKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 91.0 bits (226), Expect = 3e-21
 Identities = 66/206 (32%), Positives = 106/206 (51%), Gaps = 14/206 (6%)

Query: 53  LEKLQVLGHGNGGTV----YKVQHRCTHKIYALK-VVHGDADPTVRRQVFREMEILRRTD 107
           L+ +Q LG GN G+V    Y      T ++ A+K + H  A+    R   RE+EIL+   
Sbjct: 6   LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHL--RDFEREIEILKSLQ 63

Query: 108 SPFIVQCFGI-FEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSY 165
              IV+  G+ +     ++ ++MEY+  G+L   L K+       KL   ASQI KG+ Y
Sbjct: 64  HDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEY 123

Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE-RFD 224
           L   + +HRD+   N+LV + N +VKI DFG++K++ +  +    Y       SP   + 
Sbjct: 124 LGSKRYVHRDLATRNILVESEN-RVKIGDFGLTKVLPQDKE---YYKVREPGESPIFWYA 179

Query: 225 PDAYGGNYNGYAGDIWSLGLTLLELY 250
           P++   +    A D+WS G+ L EL+
Sbjct: 180 PESLTESKFSVASDVWSFGVVLYELF 205

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 92.0 bits (228), Expect = 3e-21
 Identities = 63/211 (29%), Positives = 103/211 (48%), Gaps = 16/211 (7%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA---DPTVRRQVFREMEILRRTDS 108
           D   L VLG G+ G V   + + T ++YA+K++  D    D  V   +  +  +      
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60

Query: 109 PFIVQ---CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
           PF+ Q   CF   ++    +  +MEY++ G L   + + G F EP     A++I  GL +
Sbjct: 61  PFLTQLHSCFQTMDR----LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFF 116

Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDP 225
           LH   II+RD+K  N+++++    +KIADFG+ K          ++ GT  Y++PE    
Sbjct: 117 LHSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAY 175

Query: 226 DAYGGNYNGYAGDIWSLGLTLLELYLGHFPF 256
             YG +      D W+ G+ L E+  G  PF
Sbjct: 176 QPYGKSV-----DWWAFGVLLYEMLAGQAPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 90.9 bits (226), Expect = 3e-21
 Identities = 62/213 (29%), Positives = 103/213 (48%), Gaps = 33/213 (15%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPF 110
           D  K++ +G G  G VYK +++ T +I A+K +  ++ +  V     RE+ +L+    P 
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 111 IV----------QCFGIFEKPSGDIAILMEYMDS----GTLDTLLNKNGTFSEPKLAHIA 156
           IV          + + IFE  S D   L +Y+DS      +D  L K+  +         
Sbjct: 61  IVCLQDVLMQESRLYLIFEFLSMD---LKKYLDSLPKGQYMDAELVKSYLY--------- 108

Query: 157 SQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA 216
            QIL+G+ + H  +++HRD+KP NLL++N  + +K+ADFG+++     +      V T  
Sbjct: 109 -QILQGILFCHSRRVLHRDLKPQNLLIDNKGV-IKLADFGLARAFGIPVRVYTHEVVTLW 166

Query: 217 YMSPERFDPDAYGGNYNGYAGDIWSLGLTLLEL 249
           Y +PE       G        DIWS+G    E+
Sbjct: 167 YRAPEVL----LGSPRYSTPVDIWSIGTIFAEM 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 92.4 bits (229), Expect = 3e-21
 Identities = 77/275 (28%), Positives = 119/275 (43%), Gaps = 59/275 (21%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFR---EMEILRRTDS 108
           D E L+V+G G  G V  VQ + T  IYA+K++   AD   + QV     E +IL   D 
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR-KADMLEKEQVAHIRAERDILVEADG 60

Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
            ++V+ F  F+    ++ ++ME++  G + TLL K  T SE       ++ +  +  +H 
Sbjct: 61  AWVVKMFYSFQDKR-NLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQ 119

Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN------------------- 209
              IHRDIKP NLL++     VK++DFG    +C  L   +                   
Sbjct: 120 LGFIHRDIKPDNLLLDAKG-HVKLSDFG----LCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174

Query: 210 --------------------SYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLEL 249
                               S VGT  Y++PE F    Y         D WSLG+ + E+
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNK-----LCDWWSLGVIMYEM 229

Query: 250 YLGHFPFLQPGQRPDWATLMC---AICFGDPPSLP 281
            +G+ PF     +  +  +M     + F  PP +P
Sbjct: 230 LIGYPPFCSETPQETYRKVMNWKETLVF--PPEVP 262

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 91.6 bits (227), Expect = 3e-21
 Identities = 63/211 (29%), Positives = 105/211 (49%), Gaps = 16/211 (7%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA---DPTVRRQVFREMEILRRTDS 108
           D   L VLG G+ G V   + + T ++YA+K++  D    D  V   +  +  +  +   
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 109 PFIVQ---CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
           PF+ Q   CF   ++    +  +MEY++ G L   + + G F EP+    A++I  GL +
Sbjct: 61  PFLTQLHSCFQTVDR----LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFF 116

Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDP 225
           LH   II+RD+K  N+++++    +KIADFG+ K          ++ GT  Y++PE    
Sbjct: 117 LHRRGIIYRDLKLDNVMLDSEG-HIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAY 175

Query: 226 DAYGGNYNGYAGDIWSLGLTLLELYLGHFPF 256
             YG +      D W+ G+ L E+  G  PF
Sbjct: 176 QPYGKSV-----DWWAYGVLLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 90.6 bits (225), Expect = 4e-21
 Identities = 75/276 (27%), Positives = 120/276 (43%), Gaps = 30/276 (10%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYK--VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILR 104
           I   D+   + +G G  G VY+         KI  A+K       P+VR +  +E  I+R
Sbjct: 3   IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMR 62

Query: 105 RTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILKGL 163
           + D P IV+  G+  +    + I+ME    G L + L  N        L   + Q+   L
Sbjct: 63  QFDHPHIVKLIGVITENP--VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTAL 120

Query: 164 SYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA-----YM 218
           +YL   + +HRDI   N+LV++ +  VK+ DFG+S    R L+  + Y  +       +M
Sbjct: 121 AYLESKRFVHRDIAARNVLVSSPDC-VKLGDFGLS----RYLEDESYYKASKGKLPIKWM 175

Query: 219 SPERFDPDAYGGNYNGY--AGDIWSLGLTLLE-LYLGHFPFLQPGQRPDWATLMCAICFG 275
           +PE         N+  +  A D+W  G+ + E L LG  PF    Q      ++  I  G
Sbjct: 176 APESI-------NFRRFTSASDVWMFGVCMWEILMLGVKPF----QGVKNNDVIGRIENG 224

Query: 276 DPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT 311
           +   +P    P   S +  C   + SKR   ++L  
Sbjct: 225 ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 90.1 bits (224), Expect = 6e-21
 Identities = 63/285 (22%), Positives = 113/285 (39%), Gaps = 37/285 (12%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYK----------VQHRCTHKIYALKVVHGDADPTVRRQVF 97
           +    +  ++ LG G+ G VY+           + R      A+K V+ +A    R +  
Sbjct: 3   LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRV-----AIKTVNENASMRERIEFL 57

Query: 98  REMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK-------NGTFSEP 150
            E  +++  +   +V+  G+       + + ME M  G L + L         N     P
Sbjct: 58  NEASVMKEFNCHHVVRLLGVVSTGQPTLVV-MELMAKGDLKSYLRSRRPEAENNPGLGPP 116

Query: 151 KLAHI---ASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA 207
            L      A++I  G++YL   K +HRD+   N +V   ++ VKI DFG    M R +  
Sbjct: 117 TLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV-AEDLTVKIGDFG----MTRDIYE 171

Query: 208 CNSYVGTCAYMSPERF-DPDAYGGNYNGYAGDIWSLGLTLLEL-YLGHFPFLQPGQRPDW 265
            + Y      + P R+  P++          D+WS G+ L E+  L   P+   G   + 
Sbjct: 172 TDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY--QGLSNE- 228

Query: 266 ATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLL 310
             ++  +  G    LP+    +    +  C Q     R T  +++
Sbjct: 229 -EVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIV 272

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 90.8 bits (225), Expect = 7e-21
 Identities = 66/250 (26%), Positives = 112/250 (44%), Gaps = 15/250 (6%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEIL-RRTDSPFIVQ 113
           +V+G G+ G V   +H+   K YA+KV+   A       + +  E  +L +    PF+V 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
               F+     +  +++Y++ G L   L +   F EP+    A++I   L YLH   I++
Sbjct: 61  LHFSFQTAD-KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVY 119

Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYN 233
           RD+KP N+L+++    + + DFG+ K         +++ GT  Y++PE      Y     
Sbjct: 120 RDLKPENILLDSQG-HIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTV- 177

Query: 234 GYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIE 293
               D W LG  L E+  G  PF        +  ++       P  L    +   R  +E
Sbjct: 178 ----DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL-----NKPLQLKPNITNSARHLLE 228

Query: 294 CCLQKEFSKR 303
             LQK+ +KR
Sbjct: 229 GLLQKDRTKR 238

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 89.9 bits (223), Expect = 7e-21
 Identities = 73/266 (27%), Positives = 120/266 (45%), Gaps = 31/266 (11%)

Query: 56  LQVLGHGNGGTVYKVQ-HRCTHKIYALKVV--HGDADPTVRRQ-------VFREMEILRR 105
           L+ LG G  G VYKV+       + ALK +  H  A    +R+       +  E+ I++ 
Sbjct: 5   LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64

Query: 106 T-DSPFIVQCFGIFEKPSGD-IAILMEYMDSGTL----DTLLNKNGTFSEPKLAHIASQI 159
               P IV+ +  F +   D + I+M+ ++   L    ++L  K   F+E ++ +I  Q+
Sbjct: 65  QLRHPNIVRYYKTFLE--NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQM 122

Query: 160 LKGLSYLHGHK-IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYM 218
           +  L YLH  K I+HRD+ P+N+++  ++ +V I DFG++K          S VGT  Y 
Sbjct: 123 VLALRYLHKEKRIVHRDLTPNNIMLGEDD-KVTITDFGLAKQKQPE-SKLTSVVGTILYS 180

Query: 219 SPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPP 278
            PE    + YG        D+W+ G  L ++     PF       +  +L   I      
Sbjct: 181 CPEIVKNEPYGEK-----ADVWAFGCILYQMCTLQPPFYS----TNMLSLATKIVEAVYE 231

Query: 279 SLPDGA-SPEFRSFIECCLQKEFSKR 303
            LP+G  S +    I  CL  +   R
Sbjct: 232 PLPEGMYSEDVTDVITSCLTPDAEAR 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 91.3 bits (226), Expect = 7e-21
 Identities = 76/275 (27%), Positives = 122/275 (44%), Gaps = 59/275 (21%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFR---EMEILRRTDS 108
           D E L+V+G G  G V  VQ + T  +YA+K++   AD   + QV     E +IL   DS
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILR-KADMLEKEQVGHIRAERDILVEADS 60

Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
            ++V+ F  F+    ++ ++ME++  G + TLL K  T +E +     ++ +  +  +H 
Sbjct: 61  LWVVKMFYSFQDKL-NLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQ 119

Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN------------------- 209
              IHRDIKP NLL+++    VK++DFG    +C  L   +                   
Sbjct: 120 LGFIHRDIKPDNLLLDSKG-HVKLSDFG----LCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174

Query: 210 --------------------SYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLEL 249
                               S VGT  Y++PE F    Y         D WSLG+ + E+
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNK-----LCDWWSLGVIMYEM 229

Query: 250 YLGHFPFLQPGQRPDWATLMC---AICFGDPPSLP 281
            +G+ PF     +  +  +M     + F  PP +P
Sbjct: 230 LIGYPPFCSETPQETYKKVMNWKETLIF--PPEVP 262

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 90.5 bits (225), Expect = 1e-20
 Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 15/208 (7%)

Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTV-RRQVFREMEILRRTDSPFIVQCFGI 117
           +G G  G V   ++  T++  A+K +    D  +  ++  RE+++LR  D   ++    I
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 118 FEKPS----GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
              P      D+ I+ E MD+  L  ++  + T S+    +   Q+L+GL Y+H   ++H
Sbjct: 73  MPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLH 131

Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER-FDPDAYGGNY 232
           RD+KPSNLL+N N   +KI DFG+++      D    YV T  Y +PE   +   Y    
Sbjct: 132 RDLKPSNLLLNANC-DLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTT-- 188

Query: 233 NGYAGDIWSLGLTLLELYLGHFPFLQPG 260
              A D+WS+G    EL LG  P L PG
Sbjct: 189 ---AIDVWSVGCIFAEL-LGRKP-LFPG 211

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 90.2 bits (224), Expect = 1e-20
 Identities = 78/272 (28%), Positives = 125/272 (45%), Gaps = 14/272 (5%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQV--FR-EMEILRRTDS 108
           D E L+V+G G  G V  V+ + T ++YA+K+++   +   R +   FR E ++L   D 
Sbjct: 2   DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILN-KWEMLKRAETACFREERDVLVNGDR 60

Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLA--HIASQILKGLSYL 166
            +I      F+    ++ ++M+Y   G L TLL+K        +A  ++A  +L  +  +
Sbjct: 61  RWITNLHYAFQD-ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVL-AIDSV 118

Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVS-KIMCRSLDACNSYVGTCAYMSPERFDP 225
           H    +HRDIKP N+L++ N   +++ADFG   +++       N  VGT  Y+SPE    
Sbjct: 119 HQLGYVHRDIKPDNVLLDKNG-HIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQA 177

Query: 226 DAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMC-AICFGDPPSLPDGA 284
              G    G   D WSLG+ + E+  G  PF        +  +M     F  PP + D  
Sbjct: 178 MEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTD-V 236

Query: 285 SPEFRSFIE--CCLQKEFSKRWTASQLLTHPF 314
           S E +  I    C  +    R        HPF
Sbjct: 237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHPF 268

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 88.7 bits (220), Expect = 2e-20
 Identities = 63/240 (26%), Positives = 99/240 (41%), Gaps = 51/240 (21%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTH-------KIYALKVVHGDADPTVRRQVFREMEILR 104
            +   + LG G  G V+  +  C H       ++ A+K +   A    R+   RE E+L 
Sbjct: 6   TIVLKRELGEGAFGKVFLGE--CYHLEPENDKELVAVKTLKETASNDARKDFEREAELLT 63

Query: 105 RTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNG--------------TFSEP 150
                 IV+ +G+  +    I +  EYM+ G L+  L  +G                +  
Sbjct: 64  NFQHENIVKFYGVCTEGDPPIMVF-EYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122

Query: 151 KLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNS 210
           +L  IA QI  G+ YL     +HRD+   N LV   ++ VKI DFG    M R +   + 
Sbjct: 123 QLLQIAVQIASGMVYLASQHFVHRDLATRNCLV-GYDLVVKIGDFG----MSRDVYTTDY 177

Query: 211 Y-VGTCA-----YMSPE-----RFDPDAYGGNYNGYAGDIWSLGLTLLELY-LGHFPFLQ 258
           Y VG        +M PE     +F  ++          D+WS G+ L E++  G  P+  
Sbjct: 178 YRVGGHTMLPIRWMPPESIMYRKFTTES----------DVWSFGVVLWEIFTYGKQPWYG 227

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 89.3 bits (221), Expect = 3e-20
 Identities = 67/257 (26%), Positives = 122/257 (47%), Gaps = 22/257 (8%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVV-----HGDAD---PTVRRQVFREMEILRRTDS 108
           +V+G G+   V  V+ +   +IYA+KVV     H D D       + VF +      + +
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQA-----SSN 55

Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V     F+  S  + +++EY++ G L   + +     E      A++I   L++LH 
Sbjct: 56  PFLVGLHSCFQTTS-RLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHE 114

Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAY 228
             II+RD+K  N+L++ +   +K+ D+G+ K      D  +++ GT  Y++PE    + Y
Sbjct: 115 RGIIYRDLKLDNVLLDADG-HIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY 173

Query: 229 GGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWAT--LMCAICFGDPPSLPDGASP 286
                G++ D W+LG+ + E+  G  PF      PD  T   +  +    P  +P   S 
Sbjct: 174 -----GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSV 228

Query: 287 EFRSFIECCLQKEFSKR 303
           +    ++  L K+  +R
Sbjct: 229 KASHVLKGFLNKDPKER 245

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 89.3 bits (221), Expect = 3e-20
 Identities = 57/203 (28%), Positives = 103/203 (50%), Gaps = 10/203 (4%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA---DPTVRRQVFREMEILRRTDSPFIVQ 113
           ++LG G+ G V+  + + T++ +A+K +  D    D  V   +  +  +    + PF+  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
            +  F+    ++  +MEY++ G L   +     F  P+    A++I+ GL +LH   I++
Sbjct: 61  LYCTFQTKE-NLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVY 119

Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYN 233
           RD+K  N+L++ +   +KIADFG+ K          ++ GT  Y++PE       G  YN
Sbjct: 120 RDLKLDNILLDTDG-HIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEIL----LGQKYN 174

Query: 234 GYAGDIWSLGLTLLELYLGHFPF 256
             + D WS G+ L E+ +G  PF
Sbjct: 175 -TSVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 88.0 bits (218), Expect = 4e-20
 Identities = 64/219 (29%), Positives = 100/219 (45%), Gaps = 23/219 (10%)

Query: 53  LEKLQVLGHGNGGTV----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS 108
           L+K++VLG G+ G V    Y   +  T ++ A+K +  +          +E+ IL+    
Sbjct: 6   LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYH 65

Query: 109 PFIVQCFGIFEKPSGDIAIL-MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
             IV+  G   +  G    L MEY+  G+L   L K+   +  +L   A QI +G++YLH
Sbjct: 66  ENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLH 124

Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER----- 222
               IHRD+   N+L++N+ + VKI DFG++K +           G   Y   E      
Sbjct: 125 SQHYIHRDLAARNVLLDNDRL-VKIGDFGLAKAVPE---------GHEYYRVREDGDSPV 174

Query: 223 --FDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQP 259
             +  +    N   YA D+WS G+TL EL         P
Sbjct: 175 FWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 88.9 bits (220), Expect = 4e-20
 Identities = 55/203 (27%), Positives = 96/203 (47%), Gaps = 10/203 (4%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQ--VFREMEIL-RRTDSPFIVQ 113
           +V+G G+ G V   + +     YA+KV+        + Q  +  E  +L +    PF+V 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
               F+     +  +++Y++ G L   L +   F EP+    A+++   + YLH   II+
Sbjct: 61  LHYSFQTAE-KLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIY 119

Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYN 233
           RD+KP N+L+++    V + DFG+ K      +  +++ GT  Y++PE    + Y     
Sbjct: 120 RDLKPENILLDSQG-HVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPY----- 173

Query: 234 GYAGDIWSLGLTLLELYLGHFPF 256
               D W LG  L E+  G  PF
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 90.1 bits (223), Expect = 5e-20
 Identities = 69/223 (30%), Positives = 107/223 (47%), Gaps = 17/223 (7%)

Query: 99  EMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTL----LNKNGTFSEPKLAH 154
           E+  L   D   IV+ F  F K    + ++MEY   G L+      L ++  F E ++  
Sbjct: 115 ELHCLAACDHFGIVKHFDDF-KSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173

Query: 155 IASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS--LDACNSYV 212
           +  QI+  L  +H  K++HRD+K +N+ +    + +K+ DFG SK    S  LD  +S+ 
Sbjct: 174 LFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI-IKLGDFGFSKQYSDSVSLDVASSFC 232

Query: 213 GTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAI 272
           GT  Y++PE ++   Y         D+WSLG+ L EL   H PF  P QR     +M  +
Sbjct: 233 GTPYYLAPELWERKRYSKK-----ADMWSLGVILYELLTLHRPFKGPSQR----EIMQQV 283

Query: 273 CFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
            +G     P   S   ++ ++  L K  + R T  QLL   FL
Sbjct: 284 LYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFL 326

Length = 478

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 87.7 bits (217), Expect = 6e-20
 Identities = 65/212 (30%), Positives = 98/212 (46%), Gaps = 11/212 (5%)

Query: 46  AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRR 105
           AA +Y +LEKL   G G+  TVYK   R   ++ ALKV+    +  V     RE  +L+ 
Sbjct: 3   AATSYLNLEKL---GEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKG 59

Query: 106 TDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
                IV    I       +  + EYM +     ++   G      +     Q+L+GL+Y
Sbjct: 60  LKHANIVLLHDIIHTKE-TLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAY 118

Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDP 225
           +HG  I+HRD+KP NLL++    ++K+ADFG+++         +S V T  Y  P+    
Sbjct: 119 IHGQHILHRDLKPQNLLISYLG-ELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVL-- 175

Query: 226 DAYGGNYNGYAGDIWSLGLTLLELYLGH--FP 255
              G      A DIW  G   +E+  G   FP
Sbjct: 176 --LGATDYSSALDIWGAGCIFIEMLQGQPAFP 205

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 87.6 bits (217), Expect = 8e-20
 Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 19/204 (9%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIV 112
           EK++ +G G  G VYK + R T++  ALK +  +  D  V     RE+ +L+      IV
Sbjct: 5   EKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIV 64

Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAH----IAS---QILKGLSY 165
           +   +       + ++ EY+D   LD    K    S P  A     I +   QIL+G++Y
Sbjct: 65  RLQDVVHSEK-RLYLVFEYLD---LDL---KKHMDSSPDFAKNPRLIKTYLYQILRGIAY 117

Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDP 225
            H H+++HRD+KP NLL++     +K+ADFG+++     +      V T  Y +PE    
Sbjct: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEIL-- 175

Query: 226 DAYGGNYNGYAGDIWSLGLTLLEL 249
              G  +     DIWS+G    E+
Sbjct: 176 --LGSRHYSTPVDIWSVGCIFAEM 197

Length = 294

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 89.2 bits (221), Expect = 9e-20
 Identities = 85/306 (27%), Positives = 139/306 (45%), Gaps = 28/306 (9%)

Query: 29  ALPPTAPNTNNNTTATTAAIAYSDLEKL---QVLGHGNGGTVYKVQHRCTHKIYALKVVH 85
           A+      T  +T A   A A    +K    +VLG G  GTV   +     + +A+KVV 
Sbjct: 7   AMIGRVCRTFPDTFAKDEATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVD 66

Query: 86  GDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGD-------IAILMEYMDSGTL 137
            +      + +   E+  L   D   IV+C   F K           IA++++Y ++G L
Sbjct: 67  MEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDL 126

Query: 138 DTLLNK----NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIA 193
              +      N TF E +   +  Q+L  + ++H   +IHRDIK +N+L+ +N + VK+ 
Sbjct: 127 RQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL-VKLG 185

Query: 194 DFGVSKIMCRSL--DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL 251
           DFG SK+   ++  D   ++ GT  Y++PE +    Y         D++SLG+ L EL  
Sbjct: 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK-----ADMFSLGVLLYELLT 240

Query: 252 GHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT 311
              PF       +   +M     G    LP   SPE +  +   L  +  +R ++S+LL 
Sbjct: 241 LKRPF----DGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296

Query: 312 HPFLCK 317
            P +CK
Sbjct: 297 MP-ICK 301

Length = 496

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 87.0 bits (215), Expect = 1e-19
 Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 12/208 (5%)

Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQ--VFREMEILRRTDSPF 110
             + +VLG G  G V   Q R T K+YA K +        + +     E +IL + +S F
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGT--FSEPKLAHIASQILKGLSYLHG 168
           +V     +E     + +++  M+ G L   +   G   F E +    A++IL GL  LH 
Sbjct: 62  VVNLAYAYETKDA-LCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR 120

Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAY 228
              ++RD+KP N+L+++    ++I+D G++ +     ++    VGT  YM+PE  +   Y
Sbjct: 121 ENTVYRDLKPENILLDDYG-HIRISDLGLA-VKIPEGESIRGRVGTVGYMAPEVLNNQRY 178

Query: 229 GGNYNGYAGDIWSLGLTLLELYLGHFPF 256
                  + D W LG  + E+  G  PF
Sbjct: 179 -----TLSPDYWGLGCLIYEMIEGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 87.0 bits (216), Expect = 1e-19
 Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 48/227 (21%)

Query: 59  LGHGNGGTVYKVQHRCTHKI----------------YALKVVHGDADPTVRRQVFREMEI 102
           LG G  G V+  +                        A+KV+  DA    R    +E++I
Sbjct: 13  LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72

Query: 103 LRRTDSPFIVQCFGI--FEKPSGDIAILMEYMDSGTL-----------DTLLNKNGTFSE 149
           L R   P I +  G+   + P   + ++MEYM++G L             L   + + S 
Sbjct: 73  LSRLSDPNIARLLGVCTVDPP---LCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129

Query: 150 PKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN 209
             L ++A+QI  G+ YL     +HRD+   N LV   N  +KIADFG    M R+L + +
Sbjct: 130 STLLYMATQIASGMRYLESLNFVHRDLATRNCLV-GKNYTIKIADFG----MSRNLYSSD 184

Query: 210 SY-VGTCA-----YMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELY 250
            Y V   A     +M+ E        G +     D+W+ G+TL E+ 
Sbjct: 185 YYRVQGRAPLPIRWMAWESV----LLGKFTT-KSDVWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 86.6 bits (214), Expect = 1e-19
 Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 16/208 (7%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQ----VFREMEILRRTDSPFIV 112
           +VLG G  G V   Q R T K+YA K +  +     +R+       E +IL + +S F+V
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKL--EKKRIKKRKGESMALNEKQILEKVNSRFVV 63

Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGT--FSEPKLAHIASQILKGLSYLHGHK 170
                +E     + +++  M+ G L   +   G   F E +    A++I  GL  LH  +
Sbjct: 64  SLAYAYETKDA-LCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER 122

Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGG 230
           I++RD+KP N+L++++   ++I+D G++ +           VGT  YM+PE    + Y  
Sbjct: 123 IVYRDLKPENILLDDHG-HIRISDLGLA-VHVPEGQTIKGRVGTVGYMAPEVVKNERY-- 178

Query: 231 NYNGYAGDIWSLGLTLLELYLGHFPFLQ 258
               ++ D W+LG  L E+  G  PF Q
Sbjct: 179 ---TFSPDWWALGCLLYEMIAGQSPFQQ 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 86.5 bits (214), Expect = 1e-19
 Identities = 56/189 (29%), Positives = 93/189 (49%), Gaps = 15/189 (7%)

Query: 78  IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTL 137
           I  LK  + +     RR    E  I+ + D P I+   G+  K S  + I+ EYM++G+L
Sbjct: 37  IKTLKAGYTEKQ---RRDFLSEASIMGQFDHPNIIHLEGVVTK-SKPVMIVTEYMENGSL 92

Query: 138 DTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFG 196
           D  L K+ G F+  +L  +   I  G+ YL     +HRD+   N+LV N+N+  K++DFG
Sbjct: 93  DAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV-NSNLVCKVSDFG 151

Query: 197 VSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPF 256
           +S+++    +A  +Y      +      P+A        A D+WS G+ + E+       
Sbjct: 152 LSRVLEDDPEA--AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV------- 202

Query: 257 LQPGQRPDW 265
           +  G+RP W
Sbjct: 203 MSYGERPYW 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 87.4 bits (216), Expect = 1e-19
 Identities = 71/266 (26%), Positives = 119/266 (44%), Gaps = 19/266 (7%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREME---ILRRTDSPFIVQ 113
           +V+G G+ G V   + +   K YA+KV+        + Q     E   +L+    PF+V 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
               F+  +  +  ++++++ G L   L +  +F EP+    A++I   L YLH   I++
Sbjct: 61  LHYSFQT-TEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVY 119

Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYN 233
           RD+KP N+L+++    V + DFG+ K      D   ++ GT  Y++PE      Y     
Sbjct: 120 RDLKPENILLDSQG-HVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTV- 177

Query: 234 GYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIE 293
               D W LG  L E+  G  PF        +  ++       P  L  GAS    S +E
Sbjct: 178 ----DWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL-----HKPLVLRPGASLTAWSILE 228

Query: 294 CCLQKEFSKRWTAS----QLLTHPFL 315
             L+K+  +R  A     ++  HPF 
Sbjct: 229 ELLEKDRQRRLGAKEDFLEIQEHPFF 254

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 87.6 bits (217), Expect = 1e-19
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 20/208 (9%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKV-----VHGDAD---PTVRRQVFREMEILRRTDS 108
           +V+G G+   V  V+ + T +IYA+KV     V+ D D       + VF        ++ 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETA-----SNH 55

Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V     F+  S  +  ++E++  G L   + +     E      +++I   L++LH 
Sbjct: 56  PFLVGLHSCFQTES-RLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHE 114

Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAY 228
             II+RD+K  N+L++     +K+ D+G+ K   R  D  +++ GT  Y++PE    + Y
Sbjct: 115 RGIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDY 173

Query: 229 GGNYNGYAGDIWSLGLTLLELYLGHFPF 256
                G++ D W+LG+ + E+  G  PF
Sbjct: 174 -----GFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 86.7 bits (215), Expect = 1e-19
 Identities = 66/238 (27%), Positives = 101/238 (42%), Gaps = 54/238 (22%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQ-----HRCTHKIYALKVVHGDADPTVRRQVFREMEI 102
           I  S +  L+ LG G  G VYK +      R +    A+K +  +A+P V+++  +E E+
Sbjct: 2   IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAEL 61

Query: 103 LRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEP------------ 150
           +     P IV   G+  K      +L EY+  G L   L +N   S+             
Sbjct: 62  MSDLQHPNIVCLLGVCTK-EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120

Query: 151 ----KLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVS-------- 198
                  HIA QI  G+ YL  H  +HRD+   N LV    + VKI+DFG+S        
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV-GEGLTVKISDFGLSRDIYSADY 179

Query: 199 -KIMCRSLDACNSYVGTCAYMSPE-----RFDPDAYGGNYNGYAGDIWSLGLTLLELY 250
            ++  +SL           +M PE     +F  ++          DIWS G+ L E++
Sbjct: 180 YRVQSKSLLPVR-------WMPPEAILYGKFTTES----------DIWSFGVVLWEIF 220

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 86.8 bits (215), Expect = 2e-19
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 10/203 (4%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA---DPTVRRQVFREMEILRRTDSPFIVQ 113
           +VLG G+ G V   + + T ++YA+KV+  D    D  V   +  +  +      PF+  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
               F+     +  +MEY++ G L   + ++  F EP+    A+++   L +LH H +I+
Sbjct: 61  LHCCFQTKD-RLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIY 119

Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYN 233
           RD+K  N+L++      K+ADFG+ K    +     ++ GT  Y++PE      YG +  
Sbjct: 120 RDLKLDNILLDAEG-HCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSV- 177

Query: 234 GYAGDIWSLGLTLLELYLGHFPF 256
               D W+LG+ + E+  G  PF
Sbjct: 178 ----DWWALGVLMYEMMAGQPPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 86.2 bits (213), Expect = 3e-19
 Identities = 66/263 (25%), Positives = 123/263 (46%), Gaps = 16/263 (6%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA---DPTVRRQVFREMEILRRTDSPFIVQ 113
           +VLG G+ G V   + +   + +A+K +  D    D  V   +  +  +    ++PF+  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
            +  F+     +  +ME+++ G L   +   G F   +    A++I+ GL +LH   II+
Sbjct: 61  LYCTFQTKE-HLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIY 119

Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYN 233
           RD+K  N++++ +   +KIADFG+ K      +  +++ GT  Y++PE      Y     
Sbjct: 120 RDLKLDNVMLDRDG-HIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKY----- 173

Query: 234 GYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIE 293
            ++ D WS G+ L E+ +G  PF       D   L  +I   D P  P   + E +  +E
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSPF----HGDDEDELFESIRV-DTPHYPRWITKESKDILE 228

Query: 294 CCLQKEFSKRW-TASQLLTHPFL 315
              +++ ++R      +  HPF 
Sbjct: 229 KLFERDPTRRLGVVGNIRGHPFF 251

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 84.4 bits (209), Expect = 4e-19
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 16/206 (7%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           + +G GN G VYK   +   ++ A+K       P ++R+  +E EIL++ D P IV+  G
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEV-AVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59

Query: 117 IFEKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILKGLSYLHGHKIIHRD 175
           +  +    I I+ME +  G+L T L K     +  KL  ++     G+ YL     IHRD
Sbjct: 60  VCVQ-KQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRD 118

Query: 176 IKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGT--CAYMSPERFDPDAYGGNYN 233
           +   N LV  NN  +KI+DFG+S+     +   +  +      + +PE         NY 
Sbjct: 119 LAARNCLVGENN-VLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEAL-------NYG 170

Query: 234 GY--AGDIWSLGLTLLELY-LGHFPF 256
            Y    D+WS G+ L E + LG  P+
Sbjct: 171 RYTSESDVWSYGILLWETFSLGDTPY 196

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 85.9 bits (212), Expect = 5e-19
 Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 20/208 (9%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVV-----HGDAD---PTVRRQVFREMEILRRTDS 108
           +V+G G+   V  V+ + T +IYA+KVV     + D D       + VF +      ++ 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA-----SNH 55

Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V     F+  S  +  ++EY++ G L   + +     E      +++I   L+YLH 
Sbjct: 56  PFLVGLHSCFQTES-RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 114

Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAY 228
             II+RD+K  N+L+++    +K+ D+G+ K   R  D  +++ GT  Y++PE    + Y
Sbjct: 115 RGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 173

Query: 229 GGNYNGYAGDIWSLGLTLLELYLGHFPF 256
                G++ D W+LG+ + E+  G  PF
Sbjct: 174 -----GFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 84.2 bits (208), Expect = 6e-19
 Identities = 63/212 (29%), Positives = 110/212 (51%), Gaps = 23/212 (10%)

Query: 59  LGHGNGGTVYKVQHRCTHKI--YALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           LG GN G V K  ++   K    A+KV+  + + +VR ++ RE EI+ + D+P+IV+  G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 117 IFEKPSGDIAILMEYMDSGTLDTLLN-KNGTFSEPKLAHIASQILKGLSYLHGHKIIHRD 175
           + E  +  + ++ME    G L+  L+ K    +   +  +  Q+  G+ YL G   +HRD
Sbjct: 63  VCEAEA--LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRD 120

Query: 176 IKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSY--VGTCAYMSPERFDPDAYGGNYN 233
           +   N+L+ N +   KI+DFG+SK    +L A +SY    +      + + P+    N+ 
Sbjct: 121 LAARNVLLVNQHY-AKISDFGLSK----ALGADDSYYKARSAGKWPLKWYAPECI--NFR 173

Query: 234 GYA--GDIWSLGLTLLELYLGHFPFLQPGQRP 263
            ++   D+WS G+T+ E     F +   GQ+P
Sbjct: 174 KFSSRSDVWSYGITMWEA----FSY---GQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 83.8 bits (207), Expect = 1e-18
 Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 17/215 (7%)

Query: 57  QVLGHGNGGTVYK--VQHRCTHKIY-ALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +V+G G  G V +  ++     +I+ A+K +        RR    E  I+ + D P I+ 
Sbjct: 10  EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKII 172
             G+  K S  + I+ E+M++G LD+ L +N G F+  +L  +   I  G+ YL     +
Sbjct: 70  LEGVVTK-SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYV 128

Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN-SYVGTCAYMSPERFD-PDAYGG 230
           HRD+   N+LV N+N+  K++DFG+S+ +    D  + +Y  +     P R+  P+A   
Sbjct: 129 HRDLAARNILV-NSNLVCKVSDFGLSRFL--EDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185

Query: 231 NYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDW 265
                A D+WS G+ + E+       +  G+RP W
Sbjct: 186 RKFTSASDVWSYGIVMWEV-------MSYGERPYW 213

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 83.1 bits (205), Expect = 2e-18
 Identities = 66/266 (24%), Positives = 117/266 (43%), Gaps = 18/266 (6%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQ--VFREMEILRRTDSPFIVQC 114
           +VLG G  G V   Q R T K+YA K +        + +     E  IL + +S F+V  
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65

Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGT--FSEPKLAHIASQILKGLSYLHGHKII 172
              +E     + +++  M+ G L   +   G   F E +    A+++  GL  L   +I+
Sbjct: 66  AYAYETKDA-LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIV 124

Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNY 232
           +RD+KP N+L+++    ++I+D G++ +     +     VGT  YM+PE  + + Y    
Sbjct: 125 YRDLKPENILLDDRG-HIRISDLGLA-VQIPEGETVRGRVGTVGYMAPEVINNEKY---- 178

Query: 233 NGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFI 292
             ++ D W LG  + E+  G  PF +  +R     +   +   D     +  S + +S  
Sbjct: 179 -TFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK-EDQEEYSEKFSEDAKSIC 236

Query: 293 ECCLQKEFSKRW-----TASQLLTHP 313
              L K   +R       A+ +  HP
Sbjct: 237 RMLLTKNPKERLGCRGNGAAGVKQHP 262

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 82.3 bits (203), Expect = 4e-18
 Identities = 57/202 (28%), Positives = 98/202 (48%), Gaps = 12/202 (5%)

Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           LG G  G V  VQ + T K+YA K +        +  +    E EIL + +SPFIV    
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 117 IFEKPSGDIAILMEYMDSGTLDTLLNKNGT--FSEPKLAHIASQILKGLSYLHGHKIIHR 174
            FE  +  + ++M  M+ G L   +   G       ++ H ++QI  G+ +LH   I++R
Sbjct: 61  AFESKT-HLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYR 119

Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNG 234
           D+KP N+L+++     +++D G++ +  +         GT  YM+PE    + Y      
Sbjct: 120 DMKPENVLLDDQG-NCRLSDLGLA-VELKDGKTITQRAGTNGYMAPEILKEEPY-----S 172

Query: 235 YAGDIWSLGLTLLELYLGHFPF 256
           Y  D +++G ++ E+  G  PF
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 83.7 bits (207), Expect = 4e-18
 Identities = 70/261 (26%), Positives = 112/261 (42%), Gaps = 70/261 (26%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFR---------EMEI 102
           D   ++V+G G  G V  VQ + T KIYA+K +       ++ ++F+         E ++
Sbjct: 2   DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTL-------LKSEMFKKDQLAHVKAERDV 54

Query: 103 LRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
           L  +DSP++V  +  F+  +  + ++ME++  G L T+L K  TFSE       ++ +  
Sbjct: 55  LAESDSPWVVSLYYSFQD-AQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLA 113

Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVS------------------KIMCRS 204
           +  +H    IHRDIKP N+L++     +K++DFG+S                  K     
Sbjct: 114 IEAVHKLGFIHRDIKPDNILIDRGG-HIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNR 172

Query: 205 LDACNSY-----------------------------VGTCAYMSPERFDPDAYGGNYNGY 235
           +D  NS                              VGT  Y++PE F    Y     G 
Sbjct: 173 IDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-----GQ 227

Query: 236 AGDIWSLGLTLLELYLGHFPF 256
             D WSLG  + E  +G  PF
Sbjct: 228 ECDWWSLGAIMFECLIGWPPF 248

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 81.9 bits (202), Expect = 4e-18
 Identities = 60/211 (28%), Positives = 104/211 (49%), Gaps = 17/211 (8%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           S+L  +Q +G G  G V+        K+ A+K +   A          E +++ +   P 
Sbjct: 4   SELTLVQEIGSGQFGLVWLGYWLEKRKV-AIKTIREGA--MSEEDFIEEAQVMMKLSHPK 60

Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           +VQ +G+  + S  I ++ E+M+ G L D L  + G FS+  L  +   + +G++YL   
Sbjct: 61  LVQLYGVCTERS-PICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS 119

Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGT---CAYMSPERFDPD 226
            +IHRD+   N LV  N + VK++DFG+++ +    D   S  GT     + SPE F   
Sbjct: 120 NVIHRDLAARNCLVGENQV-VKVSDFGMTRFVLD--DQYTSSTGTKFPVKWSSPEVFS-- 174

Query: 227 AYGGNYNGYAGDIWSLGLTLLELYL-GHFPF 256
                Y+  + D+WS G+ + E++  G  P+
Sbjct: 175 --FSKYSSKS-DVWSFGVLMWEVFSEGKTPY 202

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 84.4 bits (208), Expect = 6e-18
 Identities = 82/293 (27%), Positives = 134/293 (45%), Gaps = 45/293 (15%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVV-HGDADPTVRRQVFREMEILRRTDSP 109
           ++ E ++ +G+G  G V+ V+H+ T + +  K + +       + Q+  E+ ++R     
Sbjct: 13  NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHK 72

Query: 110 FIVQCFGIF-EKPSGDIAILMEYMDSGTLDTLLNKN----GTFSEPKLAHIASQILKGLS 164
            IV+    F  K +  + ILME+ D+G L   + K     G   E  +  I  Q+L  L+
Sbjct: 73  NIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALA 132

Query: 165 YLH-------GHKIIHRDIKPSNLLVNN------------NNMQ----VKIADFGVSK-I 200
           Y H       G +++HRD+KP N+ ++             NN+      KI DFG+SK I
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI 192

Query: 201 MCRSLDACNSYVGTCAYMSPERF--DPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQ 258
              S+   +S VGT  Y SPE    +  +Y         D+W+LG  + EL  G  PF +
Sbjct: 193 GIESM--AHSCVGTPYYWSPELLLHETKSYDDK-----SDMWALGCIIYELCSGKTPFHK 245

Query: 259 PGQRPDWATLMCAICFGDPPSLP-DGASPEFRSFIECCLQKEFSKRWTASQLL 310
                +++ L+  +  G  P LP  G S E    I+  L     +R +A Q L
Sbjct: 246 AN---NFSQLISELKRG--PDLPIKGKSKELNILIKNLLNLSAKERPSALQCL 293

Length = 1021

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 82.7 bits (204), Expect = 8e-18
 Identities = 82/311 (26%), Positives = 127/311 (40%), Gaps = 51/311 (16%)

Query: 40  NTTATTAAIAYSDLEKLQVLGHGNGGTV-YKVQHRCTHKIYALKVVHGDADPTVRRQVFR 98
           N T       Y DL   + +G G  GTV   +  R   K+   K+          ++ +R
Sbjct: 7   NKTIWEVPDRYRDL---KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR 63

Query: 99  EMEILRRTDSPFIVQCFGIFEKPSG-----DIAILMEYMDSGTLDTLLNKNGTFSEPKLA 153
           E+ +L+      ++    +F          D  ++M +M  GT    L K+   SE ++ 
Sbjct: 64  ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQ 121

Query: 154 HIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA-CNSYV 212
            +  Q+LKGL Y+H   IIHRD+KP NL V N + ++KI DFG++    R  D+    YV
Sbjct: 122 FLVYQMLKGLKYIHAAGIIHRDLKPGNLAV-NEDCELKILDFGLA----RQTDSEMTGYV 176

Query: 213 GTCAYMSPERFDPDAYGGNYNGYAG--DIWSLGLTLLELYLGHFPF-------------- 256
            T  Y +PE         N+  Y    DIWS+G  + E+  G   F              
Sbjct: 177 VTRWYRAPEVIL------NWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMK 230

Query: 257 ------------LQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRW 304
                       LQ     ++   +      D  SL   A+P   + +E  L  +   R 
Sbjct: 231 VTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRI 290

Query: 305 TASQLLTHPFL 315
           TA++ L HP+ 
Sbjct: 291 TAAEALAHPYF 301

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 81.0 bits (200), Expect = 9e-18
 Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 21/213 (9%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           S+L  L+ LG G  G V+  + R    + A+K++   A          E +++ +   P 
Sbjct: 4   SELTFLKELGSGQFGVVHLGKWRGKIDV-AIKMIREGA--MSEDDFIEEAKVMMKLSHPN 60

Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGH 169
           +VQ +G+  K    I I+ EYM +G L   L +  G      L  + S + + + YL  +
Sbjct: 61  LVQLYGVCTK-QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN 119

Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGT---CAYMSPERFDPD 226
             IHRD+   N LV  +N+ VK++DFG+++ +    D   S  GT     +  PE F   
Sbjct: 120 GFIHRDLAARNCLVGEDNV-VKVSDFGLARYVLD--DQYTSSQGTKFPVKWAPPEVF--- 173

Query: 227 AYGGNYNGYA--GDIWSLGLTLLELY-LGHFPF 256
               +Y+ ++   D+WS G+ + E++  G  P+
Sbjct: 174 ----DYSRFSSKSDVWSFGVLMWEVFSEGKMPY 202

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 80.9 bits (200), Expect = 1e-17
 Identities = 60/218 (27%), Positives = 102/218 (46%), Gaps = 28/218 (12%)

Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           ++ L+ LG G  G V++     T  +    +  G  DP        E +I+++   P ++
Sbjct: 8   IQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK---DFLAEAQIMKKLRHPKLI 64

Query: 113 QCFGI--FEKPSGDIAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHG 168
           Q + +   E+P   I I+ E M  G+L   L          P+L  +A+Q+  G++YL  
Sbjct: 65  QLYAVCTLEEP---IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA 121

Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGT---CAYMSPERFDP 225
              IHRD+   N+LV  NN+  K+ADFG+++++    D   +  G      + +PE    
Sbjct: 122 QNYIHRDLAARNVLVGENNI-CKVADFGLARVIKE--DIYEAREGAKFPIKWTAPE---- 174

Query: 226 DAYGGNYNGYA--GDIWSLGLTLLELY-LGHFPFLQPG 260
                 YN ++   D+WS G+ L E+   G  P+  PG
Sbjct: 175 ---AALYNRFSIKSDVWSFGILLTEIVTYGRMPY--PG 207

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 80.5 bits (198), Expect = 2e-17
 Identities = 61/203 (30%), Positives = 93/203 (45%), Gaps = 8/203 (3%)

Query: 55  KLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQC 114
           KL  LG G   TV+K + + T  + ALK +  + +        RE+ +L+      IV  
Sbjct: 9   KLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTL 68

Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
             I       + ++ EY+DS     L N     S   +     Q+L+GLSY H  KI+HR
Sbjct: 69  HDIIHTERC-LTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHR 127

Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNG 234
           D+KP NLL+N    ++K+ADFG+++         ++ V T  Y  P+       G     
Sbjct: 128 DLKPQNLLINEKG-ELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL----LGSTEYS 182

Query: 235 YAGDIWSLGLTLLELYLGH--FP 255
              D+W +G  L E+  G   FP
Sbjct: 183 TPIDMWGVGCILYEMATGRPMFP 205

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 80.8 bits (199), Expect = 2e-17
 Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 6/209 (2%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHG-DADPTVRRQVFRE-MEILRRTDSP 109
           D E ++V+G G  G V  V+ + T +IYA+K+++  +         FRE   +L   D  
Sbjct: 2   DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ 61

Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHG 168
           +I      F+     + ++M+Y   G L TLL+K      E       ++++  +  +H 
Sbjct: 62  WITTLHYAFQD-ENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120

Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVS-KIMCRSLDACNSYVGTCAYMSPERFDPDA 227
              +HRDIKP N+L++ N   +++ADFG   K+        +  VGT  Y+SPE      
Sbjct: 121 LHYVHRDIKPDNVLLDMNG-HIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAME 179

Query: 228 YGGNYNGYAGDIWSLGLTLLELYLGHFPF 256
            G    G   D WSLG+ + E+  G  PF
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 80.0 bits (197), Expect = 2e-17
 Identities = 67/264 (25%), Positives = 118/264 (44%), Gaps = 19/264 (7%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILR 104
           I  S + K +V+G G  G V++   +   +     A+K +        R+    E  I+ 
Sbjct: 2   IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMG 61

Query: 105 RTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQILKGL 163
           +     I++  G+  K      I+ EYM++G LD  L + +G FS  +L  +   I  G+
Sbjct: 62  QFSHHNIIRLEGVVTKFK-PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGM 120

Query: 164 SYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF 223
            YL     +HRD+   N+LV N+N++ K++DFG+S+++    D   +Y  +   +     
Sbjct: 121 KYLSDMNYVHRDLAARNILV-NSNLECKVSDFGLSRVL--EDDPEGTYTTSGGKIPIRWT 177

Query: 224 DPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDW----ATLMCAICFGDPPS 279
            P+A        A D+WS G+ + E+       +  G+RP W      +M AI  G    
Sbjct: 178 APEAIAYRKFTSASDVWSFGIVMWEV-------MSFGERPYWDMSNHEVMKAINDGFRLP 230

Query: 280 LPDGASPEFRSFIECCLQKEFSKR 303
            P          +  C Q++ ++R
Sbjct: 231 APMDCPSAVYQLMLQCWQQDRARR 254

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 80.8 bits (199), Expect = 3e-17
 Identities = 59/214 (27%), Positives = 105/214 (49%), Gaps = 17/214 (7%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQ----VFREMEIL 103
           + Y D   ++ LG G+ G V    ++       + +   +    ++++    VF E +IL
Sbjct: 27  MKYEDFNFIRTLGTGSFGRVILATYK-NEDFPPVAIKRFEKSKIIKQKQVDHVFSERKIL 85

Query: 104 RRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGL 163
              + PF V  +G F+  S  + +++E++  G   T L +N  F        A+QI+   
Sbjct: 86  NYINHPFCVNLYGSFKDESY-LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIF 144

Query: 164 SYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM-CRSLDACNSYVGTCAYMSPER 222
            YL    I++RD+KP NLL++ +   +K+ DFG +K++  R+   C    GT  Y++PE 
Sbjct: 145 EYLQSLNIVYRDLKPENLLLDKDGF-IKMTDFGFAKVVDTRTYTLC----GTPEYIAPEI 199

Query: 223 FDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPF 256
                +G      A D W+LG+ + E+ +G  PF
Sbjct: 200 LLNVGHGK-----AADWWTLGIFIYEILVGCPPF 228

Length = 340

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 80.7 bits (199), Expect = 3e-17
 Identities = 78/269 (28%), Positives = 116/269 (43%), Gaps = 60/269 (22%)

Query: 94  RQVFREMEILRRTDSPFIVQCFGIF-EKPSG----DIAILMEYMDSGTLDTLLNK--NGT 146
           ++ +RE+ +L+      ++    +F    SG    D  ++M YM      T L K     
Sbjct: 59  KRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-----TDLQKIMGHP 113

Query: 147 FSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD 206
            SE K+ ++  Q+L GL Y+H   IIHRD+KP NL V N + ++KI DFG++    R  D
Sbjct: 114 LSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAV-NEDCELKILDFGLA----RHAD 168

Query: 207 A-CNSYVGTCAYMSPERFDPDAYGGNYNGYAG--DIWSLGLTLLELYLGHFPFLQPGQRP 263
           A    YV T  Y +PE         N+  Y    DIWS+G  + E+  G   F    +  
Sbjct: 169 AEMTGYVVTRWYRAPEVIL------NWMHYNQTVDIWSVGCIMAEMLTGKTLF----KGK 218

Query: 264 DWATLMCAI--CFGDP-----------------PSLPD-----------GASPEFRSFIE 293
           D+   +  I    G P                  SLP             ASP+    +E
Sbjct: 219 DYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLE 278

Query: 294 CCLQKEFSKRWTASQLLTHPFLCKNRRSD 322
             L+ +  KR TA++ L HP+    R +D
Sbjct: 279 KMLELDVDKRLTATEALEHPYFDSFRDAD 307

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 80.5 bits (198), Expect = 3e-17
 Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 6/209 (2%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHG-DADPTVRRQVFRE-MEILRRTDSP 109
           D E L+V+G G  G V  V+ +   K++A+K+++  +         FRE  ++L   D+ 
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHG 168
           +I      F+    ++ ++M+Y   G L TLL+K      E       ++++  +  +H 
Sbjct: 62  WITTLHYAFQD-ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120

Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVS-KIMCRSLDACNSYVGTCAYMSPERFDPDA 227
              +HRDIKP N+L++ N   +++ADFG   K+M       +  VGT  Y+SPE      
Sbjct: 121 LHYVHRDIKPDNILMDMNG-HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME 179

Query: 228 YGGNYNGYAGDIWSLGLTLLELYLGHFPF 256
            G    G   D WSLG+ + E+  G  PF
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 81.0 bits (200), Expect = 4e-17
 Identities = 81/316 (25%), Positives = 130/316 (41%), Gaps = 65/316 (20%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFR---EMEILRRTD 107
           S   K++ +G G  G V  V+   T+ +YA+K +   AD  +R Q      E +IL   D
Sbjct: 1   SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLR-KADVLMRNQAAHVKAERDILAEAD 59

Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLA--HIASQILKGLSY 165
           + ++V+ +  F+    ++  +M+Y+  G + +LL + G F E  LA  +IA      +  
Sbjct: 60  NEWVVKLYYSFQDKD-NLYFVMDYIPGGDMMSLLIRLGIFEE-DLARFYIAELTC-AIES 116

Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFG----------------------------- 196
           +H    IHRDIKP N+L++ +   +K+ DFG                             
Sbjct: 117 VHKMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175

Query: 197 -VSKIMCRSLDA-------------CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSL 242
             S+I    L                +S VGT  Y++PE      Y         D WS+
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-----TQLCDWWSV 230

Query: 243 GLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA--SPEFRSFIE--CCLQK 298
           G+ L E+ +G  PFL         T +  I +     +P  A  S E    I   CC  +
Sbjct: 231 GVILYEMLVGQPPFLADTPA---ETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAE 287

Query: 299 EFSKRWTASQLLTHPF 314
           +   +  A ++  HPF
Sbjct: 288 DRLGKNGADEIKAHPF 303

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 80.2 bits (198), Expect = 5e-17
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 29/217 (13%)

Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD----ADPTVRRQVFREMEILRRTDSPFI 111
            +V+G G+ G V       T +  A+K ++      +D T   ++ RE+++LR    P I
Sbjct: 5   QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDAT---RILREIKLLRLLRHPDI 61

Query: 112 VQCFGIFEKPS----GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
           V+   I   PS     DI ++ E M+S  L  ++  N   +         Q+L+ L Y+H
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120

Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNS-----YVGTCAYMSPER 222
              + HRD+KP N+L  N + ++KI DFG++++     D   +     YV T  Y +PE 
Sbjct: 121 TANVFHRDLKPKNILA-NADCKLKICDFGLARVA--FNDTPTAIFWTDYVATRWYRAPE- 176

Query: 223 FDPDAYGGNYNGY--AGDIWSLGLTLLELYLGH--FP 255
                 G  ++ Y  A DIWS+G    E+  G   FP
Sbjct: 177 ----LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 209

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 78.7 bits (194), Expect = 5e-17
 Identities = 58/213 (27%), Positives = 112/213 (52%), Gaps = 21/213 (9%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           S+L  ++ LG G  G V+  + R   K+ A+K ++  A          E +++ +   P 
Sbjct: 4   SELTFMKELGSGQFGVVHLGKWRAQIKV-AIKAINEGA--MSEEDFIEEAKVMMKLSHPK 60

Query: 111 IVQCFGIF--EKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
           +VQ +G+   +KP   + I+ E+M++G L + L  + G  S+  L  +   + +G+ YL 
Sbjct: 61  LVQLYGVCTQQKP---LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE 117

Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PD 226
            +  IHRD+   N LV++  + VK++DFG+++ +   LD  + Y  +     P ++  P+
Sbjct: 118 RNSFIHRDLAARNCLVSSTGV-VKVSDFGMTRYV---LD--DEYTSSSGAKFPVKWSPPE 171

Query: 227 AYGGNYNGYA--GDIWSLGLTLLELYL-GHFPF 256
            +  N++ Y+   D+WS G+ + E++  G  PF
Sbjct: 172 VF--NFSKYSSKSDVWSFGVLMWEVFTEGKMPF 202

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 79.4 bits (195), Expect = 6e-17
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 8/209 (3%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           EKL+ LG G+  TVYK + +   K+ ALKV+    +        RE  +L+      IV 
Sbjct: 8   EKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVL 67

Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
              I       + ++ EY+ +     +    G      +     Q+L+GLSY+H   I+H
Sbjct: 68  LHDIIHTKE-TLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILH 126

Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYN 233
           RD+KP NLL+++   ++K+ADFG+++         ++ V T  Y  P+       G    
Sbjct: 127 RDLKPQNLLISDTG-ELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVL----LGSTEY 181

Query: 234 GYAGDIWSLGLTLLELYLGHFPFLQPGQR 262
               D+W +G   +E+  G   F  PG +
Sbjct: 182 STCLDMWGVGCIFVEMIQGVAAF--PGMK 208

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 78.9 bits (194), Expect = 8e-17
 Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 18/207 (8%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRT---DSP 109
           E +  +G G  GTVYK +   +    ALK V     +  +     RE+ +L+R    D P
Sbjct: 3   EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHP 62

Query: 110 FIVQCFGIFEKPSGD----IAILMEYMDSGTLDTLLNKNGTFSEP--KLAHIASQILKGL 163
            IV+   +      D    + ++ E++D   L T L+K      P   +  +  Q L+GL
Sbjct: 63  NIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121

Query: 164 SYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF 223
            +LH + I+HRD+KP N+LV +   QVK+ADFG+++I    + A    V T  Y +PE  
Sbjct: 122 DFLHANCIVHRDLKPENILVTSGG-QVKLADFGLARIYSCQM-ALTPVVVTLWYRAPEVL 179

Query: 224 DPDAYGGNYNGYAGDIWSLGLTLLELY 250
               Y         D+WS+G    E++
Sbjct: 180 LQSTYATPV-----DMWSVGCIFAEMF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 79.2 bits (196), Expect = 9e-17
 Identities = 75/312 (24%), Positives = 121/312 (38%), Gaps = 62/312 (19%)

Query: 60  GHGNGGTVYKV--QHRCTHKIYALKVVHGDADPT--VRRQVFREMEILRRTDSPFIVQCF 115
           G G  G VYK   ++    K YA+K   GD +    + +   RE+ +LR      +V   
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68

Query: 116 GIF-EKPSGDIAILMEYMDSGTLDTL----LNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
            +F E     + +L +Y +      +      K  +     +  +  QIL G+ YLH + 
Sbjct: 69  EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW 128

Query: 171 IIHRDIKPSNLLVNNNNMQ---VKIADFGVSKI---MCRSLDACNSYVGTCAYMSPERFD 224
           ++HRD+KP+N+LV     +   VKI D G++++     + L   +  V T  Y +PE   
Sbjct: 129 VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELL- 187

Query: 225 PDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQ----------PGQR------------ 262
               G  +   A DIW++G    EL L   P  +          P QR            
Sbjct: 188 ---LGARHYTKAIDIWAIGCIFAEL-LTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGT 243

Query: 263 ------------PDWATLMCAICFG--DPPSLPD------GASPEFRSFIECCLQKEFSK 302
                       P++ TLM           SL            +    +   L+ + +K
Sbjct: 244 PTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTK 303

Query: 303 RWTASQLLTHPF 314
           R TA + L HP+
Sbjct: 304 RITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 77.7 bits (191), Expect = 1e-16
 Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 19/214 (8%)

Query: 47  AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVF-REMEILRR 105
           A+   +L+ LQ +G G  G V    +R      A+K +  DA      Q F  E  ++ +
Sbjct: 2   ALNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATA----QAFLAEASVMTQ 55

Query: 106 TDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGL 163
                +VQ  G+  +  G + I+ EYM  G+L   L   G        L   +  + + +
Sbjct: 56  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115

Query: 164 SYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF 223
            YL  +  +HRD+   N+LV+ +N+  K++DFG++K    + D     V    + +PE  
Sbjct: 116 EYLEANNFVHRDLAARNVLVSEDNV-AKVSDFGLTKEASSTQDTGKLPV---KWTAPEAL 171

Query: 224 DPDAYGGNYNGYAGDIWSLGLTLLELY-LGHFPF 256
               +         D+WS G+ L E+Y  G  P+
Sbjct: 172 REKKFSTK-----SDVWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 78.2 bits (193), Expect = 2e-16
 Identities = 60/204 (29%), Positives = 85/204 (41%), Gaps = 54/204 (26%)

Query: 153 AHIAS---QILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA-- 207
           AH  S   QIL GL Y+H   ++HRD+KP NLLV N + ++KI DFG++    R      
Sbjct: 105 AHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV-NADCELKICDFGLA----RGFSENP 159

Query: 208 ------CNSYVGTCAYMSPERFDPDAYGGNYNGY--AGDIWSLGLTLLELYLGHFPFLQP 259
                    YV T  Y +PE         ++  Y  A D+WS+G  L EL LG  P  + 
Sbjct: 160 GENAGFMTEYVATRWYRAPEIML------SFQSYTKAIDVWSVGCILAEL-LGRKPVFKG 212

Query: 260 GQRPDWATLMCAICFGDPP-----------------SLPD-----------GASPEFRSF 291
               D    +  +  G P                  SLP+            A+P     
Sbjct: 213 KDYVDQLNQILQV-LGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDL 271

Query: 292 IECCLQKEFSKRWTASQLLTHPFL 315
           +E  L  + +KR +  + L HP+L
Sbjct: 272 LEKLLAFDPTKRISVEEALEHPYL 295

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 77.7 bits (191), Expect = 3e-16
 Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 8/203 (3%)

Query: 55  KLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQC 114
           KL+ LG G   TV+K + + T  + ALK +  + +        RE+ +L+      IV  
Sbjct: 10  KLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 69

Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
             I       + ++ EY+D      + +     S   +     QIL+GL+Y H  K++HR
Sbjct: 70  HDIVHTDK-SLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHR 128

Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNG 234
           D+KP NLL+N    ++K+ADFG+++         ++ V T  Y  P+       G +   
Sbjct: 129 DLKPQNLLINERG-ELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL----LGSSEYS 183

Query: 235 YAGDIWSLGLTLLELYLGH--FP 255
              D+W +G    E+  G   FP
Sbjct: 184 TQIDMWGVGCIFFEMASGRPLFP 206

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 76.4 bits (188), Expect = 4e-16
 Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 24/200 (12%)

Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGI- 117
           LG G  G VY+   +      A+K +  D       +  +E  +++    P +VQ  G+ 
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGVC 71

Query: 118 -FEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPK--LAHIASQILKGLSYLHGHKIIHR 174
             E P     I+ E+M  G L   L +          L ++A+QI   + YL     IHR
Sbjct: 72  TREPP---FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 128

Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGT---CAYMSPERFDPDAYGGN 231
           D+   N LV  N++ VK+ADFG+S++M  + D   ++ G      + +PE          
Sbjct: 129 DLAARNCLVGENHL-VKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPE-------SLA 178

Query: 232 YNGYA--GDIWSLGLTLLEL 249
           YN ++   D+W+ G+ L E+
Sbjct: 179 YNKFSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 77.5 bits (191), Expect = 5e-16
 Identities = 68/211 (32%), Positives = 98/211 (46%), Gaps = 26/211 (12%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALK-VVHGDADPTVRRQVFREMEILRRTDSPF 110
           D+E  + +G+G  G V+ V      K  ALK + +   +    ++VFRE+++L       
Sbjct: 1   DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDN 60

Query: 111 IVQCFGIFEKPSGD----IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
           ++    I + P  D    I ++ E M S  L  ++      S   +     QIL+GL YL
Sbjct: 61  VLSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYL 119

Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGV--------SKIMCRSLDACNSYVGTCAYM 218
           H   I+HRDIKP NLLV N+N  +KI DFG+        SK M +        V T  Y 
Sbjct: 120 HSAGILHRDIKPGNLLV-NSNCVLKICDFGLARVEEPDESKHMTQE-------VVTQYYR 171

Query: 219 SPERFDPDAYGGNYNGYAGDIWSLGLTLLEL 249
           +PE       G  +   A DIWS+G    EL
Sbjct: 172 APEIL----MGSRHYTSAVDIWSVGCIFAEL 198

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 75.8 bits (186), Expect = 6e-16
 Identities = 61/218 (27%), Positives = 103/218 (47%), Gaps = 19/218 (8%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           I    L+ ++ LG+G  G V+        K+    +  G   P        E +I+++  
Sbjct: 3   IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP---ESFLEEAQIMKKLR 59

Query: 108 SPFIVQCFGIF-EKPSGDIAILMEYMDSGTL-DTLLNKNGTFSE-PKLAHIASQILKGLS 164
              +VQ + +  E+P   I I+ EYM  G+L D L +  G   + P L  +A+Q+  G++
Sbjct: 60  HDKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMA 116

Query: 165 YLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD 224
           Y+     IHRD++ +N+LV  + +  KIADFG+++++       N Y        P ++ 
Sbjct: 117 YIERMNYIHRDLRSANILV-GDGLVCKIADFGLARLI-----EDNEYTARQGAKFPIKWT 170

Query: 225 -PDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPG 260
            P+A          D+WS G+ L EL   G  P+  PG
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGRVPY--PG 206

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 75.8 bits (187), Expect = 6e-16
 Identities = 66/216 (30%), Positives = 104/216 (48%), Gaps = 36/216 (16%)

Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTDSPFIVQCFGI 117
           LG G  G V+      T K+ A+K +  G   P       +E +I+++     +VQ + +
Sbjct: 14  LGAGQFGEVWMGTWNGTTKV-AVKTLKPGTMSPE---AFLQEAQIMKKLRHDKLVQLYAV 69

Query: 118 F--EKPSGDIAILMEYMDSGTLDTLLNKNGTFS---EPKLAHIASQILKGLSYLHGHKII 172
              E+P   I I+ EYM  G+L   L K+G       P+L  +A+QI +G++YL     I
Sbjct: 70  CSEEEP---IYIVTEYMSKGSLLDFL-KSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYI 125

Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-----PDA 227
           HRD+   N+LV  N +  KIADFG+++++       + Y    A     +F      P+A
Sbjct: 126 HRDLAARNILVGENLV-CKIADFGLARLI-----EDDEY---TAREG-AKFPIKWTAPEA 175

Query: 228 YGGNYNGYA--GDIWSLGLTLLELY-LGHFPFLQPG 260
              NY  +    D+WS G+ L E+   G  P+  PG
Sbjct: 176 --ANYGRFTIKSDVWSFGILLTEIVTYGRVPY--PG 207

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 76.1 bits (187), Expect = 6e-16
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 23/210 (10%)

Query: 53  LEKLQVLGHGNGGTV----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS 108
           L++++ LG G+ G V    Y  +   T +  A+K +  ++       + +E+EILR    
Sbjct: 6   LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH 65

Query: 109 PFIVQCFGIFEKPSGD-IAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYL 166
             IV+  GI  +  G+ I ++ME++ SG+L   L +N    +  +    A QI KG+ YL
Sbjct: 66  ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL 125

Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-- 224
              + +HRD+   N+LV + + QVKI DFG++K    +++    Y     Y   +  D  
Sbjct: 126 GSRQYVHRDLAARNVLVESEH-QVKIGDFGLTK----AIETDKEY-----YTVKDDLDSP 175

Query: 225 -----PDAYGGNYNGYAGDIWSLGLTLLEL 249
                P+    +    A D+WS G+TL EL
Sbjct: 176 VFWYAPECLIQSKFYIASDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 75.4 bits (185), Expect = 1e-15
 Identities = 60/208 (28%), Positives = 105/208 (50%), Gaps = 19/208 (9%)

Query: 54  EKLQVLGHGNGGTVYKVQH-RCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTDS--- 108
           E +  +G G  G V+K +  +   +  ALK V     +  +     RE+ +LR  ++   
Sbjct: 4   ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 63

Query: 109 PFIVQCFGIFEKPSGD----IAILMEYMDSGTLDTLLNKNGTFSEP--KLAHIASQILKG 162
           P +V+ F +      D    + ++ E++D   L T L+K      P   +  +  Q+L+G
Sbjct: 64  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRG 122

Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
           L +LH H+++HRD+KP N+LV ++  Q+K+ADFG+++I    + A  S V T  Y +PE 
Sbjct: 123 LDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGLARIYSFQM-ALTSVVVTLWYRAPEV 180

Query: 223 FDPDAYGGNYNGYAGDIWSLGLTLLELY 250
               +Y         D+WS+G    E++
Sbjct: 181 LLQSSYATPV-----DLWSVGCIFAEMF 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 74.9 bits (184), Expect = 1e-15
 Identities = 69/263 (26%), Positives = 128/263 (48%), Gaps = 19/263 (7%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
           DL  L+ LG G  G V   + R  + + A+K++   +      +   E +++ +     +
Sbjct: 5   DLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGS--MSEDEFIEEAKVMMKLSHEKL 61

Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEP-KLAHIASQILKGLSYLHGHK 170
           VQ +G+  K    I I+ EYM +G L   L ++G   +P +L  +   + +G++YL   +
Sbjct: 62  VQLYGVCTKQR-PIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ 120

Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGG 230
            IHRD+   N LV++    VK++DFG+S+ +   LD  + Y  +     P R+ P     
Sbjct: 121 FIHRDLAARNCLVDDQGC-VKVSDFGLSRYV---LD--DEYTSSVGSKFPVRWSPPEV-L 173

Query: 231 NYNGYA--GDIWSLGLTLLELY-LGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPE 287
            Y+ ++   D+W+ G+ + E+Y LG  P+    +R + +  +  +  G     P  AS +
Sbjct: 174 LYSKFSSKSDVWAFGVLMWEVYSLGKMPY----ERFNNSETVEKVSQGLRLYRPHLASEK 229

Query: 288 FRSFIECCLQKEFSKRWTASQLL 310
             + +  C  ++  +R T  QLL
Sbjct: 230 VYAIMYSCWHEKAEERPTFQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 75.5 bits (186), Expect = 1e-15
 Identities = 43/147 (29%), Positives = 77/147 (52%), Gaps = 4/147 (2%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +KL  LG G+  TVYK + + T ++ ALK +  + +        RE  +L+      IV 
Sbjct: 8   KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVT 67

Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHI-ASQILKGLSYLHGHKII 172
              I       + ++ EY+D+  L   ++  G         +   Q+L+GL+Y H  +++
Sbjct: 68  LHDIIHTKK-TLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVL 125

Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSK 199
           HRD+KP NLL++    ++K+ADFG+++
Sbjct: 126 HRDLKPQNLLISERG-ELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 74.7 bits (183), Expect = 1e-15
 Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 11/202 (5%)

Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIF 118
           +G GN G V+  + R  +   A+K       P ++ +  +E  IL++   P IV+  G+ 
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 119 EKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPK-LAHIASQILKGLSYLHGHKIIHRDIK 177
            +    I I+ME +  G   T L   G   + K L  +      G+ YL     IHRD+ 
Sbjct: 63  TQKQ-PIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLA 121

Query: 178 PSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYA- 236
             N LV   N+ +KI+DFG+S+      D   +  G    +  +   P+A   NY  Y+ 
Sbjct: 122 ARNCLVTEKNV-LKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEAL--NYGRYSS 175

Query: 237 -GDIWSLGLTLLELY-LGHFPF 256
             D+WS G+ L E + LG  P+
Sbjct: 176 ESDVWSFGILLWEAFSLGAVPY 197

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 75.4 bits (185), Expect = 1e-15
 Identities = 52/185 (28%), Positives = 89/185 (48%), Gaps = 21/185 (11%)

Query: 80  ALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDT 139
           A+K++  D   T R    +E++I+ R  +P I++  G+       + ++ EYM++G L+ 
Sbjct: 48  AVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVS-DDPLCMITEYMENGDLNQ 106

Query: 140 LLNKNGTFSE------------PKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN 187
            L++    S               L ++A QI  G+ YL     +HRD+   N LV N+ 
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNH- 165

Query: 188 MQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDP--DAYGGNYNGYAGDIWSLGLT 245
             +KIADFG    M R+L + + Y      + P R+        G +   A D+W+ G+T
Sbjct: 166 YTIKIADFG----MSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTT-ASDVWAFGVT 220

Query: 246 LLELY 250
           L E++
Sbjct: 221 LWEMF 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 75.2 bits (185), Expect = 2e-15
 Identities = 64/234 (27%), Positives = 101/234 (43%), Gaps = 29/234 (12%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHR-----CTHKIYALKVVHGDADPTVRRQVFREMEI 102
           +    +  L+ LGHG  G VY+  +R           A+K +              E  I
Sbjct: 3   VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALI 62

Query: 103 LRRTDSPFIVQCFGI-FEK-PSGDIAILMEYMDSGTLDTLLNKN-------GTFSEPKLA 153
           + + +   IV+  G+ FE+ P     IL+E M  G L + L +N        + +   L 
Sbjct: 63  MSKFNHQNIVRLIGVSFERLPR---FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLL 119

Query: 154 HIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQ--VKIADFGVSKIMCRSLDACNSY 211
             A  + KG  YL  +  IHRDI   N L+         KIADFG+++ + R+     SY
Sbjct: 120 FCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRA-----SY 174

Query: 212 --VGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELY-LGHFPFLQPGQR 262
              G  A +  +   P+A+         D+WS G+ L E++ LG+ P+  PG+ 
Sbjct: 175 YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY--PGRT 226

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 74.9 bits (184), Expect = 2e-15
 Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 35/199 (17%)

Query: 78  IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGI--FEKPSGDIAILMEYMDSG 135
           + A+K++  +A   ++    RE  ++   D P IV+  G+    KP   + +L EYM  G
Sbjct: 37  MVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP---MCLLFEYMAYG 93

Query: 136 TLDTLLNKNGTFSEPKLAH----------------------IASQILKGLSYLHGHKIIH 173
            L+  L      ++  L+H                      IA Q+  G++YL   K +H
Sbjct: 94  DLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVH 153

Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYN 233
           RD+   N LV   NM VKIADFG+S    R++ + + Y  +     P R+ P      YN
Sbjct: 154 RDLATRNCLV-GENMVVKIADFGLS----RNIYSADYYKASENDAIPIRWMPPE-SIFYN 207

Query: 234 GYA--GDIWSLGLTLLELY 250
            Y    D+W+ G+ L E++
Sbjct: 208 RYTTESDVWAYGVVLWEIF 226

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 74.4 bits (183), Expect = 2e-15
 Identities = 68/269 (25%), Positives = 117/269 (43%), Gaps = 25/269 (9%)

Query: 47  AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT 106
           AI   +L+    +G G  G V    +R   +  A+K +  D+  T  +    E  ++   
Sbjct: 2   AINSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS--TAAQAFLAEASVMTTL 57

Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNG----TFSEPKLAHIASQILKG 162
             P +VQ  G+  + +  + I+ EYM  G+L   L   G    T ++      A  + +G
Sbjct: 58  RHPNLVQLLGVVLQGNP-LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLG--FALDVCEG 114

Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
           + YL     +HRD+   N+LV+ + +  K++DFG++K   +  D+    V   A      
Sbjct: 115 MEYLEEKNFVHRDLAARNVLVSEDLV-AKVSDFGLAKEASQGQDSGKLPVKWTA------ 167

Query: 223 FDPDAYGGNYNGYAGDIWSLGLTLLELY-LGHFPFLQPGQRPDWATLMCAICFGDPPSLP 281
             P+A          D+WS G+ L E+Y  G  P+  P  R     ++  +  G     P
Sbjct: 168 --PEALREKKFSTKSDVWSFGILLWEIYSFGRVPY--P--RIPLKDVVPHVEKGYRMEAP 221

Query: 282 DGASPEFRSFIECCLQKEFSKRWTASQLL 310
           +G  PE    ++ C + + +KR T  QL 
Sbjct: 222 EGCPPEVYKVMKDCWELDPAKRPTFKQLR 250

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 75.5 bits (185), Expect = 2e-15
 Identities = 71/263 (26%), Positives = 113/263 (42%), Gaps = 47/263 (17%)

Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 61  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 118

Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D  
Sbjct: 119 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEM 174

Query: 209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPG-QRPDWAT 267
             YV T  Y +PE         +YN    DIWS+G  + EL  G   F  PG    D   
Sbjct: 175 TGYVATRWYRAPEIM---LNWMHYNQTV-DIWSVGCIMAELLTGRTLF--PGTDHIDQLK 228

Query: 268 LMCAICFGDPP-----------------SLPD-----------GASPEFRSFIECCLQKE 299
           L+  +  G P                  SL             GA+P     +E  L  +
Sbjct: 229 LILRLV-GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 287

Query: 300 FSKRWTASQLLTHPFLCKNRRSD 322
             KR TA+Q L H +  +    D
Sbjct: 288 SDKRITAAQALAHAYFAQYHDPD 310

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 74.7 bits (183), Expect = 3e-15
 Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 8/203 (3%)

Query: 55  KLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQC 114
           KL  LG G   TVYK + + T  + ALK +  + +        RE+ +L+      IV  
Sbjct: 10  KLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 69

Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
             I       + ++ EY+D      L +   + +   +     Q+L+GL+Y H  K++HR
Sbjct: 70  HDIIHTEK-SLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHR 128

Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNG 234
           D+KP NLL+N    ++K+ADFG+++         ++ V T  Y  P+       G     
Sbjct: 129 DLKPQNLLINERG-ELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDIL----LGSTDYS 183

Query: 235 YAGDIWSLGLTLLELYLGH--FP 255
              D+W +G    E+  G   FP
Sbjct: 184 TQIDMWGVGCIFYEMSTGRPLFP 206

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 76.0 bits (187), Expect = 3e-15
 Identities = 51/190 (26%), Positives = 83/190 (43%), Gaps = 19/190 (10%)

Query: 76  HKIYALKVVHGDADPTVRRQVFR---EMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYM 132
           H++ A+K++  DA P    Q  R   E  +  R   P IV      E P G +  + EY+
Sbjct: 4   HEV-AIKLLRTDA-PEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61

Query: 133 DSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQ--V 190
              TL  +L  +G     +   +  Q+L  L+  H   I+HRD+KP N++V+   ++   
Sbjct: 62  PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121

Query: 191 KIADFGVS-------KIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLG 243
           K+ DFG+             +L      +GT  Y +PE+   +    N      D+++ G
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPN-----SDLYAWG 176

Query: 244 LTLLELYLGH 253
           L  LE   G 
Sbjct: 177 LIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 74.3 bits (182), Expect = 4e-15
 Identities = 66/221 (29%), Positives = 103/221 (46%), Gaps = 29/221 (13%)

Query: 59  LGHGNGGTVYKVQ--HRCTHK---IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           LG G  G V+  +  + C  +   + A+K +  DA    R+   RE E+L       IV+
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLK-DASDNARKDFHREAELLTNLQHEHIVK 71

Query: 114 CFGIFEKPSGDIAILM-EYMDSGTLDTLLNKNG-------------TFSEPKLAHIASQI 159
            +G+  +  GD  I++ EYM  G L+  L  +G               ++ ++ HIA QI
Sbjct: 72  FYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129

Query: 160 LKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMS 219
             G+ YL     +HRD+   N LV   N+ VKI DFG+S    R + + + Y      M 
Sbjct: 130 AAGMVYLASQHFVHRDLATRNCLV-GENLLVKIGDFGMS----RDVYSTDYYRVGGHTML 184

Query: 220 PERF-DPDAYGGNYNGYAGDIWSLGLTLLELY-LGHFPFLQ 258
           P R+  P++          D+WSLG+ L E++  G  P+ Q
Sbjct: 185 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 73.9 bits (181), Expect = 4e-15
 Identities = 72/270 (26%), Positives = 115/270 (42%), Gaps = 39/270 (14%)

Query: 59  LGHGNGGTVYKVQHRCTH-------KIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
           LG G  G V+  +  C +        + A+K +  +A  + R+   RE E+L       I
Sbjct: 13  LGEGAFGKVFLAE--CHNLLPEQDKMLVAVKALK-EASESARQDFQREAELLTVLQHQHI 69

Query: 112 VQCFGIFEKPSGD-IAILMEYMDSGTLDTLLNKNG---------------TFSEPKLAHI 155
           V+ +G+  +  G  + ++ EYM  G L+  L  +G                 +  ++  I
Sbjct: 70  VRFYGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 156 ASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTC 215
           ASQI  G+ YL     +HRD+   N LV    + VKI DFG    M R + + + Y    
Sbjct: 128 ASQIASGMVYLASLHFVHRDLATRNCLV-GQGLVVKIGDFG----MSRDIYSTDYYRVGG 182

Query: 216 AYMSPERF-DPDAYGGNYNGYAGDIWSLGLTLLELY-LGHFPFLQPGQRPDWATLMCAIC 273
             M P R+  P++          DIWS G+ L E++  G  P+    Q  +   + C I 
Sbjct: 183 RTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWY---QLSNTEAIEC-IT 238

Query: 274 FGDPPSLPDGASPEFRSFIECCLQKEFSKR 303
            G     P    PE  + ++ C Q+E  +R
Sbjct: 239 QGRELERPRTCPPEVYAIMQGCWQREPQQR 268

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 72.8 bits (178), Expect = 9e-15
 Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 20/212 (9%)

Query: 55  KLQV-LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +L+V LG G  G V+      T ++    +  G   P       +E +++++     +VQ
Sbjct: 9   RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQ 65

Query: 114 CFGIF-EKPSGDIAILMEYMDSGTL-DTLLNKNGTFSE-PKLAHIASQILKGLSYLHGHK 170
            + +  E+P   I I+ EYM  G+L D L  + G +   P+L  +A+QI  G++Y+    
Sbjct: 66  LYAVVSEEP---IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 122

Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDAYG 229
            +HRD++ +N+LV   N+  K+ADFG+++++       N Y        P ++  P+A  
Sbjct: 123 YVHRDLRAANILV-GENLVCKVADFGLARLI-----EDNEYTARQGAKFPIKWTAPEAAL 176

Query: 230 GNYNGYAGDIWSLGLTLLELYL-GHFPFLQPG 260
                   D+WS G+ L EL   G  P+  PG
Sbjct: 177 YGRFTIKSDVWSFGILLTELTTKGRVPY--PG 206

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 80/315 (25%), Positives = 125/315 (39%), Gaps = 65/315 (20%)

Query: 55  KLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFR---EMEILRRTDSPFI 111
           K++ LG G  G V       TH +YA+K +    D   R QV     E +IL   D+ ++
Sbjct: 5   KIKTLGIGAFGEVCLACKVDTHALYAMKTLR-KKDVLNRNQVAHVKAERDILAEADNEWV 63

Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
           V+ +  F+    ++  +M+Y+  G + +LL +   F E       +++   +  +H    
Sbjct: 64  VKLYYSFQDKD-NLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122

Query: 172 IHRDIKPSNLLVNNNNMQVKIADFG---------------------------------VS 198
           IHRDIKP N+L++ +   +K+ DFG                                 VS
Sbjct: 123 IHRDIKPDNILIDLDG-HIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVS 181

Query: 199 KIMC------------RSLDAC--NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGL 244
              C            +    C  +S VGT  Y++PE      Y         D WS+G+
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY-----TQLCDWWSVGV 236

Query: 245 TLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA--SPEFRSFIE--CCLQKEF 300
            L E+ +G  PFL P       T +  I + +   +P     SPE    I   CC  +E 
Sbjct: 237 ILFEMLVGQPPFLAPTPT---ETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEER 293

Query: 301 SKRWTASQLLTHPFL 315
             R  A  +  HPF 
Sbjct: 294 LGRNGADDIKAHPFF 308

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 72.7 bits (178), Expect = 1e-14
 Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 19/208 (9%)

Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRT 106
           ++L+K++VLG G  GTVYK   +      KI  A+KV+  +  P   +++  E  ++   
Sbjct: 7   TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV 66

Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSY 165
            SP++ +  GI    +  + ++ + M  G L D +           L +   QI KG+SY
Sbjct: 67  GSPYVCRLLGICL--TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSY 124

Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVG----TCAYMSPE 221
           L   +++HRD+   N+LV + N  VKI DFG+++++   +D    +         +M+ E
Sbjct: 125 LEEVRLVHRDLAARNVLVKSPN-HVKITDFGLARLL--DIDETEYHADGGKVPIKWMALE 181

Query: 222 RFDPDAYGGNYNGYAGDIWSLGLTLLEL 249
                 +      +  D+WS G+T+ EL
Sbjct: 182 SILHRRF-----THQSDVWSYGVTVWEL 204

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 72.0 bits (176), Expect = 1e-14
 Identities = 64/212 (30%), Positives = 98/212 (46%), Gaps = 23/212 (10%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           ++LG GN G V+K   +    + A+K    D    ++ +   E  IL++ D P IV+  G
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPV-AVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59

Query: 117 IFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRD 175
           +  +    I I+ME +  G   + L  K       +L   A     G++YL     IHRD
Sbjct: 60  VCTQRQ-PIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRD 118

Query: 176 IKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVG----TCAYMSPERFDPDAYGGN 231
           +   N LV  NN+ +KI+DFG+S+   +  D   S  G       + +PE         N
Sbjct: 119 LAARNCLVGENNV-LKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPEAL-------N 167

Query: 232 YNGYA--GDIWSLGLTLLELY-LGHFPFLQPG 260
           Y  Y+   D+WS G+ L E + LG  P+  PG
Sbjct: 168 YGRYSSESDVWSYGILLWETFSLGVCPY--PG 197

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 72.7 bits (178), Expect = 1e-14
 Identities = 57/192 (29%), Positives = 89/192 (46%), Gaps = 30/192 (15%)

Query: 80  ALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDT 139
           A+K++  DA+   R    +E++IL R   P I++  G+       + ++ EYM++G L+ 
Sbjct: 50  AVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD-EDPLCMITEYMENGDLNQ 108

Query: 140 ------LLNKNG-------------TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSN 180
                 L +K                 S   L H+A QI  G+ YL     +HRD+   N
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRN 168

Query: 181 LLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNG---YAG 237
            LV   N+ +KIADFG    M R+L A + Y      + P R+   A+     G    A 
Sbjct: 169 CLV-GENLTIKIADFG----MSRNLYAGDYYRIQGRAVLPIRW--MAWECILMGKFTTAS 221

Query: 238 DIWSLGLTLLEL 249
           D+W+ G+TL E+
Sbjct: 222 DVWAFGVTLWEI 233

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 72.3 bits (177), Expect = 2e-14
 Identities = 67/225 (29%), Positives = 96/225 (42%), Gaps = 30/225 (13%)

Query: 59  LGHGNGGTVYKVQ--HRCTHKIYALKVVHGDADPTV--RRQVFREMEILRRTDSPFIVQC 114
           LG G  G V+  +  +    K   L  V    DPT+  R+   RE E+L       IV+ 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 115 FGIFEKPSGDIAILM-EYMDSGTLDTLL----------------NKNGTFSEPKLAHIAS 157
           +G+     GD  I++ EYM  G L+  L                   G     ++ HIAS
Sbjct: 73  YGVC--GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130

Query: 158 QILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAY 217
           QI  G+ YL     +HRD+   N LV   N+ VKI DFG    M R + + + Y      
Sbjct: 131 QIASGMVYLASQHFVHRDLATRNCLV-GANLLVKIGDFG----MSRDVYSTDYYRVGGHT 185

Query: 218 MSPERF-DPDAYGGNYNGYAGDIWSLGLTLLELY-LGHFPFLQPG 260
           M P R+  P++          D+WS G+ L E++  G  P+ Q  
Sbjct: 186 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 230

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 72.0 bits (176), Expect = 2e-14
 Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 15/206 (7%)

Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRT 106
           ++L++++VLG G  GTVYK   V    T KI  A+K+++    P    +   E  I+   
Sbjct: 7   TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM 66

Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSY 165
           D P +V+  G+   P+  I ++ + M  G L   ++++        L +   QI KG+ Y
Sbjct: 67  DHPHLVRLLGVCLSPT--IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMY 124

Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGT--CAYMSPERF 223
           L   +++HRD+   N+LV + N  VKI DFG+++++       N+  G     +M+ E  
Sbjct: 125 LEERRLVHRDLAARNVLVKSPN-HVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183

Query: 224 DPDAYGGNYNGYAGDIWSLGLTLLEL 249
               +      +  D+WS G+T+ EL
Sbjct: 184 HYRKF-----THQSDVWSYGVTIWEL 204

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 72.4 bits (177), Expect = 3e-14
 Identities = 72/258 (27%), Positives = 115/258 (44%), Gaps = 47/258 (18%)

Query: 94  RQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILME-YMDSGTLDTLLN---KNGTFSE 149
           R+ +RE+ +L+      ++    +F  P+  I    E Y+ +  +   LN   K    S+
Sbjct: 59  RRTYRELRLLKHMKHENVIGLLDVF-TPATSIENFNEVYLVTNLMGADLNNIVKCQKLSD 117

Query: 150 PKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN 209
             +  +  Q+L+GL Y+H   IIHRD+KPSN+ V N + +++I DFG+++   ++ D   
Sbjct: 118 EHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAV-NEDCELRILDFGLAR---QADDEMT 173

Query: 210 SYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLM 269
            YV T  Y +PE         +YN    DIWS+G  + EL  G   F  PG   D+   +
Sbjct: 174 GYVATRWYRAPEIM---LNWMHYNQTV-DIWSVGCIMAELLKGKALF--PGN--DYIDQL 225

Query: 270 CAI--CFGDP--------------------PSLPD--------GASPEFRSFIECCLQKE 299
             I    G P                    P +P         GA+P     +E  L  +
Sbjct: 226 KRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLD 285

Query: 300 FSKRWTASQLLTHPFLCK 317
             KR +AS+ L HP+  +
Sbjct: 286 SDKRISASEALAHPYFSQ 303

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 72.0 bits (176), Expect = 3e-14
 Identities = 49/171 (28%), Positives = 85/171 (49%), Gaps = 15/171 (8%)

Query: 91  TVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG-----DIAILMEYMDSGTLDTLLNKNG 145
           T  ++ +RE+ +L+  +   I+    +F          D+ ++ME MD+     +   + 
Sbjct: 62  THAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI---HM 118

Query: 146 TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL 205
                +++++  Q+L G+ +LH   IIHRD+KPSN++V  ++  +KI DFG+++  C + 
Sbjct: 119 ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTACTNF 177

Query: 206 DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPF 256
                YV T  Y +PE      Y  N      DIWS+G  + EL  G   F
Sbjct: 178 -MMTPYVVTRYYRAPEVILGMGYKENV-----DIWSVGCIMGELVKGSVIF 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 71.6 bits (175), Expect = 3e-14
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 15/206 (7%)

Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRT 106
           ++ +K++VLG G  GTVYK   +      KI  A+K +     P   +++  E  ++   
Sbjct: 7   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 66

Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSY 165
           D+P + +  GI    +  + ++ + M  G L D +           L +   QI KG++Y
Sbjct: 67  DNPHVCRLLGICL--TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 124

Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTC--AYMSPERF 223
           L   +++HRD+   N+LV      VKI DFG++K++       ++  G     +M+ E  
Sbjct: 125 LEERRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI 183

Query: 224 DPDAYGGNYNGYAGDIWSLGLTLLEL 249
               Y      +  D+WS G+T+ EL
Sbjct: 184 LHRIY-----THQSDVWSYGVTVWEL 204

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 71.5 bits (175), Expect = 4e-14
 Identities = 55/188 (29%), Positives = 90/188 (47%), Gaps = 28/188 (14%)

Query: 80  ALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDT 139
           A+K++  DA+   R    +E++I+ R   P I++   +    S  + ++ EYM++G L+ 
Sbjct: 50  AVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCIT-SDPLCMITEYMENGDLNQ 108

Query: 140 LLNKN-----------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNM 188
            L+++            T S   L  +A+QI  G+ YL     +HRD+   N LV  N  
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYT 168

Query: 189 QVKIADFGVSKIMCRSLDACNSY------VGTCAYMSPERFDPDAYGGNYNGYAGDIWSL 242
            +KIADFG    M R+L + + Y      V    +MS E        G +   A D+W+ 
Sbjct: 169 -IKIADFG----MSRNLYSGDYYRIQGRAVLPIRWMSWESI----LLGKFT-TASDVWAF 218

Query: 243 GLTLLELY 250
           G+TL E+ 
Sbjct: 219 GVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 71.1 bits (174), Expect = 4e-14
 Identities = 64/233 (27%), Positives = 110/233 (47%), Gaps = 36/233 (15%)

Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFRE----MEI 102
           ++L KL++LG G  GTV+K   +    + KI  A+K +   +     RQ F+E    M  
Sbjct: 7   TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG----RQTFQEITDHMLA 62

Query: 103 LRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILK 161
           +   D  +IV+  GI   P   + ++ +    G+L D +     +    +L +   QI K
Sbjct: 63  MGSLDHAYIVRLLGIC--PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAK 120

Query: 162 GLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
           G+ YL  H+++HR++   N+L+  ++  V+IADFGV+ ++         Y     Y   E
Sbjct: 121 GMYYLEEHRMVHRNLAARNILL-KSDSIVQIADFGVADLL---------YPDDKKYFYSE 170

Query: 222 RFDP-------DAYGGNYNGYAGDIWSLGLTLLELY-LGHFPF--LQPGQRPD 264
              P           G Y  +  D+WS G+T+ E+   G  P+  ++P + PD
Sbjct: 171 HKTPIKWMALESILFGRYT-HQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD 222

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 70.1 bits (172), Expect = 6e-14
 Identities = 57/227 (25%), Positives = 94/227 (41%), Gaps = 42/227 (18%)

Query: 59  LGHGNGGTVYK---VQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           LG G+ G V +             A+K +  D    +     +E  I+   D   +++ +
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 116 GIFEKPSGDIAILMEYMDSGTL-DTL-LNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
           G+       + ++ E    G+L D L  +  G F    L   A QI  G+ YL   + IH
Sbjct: 63  GVVLTHP--LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIH 120

Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGT-------CAYMSPE----- 221
           RD+   N+L+ +++ +VKI DFG+     R+L     +           A+ +PE     
Sbjct: 121 RDLAARNILLASDD-KVKIGDFGLM----RALPQNEDHYVMEEHLKVPFAWCAPESLRTR 175

Query: 222 RFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATL 268
            F           +A D+W  G+TL E+    F +   G+ P WA L
Sbjct: 176 TFS----------HASDVWMFGVTLWEM----FTY---GEEP-WAGL 204

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 69.9 bits (171), Expect = 8e-14
 Identities = 58/216 (26%), Positives = 105/216 (48%), Gaps = 21/216 (9%)

Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           L+ ++ LG G  G V+   +    K+    +  G   P        E  ++++   P +V
Sbjct: 8   LKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA---FLAEANLMKQLQHPRLV 64

Query: 113 QCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGT-FSEPKLAHIASQILKGLSYLHGHK 170
           + + +  +    I I+ EYM++G+L D L    G   +  KL  +A+QI +G++++    
Sbjct: 65  RLYAVVTQEP--IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN 122

Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDAYG 229
            IHRD++ +N+LV +  +  KIADFG+++++       N Y        P ++  P+A  
Sbjct: 123 YIHRDLRAANILV-SETLCCKIADFGLARLI-----EDNEYTAREGAKFPIKWTAPEAI- 175

Query: 230 GNYNGYA--GDIWSLGLTLLELY-LGHFPFLQPGQR 262
            NY  +    D+WS G+ L E+   G  P+  PG  
Sbjct: 176 -NYGTFTIKSDVWSFGILLTEIVTYGRIPY--PGMT 208

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 69.6 bits (170), Expect = 1e-13
 Identities = 63/270 (23%), Positives = 114/270 (42%), Gaps = 50/270 (18%)

Query: 52  DLEKL---QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVF-REMEILRRTD 107
           +L+KL   +++G G  G V + ++  T +  A+K +  D    V  Q F  E  ++ +  
Sbjct: 4   NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD----VTAQAFLEETAVMTKLH 57

Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTF--SEPKLAHIASQILKGLSY 165
              +V+  G+       + I+ME M  G L   L   G    S  +L   +  + +G+ Y
Sbjct: 58  HKNLVRLLGVILHNG--LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEY 115

Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDP 225
           L   K++HRD+   N+LV+ + +  K++DFG++++    +D     V   A        P
Sbjct: 116 LESKKLVHRDLAARNILVSEDGV-AKVSDFGLARVGSMGVDNSKLPVKWTA--------P 166

Query: 226 DAYGGNYNGYAGDIWSLGLTLLELY-LGHFPF-----------LQPGQRPDWATLMCAIC 273
           +A          D+WS G+ L E++  G  P+           ++ G R           
Sbjct: 167 EALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM---------- 216

Query: 274 FGDPPSLPDGASPEFRSFIECCLQKEFSKR 303
             +P   P+G   +    +  C + E  KR
Sbjct: 217 --EP---PEGCPADVYVLMTSCWETEPKKR 241

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 54/165 (32%), Positives = 72/165 (43%), Gaps = 15/165 (9%)

Query: 93  RRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKL 152
           R     E  ILR  + P I+Q  G F        IL  Y     L   L      +   +
Sbjct: 127 RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD--LYCYLAAKRNIAICDI 184

Query: 153 AHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD-ACNSY 211
             I   +L+ + YLH ++IIHRDIK  N+ +N+    V + DFG +   C  +D   N Y
Sbjct: 185 LAIERSVLRAIQYLHENRIIHRDIKAENIFINHPG-DVCLGDFGAA---CFPVDINANKY 240

Query: 212 ---VGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGH 253
               GT A  +PE    D YG      A DIWS G+ L E+   H
Sbjct: 241 YGWAGTIATNAPELLARDPYGP-----AVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 69.9 bits (171), Expect = 2e-13
 Identities = 36/97 (37%), Positives = 49/97 (50%), Gaps = 11/97 (11%)

Query: 155 IASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSY--V 212
           I  QIL+GL YLH  +IIHRD+K  N+ +N+ + QV I D G ++     + A       
Sbjct: 162 IEKQILEGLRYLHAQRIIHRDVKTENIFINDVD-QVCIGDLGAAQF---PVVAPAFLGLA 217

Query: 213 GTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLEL 249
           GT    +PE    D Y         DIWS G+ L E+
Sbjct: 218 GTVETNAPEVLARDKYNSK-----ADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 68.8 bits (168), Expect = 3e-13
 Identities = 70/283 (24%), Positives = 123/283 (43%), Gaps = 51/283 (18%)

Query: 57  QVLGHGNGGTVYK-----VQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
           + LG G  G V K     ++ R  +   A+K++  +A  +  R +  E  +L++ + P +
Sbjct: 6   KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65

Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLL-----------NKNGTFSEPKLAH------ 154
           ++ +G   +  G + +++EY   G+L + L             +G  +   L +      
Sbjct: 66  IKLYGACSQ-DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124

Query: 155 -------IASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA 207
                   A QI +G+ YL   K++HRD+   N+LV     ++KI+DFG+S    R +  
Sbjct: 125 TMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGR-KMKISDFGLS----RDVYE 179

Query: 208 CNSYVG------TCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELY-LGHFPFLQPG 260
            +SYV          +M+ E      Y         D+WS G+ L E+  LG  P+  PG
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDHIYTTQ-----SDVWSFGVLLWEIVTLGGNPY--PG 232

Query: 261 QRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKR 303
             P+   L   +  G     P+  S E  + +  C ++E  KR
Sbjct: 233 IAPE--RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKR 273

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 68.1 bits (166), Expect = 4e-13
 Identities = 69/265 (26%), Positives = 124/265 (46%), Gaps = 24/265 (9%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT- 106
           I    ++ ++ LG G  G V+   +  + K+    +  G    T+  Q F E   L +T 
Sbjct: 3   IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG----TMSVQAFLEEANLMKTL 58

Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLL--NKNGTFSEPKLAHIASQILKGLS 164
               +V+ + +  K    I I+ EYM  G+L   L  ++ G    PKL   ++QI +G++
Sbjct: 59  QHDKLVRLYAVVTKEE-PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 117

Query: 165 YLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD 224
           Y+     IHRD++ +N+LV+ + M  KIADFG+++++       N Y        P ++ 
Sbjct: 118 YIERKNYIHRDLRAANVLVSESLM-CKIADFGLARVI-----EDNEYTAREGAKFPIKWT 171

Query: 225 -PDAYGGNYNGYA--GDIWSLGLTLLELY-LGHFPFLQPGQRPDWATLMCAICFGDPPSL 280
            P+A   N+  +    D+WS G+ L E+   G  P+  PG     + +M A+  G     
Sbjct: 172 APEAI--NFGSFTIKSDVWSFGILLYEIVTYGKIPY--PGMSN--SDVMSALQRGYRMPR 225

Query: 281 PDGASPEFRSFIECCLQKEFSKRWT 305
            +    E    ++ C +++  +R T
Sbjct: 226 MENCPDELYDIMKTCWKEKAEERPT 250

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 68.5 bits (167), Expect = 5e-13
 Identities = 62/247 (25%), Positives = 111/247 (44%), Gaps = 19/247 (7%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIV 112
           + L+ +G G  G V         +  A+K +     + T  ++ +RE+ +++  +   I+
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 86

Query: 113 QCFGIFEKPSG-----DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F          D+ I+ME MD+     +  +       +++++  Q+L G+ +LH
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLH 143

Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDA 227
              IIHRD+KPSN++V  ++  +KI DFG+++    S      YV T  Y +PE      
Sbjct: 144 SAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMG 201

Query: 228 YGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP-PSLPDGASP 286
           Y  N      DIWS+G  + E+  G   F        W  ++  +  G P P       P
Sbjct: 202 YKENV-----DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL--GTPCPEFMKKLQP 254

Query: 287 EFRSFIE 293
             R+++E
Sbjct: 255 TVRTYVE 261

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 67.1 bits (164), Expect = 7e-13
 Identities = 49/207 (23%), Positives = 99/207 (47%), Gaps = 18/207 (8%)

Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIF 118
           LG G  G V++   +   ++ A+K++  D D   ++   +E++ L+R     ++  F + 
Sbjct: 14  LGSGYFGEVWEGLWKNRVRV-AIKILKSD-DLLKQQDFQKEVQALKRLRHKHLISLFAVC 71

Query: 119 EKPSGDIAILMEYMDSGTLDTLLN--KNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDI 176
                 + I+ E M+ G+L   L   +        L  +A Q+ +G++YL     IHRD+
Sbjct: 72  SV-GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDL 130

Query: 177 KPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYA 236
              N+LV   ++  K+ADFG+++++   +   +       + +PE         ++  ++
Sbjct: 131 AARNILV-GEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPE-------AASHGTFS 182

Query: 237 --GDIWSLGLTLLELYL-GHFPFLQPG 260
              D+WS G+ L E++  G  P+  PG
Sbjct: 183 TKSDVWSFGILLYEMFTYGQVPY--PG 207

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 67.4 bits (165), Expect = 8e-13
 Identities = 60/202 (29%), Positives = 86/202 (42%), Gaps = 35/202 (17%)

Query: 127 ILMEYMDSGTLDTLL--------NKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKP 178
           +L  YM+ G L   L        N     S  +L H+A QI  G+SYLH   +IH+DI  
Sbjct: 86  VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAA 145

Query: 179 SNLLVNNNNMQVKIADFGVSKIMCRSL---------DACNSYVGTCAYMSPERFDPDAYG 229
            N ++ +  +QVKI D  +S    R L         D  N  V    +M+ E      Y 
Sbjct: 146 RNCVI-DEELQVKITDNALS----RDLFPMDYHCLGDNENRPV---KWMALESLVNKEY- 196

Query: 230 GNYNGYAGDIWSLGLTLLELY-LGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEF 288
                 A D+WS G+ L EL  LG  P+++       A L        P + PD    E 
Sbjct: 197 ----SSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPINCPD----EL 248

Query: 289 RSFIECCLQKEFSKRWTASQLL 310
            + + CC   +  +R + SQL+
Sbjct: 249 FAVMACCWALDPEERPSFSQLV 270

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 68.1 bits (166), Expect = 9e-13
 Identities = 82/319 (25%), Positives = 130/319 (40%), Gaps = 65/319 (20%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFR---EMEILRRTD 107
           S   K++ LG G  G V   +   T  +YA+K +    D  +R QV     E +IL   D
Sbjct: 1   SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLR-KKDVLLRNQVAHVKAERDILAEAD 59

Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
           + ++V+ +  F+    ++  +M+Y+  G + +LL + G F E       +++   +  +H
Sbjct: 60  NEWVVRLYYSFQDKD-NLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVH 118

Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGV---------SKIM----------------- 201
               IHRDIKP N+L++ +   +K+ DFG+         SK                   
Sbjct: 119 KMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEW 177

Query: 202 -----CRSLDA----------------CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIW 240
                CR  D                  +S VGT  Y++PE      Y         D W
Sbjct: 178 GDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY-----TQLCDWW 232

Query: 241 SLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA--SPEFRSFIE--CCL 296
           S+G+ L E+ +G  PFL   Q P   T M  I +     +P  A  SPE    I   C  
Sbjct: 233 SVGVILYEMLVGQPPFL--AQTP-LETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRG 289

Query: 297 QKEFSKRWTASQLLTHPFL 315
            ++   +  A ++  HPF 
Sbjct: 290 PEDRLGKNGADEIKAHPFF 308

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 66.6 bits (162), Expect = 9e-13
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 19/207 (9%)

Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIF 118
           LG G  G V+      T K+    +  G   P       +E +I+++     +V  + + 
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP---EAFLQEAQIMKKLRHDKLVPLYAVV 70

Query: 119 -EKPSGDIAILMEYMDSGTL-DTLLNKNGTFSE-PKLAHIASQILKGLSYLHGHKIIHRD 175
            E+P   I I+ E+M  G+L D L   +G + + P+L  +A+QI  G++Y+     IHRD
Sbjct: 71  SEEP---IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127

Query: 176 IKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDAYGGNYNG 234
           ++ +N+LV  +N+  KIADFG+++++       N Y        P ++  P+A       
Sbjct: 128 LRAANILV-GDNLVCKIADFGLARLI-----EDNEYTARQGAKFPIKWTAPEAALYGRFT 181

Query: 235 YAGDIWSLGLTLLELYL-GHFPFLQPG 260
              D+WS G+ L EL   G  P+  PG
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPY--PG 206

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 66.7 bits (163), Expect = 1e-12
 Identities = 55/232 (23%), Positives = 96/232 (41%), Gaps = 35/232 (15%)

Query: 47  AIAYSDLEKLQVLGHGNGGTVY--KVQHRCTHKIYAL---KVVHGDADPTVRRQVFREME 101
           A   S+L+++  LG G  G V+  K +         L   K +    D  ++ +  RE++
Sbjct: 1   AFPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELD 60

Query: 102 ILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLL---------NKNGTFSEPKL 152
           + R+     +V+  G+  +      IL EY D G L   L          K    S  + 
Sbjct: 61  MFRKLSHKNVVRLLGLCREAEPHYMIL-EYTDLGDLKQFLRATKSKDEKLKPPPLSTKQK 119

Query: 153 AHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNS-- 210
             + +QI  G+ +L   + +HRD+   N LV++   +VK++   +SK      D  NS  
Sbjct: 120 VALCTQIALGMDHLSNARFVHRDLAARNCLVSSQR-EVKVSLLSLSK------DVYNSEY 172

Query: 211 --YVGTCA---YMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELY-LGHFPF 256
                      +++PE    D +         D+WS G+ + E++  G  PF
Sbjct: 173 YKLRNALIPLRWLAPEAVQEDDFSTK-----SDVWSFGVLMWEVFTQGELPF 219

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 66.2 bits (161), Expect = 1e-12
 Identities = 44/142 (30%), Positives = 78/142 (54%), Gaps = 16/142 (11%)

Query: 125 IAILMEYMDSGTL-DTLLNKNGTFSE-PKLAHIASQILKGLSYLHGHKIIHRDIKPSNLL 182
           I I+ E+M  G+L D L +  G+    PKL   ++QI +G++++     IHRD++ +N+L
Sbjct: 75  IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL 134

Query: 183 VNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDAYGGNYNGYA--GDI 239
           V + ++  KIADFG+++++       N Y        P ++  P+A   N+  +    D+
Sbjct: 135 V-SASLVCKIADFGLARVI-----EDNEYTAREGAKFPIKWTAPEAI--NFGSFTIKSDV 186

Query: 240 WSLGLTLLELY-LGHFPFLQPG 260
           WS G+ L+E+   G  P+  PG
Sbjct: 187 WSFGILLMEIVTYGRIPY--PG 206

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 66.7 bits (162), Expect = 2e-12
 Identities = 62/249 (24%), Positives = 113/249 (45%), Gaps = 23/249 (9%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIV 112
           + L+ +G G  G V         +  A+K +     + T  ++ +RE+ +++  +   I+
Sbjct: 20  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79

Query: 113 QCFGIFEKPSG-----DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F          D+ ++ME MD+     +  +       +++++  Q+L G+ +LH
Sbjct: 80  SLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLH 136

Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDA 227
              IIHRD+KPSN++V  ++  +KI DFG+++    S      YV T  Y +PE      
Sbjct: 137 SAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMG 194

Query: 228 YGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQR--PDWATLMCAICFGDP-PSLPDGA 284
           Y  N      DIWS+G  + E+      F  PG+     W  ++  +  G P P      
Sbjct: 195 YKENV-----DIWSVGCIMGEMVRHKILF--PGRDYIDQWNKVIEQL--GTPCPEFMKKL 245

Query: 285 SPEFRSFIE 293
            P  R+++E
Sbjct: 246 QPTVRNYVE 254

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 66.2 bits (161), Expect = 2e-12
 Identities = 64/236 (27%), Positives = 100/236 (42%), Gaps = 40/236 (16%)

Query: 47  AIAYSDLEKLQVLGHGNGGTVYKVQHR--CTHKIYALKVVHGDADPTVRRQVFREMEIL- 103
            + ++D++   V+G GN G V K + +        A+K +   A     R    E+E+L 
Sbjct: 3   VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 62

Query: 104 RRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN----------------GTF 147
           +    P I+   G  E   G + + +EY   G L   L K+                 T 
Sbjct: 63  KLGHHPNIINLLGACEH-RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 121

Query: 148 SEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA 207
           S  +L H A+ + +G+ YL   + IHRD+   N+LV  N +  KIADFG+S+        
Sbjct: 122 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV-AKIADFGLSR-------G 173

Query: 208 CNSYVGTCA------YMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELY-LGHFPF 256
              YV          +M+ E  +   Y  N      D+WS G+ L E+  LG  P+
Sbjct: 174 QEVYVKKTMGRLPVRWMAIESLNYSVYTTN-----SDVWSYGVLLWEIVSLGGTPY 224

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 65.9 bits (160), Expect = 3e-12
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 24/208 (11%)

Query: 59  LGHGNGGTVYKVQHR--CTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           +G G  G VYK + +     K YALK + G     +     RE+ +LR    P ++    
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQK 65

Query: 117 IFEKPSG-DIAILMEYMDSGTLDTLLNKNGTFSEPK--------LAHIASQILKGLSYLH 167
           +F   S   + +L +Y +      +     + +  K        +  +  QIL G+ YLH
Sbjct: 66  VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125

Query: 168 GHKIIHRDIKPSNLLVNNNNMQ---VKIADFGVSKIM---CRSLDACNSYVGTCAYMSPE 221
            + ++HRD+KP+N+LV     +   VKIAD G +++     + L   +  V T  Y +PE
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185

Query: 222 RFDPDAYGGNYNGYAGDIWSLGLTLLEL 249
                  G  +   A DIW++G    EL
Sbjct: 186 LL----LGARHYTKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 65.5 bits (159), Expect = 4e-12
 Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 24/208 (11%)

Query: 59  LGHGNGGTVYKVQHR--CTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           +G G  G VYK + +     + YALK + G     +     RE+ +LR    P ++    
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQK 65

Query: 117 IF-EKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPK--------LAHIASQILKGLSYLH 167
           +F       + +L +Y +      +     + +  K        +  +  QIL G+ YLH
Sbjct: 66  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125

Query: 168 GHKIIHRDIKPSNLLVNNNNMQ---VKIADFGVSKIM---CRSLDACNSYVGTCAYMSPE 221
            + ++HRD+KP+N+LV     +   VKIAD G +++     + L   +  V T  Y +PE
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185

Query: 222 RFDPDAYGGNYNGYAGDIWSLGLTLLEL 249
                  G  +   A DIW++G    EL
Sbjct: 186 LL----LGARHYTKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 65.6 bits (160), Expect = 6e-12
 Identities = 49/178 (27%), Positives = 78/178 (43%), Gaps = 16/178 (8%)

Query: 81  LKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTL 140
           +K V G   P       RE++IL+      I+     +   S    ++ +Y     L T 
Sbjct: 124 VKAVTGGKTPG------REIDILKTISHRAIINLIHAYRWKSTVCMVMPKY--KCDLFTY 175

Query: 141 LNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVS-K 199
           ++++G     +   I  ++L+ L+YLHG  IIHRD+K  N+ ++     V + DFG + K
Sbjct: 176 VDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAV-LGDFGAACK 234

Query: 200 I-MCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPF 256
           +        C  + GT    SPE    D Y         DIWS GL L E+ + +   
Sbjct: 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAK-----TDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 65.0 bits (158), Expect = 6e-12
 Identities = 51/162 (31%), Positives = 78/162 (48%), Gaps = 20/162 (12%)

Query: 158 QILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGT--- 214
           Q+ KG+ +L   K IHRD+   N+L++ NN+ VKI DFG+++ + +  D    YV     
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLSENNV-VKICDFGLARDIYKDPD----YVRKGDA 241

Query: 215 ---CAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELY-LGHFPFLQPGQRPDWATLMC 270
                +M+PE      Y         D+WS G+ L E++ LG  P+  PG + D      
Sbjct: 242 RLPLKWMAPETIFDRVY-----TIQSDVWSFGVLLWEIFSLGASPY--PGVKID-EEFCR 293

Query: 271 AICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH 312
            +  G     PD  +PE    +  C   E S+R T S+L+ H
Sbjct: 294 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 64.3 bits (156), Expect = 7e-12
 Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 34/213 (15%)

Query: 59  LGHGNGGTVYK------VQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           LG G+ G VY+      V+     ++ A+K V+  A    R +   E  +++  +   +V
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRV-AIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNK-------NGTFSEP---KLAHIASQILKG 162
           +  G+  +    + I ME M  G L + L         N   + P   K+  +A +I  G
Sbjct: 73  RLLGVVSQGQPTLVI-MELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131

Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSY------VGTCA 216
           ++YL+ +K +HRD+   N +V   +  VKI DFG    M R +   + Y      +    
Sbjct: 132 MAYLNANKFVHRDLAARNCMV-AEDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPVR 186

Query: 217 YMSPERFDPDAYGGNYNGYAGDIWSLGLTLLEL 249
           +MSPE      +         D+WS G+ L E+
Sbjct: 187 WMSPESLKDGVFTTY-----SDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 78/323 (24%), Positives = 131/323 (40%), Gaps = 74/323 (22%)

Query: 55  KLQV-LGHG--NGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF- 110
           +LQV +G G  N  +VY  +H  T  +  +++   +       +  +   +L    S F 
Sbjct: 1   ELQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVL----SHFF 56

Query: 111 ----IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLS 164
               I+  + +F   S  + ++  +M  G+ ++LL        SE  + +I    L+GL+
Sbjct: 57  RHPNIMTSWTVFTTGSW-LWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLN 115

Query: 165 YLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR---------SLDACNSYVGTC 215
           YLH +  IHR+IK S++L++ + +   ++  G+S +              D         
Sbjct: 116 YLHQNGYIHRNIKASHILISGDGL---VSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVL 172

Query: 216 AYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPF---------LQPGQRPDWA 266
            ++SPE    D YG N      DI+S+G+T  EL  G  PF         LQ  + P ++
Sbjct: 173 PWLSPELLRQDLYGYNVK---SDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYS 229

Query: 267 TLMCAI--CFGDP--------------------------------PSLPDGASPEFRSFI 292
            L      C                                    PS     SP F++ +
Sbjct: 230 PLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPS-SKTFSPAFQNLV 288

Query: 293 ECCLQKEFSKRWTASQLLTHPFL 315
           E CLQ++  KR +AS LL+H F 
Sbjct: 289 ELCLQQDPEKRPSASSLLSHAFF 311

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 63.2 bits (154), Expect = 2e-11
 Identities = 71/291 (24%), Positives = 115/291 (39%), Gaps = 64/291 (21%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHK-----IYALKVVHGDADPTVRRQVFREMEILRR 105
             L   + LG G  G V K +             A+K++  DA       +  EME+++ 
Sbjct: 12  DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71

Query: 106 T-DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN----------------GTFS 148
                 I+   G+  +  G + +++EY   G L   L                    T +
Sbjct: 72  IGKHKNIINLLGVCTQ-EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130

Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  L   A Q+ +G+ +L   K IHRD+   N+LV  +++ +KIADFG++    R +   
Sbjct: 131 QKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHV-MKIADFGLA----RDIHHI 185

Query: 209 NSYVGT------CAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELY-LGHFP------ 255
           + Y  T        +M+PE      Y      +  D+WS G+ L E++ LG  P      
Sbjct: 186 DYYRKTTNGRLPVKWMAPEALFDRVY-----THQSDVWSFGVLLWEIFTLGGSPYPGIPV 240

Query: 256 -----FLQPGQR---PDWAT-----LMCAICFGDPPSLPDGASPEFRSFIE 293
                 L+ G R   P   T     LM   C+ + PS      P F+  +E
Sbjct: 241 EELFKLLKEGYRMEKPQNCTQELYHLMRD-CWHEVPS----QRPTFKQLVE 286

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 62.9 bits (153), Expect = 3e-11
 Identities = 69/263 (26%), Positives = 115/263 (43%), Gaps = 19/263 (7%)

Query: 57  QVLGHGNGG-----TVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF- 110
           + LG G  G     T Y +         A+K++   A  + R  +  E++I+    +   
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100

Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNG-TFSEPK-LAHIASQILKGLSYLHG 168
           IV   G      G I ++ EY   G L   L +   +F   + L   + Q+ KG+++L  
Sbjct: 101 IVNLLGACTI-GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS 159

Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDA 227
              IHRD+   N+L+ +  + VKI DFG+++ IM  S    N  V   A +  +   P++
Sbjct: 160 KNCIHRDLAARNVLLTHGKI-VKICDFGLARDIMNDS----NYVVKGNARLPVKWMAPES 214

Query: 228 YGGNYNGYAGDIWSLGLTLLELY-LGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP 286
                  +  D+WS G+ L E++ LG  P+  PG   D +     I  G   + P+ A  
Sbjct: 215 IFNCVYTFESDVWSYGILLWEIFSLGSNPY--PGMPVD-SKFYKLIKEGYRMAQPEHAPA 271

Query: 287 EFRSFIECCLQKEFSKRWTASQL 309
           E    ++ C   +  KR T  Q+
Sbjct: 272 EIYDIMKTCWDADPLKRPTFKQI 294

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 62.8 bits (153), Expect = 3e-11
 Identities = 49/176 (27%), Positives = 85/176 (48%), Gaps = 17/176 (9%)

Query: 90  PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG-----DIAILMEYMDSGTLDTLLNKN 144
            T  ++ +RE+ +++  +   I+    +F          D+ ++ME MD+     +    
Sbjct: 56  VTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI---Q 112

Query: 145 GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS 204
                 +++++  Q+L G+ +LH   IIHRD+KPSN++V  ++  +KI DFG+++    S
Sbjct: 113 MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTS 171

Query: 205 LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPG 260
                 YV T  Y +PE      Y  N      DIWS+G  + E+  G   F  PG
Sbjct: 172 F-MMTPYVVTRYYRAPEVILGMGYKENV-----DIWSVGCIMGEMIRGTVLF--PG 219

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 61.6 bits (149), Expect = 8e-11
 Identities = 64/229 (27%), Positives = 97/229 (42%), Gaps = 32/229 (13%)

Query: 50  YSDLEKLQVLGHGNGGTVYK--VQHRCTHKIYALKVVHGDADPTVRRQVFREMEIL-RRT 106
           + D++   V+G GN G V +  ++        A+K++   A     R    E+E+L +  
Sbjct: 1   WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLG 60

Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN----------------GTFSEP 150
             P I+   G  E   G + I +EY   G L   L K+                 T +  
Sbjct: 61  HHPNIINLLGACEN-RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119

Query: 151 KLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNS 210
           +L   AS +  G+ YL   + IHRD+   N+LV   N+  KIADFG+S+           
Sbjct: 120 QLLQFASDVATGMQYLSEKQFIHRDLAARNVLV-GENLASKIADFGLSR-------GEEV 171

Query: 211 YVGTCAYMSPERFDPDAYGGNYNGYA--GDIWSLGLTLLELY-LGHFPF 256
           YV       P R+       NY+ Y    D+WS G+ L E+  LG  P+
Sbjct: 172 YVKKTMGRLPVRWMA-IESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY 219

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 36/99 (36%), Positives = 56/99 (56%), Gaps = 11/99 (11%)

Query: 158 QILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC---RSLDACNSYVGT 214
           Q+ + L+Y+H   I HRD+KP NLL++ N   +K+ DFG +K +    RS+    SY+ +
Sbjct: 178 QLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV----SYICS 233

Query: 215 CAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGH 253
             Y +PE         NY  +  D+WSLG  + E+ LG+
Sbjct: 234 RFYRAPELM---LGATNYTTHI-DLWSLGCIIAEMILGY 268

Length = 440

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 57/224 (25%), Positives = 93/224 (41%), Gaps = 26/224 (11%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTH-----KIYALKVVHGDADPTVRRQVFREMEI 102
           I  S +  ++ LG    G VYK     T      +  A+K +   A+  +R +   E  +
Sbjct: 2   INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMM 61

Query: 103 LRRTDSPFIVQCFGIFEK-----------PSGDIA--ILME--YMDSGTLDTLLNKNGTF 147
             R   P IV   G+  K              D+   ++M   + D G+ D       T 
Sbjct: 62  RSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTL 121

Query: 148 SEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA 207
                 HI +QI  G+ +L  H ++H+D+   N+LV  + + VKI+D G    + R + A
Sbjct: 122 EPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV-FDKLNVKISDLG----LFREVYA 176

Query: 208 CNSYVGTCAYMSPERF-DPDAYGGNYNGYAGDIWSLGLTLLELY 250
            + Y      + P R+  P+A          DIWS G+ L E++
Sbjct: 177 ADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVF 220

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 52/168 (30%), Positives = 80/168 (47%), Gaps = 36/168 (21%)

Query: 158 QILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYV--GTC 215
           Q+ +G+ +L   K IHRD+   N+L++ NN+ VKI DFG+++ + +  D    YV  G+ 
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLSENNV-VKICDFGLARDIYKDPD----YVRKGSA 236

Query: 216 ----AYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELY-LGHFPFLQPG--------QR 262
                +M+PE      Y         D+WS G+ L E++ LG  P+  PG        QR
Sbjct: 237 RLPLKWMAPESIFDKVYTTQ-----SDVWSFGVLLWEIFSLGASPY--PGVQINEEFCQR 289

Query: 263 PDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLL 310
               T M A         P+ A+PE    +  C Q +  +R T S L+
Sbjct: 290 LKDGTRMRA---------PENATPEIYRIMLACWQGDPKERPTFSALV 328

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 44/235 (18%)

Query: 56  LQVLGHGNGGTVY-KVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSPFIV 112
           ++++G G  G VY      C+ ++ ALK +  D   +P ++++  RE +I      P IV
Sbjct: 7   IRLIGKGGMGEVYLAYDPVCSRRV-ALKKIREDLSENPLLKKRFLREAKIAADLIHPGIV 65

Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-------------GTFSEPKLAHIASQI 159
             + I       +   M Y++  TL +LL K+              T S      I  +I
Sbjct: 66  PVYSI-CSDGDPVYYTMPYIEGYTLKSLL-KSVWQKESLSKELAEKT-SVGAFLSIFHKI 122

Query: 160 LKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK------------------IM 201
              + Y+H   ++HRD+KP N+L+     +V I D+G +                   I 
Sbjct: 123 CATIEYVHSKGVLHRDLKPDNILLGLFG-EVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181

Query: 202 CRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPF 256
             S+      VGT  YM+PER       G     + DI++LG+ L ++    FP+
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLL-----GVPASESTDIYALGVILYQMLTLSFPY 231

Length = 932

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 50/170 (29%), Positives = 77/170 (45%), Gaps = 36/170 (21%)

Query: 158 QILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGT--- 214
           Q+ +G+ +L   K IHRD+   N+L++ NN+ VKI DFG+++ + +  D    YV     
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILLSENNV-VKICDFGLARDIYKDPD----YVRKGDA 235

Query: 215 ---CAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELY-LGHFPFLQPG--------QR 262
                +M+PE      Y         D+WS G+ L E++ LG  P+  PG        +R
Sbjct: 236 RLPLKWMAPESIFDKVYTTQ-----SDVWSFGVLLWEIFSLGASPY--PGVQIDEEFCRR 288

Query: 263 PDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH 312
               T M A         P+ A+PE  S +  C       R T S+L+  
Sbjct: 289 LKEGTRMRA---------PEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 63/251 (25%), Positives = 103/251 (41%), Gaps = 47/251 (18%)

Query: 80  ALKVVHGDADPTVRRQVFREMEILRRTDS-PFIVQCFGIFEKPSGDIAILMEYMDSGTLD 138
           A+K++  DA       +  EME+++       I+   G   +  G + +++EY   G L 
Sbjct: 54  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASKGNLR 112

Query: 139 TLL----------------NKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLL 182
             L                      S   L   A Q+ +G+ YL   K IHRD+   N+L
Sbjct: 113 EYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 172

Query: 183 VNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF-DPDAYGGNYNGYAGDIWS 241
           V  +N+ +KIADFG++    R +   + Y  T     P ++  P+A       +  D+WS
Sbjct: 173 VTEDNV-MKIADFGLA----RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 227

Query: 242 LGLTLLELY-LGHFPF-----------LQPGQRPDWAT-------LMCAICFGDPPSLPD 282
            G+ L E++ LG  P+           L+ G R D  +       +M   C+   PS   
Sbjct: 228 FGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPS--- 284

Query: 283 GASPEFRSFIE 293
              P F+  +E
Sbjct: 285 -QRPTFKQLVE 294

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 59.6 bits (144), Expect = 4e-10
 Identities = 54/216 (25%), Positives = 98/216 (45%), Gaps = 34/216 (15%)

Query: 56  LQVLGHGNGGTVYK------VQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSP 109
           L+ LG G+ G VY+      ++     ++ A+K V+  A    R +   E  +++     
Sbjct: 11  LRELGQGSFGMVYEGNARDIIKGEAETRV-AVKTVNESASLRERIEFLNEASVMKGFTCH 69

Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLN------KNGTFSEP----KLAHIASQI 159
            +V+  G+  K    + ++ME M  G L + L       +N     P    ++  +A++I
Sbjct: 70  HVVRLLGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128

Query: 160 LKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSY------VG 213
             G++YL+  K +HRD+   N +V ++   VKI DFG    M R +   + Y      + 
Sbjct: 129 ADGMAYLNAKKFVHRDLAARNCMVAHDF-TVKIGDFG----MTRDIYETDYYRKGGKGLL 183

Query: 214 TCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLEL 249
              +M+PE        G +   + D+WS G+ L E+
Sbjct: 184 PVRWMAPESLK----DGVFTTSS-DMWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 59.6 bits (144), Expect = 5e-10
 Identities = 55/200 (27%), Positives = 89/200 (44%), Gaps = 27/200 (13%)

Query: 80  ALKVVHGDADPTVRRQVFREMEILRRTDS-PFIVQCFGIFEKPSGDIAILMEYMDSGTL- 137
           A+K++  DA       +  EME+++       I+   G   +  G + +L+EY   G L 
Sbjct: 48  AVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-DGPLYVLVEYASKGNLR 106

Query: 138 ---------------DTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLL 182
                          DT        +   L   A Q+ +G+ YL   K IHRD+   N+L
Sbjct: 107 EYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVL 166

Query: 183 VNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF-DPDAYGGNYNGYAGDIWS 241
           V  +N+ +KIADFG++    R +   + Y  T     P ++  P+A       +  D+WS
Sbjct: 167 VTEDNV-MKIADFGLA----RDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 221

Query: 242 LGLTLLELY-LGHFPFLQPG 260
            G+ L E++ LG  P+  PG
Sbjct: 222 FGVLLWEIFTLGGSPY--PG 239

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 59.9 bits (145), Expect = 5e-10
 Identities = 44/153 (28%), Positives = 64/153 (41%), Gaps = 11/153 (7%)

Query: 99  EMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIAS 157
           E  +LRR   P ++    +  +  G +  L+       L T L          ++  +A 
Sbjct: 210 EARLLRRLSHPAVLALLDV--RVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVAR 267

Query: 158 QILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM--CRSLDACNSYVGTC 215
           Q+L  + Y+HG  IIHRDIK  N+LVN     + + DFG +       S        GT 
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWSTPFHYGIAGTV 326

Query: 216 AYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLE 248
              +PE    D Y  +      DIWS GL + E
Sbjct: 327 DTNAPEVLAGDPYTPSV-----DIWSAGLVIFE 354

Length = 461

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 59.2 bits (143), Expect = 6e-10
 Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 37/205 (18%)

Query: 80  ALKVVHGDADPTVRRQVFREMEILRRTDS-PFIVQCFGIFEKPSGDIAILMEYMDSGTLD 138
           A+K++  +A       +  EME+++       I+   G+  +  G + +++EY   G L 
Sbjct: 48  AVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ-EGPLYVIVEYAAKGNLR 106

Query: 139 TLLN----------------KNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLL 182
             L                      S   L   A Q+ +G+ YL   + IHRD+   N+L
Sbjct: 107 EFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL 166

Query: 183 VNNNNMQVKIADFGVSKIMCRSLDACNSYVGT------CAYMSPERFDPDAYGGNYNGYA 236
           V  +N+ +KIADFG++    R +   + Y  T        +M+PE      Y      + 
Sbjct: 167 VTEDNV-MKIADFGLA----RGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY-----THQ 216

Query: 237 GDIWSLGLTLLELY-LGHFPFLQPG 260
            D+WS G+ + E++ LG  P+  PG
Sbjct: 217 SDVWSFGILMWEIFTLGGSPY--PG 239

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 58.4 bits (141), Expect = 7e-10
 Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 22/217 (10%)

Query: 57  QVLGHGNGGTVYKVQHRC---THKIYALKVVHGDADPTVR-RQVFREMEILRRTDSPFIV 112
           ++LG G  G+V + Q +    + +  A+K++  D   +    +  RE   ++  D P ++
Sbjct: 5   RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64

Query: 113 QCFGI--FEKPSGDIAILM---EYMDSGTLDTLLNKNGTFSEP------KLAHIASQILK 161
           +  G+    +  G + I M    +M  G L T L  +    EP       L      I  
Sbjct: 65  KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124

Query: 162 GLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
           G+ YL     IHRD+   N ++ N NM V +ADFG+SK     + + + Y   CA   P 
Sbjct: 125 GMEYLSSKNFIHRDLAARNCML-NENMTVCVADFGLSK----KIYSGDYYRQGCASKLPV 179

Query: 222 RFDP-DAYGGNYNGYAGDIWSLGLTLLELY-LGHFPF 256
           ++   ++   N      D+W+ G+T+ E+   G  P+
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY 216

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 58.4 bits (141), Expect = 8e-10
 Identities = 60/246 (24%), Positives = 103/246 (41%), Gaps = 26/246 (10%)

Query: 80  ALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDT 139
           A+  +        RR    E   L + D   IV+  G+  + +  + I+ EYM +G LD+
Sbjct: 37  AIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN-TMMIVTEYMSNGALDS 95

Query: 140 LLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVS 198
            L K+ G     +L  +   +  G+ YL     +H+ +    +LV N+++  KI+ F   
Sbjct: 96  FLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV-NSDLVCKISGFRRL 154

Query: 199 KIMCRSLDACNSYVGTCAYMSPERFD-PDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFL 257
           +      D   +   T +  SP  +  P+A   ++   A D+WS G+ + E+       +
Sbjct: 155 Q-----EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEV-------M 202

Query: 258 QPGQRPDW----ATLMCAI--CFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT 311
             G+RP W      ++ A+   F  P   P          +  C QKE  +R   SQ+  
Sbjct: 203 SYGERPYWDMSGQDVIKAVEDGFRLPA--PRNCPNLLHQLMLDCWQKERGERPRFSQI-- 258

Query: 312 HPFLCK 317
           H  L K
Sbjct: 259 HSILSK 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 59.3 bits (143), Expect = 8e-10
 Identities = 48/178 (26%), Positives = 85/178 (47%), Gaps = 10/178 (5%)

Query: 135 GTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIAD 194
              DTL+N++   S   L   + Q+  G+ +L     +HRD+   N+L+    + VKI D
Sbjct: 224 TRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKL-VKICD 282

Query: 195 FGVSKIMCRSLDACNSYVGTCAYMSPERF-DPDAYGGNYNGYAGDIWSLGLTLLELY-LG 252
           FG+++ + R     ++Y+   +   P ++  P++   N      D+WS G+ L E++ LG
Sbjct: 283 FGLARDIMRD----SNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLG 338

Query: 253 HFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLL 310
             P+    + P       AI  G   + P  AS E    ++ C +++F  R   SQL+
Sbjct: 339 GTPY---PELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLV 393

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 58.8 bits (142), Expect = 8e-10
 Identities = 56/226 (24%), Positives = 86/226 (38%), Gaps = 56/226 (24%)

Query: 148 SEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS--- 204
           SE  +A+I   +LK L Y+H    +HR +K S++L++ +  +V ++    +  M      
Sbjct: 99  SELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG-KVYLSGLRSNLSMINHGQR 157

Query: 205 ----LDACNSYVGTCAYMSPERFDPDAYGGNYNGY--AGDIWSLGLTLLELYLGHFPFLQ 258
                D     V    ++SPE         N  GY    DI+S+G+T  EL  GH PF  
Sbjct: 158 LRVVHDFPKYSVKVLPWLSPEVLQQ-----NLQGYDAKSDIYSVGITACELANGHVPFKD 212

Query: 259 ------------------------PGQ----RPDWATLMCAIC-----------FGDPPS 279
                                   P +    +P  +     +             G+  S
Sbjct: 213 MPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSS 272

Query: 280 LP--DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSDC 323
            P     SP F  F+E CLQ+    R +AS LL H F  + +R   
Sbjct: 273 HPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRAS 318

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 31/202 (15%)

Query: 80  ALKVVHGDADPTVRRQVFREMEILRRTDS-PFIVQCFGIFEKPSGDIAILMEYMDSGTLD 138
           A+K++  DA       +  EME+++       I+   G   +  G + +++EY   G L 
Sbjct: 51  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASKGNLR 109

Query: 139 TLL------------------NKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSN 180
             L                  ++  TF +  L     Q+ +G+ YL   K IHRD+   N
Sbjct: 110 EYLRARRPPGMEYSYDIARVPDEQMTFKD--LVSCTYQVARGMEYLASQKCIHRDLAARN 167

Query: 181 LLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF-DPDAYGGNYNGYAGDI 239
           +LV  NN+ +KIADFG++    R ++  + Y  T     P ++  P+A       +  D+
Sbjct: 168 VLVTENNV-MKIADFGLA----RDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 222

Query: 240 WSLGLTLLELY-LGHFPFLQPG 260
           WS G+ + E++ LG  P+  PG
Sbjct: 223 WSFGVLMWEIFTLGGSPY--PG 242

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 51/165 (30%), Positives = 79/165 (47%), Gaps = 20/165 (12%)

Query: 152 LAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNS 210
           L   +SQ+ +G+ +L     IHRD+   N+L+ +  +  KI DFG+++ IM  S    N 
Sbjct: 214 LLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRV-AKICDFGLARDIMNDS----NY 268

Query: 211 YVGTCA-----YMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELY-LGHFPFLQPGQRPD 264
            V   A     +M+PE      Y         D+WS G+ L E++ LG  P+  PG   +
Sbjct: 269 VVKGNARLPVKWMAPESIFDCVY-----TVQSDVWSYGILLWEIFSLGKSPY--PGILVN 321

Query: 265 WATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQL 309
            +     +  G   S PD A PE  S ++ C   E ++R T SQ+
Sbjct: 322 -SKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQI 365

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 56.6 bits (136), Expect = 3e-09
 Identities = 64/221 (28%), Positives = 93/221 (42%), Gaps = 32/221 (14%)

Query: 58  VLGHGNGGTVYK--VQHRCTHKIYALKVVHGDADPTVRRQVFREMEIL-RRTDSPFIVQC 114
           V+G GN G V K  ++        A+K +   A     R    E+E+L +    P I+  
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKN----------------GTFSEPKLAHIASQ 158
            G  E   G + + +EY   G L   L K+                 T S  +L H A+ 
Sbjct: 62  LGACEH-RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 159 ILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYM 218
           + +G+ YL   + IHRD+   N+LV   N   KIADFG+S+           YV      
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILV-GENYVAKIADFGLSR-------GQEVYVKKTMGR 172

Query: 219 SPERFDPDAYGGNYNGYA--GDIWSLGLTLLELY-LGHFPF 256
            P R+       NY+ Y    D+WS G+ L E+  LG  P+
Sbjct: 173 LPVRWMA-IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 212

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 56.2 bits (135), Expect = 4e-09
 Identities = 61/232 (26%), Positives = 100/232 (43%), Gaps = 43/232 (18%)

Query: 56  LQVLGHGNGGTVYK-------VQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS 108
           ++ LG    G +YK       + H    ++ A+K +    +P    +  +E  ++     
Sbjct: 10  MEELGECAFGKIYKGHLYLPGMDHA---QLVAIKTLKDINNPQQWGEFQQEASLMAELHH 66

Query: 109 PFIVQCFGIF--EKPSGDIAILMEYMDSGTLDTLL-------------NKNGTFSEP--- 150
           P IV   G+   E+P   + +L EY++ G L   L             +++GT       
Sbjct: 67  PNIVCLLGVVTQEQP---VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDH 123

Query: 151 -KLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN 209
               HIA QI  G+ YL  H  +H+D+   N+L+    + VKI+D G+S    R + + +
Sbjct: 124 GDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI-GEQLHVKISDLGLS----REIYSAD 178

Query: 210 SYVGTCAYMSPERF-DPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPF-LQP 259
            Y      + P R+  P+A          DIWS G+ L E+    F F LQP
Sbjct: 179 YYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEI----FSFGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 56.6 bits (136), Expect = 5e-09
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 12/173 (6%)

Query: 135 GTLDTLLNKNGT--FSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKI 192
             +  LL+ +G+   +   L     Q+ +G+ +L     +HRD+   N+L+    + VKI
Sbjct: 220 SEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKI-VKI 278

Query: 193 ADFGVSKIMCRSLDACNSYVGTCAYMSPERF-DPDAYGGNYNGYAGDIWSLGLTLLELY- 250
            DFG++    R +   ++YV   +   P ++  P++   N      D+WS G+ L E++ 
Sbjct: 279 CDFGLA----RDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Query: 251 LGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKR 303
           LG  P+  PG   D +T    I  G   + PD A+ E    +  C   E  KR
Sbjct: 335 LGGTPY--PGMIVD-STFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKR 384

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 56.6 bits (136), Expect = 6e-09
 Identities = 46/133 (34%), Positives = 63/133 (47%), Gaps = 15/133 (11%)

Query: 155 IASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN-SYVG 213
           I  Q+L  + Y+H  K+IHRDIK  N+ +N +   V + DFG +    +  +A +  +VG
Sbjct: 272 IMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIV-LGDFGTAMPFEKEREAFDYGWVG 330

Query: 214 TCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHF-PFLQPGQRPDWATL---- 268
           T A  SPE    D Y         DIWS GL LL++    F P    G +P    L    
Sbjct: 331 TVATNSPEILAGDGY-----CEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIID 385

Query: 269 ---MCAICFGDPP 278
              +C   F DPP
Sbjct: 386 SLSVCDEEFPDPP 398

Length = 501

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 54.9 bits (132), Expect = 1e-08
 Identities = 50/197 (25%), Positives = 83/197 (42%), Gaps = 32/197 (16%)

Query: 80  ALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGI-FEKPSGDIAILMEYMDSGTLD 138
           A+K +   A    +++  +E  ++   + P IV+  G+          I+ME M+ G L 
Sbjct: 30  AVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEP--QYIIMELMEGGDLL 87

Query: 139 TLLN--KNGTFSEP-----KLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQ-- 189
           + L   +   F  P     +L  I   + KG  YL     IHRD+   N LV+       
Sbjct: 88  SYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDAD 147

Query: 190 --VKIADFGVSKIMCRSLDACNSYVGT-------CAYMSPERFDPDAYGGNYNGYAGDIW 240
             VKI DFG+++ + +     + Y            +M+PE        G +   + D+W
Sbjct: 148 RVVKIGDFGLARDIYK-----SDYYRKEGEGLLPVRWMAPESL----LDGKFTTQS-DVW 197

Query: 241 SLGLTLLE-LYLGHFPF 256
           S G+ + E L LG  P+
Sbjct: 198 SFGVLMWEILTLGQQPY 214

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 37/221 (16%)

Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFRE---MEILRRTDS---- 108
           L +LG G  G V +   R   +  A+K+V     P   R    E   ME +R+ D     
Sbjct: 134 LSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV--PKYTRDAKIEIQFMEKVRQADPADRF 191

Query: 109 PFI-VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
           P + +Q +  F+  +G + I+M       LD ++ K+G FS   LA I  Q    L Y H
Sbjct: 192 PLMKIQRY--FQNETGHMCIVMPKYGPCLLDWIM-KHGPFSHRHLAQIIFQTGVALDYFH 248

Query: 168 GH-KIIHRDIKPSNLLVNNNNM---------------QVKIADFGVSKIMCRSLDACNSY 211
               ++H D+KP N+L+  ++                +V+I D G     C    +  + 
Sbjct: 249 TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC---CDERHSRTAI 305

Query: 212 VGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLG 252
           V T  Y SPE      +      Y+ D+WS+G  + ELY G
Sbjct: 306 VSTRHYRSPEVVLGLGWM-----YSTDMWSMGCIIYELYTG 341

Length = 467

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 51.6 bits (124), Expect = 3e-08
 Identities = 35/159 (22%), Positives = 66/159 (41%), Gaps = 19/159 (11%)

Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD--SPFIVQ 113
           +++L  G    VY +      + Y LK+         R +    +++L R     P ++ 
Sbjct: 3   IKLLKGGLTNRVYLL--GTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLA 60

Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI-- 171
                 +  G   +LME+++  TLD +       SE +   IA Q+ + L+ LH   +  
Sbjct: 61  SG----ESDGWSYLLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLV 109

Query: 172 -IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN 209
             H D+ P N+LV++    + I D+  +     + D   
Sbjct: 110 LCHGDLHPGNILVDDGK-ILGIIDWEYAGYGPPAFDLAA 147

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 52.1 bits (125), Expect = 9e-08
 Identities = 53/224 (23%), Positives = 92/224 (41%), Gaps = 20/224 (8%)

Query: 94  RQVFREMEILRRTDSPFIVQCFGIFEKPSGD---IAILMEYMDSGTLDTLLNKNGTFSEP 150
                E++ LRR DS  I++ +G       D   +++++EY   G L  +L+K    S  
Sbjct: 63  DITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFK 122

Query: 151 KLAHIASQILKGLSYLHGH-KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN 209
               +A    KGL  L+ +    ++++   + LV  N  ++KI   G+ KI+  S     
Sbjct: 123 TKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY-KLKIICHGLEKIL--SSPPFK 179

Query: 210 SYVGTCAYMSPERFDPDAYGGNYNGYA--GDIWSLGLTLLELYLGHFPFLQPGQRPDWAT 267
           + V    Y     F        ++ Y    DI+SLG+ L E++ G  PF    +      
Sbjct: 180 N-VNFMVY-----FSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF----ENLTTKE 229

Query: 268 LMCAICF-GDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLL 310
           +   I    +   LP     E +  +E C   +  KR    ++L
Sbjct: 230 IYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEIL 273

Length = 283

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 52.4 bits (125), Expect = 2e-07
 Identities = 26/52 (50%), Positives = 33/52 (63%), Gaps = 1/52 (1%)

Query: 155 IASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD 206
           +  Q+L GL  LH   I+HRDIKP NLLV  +  QVKI DFG +  MC  ++
Sbjct: 314 VMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGIN 364

Length = 507

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 50.5 bits (121), Expect = 3e-07
 Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 18/203 (8%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIY---ALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +V+G G+ G VY      +       A+K ++   D     Q  +E  I++    P ++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNK---NGTFSEPKLAHIASQILKGLSYLHGHK 170
             GI     G   +++ YM  G L   +     N T  +  L     Q+ KG+ YL   K
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKD--LIGFGLQVAKGMEYLASKK 118

Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGT---CAYMSPERFDPD 226
            +HRD+   N ++ + +  VK+ADFG+++ I  +   + +++ G      +M+ E     
Sbjct: 119 FVHRDLAARNCML-DESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177

Query: 227 AYGGNYNGYAGDIWSLGLTLLEL 249
            +         D+WS G+ L EL
Sbjct: 178 KFTTK-----SDVWSFGVLLWEL 195

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 49.5 bits (119), Expect = 4e-07
 Identities = 21/74 (28%), Positives = 41/74 (55%), Gaps = 6/74 (8%)

Query: 127 ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNN 186
           I+MEY++   L  L+N NG     +   ++ +I + +  LH   IIH D+  SN++++  
Sbjct: 76  IVMEYIEGEPLKDLINSNG----MEELELSREIGRLVGKLHSAGIIHGDLTTSNMILSGG 131

Query: 187 NMQVKIADFGVSKI 200
              + + DFG+++ 
Sbjct: 132 K--IYLIDFGLAEF 143

Length = 211

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 50.2 bits (120), Expect = 4e-07
 Identities = 49/224 (21%), Positives = 89/224 (39%), Gaps = 30/224 (13%)

Query: 57  QVLGHGNGGTVYKV---QHRCTHKIYALKVVHGDADPTVRRQV---FREMEILRRTDSPF 110
           ++LG G  G+V +    Q   +    A+K +    D     ++     E   ++  D P 
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTM--KLDIHTYSEIEEFLSEAACMKDFDHPN 62

Query: 111 IVQCFGI------FEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEP------KLAHIASQ 158
           +++  G+       +K    + IL  +M  G L + L  +     P       L      
Sbjct: 63  VMKLIGVCFEASSLQKIPKPMVIL-PFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVD 121

Query: 159 ILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYM 218
           I  G+ YL     IHRD+   N ++  + M V +ADFG+S    + + + + Y       
Sbjct: 122 IALGMEYLSNRNFIHRDLAARNCMLRED-MTVCVADFGLS----KKIYSGDYYRQGRIAK 176

Query: 219 SPERFDP-DAYGGNYNGYAGDIWSLGLTLLE-LYLGHFPFLQPG 260
            P ++   ++          D+W+ G+T+ E    G  P+  PG
Sbjct: 177 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY--PG 218

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 49.2 bits (117), Expect = 9e-07
 Identities = 47/191 (24%), Positives = 82/191 (42%), Gaps = 18/191 (9%)

Query: 81  LKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTL 140
           +K +   A    + +   E +  R      ++QC G   + +    ++ME+   G L   
Sbjct: 27  VKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVT-PYLLVMEFCPLGDLKGY 85

Query: 141 LN-----KNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADF 195
           L      +  T     L  +A +I  GL +LH +  IH D+   N L+   ++ VKI D+
Sbjct: 86  LRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLL-TADLTVKIGDY 144

Query: 196 GVSKIMCRS---LDACNSYVGTCAYMSPERFDPDAYGGNY----NGYAGDIWSLGLTLLE 248
           G+S    +    +     +V    +++PE    D   GN          ++WSLG+T+ E
Sbjct: 145 GLSHNKYKEDYYVTPDQLWV-PLRWIAPELV--DEVHGNLLVVDQTKESNVWSLGVTIWE 201

Query: 249 LY-LGHFPFLQ 258
           L+ LG  P+  
Sbjct: 202 LFELGSQPYRH 212

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 48.9 bits (116), Expect = 1e-06
 Identities = 43/180 (23%), Positives = 74/180 (41%), Gaps = 26/180 (14%)

Query: 97  FREMEILRRTDSPFIVQCFGI---------FEKPSGDIAILMEYMDSGTLDTLLNKNGTF 147
             E   ++  D P +++  G+         +  P     +++ +M  G L + L  +   
Sbjct: 48  LSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP----VVILPFMKHGDLHSFLLYSRLG 103

Query: 148 SEPK------LAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
             P+      L    + I  G+ YL     IHRD+   N ++ N NM V +ADFG+SK  
Sbjct: 104 DCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCML-NENMNVCVADFGLSK-- 160

Query: 202 CRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPG 260
            +  +      G  A M  +    ++          D+WS G+T+ E+   G  P+  PG
Sbjct: 161 -KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY--PG 217

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 46/160 (28%), Positives = 74/160 (46%), Gaps = 20/160 (12%)

Query: 158 QILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYV--GTC 215
           Q+ KG+S+L     IHRD+   N+L+ +  +  KI DFG++    R +   ++YV  G  
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRI-TKICDFGLA----RDIRNDSNYVVKGNA 276

Query: 216 ----AYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELY-LGHFPFLQPGQRPDWATLMC 270
                +M+PE      Y      +  D+WS G+ L E++ LG  P+  PG   D +    
Sbjct: 277 RLPVKWMAPESIFNCVY-----TFESDVWSYGILLWEIFSLGSSPY--PGMPVD-SKFYK 328

Query: 271 AICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLL 310
            I  G     P+ A  E    ++ C   +  KR T  Q++
Sbjct: 329 MIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIV 368

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 47.5 bits (113), Expect = 3e-06
 Identities = 47/200 (23%), Positives = 88/200 (44%), Gaps = 33/200 (16%)

Query: 125 IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVN 184
           + +++++ + G L + ++K     E  +   A++++  L  LH   I+ RD+ P+N+L++
Sbjct: 60  VFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD 119

Query: 185 NNNMQVKIADFGV-SKIMCRSLDACNSYVGTCAYMSPERFDPDAYGG-NYNGYAGDIWSL 242
           +    +++  F   S++     D+C+       Y +PE       GG +    A D WSL
Sbjct: 120 DRG-HIQLTYFSRWSEVE----DSCDGEAVENMYCAPE------VGGISEETEACDWWSL 168

Query: 243 GLTLLELYLGHFPFLQPGQRPDWATLMC---AICFGDPPSLPDGASPEFRSFIECCLQKE 299
           G  L EL  G               + C    I      ++P+  S E RS ++  LQ  
Sbjct: 169 GAILFELLTGK------------TLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFN 216

Query: 300 FSKRWTA-----SQLLTHPF 314
            ++R  A       + +HPF
Sbjct: 217 PTERLGAGVAGVEDIKSHPF 236

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 47.6 bits (113), Expect = 3e-06
 Identities = 37/129 (28%), Positives = 62/129 (48%), Gaps = 14/129 (10%)

Query: 127 ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNN 186
           IL+E +   T   +  +    ++  + +I   +L  L Y+H H I H DIKP N++V+ N
Sbjct: 104 ILLEKLVENT-KEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGN 162

Query: 187 NMQVKIADFGVS-------KIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDI 239
           N +  I D+G++       K +  S +  + + GT  Y        DA+ G      GD+
Sbjct: 163 N-RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAG-----LDAHNGACVTRRGDL 216

Query: 240 WSLGLTLLE 248
            SLG  +L+
Sbjct: 217 ESLGYCMLK 225

Length = 294

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 46.2 bits (110), Expect = 4e-06
 Identities = 34/177 (19%), Positives = 55/177 (31%), Gaps = 24/177 (13%)

Query: 144 NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR 203
               +E ++  +  Q L  L  LH        +   + L+            G       
Sbjct: 11  GRPLNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKL---------DGSVAFKTP 61

Query: 204 SLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQ-R 262
                        +M+PE     +Y         DI+SLG+TL E      P+ +  +  
Sbjct: 62  -----EQSRPDPYFMAPEVIQGQSYT-----EKADIYSLGITLYEALDYELPYNEERELS 111

Query: 263 PDWATL---MCAICFGDPPSL-PDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
                L   M A    D  +L    A+  F  F+  C  +   +R  A+  L H   
Sbjct: 112 AILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRA 168

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 46.1 bits (110), Expect = 5e-06
 Identities = 18/74 (24%), Positives = 38/74 (51%), Gaps = 9/74 (12%)

Query: 127 ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNN 186
           I+MEY++   L  ++ +           +  +I + +  LH   I+H D+  SN++V ++
Sbjct: 74  IVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVRDD 126

Query: 187 NMQVKIADFGVSKI 200
             ++ + DFG+ K 
Sbjct: 127 --KLYLIDFGLGKY 138

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 46.8 bits (111), Expect = 5e-06
 Identities = 38/181 (20%), Positives = 80/181 (44%), Gaps = 16/181 (8%)

Query: 81  LKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG--IFEKPSGDIAILMEYMDSGTLD 138
           +K +  +A    + +  ++ +  R    P I+QC G  +   P     ++ EY + G L 
Sbjct: 27  VKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIP---YLLVFEYCELGDLK 83

Query: 139 TLLN----KNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIAD 194
           + L+             L  +A +I  G++++H H  +H D+   N  + ++ + VK+ D
Sbjct: 84  SYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSD-LTVKVGD 142

Query: 195 FGV--SKIMCRSLDACNSYVGTCAYMSPE---RFDPDAYGGNYNGYAGDIWSLGLTLLEL 249
           +G+  S+     ++  +       +++PE    F              ++W+LG+TL EL
Sbjct: 143 YGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKP-SNVWALGVTLWEL 201

Query: 250 Y 250
           +
Sbjct: 202 F 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 45.6 bits (108), Expect = 1e-05
 Identities = 42/184 (22%), Positives = 80/184 (43%), Gaps = 21/184 (11%)

Query: 81  LKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG--IFEKPSGDIAILMEYMDSGTLD 138
           +K +   A P  +    +E++  R  + P ++QC G  I   P     +++E+   G L 
Sbjct: 27  VKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIP---YLLVLEFCPLGDLK 83

Query: 139 TLLNKN----GTFSEPK-LAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIA 193
             L  N       ++   L  +A ++  GL +LH    IH D+   N  +   ++ VKI 
Sbjct: 84  NYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL-TADLSVKIG 142

Query: 194 DFGVSKIMCR----SLDACNSYVGTCAYMSPE---RFDPDAYGGNYNGYAGDIWSLGLTL 246
           D+G++  + +         + +     +++PE       D    +      +IWSLG+T+
Sbjct: 143 DYGLA--LEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKK-SNIWSLGVTM 199

Query: 247 LELY 250
            EL+
Sbjct: 200 WELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 18/42 (42%), Positives = 24/42 (57%)

Query: 155 IASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFG 196
           I  QIL  L  LH   I+HRD+KP N++ +  +   KI D G
Sbjct: 260 IMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLG 301

Length = 566

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 44.4 bits (105), Expect = 3e-05
 Identities = 38/168 (22%), Positives = 70/168 (41%), Gaps = 17/168 (10%)

Query: 97  FREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHI 155
           F    ++ +     +V+ +G+  +   +I ++ EY+  G LD  L++     S      +
Sbjct: 49  FETASLMSQLSHKHLVKLYGVCVRD-ENI-MVEEYVKFGPLDVFLHREKNNVSLHWKLDV 106

Query: 156 ASQILKGLSYLHGHKIIHRDIKPSNLLV------NNNNMQVKIADFGVSKIMCRSLDACN 209
           A Q+   L YL   K++H ++   N+LV            +K++D G+      ++ +  
Sbjct: 107 AKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP----ITVLSRE 162

Query: 210 SYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLEL-YLGHFPF 256
             V    +++PE              A D WS G TLLE+   G  P 
Sbjct: 163 ERVERIPWIAPECIRNGQ---ASLTIAADKWSFGTTLLEICSNGEEPL 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 42.6 bits (100), Expect = 1e-04
 Identities = 46/187 (24%), Positives = 84/187 (44%), Gaps = 20/187 (10%)

Query: 81  LKVVHGDADPTVRR---QVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTL 137
           +KV+    DP+ R      F    ++R+     IV  +G+  +   +I ++ E+++ G L
Sbjct: 33  IKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI-MVEEFVEFGPL 91

Query: 138 DTLLNKNGT-FSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQ------V 190
           D  +++     + P    +A Q+   LSYL    ++H ++   N+L+    +       +
Sbjct: 92  DLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFI 151

Query: 191 KIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLEL- 249
           K++D G+  I   S   C   V    +++PE  +      N +  A D WS G TL E+ 
Sbjct: 152 KLSDPGIP-ITVLSRQEC---VERIPWIAPECVEDSK---NLS-IAADKWSFGTTLWEIC 203

Query: 250 YLGHFPF 256
           Y G  P 
Sbjct: 204 YNGEIPL 210

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 38.4 bits (90), Expect = 0.002
 Identities = 16/74 (21%), Positives = 34/74 (45%), Gaps = 9/74 (12%)

Query: 127 ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNN 186
           I+MEY++   L   L +           +  ++ + +  LH   I+H D+  SN++++  
Sbjct: 76  IVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG 128

Query: 187 NMQVKIADFGVSKI 200
              +   DFG+ + 
Sbjct: 129 R--IYFIDFGLGEF 140

Length = 204

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 38.7 bits (90), Expect = 0.002
 Identities = 48/185 (25%), Positives = 79/185 (42%), Gaps = 28/185 (15%)

Query: 130 EYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNM 188
           E+++ G LD  L K  G         +A Q+   LSYL    ++H ++   N+L+    +
Sbjct: 96  EFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGL 155

Query: 189 Q------VKIADFGVS-KIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWS 241
                  +K++D GVS   + R        V    +++PE       GGN    A D WS
Sbjct: 156 AEGTSPFIKLSDPGVSFTALSRE-----ERVERIPWIAPECVP----GGNSLSTAADKWS 206

Query: 242 LGLTLLEL-YLGHFPFLQ--PGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQK 298
            G TLLE+ + G  P  +  P ++  +        +     LP+ +  E  + I  CL  
Sbjct: 207 FGTTLLEICFDGEVPLKERTPSEKERF--------YEKKHRLPEPSCKELATLISQCLTY 258

Query: 299 EFSKR 303
           E ++R
Sbjct: 259 EPTQR 263

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	323
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.98
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.95
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.95
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.92
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.91
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.9
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.9
PRK12274	218	serine/threonine protein kinase; Provisional	99.89
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.89
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.88
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.88
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.87
smart00090	237	RIO RIO-like kinase.	99.85
PRK10345	210	hypothetical protein; Provisional	99.85
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.83
PRK14879	211	serine/threonine protein kinase; Provisional	99.82
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.8
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.79
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.78
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.78
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.74
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.74
KOG1243	690	consensus Protein kinase [General function predict	99.71
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.7
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.67
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.6
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.58
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.57
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.56
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.53
KOG3087	229	consensus Serine/threonine protein kinase [General	99.53
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.5
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.49
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.38
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.37
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.36
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.35
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.34
COG4248	637	Uncharacterized protein with protein kinase and he	99.32
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.31
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.22
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.11
PRK09902	216	hypothetical protein; Provisional	99.01
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	99.01
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	99.01
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.81
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.81
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.69
PF01636	239	APH: Phosphotransferase enzyme family This family	98.61
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.61
PLN02876	822	acyl-CoA dehydrogenase	98.55
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.48
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.47
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.45
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.38
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.37
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.34
KOG2268	465	consensus Serine/threonine protein kinase [Signal	98.22
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.21
KOG2270	520	consensus Serine/threonine protein kinase involved	98.19
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.19
PRK10593	297	hypothetical protein; Provisional	98.16
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	98.09
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	98.04
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.02
PRK05231	319	homoserine kinase; Provisional	98.0
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.98
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.9
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.77
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.69
PLN02236	344	choline kinase	97.68
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.66
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.58
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.55
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.46
PTZ00384	383	choline kinase; Provisional	97.34
PRK12396	409	5-methylribose kinase; Reviewed	97.27
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.18
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	97.12
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	97.07
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	97.05
PLN02756	418	S-methyl-5-thioribose kinase	97.02
PRK11768	325	serine/threonine protein kinase; Provisional	97.01
PTZ00296	442	choline kinase; Provisional	96.94
PRK06148	1013	hypothetical protein; Provisional	96.63
COG2334	331	Putative homoserine kinase type II (protein kinase	96.6
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.6
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.28
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.84

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-59  Score=391.02  Aligned_cols=267  Identities=56%  Similarity=0.942  Sum_probs=245.5

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEE
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIA  126 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  126 (323)
                      .+..++.+.+..||+|..|+||+++++.+++.+|+|++....++...+++.+|++++++.+||+||.++|.|.++...+.
T Consensus        75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~is  154 (364)
T KOG0581|consen   75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEIS  154 (364)
T ss_pred             ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEE
Confidence            35556899999999999999999999999999999999888889999999999999999999999999999998433599


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc
Q 020657          127 ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG-HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL  205 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~  205 (323)
                      |+||||++|+|++++...+.+++..+..++.+|++||.|||. .+|+||||||+|||++..| +|||+|||.+....++ 
T Consensus       155 I~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG-eVKicDFGVS~~lvnS-  232 (364)
T KOG0581|consen  155 ICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG-EVKICDFGVSGILVNS-  232 (364)
T ss_pred             eehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC-CEEeccccccHHhhhh-
Confidence            999999999999999988899999999999999999999996 8999999999999999998 9999999999887665 


Q ss_pred             cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC-CCCccHHHHHHHHhcCCCCCCCCC-
Q 020657          206 DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQP-GQRPDWATLMCAICFGDPPSLPDG-  283 (323)
Q Consensus       206 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-  283 (323)
                       ...+++||..|||||.+.+..|     +.++||||||++++|+.+|..||... .....+.+++..+..+.++.+|.. 
T Consensus       233 -~a~tfvGT~~YMsPERi~g~~Y-----s~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~  306 (364)
T KOG0581|consen  233 -IANTFVGTSAYMSPERISGESY-----SVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGE  306 (364)
T ss_pred             -hcccccccccccChhhhcCCcC-----CcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCccc
Confidence             5578899999999999985554     45999999999999999999999776 445688899999999999999997 


Q ss_pred             CChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCCC
Q 020657          284 ASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS  321 (323)
Q Consensus       284 ~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~  321 (323)
                      .|+++++||..||+.||.+|||+.++++|||+++...+
T Consensus       307 fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~  344 (364)
T KOG0581|consen  307 FSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDP  344 (364)
T ss_pred             CCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccc
Confidence            99999999999999999999999999999999877654

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.3e-58  Score=387.40  Aligned_cols=267  Identities=28%  Similarity=0.368  Sum_probs=229.8

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChH------HHHHHHHHHHHHHcCCCCccceeceeEEcCC
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT------VRRQVFREMEILRRTDSPFIVQCFGIFEKPS  122 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  122 (323)
                      ..+.|.+.+.||+|+||.|-+|..+.+|+.||+|++.......      ....+.+|+++|++|+|||||+++++|+. .
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~-~  248 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV-P  248 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec-C
Confidence            5677889999999999999999999999999999997553211      33456899999999999999999999998 5


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecC--CCcEEEeecCcchh
Q 020657          123 GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNN--NMQVKIADFGVSKI  200 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~--~~~~kl~Dfg~~~~  200 (323)
                      ...|+||||+.||.|.+.+-.++.+.+.....+++||+.|+.|||+.||+||||||+|||+..+  ...+||.|||+|..
T Consensus       249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~  328 (475)
T KOG0615|consen  249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV  328 (475)
T ss_pred             CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence            6789999999999999999999999999999999999999999999999999999999999765  23799999999987


Q ss_pred             hccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCC
Q 020657          201 MCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSL  280 (323)
Q Consensus       201 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  280 (323)
                      .+ ......+.+||+.|+|||++.......  +..++|+||+||+||-+|+|..||.+........+....-.....+..
T Consensus       329 ~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~--~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~  405 (475)
T KOG0615|consen  329 SG-EGSFMKTLCGTPSYVAPEVLASKGVEY--YPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQ  405 (475)
T ss_pred             cc-cceehhhhcCCccccChhheecCCeec--ccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChh
Confidence            65 445567889999999999998655433  235899999999999999999999887777644444444334444556


Q ss_pred             CCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          281 PDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       281 ~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      +..++++..+|+.+||..||++|||++|+|+||||+...
T Consensus       406 w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  406 WDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             hhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence            678999999999999999999999999999999998543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-56  Score=395.83  Aligned_cols=263  Identities=31%  Similarity=0.489  Sum_probs=232.7

Q ss_pred             chhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCC--CChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC
Q 020657           45 TAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS  122 (323)
Q Consensus        45 ~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  122 (323)
                      +.+....+|+..+.||+|||+.+|.+++..+|+.||+|++.+.  ..+..+..+.+|+++.+.|+|||||+++++|++ +
T Consensus        12 i~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED-s   90 (592)
T KOG0575|consen   12 IEDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED-S   90 (592)
T ss_pred             eecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec-C
Confidence            3333447899999999999999999999889999999999754  345677889999999999999999999999998 7


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          123 GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      ++.|||.|+|..++|..++++.++++|.+++.+++||+.||.|||+.+|+|||||..|++++++- +|||+|||+|....
T Consensus        91 ~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~-~VKIgDFGLAt~le  169 (592)
T KOG0575|consen   91 NNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENM-NVKIGDFGLATQLE  169 (592)
T ss_pred             CceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcC-cEEecccceeeeec
Confidence            89999999999999999999999999999999999999999999999999999999999999985 99999999999988


Q ss_pred             cCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCC
Q 020657          203 RSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPD  282 (323)
Q Consensus       203 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (323)
                      .+.....+.+||+.|+|||++....     .+..+||||+||+||.||.|+.||.    .....+....+... .-.+|.
T Consensus       170 ~~~Erk~TlCGTPNYIAPEVl~k~g-----HsfEvDiWSlGcvmYtLL~G~PPFe----tk~vkety~~Ik~~-~Y~~P~  239 (592)
T KOG0575|consen  170 YDGERKKTLCGTPNYIAPEVLNKSG-----HSFEVDIWSLGCVMYTLLVGRPPFE----TKTVKETYNKIKLN-EYSMPS  239 (592)
T ss_pred             CcccccceecCCCcccChhHhccCC-----CCCchhhhhhhhHHHhhhhCCCCcc----cchHHHHHHHHHhc-Cccccc
Confidence            7767778899999999999998443     4569999999999999999999994    44444444444332 356778


Q ss_pred             CCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          283 GASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       283 ~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      .++.++.+||+++|+.||.+|||+++||.|+||.+..
T Consensus       240 ~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~  276 (592)
T KOG0575|consen  240 HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGF  276 (592)
T ss_pred             ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCC
Confidence            9999999999999999999999999999999995443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-54  Score=359.96  Aligned_cols=262  Identities=32%  Similarity=0.539  Sum_probs=232.7

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCe
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGD  124 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  124 (323)
                      .+..++|++++.||+|+||.||+++.+.+++.+|+|++++..  .....+....|..++..++||.||+++-.|++ .+.
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt-~~k   99 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT-EEK   99 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc-CCe
Confidence            456799999999999999999999999999999999997552  22346678899999999999999999999998 789


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC
Q 020657          125 IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS  204 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~  204 (323)
                      +|+|+||+.||.|...+++.+.+++..++-++.+|+.||.|||++|||||||||+|||+|..| .++|+|||++......
T Consensus       100 LylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~G-Hi~LtDFgL~k~~~~~  178 (357)
T KOG0598|consen  100 LYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQG-HIKLTDFGLCKEDLKD  178 (357)
T ss_pred             EEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCC-cEEEeccccchhcccC
Confidence            999999999999999999999999999999999999999999999999999999999999998 8999999999877666


Q ss_pred             ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCC
Q 020657          205 LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA  284 (323)
Q Consensus       205 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (323)
                      .....+.+||+.|+|||++.+..+     +..+|+||||+++|||++|..||...+    ...+.+++..+.....+..+
T Consensus       179 ~~~t~tfcGT~eYmAPEil~~~gy-----~~~vDWWsLGillYeML~G~pPF~~~~----~~~~~~~I~~~k~~~~p~~l  249 (357)
T KOG0598|consen  179 GDATRTFCGTPEYMAPEILLGKGY-----DKAVDWWSLGILLYEMLTGKPPFYAED----VKKMYDKILKGKLPLPPGYL  249 (357)
T ss_pred             CCccccccCCccccChHHHhcCCC-----CcccchHhHHHHHHHHhhCCCCCcCcc----HHHHHHHHhcCcCCCCCccC
Confidence            667778999999999999985554     459999999999999999999995544    44555555555556666779


Q ss_pred             ChhHHHHHHHhcccCcCCCC----CHHHHhcCcccccCC
Q 020657          285 SPEFRSFIECCLQKEFSKRW----TASQLLTHPFLCKNR  319 (323)
Q Consensus       285 ~~~l~~ll~~~l~~~p~~Rp----t~~~~l~h~~f~~~~  319 (323)
                      +.+.++|++++|+.||++|.    ++++|-+||||.++.
T Consensus       250 s~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~in  288 (357)
T KOG0598|consen  250 SEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGIN  288 (357)
T ss_pred             CHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCC
Confidence            99999999999999999996    789999999998764

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=5.4e-54  Score=348.84  Aligned_cols=260  Identities=27%  Similarity=0.439  Sum_probs=221.7

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      +.|+.+.++|+|++|+||+++++.+|+.||||.+....+ +...+-..+|++++++|.|+|+|.++++|.. ...+++|+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr-krklhLVF   80 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR-KRKLHLVF   80 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh-cceeEEEe
Confidence            579999999999999999999999999999999987655 5566677899999999999999999999987 78899999


Q ss_pred             eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          130 EYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       130 e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      |||+. ++.+-+.. ...++...+.++++|++.|+.|+|+++++||||||+|||++.+| .+||||||+|+....+...+
T Consensus        81 E~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~g-vvKLCDFGFAR~L~~pgd~Y  158 (396)
T KOG0593|consen   81 EYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNG-VVKLCDFGFARTLSAPGDNY  158 (396)
T ss_pred             eecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCC-cEEeccchhhHhhcCCcchh
Confidence            99988 65555554 34689999999999999999999999999999999999999998 99999999999988777778


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCC-----------
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP-----------  277 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~-----------  277 (323)
                      ..++.|..|+|||.+.+    ...+...+||||+||++.||++|+..|.+.+.-+....+........+           
T Consensus       159 TDYVATRWYRaPELLvG----DtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~  234 (396)
T KOG0593|consen  159 TDYVATRWYRAPELLVG----DTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF  234 (396)
T ss_pred             hhhhhhhhccChhhhcc----cCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence            88999999999999974    344455999999999999999999999877665554444332221111           


Q ss_pred             ------------CCCC---CCCChhHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          278 ------------PSLP---DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       278 ------------~~~~---~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                                  .++.   ..++..+.+|++.||+.||.+|++-+++|.|+||++
T Consensus       235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~  289 (396)
T KOG0593|consen  235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG  289 (396)
T ss_pred             eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence                        0111   345678999999999999999999999999999964

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.3e-55  Score=350.00  Aligned_cols=250  Identities=31%  Similarity=0.518  Sum_probs=224.7

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCC-CChHHHHHHHHHHHHHHcCCCCccceece-eEEcCCCe
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIVQCFG-IFEKPSGD  124 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~~  124 (323)
                      -....+|+|+++||.|.||+||++++..+|+.+|.|.++-+ .+.........|+.+|++|+||||++.++ .|..+...
T Consensus        15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev   94 (375)
T KOG0591|consen   15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV   94 (375)
T ss_pred             cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence            34568899999999999999999999999999999999754 45667888999999999999999999998 45554455


Q ss_pred             EEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh--CC--CeecCCCCCCeEEecCCCcEEEeecC
Q 020657          125 IAILMEYMDSGTLDTLLNK----NGTFSEPKLAHIASQILKGLSYLHG--HK--IIHRDIKPSNLLVNNNNMQVKIADFG  196 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~Lh~--~g--ivH~di~~~nil~~~~~~~~kl~Dfg  196 (323)
                      ++||||+|.+|+|.++++.    .+.+++..+++++.|++.||..+|.  ..  ++||||||.||+++.+| .+||+|||
T Consensus        95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g-vvKLGDfG  173 (375)
T KOG0591|consen   95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG-VVKLGDFG  173 (375)
T ss_pred             hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC-ceeeccch
Confidence            8999999999999999963    4569999999999999999999999  34  99999999999999998 89999999


Q ss_pred             cchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC
Q 020657          197 VSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD  276 (323)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~  276 (323)
                      +++.+........+.+||+.||+||.+...     .++.+|||||+||++|||+.-+.||.+.    ....+..++..+.
T Consensus       174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~-----~Y~~kSDiWslGCllyEMcaL~~PF~g~----n~~~L~~KI~qgd  244 (375)
T KOG0591|consen  174 LGRFLSSKTTFAHSLVGTPYYMSPERIHES-----GYNFKSDIWSLGCLLYEMCALQSPFYGD----NLLSLCKKIEQGD  244 (375)
T ss_pred             hHhHhcchhHHHHhhcCCCcccCHHHHhcC-----CCCcchhHHHHHHHHHHHHhcCCCcccc----cHHHHHHHHHcCC
Confidence            999988777777889999999999999744     4567999999999999999999999654    7888999999999


Q ss_pred             CCCCC-CCCChhHHHHHHHhcccCcCCCCCH
Q 020657          277 PPSLP-DGASPEFRSFIECCLQKEFSKRWTA  306 (323)
Q Consensus       277 ~~~~~-~~~~~~l~~ll~~~l~~~p~~Rpt~  306 (323)
                      .+++| ..+|.++..|+..|+..||+.||+.
T Consensus       245 ~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  245 YPPLPDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             CCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence            88898 7899999999999999999999984

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-53  Score=368.29  Aligned_cols=261  Identities=32%  Similarity=0.526  Sum_probs=228.7

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCC--CChHHHHHHHHHHHHHHcC-CCCccceeceeEEcCCC
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKPSG  123 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~  123 (323)
                      .....+|...+.||+|+|++|++|++..+++.||||++.+.  ......+.+..|-..|..| +||+|++++-.|++ +.
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD-~~  147 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD-EE  147 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec-cc
Confidence            45678899999999999999999999999999999998644  2233456677888889998 89999999999998 78


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          124 DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      .+|+|+||+++|.|.+++++-+.+++..++.++.+|+.||+|||+.|||||||||+|||+|.++ .++|.|||.|..+..
T Consensus       148 sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dm-hikITDFGsAK~l~~  226 (604)
T KOG0592|consen  148 SLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDG-HIKITDFGSAKILSP  226 (604)
T ss_pred             ceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCC-cEEEeeccccccCCh
Confidence            8999999999999999999999999999999999999999999999999999999999999998 899999999987643


Q ss_pred             Cccc-----------c--ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHH
Q 020657          204 SLDA-----------C--NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMC  270 (323)
Q Consensus       204 ~~~~-----------~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~  270 (323)
                      ....           .  ..++||..|++||+|.     ....+..+|+|+|||+||+|+.|+.||.+..+.-.++.++.
T Consensus       227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~-----~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~  301 (604)
T KOG0592|consen  227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLN-----DSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA  301 (604)
T ss_pred             hhccccCccCcccccCcccceeeeecccCHHHhc-----CCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH
Confidence            2111           1  4589999999999997     44455699999999999999999999987766655555542


Q ss_pred             HHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          271 AICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                           ..-.++.+.++.+.+||+++|-.||++|+|..+|-+||||.++.
T Consensus       302 -----l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vd  345 (604)
T KOG0592|consen  302 -----LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVD  345 (604)
T ss_pred             -----hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCC
Confidence                 23567788999999999999999999999999999999998864

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-53  Score=365.07  Aligned_cols=267  Identities=31%  Similarity=0.435  Sum_probs=227.7

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCC-CCccceeceeEEcCCCeEE
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD-SPFIVQCFGIFEKPSGDIA  126 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~  126 (323)
                      +..++|.++++||.|.||.||+|+...+++.||||..+.....-....-++|++.|++|+ ||||+++.+++.+.+..++
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            456899999999999999999999999999999999876643333334468999999998 9999999999988666999


Q ss_pred             EEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc
Q 020657          127 ILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL  205 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~  205 (323)
                      +|||||+. +|.++++. ++.+++..++.|+.||++||+|+|.+|+.|||+||+|||+.... .+||+|||+|+.+... 
T Consensus        87 fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~-~iKiaDFGLARev~Sk-  163 (538)
T KOG0661|consen   87 FVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGND-VIKIADFGLAREVRSK-  163 (538)
T ss_pred             eeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccc-eeEecccccccccccC-
Confidence            99999987 99999974 56799999999999999999999999999999999999999654 8999999999887544 


Q ss_pred             cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCC------
Q 020657          206 DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPS------  279 (323)
Q Consensus       206 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------  279 (323)
                      +.+..++-|..|+|||++.    ....++.+.||||+||+++|+++-+..|.+.++-+.+.++++.+.......      
T Consensus       164 pPYTeYVSTRWYRAPEvLL----rs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~  239 (538)
T KOG0661|consen  164 PPYTEYVSTRWYRAPEVLL----RSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN  239 (538)
T ss_pred             CCcchhhhcccccchHHhh----hccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence            3445678899999999986    456678899999999999999999999988887777666665554322111      


Q ss_pred             -------------------CCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCCC
Q 020657          280 -------------------LPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS  321 (323)
Q Consensus       280 -------------------~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~  321 (323)
                                         +....+.++.+||.+|++|||.+|||+.++|+||||+.-+.+
T Consensus       240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~  300 (538)
T KOG0661|consen  240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS  300 (538)
T ss_pred             HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence                               113478999999999999999999999999999999876554

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.7e-51  Score=363.79  Aligned_cols=267  Identities=55%  Similarity=1.015  Sum_probs=224.9

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeE
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDI  125 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  125 (323)
                      .....++|+.++.||+|+||.||+|.+..+++.|++|++...........+.+|+.+++.++|+||+++++++.. .+.+
T Consensus        69 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~  147 (353)
T PLN00034         69 AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH-NGEI  147 (353)
T ss_pred             CCCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc-CCeE
Confidence            445578899999999999999999999989999999999766666667788999999999999999999999987 6789


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc
Q 020657          126 AILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL  205 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~  205 (323)
                      ++||||+.+++|...    ...++..+..++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++.......
T Consensus       148 ~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kL~DfG~~~~~~~~~  222 (353)
T PLN00034        148 QVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAK-NVKIADFGVSRILAQTM  222 (353)
T ss_pred             EEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CEEEcccccceeccccc
Confidence            999999999998653    2457788899999999999999999999999999999999987 89999999997665443


Q ss_pred             cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCC
Q 020657          206 DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS  285 (323)
Q Consensus       206 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (323)
                      .......++..|+|||++..........+.++||||||+++|+|++|+.||.... ...+..+............+..++
T Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  301 (353)
T PLN00034        223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR-QGDWASLMCAICMSQPPEAPATAS  301 (353)
T ss_pred             ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCC-CccHHHHHHHHhccCCCCCCCccC
Confidence            3334567899999999986444334455669999999999999999999996332 233444444444455566667889


Q ss_pred             hhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          286 PEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       286 ~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      .++.+||.+||+.||++|||+.++++||||.+..
T Consensus       302 ~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~  335 (353)
T PLN00034        302 REFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ  335 (353)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence            9999999999999999999999999999998764

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-52  Score=351.77  Aligned_cols=262  Identities=36%  Similarity=0.581  Sum_probs=221.7

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCC-eEEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG-DIAIL  128 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~~lv  128 (323)
                      ..+|...+.||+|+||.||++.+..+|+..|+|.+....... .+.+.+|+.+|++++|||||+++|.....++ .++++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~   94 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF   94 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence            567899999999999999999999889999999997664333 6778899999999999999999997554344 79999


Q ss_pred             EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEec-CCCcEEEeecCcchhhcc---
Q 020657          129 MEYMDSGTLDTLLNKNG-TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNN-NNMQVKIADFGVSKIMCR---  203 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~-~~~~~kl~Dfg~~~~~~~---  203 (323)
                      |||+++|+|.+++.+.+ .+++..++.+..||++||.|||++|++|+||||+|||++. ++ .+||+|||.+.....   
T Consensus        95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~-~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNG-DVKLADFGLAKKLESKGT  173 (313)
T ss_pred             eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCC-eEEeccCccccccccccc
Confidence            99999999999999866 7999999999999999999999999999999999999999 56 899999999987653   


Q ss_pred             CccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCC
Q 020657          204 SLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDG  283 (323)
Q Consensus       204 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (323)
                      .........||+.|+|||++..+.    ....++|||||||++.||+||+.||...  ......+.........+.+|..
T Consensus       174 ~~~~~~~~~Gtp~~maPEvi~~g~----~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig~~~~~P~ip~~  247 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAPEVIRNGE----VARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIGREDSLPEIPDS  247 (313)
T ss_pred             cccccccccCCccccCchhhcCCC----cCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHhccCCCCCCCcc
Confidence            112234578999999999997421    1224899999999999999999999653  2222333333333445688999


Q ss_pred             CChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          284 ASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       284 ~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      ++.++.+|+.+|+..+|++|||++++|+|||..+..
T Consensus       248 ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  248 LSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             cCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence            999999999999999999999999999999997754

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-51  Score=345.28  Aligned_cols=260  Identities=29%  Similarity=0.482  Sum_probs=225.9

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      ...+|.+...||.|+|++||+|+.+.++..||||.+.... .....+....|+++|+.++|||||.++++... ++.+++
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~-~~~i~l   86 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED-DDFIYL   86 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec-CCeEEE
Confidence            3578999999999999999999999999999999998775 66778888999999999999999999999988 789999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecC--C---CcEEEeecCcchhhc
Q 020657          128 LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNN--N---MQVKIADFGVSKIMC  202 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~--~---~~~kl~Dfg~~~~~~  202 (323)
                      |||||+||+|.+++++.+.+++..++.++.||+.||++||+++||||||||+|||++..  .   ..+||+|||+|+...
T Consensus        87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~  166 (429)
T KOG0595|consen   87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ  166 (429)
T ss_pred             EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence            99999999999999999999999999999999999999999999999999999999874  2   469999999998875


Q ss_pred             cCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcC--CCCCC
Q 020657          203 RSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFG--DPPSL  280 (323)
Q Consensus       203 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~  280 (323)
                      . .....+.+|++.|||||++....     |+.|+|+||+|+++|++++|+.||...    ...++...+..+  ..+.+
T Consensus       167 ~-~~~a~tlcGSplYMAPEV~~~~~-----YdAKADLWSiG~Ilyq~l~g~~Pf~a~----t~~eL~~~~~k~~~~~~~~  236 (429)
T KOG0595|consen  167 P-GSMAETLCGSPLYMAPEVIMSQQ-----YDAKADLWSIGTILYQCLTGKPPFDAE----TPKELLLYIKKGNEIVPVL  236 (429)
T ss_pred             c-hhHHHHhhCCccccCHHHHHhcc-----ccchhhHHHHHHHHHHHHhCCCCcccc----CHHHHHHHHhccccccCch
Confidence            3 34456789999999999997444     456999999999999999999999544    334443333332  24555


Q ss_pred             CCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          281 PDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       281 ~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      +...+..+.+|+...++.+|.+|.++.+-+.|+|+....
T Consensus       237 ~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  237 PAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             hhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            677888899999999999999999999999999987653

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-51  Score=358.78  Aligned_cols=260  Identities=32%  Similarity=0.519  Sum_probs=226.5

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC---C-hHHHHHHHHHHHHHHcCC-CCccceeceeEEcC
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA---D-PTVRRQVFREMEILRRTD-SPFIVQCFGIFEKP  121 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~---~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~  121 (323)
                      ......|.+.+.||+|+||.|++|.+..++..||+|++....   . ......+.+|+.+++++. ||||+++++++.. 
T Consensus        13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t-   91 (370)
T KOG0583|consen   13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT-   91 (370)
T ss_pred             ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec-
Confidence            456789999999999999999999999999999999876541   1 134566778999999998 9999999999998 


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecC-CCcEEEeecCcchh
Q 020657          122 SGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNN-NMQVKIADFGVSKI  200 (323)
Q Consensus       122 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~-~~~~kl~Dfg~~~~  200 (323)
                      ...+++||||+.||.|.+.+.+.+++++..+..+++||+.|++|||+.||+||||||+||+++.+ + ++||+|||++..
T Consensus        92 ~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~-~~Kl~DFG~s~~  170 (370)
T KOG0583|consen   92 PTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEG-NLKLSDFGLSAI  170 (370)
T ss_pred             CCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCC-CEEEeccccccc
Confidence            56699999999999999999998899999999999999999999999999999999999999998 6 999999999987


Q ss_pred             hccCccccccccccccccCCcccCCCC-CCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCC
Q 020657          201 MCRSLDACNSYVGTCAYMSPERFDPDA-YGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPS  279 (323)
Q Consensus       201 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  279 (323)
                      ...........+|++.|+|||++.+.. |.    ..++||||+|++||.|++|.+||..    .....+... .......
T Consensus       171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~----g~~aDvWS~GViLy~ml~G~~PF~d----~~~~~l~~k-i~~~~~~  241 (370)
T KOG0583|consen  171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYS----GKAADVWSLGVILYVLLCGRLPFDD----SNVPNLYRK-IRKGEFK  241 (370)
T ss_pred             cCCCCCcccCCCCCcccCCHHHhCCCCCcC----CchhhhhhhHHHHHHHHhCCCCCCC----ccHHHHHHH-HhcCCcc
Confidence            644445667889999999999998655 43    4699999999999999999999965    333334333 2234566


Q ss_pred             CCCCC-ChhHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          280 LPDGA-SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       280 ~~~~~-~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                      ++..+ +.++.+|+++||..||.+|+|+.++++||||+.
T Consensus       242 ~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  242 IPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            77777 999999999999999999999999999999997

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-51  Score=354.53  Aligned_cols=262  Identities=32%  Similarity=0.501  Sum_probs=224.3

Q ss_pred             CccchhccccccceeeeecccCCeEEEEEEecccCcE-EEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEE
Q 020657           42 TATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKI-YALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFE  119 (323)
Q Consensus        42 ~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~-v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  119 (323)
                      ....+.+..+++.+...+|.|+||+||+|.+.  |+. ||+|++.... .....+.+.+|+.+|.+++||||++++|++.
T Consensus        32 ~~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~  109 (362)
T KOG0192|consen   32 ELPEEEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACT  109 (362)
T ss_pred             cccceecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            34667888899999999999999999999995  556 9999997653 3333788999999999999999999999999


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-CeecCCCCCCeEEecCCCcEEEeecC
Q 020657          120 KPSGDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHGHK-IIHRDIKPSNLLVNNNNMQVKIADFG  196 (323)
Q Consensus       120 ~~~~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~g-ivH~di~~~nil~~~~~~~~kl~Dfg  196 (323)
                      ++...+++||||+++|+|.+++..  ...++...+..|+.+|++||.|||+.+ |||||||++|||++.+..++||+|||
T Consensus       110 ~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFG  189 (362)
T KOG0192|consen  110 SPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFG  189 (362)
T ss_pred             CCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCc
Confidence            854479999999999999999987  678999999999999999999999999 99999999999999985489999999


Q ss_pred             cchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC
Q 020657          197 VSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD  276 (323)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~  276 (323)
                      +++.............||..|+|||++...   ...++.++||||||+++|||+||+.||.....   ..........+.
T Consensus       190 lsr~~~~~~~~~~~~~GT~~wMAPEv~~~~---~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~---~~~~~~v~~~~~  263 (362)
T KOG0192|consen  190 LSREKVISKTSMTSVAGTYRWMAPEVLRGE---KSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP---VQVASAVVVGGL  263 (362)
T ss_pred             cceeeccccccccCCCCCccccChhhhcCC---CCcCCccchhhhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhcCC
Confidence            997765433333336799999999999844   44567799999999999999999999965543   333444444577


Q ss_pred             CCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          277 PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       277 ~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ++.++..+++.+..|+..||+.||+.||++.+++.
T Consensus       264 Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  264 RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            88888889999999999999999999999999874

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-51  Score=353.61  Aligned_cols=264  Identities=34%  Similarity=0.460  Sum_probs=225.1

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcC-CCeE
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP-SGDI  125 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~  125 (323)
                      ...+.|+.+++||+|.||.||+|++..+|+.||+|.+..+. ++.......+|+.+|++|.||||+++.+.+.+. .+.+
T Consensus       114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si  193 (560)
T KOG0600|consen  114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI  193 (560)
T ss_pred             cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence            34567999999999999999999999999999999998765 456677788999999999999999999998875 5789


Q ss_pred             EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC
Q 020657          126 AILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS  204 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~  204 (323)
                      |+|+|||++ +|.-++... -.+++.++..+++||++||+|||++|++|||||..|||+|++| .+||+|||+|+.+...
T Consensus       194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G-~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNG-VLKIADFGLARFYTPS  271 (560)
T ss_pred             EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCC-CEEeccccceeeccCC
Confidence            999999987 998888763 4799999999999999999999999999999999999999998 9999999999977654


Q ss_pred             cc-ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCC---C--
Q 020657          205 LD-ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP---P--  278 (323)
Q Consensus       205 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~---~--  278 (323)
                      .. .....+.|..|+|||++.    +...++.++|+||.||||.||++|+..|.+..+.+....+.........   +  
T Consensus       272 ~~~~~T~rVvTLWYRpPELLL----G~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~  347 (560)
T KOG0600|consen  272 GSAPYTSRVVTLWYRPPELLL----GATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS  347 (560)
T ss_pred             CCcccccceEEeeccChHHhc----CCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence            43 356678999999999996    4556778999999999999999999999877665555444433222111   0  


Q ss_pred             ------------C-------CCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          279 ------------S-------LPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       279 ------------~-------~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                                  +       ....++....+|+..||..||.+|.|+.++|+++||..
T Consensus       348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t  405 (560)
T KOG0600|consen  348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT  405 (560)
T ss_pred             cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence                        0       11346788999999999999999999999999999944

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=5.3e-51  Score=325.82  Aligned_cols=262  Identities=29%  Similarity=0.447  Sum_probs=223.4

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      ++|...+++|+|.||.||+|++..+|+.||||.+...+. ........+|++.|+.++|+||+.++++|.. .+.+.+|+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~-~~~l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH-KSNLSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC-CCceEEEE
Confidence            589999999999999999999999999999999986642 3345667899999999999999999999998 78899999


Q ss_pred             eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          130 EYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       130 e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      ||++. +|+..++.. ..++..++..|+.++++|++|||++.|+||||||.|+|++.+| .+||+|||+++.+..+....
T Consensus        81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g-~lKiADFGLAr~f~~p~~~~  158 (318)
T KOG0659|consen   81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDG-QLKIADFGLARFFGSPNRIQ  158 (318)
T ss_pred             Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCC-cEEeecccchhccCCCCccc
Confidence            99976 999999754 4699999999999999999999999999999999999999998 99999999999998777766


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCC----------
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPP----------  278 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------  278 (323)
                      ...+.|..|+|||.+.    +...+...+||||.||++.||+-|...|.+.++-+....+.+......+.          
T Consensus       159 ~~~V~TRWYRAPELLf----Gsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd  234 (318)
T KOG0659|consen  159 THQVVTRWYRAPELLF----GSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD  234 (318)
T ss_pred             ccceeeeeccChHHhc----cchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence            6668999999999986    44555669999999999999999988786665544444444433222211          


Q ss_pred             -------------CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          279 -------------SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       279 -------------~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                                   .+....+.++.||+.+||..||.+|+|+.|+|+|+||.+..
T Consensus       235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P  288 (318)
T KOG0659|consen  235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP  288 (318)
T ss_pred             HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence                         12245678899999999999999999999999999998643

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.2e-51  Score=361.31  Aligned_cols=257  Identities=29%  Similarity=0.519  Sum_probs=233.0

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCC--CChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      ..-|++...||.|+.|.|-+|++..||+.+|||++.+.  ........+.+|+.+|+.+.|||++.+++++++ ...+|+
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~-~~~lyl   89 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN-KQHLYL   89 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc-CceEEE
Confidence            45688999999999999999999999999999999765  233446678899999999999999999999998 788999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccc
Q 020657          128 LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA  207 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~  207 (323)
                      |.||+++|-|.+++-..+++++.++..+++||+.|+.|||..+|+|||+||+|+|+|..+ ++||+|||+|... .+...
T Consensus        90 vlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~-nIKIADFGMAsLe-~~gkl  167 (786)
T KOG0588|consen   90 VLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKN-NIKIADFGMASLE-VPGKL  167 (786)
T ss_pred             EEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhccc-CEeeeccceeecc-cCCcc
Confidence            999999999999999999999999999999999999999999999999999999999997 7999999999654 44556


Q ss_pred             cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChh
Q 020657          208 CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPE  287 (323)
Q Consensus       208 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (323)
                      ..+.+|.+.|.|||++.+.+|.+    .++||||.|++||.||||.+||    +++++..++.++..+. ..+|..++.+
T Consensus       168 LeTSCGSPHYA~PEIV~G~pYdG----~~sDVWSCGVILfALLtG~LPF----dDdNir~LLlKV~~G~-f~MPs~Is~e  238 (786)
T KOG0588|consen  168 LETSCGSPHYAAPEIVSGRPYDG----RPSDVWSCGVILFALLTGKLPF----DDDNIRVLLLKVQRGV-FEMPSNISSE  238 (786)
T ss_pred             ccccCCCcccCCchhhcCCCCCC----CccccchhHHHHHHHHhCCCCC----CCccHHHHHHHHHcCc-ccCCCcCCHH
Confidence            67889999999999999777765    4999999999999999999999    4677788888877665 4678999999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          288 FRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       288 l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      +++|+++||..||++|.|.++|++|||+.+-
T Consensus       239 aQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~  269 (786)
T KOG0588|consen  239 AQDLLRRMLDVDPSTRITTEEILKHPFLSGY  269 (786)
T ss_pred             HHHHHHHHhccCccccccHHHHhhCchhhcC
Confidence            9999999999999999999999999999764

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-51  Score=357.34  Aligned_cols=256  Identities=31%  Similarity=0.564  Sum_probs=222.6

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ....|....+||+|+.|.||.|+...+++.||+|.+.....+ ..+-+.+|+.+|+...|+|||.+++.|-. ++.++.|
T Consensus       271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~-~keLilnEi~Vm~~~~H~NiVnfl~Sylv-~deLWVV  348 (550)
T KOG0578|consen  271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP-KKELLLNEILVMRDLHHPNIVNFLDSYLV-GDELWVV  348 (550)
T ss_pred             hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC-chhhhHHHHHHHHhccchHHHHHHHHhcc-cceeEEE
Confidence            345688889999999999999999999999999999755433 34568899999999999999999999877 5789999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          129 MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      |||++||+|.+++... .+++.++..++.++++||+|||.+||+|||||.+|||++.+| .+||+|||++..+.......
T Consensus       349 MEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g-~vKltDFGFcaqi~~~~~KR  426 (550)
T KOG0578|consen  349 MEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDG-SVKLTDFGFCAQISEEQSKR  426 (550)
T ss_pred             EeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCC-cEEEeeeeeeeccccccCcc
Confidence            9999999999998765 589999999999999999999999999999999999999998 89999999999988777777


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC-CCCCCCCCChh
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD-PPSLPDGASPE  287 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  287 (323)
                      ...+||+.|+|||+.....|+     ++.||||||++++||+.|+.||...   ..+..+......+. ....+..+|+.
T Consensus       427 ~TmVGTPYWMAPEVvtrk~YG-----~KVDIWSLGIMaIEMveGEPPYlnE---~PlrAlyLIa~ng~P~lk~~~klS~~  498 (550)
T KOG0578|consen  427 STMVGTPYWMAPEVVTRKPYG-----PKVDIWSLGIMAIEMVEGEPPYLNE---NPLRALYLIATNGTPKLKNPEKLSPE  498 (550)
T ss_pred             ccccCCCCccchhhhhhcccC-----ccccchhhhhHHHHHhcCCCCccCC---ChHHHHHHHhhcCCCCcCCccccCHH
Confidence            889999999999999866655     4999999999999999999999652   22333333333233 23445789999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCcccc
Q 020657          288 FRSFIECCLQKEFSKRWTASQLLTHPFLC  316 (323)
Q Consensus       288 l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~  316 (323)
                      +.+||.+||+.|+++|+|+.+||+||||+
T Consensus       499 ~kdFL~~cL~~dv~~RasA~eLL~HpFl~  527 (550)
T KOG0578|consen  499 LKDFLDRCLVVDVEQRASAKELLEHPFLK  527 (550)
T ss_pred             HHHHHHHHhhcchhcCCCHHHHhcChhhh
Confidence            99999999999999999999999999994

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-50  Score=328.48  Aligned_cols=256  Identities=30%  Similarity=0.559  Sum_probs=226.5

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeE
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDI  125 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  125 (323)
                      ...++|++++.||.|+||.|.+++.+.+|..+|+|++....  .....+...+|..+|+.+.||.++++++.+.+ .+.+
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d-~~~l  119 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD-NSNL  119 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc-CCeE
Confidence            56799999999999999999999999999999999997552  23445667899999999999999999999998 7899


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc
Q 020657          126 AILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL  205 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~  205 (323)
                      ++||||.+||.|..++++.+++++..++.++.||+.||+|||+.+|++||+||+|||+|.+| .+||+|||+|...... 
T Consensus       120 ymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G-~iKitDFGFAK~v~~r-  197 (355)
T KOG0616|consen  120 YMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNG-HIKITDFGFAKRVSGR-  197 (355)
T ss_pred             EEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCC-cEEEEeccceEEecCc-
Confidence            99999999999999999999999999999999999999999999999999999999999998 8999999999876433 


Q ss_pred             cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCC
Q 020657          206 DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS  285 (323)
Q Consensus       206 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (323)
                        ..+.+||+.|+|||++....++.     ++|.|+||+++|||+.|..||.....-...+++.     .....+|...+
T Consensus       198 --T~TlCGTPeYLAPEii~sk~ynk-----avDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~-----~~~v~fP~~fs  265 (355)
T KOG0616|consen  198 --TWTLCGTPEYLAPEIIQSKGYNK-----AVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKIL-----EGKVKFPSYFS  265 (355)
T ss_pred             --EEEecCCccccChHHhhcCCCCc-----chhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHH-----hCcccCCcccC
Confidence              56789999999999998666655     9999999999999999999996654433333333     33467889999


Q ss_pred             hhHHHHHHHhcccCcCCCC-----CHHHHhcCcccccC
Q 020657          286 PEFRSFIECCLQKEFSKRW-----TASQLLTHPFLCKN  318 (323)
Q Consensus       286 ~~l~~ll~~~l~~~p~~Rp-----t~~~~l~h~~f~~~  318 (323)
                      +++++|++.+|+.|-.+|.     ..++|..||||++.
T Consensus       266 ~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v  303 (355)
T KOG0616|consen  266 SDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGV  303 (355)
T ss_pred             HHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccc
Confidence            9999999999999999994     57899999999865

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-50  Score=353.46  Aligned_cols=255  Identities=25%  Similarity=0.445  Sum_probs=222.3

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS  122 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  122 (323)
                      -..|.+..+.++.++.||+|-||.||.|.+. ....|++|.+....  .....+.+|+++|++|+|++||++++++.. +
T Consensus       198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~--m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~-~  273 (468)
T KOG0197|consen  198 RDPWEIPREELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGS--MSPEAFLREAQIMKKLRHEKLVKLYGVCTK-Q  273 (468)
T ss_pred             cCCeeecHHHHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccc--cChhHHHHHHHHHHhCcccCeEEEEEEEec-C
Confidence            7788999999999999999999999999996 34489999997653  334667899999999999999999999997 5


Q ss_pred             CeEEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchh
Q 020657          123 GDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                      +.++||||||+.|+|.++++.  +..+.....+.++.|||+||+||+++++|||||.++||||+++. .+||+|||+|+.
T Consensus       274 ~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~-~vKIsDFGLAr~  352 (468)
T KOG0197|consen  274 EPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDL-VVKISDFGLARL  352 (468)
T ss_pred             CceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCc-eEEEcccccccc
Confidence            689999999999999999986  55799999999999999999999999999999999999999997 999999999996


Q ss_pred             hccCccc-cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCC
Q 020657          201 MCRSLDA-CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPP  278 (323)
Q Consensus       201 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  278 (323)
                      ..+.... .........|.|||.+....+     |.+|||||||++||||+| |+.||.+..+    ....+.+..+.+.
T Consensus       353 ~~d~~Y~~~~~~kfPIkWtAPEa~~~~~F-----S~kSDVWSFGVlL~E~fT~G~~py~~msn----~ev~~~le~GyRl  423 (468)
T KOG0197|consen  353 IGDDEYTASEGGKFPIKWTAPEALNYGKF-----SSKSDVWSFGVLLWELFTYGRVPYPGMSN----EEVLELLERGYRL  423 (468)
T ss_pred             cCCCceeecCCCCCCceecCHHHHhhCCc-----ccccceeehhhhHHHHhccCCCCCCCCCH----HHHHHHHhccCcC
Confidence            5544332 334456789999999985554     459999999999999997 9999955544    5666677778889


Q ss_pred             CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          279 SLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       279 ~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      +.|..+|+++.++|..||+.+|++||||+.+..
T Consensus       424 p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  424 PRPEGCPDEVYELMKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence            999999999999999999999999999997763

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-50  Score=340.17  Aligned_cols=270  Identities=33%  Similarity=0.515  Sum_probs=229.1

Q ss_pred             CccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcC
Q 020657           42 TATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP  121 (323)
Q Consensus        42 ~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  121 (323)
                      ....+.+..++|++...||.|..++||+|+...+++.||||++..+.-....+.+.+|+..|+.+.||||++.+..|.. 
T Consensus        17 ~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv-   95 (516)
T KOG0582|consen   17 SEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV-   95 (516)
T ss_pred             ccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe-
Confidence            4556677889999999999999999999999999999999999877655557889999999999999999999999998 


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcch
Q 020657          122 SGDIAILMEYMDSGTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       122 ~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                      +..+|+||.+|.+|++.+++...  ..+++..+..|++++++||.|||++|.+|||||+.|||++.+| .|||+|||.+.
T Consensus        96 ~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG-~VkLadFgvsa  174 (516)
T KOG0582|consen   96 DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDG-TVKLADFGVSA  174 (516)
T ss_pred             cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCC-cEEEcCceeee
Confidence            78899999999999999999753  3499999999999999999999999999999999999999998 89999999987


Q ss_pred             hhccCccc---c-ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcC
Q 020657          200 IMCRSLDA---C-NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFG  275 (323)
Q Consensus       200 ~~~~~~~~---~-~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~  275 (323)
                      ...+....   . ..++++++|+|||++...   ...|+.|+||||||++..||.+|..||.   ..+..+.++..+.. 
T Consensus       175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~---~~GYdfKaDIwSfGITA~ELA~G~aPf~---k~pPmkvLl~tLqn-  247 (516)
T KOG0582|consen  175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQ---LHGYDFKADIWSFGITACELAHGHAPFS---KYPPMKVLLLTLQN-  247 (516)
T ss_pred             eecccCceeeEeeccccCcccccChHHhhhc---ccCccchhhhhhhhHHHHHHhcCCCCcc---cCChHHHHHHHhcC-
Confidence            65443221   1 566899999999997533   3446789999999999999999999993   33444555544433 


Q ss_pred             CCCC---------CCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          276 DPPS---------LPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       276 ~~~~---------~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                      .++.         ..+..+..+..++..||..||.+|||++++|+|+||+..+.
T Consensus       248 ~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~  301 (516)
T KOG0582|consen  248 DPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS  301 (516)
T ss_pred             CCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence            3321         11345678999999999999999999999999999987654

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=4.9e-50  Score=348.49  Aligned_cols=264  Identities=28%  Similarity=0.454  Sum_probs=225.0

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCe
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGD  124 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  124 (323)
                      .+..++|+++..||+|+||.||+|+-+.+|+.+|+|++++..  .....+.+..|-.+|....+|.||+++=.|++ .++
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD-~~~  215 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD-KEY  215 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC-CCe
Confidence            457899999999999999999999999999999999997653  23445667889999999999999999999998 789


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC
Q 020657          125 IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS  204 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~  204 (323)
                      +||||||++||++..++.+...+++..++.++.+++-|++.||+.|++||||||+|+|+|..| .+||+|||++..+...
T Consensus       216 LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~G-HiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  216 LYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKG-HIKLSDFGLSTGLDKK  294 (550)
T ss_pred             eEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCC-CEeeccccccchhhhh
Confidence            999999999999999999999999999999999999999999999999999999999999999 8999999999533110


Q ss_pred             -----------------------ccc------------------------cccccccccccCCcccCCCCCCCCCCCcch
Q 020657          205 -----------------------LDA------------------------CNSYVGTCAYMSPERFDPDAYGGNYNGYAG  237 (323)
Q Consensus       205 -----------------------~~~------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~  237 (323)
                                             ...                        ....+||+.|+|||++.+..++.     ..
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~-----~c  369 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGK-----EC  369 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCc-----cc
Confidence                                   000                        01247999999999998666554     99


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCC---HHHHhcCcc
Q 020657          238 DIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWT---ASQLLTHPF  314 (323)
Q Consensus       238 Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt---~~~~l~h~~  314 (323)
                      |+|||||||||||.|..||.+.+-...+.++..-...-..+. ...+++++.|||.+||. ||++|..   ++||-.|||
T Consensus       370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~-~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPf  447 (550)
T KOG0605|consen  370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE-EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPF  447 (550)
T ss_pred             cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC-cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCc
Confidence            999999999999999999987777766666654332222111 24578999999999999 9999995   999999999


Q ss_pred             cccCC
Q 020657          315 LCKNR  319 (323)
Q Consensus       315 f~~~~  319 (323)
                      |+++.
T Consensus       448 F~~v~  452 (550)
T KOG0605|consen  448 FKGVD  452 (550)
T ss_pred             cccCC
Confidence            99875

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-50  Score=356.82  Aligned_cols=261  Identities=30%  Similarity=0.498  Sum_probs=228.4

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcC-CCCccceeceeEEcCC
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKPS  122 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~  122 (323)
                      ..+..++|.++++||+|.||.|++|..+.+++.+|||++++..  ..+..+....|..++... +||.++.++..|++ .
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT-~  441 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT-K  441 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc-C
Confidence            4677899999999999999999999999999999999998762  334456667788887776 59999999999998 7


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          123 GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      .++|+||||..||++..+ .....+++..++-++..|+.||.|||++||||||||.+|||+|.+| .+||+|||++...-
T Consensus       442 ~~l~fvmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eG-h~kiADFGlcKe~m  519 (694)
T KOG0694|consen  442 EHLFFVMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEG-HVKIADFGLCKEGM  519 (694)
T ss_pred             CeEEEEEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccC-cEEecccccccccC
Confidence            899999999999994443 3445799999999999999999999999999999999999999999 89999999998765


Q ss_pred             cCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCC
Q 020657          203 RSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPD  282 (323)
Q Consensus       203 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (323)
                      .......+++||+.|+|||++.+..|     +..+|+|+|||+|||||.|+.||.+.++.+.++.+.     .+.+.+|.
T Consensus       520 ~~g~~TsTfCGTpey~aPEil~e~~Y-----t~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~-----~d~~~yP~  589 (694)
T KOG0694|consen  520 GQGDRTSTFCGTPEFLAPEVLTEQSY-----TRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV-----NDEVRYPR  589 (694)
T ss_pred             CCCCccccccCChhhcChhhhccCcc-----cchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh-----cCCCCCCC
Confidence            55567789999999999999975554     559999999999999999999998777665555554     34678899


Q ss_pred             CCChhHHHHHHHhcccCcCCCCC-----HHHHhcCcccccCC
Q 020657          283 GASPEFRSFIECCLQKEFSKRWT-----ASQLLTHPFLCKNR  319 (323)
Q Consensus       283 ~~~~~l~~ll~~~l~~~p~~Rpt-----~~~~l~h~~f~~~~  319 (323)
                      .+|.+..++|+++|..+|++|..     +++|..||||+++.
T Consensus       590 ~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~  631 (694)
T KOG0694|consen  590 FLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID  631 (694)
T ss_pred             cccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCC
Confidence            99999999999999999999995     68999999999874

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.1e-50  Score=330.22  Aligned_cols=273  Identities=26%  Similarity=0.359  Sum_probs=232.5

Q ss_pred             chhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCCh-HHHHHHHHHHHHHHcCCCCccceeceeEEcC-C
Q 020657           45 TAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADP-TVRRQVFREMEILRRTDSPFIVQCFGIFEKP-S  122 (323)
Q Consensus        45 ~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~  122 (323)
                      ...-..++|+++.+|++|.||.||+|+|+.+++.||+|.++.+... ...-.-++|+.++.+.+|||||.+-.++... -
T Consensus        70 ~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~  149 (419)
T KOG0663|consen   70 GGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM  149 (419)
T ss_pred             cCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc
Confidence            3445678999999999999999999999999999999999866432 2333457999999999999999999987542 3


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhh
Q 020657          123 GDIAILMEYMDSGTLDTLLNKNG-TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM  201 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~  201 (323)
                      +.+|+|||||++ +|..++..-+ +++..++.-++.|+++|++|||...|+|||||++|+|+++.| .+||+|||+|+.+
T Consensus       150 d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G-~lKiaDFGLAR~y  227 (419)
T KOG0663|consen  150 DKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKG-ILKIADFGLAREY  227 (419)
T ss_pred             ceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCC-cEEecccchhhhh
Confidence            458999999987 9999998654 899999999999999999999999999999999999999998 8999999999999


Q ss_pred             ccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCC---
Q 020657          202 CRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPP---  278 (323)
Q Consensus       202 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~---  278 (323)
                      +++.......+.|..|+|||.+.    +...++...|+||+||++.||++++..|.+.+.-+....+.+........   
T Consensus       228 gsp~k~~T~lVVTLWYRaPELLL----G~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwp  303 (419)
T KOG0663|consen  228 GSPLKPYTPLVVTLWYRAPELLL----GAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWP  303 (419)
T ss_pred             cCCcccCcceEEEeeecCHHHhc----CCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCC
Confidence            98877777889999999999996    55667789999999999999999999998887766666655444322110   


Q ss_pred             -----------------------CCCC-CCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCCCCC
Q 020657          279 -----------------------SLPD-GASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSDC  323 (323)
Q Consensus       279 -----------------------~~~~-~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~~~  323 (323)
                                             .+.. .+++...+|+..+|.+||.+|.|+++.|+|.||.+...+.|
T Consensus       304 g~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~  372 (419)
T KOG0663|consen  304 GYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPID  372 (419)
T ss_pred             CccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCC
Confidence                                   1111 15688999999999999999999999999999999877654

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=5.4e-49  Score=340.46  Aligned_cols=259  Identities=25%  Similarity=0.383  Sum_probs=210.7

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      .++|++.+.||.|+||.||+|.+..+++.||+|++...........+.+|+.+++.++||||+++++++.. ....++||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~   82 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHT-ERCLTLVF   82 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC-CCeEEEEE
Confidence            57899999999999999999999989999999999755444444567789999999999999999999987 67899999


Q ss_pred             eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          130 EYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       130 e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      ||+++ +|.+.+... ..+++..+..++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++..........
T Consensus        83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~DfG~~~~~~~~~~~~  160 (288)
T cd07871          83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKG-ELKLADFGLARAKSVPTKTY  160 (288)
T ss_pred             eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEECcCcceeeccCCCccc
Confidence            99986 898888654 3579999999999999999999999999999999999999987 89999999987654433333


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC------------
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD------------  276 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~------------  276 (323)
                      ....++..|+|||++.+    ...++.++||||+|+++|+|+||+.||.+.........+........            
T Consensus       161 ~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07871         161 SNEVVTLWYRPPDVLLG----STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE  236 (288)
T ss_pred             cCceecccccChHHhcC----CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence            45567899999998752    23346699999999999999999999976543333222221111000            


Q ss_pred             -----CC--------CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          277 -----PP--------SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       277 -----~~--------~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                           .+        .....++.++.+|+++||++||.+|||++++|+||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence                 00        0113567899999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-50  Score=333.15  Aligned_cols=267  Identities=26%  Similarity=0.394  Sum_probs=221.1

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEc----CCC
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEK----PSG  123 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~  123 (323)
                      ....|..++.||+|++|.|+.|.++.+|+.||+|.+.... .....++..+|++++++++|+||+.+.+++..    .-.
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            3456666899999999999999999999999999997443 34557788999999999999999999999764    234


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          124 DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      .+|+|+|+|+ .+|..+++.+..+++..+..+++||++||.|+|+.|++|||+||.|++++.++ .+||+|||+|+....
T Consensus       100 DvYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c-~lKI~DFGLAR~~~~  177 (359)
T KOG0660|consen  100 DVYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADC-DLKICDFGLARYLDK  177 (359)
T ss_pred             eeEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCC-CEEeccccceeeccc
Confidence            6899999995 49999999988899999999999999999999999999999999999999998 899999999987753


Q ss_pred             C--ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcC------
Q 020657          204 S--LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFG------  275 (323)
Q Consensus       204 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~------  275 (323)
                      .  ......++.|..|+|||++.    ....+|.+.||||.||++.||++|+..|.+.+.......+.......      
T Consensus       178 ~~~~~~mTeYVaTRWYRAPElll----~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~  253 (359)
T KOG0660|consen  178 FFEDGFMTEYVATRWYRAPELLL----NSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ  253 (359)
T ss_pred             cCcccchhcceeeeeecCHHHHh----ccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence            2  22234578899999999985    34456779999999999999999999998776544333322211111      


Q ss_pred             ---------------CCCC-----CCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCCC
Q 020657          276 ---------------DPPS-----LPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS  321 (323)
Q Consensus       276 ---------------~~~~-----~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~  321 (323)
                                     ..+.     +..++++++.+|+++||..||.+|+|++|+|+||||+.-+.+
T Consensus       254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp  319 (359)
T KOG0660|consen  254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP  319 (359)
T ss_pred             HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence                           1111     225789999999999999999999999999999999876543

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.3e-48  Score=340.59  Aligned_cols=263  Identities=25%  Similarity=0.384  Sum_probs=208.9

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+|+.+++.++||||+++++++.+ ....++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~   82 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT-KETLTLVF   82 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec-CCeEEEEE
Confidence            47899999999999999999999989999999999755443444567789999999999999999999987 67899999


Q ss_pred             eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          130 EYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       130 e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      ||+.+ +|.+.+.. ...+++..+..++.||+.||.|||+.|++|+||||+||+++.++ .+||+|||++..........
T Consensus        83 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~  160 (303)
T cd07869          83 EYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTG-ELKLADFGLARAKSVPSHTY  160 (303)
T ss_pred             ECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECCCCcceeccCCCccC
Confidence            99965 77777654 35689999999999999999999999999999999999999987 89999999986544333333


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCc-cHHHHHHHHhcCC-----------
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRP-DWATLMCAICFGD-----------  276 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~-~~~~~~~~~~~~~-----------  276 (323)
                      ....++..|+|||++.+    ...++.++||||||+++|+|++|..||.+..... ....+........           
T Consensus       161 ~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T cd07869         161 SNEVVTLWYRPPDVLLG----STEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP  236 (303)
T ss_pred             CCCcccCCCCChHHHcC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence            44567899999998752    2334568999999999999999999997543211 1111111110000           


Q ss_pred             ---CCCC----C---------CCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          277 ---PPSL----P---------DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       277 ---~~~~----~---------~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                         +..+    +         ...+.++.+|+.+||+.||++|||++++++||||++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence               0000    0         12356789999999999999999999999999998764

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.5e-49  Score=346.92  Aligned_cols=250  Identities=28%  Similarity=0.512  Sum_probs=212.3

Q ss_pred             eeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEeccCC
Q 020657           57 QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDS  134 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~  134 (323)
                      +.||+|+||.||+|.+..+++.||+|++....  .......+.+|+.+++.+.||||+++++++.. .+.+++||||+.+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~~   79 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT-HDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc-CCEEEEEEeCCCC
Confidence            36999999999999999999999999987432  22344567789999999999999999999987 6789999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccccccccc
Q 020657          135 GTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGT  214 (323)
Q Consensus       135 ~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  214 (323)
                      ++|.+.+...+.+++..+..++.||+.||+|||+.|++||||||+||+++.++ .+||+|||++..............++
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~-~~kl~DfG~a~~~~~~~~~~~~~~gt  158 (323)
T cd05571          80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG-HIKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC-CEEEeeCCCCcccccCCCcccceecC
Confidence            99999998888899999999999999999999999999999999999999987 89999999987543333333456789


Q ss_pred             ccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHH
Q 020657          215 CAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIEC  294 (323)
Q Consensus       215 ~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~  294 (323)
                      ..|+|||++...     .++.++||||||+++|+|++|..||.....    ..+...+. .....++..+++++.+|+++
T Consensus       159 ~~y~aPE~~~~~-----~~~~~~DiwSlG~il~elltg~~Pf~~~~~----~~~~~~~~-~~~~~~p~~~~~~~~~li~~  228 (323)
T cd05571         159 PEYLAPEVLEDN-----DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKLFELIL-MEEIRFPRTLSPEAKSLLAG  228 (323)
T ss_pred             ccccChhhhcCC-----CCCccccCcccchhhhhhhcCCCCCCCCCH----HHHHHHHH-cCCCCCCCCCCHHHHHHHHH
Confidence            999999998643     345699999999999999999999955332    33333332 23346677899999999999


Q ss_pred             hcccCcCCCC-----CHHHHhcCcccccC
Q 020657          295 CLQKEFSKRW-----TASQLLTHPFLCKN  318 (323)
Q Consensus       295 ~l~~~p~~Rp-----t~~~~l~h~~f~~~  318 (323)
                      ||+.||++||     ++.++++||||.+.
T Consensus       229 ~L~~dP~~R~~~~~~~~~~ll~h~~f~~~  257 (323)
T cd05571         229 LLKKDPKQRLGGGPEDAKEIMEHRFFASI  257 (323)
T ss_pred             HccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            9999999999     89999999999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-49  Score=340.76  Aligned_cols=254  Identities=28%  Similarity=0.465  Sum_probs=215.5

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....  .......+.+|+.+++.+.||||+++++++.+ ....++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv   79 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD-QRFLYML   79 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc-CCeEEEE
Confidence            47999999999999999999999899999999986432  22345667899999999999999999999887 6789999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          129 MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      |||+.+++|.+++...+.+++..+..++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++......   .
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~-~~kl~Dfg~~~~~~~~---~  155 (291)
T cd05612          80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG-HIKLTDFGFAKKLRDR---T  155 (291)
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEEEecCcchhccCC---c
Confidence            99999999999998888899999999999999999999999999999999999999987 8999999998765332   2


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhH
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEF  288 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (323)
                      ....++..|+|||++....     .+.++||||||+++|+|++|..||.....    ..+.+.+.. ....++..++..+
T Consensus       156 ~~~~gt~~y~aPE~~~~~~-----~~~~~DiwSlG~il~~l~~g~~pf~~~~~----~~~~~~i~~-~~~~~~~~~~~~~  225 (291)
T cd05612         156 WTLCGTPEYLAPEVIQSKG-----HNKAVDWWALGILIYEMLVGYPPFFDDNP----FGIYEKILA-GKLEFPRHLDLYA  225 (291)
T ss_pred             ccccCChhhcCHHHHcCCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHh-CCcCCCccCCHHH
Confidence            2346889999999986433     45699999999999999999999965433    222222222 2345667789999


Q ss_pred             HHHHHHhcccCcCCCCC-----HHHHhcCcccccCC
Q 020657          289 RSFIECCLQKEFSKRWT-----ASQLLTHPFLCKNR  319 (323)
Q Consensus       289 ~~ll~~~l~~~p~~Rpt-----~~~~l~h~~f~~~~  319 (323)
                      .+|+++||+.||.+|++     ++++++||||+...
T Consensus       226 ~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~  261 (291)
T cd05612         226 KDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVD  261 (291)
T ss_pred             HHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCC
Confidence            99999999999999995     99999999997643

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.3e-49  Score=330.94  Aligned_cols=264  Identities=31%  Similarity=0.508  Sum_probs=228.9

Q ss_pred             cchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcC
Q 020657           44 TTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP  121 (323)
Q Consensus        44 ~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  121 (323)
                      ....+..++|++++.||.|..|+||+++...++..+|+|++.+..  ......+...|.+||+.+.||.++.+|..|+. 
T Consensus        70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet-  148 (459)
T KOG0610|consen   70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET-  148 (459)
T ss_pred             CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec-
Confidence            446677889999999999999999999999999999999997552  23456678889999999999999999999998 


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcch
Q 020657          122 SGDIAILMEYMDSGTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       122 ~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                      +...|++||||+||+|..++++.  +.+++..++.++.+|+-||+|||..|||+|||||+|||+.++| .+.|+||.++.
T Consensus       149 ~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredG-HIMLsDFDLS~  227 (459)
T KOG0610|consen  149 DKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDG-HIMLSDFDLSL  227 (459)
T ss_pred             cceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCC-cEEeeeccccc
Confidence            78999999999999999999764  4699999999999999999999999999999999999999998 89999999985


Q ss_pred             hhcc---------------------------------Ccc-----------------------ccccccccccccCCccc
Q 020657          200 IMCR---------------------------------SLD-----------------------ACNSYVGTCAYMSPERF  223 (323)
Q Consensus       200 ~~~~---------------------------------~~~-----------------------~~~~~~~~~~y~aPE~~  223 (323)
                      ....                                 ...                       ....++||-.|+|||++
T Consensus       228 ~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI  307 (459)
T KOG0610|consen  228 RCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI  307 (459)
T ss_pred             cCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence            3210                                 000                       01235789999999999


Q ss_pred             CCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCC--CCCChhHHHHHHHhcccCcC
Q 020657          224 DPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLP--DGASPEFRSFIECCLQKEFS  301 (323)
Q Consensus       224 ~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~ll~~~l~~~p~  301 (323)
                      .+..++.     ++|+|+||+++|||+.|.-||.+.++..++.++..+     +..++  ..++..++|||+++|..||+
T Consensus       308 ~G~GHgs-----AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~-----~l~Fp~~~~vs~~akDLIr~LLvKdP~  377 (459)
T KOG0610|consen  308 RGEGHGS-----AVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ-----PLKFPEEPEVSSAAKDLIRKLLVKDPS  377 (459)
T ss_pred             ecCCCCc-----hhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC-----CCcCCCCCcchhHHHHHHHHHhccChh
Confidence            9777665     999999999999999999999999988877776532     33444  36789999999999999999


Q ss_pred             CCCC----HHHHhcCcccccCC
Q 020657          302 KRWT----ASQLLTHPFLCKNR  319 (323)
Q Consensus       302 ~Rpt----~~~~l~h~~f~~~~  319 (323)
                      +|..    +.||-+||||++.+
T Consensus       378 kRlg~~rGA~eIK~HpFF~gVn  399 (459)
T KOG0610|consen  378 KRLGSKRGAAEIKRHPFFEGVN  399 (459)
T ss_pred             hhhccccchHHhhcCccccCCC
Confidence            9998    99999999999875

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=6.9e-50  Score=348.80  Aligned_cols=255  Identities=32%  Similarity=0.558  Sum_probs=227.4

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      ++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+.. .....+.+.+|++++++++||||+..++.|++ +..+++|+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt-~~~~~vVt   80 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET-SAHLWVVT   80 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc-cceEEEEe
Confidence            57999999999999999999999999999999997664 34567889999999999999999999999998 78999999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccc
Q 020657          130 EYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN  209 (323)
Q Consensus       130 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~  209 (323)
                      ||+.| +|..++...+.++++.+..++.+++.||.|||+.+|.|+|+||.||+++..| .+|++|||+|+..........
T Consensus        81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~-~~KlcdFg~Ar~m~~~t~vlt  158 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGG-TLKLCDFGLARAMSTNTSVLT  158 (808)
T ss_pred             hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCC-ceeechhhhhhhcccCceeee
Confidence            99987 9999999999999999999999999999999999999999999999999987 899999999998877666667


Q ss_pred             cccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHH
Q 020657          210 SYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFR  289 (323)
Q Consensus       210 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  289 (323)
                      ...||+.|+|||+..+     ..++..+|+||+||++||+++|+.||...    .+..+.+.+. .++...|..++..+.
T Consensus       159 sikGtPlYmAPElv~e-----~pyd~~sDlWslGcilYE~~~G~PPF~a~----si~~Lv~~I~-~d~v~~p~~~S~~f~  228 (808)
T KOG0597|consen  159 SIKGTPLYMAPELVEE-----QPYDHTSDLWSLGCILYELYVGQPPFYAR----SITQLVKSIL-KDPVKPPSTASSSFV  228 (808)
T ss_pred             eccCcccccCHHHHcC-----CCccchhhHHHHHHHHHHHhcCCCCchHH----HHHHHHHHHh-cCCCCCcccccHHHH
Confidence            7789999999999874     44556999999999999999999999443    3344443333 345566679999999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          290 SFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       290 ~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      +|+..+|..||..|.|-.++++|||.++.
T Consensus       229 nfl~gLL~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  229 NFLQGLLIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             HHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence            99999999999999999999999998764

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=7e-49  Score=345.82  Aligned_cols=258  Identities=29%  Similarity=0.471  Sum_probs=218.9

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCC
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG  123 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  123 (323)
                      .....++|++.+.||+|+||.||+|++..+++.||+|++....  .......+.+|+.+++.++||||+++++++.. ++
T Consensus        13 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~   91 (329)
T PTZ00263         13 SSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD-EN   91 (329)
T ss_pred             CCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc-CC
Confidence            3445689999999999999999999999999999999986432  22345668899999999999999999999987 67


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          124 DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      ..++||||+.+++|.+.+.....+++..+..++.||+.||.|||+.|++|+||||+||+++.++ .+||+|||++.....
T Consensus        92 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         92 RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKG-HVKVTDFGFAKKVPD  170 (329)
T ss_pred             EEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCC-CEEEeeccCceEcCC
Confidence            8999999999999999998888899999999999999999999999999999999999999987 899999999976533


Q ss_pred             CccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCC
Q 020657          204 SLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDG  283 (323)
Q Consensus       204 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (323)
                      ..   ....++..|+|||++....     .+.++||||||+++|+|++|..||.....    ....+.+.. ....++..
T Consensus       171 ~~---~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~elltg~~pf~~~~~----~~~~~~i~~-~~~~~p~~  237 (329)
T PTZ00263        171 RT---FTLCGTPEYLAPEVIQSKG-----HGKAVDWWTMGVLLYEFIAGYPPFFDDTP----FRIYEKILA-GRLKFPNW  237 (329)
T ss_pred             Cc---ceecCChhhcCHHHHcCCC-----CCCcceeechHHHHHHHHcCCCCCCCCCH----HHHHHHHhc-CCcCCCCC
Confidence            22   2356889999999986443     45699999999999999999999965432    222233322 23456677


Q ss_pred             CChhHHHHHHHhcccCcCCCCC-----HHHHhcCcccccC
Q 020657          284 ASPEFRSFIECCLQKEFSKRWT-----ASQLLTHPFLCKN  318 (323)
Q Consensus       284 ~~~~l~~ll~~~l~~~p~~Rpt-----~~~~l~h~~f~~~  318 (323)
                      ++..+.+|+++||+.||++|++     ++++++||||.+.
T Consensus       238 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~  277 (329)
T PTZ00263        238 FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA  277 (329)
T ss_pred             CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence            8999999999999999999997     7999999999864

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-51  Score=322.82  Aligned_cols=265  Identities=28%  Similarity=0.452  Sum_probs=225.9

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeE
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDI  125 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  125 (323)
                      ....+.|++.+.||+|.|+.|+++....+|+.+++|++.... .....+.+.+|+.+-+.|+||||+.+.+.+.+ ++..
T Consensus         7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~-~~~~   85 (355)
T KOG0033|consen    7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ESFH   85 (355)
T ss_pred             cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcc-ccee
Confidence            345688999999999999999999999999999999986432 22346678899999999999999999999887 7899


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEec--CCCcEEEeecCcchhhcc
Q 020657          126 AILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNN--NNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~--~~~~~kl~Dfg~~~~~~~  203 (323)
                      ++|+|++.|+.|..-+-....+++..+-.+++||++||.|+|..||||||+||.|+++-.  .+.-+||+|||++.... 
T Consensus        86 ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-  164 (355)
T KOG0033|consen   86 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-  164 (355)
T ss_pred             EEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence            999999999999766655556899999999999999999999999999999999999954  34589999999998876 


Q ss_pred             CccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCC
Q 020657          204 SLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDG  283 (323)
Q Consensus       204 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (323)
                      ......+.+|++.|+|||++...+++.     .+|||+.|++||-|+.|.+||.+.+....++.+++ -....+.....+
T Consensus       165 ~g~~~~G~~GtP~fmaPEvvrkdpy~k-----pvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~-g~yd~~~~~w~~  238 (355)
T KOG0033|consen  165 DGEAWHGFAGTPGYLSPEVLKKDPYSK-----PVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKA-GAYDYPSPEWDT  238 (355)
T ss_pred             CccccccccCCCcccCHHHhhcCCCCC-----cchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhc-cccCCCCcccCc
Confidence            556667889999999999998777665     89999999999999999999976555443333332 222334556688


Q ss_pred             CChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          284 ASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       284 ~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      ++++.++|+++||..||.+|.|+.|+|+|||+.++.
T Consensus       239 is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~  274 (355)
T KOG0033|consen  239 VTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRE  274 (355)
T ss_pred             CCHHHHHHHHHHhccChhhhccHHHHhCCchhcchH
Confidence            999999999999999999999999999999998764

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.1e-50  Score=334.28  Aligned_cols=262  Identities=30%  Similarity=0.456  Sum_probs=219.9

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCC----eEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG----DIA  126 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~~  126 (323)
                      -.|+..+++|.|+||.||.|....+++.||||.+..+..     .-.+|+++|+.+.||||+++.-+|....+    ...
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln   98 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN   98 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence            357788999999999999999998999999999875542     23479999999999999999988754322    456


Q ss_pred             EEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          127 ILMEYMDSGTLDTLLNK----NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      +||||++. ||.+.++.    +..++.-.++-+.+||++||+|||+.||+||||||.|+|+|.+...+||||||.|....
T Consensus        99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~  177 (364)
T KOG0658|consen   99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV  177 (364)
T ss_pred             HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence            99999986 99999974    56899999999999999999999999999999999999999986699999999998876


Q ss_pred             cCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCC-----
Q 020657          203 RSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP-----  277 (323)
Q Consensus       203 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~-----  277 (323)
                      .+.+. .++..+..|+|||.+.    +...++.+.||||.||++.||+-|+..|.+.+..+....+.........     
T Consensus       178 ~~epn-iSYicSRyYRaPELif----ga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~  252 (364)
T KOG0658|consen  178 KGEPN-ISYICSRYYRAPELIF----GATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS  252 (364)
T ss_pred             cCCCc-eeEEEeccccCHHHHc----CccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            55444 5678899999999986    5667788999999999999999999999887665554444333221111     


Q ss_pred             ----------C---------CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCCCCC
Q 020657          278 ----------P---------SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSDC  323 (323)
Q Consensus       278 ----------~---------~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~~~  323 (323)
                                +         .+....++++.+|+.++|.++|.+|.++.+++.||||+.-+.++|
T Consensus       253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~  317 (364)
T KOG0658|consen  253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNT  317 (364)
T ss_pred             cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCc
Confidence                      0         134567899999999999999999999999999999998887654

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=8.6e-48  Score=339.26  Aligned_cols=263  Identities=40%  Similarity=0.716  Sum_probs=218.8

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEE
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      +..++|++.+.||+|++|.||++++..++..+++|++...........+.+|+++++.++||||+++++++.. ++..++
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~l   80 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISI   80 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCEEEE
Confidence            4568999999999999999999999999999999999876566667789999999999999999999999987 678999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc
Q 020657          128 LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH-KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD  206 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~  206 (323)
                      ||||+++++|.+++.....+++..+..++.|++.||.|||+. +++|+||||+||+++.++ .++|+|||++......  
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~--  157 (331)
T cd06649          81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS--  157 (331)
T ss_pred             EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC-cEEEccCccccccccc--
Confidence            999999999999998888899999999999999999999986 699999999999999987 8999999998765332  


Q ss_pred             ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccH---------------------
Q 020657          207 ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDW---------------------  265 (323)
Q Consensus       207 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~---------------------  265 (323)
                      ......++..|+|||++.+.     .++.++||||||+++|+|+||..||.........                     
T Consensus       158 ~~~~~~g~~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (331)
T cd06649         158 MANSFVGTRSYMSPERLQGT-----HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPR  232 (331)
T ss_pred             ccccCCCCcCcCCHhHhcCC-----CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcc
Confidence            22345688999999998633     3456999999999999999999999543221100                     


Q ss_pred             ---------------------HHHHHHHhcCCCCCCC-CCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          266 ---------------------ATLMCAICFGDPPSLP-DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       266 ---------------------~~~~~~~~~~~~~~~~-~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                                           ..+...+.....+..+ ..+++++.+||++||++||++|||++++++||||+...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence                                 0111111112222222 24688999999999999999999999999999997654

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-48  Score=343.28  Aligned_cols=258  Identities=29%  Similarity=0.438  Sum_probs=215.3

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ++|++.+.||+|++|.||+|++..+++.||+|++....  .......+.+|+.++..++||||+++++++.. .+..++|
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-~~~~~lv   79 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD-DEYLYLA   79 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc-CCEEEEE
Confidence            47999999999999999999999899999999986442  22345667889999999999999999999987 6789999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          129 MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      |||+++++|.+++.....+++..+..++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++.....   ..
T Consensus        80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kL~Dfg~a~~~~~---~~  155 (333)
T cd05600          80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASG-HIKLTDFGLSKGIVT---YA  155 (333)
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-CEEEEeCcCCccccc---cc
Confidence            99999999999998888899999999999999999999999999999999999999987 899999999976533   23


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCC---CCCC
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLP---DGAS  285 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~  285 (323)
                      ....++..|+|||++...     .++.++||||||+++|+|++|..||...........+.........+...   ..++
T Consensus       156 ~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s  230 (333)
T cd05600         156 NSVVGSPDYMAPEVLRGK-----GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLS  230 (333)
T ss_pred             CCcccCccccChhHhcCC-----CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccC
Confidence            345689999999998643     44569999999999999999999996544333333322211111112211   2568


Q ss_pred             hhHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          286 PEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       286 ~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      .++.+|+.+||+.+|.+|||++++++||||.+.
T Consensus       231 ~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         231 DEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             HHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence            999999999999999999999999999999875

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=5.9e-48  Score=333.46  Aligned_cols=259  Identities=25%  Similarity=0.428  Sum_probs=215.4

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+....  .......+.+|+.+++.+.|++|+++++++.+ .+..++||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~-~~~~~lv~   79 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET-KDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc-CCeEEEEE
Confidence            3788999999999999999999899999999986442  12234467789999999999999999999987 67899999


Q ss_pred             eccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccc
Q 020657          130 EYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA  207 (323)
Q Consensus       130 e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~  207 (323)
                      ||+++++|.+.+..  ...+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++...... ..
T Consensus        80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~-~~kl~Dfg~~~~~~~~-~~  157 (285)
T cd05631          80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRG-HIRISDLGLAVQIPEG-ET  157 (285)
T ss_pred             EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC-CEEEeeCCCcEEcCCC-Ce
Confidence            99999999888754  33689999999999999999999999999999999999999887 8999999998765322 22


Q ss_pred             cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChh
Q 020657          208 CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPE  287 (323)
Q Consensus       208 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (323)
                      .....++..|+|||++...     .++.++||||||+++|+|++|..||...........+..... .....++..++.+
T Consensus       158 ~~~~~g~~~y~aPE~~~~~-----~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~  231 (285)
T cd05631         158 VRGRVGTVGYMAPEVINNE-----KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK-EDQEEYSEKFSED  231 (285)
T ss_pred             ecCCCCCCCccCHhhhcCC-----CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhh-cccccCCccCCHH
Confidence            2345789999999998743     345699999999999999999999976554433333333322 2334566778999


Q ss_pred             HHHHHHHhcccCcCCCCC-----HHHHhcCcccccCC
Q 020657          288 FRSFIECCLQKEFSKRWT-----ASQLLTHPFLCKNR  319 (323)
Q Consensus       288 l~~ll~~~l~~~p~~Rpt-----~~~~l~h~~f~~~~  319 (323)
                      +.+|+++||+.||++||+     ++++++||||++..
T Consensus       232 ~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~  268 (285)
T cd05631         232 AKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN  268 (285)
T ss_pred             HHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence            999999999999999997     89999999998875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-50  Score=342.65  Aligned_cols=259  Identities=34%  Similarity=0.565  Sum_probs=230.3

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      ...|.....||+|.||.||+|.+..+++.||+|++..+........+++|+.++..++++||.+.++.|.. +..++++|
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~-g~~LwiiM   90 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLK-GTKLWIIM   90 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheee-cccHHHHH
Confidence            46688889999999999999999999999999999988777788899999999999999999999999987 67899999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccc
Q 020657          130 EYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN  209 (323)
Q Consensus       130 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~  209 (323)
                      |||.||++.+.++.+..+++..+.-++++++.|+.|||.++.+|+|||+.||++..+| .+||+|||.+...........
T Consensus        91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g-~vkl~DfgVa~ql~~~~~rr~  169 (467)
T KOG0201|consen   91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESG-DVKLADFGVAGQLTNTVKRRK  169 (467)
T ss_pred             HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccC-cEEEEecceeeeeechhhccc
Confidence            9999999999999888889999999999999999999999999999999999999997 899999999988877666668


Q ss_pred             cccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHH
Q 020657          210 SYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFR  289 (323)
Q Consensus       210 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  289 (323)
                      .++||+.|||||++..     ..++.++||||||++.+||.+|..|+.....    ...+-.+....++.+....++.++
T Consensus       170 tfvGTPfwMAPEVI~~-----~~Y~~KADIWSLGITaiEla~GePP~s~~hP----mrvlflIpk~~PP~L~~~~S~~~k  240 (467)
T KOG0201|consen  170 TFVGTPFWMAPEVIKQ-----SGYDTKADIWSLGITAIELAKGEPPHSKLHP----MRVLFLIPKSAPPRLDGDFSPPFK  240 (467)
T ss_pred             cccccccccchhhhcc-----ccccchhhhhhhhHHHHHHhcCCCCCcccCc----ceEEEeccCCCCCccccccCHHHH
Confidence            8999999999999973     3455699999999999999999999954432    122222333456667778899999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          290 SFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       290 ~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      +||..||+.||+.||++.++|+|+|+++..
T Consensus       241 EFV~~CL~k~P~~RpsA~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  241 EFVEACLDKNPEFRPSAKELLKHKFIKRAK  270 (467)
T ss_pred             HHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence            999999999999999999999999998743

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.9e-48  Score=342.80  Aligned_cols=261  Identities=25%  Similarity=0.429  Sum_probs=218.7

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEecccC-cEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEE
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTH-KIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFE  119 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~-~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  119 (323)
                      .....+..++|++.+.||+|+||.||+|.+..++ ..||+|++....  .......+.+|+.+++.++||||+++++++.
T Consensus        22 ~~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~  101 (340)
T PTZ00426         22 KRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK  101 (340)
T ss_pred             ccCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence            3445567889999999999999999999976554 689999986431  2234556788999999999999999999998


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcch
Q 020657          120 KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       120 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                      + .+..++||||+.+++|.+++...+.+++..+..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++.
T Consensus       102 ~-~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~-~ikL~DFG~a~  179 (340)
T PTZ00426        102 D-ESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG-FIKMTDFGFAK  179 (340)
T ss_pred             e-CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC-CEEEecCCCCe
Confidence            7 678999999999999999999888899999999999999999999999999999999999999887 89999999997


Q ss_pred             hhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCC
Q 020657          200 IMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPS  279 (323)
Q Consensus       200 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  279 (323)
                      .....   .....++..|+|||++...     .++.++||||||+++|+|++|..||.......    ....+.. ....
T Consensus       180 ~~~~~---~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~----~~~~i~~-~~~~  246 (340)
T PTZ00426        180 VVDTR---TYTLCGTPEYIAPEILLNV-----GHGKAADWWTLGIFIYEILVGCPPFYANEPLL----IYQKILE-GIIY  246 (340)
T ss_pred             ecCCC---cceecCChhhcCHHHHhCC-----CCCccccccchhhHHHHHhcCCCCCCCCCHHH----HHHHHhc-CCCC
Confidence            65322   2345689999999998643     34569999999999999999999996543322    2222222 2345


Q ss_pred             CCCCCChhHHHHHHHhcccCcCCCC-----CHHHHhcCcccccC
Q 020657          280 LPDGASPEFRSFIECCLQKEFSKRW-----TASQLLTHPFLCKN  318 (323)
Q Consensus       280 ~~~~~~~~l~~ll~~~l~~~p~~Rp-----t~~~~l~h~~f~~~  318 (323)
                      ++..+++++.+++++||+.||++|+     |++++++||||.+.
T Consensus       247 ~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~  290 (340)
T PTZ00426        247 FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI  290 (340)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            6778899999999999999999995     89999999999875

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=4e-48  Score=340.12  Aligned_cols=251  Identities=27%  Similarity=0.507  Sum_probs=210.9

Q ss_pred             eeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEeccCC
Q 020657           57 QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDS  134 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~  134 (323)
                      +.||+|+||.||++++..+++.||+|++....  .......+.+|+.+++.++||||+++++.+.. .+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~-~~~~~lv~E~~~~   79 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-HDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec-CCEEEEEEeCCCC
Confidence            36899999999999999899999999997542  22344567789999999999999999999987 6789999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccccccccc
Q 020657          135 GTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGT  214 (323)
Q Consensus       135 ~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  214 (323)
                      ++|...+.....+++..++.++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++..............++
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~gt  158 (323)
T cd05595          80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCC-CEEecccHHhccccCCCCccccccCC
Confidence            99999998888899999999999999999999999999999999999999987 89999999986543333333445789


Q ss_pred             ccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHH
Q 020657          215 CAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIEC  294 (323)
Q Consensus       215 ~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~  294 (323)
                      ..|+|||++...     .++.++||||||+++|+|++|..||...+..    ....... .....++..+++++.+|+++
T Consensus       159 ~~y~aPE~~~~~-----~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~----~~~~~~~-~~~~~~p~~~~~~~~~li~~  228 (323)
T cd05595         159 PEYLAPEVLEDN-----DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFELIL-MEEIRFPRTLSPEAKSLLAG  228 (323)
T ss_pred             cCcCCcccccCC-----CCCchhchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHh-cCCCCCCCCCCHHHHHHHHH
Confidence            999999998643     3456999999999999999999999654332    2222222 22345667889999999999


Q ss_pred             hcccCcCCCC-----CHHHHhcCcccccCC
Q 020657          295 CLQKEFSKRW-----TASQLLTHPFLCKNR  319 (323)
Q Consensus       295 ~l~~~p~~Rp-----t~~~~l~h~~f~~~~  319 (323)
                      ||+.||++|+     ++.++++|+||.+..
T Consensus       229 ~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~  258 (323)
T cd05595         229 LLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  258 (323)
T ss_pred             HccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence            9999999998     899999999998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=7.6e-48  Score=339.00  Aligned_cols=250  Identities=28%  Similarity=0.516  Sum_probs=211.2

Q ss_pred             eeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEeccCC
Q 020657           57 QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDS  134 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~  134 (323)
                      +.||+|+||.||++++..+++.||+|++....  .......+.+|+.+++.+.||||+++++++.. .+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~Ey~~~   79 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT-KDRLCFVMEYVNG   79 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-CCEEEEEEeCCCC
Confidence            36899999999999999999999999997542  23345677889999999999999999999987 6789999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccccccccc
Q 020657          135 GTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGT  214 (323)
Q Consensus       135 ~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  214 (323)
                      ++|...+.....+++..+..++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++..............++
T Consensus        80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-~~kL~DfG~~~~~~~~~~~~~~~~gt  158 (328)
T cd05593          80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDG-HIKITDFGLCKEGITDAATMKTFCGT  158 (328)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCC-cEEEecCcCCccCCCcccccccccCC
Confidence            99999998888899999999999999999999999999999999999999987 89999999986543333333445789


Q ss_pred             ccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHH
Q 020657          215 CAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIEC  294 (323)
Q Consensus       215 ~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~  294 (323)
                      ..|+|||++....     ++.++||||||+++|+|++|..||...+.    ..+...+. .....++..++.++.+|+++
T Consensus       159 ~~y~aPE~~~~~~-----~~~~~DiwslGvil~elltG~~Pf~~~~~----~~~~~~~~-~~~~~~p~~~~~~~~~li~~  228 (328)
T cd05593         159 PEYLAPEVLEDND-----YGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKLFELIL-MEDIKFPRTLSADAKSLLSG  228 (328)
T ss_pred             cCccChhhhcCCC-----CCccCCccccchHHHHHhhCCCCCCCCCH----HHHHHHhc-cCCccCCCCCCHHHHHHHHH
Confidence            9999999986433     45699999999999999999999965432    23333222 23345677899999999999


Q ss_pred             hcccCcCCCC-----CHHHHhcCcccccC
Q 020657          295 CLQKEFSKRW-----TASQLLTHPFLCKN  318 (323)
Q Consensus       295 ~l~~~p~~Rp-----t~~~~l~h~~f~~~  318 (323)
                      ||+.||++|+     +++++++|+||.+.
T Consensus       229 ~L~~dP~~R~~~~~~~~~~il~h~~~~~~  257 (328)
T cd05593         229 LLIKDPNKRLGGGPDDAKEIMRHSFFTGV  257 (328)
T ss_pred             HcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            9999999997     89999999999764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.1e-47  Score=332.19  Aligned_cols=258  Identities=28%  Similarity=0.424  Sum_probs=208.4

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      ++|++.+.||+|++|.||+|++..+++.+++|++.... .......+.+|+.+++.++|+||+++++++.. ++..++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR-RGKLYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec-CCEEEEEE
Confidence            47999999999999999999999899999999987543 23345677899999999999999999999987 67899999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc-cc
Q 020657          130 EYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD-AC  208 (323)
Q Consensus       130 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~-~~  208 (323)
                      ||++++++..+......+++..+..++.||+.||.|||+.|++|+||||+||+++.++ .+||+|||++........ ..
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~  158 (287)
T cd07848          80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND-VLKLCDFGFARNLSEGSNANY  158 (287)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEEeeccCcccccccccccc
Confidence            9999877776665556799999999999999999999999999999999999999987 899999999976543221 22


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHh------------c--
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAIC------------F--  274 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~------------~--  274 (323)
                      ....++..|+|||++....     ++.++||||||+++|+|++|+.||...........+.....            .  
T Consensus       159 ~~~~~~~~y~aPE~~~~~~-----~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07848         159 TEYVATRWYRSPELLLGAP-----YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR  233 (287)
T ss_pred             cccccccccCCcHHHcCCC-----CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence            3456889999999986433     45699999999999999999999965443222211111000            0  


Q ss_pred             ---CCCC----------CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          275 ---GDPP----------SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       275 ---~~~~----------~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                         ...+          .....++.++.+|+++||+.||++|||++++|+||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence               0000          0112367889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-48  Score=337.98  Aligned_cols=248  Identities=27%  Similarity=0.505  Sum_probs=210.2

Q ss_pred             ecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEeccCCCC
Q 020657           59 LGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGT  136 (323)
Q Consensus        59 lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~s  136 (323)
                      ||+|+||.||+|.+..+++.||+|++....  .......+.+|+.+++.++||||+++++++.. .+..++||||+++++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~g~   79 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS-PEKLYLVLAFINGGE   79 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec-CCeEEEEEcCCCCCc
Confidence            699999999999999899999999986431  23345667889999999999999999999987 678999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccccccccccc
Q 020657          137 LDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA  216 (323)
Q Consensus       137 L~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~  216 (323)
                      |.+++.....+++..+..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++..............++..
T Consensus        80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~  158 (312)
T cd05585          80 LFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQG-HIALCDFGLCKLNMKDDDKTNTFCGTPE  158 (312)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCC-cEEEEECcccccCccCCCccccccCCcc
Confidence            999998888899999999999999999999999999999999999999987 8999999998754333333345678999


Q ss_pred             ccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhc
Q 020657          217 YMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCL  296 (323)
Q Consensus       217 y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l  296 (323)
                      |+|||++...     .++.++||||||+++|+|++|..||.....    ..+..... .....++..+++++.+|+.+||
T Consensus       159 y~aPE~~~~~-----~~~~~~DvwslGvil~el~tg~~pf~~~~~----~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L  228 (312)
T cd05585         159 YLAPELLLGH-----GYTKAVDWWTLGVLLYEMLTGLPPFYDENV----NEMYRKIL-QEPLRFPDGFDRDAKDLLIGLL  228 (312)
T ss_pred             cCCHHHHcCC-----CCCCccceechhHHHHHHHhCCCCcCCCCH----HHHHHHHH-cCCCCCCCcCCHHHHHHHHHHc
Confidence            9999998643     345699999999999999999999965432    33333322 2345667789999999999999


Q ss_pred             ccCcCCCC---CHHHHhcCcccccC
Q 020657          297 QKEFSKRW---TASQLLTHPFLCKN  318 (323)
Q Consensus       297 ~~~p~~Rp---t~~~~l~h~~f~~~  318 (323)
                      +.||++||   ++.++++||||.+.
T Consensus       229 ~~dp~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         229 SRDPTRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             CCCHHHcCCCCCHHHHHcCCCcCCC
Confidence            99999997   57999999999875

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5e-47  Score=334.46  Aligned_cols=263  Identities=41%  Similarity=0.735  Sum_probs=217.5

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEE
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      +..++|++.+.||+|+||.||+|.+..++..+++|.+...........+.+|+++++.++|+||+++++++.+ ++..++
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~l   80 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISI   80 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-CCEEEE
Confidence            4568999999999999999999999999999999998766555666788999999999999999999999988 688999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc
Q 020657          128 LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH-KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD  206 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~  206 (323)
                      ||||+.+++|.+++...+.+++..+..++.+++.||.|||+. +++|+||||+||+++.++ .+||+|||++....... 
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~~-  158 (333)
T cd06650          81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSM-  158 (333)
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC-CEEEeeCCcchhhhhhc-
Confidence            999999999999998888899999999999999999999975 799999999999999987 89999999987653322 


Q ss_pred             ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccH---------------------
Q 020657          207 ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDW---------------------  265 (323)
Q Consensus       207 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~---------------------  265 (323)
                       .....++..|+|||++.+.     ..+.++|+||||+++|+|++|..||.........                     
T Consensus       159 -~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (333)
T cd06650         159 -ANSFVGTRSYMSPERLQGT-----HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPR  232 (333)
T ss_pred             -cccCCCCccccCHHHhcCC-----CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccC
Confidence             2345688999999998633     3456999999999999999999999643221110                     


Q ss_pred             -------------------HHHHHHHhcCCCCCCCC-CCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          266 -------------------ATLMCAICFGDPPSLPD-GASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       266 -------------------~~~~~~~~~~~~~~~~~-~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                                         ..+...+.....+.++. ..+.++.+|+.+||+.||++|||+++++.|+||+...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             CccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence                               01111111122222222 3678899999999999999999999999999998764

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.1e-47  Score=336.36  Aligned_cols=255  Identities=25%  Similarity=0.455  Sum_probs=211.0

Q ss_pred             eeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcC-CCCccceeceeEEcCCCeEEEEEeccC
Q 020657           57 QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKPSGDIAILMEYMD  133 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~lv~e~~~  133 (323)
                      +.||+|+||.||+|.+..+++.||+|++....  .......+.+|..+++.+ +||||+++++++.+ .+.+++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~-~~~~~lv~e~~~   79 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT-ESRLFFVIEFVS   79 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc-CCEEEEEEeCCC
Confidence            36899999999999999999999999997542  233456678899999888 79999999999987 678999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccccccc
Q 020657          134 SGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVG  213 (323)
Q Consensus       134 ~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  213 (323)
                      +++|.+++...+.+++..+..++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++..............+
T Consensus        80 ~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (329)
T cd05588          80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGIRPGDTTSTFCG  158 (329)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEECcCccccccccCCCccccccC
Confidence            999999998888899999999999999999999999999999999999999987 8999999998643222333345678


Q ss_pred             cccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCc----cHHHHHHHHhcCCCCCCCCCCChhHH
Q 020657          214 TCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRP----DWATLMCAICFGDPPSLPDGASPEFR  289 (323)
Q Consensus       214 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~  289 (323)
                      +..|+|||++...     .++.++|+||||+++|+|++|..||...+...    ................++..++.++.
T Consensus       159 t~~y~aPE~~~~~-----~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~  233 (329)
T cd05588         159 TPNYIAPEILRGE-----DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAS  233 (329)
T ss_pred             CccccCHHHHcCC-----CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHH
Confidence            9999999998643     34569999999999999999999996432211    11122222222344567778899999


Q ss_pred             HHHHHhcccCcCCCCC------HHHHhcCcccccC
Q 020657          290 SFIECCLQKEFSKRWT------ASQLLTHPFLCKN  318 (323)
Q Consensus       290 ~ll~~~l~~~p~~Rpt------~~~~l~h~~f~~~  318 (323)
                      +|+++||+.||.+|+|      ++++++||||.+.
T Consensus       234 ~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~  268 (329)
T cd05588         234 SVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI  268 (329)
T ss_pred             HHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            9999999999999997      7999999999763

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.3e-47  Score=335.56  Aligned_cols=255  Identities=29%  Similarity=0.466  Sum_probs=212.7

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCC-ccceeceeEEcCCCeEEEE
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSP-FIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~~lv  128 (323)
                      +|++.+.||+|+||.||+|.+..+++.||+|++....  .......+..|..+++.+.|+ +|+++++++.. .+.+++|
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv   79 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRLYFV   79 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc-CCEEEEE
Confidence            5899999999999999999999899999999987432  223445677889999998765 58888888887 6789999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          129 MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      |||+++++|.+.+.....+++..+..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++..........
T Consensus        80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05587          80 MEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEG-HIKIADFGMCKENIFGGKTT  158 (324)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCC-CEEEeecCcceecCCCCCce
Confidence            99999999999998888899999999999999999999999999999999999999987 89999999986433222333


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhH
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEF  288 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (323)
                      ....++..|+|||++....     ++.++||||||+++|+|+||+.||.....    ..+...+. .....++..++.++
T Consensus       159 ~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslGvil~elltG~~pf~~~~~----~~~~~~i~-~~~~~~~~~~~~~~  228 (324)
T cd05587         159 RTFCGTPDYIAPEIIAYQP-----YGKSVDWWAFGVLLYEMLAGQPPFDGEDE----DELFQSIM-EHNVSYPKSLSKEA  228 (324)
T ss_pred             eeecCCccccChhhhcCCC-----CCcccchhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHH-cCCCCCCCCCCHHH
Confidence            4456899999999987443     45699999999999999999999965433    22333322 23345677899999


Q ss_pred             HHHHHHhcccCcCCCCCH-----HHHhcCcccccC
Q 020657          289 RSFIECCLQKEFSKRWTA-----SQLLTHPFLCKN  318 (323)
Q Consensus       289 ~~ll~~~l~~~p~~Rpt~-----~~~l~h~~f~~~  318 (323)
                      .+++++||+.||.+|++.     +++++||||.+.
T Consensus       229 ~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~  263 (324)
T cd05587         229 VSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI  263 (324)
T ss_pred             HHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            999999999999999986     899999999875

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1e-47  Score=320.68  Aligned_cols=266  Identities=26%  Similarity=0.435  Sum_probs=223.0

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcCCCCc-cceeceeEEcCCC----
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-PTVRRQVFREMEILRRTDSPF-IVQCFGIFEKPSG----  123 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~----  123 (323)
                      ...|+.+++||+|.+|+||+|++..+|+.||+|++..+.. ........+|+.++++|+|+| |+.+++++.+...    
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            6778999999999999999999999999999999986654 234455679999999999999 9999999887432    


Q ss_pred             -eEEEEEeccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcc
Q 020657          124 -DIAILMEYMDSGTLDTLLNKNG----TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVS  198 (323)
Q Consensus       124 -~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~  198 (323)
                       .+++|+||++. +|..++...+    .++...++.++.||+.||+|||++||+||||||.||+++++| .+||+|||+|
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G-~lKlaDFGlA  167 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSG-VLKLADFGLA  167 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCC-cEeeeccchH
Confidence             78999999976 9999998644    478899999999999999999999999999999999999998 8999999999


Q ss_pred             hhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCC
Q 020657          199 KIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPP  278 (323)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~  278 (323)
                      +.+.-+.......++|..|+|||++.    +...++...||||+||+++||++++..|.+..+......+.+........
T Consensus       168 ra~~ip~~~yt~evvTlWYRaPEvLl----Gs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~  243 (323)
T KOG0594|consen  168 RAFSIPMRTYTPEVVTLWYRAPEVLL----GSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK  243 (323)
T ss_pred             HHhcCCcccccccEEEeeccCHHHhc----CCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence            98876777777889999999999986    44456779999999999999999999998776654444444333222110


Q ss_pred             C-------------C------------CCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCCC
Q 020657          279 S-------------L------------PDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS  321 (323)
Q Consensus       279 ~-------------~------------~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~  321 (323)
                      .             +            .+..+++..+++.+||+++|.+|.|++.+|+||||......
T Consensus       244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~  311 (323)
T KOG0594|consen  244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK  311 (323)
T ss_pred             CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence            0             0            01233589999999999999999999999999999887543

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-48  Score=343.17  Aligned_cols=258  Identities=31%  Similarity=0.512  Sum_probs=215.1

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ++|++.+.||+|++|.||+|++..+++.||+|++....  .......+.+|+.+++.+.|+||+++++++.+ ++..++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv   79 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD-EEHLYLV   79 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec-CCeEEEE
Confidence            47999999999999999999999899999999986432  22345667889999999999999999999987 6789999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc---
Q 020657          129 MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL---  205 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~---  205 (323)
                      |||+.+++|.+++.....+++..++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++.......   
T Consensus        80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~  158 (350)
T cd05573          80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADG-HIKLADFGLCKKMNKAKDRE  158 (350)
T ss_pred             EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEeecCCCCccCcccCccc
Confidence            99999999999998878899999999999999999999999999999999999999987 89999999997654332   


Q ss_pred             --------------------------cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 020657          206 --------------------------DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQP  259 (323)
Q Consensus       206 --------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~  259 (323)
                                                .......++..|+|||++.+.     .++.++||||||+++|+|++|..||...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~ell~g~~Pf~~~  233 (350)
T cd05573         159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-----PYGLECDWWSLGVILYEMLYGFPPFYSD  233 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCC-----CCCCceeeEecchhhhhhccCCCCCCCC
Confidence                                      122345689999999998744     4456999999999999999999999765


Q ss_pred             CCCccHHHHHHHHhcCCCCCCC--CCCChhHHHHHHHhcccCcCCCCC-HHHHhcCcccccCC
Q 020657          260 GQRPDWATLMCAICFGDPPSLP--DGASPEFRSFIECCLQKEFSKRWT-ASQLLTHPFLCKNR  319 (323)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~ll~~~l~~~p~~Rpt-~~~~l~h~~f~~~~  319 (323)
                      ........+...   .....++  ..+++++.+||..||. ||.+|++ ++++++||||.+..
T Consensus       234 ~~~~~~~~i~~~---~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~  292 (350)
T cd05573         234 TLQETYNKIINW---KESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGID  292 (350)
T ss_pred             CHHHHHHHHhcc---CCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCC
Confidence            433222222211   1111222  3469999999999998 9999999 99999999998753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.1e-47  Score=335.21  Aligned_cols=260  Identities=31%  Similarity=0.503  Sum_probs=216.6

Q ss_pred             ccceeeeecccCCeEEEEEEec---ccCcEEEEEeecCC---CChHHHHHHHHHHHHHHcC-CCCccceeceeEEcCCCe
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHR---CTHKIYALKVVHGD---ADPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKPSGD  124 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~---~~~~~v~iK~~~~~---~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  124 (323)
                      +|++.+.||+|+||.||++++.   .+++.||+|++...   ........+.+|+.+++.+ .|++|+++++++.. ++.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~   79 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT-EAK   79 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec-CCE
Confidence            5899999999999999999864   47889999998643   1223445677899999999 58999999999887 678


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC
Q 020657          125 IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS  204 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~  204 (323)
                      +++||||+.+++|.+.+.....+++..+..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++......
T Consensus        80 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~-~~kl~DfG~~~~~~~~  158 (332)
T cd05614          80 LHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEG-HVVLTDFGLSKEFLSE  158 (332)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCC-CEEEeeCcCCcccccc
Confidence            999999999999999998888899999999999999999999999999999999999999987 8999999998764332


Q ss_pred             c-cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCC
Q 020657          205 L-DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDG  283 (323)
Q Consensus       205 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (323)
                      . .......++..|+|||++.+.    ...+.++||||||+++|+|+||..||...........+...+. ...+.++..
T Consensus       159 ~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~  233 (332)
T cd05614         159 EKERTYSFCGTIEYMAPEIIRGK----GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL-KCDPPFPSF  233 (332)
T ss_pred             CCCccccccCCccccCHHHhcCC----CCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh-cCCCCCCCC
Confidence            2 222345689999999998632    2345689999999999999999999976555444444444333 234566778


Q ss_pred             CChhHHHHHHHhcccCcCCCC-----CHHHHhcCcccccC
Q 020657          284 ASPEFRSFIECCLQKEFSKRW-----TASQLLTHPFLCKN  318 (323)
Q Consensus       284 ~~~~l~~ll~~~l~~~p~~Rp-----t~~~~l~h~~f~~~  318 (323)
                      ++..+.+|+++||+.||++||     +++++++||||++.
T Consensus       234 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         234 IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            999999999999999999999     88999999999875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.8e-47  Score=340.04  Aligned_cols=258  Identities=28%  Similarity=0.440  Sum_probs=209.1

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++....  .......+.+|+.++..++|++|+++++.+.+ ...+++|
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~-~~~~~lv   79 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD-KLNLYLI   79 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec-CCeEEEE
Confidence            47999999999999999999999899999999996432  22344567889999999999999999999987 6789999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc--
Q 020657          129 MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD--  206 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~--  206 (323)
                      |||+++++|.+++.+.+.+++..++.++.|++.||.|||+.||+||||||+||+++.++ .+||+|||++........  
T Consensus        80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~-~vkL~DFGla~~~~~~~~~~  158 (363)
T cd05628          80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKG-HVKLSDFGLCTGLKKAHRTE  158 (363)
T ss_pred             EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC-CEEEeeccCccccccccccc
Confidence            99999999999998888899999999999999999999999999999999999999987 899999999865422100  


Q ss_pred             ---------------------------------ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCC
Q 020657          207 ---------------------------------ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGH  253 (323)
Q Consensus       207 ---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~  253 (323)
                                                       .....+||..|+|||++.+..     ++.++||||||+++|+|++|.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-----~~~~~DvwSlGvil~ell~G~  233 (363)
T cd05628         159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG-----YNKLCDWWSLGVIMYEMLIGY  233 (363)
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC-----CCCchhhhhhHHHHHHHHhCC
Confidence                                             012346899999999986443     456999999999999999999


Q ss_pred             CCCCCCCCCccHHHHHHHHhcCCCCCCC--CCCChhHHHHHHHhccc--CcCCCCCHHHHhcCcccccC
Q 020657          254 FPFLQPGQRPDWATLMCAICFGDPPSLP--DGASPEFRSFIECCLQK--EFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       254 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~ll~~~l~~--~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      .||...........+..   ......++  ..+++++.+|+.+|+..  ++..||+++++++||||++.
T Consensus       234 ~Pf~~~~~~~~~~~i~~---~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~  299 (363)
T cd05628         234 PPFCSETPQETYKKVMN---WKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGV  299 (363)
T ss_pred             CCCCCCCHHHHHHHHHc---CcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCC
Confidence            99965443322222221   11222233  24789999999997652  23356899999999999875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2e-47  Score=335.35  Aligned_cols=251  Identities=28%  Similarity=0.473  Sum_probs=209.2

Q ss_pred             eeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcC-CCCccceeceeEEcCCCeEEEEEeccC
Q 020657           57 QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKPSGDIAILMEYMD  133 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~lv~e~~~  133 (323)
                      +.||+|+||.||+|.+..+++.||+|++....  .......+..|..++..+ .||||+++++++.. .+.+++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-~~~~~iv~Ey~~   79 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT-PDRLFFVMEFVN   79 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc-CCEEEEEEcCCC
Confidence            36899999999999999899999999986431  223345566788888776 79999999999987 678999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccccccc
Q 020657          134 SGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVG  213 (323)
Q Consensus       134 ~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  213 (323)
                      +++|.+.+.....+++..+..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++..............+
T Consensus        80 ~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~-~~kL~DfG~~~~~~~~~~~~~~~~g  158 (320)
T cd05590          80 GGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGIFNGKTTSTFCG  158 (320)
T ss_pred             CchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC-cEEEeeCCCCeecCcCCCccccccc
Confidence            999999998888899999999999999999999999999999999999999987 8999999998654333333344578


Q ss_pred             cccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHH
Q 020657          214 TCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIE  293 (323)
Q Consensus       214 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~  293 (323)
                      +..|+|||++...     .++.++||||||+++|+|++|..||.....    ..+...+. .....++..++.++.+|++
T Consensus       159 t~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~~g~~Pf~~~~~----~~~~~~i~-~~~~~~~~~~~~~~~~li~  228 (320)
T cd05590         159 TPDYIAPEILQEM-----LYGPSVDWWAMGVLLYEMLCGHAPFEAENE----DDLFEAIL-NDEVVYPTWLSQDAVDILK  228 (320)
T ss_pred             CccccCHHHHcCC-----CCCCccchhhhHHHHHHHhhCCCCCCCCCH----HHHHHHHh-cCCCCCCCCCCHHHHHHHH
Confidence            9999999998643     345699999999999999999999965433    23333332 2334566778999999999


Q ss_pred             HhcccCcCCCCCH------HHHhcCcccccCC
Q 020657          294 CCLQKEFSKRWTA------SQLLTHPFLCKNR  319 (323)
Q Consensus       294 ~~l~~~p~~Rpt~------~~~l~h~~f~~~~  319 (323)
                      +||+.||++|+++      +++++||||.+..
T Consensus       229 ~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~  260 (320)
T cd05590         229 AFMTKNPTMRLGSLTLGGEEAILRHPFFKELD  260 (320)
T ss_pred             HHcccCHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence            9999999999998      9999999998753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.9e-47  Score=333.97  Aligned_cols=255  Identities=26%  Similarity=0.472  Sum_probs=210.7

Q ss_pred             eeecccCCeEEEEEEecccCcEEEEEeecCC--CChHHHHHHHHHHHHHHcC-CCCccceeceeEEcCCCeEEEEEeccC
Q 020657           57 QVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKPSGDIAILMEYMD  133 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~lv~e~~~  133 (323)
                      +.||+|+||.||+|.+..+++.+|+|++...  ........+.+|+.++.++ +||||+++++++.. .+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~-~~~~~lv~E~~~   79 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ESRLFFVIEYVN   79 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe-CCEEEEEEeCCC
Confidence            3699999999999999999999999999754  2334455677888888776 89999999999987 678999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccccccc
Q 020657          134 SGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVG  213 (323)
Q Consensus       134 ~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  213 (323)
                      +++|...+.....+++..+..++.||+.||.|||++|++||||||+||+++.++ .+||+|||++..............+
T Consensus        80 ~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~-~~kL~DfG~~~~~~~~~~~~~~~~g  158 (329)
T cd05618          80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPGDTTSTFCG  158 (329)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC-CEEEeeCCccccccCCCCccccccC
Confidence            999999998888899999999999999999999999999999999999999987 8999999998654333333345678


Q ss_pred             cccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCc----cHHHHHHHHhcCCCCCCCCCCChhHH
Q 020657          214 TCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRP----DWATLMCAICFGDPPSLPDGASPEFR  289 (323)
Q Consensus       214 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~  289 (323)
                      +..|+|||++.+.     .++.++||||||+++|+|++|..||.......    ................++..++..+.
T Consensus       159 t~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~  233 (329)
T cd05618         159 TPNYIAPEILRGE-----DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA  233 (329)
T ss_pred             CccccCHHHHcCC-----CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHH
Confidence            9999999998743     34569999999999999999999995422211    11122222222344567788999999


Q ss_pred             HHHHHhcccCcCCCCC------HHHHhcCcccccC
Q 020657          290 SFIECCLQKEFSKRWT------ASQLLTHPFLCKN  318 (323)
Q Consensus       290 ~ll~~~l~~~p~~Rpt------~~~~l~h~~f~~~  318 (323)
                      +|+++||+.||++|+|      ++++++||||.+.
T Consensus       234 ~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~  268 (329)
T cd05618         234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  268 (329)
T ss_pred             HHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            9999999999999998      5899999999764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=3.3e-47  Score=332.54  Aligned_cols=263  Identities=24%  Similarity=0.372  Sum_probs=212.5

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      .++|++.+.||+|+||.||+|++..+++.||+|.+...........+.+|+.++++++|+||+++++++.. ++..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~   83 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT-DKSLTLVF   83 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEee-CCeEEEEE
Confidence            47899999999999999999999989999999998755444444567789999999999999999999987 67899999


Q ss_pred             eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          130 EYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       130 e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      ||+.+ +|.+.+... ..+++..+..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++..........
T Consensus        84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~  161 (309)
T cd07872          84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERG-ELKLADFGLARAKSVPTKTY  161 (309)
T ss_pred             eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECccccceecCCCcccc
Confidence            99986 887777643 4589999999999999999999999999999999999999987 89999999987654433333


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhc--------------
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICF--------------  274 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~--------------  274 (323)
                      ....++..|+|||.+.+    ...++.++||||||+++|+|+||..||...+.......+......              
T Consensus       162 ~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07872         162 SNEVVTLWYRPPDVLLG----SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE  237 (309)
T ss_pred             ccccccccccCCHHHhC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence            44567889999998752    233466999999999999999999999765443332222211100              


Q ss_pred             ----CCCC-------CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          275 ----GDPP-------SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       275 ----~~~~-------~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                          ..+.       .....++.++.+|+++||+.||.+|||++++++||||++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence                0000       01135788999999999999999999999999999998754

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=5.9e-47  Score=326.37  Aligned_cols=252  Identities=32%  Similarity=0.497  Sum_probs=209.5

Q ss_pred             ecccCCeEEEEEEecccCcEEEEEeecCCCC--hHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEeccCCCC
Q 020657           59 LGHGNGGTVYKVQHRCTHKIYALKVVHGDAD--PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGT  136 (323)
Q Consensus        59 lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~s  136 (323)
                      ||+|+||+||++.+..+++.+++|.+.....  ......+..|+.+++.+.|+||+++.+++.. ....++||||+++++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~g~   79 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT-KTDLCLVMTIMNGGD   79 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC-CCeEEEEEeCCCCCC
Confidence            6999999999999998999999999864421  2233566789999999999999999999887 678999999999999


Q ss_pred             HHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccccccc
Q 020657          137 LDTLLN----KNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYV  212 (323)
Q Consensus       137 L~~~l~----~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  212 (323)
                      |...+.    .+..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++..............
T Consensus        80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~  158 (280)
T cd05608          80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG-NVRISDLGLAVELKDGQSKTKGYA  158 (280)
T ss_pred             HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCccceecCCCCccccccC
Confidence            988774    235689999999999999999999999999999999999999887 899999999976654433344557


Q ss_pred             ccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHH
Q 020657          213 GTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFI  292 (323)
Q Consensus       213 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll  292 (323)
                      ++..|+|||++....     ++.++||||||+++|+|++|+.||...+.......+..... .....++..++.++.+++
T Consensus       159 g~~~y~aPE~~~~~~-----~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li  232 (280)
T cd05608         159 GTPGFMAPELLQGEE-----YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRIL-NDSVTYPDKFSPASKSFC  232 (280)
T ss_pred             CCcCccCHHHhcCCC-----CCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhc-ccCCCCcccCCHHHHHHH
Confidence            889999999987443     45699999999999999999999976544433333333322 233456677899999999


Q ss_pred             HHhcccCcCCCC-----CHHHHhcCcccccC
Q 020657          293 ECCLQKEFSKRW-----TASQLLTHPFLCKN  318 (323)
Q Consensus       293 ~~~l~~~p~~Rp-----t~~~~l~h~~f~~~  318 (323)
                      .+||+.||++||     |++++++||||++.
T Consensus       233 ~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~  263 (280)
T cd05608         233 EALLAKDPEKRLGFRDGNCDGLRTHPLFRDL  263 (280)
T ss_pred             HHHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence            999999999999     88999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-47  Score=329.09  Aligned_cols=268  Identities=29%  Similarity=0.517  Sum_probs=219.3

Q ss_pred             cchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-------------hHHHHHHHHHHHHHHcCCCCc
Q 020657           44 TTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-------------PTVRRQVFREMEILRRTDSPF  110 (323)
Q Consensus        44 ~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~  110 (323)
                      ........+|++...||+|.||.|-+|++..+++.||+|++.+...             -...+.+.+|+.+|+++.|||
T Consensus        90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n  169 (576)
T KOG0585|consen   90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN  169 (576)
T ss_pred             cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence            3445567789999999999999999999999999999999964411             112457899999999999999


Q ss_pred             cceeceeEEcC-CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCc
Q 020657          111 IVQCFGIFEKP-SGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQ  189 (323)
Q Consensus       111 i~~~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~  189 (323)
                      ||+++.+..++ ...+|||+|||..|.+...-.....+++.+++.++.+++.||+|||.+||+||||||+|+|++.+| +
T Consensus       170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g-~  248 (576)
T KOG0585|consen  170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG-T  248 (576)
T ss_pred             eeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC-c
Confidence            99999998765 446899999999887765443444499999999999999999999999999999999999999998 9


Q ss_pred             EEEeecCcchhhccC-----ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCcc
Q 020657          190 VKIADFGVSKIMCRS-----LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPD  264 (323)
Q Consensus       190 ~kl~Dfg~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~  264 (323)
                      +||+|||.+......     .......+||+.|+|||.+..+.- ..+.+.+.||||+|++||-|+.|+.||.+...-..
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~-~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l  327 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNS-FSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL  327 (576)
T ss_pred             EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCC-ccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence            999999999766322     222344789999999999875432 33456799999999999999999999965544333


Q ss_pred             HHHHHHHHhcCCCCCCCC--CCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          265 WATLMCAICFGDPPSLPD--GASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~--~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      ..++.     ..+..+|.  .+.+.+.+||++||+.||+.|.++.+|..|||....
T Consensus       328 ~~KIv-----n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  328 FDKIV-----NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             HHHHh-----cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            33333     23444443  478999999999999999999999999999998654

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=8.2e-47  Score=332.12  Aligned_cols=254  Identities=29%  Similarity=0.463  Sum_probs=209.1

Q ss_pred             cceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHH---HcCCCCccceeceeEEcCCCeEEE
Q 020657           53 LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEIL---RRTDSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        53 ~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      |++++.||+|++|.||+|.+..+++.||+|++....  .......+.+|..++   +.++||||+++++++.. .+..++
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~-~~~~~l   79 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT-EDHVCF   79 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc-CCEEEE
Confidence            788999999999999999999899999999996432  122334556665554   56789999999999987 678999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccc
Q 020657          128 LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA  207 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~  207 (323)
                      ||||+.+++|...+.. ..+++..+..++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++.........
T Consensus        80 v~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05589          80 VMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEG-FVKIADFGLCKEGMGFGDR  157 (324)
T ss_pred             EEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC-cEEeCcccCCccCCCCCCc
Confidence            9999999999988765 4689999999999999999999999999999999999999987 8999999998654333333


Q ss_pred             cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChh
Q 020657          208 CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPE  287 (323)
Q Consensus       208 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (323)
                      .....++..|+|||.+.+.     .++.++||||||+++|+|++|..||.+...    ......+... ...++..++.+
T Consensus       158 ~~~~~g~~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~~G~~pf~~~~~----~~~~~~i~~~-~~~~p~~~~~~  227 (324)
T cd05589         158 TSTFCGTPEFLAPEVLTET-----SYTRAVDWWGLGVLIYEMLVGESPFPGDDE----EEVFDSIVND-EVRYPRFLSRE  227 (324)
T ss_pred             ccccccCccccCHhHhcCC-----CCCcccchhhHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhC-CCCCCCCCCHH
Confidence            3456789999999998643     345699999999999999999999965433    2232222222 34466788999


Q ss_pred             HHHHHHHhcccCcCCCC-----CHHHHhcCcccccCC
Q 020657          288 FRSFIECCLQKEFSKRW-----TASQLLTHPFLCKNR  319 (323)
Q Consensus       288 l~~ll~~~l~~~p~~Rp-----t~~~~l~h~~f~~~~  319 (323)
                      +.+++++||+.||.+||     ++.++++||||.+..
T Consensus       228 ~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~  264 (324)
T cd05589         228 AISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN  264 (324)
T ss_pred             HHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence            99999999999999999     799999999998753

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.9e-48  Score=323.98  Aligned_cols=255  Identities=29%  Similarity=0.478  Sum_probs=225.8

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCC--CChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIA  126 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  126 (323)
                      ...+|++.+.||+|.||.|-+|++...|+.||||.++++  .+....-.+.+|+++|..|+||||++++.+|+. .+-+.
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN-kdKIv  129 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN-KDKIV  129 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC-CceEE
Confidence            357899999999999999999999889999999999866  344556678999999999999999999999998 78899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc
Q 020657          127 ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD  206 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~  206 (323)
                      |||||..+|.|++++...+.+++.+++.++.||+.|+.|+|.++++|||||.+|||+|.++ ++||.|||++..+... .
T Consensus       130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~-NiKIADFGLSNly~~~-k  207 (668)
T KOG0611|consen  130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNN-NIKIADFGLSNLYADK-K  207 (668)
T ss_pred             EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCC-Ceeeeccchhhhhccc-c
Confidence            9999999999999999999999999999999999999999999999999999999999998 9999999999877543 3


Q ss_pred             ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCCh
Q 020657          207 ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP  286 (323)
Q Consensus       207 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (323)
                      ...+++|++.|.+||+.++.+|.+    +.+|.||||++||.|..|..||++.+    ...+..++..+...  ...-+.
T Consensus       208 fLqTFCGSPLYASPEIvNG~PY~G----PEVDsWsLGvLLYtLVyGtMPFDG~D----hk~lvrQIs~GaYr--EP~~PS  277 (668)
T KOG0611|consen  208 FLQTFCGSPLYASPEIVNGTPYKG----PEVDSWSLGVLLYTLVYGTMPFDGRD----HKRLVRQISRGAYR--EPETPS  277 (668)
T ss_pred             HHHHhcCCcccCCccccCCCCCCC----CccchhhHHHHHHHHhhcccccCCch----HHHHHHHhhccccc--CCCCCc
Confidence            446789999999999999777765    58999999999999999999996544    45555555554432  234577


Q ss_pred             hHHHHHHHhcccCcCCCCCHHHHhcCcccc
Q 020657          287 EFRSFIECCLQKEFSKRWTASQLLTHPFLC  316 (323)
Q Consensus       287 ~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~  316 (323)
                      +...||+.||-.||++|.|+++|..|=|++
T Consensus       278 dA~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  278 DASGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             hHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence            899999999999999999999999999885

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.3e-47  Score=335.94  Aligned_cols=264  Identities=25%  Similarity=0.372  Sum_probs=208.8

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC----CeEE
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS----GDIA  126 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~~  126 (323)
                      +|++.+.||+|++|.||+|++..+++.||+|.+.... .......+.+|+.+++.++||||+++++++....    ..++
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            5899999999999999999999899999999986432 2233456789999999999999999999875422    3489


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc
Q 020657          127 ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD  206 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~  206 (323)
                      +||||+. ++|.+++.....+++..+..++.||++||.|||+.|++||||||+||+++.++ .+||+|||++........
T Consensus        81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~  158 (338)
T cd07859          81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTP  158 (338)
T ss_pred             EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-cEEEccCccccccccccC
Confidence            9999996 59999998887899999999999999999999999999999999999999987 899999999975432211


Q ss_pred             ---ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHH---------------
Q 020657          207 ---ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATL---------------  268 (323)
Q Consensus       207 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~---------------  268 (323)
                         ......++..|+|||++...   ...++.++||||||+++|+|+||+.||.+.........+               
T Consensus       159 ~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i  235 (338)
T cd07859         159 TAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV  235 (338)
T ss_pred             ccccccCCCCCCCcCCHHHHhcc---ccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence               12345789999999987531   134466999999999999999999999654322111110               


Q ss_pred             --------HHHHhcCCCCCC---CCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          269 --------MCAICFGDPPSL---PDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       269 --------~~~~~~~~~~~~---~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                              ........+..+   ...+++++.+++.+||+.||++|||++++++||||.+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence                    001111111111   1346788999999999999999999999999999977554

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.7e-47  Score=336.68  Aligned_cols=250  Identities=27%  Similarity=0.518  Sum_probs=209.8

Q ss_pred             eeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEeccCC
Q 020657           57 QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDS  134 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~  134 (323)
                      +.||+|+||.||+|.+..+++.||+|++....  .......+.+|+++++.+.||||+++++++.. .+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~-~~~~~lv~E~~~~   79 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-HDRLCFVMEYANG   79 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc-CCEEEEEEeCCCC
Confidence            36899999999999999899999999997542  22334567789999999999999999999987 6789999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccccccc
Q 020657          135 GTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG-HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVG  213 (323)
Q Consensus       135 ~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  213 (323)
                      ++|...+.....+++..+..++.||+.||.|||+ .|++||||||+||+++.++ .+||+|||++..............+
T Consensus        80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (325)
T cd05594          80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKDGATMKTFCG  158 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC-CEEEecCCCCeecCCCCcccccccC
Confidence            9999999888889999999999999999999997 7999999999999999987 8999999998654332233334568


Q ss_pred             cccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHH
Q 020657          214 TCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIE  293 (323)
Q Consensus       214 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~  293 (323)
                      +..|+|||++....     ++.++||||||+++|+|+||..||.....    ..+...+. .....++..+++++.+|++
T Consensus       159 t~~y~aPE~~~~~~-----~~~~~DiwslG~il~el~tG~~Pf~~~~~----~~~~~~i~-~~~~~~p~~~~~~~~~li~  228 (325)
T cd05594         159 TPEYLAPEVLEDND-----YGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKLFELIL-MEEIRFPRTLSPEAKSLLS  228 (325)
T ss_pred             CcccCCHHHHccCC-----CCCccccccccceeeeeccCCCCCCCCCH----HHHHHHHh-cCCCCCCCCCCHHHHHHHH
Confidence            99999999986433     45699999999999999999999965432    22222222 2234567788999999999


Q ss_pred             HhcccCcCCCC-----CHHHHhcCcccccC
Q 020657          294 CCLQKEFSKRW-----TASQLLTHPFLCKN  318 (323)
Q Consensus       294 ~~l~~~p~~Rp-----t~~~~l~h~~f~~~  318 (323)
                      +||+.||++|+     ++.++++||||.+.
T Consensus       229 ~~L~~dP~~R~~~~~~~~~~il~h~~~~~~  258 (325)
T cd05594         229 GLLKKDPKQRLGGGPDDAKEIMQHKFFAGI  258 (325)
T ss_pred             HHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence            99999999997     99999999999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-47  Score=341.06  Aligned_cols=257  Identities=30%  Similarity=0.508  Sum_probs=211.4

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ++|++.+.||+|+||.||+|++..+++.||+|++....  .......+.+|+.+++.++|+||+++++++.+ ...+++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv   79 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD-ENYLYLI   79 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-CCeEEEE
Confidence            47999999999999999999999999999999996431  23345667889999999999999999999997 6889999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc--
Q 020657          129 MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD--  206 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~--  206 (323)
                      |||+.+++|.+++.....+++..+..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++........  
T Consensus        80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~  158 (364)
T cd05599          80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKG-HIKLSDFGLCTGLKKSHRTE  158 (364)
T ss_pred             ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEeecccceecccccccc
Confidence            99999999999998888899999999999999999999999999999999999999987 899999999865422110  


Q ss_pred             ------------------------------------ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHH
Q 020657          207 ------------------------------------ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELY  250 (323)
Q Consensus       207 ------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~ll  250 (323)
                                                          .....+||+.|+|||++....     ++.++|||||||++|+|+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwSlG~il~el~  233 (364)
T cd05599         159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-----YNKECDWWSLGVIMYEML  233 (364)
T ss_pred             ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC-----CCCeeeeecchhHHHHhh
Confidence                                                011245899999999986443     456999999999999999


Q ss_pred             hCCCCCCCCCCCccHHHHHHHHhcCCCCCCC--CCCChhHHHHHHHhcccCcCCCCC---HHHHhcCcccccC
Q 020657          251 LGHFPFLQPGQRPDWATLMCAICFGDPPSLP--DGASPEFRSFIECCLQKEFSKRWT---ASQLLTHPFLCKN  318 (323)
Q Consensus       251 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~ll~~~l~~~p~~Rpt---~~~~l~h~~f~~~  318 (323)
                      +|..||...........+   ........++  ..+++++.+||++|+. +|.+|++   ++++++||||++.
T Consensus       234 ~G~~Pf~~~~~~~~~~~i---~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~  302 (364)
T cd05599         234 VGYPPFCSDNPQETYRKI---INWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV  302 (364)
T ss_pred             cCCCCCCCCCHHHHHHHH---HcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            999999654332221111   1111122222  3578999999999997 9999998   9999999999875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.3e-47  Score=338.21  Aligned_cols=263  Identities=28%  Similarity=0.442  Sum_probs=216.1

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....  .......+.+|+.+++.+.|+||+++++++.+ ....++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~-~~~~~lv   79 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD-KDNLYLV   79 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec-CCeEEEE
Confidence            47999999999999999999999999999999997542  23345667889999999999999999999987 6789999


Q ss_pred             EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc-
Q 020657          129 MEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD-  206 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~-  206 (323)
                      |||+++++|.+++... ..+++..+..++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++........ 
T Consensus        80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~-~~kL~Dfg~a~~~~~~~~~  158 (330)
T cd05601          80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTG-HIKLADFGSAARLTANKMV  158 (330)
T ss_pred             ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCC-CEEeccCCCCeECCCCCce
Confidence            9999999999999875 6799999999999999999999999999999999999999987 899999999976543222 


Q ss_pred             ccccccccccccCCcccCCCCCC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCC--CC
Q 020657          207 ACNSYVGTCAYMSPERFDPDAYG-GNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLP--DG  283 (323)
Q Consensus       207 ~~~~~~~~~~y~aPE~~~~~~~~-~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  283 (323)
                      ......++..|+|||++...... ...++.++||||||+++|+|++|..||...........+..   ......++  ..
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~---~~~~~~~~~~~~  235 (330)
T cd05601         159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMN---FQRFLKFPEDPK  235 (330)
T ss_pred             eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHc---CCCccCCCCCCC
Confidence            22334688999999998643332 44567799999999999999999999965433322222221   11122222  35


Q ss_pred             CChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          284 ASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       284 ~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      ++.++.+|+..||+ +|.+|||++++++||||.+..
T Consensus       236 ~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~  270 (330)
T cd05601         236 VSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKID  270 (330)
T ss_pred             CCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCC
Confidence            78999999999998 999999999999999998754

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.9e-48  Score=305.01  Aligned_cols=258  Identities=30%  Similarity=0.453  Sum_probs=227.4

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCe
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGD  124 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  124 (323)
                      ....++|++.+.||+|-||.||+|+.+.++..||+|++.+..  ......++.+|+++-..|+||||++++++|.+ +..
T Consensus        18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd-~~r   96 (281)
T KOG0580|consen   18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD-SKR   96 (281)
T ss_pred             ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec-cce
Confidence            445789999999999999999999999999999999997553  33456788899999999999999999999998 789


Q ss_pred             EEEEEeccCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          125 IAILMEYMDSGTLDTLLN--KNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      .|+++||...|++...+.  ....+++.....++.|++.|+.|+|.++++||||||+|+|++..+ .+|++|||-+...+
T Consensus        97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~-~lkiAdfGwsV~~p  175 (281)
T KOG0580|consen   97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAP  175 (281)
T ss_pred             eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCC-CeeccCCCceeecC
Confidence            999999999999999998  566799999999999999999999999999999999999999998 89999999986643


Q ss_pred             cCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCC
Q 020657          203 RSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPD  282 (323)
Q Consensus       203 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (323)
                        .......+||..|++||+..+..+     +..+|+|++|++.||++.|..||...........+..     ....+|.
T Consensus       176 --~~kR~tlcgt~dyl~pEmv~~~~h-----d~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k-----~~~~~p~  243 (281)
T KOG0580|consen  176 --SNKRKTLCGTLDYLPPEMVEGRGH-----DKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK-----VDLKFPS  243 (281)
T ss_pred             --CCCceeeecccccCCHhhcCCCCc-----cchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH-----ccccCCc
Confidence              344567899999999999885555     4599999999999999999999977665555554432     3456778


Q ss_pred             CCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          283 GASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       283 ~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      .++.++.|||.+|+..+|.+|.+..+++.|||....
T Consensus       244 ~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  244 TISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             ccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence            999999999999999999999999999999998754

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-46  Score=337.06  Aligned_cols=259  Identities=24%  Similarity=0.315  Sum_probs=207.5

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEE
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIA  126 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  126 (323)
                      .+...+|++++.||+|+||.||+|.+..+++.||+|...       ...+.+|+.++++++||||+++++++.. ....+
T Consensus        88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~  159 (391)
T PHA03212         88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTY-NKFTC  159 (391)
T ss_pred             ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEE-CCeeE
Confidence            345578999999999999999999999999999999753       2346789999999999999999999987 67899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC-c
Q 020657          127 ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS-L  205 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~-~  205 (323)
                      +|+|++. ++|..++.....+++..++.++.||+.||.|||+.||+||||||+||+++.++ .++|+|||++...... .
T Consensus       160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~-~vkL~DFG~a~~~~~~~~  237 (391)
T PHA03212        160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPG-DVCLGDFGAACFPVDINA  237 (391)
T ss_pred             EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCC-CEEEEeCCcccccccccc
Confidence            9999996 58988888777899999999999999999999999999999999999999987 8999999998653321 1


Q ss_pred             cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCc-------cHHHHHHHH------
Q 020657          206 DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRP-------DWATLMCAI------  272 (323)
Q Consensus       206 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~-------~~~~~~~~~------  272 (323)
                      .......+|..|+|||++...     .++.++||||||+++|+|++|..||.......       ....+....      
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~  312 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARD-----PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE  312 (391)
T ss_pred             cccccccCccCCCChhhhcCC-----CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhh
Confidence            223345789999999998643     34569999999999999999998876432110       011111000      


Q ss_pred             ----------------hcC---CCCCCC-----CCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          273 ----------------CFG---DPPSLP-----DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       273 ----------------~~~---~~~~~~-----~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                                      ...   .+...+     ..++.++.+|+.+||++||++|||++++|+||||++...
T Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~  384 (391)
T PHA03212        313 FPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPD  384 (391)
T ss_pred             cCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCC
Confidence                            000   000000     135678999999999999999999999999999988654

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.9e-47  Score=333.71  Aligned_cols=250  Identities=28%  Similarity=0.452  Sum_probs=209.1

Q ss_pred             eeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcC-CCCccceeceeEEcCCCeEEEEEeccC
Q 020657           57 QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKPSGDIAILMEYMD  133 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~lv~e~~~  133 (323)
                      +.||+|+||.||+|++..+++.||+|++....  .......+..|..++..+ .||||+++++++.. .+.+++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~-~~~~~lv~E~~~   79 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT-KDRLFFVMEYVN   79 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-CCeEEEEEeCCC
Confidence            36899999999999999899999999986532  223345566788888765 79999999999987 678999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccccccc
Q 020657          134 SGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVG  213 (323)
Q Consensus       134 ~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  213 (323)
                      +++|...+.....+++..+..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++..............+
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05591          80 GGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG-HCKLADFGMCKEGILNGVTTTTFCG  158 (321)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEeecccceecccCCcccccccc
Confidence            999999998888899999999999999999999999999999999999999987 8999999998754333333445668


Q ss_pred             cccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHH
Q 020657          214 TCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIE  293 (323)
Q Consensus       214 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~  293 (323)
                      +..|+|||++...     .++.++||||||+++|+|++|+.||.....    ..+.+.+.. ....++..++.++.+|++
T Consensus       159 t~~y~aPE~~~~~-----~~~~~~DvwslG~il~el~tg~~Pf~~~~~----~~~~~~i~~-~~~~~p~~~~~~~~~ll~  228 (321)
T cd05591         159 TPDYIAPEILQEL-----EYGPSVDWWALGVLMYEMMAGQPPFEADNE----DDLFESILH-DDVLYPVWLSKEAVSILK  228 (321)
T ss_pred             CccccCHHHHcCC-----CCCCccceechhHHHHHHhcCCCCCCCCCH----HHHHHHHHc-CCCCCCCCCCHHHHHHHH
Confidence            9999999998643     345699999999999999999999965433    233333332 234456678999999999


Q ss_pred             HhcccCcCCCC-------CHHHHhcCcccccC
Q 020657          294 CCLQKEFSKRW-------TASQLLTHPFLCKN  318 (323)
Q Consensus       294 ~~l~~~p~~Rp-------t~~~~l~h~~f~~~  318 (323)
                      +||+.||++|+       +++++++||||.+.
T Consensus       229 ~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~  260 (321)
T cd05591         229 AFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI  260 (321)
T ss_pred             HHhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence            99999999999       99999999999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8.8e-47  Score=331.71  Aligned_cols=251  Identities=31%  Similarity=0.520  Sum_probs=208.9

Q ss_pred             eeeecccCCeEEEEEEec---ccCcEEEEEeecCCC---ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           56 LQVLGHGNGGTVYKVQHR---CTHKIYALKVVHGDA---DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        56 ~~~lg~G~~~~v~~~~~~---~~~~~v~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      ++.||+|+||.||++++.   .+++.||+|++....   .......+.+|+.+++.++||||+++++++.. ++..++||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-~~~~~lv~   79 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT-GGKLYLIL   79 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec-CCeEEEEE
Confidence            367999999999999864   468899999986431   22334567789999999999999999999987 67899999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccc
Q 020657          130 EYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN  209 (323)
Q Consensus       130 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~  209 (323)
                      ||+.+++|.+.+...+.+++..+..++.||+.||.|||+.|++|+||||+||+++.++ .+||+|||++...........
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~  158 (323)
T cd05584          80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG-HVKLTDFGLCKESIHEGTVTH  158 (323)
T ss_pred             eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEEeeCcCCeecccCCCccc
Confidence            9999999999998888899999999999999999999999999999999999999987 899999999865433333334


Q ss_pred             cccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHH
Q 020657          210 SYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFR  289 (323)
Q Consensus       210 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  289 (323)
                      ...++..|+|||++.+..     .+.++||||||+++|+|++|..||......    .....+.. ....++..+++++.
T Consensus       159 ~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~ell~G~~pf~~~~~~----~~~~~~~~-~~~~~~~~~~~~~~  228 (323)
T cd05584         159 TFCGTIEYMAPEILMRSG-----HGKAVDWWSLGALMYDMLTGAPPFTAENRK----KTIDKILK-GKLNLPPYLTPEAR  228 (323)
T ss_pred             ccCCCccccChhhccCCC-----CCCcceecccHHHHHHHhcCCCCCCCCCHH----HHHHHHHc-CCCCCCCCCCHHHH
Confidence            457899999999986433     356999999999999999999999654332    22222222 23456678899999


Q ss_pred             HHHHHhcccCcCCCC-----CHHHHhcCcccccC
Q 020657          290 SFIECCLQKEFSKRW-----TASQLLTHPFLCKN  318 (323)
Q Consensus       290 ~ll~~~l~~~p~~Rp-----t~~~~l~h~~f~~~  318 (323)
                      +|+++||+.+|++||     +++++++||||...
T Consensus       229 ~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         229 DLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             HHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence            999999999999999     89999999999764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.1e-46  Score=338.28  Aligned_cols=259  Identities=27%  Similarity=0.428  Sum_probs=209.8

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      +.|++++.||+|+||+||+|++..+++.||+|++....  .......+.+|+.+++.++|+||+++++++.+ .+.+++|
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-~~~~~lv   79 (381)
T cd05626           1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD-KDNLYFV   79 (381)
T ss_pred             CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec-CCEEEEE
Confidence            36899999999999999999999999999999996432  23445678899999999999999999999987 6789999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc---
Q 020657          129 MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL---  205 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~---  205 (323)
                      |||+++++|.+++.+...+++..+..++.||+.||.|||+.||+||||||+||+++.++ .++|+|||++.......   
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~-~~kL~DFGl~~~~~~~~~~~  158 (381)
T cd05626          80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG-HIKLTDFGLCTGFRWTHNSK  158 (381)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCC-CEEEeeCcCCcccccccccc
Confidence            99999999999998888899999999999999999999999999999999999999987 89999999975321000   


Q ss_pred             --------------------------------------------cccccccccccccCCcccCCCCCCCCCCCcchhHHH
Q 020657          206 --------------------------------------------DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWS  241 (323)
Q Consensus       206 --------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~s  241 (323)
                                                                  ......+||..|+|||++...     .++.++||||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~~~~~DiwS  233 (381)
T cd05626         159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK-----GYTQLCDWWS  233 (381)
T ss_pred             cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC-----CCCCccceee
Confidence                                                        001234689999999998643     3456999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCC--CCCChhHHHHHHHhc--ccCcCCCCCHHHHhcCccccc
Q 020657          242 LGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLP--DGASPEFRSFIECCL--QKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       242 lG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~ll~~~l--~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                      ||+++|||+||..||...........+   ........++  ..+++++.+|+.+|+  ..++..|++++++++||||.+
T Consensus       234 lG~il~elltG~~Pf~~~~~~~~~~~i---~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~  310 (381)
T cd05626         234 VGVILFEMLVGQPPFLAPTPTETQLKV---INWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE  310 (381)
T ss_pred             hhhHHHHHHhCCCCCcCCCHHHHHHHH---HccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence            999999999999999654432222222   1111122233  357899999999955  455566999999999999987


Q ss_pred             CC
Q 020657          318 NR  319 (323)
Q Consensus       318 ~~  319 (323)
                      ..
T Consensus       311 ~~  312 (381)
T cd05626         311 VD  312 (381)
T ss_pred             CC
Confidence            43

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-46  Score=330.97  Aligned_cols=265  Identities=31%  Similarity=0.416  Sum_probs=226.7

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC--hHHHHHHHHHHHHHHcCC-CCccceeceeEEcCC
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD--PTVRRQVFREMEILRRTD-SPFIVQCFGIFEKPS  122 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~  122 (323)
                      ..-....|++.+.||+|.||.||+++...+|+.+|+|++.+...  ......+.+|+.+|+++. ||||+.+.++|++ .
T Consensus        30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~-~  108 (382)
T KOG0032|consen   30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED-P  108 (382)
T ss_pred             cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc-C
Confidence            34456789999999999999999999999999999999976643  224578899999999998 9999999999998 6


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC---CcEEEeecCcch
Q 020657          123 GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN---MQVKIADFGVSK  199 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~---~~~kl~Dfg~~~  199 (323)
                      ..+++|||++.||.|.+.+... .+++..+..++.|++.++.|||+.|++||||||+|+|+....   ..++++|||++.
T Consensus       109 ~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  109 DSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             CeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            7899999999999999999766 499999999999999999999999999999999999997542   279999999998


Q ss_pred             hhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCC
Q 020657          200 IMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPS  279 (323)
Q Consensus       200 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  279 (323)
                      .... .......+||+.|+|||++..     ..++..+||||+|+++|.|++|..||.+.........+..... .....
T Consensus       188 ~~~~-~~~~~~~~Gtp~y~APEvl~~-----~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~-~f~~~  260 (382)
T KOG0032|consen  188 FIKP-GERLHTIVGTPEYVAPEVLGG-----RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF-DFTSE  260 (382)
T ss_pred             EccC-CceEeeecCCccccCchhhcC-----CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC-CCCCC
Confidence            8766 555677899999999999974     4445699999999999999999999987766555443332221 12233


Q ss_pred             CCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          280 LPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       280 ~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      ....++..+.++++.||..||..|+|+.++|+|||+++..
T Consensus       261 ~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~  300 (382)
T KOG0032|consen  261 PWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG  300 (382)
T ss_pred             CccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence            4467899999999999999999999999999999998763

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=8.4e-47  Score=330.77  Aligned_cols=251  Identities=25%  Similarity=0.469  Sum_probs=207.4

Q ss_pred             eeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHc-CCCCccceeceeEEcCCCeEEEEEeccC
Q 020657           57 QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRR-TDSPFIVQCFGIFEKPSGDIAILMEYMD  133 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~~lv~e~~~  133 (323)
                      +.||+|+||.||+|.+..+++.||+|++....  ..........|..++.. +.||+|+++++++.+ .+..++||||+.
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv~E~~~   79 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT-KEHLFFVMEFLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe-CCEEEEEECCCC
Confidence            36999999999999999999999999996432  11233445667777765 489999999999987 678999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccccccc
Q 020657          134 SGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVG  213 (323)
Q Consensus       134 ~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  213 (323)
                      +++|...+.....+++..+..++.||+.||+|||+.|++||||||+||+++.++ .++|+|||++..............+
T Consensus        80 ~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05620          80 GGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG-HIKIADFGMCKENVFGDNRASTFCG  158 (316)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEeCccCCCeecccCCCceeccCC
Confidence            999999998877899999999999999999999999999999999999999987 8999999998643222233345668


Q ss_pred             cccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHH
Q 020657          214 TCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIE  293 (323)
Q Consensus       214 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~  293 (323)
                      +..|+|||++....     ++.++||||||+++|+|++|..||...+.    ..+.+.+.. ..+.++..++.++.+|++
T Consensus       159 t~~y~aPE~~~~~~-----~~~~~DiwslGvil~el~~g~~Pf~~~~~----~~~~~~~~~-~~~~~~~~~~~~~~~li~  228 (316)
T cd05620         159 TPDYIAPEILQGLK-----YTFSVDWWSFGVLLYEMLIGQSPFHGDDE----DELFESIRV-DTPHYPRWITKESKDILE  228 (316)
T ss_pred             CcCccCHHHHcCCC-----CCcccchhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHHh-CCCCCCCCCCHHHHHHHH
Confidence            99999999987433     45699999999999999999999965432    333333332 235566778999999999


Q ss_pred             HhcccCcCCCCCH-HHHhcCcccccCC
Q 020657          294 CCLQKEFSKRWTA-SQLLTHPFLCKNR  319 (323)
Q Consensus       294 ~~l~~~p~~Rpt~-~~~l~h~~f~~~~  319 (323)
                      +||+.||++|+++ +++++||||++..
T Consensus       229 ~~l~~dP~~R~~~~~~~~~h~~f~~~~  255 (316)
T cd05620         229 KLFERDPTRRLGVVGNIRGHPFFKTIN  255 (316)
T ss_pred             HHccCCHHHcCCChHHHHcCCCcCCCC
Confidence            9999999999998 6899999998764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-46  Score=331.23  Aligned_cols=266  Identities=26%  Similarity=0.394  Sum_probs=211.6

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCC--CChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ++|++.+.||+|+||.||++++..+++.||+|++...  ........+.+|..++..+.|+||+++++++.+ .+.+++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv   79 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD-ENNLYLV   79 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec-CCeEEEE
Confidence            4799999999999999999999989999999998642  122334567789999999999999999999987 6889999


Q ss_pred             EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc-
Q 020657          129 MEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD-  206 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~-  206 (323)
                      |||+.+++|.+++.+ ...+++..+..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++........ 
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~  158 (331)
T cd05597          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNG-HIRLADFGSCLRLLADGTV  158 (331)
T ss_pred             EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCC-CEEEEECCceeecCCCCCc
Confidence            999999999999976 45789999999999999999999999999999999999999987 899999999866543222 


Q ss_pred             ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCCh
Q 020657          207 ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP  286 (323)
Q Consensus       207 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (323)
                      ......++..|+|||++.....+...++.++||||||+++|+|++|..||...........+.........+.....++.
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  238 (331)
T cd05597         159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSE  238 (331)
T ss_pred             cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCH
Confidence            12234689999999998643323344567999999999999999999999654332222222211111111222345799


Q ss_pred             hHHHHHHHhcccCcCC--CCCHHHHhcCcccccC
Q 020657          287 EFRSFIECCLQKEFSK--RWTASQLLTHPFLCKN  318 (323)
Q Consensus       287 ~l~~ll~~~l~~~p~~--Rpt~~~~l~h~~f~~~  318 (323)
                      ++.+|+++||..+++.  |++++++++||||.+.
T Consensus       239 ~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~  272 (331)
T cd05597         239 EAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI  272 (331)
T ss_pred             HHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence            9999999998764443  7899999999999764

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.4e-46  Score=331.14  Aligned_cols=257  Identities=26%  Similarity=0.420  Sum_probs=209.8

Q ss_pred             hhccccccceeeeecccCCeEEEEEEec-----ccCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceeceeEE
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHR-----CTHKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFGIFE  119 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~  119 (323)
                      |.++.++|++.+.||+|+||.||+|.+.     .+++.||+|++...........+.+|+.+++.+ +||||+++++++.
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (338)
T cd05102           2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT   81 (338)
T ss_pred             cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence            5678899999999999999999999752     345689999997655455567789999999999 8999999999988


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHhc-------------------------------------------------------
Q 020657          120 KPSGDIAILMEYMDSGTLDTLLNKN-------------------------------------------------------  144 (323)
Q Consensus       120 ~~~~~~~lv~e~~~~~sL~~~l~~~-------------------------------------------------------  144 (323)
                      ...+.+++||||+++|+|.+++...                                                       
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence            7666789999999999999988642                                                       


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc--ccccccccc
Q 020657          145 -------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD--ACNSYVGTC  215 (323)
Q Consensus       145 -------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~  215 (323)
                             .++++..+..++.||++||+|||+.|++||||||+||+++.++ .+||+|||++........  ......++.
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC-cEEEeecccccccccCcchhcccCCCCCc
Confidence                   2477888999999999999999999999999999999999987 899999999976532211  112234567


Q ss_pred             cccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHH
Q 020657          216 AYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIEC  294 (323)
Q Consensus       216 ~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~  294 (323)
                      .|+|||++...     .++.++||||||+++|||++ |..||.......   .+......+.....+..+++++.+|+.+
T Consensus       241 ~y~aPE~~~~~-----~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~  312 (338)
T cd05102         241 KWMAPESIFDK-----VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE---EFCQRLKDGTRMRAPENATPEIYRIMLA  312 (338)
T ss_pred             cccCcHHhhcC-----CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH---HHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence            89999998643     34569999999999999997 999996644332   2333333444455567889999999999


Q ss_pred             hcccCcCCCCCHHHHhc
Q 020657          295 CLQKEFSKRWTASQLLT  311 (323)
Q Consensus       295 ~l~~~p~~Rpt~~~~l~  311 (323)
                      ||+.||++|||+.++++
T Consensus       313 cl~~dp~~RPs~~el~~  329 (338)
T cd05102         313 CWQGDPKERPTFSALVE  329 (338)
T ss_pred             HccCChhhCcCHHHHHH
Confidence            99999999999999985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.1e-46  Score=336.66  Aligned_cols=267  Identities=27%  Similarity=0.482  Sum_probs=217.9

Q ss_pred             chhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC
Q 020657           45 TAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS  122 (323)
Q Consensus        45 ~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  122 (323)
                      ...+..++|++.+.||+|+||.||+|++..+++.||+|++....  .......+.+|+.+++.++||||+++++++.+ .
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~-~  115 (370)
T cd05596          37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD-D  115 (370)
T ss_pred             cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence            44567789999999999999999999999999999999986431  22234457789999999999999999999987 6


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          123 GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      ...++||||+++++|.+++... .+++..+..++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++....
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~-~~kL~DfG~~~~~~  193 (370)
T cd05596         116 KYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMD  193 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCC-CEEEEeccceeecc
Confidence            7899999999999999988654 689999999999999999999999999999999999999987 89999999997654


Q ss_pred             cCc-cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCC
Q 020657          203 RSL-DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLP  281 (323)
Q Consensus       203 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (323)
                      ... .......++..|+|||++..... ...++.++||||||+++|+|++|..||...........+..   ......++
T Consensus       194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~---~~~~~~~~  269 (370)
T cd05596         194 ANGMVRCDTAVGTPDYISPEVLKSQGG-DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMD---HKNSLTFP  269 (370)
T ss_pred             CCCcccCCCCCCCcCeECHHHhccCCC-CCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHc---CCCcCCCC
Confidence            322 12234578999999999864321 23456799999999999999999999965443322222221   11122333


Q ss_pred             C--CCChhHHHHHHHhcccCcCC--CCCHHHHhcCcccccC
Q 020657          282 D--GASPEFRSFIECCLQKEFSK--RWTASQLLTHPFLCKN  318 (323)
Q Consensus       282 ~--~~~~~l~~ll~~~l~~~p~~--Rpt~~~~l~h~~f~~~  318 (323)
                      .  .++.++.+|+++||+.+|.+  |+|++++++||||++.
T Consensus       270 ~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~  310 (370)
T cd05596         270 DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND  310 (370)
T ss_pred             CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence            3  57999999999999999987  9999999999999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.5e-46  Score=342.41  Aligned_cols=263  Identities=24%  Similarity=0.331  Sum_probs=207.3

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcC-----
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP-----  121 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----  121 (323)
                      .....+|++.+.||+|+||.||+|.+..+++.||+|.+....     ....+|+.+++.++|+||+++++++...     
T Consensus        62 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~  136 (440)
T PTZ00036         62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN  136 (440)
T ss_pred             cCcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence            345578999999999999999999998899999999886432     2234799999999999999999886431     


Q ss_pred             --CCeEEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeec
Q 020657          122 --SGDIAILMEYMDSGTLDTLLN----KNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADF  195 (323)
Q Consensus       122 --~~~~~lv~e~~~~~sL~~~l~----~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Df  195 (323)
                        ...+++||||+++ +|.+++.    ....+++..++.++.||+.||.|||+.||+||||||+||+++.++..+||+||
T Consensus       137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence              1246799999986 7777664    34579999999999999999999999999999999999999976547999999


Q ss_pred             CcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcC
Q 020657          196 GVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFG  275 (323)
Q Consensus       196 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~  275 (323)
                      |++....... ......++..|+|||++.+    ...++.++||||||+++|+|++|..||.+.........+.+.....
T Consensus       216 Gla~~~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p  290 (440)
T PTZ00036        216 GSAKNLLAGQ-RSVSYICSRFYRAPELMLG----ATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTP  290 (440)
T ss_pred             ccchhccCCC-CcccCCCCcCccCHHHhcC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            9997654322 2234567899999998752    2335669999999999999999999997654433333322211000


Q ss_pred             ------------------------CCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          276 ------------------------DPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       276 ------------------------~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                                              ....++...+.++.+||.+||+.||.+|||+.++|+||||++.+.
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD  359 (440)
T ss_pred             CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence                                    001134457889999999999999999999999999999987654

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.1e-46  Score=330.11  Aligned_cols=250  Identities=28%  Similarity=0.505  Sum_probs=206.7

Q ss_pred             eeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHc-CCCCccceeceeEEcCCCeEEEEEeccC
Q 020657           57 QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRR-TDSPFIVQCFGIFEKPSGDIAILMEYMD  133 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~~lv~e~~~  133 (323)
                      +.||+|+||.||+|.+..+++.||+|++....  ..........|..++.. ..||||+++++++.. .+..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-~~~~~lv~e~~~   79 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT-KEHLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc-CCEEEEEEcCCC
Confidence            36999999999999999899999999987442  12233444556666665 489999999999987 678999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccccccc
Q 020657          134 SGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVG  213 (323)
Q Consensus       134 ~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  213 (323)
                      +++|.+.+.....+++..+..++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++..............+
T Consensus        80 gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~g  158 (316)
T cd05592          80 GGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG-HIKIADFGMCKENMNGEGKASTFCG  158 (316)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCC-CEEEccCcCCeECCCCCCccccccC
Confidence            999999998888899999999999999999999999999999999999999987 8999999999754333333445678


Q ss_pred             cccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHH
Q 020657          214 TCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIE  293 (323)
Q Consensus       214 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~  293 (323)
                      +..|+|||++.+..     ++.++||||||+++|+|++|..||.+...    ..+...+. ...+.++..++.++.+|++
T Consensus       159 t~~y~aPE~~~~~~-----~~~~~DvwslG~il~ell~G~~Pf~~~~~----~~~~~~i~-~~~~~~~~~~~~~~~~ll~  228 (316)
T cd05592         159 TPDYIAPEILKGQK-----YNESVDWWSFGVLLYEMLIGQSPFHGEDE----DELFDSIL-NDRPHFPRWISKEAKDCLS  228 (316)
T ss_pred             CccccCHHHHcCCC-----CCCcccchhHHHHHHHHHhCCCCCCCCCH----HHHHHHHH-cCCCCCCCCCCHHHHHHHH
Confidence            99999999986433     45699999999999999999999965433    23333332 2345667788999999999


Q ss_pred             HhcccCcCCCCCH-HHHhcCcccccC
Q 020657          294 CCLQKEFSKRWTA-SQLLTHPFLCKN  318 (323)
Q Consensus       294 ~~l~~~p~~Rpt~-~~~l~h~~f~~~  318 (323)
                      +||+.||++||++ .++++||||.+.
T Consensus       229 ~~l~~~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05592         229 KLFERDPTKRLGVDGDIRQHPFFRGI  254 (316)
T ss_pred             HHccCCHHHcCCChHHHHcCcccCCC
Confidence            9999999999986 588899999865

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-47  Score=339.44  Aligned_cols=257  Identities=30%  Similarity=0.481  Sum_probs=209.1

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ++|++++.||+|+||.||+|.+..+++.||+|++....  .......+.+|+.+++.++||||+++++++.+ ....++|
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-~~~~~lv   79 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD-AQYLYLI   79 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc-CCeeEEE
Confidence            47999999999999999999999999999999986432  23345677889999999999999999999987 6789999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc--
Q 020657          129 MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD--  206 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~--  206 (323)
                      |||+++++|.+++...+.+++..++.++.|++.||+|||+.|++||||||+||+++.++ .++|+|||++..+.....  
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~-~~kl~DfGla~~~~~~~~~~  158 (377)
T cd05629          80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGG-HIKLSDFGLSTGFHKQHDSA  158 (377)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC-CEEEeecccccccccccccc
Confidence            99999999999998888899999999999999999999999999999999999999987 899999999863211000  


Q ss_pred             ---------------------------------------------ccccccccccccCCcccCCCCCCCCCCCcchhHHH
Q 020657          207 ---------------------------------------------ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWS  241 (323)
Q Consensus       207 ---------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~s  241 (323)
                                                                   .....+||..|+|||++....     ++.++||||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwS  233 (377)
T cd05629         159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG-----YGQECDWWS  233 (377)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC-----CCCceeeEe
Confidence                                                         001246889999999986433     456999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCC--CCCChhHHHHHHHhcccCcCCC---CCHHHHhcCcccc
Q 020657          242 LGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLP--DGASPEFRSFIECCLQKEFSKR---WTASQLLTHPFLC  316 (323)
Q Consensus       242 lG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~ll~~~l~~~p~~R---pt~~~~l~h~~f~  316 (323)
                      |||++|||++|..||...........+.   .......++  ..++.++.+|+++||+ +|.+|   +|+.++++||||+
T Consensus       234 lGvil~elltG~~Pf~~~~~~~~~~~i~---~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~  309 (377)
T cd05629         234 LGAIMFECLIGWPPFCSENSHETYRKII---NWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFR  309 (377)
T ss_pred             cchhhhhhhcCCCCCCCCCHHHHHHHHH---ccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcC
Confidence            9999999999999996544322222221   111222233  2578999999999998 77765   5999999999998


Q ss_pred             cC
Q 020657          317 KN  318 (323)
Q Consensus       317 ~~  318 (323)
                      +.
T Consensus       310 ~~  311 (377)
T cd05629         310 GV  311 (377)
T ss_pred             CC
Confidence            64

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.1e-46  Score=331.19  Aligned_cols=251  Identities=29%  Similarity=0.505  Sum_probs=205.8

Q ss_pred             eeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHH-HHHcCCCCccceeceeEEcCCCeEEEEEeccC
Q 020657           57 QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREME-ILRRTDSPFIVQCFGIFEKPSGDIAILMEYMD  133 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~  133 (323)
                      +.||+|+||.||+|.+..+++.||+|++....  .......+..|.. +++.++||||+++++.+.. .+..++||||+.
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~   79 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-ADKLYFVLDYVN   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe-CCEEEEEEcCCC
Confidence            36899999999999999999999999986432  1122334444544 4677999999999999987 678999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccccccc
Q 020657          134 SGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVG  213 (323)
Q Consensus       134 ~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  213 (323)
                      +++|...+.....+++..+..++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++..............+
T Consensus        80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (323)
T cd05575          80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGIEHSKTTSTFCG  158 (323)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC-cEEEeccCCCcccccCCCccccccC
Confidence            999999998888899999999999999999999999999999999999999987 8999999998654333333345578


Q ss_pred             cccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHH
Q 020657          214 TCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIE  293 (323)
Q Consensus       214 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~  293 (323)
                      +..|+|||++...     .++.++||||||+++|+|++|..||...+.    ..+...+.. ....++..++..+.++++
T Consensus       159 t~~y~aPE~~~~~-----~~~~~~DvwslG~il~ell~g~~pf~~~~~----~~~~~~i~~-~~~~~~~~~~~~~~~li~  228 (323)
T cd05575         159 TPEYLAPEVLRKQ-----PYDRTVDWWCLGAVLYEMLYGLPPFYSRDT----AEMYDNILN-KPLRLKPNISVSARHLLE  228 (323)
T ss_pred             ChhhcChhhhcCC-----CCCccccccccchhhhhhhcCCCCCCCCCH----HHHHHHHHc-CCCCCCCCCCHHHHHHHH
Confidence            9999999998643     345699999999999999999999965432    333333322 234455678999999999


Q ss_pred             HhcccCcCCCCCH----HHHhcCcccccCC
Q 020657          294 CCLQKEFSKRWTA----SQLLTHPFLCKNR  319 (323)
Q Consensus       294 ~~l~~~p~~Rpt~----~~~l~h~~f~~~~  319 (323)
                      +||+.||++||++    +++++||||.+..
T Consensus       229 ~~l~~~p~~R~~~~~~~~~il~~~~~~~~~  258 (323)
T cd05575         229 GLLQKDRTKRLGAKDDFLEIKNHVFFSSIN  258 (323)
T ss_pred             HHhhcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence            9999999999987    6999999997643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=5.6e-47  Score=339.84  Aligned_cols=257  Identities=26%  Similarity=0.403  Sum_probs=209.1

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ++|++++.||+|+||.||+|++..+++.||+|++....  .......+.+|+.+++.+.|+||+++++.+.+ .+.+++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv   79 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD-KDNLYFV   79 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc-CCEEEEE
Confidence            47999999999999999999999999999999986431  12234567789999999999999999999987 6899999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC----
Q 020657          129 MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS----  204 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~----  204 (323)
                      |||+++++|.+++...+.+++..+..++.||+.||+|||+.||+||||||+||+++.++ .++|+|||++..+...    
T Consensus        80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~-~ikL~DFG~a~~~~~~~~~~  158 (376)
T cd05598          80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGFRWTHDSK  158 (376)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCC-CEEEEeCCCCcccccccccc
Confidence            99999999999998888899999999999999999999999999999999999999987 8999999997532100    


Q ss_pred             ---------------------------------------ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHH
Q 020657          205 ---------------------------------------LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLT  245 (323)
Q Consensus       205 ---------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~l  245 (323)
                                                             ........|+..|+|||++....     ++.++|||||||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwSlGvi  233 (376)
T cd05598         159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-----YTQLCDWWSVGVI  233 (376)
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC-----CCcceeeeeccce
Confidence                                                   00011346899999999986433     4569999999999


Q ss_pred             HHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCC--CCCCChhHHHHHHHhcccCcCCCC---CHHHHhcCcccccC
Q 020657          246 LLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSL--PDGASPEFRSFIECCLQKEFSKRW---TASQLLTHPFLCKN  318 (323)
Q Consensus       246 l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~ll~~~l~~~p~~Rp---t~~~~l~h~~f~~~  318 (323)
                      +|+|++|..||...........+   ........+  ...+++++.+++.+|+ .+|.+|+   |++++++||||++.
T Consensus       234 lyell~G~~Pf~~~~~~~~~~~i---~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~  307 (376)
T cd05598         234 LYEMLVGQPPFLADTPAETQLKV---INWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI  307 (376)
T ss_pred             eeehhhCCCCCCCCCHHHHHHHH---hccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence            99999999999655432221211   111111122  2467899999999977 5999999   99999999999875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2e-46  Score=329.49  Aligned_cols=255  Identities=28%  Similarity=0.458  Sum_probs=212.2

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcC-CCCccceeceeEEcCCCeEEEE
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      +|++...||+|+||.||+|++..+++.||+|++....  .......+..|..++..+ .|++|+++++++.. .+.+++|
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv   79 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT-MDRLYFV   79 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec-CCEEEEE
Confidence            5889999999999999999999899999999987542  222334566777777776 58899999999887 6789999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          129 MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      |||+++++|.+.+.....+++..+..++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++..........
T Consensus        80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-~~kL~DfG~~~~~~~~~~~~  158 (323)
T cd05616          80 MEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENMWDGVTT  158 (323)
T ss_pred             EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCC-cEEEccCCCceecCCCCCcc
Confidence            99999999999998888899999999999999999999999999999999999999987 89999999986543333333


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhH
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEF  288 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (323)
                      ....++..|+|||++....     ++.++||||||+++|+|+||..||.....    ..+...+.. ....++..++.++
T Consensus       159 ~~~~gt~~y~aPE~~~~~~-----~~~~~DiwSlGvil~elltg~~Pf~~~~~----~~~~~~i~~-~~~~~p~~~s~~~  228 (323)
T cd05616         159 KTFCGTPDYIAPEIIAYQP-----YGKSVDWWAFGVLLYEMLAGQAPFEGEDE----DELFQSIME-HNVAYPKSMSKEA  228 (323)
T ss_pred             ccCCCChhhcCHHHhcCCC-----CCCccchhchhHHHHHHHhCCCCCCCCCH----HHHHHHHHh-CCCCCCCcCCHHH
Confidence            4567899999999987443     45699999999999999999999965433    233333322 2345667899999


Q ss_pred             HHHHHHhcccCcCCCCCH-----HHHhcCcccccC
Q 020657          289 RSFIECCLQKEFSKRWTA-----SQLLTHPFLCKN  318 (323)
Q Consensus       289 ~~ll~~~l~~~p~~Rpt~-----~~~l~h~~f~~~  318 (323)
                      .+|+.+||+.||.+|++.     .++++||||+..
T Consensus       229 ~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~  263 (323)
T cd05616         229 VAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  263 (323)
T ss_pred             HHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence            999999999999999984     899999999865

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.5e-46  Score=329.45  Aligned_cols=251  Identities=31%  Similarity=0.500  Sum_probs=209.5

Q ss_pred             eeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcC-CCCccceeceeEEcCCCeEEEEEeccC
Q 020657           57 QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKPSGDIAILMEYMD  133 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~lv~e~~~  133 (323)
                      +.||+|+||.||+|.+..+++.||+|++....  .......+.+|..+++.+ .||||+++++++.. .+.+++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~   79 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT-KDRLFFVMEYVN   79 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-CCEEEEEEcCCC
Confidence            36999999999999999899999999987432  223345567888888877 69999999999987 678999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccccccc
Q 020657          134 SGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVG  213 (323)
Q Consensus       134 ~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  213 (323)
                      +++|...+.....+++..+..++.||+.||.|||+.|++|+||||+||+++.++ .++|+|||++..............+
T Consensus        80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (318)
T cd05570          80 GGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEG-HIKIADFGMCKEGILGGVTTSTFCG  158 (318)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCC-cEEecccCCCeecCcCCCcccceec
Confidence            999999998888899999999999999999999999999999999999999987 8999999998653222233344568


Q ss_pred             cccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHH
Q 020657          214 TCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIE  293 (323)
Q Consensus       214 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~  293 (323)
                      +..|+|||++.+.     .++.++||||||+++|+|++|..||.....    ..+...+. .....++..++.++.+|++
T Consensus       159 ~~~y~aPE~~~~~-----~~~~~~DiwslGvil~~l~~G~~pf~~~~~----~~~~~~i~-~~~~~~~~~~~~~~~~li~  228 (318)
T cd05570         159 TPDYIAPEILSYQ-----PYGPAVDWWALGVLLYEMLAGQSPFEGDDE----DELFQSIL-EDEVRYPRWLSKEAKSILK  228 (318)
T ss_pred             CccccCHHHhcCC-----CCCcchhhhhHHHHHHHHhhCCCCCCCCCH----HHHHHHHH-cCCCCCCCcCCHHHHHHHH
Confidence            8999999998643     345699999999999999999999965432    22322222 2234566788999999999


Q ss_pred             HhcccCcCCCCCH-----HHHhcCcccccCC
Q 020657          294 CCLQKEFSKRWTA-----SQLLTHPFLCKNR  319 (323)
Q Consensus       294 ~~l~~~p~~Rpt~-----~~~l~h~~f~~~~  319 (323)
                      +||+.||++|||+     .++++||||.+..
T Consensus       229 ~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~  259 (318)
T cd05570         229 SFLTKNPEKRLGCLPTGEQDIKGHPFFREID  259 (318)
T ss_pred             HHccCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence            9999999999999     9999999998753

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-46  Score=321.70  Aligned_cols=258  Identities=26%  Similarity=0.432  Sum_probs=214.6

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      .|++.+.||+|+||.||++.+..+++.||+|++....  .......+.+|+.+++.++|+||+++++.+.. ....++||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~   79 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-KDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC-CCeEEEEE
Confidence            4889999999999999999998899999999986432  22234556789999999999999999999987 57899999


Q ss_pred             eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccc
Q 020657          130 EYMDSGTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA  207 (323)
Q Consensus       130 e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~  207 (323)
                      ||+.+++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||+|+||++++++ .++|+|||++...... ..
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~~-~~  157 (285)
T cd05605          80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG-HIRISDLGLAVEIPEG-ET  157 (285)
T ss_pred             eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCC-CEEEeeCCCceecCCC-Cc
Confidence            999999999887643  4689999999999999999999999999999999999999887 8999999998765322 22


Q ss_pred             cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChh
Q 020657          208 CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPE  287 (323)
Q Consensus       208 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (323)
                      .....++..|+|||++...     .++.++||||+|+++|+|++|..||.+.........+...+. .....++..++..
T Consensus       158 ~~~~~~~~~y~aPE~~~~~-----~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  231 (285)
T cd05605         158 IRGRVGTVGYMAPEVVKNE-----RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVK-EDQEEYSEKFSEA  231 (285)
T ss_pred             cccccCCCCccCcHHhcCC-----CCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhh-hcccccCcccCHH
Confidence            2344688999999998633     345689999999999999999999976544433334433332 3344566778999


Q ss_pred             HHHHHHHhcccCcCCCC-----CHHHHhcCcccccC
Q 020657          288 FRSFIECCLQKEFSKRW-----TASQLLTHPFLCKN  318 (323)
Q Consensus       288 l~~ll~~~l~~~p~~Rp-----t~~~~l~h~~f~~~  318 (323)
                      +.+|+.+||..||++||     +++++++||||++.
T Consensus       232 ~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05605         232 ARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA  267 (285)
T ss_pred             HHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence            99999999999999999     89999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-48  Score=337.66  Aligned_cols=249  Identities=28%  Similarity=0.456  Sum_probs=215.3

Q ss_pred             CccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcC
Q 020657           42 TATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP  121 (323)
Q Consensus        42 ~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  121 (323)
                      ....|+|+.+...-++.||.|+.|.||+|+.  .++.||||.++..        -..+++-|++|+|+||+.+.|+|.. 
T Consensus       115 q~e~WeiPFe~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~el--------kETdIKHLRkLkH~NII~FkGVCtq-  183 (904)
T KOG4721|consen  115 QEELWEIPFEEISELEWLGSGAQGAVFLGRL--HNETVAVKKVREL--------KETDIKHLRKLKHPNIITFKGVCTQ-  183 (904)
T ss_pred             hhhhccCCHHHhhhhhhhccCcccceeeeec--cCceehhHHHhhh--------hhhhHHHHHhccCcceeeEeeeecC-
Confidence            3566788888888999999999999999999  5889999998532        2356788999999999999999997 


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhh
Q 020657          122 SGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM  201 (323)
Q Consensus       122 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~  201 (323)
                      ...+|||||||..|.|..+++.+.+++....+.|.++|+.+|.|||.+.|||||||.-||||..+. .|||+|||.++..
T Consensus       184 sPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d-~VKIsDFGTS~e~  262 (904)
T KOG4721|consen  184 SPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDD-VVKISDFGTSKEL  262 (904)
T ss_pred             CceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccc-eEEeccccchHhh
Confidence            788999999999999999999999999999999999999999999999999999999999999987 8999999999876


Q ss_pred             ccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcC-CCCCC
Q 020657          202 CRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFG-DPPSL  280 (323)
Q Consensus       202 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~  280 (323)
                      ... .....+.||..|||||++.     +.+.+.|+||||||++|||||||+.||...+....    +..+... ...+.
T Consensus       263 ~~~-STkMSFaGTVaWMAPEvIr-----nePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI----IwGVGsNsL~Lpv  332 (904)
T KOG4721|consen  263 SDK-STKMSFAGTVAWMAPEVIR-----NEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI----IWGVGSNSLHLPV  332 (904)
T ss_pred             hhh-hhhhhhhhhHhhhCHHHhh-----cCCcccccceehhHHHHHHHHhcCCCccccchhee----EEeccCCcccccC
Confidence            554 4556789999999999998     44556699999999999999999999965444322    1111111 12456


Q ss_pred             CCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          281 PDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       281 ~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      |..++..+.-||++||+-.|.+||+|.+||.|
T Consensus       333 PstcP~GfklL~Kqcw~sKpRNRPSFrqil~H  364 (904)
T KOG4721|consen  333 PSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH  364 (904)
T ss_pred             cccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence            78899999999999999999999999999998

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.3e-46  Score=328.52  Aligned_cols=256  Identities=25%  Similarity=0.451  Sum_probs=211.9

Q ss_pred             eeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcC-CCCccceeceeEEcCCCeEEEEEeccC
Q 020657           57 QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKPSGDIAILMEYMD  133 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~lv~e~~~  133 (323)
                      +.||+|+||.||+|.+..+++.+|+|++....  .......+.+|..++.++ .|++|+++++++.. .+.+++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~   79 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT-TSRLFLVIEYVN   79 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe-CCEEEEEEeCCC
Confidence            46999999999999999899999999997542  223456678899998887 69999999999987 678999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccccccc
Q 020657          134 SGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVG  213 (323)
Q Consensus       134 ~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  213 (323)
                      +++|...+...+.+++..+..++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++..............+
T Consensus        80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (327)
T cd05617          80 GGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADG-HIKLTDYGMCKEGLGPGDTTSTFCG  158 (327)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCC-CEEEeccccceeccCCCCceecccC
Confidence            999999998878899999999999999999999999999999999999999987 8999999998653333333345678


Q ss_pred             cccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCc--cHHHHHHHHhcCCCCCCCCCCChhHHHH
Q 020657          214 TCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRP--DWATLMCAICFGDPPSLPDGASPEFRSF  291 (323)
Q Consensus       214 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~l  291 (323)
                      +..|+|||++.+.     .++.++||||||+++|+|++|..||.......  .............+..++..++..+.++
T Consensus       159 t~~y~aPE~~~~~-----~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l  233 (327)
T cd05617         159 TPNYIAPEILRGE-----EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHV  233 (327)
T ss_pred             CcccCCHHHHCCC-----CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            9999999998643     34569999999999999999999996433221  1112222222334556778899999999


Q ss_pred             HHHhcccCcCCCCC------HHHHhcCcccccCC
Q 020657          292 IECCLQKEFSKRWT------ASQLLTHPFLCKNR  319 (323)
Q Consensus       292 l~~~l~~~p~~Rpt------~~~~l~h~~f~~~~  319 (323)
                      +++||+.||++|++      ++++++||||.++.
T Consensus       234 i~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~  267 (327)
T cd05617         234 LKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID  267 (327)
T ss_pred             HHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence            99999999999997      57999999998764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.4e-46  Score=337.86  Aligned_cols=258  Identities=27%  Similarity=0.428  Sum_probs=210.2

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ++|++++.||+|+||.||+|++..+++.+|+|++....  .......+.+|+.+++.+.|+||+++++.+.+ .+.+++|
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~-~~~~~lv   79 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD-KDNLYFV   79 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe-CCEEEEE
Confidence            36899999999999999999999999999999986432  22345678899999999999999999999987 6789999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc---
Q 020657          129 MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL---  205 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~---  205 (323)
                      |||+++++|.+++.+.+.+++..+..++.||+.||.|||+.||+||||||+||+++.++ .+||+|||++.......   
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g-~~kL~DFGla~~~~~~~~~~  158 (382)
T cd05625          80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGFRWTHDSK  158 (382)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEEeECCCCcccccccccc
Confidence            99999999999998877899999999999999999999999999999999999999987 89999999975321000   


Q ss_pred             --------------------------------------------cccccccccccccCCcccCCCCCCCCCCCcchhHHH
Q 020657          206 --------------------------------------------DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWS  241 (323)
Q Consensus       206 --------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~s  241 (323)
                                                                  ......+||..|+|||++....     ++.++||||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-----~~~~~DiwS  233 (382)
T cd05625         159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG-----YTQLCDWWS  233 (382)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCC-----CCCeeeEEe
Confidence                                                        0012346889999999987443     456999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCC--CCCChhHHHHHHHhcccCcCCCCC---HHHHhcCcccc
Q 020657          242 LGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLP--DGASPEFRSFIECCLQKEFSKRWT---ASQLLTHPFLC  316 (323)
Q Consensus       242 lG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~ll~~~l~~~p~~Rpt---~~~~l~h~~f~  316 (323)
                      |||++|||++|..||......   ..............++  ..+++++.+|+.+|+ .+|++|++   ++++++||||+
T Consensus       234 lGvil~elltG~~Pf~~~~~~---~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~  309 (382)
T cd05625         234 VGVILYEMLVGQPPFLAQTPL---ETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFK  309 (382)
T ss_pred             chHHHHHHHhCCCCCCCCCHH---HHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcC
Confidence            999999999999999654322   2222222212222222  467999999999976 59999997   99999999998


Q ss_pred             cCC
Q 020657          317 KNR  319 (323)
Q Consensus       317 ~~~  319 (323)
                      +..
T Consensus       310 ~~~  312 (382)
T cd05625         310 TID  312 (382)
T ss_pred             CcC
Confidence            753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.6e-46  Score=324.81  Aligned_cols=264  Identities=24%  Similarity=0.376  Sum_probs=212.2

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ..++|++.+.||.|++|.||+|.+..+++.|++|.+...........+.+|+.+++.++|+||+++++++.. .+..++|
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~-~~~~~lv   82 (301)
T cd07873           4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-EKSLTLV   82 (301)
T ss_pred             cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEec-CCeEEEE
Confidence            357899999999999999999999989999999998755444444567789999999999999999999987 6789999


Q ss_pred             EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccc
Q 020657          129 MEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA  207 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~  207 (323)
                      |||+.+ +|.+.+.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++.........
T Consensus        83 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~  160 (301)
T cd07873          83 FEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERG-ELKLADFGLARAKSIPTKT  160 (301)
T ss_pred             Eecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCC-cEEECcCcchhccCCCCCc
Confidence            999975 88888765 45689999999999999999999999999999999999999987 8999999999765433333


Q ss_pred             cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcC------------
Q 020657          208 CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFG------------  275 (323)
Q Consensus       208 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~------------  275 (323)
                      .....++..|+|||.+.+    ...++.++||||||+++|+|+||+.||...+.......+.......            
T Consensus       161 ~~~~~~~~~y~~PE~~~~----~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (301)
T cd07873         161 YSNEVVTLWYRPPDILLG----STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE  236 (301)
T ss_pred             ccccceeecccCcHHHhC----CCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence            334567889999998753    2334569999999999999999999996554322221111111000            


Q ss_pred             -----CCC--------CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          276 -----DPP--------SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       276 -----~~~--------~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                           ..+        .....+++++.+|+.+||+.||.+|||++++++||||....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence                 000        11235788999999999999999999999999999997643

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.9e-46  Score=322.93  Aligned_cols=257  Identities=26%  Similarity=0.429  Sum_probs=201.2

Q ss_pred             cccceeeeecccCCeEEEEEEecc-cCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcC---CCCccceeceeEEc----C
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRC-THKIYALKVVHGDAD-PTVRRQVFREMEILRRT---DSPFIVQCFGIFEK----P  121 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~-~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~----~  121 (323)
                      .+|++.+.||+|+||.||+|++.. +++.||+|.+..... ......+.+|+.+++.+   .||||+++++++..    .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            479999999999999999999854 467899999864432 22233455677766655   69999999998752    2


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcch
Q 020657          122 SGDIAILMEYMDSGTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       122 ~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                      ...+++||||+.+ +|.+++...  ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++ .++|+|||++.
T Consensus        81 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~-~~kl~Dfg~~~  158 (290)
T cd07862          81 ETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGLAR  158 (290)
T ss_pred             CCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCC-CEEEccccceE
Confidence            4568999999974 898888653  3589999999999999999999999999999999999999987 89999999997


Q ss_pred             hhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCC-
Q 020657          200 IMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPP-  278 (323)
Q Consensus       200 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~-  278 (323)
                      ..... .......++..|+|||++...     .++.++||||||+++|+|++|..||.+.........+........+. 
T Consensus       159 ~~~~~-~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~  232 (290)
T cd07862         159 IYSFQ-MALTSVVVTLWYRAPEVLLQS-----SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  232 (290)
T ss_pred             eccCC-cccccccccccccChHHHhCC-----CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence            65433 223445688999999998643     34569999999999999999999997655443333333221111000 


Q ss_pred             ---------------------CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          279 ---------------------SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       279 ---------------------~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                                           .+...++..+.+|+.+||+.||++|||+.++|+||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                                 1123577889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-46  Score=320.73  Aligned_cols=264  Identities=33%  Similarity=0.562  Sum_probs=221.4

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      +.++|++.+.||.|++|.||+|.+..+++.+++|++... .......+.+|+.++++++|+||+++++.+.. ....++|
T Consensus         3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv   80 (280)
T cd06611           3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAYFY-ENKLWIL   80 (280)
T ss_pred             chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEec-CCeEEEE
Confidence            357899999999999999999999888999999998754 33445678899999999999999999999987 6789999


Q ss_pred             EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccc
Q 020657          129 MEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA  207 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~  207 (323)
                      |||+++++|.+++.. ...+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++ .++|+|||.+.........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~  159 (280)
T cd06611          81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTLQK  159 (280)
T ss_pred             eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCC-CEEEccCccchhhcccccc
Confidence            999999999999876 35699999999999999999999999999999999999999987 8999999998765443333


Q ss_pred             cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCC--CCCCCC
Q 020657          208 CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPS--LPDGAS  285 (323)
Q Consensus       208 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  285 (323)
                      .....++..|+|||.+..........+.++|+||||+++|+|++|..||......    ...........+.  .+..++
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~  235 (280)
T cd06611         160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM----RVLLKILKSEPPTLDQPSKWS  235 (280)
T ss_pred             cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH----HHHHHHhcCCCCCcCCcccCC
Confidence            3445688899999998765555566778999999999999999999999654322    2222222222222  345678


Q ss_pred             hhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          286 PEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       286 ~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      .++.+++.+||+.+|.+|||++++++||||.+..
T Consensus       236 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (280)
T cd06611         236 SSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS  269 (280)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence            9999999999999999999999999999998764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-47  Score=335.16  Aligned_cols=262  Identities=24%  Similarity=0.420  Sum_probs=218.4

Q ss_pred             CCCCCccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCC-CChHHHHHHHHHHHHHHcCCCCccceece
Q 020657           38 NNNTTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIVQCFG  116 (323)
Q Consensus        38 ~~~~~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~  116 (323)
                      +...+...|+|..+++.+...||+|.||+||+|.|.++   ||||++... ..++..+.|.+|+.++++-+|.||+-+.|
T Consensus       379 ~~s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG  455 (678)
T KOG0193|consen  379 QASDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMG  455 (678)
T ss_pred             cCCccccccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeeh
Confidence            33445689999999999999999999999999999765   999999765 35667889999999999999999999999


Q ss_pred             eEEcCCCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeec
Q 020657          117 IFEKPSGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADF  195 (323)
Q Consensus       117 ~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Df  195 (323)
                      ++..+ + +.||+.||+|.+|+.+++. ...++....+.|++||++||.|||.++|+|+|||..||++.+++ .|||+||
T Consensus       456 ~~~~p-~-~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~-kVkIgDF  532 (678)
T KOG0193|consen  456 ACMNP-P-LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDL-KVKIGDF  532 (678)
T ss_pred             hhcCC-c-eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCC-cEEEecc
Confidence            99873 3 4999999999999999974 34699999999999999999999999999999999999999986 9999999


Q ss_pred             Ccchhhc--cCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHh
Q 020657          196 GVSKIMC--RSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAIC  273 (323)
Q Consensus       196 g~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~  273 (323)
                      |++....  ..........+...|+|||++.  .....++++++||||||+++|||+||.+||. ....   +.++-.+.
T Consensus       533 GLatvk~~w~g~~q~~qp~gsilwmAPEvIR--mqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~---dqIifmVG  606 (678)
T KOG0193|consen  533 GLATVKTRWSGEQQLEQPHGSLLWMAPEVIR--MQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNR---DQIIFMVG  606 (678)
T ss_pred             cceeeeeeeccccccCCCccchhhhcHHHHh--hcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCCh---hheEEEec
Confidence            9996432  2233345567889999999998  3346788999999999999999999999996 2222   22222222


Q ss_pred             cC----CCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          274 FG----DPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       274 ~~----~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      .+    +.......++.++.+|+..||+.++++||++.+||.
T Consensus       607 rG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  607 RGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             ccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            22    122333567889999999999999999999999986

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-46  Score=318.24  Aligned_cols=258  Identities=34%  Similarity=0.576  Sum_probs=220.2

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEe
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILME  130 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e  130 (323)
                      ++|++.+.||.|++|.||+|.+..+++.+++|.+...........+.+|+.+++.++|+||+++++.+.. +...++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e   79 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK-GSKLWIIME   79 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE-CCeEEEEEE
Confidence            4789999999999999999999989999999999766544555678899999999999999999999887 678999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccccc
Q 020657          131 YMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNS  210 (323)
Q Consensus       131 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~  210 (323)
                      |+.+++|.+++... .+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++ .++|+|||++............
T Consensus        80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~~~~~~  157 (274)
T cd06609          80 YCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEG-DVKLADFGVSGQLTSTMSKRNT  157 (274)
T ss_pred             eeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEcccccceeeccccccccc
Confidence            99999999999765 789999999999999999999999999999999999999987 8999999999776554333445


Q ss_pred             ccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCC-CChhHH
Q 020657          211 YVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDG-ASPEFR  289 (323)
Q Consensus       211 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~  289 (323)
                      ..++..|+|||.+....     ++.++|||+||+++|+|+||..||.....    ......+.....+..+.. ++.++.
T Consensus       158 ~~~~~~y~~PE~~~~~~-----~~~~sDv~slG~il~~l~tg~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~  228 (274)
T cd06609         158 FVGTPFWMAPEVIKQSG-----YDEKADIWSLGITAIELAKGEPPLSDLHP----MRVLFLIPKNNPPSLEGNKFSKPFK  228 (274)
T ss_pred             ccCCccccChhhhccCC-----CCchhhHHHHHHHHHHHHhCCCCcccCch----HHHHHHhhhcCCCCCcccccCHHHH
Confidence            56788999999986433     56799999999999999999999965432    222233333444455544 889999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          290 SFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       290 ~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                      +++.+||..+|++|||++++++||||++..+
T Consensus       229 ~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~  259 (274)
T cd06609         229 DFVSLCLNKDPKERPSAKELLKHKFIKKAKK  259 (274)
T ss_pred             HHHHHHhhCChhhCcCHHHHhhChhhcCCCc
Confidence            9999999999999999999999999988664

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4e-46  Score=333.79  Aligned_cols=262  Identities=30%  Similarity=0.400  Sum_probs=210.2

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC----CeEE
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS----GDIA  126 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~~  126 (323)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++|+||+++++++....    ...+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            5788999999999999999998899999999986542 3344567889999999999999999999987633    2689


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc-
Q 020657          127 ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL-  205 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~-  205 (323)
                      +|+||+. ++|.+.+.....+++..+..++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++....... 
T Consensus        81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~a~~~~~~~~  158 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNC-VLKICDFGLARVEEPDES  158 (372)
T ss_pred             EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCC-CEEeccccceeecccCcc
Confidence            9999997 48888888777899999999999999999999999999999999999999987 89999999997643221 


Q ss_pred             cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHH--------------
Q 020657          206 DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCA--------------  271 (323)
Q Consensus       206 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~--------------  271 (323)
                      .......++..|+|||++.+.    ..++.++||||||+++|+|++|+.||.+.........+...              
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  234 (372)
T cd07853         159 KHMTQEVVTQYYRAPEILMGS----RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE  234 (372)
T ss_pred             ccCCCCCcCCCcCCHHHHcCC----CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence            122334678899999988632    23456999999999999999999999665432222221110              


Q ss_pred             -----H-hcCC-CC------CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          272 -----I-CFGD-PP------SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       272 -----~-~~~~-~~------~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                           . .... ++      .+....++++.+||.+||+.||++|||+.++|+||||.+.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence                 0 0000 01      12345688999999999999999999999999999998753

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=5.6e-46  Score=325.44  Aligned_cols=251  Identities=25%  Similarity=0.462  Sum_probs=207.1

Q ss_pred             eeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHc-CCCCccceeceeEEcCCCeEEEEEeccC
Q 020657           57 QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRR-TDSPFIVQCFGIFEKPSGDIAILMEYMD  133 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~~lv~e~~~  133 (323)
                      +.||+|+||.||+|++..+++.||+|++....  ..........|..++.. +.||||+++++++.+ .+.+++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~-~~~~~lv~ey~~   79 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT-KENLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe-CCEEEEEEeCCC
Confidence            36999999999999999899999999987541  11223445667777776 589999999999987 678999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccccccc
Q 020657          134 SGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVG  213 (323)
Q Consensus       134 ~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  213 (323)
                      +++|.+++.....+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++..............+
T Consensus        80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05619          80 GGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDG-HIKIADFGMCKENMLGDAKTCTFCG  158 (316)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC-CEEEccCCcceECCCCCCceeeecC
Confidence            999999998877899999999999999999999999999999999999999987 8999999998653322233344568


Q ss_pred             cccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHH
Q 020657          214 TCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIE  293 (323)
Q Consensus       214 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~  293 (323)
                      +..|+|||++...     .++.++||||||+++|+|++|..||.....    ..+.+.+... .+.++..++.++.+|+.
T Consensus       159 t~~y~aPE~~~~~-----~~~~~~DvwslG~il~el~~G~~pf~~~~~----~~~~~~i~~~-~~~~~~~~~~~~~~li~  228 (316)
T cd05619         159 TPDYIAPEILLGQ-----KYNTSVDWWSFGVLLYEMLIGQSPFHGHDE----EELFQSIRMD-NPCYPRWLTREAKDILV  228 (316)
T ss_pred             CccccCHHHHcCC-----CCCchhhhhhHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhC-CCCCCccCCHHHHHHHH
Confidence            9999999998643     345699999999999999999999965432    3333333322 34456678999999999


Q ss_pred             HhcccCcCCCCCHH-HHhcCcccccCC
Q 020657          294 CCLQKEFSKRWTAS-QLLTHPFLCKNR  319 (323)
Q Consensus       294 ~~l~~~p~~Rpt~~-~~l~h~~f~~~~  319 (323)
                      +||+.||++||++. ++++||||++..
T Consensus       229 ~~l~~~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05619         229 KLFVREPERRLGVKGDIRQHPFFREID  255 (316)
T ss_pred             HHhccCHhhcCCChHHHHcCcccCCCC
Confidence            99999999999996 999999998754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.3e-45  Score=319.01  Aligned_cols=266  Identities=40%  Similarity=0.670  Sum_probs=222.5

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEe
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILME  130 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e  130 (323)
                      ++|++++.||+|++|.||+|.+..+++.+++|.+...........+.+|+.+++++.|+||+++++.+.. .+..++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e   79 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI-EGAVYMCME   79 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec-CCeEEEEEe
Confidence            4799999999999999999999989999999998765555556788899999999999999999999887 688999999


Q ss_pred             ccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc
Q 020657          131 YMDSGTLDTLLNKN---GTFSEPKLAHIASQILKGLSYLHG-HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD  206 (323)
Q Consensus       131 ~~~~~sL~~~l~~~---~~~~~~~~~~i~~~i~~~l~~Lh~-~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~  206 (323)
                      |+++++|..++...   ..+++..+..++.+++.||.|||+ .|++|+||+|+||+++.++ .++|+|||.+....... 
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~-  157 (286)
T cd06622          80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLVASL-  157 (286)
T ss_pred             ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC-CEEEeecCCcccccCCc-
Confidence            99999999988763   368999999999999999999997 5999999999999999987 89999999987653322 


Q ss_pred             ccccccccccccCCcccCCCCC-CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCC
Q 020657          207 ACNSYVGTCAYMSPERFDPDAY-GGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS  285 (323)
Q Consensus       207 ~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (323)
                       .....++..|+|||.+..... ....++.++|+||||+++|+|++|..||........ ...........++.++..++
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd06622         158 -AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI-FAQLSAIVDGDPPTLPSGYS  235 (286)
T ss_pred             -cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH-HHHHHHHhhcCCCCCCcccC
Confidence             233457788999999864432 334457799999999999999999999965433222 22233344455566777799


Q ss_pred             hhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCCC
Q 020657          286 PEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS  321 (323)
Q Consensus       286 ~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~  321 (323)
                      .++.+|+.+||+.+|++||+++++++||||...+.+
T Consensus       236 ~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         236 DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             HHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence            999999999999999999999999999999887654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.3e-46  Score=329.31  Aligned_cols=267  Identities=24%  Similarity=0.384  Sum_probs=212.2

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ++|++.+.||+|+||.||++++..+++.+++|++....  .......+.+|..++..+.|++|+++++.+.+ ...+++|
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv   79 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD-ENNLYLV   79 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec-CCEEEEE
Confidence            47999999999999999999999899999999985321  22234457788999999999999999999987 6789999


Q ss_pred             EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc-c
Q 020657          129 MEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL-D  206 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~-~  206 (323)
                      |||+.+++|.+++.+ ...+++..+..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++....... .
T Consensus        80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~-~~kL~DfG~a~~~~~~~~~  158 (332)
T cd05623          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG-HIRLADFGSCLKLMEDGTV  158 (332)
T ss_pred             EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC-CEEEeecchheecccCCcc
Confidence            999999999999976 45789999999999999999999999999999999999999887 89999999986543222 1


Q ss_pred             ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCCh
Q 020657          207 ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP  286 (323)
Q Consensus       207 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (323)
                      ......++..|+|||++.........++.++||||||+++|+|++|..||...........+.........+.....++.
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~  238 (332)
T cd05623         159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSE  238 (332)
T ss_pred             eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCH
Confidence            22345689999999998643333445677999999999999999999999654333222222211111111222346799


Q ss_pred             hHHHHHHHhcccCcCC--CCCHHHHhcCcccccCC
Q 020657          287 EFRSFIECCLQKEFSK--RWTASQLLTHPFLCKNR  319 (323)
Q Consensus       287 ~l~~ll~~~l~~~p~~--Rpt~~~~l~h~~f~~~~  319 (323)
                      ++.+|+++||..++..  |++++++++||||.+..
T Consensus       239 ~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~  273 (332)
T cd05623         239 DAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID  273 (332)
T ss_pred             HHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence            9999999999665444  68999999999998753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.5e-45  Score=317.30  Aligned_cols=265  Identities=33%  Similarity=0.537  Sum_probs=218.8

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEE
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      ...+.|++++.||+|++|.||+|.+..+++.+++|.+... +......+.+|+.+++.++|+||+++++.+.. ++..++
T Consensus         9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l   86 (292)
T cd06644           9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYMVEIEILATCNHPYIVKLLGAFYW-DGKLWI   86 (292)
T ss_pred             CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-CCeEEE
Confidence            3457899999999999999999999989999999998754 34456778889999999999999999999887 678999


Q ss_pred             EEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc
Q 020657          128 LMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD  206 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~  206 (323)
                      ||||+++++|..++.+ ...+++..+..++.|++.++.+||+.|++|+||+|+||+++.++ .++|+|||++........
T Consensus        87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~~~~~  165 (292)
T cd06644          87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG-DIKLADFGVSAKNVKTLQ  165 (292)
T ss_pred             EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCC-CEEEccCccceecccccc
Confidence            9999999999887754 45689999999999999999999999999999999999999887 899999999866443333


Q ss_pred             ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCC--CCCCCCC
Q 020657          207 ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP--PSLPDGA  284 (323)
Q Consensus       207 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  284 (323)
                      ......++..|+|||++.........++.++|+||||+++|+|++|..||.....    ............  ...+..+
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~  241 (292)
T cd06644         166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP----MRVLLKIAKSEPPTLSQPSKW  241 (292)
T ss_pred             ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH----HHHHHHHhcCCCccCCCCccc
Confidence            3344567889999999865544455567799999999999999999999954332    111112222222  2234567


Q ss_pred             ChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       285 ~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      +.++.+++++||..+|++||+++++++||||...+
T Consensus       242 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  276 (292)
T cd06644         242 SMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT  276 (292)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            88999999999999999999999999999998654

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=7e-46  Score=325.90  Aligned_cols=256  Identities=29%  Similarity=0.458  Sum_probs=212.0

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCC-CCccceeceeEEcCCCeEEEE
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTD-SPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      +|+..+.||+|+||.||+|.+..+++.||+|++....  .......+..|..+++.+. |++|+++++++.. .+..++|
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv   79 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT-VDRLYFV   79 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec-CCEEEEE
Confidence            4788999999999999999999999999999987432  2233455677888888875 5778889888887 6789999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          129 MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      |||+++++|.+++.....+++..+..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++..........
T Consensus        80 ~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~-~ikL~Dfg~~~~~~~~~~~~  158 (323)
T cd05615          80 MEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEG-HIKIADFGMCKEHMVDGVTT  158 (323)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEeccccccccCCCCccc
Confidence            99999999999998888899999999999999999999999999999999999999987 89999999987543333333


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhH
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEF  288 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (323)
                      ....++..|+|||++...     .++.++||||||+++|+|++|..||.....    ..+.+.+.. ....++..++.++
T Consensus       159 ~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslGvil~elltG~~pf~~~~~----~~~~~~i~~-~~~~~p~~~~~~~  228 (323)
T cd05615         159 RTFCGTPDYIAPEIIAYQ-----PYGKSVDWWAYGVLLYEMLAGQPPFDGEDE----DELFQSIME-HNVSYPKSLSKEA  228 (323)
T ss_pred             cCccCCccccCHHHHcCC-----CCCCccchhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHHh-CCCCCCccCCHHH
Confidence            455689999999998643     345699999999999999999999965433    223333222 2345667889999


Q ss_pred             HHHHHHhcccCcCCCCC-----HHHHhcCcccccCC
Q 020657          289 RSFIECCLQKEFSKRWT-----ASQLLTHPFLCKNR  319 (323)
Q Consensus       289 ~~ll~~~l~~~p~~Rpt-----~~~~l~h~~f~~~~  319 (323)
                      .+++.+||+.+|.+|++     .+++++||||.+..
T Consensus       229 ~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~  264 (323)
T cd05615         229 VSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID  264 (323)
T ss_pred             HHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence            99999999999999997     57999999998753

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-45  Score=312.34  Aligned_cols=255  Identities=31%  Similarity=0.487  Sum_probs=214.4

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC----hHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD----PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIA  126 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  126 (323)
                      +.|++.+.||+|++|.||.|.+..+++.+++|.+.....    ......+.+|+.++++++||||+++++++.. +...+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~   80 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD-DETLS   80 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc-CCeEE
Confidence            468999999999999999999988999999999864421    1234567889999999999999999999987 67899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc
Q 020657          127 ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD  206 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~  206 (323)
                      +|+||+++++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||++........
T Consensus        81 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~-~~~l~dfg~~~~~~~~~~  159 (263)
T cd06625          81 IFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGASKRLQTICS  159 (263)
T ss_pred             EEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeecccceecccccc
Confidence            9999999999999998888899999999999999999999999999999999999999887 899999999875533211


Q ss_pred             cc---ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCC
Q 020657          207 AC---NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDG  283 (323)
Q Consensus       207 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (323)
                      ..   ....++..|+|||.+....     .+.++||||||+++|+|++|+.||.....   ...............++..
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~  231 (263)
T cd06625         160 SGTGMKSVTGTPYWMSPEVISGEG-----YGRKADVWSVGCTVVEMLTEKPPWAEFEA---MAAIFKIATQPTNPQLPSH  231 (263)
T ss_pred             ccccccCCCcCccccCcceeccCC-----CCchhhhHHHHHHHHHHHhCCCCccccch---HHHHHHHhccCCCCCCCcc
Confidence            11   2345678999999987433     55699999999999999999999954422   2223333333445567778


Q ss_pred             CChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          284 ASPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       284 ~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                      ++..+.+++++||..+|++|||++++++|+||
T Consensus       232 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         232 VSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             CCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            89999999999999999999999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.1e-46  Score=330.39  Aligned_cols=251  Identities=29%  Similarity=0.501  Sum_probs=208.5

Q ss_pred             eeeecccCCeEEEEEEec---ccCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEec
Q 020657           56 LQVLGHGNGGTVYKVQHR---CTHKIYALKVVHGDAD-PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEY  131 (323)
Q Consensus        56 ~~~lg~G~~~~v~~~~~~---~~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~  131 (323)
                      ++.||+|+||.||++++.   .+++.+|+|++..... ......+.+|+.++++++||||+++++++.. .+..++||||
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~   79 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT-EGKLYLILDF   79 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc-CCEEEEEEcC
Confidence            357999999999999863   5788999999964321 1233456789999999999999999999987 6789999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccccc
Q 020657          132 MDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSY  211 (323)
Q Consensus       132 ~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  211 (323)
                      +.+++|.+.+.+...+++..+..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++.............
T Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~  158 (318)
T cd05582          80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG-HIKLTDFGLSKESIDHEKKAYSF  158 (318)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCC-cEEEeeccCCcccCCCCCceecc
Confidence            99999999998877899999999999999999999999999999999999999987 89999999987654433333456


Q ss_pred             cccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHH
Q 020657          212 VGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSF  291 (323)
Q Consensus       212 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  291 (323)
                      .++..|+|||.+...     ..+.++||||||+++|+|++|+.||.....    ......+. .....++..++.++.+|
T Consensus       159 ~g~~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~tg~~p~~~~~~----~~~~~~i~-~~~~~~p~~~~~~~~~l  228 (318)
T cd05582         159 CGTVEYMAPEVVNRR-----GHTQSADWWSFGVLMFEMLTGSLPFQGKDR----KETMTMIL-KAKLGMPQFLSPEAQSL  228 (318)
T ss_pred             cCChhhcCHHHHcCC-----CCCCccceeccceEeeeeccCCCCCCCCCH----HHHHHHHH-cCCCCCCCCCCHHHHHH
Confidence            789999999998643     335699999999999999999999965432    22222222 22345667789999999


Q ss_pred             HHHhcccCcCCCCC-----HHHHhcCcccccC
Q 020657          292 IECCLQKEFSKRWT-----ASQLLTHPFLCKN  318 (323)
Q Consensus       292 l~~~l~~~p~~Rpt-----~~~~l~h~~f~~~  318 (323)
                      +++||+.||++|||     ++++++|+||.+.
T Consensus       229 i~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~  260 (318)
T cd05582         229 LRALFKRNPANRLGAGPDGVEEIKRHPFFSTI  260 (318)
T ss_pred             HHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence            99999999999999     7889999999764

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=6.2e-45  Score=309.77  Aligned_cols=254  Identities=28%  Similarity=0.478  Sum_probs=213.8

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEe
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILME  130 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e  130 (323)
                      +|++.+.||+|++|.||++.+..+++.+++|.+.... .....+.+.+|+.+++.++|+|++++++.+...+..++++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4899999999999999999999889999999986543 334456788899999999999999999988754567899999


Q ss_pred             ccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          131 YMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       131 ~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      |+++++|.+++..  ...+++..+..++.+++.++.+||+.|++|+||+|+||+++.++ .++|+|||++..........
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~  159 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTN-IIKVGDLGIARVLENQCDMA  159 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCC-cEEEecccceEEecccCCcc
Confidence            9999999999875  34589999999999999999999999999999999999999987 89999999997664433333


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhH
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEF  288 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (323)
                      ....++..|+|||++...     ..+.++|+||||+++++|++|+.||....    ..........+..+..+..+++++
T Consensus       160 ~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~il~~l~~g~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  230 (257)
T cd08223         160 STLIGTPYYMSPELFSNK-----PYNYKSDVWALGCCVYEMATLKHAFNAKD----MNSLVYRIIEGKLPPMPKDYSPEL  230 (257)
T ss_pred             ccccCCcCccChhHhcCC-----CCCchhhhHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHhcCCCCCccccCHHH
Confidence            445678899999998633     34569999999999999999999996433    233333333344455667789999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          289 RSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       289 ~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                      .+++.+||+.+|++|||+.++++||||
T Consensus       231 ~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         231 GELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=5.1e-46  Score=332.05  Aligned_cols=266  Identities=27%  Similarity=0.490  Sum_probs=214.5

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCC--CChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCC
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG  123 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  123 (323)
                      ..+..++|++.+.||+|+||.||+|++..+++.+|+|++...  ........+.+|+.+++.++||||+++++++.+ +.
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-~~  116 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD-DK  116 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CC
Confidence            345568899999999999999999999989999999998642  122334557789999999999999999999987 68


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          124 DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      ..++||||+++++|.+++... .+++..+..++.||+.||.|||+.||+||||||+||+++.++ .+||+|||++.....
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~-~~kL~DFG~a~~~~~  194 (370)
T cd05621         117 YLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG-HLKLADFGTCMKMDE  194 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC-CEEEEecccceeccc
Confidence            899999999999999998754 589999999999999999999999999999999999999987 899999999976543


Q ss_pred             Ccc-ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCC-
Q 020657          204 SLD-ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLP-  281 (323)
Q Consensus       204 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-  281 (323)
                      ... ......++..|+|||++..... ...++.++||||||+++|+|++|..||...........+.   .......++ 
T Consensus       195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~---~~~~~~~~p~  270 (370)
T cd05621         195 TGMVRCDTAVGTPDYISPEVLKSQGG-DGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM---DHKNSLNFPE  270 (370)
T ss_pred             CCceecccCCCCcccCCHHHHhccCC-CCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHH---hCCcccCCCC
Confidence            221 2235678999999999864321 2335679999999999999999999996544322222222   111222333 


Q ss_pred             -CCCChhHHHHHHHhcccCcCC--CCCHHHHhcCcccccC
Q 020657          282 -DGASPEFRSFIECCLQKEFSK--RWTASQLLTHPFLCKN  318 (323)
Q Consensus       282 -~~~~~~l~~ll~~~l~~~p~~--Rpt~~~~l~h~~f~~~  318 (323)
                       ..++..+.+++..||..++..  |+|++++++||||++.
T Consensus       271 ~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         271 DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence             357899999999999855543  8999999999999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.6e-46  Score=333.51  Aligned_cols=258  Identities=28%  Similarity=0.477  Sum_probs=210.6

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ++|++++.||+|+||.||+|.+..+++.||+|++....  .......+.+|+.++..++|++|+++++.+.+ .+.+++|
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-~~~~~lv   79 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD-KRNLYLI   79 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEEEEE
Confidence            47999999999999999999999899999999986431  23345677889999999999999999999987 6789999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc---
Q 020657          129 MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL---  205 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~---  205 (323)
                      |||+++++|.+++.+...+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++.......   
T Consensus        80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~-~vkL~DfG~~~~~~~~~~~~  158 (360)
T cd05627          80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKG-HVKLSDFGLCTGLKKAHRTE  158 (360)
T ss_pred             EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC-CEEEeeccCCcccccccccc
Confidence            99999999999998888899999999999999999999999999999999999999987 89999999986442110   


Q ss_pred             --------------------------------cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCC
Q 020657          206 --------------------------------DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGH  253 (323)
Q Consensus       206 --------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~  253 (323)
                                                      ......+||..|+|||++.+..     ++.++||||||+++|+|++|.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-----~~~~~DiwSlGvilyel~tG~  233 (360)
T cd05627         159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-----YNKLCDWWSLGVIMYEMLIGY  233 (360)
T ss_pred             cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC-----CCCcceeccccceeeecccCC
Confidence                                            0011346899999999986443     456999999999999999999


Q ss_pred             CCCCCCCCCccHHHHHHHHhcCCCCCCCC--CCChhHHHHHHHhcccCcCCCC---CHHHHhcCcccccCC
Q 020657          254 FPFLQPGQRPDWATLMCAICFGDPPSLPD--GASPEFRSFIECCLQKEFSKRW---TASQLLTHPFLCKNR  319 (323)
Q Consensus       254 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~ll~~~l~~~p~~Rp---t~~~~l~h~~f~~~~  319 (323)
                      .||...........+..   ......++.  .++.++.+|+.+|+ .||++|+   +++++++||||++..
T Consensus       234 ~Pf~~~~~~~~~~~i~~---~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~  300 (360)
T cd05627         234 PPFCSETPQETYRKVMN---WKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVD  300 (360)
T ss_pred             CCCCCCCHHHHHHHHHc---CCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCC
Confidence            99965443322222221   111222332  47899999999977 4999998   489999999998753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.8e-46  Score=334.18  Aligned_cols=259  Identities=31%  Similarity=0.462  Sum_probs=212.0

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCC-C-----CccceeceeEEc
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD-S-----PFIVQCFGIFEK  120 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~i~~~~~~~~~  120 (323)
                      +....+|.+++.||+|.||.|.+|.|..+++.||||+++.  ......+...|+.+|..|+ |     -|+|.++++|..
T Consensus       182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN--~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f  259 (586)
T KOG0667|consen  182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN--KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF  259 (586)
T ss_pred             ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeecc--ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence            3344489999999999999999999999999999999964  4567788889999999987 4     489999999998


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEec-CCCcEEEeecCc
Q 020657          121 PSGDIAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNN-NNMQVKIADFGV  197 (323)
Q Consensus       121 ~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~-~~~~~kl~Dfg~  197 (323)
                       .+++|||+|.+.. +|.++++.++  .++...++.++.||+.||.+||..||||+||||+|||+.. +...||++|||.
T Consensus       260 -r~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGS  337 (586)
T KOG0667|consen  260 -RNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGS  337 (586)
T ss_pred             -ccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccc
Confidence             7899999999965 9999998654  5899999999999999999999999999999999999965 335899999999


Q ss_pred             chhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcC--
Q 020657          198 SKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFG--  275 (323)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~--  275 (323)
                      |+.......   .++.+..|+|||++.+.++..     +.|||||||+++||++|...|.+.+..+.+..+.+.....  
T Consensus       338 Sc~~~q~vy---tYiQSRfYRAPEVILGlpY~~-----~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~  409 (586)
T KOG0667|consen  338 SCFESQRVY---TYIQSRFYRAPEVILGLPYDT-----AIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPP  409 (586)
T ss_pred             ccccCCcce---eeeeccccccchhhccCCCCC-----ccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCH
Confidence            987544332   677889999999999666654     9999999999999999998886665443332222111000  


Q ss_pred             ---------------------------------------------C---CC--------CCCCCCChhHHHHHHHhcccC
Q 020657          276 ---------------------------------------------D---PP--------SLPDGASPEFRSFIECCLQKE  299 (323)
Q Consensus       276 ---------------------------------------------~---~~--------~~~~~~~~~l~~ll~~~l~~~  299 (323)
                                                                   .   .+        .........+.++|++||.+|
T Consensus       410 ~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~d  489 (586)
T KOG0667|consen  410 KMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWD  489 (586)
T ss_pred             HHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccC
Confidence                                                         0   00        011123466899999999999


Q ss_pred             cCCCCCHHHHhcCccccc
Q 020657          300 FSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       300 p~~Rpt~~~~l~h~~f~~  317 (323)
                      |.+|+|+.++|+||||.+
T Consensus       490 P~~R~tp~qal~Hpfl~~  507 (586)
T KOG0667|consen  490 PAERITPAQALNHPFLTG  507 (586)
T ss_pred             chhcCCHHHHhcCccccc
Confidence            999999999999999973

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.6e-45  Score=337.15  Aligned_cols=263  Identities=29%  Similarity=0.411  Sum_probs=219.5

Q ss_pred             chhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCC
Q 020657           45 TAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG  123 (323)
Q Consensus        45 ~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  123 (323)
                      .......+|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.++..+.|+||+++++.+.....
T Consensus        26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~  105 (496)
T PTZ00283         26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP  105 (496)
T ss_pred             cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence            33445689999999999999999999999899999999986543 34556678899999999999999999887653221


Q ss_pred             -------eEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEE
Q 020657          124 -------DIAILMEYMDSGTLDTLLNK----NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKI  192 (323)
Q Consensus       124 -------~~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl  192 (323)
                             .+++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.|++||||||+||+++.++ .+||
T Consensus       106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~-~vkL  184 (496)
T PTZ00283        106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG-LVKL  184 (496)
T ss_pred             cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCC-CEEE
Confidence                   36899999999999998864    34689999999999999999999999999999999999999987 8999


Q ss_pred             eecCcchhhccC--ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHH
Q 020657          193 ADFGVSKIMCRS--LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMC  270 (323)
Q Consensus       193 ~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~  270 (323)
                      +|||++......  ........++..|+|||++...     .++.++||||||+++|+|++|..||...    ....+..
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-----~~s~k~DVwSlGvilyeLltG~~Pf~~~----~~~~~~~  255 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK-----PYSKKADMFSLGVLLYELLTLKRPFDGE----NMEEVMH  255 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHHhCCC-----CCCcHHHHHHHHHHHHHHHHCCCCCCCC----CHHHHHH
Confidence            999999765432  1223446789999999998743     3456999999999999999999999543    3344445


Q ss_pred             HHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          271 AICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                      ....+....++..+++++.+|+.+||+.||.+|||+.++++|||++.
T Consensus       256 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~  302 (496)
T PTZ00283        256 KTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL  302 (496)
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence            55555556677889999999999999999999999999999999864

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.5e-45  Score=327.19  Aligned_cols=260  Identities=24%  Similarity=0.398  Sum_probs=205.6

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC----
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS----  122 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----  122 (323)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.++||||+++++++....    
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            34689999999999999999999999899999999986542 3344567789999999999999999999986532    


Q ss_pred             -CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhh
Q 020657          123 -GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM  201 (323)
Q Consensus       123 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~  201 (323)
                       ...++||||+.+ ++...+..  .+++..+..++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++...
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~-~~kl~Dfg~a~~~  173 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTA  173 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEecCCCcccc
Confidence             247999999976 66666543  478999999999999999999999999999999999999987 8999999999654


Q ss_pred             ccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHh--------
Q 020657          202 CRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAIC--------  273 (323)
Q Consensus       202 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~--------  273 (323)
                      ... .......++..|+|||++.+..     ++.++||||||+++|+|++|..||.+.+....+..+.....        
T Consensus       174 ~~~-~~~~~~~~t~~y~aPE~~~~~~-----~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  247 (359)
T cd07876         174 CTN-FMMTPYVVTRYYRAPEVILGMG-----YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN  247 (359)
T ss_pred             ccC-ccCCCCcccCCCCCchhccCCC-----CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence            322 1223456789999999986433     45699999999999999999999976543222221111100        


Q ss_pred             ----------cCC-------------------CCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          274 ----------FGD-------------------PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       274 ----------~~~-------------------~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                                ...                   ........+.++.+|+.+||..||++|||++|+|+||||..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV  320 (359)
T ss_pred             HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence                      000                   00011234678999999999999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-46  Score=327.06  Aligned_cols=258  Identities=32%  Similarity=0.512  Sum_probs=228.0

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      .++|..++.+|+|+||.+++++.+.+++.+++|.+.... ....+....+|+.+++++.||||+.+.+.|...+...+||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            478999999999999999999999999999999997654 2334557889999999999999999999999855559999


Q ss_pred             EeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc
Q 020657          129 MEYMDSGTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD  206 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~  206 (323)
                      |+||+||++.+.+...  .-++++.++.|+.|++.|+.|||+++|+|||||+.||+++.++ .|+|+|||+|........
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~-~VkLgDfGlaK~l~~~~~  161 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDK-KVKLGDFGLAKILNPEDS  161 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccC-ceeecchhhhhhcCCchh
Confidence            9999999999999754  3689999999999999999999999999999999999999998 789999999999877766


Q ss_pred             ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCCh
Q 020657          207 ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP  286 (323)
Q Consensus       207 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (323)
                      ...+.+||+.|++||++...+|+     .++|||||||++|||++-+.+|.+.+.    ..+...+......+++...+.
T Consensus       162 ~a~tvvGTp~YmcPEil~d~pYn-----~KSDiWsLGC~~yEm~~lk~aF~a~~m----~~Li~ki~~~~~~Plp~~ys~  232 (426)
T KOG0589|consen  162 LASTVVGTPYYMCPEILSDIPYN-----EKSDIWSLGCCLYEMCTLKPAFKASNM----SELILKINRGLYSPLPSMYSS  232 (426)
T ss_pred             hhheecCCCcccCHHHhCCCCCC-----ccCcchhhcchHHHHHhcccccCccch----HHHHHHHhhccCCCCCccccH
Confidence            67788999999999999866655     499999999999999999999965544    445555555556788899999


Q ss_pred             hHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          287 EFRSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       287 ~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                      ++..||+.||..+|+.||++.++|.+|.++.
T Consensus       233 el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~  263 (426)
T KOG0589|consen  233 ELRSLVKSMLRKNPEHRPSALELLRRPHLLR  263 (426)
T ss_pred             HHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence            9999999999999999999999999987753

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.6e-47  Score=307.23  Aligned_cols=262  Identities=28%  Similarity=0.471  Sum_probs=221.3

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCC-------CChHHHHHHHHHHHHHHcC-CCCccceeceeEEc
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-------ADPTVRRQVFREMEILRRT-DSPFIVQCFGIFEK  120 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~-------~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~  120 (323)
                      ....|.-.+.||.|..++|-++..+.+++.+++|++...       ......+.-..|+.+++++ +||+|+.+.++|++
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            356777888999999999999999999999999998532       2223455667899999996 89999999999998


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchh
Q 020657          121 PSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       121 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                       +...++|+|.|+.|.|.+++...-.+++...+.|++|++++++|||..+||||||||+|||++++. +++|+|||+++.
T Consensus        95 -~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~-~i~isDFGFa~~  172 (411)
T KOG0599|consen   95 -DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNM-NIKISDFGFACQ  172 (411)
T ss_pred             -cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeecccc-ceEEeccceeec
Confidence             788999999999999999999888899999999999999999999999999999999999999986 999999999998


Q ss_pred             hccCccccccccccccccCCcccCCCCC-CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC---
Q 020657          201 MCRSLDACNSYVGTCAYMSPERFDPDAY-GGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD---  276 (323)
Q Consensus       201 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~---  276 (323)
                      +..+.. ....+||++|+|||.+....+ +...++..+|+|++|++||.|+.|..||....+-    .+++.+..+.   
T Consensus       173 l~~Gek-LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm----lMLR~ImeGkyqF  247 (411)
T KOG0599|consen  173 LEPGEK-LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM----LMLRMIMEGKYQF  247 (411)
T ss_pred             cCCchh-HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH----HHHHHHHhccccc
Confidence            865443 456789999999999985554 3456788999999999999999999999433222    2222232232   


Q ss_pred             CCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          277 PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       277 ~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                      ..+-+..++....+|+.+||+.||.+|.|++|+|.||||+.
T Consensus       248 ~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q  288 (411)
T KOG0599|consen  248 RSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ  288 (411)
T ss_pred             CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence            23344678999999999999999999999999999999954

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=5.3e-46  Score=327.10  Aligned_cols=250  Identities=28%  Similarity=0.496  Sum_probs=205.1

Q ss_pred             eeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHH-HHHcCCCCccceeceeEEcCCCeEEEEEeccC
Q 020657           57 QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREME-ILRRTDSPFIVQCFGIFEKPSGDIAILMEYMD  133 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~  133 (323)
                      +.||+|+||.||+|.+..+++.+|+|++....  .......+..|.. +++.++||||+++++++.. .+..++||||+.
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~-~~~~~lv~e~~~   79 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-TEKLYFVLDFVN   79 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec-CCEEEEEEcCCC
Confidence            36899999999999999999999999986432  1223344555554 4677899999999999987 678999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccccccc
Q 020657          134 SGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVG  213 (323)
Q Consensus       134 ~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  213 (323)
                      +++|...+.....+++..+..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++..............+
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~-~~kL~DfG~~~~~~~~~~~~~~~~g  158 (325)
T cd05604          80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQG-HVVLTDFGLCKEGIAQSDTTTTFCG  158 (325)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEEeecCCcccCCCCCCCcccccC
Confidence            999999998888899999999999999999999999999999999999999987 8999999998654333333345678


Q ss_pred             cccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHH
Q 020657          214 TCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIE  293 (323)
Q Consensus       214 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~  293 (323)
                      +..|+|||++....     ++.++||||||+++|+|++|..||.....    ..+...+... ...+....+..+.++++
T Consensus       159 t~~y~aPE~~~~~~-----~~~~~DvwslG~il~el~~G~~pf~~~~~----~~~~~~~~~~-~~~~~~~~~~~~~~ll~  228 (325)
T cd05604         159 TPEYLAPEVIRKQP-----YDNTVDWWCLGAVLYEMLYGLPPFYCRDV----AEMYDNILHK-PLVLRPGASLTAWSILE  228 (325)
T ss_pred             ChhhCCHHHHcCCC-----CCCcCccccccceehhhhcCCCCCCCCCH----HHHHHHHHcC-CccCCCCCCHHHHHHHH
Confidence            99999999987443     45699999999999999999999965432    2333333322 33445678999999999


Q ss_pred             HhcccCcCCCCCH----HHHhcCcccccC
Q 020657          294 CCLQKEFSKRWTA----SQLLTHPFLCKN  318 (323)
Q Consensus       294 ~~l~~~p~~Rpt~----~~~l~h~~f~~~  318 (323)
                      +||+.+|++||++    .++++||||.+.
T Consensus       229 ~ll~~~p~~R~~~~~~~~~i~~h~~f~~~  257 (325)
T cd05604         229 ELLEKDRQRRLGAKEDFLEIQEHPFFESL  257 (325)
T ss_pred             HHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence            9999999999976    599999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.8e-46  Score=317.64  Aligned_cols=257  Identities=35%  Similarity=0.573  Sum_probs=209.6

Q ss_pred             cceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHH-HHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEec
Q 020657           53 LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTV-RRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEY  131 (323)
Q Consensus        53 ~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~  131 (323)
                      |++.+.||+|++|+||++.+..+++.+|+|++........ .....+|+.++++++|+||+++++++.. +...++|||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-DNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-SSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-cccccccccc
Confidence            7889999999999999999999999999999987754332 2234569999999999999999999988 7889999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccccc
Q 020657          132 MDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSY  211 (323)
Q Consensus       132 ~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  211 (323)
                      +.+++|.+++.....+++..+..++.||++||.+||+.|++|+||+|+||+++.++ .++|+|||.+.............
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~  158 (260)
T PF00069_consen   80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENG-EVKLIDFGSSVKLSENNENFNPF  158 (260)
T ss_dssp             ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTS-EEEESSGTTTEESTSTTSEBSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccc
Confidence            99999999999778899999999999999999999999999999999999999887 89999999987543333444566


Q ss_pred             cccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC--CCCCCCCCChhHH
Q 020657          212 VGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD--PPSLPDGASPEFR  289 (323)
Q Consensus       212 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~  289 (323)
                      .++..|.|||++.    .....+.++|+||||+++|+|++|..||...........+........  ........+..+.
T Consensus       159 ~~~~~y~aPE~~~----~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  234 (260)
T PF00069_consen  159 VGTPEYMAPEVLQ----QGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELR  234 (260)
T ss_dssp             SSSGGGSCHHHHT----TTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHH
T ss_pred             ccccccccccccc----ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHH
Confidence            7889999999976    233445699999999999999999999965521122222221111110  0111122348999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          290 SFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       290 ~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                      ++++.||+.||++|||+.++++||||
T Consensus       235 ~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  235 DLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHHHccCChhHCcCHHHHhcCCCC
Confidence            99999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-46  Score=328.51  Aligned_cols=250  Identities=31%  Similarity=0.509  Sum_probs=203.2

Q ss_pred             ecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcC---CCCccceeceeEEcCCCeEEEEEeccC
Q 020657           59 LGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRT---DSPFIVQCFGIFEKPSGDIAILMEYMD  133 (323)
Q Consensus        59 lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~~lv~e~~~  133 (323)
                      ||+|+||+||+|++..+++.||+|++....  ..........|..++..+   .||+|+++++++.. ....++||||+.
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~-~~~~~lv~e~~~   79 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT-DSDLYLVTDYMS   79 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec-CCeEEEEEcCCC
Confidence            699999999999999899999999986431  112233445566666654   69999999999987 678999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccccccc
Q 020657          134 SGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVG  213 (323)
Q Consensus       134 ~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  213 (323)
                      +++|...+.....+++..+..++.||++||.|||+.|++||||||+||+++.++ .++|+|||++..............+
T Consensus        80 ~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~g  158 (330)
T cd05586          80 GGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATG-HIALCDFGLSKANLTDNKTTNTFCG  158 (330)
T ss_pred             CChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEecCCcCcCCCCCCCCccCccC
Confidence            999999998888899999999999999999999999999999999999999987 8999999998764433333445678


Q ss_pred             cccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHH
Q 020657          214 TCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIE  293 (323)
Q Consensus       214 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~  293 (323)
                      +..|+|||++...    ..++.++||||||+++|+|++|..||.....    ..+...+..+....-...++.++.+|++
T Consensus       159 t~~y~aPE~~~~~----~~~~~~~DvwslGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~li~  230 (330)
T cd05586         159 TTEYLAPEVLLDE----KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT----QQMYRNIAFGKVRFPKNVLSDEGRQFVK  230 (330)
T ss_pred             CccccCHHHHcCC----CCCCCccceeccccEEEEeccCCCCCCCCCH----HHHHHHHHcCCCCCCCccCCHHHHHHHH
Confidence            9999999988532    2345689999999999999999999965432    3333333333322222357899999999


Q ss_pred             HhcccCcCCCC----CHHHHhcCcccccC
Q 020657          294 CCLQKEFSKRW----TASQLLTHPFLCKN  318 (323)
Q Consensus       294 ~~l~~~p~~Rp----t~~~~l~h~~f~~~  318 (323)
                      +||+.||++||    +++++++||||.+.
T Consensus       231 ~~L~~~P~~R~~~~~~~~~ll~h~~~~~~  259 (330)
T cd05586         231 GLLNRNPQHRLGAHRDAVELKEHPFFADI  259 (330)
T ss_pred             HHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence            99999999998    79999999999864

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.5e-45  Score=314.88  Aligned_cols=253  Identities=25%  Similarity=0.372  Sum_probs=204.8

Q ss_pred             ecccCCeEEEEEEecccCcEEEEEeecCCCC--hHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEeccCCCC
Q 020657           59 LGHGNGGTVYKVQHRCTHKIYALKVVHGDAD--PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGT  136 (323)
Q Consensus        59 lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~s  136 (323)
                      ||+|+||.||++.+..+|+.+++|.+.....  .........|+++++.++||||+++++.+.. +...++||||+++++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~g~~   79 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES-KTHLCLVMSLMNGGD   79 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec-CCeEEEEEecCCCCC
Confidence            6999999999999998999999999864321  1223345569999999999999999999987 678999999999999


Q ss_pred             HHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccccccccc
Q 020657          137 LDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGT  214 (323)
Q Consensus       137 L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  214 (323)
                      |.+.+...  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++....... ......++
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~-~~~l~Dfg~~~~~~~~~-~~~~~~~~  157 (277)
T cd05607          80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGK-TITQRAGT  157 (277)
T ss_pred             HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCC-CEEEeeceeeeecCCCc-eeeccCCC
Confidence            99888543  3589999999999999999999999999999999999999987 89999999987654322 22334678


Q ss_pred             ccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHH
Q 020657          215 CAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIEC  294 (323)
Q Consensus       215 ~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~  294 (323)
                      ..|+|||++....     ++.++||||||+++|+|++|..||...........+...............++.++.+|+++
T Consensus       158 ~~y~aPE~~~~~~-----~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  232 (277)
T cd05607         158 NGYMAPEILKEEP-----YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRL  232 (277)
T ss_pred             CCccCHHHHccCC-----CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHH
Confidence            8999999986333     55699999999999999999999965444333334433333322222234689999999999


Q ss_pred             hcccCcCCCCCH----HHHhcCcccccCC
Q 020657          295 CLQKEFSKRWTA----SQLLTHPFLCKNR  319 (323)
Q Consensus       295 ~l~~~p~~Rpt~----~~~l~h~~f~~~~  319 (323)
                      ||+.||++||++    ++++.|+||++..
T Consensus       233 ~L~~~P~~R~~~~~~~~~~~~h~~f~~~~  261 (277)
T cd05607         233 FLAKKPEDRLGSREKNDDPRKHEFFKTIN  261 (277)
T ss_pred             HhccCHhhCCCCccchhhhhcChhhcCCC
Confidence            999999999999    6788999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.1e-44  Score=308.10  Aligned_cols=253  Identities=33%  Similarity=0.573  Sum_probs=216.1

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCC-CChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEe
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILME  130 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e  130 (323)
                      +|++.+.||+|++|.||+|.+..+++.|++|.+... ........+.+|+.+++.++||||+++++.+.. .+..++|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD-KGKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc-CCEEEEEEE
Confidence            588899999999999999999989999999998643 234556778899999999999999999999987 678999999


Q ss_pred             ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          131 YMDSGTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       131 ~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      |+++++|.+++...  ..+++..+..++.+++.||.|||+.|++|+||+|+||+++.++ .++|+|||++..........
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~-~~~l~df~~~~~~~~~~~~~  158 (256)
T cd08529          80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTNFA  158 (256)
T ss_pred             eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCC-CEEEcccccceeccCccchh
Confidence            99999999999764  5789999999999999999999999999999999999999987 89999999987665443333


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhH
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEF  288 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (323)
                      ....++..|+|||++....     .+.++|+||||+++|+|++|..||....    .............+.++..++.++
T Consensus       159 ~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  229 (256)
T cd08529         159 NTIVGTPYYLSPELCEDKP-----YNEKSDVWALGVVLYECCTGKHPFDANN----QGALILKIIRGVFPPVSQMYSQQL  229 (256)
T ss_pred             hccccCccccCHHHhcCCC-----CCCccchHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHcCCCCCCccccCHHH
Confidence            4456788999999986433     4569999999999999999999996543    233334444455566666889999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          289 RSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       289 ~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                      .+++++||+.+|++||++.++++|||+
T Consensus       230 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         230 AQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHHHHHccCCcccCcCHHHHhhCCCC
Confidence            999999999999999999999999996

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.1e-45  Score=324.60  Aligned_cols=250  Identities=26%  Similarity=0.481  Sum_probs=205.2

Q ss_pred             eeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHH-HHHcCCCCccceeceeEEcCCCeEEEEEeccC
Q 020657           57 QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREME-ILRRTDSPFIVQCFGIFEKPSGDIAILMEYMD  133 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~  133 (323)
                      +.||+|+||.||+|++..+++.|++|++....  .......+..|.. +++.++||||+++++++.+ .+..++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~-~~~~~lv~e~~~   79 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT-AEKLYFVLDYVN   79 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc-CCEEEEEEcCCC
Confidence            36999999999999999899999999986432  1222334445544 5778999999999999987 678999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccccccc
Q 020657          134 SGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVG  213 (323)
Q Consensus       134 ~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  213 (323)
                      +++|...+.....+++..+..++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++..............+
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05603          80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGVEPEETTSTFCG  158 (321)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEccCCCCccCCCCCCccccccC
Confidence            999999988878899999999999999999999999999999999999999987 8999999998654333333345578


Q ss_pred             cccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHH
Q 020657          214 TCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIE  293 (323)
Q Consensus       214 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~  293 (323)
                      +..|+|||++...     .++.++||||||+++|+|++|..||...+    ...+...+. ..+..++...+..+.+++.
T Consensus       159 t~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~~g~~pf~~~~----~~~~~~~i~-~~~~~~~~~~~~~~~~li~  228 (321)
T cd05603         159 TPEYLAPEVLRKE-----PYDRTVDWWCLGAVLYEMLYGLPPFYSRD----VSQMYDNIL-HKPLQLPGGKTVAACDLLV  228 (321)
T ss_pred             CcccCCHHHhcCC-----CCCCcCcccccchhhhhhhcCCCCCCCCC----HHHHHHHHh-cCCCCCCCCCCHHHHHHHH
Confidence            9999999998643     34569999999999999999999996543    233333332 2345566778999999999


Q ss_pred             HhcccCcCCCCCH----HHHhcCcccccC
Q 020657          294 CCLQKEFSKRWTA----SQLLTHPFLCKN  318 (323)
Q Consensus       294 ~~l~~~p~~Rpt~----~~~l~h~~f~~~  318 (323)
                      +||+.||.+|+++    .++++|+||...
T Consensus       229 ~~l~~~p~~R~~~~~~~~~~~~~~~~~~~  257 (321)
T cd05603         229 GLLHKDQRRRLGAKADFLEIKNHVFFSPI  257 (321)
T ss_pred             HHccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence            9999999999875    599999999754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.2e-45  Score=311.71  Aligned_cols=259  Identities=29%  Similarity=0.498  Sum_probs=216.8

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-----hHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEE
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-----PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIA  126 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  126 (323)
                      +|+..+.||+|++|.||+|.+..+++.+++|++.....     ......+.+|+.+++.++|+||+++++++.+ .+..+
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~   79 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE-DSHFN   79 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc-CCeEE
Confidence            47888999999999999999988999999999864421     2345778899999999999999999999987 67899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc
Q 020657          127 ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD  206 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~  206 (323)
                      +|+||+.+++|.+++.+.+++++..+..++.||+.||.+||+.|++|+||+|+||+++.++..++|+|||.+........
T Consensus        80 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~  159 (268)
T cd06630          80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT  159 (268)
T ss_pred             EEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence            99999999999999988788999999999999999999999999999999999999987765799999999876643211


Q ss_pred             ----ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCC
Q 020657          207 ----ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPD  282 (323)
Q Consensus       207 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (323)
                          ......++..|+|||.+...     ..+.++|+|+||+++|+|++|..||...........+.........+.++.
T Consensus       160 ~~~~~~~~~~~~~~~~~PE~~~~~-----~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (268)
T cd06630         160 GAGEFQGQLLGTIAFMAPEVLRGE-----QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPE  234 (268)
T ss_pred             cCCccccccccccceeCHhHhccC-----CCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCch
Confidence                11234577899999998633     345699999999999999999999965443333333333333344556677


Q ss_pred             CCChhHHHHHHHhcccCcCCCCCHHHHhcCcccc
Q 020657          283 GASPEFRSFIECCLQKEFSKRWTASQLLTHPFLC  316 (323)
Q Consensus       283 ~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~  316 (323)
                      .+++++.+++.+||..+|.+|||+.++++||||+
T Consensus       235 ~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         235 HLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             hhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            8899999999999999999999999999999995

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.1e-45  Score=325.75  Aligned_cols=266  Identities=26%  Similarity=0.374  Sum_probs=211.4

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCC--CChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ++|++.+.||+|+||.||++++..+++.||+|++...  ........+.+|..++..+.|++|+++++++.+ .+..++|
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~-~~~~~lv   79 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD-ENYLYLV   79 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEEEEE
Confidence            5799999999999999999999989999999998642  122334557788999999999999999999987 6889999


Q ss_pred             EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc-
Q 020657          129 MEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD-  206 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~-  206 (323)
                      |||+.+++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .+||+|||++........ 
T Consensus        80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~  158 (331)
T cd05624          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNG-HIRLADFGSCLKMNQDGTV  158 (331)
T ss_pred             EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCC-CEEEEeccceeeccCCCce
Confidence            999999999999976 45789999999999999999999999999999999999999887 899999999876543222 


Q ss_pred             ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCCh
Q 020657          207 ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP  286 (323)
Q Consensus       207 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (323)
                      ......++..|+|||++..........+.++||||||+++|+|++|..||...........+.........+.....++.
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~  238 (331)
T cd05624         159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSE  238 (331)
T ss_pred             eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCH
Confidence            22335689999999998643322234567999999999999999999999654332222222211110111222245789


Q ss_pred             hHHHHHHHhcccCcCC--CCCHHHHhcCcccccC
Q 020657          287 EFRSFIECCLQKEFSK--RWTASQLLTHPFLCKN  318 (323)
Q Consensus       287 ~l~~ll~~~l~~~p~~--Rpt~~~~l~h~~f~~~  318 (323)
                      ++.+|+.+||..++++  |++++++++|+||.+.
T Consensus       239 ~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~  272 (331)
T cd05624         239 EAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI  272 (331)
T ss_pred             HHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence            9999999999876544  5689999999999864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.9e-45  Score=335.39  Aligned_cols=256  Identities=26%  Similarity=0.392  Sum_probs=215.5

Q ss_pred             ccccceeeeecccCCeEEEEEEeccc-CcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCT-HKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~-~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ...|.+.+.||+|++|.||+|.+..+ ++.|++|.+... .......+.+|+.+++.++||||+++++++.. .+..++|
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-~~~~~lv  143 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN-DERQAAYARSELHCLAACDHFGIVKHFDDFKS-DDKLLLI  143 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE-CCEEEEE
Confidence            45599999999999999999998766 778888877543 33445567789999999999999999999987 6889999


Q ss_pred             EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC
Q 020657          129 MEYMDSGTLDTLLNK----NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS  204 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~  204 (323)
                      |||+++++|.+.+..    ..++++..+..++.||+.||.|||+.||+||||||+||+++.++ .+||+|||++......
T Consensus       144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~-~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG-IIKLGDFGFSKQYSDS  222 (478)
T ss_pred             EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCC-cEEEEeCcCceecCCc
Confidence            999999999987753    34689999999999999999999999999999999999999987 8999999999765433


Q ss_pred             cc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCC
Q 020657          205 LD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPD  282 (323)
Q Consensus       205 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (323)
                      ..  ......++..|+|||++...     .++.++||||||+++|+|++|..||....    ...+...+..+....++.
T Consensus       223 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~~l~el~tg~~Pf~~~~----~~~~~~~~~~~~~~~~~~  293 (478)
T PTZ00267        223 VSLDVASSFCGTPYYLAPELWERK-----RYSKKADMWSLGVILYELLTLHRPFKGPS----QREIMQQVLYGKYDPFPC  293 (478)
T ss_pred             cccccccccCCCccccCHhHhCCC-----CCCcHHhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCCCCCCc
Confidence            21  23345689999999998643     34569999999999999999999995433    334444444455556677


Q ss_pred             CCChhHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          283 GASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       283 ~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                      .++.++.+||..||+.||++||++++++.|+|++.
T Consensus       294 ~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        294 PVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             cCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence            88999999999999999999999999999999853

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=9.3e-45  Score=309.76  Aligned_cols=261  Identities=59%  Similarity=1.002  Sum_probs=224.6

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEe
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILME  130 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e  130 (323)
                      ++|++.+.||+|++|.||+|.+..+++.+++|.+...........+.+|+..+.+++|+|++++++.+.. ....++|||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e   79 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK-EGEISIVLE   79 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc-CCeEEEEEE
Confidence            4689999999999999999999989999999999766554567788999999999999999999999987 688999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccc
Q 020657          131 YMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG-HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN  209 (323)
Q Consensus       131 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~  209 (323)
                      |+++++|.+++.....+++..+..++.|+++++.+||+ .|++|+||+|+||+++.++ .++|+|||.+...........
T Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~-~~~l~df~~~~~~~~~~~~~~  158 (264)
T cd06623          80 YMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG-EVKIADFGISKVLENTLDQCN  158 (264)
T ss_pred             ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCC-CEEEccCccceecccCCCccc
Confidence            99999999999887889999999999999999999999 9999999999999999987 899999999976654433333


Q ss_pred             cccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCC-CChhH
Q 020657          210 SYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDG-ASPEF  288 (323)
Q Consensus       210 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l  288 (323)
                      ...++..|+|||.+...     ..+.++|+|+||+++|+|+||..||...... .................+.. ++..+
T Consensus       159 ~~~~~~~y~~pE~~~~~-----~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l  232 (264)
T cd06623         159 TFVGTVTYMSPERIQGE-----SYSYAADIWSLGLTLLECALGKFPFLPPGQP-SFFELMQAICDGPPPSLPAEEFSPEF  232 (264)
T ss_pred             ceeecccccCHhhhCCC-----CCCchhhHHHHHHHHHHHHhCCCCCcccccc-CHHHHHHHHhcCCCCCCCcccCCHHH
Confidence            45678899999987633     4567999999999999999999999665432 33444444444455555566 89999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          289 RSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       289 ~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      .+++.+||..+|++|||++++++||||+..+
T Consensus       233 ~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         233 RDFISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             HHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence            9999999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.7e-45  Score=313.86  Aligned_cols=262  Identities=29%  Similarity=0.422  Sum_probs=211.0

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEE
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      ...++|++.+.||+|++|.||+|.+..+++.+++|++..... .....+.+|+.+++.++|+||+++++++.. .+..++
T Consensus         6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-~~~~~i   83 (267)
T cd06646           6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLS-REKLWI   83 (267)
T ss_pred             CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEe-CCEEEE
Confidence            346789999999999999999999988999999999875432 233567789999999999999999999987 678999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccc
Q 020657          128 LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA  207 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~  207 (323)
                      ||||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.........
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~~~~~~  162 (267)
T cd06646          84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNG-DVKLADFGVAAKITATIAK  162 (267)
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-CEEECcCccceeecccccc
Confidence            999999999999998777899999999999999999999999999999999999999887 8999999999766433333


Q ss_pred             cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChh
Q 020657          208 CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPE  287 (323)
Q Consensus       208 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (323)
                      .....++..|+|||.+....  ....+.++|+||||+++|+|++|+.||...........+...............++..
T Consensus       163 ~~~~~~~~~y~~PE~~~~~~--~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (267)
T cd06646         163 RKSFIGTPYWMAPEVAAVEK--NGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSST  240 (267)
T ss_pred             cCccccCccccCHhHccccc--CCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHH
Confidence            34456788999999875322  2334568999999999999999999995433221111111100000011112356889


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCcc
Q 020657          288 FRSFIECCLQKEFSKRWTASQLLTHPF  314 (323)
Q Consensus       288 l~~ll~~~l~~~p~~Rpt~~~~l~h~~  314 (323)
                      +.+|+++||+.+|++|||++++++|+|
T Consensus       241 ~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         241 FHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=7.3e-45  Score=317.55  Aligned_cols=260  Identities=44%  Similarity=0.761  Sum_probs=213.6

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEe
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILME  130 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e  130 (323)
                      ++|++.+.||+|+||.||+|.+..++..+++|.+...........+.+|++++++++||||+++++.+.. ++.+++|||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e   79 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-DGEISICME   79 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-CCEEEEEee
Confidence            4799999999999999999999989999999998766555666778899999999999999999999987 788999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccc
Q 020657          131 YMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG-HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN  209 (323)
Q Consensus       131 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~  209 (323)
                      |+++++|.+++.....+++..+..++.|+++||.|||+ .|++|+||+|+||+++.++ .++|+|||++.......  ..
T Consensus        80 y~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~--~~  156 (308)
T cd06615          80 HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSM--AN  156 (308)
T ss_pred             ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC-cEEEccCCCcccccccc--cc
Confidence            99999999999888889999999999999999999997 5999999999999999987 89999999986543321  23


Q ss_pred             cccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHH-----------------------
Q 020657          210 SYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWA-----------------------  266 (323)
Q Consensus       210 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~-----------------------  266 (323)
                      ...++..|+|||.+.+.     ..+.++|+||||+++|+|++|..||..........                       
T Consensus       157 ~~~~~~~~~aPE~~~~~-----~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (308)
T cd06615         157 SFVGTRSYMSPERLQGT-----HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP  231 (308)
T ss_pred             cCCCCcCccChhHhcCC-----CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence            45678899999987532     34569999999999999999999985433111100                       


Q ss_pred             ---------HHHHHHhcCCCCCCC-CCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          267 ---------TLMCAICFGDPPSLP-DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       267 ---------~~~~~~~~~~~~~~~-~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                               .+........++..+ ..++.++.+|+.+||..+|++|||++++++||||.+-.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  294 (308)
T cd06615         232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE  294 (308)
T ss_pred             CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence                     011111111122222 23678899999999999999999999999999998743

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=7.8e-45  Score=313.53  Aligned_cols=262  Identities=33%  Similarity=0.557  Sum_probs=216.0

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEe
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILME  130 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e  130 (323)
                      +-|++.+.||+|++|.||+|.+..++..+++|.+.... ......+.+|+.+++.+.|+||+++++.+.. .+..++|+|
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-~~~~~~v~e   82 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYY-ENNLWILIE   82 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-CCEEEEEEE
Confidence            34788999999999999999999889999999986443 3445678889999999999999999999887 678999999


Q ss_pred             ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccc
Q 020657          131 YMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN  209 (323)
Q Consensus       131 ~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~  209 (323)
                      |+++++|..++.+ ..++++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++...........
T Consensus        83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~~~~~~~~  161 (282)
T cd06643          83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRD  161 (282)
T ss_pred             ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCC-CEEEccccccccccccccccc
Confidence            9999999988764 45789999999999999999999999999999999999999887 899999999876544333334


Q ss_pred             cccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC--CCCCCCCCChh
Q 020657          210 SYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD--PPSLPDGASPE  287 (323)
Q Consensus       210 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  287 (323)
                      ...++..|+|||++.........++.++|+||||+++|+|++|..||......   ..... .....  ....+..++.+
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~~-~~~~~~~~~~~~~~~~~~  237 (282)
T cd06643         162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM---RVLLK-IAKSEPPTLAQPSRWSSE  237 (282)
T ss_pred             cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH---HHHHH-HhhcCCCCCCCccccCHH
Confidence            45688899999998654444556678999999999999999999999543322   22222 11111  22334568899


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          288 FRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       288 l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      +.+|+++||+.||.+|||++++++||||....
T Consensus       238 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  269 (282)
T cd06643         238 FKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS  269 (282)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence            99999999999999999999999999997543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=5.1e-45  Score=312.95  Aligned_cols=261  Identities=33%  Similarity=0.541  Sum_probs=213.0

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceeceeEEcC-----C
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKP-----S  122 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-----~  122 (323)
                      +...|++.+.||+|++|.||+|.+..+++.+++|.+....  .....+.+|+.+++.+ .|+||+++++++...     .
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            3577999999999999999999999899999999986543  2235677899999998 699999999998652     2


Q ss_pred             CeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchh
Q 020657          123 GDIAILMEYMDSGTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                      ...++||||+.+++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++..
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~-~~~l~Dfg~~~~  160 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQ  160 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCC-CEEEccCCCcee
Confidence            4589999999999999998763  3689999999999999999999999999999999999999987 899999999876


Q ss_pred             hccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCC
Q 020657          201 MCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSL  280 (323)
Q Consensus       201 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  280 (323)
                      ............++..|+|||++.........++.++|+||||+++|+|++|..||......   ...............
T Consensus       161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~~  237 (272)
T cd06637         161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM---RALFLIPRNPAPRLK  237 (272)
T ss_pred             cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH---HHHHHHhcCCCCCCC
Confidence            54333334456788899999998754444455677999999999999999999999543322   111111112222233


Q ss_pred             CCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          281 PDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       281 ~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                      ...++.++.+|+.+||..+|.+|||+.+++.||||
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         238 SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            35678999999999999999999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.1e-45  Score=325.02  Aligned_cols=250  Identities=28%  Similarity=0.495  Sum_probs=203.7

Q ss_pred             eeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHH-HHHHcCCCCccceeceeEEcCCCeEEEEEeccC
Q 020657           57 QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREM-EILRRTDSPFIVQCFGIFEKPSGDIAILMEYMD  133 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~  133 (323)
                      +.||+|+||.||+|++..+++.||+|++....  .......+..|. .+++.+.|+||+++++++.. .+..++||||+.
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~-~~~~~lv~e~~~   79 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-ADKLYFVLDYIN   79 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc-CCeEEEEEeCCC
Confidence            36999999999999999899999999986432  112223344444 35677899999999999987 678999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccccccc
Q 020657          134 SGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVG  213 (323)
Q Consensus       134 ~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  213 (323)
                      +++|.+.+.....+++..+..++.||++||.|||+.|++||||||+||+++.++ .++|+|||++..............+
T Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~-~~kl~DfG~a~~~~~~~~~~~~~~g  158 (325)
T cd05602          80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEHNGTTSTFCG  158 (325)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEEccCCCCcccccCCCCcccccC
Confidence            999999998888899999999999999999999999999999999999999987 8999999998754333333445678


Q ss_pred             cccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHH
Q 020657          214 TCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIE  293 (323)
Q Consensus       214 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~  293 (323)
                      +..|+|||++.+.     .++.++||||||+++|+|++|..||.......    +...+.. ....++..++..+.++++
T Consensus       159 t~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i~~-~~~~~~~~~~~~~~~li~  228 (325)
T cd05602         159 TPEYLAPEVLHKQ-----PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE----MYDNILN-KPLQLKPNITNSARHLLE  228 (325)
T ss_pred             CccccCHHHHcCC-----CCCCccccccccHHHHHHhcCCCCCCCCCHHH----HHHHHHh-CCcCCCCCCCHHHHHHHH
Confidence            9999999998743     34569999999999999999999996543322    2222221 233455678999999999


Q ss_pred             HhcccCcCCCCCHH----HHhcCcccccC
Q 020657          294 CCLQKEFSKRWTAS----QLLTHPFLCKN  318 (323)
Q Consensus       294 ~~l~~~p~~Rpt~~----~~l~h~~f~~~  318 (323)
                      +||+.||.+|+++.    ++++|+||...
T Consensus       229 ~~l~~~p~~R~~~~~~~~~i~~~~~~~~~  257 (325)
T cd05602         229 GLLQKDRTKRLGAKDDFMEIKNHIFFSPI  257 (325)
T ss_pred             HHcccCHHHCCCCCCCHHHHhcCcccCCC
Confidence            99999999999865    89999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=5.8e-45  Score=314.76  Aligned_cols=258  Identities=26%  Similarity=0.437  Sum_probs=211.5

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      .|++.+.||+|+||.||+|.+..+++.+++|.+....  .......+.+|+.+++.++|++++++++.+.+ .+..++||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~   79 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET-KDALCLVL   79 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec-CCEEEEEE
Confidence            4788899999999999999999999999999986442  22334556789999999999999999999987 67899999


Q ss_pred             eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccc
Q 020657          130 EYMDSGTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA  207 (323)
Q Consensus       130 e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~  207 (323)
                      ||+.+++|.+.+...  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++....... .
T Consensus        80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~-~~~l~Dfg~~~~~~~~~-~  157 (285)
T cd05630          80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHG-HIRISDLGLAVHVPEGQ-T  157 (285)
T ss_pred             EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC-CEEEeeccceeecCCCc-c
Confidence            999999999988643  3589999999999999999999999999999999999999987 89999999986543221 2


Q ss_pred             cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChh
Q 020657          208 CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPE  287 (323)
Q Consensus       208 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (323)
                      .....++..|+|||++...     .++.++|+||||+++|+|++|..||.............. ........++..++++
T Consensus       158 ~~~~~g~~~y~aPE~~~~~-----~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  231 (285)
T cd05630         158 IKGRVGTVGYMAPEVVKNE-----RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER-LVKEVQEEYSEKFSPD  231 (285)
T ss_pred             ccCCCCCccccChHHHcCC-----CCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHh-hhhhhhhhcCccCCHH
Confidence            2344688999999998643     345699999999999999999999976543322222211 1112223455678999


Q ss_pred             HHHHHHHhcccCcCCCCC-----HHHHhcCcccccC
Q 020657          288 FRSFIECCLQKEFSKRWT-----ASQLLTHPFLCKN  318 (323)
Q Consensus       288 l~~ll~~~l~~~p~~Rpt-----~~~~l~h~~f~~~  318 (323)
                      +.+|+++||+.||++|||     ++++++||||++.
T Consensus       232 ~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~  267 (285)
T cd05630         232 ARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI  267 (285)
T ss_pred             HHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence            999999999999999999     8999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.2e-45  Score=328.20  Aligned_cols=267  Identities=28%  Similarity=0.487  Sum_probs=214.8

Q ss_pred             chhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC
Q 020657           45 TAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS  122 (323)
Q Consensus        45 ~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  122 (323)
                      ...+..++|++.+.||+|+||.||+|++..+++.+|+|++....  .......+.+|+.+++.++||||+++++++.. .
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-~  115 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-D  115 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-C
Confidence            45566799999999999999999999999999999999986421  22334557789999999999999999999987 6


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          123 GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      ...++||||+++++|.+++... .+++..+..++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++....
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~-~ikL~DfG~a~~~~  193 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMN  193 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCC-CEEEEeCCceeEcC
Confidence            8899999999999999998754 589999999999999999999999999999999999999987 89999999997654


Q ss_pred             cCc-cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCC
Q 020657          203 RSL-DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLP  281 (323)
Q Consensus       203 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (323)
                      ... .......+|..|+|||++..... ...++.++||||||+++|+|++|..||...+.......+..   ......++
T Consensus       194 ~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~---~~~~~~~~  269 (371)
T cd05622         194 KEGMVRCDTAVGTPDYISPEVLKSQGG-DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN---HKNSLTFP  269 (371)
T ss_pred             cCCcccccCcccCccccCHHHHhccCC-CccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHc---CCCcccCC
Confidence            322 12235678999999999864321 23356799999999999999999999965433222222221   11122222


Q ss_pred             --CCCChhHHHHHHHhcccCcCC--CCCHHHHhcCcccccC
Q 020657          282 --DGASPEFRSFIECCLQKEFSK--RWTASQLLTHPFLCKN  318 (323)
Q Consensus       282 --~~~~~~l~~ll~~~l~~~p~~--Rpt~~~~l~h~~f~~~  318 (323)
                        ..++..+.+|+.+||..++.+  |++++++++|+||.+.
T Consensus       270 ~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         270 DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence              468999999999999844432  7899999999999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-45  Score=321.10  Aligned_cols=271  Identities=27%  Similarity=0.409  Sum_probs=215.1

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceeceeEEcC
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKP  121 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~  121 (323)
                      .....+..+.|++++.||.||.+.||++.....+-+++.|+.....+.....-+.+|+.+|.+| +|.+|++++++-.. 
T Consensus       353 ~~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-  431 (677)
T KOG0596|consen  353 NEIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-  431 (677)
T ss_pred             CeeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-
Confidence            3456678899999999999999999999987555555556666667888899999999999999 68999999999665 


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchh
Q 020657          122 SGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       122 ~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                      ++.+|+|||+-+. +|..++++... +..-.++.+++||+.|+.++|.+||||.||||.|+++-.+  .+||+|||.|..
T Consensus       432 d~~lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG--~LKLIDFGIA~a  508 (677)
T KOG0596|consen  432 DGYLYMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKG--RLKLIDFGIANA  508 (677)
T ss_pred             CceEEEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEee--eEEeeeechhcc
Confidence            8999999999865 99999987654 3335899999999999999999999999999999999864  799999999987


Q ss_pred             hccCc--cccccccccccccCCcccCCCCCCCC------CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHH
Q 020657          201 MCRSL--DACNSYVGTCAYMSPERFDPDAYGGN------YNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAI  272 (323)
Q Consensus       201 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~------~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~  272 (323)
                      +....  -....-+||..|++||.+.....+..      -.+.++|||||||+||+|+.|+.||-.-.  ..+.++....
T Consensus       509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~aI~  586 (677)
T KOG0596|consen  509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHAIT  586 (677)
T ss_pred             cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHhhc
Confidence            65432  22346689999999999874443311      14568999999999999999999992211  1122232222


Q ss_pred             hcCCCCCCCCCCChh-HHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          273 CFGDPPSLPDGASPE-FRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       273 ~~~~~~~~~~~~~~~-l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      ..+..-.++..-+.. +.++++.||++||++|||+.++|+|||++.+.
T Consensus       587 ~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~  634 (677)
T KOG0596|consen  587 DPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQP  634 (677)
T ss_pred             CCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccccc
Confidence            222223455444444 99999999999999999999999999998743

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.4e-44  Score=311.47  Aligned_cols=256  Identities=42%  Similarity=0.724  Sum_probs=211.4

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEe
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILME  130 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e  130 (323)
                      ++|++.+.||+|++|.||+|.+..+++.|++|.+...........+.+|+++++++.||||+++++.+.. .+..++|||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e   79 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-ENRISICTE   79 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-CCEEEEEEe
Confidence            4688999999999999999999989999999999766555566778899999999999999999999987 678999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccccc
Q 020657          131 YMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNS  210 (323)
Q Consensus       131 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~  210 (323)
                      |+++++|...    ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++......  ....
T Consensus        80 ~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~-~~~l~dfg~~~~~~~~--~~~~  152 (279)
T cd06619          80 FMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVNS--IAKT  152 (279)
T ss_pred             cCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCC-CEEEeeCCcceecccc--cccC
Confidence            9999998654    2578899999999999999999999999999999999999987 8999999998765332  2234


Q ss_pred             ccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCc---cHHHHHHHHhcCCCCCC-CCCCCh
Q 020657          211 YVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRP---DWATLMCAICFGDPPSL-PDGASP  286 (323)
Q Consensus       211 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~-~~~~~~  286 (323)
                      ..++..|+|||++...     .++.++|+||||+++|+|++|..||.......   ................. ....++
T Consensus       153 ~~~~~~y~aPE~~~~~-----~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (279)
T cd06619         153 YVGTNAYMAPERISGE-----QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSE  227 (279)
T ss_pred             CCCChhhcCceeecCC-----CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCH
Confidence            5788899999998643     34569999999999999999999996533221   11222222222223332 235788


Q ss_pred             hHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          287 EFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       287 ~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      ++.+++.+||+.+|++||+++++++||||+...
T Consensus       228 ~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~  260 (279)
T cd06619         228 KFVHFITQCMRKQPKERPAPENLMDHPFIVQYN  260 (279)
T ss_pred             HHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence            999999999999999999999999999997653

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.7e-45  Score=316.64  Aligned_cols=257  Identities=28%  Similarity=0.479  Sum_probs=205.0

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEe
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILME  130 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e  130 (323)
                      +|++.+.||+|++|.||+|.+..+|+.+++|.+.... .......+.+|+.+++.++|+||+++++++.+ ....++|+|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS-DKKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc-CCceEEEEe
Confidence            5889999999999999999999899999999986542 22334566789999999999999999999987 678999999


Q ss_pred             ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccc
Q 020657          131 YMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN  209 (323)
Q Consensus       131 ~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~  209 (323)
                      |+.+ +|.+.+.. ...+++..++.++.||++||.|||+.|++|+||+|+||+++.++ .++|+|||++...........
T Consensus        80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~  157 (284)
T cd07839          80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNG-ELKLADFGLARAFGIPVRCYS  157 (284)
T ss_pred             cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCC-cEEECccchhhccCCCCCCcC
Confidence            9975 78777654 56799999999999999999999999999999999999999987 899999999976544433334


Q ss_pred             cccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCcc-HHHHHHHH---------------h
Q 020657          210 SYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPD-WATLMCAI---------------C  273 (323)
Q Consensus       210 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~-~~~~~~~~---------------~  273 (323)
                      ...++..|+|||++.+    ...++.++||||||+++|+|+||..||........ ...+....               .
T Consensus       158 ~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07839         158 AEVVTLWYRPPDVLFG----AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD  233 (284)
T ss_pred             CCccccCCcChHHHhC----CcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence            4567889999998753    23346699999999999999999999754332211 11111100               0


Q ss_pred             cCCCC---------CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          274 FGDPP---------SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       274 ~~~~~---------~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                      ....+         .....+++++.+|+++||+.||.+|||++++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            00001         1113468899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=5e-45  Score=311.77  Aligned_cols=259  Identities=46%  Similarity=0.794  Sum_probs=219.8

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEe
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILME  130 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e  130 (323)
                      ++|++.+.||.|++|.||+|.+..+++.+++|.+...........+.+|+.+++++.||||+++++.+.. ++..++++|
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e   79 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN-NGDISICME   79 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec-CCEEEEEEE
Confidence            4688899999999999999999989999999999876655667788999999999999999999999987 688999999


Q ss_pred             ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          131 YMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHG-HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       131 ~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~-~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      |+.+++|.+++... ..+++..+..++.|++.+|.+||+ .|++|+||+|+||+++.++ .++|+|||.+......... 
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~-~~~l~d~g~~~~~~~~~~~-  157 (265)
T cd06605          80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG-QIKLCDFGVSGQLVNSLAK-  157 (265)
T ss_pred             ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC-CEEEeecccchhhHHHHhh-
Confidence            99999999999875 688999999999999999999999 9999999999999999987 8999999998765432221 


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-CccHHHHHHHHhcCCCCCCCCC-CCh
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQ-RPDWATLMCAICFGDPPSLPDG-ASP  286 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-~~~  286 (323)
                       ...++..|+|||.+.+.     ..+.++|+||||+++|+|++|..||..... ........+.......+..+.. ++.
T Consensus       158 -~~~~~~~y~~PE~~~~~-----~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (265)
T cd06605         158 -TFVGTSSYMAPERIQGN-----DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSP  231 (265)
T ss_pred             -cccCChhccCHHHHcCC-----CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCH
Confidence             25678899999988643     456699999999999999999999965432 1223334444444444555554 899


Q ss_pred             hHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          287 EFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       287 ~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      ++.+++.+||..+|++|||+.+++.||||++-
T Consensus       232 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         232 DFQDFVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             HHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence            99999999999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-46  Score=302.93  Aligned_cols=257  Identities=30%  Similarity=0.453  Sum_probs=213.1

Q ss_pred             ccccee-eeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHH-HcCCCCccceeceeEEcC---CCeE
Q 020657           51 SDLEKL-QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEIL-RRTDSPFIVQCFGIFEKP---SGDI  125 (323)
Q Consensus        51 ~~~~~~-~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~~---~~~~  125 (323)
                      ++|++- ++||-|-.|.|..+..+.+++.+|+|++....      ...+|+++- ..-.|||||.++++|++.   ...+
T Consensus        61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL  134 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP------KARREVELHWMASGHPHIVSIIDVYENSYQGRKCL  134 (400)
T ss_pred             hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH------HHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence            444443 68999999999999999999999999986442      234677764 335799999999998642   4467


Q ss_pred             EEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC--CcEEEeecCcchhh
Q 020657          126 AILMEYMDSGTLDTLLNKNGT--FSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN--MQVKIADFGVSKIM  201 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~--~~~kl~Dfg~~~~~  201 (323)
                      .+|||.|+||.|...++..+.  +++.++..|++||+.|+.|||+.+|+||||||+|+|....+  ..+||+|||+|...
T Consensus       135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t  214 (400)
T KOG0604|consen  135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET  214 (400)
T ss_pred             EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccccc
Confidence            899999999999999987654  99999999999999999999999999999999999997643  47999999999765


Q ss_pred             ccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC---CC
Q 020657          202 CRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD---PP  278 (323)
Q Consensus       202 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~---~~  278 (323)
                      .. .....+.+.|+.|+|||++..+.+..     ..|+||+|++||-|++|..||...........+...+..+.   +.
T Consensus       215 ~~-~~~L~TPc~TPyYvaPevlg~eKydk-----scdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~  288 (400)
T KOG0604|consen  215 QE-PGDLMTPCFTPYYVAPEVLGPEKYDK-----SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPE  288 (400)
T ss_pred             CC-CccccCCcccccccCHHHhCchhcCC-----CCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCC
Confidence            43 34446778999999999998666544     89999999999999999999987766665566666655544   33


Q ss_pred             CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          279 SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       279 ~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      +-+..+|+..+++|+.+|..+|.+|.|+++++.|||+.+-.
T Consensus       289 pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~  329 (400)
T KOG0604|consen  289 PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE  329 (400)
T ss_pred             hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence            33467899999999999999999999999999999997644

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=8.6e-45  Score=334.06  Aligned_cols=260  Identities=25%  Similarity=0.362  Sum_probs=200.6

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCC------CccceeceeEEcC
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS------PFIVQCFGIFEKP  121 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~  121 (323)
                      +...+|++.+.||+|+||+||+|.+..+++.||+|++....  ........|+.+++.+.|      .+++.+++++...
T Consensus       126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            34578999999999999999999999899999999996432  223345567777666544      5688899998876


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCCeEEecCCC------------
Q 020657          122 SGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG-HKIIHRDIKPSNLLVNNNNM------------  188 (323)
Q Consensus       122 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~givH~di~~~nil~~~~~~------------  188 (323)
                      ...+++||+++ +++|.+++.+.+.+++..+..++.||+.||.|||+ .||+||||||+||+++.++.            
T Consensus       204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~  282 (467)
T PTZ00284        204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP  282 (467)
T ss_pred             CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence            67899999998 56899988877789999999999999999999998 59999999999999987642            


Q ss_pred             ---cEEEeecCcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccH
Q 020657          189 ---QVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDW  265 (323)
Q Consensus       189 ---~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~  265 (323)
                         .+||+|||.+.....   ......+|..|+|||++.+..     ++.++|||||||++|||++|+.||.+.......
T Consensus       283 ~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~~~~-----~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~  354 (467)
T PTZ00284        283 DPCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVLGLG-----WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL  354 (467)
T ss_pred             CCceEEECCCCccccCcc---ccccccCCccccCcHHhhcCC-----CCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence               499999998754322   223467899999999987443     456999999999999999999999765433222


Q ss_pred             HHHHHHHhc---------------------CC-CCC--------------CC-CCCChhHHHHHHHhcccCcCCCCCHHH
Q 020657          266 ATLMCAICF---------------------GD-PPS--------------LP-DGASPEFRSFIECCLQKEFSKRWTASQ  308 (323)
Q Consensus       266 ~~~~~~~~~---------------------~~-~~~--------------~~-~~~~~~l~~ll~~~l~~~p~~Rpt~~~  308 (323)
                      ..+......                     .. .+.              .. ...++.+.+||++||++||++|||++|
T Consensus       355 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e  434 (467)
T PTZ00284        355 HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQ  434 (467)
T ss_pred             HHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHH
Confidence            211111000                     00 000              00 012456889999999999999999999


Q ss_pred             HhcCcccccC
Q 020657          309 LLTHPFLCKN  318 (323)
Q Consensus       309 ~l~h~~f~~~  318 (323)
                      +|+||||.+.
T Consensus       435 ~L~Hp~~~~~  444 (467)
T PTZ00284        435 MTTHPYVLKY  444 (467)
T ss_pred             HhcCcccccc
Confidence            9999999863

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=5.4e-45  Score=315.44  Aligned_cols=256  Identities=28%  Similarity=0.425  Sum_probs=200.5

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcC---CCCccceeceeEEcC----CC
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-PTVRRQVFREMEILRRT---DSPFIVQCFGIFEKP----SG  123 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~----~~  123 (323)
                      +|++.+.||+|++|+||+|.+..+++.|++|.+..... ......+.+|+.+++.+   +||||+++++++...    ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            58999999999999999999999999999999875422 12223445666666654   799999999987642    34


Q ss_pred             eEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhh
Q 020657          124 DIAILMEYMDSGTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM  201 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~  201 (323)
                      ..++||||+.+ +|.+++...  ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++ .+||+|||++...
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~-~~kl~dfg~~~~~  158 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG-QVKLADFGLARIY  158 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECccCccccc
Confidence            57999999985 888888653  3489999999999999999999999999999999999999987 8999999999765


Q ss_pred             ccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCC----
Q 020657          202 CRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP----  277 (323)
Q Consensus       202 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~----  277 (323)
                      .... ......++..|+|||++...     .++.++||||||+++|+|++|..||...........+.........    
T Consensus       159 ~~~~-~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07863         159 SCQM-ALTPVVVTLWYRAPEVLLQS-----TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  232 (288)
T ss_pred             cCcc-cCCCccccccccCchHhhCC-----CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence            4322 22334678899999998633     3456999999999999999999999655443333333222111000    


Q ss_pred             ------------------CCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          278 ------------------PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       278 ------------------~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                                        ......++..+.+|+.+||+.||++|||+.+++.||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                              01123567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6.2e-45  Score=314.61  Aligned_cols=259  Identities=28%  Similarity=0.496  Sum_probs=210.4

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      ++|++...||+|++|.||+|.+..+++.|++|++..... ....+.+.+|+.+++.++|+|++++++++.. ....++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR-KRKLHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee-CCEEEEEE
Confidence            479999999999999999999998899999999864432 2334567899999999999999999999987 67899999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccc
Q 020657          130 EYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN  209 (323)
Q Consensus       130 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~  209 (323)
                      ||+++++|..++.....+++..+..++.||+.+|.|||+.|++|+||+|+||+++.++ .++|+|||++...........
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~  158 (286)
T cd07847          80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG-QIKLCDFGFARILTGPGDDYT  158 (286)
T ss_pred             eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCC-cEEECccccceecCCCccccc
Confidence            9999988988887777899999999999999999999999999999999999999987 899999999977654433333


Q ss_pred             cccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhc---------------
Q 020657          210 SYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICF---------------  274 (323)
Q Consensus       210 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~---------------  274 (323)
                      ...++..|+|||.+.+    ...++.++|+||||+++|+|++|..||.+.........+......               
T Consensus       159 ~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07847         159 DYVATRWYRAPELLVG----DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF  234 (286)
T ss_pred             CcccccccCCHHHHhC----CCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence            4557789999998753    223456999999999999999999999765433222222111100               


Q ss_pred             -----CCCC------CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          275 -----GDPP------SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       275 -----~~~~------~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                           ....      .....++..+.+|+.+||+.+|++|||+.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence                 0000      0113467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=9.4e-45  Score=312.21  Aligned_cols=257  Identities=35%  Similarity=0.578  Sum_probs=217.5

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEe
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILME  130 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e  130 (323)
                      ..|+..+.||.|++|.||+|.+..+++.+++|++...........+.+|+.+++.+.|+||+++++.+.+ ....++|||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e   82 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-GTKLWIIME   82 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCEEEEEEe
Confidence            5688899999999999999999888999999998765545566788899999999999999999999987 678999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccccc
Q 020657          131 YMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNS  210 (323)
Q Consensus       131 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~  210 (323)
                      |+++++|.+++..+ ++++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||++............
T Consensus        83 ~~~~~~L~~~i~~~-~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06640          83 YLGGGSALDLLRAG-PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             cCCCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCC-CEEEcccccceeccCCcccccc
Confidence            99999999988754 689999999999999999999999999999999999999887 8999999999765443323334


Q ss_pred             ccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHH
Q 020657          211 YVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS  290 (323)
Q Consensus       211 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  290 (323)
                      ..++..|+|||++...     ..+.++|+||||+++|+|+||..||.....    ...........++.++..++..+.+
T Consensus       161 ~~~~~~y~apE~~~~~-----~~~~~~Dv~slG~il~el~tg~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~  231 (277)
T cd06640         161 FVGTPFWMAPEVIQQS-----AYDSKADIWSLGITAIELAKGEPPNSDMHP----MRVLFLIPKNNPPTLTGEFSKPFKE  231 (277)
T ss_pred             ccCcccccCHhHhccC-----CCccHHHHHHHHHHHHHHHHCCCCCCCcCh----HhHhhhhhcCCCCCCchhhhHHHHH
Confidence            4577889999988633     346699999999999999999999965432    2222223334455666678899999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          291 FIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       291 ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      ++.+||+.+|++||+++++++|+||.+..
T Consensus       232 li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06640         232 FIDACLNKDPSFRPTAKELLKHKFIVKNA  260 (277)
T ss_pred             HHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence            99999999999999999999999997754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=7.3e-45  Score=314.09  Aligned_cols=257  Identities=25%  Similarity=0.393  Sum_probs=205.6

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEe
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILME  130 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e  130 (323)
                      +|++.+.||+|++|.||+|.+..+++.|++|.+..... ......+.+|+.+++.++||||+++++++.. +...++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ-ESRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee-CCeEEEEEe
Confidence            58899999999999999999988999999999865432 2234567789999999999999999999987 678999999


Q ss_pred             ccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccc
Q 020657          131 YMDSGTLDTLLNKN---GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA  207 (323)
Q Consensus       131 ~~~~~sL~~~l~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~  207 (323)
                      |+. ++|.+++...   ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++.........
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~  157 (285)
T cd07861          80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKG-VIKLADFGLARAFGIPVRV  157 (285)
T ss_pred             cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCC-cEEECcccceeecCCCccc
Confidence            997 4888887542   4689999999999999999999999999999999999999987 8999999998765433333


Q ss_pred             cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHh--------------
Q 020657          208 CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAIC--------------  273 (323)
Q Consensus       208 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~--------------  273 (323)
                      .....++..|+|||.+.+.    ...+.++||||||+++|+|+||..||.............+...              
T Consensus       158 ~~~~~~~~~y~aPE~~~~~----~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd07861         158 YTHEVVTLWYRAPEVLLGS----PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP  233 (285)
T ss_pred             ccCCcccccccChHHhcCC----CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence            3344678899999987532    2345699999999999999999999965432211111111000              


Q ss_pred             ----------cCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          274 ----------FGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       274 ----------~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                                ..........+++++.++|++||+.||++|||++++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                      000001123578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.3e-45  Score=337.31  Aligned_cols=262  Identities=27%  Similarity=0.465  Sum_probs=225.0

Q ss_pred             CCCCCccchhccccccceeeeecccCCeEEEEEEecc-----cCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccc
Q 020657           38 NNNTTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRC-----THKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIV  112 (323)
Q Consensus        38 ~~~~~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~  112 (323)
                      ...+....-.+..++.+..+.||+|+||.||+|+-.+     ....||||.++...+.+...+|.+|+.++..++|||||
T Consensus       473 ~~~~~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIV  552 (774)
T KOG1026|consen  473 QLNPDLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIV  552 (774)
T ss_pred             CCCCccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeE
Confidence            3344567778899999999999999999999998542     45589999999888888899999999999999999999


Q ss_pred             eeceeEEcCCCeEEEEEeccCCCCHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCC
Q 020657          113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN--------------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKP  178 (323)
Q Consensus       113 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--------------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~  178 (323)
                      +++|++.. ++.+++|+|||..|+|.+++...              ++++..+.+.|+.|||.||.||-++.+|||||.+
T Consensus       553 rLlGVC~~-~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLAT  631 (774)
T KOG1026|consen  553 RLLGVCRE-GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLAT  631 (774)
T ss_pred             EEEEEEcc-CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhh
Confidence            99999998 78999999999999999999631              2388999999999999999999999999999999


Q ss_pred             CCeEEecCCCcEEEeecCcchhhccC-c-cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCC
Q 020657          179 SNLLVNNNNMQVKIADFGVSKIMCRS-L-DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFP  255 (323)
Q Consensus       179 ~nil~~~~~~~~kl~Dfg~~~~~~~~-~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p  255 (323)
                      +|+||.++- .|||+|||+++.+-.. + +......-..+|||||.+.-+.+     |.+|||||+|++|||+++ |..|
T Consensus       632 RNCLVge~l-~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kF-----TteSDVWs~GVvLWEIFsyG~QP  705 (774)
T KOG1026|consen  632 RNCLVGENL-VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKF-----TTESDVWSFGVVLWEIFSYGKQP  705 (774)
T ss_pred             hhceeccce-EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcc-----cchhhhhhhhhhhhhhhccccCc
Confidence            999999885 9999999999865432 2 22224556789999999985555     459999999999999995 9999


Q ss_pred             CCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHh
Q 020657          256 FLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLL  310 (323)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l  310 (323)
                      |.+..+.    +.++.+..+.....|..+|.++++||..||+.+|++||++.||-
T Consensus       706 y~glSn~----EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  706 YYGLSNQ----EVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             ccccchH----HHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            9777664    44455555666778899999999999999999999999999984

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-44  Score=308.42  Aligned_cols=260  Identities=33%  Similarity=0.496  Sum_probs=212.6

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      .++|++...||.|++|.||+|.+..+++.+++|++...... ....+.+|+.+++.++||||+++++.+.. ...++++|
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~l~~   79 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLR-RDKLWIVM   79 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEe-CCEEEEEE
Confidence            57899999999999999999999888999999999765433 45778899999999999999999999887 67899999


Q ss_pred             eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          130 EYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       130 e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      ||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||.+..........
T Consensus        80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~~~~  158 (262)
T cd06613          80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDG-DVKLADFGVSAQLTATIAKR  158 (262)
T ss_pred             eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCC-CEEECccccchhhhhhhhcc
Confidence            999999999998765 6899999999999999999999999999999999999999987 89999999997665433333


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhH
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEF  288 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (323)
                      ....++..|+|||.+....  ....+.++|+||||+++|+|+||..||............................+.++
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~--~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (262)
T cd06613         159 KSFIGTPYWMAPEVAAVER--KGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVF  236 (262)
T ss_pred             ccccCCccccCchhhcccc--cCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHH
Confidence            4456788999999876331  12445699999999999999999999965442222211111100000111223467889


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCcc
Q 020657          289 RSFIECCLQKEFSKRWTASQLLTHPF  314 (323)
Q Consensus       289 ~~ll~~~l~~~p~~Rpt~~~~l~h~~  314 (323)
                      .+++++||..+|.+|||+.+++.|+|
T Consensus       237 ~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         237 HDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            99999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=6.6e-45  Score=324.03  Aligned_cols=260  Identities=23%  Similarity=0.378  Sum_probs=205.7

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC----
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS----  122 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----  122 (323)
                      ...++|++.+.||+|+||.||+|.+..+++.+++|.+.... .......+.+|+.+++.++||||+++++++....    
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            35689999999999999999999998899999999987543 3344567788999999999999999999986422    


Q ss_pred             -CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhh
Q 020657          123 -GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM  201 (323)
Q Consensus       123 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~  201 (323)
                       ...++||||+++ ++.+.+..  .+++..+..++.|++.||.|||+.|++||||||+||+++.++ .+||+|||++...
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~-~~kl~Dfg~~~~~  169 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTA  169 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCC-CEEEeeCcccccC
Confidence             357999999976 67666643  488999999999999999999999999999999999999987 8999999999765


Q ss_pred             ccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhc-------
Q 020657          202 CRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICF-------  274 (323)
Q Consensus       202 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~-------  274 (323)
                      .... ......++..|+|||++.+.     .++.++||||||+++|+|++|..||.+................       
T Consensus       170 ~~~~-~~~~~~~t~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (355)
T cd07874         170 GTSF-MMTPYVVTRYYRAPEVILGM-----GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  243 (355)
T ss_pred             CCcc-ccCCccccCCccCHHHHcCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            3322 22345688999999998643     3456999999999999999999999654432222211111000       


Q ss_pred             -----------CC-------------------CCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          275 -----------GD-------------------PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       275 -----------~~-------------------~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                                 ..                   ........+.++.+|+.+||+.||++|||++++|+||||+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~  316 (355)
T cd07874         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV  316 (355)
T ss_pred             hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence                       00                   00111234567899999999999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=6.5e-45  Score=311.51  Aligned_cols=260  Identities=31%  Similarity=0.477  Sum_probs=212.1

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEE
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      ...++|++.+.||+|++|.||+|.+..+++.|++|++..... .....+.+|+.+++.++||||+++++.+.. .+..++
T Consensus         6 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-~~~~~l   83 (267)
T cd06645           6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-RDKLWI   83 (267)
T ss_pred             CcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-CCEEEE
Confidence            345789999999999999999999998999999999875543 333557789999999999999999999987 688999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccc
Q 020657          128 LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA  207 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~  207 (323)
                      ||||+++++|.+++...+.+++..+..++.|++.++.|||+.|++|+||+|+||+++.++ .++|+|||++.........
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~~~~~~~  162 (267)
T cd06645          84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNG-HVKLADFGVSAQITATIAK  162 (267)
T ss_pred             EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECcceeeeEccCcccc
Confidence            999999999999998888899999999999999999999999999999999999999887 8999999998765443333


Q ss_pred             cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCC--CCCC
Q 020657          208 CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLP--DGAS  285 (323)
Q Consensus       208 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  285 (323)
                      .....++..|+|||++....  ....+.++|+||||+++|+|++|..||..............  ....++...  ..++
T Consensus       163 ~~~~~~~~~y~aPE~~~~~~--~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  238 (267)
T cd06645         163 RKSFIGTPYWMAPEVAAVER--KGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK--SNFQPPKLKDKMKWS  238 (267)
T ss_pred             cccccCcccccChhhhcccc--CCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc--cCCCCCcccccCCCC
Confidence            34557889999999874221  23345699999999999999999999965432221111111  111111111  2467


Q ss_pred             hhHHHHHHHhcccCcCCCCCHHHHhcCcc
Q 020657          286 PEFRSFIECCLQKEFSKRWTASQLLTHPF  314 (323)
Q Consensus       286 ~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~  314 (323)
                      ..+.+++++||+.+|++|||++++++|||
T Consensus       239 ~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         239 NSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            88999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.6e-44  Score=311.48  Aligned_cols=262  Identities=33%  Similarity=0.521  Sum_probs=212.4

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceeceeEEc-----C
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFGIFEK-----P  121 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-----~  121 (323)
                      ...+.|++.+.||.|+||.||+|.+..+++.+++|++....  .....+..|+.+++++ .|+||+++++++..     .
T Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   90 (282)
T cd06636          13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH   90 (282)
T ss_pred             ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence            34579999999999999999999999899999999985442  3345678899999988 69999999999853     2


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcch
Q 020657          122 SGDIAILMEYMDSGTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       122 ~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                      ....+++|||+++++|.+++...  ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++.
T Consensus        91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~-~~~l~dfg~~~  169 (282)
T cd06636          91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENA-EVKLVDFGVSA  169 (282)
T ss_pred             CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCcchh
Confidence            45789999999999999998753  3588899999999999999999999999999999999999987 89999999987


Q ss_pred             hhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCC
Q 020657          200 IMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPS  279 (323)
Q Consensus       200 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  279 (323)
                      .............++..|+|||.+.........++.++|+||||+++|+|++|..||......   ..............
T Consensus       170 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~  246 (282)
T cd06636         170 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM---RALFLIPRNPPPKL  246 (282)
T ss_pred             hhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH---hhhhhHhhCCCCCC
Confidence            654433334456688899999998644333455677999999999999999999999544322   22211111111222


Q ss_pred             CCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          280 LPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       280 ~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                      ....++.++.+||++||..||.+|||+.++++||||
T Consensus       247 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         247 KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             cccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            334678999999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1e-44  Score=323.88  Aligned_cols=260  Identities=25%  Similarity=0.399  Sum_probs=206.2

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC-----
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS-----  122 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----  122 (323)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.++||||+++++++....     
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            4689999999999999999999999899999999987543 2344567788999999999999999999875422     


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          123 GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      ...++||||+++ +|.+.+..  .+++..+..++.|++.||.|||+.|++||||||+||+++.++ .+||+|||++....
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~  177 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAG  177 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCC-cEEEEeCCCccccC
Confidence            357999999976 77777653  478999999999999999999999999999999999999987 89999999997653


Q ss_pred             cCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhc--------
Q 020657          203 RSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICF--------  274 (323)
Q Consensus       203 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~--------  274 (323)
                      ... ......++..|+|||++.+.     .++.++||||||+++|+|++|+.||.+.+.......+......        
T Consensus       178 ~~~-~~~~~~~t~~y~aPE~~~~~-----~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (364)
T cd07875         178 TSF-MMTPYVVTRYYRAPEVILGM-----GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  251 (364)
T ss_pred             CCC-cccCCcccCCcCCHHHHhCC-----CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence            322 22345688999999998643     3456999999999999999999999665433222222211000        


Q ss_pred             ---------CCCC--------------------CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          275 ---------GDPP--------------------SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       275 ---------~~~~--------------------~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                               ...+                    ......+.++.+|+.+||+.||++|||++++|+||||+..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~  324 (364)
T cd07875         252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  324 (364)
T ss_pred             hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence                     0000                    0111235678999999999999999999999999999753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.1e-44  Score=315.13  Aligned_cols=263  Identities=25%  Similarity=0.401  Sum_probs=212.5

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC----hHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEE
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD----PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      +|++.+.||+|++|.||+|.+..+++.|++|.+.....    ......+.+|+.+++.++|+||+++++++.+ ....++
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~l   79 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-KSNINL   79 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-CCEEEE
Confidence            58899999999999999999988899999999975532    2344566789999999999999999999987 688999


Q ss_pred             EEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc
Q 020657          128 LMEYMDSGTLDTLLNKNG-TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD  206 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~  206 (323)
                      ||||+ +++|.+++.... .+++..+..++.||++||.|||+.|++|+||+|+||+++.++ .++|+|||++........
T Consensus        80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~~~~~  157 (298)
T cd07841          80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDG-VLKLADFGLARSFGSPNR  157 (298)
T ss_pred             EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCC-CEEEccceeeeeccCCCc
Confidence            99999 789999998765 799999999999999999999999999999999999999987 899999999977654433


Q ss_pred             ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC----------
Q 020657          207 ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD----------  276 (323)
Q Consensus       207 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~----------  276 (323)
                      ......++..|+|||.+.+    ....+.++|+||||+++|+|++|..+|....................          
T Consensus       158 ~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (298)
T cd07841         158 KMTHQVVTRWYRAPELLFG----ARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSL  233 (298)
T ss_pred             cccccccceeeeCHHHHhC----CCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccc
Confidence            3334456788999998742    23446699999999999999999777765443222222221110000          


Q ss_pred             --------C-----CCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCCC
Q 020657          277 --------P-----PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS  321 (323)
Q Consensus       277 --------~-----~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~  321 (323)
                              .     .......+..+.+++.+||+++|++|||++++++|+||++...+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~  291 (298)
T cd07841         234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAP  291 (298)
T ss_pred             cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCC
Confidence                    0     01123457889999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.7e-44  Score=310.72  Aligned_cols=262  Identities=31%  Similarity=0.502  Sum_probs=211.8

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceeceeEEcCC----
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKPS----  122 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~----  122 (323)
                      ...++|++...||+|++|.||+|.+..+++.+++|++....  .....+.+|+.+++++ +|+|++++++++...+    
T Consensus        19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~   96 (291)
T cd06639          19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG   96 (291)
T ss_pred             CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence            34688999999999999999999998899999999986442  2345667899999998 8999999999986532    


Q ss_pred             CeEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcc
Q 020657          123 GDIAILMEYMDSGTLDTLLNK----NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVS  198 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~  198 (323)
                      +..++||||+++++|.+++..    ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||++
T Consensus        97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~-~~kl~dfg~~  175 (291)
T cd06639          97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEG-GVKLVDFGVS  175 (291)
T ss_pred             CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC-CEEEeecccc
Confidence            468999999999999998752    45689999999999999999999999999999999999999987 8999999998


Q ss_pred             hhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCC
Q 020657          199 KIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPP  278 (323)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~  278 (323)
                      ..............++..|+|||++..........+.++||||||+++|+|++|..||......   ..+.. .......
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~---~~~~~-~~~~~~~  251 (291)
T cd06639         176 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV---KTLFK-IPRNPPP  251 (291)
T ss_pred             hhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH---HHHHH-HhcCCCC
Confidence            7654433333345678899999998644333334567999999999999999999999654322   22221 1112222


Q ss_pred             C--CCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccc
Q 020657          279 S--LPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLC  316 (323)
Q Consensus       279 ~--~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~  316 (323)
                      .  .+...+..+.+|+.+||+.+|++||++.++++||||+
T Consensus       252 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         252 TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            2  2345678899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.8e-44  Score=313.37  Aligned_cols=259  Identities=28%  Similarity=0.515  Sum_probs=214.4

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ...+|++.+.||+|++|.||+|.+..+++.+++|.+...... ....+.+|+.+++.+.|+||+++++.+.. ....++|
T Consensus        18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-~~~~~lv   95 (296)
T cd06654          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVV   95 (296)
T ss_pred             cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEe-CCEEEEe
Confidence            457899999999999999999999889999999998755433 34667889999999999999999999887 6789999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          129 MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      |||+++++|.+++... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++..........
T Consensus        96 ~e~~~~~~L~~~~~~~-~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~~  173 (296)
T cd06654          96 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKR  173 (296)
T ss_pred             ecccCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-CEEECccccchhcccccccc
Confidence            9999999999998654 689999999999999999999999999999999999999987 89999999987654333333


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC-CCCCCCCCChh
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD-PPSLPDGASPE  287 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  287 (323)
                      ....++..|+|||.+..     ...+.++||||||+++|+|++|+.||.......   .+........ ....+..++..
T Consensus       174 ~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  245 (296)
T cd06654         174 STMVGTPYWMAPEVVTR-----KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR---ALYLIATNGTPELQNPEKLSAI  245 (296)
T ss_pred             CcccCCccccCHHHHcC-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH---hHHHHhcCCCCCCCCccccCHH
Confidence            34567889999998863     334569999999999999999999996543321   1211111111 22234568899


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          288 FRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       288 l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      +.+|+.+||..+|++|||++++++||||...+
T Consensus       246 l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  277 (296)
T cd06654         246 FRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK  277 (296)
T ss_pred             HHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence            99999999999999999999999999997654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-44  Score=324.65  Aligned_cols=261  Identities=25%  Similarity=0.390  Sum_probs=208.5

Q ss_pred             chhccccccceeeeecccCCeEEEEEEec--ccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC
Q 020657           45 TAAIAYSDLEKLQVLGHGNGGTVYKVQHR--CTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS  122 (323)
Q Consensus        45 ~~~~~~~~~~~~~~lg~G~~~~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  122 (323)
                      ...+...+|+++..||+|++|.||++...  .+++.|++|.+....      ...+|+.+++.++|+||+++++++.. .
T Consensus        86 ~~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~------~~~~E~~il~~l~h~~iv~~~~~~~~-~  158 (392)
T PHA03207         86 PASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK------TPGREIDILKTISHRAIINLIHAYRW-K  158 (392)
T ss_pred             cchhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc------cHHHHHHHHHhcCCCCccceeeeEee-C
Confidence            34455678999999999999999999754  356789999886432      34579999999999999999999987 6


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          123 GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      ...++|||++. ++|.+++.....+++..++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++....
T Consensus       159 ~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~-~~~l~DfG~a~~~~  236 (392)
T PHA03207        159 STVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPE-NAVLGDFGAACKLD  236 (392)
T ss_pred             CEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC-CEEEccCccccccC
Confidence            78999999996 48888887777899999999999999999999999999999999999999987 89999999997654


Q ss_pred             cCcc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHh-------
Q 020657          203 RSLD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAIC-------  273 (323)
Q Consensus       203 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~-------  273 (323)
                      ....  ......++..|+|||++....     ++.++||||||+++|+|++|..||.+.........+.....       
T Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~  311 (392)
T PHA03207        237 AHPDTPQCYGWSGTLETNSPELLALDP-----YCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPL  311 (392)
T ss_pred             cccccccccccccccCccCHhHhcCCC-----CCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcc
Confidence            3222  223467899999999986433     45699999999999999999999976544322222211110       


Q ss_pred             ------------------cCCCCC--CC-----CCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          274 ------------------FGDPPS--LP-----DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       274 ------------------~~~~~~--~~-----~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                                        ....+.  .+     ..++.++.++|++||..||++|||+.++|.||||.+..
T Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~  382 (392)
T PHA03207        312 EFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP  382 (392)
T ss_pred             ccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence                              000010  11     24567899999999999999999999999999998754

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.1e-44  Score=307.29  Aligned_cols=253  Identities=34%  Similarity=0.536  Sum_probs=211.3

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC--------hHHHHHHHHHHHHHHcCCCCccceeceeEEcCCC
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD--------PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG  123 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  123 (323)
                      +|.+...||+|++|.||+|.+..+++.+++|.+.....        ....+.+.+|+.+++.++||||+++++++.. .+
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   79 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD-AD   79 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CC
Confidence            47888999999999999999988899999998864421        1234567889999999999999999999887 67


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          124 DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      ..++||||+++++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+.....
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~-~~~l~dfg~~~~~~~  158 (267)
T cd06628          80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKG-GIKISDFGISKKLEA  158 (267)
T ss_pred             ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCC-CEEecccCCCccccc
Confidence            8999999999999999998888899999999999999999999999999999999999999887 899999999876642


Q ss_pred             Ccc------ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCC
Q 020657          204 SLD------ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP  277 (323)
Q Consensus       204 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~  277 (323)
                      ...      ......++..|+|||.+...     ..+.++|+|+||+++|+|++|+.||.....   ...+. .......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-----~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~-~~~~~~~  229 (267)
T cd06628         159 NSLSTKTNGARPSLQGSVFWMAPEVVKQT-----SYTRKADIWSLGCLVVEMLTGKHPFPDCTQ---LQAIF-KIGENAS  229 (267)
T ss_pred             ccccCCccccccccCCCcCccChhHhccC-----CCCchhhhHHHHHHHHHHhhCCCCCCCccH---HHHHH-HHhccCC
Confidence            211      11223577899999988643     335689999999999999999999965432   22222 2222344


Q ss_pred             CCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          278 PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       278 ~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                      +.++..++..+.+++++||+.||.+||++.++++||||
T Consensus       230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         230 PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            56667889999999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.2e-44  Score=306.24  Aligned_cols=253  Identities=26%  Similarity=0.459  Sum_probs=213.9

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEe
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILME  130 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e  130 (323)
                      +|++.+.||+|++|.+|.+.+..+++.+++|.+.... .......+.+|+.+++.++|+||+++++.+.. .+..++|+|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE-NGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC-CCeEEEEEe
Confidence            5899999999999999999999899999999986432 33445678899999999999999999999987 678999999


Q ss_pred             ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          131 YMDSGTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       131 ~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      |+.+++|.+.+...  ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++ .++|+|||++..........
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~  158 (256)
T cd08218          80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVELA  158 (256)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEEeeccceeecCcchhhh
Confidence            99999999988753  2578999999999999999999999999999999999999887 89999999997654433333


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhH
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEF  288 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (323)
                      ....++..|+|||++.+.     ..+.++|+||||+++++|++|..||....    ..........+..+..+..++.++
T Consensus       159 ~~~~~~~~~~~pe~~~~~-----~~~~~~Dv~slG~i~~~l~~g~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  229 (256)
T cd08218         159 RTCIGTPYYLSPEICENR-----PYNNKSDIWALGCVLYEMCTLKHAFEAGN----MKNLVLKIIRGSYPPVSSHYSYDL  229 (256)
T ss_pred             hhccCCccccCHHHhCCC-----CCCCccchhHHHHHHHHHHcCCCCccCCC----HHHHHHHHhcCCCCCCcccCCHHH
Confidence            344578889999998643     34569999999999999999999995432    233333444455556677889999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          289 RSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       289 ~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                      .+++.+||+.+|.+||++.++++||||
T Consensus       230 ~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         230 RNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence            999999999999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-44  Score=310.86  Aligned_cols=259  Identities=32%  Similarity=0.581  Sum_probs=215.7

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCC---CCccceeceeEEcCCCeEEEE
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD---SPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      .|++.+.||+|++|.||+|.+..+++.+++|.+...........+.+|+.+++.+.   |+|++++++++.. +...++|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-~~~~~lv   80 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK-GPRLWII   80 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-CCEEEEE
Confidence            57889999999999999999988999999999876655555677889999999986   9999999999886 6789999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          129 MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      |||+++++|.+++..+ .+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++ .++|+|||++..........
T Consensus        81 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06917          81 MEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG-NVKLCDFGVAALLNQNSSKR  158 (277)
T ss_pred             EecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC-CEEEccCCceeecCCCcccc
Confidence            9999999999998664 789999999999999999999999999999999999999987 89999999997765444333


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCC-CCChh
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPD-GASPE  287 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  287 (323)
                      ....++..|+|||.+..    ....+.++|+||||+++|+|++|..||......    ..........++.++. ..+.+
T Consensus       159 ~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~  230 (277)
T cd06917         159 STFVGTPYWMAPEVITE----GKYYDTKADIWSLGITIYEMATGNPPYSDVDAF----RAMMLIPKSKPPRLEDNGYSKL  230 (277)
T ss_pred             ccccCCcceeCHHHhcc----CCccccchhHHHHHHHHHHHHhCCCCCCCCChh----hhhhccccCCCCCCCcccCCHH
Confidence            44568889999998753    233456999999999999999999999654322    1111122222334443 37889


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCcccccCCCC
Q 020657          288 FRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS  321 (323)
Q Consensus       288 l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~  321 (323)
                      +.+++.+||+.||++|||+.+++.|+||++..+.
T Consensus       231 ~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~~  264 (277)
T cd06917         231 LREFVAACLDEEPKERLSAEELLKSKWIKAHSKT  264 (277)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHhhChHhhccccC
Confidence            9999999999999999999999999999887653

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.2e-44  Score=307.97  Aligned_cols=255  Identities=33%  Similarity=0.549  Sum_probs=212.2

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEe
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILME  130 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e  130 (323)
                      ++|++.+.||.|++|+||+|.+..++..+++|++...........+.+|+.+++.+.|+||+++++.+.. ....++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~e   79 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV-GDELWLVMP   79 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee-CCEEEEEEe
Confidence            4799999999999999999999888999999999765544466788999999999999999999999887 688999999


Q ss_pred             ccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccc
Q 020657          131 YMDSGTLDTLLNKN---GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA  207 (323)
Q Consensus       131 ~~~~~sL~~~l~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~  207 (323)
                      ++++++|.+.+...   ..+++..+..++.|++.||.+||+.|++|+||+|+||++++++ .++|+|||++.........
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~-~~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDG-SVKIADFGVSASLADGGDR  158 (267)
T ss_pred             ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC-CEEEcccchHHHhccCccc
Confidence            99999999999763   3589999999999999999999999999999999999999987 8999999999766543222


Q ss_pred             ----cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCC--
Q 020657          208 ----CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLP--  281 (323)
Q Consensus       208 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--  281 (323)
                          .....++..|++||.+...    ...+.++|+||||+++|+|++|+.||.............    ...+..+.  
T Consensus       159 ~~~~~~~~~~~~~y~~Pe~~~~~----~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~  230 (267)
T cd06610         159 TRKVRKTFVGTPCWMAPEVMEQV----HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTL----QNDPPSLETG  230 (267)
T ss_pred             cccccccccCChhhcChHHHccc----cCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHh----cCCCCCcCCc
Confidence                1334578899999988633    245679999999999999999999996443322222221    12222222  


Q ss_pred             ---CCCChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          282 ---DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       282 ---~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                         ..+++++.+++.+||+.||++|||++++++||||
T Consensus       231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             cccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence               3568899999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.5e-44  Score=310.69  Aligned_cols=254  Identities=31%  Similarity=0.538  Sum_probs=216.3

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ++|++.+.||+|++|.||+|.+..+++.+++|++....  .......+.+|+++++++.||||+++++++.. +...++|
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v   79 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD-DSNLYLV   79 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc-CCeEEEE
Confidence            47999999999999999999999899999999986432  23345678899999999999999999999987 6789999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          129 MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      |||+++++|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||++......   .
T Consensus        80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~-~~kl~dfg~~~~~~~~---~  155 (290)
T cd05580          80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG-YIKITDFGFAKRVKGR---T  155 (290)
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC-CEEEeeCCCccccCCC---C
Confidence            99999999999998888899999999999999999999999999999999999999987 8999999998765443   2


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhH
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEF  288 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (323)
                      ....++..|+|||.+...     ..+.++|+||||+++|+|++|..||....    .....+... .....++...+..+
T Consensus       156 ~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~-~~~~~~~~~~~~~l  225 (290)
T cd05580         156 YTLCGTPEYLAPEIILSK-----GYGKAVDWWALGILIYEMLAGYPPFFDDN----PIQIYEKIL-EGKVRFPSFFSPDA  225 (290)
T ss_pred             CCCCCCccccChhhhcCC-----CCCccccHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHh-cCCccCCccCCHHH
Confidence            344678899999987633     34568999999999999999999996543    222222222 33445667789999


Q ss_pred             HHHHHHhcccCcCCCC-----CHHHHhcCcccccCC
Q 020657          289 RSFIECCLQKEFSKRW-----TASQLLTHPFLCKNR  319 (323)
Q Consensus       289 ~~ll~~~l~~~p~~Rp-----t~~~~l~h~~f~~~~  319 (323)
                      .+++.+||+.||.+|+     +++++++||||....
T Consensus       226 ~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  261 (290)
T cd05580         226 KDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID  261 (290)
T ss_pred             HHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence            9999999999999999     999999999997643

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.9e-44  Score=311.47  Aligned_cols=263  Identities=41%  Similarity=0.709  Sum_probs=219.5

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEE
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      +..++|++.+.||+|++|+||+|.+..+++.+++|++...........+.+|+++++.++||||+++++.+.. ...+++
T Consensus         2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~l   80 (284)
T cd06620           2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN-ENNICM   80 (284)
T ss_pred             ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec-CCEEEE
Confidence            4568999999999999999999999888999999998766555667788999999999999999999999987 588999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc
Q 020657          128 LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG-HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD  206 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~  206 (323)
                      ||||+++++|.+++...+.+++..+..++.+++.+|.|||+ .|++|+||+|+||+++.++ .++|+|||++....... 
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~d~gl~~~~~~~~-  158 (284)
T cd06620          81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG-QIKLCDFGVSGELINSI-  158 (284)
T ss_pred             EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC-cEEEccCCcccchhhhc-
Confidence            99999999999999887789999999999999999999997 5999999999999999987 89999999986543221 


Q ss_pred             ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC-------ccHHHHHHHHhcCCCCC
Q 020657          207 ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQR-------PDWATLMCAICFGDPPS  279 (323)
Q Consensus       207 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~-------~~~~~~~~~~~~~~~~~  279 (323)
                       .....++..|+|||++...     ..+.++|+||||+++|+++||..||......       ..............++.
T Consensus       159 -~~~~~~~~~~~aPE~~~~~-----~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd06620         159 -ADTFVGTSTYMSPERIQGG-----KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPR  232 (284)
T ss_pred             -cCccccCcccCCHHHHccC-----CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCC
Confidence             2345688999999988633     4456999999999999999999999754332       11122333333333344


Q ss_pred             CCC-CCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          280 LPD-GASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       280 ~~~-~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      ++. .++.++.+|+.+||+.||.+|||++++++|+||....
T Consensus       233 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~  273 (284)
T cd06620         233 LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL  273 (284)
T ss_pred             CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            433 3788999999999999999999999999999996643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.9e-44  Score=311.99  Aligned_cols=258  Identities=28%  Similarity=0.518  Sum_probs=214.4

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ...+|++.+.||.|++|.||+|.+..+++.|++|.+..... .....+.+|+.+++.++|+||+++++.+.. ....++|
T Consensus        17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv   94 (296)
T cd06655          17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-PKKELIINEILVMKELKNPNIVNFLDSFLV-GDELFVV   94 (296)
T ss_pred             CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC-chHHHHHHHHHHHHhcCCCceeeeeeeEec-CceEEEE
Confidence            45679999999999999999999988999999999875433 335667899999999999999999999987 6789999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          129 MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      +||+.+++|..++... .+++..+..++.+++.||.+||+.|++|+||+|+||+++.++ .++|+|||++..........
T Consensus        95 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~-~~kl~dfg~~~~~~~~~~~~  172 (296)
T cd06655          95 MEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQSKR  172 (296)
T ss_pred             EEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEccCccchhcccccccC
Confidence            9999999999988654 689999999999999999999999999999999999999887 89999999987654433333


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcC-CCCCCCCCCChh
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFG-DPPSLPDGASPE  287 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  287 (323)
                      ....++..|+|||.+...     ..+.++|+||||+++|+|++|..||......   ..+....... .....+..++..
T Consensus       173 ~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slGvil~~lltg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  244 (296)
T cd06655         173 STMVGTPYWMAPEVVTRK-----AYGPKVDIWSLGIMAIEMVEGEPPYLNENPL---RALYLIATNGTPELQNPEKLSPI  244 (296)
T ss_pred             CCcCCCccccCcchhcCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhcCCcccCCcccCCHH
Confidence            345678899999988633     3456999999999999999999999654332   2221111111 122344678899


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          288 FRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       288 l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      +.+|+++||..||++|||+.++++||||+..
T Consensus       245 ~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~  275 (296)
T cd06655         245 FRDFLNRCLEMDVEKRGSAKELLQHPFLKLA  275 (296)
T ss_pred             HHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence            9999999999999999999999999999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2e-44  Score=311.50  Aligned_cols=266  Identities=30%  Similarity=0.442  Sum_probs=212.8

Q ss_pred             cchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceeceeEEc--
Q 020657           44 TTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFGIFEK--  120 (323)
Q Consensus        44 ~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--  120 (323)
                      .......++|++.+.||+|++|.||+|.+..+++.+++|++....  .....+.+|+.+++.+ +|+||+++++++..  
T Consensus        11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638          11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            344456789999999999999999999999899999999986432  2235677899999998 69999999998742  


Q ss_pred             --CCCeEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEee
Q 020657          121 --PSGDIAILMEYMDSGTLDTLLNK----NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIAD  194 (323)
Q Consensus       121 --~~~~~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~D  194 (323)
                        .++..++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .++|+|
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~-~~kl~d  167 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEG-GVKLVD  167 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCC-CEEEcc
Confidence              24578999999999999988752    34688999999999999999999999999999999999999987 899999


Q ss_pred             cCcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhc
Q 020657          195 FGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICF  274 (323)
Q Consensus       195 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~  274 (323)
                      ||++..............++..|+|||++.........++.++||||||+++|+|++|+.||......   ..+......
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~---~~~~~~~~~  244 (286)
T cd06638         168 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM---RALFKIPRN  244 (286)
T ss_pred             CCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh---HHHhhcccc
Confidence            99987654433333445688999999998644433445677999999999999999999999654322   111111111


Q ss_pred             C-CCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          275 G-DPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       275 ~-~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                      . .....+...+.++.+|+.+||+.||++|||+.++++|+||
T Consensus       245 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         245 PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            1 1112334567899999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.4e-45  Score=321.91  Aligned_cols=262  Identities=25%  Similarity=0.399  Sum_probs=207.4

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcCCCCccceeceeEEcC-----CC
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-PTVRRQVFREMEILRRTDSPFIVQCFGIFEKP-----SG  123 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~  123 (323)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++|+||+++++++...     ..
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN   93 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence            4789999999999999999999998999999999875432 23345677899999999999999999987542     13


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          124 DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      ..+++++++ +++|.+++.. ..+++..+..++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++.....
T Consensus        94 ~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~~  170 (343)
T cd07878          94 EVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC-ELRILDFGLARQADD  170 (343)
T ss_pred             cEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCC-CEEEcCCccceecCC
Confidence            478999998 5699888754 4699999999999999999999999999999999999999987 899999999976533


Q ss_pred             CccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcC--------
Q 020657          204 SLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFG--------  275 (323)
Q Consensus       204 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~--------  275 (323)
                      .   .....++..|+|||++.+    ...++.++||||||+++|+|++|..||...........+.......        
T Consensus       171 ~---~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07878         171 E---MTGYVATRWYRAPEIMLN----WMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI  243 (343)
T ss_pred             C---cCCccccccccCchHhcC----CccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            2   234568899999999853    2334569999999999999999999996543322222221110000        


Q ss_pred             ----------CCC--------CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCCC
Q 020657          276 ----------DPP--------SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS  321 (323)
Q Consensus       276 ----------~~~--------~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~  321 (323)
                                ..+        ......++.+.+|+.+||..||++|||+.++|+||||.+...+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~  307 (343)
T cd07878         244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP  307 (343)
T ss_pred             chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCC
Confidence                      000        0112456778999999999999999999999999999876543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.2e-44  Score=310.17  Aligned_cols=258  Identities=26%  Similarity=0.421  Sum_probs=213.0

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      .|+..+.||+|+||+||+|.+..+++.+|+|.+....  .......+.+|+.+++.++|++|+++.+.+.. ++..++||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~   79 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET-KDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec-CCEEEEEE
Confidence            3778899999999999999999999999999986442  12234456789999999999999999999887 67899999


Q ss_pred             eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccc
Q 020657          130 EYMDSGTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA  207 (323)
Q Consensus       130 e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~  207 (323)
                      ||+.+++|.+.+...  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++...... ..
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~-~~  157 (285)
T cd05632          80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG-HIRISDLGLAVKIPEG-ES  157 (285)
T ss_pred             EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCC-CEEEecCCcceecCCC-Cc
Confidence            999999999888643  3699999999999999999999999999999999999999887 8999999998654322 12


Q ss_pred             cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChh
Q 020657          208 CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPE  287 (323)
Q Consensus       208 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (323)
                      .....++..|+|||.+...     .++.++|+||||+++|+|++|..||...........+..... .....++..++.+
T Consensus       158 ~~~~~g~~~~~aPE~~~~~-----~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  231 (285)
T cd05632         158 IRGRVGTVGYMAPEVLNNQ-----RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVL-ETEEVYSAKFSEE  231 (285)
T ss_pred             ccCCCCCcCccChHHhcCC-----CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhh-ccccccCccCCHH
Confidence            2345688999999998633     345689999999999999999999976544333333333322 2234456778999


Q ss_pred             HHHHHHHhcccCcCCCCC-----HHHHhcCcccccC
Q 020657          288 FRSFIECCLQKEFSKRWT-----ASQLLTHPFLCKN  318 (323)
Q Consensus       288 l~~ll~~~l~~~p~~Rpt-----~~~~l~h~~f~~~  318 (323)
                      +.+|+..||+.||++|||     +++++.|+||+..
T Consensus       232 ~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05632         232 AKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM  267 (285)
T ss_pred             HHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence            999999999999999999     8999999999775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-45  Score=293.57  Aligned_cols=262  Identities=37%  Similarity=0.691  Sum_probs=220.3

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceeceeEEcCCCeEEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      +..+.+++..||.|..|+||+++.+.+|...|||......+.+..++++..+.++..- .+|+||+++|+|.. +...++
T Consensus        90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~-n~dV~I  168 (391)
T KOG0983|consen   90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT-NTDVFI  168 (391)
T ss_pred             ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee-CchHHH
Confidence            3445677899999999999999999999999999999888888899999999987765 48999999999987 566788


Q ss_pred             EEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc
Q 020657          128 LMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGH-KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL  205 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~-givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~  205 (323)
                      -||.|.. .++.++.+ .+++++..+-++...++.||.||..+ |++|||+||+|||+|+.| ++||||||.+.+.-++.
T Consensus       169 cMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G-niKlCDFGIsGrlvdSk  246 (391)
T KOG0983|consen  169 CMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-NIKLCDFGISGRLVDSK  246 (391)
T ss_pred             HHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC-CEEeecccccceeeccc
Confidence            8999854 66666654 45799999999999999999999976 999999999999999998 99999999998775543


Q ss_pred             cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCC--C
Q 020657          206 DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPD--G  283 (323)
Q Consensus       206 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~  283 (323)
                      . .....|.+.|+|||.+....  ...++.++||||||++++||.||+.||.+...  +++.+. ++....++.++.  +
T Consensus       247 A-htrsAGC~~YMaPERidp~~--~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t--dFe~lt-kvln~ePP~L~~~~g  320 (391)
T KOG0983|consen  247 A-HTRSAGCAAYMAPERIDPPD--KPKYDIRADVWSLGITLVELATGQYPYKGCKT--DFEVLT-KVLNEEPPLLPGHMG  320 (391)
T ss_pred             c-cccccCCccccCccccCCCC--CCccchhhhhhhhccchhhhhcccCCCCCCCc--cHHHHH-HHHhcCCCCCCcccC
Confidence            3 34457899999999998665  45567899999999999999999999966433  344443 333356666663  5


Q ss_pred             CChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          284 ASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       284 ~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      .|+++.+|+..||+.|+.+||.+.++|+|||+....
T Consensus       321 FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye  356 (391)
T KOG0983|consen  321 FSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE  356 (391)
T ss_pred             cCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence            799999999999999999999999999999986543

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=7.4e-44  Score=302.92  Aligned_cols=253  Identities=31%  Similarity=0.470  Sum_probs=212.7

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEe
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILME  130 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e  130 (323)
                      +|++.+.||+|++|.||+|.+..+++.+++|.+.... .......+.+|+.+++.++|+|++++++.+.. ++..++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE-DKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec-CCEEEEEEe
Confidence            5899999999999999999998899999999987542 33456778899999999999999999999886 678999999


Q ss_pred             ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          131 YMDSGTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       131 ~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      |+++++|.+++...  ..+++..+..++.+++.+|.+||++|++|+||+|+||+++.++..++|+|||.+........ .
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-~  158 (256)
T cd08220          80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK-A  158 (256)
T ss_pred             cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc-c
Confidence            99999999999753  35899999999999999999999999999999999999987655789999999976643322 2


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhH
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEF  288 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (323)
                      ....++..|+|||.+...     ..+.++||||||+++|+|++|..||.....    ..............++..++.++
T Consensus       159 ~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l  229 (256)
T cd08220         159 YTVVGTPCYISPELCEGK-----PYNQKSDIWALGCVLYELASLKRAFEAANL----PALVLKIMSGTFAPISDRYSPDL  229 (256)
T ss_pred             cccccCCcccCchhccCC-----CCCcccchHHHHHHHHHHHhCCCCcccCch----HHHHHHHHhcCCCCCCCCcCHHH
Confidence            234678899999998633     345699999999999999999999955432    22333333344455667789999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          289 RSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       289 ~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                      .+++.+||+.+|++|||++++++||||
T Consensus       230 ~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         230 RQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHHHHHHccCChhhCCCHHHHhhCCCC
Confidence            999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=5.1e-44  Score=305.84  Aligned_cols=256  Identities=32%  Similarity=0.477  Sum_probs=210.8

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC----ChHHHHHHHHHHHHHHcCCCCccceeceeEEcC-CCeE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA----DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP-SGDI  125 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~  125 (323)
                      .+|+..+.||+|++|.||+|.+..+++.|++|.+....    .......+.+|+.+++.++|+||+++++.+... ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            36889999999999999999998899999999986432    223455688899999999999999999988653 4578


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc
Q 020657          126 AILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL  205 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~  205 (323)
                      ++++||+++++|.+++.....+++..++.++.|++.||++||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~-~~~l~dfg~~~~~~~~~  160 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGASKRLQTIC  160 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEccCCCcccccccc
Confidence            89999999999999998877899999999999999999999999999999999999999887 89999999987543211


Q ss_pred             ---cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCC
Q 020657          206 ---DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPD  282 (323)
Q Consensus       206 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (323)
                         .......++..|+|||.+...     ..+.++|+||||+++|+|++|+.||....   ....+.........+.++.
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~i~~el~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~  232 (266)
T cd06651         161 MSGTGIRSVTGTPYWMSPEVISGE-----GYGRKADVWSLGCTVVEMLTEKPPWAEYE---AMAAIFKIATQPTNPQLPS  232 (266)
T ss_pred             ccCCccccCCccccccCHHHhCCC-----CCCchhhhHHHHHHHHHHHHCCCCccccc---hHHHHHHHhcCCCCCCCch
Confidence               111234578899999988633     34569999999999999999999996442   2233333333344556667


Q ss_pred             CCChhHHHHHHHhcccCcCCCCCHHHHhcCcccc
Q 020657          283 GASPEFRSFIECCLQKEFSKRWTASQLLTHPFLC  316 (323)
Q Consensus       283 ~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~  316 (323)
                      .+++.+.+++ +||..+|++|||++++++||||+
T Consensus       233 ~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         233 HISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             hcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            7889999999 67778999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=8.1e-44  Score=303.93  Aligned_cols=254  Identities=33%  Similarity=0.501  Sum_probs=217.0

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEc-CCCeEEEEE
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEK-PSGDIAILM  129 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~lv~  129 (323)
                      +|++...||.|++|.||+|.+..+++.+++|.+.... .......+.+|+.+++.++|+||+++++.+.. .....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            5889999999999999999999899999999987543 34456678899999999999999999998764 245689999


Q ss_pred             eccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----hCCCeecCCCCCCeEEecCCCcEEEeecCcchh
Q 020657          130 EYMDSGTLDTLLNK----NGTFSEPKLAHIASQILKGLSYLH-----GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       130 e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~Lh-----~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                      ||+++++|.+++..    ..++++..++.++.+|+.||.+||     +.+++|+||+|+||+++.++ .++|+|||++..
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~-~~kl~d~g~~~~  159 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN-NVKLGDFGLAKI  159 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC-CEEEeccccccc
Confidence            99999999999865    357899999999999999999999     88999999999999999987 899999999987


Q ss_pred             hccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCC
Q 020657          201 MCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSL  280 (323)
Q Consensus       201 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  280 (323)
                      ............++..|+|||.+...     ..+.++|+|+||+++|+|++|..||....    ...+.+.+.....+.+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~pE~~~~~-----~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~  230 (265)
T cd08217         160 LGHDSSFAKTYVGTPYYMSPEQLNHM-----SYDEKSDIWSLGCLIYELCALSPPFTARN----QLQLASKIKEGKFRRI  230 (265)
T ss_pred             ccCCcccccccccCCCccChhhhcCC-----CCCchhHHHHHHHHHHHHHHCCCcccCcC----HHHHHHHHhcCCCCCC
Confidence            65444323445688999999998633     35569999999999999999999996543    3445555555566677


Q ss_pred             CCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          281 PDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       281 ~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                      +...+.++.+++.+||+.+|++|||++++++|||+
T Consensus       231 ~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         231 PYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            78899999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-46  Score=328.99  Aligned_cols=264  Identities=31%  Similarity=0.515  Sum_probs=228.8

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      +.+.|.|++.||.|+||.||+|.++.++-..|.|++... +.+....+.-|+.+|..+.||+|+++++.|.. ++.++|+
T Consensus        30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk-seEELEDylVEIeILa~CdHP~ivkLl~ayy~-enkLwil  107 (1187)
T KOG0579|consen   30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK-SEEELEDYLVEIEILAECDHPVIVKLLSAYYF-ENKLWIL  107 (1187)
T ss_pred             HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc-chhHHhhhhhhhhhhhcCCChHHHHHHHHHhc-cCceEEE
Confidence            456789999999999999999999988888888988644 34556778899999999999999999999877 7889999


Q ss_pred             EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccc
Q 020657          129 MEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA  207 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~  207 (323)
                      .|+|.||-+..++-. +..+++.++.-+++|++.||.|||+++|+|||||+.|||++-+| .++|.|||.+.........
T Consensus       108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldG-dirLADFGVSAKn~~t~qk  186 (1187)
T KOG0579|consen  108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDG-DIRLADFGVSAKNKSTRQK  186 (1187)
T ss_pred             EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecC-cEeeecccccccchhHHhh
Confidence            999999999888754 66899999999999999999999999999999999999999998 8999999999766555555


Q ss_pred             cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCC--CCCCC
Q 020657          208 CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSL--PDGAS  285 (323)
Q Consensus       208 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  285 (323)
                      ...++||++|+|||+.....+...+|+.++||||||++|.||..+..|-..    -..-..+..+....++.+  |.+-+
T Consensus       187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe----lnpMRVllKiaKSePPTLlqPS~Ws  262 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE----LNPMRVLLKIAKSEPPTLLQPSHWS  262 (1187)
T ss_pred             hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc----cchHHHHHHHhhcCCCcccCcchhh
Confidence            678999999999999999999999999999999999999999999988732    222333333444445443  46778


Q ss_pred             hhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          286 PEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       286 ~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      ..+.|+++.||..||..||+++++|+||||++..
T Consensus       263 ~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~  296 (1187)
T KOG0579|consen  263 RSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP  296 (1187)
T ss_pred             hHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence            9999999999999999999999999999998754

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-44  Score=307.42  Aligned_cols=260  Identities=33%  Similarity=0.557  Sum_probs=213.4

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceeceeEEcC-----C
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKP-----S  122 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-----~  122 (323)
                      ..++|++.+.||+|++|.||+|.+..+++.+++|++....  .....+.+|+.+++++ .|+||+++++.+...     .
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE--DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            4589999999999999999999998889999999986553  2346788999999998 799999999998652     2


Q ss_pred             CeEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcc
Q 020657          123 GDIAILMEYMDSGTLDTLLNK----NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVS  198 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~  198 (323)
                      ..+++||||+++++|.+++..    +..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~-~~~l~d~~~~  160 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNA-EVKLVDFGVS  160 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCC-eEEECCCccc
Confidence            358999999999999998864    35789999999999999999999999999999999999999987 8999999998


Q ss_pred             hhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCC
Q 020657          199 KIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPP  278 (323)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~  278 (323)
                      ..............++..|+|||++.........++.++||||||+++|+|++|+.||......   ..+.+. .....+
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~-~~~~~~  236 (275)
T cd06608         161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM---RALFKI-PRNPPP  236 (275)
T ss_pred             eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH---HHHHHh-hccCCC
Confidence            7654443334456688899999998755544556678999999999999999999999643222   222221 112222


Q ss_pred             CC--CCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          279 SL--PDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       279 ~~--~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                      .+  +...+.++.+|+.+||..||++|||++++++|||+
T Consensus       237 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         237 TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            22  23467899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.2e-43  Score=301.85  Aligned_cols=253  Identities=30%  Similarity=0.425  Sum_probs=215.0

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEe
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILME  130 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e  130 (323)
                      +|+..+.||.|++|.||.+++..+++.+++|.+.... +......+.+|+.++++++|+||+++++++.+ .+..+++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-DNTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-CCeEEEEEE
Confidence            5899999999999999999999999999999986542 34556678899999999999999999999987 678999999


Q ss_pred             ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          131 YMDSGTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       131 ~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      |+++++|.+++...  ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++ .+||+|||.+..........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~-~~kl~d~~~~~~~~~~~~~~  158 (256)
T cd08221          80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAG-LIKLGDFGISKILGSEYSMA  158 (256)
T ss_pred             ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCC-CEEECcCcceEEcccccccc
Confidence            99999999999764  4689999999999999999999999999999999999999987 89999999997664443333


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhH
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEF  288 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (323)
                      ....++..|+|||.+.+.     ..+.++|+||||+++|+|++|..||....    ..........+.....+..++.++
T Consensus       159 ~~~~~~~~y~ape~~~~~-----~~~~~~Dv~slG~i~~~l~~g~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  229 (256)
T cd08221         159 ETVVGTPYYMSPELCQGV-----KYNFKSDIWALGCVLYELLTLKRTFDATN----PLNLVVKIVQGNYTPVVSVYSSEL  229 (256)
T ss_pred             cccCCCccccCHhhcCCC-----CCCCcchhHHHHHHHHHHHHCCCCCCCCC----HHHHHHHHHcCCCCCCccccCHHH
Confidence            455688999999987633     34568999999999999999999995432    233333333444455557789999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          289 RSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       289 ~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                      .+++.+||+.+|.+|||++++++|+|+
T Consensus       230 ~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         230 ISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHHHHHcccCcccCCCHHHHhhCcCC
Confidence            999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.4e-44  Score=311.78  Aligned_cols=259  Identities=28%  Similarity=0.526  Sum_probs=213.7

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ...+|++.+.||+|++|.||+|.+..+++.|++|.+...... ....+.+|+.+++.++|+||+++++.+.. ....++|
T Consensus        17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv   94 (297)
T cd06656          17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVV   94 (297)
T ss_pred             hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEe
Confidence            348899999999999999999999889999999999754433 34567889999999999999999999987 6789999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          129 MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      |||+++++|.+++.+. .+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++ .++|+|||++..........
T Consensus        95 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~-~~~l~Dfg~~~~~~~~~~~~  172 (297)
T cd06656          95 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKR  172 (297)
T ss_pred             ecccCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEECcCccceEccCCccCc
Confidence            9999999999998653 589999999999999999999999999999999999999887 89999999987654433333


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC-CCCCCCCCChh
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD-PPSLPDGASPE  287 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  287 (323)
                      ....++..|+|||.+..     ...+.++|+||||+++|++++|..||.......   .+......+. ....+..++..
T Consensus       173 ~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  244 (297)
T cd06656         173 STMVGTPYWMAPEVVTR-----KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---ALYLIATNGTPELQNPERLSAV  244 (297)
T ss_pred             CcccCCccccCHHHHcC-----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch---heeeeccCCCCCCCCccccCHH
Confidence            34567889999998863     334569999999999999999999996543221   1111111111 12234567889


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          288 FRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       288 l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      +.+|+.+||..+|++|||++++++||||...+
T Consensus       245 ~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (297)
T cd06656         245 FRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK  276 (297)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence            99999999999999999999999999997654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.6e-44  Score=312.16  Aligned_cols=259  Identities=29%  Similarity=0.458  Sum_probs=210.0

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      ++|++.+.||+|++|.||+|.+..+++.+++|++..... ....+.+.+|+++++.++||||+++++++.. .+..++|+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~   79 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR-KKRLYLVF   79 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc-CCeEEEEE
Confidence            478999999999999999999988899999999865432 2345677899999999999999999999987 77899999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccc
Q 020657          130 EYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN  209 (323)
Q Consensus       130 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~  209 (323)
                      ||+++++|..+......+++..+..++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++...........
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~-~~~l~dfg~~~~~~~~~~~~~  158 (286)
T cd07846          80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSG-VVKLCDFGFARTLAAPGEVYT  158 (286)
T ss_pred             ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-cEEEEeeeeeeeccCCccccC
Confidence            9999999998887766799999999999999999999999999999999999999987 899999999876544433334


Q ss_pred             cccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhc---------------
Q 020657          210 SYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICF---------------  274 (323)
Q Consensus       210 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~---------------  274 (323)
                      ...++..|+|||++.+.    ...+.++||||||+++|+|++|..||...........+......               
T Consensus       159 ~~~~~~~y~aPE~~~~~----~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07846         159 DYVATRWYRAPELLVGD----TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF  234 (286)
T ss_pred             cccceeeccCcHHhccc----cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence            45678899999987532    23456899999999999999999998654322211111110000               


Q ss_pred             --CCCC---------CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          275 --GDPP---------SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       275 --~~~~---------~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                        ...+         .....++..+.+|+.+||+.+|++|||+.++++|+||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence              0000         0123568899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.3e-44  Score=311.40  Aligned_cols=255  Identities=35%  Similarity=0.586  Sum_probs=214.4

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEe
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILME  130 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e  130 (323)
                      +.|++.+.||+|++|.||+|.+..+++.|++|.+...........+.+|+.++++++|+||+++++.+.. ....++|||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e   82 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK-GTKLWIIME   82 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccccc-CCceEEEEE
Confidence            5688889999999999999999888999999998755545566788999999999999999999999987 678999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccccc
Q 020657          131 YMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNS  210 (323)
Q Consensus       131 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~  210 (323)
                      |+++++|.+++.. ..+++..+..++.+++.|+.|||+.|++|+||+|+||+++.++ .++|+|||++............
T Consensus        83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06642          83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCC-CEEEccccccccccCcchhhhc
Confidence            9999999998865 4689999999999999999999999999999999999999987 8999999998765443322333


Q ss_pred             ccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHH
Q 020657          211 YVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS  290 (323)
Q Consensus       211 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  290 (323)
                      ..++..|+|||.+...     ..+.++|+||||+++|+|++|..||.....    ...........++.+...++.++.+
T Consensus       161 ~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~il~el~tg~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~  231 (277)
T cd06642         161 FVGTPFWMAPEVIKQS-----AYDFKADIWSLGITAIELAKGEPPNSDLHP----MRVLFLIPKNSPPTLEGQYSKPFKE  231 (277)
T ss_pred             ccCcccccCHHHhCcC-----CCchhhhHHHHHHHHHHHHhCCCCCcccch----hhHHhhhhcCCCCCCCcccCHHHHH
Confidence            4578899999998633     345699999999999999999999854322    1222223333445555678899999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          291 FIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       291 ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                      ++.+||+.+|++|||+.++++|+||.+
T Consensus       232 li~~~l~~~p~~Rp~~~~il~~~~~~~  258 (277)
T cd06642         232 FVEACLNKDPRFRPTAKELLKHKFITR  258 (277)
T ss_pred             HHHHHccCCcccCcCHHHHHHhHHHHH
Confidence            999999999999999999999999974

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=7.6e-44  Score=304.79  Aligned_cols=253  Identities=22%  Similarity=0.325  Sum_probs=208.7

Q ss_pred             ccccccceeeeecccCCeEEEEEEec---ccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCe
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHR---CTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGD  124 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  124 (323)
                      +...+|++.+.||+|+||.||+|.+.   ..+..|++|.+...........+.+|+.+++.++||||+++++++.. .+.
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~   80 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR-GNT   80 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-CCC
Confidence            56688999999999999999999865   35668999999876665666788999999999999999999999987 678


Q ss_pred             EEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          125 IAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      .++||||+++++|.+++... ..+++..++.++.||+.||+|||+.|++|+||+|+||+++.++ .++++|||.+.....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~-~~~l~dfg~~~~~~~  159 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL-VCKISGFRRLQEDKS  159 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCC-cEEECCCcccccccc
Confidence            99999999999999998763 4789999999999999999999999999999999999999987 899999998755322


Q ss_pred             Ccc-ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCC
Q 020657          204 SLD-ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLP  281 (323)
Q Consensus       204 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (323)
                      ... ......++..|+|||.+..     ..++.++||||||+++|++++ |..||.....    ..+...+..+.....+
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~----~~~~~~~~~~~~~~~~  230 (266)
T cd05064         160 EAIYTTMSGKSPVLWAAPEAIQY-----HHFSSASDVWSFGIVMWEVMSYGERPYWDMSG----QDVIKAVEDGFRLPAP  230 (266)
T ss_pred             cchhcccCCCCceeecCHHHHhh-----CCccchhHHHHHHHHHHHHhcCCCCCcCcCCH----HHHHHHHHCCCCCCCC
Confidence            211 1112234568999998863     344569999999999999874 9999965433    2333344444455567


Q ss_pred             CCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          282 DGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       282 ~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ..++..+.+++.+||+.+|.+|||+++|++
T Consensus       231 ~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         231 RNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             CCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence            788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=6.8e-44  Score=303.13  Aligned_cols=250  Identities=30%  Similarity=0.497  Sum_probs=213.1

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEec
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEY  131 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~  131 (323)
                      +|++.+.||+|++|.||++.+..+++.+++|.+.........+.+.+|+.+++.++|+||+++++.+.. ++.++++|||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~   79 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA-DGHLYIVMEY   79 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEE-CCEEEEEEee
Confidence            588999999999999999999999999999998765555566778899999999999999999999987 6889999999


Q ss_pred             cCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccc
Q 020657          132 MDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN  209 (323)
Q Consensus       132 ~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~  209 (323)
                      +++++|.+.+..  ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+...........
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~~~~~~~~  158 (255)
T cd08219          80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNG-KVKLGDFGSARLLTSPGAYAC  158 (255)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCC-cEEEcccCcceeecccccccc
Confidence            999999998864  34589999999999999999999999999999999999999887 899999999876544333333


Q ss_pred             cccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHH
Q 020657          210 SYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFR  289 (323)
Q Consensus       210 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  289 (323)
                      ...++..|+|||++...     ..+.++|+||||+++|+|++|..||...    ...........+....++..++..+.
T Consensus       159 ~~~~~~~~~aPE~~~~~-----~~~~~~Dv~slG~i~~~l~~g~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (255)
T cd08219         159 TYVGTPYYVPPEIWENM-----PYNNKSDIWSLGCILYELCTLKHPFQAN----SWKNLILKVCQGSYKPLPSHYSYELR  229 (255)
T ss_pred             cccCCccccCHHHHccC-----CcCchhhhhhhchhheehhhccCCCCCC----CHHHHHHHHhcCCCCCCCcccCHHHH
Confidence            45678899999998643     3456999999999999999999999543    33344444444555666778899999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcC
Q 020657          290 SFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       290 ~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      +|+++||+.||++|||+.++++-
T Consensus       230 ~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         230 SLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHHHHhCCcccCCCHHHHhhc
Confidence            99999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.3e-44  Score=318.05  Aligned_cols=253  Identities=23%  Similarity=0.348  Sum_probs=197.8

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ...+|++.+.||+|+||.||+|.+..+++.|++|+.....       ...|+.+++.++|+||+++++++.. ....++|
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~-------~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv  135 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT-------TLIEAMLLQNVNHPSVIRMKDTLVS-GAITCMV  135 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc-------cHHHHHHHHhCCCCCCcChhheEEe-CCeeEEE
Confidence            3457999999999999999999999899999999854322       2468999999999999999999987 6788999


Q ss_pred             EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccc
Q 020657          129 MEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA  207 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~  207 (323)
                      +|++.+ +|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+||+++.++ .++|+|||++...... ..
T Consensus       136 ~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~-~~  212 (357)
T PHA03209        136 LPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVD-QVCIGDLGAAQFPVVA-PA  212 (357)
T ss_pred             EEccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEecCccccccccC-cc
Confidence            999965 77777754 56799999999999999999999999999999999999999987 8999999998643221 22


Q ss_pred             cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCc-c------HHHHHHHHh--cCCCC
Q 020657          208 CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRP-D------WATLMCAIC--FGDPP  278 (323)
Q Consensus       208 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~-~------~~~~~~~~~--~~~~~  278 (323)
                      .....++..|+|||++.+..     ++.++||||||+++|||+++..++....... .      ...+...+.  ...+.
T Consensus       213 ~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  287 (357)
T PHA03209        213 FLGLAGTVETNAPEVLARDK-----YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE  287 (357)
T ss_pred             cccccccccccCCeecCCCC-----CCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh
Confidence            23456889999999987443     4569999999999999998655543321111 0      001111000  00001


Q ss_pred             CCC------------------------------CCCChhHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          279 SLP------------------------------DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       279 ~~~------------------------------~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                      .++                              ..++.++.+||.+||+.||++|||++|+|+||||++
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        288 EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             hcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence            111                              245678888999999999999999999999999986

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=5.6e-44  Score=308.29  Aligned_cols=254  Identities=27%  Similarity=0.427  Sum_probs=212.1

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccC-----cEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTH-----KIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS  122 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  122 (323)
                      +...+|++.+.||+|++|.||+|.+...+     ..|++|.+...........+.+|+.+++.++||||+++++++.. .
T Consensus         2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-~   80 (283)
T cd05048           2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK-E   80 (283)
T ss_pred             CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC-C
Confidence            45678999999999999999999976544     67999998766666667788999999999999999999999886 6


Q ss_pred             CeEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecC
Q 020657          123 GDIAILMEYMDSGTLDTLLNKN----------------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNN  186 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~  186 (323)
                      +..+++|||+++++|.+++...                ..+++..+..++.|++.||.|||+.|++|+||||+||+++.+
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG  160 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence            7899999999999999999753                457889999999999999999999999999999999999998


Q ss_pred             CCcEEEeecCcchhhccCc--cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 020657          187 NMQVKIADFGVSKIMCRSL--DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRP  263 (323)
Q Consensus       187 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~  263 (323)
                      + .++|+|||++.......  .......++..|+|||.+...     ..+.++||||||+++|||++ |..||.+...  
T Consensus       161 ~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~sDv~slG~il~el~~~g~~p~~~~~~--  232 (283)
T cd05048         161 L-TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-----KFTTESDIWSFGVVLWEIFSYGLQPYYGFSN--  232 (283)
T ss_pred             C-cEEECCCcceeeccccccccccCCCcccccccCHHHhccC-----cCchhhhHHHHHHHHHHHHcCCCCCCCCCCH--
Confidence            7 89999999986543221  122334567889999988633     34569999999999999998 9999965433  


Q ss_pred             cHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          264 DWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                        ..+...+........+..++.++.+|+++||+.||++|||+.+++++
T Consensus       233 --~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         233 --QEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             --HHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence              33444444455556677899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.4e-44  Score=304.97  Aligned_cols=254  Identities=37%  Similarity=0.587  Sum_probs=210.8

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      .++|++.+.||+|++|.||+|.+..+++.+++|.+....   ....+.+|+.+++.++|+||+++++.+.. ....++++
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~l~~   77 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE---DLQEIIKEISILKQCDSPYIVKYYGSYFK-NTDLWIVM   77 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH---HHHHHHHHHHHHHhCCCCcEeeeeeeeec-CCcEEEEE
Confidence            478999999999999999999998888999999986442   26778899999999999999999999987 67899999


Q ss_pred             eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          130 EYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       130 e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      ||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++..........
T Consensus        78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~-~~~l~dfg~~~~~~~~~~~~  156 (256)
T cd06612          78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEG-QAKLADFGVSGQLTDTMAKR  156 (256)
T ss_pred             ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCC-cEEEcccccchhcccCcccc
Confidence            99999999999875 45789999999999999999999999999999999999999987 89999999997765443333


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhH
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEF  288 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (323)
                      ....++..|+|||++.+.     ..+.++||||||+++|+|++|..||.............  .........+..++.++
T Consensus       157 ~~~~~~~~y~~PE~~~~~-----~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  229 (256)
T cd06612         157 NTVIGTPFWMAPEVIQEI-----GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP--NKPPPTLSDPEKWSPEF  229 (256)
T ss_pred             ccccCCccccCHHHHhcC-----CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc--cCCCCCCCchhhcCHHH
Confidence            445578899999998643     34569999999999999999999996543221111110  00111112334578899


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          289 RSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       289 ~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                      .+++.+||+.||++|||+.++|+||||
T Consensus       230 ~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         230 NDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.1e-43  Score=301.55  Aligned_cols=257  Identities=34%  Similarity=0.602  Sum_probs=215.2

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEe
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILME  130 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e  130 (323)
                      +|++.+.||+|++|.||+|.+..+++.+++|.+..... ......+.+|+.+++.++|+||+++++.+.. .+..++|+|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH-REKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec-CCEEEEEEe
Confidence            68999999999999999999988899999999876543 3467788999999999999999999999876 678999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccc---
Q 020657          131 YMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA---  207 (323)
Q Consensus       131 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~---  207 (323)
                      |+.+++|.+++.....+++..+..++.+++.||.+||+.|++|+||+|+||+++.++ .++|+|||++.........   
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~-~~kl~d~g~~~~~~~~~~~~~~  158 (264)
T cd06626          80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNG-VIKLGDFGCAVKLKNNTTTMGE  158 (264)
T ss_pred             cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEcccccccccCCCCCcccc
Confidence            999999999998877789999999999999999999999999999999999999987 8999999999776433222   


Q ss_pred             -cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCC--C
Q 020657          208 -CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDG--A  284 (323)
Q Consensus       208 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~  284 (323)
                       .....++..|+|||++....  ....+.++|||+||+++|++++|..||......   ............+.++..  +
T Consensus       159 ~~~~~~~~~~~~~PE~~~~~~--~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~  233 (264)
T cd06626         159 EVQSLAGTPAYMAPEVITGGK--GKGHGRAADIWSLGCVVLEMATGKRPWSELDNE---FQIMFHVGAGHKPPIPDSLQL  233 (264)
T ss_pred             cccCCcCCcCccChhhccCCC--CCCCCcccchHHHHHHHHHHHhCCCCccCCcch---HHHHHHHhcCCCCCCCccccc
Confidence             12345778999999986433  223567999999999999999999999654322   222222333444455544  4


Q ss_pred             ChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       285 ~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                      +..+.+++++||+.+|.+|||+++++.|||+
T Consensus       234 ~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         234 SPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             CHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            8999999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=6e-44  Score=309.38  Aligned_cols=259  Identities=25%  Similarity=0.409  Sum_probs=204.3

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      .++|++.+.||+|++|.||+|.+..+++.|++|.+...........+.+|+.+++.++|+||+++++++.+ +...++||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~   82 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHT-KKTLTLVF   82 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEec-CCeEEEEE
Confidence            47899999999999999999999888999999998755433333456789999999999999999999987 67899999


Q ss_pred             eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          130 EYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       130 e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      ||+.+ +|.+++... ..+++..+..++.|+++||.|||+.|++|+||+|+||+++.++ .++|+|||++..........
T Consensus        83 e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~  160 (291)
T cd07844          83 EYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERG-ELKLADFGLARAKSVPSKTY  160 (291)
T ss_pred             ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCC-CEEECccccccccCCCCccc
Confidence            99985 899888653 4689999999999999999999999999999999999999987 89999999986543322222


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCcc-HHHHHHHHhcCC-----------
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPD-WATLMCAICFGD-----------  276 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~-~~~~~~~~~~~~-----------  276 (323)
                      ....++..|+|||++.+    ....+.++||||+|+++|+|++|..||........ ...+........           
T Consensus       161 ~~~~~~~~~~aPE~~~~----~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07844         161 SNEVVTLWYRPPDVLLG----STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP  236 (291)
T ss_pred             cccccccccCCcHHhhc----CcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence            33346788999998752    22345699999999999999999999965432111 111110000000           


Q ss_pred             -----------CC---CCCCCCC--hhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          277 -----------PP---SLPDGAS--PEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       277 -----------~~---~~~~~~~--~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                                 ..   .....++  .++.+++.+||+.+|++|||+.++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                       00   0001234  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4.6e-44  Score=312.71  Aligned_cols=267  Identities=27%  Similarity=0.362  Sum_probs=211.3

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcCCCCccceeceeEEcCC-CeEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS-GDIA  126 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~  126 (323)
                      ..++|++.+.||+|++|.||+|.+..+++.|++|++..... ......+.+|+.+++.++|+||+++++++.... +..+
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            56899999999999999999999998999999999875432 222334568999999999999999999987533 5689


Q ss_pred             EEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc
Q 020657          127 ILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL  205 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~  205 (323)
                      +||||+.+ +|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus        85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG-CLKIADFGLARTYGLPA  162 (309)
T ss_pred             EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECccceeeecCCcc
Confidence            99999975 88888865 35789999999999999999999999999999999999999987 89999999997765433


Q ss_pred             cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC---------
Q 020657          206 DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD---------  276 (323)
Q Consensus       206 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~---------  276 (323)
                      .......++..|+|||.+.+    ....+.++||||||+++|+|++|..||...+.......+........         
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07845         163 KPMTPKVVTLWYRAPELLLG----CTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD  238 (309)
T ss_pred             CCCCcccccccccChhhhcC----CCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence            33333445778999998753    23345699999999999999999999965543332222222111000         


Q ss_pred             -----CCCC-----------CCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCCC
Q 020657          277 -----PPSL-----------PDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS  321 (323)
Q Consensus       277 -----~~~~-----------~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~  321 (323)
                           ...+           ....++++.+||.+||++||++|||+++++.||||++..-+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~  299 (309)
T cd07845         239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP  299 (309)
T ss_pred             ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence                 0000           12357889999999999999999999999999999876554

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=8.9e-44  Score=303.62  Aligned_cols=252  Identities=29%  Similarity=0.445  Sum_probs=211.6

Q ss_pred             ecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEeccCCCC
Q 020657           59 LGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGT  136 (323)
Q Consensus        59 lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~s  136 (323)
                      ||.|++|.||+|.+..+++.+++|++....  .......+.+|+.+++.++|+||+++++.+.+ +...++++||+++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~   79 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD-KKYIYMLMEYCLGGE   79 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc-CCccEEEEecCCCCc
Confidence            689999999999998889999999997543  23455778999999999999999999999887 678999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccccccccccc
Q 020657          137 LDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA  216 (323)
Q Consensus       137 L~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~  216 (323)
                      |.+++.+...+++..+..++.||+.||.+||+.|++|+||+|+||+++.++ .++|+|||.+....... ......++..
T Consensus        80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~-~~~l~df~~~~~~~~~~-~~~~~~~~~~  157 (262)
T cd05572          80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNG-YVKLVDFGFAKKLKSGQ-KTWTFCGTPE  157 (262)
T ss_pred             HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCC-CEEEeeCCcccccCccc-ccccccCCcC
Confidence            999998877899999999999999999999999999999999999999987 89999999997664432 2233467889


Q ss_pred             ccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhc
Q 020657          217 YMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCL  296 (323)
Q Consensus       217 y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l  296 (323)
                      |++||.+..     ...+.++|+|+||+++|+|++|..||..... .................++...+.++.+++.+||
T Consensus       158 ~~~PE~~~~-----~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  231 (262)
T cd05572         158 YVAPEIILN-----KGYDFSVDYWSLGILLYELLTGRPPFGEDDE-DPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLL  231 (262)
T ss_pred             ccChhHhcC-----CCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-CHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHc
Confidence            999998753     3345699999999999999999999965543 1222222222224455666777999999999999


Q ss_pred             ccCcCCCCC-----HHHHhcCcccccCC
Q 020657          297 QKEFSKRWT-----ASQLLTHPFLCKNR  319 (323)
Q Consensus       297 ~~~p~~Rpt-----~~~~l~h~~f~~~~  319 (323)
                      +.+|++||+     ++++++||||++..
T Consensus       232 ~~~p~~R~~~~~~~~~~l~~~~~~~~~~  259 (262)
T cd05572         232 RRNPEERLGNLKGGIKDIKKHKWFNGFD  259 (262)
T ss_pred             cCChhhCcCCcccCHHHHhcChhhhCCC
Confidence            999999999     99999999998753

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=4.3e-44  Score=315.31  Aligned_cols=260  Identities=24%  Similarity=0.334  Sum_probs=202.8

Q ss_pred             eeeeeccc--CCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEec
Q 020657           55 KLQVLGHG--NGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEY  131 (323)
Q Consensus        55 ~~~~lg~G--~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~  131 (323)
                      +++.||+|  ++++||++.+..+|+.||+|.+.... .......+.+|+.+++.++||||+++++++.. ++..++||||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~   80 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-DNELWVVTSF   80 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE-CCEEEEEEec
Confidence            56789999  67899999999999999999997553 33455677889999999999999999999987 6789999999


Q ss_pred             cCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc---
Q 020657          132 MDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD---  206 (323)
Q Consensus       132 ~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~---  206 (323)
                      +++++|.+++..  ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++ .++++||+.+........   
T Consensus        81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~-~~~l~~~~~~~~~~~~~~~~~  159 (327)
T cd08227          81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG-KVYLSGLRSNLSMINHGQRLR  159 (327)
T ss_pred             cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCC-cEEEcccchhhcccccccccc
Confidence            999999999864  34589999999999999999999999999999999999999987 899999986543321111   


Q ss_pred             ----ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhc--------
Q 020657          207 ----ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICF--------  274 (323)
Q Consensus       207 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~--------  274 (323)
                          ......++..|+|||++....   ..++.++||||||+++|+|++|..||..................        
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         160 VVHDFPKYSVKVLPWLSPEVLQQNL---QGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             ccccccccccceecccChHHhhccc---CCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence                112234567899999986321   23467999999999999999999999653322111111000000        


Q ss_pred             ---------------------------------CCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          275 ---------------------------------GDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       275 ---------------------------------~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                                                       .........+++++.+|+++||++||++|||++++++||||++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence                                             000011224567899999999999999999999999999998754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.1e-43  Score=306.41  Aligned_cols=263  Identities=37%  Similarity=0.643  Sum_probs=210.2

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHH-HHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEI-LRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.+...........+..|+.. ++.+.|+||+++++++.. ++..+++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-~~~~~lv~   79 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR-EGDVWICM   79 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec-CCcEEEEh
Confidence            4799999999999999999999999999999999766443444556666665 566789999999999987 67899999


Q ss_pred             eccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCCeEEecCCCcEEEeecCcchhhccC
Q 020657          130 EYMDSGTLDTLLNK----NGTFSEPKLAHIASQILKGLSYLHGH-KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS  204 (323)
Q Consensus       130 e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~-givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~  204 (323)
                      ||++ ++|.+++..    ...+++..++.++.||+.||.|||+. +++|+||+|+||+++.++ .+||+|||++......
T Consensus        80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~  157 (283)
T cd06617          80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG-QVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEEEeecccccccccc
Confidence            9997 488877753    34689999999999999999999997 999999999999999987 8999999998765332


Q ss_pred             ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCC-CC
Q 020657          205 LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLP-DG  283 (323)
Q Consensus       205 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  283 (323)
                      . ......++..|+|||.+.+... ...++.++|+|+||+++|+|++|+.||.....  ....+..... ...+.++ ..
T Consensus       158 ~-~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~-~~~~~~~~~~  232 (283)
T cd06617         158 V-AKTIDAGCKPYMAPERINPELN-QKGYDVKSDVWSLGITMIELATGRFPYDSWKT--PFQQLKQVVE-EPSPQLPAEK  232 (283)
T ss_pred             c-ccccccCCccccChhhcCCccc-ccccCccccchhhHHHHHHHHhCCCCCCcccc--CHHHHHHHHh-cCCCCCCccc
Confidence            1 1123457788999998864322 23456799999999999999999999954322  2233333222 2233333 45


Q ss_pred             CChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCCC
Q 020657          284 ASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS  321 (323)
Q Consensus       284 ~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~  321 (323)
                      ++.++.+++.+||..+|.+|||++++++||||.+..++
T Consensus       233 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  270 (283)
T cd06617         233 FSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSK  270 (283)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence            78999999999999999999999999999999988765

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.1e-43  Score=305.46  Aligned_cols=256  Identities=35%  Similarity=0.577  Sum_probs=215.0

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEe
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILME  130 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e  130 (323)
                      +-|++.+.||.|+||.||+|.+..+++.+++|++...........+.+|+.+++++.|+||+++++.+.. +...++|||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e   82 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-DTKLWIIME   82 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe-CCeEEEEEE
Confidence            4578899999999999999999888999999998755444556778899999999999999999999987 678999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccccc
Q 020657          131 YMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNS  210 (323)
Q Consensus       131 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~  210 (323)
                      |+++++|.+++... .+++..+..++.+++.++.+||+.|++|+||+|+||+++.++ .++|+|||++............
T Consensus        83 ~~~~~~l~~~i~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~-~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06641          83 YLGGGSALDLLEPG-PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             eCCCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCC-CEEEeecccceecccchhhhcc
Confidence            99999999988654 689999999999999999999999999999999999999987 8999999998655433222334


Q ss_pred             ccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHH
Q 020657          211 YVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS  290 (323)
Q Consensus       211 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  290 (323)
                      ..++..|+|||.+...     ..+.++|+||||+++|+|++|..||.....    ......+.....+.+...++.++.+
T Consensus       161 ~~~~~~y~~PE~~~~~-----~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~  231 (277)
T cd06641         161 FVGTPFWMAPEVIKQS-----AYDSKADIWSLGITAIELAKGEPPHSELHP----MKVLFLIPKNNPPTLEGNYSKPLKE  231 (277)
T ss_pred             ccCCccccChhhhccC-----CCCchhhHHHHHHHHHHHHcCCCCCCccch----HHHHHHHhcCCCCCCCcccCHHHHH
Confidence            4678889999988633     345689999999999999999999954322    2233333334455566778999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          291 FIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       291 ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      ++.+||..+|.+||++.++++||||.+.
T Consensus       232 ~i~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         232 FVEACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             HHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence            9999999999999999999999999763

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.7e-43  Score=302.40  Aligned_cols=253  Identities=32%  Similarity=0.516  Sum_probs=209.7

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-----hHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEE
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-----PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIA  126 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  126 (323)
                      +|++.+.||+|+||.||+|.+. +++.+++|.+.....     ......+.+|+.+++.++|+||+++++++.+ .+..+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~   78 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD-DNTIS   78 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec-CCeEE
Confidence            5888999999999999999875 788999998864421     2234568889999999999999999999987 68899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC--
Q 020657          127 ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS--  204 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~--  204 (323)
                      +|+||+++++|.+++.+...+++..+..++.|++.+|++||+.|++|+||+|+||+++.++ .++|+|||++......  
T Consensus        79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~  157 (265)
T cd06631          79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG-IIKLIDFGCARRLAWVGL  157 (265)
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCC-eEEeccchhhHhhhhccc
Confidence            9999999999999998877899999999999999999999999999999999999999887 8999999998764321  


Q ss_pred             ----ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHH-hcCCCCC
Q 020657          205 ----LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAI-CFGDPPS  279 (323)
Q Consensus       205 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~  279 (323)
                          ........++..|+|||++...     ..+.++|+|+||+++|+|++|..||.......   ...... .....+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~pe~~~~~-----~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~  229 (265)
T cd06631         158 HGTHSNMLKSMHGTPYWMAPEVINES-----GYGRKSDIWSIGCTVFEMATGKPPLASMDRLA---AMFYIGAHRGLMPR  229 (265)
T ss_pred             cccccccccccCCCccccChhhhcCC-----CCcchhhHHHHHHHHHHHHhCCCccccCChHH---HHHHhhhccCCCCC
Confidence                1112334578899999998643     34569999999999999999999996543222   221111 1123345


Q ss_pred             CCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          280 LPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       280 ~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                      .+..++.++.+++++||+.+|++|||+.++++||||
T Consensus       230 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         230 LPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            667889999999999999999999999999999998

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=5.2e-44  Score=308.63  Aligned_cols=257  Identities=26%  Similarity=0.458  Sum_probs=206.4

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEe
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILME  130 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e  130 (323)
                      +|++.+.||.|++|.||+|.+..+++.|++|.+..... ......+.+|++++++++||||+++++++.+ ....++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-ENKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc-CCcEEEEee
Confidence            48899999999999999999988999999999865432 2334578899999999999999999999887 678999999


Q ss_pred             ccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          131 YMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       131 ~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      |+. ++|..++..  ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||++..........
T Consensus        80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~-~~~l~dfg~~~~~~~~~~~~  157 (284)
T cd07860          80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTY  157 (284)
T ss_pred             ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEeeccchhhcccCcccc
Confidence            996 588888864  34689999999999999999999999999999999999999987 89999999987654433333


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC------------
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD------------  276 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~------------  276 (323)
                      ....++..|+|||.+.+.    ...+.++||||||+++|+|+||..||...........+........            
T Consensus       158 ~~~~~~~~y~aPE~~~~~----~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07860         158 THEVVTLWYRAPEILLGC----KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD  233 (284)
T ss_pred             ccccccccccCCeEEecC----CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence            344567889999987532    2345689999999999999999999965543222222211111000            


Q ss_pred             ------------CCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          277 ------------PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       277 ------------~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                                  ...+...++.++.++|.+||+.||.+|||++++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                        001123467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=6.7e-44  Score=314.88  Aligned_cols=258  Identities=25%  Similarity=0.391  Sum_probs=210.4

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecc-----cCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceeceeEE
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRC-----THKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFGIFE  119 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~  119 (323)
                      |.++.++|++.+.||+|+||.||+|.+..     +++.|++|++...........+.+|+.+++++ .|+||+++++++.
T Consensus         2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~   81 (337)
T cd05054           2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT   81 (337)
T ss_pred             cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence            67788999999999999999999997533     45789999997655445556778899999999 7999999999987


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHhc-------------------------------------------------------
Q 020657          120 KPSGDIAILMEYMDSGTLDTLLNKN-------------------------------------------------------  144 (323)
Q Consensus       120 ~~~~~~~lv~e~~~~~sL~~~l~~~-------------------------------------------------------  144 (323)
                      ..+..+++++||+++++|.+++...                                                       
T Consensus        82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence            7677899999999999999988532                                                       


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc--cccccccccc
Q 020657          145 ------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD--ACNSYVGTCA  216 (323)
Q Consensus       145 ------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~  216 (323)
                            .++++..+..++.||+.||.|||+.||+||||||.||+++.++ .++|+|||++........  ......++..
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~-~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC-cEEEeccccchhcccCcchhhccCCCCCcc
Confidence                  2578999999999999999999999999999999999999987 899999999976532211  1223345678


Q ss_pred             ccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHh
Q 020657          217 YMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECC  295 (323)
Q Consensus       217 y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~  295 (323)
                      |+|||++..     ..++.++||||||+++|+|++ |..||.+......   +............+...++++.+++.+|
T Consensus       241 y~aPE~~~~-----~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~~c  312 (337)
T cd05054         241 WMAPESIFD-----KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE---FCRRLKEGTRMRAPEYATPEIYSIMLDC  312 (337)
T ss_pred             ccCcHHhcC-----CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH---HHHHHhccCCCCCCccCCHHHHHHHHHH
Confidence            999998863     345669999999999999997 9999965433322   2223333344455567889999999999


Q ss_pred             cccCcCCCCCHHHHhcC
Q 020657          296 LQKEFSKRWTASQLLTH  312 (323)
Q Consensus       296 l~~~p~~Rpt~~~~l~h  312 (323)
                      |+.+|++|||++++++|
T Consensus       313 l~~~p~~RPs~~ell~~  329 (337)
T cd05054         313 WHNNPEDRPTFSELVEI  329 (337)
T ss_pred             ccCChhhCcCHHHHHHH
Confidence            99999999999999976

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=4.6e-44  Score=310.15  Aligned_cols=261  Identities=28%  Similarity=0.489  Sum_probs=214.7

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      .+.|.....||+|++|.||++.+..+++.|++|.+.... ......+.+|+.+++.++|+||+++++.+.. .+..++||
T Consensus        21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-~~~~~lv~   98 (292)
T cd06658          21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLV-GDELWVVM   98 (292)
T ss_pred             HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheec-CCeEEEEE
Confidence            456666788999999999999998889999999986443 3445668899999999999999999999887 67899999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccc
Q 020657          130 EYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN  209 (323)
Q Consensus       130 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~  209 (323)
                      ||+++++|.+++... .+++..+..++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++...........
T Consensus        99 e~~~~~~L~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-~~kL~dfg~~~~~~~~~~~~~  176 (292)
T cd06658          99 EFLEGGALTDIVTHT-RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRK  176 (292)
T ss_pred             eCCCCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CEEEccCcchhhcccccccCc
Confidence            999999999988654 689999999999999999999999999999999999999987 899999999876544433334


Q ss_pred             cccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCC--CCCCCChh
Q 020657          210 SYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPS--LPDGASPE  287 (323)
Q Consensus       210 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  287 (323)
                      ...++..|+|||.+...     ..+.++|+||||+++|+|++|..||..........    .........  ....++..
T Consensus       177 ~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~  247 (292)
T cd06658         177 SLVGTPYWMAPEVISRL-----PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMR----RIRDNLPPRVKDSHKVSSV  247 (292)
T ss_pred             eeecCccccCHHHHccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhcCCCccccccccCHH
Confidence            45678899999988633     34569999999999999999999996543222111    111111222  22357889


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCcccccCCCCCC
Q 020657          288 FRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSDC  323 (323)
Q Consensus       288 l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~~~  323 (323)
                      +.+++.+||..||++|||++++++||||+....|-|
T Consensus       248 ~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~~  283 (292)
T cd06658         248 LRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPSC  283 (292)
T ss_pred             HHHHHHHHccCChhHCcCHHHHhhChhhhccCCccc
Confidence            999999999999999999999999999998877765

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.4e-43  Score=301.99  Aligned_cols=261  Identities=34%  Similarity=0.543  Sum_probs=210.8

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEE
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      ...+.+.....||+|++|.||+|.+..++..|++|.+.... ......+.+|+.+++.++|+||+++++++.. .+..++
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~l   82 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSE-NGFFKI   82 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeecc-CCEEEE
Confidence            34455556678999999999999998889999999886553 2345678899999999999999999999887 678999


Q ss_pred             EEeccCCCCHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC
Q 020657          128 LMEYMDSGTLDTLLNKN-GTF--SEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS  204 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~~-~~~--~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~  204 (323)
                      |+||+++++|.+++... ..+  ++..+..++.||+.||.|||+.|++|+||+|+||+++.+...++|+|||.+......
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~  162 (268)
T cd06624          83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI  162 (268)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence            99999999999999754 445  888999999999999999999999999999999999874348999999998765433


Q ss_pred             ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCC
Q 020657          205 LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA  284 (323)
Q Consensus       205 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (323)
                      ........++..|+|||.+....   ...+.++|+||||+++|+|++|..||.......  ............+.++..+
T Consensus       163 ~~~~~~~~~~~~~~aPE~~~~~~---~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~  237 (268)
T cd06624         163 NPCTETFTGTLQYMAPEVIDKGP---RGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ--AAMFKVGMFKIHPEIPESL  237 (268)
T ss_pred             CCccccCCCCccccChhhhcccc---ccCCchhhhHHHHHHHHHHHhCCCCCccccChh--hhHhhhhhhccCCCCCccc
Confidence            33333445788999999975322   224569999999999999999999996543221  1111111223345567788


Q ss_pred             ChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       285 ~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                      ++++.+|+++||+.+|++|||+.++++||||
T Consensus       238 ~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         238 SAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             CHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence            9999999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=5.4e-44  Score=304.27  Aligned_cols=254  Identities=30%  Similarity=0.456  Sum_probs=216.2

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      +|++.+.||.|++|.||+|.+..+++.+++|++....  .....+.+.+|++++++++||||+++++.+.. ....++|+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~   79 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD-EENMYLVV   79 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC-CCeEEEEE
Confidence            5899999999999999999998889999999997542  23456788999999999999999999999887 67899999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccc
Q 020657          130 EYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN  209 (323)
Q Consensus       130 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~  209 (323)
                      ||+.+++|.+.+....++++..+..++.||+++|.|||+.|++|+||+|+||+++.++ .++|+|||.+....... ...
T Consensus        80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~~-~~~  157 (258)
T cd05578          80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQG-HVHITDFNIATKVTPDT-LTT  157 (258)
T ss_pred             eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCC-CEEEeecccccccCCCc-ccc
Confidence            9999999999998777899999999999999999999999999999999999999987 89999999987654332 223


Q ss_pred             cccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHH
Q 020657          210 SYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFR  289 (323)
Q Consensus       210 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  289 (323)
                      ...++..|+|||.+....     .+.++|+||||+++|+|++|..||...... ....+..... .....++...+.++.
T Consensus       158 ~~~~~~~y~~PE~~~~~~-----~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~  230 (258)
T cd05578         158 STSGTPGYMAPEVLCRQG-----YSVAVDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIRAKQE-TADVLYPATWSTEAI  230 (258)
T ss_pred             ccCCChhhcCHHHHcccC-----CCCcccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHHHHhc-cccccCcccCcHHHH
Confidence            456788999999986433     456999999999999999999999765443 2222222222 244566678899999


Q ss_pred             HHHHHhcccCcCCCCCH--HHHhcCccc
Q 020657          290 SFIECCLQKEFSKRWTA--SQLLTHPFL  315 (323)
Q Consensus       290 ~ll~~~l~~~p~~Rpt~--~~~l~h~~f  315 (323)
                      +++.+||+.||.+||++  .++++||||
T Consensus       231 ~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         231 DAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHHHHHccCChhHcCCccHHHHhcCCCC
Confidence            99999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=6.5e-44  Score=319.09  Aligned_cols=260  Identities=25%  Similarity=0.348  Sum_probs=210.3

Q ss_pred             CccchhccccccceeeeecccCCeEEEEEEeccc-----CcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceec
Q 020657           42 TATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCT-----HKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCF  115 (323)
Q Consensus        42 ~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~-----~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~  115 (323)
                      ....|.+..++|++.+.||+|+||.||+|++...     +..||+|++...........+.+|+.+++.+ +|+||++++
T Consensus        29 ~~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~  108 (374)
T cd05106          29 YNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLL  108 (374)
T ss_pred             ccccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEe
Confidence            4556778889999999999999999999986433     3579999998665555667788999999999 899999999


Q ss_pred             eeEEcCCCeEEEEEeccCCCCHHHHHHhc---------------------------------------------------
Q 020657          116 GIFEKPSGDIAILMEYMDSGTLDTLLNKN---------------------------------------------------  144 (323)
Q Consensus       116 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---------------------------------------------------  144 (323)
                      +.+.. .+..++||||+.+++|.+++...                                                   
T Consensus       109 ~~~~~-~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (374)
T cd05106         109 GACTH-GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPV  187 (374)
T ss_pred             eEecC-CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCc
Confidence            99987 67899999999999999988532                                                   


Q ss_pred             -------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc
Q 020657          145 -------------------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL  205 (323)
Q Consensus       145 -------------------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~  205 (323)
                                         .++++..++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++.......
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~-~~kL~DfGla~~~~~~~  266 (374)
T cd05106         188 SSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR-VAKICDFGLARDIMNDS  266 (374)
T ss_pred             cccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC-eEEEeeceeeeeccCCc
Confidence                               2468889999999999999999999999999999999999887 89999999987653322


Q ss_pred             c--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCCC
Q 020657          206 D--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLPD  282 (323)
Q Consensus       206 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (323)
                      .  ......++..|+|||++...     .++.++||||||+++|+|++ |..||........   +............+.
T Consensus       267 ~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~---~~~~~~~~~~~~~~~  338 (374)
T cd05106         267 NYVVKGNARLPVKWMAPESIFDC-----VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK---FYKMVKRGYQMSRPD  338 (374)
T ss_pred             ceeeccCCCCccceeCHHHhcCC-----CCCccccHHHHHHHHHHHHhCCCCCCccccccHH---HHHHHHcccCccCCC
Confidence            1  11122345679999998633     35669999999999999997 9999965433322   222222333444556


Q ss_pred             CCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          283 GASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       283 ~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      .+++++.+++.+||+.||++|||++++++
T Consensus       339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         339 FAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            67899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=9.5e-44  Score=308.13  Aligned_cols=257  Identities=27%  Similarity=0.395  Sum_probs=202.6

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      ..+|++.+.||+|++|.||+|.+..+++.|++|.+...........+.+|+.+++.++|+||+++++++.. +...++|+
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv~   82 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT-KETLTFVF   82 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec-CCeEEEEE
Confidence            47899999999999999999999889999999999755433334456789999999999999999999987 67899999


Q ss_pred             eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          130 EYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       130 e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      ||+. +++.+.+.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ +++|+|||++..........
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~~~~~~  160 (291)
T cd07870          83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLG-ELKLADFGLARAKSIPSQTY  160 (291)
T ss_pred             eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCC-cEEEeccccccccCCCCCCC
Confidence            9996 476666543 45678899999999999999999999999999999999999987 89999999987544333333


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhc-CC-----------
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICF-GD-----------  276 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~-~~-----------  276 (323)
                      ....++..|+|||.+.+.    ...+.++||||||+++|+|++|..||......  .+.+.+.... +.           
T Consensus       161 ~~~~~~~~y~aPE~~~~~----~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07870         161 SSEVVTLWYRPPDVLLGA----TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTWPGVSK  234 (291)
T ss_pred             CCccccccccCCceeecC----CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhhhhhhh
Confidence            444578899999987522    23456899999999999999999999654321  1111111000 00           


Q ss_pred             -------------CCC---CC--CCCChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          277 -------------PPS---LP--DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       277 -------------~~~---~~--~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                                   +..   ..  ...+.++.+++.+|++.||++|||+.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence                         000   00  0125789999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-44  Score=320.65  Aligned_cols=259  Identities=24%  Similarity=0.409  Sum_probs=220.5

Q ss_pred             CCccchhccccccceeeeecccCCeEEEEEEecccCc---E-EEEEeecCC--CChHHHHHHHHHHHHHHcCCCCcccee
Q 020657           41 TTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHK---I-YALKVVHGD--ADPTVRRQVFREMEILRRTDSPFIVQC  114 (323)
Q Consensus        41 ~~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~---~-v~iK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~  114 (323)
                      ..-+.|.+..++..+.++||+|+||.||+|.....+.   . ||+|.....  ...+....+.+|+++|+.++||||+++
T Consensus       147 I~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~  226 (474)
T KOG0194|consen  147 IPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRF  226 (474)
T ss_pred             ccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence            3466799999999999999999999999999765322   3 899998752  346778899999999999999999999


Q ss_pred             ceeEEcCCCeEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEe
Q 020657          115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNG-TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIA  193 (323)
Q Consensus       115 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~  193 (323)
                      +|+... +..+++|||+|.||+|.+++.+.+ .++..+...++.+.+.||+|||+++++||||.++|+|++.++ .+||+
T Consensus       227 yGVa~~-~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~-~vKIS  304 (474)
T KOG0194|consen  227 YGVAVL-EEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKG-VVKIS  304 (474)
T ss_pred             EEEEcC-CCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCC-eEEeC
Confidence            999887 789999999999999999999876 499999999999999999999999999999999999999986 78999


Q ss_pred             ecCcchhhccCccccc-cccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHH
Q 020657          194 DFGVSKIMCRSLDACN-SYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCA  271 (323)
Q Consensus       194 Dfg~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~  271 (323)
                      |||+++... ...... ......+|+|||.+...     .+|.++||||||+++||+++ |..||.+....    .+...
T Consensus       305 DFGLs~~~~-~~~~~~~~~klPirWLAPEtl~~~-----~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~----~v~~k  374 (474)
T KOG0194|consen  305 DFGLSRAGS-QYVMKKFLKKLPIRWLAPETLNTG-----IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY----EVKAK  374 (474)
T ss_pred             ccccccCCc-ceeeccccccCcceecChhhhccC-----ccccccchhheeeeEEeeeccCCCCCCCCCHH----HHHHH
Confidence            999986543 112112 23467899999998733     56779999999999999997 88899665443    44444


Q ss_pred             H-hcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          272 I-CFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       272 ~-~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      + ..+.+...+...+.++..++.+||..+|+.|||+.++.+
T Consensus       375 I~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  375 IVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence            4 557778888899999999999999999999999998864

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=8.1e-44  Score=307.40  Aligned_cols=257  Identities=27%  Similarity=0.461  Sum_probs=208.0

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEec
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEY  131 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~  131 (323)
                      +|++.+.||.|++|.||+|.+..+++.|++|++...........+.+|+.+++.++|+||+++++.+.+ .+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~   79 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT-ENKLMLVFEY   79 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee-CCcEEEEEec
Confidence            589999999999999999999889999999999765444445667789999999999999999999987 6789999999


Q ss_pred             cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          132 MDSGTLDTLLNKN---GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       132 ~~~~sL~~~l~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      +.+ +|.+++...   ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++..........
T Consensus        80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~-~~~l~d~g~~~~~~~~~~~~  157 (284)
T cd07836          80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRG-ELKLADFGLARAFGIPVNTF  157 (284)
T ss_pred             CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC-cEEEeecchhhhhcCCcccc
Confidence            986 888887643   3589999999999999999999999999999999999999887 89999999997654433333


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC------------
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD------------  276 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~------------  276 (323)
                      ....++..|++||.+...    ..++.++|+|+||+++|+|++|+.||...........+........            
T Consensus       158 ~~~~~~~~y~~PE~~~~~----~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         158 SNEVVTLWYRAPDVLLGS----RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             ccccccccccChHHhcCC----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence            344567889999987532    2345699999999999999999999976544332222221110000            


Q ss_pred             -CC-----------CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          277 -PP-----------SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       277 -~~-----------~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                       ..           .+...++.++.+++.+||+.||.+|||++++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence             00           0113457889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=8.9e-44  Score=307.39  Aligned_cols=258  Identities=28%  Similarity=0.460  Sum_probs=208.8

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEe
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILME  130 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e  130 (323)
                      +|++.+.||+|++|.||+|.+..+++.|++|++..... ......+.+|+.++++++|+||+++++++.. ....++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-GSGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-CCeeEEEec
Confidence            58999999999999999999988999999999875542 3445678899999999999999999999987 678999999


Q ss_pred             ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc-cc
Q 020657          131 YMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD-AC  208 (323)
Q Consensus       131 ~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~-~~  208 (323)
                      |+ +++|.+++.. ...+++..++.++.||+.+|.|||+.|++|+||+|+||+++.++ .++|+|||.+........ ..
T Consensus        80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~-~~~l~dfg~~~~~~~~~~~~~  157 (286)
T cd07832          80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADG-VLKIADFGLARLFSEEEPRLY  157 (286)
T ss_pred             cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCC-cEEEeeeeecccccCCCCCcc
Confidence            99 8899998864 45689999999999999999999999999999999999999987 899999999976644321 23


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC------------
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD------------  276 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~------------  276 (323)
                      ....++..|+|||.+..    ....+.++||||+|+++|+|++|..+|....................            
T Consensus       158 ~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07832         158 SHQVATRWYRAPELLYG----ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD  233 (286)
T ss_pred             ccccCcccccCceeeec----cccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence            34568889999998752    23346699999999999999999877755433222222221110000            


Q ss_pred             --------C-----CCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccc
Q 020657          277 --------P-----PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLC  316 (323)
Q Consensus       277 --------~-----~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~  316 (323)
                              .     .......+.++.+|+.+||+.+|++|||++++++||||.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence                    0     011134678999999999999999999999999999994

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-43  Score=322.90  Aligned_cols=255  Identities=23%  Similarity=0.313  Sum_probs=201.3

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ....|.+.+.||+|+||.||+|.+..+++.|++|....       ..+.+|++++++++|+||+++++++.. .+..++|
T Consensus       167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~-~~~~~lv  238 (461)
T PHA03211        167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVV-GGLTCLV  238 (461)
T ss_pred             ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEE-CCEEEEE
Confidence            35579999999999999999999998999999996431       235689999999999999999999887 6789999


Q ss_pred             EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc-
Q 020657          129 MEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD-  206 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~-  206 (323)
                      ||++. ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++ .++|+|||++........ 
T Consensus       239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~-~vkL~DFGla~~~~~~~~~  316 (461)
T PHA03211        239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWST  316 (461)
T ss_pred             EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCC-CEEEcccCCceeccccccc
Confidence            99996 588887765 34699999999999999999999999999999999999999987 899999999976533211 


Q ss_pred             -ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC----ccHHHHHHHHhcCC-----
Q 020657          207 -ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQR----PDWATLMCAICFGD-----  276 (323)
Q Consensus       207 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~----~~~~~~~~~~~~~~-----  276 (323)
                       ......+|..|+|||++.+.     .++.++||||||+++|||++|..+++.....    .....+.+.+....     
T Consensus       317 ~~~~~~~GT~~Y~APE~~~~~-----~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~  391 (461)
T PHA03211        317 PFHYGIAGTVDTNAPEVLAGD-----PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE  391 (461)
T ss_pred             ccccccCCCcCCcCHHHHcCC-----CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence             12245689999999998643     3456999999999999999988766443211    11111111111100     


Q ss_pred             ---------------------CCCC-------CCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          277 ---------------------PPSL-------PDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       277 ---------------------~~~~-------~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                                           .+..       ...++.++.+||..||+.||++|||++|+|+||||+++
T Consensus       392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~~  461 (461)
T PHA03211        392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQSK  461 (461)
T ss_pred             CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCCC
Confidence                                 0000       01356789999999999999999999999999999763

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-43  Score=310.23  Aligned_cols=258  Identities=31%  Similarity=0.517  Sum_probs=213.1

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCCh--HHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADP--TVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ++|++.+.||+|++|.||+|.+..+++.+++|.+......  .....+.+|+.+++.+.|+||+++++.+.. ....++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv   79 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT-ETYLCLV   79 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec-CCEEEEE
Confidence            4799999999999999999999888999999999765322  355678899999999999999999999987 6789999


Q ss_pred             EeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc
Q 020657          129 MEYMDSGTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD  206 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~  206 (323)
                      |||+.+++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++........
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~  158 (316)
T cd05574          80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESG-HIMLSDFDLSKQSDVEPP  158 (316)
T ss_pred             EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCC-CEEEeecchhhccccccc
Confidence            9999999999998753  4689999999999999999999999999999999999999987 899999999865432110


Q ss_pred             -----------------------------ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 020657          207 -----------------------------ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFL  257 (323)
Q Consensus       207 -----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~  257 (323)
                                                   ......++..|+|||++.+.     ..+.++||||||+++|+|++|..||.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Di~slG~ll~~l~~g~~pf~  233 (316)
T cd05574         159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-----GHGSAVDWWTLGILLYEMLYGTTPFK  233 (316)
T ss_pred             ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-----CCCchHHHHHHHHHHHHHhhCCCCCC
Confidence                                         11123577889999998633     34569999999999999999999996


Q ss_pred             CCCCCccHHHHHHHHhcCCCCCCC--CCCChhHHHHHHHhcccCcCCCCC----HHHHhcCcccccCCC
Q 020657          258 QPGQRPDWATLMCAICFGDPPSLP--DGASPEFRSFIECCLQKEFSKRWT----ASQLLTHPFLCKNRR  320 (323)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~ll~~~l~~~p~~Rpt----~~~~l~h~~f~~~~~  320 (323)
                      ..+.......+.    . ....++  ..++..+.+++++||..||++|||    +++++.||||++.+-
T Consensus       234 ~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~  297 (316)
T cd05574         234 GSNRDETFSNIL----K-KEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNW  297 (316)
T ss_pred             CCchHHHHHHHh----c-CCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCCh
Confidence            554433322222    1 112222  237899999999999999999999    999999999988653

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=9.2e-44  Score=318.36  Aligned_cols=260  Identities=23%  Similarity=0.330  Sum_probs=208.7

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEe-----cccCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceece
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQH-----RCTHKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFG  116 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~-----~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~  116 (323)
                      ...+.++.++|++.+.||+|+||.||+|.+     ..++..||+|++...........+.+|+.+++.+ .||||+++++
T Consensus        27 ~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~  106 (375)
T cd05104          27 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLG  106 (375)
T ss_pred             ccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeee
Confidence            445677788999999999999999999974     3356689999997554445566788999999999 8999999999


Q ss_pred             eEEcCCCeEEEEEeccCCCCHHHHHHhc----------------------------------------------------
Q 020657          117 IFEKPSGDIAILMEYMDSGTLDTLLNKN----------------------------------------------------  144 (323)
Q Consensus       117 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~----------------------------------------------------  144 (323)
                      ++.. .+..++||||+++|+|.+++...                                                    
T Consensus       107 ~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  185 (375)
T cd05104         107 ACTV-GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADK  185 (375)
T ss_pred             eecc-CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccc
Confidence            9987 67899999999999999888542                                                    


Q ss_pred             -----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhh
Q 020657          145 -----------------------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM  201 (323)
Q Consensus       145 -----------------------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~  201 (323)
                                             ..+++..+..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++...
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~-~~kl~DfG~a~~~  264 (375)
T cd05104         186 RRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR-ITKICDFGLARDI  264 (375)
T ss_pred             ccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC-cEEEecCccceec
Confidence                                   1467888999999999999999999999999999999999886 8999999999765


Q ss_pred             ccCccc--cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCC
Q 020657          202 CRSLDA--CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPP  278 (323)
Q Consensus       202 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  278 (323)
                      ......  .....++..|+|||++...     .++.++||||||+++|+|++ |..||.......   .+...+..+...
T Consensus       265 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~---~~~~~~~~~~~~  336 (375)
T cd05104         265 RNDSNYVVKGNARLPVKWMAPESIFNC-----VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS---KFYKMIKEGYRM  336 (375)
T ss_pred             cCcccccccCCCCCCcceeChhHhcCC-----CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH---HHHHHHHhCccC
Confidence            432211  1122345679999998643     34569999999999999997 899986543322   222233333344


Q ss_pred             CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          279 SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       279 ~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ..+...+.++.+|+.+||+.||++|||+.++++.
T Consensus       337 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         337 LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            4456678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.3e-43  Score=300.13  Aligned_cols=254  Identities=36%  Similarity=0.551  Sum_probs=214.2

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC----ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEE
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA----DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      +|+..+.||+|++|.||+|.+..+++.|++|.+....    ..+..+.+.+|+.+++.++|+||+++++++.. ....++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~l   79 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE-EDNLYI   79 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec-CCeEEE
Confidence            5788899999999999999998889999999986442    23456778899999999999999999999887 678999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccc
Q 020657          128 LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA  207 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~  207 (323)
                      ++||+++++|.+++.+...+++..+..++.||+.++.+||+.|++|+||+|+||+++.++ .+||+|||++....... .
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~-~~kl~d~~~~~~~~~~~-~  157 (258)
T cd06632          80 FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNG-VVKLADFGMAKQVVEFS-F  157 (258)
T ss_pred             EEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEccCccceeccccc-c
Confidence            999999999999998887899999999999999999999999999999999999999887 89999999987654332 2


Q ss_pred             cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChh
Q 020657          208 CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPE  287 (323)
Q Consensus       208 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (323)
                      .....++..|++||.+....    ..+.++|+||||+++|+|++|..||....   ..............+.++..+++.
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~----~~~~~~D~~slG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  230 (258)
T cd06632         158 AKSFKGSPYWMAPEVIAQQG----GYGLAADIWSLGCTVLEMATGKPPWSQLE---GVAAVFKIGRSKELPPIPDHLSDE  230 (258)
T ss_pred             ccccCCCcceeCHHHhcCCC----CCCchhhhHHHHHHHHHHHhCCCCcccCc---HHHHHHHHHhcccCCCcCCCcCHH
Confidence            23456788899999875322    24669999999999999999999995443   222333333324455667788999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          288 FRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       288 l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                      +.+++++||+.+|.+|||++++++|||+
T Consensus       231 ~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         231 AKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence            9999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3e-43  Score=304.59  Aligned_cols=262  Identities=23%  Similarity=0.370  Sum_probs=212.4

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecc-----cCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEc
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRC-----THKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEK  120 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  120 (323)
                      |++..++|++.+.||+|++|.||+|.+..     .+..|++|.+...........+.+|+.+++.++|+||+++++++..
T Consensus         1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (288)
T cd05061           1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK   80 (288)
T ss_pred             CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            56778999999999999999999997542     3457999998755544455667889999999999999999999887


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcE
Q 020657          121 PSGDIAILMEYMDSGTLDTLLNKN----------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQV  190 (323)
Q Consensus       121 ~~~~~~lv~e~~~~~sL~~~l~~~----------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~  190 (323)
                       ....++||||+.+++|.+++...          ..++...+..++.||+.||.|||+.|++|+||||+||+++.++ .+
T Consensus        81 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~-~~  158 (288)
T cd05061          81 -GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF-TV  158 (288)
T ss_pred             -CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCC-cE
Confidence             56899999999999999999642          2356778899999999999999999999999999999999987 89


Q ss_pred             EEeecCcchhhccCcc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHH
Q 020657          191 KIADFGVSKIMCRSLD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWAT  267 (323)
Q Consensus       191 kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~  267 (323)
                      +|+|||+++.......  ......++..|+|||.+...     ..+.++|+||||+++|+|++ |..||.....    ..
T Consensus       159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-----~~~~~~DvwslG~~l~el~~~~~~p~~~~~~----~~  229 (288)
T cd05061         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-----VFTTSSDMWSFGVVLWEITSLAEQPYQGLSN----EQ  229 (288)
T ss_pred             EECcCCccccccccccccccCCCcccccccCHHHhccC-----CCChHhHHHHHHHHHHHHHhCCCCCCCCCCH----HH
Confidence            9999999875433221  11223346789999988633     34569999999999999998 7888854332    33


Q ss_pred             HHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc------CcccccC
Q 020657          268 LMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT------HPFLCKN  318 (323)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~------h~~f~~~  318 (323)
                      ....+..+.....+...++.+.+++.+||+.+|++|||+.++++      ||||+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~  286 (288)
T cd05061         230 VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV  286 (288)
T ss_pred             HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence            43344444445556677899999999999999999999999987      9999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.5e-43  Score=337.66  Aligned_cols=269  Identities=27%  Similarity=0.427  Sum_probs=215.8

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcC
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP  121 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  121 (323)
                      .........+|++++.||+|+||+||+|.+..+++.+++|++.... .......+..|+.+++.+.||||++++++|...
T Consensus         5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de   84 (1021)
T PTZ00266          5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK   84 (1021)
T ss_pred             ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence            3445667789999999999999999999999999999999987542 334567788999999999999999999988543


Q ss_pred             -CCeEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-------CCeecCCCCCCeEEecC---
Q 020657          122 -SGDIAILMEYMDSGTLDTLLNK----NGTFSEPKLAHIASQILKGLSYLHGH-------KIIHRDIKPSNLLVNNN---  186 (323)
Q Consensus       122 -~~~~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~-------givH~di~~~nil~~~~---  186 (323)
                       ...+++||||+.+++|.+++..    ...+++..++.|+.||+.||.|||+.       +|+|+||||+|||++.+   
T Consensus        85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~  164 (1021)
T PTZ00266         85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH  164 (1021)
T ss_pred             CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence             4568999999999999999864    35699999999999999999999985       49999999999999642   


Q ss_pred             -------------CCcEEEeecCcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCC
Q 020657          187 -------------NMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGH  253 (323)
Q Consensus       187 -------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~  253 (323)
                                   ...+||+|||++....... ......+++.|+|||++...   ...++.++|||||||+||+|+||.
T Consensus       165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge---~~~~s~KSDVWSLG~ILYELLTGk  240 (1021)
T PTZ00266        165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHE---TKSYDDKSDMWALGCIIYELCSGK  240 (1021)
T ss_pred             cccccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhcc---CCCCCchhHHHHHHHHHHHHHHCC
Confidence                         1248999999997653322 22345789999999998532   223466999999999999999999


Q ss_pred             CCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          254 FPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       254 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      .||....   ....+...+.... ..-....+.++.+||..||..+|.+|||+.++|.|+||....
T Consensus       241 ~PF~~~~---~~~qli~~lk~~p-~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~  302 (1021)
T PTZ00266        241 TPFHKAN---NFSQLISELKRGP-DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG  302 (1021)
T ss_pred             CCCCcCC---cHHHHHHHHhcCC-CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence            9996433   2233333332221 111245789999999999999999999999999999997653

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.2e-43  Score=302.94  Aligned_cols=263  Identities=41%  Similarity=0.699  Sum_probs=211.9

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcC-CCeEEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP-SGDIAILM  129 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~lv~  129 (323)
                      ++|...+.||.|++|.||+|.+..+++.+++|.+...........+.+|+++++.++|+||+++++++... .+.+++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            46889999999999999999998899999999998665556677889999999999999999999988643 34689999


Q ss_pred             eccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc
Q 020657          130 EYMDSGTLDTLLNK----NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL  205 (323)
Q Consensus       130 e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~  205 (323)
                      ||+++++|.+++..    ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~~  159 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKG-QVKLCDFGVSGELVNSL  159 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCC-eEEEeeccccccccccc
Confidence            99999999887653    34589999999999999999999999999999999999999987 89999999986543322


Q ss_pred             cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC-ccHHHHHHHHhcCCCCCCC---
Q 020657          206 DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQR-PDWATLMCAICFGDPPSLP---  281 (323)
Q Consensus       206 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~---  281 (323)
                      .  ....++..|+|||.+...     .++.++|||+||+++|+|++|..||...... .....+.........+.+.   
T Consensus       160 ~--~~~~~~~~y~~pE~~~~~-----~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd06621         160 A--GTFTGTSFYMAPERIQGK-----PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEP  232 (287)
T ss_pred             c--ccccCCccccCHHHhcCC-----CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCC
Confidence            1  234567889999988633     3456999999999999999999999765321 1112222222222222221   


Q ss_pred             ---CCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCCC
Q 020657          282 ---DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS  321 (323)
Q Consensus       282 ---~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~  321 (323)
                         ...++.+.+++.+||..+|++|||+.++++||||.+..+.
T Consensus       233 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~  275 (287)
T cd06621         233 GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK  275 (287)
T ss_pred             CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccc
Confidence               2345789999999999999999999999999999776554

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.8e-43  Score=300.74  Aligned_cols=254  Identities=30%  Similarity=0.482  Sum_probs=212.3

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEe
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILME  130 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e  130 (323)
                      +|++.+.||+|++|.||+|.+..++..+++|.+.... .....+.+.+|+.+++.++|+||+++++.+.. .+..++|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE-NGRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc-CCeEEEEEe
Confidence            5889999999999999999999899999999986542 12334567789999999999999999999887 678999999


Q ss_pred             ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          131 YMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       131 ~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      |+++++|.+++....  .+++..+..++.|+++||.|||+.|++|+||+|+||+++.++..++|+|||.+..........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~  159 (257)
T cd08225          80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA  159 (257)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence            999999999987543  479999999999999999999999999999999999999886567999999997765443333


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhH
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEF  288 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (323)
                      ....++..|+|||.+...     ..+.++|+||||+++|+|++|..||....    ....................+.++
T Consensus       160 ~~~~~~~~~~ape~~~~~-----~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  230 (257)
T cd08225         160 YTCVGTPYYLSPEICQNR-----PYNNKTDIWSLGCVLYELCTLKHPFEGNN----LHQLVLKICQGYFAPISPNFSRDL  230 (257)
T ss_pred             cccCCCccccCHHHHcCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCcc----HHHHHHHHhcccCCCCCCCCCHHH
Confidence            345678899999987533     34569999999999999999999995432    233333333344445556788999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          289 RSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       289 ~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                      .+++++||+.+|++|||+++++.||||
T Consensus       231 ~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         231 RSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHHHHHhccChhhCcCHHHHhhCCCC
Confidence            999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3.6e-43  Score=300.39  Aligned_cols=256  Identities=31%  Similarity=0.449  Sum_probs=210.3

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC----ChHHHHHHHHHHHHHHcCCCCccceeceeEEcC-CCeE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA----DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP-SGDI  125 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~  125 (323)
                      .+|++.+.||+|++|.||+|.+..+++.|++|.+....    .......+.+|+.+++++.|+||+++++.+.+. ...+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57999999999999999999999899999999885332    223456788899999999999999999988753 3467


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc
Q 020657          126 AILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL  205 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~  205 (323)
                      +++|||+++++|.+++.+...+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~~l~Dfg~~~~~~~~~  160 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVG-NVKLGDFGASKRLQTIC  160 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCC-CEEECcCcccccccccc
Confidence            89999999999999998777789999999999999999999999999999999999999887 89999999987543211


Q ss_pred             ---cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCC
Q 020657          206 ---DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPD  282 (323)
Q Consensus       206 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (323)
                         .......++..|+|||++...     ..+.++|+||||+++|+|++|+.||...   ...............+..+.
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~il~el~~g~~p~~~~---~~~~~~~~~~~~~~~~~~~~  232 (265)
T cd06652         161 LSGTGMKSVTGTPYWMSPEVISGE-----GYGRKADIWSVGCTVVEMLTEKPPWAEF---EAMAAIFKIATQPTNPVLPP  232 (265)
T ss_pred             ccccccccCCCCccccChhhhcCC-----CCCcchhHHHHHHHHHHHhhCCCCCCcc---chHHHHHHHhcCCCCCCCch
Confidence               112234578899999988633     3456999999999999999999999543   22233333333333455667


Q ss_pred             CCChhHHHHHHHhcccCcCCCCCHHHHhcCcccc
Q 020657          283 GASPEFRSFIECCLQKEFSKRWTASQLLTHPFLC  316 (323)
Q Consensus       283 ~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~  316 (323)
                      ..+..+.+++++||. +|++|||++++++|||+.
T Consensus       233 ~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         233 HVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             hhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            788899999999995 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-44  Score=330.78  Aligned_cols=266  Identities=28%  Similarity=0.363  Sum_probs=218.0

Q ss_pred             CCCCCCCCccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCC-CCccce
Q 020657           35 PNTNNNTTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD-SPFIVQ  113 (323)
Q Consensus        35 ~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~  113 (323)
                      +............+...+++|.+.|.+|||+.||+|++...+..||+|..... +......+.+|+.+|+.|+ |+|||.
T Consensus        21 ~~~~~~~~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~   99 (738)
T KOG1989|consen   21 PQSENYFVGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVS   99 (738)
T ss_pred             cccccCCCceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceee
Confidence            33344455678888999999999999999999999999977799999998766 6777888999999999995 999999


Q ss_pred             ece-eEEcC-----CCeEEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCCeEE
Q 020657          114 CFG-IFEKP-----SGDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHGHK--IIHRDIKPSNLLV  183 (323)
Q Consensus       114 ~~~-~~~~~-----~~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~g--ivH~di~~~nil~  183 (323)
                      +++ .....     ...+.|+||||.|+.|-++++.  ...|++.++++|+.++++|+.+||...  |||||||-+|||+
T Consensus       100 yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl  179 (738)
T KOG1989|consen  100 YIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL  179 (738)
T ss_pred             EeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE
Confidence            999 33221     1246799999999999999984  345999999999999999999999997  9999999999999


Q ss_pred             ecCCCcEEEeecCcchhhccCcccc---------ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCC
Q 020657          184 NNNNMQVKIADFGVSKIMCRSLDAC---------NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHF  254 (323)
Q Consensus       184 ~~~~~~~kl~Dfg~~~~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~  254 (323)
                      +.+| +.||||||.+..........         -....|+.|+|||+++  -|.+...+.|+|||+|||+||.||....
T Consensus       180 s~~g-~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMID--lysg~pI~eKsDIWALGclLYkLCy~t~  256 (738)
T KOG1989|consen  180 SADG-NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMID--LYSGLPIGEKSDIWALGCLLYKLCYFTT  256 (738)
T ss_pred             cCCC-CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHh--hhcCCCCcchhHHHHHHHHHHHHHHhCC
Confidence            9998 89999999997543222111         1234689999999997  4557778889999999999999999999


Q ss_pred             CCCCCCCCccHHHHHHHHhcCCCCCCC--CCCChhHHHHHHHhcccCcCCCCCHHHHhcCc
Q 020657          255 PFLQPGQRPDWATLMCAICFGDPPSLP--DGASPEFRSFIECCLQKEFSKRWTASQLLTHP  313 (323)
Q Consensus       255 p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~  313 (323)
                      ||...+......        + .-.+|  ..++..+.+||+.||++||.+||++-+++++-
T Consensus       257 PFe~sg~laIln--------g-~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~  308 (738)
T KOG1989|consen  257 PFEESGKLAILN--------G-NYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI  308 (738)
T ss_pred             CcCcCcceeEEe--------c-cccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence            997664432211        1 11222  47899999999999999999999999999763

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-45  Score=301.65  Aligned_cols=262  Identities=27%  Similarity=0.532  Sum_probs=230.0

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCC
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG  123 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  123 (323)
                      ..+..++|..+++||+|.||.|.+++-+.+++.+|+|+++++.  ..+....-..|-++|+..+||.+..+-=.|+. ..
T Consensus       163 ~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt-~d  241 (516)
T KOG0690|consen  163 NKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT-QD  241 (516)
T ss_pred             ceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc-Cc
Confidence            3456788999999999999999999999999999999998662  33444556788999999999999988888887 68


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          124 DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      ++|+||||.+||.|.-.+++.+.+++...+.+-..|+.||.|||+.+||+||||.+|.++|.+| .+||.|||++...-.
T Consensus       242 rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDG-HIKitDFGLCKE~I~  320 (516)
T KOG0690|consen  242 RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDG-HIKITDFGLCKEEIK  320 (516)
T ss_pred             eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCC-ceEeeecccchhccc
Confidence            9999999999999999999988999999999999999999999999999999999999999998 899999999976555


Q ss_pred             CccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCC
Q 020657          204 SLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDG  283 (323)
Q Consensus       204 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (323)
                      .....+.++||+.|+|||++....++.     ++|+|++|++||||++|.+||...++.-.++-+.     .....+|..
T Consensus       321 ~g~t~kTFCGTPEYLAPEVleDnDYgr-----aVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl-----~ed~kFPr~  390 (516)
T KOG0690|consen  321 YGDTTKTFCGTPEYLAPEVLEDNDYGR-----AVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL-----MEDLKFPRT  390 (516)
T ss_pred             ccceeccccCChhhcCchhhccccccc-----eeehhhhhHHHHHHHhccCcccccchhHHHHHHH-----hhhccCCcc
Confidence            566778899999999999998777665     9999999999999999999997665543333332     234568899


Q ss_pred             CChhHHHHHHHhcccCcCCCC-----CHHHHhcCcccccCC
Q 020657          284 ASPEFRSFIECCLQKEFSKRW-----TASQLLTHPFLCKNR  319 (323)
Q Consensus       284 ~~~~l~~ll~~~l~~~p~~Rp-----t~~~~l~h~~f~~~~  319 (323)
                      ++++...|+..+|..||++|.     .+.+|.+|+||.++.
T Consensus       391 ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~  431 (516)
T KOG0690|consen  391 LSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVD  431 (516)
T ss_pred             CCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCC
Confidence            999999999999999999998     689999999998764

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=4e-43  Score=303.26  Aligned_cols=258  Identities=31%  Similarity=0.529  Sum_probs=212.9

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEe
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILME  130 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e  130 (323)
                      ..|.....||+|++|.||+|.+..+++.+++|++.... ......+.+|+.+++.+.|+||+++++++.. .+..++++|
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-~~~~~~v~e   96 (285)
T cd06648          19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-GDELWVVME   96 (285)
T ss_pred             HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEEc-CCeEEEEEe
Confidence            45666789999999999999998899999999986443 2345567899999999999999999999887 678999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccccc
Q 020657          131 YMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNS  210 (323)
Q Consensus       131 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~  210 (323)
                      |+.+++|.+++.. ..+++..+..++.|++.||++||+.|++||||+|+||+++.++ .++|+|||.+............
T Consensus        97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~d~g~~~~~~~~~~~~~~  174 (285)
T cd06648          97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDG-RVKLSDFGFCAQVSKEVPRRKS  174 (285)
T ss_pred             ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCC-cEEEcccccchhhccCCccccc
Confidence            9999999999877 5789999999999999999999999999999999999999987 8999999988765443333344


Q ss_pred             ccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCC--CCCCChhH
Q 020657          211 YVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSL--PDGASPEF  288 (323)
Q Consensus       211 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l  288 (323)
                      ..++..|+|||.+...     .++.++|+||||+++|+|++|+.||.....    ............+..  +..++..+
T Consensus       175 ~~~~~~y~aPE~~~~~-----~~~~~~Dv~slGv~l~ell~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l  245 (285)
T cd06648         175 LVGTPYWMAPEVISRL-----PYGTEVDIWSLGIMVIEMVDGEPPYFNEPP----LQAMKRIRDNLPPKLKNLHKVSPRL  245 (285)
T ss_pred             ccCCccccCHHHhcCC-----CCCCcccHHHHHHHHHHHHhCCCCCcCCCH----HHHHHHHHhcCCCCCcccccCCHHH
Confidence            5678899999998643     345699999999999999999999965332    222222222222222  23478899


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCcccccCCCC
Q 020657          289 RSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS  321 (323)
Q Consensus       289 ~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~  321 (323)
                      .+++.+||+.+|++|||+.++++|+||++.+-|
T Consensus       246 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  278 (285)
T cd06648         246 RSFLDRMLVRDPAQRATAAELLNHPFLAKAGPP  278 (285)
T ss_pred             HHHHHHHcccChhhCcCHHHHccCcccccCCCc
Confidence            999999999999999999999999999886653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.6e-43  Score=304.57  Aligned_cols=252  Identities=31%  Similarity=0.474  Sum_probs=209.2

Q ss_pred             ecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEeccCCCC
Q 020657           59 LGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGT  136 (323)
Q Consensus        59 lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~s  136 (323)
                      ||+|+||+||+|.+..+++.+++|.+....  .......+.+|+.+++.++||||+++++++.. .+..++||||+++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~   79 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET-KDDLCLVMTLMNGGD   79 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec-CCeEEEEEecCCCCc
Confidence            689999999999998899999999986432  22234456789999999999999999999987 678999999999999


Q ss_pred             HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccccccccc
Q 020657          137 LDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGT  214 (323)
Q Consensus       137 L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  214 (323)
                      |.+++....  .+++..+..++.|++.||.|||+.|++|+||+|+||++++++ .++|+|||.+...... .......++
T Consensus        80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~-~~~l~dfg~~~~~~~~-~~~~~~~~~  157 (277)
T cd05577          80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHG-NVRISDLGLAVELKGG-KKIKGRAGT  157 (277)
T ss_pred             HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEccCcchhhhccC-CccccccCC
Confidence            999987655  689999999999999999999999999999999999999987 8999999998765432 222344577


Q ss_pred             ccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHH
Q 020657          215 CAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIEC  294 (323)
Q Consensus       215 ~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~  294 (323)
                      ..|+|||++....     ++.++|+||||+++|+|++|+.||...........+..... ..+..++...++.+.+++++
T Consensus       158 ~~y~~PE~~~~~~-----~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~  231 (277)
T cd05577         158 PGYMAPEVLQGEV-----YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL-EMAVEYPDKFSPEAKDLCEA  231 (277)
T ss_pred             CCcCCHHHhcCCC-----CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc-cccccCCccCCHHHHHHHHH
Confidence            8999999986333     55699999999999999999999976655444444433322 33455667789999999999


Q ss_pred             hcccCcCCCC-----CHHHHhcCcccccCC
Q 020657          295 CLQKEFSKRW-----TASQLLTHPFLCKNR  319 (323)
Q Consensus       295 ~l~~~p~~Rp-----t~~~~l~h~~f~~~~  319 (323)
                      ||+.+|.+||     ++.++++||||.+..
T Consensus       232 ~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~  261 (277)
T cd05577         232 LLQKDPEKRLGCRGGSADEVREHPLFKDLN  261 (277)
T ss_pred             HccCChhHccCCCcccHHHHHhChhhhcCC
Confidence            9999999999     888899999997654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.3e-43  Score=307.60  Aligned_cols=256  Identities=24%  Similarity=0.343  Sum_probs=202.1

Q ss_pred             ccccccceeeeecccCCeEEEEEEecc----------------cCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCcc
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRC----------------THKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI  111 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~----------------~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i  111 (323)
                      +..++|++.+.||+|+||.||+|.+..                ++..||+|++...........+.+|+.++++++||||
T Consensus         2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni   81 (304)
T cd05096           2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNI   81 (304)
T ss_pred             CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCe
Confidence            456799999999999999999998632                3447999999876556667788999999999999999


Q ss_pred             ceeceeEEcCCCeEEEEEeccCCCCHHHHHHhc-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 020657          112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-------------------GTFSEPKLAHIASQILKGLSYLHGHKII  172 (323)
Q Consensus       112 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-------------------~~~~~~~~~~i~~~i~~~l~~Lh~~giv  172 (323)
                      +++++++.+ .+..++||||+.+++|.+++...                   ..+++..+..++.||+.||.|||+.|++
T Consensus        82 v~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv  160 (304)
T cd05096          82 IRLLGVCVD-EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV  160 (304)
T ss_pred             eEEEEEEec-CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            999999987 67799999999999999988642                   2367788999999999999999999999


Q ss_pred             ecCCCCCCeEEecCCCcEEEeecCcchhhccCc--cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHH
Q 020657          173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL--DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELY  250 (323)
Q Consensus       173 H~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~ll  250 (323)
                      |+||||+||+++.++ .+||+|||++.......  .......++..|+|||++...     .++.++||||||+++|+|+
T Consensus       161 H~dlkp~Nill~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~~l~el~  234 (304)
T cd05096         161 HRDLATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-----KFTTASDVWAFGVTLWEIL  234 (304)
T ss_pred             ccCcchhheEEcCCc-cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-----CCCchhhhHHHHHHHHHHH
Confidence            999999999999987 89999999987543321  112233457789999998643     3456999999999999998


Q ss_pred             h--CCCCCCCCCCCccHHHHHHHHhc---CCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHh
Q 020657          251 L--GHFPFLQPGQRPDWATLMCAICF---GDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLL  310 (323)
Q Consensus       251 t--g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l  310 (323)
                      +  +..||..................   ......+..++..+.+|+.+||+.||++|||+++|.
T Consensus       235 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~  299 (304)
T cd05096         235 MLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH  299 (304)
T ss_pred             HccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence            6  66777554332222222211111   111223456789999999999999999999999994

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.1e-43  Score=306.45  Aligned_cols=263  Identities=25%  Similarity=0.400  Sum_probs=209.0

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      ++|++...||+|++|.||+|.+..+++.|++|.+..... ......+.+|+++++++.|+||+++++++.. ....++||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~   80 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-EKRLYLVF   80 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec-CCeEEEEE
Confidence            579999999999999999999998999999999865432 2344667889999999999999999999987 67899999


Q ss_pred             eccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccc
Q 020657          130 EYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA  207 (323)
Q Consensus       130 e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~  207 (323)
                      ||+++ +|.+.+....  .+++..+..++.||+.||.|||+.|++|+||+|+||+++.++..+||+|||++.........
T Consensus        81 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~  159 (294)
T PLN00009         81 EYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT  159 (294)
T ss_pred             ecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence            99965 8877776543  35788999999999999999999999999999999999965557999999999765443333


Q ss_pred             cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC-----------
Q 020657          208 CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD-----------  276 (323)
Q Consensus       208 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~-----------  276 (323)
                      .....++..|+|||.+.+    ...++.++||||||+++|+|+||..||...........+........           
T Consensus       160 ~~~~~~~~~y~~PE~~~~----~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (294)
T PLN00009        160 FTHEVVTLWYRAPEILLG----SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP  235 (294)
T ss_pred             cccCceeecccCHHHHhC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence            344566789999998753    23456699999999999999999999965443322222211111000           


Q ss_pred             ---------CC----CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          277 ---------PP----SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       277 ---------~~----~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                               ..    .....+++.+.+++.+||+.+|++||+++++++||||.+.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~  291 (294)
T PLN00009        236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG  291 (294)
T ss_pred             hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence                     00    01235688899999999999999999999999999998754

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=5.1e-44  Score=304.58  Aligned_cols=247  Identities=29%  Similarity=0.517  Sum_probs=202.0

Q ss_pred             ceeeeecccCCeEEEEEEec----ccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           54 EKLQVLGHGNGGTVYKVQHR----CTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        54 ~~~~~lg~G~~~~v~~~~~~----~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      ++.+.||.|.||.||+|.+.    ..+..|++|.+.........+.+.+|++.+++++||||++++|++.. .+..++|+
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~-~~~~~lv~   80 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE-NEPLFLVM   80 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES-SSSEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccc-cccccccc
Confidence            46789999999999999987    45678999999766666668899999999999999999999999995 66799999


Q ss_pred             eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC--c
Q 020657          130 EYMDSGTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS--L  205 (323)
Q Consensus       130 e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~--~  205 (323)
                      ||+++++|.+++...  ..+++..+..|+.||+.||.|||+.+++|+||+++||+++.++ .+||+|||++......  .
T Consensus        81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~-~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNG-QVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTT-EEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccc
Confidence            999999999999876  6799999999999999999999999999999999999999987 9999999999766221  1


Q ss_pred             cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCC
Q 020657          206 DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA  284 (323)
Q Consensus       206 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (323)
                      ...........|+|||.+....     .+.++||||||+++|||++ |+.||...    ....+............+..+
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~-----~~~ksDVysfG~~l~ei~~~~~~p~~~~----~~~~~~~~~~~~~~~~~~~~~  230 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGE-----YTKKSDVYSFGMLLYEILTLGKFPFSDY----DNEEIIEKLKQGQRLPIPDNC  230 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSE-----ESHHHHHHHHHHHHHHHHTTSSGTTTTS----CHHHHHHHHHTTEETTSBTTS
T ss_pred             cccccccccccccccccccccc-----cccccccccccccccccccccccccccc----ccccccccccccccceeccch
Confidence            2223345678999999986433     5679999999999999999 78888443    334444555555566677889


Q ss_pred             ChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          285 SPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       285 ~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      +..+.+++.+||+.+|++|||+.++++
T Consensus       231 ~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  231 PKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             BHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             hHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            999999999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.8e-43  Score=303.35  Aligned_cols=252  Identities=30%  Similarity=0.502  Sum_probs=202.7

Q ss_pred             eecccCCeEEEEEEecccCcEEEEEeecCCCC--hHHHHHHHHHHHHH---HcCCCCccceeceeEEcCCCeEEEEEecc
Q 020657           58 VLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD--PTVRRQVFREMEIL---RRTDSPFIVQCFGIFEKPSGDIAILMEYM  132 (323)
Q Consensus        58 ~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~~lv~e~~  132 (323)
                      .||+|+||.||++.+..+++.+++|.+.....  ........+|..++   ....|++|+.+++.+.. .+..++||||+
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~   79 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-PDKLCFILDLM   79 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-CCeEEEEEecC
Confidence            48999999999999988999999999865421  12222333444333   33579999999999987 67899999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccccccc
Q 020657          133 DSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYV  212 (323)
Q Consensus       133 ~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  212 (323)
                      ++++|.+++...+.+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++......  ......
T Consensus        80 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~-~~~l~dfg~~~~~~~~--~~~~~~  156 (279)
T cd05633          80 NGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKK--KPHASV  156 (279)
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCC-CEEEccCCcceecccc--CccCcC
Confidence            9999999998888899999999999999999999999999999999999999887 8999999998654332  223346


Q ss_pred             ccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHH
Q 020657          213 GTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFI  292 (323)
Q Consensus       213 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll  292 (323)
                      ++..|+|||.+..    ....+.++|+||+|+++|+|++|..||....... ...+ ..........++..++.++.+++
T Consensus       157 ~~~~y~aPE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~li  230 (279)
T cd05633         157 GTHGYMAPEVLQK----GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEI-DRMTLTVNVELPDSFSPELKSLL  230 (279)
T ss_pred             CCcCccCHHHhcC----CCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC-HHHH-HHHhhcCCcCCccccCHHHHHHH
Confidence            8899999998752    2334569999999999999999999997554322 2222 22222334556678899999999


Q ss_pred             HHhcccCcCCCC-----CHHHHhcCcccccCC
Q 020657          293 ECCLQKEFSKRW-----TASQLLTHPFLCKNR  319 (323)
Q Consensus       293 ~~~l~~~p~~Rp-----t~~~~l~h~~f~~~~  319 (323)
                      ++||..||++|+     |+.++++||||++..
T Consensus       231 ~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~  262 (279)
T cd05633         231 EGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID  262 (279)
T ss_pred             HHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence            999999999999     699999999999865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.5e-43  Score=303.13  Aligned_cols=254  Identities=22%  Similarity=0.308  Sum_probs=207.2

Q ss_pred             chhcccccccee--eeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEc
Q 020657           45 TAAIAYSDLEKL--QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEK  120 (323)
Q Consensus        45 ~~~~~~~~~~~~--~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  120 (323)
                      ...+..++++..  ..+++|+++.||+|.+  +|+.||+|.+....  .....+.+.+|+.++++++||||+++++++.+
T Consensus        12 ~~~i~~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~   89 (283)
T PHA02988         12 IKCIESDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIID   89 (283)
T ss_pred             ceecCHHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEe
Confidence            344455555555  7899999999999998  68899999997553  22335678899999999999999999999865


Q ss_pred             --C-CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCCeEEecCCCcEEEeecC
Q 020657          121 --P-SGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH-KIIHRDIKPSNLLVNNNNMQVKIADFG  196 (323)
Q Consensus       121 --~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-givH~di~~~nil~~~~~~~~kl~Dfg  196 (323)
                        . ....++||||+++|+|.+++...+.+++.....++.+++.||.+||+. +++||||+|+||+++.++ .+||+|||
T Consensus        90 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~-~~kl~dfg  168 (283)
T PHA02988         90 IVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY-KLKIICHG  168 (283)
T ss_pred             cccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC-cEEEcccc
Confidence              2 346899999999999999998888899999999999999999999985 999999999999999987 89999999


Q ss_pred             cchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHH-hcC
Q 020657          197 VSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAI-CFG  275 (323)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~-~~~  275 (323)
                      ++.......   ....++..|+|||++...   ...++.++||||||+++|||++|..||.....    ..+...+ ...
T Consensus       169 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~---~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~----~~~~~~i~~~~  238 (283)
T PHA02988        169 LEKILSSPP---FKNVNFMVYFSYKMLNDI---FSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT----KEIYDLIINKN  238 (283)
T ss_pred             hHhhhcccc---ccccCcccccCHHHhhhc---cccccchhhhhHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHhcC
Confidence            987653321   234678899999998631   13456799999999999999999999965432    2222222 223


Q ss_pred             CCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          276 DPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       276 ~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ....++..+++++.+|+.+||+.||++|||++++++
T Consensus       239 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        239 NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            345566678999999999999999999999999985

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2e-43  Score=306.61  Aligned_cols=260  Identities=26%  Similarity=0.407  Sum_probs=203.9

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCCh-HHHHHHHHHHHHHHcCC-CCccceeceeEEcCCC----e
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADP-TVRRQVFREMEILRRTD-SPFIVQCFGIFEKPSG----D  124 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~----~  124 (323)
                      ++|++.+.||+|++|.||+|.+..+++.|++|.+...... .....+.+|+.+++.+. |+||+++++++...+.    .
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            4799999999999999999999989999999998654322 23456778999999995 6999999999876322    3


Q ss_pred             EEEEEeccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEec-CCCcEEEeecCcc
Q 020657          125 IAILMEYMDSGTLDTLLNK-----NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNN-NNMQVKIADFGVS  198 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~-~~~~~kl~Dfg~~  198 (323)
                      .++||||+++ +|.+++..     ...+++..++.++.||+.||.|||+.|++|+||+|+||+++. ++ .++|+|||++
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~-~~kl~dfg~~  158 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKG-LLKIADLGLG  158 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCC-eEEEeecccc
Confidence            7999999986 88887753     235799999999999999999999999999999999999998 55 8999999998


Q ss_pred             hhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCC-
Q 020657          199 KIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP-  277 (323)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~-  277 (323)
                      ..............++..|+|||.+.+    ....+.++|+||||+++|+|++|..||.+.+.......+......... 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (295)
T cd07837         159 RAFSIPVKSYTHEIVTLWYRAPEVLLG----STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ  234 (295)
T ss_pred             eecCCCccccCCcccccCCCChHHhhC----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            765443333334456788999998752    233466999999999999999999999764433222222211110000 


Q ss_pred             ----------------------CCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccc
Q 020657          278 ----------------------PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLC  316 (323)
Q Consensus       278 ----------------------~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~  316 (323)
                                            ......++.++.+|+.+||..||.+|||+++++.||||+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                                  001135788999999999999999999999999999995

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-44  Score=337.58  Aligned_cols=255  Identities=24%  Similarity=0.392  Sum_probs=217.1

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccC-----cEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEc
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTH-----KIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEK  120 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  120 (323)
                      ..+.....+..+.||+|.||.||.|......     ..|++|.+....+.+....|.+|..+|+.+.||||++++|++.+
T Consensus       687 p~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~  766 (1025)
T KOG1095|consen  687 PEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD  766 (1025)
T ss_pred             ccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence            4466888999999999999999999965432     24999999988888889999999999999999999999999998


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEe
Q 020657          121 PSGDIAILMEYMDSGTLDTLLNKN-------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIA  193 (323)
Q Consensus       121 ~~~~~~lv~e~~~~~sL~~~l~~~-------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~  193 (323)
                       .+..++++|||.+|+|..++++.       ..++....+.++.+||+|+.||+++++|||||.++|+|++... .+||+
T Consensus       767 -~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r-~VKIa  844 (1025)
T KOG1095|consen  767 -SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERR-VVKIA  844 (1025)
T ss_pred             -CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccC-cEEEc
Confidence             78899999999999999999865       3589999999999999999999999999999999999999996 99999


Q ss_pred             ecCcchhhccCcc-cccc-ccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHH
Q 020657          194 DFGVSKIMCRSLD-ACNS-YVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMC  270 (323)
Q Consensus       194 Dfg~~~~~~~~~~-~~~~-~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~  270 (323)
                      |||+|+.+..... .... ..-..+|||||.+....     .|.|+||||||+++||++| |..||....+.   + ++.
T Consensus       845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~i-----FtskSDvWsFGVllWEifslG~~PY~~~~n~---~-v~~  915 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGI-----FTSKSDVWSFGVLLWEIFSLGATPYPSRSNF---E-VLL  915 (1025)
T ss_pred             ccchhHhhhhchheeccCccccceecCCHHHHhhcc-----cccccchhhhHHHHHHHHhCCCCCCCCcchH---H-HHH
Confidence            9999995543322 2222 24557999999997544     4569999999999999997 99999554432   3 333


Q ss_pred             HHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          271 AICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ....+.+...|..++..++++|.+||+.+|++||++..|++
T Consensus       916 ~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  916 DVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             HHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            23334478888999999999999999999999999999986

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=5.1e-43  Score=297.71  Aligned_cols=253  Identities=35%  Similarity=0.609  Sum_probs=217.4

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEe
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILME  130 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e  130 (323)
                      +|++.+.||.|++|.||++.+..+++.+++|++..... ......+.+|+++++.++|+|++++.+.+.. ....++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-~~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE-KGKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec-CCEEEEEEE
Confidence            58899999999999999999988899999999975532 3556778899999999999999999999987 588999999


Q ss_pred             ccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc
Q 020657          131 YMDSGTLDTLLNKN----GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD  206 (323)
Q Consensus       131 ~~~~~sL~~~l~~~----~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~  206 (323)
                      ++++++|.+.+...    ..+++..+..++.+++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+........
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~~~  158 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNG-LVKLGDFGISKVLSSTVD  158 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCC-cEEECCccceeecccCcc
Confidence            99999999998763    6799999999999999999999999999999999999999987 899999999977655433


Q ss_pred             ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCCh
Q 020657          207 ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP  286 (323)
Q Consensus       207 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (323)
                      ......++..|+|||.+....     .+.++|+|++|+++++|++|..||...+    ...+...........++...+.
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~-----~~~~~Dv~slG~~~~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~  229 (258)
T cd08215         159 LAKTVVGTPYYLSPELCQNKP-----YNYKSDIWSLGCVLYELCTLKHPFEGEN----LLELALKILKGQYPPIPSQYSS  229 (258)
T ss_pred             eecceeeeecccChhHhccCC-----CCccccHHHHHHHHHHHHcCCCCCCCCc----HHHHHHHHhcCCCCCCCCCCCH
Confidence            334456788999999876433     4569999999999999999999995443    3344444444455667778899


Q ss_pred             hHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          287 EFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       287 ~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                      ++.+++++||+.+|.+|||++++|+||||
T Consensus       230 ~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         230 ELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            99999999999999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=6e-43  Score=305.13  Aligned_cols=258  Identities=29%  Similarity=0.482  Sum_probs=210.8

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC--hHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD--PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ++|++.+.||+|++|.||++.+..+++.|++|.+.....  ......+.+|+.+++.++||||+++++.+.. .+..++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv   79 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET-KRHLCMV   79 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec-CCEEEEE
Confidence            478999999999999999999999999999999865431  2345677889999999999999999999987 6789999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc---
Q 020657          129 MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL---  205 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~---  205 (323)
                      |||+++++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.......   
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~-~~~l~dfg~~~~~~~~~~~~  158 (305)
T cd05609          80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMG-HIKLTDFGLSKIGLMSLTTN  158 (305)
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCC-CEEEeeCCCccccCcCcccc
Confidence            99999999999998888899999999999999999999999999999999999999987 89999999886321100   


Q ss_pred             ------------cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHh
Q 020657          206 ------------DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAIC  273 (323)
Q Consensus       206 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~  273 (323)
                                  .......++..|+|||.+..     ...+.++|+||||+++|+|++|..||.+...    ..+.....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~vl~el~~g~~pf~~~~~----~~~~~~~~  229 (305)
T cd05609         159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-----QGYGKPVDWWAMGIILYEFLVGCVPFFGDTP----EELFGQVI  229 (305)
T ss_pred             ccccccccchhhccccCCccCccccCchhccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHH
Confidence                        01112346778999998763     3345699999999999999999999964422    33333332


Q ss_pred             cCC--CCCCCCCCChhHHHHHHHhcccCcCCCCC---HHHHhcCcccccCC
Q 020657          274 FGD--PPSLPDGASPEFRSFIECCLQKEFSKRWT---ASQLLTHPFLCKNR  319 (323)
Q Consensus       274 ~~~--~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt---~~~~l~h~~f~~~~  319 (323)
                      ...  .+.....++.++.+++.+||+.+|++||+   +.++|+||||.+.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~  280 (305)
T cd05609         230 SDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD  280 (305)
T ss_pred             hcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence            221  12222367899999999999999999998   79999999996643

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1e-43  Score=308.66  Aligned_cols=260  Identities=28%  Similarity=0.501  Sum_probs=213.5

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEe
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILME  130 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e  130 (323)
                      +.|.....||+|+||.||+|.+..+++.|++|++..... .....+.+|+.+++.+.||||+++++.+.. ++..++|+|
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~~~iv~e   98 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLV-GEELWVLME   98 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheee-CCeEEEEEe
Confidence            445666789999999999999988899999999864432 334667899999999999999999999887 678999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccccc
Q 020657          131 YMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNS  210 (323)
Q Consensus       131 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~  210 (323)
                      |+++++|..++.. ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||++............
T Consensus        99 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~-~~kL~dfg~~~~~~~~~~~~~~  176 (297)
T cd06659          99 FLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKS  176 (297)
T ss_pred             cCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCC-cEEEeechhHhhcccccccccc
Confidence            9999999987755 4689999999999999999999999999999999999999987 8999999998765443333345


Q ss_pred             ccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC--CCCCCCCCChhH
Q 020657          211 YVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD--PPSLPDGASPEF  288 (323)
Q Consensus       211 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l  288 (323)
                      ..++..|+|||++...     ..+.++||||||+++|+|++|+.||.......   .+ .......  .......++..+
T Consensus       177 ~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~-~~~~~~~~~~~~~~~~~~~~l  247 (297)
T cd06659         177 LVGTPYWMAPEVISRT-----PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AM-KRLRDSPPPKLKNAHKISPVL  247 (297)
T ss_pred             eecCccccCHHHHccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH-HHHhccCCCCccccCCCCHHH
Confidence            6688999999998633     34569999999999999999999996543221   11 1111111  122234678899


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCcccccCCCCCC
Q 020657          289 RSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSDC  323 (323)
Q Consensus       289 ~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~~~  323 (323)
                      .+++++||+.+|++||+++++++|+||.+-..+.|
T Consensus       248 ~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~~~  282 (297)
T cd06659         248 RDFLERMLTREPQERATAQELLDHPFLLQTGLPEC  282 (297)
T ss_pred             HHHHHHHhcCCcccCcCHHHHhhChhhccCCCccc
Confidence            99999999999999999999999999988776665

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.5e-43  Score=310.53  Aligned_cols=251  Identities=25%  Similarity=0.382  Sum_probs=190.7

Q ss_pred             eeeecccCCeEEEEEEec--ccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcC-CCeEEEEEecc
Q 020657           56 LQVLGHGNGGTVYKVQHR--CTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP-SGDIAILMEYM  132 (323)
Q Consensus        56 ~~~lg~G~~~~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~lv~e~~  132 (323)
                      ..+||+|+||.||+|++.  .+++.+++|.+.....   ...+.+|+.++++++||||+++++++... +...+++|||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence            358999999999999965  4678899999864432   23467899999999999999999998642 45688999999


Q ss_pred             CCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEe----cCCCcEEEeecCcch
Q 020657          133 DSGTLDTLLNKN---------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVN----NNNMQVKIADFGVSK  199 (323)
Q Consensus       133 ~~~sL~~~l~~~---------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~----~~~~~~kl~Dfg~~~  199 (323)
                      .+ +|.+++...         ..+++..++.++.||+.||.|||+.|++|+||||+||+++    ..+ .+||+|||++.
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~-~~kl~DfG~a~  160 (317)
T cd07868          83 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG-RVKIADMGFAR  160 (317)
T ss_pred             CC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcC-cEEEeecCcee
Confidence            65 888877521         2489999999999999999999999999999999999994    334 89999999997


Q ss_pred             hhccCcc---ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCcc---------HHH
Q 020657          200 IMCRSLD---ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPD---------WAT  267 (323)
Q Consensus       200 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~---------~~~  267 (323)
                      .......   ......++..|+|||++.+.    ..++.++||||+|+++|+|++|+.||........         ...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~  236 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGA----RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR  236 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcCC----CCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence            6643321   22345678999999988632    2345699999999999999999999965432110         011


Q ss_pred             HHHHHhc------------CC------------C---------CCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcc
Q 020657          268 LMCAICF------------GD------------P---------PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPF  314 (323)
Q Consensus       268 ~~~~~~~------------~~------------~---------~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~  314 (323)
                      +......            ..            .         .......+.++.+|+++||++||++|||++|+|+|||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~  316 (317)
T cd07868         237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY  316 (317)
T ss_pred             HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence            1000000            00            0         0001123567899999999999999999999999999


Q ss_pred             c
Q 020657          315 L  315 (323)
Q Consensus       315 f  315 (323)
                      |
T Consensus       317 f  317 (317)
T cd07868         317 F  317 (317)
T ss_pred             C
Confidence            8

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-43  Score=313.09  Aligned_cols=264  Identities=30%  Similarity=0.422  Sum_probs=207.8

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC----CeE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS----GDI  125 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~  125 (323)
                      .++|++.+.||+|++|.||+|.+..+++.|++|++...........+.+|+.+++.++|+||+++++++....    ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            4789999999999999999999998999999999875444455667888999999999999999999875422    357


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc
Q 020657          126 AILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL  205 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~  205 (323)
                      ++|+||+.+ +|.+.+.. ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus        84 ~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~  160 (336)
T cd07849          84 YIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNC-DLKICDFGLARIADPEH  160 (336)
T ss_pred             EEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC-CEEECcccceeeccccc
Confidence            999999975 88877754 4689999999999999999999999999999999999999987 89999999987653322


Q ss_pred             c---ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhc--------
Q 020657          206 D---ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICF--------  274 (323)
Q Consensus       206 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~--------  274 (323)
                      .   ......++..|+|||.+..    ....+.++||||||+++|+|++|+.||...........+......        
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
T cd07849         161 DHTGFLTEYVATRWYRAPEIMLN----SKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC  236 (336)
T ss_pred             cccCCcCCcCcCCCccChHHhhC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence            1   1123467889999998642    233456999999999999999999999654322111111100000        


Q ss_pred             -------------CCCCC-----CCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          275 -------------GDPPS-----LPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       275 -------------~~~~~-----~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                                   .....     .....+.++.+++.+||+.+|++|||+.++++||||.....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence                         00000     11346788999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.9e-43  Score=306.59  Aligned_cols=260  Identities=27%  Similarity=0.385  Sum_probs=207.9

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcCCCCccceeceeEEcCC-CeEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS-GDIAI  127 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~l  127 (323)
                      .++|++.+.||.|++|.||+|.+..+++.+++|.+..... ......+.+|+.++++++||||+++++++.... ...++
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            4689999999999999999999998899999999975432 223345678999999999999999999987622 78999


Q ss_pred             EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc
Q 020657          128 LMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD  206 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~  206 (323)
                      ||||+.+ +|.+++... ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++........
T Consensus        84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~  161 (293)
T cd07843          84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRG-ILKICDFGLAREYGSPLK  161 (293)
T ss_pred             EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC-cEEEeecCceeeccCCcc
Confidence            9999975 999888754 3589999999999999999999999999999999999999987 899999999987655433


Q ss_pred             ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhc------------
Q 020657          207 ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICF------------  274 (323)
Q Consensus       207 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~------------  274 (323)
                      ......++..|+|||.+.+..    ..+.++|+||||+++|+|++|..||...........+......            
T Consensus       162 ~~~~~~~~~~~~aPE~~~~~~----~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
T cd07843         162 PYTQLVVTLWYRAPELLLGAK----EYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL  237 (293)
T ss_pred             ccccccccccccCchhhcCCc----cccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence            334456788999999875322    2456999999999999999999999654432222222111100            


Q ss_pred             --------------CCCCCCCCC-CChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          275 --------------GDPPSLPDG-ASPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       275 --------------~~~~~~~~~-~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                                    .....++.. +++.+.+++++||+.+|++|||+.++++|+||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                          000112222 58889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.8e-43  Score=301.57  Aligned_cols=256  Identities=22%  Similarity=0.357  Sum_probs=207.6

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecc-----cCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEc
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRC-----THKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEK  120 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  120 (323)
                      |.+..++|++.+.||+|++|.||+|.+..     ++..|++|++...........+.+|+.+++.++|+||+++++++..
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~   80 (277)
T cd05062           1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   80 (277)
T ss_pred             CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            45678899999999999999999998642     3567999998655444456678899999999999999999999876


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcE
Q 020657          121 PSGDIAILMEYMDSGTLDTLLNKNG----------TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQV  190 (323)
Q Consensus       121 ~~~~~~lv~e~~~~~sL~~~l~~~~----------~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~  190 (323)
                       ....++||||+++++|.+++....          .++...+..++.|++.||.|||+.|++|+||||+||+++.++ .+
T Consensus        81 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~-~~  158 (277)
T cd05062          81 -GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-TV  158 (277)
T ss_pred             -CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCC-CE
Confidence             678999999999999999986522          357788999999999999999999999999999999999987 89


Q ss_pred             EEeecCcchhhccCcc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHH
Q 020657          191 KIADFGVSKIMCRSLD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWAT  267 (323)
Q Consensus       191 kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~  267 (323)
                      +|+|||++........  ......++..|+|||.+..     ...+.++||||||+++|+|++ |..||.+..    ...
T Consensus       159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~~~~~p~~~~~----~~~  229 (277)
T cd05062         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-----GVFTTYSDVWSFGVVLWEIATLAEQPYQGMS----NEQ  229 (277)
T ss_pred             EECCCCCccccCCcceeecCCCCccCHhhcChhHhhc-----CCcCchhHHHHHHHHHHHHHcCCCCCCCCCC----HHH
Confidence            9999999865433211  1112344678999999863     334569999999999999998 788885442    233


Q ss_pred             HHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          268 LMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      .............+..++..+.+++.+||+.+|++|||+.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         230 VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            333333444455667789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=6.4e-43  Score=298.57  Aligned_cols=254  Identities=24%  Similarity=0.375  Sum_probs=210.0

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeE
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDI  125 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  125 (323)
                      |++...+|.+.+.||+|++|.||+|.+..+++.+++|.+....  .....+.+|+.+++.++|+||+++++++.. ++..
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   77 (263)
T cd05052           1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPF   77 (263)
T ss_pred             CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc--hHHHHHHHHHHHHHhCCCCChhheEEEEcC-CCCc
Confidence            4577788999999999999999999998889999999986442  334668899999999999999999999887 6789


Q ss_pred             EEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          126 AILMEYMDSGTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      +++|||+++++|.+++...  ..+++..+..++.|++++|.+||+.|++|+||+|+||+++.++ .++|+|||++.....
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~df~~~~~~~~  156 (263)
T cd05052          78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTG  156 (263)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC-cEEeCCCcccccccc
Confidence            9999999999999998653  3589999999999999999999999999999999999999887 899999999976543


Q ss_pred             Ccccc-ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCC
Q 020657          204 SLDAC-NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLP  281 (323)
Q Consensus       204 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (323)
                      ..... .....+..|+|||.+...     ..+.++||||||+++|+|++ |..||.+..    ................+
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~il~el~t~g~~p~~~~~----~~~~~~~~~~~~~~~~~  227 (263)
T cd05052         157 DTYTAHAGAKFPIKWTAPESLAYN-----KFSIKSDVWAFGVLLWEIATYGMSPYPGID----LSQVYELLEKGYRMERP  227 (263)
T ss_pred             ceeeccCCCCCccccCCHHHhccC-----CCCchhHHHHHHHHHHHHHcCCCCCCCCCC----HHHHHHHHHCCCCCCCC
Confidence            22111 122235679999987633     34568999999999999998 999985433    23333334434455667


Q ss_pred             CCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          282 DGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       282 ~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ..++.++.+++.+||+.+|++|||+.++++.
T Consensus       228 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~  258 (263)
T cd05052         228 EGCPPKVYELMRACWQWNPSDRPSFAEIHQA  258 (263)
T ss_pred             CCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence            7889999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-43  Score=304.23  Aligned_cols=256  Identities=24%  Similarity=0.427  Sum_probs=206.1

Q ss_pred             cceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEec
Q 020657           53 LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEY  131 (323)
Q Consensus        53 ~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~  131 (323)
                      |++.+.||.|++|.||+|.+..+|+.|++|++..... ......+.+|+.+++.++|+|++++++++.+ .+..+++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~-~~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS-ENKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc-CCeEEEEEec
Confidence            6788999999999999999988999999999875432 2234567789999999999999999999987 6889999999


Q ss_pred             cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccc
Q 020657          132 MDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN  209 (323)
Q Consensus       132 ~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~  209 (323)
                      ++ ++|.+++....  .+++..+..++.|+++||.|||+.|++|+||+|+||+++.++ .++|+|||.+...........
T Consensus        80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~  157 (283)
T cd07835          80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG-ALKLADFGLARAFGVPVRTYT  157 (283)
T ss_pred             cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC-cEEEeecccccccCCCccccC
Confidence            96 58999987665  689999999999999999999999999999999999999987 899999999976543333333


Q ss_pred             cccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHh----------------
Q 020657          210 SYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAIC----------------  273 (323)
Q Consensus       210 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~----------------  273 (323)
                      ...++..|+|||++..    ....+.++|+||||+++|+|++|+.||...+.......+.+...                
T Consensus       158 ~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         158 HEVVTLWYRAPEILLG----SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             ccccccCCCCCceeec----CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence            4456789999998752    22345699999999999999999999965433221111111100                


Q ss_pred             --------cCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          274 --------FGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       274 --------~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                              ..........++..+.+++.+||+.+|.+|||++++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                    000111234677899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.5e-43  Score=305.01  Aligned_cols=262  Identities=37%  Similarity=0.633  Sum_probs=209.8

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCC-CCccceeceeEEcCCCeEEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD-SPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      .++|+..+.||+|++|.||++.+..+++.+++|.+...........+.+|+.++.++. |+||+++++++.. ++..+++
T Consensus         3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-~~~~~~~   81 (288)
T cd06616           3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-EGDCWIC   81 (288)
T ss_pred             HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-CCcEEEE
Confidence            4678888999999999999999999999999999976554455677889999999985 9999999999887 6778999


Q ss_pred             EeccCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          129 MEYMDSGTLDTLLN-----KNGTFSEPKLAHIASQILKGLSYLHGH-KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       129 ~e~~~~~sL~~~l~-----~~~~~~~~~~~~i~~~i~~~l~~Lh~~-givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      |||+.. ++.++..     ....+++..+..++.+++.||+|||+. |++|+||+|+||+++.++ .++|+|||++....
T Consensus        82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~  159 (288)
T cd06616          82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG-NIKLCDFGISGQLV  159 (288)
T ss_pred             EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC-cEEEeecchhHHhc
Confidence            999864 6655432     245799999999999999999999975 999999999999999887 89999999997654


Q ss_pred             cCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCC-
Q 020657          203 RSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLP-  281 (323)
Q Consensus       203 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-  281 (323)
                      .... .....++..|+|||++....  ...++.++||||||+++|+|++|+.||....  .....+. .......+.+. 
T Consensus       160 ~~~~-~~~~~~~~~y~aPE~~~~~~--~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~-~~~~~~~~~~~~  233 (288)
T cd06616         160 DSIA-KTRDAGCRPYMAPERIDPSA--RDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLT-QVVKGDPPILSN  233 (288)
T ss_pred             cCCc-cccccCccCccCHHHhcccc--ccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHh-hhcCCCCCcCCC
Confidence            3322 22345788999999986432  2345679999999999999999999996443  2222222 22222222222 


Q ss_pred             ---CCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          282 ---DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       282 ---~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                         ..++.++.+|+++||+.+|++|||++++++||||++...
T Consensus       234 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~  275 (288)
T cd06616         234 SEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEE  275 (288)
T ss_pred             cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhh
Confidence               347899999999999999999999999999999987543

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.7e-43  Score=300.29  Aligned_cols=256  Identities=31%  Similarity=0.485  Sum_probs=207.6

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC---------hHHHHHHHHHHHHHHcCCCCccceeceeEEcCC
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD---------PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS  122 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  122 (323)
                      +|.+.+.||+|++|.||+|.+..+++.+++|.+.....         ....+.+.+|+.+++.++|+|++++++++.. .
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   80 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-E   80 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc-C
Confidence            57889999999999999999988899999998853211         1124567889999999999999999999887 6


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          123 GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      +..++||||+++++|.+.+.....+++..+..++.||+.||.+||+.|++|+||+|+||+++.++ .++|+|||++....
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~-~~~l~d~~~~~~~~  159 (272)
T cd06629          81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADG-ICKISDFGISKKSD  159 (272)
T ss_pred             CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCC-eEEEeecccccccc
Confidence            78999999999999999998877899999999999999999999999999999999999999887 89999999987543


Q ss_pred             cCcc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCC-
Q 020657          203 RSLD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPS-  279 (323)
Q Consensus       203 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-  279 (323)
                      ....  ......++..|+|||.+....   ...+.++|+||||+++|++++|..||......   ..+........... 
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~---~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~  233 (272)
T cd06629         160 DIYDNDQNMSMQGSVFWMAPEVIHSYS---QGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI---AAMFKLGNKRSAPPI  233 (272)
T ss_pred             ccccccccccccCCccccCHHHhcccc---CCCCccchhHHHHHHHHHHHhCCCCCcCcchH---HHHHHhhccccCCcC
Confidence            2211  122345778999999876332   23566999999999999999999999533222   22222211222222 


Q ss_pred             ---CCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          280 ---LPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       280 ---~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                         ....++.++.+++.+||+.+|.+|||++++++||||
T Consensus       234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         234 PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence               224568999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.7e-43  Score=312.74  Aligned_cols=265  Identities=27%  Similarity=0.390  Sum_probs=210.6

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC----Ce
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS----GD  124 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~  124 (323)
                      ..+|++...||+|++|.||+|.+..+++.|++|.+.... .......+.+|+.+++.++|+||+++++++....    ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            458999999999999999999999899999999987542 2233456778999999999999999999876432    35


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC
Q 020657          125 IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS  204 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~  204 (323)
                      .++|+||+. ++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~  161 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARTTSEK  161 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEECcCccccccCCC
Confidence            899999996 58999998878899999999999999999999999999999999999999987 8999999999765443


Q ss_pred             ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHH--------------
Q 020657          205 LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMC--------------  270 (323)
Q Consensus       205 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~--------------  270 (323)
                      ........++..|+|||.+...    ...+.++|+||||+++|+|++|..||.+.+.......+..              
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07858         162 GDFMTEYVVTRWYRAPELLLNC----SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR  237 (337)
T ss_pred             cccccccccccCccChHHHhcC----CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence            2223344678899999987532    2245699999999999999999999965432111111110              


Q ss_pred             ---------HHhcCCC---CCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          271 ---------AICFGDP---PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       271 ---------~~~~~~~---~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                               .......   ......+++++.+|+++||+.+|++|||++++++||||...+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~  299 (337)
T cd07858         238 NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD  299 (337)
T ss_pred             chhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence                     0000000   0122467899999999999999999999999999999987554

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-43  Score=303.99  Aligned_cols=259  Identities=29%  Similarity=0.489  Sum_probs=209.8

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      ++|++.+.||+|++|.||+|.+..+++.|++|.+.... .......+.+|+++++.+.|+||+++++++.. .+..++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~   79 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-KGRLYLVF   79 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-CCEEEEEE
Confidence            47999999999999999999999889999999987543 23445778899999999999999999999987 67899999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc-cc
Q 020657          130 EYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD-AC  208 (323)
Q Consensus       130 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~-~~  208 (323)
                      ||++++.+..+..+...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++........ ..
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~-~~kl~d~g~~~~~~~~~~~~~  158 (288)
T cd07833          80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESG-VLKLCDFGFARALRARPASPL  158 (288)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEEEeeecccccCCCccccc
Confidence            9999877777776666799999999999999999999999999999999999999987 899999999876654332 33


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhc--------------
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICF--------------  274 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~--------------  274 (323)
                      ....++..|+|||++...    ...+.++|+||||+++|+|++|..||...........+......              
T Consensus       159 ~~~~~~~~~~~PE~~~~~----~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07833         159 TDYVATRWYRAPELLVGD----TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR  234 (288)
T ss_pred             cCcccccCCcCCchhcCC----CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence            345677889999998633    14566999999999999999999999654332211111110000              


Q ss_pred             --C-C----------CCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          275 --G-D----------PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       275 --~-~----------~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                        . .          ...++..++.++.+|+++||..+|++|||++++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence              0 0          001223458899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=8e-43  Score=298.50  Aligned_cols=253  Identities=26%  Similarity=0.450  Sum_probs=208.7

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCC--CChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ++|++.+.||+|++|.||+|++..+++.|++|.+...  .+......+.+|+.+++.++||||+++++++.. .+..++|
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v   80 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-DNELNIV   80 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-CCeEEEE
Confidence            6899999999999999999999989999999987642  334556678899999999999999999999987 5789999


Q ss_pred             EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC
Q 020657          129 MEYMDSGTLDTLLNK----NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS  204 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~  204 (323)
                      +||+++++|.+++..    ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~-~~~l~d~g~~~~~~~~  159 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCC-CEEECccccceeccch
Confidence            999999999988853    34589999999999999999999999999999999999999987 8999999998765443


Q ss_pred             ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCC-CC
Q 020657          205 LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLP-DG  283 (323)
Q Consensus       205 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  283 (323)
                      ........++..|+|||.+...     ..+.++|+||||+++|+|++|..||.....  ....+.........+..+ ..
T Consensus       160 ~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~Di~slG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~  232 (267)
T cd08228         160 TTAAHSLVGTPYYMSPERIHEN-----GYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLFSLCQKIEQCDYPPLPTEH  232 (267)
T ss_pred             hHHHhcCCCCccccChhhhccC-----CCCchhhHHHHHHHHHHHhcCCCCCccccc--cHHHHHHHHhcCCCCCCChhh
Confidence            3333345678899999988633     345689999999999999999999965432  223333333333333333 46


Q ss_pred             CChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          284 ASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       284 ~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      .+..+.+++.+||+.+|++|||++++++.
T Consensus       233 ~~~~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         233 YSEKLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             cCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence            78899999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3.2e-43  Score=303.31  Aligned_cols=255  Identities=28%  Similarity=0.413  Sum_probs=200.4

Q ss_pred             cceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCC-CCccceeceeEEcC-CCeEEEEEe
Q 020657           53 LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD-SPFIVQCFGIFEKP-SGDIAILME  130 (323)
Q Consensus        53 ~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~-~~~~~lv~e  130 (323)
                      |++.+.||+|++|.||+|.+..+++.+++|.+.............+|+.+++++. |+|++++++++.+. .+..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            6789999999999999999998999999999875533333334557888888885 99999999998863 167999999


Q ss_pred             ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccc
Q 020657          131 YMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN  209 (323)
Q Consensus       131 ~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~  209 (323)
                      |+.+ ++.+.+.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++. + .++|+|||++........ ..
T Consensus        81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~-~~kl~dfg~~~~~~~~~~-~~  156 (282)
T cd07831          81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-D-ILKLADFGSCRGIYSKPP-YT  156 (282)
T ss_pred             cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-C-CeEEEecccccccccCCC-cC
Confidence            9975 77777765 457899999999999999999999999999999999999999 6 899999999976543322 22


Q ss_pred             cccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHH-----------hcCC--
Q 020657          210 SYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAI-----------CFGD--  276 (323)
Q Consensus       210 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~-----------~~~~--  276 (323)
                      ...++..|+|||.+..    ....+.++||||||+++|+|++|..||...+.......+....           ....  
T Consensus       157 ~~~~~~~y~aPE~~~~----~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07831         157 EYISTRWYRAPECLLT----DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM  232 (282)
T ss_pred             CCCCCcccCChhHhhc----CCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence            3457889999997642    2334569999999999999999999996654322222111100           0000  


Q ss_pred             CC-----------CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          277 PP-----------SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       277 ~~-----------~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                      ..           .+...++.++.+++.+||+.+|++|||++++++||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            00           0113568999999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=8.6e-43  Score=300.95  Aligned_cols=254  Identities=23%  Similarity=0.387  Sum_probs=208.8

Q ss_pred             ccccccceeeeecccCCeEEEEEEec----ccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCC
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHR----CTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG  123 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~----~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  123 (323)
                      +..++|++.+.||+|+||.||+|.+.    .++..+++|.+...........+.+|+.+++.++|+||+++++++.. ..
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~   80 (283)
T cd05090           2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ-EQ   80 (283)
T ss_pred             CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-CC
Confidence            45688999999999999999999853    35678999999766555666778899999999999999999999887 67


Q ss_pred             eEEEEEeccCCCCHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecC
Q 020657          124 DIAILMEYMDSGTLDTLLNKN-----------------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNN  186 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~-----------------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~  186 (323)
                      ..++||||+++++|.+++...                 ..+++..+..++.|++.||.|||++|++|+||+|+||+++.+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~  160 (283)
T cd05090          81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ  160 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence            899999999999999998532                 247888999999999999999999999999999999999988


Q ss_pred             CCcEEEeecCcchhhccCc--cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 020657          187 NMQVKIADFGVSKIMCRSL--DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRP  263 (323)
Q Consensus       187 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~  263 (323)
                      + .++|+|||++.......  .......++..|+|||.+...     ..+.++|+||||+++|+|++ |..||.+...  
T Consensus       161 ~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--  232 (283)
T cd05090         161 L-HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-----KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--  232 (283)
T ss_pred             C-cEEeccccccccccCCcceecccCCCccceecChHHhccC-----CCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--
Confidence            6 89999999997653221  112233456679999988633     34569999999999999998 9999955432  


Q ss_pred             cHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          264 DWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                        ..+.+.+........+..+++.+.+++.+||+.||++||++.+++++
T Consensus       233 --~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         233 --QEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             --HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence              33344444444555667889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=6.4e-43  Score=306.41  Aligned_cols=253  Identities=23%  Similarity=0.373  Sum_probs=207.4

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCc----EEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCC
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHK----IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG  123 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  123 (323)
                      +...+|++.+.||+|+||.||+|.+..+++    .|++|++...........+.+|+.+++.+.||||+++++++..  .
T Consensus         4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~--~   81 (316)
T cd05108           4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--S   81 (316)
T ss_pred             cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC--C
Confidence            456789999999999999999999865555    3899998766556667788899999999999999999999875  3


Q ss_pred             eEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          124 DIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      ..+++++|+.+|+|.+++... ..+++..+..++.||+.||+|||+.|++|+||||+||+++.++ .+||+|||++....
T Consensus        82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~-~~kl~DfG~a~~~~  160 (316)
T cd05108          82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG  160 (316)
T ss_pred             CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCC-cEEEcccccccccc
Confidence            578999999999999999764 3588999999999999999999999999999999999999887 89999999997654


Q ss_pred             cCccc--cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCC
Q 020657          203 RSLDA--CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPS  279 (323)
Q Consensus       203 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  279 (323)
                      .....  ......+..|+|||.+...     .++.++||||||+++|||++ |..||.+..    ...+...........
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~-----~~~~~~Di~slGv~l~el~t~g~~p~~~~~----~~~~~~~~~~~~~~~  231 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHR-----IYTHQSDVWSYGVTVWELMTFGSKPYDGIP----ASEISSILEKGERLP  231 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccC-----CCCchhhhHHHHHHHHHHHcCCCCCCCCCC----HHHHHHHHhCCCCCC
Confidence            32221  1222345689999998643     34569999999999999997 999995432    223333333344445


Q ss_pred             CCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          280 LPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       280 ~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      .+..++.++.+++.+||..+|.+|||+.+++.+
T Consensus       232 ~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         232 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            556788999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=6.7e-43  Score=301.05  Aligned_cols=253  Identities=24%  Similarity=0.408  Sum_probs=209.2

Q ss_pred             ccccccceeeeecccCCeEEEEEEecc-----cCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRC-----THKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS  122 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  122 (323)
                      +..++|.+.+.||+|++|.||+|.+..     +++.|++|.+......+....+.+|+++++.+.|+||+++++++.. .
T Consensus         2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~   80 (280)
T cd05049           2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE-G   80 (280)
T ss_pred             CChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec-C
Confidence            346789999999999999999998743     3578999999876666567889999999999999999999999987 6


Q ss_pred             CeEEEEEeccCCCCHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCC
Q 020657          123 GDIAILMEYMDSGTLDTLLNKN--------------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNM  188 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~--------------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~  188 (323)
                      ...++||||+++++|.+++...              ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++ 
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~-  159 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL-  159 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC-
Confidence            7899999999999999999753              2478899999999999999999999999999999999999987 


Q ss_pred             cEEEeecCcchhhccCc--cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccH
Q 020657          189 QVKIADFGVSKIMCRSL--DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDW  265 (323)
Q Consensus       189 ~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~  265 (323)
                      .++|+|||++.......  ........+..|+|||++...     .++.++||||||+++|+|++ |..||......   
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---  231 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR-----KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---  231 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhhccC-----CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---
Confidence            89999999986542211  112233456789999998643     34569999999999999998 99999655432   


Q ss_pred             HHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          266 ATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                       ........+.....+..++..+.+++++||+.||++|||++++++
T Consensus       232 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         232 -EVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             -HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence             333333344444556678999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=9e-43  Score=299.89  Aligned_cols=255  Identities=25%  Similarity=0.365  Sum_probs=209.1

Q ss_pred             ccccccceeeeecccCCeEEEEEEecc-----cCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRC-----THKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS  122 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  122 (323)
                      +..++|++.+.||+|++|.||+|.+..     ++..|++|.+...........+.+|+.+++.++|+||+++++++.+ .
T Consensus         3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~   81 (277)
T cd05036           3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE-R   81 (277)
T ss_pred             CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-C
Confidence            456889999999999999999999976     6788999998766655666778999999999999999999999887 5


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC--CcEEEe
Q 020657          123 GDIAILMEYMDSGTLDTLLNKNG-------TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN--MQVKIA  193 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~~-------~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~--~~~kl~  193 (323)
                      ...++||||+.+++|.+++....       .+++..+..++.||+.||.|||+.|++|+||+|+||+++.++  ..++|+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence            67899999999999999997543       489999999999999999999999999999999999998653  369999


Q ss_pred             ecCcchhhccCccc--cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHH
Q 020657          194 DFGVSKIMCRSLDA--CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMC  270 (323)
Q Consensus       194 Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~  270 (323)
                      |||++.........  ......+..|+|||++..     ..++.++||||||+++|+|++ |..||.....    ..+..
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~~g~~pf~~~~~----~~~~~  232 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-----GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN----QEVME  232 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhc-----CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHH
Confidence            99999765322111  112233467999999863     335669999999999999996 9999964332    23333


Q ss_pred             HHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          271 AICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      .+........+..++..+.+++.+||+.+|++|||++++++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         233 FVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            343344455667889999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.4e-42  Score=294.60  Aligned_cols=244  Identities=25%  Similarity=0.398  Sum_probs=200.8

Q ss_pred             eeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEeccCCCC
Q 020657           57 QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGT  136 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~s  136 (323)
                      +.||+|++|.||+|.+..+++.+++|.+......+....+.+|+++++.++|+||+++++++.. ....++||||+.+++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~   79 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-KQPIYIVMELVQGGD   79 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCeEEEEeeccCCc
Confidence            3689999999999999889999999998766666677889999999999999999999999987 678999999999999


Q ss_pred             HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc--ccccc
Q 020657          137 LDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC--NSYVG  213 (323)
Q Consensus       137 L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~  213 (323)
                      |.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++..........  .....
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~  158 (252)
T cd05084          80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKN-VLKISDFGMSREEEDGVYASTGGMKQI  158 (252)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCC-cEEECccccCcccccccccccCCCCCC
Confidence            99998754 4689999999999999999999999999999999999999987 89999999986543221111  11122


Q ss_pred             cccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHH
Q 020657          214 TCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFI  292 (323)
Q Consensus       214 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll  292 (323)
                      +..|+|||.+....     .+.++||||||+++|+|++ |..||.....    ...............+...+..+.+|+
T Consensus       159 ~~~y~aPE~~~~~~-----~~~~~Dv~slG~il~e~~~~~~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li  229 (252)
T cd05084         159 PVKWTAPEALNYGR-----YSSESDVWSFGILLWEAFSLGAVPYANLSN----QQTREAIEQGVRLPCPELCPDAVYRLM  229 (252)
T ss_pred             ceeecCchhhcCCC-----CChHHHHHHHHHHHHHHHhCCCCCccccCH----HHHHHHHHcCCCCCCcccCCHHHHHHH
Confidence            45699999886433     4569999999999999997 8888854322    223333333344556677899999999


Q ss_pred             HHhcccCcCCCCCHHHHhc
Q 020657          293 ECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       293 ~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ++||+.+|++|||+.++++
T Consensus       230 ~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         230 ERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             HHHcCCChhhCcCHHHHHH
Confidence            9999999999999999975

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=4.3e-43  Score=304.26  Aligned_cols=259  Identities=29%  Similarity=0.523  Sum_probs=212.3

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ..++|++.+.||+|++|.||++.+..+++.+++|.+..... ...+.+.+|+.+++.++||||+++++.+.. .+..++|
T Consensus        17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~~~lv   94 (293)
T cd06647          17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKHPNIVNYLDSYLV-GDELWVV   94 (293)
T ss_pred             chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc-hHHHHHHHHHHHHhhcCCCCeeehhheeee-CCcEEEE
Confidence            35899999999999999999999988899999999864432 334667899999999999999999999987 6789999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          129 MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      +||+++++|.+++.+. .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||++..........
T Consensus        95 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~-~~kL~dfg~~~~~~~~~~~~  172 (293)
T cd06647          95 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKR  172 (293)
T ss_pred             EecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCC-CEEEccCcceeccccccccc
Confidence            9999999999998754 578999999999999999999999999999999999999887 89999999886654433333


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCC-CCCCCCCChh
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP-PSLPDGASPE  287 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  287 (323)
                      ....++..|++||.+...     ..+.++|+||||+++|++++|..||........   +........+ ...+..++..
T Consensus       173 ~~~~~~~~y~~PE~~~~~-----~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  244 (293)
T cd06647         173 STMVGTPYWMAPEVVTRK-----AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---LYLIATNGTPELQNPEKLSAI  244 (293)
T ss_pred             ccccCChhhcCchhhccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh---eeehhcCCCCCCCCccccCHH
Confidence            445678889999988633     345699999999999999999999965432211   1111111111 1123456788


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          288 FRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       288 l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      +.+++++||+.+|++||+++++++|+||++.+
T Consensus       245 l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         245 FRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence            99999999999999999999999999998765

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-42  Score=293.30  Aligned_cols=253  Identities=36%  Similarity=0.604  Sum_probs=216.5

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEe
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILME  130 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e  130 (323)
                      +|++...||+|++|.+|+|.+..+++.+++|.+..... ......+.+|+++++++.|+|++++++++.+ .+..+++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET-SDSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe-CCEEEEEEe
Confidence            58899999999999999999988899999999976542 2456778999999999999999999999887 688999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccccc
Q 020657          131 YMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNS  210 (323)
Q Consensus       131 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~  210 (323)
                      ++++++|.+++.....+++..+..++.|++.++.+||+.|++|+||+|+||+++.++ .++|+|||.+............
T Consensus        80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~~~~  158 (254)
T cd06627          80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG-VVKLADFGVATKLNDVSKDDAS  158 (254)
T ss_pred             cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCC-CEEEeccccceecCCCcccccc
Confidence            999999999998878899999999999999999999999999999999999999987 8999999999876554443344


Q ss_pred             ccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHH
Q 020657          211 YVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS  290 (323)
Q Consensus       211 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  290 (323)
                      ..++..|+|||.+....     .+.++|+|++|+++|+|++|..||......   .... .........++..++..+.+
T Consensus       159 ~~~~~~y~~pe~~~~~~-----~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~---~~~~-~~~~~~~~~~~~~~~~~~~~  229 (254)
T cd06627         159 VVGTPYWMAPEVIEMSG-----ASTASDIWSLGCTVIELLTGNPPYYDLNPM---AALF-RIVQDDHPPLPEGISPELKD  229 (254)
T ss_pred             cccchhhcCHhhhcCCC-----CCcchhHHHHHHHHHHHHhCCCCCCCccHH---HHHH-HHhccCCCCCCCCCCHHHHH
Confidence            56788999999886332     456999999999999999999999654321   2222 22234445667788999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCccc
Q 020657          291 FIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       291 ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                      ++.+||..+|++|||+++++.||||
T Consensus       230 ~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         230 FLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHHHHHhCChhhCcCHHHHhcCCCC
Confidence            9999999999999999999999998

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-42  Score=296.32  Aligned_cols=253  Identities=26%  Similarity=0.400  Sum_probs=209.0

Q ss_pred             cccccceeeeecccCCeEEEEEEeccc---CcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCT---HKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDI  125 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  125 (323)
                      ..++|++.+.||+|+||.||+|.+..+   ...|++|.+...........+.+|+.+++.++|+||+++++.+.. .+..
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   80 (266)
T cd05033           2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK-SRPV   80 (266)
T ss_pred             ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec-CCce
Confidence            356899999999999999999998643   457999998766666667788899999999999999999999887 6789


Q ss_pred             EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC
Q 020657          126 AILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS  204 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~  204 (323)
                      +++|||+++++|.+++... ..+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~-~~~l~dfg~~~~~~~~  159 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRRLEDS  159 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-CEEECccchhhccccc
Confidence            9999999999999998753 4689999999999999999999999999999999999999987 8999999999876422


Q ss_pred             ccc--cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCC
Q 020657          205 LDA--CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLP  281 (323)
Q Consensus       205 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (323)
                      ...  ......+..|+|||.+...     ..+.++||||||+++|+|++ |..||....    ...+...+........+
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~-----~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~----~~~~~~~~~~~~~~~~~  230 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYR-----KFTSASDVWSFGIVMWEVMSYGERPYWDMS----NQDVIKAVEDGYRLPPP  230 (266)
T ss_pred             ccceeccCCCCCccccChhhhccC-----CCccccchHHHHHHHHHHHccCCCCCCCCC----HHHHHHHHHcCCCCCCC
Confidence            211  1223345689999988633     34569999999999999997 999995432    23333444434444555


Q ss_pred             CCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          282 DGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       282 ~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ..++..+.+++.+||+.+|++||++++++++
T Consensus       231 ~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         231 MDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            6789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.1e-42  Score=294.00  Aligned_cols=256  Identities=37%  Similarity=0.604  Sum_probs=216.7

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcCCCCccceeceeEEcCC-CeEEEEE
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS-GDIAILM  129 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~lv~  129 (323)
                      +|++.+.||+|++|.||+|.+..+++.+++|++..... ....+.+.+|+.++++++|+||+++++.+.... ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            58889999999999999999988899999999875532 345678889999999999999999999988621 6899999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc--c
Q 020657          130 EYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD--A  207 (323)
Q Consensus       130 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~--~  207 (323)
                      |++++++|.+++.+...+++..+..++.+++.+|.|||+.|++|+||+|+||+++.++ .++|+|||.+........  .
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~~~  159 (260)
T cd06606          81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDG-VVKLADFGCAKRLGDIETGEG  159 (260)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC-CEEEcccccEEeccccccccc
Confidence            9999999999998877899999999999999999999999999999999999999987 899999999977654432  1


Q ss_pred             cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChh
Q 020657          208 CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPE  287 (323)
Q Consensus       208 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (323)
                      .....++..|++||.+....     .+.++|+|+||+++++|++|..||....  .................++...+..
T Consensus       160 ~~~~~~~~~y~~pE~~~~~~-----~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  232 (260)
T cd06606         160 TGSVRGTPYWMAPEVIRGEE-----YGRAADIWSLGCTVIEMATGKPPWSELG--NPMAALYKIGSSGEPPEIPEHLSEE  232 (260)
T ss_pred             ccCCCCCccccCHhhhcCCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCC--chHHHHHhccccCCCcCCCcccCHH
Confidence            33456788999999886433     5669999999999999999999996654  1222222222223455677788999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          288 FRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       288 l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                      +.+++.+||+.+|.+||++.++++||||
T Consensus       233 l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         233 AKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            9999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-44  Score=307.65  Aligned_cols=261  Identities=26%  Similarity=0.412  Sum_probs=226.4

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ..-|.+.+.||+|-|+.|-+|++--+|+.||||++.+.. +......+.+|++.|+.++|||||++|++... .--+|+|
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT-QTKlyLi   95 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT-QTKLYLI   95 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc-cceEEEE
Confidence            345888899999999999999999999999999998664 44556778899999999999999999999877 5679999


Q ss_pred             EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccc
Q 020657          129 MEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA  207 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~  207 (323)
                      .|.-++|+|.+++.+. ..+.+..+.+++.||+.|+.|+|+..+|||||||+||.+.+.-.-|||.|||++..+..+ ..
T Consensus        96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG-~k  174 (864)
T KOG4717|consen   96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG-KK  174 (864)
T ss_pred             EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc-ch
Confidence            9999999999999754 469999999999999999999999999999999999998876448999999999776443 44


Q ss_pred             cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChh
Q 020657          208 CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPE  287 (323)
Q Consensus       208 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (323)
                      ....+|...|-|||++.+..|.    .+++||||||++||.|.+|+.||......+....++.-     ...+|.+++.+
T Consensus       175 L~TsCGSLAYSAPEILLGDsYD----APAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDC-----KYtvPshvS~e  245 (864)
T KOG4717|consen  175 LTTSCGSLAYSAPEILLGDSYD----APAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDC-----KYTVPSHVSKE  245 (864)
T ss_pred             hhcccchhhccCchhhhcCccC----CcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcc-----cccCchhhhHH
Confidence            5678999999999999855554    47999999999999999999999766655554444321     34577899999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCcccccCCCC
Q 020657          288 FRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS  321 (323)
Q Consensus       288 l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~  321 (323)
                      .++||..||..||++|.+.++|..|+|++...++
T Consensus       246 CrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~  279 (864)
T KOG4717|consen  246 CRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRG  279 (864)
T ss_pred             HHHHHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence            9999999999999999999999999999988765

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.2e-43  Score=311.28  Aligned_cols=263  Identities=30%  Similarity=0.428  Sum_probs=213.5

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcCCCCccceeceeEEcCC----CeEE
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS----GDIA  126 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~~  126 (323)
                      +|++.+.||.|++|.||+|.+..+++.+++|.+..... ....+.+.+|+.+++.++|+||+++++++....    ...+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            58999999999999999999988899999999875532 445677889999999999999999999987643    3689


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc-
Q 020657          127 ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL-  205 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~-  205 (323)
                      ++|||+.+ +|.+++.+...+++..+..++.+|+.||.+||+.|++|+||+|.||+++.++ .++|+|||.+....... 
T Consensus        81 lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~-~~~L~dfg~~~~~~~~~~  158 (330)
T cd07834          81 IVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNC-DLKICDFGLARGVDPDED  158 (330)
T ss_pred             EEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEcccCceEeeccccc
Confidence            99999975 8999998877899999999999999999999999999999999999999987 89999999998765433 


Q ss_pred             --cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhc---------
Q 020657          206 --DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICF---------  274 (323)
Q Consensus       206 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~---------  274 (323)
                        .......++..|+|||.+.+..    ..+.++|+||||+++|+|++|..||...........+......         
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  234 (330)
T cd07834         159 EKGFLTEYVVTRWYRAPELLLSSS----RYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI  234 (330)
T ss_pred             ccccccccccccCcCCceeeeccc----CCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence              1233456788999999986431    4566999999999999999999999665432222111111000         


Q ss_pred             --------------CCC---CCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          275 --------------GDP---PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       275 --------------~~~---~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                                    ...   ..+...++.++.+++++||+++|++|||++++++||||++.+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence                          000   0112346889999999999999999999999999999987664

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-42  Score=298.63  Aligned_cols=255  Identities=22%  Similarity=0.383  Sum_probs=210.5

Q ss_pred             hhccccccceeeeecccCCeEEEEEEeccc-----CcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEc
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCT-----HKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEK  120 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~-----~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  120 (323)
                      +.+..++|++.+.||+|++|.||+|.+...     +..|++|.+...........+.+|+.+++.++|+||+++++++..
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (277)
T cd05032           1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST   80 (277)
T ss_pred             CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence            457788999999999999999999998643     378999998766555556678899999999999999999999987


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcE
Q 020657          121 PSGDIAILMEYMDSGTLDTLLNKN----------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQV  190 (323)
Q Consensus       121 ~~~~~~lv~e~~~~~sL~~~l~~~----------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~  190 (323)
                       ....++||||+++++|.+++...          ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .+
T Consensus        81 -~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~-~~  158 (277)
T cd05032          81 -GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL-TV  158 (277)
T ss_pred             -CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCC-CE
Confidence             67899999999999999998642          2367889999999999999999999999999999999999987 89


Q ss_pred             EEeecCcchhhccCcc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHH
Q 020657          191 KIADFGVSKIMCRSLD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWAT  267 (323)
Q Consensus       191 kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~  267 (323)
                      +|+|||++........  ......++..|+|||.+..     ...+.++||||||+++|+++| |..||....    ...
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~t~g~~p~~~~~----~~~  229 (277)
T cd05032         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-----GVFTTKSDVWSFGVVLWEMATLAEQPYQGLS----NEE  229 (277)
T ss_pred             EECCcccchhhccCcccccCCCCCccccccCHHHHhc-----CCCCcccchHHHHHHHHHhhccCCCCCccCC----HHH
Confidence            9999999876543221  1223345778999998753     335669999999999999998 999995433    233


Q ss_pred             HHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          268 LMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ............++...+.++.+++.+||+.+|++|||+.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         230 VLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            33344444555667778999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.7e-42  Score=296.56  Aligned_cols=250  Identities=26%  Similarity=0.453  Sum_probs=201.9

Q ss_pred             ccccceeeee--cccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceeceeEEcCCCeEE
Q 020657           50 YSDLEKLQVL--GHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKPSGDIA  126 (323)
Q Consensus        50 ~~~~~~~~~l--g~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~  126 (323)
                      .++|.+.+.+  |+|+||.||++.+..+++.+++|.+.......      .|+.....+ .|+||+++++.+.. .+..+
T Consensus        13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~-~~~~~   85 (267)
T PHA03390         13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTT-LKGHV   85 (267)
T ss_pred             HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEec-CCeeE
Confidence            3566777666  99999999999999899999999986442111      122222222 69999999999987 57899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc
Q 020657          127 ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD  206 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~  206 (323)
                      +||||+++++|.+++.....+++..+..++.|+++||.+||+.|++|+||+|+||+++.++..++|+|||++......  
T Consensus        86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--  163 (267)
T PHA03390         86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--  163 (267)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--
Confidence            999999999999999887789999999999999999999999999999999999999987657999999998655322  


Q ss_pred             ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCc-cHHHHHHHHhcCCCCCCCCCCC
Q 020657          207 ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRP-DWATLMCAICFGDPPSLPDGAS  285 (323)
Q Consensus       207 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  285 (323)
                        ....++..|+|||++....     ++.++|+||||+++|+|++|..||....... ....+....  ......+..++
T Consensus       164 --~~~~~~~~y~aPE~~~~~~-----~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  234 (267)
T PHA03390        164 --SCYDGTLDYFSPEKIKGHN-----YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--QKKLPFIKNVS  234 (267)
T ss_pred             --ccCCCCCcccChhhhcCCC-----CCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--cccCCcccccC
Confidence              2335788999999986433     4568999999999999999999997543332 223333332  23334556799


Q ss_pred             hhHHHHHHHhcccCcCCCCC-HHHHhcCccccc
Q 020657          286 PEFRSFIECCLQKEFSKRWT-ASQLLTHPFLCK  317 (323)
Q Consensus       286 ~~l~~ll~~~l~~~p~~Rpt-~~~~l~h~~f~~  317 (323)
                      +.+.+|+.+||+.+|.+|++ ++++|+||||.+
T Consensus       235 ~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        235 KNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             HHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence            99999999999999999996 699999999975

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.1e-42  Score=312.50  Aligned_cols=259  Identities=25%  Similarity=0.348  Sum_probs=210.0

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEeccc-----CcEEEEEeecCCCChHHHHHHHHHHHHHHcCC-CCccceece
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCT-----HKIYALKVVHGDADPTVRRQVFREMEILRRTD-SPFIVQCFG  116 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~-----~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~  116 (323)
                      ...+.+..++|++.+.||+|+||.||+|.+...     +..||+|++...........+.+|+.+++++. ||||+++++
T Consensus        29 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~  108 (400)
T cd05105          29 DSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLG  108 (400)
T ss_pred             CCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence            456778899999999999999999999987432     34699999976655555678899999999996 999999999


Q ss_pred             eEEcCCCeEEEEEeccCCCCHHHHHHhc----------------------------------------------------
Q 020657          117 IFEKPSGDIAILMEYMDSGTLDTLLNKN----------------------------------------------------  144 (323)
Q Consensus       117 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~----------------------------------------------------  144 (323)
                      ++.. .+..++||||+++|+|.+++...                                                    
T Consensus       109 ~~~~-~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (400)
T cd05105         109 ACTK-SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQ  187 (400)
T ss_pred             EEcc-CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccc
Confidence            9987 67899999999999999887542                                                    


Q ss_pred             --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 020657          145 --------------------------------------------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSN  180 (323)
Q Consensus       145 --------------------------------------------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~n  180 (323)
                                                                  ..+++..+..++.||++||.|||+.|++|+||||+|
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~N  267 (400)
T cd05105         188 YVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARN  267 (400)
T ss_pred             cchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHh
Confidence                                                        236788889999999999999999999999999999


Q ss_pred             eEEecCCCcEEEeecCcchhhccCcc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 020657          181 LLVNNNNMQVKIADFGVSKIMCRSLD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFL  257 (323)
Q Consensus       181 il~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~  257 (323)
                      |+++.++ .+||+|||++........  ......++..|+|||.+...     .++.++||||||+++|+|++ |..||.
T Consensus       268 ill~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwSlGvil~ellt~g~~P~~  341 (400)
T cd05105         268 VLLAQGK-IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN-----LYTTLSDVWSYGILLWEIFSLGGTPYP  341 (400)
T ss_pred             EEEeCCC-EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC-----CCCchhhHHHHHHHHHHHHHCCCCCCc
Confidence            9999987 899999999876533221  12233456789999988643     34569999999999999997 999996


Q ss_pred             CCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          258 QPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ......   .+......+.....+..++.++.+++.+||+.+|++|||+.++.+
T Consensus       342 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         342 GMIVDS---TFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             ccchhH---HHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            543322   222333334445556788999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5e-44  Score=292.86  Aligned_cols=265  Identities=28%  Similarity=0.401  Sum_probs=222.9

Q ss_pred             ccee-eeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceeceeEEcCCCeEEEEEe
Q 020657           53 LEKL-QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKPSGDIAILME  130 (323)
Q Consensus        53 ~~~~-~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~lv~e  130 (323)
                      |++. +.||+|+++.|-.+....++..+|||++.+. ....+.++.+|++++... .|+||++++++|++ +...|+|||
T Consensus        79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd-d~~FYLVfE  156 (463)
T KOG0607|consen   79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFED-DTRFYLVFE  156 (463)
T ss_pred             HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc-cceEEEEEe
Confidence            4443 6899999999999999999999999999866 456788999999999997 69999999999998 788999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC--CcEEEeecCcchhhccC----
Q 020657          131 YMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN--MQVKIADFGVSKIMCRS----  204 (323)
Q Consensus       131 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~--~~~kl~Dfg~~~~~~~~----  204 (323)
                      .|.||+|...+.+.+-+++.++..+.++|+.||.+||.+||+|||+||+|||....+  ..+||+||.+...+...    
T Consensus       157 Km~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s  236 (463)
T KOG0607|consen  157 KMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS  236 (463)
T ss_pred             cccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence            999999999999988999999999999999999999999999999999999986532  36999999988654221    


Q ss_pred             ---ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC-----------ccHHHHHH
Q 020657          205 ---LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQR-----------PDWATLMC  270 (323)
Q Consensus       205 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~-----------~~~~~~~~  270 (323)
                         .+..-+++|+..|||||+..--.-....++-+.|.||||+++|-||.|+.||.+....           .-.+.+.+
T Consensus       237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe  316 (463)
T KOG0607|consen  237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE  316 (463)
T ss_pred             CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence               2223457889999999987643334556778999999999999999999999765432           22345555


Q ss_pred             HHhcCC---CCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          271 AICFGD---PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       271 ~~~~~~---~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      .+..+.   +..-+.++|.+..+|++.+|..|+.+|.++.++++|||++...
T Consensus       317 sIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~  368 (463)
T KOG0607|consen  317 SIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA  368 (463)
T ss_pred             HHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence            555544   3333458999999999999999999999999999999998764

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.2e-42  Score=294.06  Aligned_cols=249  Identities=24%  Similarity=0.407  Sum_probs=203.3

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      +.++|++.+.||+|+||.||+|.+. ++..+++|.+....  .....+.+|+.+++.++||||+++++++.. .+..++|
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~iv   77 (256)
T cd05114           2 NPSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ-QKPLYIV   77 (256)
T ss_pred             CHHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEEcc-CCCEEEE
Confidence            3478999999999999999999886 55679999876432  234568889999999999999999999887 6789999


Q ss_pred             EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccc
Q 020657          129 MEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA  207 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~  207 (323)
                      |||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||.+.........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05114          78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG-VVKVSDFGMTRYVLDDEYT  156 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCC-eEEECCCCCccccCCCcee
Confidence            999999999999875 34689999999999999999999999999999999999999887 8999999998765332221


Q ss_pred             -cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCC
Q 020657          208 -CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS  285 (323)
Q Consensus       208 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (323)
                       .....++..|+|||.+...     .++.++|+||||+++|+|++ |+.||.....    ......+..+.....+...+
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~----~~~~~~i~~~~~~~~~~~~~  227 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFS-----KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN----YEVVEMISRGFRLYRPKLAS  227 (256)
T ss_pred             ccCCCCCchhhCChhhcccC-----ccchhhhhHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHHCCCCCCCCCCCC
Confidence             1222345689999998633     34569999999999999999 8999954432    33333344344445566678


Q ss_pred             hhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          286 PEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       286 ~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ..+.+++++||+.+|.+|||++++++
T Consensus       228 ~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         228 MTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHH
Confidence            89999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.4e-42  Score=300.02  Aligned_cols=256  Identities=35%  Similarity=0.608  Sum_probs=213.6

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ..+.|++...||+|++|.||+|.+..+++.+++|++.....  ....+.+|+.+++.++|+|++++++.+.. ....+++
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv   93 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLV-GDELWVV   93 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEE-CCEEEEE
Confidence            45679999999999999999999988899999999975543  45678899999999999999999999987 6889999


Q ss_pred             EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccc
Q 020657          129 MEYMDSGTLDTLLNKNG-TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA  207 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~  207 (323)
                      +||+++++|.+++.... .+++..+..++.+++.||.+||+.|++|+||+|+||+++.++ .++|+|||++.........
T Consensus        94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~  172 (286)
T cd06614          94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDG-SVKLADFGFAAQLTKEKSK  172 (286)
T ss_pred             EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCC-CEEECccchhhhhccchhh
Confidence            99999999999998776 899999999999999999999999999999999999999887 8999999998765443333


Q ss_pred             cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCC--CCCCC
Q 020657          208 CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSL--PDGAS  285 (323)
Q Consensus       208 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  285 (323)
                      .....++..|++||.+.+.     ..+.++|+|+||+++|+|++|..||......   .... ..........  +..++
T Consensus       173 ~~~~~~~~~y~~PE~~~~~-----~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~---~~~~-~~~~~~~~~~~~~~~~~  243 (286)
T cd06614         173 RNSVVGTPYWMAPEVIKRK-----DYGPKVDIWSLGIMCIEMAEGEPPYLREPPL---RALF-LITTKGIPPLKNPEKWS  243 (286)
T ss_pred             hccccCCcccCCHhHhcCC-----CCCCccccHHHHHHHHHHHhCCCCCCCCCHH---HHHH-HHHhcCCCCCcchhhCC
Confidence            3344577899999987633     3456999999999999999999999543221   1121 1212222222  23478


Q ss_pred             hhHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          286 PEFRSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       286 ~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                      .++.+++++||+.+|.+|||+.++++|+||.+
T Consensus       244 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  275 (286)
T cd06614         244 PEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK  275 (286)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence            99999999999999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3.2e-43  Score=310.68  Aligned_cols=266  Identities=28%  Similarity=0.431  Sum_probs=212.0

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcCCCCccceeceeEEcC---CCeE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-PTVRRQVFREMEILRRTDSPFIVQCFGIFEKP---SGDI  125 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~  125 (323)
                      .++|++.+.||+|++|.||+|.+..+++.|++|++..... ......+.+|+.+++.++|+||+++++++...   ...+
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            3789999999999999999999999999999999875432 23456677899999999999999999987532   3468


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc
Q 020657          126 AILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL  205 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~  205 (323)
                      ++||||+. ++|.+++.....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~  161 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDC-ELRIGDFGMARGLSSSP  161 (334)
T ss_pred             EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEecccccceeecccC
Confidence            99999996 58999998777899999999999999999999999999999999999999987 89999999986653322


Q ss_pred             cc----cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHH----------
Q 020657          206 DA----CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCA----------  271 (323)
Q Consensus       206 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~----------  271 (323)
                      ..    .....++..|+|||.+...    ...+.++||||||+++|+|++|..||...+.......+...          
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~----~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         162 TEHKYFMTEYVATRWYRAPELLLSL----PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             cCCCcccccccccccccChHHhcCC----cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence            11    1234678899999987532    23466999999999999999999999655432211111100          


Q ss_pred             ----------H-hcCCCCC-----CCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCCC
Q 020657          272 ----------I-CFGDPPS-----LPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS  321 (323)
Q Consensus       272 ----------~-~~~~~~~-----~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~  321 (323)
                                . .......     +....+.++.++|++||+.+|.+|||+++++.||||.+.+.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~  303 (334)
T cd07855         238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP  303 (334)
T ss_pred             hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence                      0 0011111     124568999999999999999999999999999999877654

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-44  Score=283.58  Aligned_cols=264  Identities=25%  Similarity=0.319  Sum_probs=210.8

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEE---
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFE---  119 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---  119 (323)
                      .....+...+|++.+.||+|||+-||+++...+++.+|+|.+.... .+..+...+|++..++++|||+++++++..   
T Consensus        13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~   91 (302)
T KOG2345|consen   13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREE   91 (302)
T ss_pred             CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh
Confidence            4566788999999999999999999999999999999999997665 455677889999999999999999998742   


Q ss_pred             -cCCCeEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCCeEEecCCCcEEE
Q 020657          120 -KPSGDIAILMEYMDSGTLDTLLNK----NGTFSEPKLAHIASQILKGLSYLHGHK--IIHRDIKPSNLLVNNNNMQVKI  192 (323)
Q Consensus       120 -~~~~~~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~g--ivH~di~~~nil~~~~~~~~kl  192 (323)
                       +.+...|++++|+..|||.+.+..    +..+++.+++.|+.+|++||.+||...  ++|+||||.||++..++ .++|
T Consensus        92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~-~~vl  170 (302)
T KOG2345|consen   92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSG-LPVL  170 (302)
T ss_pred             ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCC-ceEE
Confidence             234568999999999999998863    346999999999999999999999998  99999999999999987 8999


Q ss_pred             eecCcchhhccC---------ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCc
Q 020657          193 ADFGVSKIMCRS---------LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRP  263 (323)
Q Consensus       193 ~Dfg~~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~  263 (323)
                      +|||.++...-.         .........|..|+|||.+.-..  ....+.++|||||||++|+|+.|..||....+..
T Consensus       171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~--~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G  248 (302)
T KOG2345|consen  171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKS--HCTITERTDIWSLGCTLYAMMFGESPFERIYQQG  248 (302)
T ss_pred             EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheeccc--CcccccccchhhhhHHHHHHHHcCCcchHHhhcC
Confidence            999998654211         01112335689999999987443  4567789999999999999999999995432211


Q ss_pred             cHHHHHHHHhcCC-CCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          264 DWATLMCAICFGD-PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       264 ~~~~~~~~~~~~~-~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ..  +..++..+. ..+-...+|+.+.+|++.||+.||.+||++.+++.+
T Consensus       249 gS--laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  249 GS--LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             Ce--EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            10  000000000 011123489999999999999999999999999864

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.5e-42  Score=307.32  Aligned_cols=258  Identities=26%  Similarity=0.402  Sum_probs=208.7

Q ss_pred             hhccccccceeeeecccCCeEEEEEEec-----ccCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceeceeEE
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHR-----CTHKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFGIFE  119 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~  119 (323)
                      |.+..++|++.+.||+|+||.||+|.+.     .+++.||+|++...........+.+|+.++.++ .|+||+++++++.
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (343)
T cd05103           2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT   81 (343)
T ss_pred             cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence            5677899999999999999999999853     467889999997655555566788999999999 6899999999987


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHhc-------------------------------------------------------
Q 020657          120 KPSGDIAILMEYMDSGTLDTLLNKN-------------------------------------------------------  144 (323)
Q Consensus       120 ~~~~~~~lv~e~~~~~sL~~~l~~~-------------------------------------------------------  144 (323)
                      ..+...++||||+++++|.+++...                                                       
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence            7667789999999999999998642                                                       


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc--cccc
Q 020657          145 ------------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD--ACNS  210 (323)
Q Consensus       145 ------------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~  210 (323)
                                  ..+++..+..++.|+++||.|||+.|++|+||||.||+++.++ .++|+|||++........  ....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC-cEEEEecccccccccCcchhhcCC
Confidence                        1367788899999999999999999999999999999999887 899999999876432211  1112


Q ss_pred             ccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHH
Q 020657          211 YVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFR  289 (323)
Q Consensus       211 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  289 (323)
                      ..++..|+|||.+...     .++.++||||||+++|+|++ |..||......   ..+......+.....+...++++.
T Consensus       241 ~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  312 (343)
T cd05103         241 ARLPLKWMAPETIFDR-----VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---EEFCRRLKEGTRMRAPDYTTPEMY  312 (343)
T ss_pred             CCCCcceECcHHhcCC-----CCCchhhHHHHHHHHHHHHHCCCCCCCCcccc---HHHHHHHhccCCCCCCCCCCHHHH
Confidence            2345679999988633     34569999999999999996 99999654332   223333333444455566788999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcC
Q 020657          290 SFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       290 ~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      +++..||+.+|++|||+.++++|
T Consensus       313 ~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         313 QTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             HHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3.2e-42  Score=300.83  Aligned_cols=260  Identities=30%  Similarity=0.492  Sum_probs=210.2

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCC--CChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIA  126 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  126 (323)
                      ....|++...||+|++|.||+|.+..+++.|++|.+...  ........+.+|+.+++.++||||+++.+++.. +...+
T Consensus        13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-~~~~~   91 (307)
T cd06607          13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-EHTAW   91 (307)
T ss_pred             cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-CCeEE
Confidence            346799999999999999999999888999999998643  233445678899999999999999999999987 67899


Q ss_pred             EEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc
Q 020657          127 ILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL  205 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~  205 (323)
                      +|+||+.+ ++.+.+.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++...... 
T Consensus        92 lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~-~~kL~dfg~~~~~~~~-  168 (307)
T cd06607          92 LVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPG-TVKLADFGSASLVSPA-  168 (307)
T ss_pred             EEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCC-CEEEeecCcceecCCC-
Confidence            99999975 77776653 45789999999999999999999999999999999999999987 8999999998654322 


Q ss_pred             cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCC-CCCC
Q 020657          206 DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSL-PDGA  284 (323)
Q Consensus       206 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  284 (323)
                         ....++..|+|||++....  ....+.++||||||+++|+|+||+.||.......   ... .......+.. ....
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~--~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~---~~~-~~~~~~~~~~~~~~~  239 (307)
T cd06607         169 ---NSFVGTPYWMAPEVILAMD--EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALY-HIAQNDSPTLSSNDW  239 (307)
T ss_pred             ---CCccCCccccCceeeeccC--CCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH---HHH-HHhcCCCCCCCchhh
Confidence               2345778999999875221  2345679999999999999999999995543221   111 1122222222 3456


Q ss_pred             ChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCCC
Q 020657          285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS  321 (323)
Q Consensus       285 ~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~  321 (323)
                      +..+.+++.+||+.+|++||++.+++.||||...+.+
T Consensus       240 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  276 (307)
T cd06607         240 SDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPP  276 (307)
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccCCc
Confidence            8899999999999999999999999999999876644

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=8.5e-43  Score=300.19  Aligned_cols=253  Identities=30%  Similarity=0.505  Sum_probs=213.3

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCC--CChHHHHHHHHHHHHHHcCC-CCccceeceeEEcCCCeEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTD-SPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~l  127 (323)
                      ++|++.+.||+|++|.||+|.+..+++.+++|++...  ........+.+|+.+++++. |+||+++++++.. ++..++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~l   79 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD-EENLYF   79 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC-CceEEE
Confidence            4799999999999999999999989999999998653  22344567888999999998 9999999999887 678999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc--
Q 020657          128 LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL--  205 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~--  205 (323)
                      |||++.+++|.+++.+.+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||++.......  
T Consensus        80 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~-~~~l~df~~~~~~~~~~~~  158 (280)
T cd05581          80 VLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDM-HIKITDFGTAKVLDPNSSP  158 (280)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEecCCccccccCCcccc
Confidence            999999999999999888899999999999999999999999999999999999999987 89999999997654322  


Q ss_pred             ------------------cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHH
Q 020657          206 ------------------DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWAT  267 (323)
Q Consensus       206 ------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~  267 (323)
                                        .......++..|+|||.+...     ..+.++|+|+||++++++++|..||........   
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-----~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---  230 (280)
T cd05581         159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK-----PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT---  230 (280)
T ss_pred             ccCCCCCccccccccccccccccccCCccccCHHHhCCC-----CCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH---
Confidence                              112234567899999987633     356699999999999999999999965542211   


Q ss_pred             HHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCH----HHHhcCccc
Q 020657          268 LMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTA----SQLLTHPFL  315 (323)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~----~~~l~h~~f  315 (323)
                       .+... .....++..+++.+.+++++||+.+|++|||+    +++++||||
T Consensus       231 -~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         231 -FQKIL-KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             -HHHHH-hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence             12221 23345667789999999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.3e-42  Score=294.74  Aligned_cols=252  Identities=23%  Similarity=0.390  Sum_probs=206.5

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeE
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDI  125 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  125 (323)
                      |.+..++|++.+.||+|++|.||+|.+. ++..|++|.+....  ...+.+.+|+.+++.++|+||+++++.+.. .+..
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   76 (261)
T cd05072           1 WEIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVTK-EEPI   76 (261)
T ss_pred             CcCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCCc
Confidence            4678899999999999999999999975 56779999876432  335678899999999999999999999887 6778


Q ss_pred             EEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          126 AILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      +++|||+.+++|.+++..  ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.....
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~~  155 (261)
T cd05072          77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESL-MCKIADFGLARVIED  155 (261)
T ss_pred             EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCC-cEEECCCccceecCC
Confidence            999999999999999865  34688999999999999999999999999999999999999987 899999999976543


Q ss_pred             Cccc-cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCC
Q 020657          204 SLDA-CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLP  281 (323)
Q Consensus       204 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (323)
                      .... .....++..|+|||.+...     ..+.++||||||+++|+|+| |..||.....    .............+..
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~----~~~~~~~~~~~~~~~~  226 (261)
T cd05072         156 NEYTAREGAKFPIKWTAPEAINFG-----SFTIKSDVWSFGILLYEIVTYGKIPYPGMSN----SDVMSALQRGYRMPRM  226 (261)
T ss_pred             CceeccCCCccceecCCHHHhccC-----CCChhhhhhhhHHHHHHHHccCCCCCCCCCH----HHHHHHHHcCCCCCCC
Confidence            2211 1223356689999988633     34568999999999999998 9999965432    2233333333344445


Q ss_pred             CCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          282 DGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       282 ~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ..++.++.+++.+||+.+|++|||++++++
T Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         227 ENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             CCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.5e-42  Score=296.02  Aligned_cols=248  Identities=31%  Similarity=0.512  Sum_probs=205.6

Q ss_pred             ecccCCeEEEEEEecccCcEEEEEeecCCCC--hHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEeccCCCC
Q 020657           59 LGHGNGGTVYKVQHRCTHKIYALKVVHGDAD--PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGT  136 (323)
Q Consensus        59 lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~s  136 (323)
                      ||.|++|.||++.+..+++.+++|++.....  ......+.+|+.++++++|+||+++++.+.. ....++++||+.+++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~   79 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG-KKNLYLVMEYLPGGD   79 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec-CcEEEEEEecCCCCc
Confidence            6899999999999988899999999865432  2456678899999999999999999999887 678999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc--------cc
Q 020657          137 LDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD--------AC  208 (323)
Q Consensus       137 L~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~--------~~  208 (323)
                      |.+++.+...+++..+..++.||++||.+||+.|++|+||+|+||+++.++ .++|+|||++........        ..
T Consensus        80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~  158 (265)
T cd05579          80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNG-HLKLTDFGLSKVGLVRRQINLNDDEKED  158 (265)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCC-CEEEEecccchhcccCcccccccccccc
Confidence            999998877899999999999999999999999999999999999999987 899999999875433211        22


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCC--CCh
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDG--ASP  286 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  286 (323)
                      ....++..|++||.+....     .+.++|+||||+++|++++|..||.....    .........+. ...+..  ++.
T Consensus       159 ~~~~~~~~~~~Pe~~~~~~-----~~~~~Dv~slG~~~~~l~~g~~p~~~~~~----~~~~~~~~~~~-~~~~~~~~~~~  228 (265)
T cd05579         159 KRIVGTPDYIAPEVILGQG-----HSKTVDWWSLGCILYEFLVGIPPFHGETP----EEIFQNILNGK-IEWPEDVEVSD  228 (265)
T ss_pred             cCcccCccccCHHHhcCCC-----CCcchhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhcCC-cCCCccccCCH
Confidence            3345778899999886433     45699999999999999999999954432    23332222212 222333  489


Q ss_pred             hHHHHHHHhcccCcCCCCCH---HHHhcCcccccC
Q 020657          287 EFRSFIECCLQKEFSKRWTA---SQLLTHPFLCKN  318 (323)
Q Consensus       287 ~l~~ll~~~l~~~p~~Rpt~---~~~l~h~~f~~~  318 (323)
                      .+.+++++||+.+|.+|||+   .++|+||||.++
T Consensus       229 ~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~  263 (265)
T cd05579         229 EAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI  263 (265)
T ss_pred             HHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence            99999999999999999999   999999999865

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.2e-42  Score=302.86  Aligned_cols=254  Identities=26%  Similarity=0.377  Sum_probs=204.9

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcE--EEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceeceeEEcCCC
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKI--YALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKPSG  123 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~--v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~  123 (323)
                      .+..++|++.+.||+|+||.||+|.+..++..  +++|.+...........+.+|+.++.++ +|+||+++++++.. ++
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~-~~   81 (303)
T cd05088           3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RG   81 (303)
T ss_pred             ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC-CC
Confidence            35678999999999999999999998766654  5777766544555667888999999999 89999999999987 67


Q ss_pred             eEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC
Q 020657          124 DIAILMEYMDSGTLDTLLNKN----------------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN  187 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~  187 (323)
                      .+++||||+++++|.+++...                ..+++..++.++.||+.|++|||+.|++|+||||+||+++.++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~  161 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  161 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence            899999999999999999643                2478999999999999999999999999999999999999887


Q ss_pred             CcEEEeecCcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHH
Q 020657          188 MQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWA  266 (323)
Q Consensus       188 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~  266 (323)
                       .++|+|||++...... ........+..|+|||.+...     ..+.++||||||+++|+|+| |..||......    
T Consensus       162 -~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----  230 (303)
T cd05088         162 -VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYS-----VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----  230 (303)
T ss_pred             -cEEeCccccCcccchh-hhcccCCCcccccCHHHHhcc-----CCcccccchhhhhHHHHHHhcCCCCcccCChH----
Confidence             8999999998543211 111122335679999987533     34569999999999999998 99999654332    


Q ss_pred             HHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          267 TLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ..............+...+.++.+|+.+||+.+|++|||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         231 ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             HHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2333333333344556678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-42  Score=296.15  Aligned_cols=251  Identities=27%  Similarity=0.462  Sum_probs=200.4

Q ss_pred             eeecccCCeEEEEEEecccCcEEEEEeecCCCC--hHHHHHHHHHHHHH-HcCCCCccceeceeEEcCCCeEEEEEeccC
Q 020657           57 QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD--PTVRRQVFREMEIL-RRTDSPFIVQCFGIFEKPSGDIAILMEYMD  133 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~  133 (323)
                      +.||+|++|.||+|.+..+++.|++|++.....  ......+..|..++ ....|+|++++++++.. ++..++|+||++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~   80 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS-KDYLYLVMEYLN   80 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc-CCeEEEEEeccC
Confidence            568999999999999988999999999864421  12223344554444 44589999999999987 678999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccccccc
Q 020657          134 SGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVG  213 (323)
Q Consensus       134 ~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  213 (323)
                      +++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.....    .....+
T Consensus        81 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~----~~~~~~  155 (260)
T cd05611          81 GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTG-HLKLTDFGLSRNGLE----NKKFVG  155 (260)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-cEEEeecccceeccc----cccCCC
Confidence            999999998877899999999999999999999999999999999999999987 899999998865432    233457


Q ss_pred             cccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHH
Q 020657          214 TCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIE  293 (323)
Q Consensus       214 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~  293 (323)
                      +..|++||.+.+..     .+.++|||+||+++|+|++|..||...........+... ...........++.++.+++.
T Consensus       156 ~~~y~~pe~~~~~~-----~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~  229 (260)
T cd05611         156 TPDYLAPETILGVG-----DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSR-RINWPEEVKEFCSPEAVDLIN  229 (260)
T ss_pred             CcCccChhhhcCCC-----CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc-ccCCCCcccccCCHHHHHHHH
Confidence            78999999986332     456999999999999999999999654332222222111 111122334468999999999


Q ss_pred             HhcccCcCCCC---CHHHHhcCcccccCC
Q 020657          294 CCLQKEFSKRW---TASQLLTHPFLCKNR  319 (323)
Q Consensus       294 ~~l~~~p~~Rp---t~~~~l~h~~f~~~~  319 (323)
                      +||+.+|++||   +++++++||||.+.+
T Consensus       230 ~~l~~~p~~R~~~~~~~~~l~~~~~~~~~  258 (260)
T cd05611         230 RLLCMDPAKRLGANGYQEIKSHPFFKSIN  258 (260)
T ss_pred             HHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence            99999999999   558999999998764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=4.4e-42  Score=293.81  Aligned_cols=252  Identities=29%  Similarity=0.481  Sum_probs=209.2

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCC--CChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ++|++.+.||+|++|.||+|.+..+++.+++|.++..  .+......+.+|++++++++|++++++++.+.. .+..++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-~~~~~lv   80 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-NNELNIV   80 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-CCeEEEE
Confidence            5899999999999999999999889999999988642  233446778899999999999999999999987 6789999


Q ss_pred             EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC
Q 020657          129 MEYMDSGTLDTLLNK----NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS  204 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~  204 (323)
                      |||+++++|.+++..    ...+++..+..++.+++.||.+||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~-~~~l~d~~~~~~~~~~  159 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATG-VVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCC-cEEEeccceeeeccCC
Confidence            999999999998863    34589999999999999999999999999999999999999987 8999999998765443


Q ss_pred             ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCC-C
Q 020657          205 LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPD-G  283 (323)
Q Consensus       205 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  283 (323)
                      ........++..|.|||.+...     .++.++|+||||+++|+|++|..||....  .....+.........+..+. .
T Consensus       160 ~~~~~~~~~~~~y~apE~~~~~-----~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~  232 (267)
T cd08224         160 TTAAHSLVGTPYYMSPERIHEN-----GYNFKSDIWSLGCLLYEMAALQSPFYGDK--MNLYSLCKKIEKCDYPPLPADH  232 (267)
T ss_pred             CcccceecCCccccCHHHhccC-----CCCchhcHHHHHHHHHHHHHCCCCcccCC--ccHHHHHhhhhcCCCCCCChhh
Confidence            3333345678889999988633     34569999999999999999999995443  22333333333334444444 7


Q ss_pred             CChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          284 ASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       284 ~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      .+..+.+++.+||..+|++|||+.++++
T Consensus       233 ~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         233 YSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             cCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            8889999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=4.4e-42  Score=290.85  Aligned_cols=250  Identities=38%  Similarity=0.651  Sum_probs=209.8

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEec
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEY  131 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~  131 (323)
                      +|++.+.||+|++|.||++.+..+++.+++|++..... .....+.+|+.+++.+.|++++++++.+.. ....++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~l~~e~   78 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLK-KDELWIVMEF   78 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEec-CCeEEEEEec
Confidence            58889999999999999999988899999999976543 355778899999999999999999999987 6789999999


Q ss_pred             cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccccc
Q 020657          132 MDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNS  210 (323)
Q Consensus       132 ~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~  210 (323)
                      +++++|.+++... ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++ .++|+|||.+........ ...
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~-~~~  156 (253)
T cd05122          79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDG-EVKLIDFGLSAQLSDTKA-RNT  156 (253)
T ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCC-eEEEeecccccccccccc-ccc
Confidence            9999999999775 5799999999999999999999999999999999999999987 899999999977654332 344


Q ss_pred             ccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCC--CChhH
Q 020657          211 YVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDG--ASPEF  288 (323)
Q Consensus       211 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l  288 (323)
                      ..++..|++||.+....     .+.++|+|+||+++|+|++|..||...+..   ..+.... .......+..  ++..+
T Consensus       157 ~~~~~~~~~PE~~~~~~-----~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~-~~~~~~~~~~~~~~~~~  227 (253)
T cd05122         157 MVGTPYWMAPEVINGKP-----YDYKADIWSLGITAIELAEGKPPYSELPPM---KALFKIA-TNGPPGLRNPEKWSDEF  227 (253)
T ss_pred             eecCCcccCHHHHcCCC-----CCccccHHHHHHHHHHHHhCCCCCCCCchH---HHHHHHH-hcCCCCcCcccccCHHH
Confidence            56788999999986433     566999999999999999999999644322   2221111 1223333333  38999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCcc
Q 020657          289 RSFIECCLQKEFSKRWTASQLLTHPF  314 (323)
Q Consensus       289 ~~ll~~~l~~~p~~Rpt~~~~l~h~~  314 (323)
                      .+++.+||+.||++|||+.++++|||
T Consensus       228 ~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         228 KDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HHHHHHHccCChhhCCCHHHHhcCCC
Confidence            99999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.5e-42  Score=299.18  Aligned_cols=251  Identities=26%  Similarity=0.365  Sum_probs=203.6

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCc--EEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceeceeEEcCCCeEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHK--IYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKPSGDIA  126 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~--~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~  126 (323)
                      +++|++.+.||+|+||.||+|.+..++.  .+++|.+...........+.+|+.+++++ .||||+++++++.. .+..+
T Consensus         1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~~~~~   79 (297)
T cd05089           1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN-RGYLY   79 (297)
T ss_pred             CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc-CCcce
Confidence            4689999999999999999999876654  46888877544555567788999999999 79999999999887 67799


Q ss_pred             EEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcE
Q 020657          127 ILMEYMDSGTLDTLLNKNG----------------TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQV  190 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~  190 (323)
                      +|+||+++++|.+++....                .+++..++.++.|++.||++||+.|++|+||||+||+++.++ .+
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-~~  158 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL-AS  158 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC-eE
Confidence            9999999999999996532                478899999999999999999999999999999999999887 89


Q ss_pred             EEeecCcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHH
Q 020657          191 KIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLM  269 (323)
Q Consensus       191 kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~  269 (323)
                      ||+|||++........ ......+..|+|||++...     .++.++||||||+++|+|++ |..||.....    ..+.
T Consensus       159 kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwSlG~il~el~t~g~~pf~~~~~----~~~~  228 (297)
T cd05089         159 KIADFGLSRGEEVYVK-KTMGRLPVRWMAIESLNYS-----VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC----AELY  228 (297)
T ss_pred             EECCcCCCccccceec-cCCCCcCccccCchhhccC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCH----HHHH
Confidence            9999999864322111 1112234579999988633     34569999999999999997 9999955433    3333


Q ss_pred             HHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          270 CAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ...........+..++..+.+|+.+||+.+|.+|||++++++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         229 EKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            4444444455667789999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-42  Score=293.08  Aligned_cols=255  Identities=32%  Similarity=0.479  Sum_probs=213.1

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCC----CChHHHHHHHHHHHHHHcCCCCccceeceeEEcC-CCeE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD----ADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP-SGDI  125 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~  125 (323)
                      .+|++.+.||+|++|.||+|.+..+++.+++|.+...    ........+.+|+.+++.++|+||+++++.+.+. ...+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            5799999999999999999999989999999987532    2234556788999999999999999999998753 3468


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc
Q 020657          126 AILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL  205 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~  205 (323)
                      ++++||+++++|.+.+.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~  160 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGASKRIQTIC  160 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEECcccccccccccc
Confidence            89999999999999998777799999999999999999999999999999999999999887 89999999997653211


Q ss_pred             ---cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCC
Q 020657          206 ---DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPD  282 (323)
Q Consensus       206 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (323)
                         .......++..|+|||.+.+.     ..+.++|+||||+++|+|++|..||...   .....+.+.......+.++.
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~g~~p~~~~---~~~~~~~~~~~~~~~~~~p~  232 (264)
T cd06653         161 MSGTGIKSVTGTPYWMSPEVISGE-----GYGRKADVWSVACTVVEMLTEKPPWAEY---EAMAAIFKIATQPTKPMLPD  232 (264)
T ss_pred             ccCccccccCCcccccCHhhhcCC-----CCCccccHHHHHHHHHHHHhCCCCCCcc---CHHHHHHHHHcCCCCCCCCc
Confidence               111234578899999988633     3456999999999999999999999543   23344444444455567788


Q ss_pred             CCChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          283 GASPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       283 ~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                      .+++++.+++.+||. +|..|||+.++++|||.
T Consensus       233 ~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         233 GVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             ccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            999999999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=4.1e-42  Score=298.64  Aligned_cols=271  Identities=35%  Similarity=0.686  Sum_probs=214.8

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceeceeEEcC
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKP  121 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~  121 (323)
                      ...+.+..++|++.+.||+|++|.||+|.+..+++.|++|.+...........+..|+.++... .|+||+++++++.+ 
T Consensus         7 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-   85 (296)
T cd06618           7 GQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT-   85 (296)
T ss_pred             ceeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec-
Confidence            3455677899999999999999999999998889999999997655444556667777766666 59999999999987 


Q ss_pred             CCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCCeEEecCCCcEEEeecCcch
Q 020657          122 SGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHG-HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       122 ~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~-~givH~di~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                      +...+++|||+.+ ++.+++.. ...+++..+..++.|++.+|.|||+ .|++|+||+|+||+++.++ .++|+|||++.
T Consensus        86 ~~~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~-~~kL~dfg~~~  163 (296)
T cd06618          86 DSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG-NVKLCDFGISG  163 (296)
T ss_pred             CCeEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC-CEEECccccch
Confidence            6789999999865 77777754 4578999999999999999999997 5999999999999999887 89999999987


Q ss_pred             hhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCC
Q 020657          200 IMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPS  279 (323)
Q Consensus       200 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  279 (323)
                      ........ ....++..|+|||.+..... ....+.++|+||||+++|+|++|+.||.....  ....+.... ......
T Consensus       164 ~~~~~~~~-~~~~~~~~y~aPE~~~~~~~-~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~-~~~~~~  238 (296)
T cd06618         164 RLVDSKAK-TRSAGCAAYMAPERIDPPDP-NPKYDIRADVWSLGISLVELATGQFPYKNCKT--EFEVLTKIL-QEEPPS  238 (296)
T ss_pred             hccCCCcc-cCCCCCccccCHhhcCCCCC-ccccccchhHHHHHHHHHHHHhCCCCCCcchh--HHHHHHHHh-cCCCCC
Confidence            65432222 23356788999999864432 23456799999999999999999999954221  122222222 222222


Q ss_pred             CC--CCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCCC
Q 020657          280 LP--DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS  321 (323)
Q Consensus       280 ~~--~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~  321 (323)
                      .+  ..++.++.+|+.+||+.||++|||++++++|+||...+.+
T Consensus       239 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  282 (296)
T cd06618         239 LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETA  282 (296)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccchh
Confidence            22  2478899999999999999999999999999999876553

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-42  Score=320.43  Aligned_cols=263  Identities=23%  Similarity=0.288  Sum_probs=194.0

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccC-cEEEEEee--------------cC--CCChHHHHHHHHHHHHHHcCCCCc
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTH-KIYALKVV--------------HG--DADPTVRRQVFREMEILRRTDSPF  110 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~-~~v~iK~~--------------~~--~~~~~~~~~~~~e~~~l~~l~h~~  110 (323)
                      ...++|++++.||+|+||+||++..+... ...+.|.+              ..  .........+.+|+.++++++|+|
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            34578999999999999999998764322 22222211              00  112234556789999999999999


Q ss_pred             cceeceeEEcCCCeEEEEEeccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEec
Q 020657          111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-----GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNN  185 (323)
Q Consensus       111 i~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~  185 (323)
                      |+++++++.. .+..++|++++.+ +|.+++...     .......+..++.||+.||.|||++||+||||||+||+++.
T Consensus       225 Iv~l~~~~~~-~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~  302 (501)
T PHA03210        225 ILKIEEILRS-EANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC  302 (501)
T ss_pred             cCcEeEEEEE-CCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence            9999999987 6778999999965 777666432     22446778899999999999999999999999999999999


Q ss_pred             CCCcEEEeecCcchhhccCcc-ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCcc
Q 020657          186 NNMQVKIADFGVSKIMCRSLD-ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPD  264 (323)
Q Consensus       186 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~  264 (323)
                      ++ .+||+|||++..+..... ......++..|+|||++.+..     ++.++||||||+++|||++|..++........
T Consensus       303 ~~-~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~  376 (501)
T PHA03210        303 DG-KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG-----YCEITDIWSCGLILLDMLSHDFCPIGDGGGKP  376 (501)
T ss_pred             CC-CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCC-----CCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH
Confidence            87 899999999976644322 223457899999999987443     45699999999999999998765544333222


Q ss_pred             HHHHHHHHhcC---------------------CC----CCC-----CCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcc
Q 020657          265 WATLMCAICFG---------------------DP----PSL-----PDGASPEFRSFIECCLQKEFSKRWTASQLLTHPF  314 (323)
Q Consensus       265 ~~~~~~~~~~~---------------------~~----~~~-----~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~  314 (323)
                      ...+.+.+...                     ..    ..+     ...++.++.+++.+||++||++|||+.|+|+|||
T Consensus       377 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~  456 (501)
T PHA03210        377 GKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL  456 (501)
T ss_pred             HHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence            22222111100                     00    000     1245678899999999999999999999999999


Q ss_pred             cccC
Q 020657          315 LCKN  318 (323)
Q Consensus       315 f~~~  318 (323)
                      |.+.
T Consensus       457 f~~~  460 (501)
T PHA03210        457 FSAE  460 (501)
T ss_pred             hhcC
Confidence            9764

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.1e-42  Score=300.01  Aligned_cols=258  Identities=24%  Similarity=0.377  Sum_probs=211.1

Q ss_pred             cchhccccccceeeeecccCCeEEEEEEeccc-----CcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceecee
Q 020657           44 TTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCT-----HKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFGI  117 (323)
Q Consensus        44 ~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~-----~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~  117 (323)
                      ..+.+..++|++...||+|++|.||++.+...     ...+++|.+...........+.+|+.+++.+ +|+||++++++
T Consensus         5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   84 (293)
T cd05053           5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGV   84 (293)
T ss_pred             cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            45677889999999999999999999997643     3689999988665555566788999999999 79999999999


Q ss_pred             EEcCCCeEEEEEeccCCCCHHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCe
Q 020657          118 FEKPSGDIAILMEYMDSGTLDTLLNK----------------NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNL  181 (323)
Q Consensus       118 ~~~~~~~~~lv~e~~~~~sL~~~l~~----------------~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~ni  181 (323)
                      +.. ++..+++|||+.+++|..++..                ...+++..+..++.|++.||.|||+.|++|+||+|+||
T Consensus        85 ~~~-~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni  163 (293)
T cd05053          85 CTQ-EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV  163 (293)
T ss_pred             EcC-CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence            887 6789999999999999999854                24588999999999999999999999999999999999


Q ss_pred             EEecCCCcEEEeecCcchhhccCcc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 020657          182 LVNNNNMQVKIADFGVSKIMCRSLD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQ  258 (323)
Q Consensus       182 l~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~  258 (323)
                      +++.++ .++|+|||++........  .......+..|+|||++..     ..++.++||||||+++|+|++ |..||..
T Consensus       164 l~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~~g~~p~~~  237 (293)
T cd05053         164 LVTEDH-VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-----RVYTHQSDVWSFGVLLWEIFTLGGSPYPG  237 (293)
T ss_pred             EEcCCC-eEEeCccccccccccccceeccCCCCCCccccCHHHhcc-----CCcCcccceeehhhHHHHHhcCCCCCCCC
Confidence            999987 899999999976543221  1112234567999998753     334569999999999999997 9999854


Q ss_pred             CCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          259 PGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ..    ...+............+...+.++.+|+.+||..||++|||+.+++++
T Consensus       238 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         238 IP----VEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             CC----HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            32    233334444444455666788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.9e-42  Score=296.09  Aligned_cols=252  Identities=29%  Similarity=0.513  Sum_probs=202.3

Q ss_pred             eecccCCeEEEEEEecccCcEEEEEeecCCCC--hHHHHHHHHH---HHHHHcCCCCccceeceeEEcCCCeEEEEEecc
Q 020657           58 VLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD--PTVRRQVFRE---MEILRRTDSPFIVQCFGIFEKPSGDIAILMEYM  132 (323)
Q Consensus        58 ~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~e---~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~  132 (323)
                      .||+|++|.||+|.+..+++.|++|.+.....  .........|   +..++...||+|+.+++.+.. ....++||||+
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~v~e~~   79 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-PDKLSFILDLM   79 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-CCEEEEEEecC
Confidence            48999999999999988899999999865421  1111223333   334455689999999999987 67899999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccccccc
Q 020657          133 DSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYV  212 (323)
Q Consensus       133 ~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  212 (323)
                      .+++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++......  ......
T Consensus        80 ~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~-~~kl~dfg~~~~~~~~--~~~~~~  156 (278)
T cd05606          80 NGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKK--KPHASV  156 (278)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCC-CEEEccCcCccccCcc--CCcCcC
Confidence            9999999998878899999999999999999999999999999999999999987 8999999998755332  223456


Q ss_pred             ccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHH
Q 020657          213 GTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFI  292 (323)
Q Consensus       213 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll  292 (323)
                      ++..|+|||++.+.    ..++.++|+||+|+++|+|++|..||........ ...... .......++...+.++.+++
T Consensus       157 ~~~~y~aPE~~~~~----~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-~~~~~~-~~~~~~~~~~~~s~~~~~li  230 (278)
T cd05606         157 GTHGYMAPEVLQKG----VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRM-TLTMAVELPDSFSPELRSLL  230 (278)
T ss_pred             CCcCCcCcHHhcCC----CCCCcccchHhHHHHHHHHHhCCCCCCCCCccch-HHHHHH-hhccCCCCCCcCCHHHHHHH
Confidence            88999999998632    2345689999999999999999999976533222 222222 22234556667899999999


Q ss_pred             HHhcccCcCCCC-----CHHHHhcCcccccCC
Q 020657          293 ECCLQKEFSKRW-----TASQLLTHPFLCKNR  319 (323)
Q Consensus       293 ~~~l~~~p~~Rp-----t~~~~l~h~~f~~~~  319 (323)
                      ++||..+|.+||     ++.++++||||++..
T Consensus       231 ~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~  262 (278)
T cd05606         231 EGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD  262 (278)
T ss_pred             HHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence            999999999999     999999999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.9e-42  Score=298.72  Aligned_cols=254  Identities=23%  Similarity=0.351  Sum_probs=208.9

Q ss_pred             ccccccceeeeecccCCeEEEEEEecc-----cCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRC-----THKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS  122 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  122 (323)
                      +..++|++.+.||+|+||.||+|.+..     .++.|++|++...........+.+|+.++..++||||+++++++.. .
T Consensus         2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-~   80 (283)
T cd05091           2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK-E   80 (283)
T ss_pred             CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-C
Confidence            456789999999999999999998753     3578999999866655666778899999999999999999999987 5


Q ss_pred             CeEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecC
Q 020657          123 GDIAILMEYMDSGTLDTLLNKN----------------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNN  186 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~  186 (323)
                      ...++++||+.+++|.+++...                ..+++..+..++.|++.||.|||+.|++|+||||+||+++.+
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence            6789999999999999998521                247888999999999999999999999999999999999988


Q ss_pred             CCcEEEeecCcchhhccCcc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 020657          187 NMQVKIADFGVSKIMCRSLD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRP  263 (323)
Q Consensus       187 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~  263 (323)
                      + .+||+|||++........  ......++..|+|||.+...     ..+.++||||||+++|||++ |..||.+..   
T Consensus       161 ~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~~l~el~~~g~~p~~~~~---  231 (283)
T cd05091         161 L-NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG-----KFSIDSDIWSYGVVLWEVFSYGLQPYCGYS---  231 (283)
T ss_pred             C-ceEecccccccccccchheeeccCccCCccccCHHHHhcC-----CCCcchhHHHHHHHHHHHHcCCCCCCCCCC---
Confidence            6 899999999875432211  12233456789999988633     34569999999999999998 888885432   


Q ss_pred             cHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          264 DWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                       ...+...+.......++..++..+.+|+.+||+.+|++||++++|+..
T Consensus       232 -~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         232 -NQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             -HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence             234444454555556678899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=7.9e-43  Score=310.39  Aligned_cols=259  Identities=25%  Similarity=0.405  Sum_probs=204.8

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC-----
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS-----  122 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----  122 (323)
                      ...+|++.+.||+|++|.||+|.+..+++.|++|.+.... .......+.+|+.+++.++|+||+++++++....     
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4588999999999999999999999999999999986442 3344566778999999999999999999886422     


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          123 GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      ...++||||+.+ +|.+.+...  ++...+..++.|++.||+|||+.|++|+||||+||+++.++ .++|+|||++....
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~  169 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAG  169 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEccCccceeCC
Confidence            357999999975 888887654  89999999999999999999999999999999999999987 89999999997654


Q ss_pred             cCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhc--------
Q 020657          203 RSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICF--------  274 (323)
Q Consensus       203 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~--------  274 (323)
                      .... .....++..|+|||.+...     .++.++||||||+++|+|++|..||...+....+..+......        
T Consensus       170 ~~~~-~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
T cd07850         170 TSFM-MTPYVVTRYYRAPEVILGM-----GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR  243 (353)
T ss_pred             CCCC-CCCCcccccccCHHHHhCC-----CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            3222 2334578899999998643     3456999999999999999999999655432222221110000        


Q ss_pred             ----------CCC----CC---------C-------CCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          275 ----------GDP----PS---------L-------PDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       275 ----------~~~----~~---------~-------~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                                ...    ..         +       ....+.++.+|+.+||+.||++|||+.++|+||||+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~  316 (353)
T cd07850         244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV  316 (353)
T ss_pred             hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence                      000    00         0       1134567899999999999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-43  Score=308.69  Aligned_cols=256  Identities=25%  Similarity=0.392  Sum_probs=219.0

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEeccc----CcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeE
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCT----HKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIF  118 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~----~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~  118 (323)
                      ....++........++||.|-||.||.|....-    .-.||||..+.+..++..+.|..|+.+|+.+.||||++++|++
T Consensus       381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~  460 (974)
T KOG4257|consen  381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVC  460 (974)
T ss_pred             CCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeee
Confidence            334456666677779999999999999986532    2368999998877777889999999999999999999999999


Q ss_pred             EcCCCeEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCc
Q 020657          119 EKPSGDIAILMEYMDSGTLDTLLNKNG-TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGV  197 (323)
Q Consensus       119 ~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~  197 (323)
                      .+  ...+||||.++-|.|..+++.++ .++......++.||+.||+|||+..+|||||..+|||+.... .|||+|||+
T Consensus       461 ~e--~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~-CVKLaDFGL  537 (974)
T KOG4257|consen  461 VE--QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQ-CVKLADFGL  537 (974)
T ss_pred             ec--cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcc-eeeecccch
Confidence            85  68999999999999999998654 699999999999999999999999999999999999999886 899999999


Q ss_pred             chhhccCc-cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCCCccHHHHHHHHhcC
Q 020657          198 SKIMCRSL-DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELY-LGHFPFLQPGQRPDWATLMCAICFG  275 (323)
Q Consensus       198 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~ll-tg~~p~~~~~~~~~~~~~~~~~~~~  275 (323)
                      ++...+.. .......-...|+|||.++-..++     .++|||.||++|||++ .|..||.+..+.+-+..+    ..+
T Consensus       538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFT-----tASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i----EnG  608 (974)
T KOG4257|consen  538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFT-----TASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI----ENG  608 (974)
T ss_pred             hhhccccchhhccccccceeecCccccchhccc-----chhhHHHHHHHHHHHHHhcCCccccccccceEEEe----cCC
Confidence            98776542 233344556899999999855554     4999999999999999 599999888776544333    447


Q ss_pred             CCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHh
Q 020657          276 DPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLL  310 (323)
Q Consensus       276 ~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l  310 (323)
                      .+.+.|..+++.++.|+.+||+++|.+||++.+|.
T Consensus       609 eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  609 ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence            78899999999999999999999999999988764

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=5.1e-42  Score=291.54  Aligned_cols=251  Identities=33%  Similarity=0.519  Sum_probs=213.9

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEe
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILME  130 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e  130 (323)
                      +|++.+.||+|++|.||++.+..+++.+++|.+.... .......+.+|+.+++.++|+||+++.+++.. ....++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD-GNKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc-CCEEEEEeh
Confidence            5889999999999999999998899999999987543 33445677889999999999999999999887 688999999


Q ss_pred             ccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc
Q 020657          131 YMDSGTLDTLLNK----NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD  206 (323)
Q Consensus       131 ~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~  206 (323)
                      |+++++|.+++..    ...+++..+..++.+++.||.+||+.|++|+||+|+||+++.++ .++|+|||++......  
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~-~~kl~d~g~~~~~~~~--  156 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND-LVKIGDLGISKVLKKN--  156 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCC-cEEEeeccchhhhccC--
Confidence            9999999998865    35689999999999999999999999999999999999999987 8999999999776544  


Q ss_pred             ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCCh
Q 020657          207 ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP  286 (323)
Q Consensus       207 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (323)
                      ......++..|++||.+...     ..+.++|+||||+++|+|++|..||...+    ...+.........+..+...+.
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~-----~~~~~~D~~slG~~~~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~  227 (256)
T cd08530         157 MAKTQIGTPHYMAPEVWKGR-----PYSYKSDIWSLGCLLYEMATFAPPFEARS----MQDLRYKVQRGKYPPIPPIYSQ  227 (256)
T ss_pred             CcccccCCccccCHHHHCCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhcCCCCCCchhhCH
Confidence            22335578899999998633     34568999999999999999999995443    3344444444555666678899


Q ss_pred             hHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          287 EFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       287 ~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                      ++.+++.+||+.+|++|||+.++++||++
T Consensus       228 ~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         228 DLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence            99999999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4.4e-42  Score=299.94  Aligned_cols=259  Identities=25%  Similarity=0.351  Sum_probs=210.2

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEecc-------cCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCcccee
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRC-------THKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQC  114 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~  114 (323)
                      .+.+.+..++|.+.+.||+|+||.||+|.+..       +...+++|.+...........+.+|+.+++.+ +|+||+++
T Consensus        10 ~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~   89 (307)
T cd05098          10 DPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL   89 (307)
T ss_pred             CCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence            34566778999999999999999999998643       23469999997654444556788899999999 79999999


Q ss_pred             ceeEEcCCCeEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCC
Q 020657          115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNG----------------TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKP  178 (323)
Q Consensus       115 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~  178 (323)
                      ++++.. .+..++||||+++++|.+++...+                .++...+..++.|++.||.|||+.|++|+||+|
T Consensus        90 ~~~~~~-~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp  168 (307)
T cd05098          90 LGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAA  168 (307)
T ss_pred             EEEEec-CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccH
Confidence            999987 678999999999999999997532                378899999999999999999999999999999


Q ss_pred             CCeEEecCCCcEEEeecCcchhhccCccc--cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCC
Q 020657          179 SNLLVNNNNMQVKIADFGVSKIMCRSLDA--CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFP  255 (323)
Q Consensus       179 ~nil~~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p  255 (323)
                      +||+++.++ .++|+|||.+.........  ......+..|+|||.+...     .++.++|+||||+++|+|++ |..|
T Consensus       169 ~Nill~~~~-~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslG~~l~el~~~g~~p  242 (307)
T cd05098         169 RNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-----IYTHQSDVWSFGVLLWEIFTLGGSP  242 (307)
T ss_pred             HheEEcCCC-cEEECCCcccccccccchhhccccCCCccceeChHHhccC-----CCCcHHHHHHHHHHHHHHHcCCCCC
Confidence            999999987 8999999998755322111  1122334689999988633     34569999999999999998 8888


Q ss_pred             CCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          256 FLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      |...    ....+............+..++.++.+|+.+||..+|++|||+.+++++
T Consensus       243 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         243 YPGV----PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             CCcC----CHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            8433    2344444444455556677889999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.3e-42  Score=303.04  Aligned_cols=250  Identities=25%  Similarity=0.396  Sum_probs=189.2

Q ss_pred             eeecccCCeEEEEEEecc--cCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEc-CCCeEEEEEeccC
Q 020657           57 QVLGHGNGGTVYKVQHRC--THKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEK-PSGDIAILMEYMD  133 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~lv~e~~~  133 (323)
                      .+||+|+||.||+|.+..  ++..|++|.+.....   ...+.+|+.+++.++||||+++++++.. .+...++|+||+.
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI---SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC---cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            579999999999999653  567899999864432   2356789999999999999999998854 3457899999997


Q ss_pred             CCCHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEe----cCCCcEEEeecCcchh
Q 020657          134 SGTLDTLLNK---------NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVN----NNNMQVKIADFGVSKI  200 (323)
Q Consensus       134 ~~sL~~~l~~---------~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~----~~~~~~kl~Dfg~~~~  200 (323)
                      + +|.+++..         ...+++..++.++.||+.||.|||+.|++|+||||+||++.    .++ .+||+|||++..
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~-~~kl~DfG~a~~  161 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG-RVKIADMGFARL  161 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCC-cEEEeeccceec
Confidence            5 77777642         12488999999999999999999999999999999999993    444 899999999976


Q ss_pred             hccCcc---ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCcc---------HHHH
Q 020657          201 MCRSLD---ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPD---------WATL  268 (323)
Q Consensus       201 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~---------~~~~  268 (323)
                      ......   ......++..|+|||++.+    ...++.++||||||+++|+|+||..||........         ...+
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~  237 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLG----ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI  237 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcC----CCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence            644322   1234567889999998853    23345699999999999999999999964332110         0000


Q ss_pred             HHHHh------------cCC---------------------CCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          269 MCAIC------------FGD---------------------PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       269 ~~~~~------------~~~---------------------~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                      .....            ...                     ........+..+.+|+.+||..||++|||++|+|+||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            00000            000                     000112345678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.2e-42  Score=305.51  Aligned_cols=264  Identities=24%  Similarity=0.332  Sum_probs=208.2

Q ss_pred             ccccce-eeeecccCCeEEEEEEecccCcEEEEEeecCCCChH-------------HHHHHHHHHHHHHcCCCCccceec
Q 020657           50 YSDLEK-LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-------------VRRQVFREMEILRRTDSPFIVQCF  115 (323)
Q Consensus        50 ~~~~~~-~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~-------------~~~~~~~e~~~l~~l~h~~i~~~~  115 (323)
                      .++|.. .+.||+|++|.||+|.+..+++.|++|++.......             ....+.+|+.+++.++|+||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            356654 577999999999999999899999999986443221             112467899999999999999999


Q ss_pred             eeEEcCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeec
Q 020657          116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADF  195 (323)
Q Consensus       116 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Df  195 (323)
                      +++.. ++..++||||+. ++|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+||
T Consensus        87 ~~~~~-~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~-~~kl~df  163 (335)
T PTZ00024         87 DVYVE-GDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKG-ICKIADF  163 (335)
T ss_pred             EEEec-CCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCC-CEEECCc
Confidence            99987 678999999997 49999998877899999999999999999999999999999999999999987 8999999


Q ss_pred             CcchhhccC--------------ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 020657          196 GVSKIMCRS--------------LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQ  261 (323)
Q Consensus       196 g~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~  261 (323)
                      |.+......              ........++..|+|||.+.+.    ...+.++|+||||+++|+|++|..||...+.
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA----EKYHFAVDMWSVGCIFAELLTGKPLFPGENE  239 (335)
T ss_pred             cceeecccccccccccccccccccccccccccccCCCCChhcccC----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999765411              1111223457789999988532    2346699999999999999999999976554


Q ss_pred             CccHHHHHHHHhcCCCC-----------------------CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          262 RPDWATLMCAICFGDPP-----------------------SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       262 ~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      ......+..........                       ......+.++.+++.+||+.+|++|||++++|.||||++.
T Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~  319 (335)
T PTZ00024        240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD  319 (335)
T ss_pred             HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence            33222222211111000                       0113457889999999999999999999999999999876


Q ss_pred             CC
Q 020657          319 RR  320 (323)
Q Consensus       319 ~~  320 (323)
                      ..
T Consensus       320 ~~  321 (335)
T PTZ00024        320 PL  321 (335)
T ss_pred             CC
Confidence            53

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.8e-42  Score=290.65  Aligned_cols=247  Identities=25%  Similarity=0.416  Sum_probs=207.1

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEE
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIA  126 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  126 (323)
                      .+...+|++.+.||.|++|.||+|.+  .++.|++|.+.....  ....+.+|+.+++.++|+||+++++++.. ....+
T Consensus         2 ~~~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~   76 (256)
T cd05039           2 AINSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-GNPLY   76 (256)
T ss_pred             ccChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcC-CCCeE
Confidence            35678999999999999999999998  478999999975543  45778899999999999999999999887 77899


Q ss_pred             EEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC
Q 020657          127 ILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS  204 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~  204 (323)
                      +||||+++++|.+++....  .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||.+......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~-~~~l~d~g~~~~~~~~  155 (256)
T cd05039          77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDL-VAKVSDFGLAKEASQG  155 (256)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCC-CEEEcccccccccccc
Confidence            9999999999999997654  689999999999999999999999999999999999999987 8999999999765322


Q ss_pred             ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCCCC
Q 020657          205 LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLPDG  283 (323)
Q Consensus       205 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (323)
                      ..   ....+..|+|||.+...     ..+.++|+||||+++|++++ |..||...    ....+............+..
T Consensus       156 ~~---~~~~~~~~~ape~~~~~-----~~~~~~Di~slG~il~~l~~~g~~p~~~~----~~~~~~~~~~~~~~~~~~~~  223 (256)
T cd05039         156 QD---SGKLPVKWTAPEALREK-----KFSTKSDVWSFGILLWEIYSFGRVPYPRI----PLKDVVPHVEKGYRMEAPEG  223 (256)
T ss_pred             cc---cCCCcccccCchhhcCC-----cCCcHHHHHHHHHHHHHHHhcCCCCCCCC----CHHHHHHHHhcCCCCCCccC
Confidence            21   22345679999988633     34569999999999999997 99999543    23334433333444455667


Q ss_pred             CChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          284 ASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       284 ~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      .++++.+++++||+.+|++|||++++++
T Consensus       224 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         224 CPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            8999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.3e-42  Score=294.73  Aligned_cols=252  Identities=21%  Similarity=0.364  Sum_probs=209.4

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEE
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIA  126 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  126 (323)
                      +.+..+|++.+.||.|++|.||+|.+.. +..+++|++.... ......+.+|+.+++.++|+||+++++++.. ....+
T Consensus         2 ~~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~   78 (261)
T cd05148           2 ERPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD-LLKQQDFQKEVQALKRLRHKHLISLFAVCSV-GEPVY   78 (261)
T ss_pred             cCcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc-hhhHHHHHHHHHHHhcCCCcchhheeeeEec-CCCeE
Confidence            3456789999999999999999999986 8899999987553 2335568899999999999999999999887 67899


Q ss_pred             EEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC
Q 020657          127 ILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS  204 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~  204 (323)
                      +||||+++++|.+++..  ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||.+......
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~-~~kl~d~g~~~~~~~~  157 (261)
T cd05148          79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDL-VCKVADFGLARLIKED  157 (261)
T ss_pred             EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCc-eEEEccccchhhcCCc
Confidence            99999999999999975  34689999999999999999999999999999999999999987 8999999999776443


Q ss_pred             ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCCCC
Q 020657          205 LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLPDG  283 (323)
Q Consensus       205 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (323)
                      ........++..|++||.+..     ..++.++|||+||+++|+|++ |..||.....    ...............+..
T Consensus       158 ~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~  228 (261)
T cd05148         158 VYLSSDKKIPYKWTAPEAASH-----GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN----HEVYDQITAGYRMPCPAK  228 (261)
T ss_pred             cccccCCCCceEecCHHHHcc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH----HHHHHHHHhCCcCCCCCC
Confidence            332233445678999998763     334569999999999999998 8999965432    223333334445566678


Q ss_pred             CChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          284 ASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       284 ~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ++..+.+++.+||+.||.+|||+.++++
T Consensus       229 ~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         229 CPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             CCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            8999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.5e-42  Score=291.28  Aligned_cols=252  Identities=24%  Similarity=0.389  Sum_probs=205.5

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeE
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDI  125 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  125 (323)
                      |++..++|++.+.||+|++|.||+|.+. +++.|++|.+.....  ....+.+|+.++++++|+||+++++++.. .+..
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   76 (261)
T cd05068           1 WEIDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM--DPKDFLAEAQIMKKLRHPKLIQLYAVCTL-EEPI   76 (261)
T ss_pred             CccchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc--cHHHHHHHHHHHHHCCCCCccceeEEEec-CCCe
Confidence            3567889999999999999999999975 567899999865432  24567889999999999999999999887 6789


Q ss_pred             EEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          126 AILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      +++|||+.+++|.+++....  .+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++ .++|+|||++.....
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~  155 (261)
T cd05068          77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENN-ICKVADFGLARVIKE  155 (261)
T ss_pred             eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCC-CEEECCcceEEEccC
Confidence            99999999999999997643  689999999999999999999999999999999999999987 899999999976643


Q ss_pred             Cccc-cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCC
Q 020657          204 SLDA-CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLP  281 (323)
Q Consensus       204 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (323)
                      .... ......+..|+|||.+..     ...+.++|+||||+++|+|+| |+.||.+...    ..+...+........+
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~~~~~~~~~~~  226 (261)
T cd05068         156 DIYEAREGAKFPIKWTAPEAALY-----NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN----AEVLQQVDQGYRMPCP  226 (261)
T ss_pred             CcccccCCCcCceeccCcccccc-----CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHHcCCCCCCC
Confidence            2111 112223457999998763     334569999999999999998 9999955432    2233333333334455


Q ss_pred             CCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          282 DGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       282 ~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ..++..+.+++.+||+.+|++||++.++++
T Consensus       227 ~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         227 PGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             CcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3.9e-42  Score=293.16  Aligned_cols=251  Identities=23%  Similarity=0.396  Sum_probs=205.7

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeE
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDI  125 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  125 (323)
                      |++..++|++.++||+|++|.||+|.+. +++.+++|.+.....  ....+.+|+.++++++|+||+++++++.  .+..
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~   75 (260)
T cd05067           1 WEVPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVVT--QEPI   75 (260)
T ss_pred             CccchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC--cHHHHHHHHHHHHhcCCcCeeeEEEEEc--cCCc
Confidence            4677899999999999999999999976 678899999875432  2356889999999999999999999875  4568


Q ss_pred             EEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          126 AILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      +++|||+.+++|.+++..  +..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.....
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~  154 (260)
T cd05067          76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETL-CCKIADFGLARLIED  154 (260)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCC-CEEEccCcceeecCC
Confidence            999999999999998865  34689999999999999999999999999999999999999987 899999999976542


Q ss_pred             C-ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCC
Q 020657          204 S-LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLP  281 (323)
Q Consensus       204 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (323)
                      . ........++..|+|||++..     ...+.++||||||+++|++++ |..||......    .+............+
T Consensus       155 ~~~~~~~~~~~~~~y~~pe~~~~-----~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~~~~~~~~~~~  225 (260)
T cd05067         155 NEYTAREGAKFPIKWTAPEAINY-----GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP----EVIQNLERGYRMPRP  225 (260)
T ss_pred             CCcccccCCcccccccCHHHhcc-----CCcCcccchHHHHHHHHHHHhCCCCCCCCCChH----HHHHHHHcCCCCCCC
Confidence            2 122223345678999998863     334569999999999999998 99999654332    223333333444566


Q ss_pred             CCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          282 DGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       282 ~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ...+.++.+++.+||+.+|++|||++++++
T Consensus       226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         226 DNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             CCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            778899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=7.2e-42  Score=296.21  Aligned_cols=262  Identities=30%  Similarity=0.489  Sum_probs=215.1

Q ss_pred             ccceeeeecccCCeEEEEEEec---ccCcEEEEEeecCCC---ChHHHHHHHHHHHHHHcC-CCCccceeceeEEcCCCe
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHR---CTHKIYALKVVHGDA---DPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKPSGD  124 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~---~~~~~v~iK~~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  124 (323)
                      .|++.+.||+|++|.||+|.+.   .+|+.|++|++....   .....+.+.+|+.+++.+ +|++|+++++.+.. +..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~   79 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-DTK   79 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec-CCe
Confidence            4889999999999999999874   378899999986432   223346678899999999 58999999999887 678


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC
Q 020657          125 IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS  204 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~  204 (323)
                      .++||||+++++|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~  158 (290)
T cd05613          80 LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKEFHED  158 (290)
T ss_pred             EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCC-CEEEeeCccceecccc
Confidence            899999999999999998888899999999999999999999999999999999999999987 8999999998765332


Q ss_pred             c-cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCC
Q 020657          205 L-DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDG  283 (323)
Q Consensus       205 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (323)
                      . .......++..|+|||.+...   ....+.++|||+||+++|+|++|..||...........+....... ...++..
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~  234 (290)
T cd05613         159 EVERAYSFCGTIEYMAPDIVRGG---DGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-EPPYPQE  234 (290)
T ss_pred             cccccccccCCcccCChhhccCC---CCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc-CCCCCcc
Confidence            1 122234578899999987532   1234568999999999999999999996544444444444433332 3455677


Q ss_pred             CChhHHHHHHHhcccCcCCCC-----CHHHHhcCcccccCC
Q 020657          284 ASPEFRSFIECCLQKEFSKRW-----TASQLLTHPFLCKNR  319 (323)
Q Consensus       284 ~~~~l~~ll~~~l~~~p~~Rp-----t~~~~l~h~~f~~~~  319 (323)
                      ++..+.+++++||+.||++||     +.+++++||||+...
T Consensus       235 ~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  275 (290)
T cd05613         235 MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN  275 (290)
T ss_pred             CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence            899999999999999999997     899999999998765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-45  Score=297.51  Aligned_cols=257  Identities=33%  Similarity=0.579  Sum_probs=219.1

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      ..-|.++.+||+|++|.||+|.++.+|..+|||.+..+.+   ...+.+|+.+|+++..+++|++||.|-. ...+++||
T Consensus        32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD---LQEIIKEISIMQQC~S~yVVKYYGSYFK-~sDLWIVM  107 (502)
T KOG0574|consen   32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD---LQEIIKEISIMQQCKSKYVVKYYGSYFK-HSDLWIVM  107 (502)
T ss_pred             HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch---HHHHHHHHHHHHHcCCchhhhhhhhhcc-CCceEeeh
Confidence            3558899999999999999999999999999999976643   4678899999999999999999998876 56799999


Q ss_pred             eccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          130 EYMDSGTLDTLLN-KNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       130 e~~~~~sL~~~l~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      |||..|++.++++ +++++++.++..+++.-+.+|.|||...=+|||||+.|||++.+| ..||.|||.+....+.....
T Consensus       108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G-~AKLADFGVAGQLTDTMAKR  186 (502)
T KOG0574|consen  108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDG-IAKLADFGVAGQLTDTMAKR  186 (502)
T ss_pred             hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccc-hhhhhhccccchhhhhHHhh
Confidence            9999999999997 567899999999999999999999999999999999999999998 89999999998887776667


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCC--CCCCCh
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSL--PDGASP  286 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  286 (323)
                      .+..||+.|+|||++..-.|     +.++||||||++..||..|+.||.....-   ..+.. +....++.+  |..-|.
T Consensus       187 NTVIGTPFWMAPEVI~EIGY-----~~~ADIWSLGITaIEMAEG~PPYsDIHPM---RAIFM-IPT~PPPTF~KPE~WS~  257 (502)
T KOG0574|consen  187 NTVIGTPFWMAPEVIEEIGY-----DTKADIWSLGITAIEMAEGRPPYSDIHPM---RAIFM-IPTKPPPTFKKPEEWSS  257 (502)
T ss_pred             CccccCcccccHHHHHHhcc-----chhhhHhhhcchhhhhhcCCCCccccccc---ceeEe-ccCCCCCCCCChHhhhh
Confidence            78899999999999975554     34999999999999999999999432111   01110 111222333  235578


Q ss_pred             hHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          287 EFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       287 ~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                      ++.+++++||-.+|++|-|+.++++|+|.++-.+
T Consensus       258 ~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g  291 (502)
T KOG0574|consen  258 EFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPG  291 (502)
T ss_pred             HHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCc
Confidence            9999999999999999999999999999987553

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=4.3e-42  Score=297.76  Aligned_cols=259  Identities=28%  Similarity=0.497  Sum_probs=211.5

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEec
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEY  131 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~  131 (323)
                      .|.....||+|++|.||++.+..+++.|++|.+.... ......+.+|+.+++.++|+|++++++.+.. .+..++||||
T Consensus        21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~   98 (292)
T cd06657          21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVMEF   98 (292)
T ss_pred             HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEe-CCEEEEEEec
Confidence            3444578999999999999998899999999986433 3445678899999999999999999999987 6789999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccccc
Q 020657          132 MDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSY  211 (323)
Q Consensus       132 ~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  211 (323)
                      +++++|.+++.. ..+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++ .++|+|||++.............
T Consensus        99 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~-~~~l~dfg~~~~~~~~~~~~~~~  176 (292)
T cd06657          99 LEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKSL  176 (292)
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEcccccceeccccccccccc
Confidence            999999998754 3689999999999999999999999999999999999999987 89999999987654433333345


Q ss_pred             cccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCC--CCCCCChhHH
Q 020657          212 VGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPS--LPDGASPEFR  289 (323)
Q Consensus       212 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~  289 (323)
                      .++..|++||.+...     ..+.++|+||+|+++|+|++|..||.........    .......+..  ....++..+.
T Consensus       177 ~~~~~y~~pE~~~~~-----~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~  247 (292)
T cd06657         177 VGTPYWMAPELISRL-----PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM----KMIRDNLPPKLKNLHKVSPSLK  247 (292)
T ss_pred             ccCccccCHHHhcCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhhCCcccCCcccCCHHHH
Confidence            678899999987533     3456999999999999999999999643322111    1111122222  2346789999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCcccccCCCCCC
Q 020657          290 SFIECCLQKEFSKRWTASQLLTHPFLCKNRRSDC  323 (323)
Q Consensus       290 ~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~~~  323 (323)
                      +++.+||+.+|.+||+++++++||||.....+.|
T Consensus       248 ~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~~~~  281 (292)
T cd06657         248 GFLDRLLVRDPAQRATAAELLKHPFLAKAGPPSC  281 (292)
T ss_pred             HHHHHHHhCCcccCcCHHHHhcChHHhccCCCcc
Confidence            9999999999999999999999999998877655

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.8e-42  Score=301.44  Aligned_cols=260  Identities=27%  Similarity=0.443  Sum_probs=201.4

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcCCCCccceeceeEEcCC-----
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS-----  122 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----  122 (323)
                      ..++|++.+.||+|++|.||+|.+..+++.|++|.+..... ......+.+|+.+++++.||||+++++++...+     
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            45789999999999999999999998999999999865432 223345568999999999999999999876532     


Q ss_pred             --CeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcch
Q 020657          123 --GDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       123 --~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                        ...++||||+.+ +|.+.+... ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++.
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~  167 (310)
T cd07865          90 YKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG-ILKLADFGLAR  167 (310)
T ss_pred             CCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC-cEEECcCCCcc
Confidence              346999999975 887777653 3689999999999999999999999999999999999999987 89999999997


Q ss_pred             hhccCcc----ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcC
Q 020657          200 IMCRSLD----ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFG  275 (323)
Q Consensus       200 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~  275 (323)
                      .......    ......++..|+|||.+.+.    ...+.++|+||||+++|+|++|..||.......... ........
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~-~~~~~~~~  242 (310)
T cd07865         168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGE----RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLT-LISQLCGS  242 (310)
T ss_pred             cccCCcccCCCCccCcccCccccCcHHhcCC----cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhCC
Confidence            6543221    11234567889999987532    223568999999999999999999996543221111 11111110


Q ss_pred             CCCC---------------C-------------CCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          276 DPPS---------------L-------------PDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       276 ~~~~---------------~-------------~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                      .++.               +             ....+..+.+||.+||+.||++|||++++|+||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            0000               0             11235678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.2e-42  Score=301.04  Aligned_cols=263  Identities=30%  Similarity=0.393  Sum_probs=207.2

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcCCCCccceeceeEEcCC---
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS---  122 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---  122 (323)
                      +...++|++.+.||+|++|.||+|.+..+++.|++|.+..... ......+.+|+.+++.++||||+++++++.+..   
T Consensus         3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence            3456889999999999999999999998899999999975432 233456678999999999999999999887532   


Q ss_pred             ------CeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeec
Q 020657          123 ------GDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADF  195 (323)
Q Consensus       123 ------~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Df  195 (323)
                            +.+++|+||+++ ++...+.. ...+++..++.++.|++.||.|||+.|++|+||+|+||++++++ .+||+||
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~-~~kl~df  160 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG-QIKLADF  160 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-cEEeCcc
Confidence                  378999999986 67666654 34689999999999999999999999999999999999999987 8999999


Q ss_pred             CcchhhccCcc-ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhc
Q 020657          196 GVSKIMCRSLD-ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICF  274 (323)
Q Consensus       196 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~  274 (323)
                      |.+........ .......+..|+|||.+...    ...+.++||||||+++|+|++|..||...........+.+....
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~----~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~  236 (302)
T cd07864         161 GLARLYNSEESRPYTNKVITLWYRPPELLLGE----ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS  236 (302)
T ss_pred             cccccccCCcccccccceeccCccChHHhcCC----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            99976543321 12223457789999987522    23456999999999999999999999654433333333322111


Q ss_pred             CCCC-------------------------CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          275 GDPP-------------------------SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       275 ~~~~-------------------------~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                      ..+.                         .....++..+.+++.+||+.+|.+|||++++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            1100                         0122468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=7.5e-42  Score=295.81  Aligned_cols=252  Identities=26%  Similarity=0.446  Sum_probs=205.5

Q ss_pred             ccccccceeeeecccCCeEEEEEEec-----ccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHR-----CTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS  122 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  122 (323)
                      +..++|.+.+.||+|+||.||++.+.     .++..+++|.+.... ......+.+|+.++++++|+||+++++++.. .
T Consensus         2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   79 (288)
T cd05093           2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVE-G   79 (288)
T ss_pred             CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence            45678999999999999999999852     345678899886543 3445678899999999999999999999987 6


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCc
Q 020657          123 GDIAILMEYMDSGTLDTLLNKNG-------------TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQ  189 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~~-------------~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~  189 (323)
                      +..++||||+++++|.+++...+             .+++..+..++.|++.||+|||+.|++||||||+||+++.++ .
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~-~  158 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL-L  158 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC-c
Confidence            78999999999999999986433             489999999999999999999999999999999999999987 8


Q ss_pred             EEEeecCcchhhccCcc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHH
Q 020657          190 VKIADFGVSKIMCRSLD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWA  266 (323)
Q Consensus       190 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~  266 (323)
                      ++|+|||++........  ......++..|+|||++...     ..+.++|+||||+++|+|++ |..||.....    .
T Consensus       159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~sDiwslG~il~~l~t~g~~p~~~~~~----~  229 (288)
T cd05093         159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-----KFTTESDVWSLGVVLWEIFTYGKQPWYQLSN----N  229 (288)
T ss_pred             EEeccCCccccccCCceeecCCCCCccccccCHHHhccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----H
Confidence            99999999875432211  12223446789999988633     34569999999999999998 9999855432    2


Q ss_pred             HHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          267 TLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      .....+..+.....+...+.++.+|+.+||+.||.+|||+++++.
T Consensus       230 ~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         230 EVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             HHHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            333344444445556678999999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=6.9e-42  Score=291.42  Aligned_cols=245  Identities=27%  Similarity=0.433  Sum_probs=209.5

Q ss_pred             eeecccCCeEEEEEEeccc---CcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEeccC
Q 020657           57 QVLGHGNGGTVYKVQHRCT---HKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMD  133 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~  133 (323)
                      +.||+|++|.||+|.+...   +..+++|.+...........+.+|+.+++.++|+||+++++++.. ....++||||++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~   79 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-EEPLYLVLEYME   79 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-CCceEEEEEecc
Confidence            3689999999999999765   889999999876655557788999999999999999999999987 788999999999


Q ss_pred             CCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC
Q 020657          134 SGTLDTLLNKN---------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS  204 (323)
Q Consensus       134 ~~sL~~~l~~~---------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~  204 (323)
                      +++|.+++...         ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+......
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~-~~~l~dfg~~~~~~~~  158 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDL-VVKISDFGLSRDVYDD  158 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCC-cEEEcccccccccccc
Confidence            99999999875         6799999999999999999999999999999999999999987 8999999999776543


Q ss_pred             c--cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCC
Q 020657          205 L--DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLP  281 (323)
Q Consensus       205 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (323)
                      .  .......++..|+|||.+...     ..+.++||||||+++|+|++ |..||...    ....+......+.....+
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~~g~~p~~~~----~~~~~~~~~~~~~~~~~~  229 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDG-----IFTSKSDVWSFGVLLWEIFTLGATPYPGL----SNEEVLEYLRKGYRLPKP  229 (262)
T ss_pred             cccccccCCCcCccccCHHHhccC-----CcchhhccHHHHHHHHHHHhcCCCCCCCC----CHHHHHHHHHcCCCCCCC
Confidence            2  223345567899999988643     45669999999999999998 69999655    234444444445566677


Q ss_pred             CCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          282 DGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       282 ~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ..++.++.+++.+||+.+|.+|||+++++++
T Consensus       230 ~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         230 EYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             ccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            7889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=5.6e-42  Score=291.61  Aligned_cols=250  Identities=24%  Similarity=0.391  Sum_probs=203.5

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ..++|++.+.||+|++|.||+|.+. .+..+++|.+....  .....+.+|+.+++.+.||||+++++++.. ....++|
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv   77 (256)
T cd05113           2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK-QRPIYIV   77 (256)
T ss_pred             ChHHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEcc-CCCcEEE
Confidence            4578999999999999999999875 34569999886443  223568899999999999999999999886 5678999


Q ss_pred             EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc-
Q 020657          129 MEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD-  206 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~-  206 (323)
                      |||+.+++|.+++... ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++ .+||+|||.+........ 
T Consensus        78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~-~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05113          78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQG-CVKVSDFGLSRYVLDDEYT  156 (256)
T ss_pred             EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC-CEEECCCccceecCCCcee
Confidence            9999999999998764 3689999999999999999999999999999999999999887 899999999875533221 


Q ss_pred             ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCC
Q 020657          207 ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS  285 (323)
Q Consensus       207 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (323)
                      ......++..|++||.+...     .++.++||||||+++|+|++ |..||.....    ......+..+.....+...+
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~-----~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~  227 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYS-----KFSSKSDVWAFGVLMWEVYSLGKMPYERFNN----SETVEKVSQGLRLYRPHLAS  227 (256)
T ss_pred             ecCCCccChhhCCHHHHhcC-----cccchhHHHHHHHHHHHHhcCCCCCcCcCCH----HHHHHHHhcCCCCCCCCCCC
Confidence            11223355689999998633     34569999999999999998 9999954432    23333334444445556678


Q ss_pred             hhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          286 PEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       286 ~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ..+.+++.+||+.+|.+|||+.+++++
T Consensus       228 ~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         228 EKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence            999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=8.6e-42  Score=294.10  Aligned_cols=252  Identities=24%  Similarity=0.378  Sum_probs=206.3

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCc----EEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCC
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHK----IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG  123 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  123 (323)
                      +..++|++.+.||+|++|+||+|.+..+++    .|++|++...........+.+|+.+++.+.|+||+++++++..  .
T Consensus         4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~   81 (279)
T cd05109           4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT--S   81 (279)
T ss_pred             cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC--C
Confidence            456889999999999999999999876666    4799998766666667788999999999999999999999875  4


Q ss_pred             eEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          124 DIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      ..+++++|+++++|.+++... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++ .+||+|||++....
T Consensus        82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~-~~kL~dfG~~~~~~  160 (279)
T cd05109          82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPN-HVKITDFGLARLLD  160 (279)
T ss_pred             CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC-cEEECCCCceeecc
Confidence            578999999999999999763 4689999999999999999999999999999999999999887 89999999987654


Q ss_pred             cCccc--cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCC
Q 020657          203 RSLDA--CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPS  279 (323)
Q Consensus       203 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  279 (323)
                      .....  .....++..|+|||.+...     ..+.++||||||+++|||++ |..||.....    ..+...........
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~-----~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~~~~~~~~~  231 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHR-----RFTHQSDVWSYGVTVWELMTFGAKPYDGIPA----REIPDLLEKGERLP  231 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccC-----CCCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHHCCCcCC
Confidence            32221  1122345689999988633     34569999999999999998 9999854322    22333333344445


Q ss_pred             CCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          280 LPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       280 ~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      .+...+.++.+++.+||+.||++||++.++++
T Consensus       232 ~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         232 QPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            56678999999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-43  Score=315.65  Aligned_cols=257  Identities=34%  Similarity=0.537  Sum_probs=223.4

Q ss_pred             eeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEeccCC
Q 020657           55 KLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDS  134 (323)
Q Consensus        55 ~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~  134 (323)
                      -.-+||+|.+|+||.|+|..+...+|||-+.... .....-+..|+.+-++|+|.|||+++|.+.. .+.+-|+||-.+|
T Consensus       579 ervVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd-sr~~QPLhEEIaLH~~LrHkNIVrYLGs~se-nGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  579 ERVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD-SREVQPLHEEIALHSTLRHKNIVRYLGSVSE-NGFFKIFMEQVPG  656 (1226)
T ss_pred             ceEEeecCceeEEEeeccccceeEEEeeeccccc-chhhccHHHHHHHHHHHhhHhHHHHhhccCC-CCeEEEEeecCCC
Confidence            3458999999999999999999999999997543 3445667899999999999999999999876 6788999999999


Q ss_pred             CCHHHHHHh-cCCC--CHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccccc
Q 020657          135 GTLDTLLNK-NGTF--SEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSY  211 (323)
Q Consensus       135 ~sL~~~l~~-~~~~--~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  211 (323)
                      |+|.++++. -+++  .+...-.+.+||++||.|||...|||||||-+|||++.-...+||+|||.+.+...-.+-..++
T Consensus       657 GSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETF  736 (1226)
T KOG4279|consen  657 GSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETF  736 (1226)
T ss_pred             CcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccc
Confidence            999999975 4566  7888999999999999999999999999999999998754589999999999987777777888


Q ss_pred             cccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHH
Q 020657          212 VGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSF  291 (323)
Q Consensus       212 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  291 (323)
                      -||..|+|||++..++   ..+..++|||||||++.||.||+.||...+...  ..+.+--.++..+++|..++.+.+++
T Consensus       737 TGTLQYMAPEvIDqG~---RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq--AAMFkVGmyKvHP~iPeelsaeak~F  811 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGP---RGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ--AAMFKVGMYKVHPPIPEELSAEAKNF  811 (1226)
T ss_pred             ccchhhhChHhhccCC---cCCCchhhhhhccceeEeeccCCCCeeecCChh--HhhhhhcceecCCCCcHHHHHHHHHH
Confidence            9999999999998554   334569999999999999999999997665542  33444444556788999999999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          292 IECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       292 l~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      +.+|+.++|.+||++.++|+.||++..
T Consensus       812 ilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  812 ILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             HHHHcCCCcccCccHHHhccCcccccC
Confidence            999999999999999999999999866

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=7.4e-42  Score=290.80  Aligned_cols=248  Identities=24%  Similarity=0.425  Sum_probs=205.4

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeE
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDI  125 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  125 (323)
                      |.+..++|++.+.||+|++|.||++..  .+..+++|.+....   ..+.+.+|+.+++.++|+|++++++++....+..
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (256)
T cd05082           1 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   75 (256)
T ss_pred             CCccHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence            456788999999999999999999987  47889999986432   3456889999999999999999999876556779


Q ss_pred             EEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          126 AILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      ++++||+++++|.+++....  .+++..+..++.|++.||.+||++|++|+||+|+||+++.++ .+||+|||++.....
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~  154 (256)
T cd05082          76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASS  154 (256)
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCC-cEEecCCccceeccc
Confidence            99999999999999987543  478999999999999999999999999999999999999987 899999999865433


Q ss_pred             CccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCCC
Q 020657          204 SLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLPD  282 (323)
Q Consensus       204 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (323)
                      ..   .....+..|+|||++...     ..+.++||||||+++|+|++ |..||...    ....+...+........+.
T Consensus       155 ~~---~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~i~~~l~~~g~~p~~~~----~~~~~~~~~~~~~~~~~~~  222 (256)
T cd05082         155 TQ---DTGKLPVKWTAPEALREK-----KFSTKSDVWSFGILLWEIYSFGRVPYPRI----PLKDVVPRVEKGYKMDAPD  222 (256)
T ss_pred             cC---CCCccceeecCHHHHccC-----CCCchhhhHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHHhcCCCCCCCC
Confidence            22   122345689999988633     34569999999999999997 99999543    3344444444444555667


Q ss_pred             CCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          283 GASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       283 ~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      .+++.+.+++.+||+.+|++|||++++++
T Consensus       223 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         223 GCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             CCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            88999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=8.6e-42  Score=290.60  Aligned_cols=243  Identities=26%  Similarity=0.450  Sum_probs=199.9

Q ss_pred             eecccCCeEEEEEEe--cccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEeccCC
Q 020657           58 VLGHGNGGTVYKVQH--RCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDS  134 (323)
Q Consensus        58 ~lg~G~~~~v~~~~~--~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~  134 (323)
                      .||+|+||.||+|.+  ..++..+++|++.... +....+.+.+|+.+++.+.|+||+++++++..  ...++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA--ESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCcEEEEecCCC
Confidence            589999999999975  3567899999986543 34456778899999999999999999998764  567899999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccc---cccc
Q 020657          135 GTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA---CNSY  211 (323)
Q Consensus       135 ~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~  211 (323)
                      ++|.+++.....+++..+..++.|++.||.+||+.|++|+||||.||+++.++ .++|+|||++.........   ....
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05116          80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH-YAKISDFGLSKALGADENYYKAKTHG  158 (257)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCC-eEEECCCccccccCCCCCeeeecCCC
Confidence            99999998877899999999999999999999999999999999999999987 8999999999765433221   1122


Q ss_pred             cccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHH
Q 020657          212 VGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS  290 (323)
Q Consensus       212 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  290 (323)
                      .++..|+|||.+..     ...+.++|+||||+++|||++ |..||.....    ..+...+..+.....+..+++++.+
T Consensus       159 ~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~i~~~~~~~~~~~~~~~l~~  229 (257)
T cd05116         159 KWPVKWYAPECMNY-----YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG----NEVTQMIESGERMECPQRCPPEMYD  229 (257)
T ss_pred             CCCccccCHhHhcc-----CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHCCCCCCCCCCCCHHHHH
Confidence            33578999998763     334569999999999999998 9999965433    2333444444556677789999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcC
Q 020657          291 FIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       291 ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      +|.+||+.||++||++++|.+.
T Consensus       230 li~~~~~~~p~~Rp~~~~i~~~  251 (257)
T cd05116         230 LMKLCWTYGVDERPGFAVVELR  251 (257)
T ss_pred             HHHHHhccCchhCcCHHHHHHH
Confidence            9999999999999999998753

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=5e-42  Score=293.57  Aligned_cols=252  Identities=27%  Similarity=0.460  Sum_probs=207.3

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ++|++.+.||+|++|.||+|.+..+++.+++|.+....  +......+.+|+.+++.+.|+||+++++.+.. .+..+++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~v   80 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-DNELNIV   80 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-CCeEEEE
Confidence            57999999999999999999998899999999886432  23445678899999999999999999999987 6789999


Q ss_pred             EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC
Q 020657          129 MEYMDSGTLDTLLNK----NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS  204 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~  204 (323)
                      |||+++++|.+++..    ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~~~  159 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEECcchhhhccccC
Confidence            999999999998863    34689999999999999999999999999999999999999987 8999999998766443


Q ss_pred             ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCC-CCC
Q 020657          205 LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSL-PDG  283 (323)
Q Consensus       205 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  283 (323)
                      ........++..|+|||.+...     ..+.++|+||||+++|+|++|..||.....  ....+.........+.. ...
T Consensus       160 ~~~~~~~~~~~~~~ape~~~~~-----~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~  232 (267)
T cd08229         160 TTAAHSLVGTPYYMSPERIHEN-----GYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLYSLCKKIEQCDYPPLPSDH  232 (267)
T ss_pred             CcccccccCCcCccCHHHhcCC-----CccchhhHHHHHHHHHHHHhCCCCcccccc--hHHHHhhhhhcCCCCCCCccc
Confidence            3333445678899999988633     345689999999999999999999965432  22233333333333333 346


Q ss_pred             CChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          284 ASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       284 ~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      .+..+.+++.+||+.+|++|||+.+|++
T Consensus       233 ~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         233 YSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             ccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence            7899999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=9.9e-42  Score=293.71  Aligned_cols=253  Identities=22%  Similarity=0.328  Sum_probs=203.5

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCc----EEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCC
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHK----IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG  123 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  123 (323)
                      +...+|++.+.||+|+||+||+|.+..+++    .+++|.+...........+..|+..++.+.||||+++++++.  ..
T Consensus         4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~--~~   81 (279)
T cd05111           4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP--GA   81 (279)
T ss_pred             CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC--CC
Confidence            345789999999999999999999876665    477787754444445567788888999999999999999875  35


Q ss_pred             eEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          124 DIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      ..++++||+++++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||||+||+++.++ .+||+|||.+....
T Consensus        82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~-~~kl~Dfg~~~~~~  160 (279)
T cd05111          82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDS-IVQIADFGVADLLY  160 (279)
T ss_pred             ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC-cEEEcCCccceecc
Confidence            67899999999999999975 45789999999999999999999999999999999999999987 89999999997653


Q ss_pred             cCcc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCC
Q 020657          203 RSLD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPS  279 (323)
Q Consensus       203 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  279 (323)
                      ....  ......++..|+|||.+...     .++.++||||||+++||+++ |..||.+...    ..+......+....
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~-----~~~~~~Dv~slG~il~el~t~g~~p~~~~~~----~~~~~~~~~~~~~~  231 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFG-----RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP----HEVPDLLEKGERLA  231 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccC-----CcCchhhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHHCCCcCC
Confidence            2211  12233456789999988633     34669999999999999998 9999955422    22223333344445


Q ss_pred             CCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          280 LPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       280 ~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      .+..++.++.+++.+||..||++|||+.++++.
T Consensus       232 ~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~  264 (279)
T cd05111         232 QPQICTIDVYMVMVKCWMIDENVRPTFKELANE  264 (279)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            556678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-44  Score=312.96  Aligned_cols=258  Identities=31%  Similarity=0.498  Sum_probs=220.8

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCC--CChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ..|.-++.||.|+||.||-|+|..+.+.||||.....  ...+....+.+|+.+|+.+.|||++.+-|.|-. +...++|
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr-e~TaWLV  104 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR-EHTAWLV  104 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec-cchHHHH
Confidence            3477889999999999999999999999999998654  345678889999999999999999999999986 6788999


Q ss_pred             EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccc
Q 020657          129 MEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA  207 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~  207 (323)
                      ||||-| +..+++.- .+++.+.++..|+.+.+.||+|||+.+.||||||+.|||+++.| .|||+|||.+...    ..
T Consensus       105 MEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g-~VKLaDFGSAsi~----~P  178 (948)
T KOG0577|consen  105 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPG-LVKLADFGSASIM----AP  178 (948)
T ss_pred             HHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCC-eeeeccccchhhc----Cc
Confidence            999965 99999874 45799999999999999999999999999999999999999998 8999999998664    33


Q ss_pred             cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCC-CCCCh
Q 020657          208 CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLP-DGASP  286 (323)
Q Consensus       208 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  286 (323)
                      ..+++||+.|+|||++.  ....+.++-++||||||++..||...+.|++.++.-.....+-+    +..+.+. ..-+.
T Consensus       179 AnsFvGTPywMAPEVIL--AMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQ----NesPtLqs~eWS~  252 (948)
T KOG0577|consen  179 ANSFVGTPYWMAPEVIL--AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----NESPTLQSNEWSD  252 (948)
T ss_pred             hhcccCCccccchhHhe--eccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHh----cCCCCCCCchhHH
Confidence            46789999999999986  33455566699999999999999999999977655444444433    3444444 45678


Q ss_pred             hHHHHHHHhcccCcCCCCCHHHHhcCcccccCCCC
Q 020657          287 EFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS  321 (323)
Q Consensus       287 ~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~  321 (323)
                      .+.+||..||+.-|.+|||.+++|.|+|....|-+
T Consensus       253 ~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~  287 (948)
T KOG0577|consen  253 YFRNFVDSCLQKIPQERPTSEELLKHRFVLRERPP  287 (948)
T ss_pred             HHHHHHHHHHhhCcccCCcHHHHhhcchhccCCCc
Confidence            89999999999999999999999999999766543

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-44  Score=333.15  Aligned_cols=268  Identities=30%  Similarity=0.436  Sum_probs=229.9

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCC
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG  123 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  123 (323)
                      ..+..++|.|++.||+|+||.|.+++.+++++.||.|++.+..  .......|..|-.+|..-..+=|++++=.|++ +.
T Consensus        70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD-~~  148 (1317)
T KOG0612|consen   70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD-ER  148 (1317)
T ss_pred             HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC-cc
Confidence            4566789999999999999999999999999999999986521  12234667888889988888999999999998 78


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc-
Q 020657          124 DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC-  202 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~-  202 (323)
                      ++|+|||||+||+|-.++.+..++++..++.++..|+-||..||+.|+|||||||+|||+|..| .+||+|||.+.... 
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~G-HikLADFGsClkm~~  227 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSG-HIKLADFGSCLKMDA  227 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccC-cEeeccchhHHhcCC
Confidence            9999999999999999999887899999999999999999999999999999999999999998 89999999998876 


Q ss_pred             cCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCC-
Q 020657          203 RSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLP-  281 (323)
Q Consensus       203 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-  281 (323)
                      ++.-.....+||+.|++||++.....+.+.+....|+||+|+++|||+.|.-||....-..++.+++.-...   ..+| 
T Consensus       228 dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~---l~FP~  304 (1317)
T KOG0612|consen  228 DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKES---LSFPD  304 (1317)
T ss_pred             CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhh---cCCCc
Confidence            344445678999999999999755544566778999999999999999999999777666666666544222   2333 


Q ss_pred             -CCCChhHHHHHHHhcccCcCCCCC---HHHHhcCcccccCC
Q 020657          282 -DGASPEFRSFIECCLQKEFSKRWT---ASQLLTHPFLCKNR  319 (323)
Q Consensus       282 -~~~~~~l~~ll~~~l~~~p~~Rpt---~~~~l~h~~f~~~~  319 (323)
                       ..+|.+..+||++++. +|+.|..   ++++-.||||.++.
T Consensus       305 ~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~  345 (1317)
T KOG0612|consen  305 ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGID  345 (1317)
T ss_pred             ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCC
Confidence             4599999999999886 5788998   99999999998864

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=4.6e-42  Score=292.72  Aligned_cols=252  Identities=33%  Similarity=0.516  Sum_probs=205.8

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCC----CChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEE
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD----ADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      +|.+.+.||+|++|.||++.+...+..+++|+....    ........+..|+.+++.++||||+++++.+.+ ....++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l   79 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE-RDAFCI   79 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc-CCceEE
Confidence            689999999999999999999877666666665432    122234456678999999999999999999887 567999


Q ss_pred             EEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          128 LMEYMDSGTLDTLLNK----NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      |+||+++++|.+++..    ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.+  .++|+|||.+.....
T Consensus        80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~--~~~l~d~g~~~~~~~  157 (260)
T cd08222          80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN--LLKIGDFGVSRLLMG  157 (260)
T ss_pred             EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecC--CEeecccCceeecCC
Confidence            9999999999988853    4568999999999999999999999999999999999999864  699999999876544


Q ss_pred             CccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCC
Q 020657          204 SLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDG  283 (323)
Q Consensus       204 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (323)
                      .........++..|+|||.+...     ..+.++|+|+||+++|+|++|..||....    .............+..+..
T Consensus       158 ~~~~~~~~~~~~~~~~pe~~~~~-----~~~~~~Dv~slG~~~~~l~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~  228 (260)
T cd08222         158 SCDLATTFTGTPYYMSPEALKHQ-----GYDSKSDIWSLGCILYEMCCLAHAFEGQN----FLSVVLRIVEGPTPSLPET  228 (260)
T ss_pred             CcccccCCCCCcCccCHHHHccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCcc----HHHHHHHHHcCCCCCCcch
Confidence            43333445578899999987533     34558999999999999999999995322    2333334444555566778


Q ss_pred             CChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          284 ASPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       284 ~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                      ++.++.+++++||..+|++||+++++++||||
T Consensus       229 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         229 YSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             hcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            89999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-43  Score=302.91  Aligned_cols=264  Identities=30%  Similarity=0.477  Sum_probs=227.8

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCe
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGD  124 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  124 (323)
                      .+....|..-++||+|+||.||.++-+.+|+-+|.|.+.+..  .........+|-.++.+++.+.||.+-=.|++ .+.
T Consensus       181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT-kd~  259 (591)
T KOG0986|consen  181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET-KDA  259 (591)
T ss_pred             hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC-CCc
Confidence            445667888999999999999999999999999999885432  12233446789999999999999998888887 788


Q ss_pred             EEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          125 IAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      +|+|+..|+||+|.-++.+-+  .+++..++.++.+|+.+|++||+.+||+||+||+|||+|+.| +++|+|+|+|..+.
T Consensus       260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~G-hvRISDLGLAvei~  338 (591)
T KOG0986|consen  260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHG-HVRISDLGLAVEIP  338 (591)
T ss_pred             eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCC-CeEeeccceEEecC
Confidence            999999999999999987644  799999999999999999999999999999999999999998 89999999998886


Q ss_pred             cCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCC
Q 020657          203 RSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPD  282 (323)
Q Consensus       203 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (323)
                      ..... ...+||.+|||||++.++.     ++...|+|+|||+||||+.|+.||..-..+.-.+++.+.+. ..+..++.
T Consensus       339 ~g~~~-~~rvGT~GYMAPEvl~ne~-----Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~-~~~~ey~~  411 (591)
T KOG0986|consen  339 EGKPI-RGRVGTVGYMAPEVLQNEV-----YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTL-EDPEEYSD  411 (591)
T ss_pred             CCCcc-ccccCcccccCHHHHcCCc-----ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHh-cchhhccc
Confidence            65444 3459999999999998444     56699999999999999999999988777776666655554 45567889


Q ss_pred             CCChhHHHHHHHhcccCcCCCC-----CHHHHhcCcccccCC
Q 020657          283 GASPEFRSFIECCLQKEFSKRW-----TASQLLTHPFLCKNR  319 (323)
Q Consensus       283 ~~~~~l~~ll~~~l~~~p~~Rp-----t~~~~l~h~~f~~~~  319 (323)
                      ..|+++.+|.+.+|+.||++|.     .++++-+||||++.+
T Consensus       412 kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ln  453 (591)
T KOG0986|consen  412 KFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLN  453 (591)
T ss_pred             ccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCC
Confidence            9999999999999999999998     578999999998764

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1e-41  Score=306.12  Aligned_cols=260  Identities=25%  Similarity=0.391  Sum_probs=210.7

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEec-----ccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCC-CCccceece
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHR-----CTHKIYALKVVHGDADPTVRRQVFREMEILRRTD-SPFIVQCFG  116 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~  116 (323)
                      ...+.+..++|.+.+.||+|+||.||+|++.     .+++.||+|++...........+.+|+.++.++. ||||+++++
T Consensus        29 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~  108 (401)
T cd05107          29 DSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLG  108 (401)
T ss_pred             CCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence            4458889999999999999999999999964     3456899999986654555567889999999997 999999999


Q ss_pred             eEEcCCCeEEEEEeccCCCCHHHHHHhcC---------------------------------------------------
Q 020657          117 IFEKPSGDIAILMEYMDSGTLDTLLNKNG---------------------------------------------------  145 (323)
Q Consensus       117 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------------------------------------------  145 (323)
                      ++.. .+..++||||+.+|+|.+++...+                                                   
T Consensus       109 ~~~~-~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (401)
T cd05107         109 ACTK-GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA  187 (401)
T ss_pred             EEcc-CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence            9987 578999999999999999986431                                                   


Q ss_pred             -----------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCC
Q 020657          146 -----------------------------------------------TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKP  178 (323)
Q Consensus       146 -----------------------------------------------~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~  178 (323)
                                                                     .+++..++.++.||+.||.|||+.|++|+||||
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp  267 (401)
T cd05107         188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAA  267 (401)
T ss_pred             CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCc
Confidence                                                           256777889999999999999999999999999


Q ss_pred             CCeEEecCCCcEEEeecCcchhhccCcc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCC
Q 020657          179 SNLLVNNNNMQVKIADFGVSKIMCRSLD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFP  255 (323)
Q Consensus       179 ~nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p  255 (323)
                      +||+++.++ .++|+|||++........  ......++..|+|||.+...     .++.++||||||+++|||++ |..|
T Consensus       268 ~NiLl~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslGvil~e~l~~g~~P  341 (401)
T cd05107         268 RNVLICEGK-LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN-----LYTTLSDVWSFGILLWEIFTLGGTP  341 (401)
T ss_pred             ceEEEeCCC-EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC-----CCCcHhHHHHHHHHHHHHHHcCCCC
Confidence            999999886 899999999976532211  11223456789999988633     34569999999999999998 8999


Q ss_pred             CCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          256 FLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      |......   ......+..+.+...+..++.++.+|+.+||+.+|.+||++++|++.
T Consensus       342 ~~~~~~~---~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         342 YPELPMN---EQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             CCCCCch---HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            8554322   22223333344455667789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=9e-42  Score=301.40  Aligned_cols=259  Identities=25%  Similarity=0.349  Sum_probs=211.4

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEeccc-------CcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCcccee
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCT-------HKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQC  114 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~-------~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~  114 (323)
                      ...|++...+|++.+.||+|+||.||+|++...       +..|++|.+...........+.+|+.+++++ +|+||+++
T Consensus         4 ~~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~   83 (334)
T cd05100           4 DPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINL   83 (334)
T ss_pred             CcccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence            457788889999999999999999999986432       2368999987655556667889999999999 79999999


Q ss_pred             ceeEEcCCCeEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCC
Q 020657          115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKN----------------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKP  178 (323)
Q Consensus       115 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~  178 (323)
                      ++++.. .+..++++||+++++|.+++...                ..++...+..++.|++.||.|||+.|++|+||+|
T Consensus        84 ~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp  162 (334)
T cd05100          84 LGACTQ-DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAA  162 (334)
T ss_pred             eEEEcc-CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence            999987 67899999999999999998753                2377888999999999999999999999999999


Q ss_pred             CCeEEecCCCcEEEeecCcchhhccCccc--cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCC
Q 020657          179 SNLLVNNNNMQVKIADFGVSKIMCRSLDA--CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFP  255 (323)
Q Consensus       179 ~nil~~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p  255 (323)
                      +||+++.++ .++|+|||++.........  .....++..|+|||++...     .++.++||||||+++|+|++ |..|
T Consensus       163 ~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~el~~~g~~p  236 (334)
T cd05100         163 RNVLVTEDN-VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR-----VYTHQSDVWSFGVLLWEIFTLGGSP  236 (334)
T ss_pred             ceEEEcCCC-cEEECCcccceecccccccccccCCCcCceEcCHHHhccC-----CcCchhhhHHHHHHHHHHHhcCCCC
Confidence            999999887 8999999998755332111  1222334679999988643     34569999999999999998 8888


Q ss_pred             CCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          256 FLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      |....    ...+...+........+..++.++.+|+.+||+.+|++|||+.+++++
T Consensus       237 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         237 YPGIP----VEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             CCCCC----HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            85432    344444444445555667788999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.4e-41  Score=295.92  Aligned_cols=257  Identities=23%  Similarity=0.359  Sum_probs=208.4

Q ss_pred             chhccccccceeeeecccCCeEEEEEEec-----ccCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceeceeE
Q 020657           45 TAAIAYSDLEKLQVLGHGNGGTVYKVQHR-----CTHKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFGIF  118 (323)
Q Consensus        45 ~~~~~~~~~~~~~~lg~G~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~  118 (323)
                      .+.+..++|++.+.||+|+||.||+|.+.     .++..+++|.+...........+.+|+.+++++ +|+||+++++.+
T Consensus        29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  108 (302)
T cd05055          29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC  108 (302)
T ss_pred             cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence            45577889999999999999999999752     345689999987665555567788999999999 799999999998


Q ss_pred             EcCCCeEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecC
Q 020657          119 EKPSGDIAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFG  196 (323)
Q Consensus       119 ~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg  196 (323)
                      .. .+..++||||+.+++|.+++....  .+++..+..++.+++.||.|||+.|++|+||+|+||+++.++ .++|+|||
T Consensus       109 ~~-~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~~l~dfg  186 (302)
T cd05055         109 TI-GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK-IVKICDFG  186 (302)
T ss_pred             ec-CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC-eEEECCCc
Confidence            87 678999999999999999997543  389999999999999999999999999999999999999886 89999999


Q ss_pred             cchhhccCcc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHh
Q 020657          197 VSKIMCRSLD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAIC  273 (323)
Q Consensus       197 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~  273 (323)
                      ++........  ......++..|+|||.+...     ..+.++||||||+++|+|++ |..||...........   ...
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~---~~~  258 (302)
T cd05055         187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNC-----VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK---LIK  258 (302)
T ss_pred             ccccccCCCceeecCCCCcccccCCHhhhccC-----CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHH---HHH
Confidence            9876533221  11223456789999988633     34569999999999999998 9999965543322222   222


Q ss_pred             cCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          274 FGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       274 ~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      .+.....+...+.++.+++.+||+.+|++|||+.++++
T Consensus       259 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         259 EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            23334445677899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1e-41  Score=291.00  Aligned_cols=251  Identities=24%  Similarity=0.353  Sum_probs=203.2

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeE
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDI  125 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  125 (323)
                      |.+...+|++.+.||+|++|.||+|.+..+ ..|++|.+.....  ....+.+|+.+++.++|+||+++++.+.  +...
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~--~~~~   75 (262)
T cd05071           1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS--EEPI   75 (262)
T ss_pred             CCCChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEEC--CCCc
Confidence            356778999999999999999999998644 4699999875432  2356788999999999999999999875  3568


Q ss_pred             EEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          126 AILMEYMDSGTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      ++||||+++++|.+++...  ..+++..+..++.|+++||.+||+.|++|+||+|+||+++.++ .++|+|||.+.....
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~-~~~L~dfg~~~~~~~  154 (262)
T cd05071          76 YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIED  154 (262)
T ss_pred             EEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCC-cEEeccCCceeeccc
Confidence            9999999999999999753  3578999999999999999999999999999999999999987 899999999976543


Q ss_pred             Cccc-cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCC
Q 020657          204 SLDA-CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLP  281 (323)
Q Consensus       204 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (323)
                      .... .....++..|+|||.....     ..+.++|+||||+++|+|+| |..||......    .+............+
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~-----~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~----~~~~~~~~~~~~~~~  225 (262)
T cd05071         155 NEYTARQGAKFPIKWTAPEAALYG-----RFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLDQVERGYRMPCP  225 (262)
T ss_pred             cccccccCCcccceecCHhHhccC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCCChH----HHHHHHhcCCCCCCc
Confidence            3221 1233456789999987533     34669999999999999999 88888554322    233333333344455


Q ss_pred             CCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          282 DGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       282 ~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ..++..+.+++.+||+.+|++|||++++++
T Consensus       226 ~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         226 PECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             cccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.7e-41  Score=295.65  Aligned_cols=257  Identities=30%  Similarity=0.469  Sum_probs=207.2

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      .|.....||+|++|.||+|.+..+++.+++|.+....  .......+.+|+.+++.++|+|++++++++.+ ....++||
T Consensus        22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~  100 (313)
T cd06633          22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-EHTAWLVM  100 (313)
T ss_pred             HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-CCEEEEEE
Confidence            3777788999999999999998899999999986542  23344668889999999999999999999987 67899999


Q ss_pred             eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          130 EYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       130 e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      ||+.+ ++.+.+.. ..++++..+..++.||+.++.|||+.|++|+||+|+||+++.++ .++|+|||++....    ..
T Consensus       101 e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~-~~kL~dfg~~~~~~----~~  174 (313)
T cd06633         101 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG-QVKLADFGSASKSS----PA  174 (313)
T ss_pred             ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCC-CEEEeecCCCcccC----CC
Confidence            99975 77776654 45789999999999999999999999999999999999999987 89999999885422    22


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhH
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEF  288 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (323)
                      ....++..|+|||.+....  ....+.++||||||+++|+|++|..||............   .....+......++..+
T Consensus       175 ~~~~~~~~y~aPE~~~~~~--~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l  249 (313)
T cd06633         175 NSFVGTPYWMAPEVILAMD--EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---AQNDSPTLQSNEWTDSF  249 (313)
T ss_pred             CCccccccccChhhccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HhcCCCCCCccccCHHH
Confidence            3456788999999974221  233566999999999999999999999654332222221   11222222334577889


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          289 RSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       289 ~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                      .+|+.+||+.+|++||++++++.||||...+.
T Consensus       250 ~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~  281 (313)
T cd06633         250 RGFVDYCLQKIPQERPASAELLRHDFVRRDRP  281 (313)
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCcccCCCch
Confidence            99999999999999999999999999987654

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.4e-41  Score=297.77  Aligned_cols=256  Identities=23%  Similarity=0.360  Sum_probs=207.3

Q ss_pred             chhccccccceeeeecccCCeEEEEEEecc-------cCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceece
Q 020657           45 TAAIAYSDLEKLQVLGHGNGGTVYKVQHRC-------THKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFG  116 (323)
Q Consensus        45 ~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~  116 (323)
                      .+.+..++|.+.+.||+|++|.||+|.+..       ....+++|.+...........+.+|+.+++.+ .||||+++++
T Consensus         6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~   85 (314)
T cd05099           6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLG   85 (314)
T ss_pred             cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence            456778999999999999999999998632       34578999987655555667788999999998 6999999999


Q ss_pred             eEEcCCCeEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 020657          117 IFEKPSGDIAILMEYMDSGTLDTLLNKN----------------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSN  180 (323)
Q Consensus       117 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~n  180 (323)
                      ++.. .+..++||||+++++|.+++...                ..++...+..++.||+.||.|||+.|++|+||||+|
T Consensus        86 ~~~~-~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N  164 (314)
T cd05099          86 VCTQ-EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN  164 (314)
T ss_pred             EEcc-CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence            9887 67899999999999999999653                247889999999999999999999999999999999


Q ss_pred             eEEecCCCcEEEeecCcchhhccCcc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 020657          181 LLVNNNNMQVKIADFGVSKIMCRSLD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFL  257 (323)
Q Consensus       181 il~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~  257 (323)
                      |+++.++ .+||+|||.+........  ......++..|+|||++...     .++.++||||||+++|+|++ |..||.
T Consensus       165 ill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslG~~l~el~~~g~~p~~  238 (314)
T cd05099         165 VLVTEDN-VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR-----VYTHQSDVWSFGILMWEIFTLGGSPYP  238 (314)
T ss_pred             EEEcCCC-cEEEccccccccccccccccccccCCCCccccCHHHHccC-----CcCccchhhHHHHHHHHHHhCCCCCCC
Confidence            9999987 899999999976533211  11122234579999988633     34569999999999999998 888985


Q ss_pred             CCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          258 QPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ...    ...+............+..++.++.+|+.+||+.+|++|||+.++++
T Consensus       239 ~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         239 GIP----VEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             CCC----HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            432    23333333344444556778899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=7e-42  Score=295.54  Aligned_cols=257  Identities=30%  Similarity=0.455  Sum_probs=205.5

Q ss_pred             cceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcC-CCeEEEEEe
Q 020657           53 LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP-SGDIAILME  130 (323)
Q Consensus        53 ~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~lv~e  130 (323)
                      |++.+.||+|++|.||+|.+..+++.+++|.+.... .......+.+|+.+++.+.|+|++++++++... .+..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            678999999999999999999889999999998653 234456678899999999999999999999873 278999999


Q ss_pred             ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc-cc
Q 020657          131 YMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD-AC  208 (323)
Q Consensus       131 ~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~-~~  208 (323)
                      |+++ +|.+++... ..+++..++.++.||++||++||+.|++|+||+|+||++++++ .++|+|||.+........ ..
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~-~~~l~d~g~~~~~~~~~~~~~  158 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDG-VLKLADFGLARPYTKRNSADY  158 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCC-CEEEccccceeeccCCCcccc
Confidence            9975 888888654 5799999999999999999999999999999999999999987 899999999976644321 12


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCC-----------
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP-----------  277 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~-----------  277 (323)
                      ....++..|+|||.+.+    ....+.++|||+||+++|+|+||+.||...........+.........           
T Consensus       159 ~~~~~~~~y~~PE~~~~----~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07840         159 TNRVITLWYRPPELLLG----ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW  234 (287)
T ss_pred             cccccccccCCceeeEc----cccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence            23456778999997752    223456999999999999999999999655432222222211110000           


Q ss_pred             ---------------CCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          278 ---------------PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       278 ---------------~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                                     ..+...++..+.+++++||+.+|.+|||++++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                           00111238899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.2e-41  Score=289.63  Aligned_cols=243  Identities=26%  Similarity=0.450  Sum_probs=198.6

Q ss_pred             eecccCCeEEEEEEec--ccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEeccCCC
Q 020657           58 VLGHGNGGTVYKVQHR--CTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSG  135 (323)
Q Consensus        58 ~lg~G~~~~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~  135 (323)
                      .||+|+||.||+|.+.  .++..|++|++.........+.+.+|+.+++.++|+||+++++++..  ...++||||++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~--~~~~lv~e~~~~~   79 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA--EALMLVMEMASGG   79 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC--CCeEEEEEeCCCC
Confidence            3899999999999875  34557999999766655666788999999999999999999998764  5789999999999


Q ss_pred             CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccc---cccc
Q 020657          136 TLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA---CNSY  211 (323)
Q Consensus       136 sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~  211 (323)
                      +|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.........   ....
T Consensus        80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05115          80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH-YAKISDFGLSKALGADDSYYKARSAG  158 (257)
T ss_pred             CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCC-cEEeccCCccccccCCccceeccCCC
Confidence            99999874 45789999999999999999999999999999999999999887 8999999999755332211   1112


Q ss_pred             cccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHH
Q 020657          212 VGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS  290 (323)
Q Consensus       212 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  290 (323)
                      .++..|+|||.+...     ..+.++||||||+++|++++ |..||.....    ..+...+..+.....+...++++.+
T Consensus       159 ~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~  229 (257)
T cd05115         159 KWPLKWYAPECINFR-----KFSSRSDVWSYGITMWEAFSYGQKPYKKMKG----PEVMSFIEQGKRLDCPAECPPEMYA  229 (257)
T ss_pred             CCCcccCCHHHHccC-----CCCchhhHHHHHHHHHHHhcCCCCCcCcCCH----HHHHHHHHCCCCCCCCCCCCHHHHH
Confidence            234689999987633     34569999999999999996 9999955432    3333444445556677788999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcC
Q 020657          291 FIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       291 ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ++.+||..+|++||++.++.+.
T Consensus       230 li~~c~~~~~~~Rp~~~~i~~~  251 (257)
T cd05115         230 LMKDCWIYKWEDRPNFAKVEER  251 (257)
T ss_pred             HHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999998753

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-42  Score=299.80  Aligned_cols=258  Identities=25%  Similarity=0.390  Sum_probs=201.6

Q ss_pred             ccceeeeecccCCeEEEEEEecc--cCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcC-CCeEE
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRC--THKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP-SGDIA  126 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~--~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~  126 (323)
                      +|++.+.||+|++|.||+|.+..  +++.||+|.+....  .......+.+|+.+++.++||||+++++++.+. ...++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            58899999999999999999987  78999999997632  123345677899999999999999999999873 26799


Q ss_pred             EEEeccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEec----CCCcEEEeecCc
Q 020657          127 ILMEYMDSGTLDTLLNK-----NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNN----NNMQVKIADFGV  197 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~----~~~~~kl~Dfg~  197 (323)
                      +||||+++ ++.+.+..     ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.    ++ .+||+|||+
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~-~~kl~Dfg~  158 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERG-VVKIGDLGL  158 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccc-eEEECCCcc
Confidence            99999975 77776642     136899999999999999999999999999999999999998    76 899999999


Q ss_pred             chhhccCcc---ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCc---------cH
Q 020657          198 SKIMCRSLD---ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRP---------DW  265 (323)
Q Consensus       198 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~---------~~  265 (323)
                      +........   ......++..|+|||++.+    ...++.++||||||+++++|++|..||.......         ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
T cd07842         159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLG----ARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL  234 (316)
T ss_pred             ccccCCCcccccccCCccccccccCHHHHhC----CCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHH
Confidence            876543322   2233467888999998752    2234569999999999999999999997554332         00


Q ss_pred             HHHHHHHh---------------------cCCCCCCC-----------CCCChhHHHHHHHhcccCcCCCCCHHHHhcCc
Q 020657          266 ATLMCAIC---------------------FGDPPSLP-----------DGASPEFRSFIECCLQKEFSKRWTASQLLTHP  313 (323)
Q Consensus       266 ~~~~~~~~---------------------~~~~~~~~-----------~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~  313 (323)
                      ..+.....                     ......++           ...+.++.+++.+||++||++|||+.++++||
T Consensus       235 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~  314 (316)
T cd07842         235 ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHP  314 (316)
T ss_pred             HHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCC
Confidence            00100000                     00001111           15677899999999999999999999999999


Q ss_pred             cc
Q 020657          314 FL  315 (323)
Q Consensus       314 ~f  315 (323)
                      ||
T Consensus       315 ~f  316 (316)
T cd07842         315 YF  316 (316)
T ss_pred             CC
Confidence            98

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.9e-42  Score=290.67  Aligned_cols=250  Identities=25%  Similarity=0.414  Sum_probs=203.0

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      +..+|++.+.||+|++|.||+|.+. ++..+++|++.....  ....+.+|+.+++.++|+||+++++++.. .+..++|
T Consensus         2 ~~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv   77 (256)
T cd05059           2 DPSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCTK-QRPIFIV   77 (256)
T ss_pred             ChHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEEEEEEEEcC-CCceEEE
Confidence            4567999999999999999999986 567899999864322  23457789999999999999999999887 6789999


Q ss_pred             EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccc
Q 020657          129 MEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA  207 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~  207 (323)
                      |||+++++|.+++.. ...+++..+..++.||+.|+.+||+.|++|+||+|+||+++.++ .++|+|||++.........
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~kl~dfg~~~~~~~~~~~  156 (256)
T cd05059          78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDN-VVKVSDFGLARYVLDDQYT  156 (256)
T ss_pred             EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCC-cEEECCcccceeccccccc
Confidence            999999999999875 34689999999999999999999999999999999999999987 8999999998755332111


Q ss_pred             -cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCC
Q 020657          208 -CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS  285 (323)
Q Consensus       208 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (323)
                       ......+..|+|||.+.+..     ++.++|+||||+++|+|++ |..||......    ..............+...+
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~-----~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~  227 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSR-----FSSKSDVWSFGVLMWEVFSEGKMPYERFSNS----EVVESVSAGYRLYRPKLAP  227 (256)
T ss_pred             ccCCCCCCccccCHHHhccCC-----CCchhhHHHHHHHHHHHhccCCCCCCCCCHH----HHHHHHHcCCcCCCCCCCC
Confidence             11122345799999886433     4569999999999999998 89999654332    2333333344455667789


Q ss_pred             hhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          286 PEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       286 ~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      .++.+++.+||+.+|++|||+.++++.
T Consensus       228 ~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         228 TEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=3.9e-42  Score=300.63  Aligned_cols=260  Identities=27%  Similarity=0.400  Sum_probs=201.1

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcCCCCccceeceeEEcCC------
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS------  122 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------  122 (323)
                      .++|++.+.||+|++|.||+|.+..+++.+++|.+..... ......+.+|+++++.++|+||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            6899999999999999999999998999999999864432 222345678999999999999999999875432      


Q ss_pred             -CeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchh
Q 020657          123 -GDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       123 -~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                       ..+++|+||+.+ ++...+.. ...+++..+..++.||++||.|||+.|++|+||+|+||+++.++ .++|+|||++..
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~  164 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQG-ILKIADFGLARP  164 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECcCccchh
Confidence             347999999976 67666654 45799999999999999999999999999999999999999987 899999999976


Q ss_pred             hccCccc-----------cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHH
Q 020657          201 MCRSLDA-----------CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLM  269 (323)
Q Consensus       201 ~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~  269 (323)
                      .......           .....++..|+|||.+.+.    ...+.++||||||+++|+|++|..||...........+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~  240 (311)
T cd07866         165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE----RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF  240 (311)
T ss_pred             ccCCCcccccCCcccccccccceeccCcCChHHhhCC----CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            5432211           1123457789999987532    234568999999999999999999996544332222222


Q ss_pred             HHHhcCCC------------------CCC-------CCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          270 CAICFGDP------------------PSL-------PDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       270 ~~~~~~~~------------------~~~-------~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                      .......+                  ...       ...+++++.+++.+||+.||++|||+.++++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            11100000                  000       12345788999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.5e-41  Score=290.80  Aligned_cols=252  Identities=27%  Similarity=0.428  Sum_probs=205.4

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCc---EEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDI  125 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~---~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  125 (323)
                      ...+|++.+.||+|+||.||+|.+..++.   .+++|.+...........+.+|+.+++.++||||+++++++.. ++..
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   80 (267)
T cd05066           2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-SKPV   80 (267)
T ss_pred             CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CCcc
Confidence            45789999999999999999999864443   7899998765555566788999999999999999999999887 6789


Q ss_pred             EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC
Q 020657          126 AILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS  204 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~  204 (323)
                      ++||||+++++|.+++... ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~-~~~l~dfg~~~~~~~~  159 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDD  159 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCC-eEEeCCCCcccccccc
Confidence            9999999999999999764 4689999999999999999999999999999999999999887 8999999999765432


Q ss_pred             ccc---cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCC
Q 020657          205 LDA---CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSL  280 (323)
Q Consensus       205 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  280 (323)
                      ...   ......+..|++||.+..     ...+.++|+|+||+++|++++ |..||.......    ....+......+.
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~~-----~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~----~~~~~~~~~~~~~  230 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIAY-----RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD----VIKAIEEGYRLPA  230 (267)
T ss_pred             cceeeecCCCccceeecCHhHhcc-----CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH----HHHHHhCCCcCCC
Confidence            211   112223467999998863     334569999999999999886 999996543322    2222333333445


Q ss_pred             CCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          281 PDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       281 ~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      +..++..+.+++.+||+.+|.+|||+.++++
T Consensus       231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         231 PMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             CCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence            5678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-41  Score=287.84  Aligned_cols=245  Identities=35%  Similarity=0.578  Sum_probs=208.7

Q ss_pred             ecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEeccCCCC
Q 020657           59 LGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGT  136 (323)
Q Consensus        59 lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~s  136 (323)
                      ||.|++|.||++.+..+++.+++|++....  .......+.+|+.+++.++|+||+++++.+.. +...++||||+.+++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~   79 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT-EEKLYLVLEYAPGGE   79 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec-CCeeEEEEecCCCCc
Confidence            689999999999998889999999987543  22356678899999999999999999999987 788999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccccccccccc
Q 020657          137 LDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA  216 (323)
Q Consensus       137 L~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~  216 (323)
                      |.+++.....+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++ .++|+|||.+..............++..
T Consensus        80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (250)
T cd05123          80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADG-HIKLTDFGLAKELSSEGSRTNTFCGTPE  158 (250)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCC-cEEEeecCcceecccCCCcccCCcCCcc
Confidence            999998887899999999999999999999999999999999999999987 8999999999766443333445567889


Q ss_pred             ccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhc
Q 020657          217 YMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCL  296 (323)
Q Consensus       217 y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l  296 (323)
                      |++||.+....     .+.++|+|+||+++|++++|..||...+.    ......... ....++...+..+.+++++||
T Consensus       159 ~~~Pe~~~~~~-----~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~~~~~~~-~~~~~~~~~~~~l~~~i~~~l  228 (250)
T cd05123         159 YLAPEVLLGKG-----YGKAVDWWSLGVLLYEMLTGKPPFYAEDR----KEIYEKILK-DPLRFPEFLSPEARDLISGLL  228 (250)
T ss_pred             ccChHHhCCCC-----CCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHhc-CCCCCCCCCCHHHHHHHHHHh
Confidence            99999886333     45699999999999999999999955433    233333322 345567778999999999999


Q ss_pred             ccCcCCCCCH---HHHhcCccc
Q 020657          297 QKEFSKRWTA---SQLLTHPFL  315 (323)
Q Consensus       297 ~~~p~~Rpt~---~~~l~h~~f  315 (323)
                      ..||++|||+   +++++||||
T Consensus       229 ~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         229 QKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             cCCHhhCCCcccHHHHHhCCCC
Confidence            9999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-41  Score=288.76  Aligned_cols=243  Identities=26%  Similarity=0.405  Sum_probs=200.1

Q ss_pred             eeecccCCeEEEEEEecccC---cEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEeccC
Q 020657           57 QVLGHGNGGTVYKVQHRCTH---KIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMD  133 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~  133 (323)
                      +.||+|++|.||+|.+...+   ..+++|.+.........+.+.+|+.+++.+.|+||+++++++..  ...++||||+.
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~   78 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG--EPLMLVMELAP   78 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC--CceEEEEEeCC
Confidence            36999999999999876544   78999999766554556778899999999999999999998764  56899999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccc---c
Q 020657          134 SGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN---S  210 (323)
Q Consensus       134 ~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~---~  210 (323)
                      +++|.+++.....+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++ .++|+|||++...........   .
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~-~~kl~df~~~~~~~~~~~~~~~~~~  157 (257)
T cd05060          79 LGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRH-QAKISDFGMSRALGAGSDYYRATTA  157 (257)
T ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCC-cEEeccccccceeecCCcccccccC
Confidence            999999998877899999999999999999999999999999999999999987 899999999976543322111   1


Q ss_pred             ccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHH
Q 020657          211 YVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFR  289 (323)
Q Consensus       211 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  289 (323)
                      ..++..|+|||.+...     ..+.++||||||+++|++++ |..||.....    ..+...+........+..++..+.
T Consensus       158 ~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~  228 (257)
T cd05060         158 GRWPLKWYAPECINYG-----KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG----AEVIAMLESGERLPRPEECPQEIY  228 (257)
T ss_pred             ccccccccCHHHhcCC-----CCCccchHHHHHHHHHHHHcCCCCCcccCCH----HHHHHHHHcCCcCCCCCCCCHHHH
Confidence            1234579999988633     34569999999999999998 9999955432    233333344445566678899999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhc
Q 020657          290 SFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       290 ~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      +++.+||+.+|++|||+.++++
T Consensus       229 ~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         229 SIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHHHHHhcCChhhCcCHHHHHH
Confidence            9999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.3e-41  Score=289.91  Aligned_cols=251  Identities=24%  Similarity=0.381  Sum_probs=204.5

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeE
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDI  125 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  125 (323)
                      |.+..++|++.+.||+|++|.||+|.+. ++..+++|.+.....  ....+.+|+.+++.++|++++++++++.  ....
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~--~~~~   75 (260)
T cd05070           1 WEIPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS--EEPI   75 (260)
T ss_pred             CCCchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC--CCCc
Confidence            4577889999999999999999999876 567799999875432  2356889999999999999999999875  3568


Q ss_pred             EEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          126 AILMEYMDSGTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      +++|||+.+++|.+++...  ..+++..+..++.+++.||.|||+.|++|+||+|+||+++.++ .++|+|||.+.....
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~-~~~l~dfg~~~~~~~  154 (260)
T cd05070          76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGL-VCKIADFGLARLIED  154 (260)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCc-eEEeCCceeeeeccC
Confidence            8999999999999998753  3589999999999999999999999999999999999999987 899999999976543


Q ss_pred             Ccc-ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCC
Q 020657          204 SLD-ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLP  281 (323)
Q Consensus       204 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (323)
                      ... ......++..|+|||.+..     ...+.++|+||||+++|+|++ |..||......    ..............+
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~----~~~~~~~~~~~~~~~  225 (260)
T cd05070         155 NEYTARQGAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR----EVLEQVERGYRMPCP  225 (260)
T ss_pred             cccccccCCCCCccccChHHHhc-----CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH----HHHHHHHcCCCCCCC
Confidence            221 1122234567999998753     334569999999999999999 89999654332    233333334455566


Q ss_pred             CCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          282 DGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       282 ~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ...+..+.+|+.+||+.+|++|||++++++
T Consensus       226 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         226 QDCPISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             CcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            778999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=3.8e-42  Score=304.68  Aligned_cols=262  Identities=27%  Similarity=0.439  Sum_probs=204.8

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC-------
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS-------  122 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------  122 (323)
                      ..+|++.+.||.|++|.||+|.+..+++.|++|.+..... ...+.+.+|+.+++.++||||+++++++....       
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV   82 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence            4789999999999999999999998999999999865543 44566788999999999999999998765422       


Q ss_pred             ------CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecC
Q 020657          123 ------GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFG  196 (323)
Q Consensus       123 ------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg  196 (323)
                            ...++||||+++ +|.+++..+ .+++..++.++.||++||.|||+.|++|+||+|+||+++.++..++|+|||
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg  160 (342)
T cd07854          83 GSLTELNSVYIVQEYMET-DLANVLEQG-PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFG  160 (342)
T ss_pred             ccccccceEEEEeecccc-cHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcc
Confidence                  357899999975 898887643 689999999999999999999999999999999999998665579999999


Q ss_pred             cchhhccCcc---ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHH-
Q 020657          197 VSKIMCRSLD---ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAI-  272 (323)
Q Consensus       197 ~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~-  272 (323)
                      .+........   ......++..|+|||.+..    ....+.++||||||+++|+|++|..||................ 
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~  236 (342)
T cd07854         161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS----PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP  236 (342)
T ss_pred             cceecCCccccccccccccccccccCHHHHhC----ccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            9875532211   1122356788999998652    2234569999999999999999999996543222111111100 


Q ss_pred             ------------------h-cCCCC-----CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          273 ------------------C-FGDPP-----SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       273 ------------------~-~~~~~-----~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                                        . .....     .+...++.++.+|+++||+.||++|||++++++||||+.-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  306 (342)
T cd07854         237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY  306 (342)
T ss_pred             CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence                              0 00000     1123578899999999999999999999999999999744

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=3.7e-42  Score=304.24  Aligned_cols=266  Identities=30%  Similarity=0.452  Sum_probs=209.8

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCC-CChHHHHHHHHHHHHHHcC-CCCccceeceeEEcC-CCeE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKP-SGDI  125 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~~~~  125 (323)
                      ..++|++.+.||+|++|.||+|.+..+++.+++|.+... ........+.+|+.+++++ +|+||+++++++... ....
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            357899999999999999999999888999999988543 2223345677899999999 999999999998653 3468


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc
Q 020657          126 AILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL  205 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~  205 (323)
                      ++||||+.+ +|.+++..+ .+++..+..++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus        85 ~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~-~~kl~d~g~~~~~~~~~  161 (337)
T cd07852          85 YLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDC-RVKLADFGLARSLSELE  161 (337)
T ss_pred             EEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEEeeccchhcccccc
Confidence            999999975 999988766 789999999999999999999999999999999999999997 89999999997654322


Q ss_pred             -----cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHH---------
Q 020657          206 -----DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCA---------  271 (323)
Q Consensus       206 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~---------  271 (323)
                           .......++..|+|||.+..    ....+.++|+||||+++|+|+||+.||...........+...         
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07852         162 ENPENPVLTDYVATRWYRAPEILLG----STRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI  237 (337)
T ss_pred             ccccCcchhcccccccccCceeeec----cccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence                 12233467889999998752    233456899999999999999999999654332221111111         


Q ss_pred             --------------HhcCCC---CCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCCC
Q 020657          272 --------------ICFGDP---PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS  321 (323)
Q Consensus       272 --------------~~~~~~---~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~  321 (323)
                                    ......   ......++.++.+++.+||+.||++|||+.++++||||++.+.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~  304 (337)
T cd07852         238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNP  304 (337)
T ss_pred             HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccC
Confidence                          000000   11123478999999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.5e-41  Score=296.12  Aligned_cols=257  Identities=24%  Similarity=0.348  Sum_probs=210.0

Q ss_pred             chhccccccceeeeecccCCeEEEEEEec-------ccCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceece
Q 020657           45 TAAIAYSDLEKLQVLGHGNGGTVYKVQHR-------CTHKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFG  116 (323)
Q Consensus        45 ~~~~~~~~~~~~~~lg~G~~~~v~~~~~~-------~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~  116 (323)
                      .+.+..++|++.+.||+|+||.||+|++.       .++..+++|.+...........+.+|+.+++.+ +||||+++++
T Consensus         9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   88 (304)
T cd05101           9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG   88 (304)
T ss_pred             cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeE
Confidence            45678899999999999999999999752       234579999987554455567788999999999 8999999999


Q ss_pred             eEEcCCCeEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 020657          117 IFEKPSGDIAILMEYMDSGTLDTLLNKN----------------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSN  180 (323)
Q Consensus       117 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~n  180 (323)
                      .+.. ....++||||+.+++|.+++...                ..++...+..++.||++||.|||+.|++|+||||+|
T Consensus        89 ~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N  167 (304)
T cd05101          89 ACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN  167 (304)
T ss_pred             EEec-CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence            9987 67889999999999999999753                246788899999999999999999999999999999


Q ss_pred             eEEecCCCcEEEeecCcchhhccCcc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 020657          181 LLVNNNNMQVKIADFGVSKIMCRSLD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFL  257 (323)
Q Consensus       181 il~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~  257 (323)
                      |+++.++ .++|+|||.+........  ......++..|+|||++...     .++.++||||||+++|+|++ |..||.
T Consensus       168 ili~~~~-~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~el~~~g~~p~~  241 (304)
T cd05101         168 VLVTENN-VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR-----VYTHQSDVWSFGVLMWEIFTLGGSPYP  241 (304)
T ss_pred             EEEcCCC-cEEECCCccceecccccccccccCCCCCceeeCchhhccC-----CCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence            9999887 899999999976543221  12223455689999988633     34569999999999999998 788885


Q ss_pred             CCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          258 QPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ..    ....+...+........+..++.++.+|+.+||..+|.+|||+.++++.
T Consensus       242 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         242 GI----PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             cC----CHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            43    3344444455555555667889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-42  Score=305.87  Aligned_cols=258  Identities=24%  Similarity=0.364  Sum_probs=220.9

Q ss_pred             CCccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEc
Q 020657           41 TTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEK  120 (323)
Q Consensus        41 ~~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  120 (323)
                      +..+.|++...++....+||.|.||.||.|.|+.-.-.||||.++.+  ....+.|+.|+.+|+.+.|||+|+++|+|..
T Consensus       257 Pn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED--tMeveEFLkEAAvMKeikHpNLVqLLGVCT~  334 (1157)
T KOG4278|consen  257 PNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH  334 (1157)
T ss_pred             CCcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc--chhHHHHHHHHHHHHhhcCccHHHHhhhhcc
Confidence            45688999999999999999999999999999988889999999644  3567889999999999999999999999997


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcc
Q 020657          121 PSGDIAILMEYMDSGTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVS  198 (323)
Q Consensus       121 ~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~  198 (323)
                       +...|||+|||..|+|.++++..  ..++....+.++.||..||+||..+++|||||.++|+|+.++. .||+.|||++
T Consensus       335 -EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnh-iVKvADFGLs  412 (1157)
T KOG4278|consen  335 -EPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-IVKVADFGLS  412 (1157)
T ss_pred             -CCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccc-eEEeeccchh
Confidence             78899999999999999999753  3477788899999999999999999999999999999999986 8999999999


Q ss_pred             hhhccCcccc-ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCC
Q 020657          199 KIMCRSLDAC-NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGD  276 (323)
Q Consensus       199 ~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~  276 (323)
                      +......... .+....+.|.|||.+.     ....+.++|||+||++|||+.| |-.||.+.+    ......-+..+.
T Consensus       413 RlMtgDTYTAHAGAKFPIKWTAPEsLA-----yNtFSiKSDVWAFGVLLWEIATYGMsPYPGid----lSqVY~LLEkgy  483 (1157)
T KOG4278|consen  413 RLMTGDTYTAHAGAKFPIKWTAPESLA-----YNTFSIKSDVWAFGVLLWEIATYGMSPYPGID----LSQVYGLLEKGY  483 (1157)
T ss_pred             hhhcCCceecccCccCcccccCccccc-----ccccccchhhHHHHHHHHHHHhcCCCCCCCcc----HHHHHHHHhccc
Confidence            9876543332 2344578999999885     3344669999999999999996 888995543    333333344466


Q ss_pred             CCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          277 PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       277 ~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      +..-|.++++.+++||++||+|+|.+||+++++-+
T Consensus       484 RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq  518 (1157)
T KOG4278|consen  484 RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQ  518 (1157)
T ss_pred             cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence            77788999999999999999999999999999864

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.9e-41  Score=292.06  Aligned_cols=255  Identities=24%  Similarity=0.315  Sum_probs=208.5

Q ss_pred             hccccccceeeeecccCCeEEEEEEecc----cCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRC----THKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS  122 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~----~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  122 (323)
                      .+..++|++.+.||+|+||.||+|.+..    ++..|++|.+...........+.+|+.+++.++|+||+++++++....
T Consensus         2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   81 (280)
T cd05043           2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG   81 (280)
T ss_pred             ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            3567899999999999999999999875    367899999876656666778899999999999999999999877656


Q ss_pred             CeEEEEEeccCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEee
Q 020657          123 GDIAILMEYMDSGTLDTLLNKN--------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIAD  194 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~--------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~D  194 (323)
                      ...+++++|+.+++|.+++...        ..+++..+..++.+++.||.|||+.|++|+||+|+||+++.++ .+||+|
T Consensus        82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~-~~kl~d  160 (280)
T cd05043          82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL-QVKITD  160 (280)
T ss_pred             CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCC-cEEECC
Confidence            7789999999999999998653        4589999999999999999999999999999999999999886 899999


Q ss_pred             cCcchhhccCcc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHH
Q 020657          195 FGVSKIMCRSLD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCA  271 (323)
Q Consensus       195 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~  271 (323)
                      ||+++.+.....  ......++..|+|||++..     ..++.++||||||+++|++++ |..||.....    ..+...
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-----~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~~  231 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVN-----KEYSSASDVWSFGVLLWELMTLGQTPYVEIDP----FEMAAY  231 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhc-----CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH----HHHHHH
Confidence            999975532211  1122345667999998863     334569999999999999998 9999954322    233333


Q ss_pred             HhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          272 ICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       272 ~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      .........+..+++++.+++.+||..+|++|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         232 LKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             HHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            3333344445667899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.1e-42  Score=303.62  Aligned_cols=261  Identities=24%  Similarity=0.349  Sum_probs=200.9

Q ss_pred             eeeccc--CCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEeccC
Q 020657           57 QVLGHG--NGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMD  133 (323)
Q Consensus        57 ~~lg~G--~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~  133 (323)
                      ..||.|  ++|+||+|.+..+++.|++|++.... .....+.+.+|+.+++.++||||+++++++.. .+..++|+||+.
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~~~~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT-GSWLWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec-CCceEEEEeccc
Confidence            356666  99999999999899999999987543 34455778899999999999999999999987 678999999999


Q ss_pred             CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccc----
Q 020657          134 SGTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA----  207 (323)
Q Consensus       134 ~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~----  207 (323)
                      ++++.+++.+.  ..+++..+..++.||+.||+|||+.|++|+||||+||+++.++ .++++||+.+.........    
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~-~~~~~~~~~~~~~~~~~~~~~~~  161 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDG-LVSLSGLSHLYSLVRNGQKAKVV  161 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCC-cEEEechHHHhhhhccCcccccc
Confidence            99999998764  3589999999999999999999999999999999999999987 8999999865433221111    


Q ss_pred             ---cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHh-----------
Q 020657          208 ---CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAIC-----------  273 (323)
Q Consensus       208 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~-----------  273 (323)
                         .....++..|+|||++....   ..++.++||||||+++|+|++|..||.................           
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd08226         162 YDFPQFSTSVLPWLSPELLRQDL---YGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC  238 (328)
T ss_pred             ccccccccCccCccChhhhcCCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence               01122456799999986432   2245699999999999999999999965432211111100000           


Q ss_pred             -------------------------------cCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCCCC
Q 020657          274 -------------------------------FGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSD  322 (323)
Q Consensus       274 -------------------------------~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~~  322 (323)
                                                     ...........+.++.+|+++||+.||++|||++++|+||||.+.+++-
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~~  318 (328)
T cd08226         239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQT  318 (328)
T ss_pred             hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHhc
Confidence                                           0000111234567899999999999999999999999999998876543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.9e-41  Score=293.55  Aligned_cols=249  Identities=24%  Similarity=0.405  Sum_probs=202.8

Q ss_pred             ccceeeeecccCCeEEEEEEecc-----cCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEE
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRC-----THKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIA  126 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  126 (323)
                      +|++.+.||+|+||.||+|.+..     ....+++|.+...........+.+|+.+++.++||||+++++.+.. .+..+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ-DGPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec-CCCcE
Confidence            47889999999999999998753     2357889988766555556778899999999999999999999887 67789


Q ss_pred             EEEeccCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeE
Q 020657          127 ILMEYMDSGTLDTLLNKN------------------------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLL  182 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~~------------------------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil  182 (323)
                      +++||+.+++|.+++...                        ..+++..++.++.|++.||.|||+.|++|+||+|+||+
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil  159 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL  159 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence            999999999999988642                        24788999999999999999999999999999999999


Q ss_pred             EecCCCcEEEeecCcchhhccCcc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 020657          183 VNNNNMQVKIADFGVSKIMCRSLD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQP  259 (323)
Q Consensus       183 ~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~  259 (323)
                      ++.++ .++|+|||++........  ......++..|+|||.+..     ..++.++||||||+++|+|+| |..||.+.
T Consensus       160 l~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-----~~~~~~~Di~slG~~l~el~t~g~~p~~~~  233 (290)
T cd05045         160 VAEGR-KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-----HIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  233 (290)
T ss_pred             EcCCC-cEEeccccccccccCccchhcccCCCCCccccCHHHHcc-----CCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence            99887 899999999875432211  1222345678999998753     335569999999999999998 99999543


Q ss_pred             CCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          260 GQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      .    ...+.+..........+..++.++.+++..||+.+|++||+++++++
T Consensus       234 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         234 A----PERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             C----HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            2    23333344434445556778999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-42  Score=295.57  Aligned_cols=256  Identities=30%  Similarity=0.518  Sum_probs=206.9

Q ss_pred             cceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEec
Q 020657           53 LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEY  131 (323)
Q Consensus        53 ~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~  131 (323)
                      |++.+.||+|++|.||+|.+..+++.+++|.+..... ......+.+|+.++++++|+||+++++++.. ....++|+||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH-KGDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc-CCCEEEEEec
Confidence            6788999999999999999988999999999875532 2445678889999999999999999999887 6789999999


Q ss_pred             cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccccc
Q 020657          132 MDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNS  210 (323)
Q Consensus       132 ~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~  210 (323)
                      +.+ ++.+.+.. ...+++..+..++.||+.||.+||+.|++|+||+|+||+++.++ .++|+|||.+............
T Consensus        80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~df~~~~~~~~~~~~~~~  157 (283)
T cd05118          80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG-VLKLADFGLARSFGSPVRPYTH  157 (283)
T ss_pred             cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCC-cEEEeeeeeeEecCCCcccccC
Confidence            976 88777765 45789999999999999999999999999999999999999887 8999999999766544323334


Q ss_pred             ccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCC-------------
Q 020657          211 YVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP-------------  277 (323)
Q Consensus       211 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~-------------  277 (323)
                      ..++..|+|||.+...    ...+.++|+||||+++|+|+||+.||...+................+             
T Consensus       158 ~~~~~~~~~PE~~~~~----~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd05118         158 YVVTRWYRAPELLLGD----KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY  233 (283)
T ss_pred             ccCcccccCcHHHhcC----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence            5677889999988632    24567999999999999999999999655432222222211110000             


Q ss_pred             ------------CCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          278 ------------PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       278 ------------~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                                  ......++.++.+++.+||+.||.+||++++++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                        01123468899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.8e-41  Score=292.70  Aligned_cols=254  Identities=26%  Similarity=0.380  Sum_probs=201.2

Q ss_pred             ccc-ceeeeecccCCeEEEEEE----ecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcC-CCe
Q 020657           51 SDL-EKLQVLGHGNGGTVYKVQ----HRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP-SGD  124 (323)
Q Consensus        51 ~~~-~~~~~lg~G~~~~v~~~~----~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~  124 (323)
                      ++| ++.+.||+|+||+||++.    ...++..|++|.+...........+.+|+.+++.++||||+++++++... ...
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            355 999999999999998865    33467889999997665555567788999999999999999999987653 345


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC
Q 020657          125 IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS  204 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~  204 (323)
                      .+++|||+++++|.+++... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++......
T Consensus        83 ~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~  160 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR-LVKIGDFGLAKAVPEG  160 (283)
T ss_pred             EEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCC-cEEEeecccccccCCc
Confidence            88999999999999998764 589999999999999999999999999999999999999987 8999999999765432


Q ss_pred             ccc---cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC-----------ccHHHHHH
Q 020657          205 LDA---CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQR-----------PDWATLMC  270 (323)
Q Consensus       205 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~-----------~~~~~~~~  270 (323)
                      ...   .....++..|+|||.+...     ..+.++||||||+++|+|+||..||......           .....+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~PE~~~~~-----~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd05080         161 HEYYRVREDGDSPVFWYAVECLKEN-----KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE  235 (283)
T ss_pred             chhhccCCCCCCCceeeCHhHhccc-----CCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence            211   1223355679999988633     3456999999999999999999998543211           01111111


Q ss_pred             HHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          271 AICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ..........+..++..+.+++.+||+.+|++|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            12222233445678899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.3e-41  Score=293.24  Aligned_cols=252  Identities=27%  Similarity=0.445  Sum_probs=204.9

Q ss_pred             ccccccceeeeecccCCeEEEEEEecc-----cCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRC-----THKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS  122 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  122 (323)
                      +...+|.+.+.||+|++|.||+|.+..     ++..+++|.+.... ....+.+.+|+.+++.++|+||+++++++.. .
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   79 (291)
T cd05094           2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGD-G   79 (291)
T ss_pred             CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEcc-C
Confidence            346789999999999999999998532     45568888876433 3344668899999999999999999999987 6


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecC
Q 020657          123 GDIAILMEYMDSGTLDTLLNKNG----------------TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNN  186 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~  186 (323)
                      ...++||||+++++|.+++....                .+++..++.++.||+.|+.|||++|++|+||+|+||+++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~  159 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN  159 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence            78999999999999999997532                37899999999999999999999999999999999999998


Q ss_pred             CCcEEEeecCcchhhccCc--cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 020657          187 NMQVKIADFGVSKIMCRSL--DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRP  263 (323)
Q Consensus       187 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~  263 (323)
                      + .++|+|||++.......  .......++..|+|||.+..     ...+.++||||||+++|+|+| |..||.....  
T Consensus       160 ~-~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--  231 (291)
T cd05094         160 L-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-----RKFTTESDVWSFGVILWEIFTYGKQPWFQLSN--  231 (291)
T ss_pred             C-cEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence            7 89999999986543321  11223445778999998863     334569999999999999998 9999855433  


Q ss_pred             cHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          264 DWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                        ....+....+.....+...+..+.+++.+||+.+|++|||++++++
T Consensus       232 --~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         232 --TEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             --HHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence              2333444444455556678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-42  Score=300.45  Aligned_cols=263  Identities=27%  Similarity=0.374  Sum_probs=202.9

Q ss_pred             CCccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEc
Q 020657           41 TTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEK  120 (323)
Q Consensus        41 ~~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  120 (323)
                      .+........+.|.-...||+|+||.||+|... ++..||||......... ..+|.+|+.++.+++|||+++++|+|.+
T Consensus        65 fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e  142 (361)
T KOG1187|consen   65 FSYDELRKATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYCLE  142 (361)
T ss_pred             eeHHHHHHHHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEEec
Confidence            345555667788988899999999999999986 45899999886554432 5569999999999999999999999998


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---CeecCCCCCCeEEecCCCcEEEeec
Q 020657          121 PSGDIAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHK---IIHRDIKPSNLLVNNNNMQVKIADF  195 (323)
Q Consensus       121 ~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~g---ivH~di~~~nil~~~~~~~~kl~Df  195 (323)
                      .++..++|+||+++|+|.+++....  +++|..+.+|+.++|+||+|||...   |+|||||+.|||+|++. +.||+||
T Consensus       143 ~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~-~aKlsDF  221 (361)
T KOG1187|consen  143 GGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF-NAKLSDF  221 (361)
T ss_pred             CCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC-CEEccCc
Confidence            3336999999999999999998654  8999999999999999999999863   99999999999999884 9999999


Q ss_pred             CcchhhccCccccccc-cccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--CCccHHHHHHHH
Q 020657          196 GVSKIMCRSLDACNSY-VGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPG--QRPDWATLMCAI  272 (323)
Q Consensus       196 g~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~--~~~~~~~~~~~~  272 (323)
                      |+|............. .||.+|++||++..     ...|.++||||||++|.||+||..+.+...  .......+....
T Consensus       222 GLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~-----g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~  296 (361)
T KOG1187|consen  222 GLAKLGPEGDTSVSTTVMGTFGYLAPEYAST-----GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL  296 (361)
T ss_pred             cCcccCCccccceeeecCCCCccCChhhhcc-----CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence            9995543311111122 78999999999863     345669999999999999999998886542  222222221111


Q ss_pred             hc------CCCCCCC-CCCC--hh---HHHHHHHhcccCcCCCCCHHHHhc
Q 020657          273 CF------GDPPSLP-DGAS--PE---FRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       273 ~~------~~~~~~~-~~~~--~~---l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ..      ...+.+. ...+  .+   +..+...|++.+|++||++.++++
T Consensus       297 ~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  297 LEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             HHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            11      1122222 2223  22   566678899999999999999754

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-41  Score=289.02  Aligned_cols=252  Identities=25%  Similarity=0.372  Sum_probs=206.5

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeE
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDI  125 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  125 (323)
                      |++..++|++.+.||+|++|.||+|.+. ++..+++|.+.....  ..+.+.+|+.+++.++|+||+++++++.. ....
T Consensus         1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   76 (261)
T cd05034           1 WEIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQLYAVCSE-EEPI   76 (261)
T ss_pred             CccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc--CHHHHHHHHHHHhhCCCCCEeeeeeeeec-CCce
Confidence            4577899999999999999999999976 567899999875432  34568899999999999999999999886 6789


Q ss_pred             EEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          126 AILMEYMDSGTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      ++||||+++++|.+++...  ..+++..+..++.+++.|+.|||+.|++|+||+|+||+++.++ .++|+|||.+.....
T Consensus        77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~  155 (261)
T cd05034          77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENL-VCKIADFGLARLIED  155 (261)
T ss_pred             EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCC-CEEECccccceeccc
Confidence            9999999999999999754  3689999999999999999999999999999999999999987 899999999876543


Q ss_pred             Ccc-ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCC
Q 020657          204 SLD-ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLP  281 (323)
Q Consensus       204 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (323)
                      ... .......+..|+|||.+.+.     ..+.++|+||||+++|++++ |..||.+...    ...............+
T Consensus       156 ~~~~~~~~~~~~~~y~~PE~~~~~-----~~~~~~Di~slG~il~~l~t~g~~p~~~~~~----~~~~~~~~~~~~~~~~  226 (261)
T cd05034         156 DEYTAREGAKFPIKWTAPEAANYG-----RFTIKSDVWSFGILLTEIVTYGRVPYPGMTN----REVLEQVERGYRMPRP  226 (261)
T ss_pred             hhhhhhhccCCCccccCHHHhccC-----CcCchhHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHcCCCCCCC
Confidence            211 11122345689999988633     34569999999999999998 9999955432    2333333334344555


Q ss_pred             CCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          282 DGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       282 ~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ...+.++.+++.+||+.+|++||+++++++
T Consensus       227 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         227 PNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             CCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            677899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.7e-41  Score=293.62  Aligned_cols=253  Identities=26%  Similarity=0.427  Sum_probs=206.9

Q ss_pred             ccccccceeeeecccCCeEEEEEEecc-----cCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRC-----THKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS  122 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  122 (323)
                      +..++|++.+.||+|+||.||+|.+..     ++..+++|++...........+.+|+.+++.+.||||+++++++.. +
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~-~   80 (288)
T cd05050           2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV-G   80 (288)
T ss_pred             CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC-C
Confidence            456889999999999999999998743     5788999999866666666788999999999999999999999887 6


Q ss_pred             CeEEEEEeccCCCCHHHHHHhc----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 020657          123 GDIAILMEYMDSGTLDTLLNKN----------------------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSN  180 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~----------------------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~n  180 (323)
                      ...++|+||+++++|.+++...                      ..+++..++.++.|++.||.+||+.|++|+||+|+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n  160 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN  160 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence            7899999999999999998642                      236788899999999999999999999999999999


Q ss_pred             eEEecCCCcEEEeecCcchhhccCc--cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 020657          181 LLVNNNNMQVKIADFGVSKIMCRSL--DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFL  257 (323)
Q Consensus       181 il~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~  257 (323)
                      |+++.++ .++|+|||++.......  ........+..|+|||.+...     .++.++||||||+++|+|++ |..||.
T Consensus       161 il~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~il~el~~~~~~p~~  234 (288)
T cd05050         161 CLVGENM-VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-----RYTTESDVWAYGVVLWEIFSYGMQPYY  234 (288)
T ss_pred             eEecCCC-ceEECccccceecccCccccccCCCccChhhcCHHHHhcC-----CCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            9999987 89999999986543221  111223345679999987633     34569999999999999997 888885


Q ss_pred             CCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          258 QPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      +...    .........+.....+..++.++.+|+.+||+.+|.+|||++++++
T Consensus       235 ~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         235 GMAH----EEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             CCCH----HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            4322    3333444444444556678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-41  Score=295.35  Aligned_cols=257  Identities=23%  Similarity=0.338  Sum_probs=203.0

Q ss_pred             ccccccceeeeecccCCeEEEEEEeccc--------------CcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccce
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCT--------------HKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ  113 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~--------------~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~  113 (323)
                      +..++|++.+.||+|+||.||++++..+              ...|++|.+...........+.+|++++++++|+|+++
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~   81 (295)
T cd05097           2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIR   81 (295)
T ss_pred             CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence            4567999999999999999999987543              23589999986655666678899999999999999999


Q ss_pred             eceeEEcCCCeEEEEEeccCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCe
Q 020657          114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKN------------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNL  181 (323)
Q Consensus       114 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~------------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~ni  181 (323)
                      +++++.. .+..++||||+.+++|.+++...            ..+++..+..++.|++.||.|||+.|++|+||+|+||
T Consensus        82 ~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni  160 (295)
T cd05097          82 LLGVCVS-DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC  160 (295)
T ss_pred             EEEEEcC-CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence            9999987 67899999999999999998643            1368889999999999999999999999999999999


Q ss_pred             EEecCCCcEEEeecCcchhhccCcc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh--CCCCCC
Q 020657          182 LVNNNNMQVKIADFGVSKIMCRSLD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL--GHFPFL  257 (323)
Q Consensus       182 l~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt--g~~p~~  257 (323)
                      +++.++ .+||+|||++........  ......++..|+|||.+...     ..+.++|+||||+++|+|++  +..||.
T Consensus       161 ll~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwSlG~~l~el~~~~~~~p~~  234 (295)
T cd05097         161 LVGNHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG-----KFTTASDVWAFGVTLWEMFTLCKEQPYS  234 (295)
T ss_pred             EEcCCC-cEEecccccccccccCcceeccCcCcCceeecChhhhccC-----CcCchhhHHHHHHHHHHHHHcCCCCCCc
Confidence            999887 899999999875432211  11223446789999988633     34569999999999999997  677885


Q ss_pred             CCCCCccHHHHHHHHh---cCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          258 QPGQRPDWATLMCAIC---FGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       258 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ............+...   .......+..+++.+.+|+++||+.||++|||++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         235 LLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             ccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            5433322222221111   11122334567899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=3.9e-41  Score=288.26  Aligned_cols=253  Identities=25%  Similarity=0.403  Sum_probs=206.7

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCc---EEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCe
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGD  124 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~---~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  124 (323)
                      +..++|+..+.||+|++|.||+|.+..+++   .+++|.+...........+.+|+.+++.++|+|++++.+++.. .+.
T Consensus         2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   80 (268)
T cd05063           2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK-FKP   80 (268)
T ss_pred             CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc-CCC
Confidence            445788999999999999999999875554   7899998766555566778899999999999999999999987 678


Q ss_pred             EEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          125 IAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      .++||||+++++|.+++.. ...+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++ .++|+|||++.....
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~~  159 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNL-ECKVSDFGLSRVLED  159 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCC-cEEECCCccceeccc
Confidence            9999999999999999875 35689999999999999999999999999999999999999887 899999999876543


Q ss_pred             Cccccc---cccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCC
Q 020657          204 SLDACN---SYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPS  279 (323)
Q Consensus       204 ~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  279 (323)
                      ......   ....+..|+|||++...     ..+.++||||||+++|+|++ |..||.....    ..+...+......+
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~-----~~~~~~Dv~slG~il~ell~~g~~p~~~~~~----~~~~~~i~~~~~~~  230 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYR-----KFTSASDVWSFGIVMWEVMSFGERPYWDMSN----HEVMKAINDGFRLP  230 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcC-----CcChHhHHHHHHHHHHHHHhCCCCCCCcCCH----HHHHHHHhcCCCCC
Confidence            222111   11234579999988633     34569999999999999997 9999965433    23333333334444


Q ss_pred             CCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          280 LPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       280 ~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      .+..++..+.+++.+||+.+|++||++.++++
T Consensus       231 ~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         231 APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            45678899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.8e-41  Score=291.11  Aligned_cols=252  Identities=27%  Similarity=0.437  Sum_probs=204.3

Q ss_pred             ccccccceeeeecccCCeEEEEEEec-----ccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHR-----CTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS  122 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  122 (323)
                      +..++|...+.||+|+||.||+|...     .++..+++|.+.... ......+.+|+++++.++|+||+++++++.. .
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   79 (280)
T cd05092           2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTE-G   79 (280)
T ss_pred             CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEec-C
Confidence            45678999999999999999999743     346688889876443 3456678999999999999999999999887 6


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC
Q 020657          123 GDIAILMEYMDSGTLDTLLNKNG---------------TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN  187 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~~---------------~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~  187 (323)
                      +..+++|||+.+++|.+++...+               .+++..+..++.||+.|+.|||+.|++|+||+|+||++++++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~  159 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL  159 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence            78999999999999999987542               478999999999999999999999999999999999999886


Q ss_pred             CcEEEeecCcchhhccCc--cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCcc
Q 020657          188 MQVKIADFGVSKIMCRSL--DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPD  264 (323)
Q Consensus       188 ~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~  264 (323)
                       .++|+|||++.......  .......++..|+|||.+...     .++.++||||||+++|+|++ |..||.....   
T Consensus       160 -~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~el~~~g~~p~~~~~~---  230 (280)
T cd05092         160 -VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-----KFTTESDIWSFGVVLWEIFTYGKQPWYQLSN---  230 (280)
T ss_pred             -CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC-----CcCchhhHHHHHHHHHHHHcCCCCCCccCCH---
Confidence             89999999986543221  112223346789999988633     34669999999999999998 8999854332   


Q ss_pred             HHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          265 WATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                       ...............+..+++.+.+|+.+||+.||++||+++++++
T Consensus       231 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         231 -TEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             -HHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence             2233333344445556778999999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.3e-41  Score=287.51  Aligned_cols=251  Identities=24%  Similarity=0.382  Sum_probs=202.5

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeE
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDI  125 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  125 (323)
                      |++..++|++.+.||+|++|.||+|.+..+ ..+++|.+....  .....+.+|+.+++.+.|+|++++++++.  ....
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~   75 (260)
T cd05069           1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVS--EEPI   75 (260)
T ss_pred             CcCChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEc--CCCc
Confidence            346678899999999999999999998644 468899876443  23456788999999999999999999875  3568


Q ss_pred             EEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          126 AILMEYMDSGTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      +++|||+.+++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||.+.....
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~-~~~l~dfg~~~~~~~  154 (260)
T cd05069          76 YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNL-VCKIADFGLARLIED  154 (260)
T ss_pred             EEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC-eEEECCCccceEccC
Confidence            8999999999999999753  3478999999999999999999999999999999999999987 899999999976533


Q ss_pred             Ccc-ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCC
Q 020657          204 SLD-ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLP  281 (323)
Q Consensus       204 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (323)
                      ... ......++..|+|||.+..     ...+.++|+||||+++|+|+| |..||......    ..............+
T Consensus       155 ~~~~~~~~~~~~~~y~~Pe~~~~-----~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~~~~~~~~~~~  225 (260)
T cd05069         155 NEYTARQGAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR----EVLEQVERGYRMPCP  225 (260)
T ss_pred             CcccccCCCccchhhCCHHHhcc-----CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHHcCCCCCCC
Confidence            221 1122345678999998763     334569999999999999999 99999654332    222333333444556


Q ss_pred             CCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          282 DGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       282 ~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ...+..+.+++++||+.||++||+++++++
T Consensus       226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         226 QGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             cccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            778999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.5e-41  Score=292.00  Aligned_cols=256  Identities=27%  Similarity=0.365  Sum_probs=205.6

Q ss_pred             cccceeeeecccCCeEEEEEEe----cccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcC-CCeE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQH----RCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP-SGDI  125 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~----~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~  125 (323)
                      .-|++++.||+|+||.||+|..    ..++..|++|.+...........+.+|+.+++.++|+||+++.+++... ....
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4579999999999999999984    3468899999997665566667899999999999999999999998764 3568


Q ss_pred             EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC
Q 020657          126 AILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS  204 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~  204 (323)
                      ++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~-~~~l~dfg~~~~~~~~  162 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH-QVKIGDFGLTKAIETD  162 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCC-CEEECCCccccccccC
Confidence            9999999999999998754 3589999999999999999999999999999999999999987 8999999999765432


Q ss_pred             cc---ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----------CCccHHHHHH
Q 020657          205 LD---ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPG-----------QRPDWATLMC  270 (323)
Q Consensus       205 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~-----------~~~~~~~~~~  270 (323)
                      ..   ......++..|+|||.+..     ...+.++||||||+++|+|+|+..|+....           ..........
T Consensus       163 ~~~~~~~~~~~~~~~y~apE~~~~-----~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05079         163 KEYYTVKDDLDSPVFWYAPECLIQ-----SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR  237 (284)
T ss_pred             ccceeecCCCCCCccccCHHHhcc-----CCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence            21   1123445678999998763     334569999999999999999876653211           1111222333


Q ss_pred             HHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          271 AICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ....+...+.+..++..+.+|+.+||+.+|++|||+++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         238 VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             HHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            333334445566789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.1e-41  Score=294.15  Aligned_cols=257  Identities=25%  Similarity=0.351  Sum_probs=205.4

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccC----------------cEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCcc
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTH----------------KIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI  111 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~----------------~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i  111 (323)
                      +...+|++.+.||+|+||.||+|.+...+                ..|++|.+...........+.+|+.+++.++|+||
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i   81 (296)
T cd05051           2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNI   81 (296)
T ss_pred             CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCE
Confidence            34678999999999999999999876533                45899998876666667788999999999999999


Q ss_pred             ceeceeEEcCCCeEEEEEeccCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 020657          112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNG-----------TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSN  180 (323)
Q Consensus       112 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~n  180 (323)
                      +++++++.. ++..+++||++.+++|.+++....           .+++..++.++.|++.||.|||+.|++|+||||+|
T Consensus        82 ~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N  160 (296)
T cd05051          82 ARLLGVCTV-DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN  160 (296)
T ss_pred             eEEEEEEec-CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence            999999987 678999999999999999997655           68999999999999999999999999999999999


Q ss_pred             eEEecCCCcEEEeecCcchhhccCc--cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh--CCCCC
Q 020657          181 LLVNNNNMQVKIADFGVSKIMCRSL--DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL--GHFPF  256 (323)
Q Consensus       181 il~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt--g~~p~  256 (323)
                      |+++.++ .++|+|||++.......  .......++..|+|||.+...     ..+.++||||||+++|+|++  +..||
T Consensus       161 ili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~~l~el~~~~~~~p~  234 (296)
T cd05051         161 CLVGKNY-TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-----KFTTKSDVWAFGVTLWEILTLCREQPY  234 (296)
T ss_pred             eeecCCC-ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-----CCCccchhhhhHHHHHHHHhcCCCCCC
Confidence            9999987 89999999987543221  112234456789999987633     35569999999999999997  77888


Q ss_pred             CCCCCCccHHHHHHHHh---cCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          257 LQPGQRPDWATLMCAIC---FGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       257 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ........+........   .......+..++.++.+++.+||+.||++|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         235 EHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             CCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            54433222222221100   01112234567889999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.6e-41  Score=288.64  Aligned_cols=252  Identities=26%  Similarity=0.416  Sum_probs=205.2

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCc---EEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIA  126 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~---~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  126 (323)
                      ..+|++.+.||+|++|.||+|.+..+++   .|++|.+...........+.+|+.+++.+.||||+++++++.. ++..+
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~   81 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-SRPVM   81 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC-CCceE
Confidence            4678999999999999999999876654   5999998766556667789999999999999999999999876 67899


Q ss_pred             EEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc
Q 020657          127 ILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL  205 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~  205 (323)
                      +||||+++++|.+++.. .+.+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~-~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCC-cEEECCCccccccccCc
Confidence            99999999999999875 34689999999999999999999999999999999999999886 89999999986553322


Q ss_pred             cc--ccc---ccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCC
Q 020657          206 DA--CNS---YVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPS  279 (323)
Q Consensus       206 ~~--~~~---~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  279 (323)
                      ..  ...   ...+..|+|||.+...     .++.++||||||+++||+++ |..||.....    ......+......+
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~-----~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~----~~~~~~i~~~~~~~  231 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYR-----KFTSASDVWSYGIVMWEVMSYGERPYWDMSN----QDVINAIEQDYRLP  231 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccC-----cccchhhhhhhHHHHHHHhcCCCCCCCCCCH----HHHHHHHHcCCcCC
Confidence            11  111   1123579999988633     34569999999999999886 9999965433    23333333333444


Q ss_pred             CCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          280 LPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       280 ~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      .+..++..+.+++.+||+.+|.+||+++++++.
T Consensus       232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  264 (269)
T cd05065         232 PPMDCPTALHQLMLDCWQKDRNARPKFGQIVST  264 (269)
T ss_pred             CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            556788999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.8e-41  Score=292.22  Aligned_cols=262  Identities=31%  Similarity=0.489  Sum_probs=212.6

Q ss_pred             ccceeeeecccCCeEEEEEEec---ccCcEEEEEeecCCC---ChHHHHHHHHHHHHHHcC-CCCccceeceeEEcCCCe
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHR---CTHKIYALKVVHGDA---DPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKPSGD  124 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~---~~~~~v~iK~~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  124 (323)
                      +|++.+.||+|++|.||++.+.   .+++.+++|++....   .......+.+|+.++.++ .|++|+++++.+.. ...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~-~~~   79 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT-DTK   79 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec-CCE
Confidence            4889999999999999999864   367889999986432   223455678899999999 59999999999887 678


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC
Q 020657          125 IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS  204 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~  204 (323)
                      .++||||+.+++|.+.+.....+++..+..++.|++++|.+||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~  158 (288)
T cd05583          80 LHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEG-HVVLTDFGLSKEFLAE  158 (288)
T ss_pred             EEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEEECccccccccc
Confidence            999999999999999998777899999999999999999999999999999999999999987 8999999998765332


Q ss_pred             cc-ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCC
Q 020657          205 LD-ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDG  283 (323)
Q Consensus       205 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (323)
                      .. ......++..|++||.+....   ...+.++|+|+||+++|+|++|..||...........+.+.... .....+..
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~  234 (288)
T cd05583         159 EEERAYSFCGTIEYMAPEVIRGGS---GGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK-SKPPFPKT  234 (288)
T ss_pred             cccccccccCCccccCHHHhcCCC---CCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc-cCCCCCcc
Confidence            21 122345788999999875322   22456999999999999999999999654443333444333332 23455677


Q ss_pred             CChhHHHHHHHhcccCcCCCCC---HHHHhcCcccccCC
Q 020657          284 ASPEFRSFIECCLQKEFSKRWT---ASQLLTHPFLCKNR  319 (323)
Q Consensus       284 ~~~~l~~ll~~~l~~~p~~Rpt---~~~~l~h~~f~~~~  319 (323)
                      ++.++.+++.+||+.||++|||   +.++|+||||++..
T Consensus       235 ~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~  273 (288)
T cd05583         235 MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID  273 (288)
T ss_pred             cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence            8999999999999999999998   57789999998764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.1e-40  Score=292.43  Aligned_cols=259  Identities=31%  Similarity=0.465  Sum_probs=209.5

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      ...|+..+.||+|+||.||+|.+..++..+++|.+....  ..+....+.+|+.+++.++|+|++++++++.. +...++
T Consensus        24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~l  102 (317)
T cd06635          24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-EHTAWL  102 (317)
T ss_pred             hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-CCeEEE
Confidence            345889999999999999999998889999999986442  23445678899999999999999999999987 678899


Q ss_pred             EEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc
Q 020657          128 LMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD  206 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~  206 (323)
                      ||||+.+ ++.+.+.. ..++++..+..++.+++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.....   
T Consensus       103 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~-~~kl~dfg~~~~~~~---  177 (317)
T cd06635         103 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG-QVKLADFGSASIASP---  177 (317)
T ss_pred             EEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCC-CEEEecCCCccccCC---
Confidence            9999976 77776653 55689999999999999999999999999999999999999987 899999998865432   


Q ss_pred             ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCCh
Q 020657          207 ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP  286 (323)
Q Consensus       207 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (323)
                       .....++..|+|||.+....  ....+.++||||||+++|+|++|..||..........   ...............+.
T Consensus       178 -~~~~~~~~~y~aPE~~~~~~--~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  251 (317)
T cd06635         178 -ANSFVGTPYWMAPEVILAMD--EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---HIAQNESPTLQSNEWSD  251 (317)
T ss_pred             -cccccCCccccChhhhhcCC--CCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH---HHHhccCCCCCCccccH
Confidence             22345788999999874221  2335669999999999999999999996543222222   22222223333456788


Q ss_pred             hHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          287 EFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       287 ~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                      .+.+++.+||+.+|.+||+++++++|+|+...+.
T Consensus       252 ~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  285 (317)
T cd06635         252 YFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP  285 (317)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence            9999999999999999999999999999976543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-41  Score=293.07  Aligned_cols=255  Identities=32%  Similarity=0.448  Sum_probs=202.7

Q ss_pred             cceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCC-CCccceeceeEEcCCCeEEEEEec
Q 020657           53 LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD-SPFIVQCFGIFEKPSGDIAILMEY  131 (323)
Q Consensus        53 ~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~lv~e~  131 (323)
                      |++.+.||+|++|.||+|.+..+++.|++|.+.............+|+..++++. |+|++++++++.. ++..++||||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-~~~~~lv~e~   79 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-NDELYFVFEY   79 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-CCcEEEEEec
Confidence            6788999999999999999988899999999875543333344567889999998 9999999999987 7889999999


Q ss_pred             cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccc
Q 020657          132 MDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN  209 (323)
Q Consensus       132 ~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~  209 (323)
                      + +++|.+.+....  .+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++ .++|+|||.+....... ...
T Consensus        80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~-~~~l~d~~~~~~~~~~~-~~~  156 (283)
T cd07830          80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPE-VVKIADFGLAREIRSRP-PYT  156 (283)
T ss_pred             C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC-CEEEeecccceeccCCC-CcC
Confidence            9 679988887654  789999999999999999999999999999999999999987 89999999987654322 223


Q ss_pred             cccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhc---------------
Q 020657          210 SYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICF---------------  274 (323)
Q Consensus       210 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~---------------  274 (323)
                      ...++..|+|||++..    ....+.++|+||||+++|+|++|+.||..................               
T Consensus       157 ~~~~~~~~~aPE~~~~----~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         157 DYVSTRWYRAPEILLR----STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             CCCCcccccCceeeec----CcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence            3457889999998752    233466999999999999999999999655432222211110000               


Q ss_pred             ---CC-------CCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          275 ---GD-------PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       275 ---~~-------~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                         ..       ........+.++.+++++||+.+|++|||+++++.||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence               00       000112336889999999999999999999999999998

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-41  Score=293.52  Aligned_cols=256  Identities=30%  Similarity=0.485  Sum_probs=206.5

Q ss_pred             cceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEec
Q 020657           53 LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEY  131 (323)
Q Consensus        53 ~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~  131 (323)
                      |++...||+|++|.||+|.+..+++.+++|++.... .......+.+|+.+++.+.|+|++++++++.. .+..++|+||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT-ERKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc-CCceEEEecC
Confidence            677889999999999999999889999999997653 23345667789999999999999999999887 5789999999


Q ss_pred             cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccccc
Q 020657          132 MDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNS  210 (323)
Q Consensus       132 ~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~  210 (323)
                      +++ +|.+++.+. ..+++..+..++.+++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+............
T Consensus        80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~-~~~l~d~g~~~~~~~~~~~~~~  157 (282)
T cd07829          80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDG-VLKLADFGLARAFGIPLRTYTH  157 (282)
T ss_pred             cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCC-CEEEecCCcccccCCCccccCc
Confidence            985 999999875 5799999999999999999999999999999999999999987 8999999999766544333334


Q ss_pred             ccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcC---------------
Q 020657          211 YVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFG---------------  275 (323)
Q Consensus       211 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~---------------  275 (323)
                      ...+..|+|||.+...    ...+.++|+|+||+++|+|++|..||...........+.......               
T Consensus       158 ~~~~~~~~aPE~~~~~----~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07829         158 EVVTLWYRAPEILLGS----KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK  233 (282)
T ss_pred             cccCcCcCChHHhcCC----cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence            4567789999988532    244669999999999999999999996544322222221111000               


Q ss_pred             -CCC--------CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          276 -DPP--------SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       276 -~~~--------~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                       ..+        .....++.++.+++++||..+|++||+++++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence             000        0112347889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.7e-41  Score=320.97  Aligned_cols=249  Identities=24%  Similarity=0.372  Sum_probs=200.0

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      .+|++.+.||+|+||.||+|.+..+++.||+|++....  .....+++.+|+.+++.++||||+++++++.+ .+..++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d-~~~lyLV   80 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD-GDPVYYT   80 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee-CCEEEEE
Confidence            68999999999999999999999899999999997542  33456778999999999999999999999987 6789999


Q ss_pred             EeccCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCc
Q 020657          129 MEYMDSGTLDTLLNKN-----------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGV  197 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~-----------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~  197 (323)
                      |||++|++|.+++...           ...+...+..++.||++||.|||+.|++||||||+||+++.++ .++|+|||+
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg-~vKLiDFGL  159 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFG-EVVILDWGA  159 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCC-CEEEEecCc
Confidence            9999999999988631           2356678899999999999999999999999999999999987 899999999


Q ss_pred             chhhccCc------------------cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 020657          198 SKIMCRSL------------------DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQP  259 (323)
Q Consensus       198 ~~~~~~~~------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~  259 (323)
                      +.......                  .......||..|+|||.+.+.     ..+.++||||||+++|+|+||..||...
T Consensus       160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-----~~S~kSDIWSLGVILyELLTG~~PF~~~  234 (932)
T PRK13184        160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-----PASESTDIYALGVILYQMLTLSFPYRRK  234 (932)
T ss_pred             ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-----CCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence            97652110                  011124689999999998643     3466999999999999999999999653


Q ss_pred             CCCccHHHHHHHHhcCCCCCC--CCCCChhHHHHHHHhcccCcCCCCCHHHHh
Q 020657          260 GQRPDWATLMCAICFGDPPSL--PDGASPEFRSFIECCLQKEFSKRWTASQLL  310 (323)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l  310 (323)
                      ...    .+........+...  ...+++.+.+++.+||+.||++|++..+.+
T Consensus       235 ~~~----ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL  283 (932)
T PRK13184        235 KGR----KISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQEL  283 (932)
T ss_pred             chh----hhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            322    11111111111111  246789999999999999999998765544

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7e-41  Score=288.43  Aligned_cols=252  Identities=25%  Similarity=0.392  Sum_probs=208.3

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCc----EEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCC
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHK----IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG  123 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  123 (323)
                      +...+|++.+.||+|+||.||+|.+..+++    .+++|.............+.+|+.+++.++|+||+++++++..  .
T Consensus         4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~   81 (279)
T cd05057           4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS--S   81 (279)
T ss_pred             cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--C
Confidence            456889999999999999999999876554    5889988766656667788899999999999999999999875  6


Q ss_pred             eEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          124 DIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      ..++||||+.+++|.+++... ..+++..+..++.||+.||+|||+.|++|+||+|+||+++.++ .++|+|||.+....
T Consensus        82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~-~~kL~dfg~~~~~~  160 (279)
T cd05057          82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLD  160 (279)
T ss_pred             ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCC-eEEECCCccccccc
Confidence            789999999999999998764 4689999999999999999999999999999999999999887 89999999997654


Q ss_pred             cCcccc--ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCC
Q 020657          203 RSLDAC--NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPS  279 (323)
Q Consensus       203 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  279 (323)
                      ......  .....+..|+|||.+..     ...+.++|+||||+++|++++ |..||...    ....+...........
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~Di~slG~~l~el~~~g~~p~~~~----~~~~~~~~~~~~~~~~  231 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILH-----RIYTHKSDVWSYGVTVWELMTFGAKPYEGI----PAVEIPDLLEKGERLP  231 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhc-----CCcCchhhHHHHHHHHHHHhcCCCCCCCCC----CHHHHHHHHhCCCCCC
Confidence            322211  11223467999998753     334569999999999999998 99999543    3344444444455556


Q ss_pred             CCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          280 LPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       280 ~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      .+...+.++.+++.+||..+|++|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         232 QPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            66678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-43  Score=294.18  Aligned_cols=266  Identities=29%  Similarity=0.467  Sum_probs=227.2

Q ss_pred             CccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcC-CCCccceeceeE
Q 020657           42 TATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRT-DSPFIVQCFGIF  118 (323)
Q Consensus        42 ~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~  118 (323)
                      ......+...+|..+.+||+|+||.|.+|..+.+.+.+|||+++++-  +.+..+--..|-++|... +-|.+++++..|
T Consensus       340 ~~~~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF  419 (683)
T KOG0696|consen  340 SSKRDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF  419 (683)
T ss_pred             CCcccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh
Confidence            34455788899999999999999999999999999999999997651  111122223566666665 467899999999


Q ss_pred             EcCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcc
Q 020657          119 EKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVS  198 (323)
Q Consensus       119 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~  198 (323)
                      ++ -+++|+||||+.||+|-..+++-+.+.+..+..++.+|+-+|-+||++||++||||.+||++|.+| .+||.|||++
T Consensus       420 QT-mDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eG-HiKi~DFGmc  497 (683)
T KOG0696|consen  420 QT-MDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG-HIKIADFGMC  497 (683)
T ss_pred             hh-hhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCC-ceEeeecccc
Confidence            88 678999999999999999999988999999999999999999999999999999999999999998 8999999999


Q ss_pred             hhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCC
Q 020657          199 KIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPP  278 (323)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~  278 (323)
                      ..--.......+++||+.|+|||++.-.+|     ...+|+||+|++||||+.|+.||++.++...+..+.+     ...
T Consensus       498 KEni~~~~TTkTFCGTPdYiAPEIi~YqPY-----gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~e-----hnv  567 (683)
T KOG0696|consen  498 KENIFDGVTTKTFCGTPDYIAPEIIAYQPY-----GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIME-----HNV  567 (683)
T ss_pred             cccccCCcceeeecCCCcccccceEEeccc-----ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH-----ccC
Confidence            765556667788999999999999974444     4499999999999999999999988776655555543     356


Q ss_pred             CCCCCCChhHHHHHHHhcccCcCCCCC-----HHHHhcCcccccCC
Q 020657          279 SLPDGASPEFRSFIECCLQKEFSKRWT-----ASQLLTHPFLCKNR  319 (323)
Q Consensus       279 ~~~~~~~~~l~~ll~~~l~~~p~~Rpt-----~~~~l~h~~f~~~~  319 (323)
                      .+|+.+|.+..++.+..|...|.+|..     -++|-+||||+.+.
T Consensus       568 syPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iD  613 (683)
T KOG0696|consen  568 SYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRID  613 (683)
T ss_pred             cCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhcc
Confidence            789999999999999999999999984     47899999998764

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-42  Score=307.11  Aligned_cols=258  Identities=29%  Similarity=0.483  Sum_probs=216.6

Q ss_pred             cccc-ceeeeecccCCeEEEEEEecccCcEEEEE---eecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC-Ce
Q 020657           50 YSDL-EKLQVLGHGNGGTVYKVQHRCTHKIYALK---VVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS-GD  124 (323)
Q Consensus        50 ~~~~-~~~~~lg~G~~~~v~~~~~~~~~~~v~iK---~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~  124 (323)
                      ..+| +....||+|+|.+||+|.|..+|-.||=-   .-....++....++..|+.+|+.|+|+||++++.++.+.. ..
T Consensus        38 ~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~  117 (632)
T KOG0584|consen   38 TGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT  117 (632)
T ss_pred             CCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence            3444 33568999999999999998888887643   3233456677789999999999999999999999987643 34


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--CCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          125 IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH--KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~--givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      +.+|+|.+..|+|..++++.+.++...++.|++||++||.|||++  -|+|||||.+||+|+.+...|||+|+|+|....
T Consensus       118 in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r  197 (632)
T KOG0584|consen  118 INFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR  197 (632)
T ss_pred             eeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence            789999999999999999999999999999999999999999998  599999999999999876699999999998875


Q ss_pred             cCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC-CCCCC
Q 020657          203 RSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD-PPSLP  281 (323)
Q Consensus       203 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~  281 (323)
                      .+..  ...+||+-|||||+..      ..|+..+||||||.+|.||.|+..||....+.   ..+..++..+. |..+.
T Consensus       198 ~s~a--ksvIGTPEFMAPEmYE------E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~---AQIYKKV~SGiKP~sl~  266 (632)
T KOG0584|consen  198 KSHA--KSVIGTPEFMAPEMYE------ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP---AQIYKKVTSGIKPAALS  266 (632)
T ss_pred             cccc--ceeccCccccChHHHh------hhcchhhhhhhhhHHHHHHHhccCChhhhCCH---HHHHHHHHcCCCHHHhh
Confidence            5433  3478999999999874      44566999999999999999999999776555   44444444444 44455


Q ss_pred             CCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          282 DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       282 ~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      +--.+++++||.+||.. .++|+|+.|+|.||||+...
T Consensus       267 kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~  303 (632)
T KOG0584|consen  267 KVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDEDG  303 (632)
T ss_pred             ccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcccc
Confidence            55689999999999999 89999999999999998764

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=8.1e-41  Score=286.64  Aligned_cols=253  Identities=26%  Similarity=0.420  Sum_probs=206.6

Q ss_pred             ccccccceeeeecccCCeEEEEEEeccc---CcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCe
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCT---HKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGD  124 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  124 (323)
                      +...+|.+.+.||+|++|.||+|.+...   ...|++|.+.........+.+.+|+.+++.+.|+||+++++++.+  +.
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~   80 (270)
T cd05056           3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE--NP   80 (270)
T ss_pred             echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC--CC
Confidence            4567899999999999999999987543   346899998766656667788999999999999999999998875  45


Q ss_pred             EEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          125 IAILMEYMDSGTLDTLLNKNG-TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      .++||||+++++|.+++.... .+++..+..++.+++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~  159 (270)
T cd05056          81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD-CVKLGDFGLSRYLED  159 (270)
T ss_pred             cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCC-CeEEccCceeeeccc
Confidence            789999999999999997643 589999999999999999999999999999999999999987 899999999865533


Q ss_pred             Ccc-ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCC
Q 020657          204 SLD-ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLP  281 (323)
Q Consensus       204 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (323)
                      ... ......++..|+|||.+...     ..+.++||||||+++|++++ |..||......    ........+.....+
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~el~~~g~~pf~~~~~~----~~~~~~~~~~~~~~~  230 (270)
T cd05056         160 ESYYKASKGKLPIKWMAPESINFR-----RFTSASDVWMFGVCMWEILMLGVKPFQGVKNN----DVIGRIENGERLPMP  230 (270)
T ss_pred             ccceecCCCCccccccChhhhccC-----CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHHcCCcCCCC
Confidence            211 11122334679999987633     34569999999999999996 99999655433    222333344455667


Q ss_pred             CCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          282 DGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       282 ~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ..++..+.+++.+||.++|.+|||+.+++..
T Consensus       231 ~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         231 PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            7889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.1e-40  Score=282.41  Aligned_cols=244  Identities=25%  Similarity=0.392  Sum_probs=200.1

Q ss_pred             eeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEeccCCCC
Q 020657           57 QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGT  136 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~s  136 (323)
                      +.||+|++|.||+|... +++.+++|.+...........+.+|+.+++.+.||||+++++++.. .+..++||||+++++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~   78 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ-RQPIYIVMELVPGGD   78 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-CCccEEEEECCCCCc
Confidence            36899999999999865 6889999998876666666678899999999999999999999887 678999999999999


Q ss_pred             HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc-cccccc
Q 020657          137 LDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC-NSYVGT  214 (323)
Q Consensus       137 L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~  214 (323)
                      |.+++.. ...+++..+..++.+++.+|.+||+.|++|+||+|+||+++.++ .++|+|||++.......... .....+
T Consensus        79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (250)
T cd05085          79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENN-VLKISDFGMSRQEDDGIYSSSGLKQIP  157 (250)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCC-eEEECCCccceeccccccccCCCCCCc
Confidence            9998865 34689999999999999999999999999999999999999887 89999999986543322111 122335


Q ss_pred             ccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHH
Q 020657          215 CAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIE  293 (323)
Q Consensus       215 ~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~  293 (323)
                      ..|+|||++...     ..+.++||||||+++|++++ |..||.....    ...............+..++..+.+++.
T Consensus       158 ~~y~aPE~~~~~-----~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~  228 (250)
T cd05085         158 IKWTAPEALNYG-----RYSSESDVWSYGILLWETFSLGVCPYPGMTN----QQAREQVEKGYRMSCPQKCPDDVYKVMQ  228 (250)
T ss_pred             ccccCHHHhccC-----CCCchhHHHHHHHHHHHHhcCCCCCCCCCCH----HHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence            679999988633     34569999999999999998 9999965432    2233333334445566778999999999


Q ss_pred             HhcccCcCCCCCHHHHhcC
Q 020657          294 CCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       294 ~~l~~~p~~Rpt~~~~l~h  312 (323)
                      +||+.+|++|||+.++++.
T Consensus       229 ~~l~~~p~~Rp~~~~l~~~  247 (250)
T cd05085         229 RCWDYKPENRPKFSELQKE  247 (250)
T ss_pred             HHcccCcccCCCHHHHHHH
Confidence            9999999999999999763

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4.9e-41  Score=295.72  Aligned_cols=263  Identities=27%  Similarity=0.418  Sum_probs=208.5

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      ..++|++.+.||.|++|.||+|.+..+++.|++|.+.... .......+.+|+.+++.++||||+++.+++.......++
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l   87 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF   87 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence            4678999999999999999999999999999999886432 233456677899999999999999999998765677899


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccc
Q 020657          128 LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA  207 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~  207 (323)
                      ++||+. ++|..++... .+++..+..++.|+++||.+||+.|++|+||+|+||+++.++ .++|+|||.+......   
T Consensus        88 v~e~~~-~~L~~~~~~~-~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~-~~~l~dfg~~~~~~~~---  161 (328)
T cd07856          88 VTELLG-TDLHRLLTSR-PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENC-DLKICDFGLARIQDPQ---  161 (328)
T ss_pred             Eeehhc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCC-CEEeCccccccccCCC---
Confidence            999995 5898887653 578899999999999999999999999999999999999887 8999999998654321   


Q ss_pred             cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHH-----------------
Q 020657          208 CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMC-----------------  270 (323)
Q Consensus       208 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~-----------------  270 (323)
                      .....++..|+|||.+..    ....+.++|+|+||+++|+|+||..||...........+..                 
T Consensus       162 ~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (328)
T cd07856         162 MTGYVSTRYYRAPEIMLT----WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN  237 (328)
T ss_pred             cCCCcccccccCceeeec----cCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchh
Confidence            123456788999998752    23456799999999999999999999965432111111110                 


Q ss_pred             ------HHhcCCCC---CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCCC
Q 020657          271 ------AICFGDPP---SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS  321 (323)
Q Consensus       271 ------~~~~~~~~---~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~  321 (323)
                            ........   .....++..+.+++++||+.+|++|||+++++.||||...+.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~  297 (328)
T cd07856         238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP  297 (328)
T ss_pred             hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence                  00000010   1113567899999999999999999999999999999776554

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3e-41  Score=298.98  Aligned_cols=261  Identities=27%  Similarity=0.380  Sum_probs=207.6

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC-----
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS-----  122 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----  122 (323)
                      ..++|++.+.||+|++|.||+|.+..+++.||+|.+.... .......+.+|+.+++.++|+||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            4678999999999999999999999899999999986443 2344567889999999999999999999987532     


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          123 GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      ..+++|||++ +++|.+++.. ..+++..+..++.||++||.|||+.|++|+||+|+||+++.++ .++|+|||++....
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~-~~kl~dfg~~~~~~  169 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQTD  169 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeecccccccc
Confidence            2468999999 5699888864 4689999999999999999999999999999999999999887 89999999987653


Q ss_pred             cCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHH----------
Q 020657          203 RSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAI----------  272 (323)
Q Consensus       203 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~----------  272 (323)
                      ..   .....++..|+|||.+...    ...+.++|+||||+++|++++|..||...........+....          
T Consensus       170 ~~---~~~~~~~~~y~aPE~~~~~----~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (343)
T cd07880         170 SE---MTGYVVTRWYRAPEVILNW----MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK  242 (343)
T ss_pred             cC---ccccccCCcccCHHHHhCC----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence            32   2234567889999988532    234569999999999999999999996543321111111100          


Q ss_pred             -------------hcCC---CCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          273 -------------CFGD---PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       273 -------------~~~~---~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                                   ....   ...+...++.++.+++.+||+.||++|||+.+++.||||+..+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~  305 (343)
T cd07880         243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH  305 (343)
T ss_pred             hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence                         0000   0112246788899999999999999999999999999998754

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=9e-41  Score=284.10  Aligned_cols=248  Identities=30%  Similarity=0.441  Sum_probs=207.2

Q ss_pred             cceeeeecccCCeEEEEEEecccC----cEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           53 LEKLQVLGHGNGGTVYKVQHRCTH----KIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        53 ~~~~~~lg~G~~~~v~~~~~~~~~----~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      +++.+.||.|++|.||++.+...+    ..+++|++...........+.+|+.+++.++|+||+++++++.+ .+..+++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~i   79 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE-EEPLMIV   79 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC-CCeeEEE
Confidence            467889999999999999997665    89999999766555467788999999999999999999999987 5789999


Q ss_pred             EeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc
Q 020657          129 MEYMDSGTLDTLLNKNGT--FSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD  206 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~~--~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~  206 (323)
                      |||+++++|.+++.....  +++..+..++.|++.||++||+.|++|+||+|+||+++.++ .++|+|||++........
T Consensus        80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL-VVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCC-eEEEcccCCceecccccc
Confidence            999999999999976544  89999999999999999999999999999999999999987 899999999976644311


Q ss_pred             ccc-cccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCC
Q 020657          207 ACN-SYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA  284 (323)
Q Consensus       207 ~~~-~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (323)
                      ... ...++..|+|||.+.     ....+.++|+|+||+++++|++ |..||...    ....+.+..........+..+
T Consensus       159 ~~~~~~~~~~~y~~Pe~~~-----~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~----~~~~~~~~~~~~~~~~~~~~~  229 (258)
T smart00219      159 YKKKGGKLPIRWMAPESLK-----DGKFTSKSDVWSFGVLLWEIFTLGESPYPGM----SNEEVLEYLKKGYRLPKPENC  229 (258)
T ss_pred             cccccCCCcccccChHHhc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHHhcCCCCCCCCcC
Confidence            111 223567899999874     3344569999999999999998 78888542    334444444445555666778


Q ss_pred             ChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          285 SPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       285 ~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      +.++.+++.+||+.+|++|||+.++++
T Consensus       230 ~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      230 PPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             CHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence            999999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-41  Score=287.39  Aligned_cols=242  Identities=28%  Similarity=0.379  Sum_probs=195.7

Q ss_pred             eecccCCeEEEEEEecccCc--EEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceeceeEEcCCCeEEEEEeccCC
Q 020657           58 VLGHGNGGTVYKVQHRCTHK--IYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKPSGDIAILMEYMDS  134 (323)
Q Consensus        58 ~lg~G~~~~v~~~~~~~~~~--~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~lv~e~~~~  134 (323)
                      .||+|++|.||+|.+..++.  .+++|.+...........+.+|+.++.++ .||||+++++++.. .+..++||||+++
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~~~~~lv~e~~~~   80 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYLYLAIEYAPH   80 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-CCCceEEEEeCCC
Confidence            58999999999999877665  46888887555556667888999999999 79999999999987 6789999999999


Q ss_pred             CCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcc
Q 020657          135 GTLDTLLNKNG----------------TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVS  198 (323)
Q Consensus       135 ~sL~~~l~~~~----------------~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~  198 (323)
                      ++|.+++....                .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||++
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~-~~kl~dfgl~  159 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VAKIADFGLS  159 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCC-eEEECCCCCc
Confidence            99999986532                478999999999999999999999999999999999999987 8999999998


Q ss_pred             hhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCC
Q 020657          199 KIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDP  277 (323)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~  277 (323)
                      ...... ........+..|+|||++..     ..++.++||||||+++|+|++ |..||.....    ............
T Consensus       160 ~~~~~~-~~~~~~~~~~~y~apE~~~~-----~~~~~~~Di~slG~il~el~~~g~~pf~~~~~----~~~~~~~~~~~~  229 (270)
T cd05047         160 RGQEVY-VKKTMGRLPVRWMAIESLNY-----SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----AELYEKLPQGYR  229 (270)
T ss_pred             cccchh-hhccCCCCccccCChHHHcc-----CCCCchhhHHHHHHHHHHHHcCCCCCccccCH----HHHHHHHhCCCC
Confidence            532211 11112223567999998753     334569999999999999996 9999955432    233333333334


Q ss_pred             CCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          278 PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       278 ~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ...+..++.++.+|+.+||..+|.+|||+++++.
T Consensus       230 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         230 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            4455678899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.5e-41  Score=296.15  Aligned_cols=250  Identities=26%  Similarity=0.366  Sum_probs=195.8

Q ss_pred             CCeEEEEEEecccCcEEEEEeecCC-CChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEeccCCCCHHHHH
Q 020657           63 NGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLL  141 (323)
Q Consensus        63 ~~~~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l  141 (323)
                      +++.+|.+++..+++.||+|++... ........+.+|+.+++.++|+||+++++++.. .+..+++|||+++++|.+++
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~-~~~~~~~~e~~~~~~l~~~l   90 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV-DSELYVVSPLMAYGSCEDLL   90 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec-CCeEEEEEeccCCCCHHHHH
Confidence            4466777777778999999999765 345566789999999999999999999999987 67899999999999999999


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc-------cccccc
Q 020657          142 NKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD-------ACNSYV  212 (323)
Q Consensus       142 ~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~  212 (323)
                      ...  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||.+........       ......
T Consensus        91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~-~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~  169 (314)
T cd08216          91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDG-KVVLSGLRYSVSMIKHGKRQRVVHDFPKSSV  169 (314)
T ss_pred             HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCC-ceEEecCccceeecccccccccccccccccc
Confidence            753  4689999999999999999999999999999999999999887 899999998865432111       112334


Q ss_pred             ccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC----------------
Q 020657          213 GTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD----------------  276 (323)
Q Consensus       213 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~----------------  276 (323)
                      ++..|+|||++....   ..++.++|+||||+++|+|++|..||......   ....+......                
T Consensus       170 ~~~~y~aPE~~~~~~---~~~~~~~Diws~G~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
T cd08216         170 KNLPWLSPEVLQQNL---QGYNEKSDIYSVGITACELANGHVPFKDMPAT---QMLLEKVRGTVPCLLDKSTYPLYEDSM  243 (314)
T ss_pred             ccccccCHHHhcCCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhccCccccccCchhhhcCCc
Confidence            667899999986321   23456899999999999999999999653222   11111111000                


Q ss_pred             ----------------CCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          277 ----------------PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       277 ----------------~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                                      .......++.++.+|+++||++||++|||++++|+||||++.+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~  303 (314)
T cd08216         244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKR  303 (314)
T ss_pred             CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcc
Confidence                            00111233467899999999999999999999999999987753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-41  Score=299.70  Aligned_cols=260  Identities=27%  Similarity=0.424  Sum_probs=204.3

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC-----C
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS-----G  123 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~  123 (323)
                      ..+|.+...||+|++|.||+|.+..+++.|++|.+.... .......+.+|+.+++.+.|+||+++++++....     .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            468999999999999999999998899999999986542 2334456789999999999999999999986532     3


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          124 DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      .+++|+||+.. +|..+..  ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++ .++|+|||++.....
T Consensus        94 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~-~~kL~dfg~~~~~~~  169 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC-ELKILDFGLARHADA  169 (342)
T ss_pred             eEEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCCCCcCCCC
Confidence            46899999965 7776653  3689999999999999999999999999999999999999987 899999999865422


Q ss_pred             CccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHh----------
Q 020657          204 SLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAIC----------  273 (323)
Q Consensus       204 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~----------  273 (323)
                         ......++..|+|||.+..    ....+.++||||||+++|+|++|+.||.+.........+.....          
T Consensus       170 ---~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (342)
T cd07879         170 ---EMTGYVVTRWYRAPEVILN----WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL  242 (342)
T ss_pred             ---CCCCceeeecccChhhhcC----ccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence               1223456788999998753    12345699999999999999999999965432222211111000          


Q ss_pred             --------cCCCCC--------CCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          274 --------FGDPPS--------LPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       274 --------~~~~~~--------~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                              ....+.        .....+.++.+|+++||+.||++|||+++++.||||.+.+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence                    000000        11346788999999999999999999999999999988764

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.1e-40  Score=284.31  Aligned_cols=251  Identities=23%  Similarity=0.375  Sum_probs=204.4

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeE
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDI  125 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  125 (323)
                      |++..++|++.+.||+|++|.||+|.+. .+..+++|.+...  ......+.+|+.+++.++|+||+++++.+..  ...
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~   75 (260)
T cd05073           1 WEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK--EPI   75 (260)
T ss_pred             CcccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC--CCe
Confidence            5678899999999999999999999865 5667899988643  2345678899999999999999999999875  678


Q ss_pred             EEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          126 AILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      +++|||+++++|.+++..  ...++...+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+.....
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~  154 (260)
T cd05073          76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL-VCKIADFGLARVIED  154 (260)
T ss_pred             EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC-cEEECCCcceeeccC
Confidence            999999999999999975  34578899999999999999999999999999999999999987 899999999876543


Q ss_pred             Ccc-ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCC
Q 020657          204 SLD-ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLP  281 (323)
Q Consensus       204 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (323)
                      ... ......++..|+|||++..     ...+.++|+||||+++|+++| |..||.....    ..+............+
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~----~~~~~~~~~~~~~~~~  225 (260)
T cd05073         155 NEYTAREGAKFPIKWTAPEAINF-----GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN----PEVIRALERGYRMPRP  225 (260)
T ss_pred             CCcccccCCcccccccCHhHhcc-----CCcCccccchHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHhCCCCCCCc
Confidence            221 1122334567999999863     334669999999999999998 9999965432    2333333333344455


Q ss_pred             CCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          282 DGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       282 ~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ...+.++.+++.+||+.+|++||++.++++
T Consensus       226 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         226 ENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             ccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            678899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-41  Score=289.96  Aligned_cols=255  Identities=29%  Similarity=0.457  Sum_probs=200.0

Q ss_pred             cceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcC---CCCccceeceeEEcCCC----e
Q 020657           53 LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-PTVRRQVFREMEILRRT---DSPFIVQCFGIFEKPSG----D  124 (323)
Q Consensus        53 ~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~----~  124 (323)
                      |++.+.||+|++|.||+|.+..+++.+++|.+..... ......+.+|+.+++++   .|+|++++++++...+.    .
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            6789999999999999999988899999999975432 22334566777777665   59999999999886322    3


Q ss_pred             EEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          125 IAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      .+++|||+.+ +|.+++....  .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+....
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~-~~~l~dfg~~~~~~  158 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG-QVKIADFGLARIYS  158 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCC-CEEEeccCcceecc
Confidence            8999999975 8888886543  589999999999999999999999999999999999999997 89999999987654


Q ss_pred             cCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCC-----
Q 020657          203 RSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP-----  277 (323)
Q Consensus       203 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~-----  277 (323)
                      .... .....++..|+|||++...     ..+.++|+||||+++|+|++|..||...........+.........     
T Consensus       159 ~~~~-~~~~~~~~~~~~PE~~~~~-----~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         159 FEMA-LTSVVVTLWYRAPEVLLQS-----SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             CCcc-cccccccccccChHHhccC-----CCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence            3322 2233467889999998643     3456999999999999999999999665443333333322111000     


Q ss_pred             -----------------CCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          278 -----------------PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       278 -----------------~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                                       ......++..+.+++++||+.||.+||+++++++||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                             00112356788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=7.9e-41  Score=286.93  Aligned_cols=250  Identities=20%  Similarity=0.309  Sum_probs=198.8

Q ss_pred             cceeeeecccCCeEEEEEEecccCc--EEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcC-----CCe
Q 020657           53 LEKLQVLGHGNGGTVYKVQHRCTHK--IYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP-----SGD  124 (323)
Q Consensus        53 ~~~~~~lg~G~~~~v~~~~~~~~~~--~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~  124 (323)
                      |.+.+.||+|+||.||+|.+..++.  .+++|.+.... .......+.+|+.+++.++|+||+++++++...     ...
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3567899999999999999876665  68999886542 344467788999999999999999999986431     224


Q ss_pred             EEEEEeccCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcc
Q 020657          125 IAILMEYMDSGTLDTLLNK------NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVS  198 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~------~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~  198 (323)
                      .+++|||+.+++|.+++..      ...+++..+..++.||+.||.|||+.|++|+||||+||+++.++ .++|+|||++
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~  159 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENM-NVCVADFGLS  159 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCC-CEEECCCCcc
Confidence            6899999999999988742      23488999999999999999999999999999999999999887 8999999999


Q ss_pred             hhhccCcc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcC
Q 020657          199 KIMCRSLD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFG  275 (323)
Q Consensus       199 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~  275 (323)
                      ........  .......+..|++||.+..     ...+.++||||||+++|+|++ |+.||.....    ..+...+..+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~~~~~~~~~~  230 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLAD-----RVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN----SEIYDYLRQG  230 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccC-----CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHHcC
Confidence            76543221  1122335668999998763     334569999999999999998 8999965332    2333344444


Q ss_pred             CCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          276 DPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       276 ~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      .....+..++..+.+++.+||+.||++|||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         231 NRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            4445566788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=5.2e-41  Score=293.27  Aligned_cols=260  Identities=29%  Similarity=0.459  Sum_probs=209.4

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCC--CChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIA  126 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  126 (323)
                      ....|+..+.||+|++|.||+|++..+++.+++|.+...  ........+.+|+.+++.++|+|++++++++.. ....+
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   91 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAW   91 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-CCeeE
Confidence            456688899999999999999999888999999998643  233445677889999999999999999999987 67889


Q ss_pred             EEEeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc
Q 020657          127 ILMEYMDSGTLDTLLN-KNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL  205 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~  205 (323)
                      +||||+.+ ++.+.+. ....+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++ .++|+|||++...... 
T Consensus        92 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~-  168 (308)
T cd06634          92 LVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAPA-  168 (308)
T ss_pred             EEEEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCC-cEEECCcccceeecCc-
Confidence            99999975 7777664 345689999999999999999999999999999999999999987 8999999998654322 


Q ss_pred             cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCC
Q 020657          206 DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS  285 (323)
Q Consensus       206 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (323)
                         ....++..|+|||.+....  ....+.++||||||+++|+|++|..||........   .........+.......+
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~--~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~  240 (308)
T cd06634         169 ---NXFVGTPYWMAPEVILAMD--EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYHIAQNESPALQSGHWS  240 (308)
T ss_pred             ---ccccCCccccCHHHHhhcc--cCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH---HHHHhhcCCCCcCccccc
Confidence               2345778999999874221  23345699999999999999999999855432211   111111122222345678


Q ss_pred             hhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          286 PEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       286 ~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                      ..+.+|+++||+.+|++||+++++++|+|+.+.+.
T Consensus       241 ~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~  275 (308)
T cd06634         241 EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP  275 (308)
T ss_pred             HHHHHHHHHHhhCCcccCCCHHHHhhCccccccCC
Confidence            89999999999999999999999999999987654

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-42  Score=300.53  Aligned_cols=261  Identities=25%  Similarity=0.363  Sum_probs=218.4

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS  122 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  122 (323)
                      ....+++.+...+.++||+|.||.|.++.-. .+..||+|..+.+.....+..|.+|+++|.+|+||||+.++|+|.. +
T Consensus       530 ~al~EfPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~-D  607 (807)
T KOG1094|consen  530 PALVEFPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ-D  607 (807)
T ss_pred             cchhhcchhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec-C
Confidence            3445677888899999999999999999985 4689999999988777788999999999999999999999999998 7


Q ss_pred             CeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchh
Q 020657          123 GDIAILMEYMDSGTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                      +.+|+|+||+++|+|.+++...  +.+......+|+.||+.||+||.+.++|||||.++|||++.+. ++||+|||+++.
T Consensus       608 ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~-~iKiadfgmsR~  686 (807)
T KOG1094|consen  608 DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEF-TIKIADFGMSRN  686 (807)
T ss_pred             CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcc-cEEecCcccccc
Confidence            8999999999999999999876  3456677788999999999999999999999999999999986 999999999985


Q ss_pred             hccC--ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHH--hCCCCCCCCCCCccHHHHHHHHhcCC
Q 020657          201 MCRS--LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELY--LGHFPFLQPGQRPDWATLMCAICFGD  276 (323)
Q Consensus       201 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~ll--tg~~p~~~~~~~~~~~~~~~~~~~~~  276 (323)
                      .-..  .......+-..+|+|+|.+..+.++.     ++|+|+||+++||++  +.+.||.........++...-...+.
T Consensus       687 lysg~yy~vqgr~vlpiRwmawEsillgkFtt-----aSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~  761 (807)
T KOG1094|consen  687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTT-----ASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQG  761 (807)
T ss_pred             cccCCceeeecceeeeeeehhHHHHHhccccc-----hhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCC
Confidence            4322  22233456678999999998666654     999999999999987  58999976655544444333222222


Q ss_pred             ---CCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          277 ---PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       277 ---~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                         ....|.-++..+.+||..||..+.++||+++++..
T Consensus       762 ~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  762 RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence               24566789999999999999999999999999854

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-41  Score=300.99  Aligned_cols=261  Identities=27%  Similarity=0.415  Sum_probs=207.1

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCC----
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG----  123 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----  123 (323)
                      ..++|++...||+|++|.||+|++..+++.|++|++.... .......+.+|+.+++.+.|+|++++.+++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            3578999999999999999999999899999999986542 23344667789999999999999999998765322    


Q ss_pred             -eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          124 -DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       124 -~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                       ..++|+||+ +++|.+++.. ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||++....
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~-~~kL~dfg~~~~~~  169 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC-ELKILDFGLARHTD  169 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEEcccccccccc
Confidence             389999999 4599998876 4689999999999999999999999999999999999999987 89999999997653


Q ss_pred             cCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHh---------
Q 020657          203 RSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAIC---------  273 (323)
Q Consensus       203 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~---------  273 (323)
                      ..   .....++..|+|||.+...    ...+.++||||||+++|+|++|..||...........+.....         
T Consensus       170 ~~---~~~~~~~~~y~aPE~~~~~----~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (343)
T cd07851         170 DE---MTGYVATRWYRAPEIMLNW----MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK  242 (343)
T ss_pred             cc---ccCCcccccccCHHHHhCC----CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Confidence            32   2334577889999987532    2446699999999999999999999965433222222111100         


Q ss_pred             --------------cCCCC---CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          274 --------------FGDPP---SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       274 --------------~~~~~---~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                                    .....   ......+.++.+|+++||+.+|++|||+.++++||||++..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~  305 (343)
T cd07851         243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH  305 (343)
T ss_pred             ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence                          00000   11134688999999999999999999999999999998654

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.5e-42  Score=303.51  Aligned_cols=257  Identities=28%  Similarity=0.444  Sum_probs=223.0

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEE
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIA  126 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  126 (323)
                      .....|.+...||+|.|+.|.+|++..++..||+|.+.+.. +...+..+.+|+++|..++||||++++.+.+. ...++
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t-~~~ly  131 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET-EATLY  131 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee-cceeE
Confidence            34567999999999999999999999999999999998764 33445668999999999999999999999987 68899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc
Q 020657          127 ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD  206 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~  206 (323)
                      +||||..+|.+.+++.+.+.+.+..+..++.|+++|++|||+++|||||||++||+++.+. ++||+|||++..+. ...
T Consensus       132 lV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~m-nikIaDfgfS~~~~-~~~  209 (596)
T KOG0586|consen  132 LVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENM-NIKIADFGFSTFFD-YGL  209 (596)
T ss_pred             EEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccccc-ceeeeccccceeec-ccc
Confidence            9999999999999999999999999999999999999999999999999999999999985 89999999998876 344


Q ss_pred             ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCCh
Q 020657          207 ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP  286 (323)
Q Consensus       207 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (323)
                      ...+++|++.|.|||++.+..+.    .+++|+|++|+++|.|+.|.+||++..-..    +......+ ...++--++.
T Consensus       210 ~lqt~cgsppyAaPEl~~g~~y~----gpe~D~Wslgvvly~LV~GsLPFDG~~lk~----Lr~rvl~g-k~rIp~~ms~  280 (596)
T KOG0586|consen  210 MLQTFCGSPPYAAPELFNGKKYD----GPEVDIWSLGVVLYALVEGSLPFDGQNLKE----LRPRVLRG-KYRIPFYMSC  280 (596)
T ss_pred             cccccCCCCCccChHhhcCcccC----CcceehhhhhhhheeeeecccccCCccccc----ccchheee-eecccceeec
Confidence            55678999999999999866644    469999999999999999999996654332    22222111 2335566788


Q ss_pred             hHHHHHHHhcccCcCCCCCHHHHhcCcccc
Q 020657          287 EFRSFIECCLQKEFSKRWTASQLLTHPFLC  316 (323)
Q Consensus       287 ~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~  316 (323)
                      +..+||+++|-.+|.+|++.++++.|.|..
T Consensus       281 dce~lLrk~lvl~Pskr~~~dqim~~~W~n  310 (596)
T KOG0586|consen  281 DCEDLLRKFLVLNPSKRGPCDQIMKDRWRN  310 (596)
T ss_pred             hhHHHHHHhhccCccccCCHHHhhhhcccc
Confidence            999999999999999999999999999975

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.7e-41  Score=286.42  Aligned_cols=250  Identities=20%  Similarity=0.326  Sum_probs=201.8

Q ss_pred             cceeeeecccCCeEEEEEEeccc---CcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCC-----
Q 020657           53 LEKLQVLGHGNGGTVYKVQHRCT---HKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG-----  123 (323)
Q Consensus        53 ~~~~~~lg~G~~~~v~~~~~~~~---~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----  123 (323)
                      |++.+.||+|+||.||.|.+..+   +..|++|.+.... .......+.+|+.+++.+.|+||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            67889999999999999987543   4789999987543 23445678899999999999999999998765322     


Q ss_pred             eEEEEEeccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCc
Q 020657          124 DIAILMEYMDSGTLDTLLNKN------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGV  197 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~  197 (323)
                      ..++++||+++++|..++...      ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .+||+|||+
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~  159 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDM-TVCVADFGL  159 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCC-eEEECCccc
Confidence            378999999999999888432      3589999999999999999999999999999999999999987 899999999


Q ss_pred             chhhccCcc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhc
Q 020657          198 SKIMCRSLD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICF  274 (323)
Q Consensus       198 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~  274 (323)
                      +........  .......+..|+|||.+..     ...+.++||||||+++|||++ |..||.....    ..+......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~----~~~~~~~~~  230 (273)
T cd05035         160 SKKIYSGDYYRQGRIAKMPVKWIAIESLAD-----RVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN----HEIYDYLRH  230 (273)
T ss_pred             eeeccccccccccccccCCccccCHhhccc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHc
Confidence            876533221  1112234568999998753     344569999999999999998 8888854332    334444455


Q ss_pred             CCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          275 GDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       275 ~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      +.....+..++..+.+++.+||+.||++|||+.+++++
T Consensus       231 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         231 GNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            55666778899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-42  Score=260.55  Aligned_cols=261  Identities=27%  Similarity=0.454  Sum_probs=219.4

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      .+|...++||+|.+|+||+|++..+++.||+|.++.+.+ ........+|+-+++.++|.||++++++..+ +..+-+|+
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs-dkkltlvf   80 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-DKKLTLVF   80 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc-CceeEEeH
Confidence            467788999999999999999999999999999986643 3456677899999999999999999999887 67899999


Q ss_pred             eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          130 EYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       130 e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      |||.. .|..+... ++.++.+.+++++.|++++|.++|++++.|||+||.|.+++.+| .+||.|||+++.++-+..-.
T Consensus        81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ng-elkladfglarafgipvrcy  158 (292)
T KOG0662|consen   81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNG-ELKLADFGLARAFGIPVRCY  158 (292)
T ss_pred             HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCC-cEEecccchhhhcCCceEee
Confidence            99976 78777754 67899999999999999999999999999999999999999998 99999999999888777777


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCCCccHHHHHHHHhcCCCC---------
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELY-LGHFPFLQPGQRPDWATLMCAICFGDPP---------  278 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~ll-tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------  278 (323)
                      +..+.|..|.+|.++.    +..-++...|+||-||++.|+. .|...|.+.+-.+....+..........         
T Consensus       159 saevvtlwyrppdvlf----gakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp  234 (292)
T KOG0662|consen  159 SAEVVTLWYRPPDVLF----GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP  234 (292)
T ss_pred             eceeeeeeccCcceee----eeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence            7788999999999996    4445667999999999999999 5777777766665555555444322211         


Q ss_pred             ------CCC---------CCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          279 ------SLP---------DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       279 ------~~~---------~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                            .++         ..+...-++|+.++|.-+|..|.+++++|+||||.+.
T Consensus       235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence                  111         1234557899999999999999999999999999864

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=7.1e-41  Score=295.46  Aligned_cols=263  Identities=25%  Similarity=0.353  Sum_probs=205.1

Q ss_pred             ccceeeeecccCCeEEEEEEeccc--CcEEEEEeecCCC-ChHHHHHHHHHHHHHHcC-CCCccceeceeEEc---CCCe
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCT--HKIYALKVVHGDA-DPTVRRQVFREMEILRRT-DSPFIVQCFGIFEK---PSGD  124 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~--~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---~~~~  124 (323)
                      +|++.+.||+|+||.||+|.+..+  +..+|+|.+.... .......+.+|+.+++++ .|+||+++++....   ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            588999999999999999999877  8899999987543 223456677899999998 59999999987432   2345


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC
Q 020657          125 IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS  204 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~  204 (323)
                      .+++++++. ++|.+++.....+++..++.++.||+.||.|||+.|++|+||||+||+++.++ .++|+|||++......
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~-~~kl~Dfg~a~~~~~~  158 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADC-ELKICDFGLARGFSEN  158 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCC-CEEeCcCCCceecccc
Confidence            788999986 59999998878899999999999999999999999999999999999999987 8999999999765432


Q ss_pred             cc----ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHH--------
Q 020657          205 LD----ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAI--------  272 (323)
Q Consensus       205 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~--------  272 (323)
                      ..    ......++..|+|||.+..    ....+.++|+||||+++|+|++|..||...+.......+....        
T Consensus       159 ~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (332)
T cd07857         159 PGENAGFMTEYVATRWYRAPEIMLS----FQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL  234 (332)
T ss_pred             cccccccccCcccCccccCcHHHhC----CCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            11    1223467889999998742    2334569999999999999999999996543221111111100        


Q ss_pred             ---------------hcCCC---CCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          273 ---------------CFGDP---PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       273 ---------------~~~~~---~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                                     .....   .......+..+.+++.+||+.||++|||+.+++.||||+.-+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~  300 (332)
T cd07857         235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHD  300 (332)
T ss_pred             HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcC
Confidence                           00000   1122346889999999999999999999999999999975553

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=8.2e-41  Score=290.44  Aligned_cols=257  Identities=24%  Similarity=0.353  Sum_probs=201.1

Q ss_pred             ccccccceeeeecccCCeEEEEEEecc----------------cCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCcc
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRC----------------THKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI  111 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~----------------~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i  111 (323)
                      ++.++|++.+.||+|+||.||++.+..                ++..+++|++...........+.+|+.+++.++|+||
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (296)
T cd05095           2 FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNI   81 (296)
T ss_pred             CChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCc
Confidence            456789999999999999999986532                3457899999766555566788999999999999999


Q ss_pred             ceeceeEEcCCCeEEEEEeccCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 020657          112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNG-----------TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSN  180 (323)
Q Consensus       112 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~n  180 (323)
                      +++++++.. .+..++||||+.+++|.+++....           .+++..+..++.|++.||.|||+.|++|+||||+|
T Consensus        82 ~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N  160 (296)
T cd05095          82 IRLLAVCIT-SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN  160 (296)
T ss_pred             ceEEEEEec-CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence            999999987 677999999999999999987532           36778899999999999999999999999999999


Q ss_pred             eEEecCCCcEEEeecCcchhhccCcc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh--CCCCC
Q 020657          181 LLVNNNNMQVKIADFGVSKIMCRSLD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL--GHFPF  256 (323)
Q Consensus       181 il~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt--g~~p~  256 (323)
                      |+++.++ .++|+|||++........  .......+..|++||.....     .++.++|+||||+++|||++  |..||
T Consensus       161 ili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-----~~~~~~DiwSlG~~l~el~~~~~~~p~  234 (296)
T cd05095         161 CLVGKNY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-----KFTTASDVWAFGVTLWEILTLCKEQPY  234 (296)
T ss_pred             EEEcCCC-CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-----CccchhhhhHHHHHHHHHHHhCCCCCc
Confidence            9999887 899999999875433211  11122345789999987533     34569999999999999998  77888


Q ss_pred             CCCCCCccHHHHHHHH---hcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          257 LQPGQRPDWATLMCAI---CFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       257 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ................   ........+..++..+.+|+.+||+.||++|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         235 SQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             cccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            5443322222211111   111122334567899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.2e-40  Score=286.06  Aligned_cols=255  Identities=28%  Similarity=0.405  Sum_probs=200.6

Q ss_pred             ccccceeeeecccCCeEEEEEE----ecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcC-CCe
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQ----HRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP-SGD  124 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~----~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~  124 (323)
                      ..+|++.+.||+|+||.||.|.    +..+++.|++|.+.... ......+.+|+.+++.++||||+++++++... ...
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   81 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence            4689999999999999999997    34578899999986543 34456788999999999999999999986542 346


Q ss_pred             EEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          125 IAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      +++||||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++.....
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~~~  160 (284)
T cd05081          82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESEN-RVKIGDFGLTKVLPQ  160 (284)
T ss_pred             eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCC-eEEECCCcccccccC
Confidence            89999999999999999754 4689999999999999999999999999999999999999987 899999999976543


Q ss_pred             Cccc---cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC------------ccHHHH
Q 020657          204 SLDA---CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQR------------PDWATL  268 (323)
Q Consensus       204 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~------------~~~~~~  268 (323)
                      ....   ......+..|+|||.+...     .++.++||||||+++|||++|..++......            .....+
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTES-----KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL  235 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccC-----CcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence            2211   1112234569999988633     3456999999999999999987775332211            011112


Q ss_pred             HHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          269 MCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ............+..++.++.+|+.+||+.+|++|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            2222333334445678899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=334.46  Aligned_cols=258  Identities=34%  Similarity=0.556  Sum_probs=225.5

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEe
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILME  130 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e  130 (323)
                      +|+....||.|.||.||.|.+..+|+..|+|.+.... .....+.+.+|+.++..++|||+|+.+|+=.+ .+..+|.||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH-Rekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH-REKVYIFME 1314 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec-HHHHHHHHH
Confidence            4667789999999999999999999999999987553 34556778899999999999999999999666 567889999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc----c
Q 020657          131 YMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL----D  206 (323)
Q Consensus       131 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~----~  206 (323)
                      ||.+|+|.+.+..++-.++.....+..|+++|+.|||++|||||||||.||+++.+| .+|++|||.|..+....    .
T Consensus      1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g-~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNG-LIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred             HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCC-cEEeecccceeEecCchhcCCH
Confidence            999999999999888888999999999999999999999999999999999999998 89999999998775443    2


Q ss_pred             ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCCh
Q 020657          207 ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP  286 (323)
Q Consensus       207 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (323)
                      +....+||+-|||||++.+....+  ..-++|||||||++.||.||+.||...++.   -.++..+..+..+.+|..++.
T Consensus      1394 el~~~~GT~~YMAPEvit~t~~kG--~~~A~DiWslGCVVlEM~tGkrPW~~~dne---~aIMy~V~~gh~Pq~P~~ls~ 1468 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKG--HGGAADIWSLGCVVLEMATGKRPWAELDNE---WAIMYHVAAGHKPQIPERLSS 1468 (1509)
T ss_pred             HHHhhcCCchhcCchhhcccccCC--CCcchhhhcccceEEEeecCCCchhhccch---hHHHhHHhccCCCCCchhhhH
Confidence            344678999999999998554222  223899999999999999999999655443   456677788899999999999


Q ss_pred             hHHHHHHHhcccCcCCCCCHHHHhcCcccc
Q 020657          287 EFRSFIECCLQKEFSKRWTASQLLTHPFLC  316 (323)
Q Consensus       287 ~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~  316 (323)
                      +..+++..||..||++|.++.|+|+|.|-+
T Consensus      1469 ~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1469 EGRDFLEHCLEQDPKMRWTASQLLEHAFGK 1498 (1509)
T ss_pred             hHHHHHHHHHhcCchhhhHHHHHHHhhccc
Confidence            999999999999999999999999999864

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.7e-40  Score=282.30  Aligned_cols=250  Identities=25%  Similarity=0.423  Sum_probs=203.2

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ...+|++.+.||+|++|.||+|.+. ++..+++|.+.....  ....+.+|+++++.+.||+++++++++.. ....++|
T Consensus         2 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v   77 (256)
T cd05112           2 HPSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCTE-RSPICLV   77 (256)
T ss_pred             ChhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC--CHHHHHHHHHHHHhCCCCCeeeEEEEEcc-CCceEEE
Confidence            3568999999999999999999886 577899998864432  23467889999999999999999999887 6788999


Q ss_pred             EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccc
Q 020657          129 MEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA  207 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~  207 (323)
                      |||+.+++|.+++... ..+++..+..++.+++.++.+||+.|++|+||+|+||+++.++ .++|+|||.+.........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~~~  156 (256)
T cd05112          78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ-VVKVSDFGMTRFVLDDQYT  156 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCC-eEEECCCcceeecccCccc
Confidence            9999999999998753 4689999999999999999999999999999999999999887 8999999998755332211


Q ss_pred             -cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCC
Q 020657          208 -CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS  285 (323)
Q Consensus       208 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (323)
                       ......+..|+|||.+...     .++.++||||||+++|+|++ |..||....    ...+......+.....+...+
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~-----~~~~~~Dv~slG~~l~el~~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~  227 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFS-----KYSSKSDVWSFGVLMWEVFSEGKTPYENRS----NSEVVETINAGFRLYKPRLAS  227 (256)
T ss_pred             ccCCCccchhhcCHhHhccC-----CcChHHHHHHHHHHHHHHHcCCCCCCCcCC----HHHHHHHHhCCCCCCCCCCCC
Confidence             1223345789999988633     34569999999999999998 999995433    233444444333444456678


Q ss_pred             hhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          286 PEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       286 ~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ..+.+|+.+||+.+|++|||+.+++++
T Consensus       228 ~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         228 QSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHHHHHHHHHcccChhhCCCHHHHHHh
Confidence            999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.4e-40  Score=289.85  Aligned_cols=253  Identities=23%  Similarity=0.358  Sum_probs=204.5

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCc----EEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCC
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHK----IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG  123 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  123 (323)
                      +...+|++.+.||+|++|.||+|.+..++.    .+++|.+...........+.+|+.+++.+.|+||+++++++..  .
T Consensus         4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~   81 (303)
T cd05110           4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS--P   81 (303)
T ss_pred             cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC--C
Confidence            456789999999999999999999876665    4788888766555555678899999999999999999999875  3


Q ss_pred             eEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          124 DIAILMEYMDSGTLDTLLNKNG-TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      ..++++||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .+||+|||++....
T Consensus        82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~-~~kL~Dfg~~~~~~  160 (303)
T cd05110          82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPN-HVKITDFGLARLLE  160 (303)
T ss_pred             CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCC-ceEEcccccccccc
Confidence            4679999999999999987643 589999999999999999999999999999999999999887 89999999997654


Q ss_pred             cCccc--cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCC
Q 020657          203 RSLDA--CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPS  279 (323)
Q Consensus       203 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  279 (323)
                      .....  ......+..|+|||.+..     ...+.++||||||+++|+|++ |..||.+..    ...+...........
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~DiwslG~~l~el~t~g~~p~~~~~----~~~~~~~~~~~~~~~  231 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHY-----RKFTHQSDVWSYGVTIWELMTFGGKPYDGIP----TREIPDLLEKGERLP  231 (303)
T ss_pred             CcccccccCCCccccccCCHHHhcc-----CCCChHHHHHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHHHCCCCCC
Confidence            32221  222345678999998763     335669999999999999997 999995442    222222233333444


Q ss_pred             CCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          280 LPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       280 ~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      .+...+..+.+++..||..+|++||+++++++.
T Consensus       232 ~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         232 QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            456678999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.7e-40  Score=285.33  Aligned_cols=253  Identities=21%  Similarity=0.415  Sum_probs=205.1

Q ss_pred             cccccceeeeecccCCeEEEEEEecc-----cCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCC
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRC-----THKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG  123 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  123 (323)
                      ..++|++.+.||+|+||.||+|+...     +.+.+++|.+...........+.+|+.++++++|+||+++++++.. .+
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~   81 (275)
T cd05046           3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE-AE   81 (275)
T ss_pred             ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECC-CC
Confidence            45789999999999999999999653     3567999988765554466788999999999999999999999876 67


Q ss_pred             eEEEEEeccCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEee
Q 020657          124 DIAILMEYMDSGTLDTLLNKNG---------TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIAD  194 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~~---------~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~D  194 (323)
                      ..++||||+++++|.+++....         .+++..+..++.||+.||.|||+.|++|+||+|+||+++.++ .++++|
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~-~~~l~~  160 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQR-EVKVSL  160 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCC-cEEEcc
Confidence            8899999999999999997655         689999999999999999999999999999999999999987 899999


Q ss_pred             cCcchhhccC-ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHH
Q 020657          195 FGVSKIMCRS-LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAI  272 (323)
Q Consensus       195 fg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~  272 (323)
                      ||++...... ........++..|+|||.+...     ..+.++||||||+++|+|++ |..||.....    .......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-----~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~----~~~~~~~  231 (275)
T cd05046         161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQED-----DFSTKSDVWSFGVLMWEVFTQGELPFYGLSD----EEVLNRL  231 (275)
T ss_pred             cccccccCcccccccCCceeEEeecChhhhccC-----CCCchhhHHHHHHHHHHHHhCCCCCccccch----HHHHHHH
Confidence            9998643221 1222334556789999987633     34568999999999999998 8889854322    2222222


Q ss_pred             hcC-CCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          273 CFG-DPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       273 ~~~-~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ..+ .....+..++..+.+++.+||+.+|++|||+.+++..
T Consensus       232 ~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         232 QAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             HcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            222 2233456788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-40  Score=295.55  Aligned_cols=261  Identities=25%  Similarity=0.381  Sum_probs=205.0

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcC-----C
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP-----S  122 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~  122 (323)
                      ..++|++.+.||+|++|.||+|.+..+++.||+|++.... .......+.+|+.++++++|+||+++++++...     .
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   94 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence            4588999999999999999999998899999999987543 223355677899999999999999999987642     1


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          123 GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      ...+++++++ +++|.+++... .+++..+..++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++....
T Consensus        95 ~~~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kl~dfg~~~~~~  171 (345)
T cd07877          95 NDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTD  171 (345)
T ss_pred             ccEEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCC-CEEEeccccccccc
Confidence            3467888887 66998887654 689999999999999999999999999999999999999987 89999999987543


Q ss_pred             cCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHh---------
Q 020657          203 RSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAIC---------  273 (323)
Q Consensus       203 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~---------  273 (323)
                      ..   .....++..|+|||.+.+    ....+.++||||||+++|+|++|..||...........+.....         
T Consensus       172 ~~---~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (345)
T cd07877         172 DE---MTGYVATRWYRAPEIMLN----WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  244 (345)
T ss_pred             cc---ccccccCCCccCHHHHhC----ccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            22   233457788999998752    22345699999999999999999999965433222111111000         


Q ss_pred             --------------cCCC---CCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          274 --------------FGDP---PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       274 --------------~~~~---~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                                    ....   .......+.++.++|.+||+.||.+|||+.++++||||++-.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~  307 (345)
T cd07877         245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  307 (345)
T ss_pred             cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence                          0000   011124678899999999999999999999999999998644

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.5e-40  Score=282.32  Aligned_cols=246  Identities=22%  Similarity=0.340  Sum_probs=194.7

Q ss_pred             eeecccCCeEEEEEEecc---cCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEeccC
Q 020657           57 QVLGHGNGGTVYKVQHRC---THKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMD  133 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~  133 (323)
                      +.||+|+||.||+|.+..   .+..+++|.+...........+.+|+.+++.++||||+++++++...++..++++||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            368999999999998643   34579999986554555567788999999999999999999987655667899999999


Q ss_pred             CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc----ccc
Q 020657          134 SGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL----DAC  208 (323)
Q Consensus       134 ~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~----~~~  208 (323)
                      +++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .+||+|||++.......    ...
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~  159 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESF-TVKVADFGLARDIYDKEYYSVHNH  159 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC-cEEECCccccccccCCcceeeccc
Confidence            99999999753 3567888899999999999999999999999999999999987 89999999987543211    111


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChh
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLG-HFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPE  287 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (323)
                      ....++..|+|||.+...     ..+.++||||||+++|||++| ..||...    ....+......+.....+..++..
T Consensus       160 ~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~el~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  230 (262)
T cd05058         160 TGAKLPVKWMALESLQTQ-----KFTTKSDVWSFGVLLWELMTRGAPPYPDV----DSFDITVYLLQGRRLLQPEYCPDP  230 (262)
T ss_pred             ccCcCCccccChhHhccC-----ccchHHHHHHHHHHHHHHHcCCCCCCCCC----CHHHHHHHHhcCCCCCCCCcCCHH
Confidence            223456689999987633     345699999999999999995 5555332    222333334444445556677899


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          288 FRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       288 l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      +.+++.+||+.+|++||++.++++.
T Consensus       231 ~~~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         231 LYEVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             HHHHHHHHcCCChhhCCCHHHHHHH
Confidence            9999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=5.9e-42  Score=279.72  Aligned_cols=268  Identities=25%  Similarity=0.407  Sum_probs=212.4

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCc----EEEEEeecCCCC-hHHHHHHHHHHHHHHcCCCCccceeceeEEcCC
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHK----IYALKVVHGDAD-PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS  122 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~----~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  122 (323)
                      -....|++++.||+|.+|.||+|...+++.    .+|+|.+..+.+ ........+|+.+++.++|+|++.+..+|.+.+
T Consensus        21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d  100 (438)
T KOG0666|consen   21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD  100 (438)
T ss_pred             HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence            345679999999999999999996544333    689999976643 234456679999999999999999999998778


Q ss_pred             CeEEEEEeccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecC----CCcEEEe
Q 020657          123 GDIAILMEYMDSGTLDTLLNK-----NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNN----NMQVKIA  193 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~----~~~~kl~  193 (323)
                      ..+++++||.+. +|..+++-     .+.++...+.+|+.||+.++.|||+.=++||||||.||++..+    | .|||+
T Consensus       101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG-~VKIa  178 (438)
T KOG0666|consen  101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERG-RVKIA  178 (438)
T ss_pred             ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccC-eeEee
Confidence            889999999987 99999962     3469999999999999999999999999999999999999877    6 89999


Q ss_pred             ecCcchhhccCccc---cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCcc------
Q 020657          194 DFGVSKIMCRSLDA---CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPD------  264 (323)
Q Consensus       194 Dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~------  264 (323)
                      |||+++.+.++...   ....+.|..|+|||.+.    +..-+|.+.|||+.||++.||+|.+..|.+...+..      
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLL----Ga~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq  254 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLL----GARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQ  254 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhc----ccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCch
Confidence            99999998775433   34567899999999996    455677899999999999999999988865432211      


Q ss_pred             ---HHHHHHHHhcCCC------------------------CC--------CCCCCChhHHHHHHHhcccCcCCCCCHHHH
Q 020657          265 ---WATLMCAICFGDP------------------------PS--------LPDGASPEFRSFIECCLQKEFSKRWTASQL  309 (323)
Q Consensus       265 ---~~~~~~~~~~~~~------------------------~~--------~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~  309 (323)
                         ...+.+.......                        ..        ....-++...+|+.+||++||.+|.|++++
T Consensus       255 ~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qA  334 (438)
T KOG0666|consen  255 HDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQA  334 (438)
T ss_pred             HHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHH
Confidence               1111111111100                        00        001134559999999999999999999999


Q ss_pred             hcCcccccCCCC
Q 020657          310 LTHPFLCKNRRS  321 (323)
Q Consensus       310 l~h~~f~~~~~~  321 (323)
                      |+|+||.....+
T Consensus       335 leh~yF~~d~lp  346 (438)
T KOG0666|consen  335 LEHPYFTEDPLP  346 (438)
T ss_pred             hcccccccCCCC
Confidence            999999877543

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-40  Score=280.28  Aligned_cols=243  Identities=27%  Similarity=0.409  Sum_probs=199.1

Q ss_pred             eeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEeccCCCC
Q 020657           57 QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGT  136 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~s  136 (323)
                      +.||+|++|.||+|.+.. ++.|++|.+...........+.+|+++++.+.|+||+++++++.. ....++||||+.+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~~~~~   78 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ-KQPIYIVMELVPGGS   78 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEec-CCCeEEEEEcCCCCc
Confidence            368999999999999976 999999998766555566788999999999999999999999887 678999999999999


Q ss_pred             HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc--ccccc
Q 020657          137 LDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC--NSYVG  213 (323)
Q Consensus       137 L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~  213 (323)
                      |.+++.. ...++...+..++.+++.++.+||+.|++|+||+|+||+++.++ .++|+|||++..........  .....
T Consensus        79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN-VLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCC-cEEEeeccccccccCCcceeccccCcc
Confidence            9999865 34689999999999999999999999999999999999999987 89999999987553221111  11223


Q ss_pred             cccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHH
Q 020657          214 TCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFI  292 (323)
Q Consensus       214 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll  292 (323)
                      +..|+|||.+...     ..+.++|+||||+++|+|+| |..||.....    ...............+..++.++.+++
T Consensus       158 ~~~y~~PE~~~~~-----~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li  228 (251)
T cd05041         158 PIKWTAPEALNYG-----RYTSESDVWSYGILLWETFSLGDTPYPGMSN----QQTRERIESGYRMPAPQLCPEEIYRLM  228 (251)
T ss_pred             eeccCChHhhccC-----CCCcchhHHHHHHHHHHHHhccCCCCccCCH----HHHHHHHhcCCCCCCCccCCHHHHHHH
Confidence            5679999987633     34569999999999999998 8888854432    222233333334445667889999999


Q ss_pred             HHhcccCcCCCCCHHHHhc
Q 020657          293 ECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       293 ~~~l~~~p~~Rpt~~~~l~  311 (323)
                      .+||+.+|.+|||++++++
T Consensus       229 ~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         229 LQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             HHHhccChhhCcCHHHHHH
Confidence            9999999999999999985

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-42  Score=289.08  Aligned_cols=264  Identities=27%  Similarity=0.429  Sum_probs=208.6

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCC-C-C----ccceece
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD-S-P----FIVQCFG  116 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h-~----~i~~~~~  116 (323)
                      ....+....+|.++..+|+|.||.|..+.|..++..||+|+++.-  ...++.-.-|+++++++. + |    .++++.+
T Consensus        81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~  158 (415)
T KOG0671|consen   81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV--DKYREAALIEIEVLQKINESDPNGKFRCVQMRD  158 (415)
T ss_pred             EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence            344566688999999999999999999999989999999998633  244455566888888883 2 2    3677777


Q ss_pred             eEEcCCCeEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecC--------
Q 020657          117 IFEKPSGDIAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNN--------  186 (323)
Q Consensus       117 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~--------  186 (323)
                      +|.. .++.|||+|.+ |.|+.+++..+.  +++...++.+.+|+++++++||+.+++|-||||+|||+..+        
T Consensus       159 wFdy-rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~  236 (415)
T KOG0671|consen  159 WFDY-RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNP  236 (415)
T ss_pred             hhhc-cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEecc
Confidence            7877 78999999999 459999997654  68999999999999999999999999999999999999421        


Q ss_pred             -----------CCcEEEeecCcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 020657          187 -----------NMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFP  255 (323)
Q Consensus       187 -----------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p  255 (323)
                                 ...++++|||.|+......   ...+.|..|+|||++.+..+     +...||||+||+|+|++||...
T Consensus       237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEViLgLGw-----S~pCDvWSiGCIL~ElytG~~L  308 (415)
T KOG0671|consen  237 KKKVCFIRPLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEVILGLGW-----SQPCDVWSIGCILVELYTGETL  308 (415)
T ss_pred             CCccceeccCCCcceEEEecCCcceeccCc---ceeeeccccCCchheeccCc-----CCccCceeeeeEEEEeecccee
Confidence                       1368999999997654332   45678999999999985554     5599999999999999999999


Q ss_pred             CCCCCCCccHHHHHHHHhcCCCCCC-----------------C-------------------------CCCChhHHHHHH
Q 020657          256 FLQPGQRPDWATLMCAICFGDPPSL-----------------P-------------------------DGASPEFRSFIE  293 (323)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~-------------------------~~~~~~l~~ll~  293 (323)
                      |..-++.+... +++.+....+..+                 +                         ...-.+|.|||+
T Consensus       309 FqtHen~EHLa-MMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~  387 (415)
T KOG0671|consen  309 FQTHENLEHLA-MMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR  387 (415)
T ss_pred             cccCCcHHHHH-HHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence            97776655442 3333322211100                 0                         011145999999


Q ss_pred             HhcccCcCCCCCHHHHhcCcccccCC
Q 020657          294 CCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       294 ~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      +||..||.+|+|+.|+|.||||+.-.
T Consensus       388 ~mL~fDP~~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  388 RMLEFDPARRITLREALSHPFFARLT  413 (415)
T ss_pred             HHHccCccccccHHHHhcCHHhhcCC
Confidence            99999999999999999999998643

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.1e-40  Score=281.90  Aligned_cols=244  Identities=23%  Similarity=0.382  Sum_probs=198.3

Q ss_pred             eeecccCCeEEEEEEecc-cCc--EEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEeccC
Q 020657           57 QVLGHGNGGTVYKVQHRC-THK--IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMD  133 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~-~~~--~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~  133 (323)
                      +.||+|++|.||+|.+.. .++  .+++|.+.........+.+.+|+.+++++.|+||+++++++..  ...++||||++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~   78 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT--HPLMMVTELAP   78 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC--CeEEEEEEecC
Confidence            368999999999999864 333  6899999766554667789999999999999999999999886  78899999999


Q ss_pred             CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc---cc
Q 020657          134 SGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD---AC  208 (323)
Q Consensus       134 ~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~---~~  208 (323)
                      +++|.+.+....  .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .+||+|||++........   ..
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~  157 (257)
T cd05040          79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD-KVKIGDFGLMRALPQNEDHYVME  157 (257)
T ss_pred             CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC-EEEeccccccccccccccceecc
Confidence            999999997653  689999999999999999999999999999999999999987 899999999977643221   11


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChh
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPE  287 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (323)
                      ....++..|+|||.+..     ...+.++||||||+++|+|++ |..||...........+   .........+...+..
T Consensus       158 ~~~~~~~~y~~pE~~~~-----~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~  229 (257)
T cd05040         158 EHLKVPFAWCAPESLRT-----RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI---DKEGERLERPEACPQD  229 (257)
T ss_pred             cCCCCCceecCHHHhcc-----cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---HhcCCcCCCCccCCHH
Confidence            23446678999998763     334568999999999999998 99999544322211111   1123334455677899


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhc
Q 020657          288 FRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       288 l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      +.+++.+||+.+|++|||+.++++
T Consensus       230 ~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         230 IYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHHHHHCCCCcccCCCHHHHHH
Confidence            999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.2e-40  Score=280.38  Aligned_cols=244  Identities=22%  Similarity=0.413  Sum_probs=199.9

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEE
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      +...+|++.+.||+|++|.||++..  +++.+++|.+....   ....+.+|+.+++.++|+|++++++++..  +..++
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~   75 (254)
T cd05083           3 LNLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILH--NGLYI   75 (254)
T ss_pred             ccHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcC--CCcEE
Confidence            4568899999999999999999875  68889999986442   34567899999999999999999999875  34799


Q ss_pred             EEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc
Q 020657          128 LMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL  205 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~  205 (323)
                      ||||+.+++|.+++....  .+++..+..++.|++.|+.+||+.|++||||+|+||+++.++ .++|+|||.+...... 
T Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~-~~kl~Dfg~~~~~~~~-  153 (254)
T cd05083          76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG-VAKVSDFGLARVGSMG-  153 (254)
T ss_pred             EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC-cEEECCCccceecccc-
Confidence            999999999999997543  579999999999999999999999999999999999999987 8999999998654322 


Q ss_pred             cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCC
Q 020657          206 DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA  284 (323)
Q Consensus       206 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (323)
                        ......+..|+|||.+...     ..+.++|+||||+++|+|++ |..||.....    ...............+..+
T Consensus       154 --~~~~~~~~~y~~pe~~~~~-----~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~  222 (254)
T cd05083         154 --VDNSKLPVKWTAPEALKHK-----KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL----KEVKECVEKGYRMEPPEGC  222 (254)
T ss_pred             --CCCCCCCceecCHHHhccC-----CcCchhhHHHHHHHHHHHHhCCCCCCccCCH----HHHHHHHhCCCCCCCCCcC
Confidence              1222345689999988633     34569999999999999997 9999954432    3333333333344445678


Q ss_pred             ChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          285 SPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       285 ~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      +..+.+++.+||+.+|++|||++++++
T Consensus       223 ~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         223 PADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4.6e-40  Score=281.86  Aligned_cols=252  Identities=21%  Similarity=0.260  Sum_probs=191.9

Q ss_pred             eeecccCCeEEEEEEec--ccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEeccCC
Q 020657           57 QVLGHGNGGTVYKVQHR--CTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDS  134 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~  134 (323)
                      +.||+|+||.||+|.+.  .++..+++|.+...........+.+|+.+++.++||||+++++.+.+ ....++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~   79 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE-VTPYLLVMEFCPL   79 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CCCcEEEEECCCC
Confidence            36899999999999864  34567999998766555555678899999999999999999999887 5678999999999


Q ss_pred             CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc--c
Q 020657          135 GTLDTLLNKN-----GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD--A  207 (323)
Q Consensus       135 ~sL~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~--~  207 (323)
                      ++|.+++...     ...++..+..++.|++.|+.|||+.|++|+||||+||+++.++ .++|+|||.+........  .
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~-~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC-cEEECCccccccccCcceeec
Confidence            9999998642     2356778889999999999999999999999999999999987 899999999865432211  1


Q ss_pred             cccccccccccCCcccCCCCC--CCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHH-hcCCCCCCCCC
Q 020657          208 CNSYVGTCAYMSPERFDPDAY--GGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAI-CFGDPPSLPDG  283 (323)
Q Consensus       208 ~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  283 (323)
                      .....++..|+|||++.....  .....+.++|+||||+++|+|++ |..||................ .....+.+...
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP  238 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence            123456778999999863221  11234679999999999999996 999995543322111111100 00111223345


Q ss_pred             CChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          284 ASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       284 ~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      .++.+.++++.|| .+|++|||+++|+.
T Consensus       239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         239 LSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            6788999999999 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=303.19  Aligned_cols=259  Identities=23%  Similarity=0.382  Sum_probs=220.0

Q ss_pred             chhccccccceeeeecccCCeEEEEEEeccc-Cc--EEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcC
Q 020657           45 TAAIAYSDLEKLQVLGHGNGGTVYKVQHRCT-HK--IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP  121 (323)
Q Consensus        45 ~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~-~~--~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  121 (323)
                      .--|...+.+..+.||+|.||.|++|.|+.. |+  .||||.+..+........|++|+.+|.+|+|+|++++||++-+ 
T Consensus       104 kclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-  182 (1039)
T KOG0199|consen  104 KCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-  182 (1039)
T ss_pred             ceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-
Confidence            3446678888999999999999999998753 33  6999999877766678999999999999999999999999885 


Q ss_pred             CCeEEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcch
Q 020657          122 SGDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       122 ~~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                       ....+|||.+++|+|.+.+.+  ...+-......++.||+.||.||.++++|||||..+|+++-... .|||+|||+.+
T Consensus       183 -qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllaspr-tVKI~DFGLmR  260 (1039)
T KOG0199|consen  183 -QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPR-TVKICDFGLMR  260 (1039)
T ss_pred             -chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccc-eeeeeccccee
Confidence             568999999999999999976  34588899999999999999999999999999999999998876 89999999998


Q ss_pred             hhccCcccc---ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcC
Q 020657          200 IMCRSLDAC---NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFG  275 (323)
Q Consensus       200 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~  275 (323)
                      .+....+.+   ........|+|||.+.-..+..     ++|||++|++||||+| |+.||.+...    ..+++.+..+
T Consensus       261 aLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFSh-----aSDvWmyGVTiWEMFtyGEePW~G~~g----~qIL~~iD~~  331 (1039)
T KOG0199|consen  261 ALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSH-----ASDVWMYGVTIWEMFTYGEEPWVGCRG----IQILKNIDAG  331 (1039)
T ss_pred             ccCCCCcceEecCCCcCcccccCHhHhccccccc-----cchhhhhhhhHHhhhccCCCCCCCCCH----HHHHHhcccc
Confidence            776543332   2234557899999998666654     9999999999999995 9999966544    4455555567


Q ss_pred             CCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          276 DPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       276 ~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                      .+...++.++++++++++.||+.+|++||||..|.+.-+.
T Consensus       332 erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l  371 (1039)
T KOG0199|consen  332 ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL  371 (1039)
T ss_pred             ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence            7788889999999999999999999999999999765444

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.1e-40  Score=282.85  Aligned_cols=253  Identities=21%  Similarity=0.297  Sum_probs=192.4

Q ss_pred             eeecccCCeEEEEEEecc--cCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEeccCC
Q 020657           57 QVLGHGNGGTVYKVQHRC--THKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDS  134 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~  134 (323)
                      +.||+|+||.||+|....  ....+++|.+...........+.+|+.+++.++|+||+++++.+.. ....++||||+++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~-~~~~~lv~e~~~~   79 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE-SIPYLLVLEFCPL   79 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECC-CCceEEEEEeCCC
Confidence            368999999999997532  3457888887655555556678899999999999999999999887 6789999999999


Q ss_pred             CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc--cc
Q 020657          135 GTLDTLLNKNG-----TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL--DA  207 (323)
Q Consensus       135 ~sL~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~--~~  207 (323)
                      ++|.+++....     ..++..+..++.||+.||.|||+.|++|+||||+||+++.++ .+||+|||++.......  ..
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADL-SVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCC-cEEEeccccccccccchheec
Confidence            99999997543     246788899999999999999999999999999999999987 89999999986532221  11


Q ss_pred             cccccccccccCCcccCCCC--CCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhc-CCCCCCCCC
Q 020657          208 CNSYVGTCAYMSPERFDPDA--YGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICF-GDPPSLPDG  283 (323)
Q Consensus       208 ~~~~~~~~~y~aPE~~~~~~--~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  283 (323)
                      .....++..|+|||++....  ......+.++||||||+++|+|++ |..||.................. ...+.++..
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK  238 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence            12234566799999875322  223456779999999999999998 78888544322221211111110 112234456


Q ss_pred             CChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          284 ASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       284 ~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ++..+.+++..|| .||++|||++++++-
T Consensus       239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~  266 (269)
T cd05042         239 YSDRWYEVMQFCW-LDPETRPTAEEVHEL  266 (269)
T ss_pred             CCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence            7889999999998 599999999999863

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=6.2e-40  Score=283.03  Aligned_cols=256  Identities=29%  Similarity=0.430  Sum_probs=205.8

Q ss_pred             ccccceeeeecccCCeEEEEEEec----ccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcC-CCe
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHR----CTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP-SGD  124 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~----~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~  124 (323)
                      .++|++.+.||+|++|.||+|.+.    .+++.+++|++...........+.+|+++++.+.|+||+++++++... ...
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~   82 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS   82 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence            467899999999999999999864    347899999997665444567889999999999999999999987652 346


Q ss_pred             EEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          125 IAILMEYMDSGTLDTLLNKNG-TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      .+++|||+++++|.+++.... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+.....
T Consensus        83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~  161 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED-LVKISDFGLAKVLPE  161 (284)
T ss_pred             eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC-CEEEccccccccccc
Confidence            899999999999999997654 589999999999999999999999999999999999999987 899999999977653


Q ss_pred             Cccc---cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCc-----------cHHHHH
Q 020657          204 SLDA---CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRP-----------DWATLM  269 (323)
Q Consensus       204 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~-----------~~~~~~  269 (323)
                      ....   ......+..|++||.+...     ..+.++|+||||+++|+|+||..|+.......           ....+.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~-----~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAPECLRTS-----KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL  236 (284)
T ss_pred             CCcceeccCCCCCcccccCcHHHccC-----CCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence            2211   1122345679999988633     44569999999999999999999985532221           123333


Q ss_pred             HHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          270 CAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ...........+..++.++.+|+.+||+.+|++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            333333344445677889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-41  Score=297.77  Aligned_cols=245  Identities=25%  Similarity=0.400  Sum_probs=205.5

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHc-CCCCccceeceeEEcCCCeEEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRR-TDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      .+.|.+...+|.|+|+.+-.+.+..+++..++|++....     ..-.+|+.++.. -+||||+++.+++.+ ....++|
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-----~~~~~e~~~~~~~~~h~niv~~~~v~~~-~~~~~~v  394 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-----DDNQDEIPISLLVRDHPNIVKSHDVYED-GKEIYLV  394 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc-----cccccccchhhhhcCCCcceeecceecC-Cceeeee
Confidence            667899999999999999999999999999999997552     222356655555 479999999999998 7889999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEe-cCCCcEEEeecCcchhhccCccc
Q 020657          129 MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVN-NNNMQVKIADFGVSKIMCRSLDA  207 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~-~~~~~~kl~Dfg~~~~~~~~~~~  207 (323)
                      ||.+.|+-+.+.+...+..+ ..+..|+.+|+.|+.|||.+|+|||||||+|||++ ..+ +++|+|||.+......   
T Consensus       395 ~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g-~lrltyFG~a~~~~~~---  469 (612)
T KOG0603|consen  395 MELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAG-HLRLTYFGFWSELERS---  469 (612)
T ss_pred             ehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCC-cEEEEEechhhhCchh---
Confidence            99999998888887665555 88889999999999999999999999999999994 666 8999999999765443   


Q ss_pred             cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChh
Q 020657          208 CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPE  287 (323)
Q Consensus       208 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (323)
                      ..+.+.|..|.|||++.     ...+++++|+||||++||+||+|..||......   .++...   ...+++...+|.+
T Consensus       470 ~~tp~~t~~y~APEvl~-----~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~---i~~~~~s~~vS~~  538 (612)
T KOG0603|consen  470 CDTPALTLQYVAPEVLA-----IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTR---IQMPKFSECVSDE  538 (612)
T ss_pred             hcccchhhcccChhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHh---hcCCccccccCHH
Confidence            44567889999999987     455677999999999999999999999544333   233322   2345555899999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCcccc
Q 020657          288 FRSFIECCLQKEFSKRWTASQLLTHPFLC  316 (323)
Q Consensus       288 l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~  316 (323)
                      +++||.+||+.||.+|+++.+++.|+||-
T Consensus       539 AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~  567 (612)
T KOG0603|consen  539 AKDLLQQLLQVDPALRLGADEIGAHPWFL  567 (612)
T ss_pred             HHHHHHHhccCChhhCcChhhhccCcchh
Confidence            99999999999999999999999999993

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.1e-39  Score=279.36  Aligned_cols=249  Identities=27%  Similarity=0.454  Sum_probs=201.0

Q ss_pred             ccceeeeecccCCeEEEEEEecc-cCcEEEEEeecCC---------CChHHHHHHHHHHHHHHc-CCCCccceeceeEEc
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRC-THKIYALKVVHGD---------ADPTVRRQVFREMEILRR-TDSPFIVQCFGIFEK  120 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~-~~~~v~iK~~~~~---------~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~  120 (323)
                      .|++.+.||+|++|.||+|.+.. +++.+++|.+...         ........+.+|+.++.+ ++|+||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48889999999999999999986 6788999987532         223345567788888875 799999999999987


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCCeEEecCCCcEEEeec
Q 020657          121 PSGDIAILMEYMDSGTLDTLLNK----NGTFSEPKLAHIASQILKGLSYLHG-HKIIHRDIKPSNLLVNNNNMQVKIADF  195 (323)
Q Consensus       121 ~~~~~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~Lh~-~givH~di~~~nil~~~~~~~~kl~Df  195 (323)
                       ++..+++|||+.+++|.+++..    ...+++..++.++.|++.+|.+||+ .|++|+||+|+||+++.++ .++|+||
T Consensus        81 -~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~-~~~l~df  158 (269)
T cd08528          81 -NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD-KVTITDF  158 (269)
T ss_pred             -CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC-cEEEecc
Confidence             6889999999999999988742    3468999999999999999999996 6899999999999999987 8999999


Q ss_pred             CcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcC
Q 020657          196 GVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFG  275 (323)
Q Consensus       196 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~  275 (323)
                      |.+....... ......++..|++||.+....     .+.++|+||||+++|+|++|..||....    ...........
T Consensus       159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~-----~~~~~Dv~slG~ll~~l~~g~~p~~~~~----~~~~~~~~~~~  228 (269)
T cd08528         159 GLAKQKQPES-KLTSVVGTILYSCPEIVKNEP-----YGEKADVWAFGCILYQMCTLQPPFYSTN----MLSLATKIVEA  228 (269)
T ss_pred             cceeeccccc-ccccccCcccCcChhhhcCCC-----CchHHHHHHHHHHHHHHHhCCCcccccC----HHHHHHHHhhc
Confidence            9997654432 334456788999999986433     4569999999999999999999995332    22222233223


Q ss_pred             CCCCCC-CCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          276 DPPSLP-DGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       276 ~~~~~~-~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ...+.+ ...+.++.+++++||+.||++||++.++..+
T Consensus       229 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         229 VYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             cCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            323333 3678999999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.9e-40  Score=277.83  Aligned_cols=229  Identities=23%  Similarity=0.298  Sum_probs=187.7

Q ss_pred             cCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEeccCCCCHHHHH
Q 020657           62 GNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLL  141 (323)
Q Consensus        62 G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l  141 (323)
                      |.++.||++++..+++.+++|.+....      ...+|...+....||||+++++++.. ....++||||+++++|.+.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l   76 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVS-EDSVFLVLQHAEGGKLWSHI   76 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheec-CCeEEEEEecCCCCCHHHHH
Confidence            889999999999999999999996542      12234444555679999999999987 67899999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccccccccccccCCc
Q 020657          142 NKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE  221 (323)
Q Consensus       142 ~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE  221 (323)
                      .....+++..+..++.|+++||.|||+.|++|+||||+||+++.++ .++++|||.+......   .....++..|+|||
T Consensus        77 ~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~df~~~~~~~~~---~~~~~~~~~y~aPE  152 (237)
T cd05576          77 SKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRG-HIQLTYFSRWSEVEDS---CDGEAVENMYCAPE  152 (237)
T ss_pred             HHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC-CEEEecccchhccccc---cccCCcCccccCCc
Confidence            8777899999999999999999999999999999999999999987 8999999987654332   12334567799999


Q ss_pred             ccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcC
Q 020657          222 RFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFS  301 (323)
Q Consensus       222 ~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~  301 (323)
                      .+...     ..+.++|+||+|+++|+|++|..|+......         ........++..+++.+.+++++||+.||+
T Consensus       153 ~~~~~-----~~~~~~DvwslG~il~el~~g~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  218 (237)
T cd05576         153 VGGIS-----EETEACDWWSLGAILFELLTGKTLVECHPSG---------INTHTTLNIPEWVSEEARSLLQQLLQFNPT  218 (237)
T ss_pred             ccCCC-----CCCchhhHHHHHHHHHHHHHCcchhhcCchh---------cccccccCCcccCCHHHHHHHHHHccCCHH
Confidence            87533     3456999999999999999999887432111         001112235567899999999999999999


Q ss_pred             CCCCH-----HHHhcCccc
Q 020657          302 KRWTA-----SQLLTHPFL  315 (323)
Q Consensus       302 ~Rpt~-----~~~l~h~~f  315 (323)
                      +|+|+     +++++||||
T Consensus       219 ~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         219 ERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             HhcCCCccchHHHHcCCCC
Confidence            99985     999999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=6.3e-40  Score=280.91  Aligned_cols=244  Identities=23%  Similarity=0.373  Sum_probs=196.6

Q ss_pred             eecccCCeEEEEEEecccC------cEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEec
Q 020657           58 VLGHGNGGTVYKVQHRCTH------KIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEY  131 (323)
Q Consensus        58 ~lg~G~~~~v~~~~~~~~~------~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~  131 (323)
                      .||+|++|.||+|.+....      +.+++|.+...........+.+|+.+++.+.||||+++++++.. ....++||||
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~   80 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-NEPQYIIMEL   80 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-CCCeEEEEec
Confidence            6899999999999975433      67999998755444556678899999999999999999999887 6789999999


Q ss_pred             cCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC----CcEEEeecCcchh
Q 020657          132 MDSGTLDTLLNKN-------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN----MQVKIADFGVSKI  200 (323)
Q Consensus       132 ~~~~sL~~~l~~~-------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~----~~~kl~Dfg~~~~  200 (323)
                      +++++|.+++...       ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++    ..++|+|||++..
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~  160 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD  160 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence            9999999998642       3478899999999999999999999999999999999998753    2699999999865


Q ss_pred             hccCc--cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCC
Q 020657          201 MCRSL--DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDP  277 (323)
Q Consensus       201 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~  277 (323)
                      .....  ........+..|+|||.+...     ..+.++||||||+++|+|+| |..||.....    ......+..+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~il~ellt~g~~p~~~~~~----~~~~~~~~~~~~  231 (269)
T cd05044         161 IYKSDYYRKEGEGLLPVRWMAPESLLDG-----KFTTQSDVWSFGVLMWEILTLGQQPYPALNN----QEVLQHVTAGGR  231 (269)
T ss_pred             cccccccccCcccCCCccccCHHHHccC-----CcccchhHHHHHHHHHHHHHcCCCCCcccCH----HHHHHHHhcCCc
Confidence            43221  111223456789999988643     34569999999999999998 9999954332    233333333444


Q ss_pred             CCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          278 PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       278 ~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ...+..++..+.+++.+||..+|.+||+++++++
T Consensus       232 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         232 LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            5556778999999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=307.01  Aligned_cols=257  Identities=26%  Similarity=0.445  Sum_probs=223.5

Q ss_pred             chhccccccceeeeecccCCeEEEEEEecccCc---EEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcC
Q 020657           45 TAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP  121 (323)
Q Consensus        45 ~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~---~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  121 (323)
                      .-+|+.+..+|.++||.|.||.|+.|+.+..++   .||||.++.......+..|+.|+.+|-++.||||+.+.|++.. 
T Consensus       623 akEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk-  701 (996)
T KOG0196|consen  623 AKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK-  701 (996)
T ss_pred             hhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec-
Confidence            347788889999999999999999999876554   7999999988888889999999999999999999999999987 


Q ss_pred             CCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchh
Q 020657          122 SGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       122 ~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                      ....+||+|||++|+|+.+++. .+.++..++..+++.|+.||.||.+.|+|||||.++|||++.+ ...|++|||+++.
T Consensus       702 s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsn-LvCKVsDFGLSRv  780 (996)
T KOG0196|consen  702 SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSN-LVCKVSDFGLSRV  780 (996)
T ss_pred             CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccc-eEEEeccccceee
Confidence            7889999999999999999975 4579999999999999999999999999999999999999988 5899999999997


Q ss_pred             hccCccc---cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCCCccHHHHHHHHhcCC
Q 020657          201 MCRSLDA---CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELY-LGHFPFLQPGQRPDWATLMCAICFGD  276 (323)
Q Consensus       201 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~ll-tg~~p~~~~~~~~~~~~~~~~~~~~~  276 (323)
                      ..+....   ..+..-..+|.|||.+.-..++     .+|||||+|++|||.+ .|+.||....+    +..+..+..+.
T Consensus       781 ledd~~~~ytt~GGKIPiRWTAPEAIa~RKFT-----sASDVWSyGIVmWEVmSyGERPYWdmSN----QdVIkaIe~gy  851 (996)
T KOG0196|consen  781 LEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFT-----SASDVWSYGIVMWEVMSYGERPYWDMSN----QDVIKAIEQGY  851 (996)
T ss_pred             cccCCCccccccCCccceeecChhHhhhcccC-----chhhccccceEEEEecccCCCcccccch----HHHHHHHHhcc
Confidence            7554422   2233446899999998755554     4999999999999988 69999965544    55566666667


Q ss_pred             CCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          277 PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       277 ~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      +.+-|-.+|..|..||..||+.|-++||.|.+|+.+
T Consensus       852 RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  852 RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence            767778899999999999999999999999999854

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-42  Score=295.82  Aligned_cols=256  Identities=32%  Similarity=0.507  Sum_probs=220.1

Q ss_pred             ccee--eeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           53 LEKL--QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        53 ~~~~--~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      |+|.  +.||+|.||+||-|..+.+|+.||||++.+.. .......+.+|+.+|+.+.||+||.+.-.|++ .+.++.||
T Consensus       564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET-~ervFVVM  642 (888)
T KOG4236|consen  564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET-PERVFVVM  642 (888)
T ss_pred             HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC-CceEEEEe
Confidence            5554  68999999999999999999999999997663 33445778899999999999999999999998 68899999


Q ss_pred             eccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC--CcEEEeecCcchhhccCcc
Q 020657          130 EYMDSGTLDTLLN-KNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN--MQVKIADFGVSKIMCRSLD  206 (323)
Q Consensus       130 e~~~~~sL~~~l~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~--~~~kl~Dfg~~~~~~~~~~  206 (323)
                      |.+.|--|+.++. ..+++++.....++.||+.||.|||.++|+|.||||+|||+....  .++||||||+|+.++... 
T Consensus       643 EKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-  721 (888)
T KOG4236|consen  643 EKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-  721 (888)
T ss_pred             hhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh-
Confidence            9997634444444 345799999999999999999999999999999999999997543  489999999999886543 


Q ss_pred             ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCCh
Q 020657          207 ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP  286 (323)
Q Consensus       207 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (323)
                      -....+||+.|+|||++....|..     .-|+||.|+++|--+.|..||   .+.+++...+++..+..++.=+..+++
T Consensus       722 FRrsVVGTPAYLaPEVLrnkGyNr-----SLDMWSVGVIiYVsLSGTFPF---NEdEdIndQIQNAaFMyPp~PW~eis~  793 (888)
T KOG4236|consen  722 FRRSVVGTPAYLAPEVLRNKGYNR-----SLDMWSVGVIIYVSLSGTFPF---NEDEDINDQIQNAAFMYPPNPWSEISP  793 (888)
T ss_pred             hhhhhcCCccccCHHHHhhccccc-----cccceeeeEEEEEEecccccC---CCccchhHHhhccccccCCCchhhcCH
Confidence            345678999999999998665544     899999999999999999999   345566777777777777776789999


Q ss_pred             hHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          287 EFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       287 ~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      +..+||..+|+..=++|.|++..|.|||+++-
T Consensus       794 ~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  794 EAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             HHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence            99999999999999999999999999999864

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.4e-40  Score=280.92  Aligned_cols=240  Identities=21%  Similarity=0.338  Sum_probs=189.3

Q ss_pred             eeecccCCeEEEEEEecccCc-------EEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           57 QVLGHGNGGTVYKVQHRCTHK-------IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~~~~-------~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      +.||+|+||.||+|.+...+.       .+++|.+.... ......+.+|+.+++.+.||||+++++++.. +...++||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-~~~~~lv~   78 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVC-GDESIMVQ   78 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEe-CCCcEEEE
Confidence            368999999999999865443       47888875332 3445677889999999999999999999987 57789999


Q ss_pred             eccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCc-------EEEeecCcchhh
Q 020657          130 EYMDSGTLDTLLNKNG-TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQ-------VKIADFGVSKIM  201 (323)
Q Consensus       130 e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~-------~kl~Dfg~~~~~  201 (323)
                      ||+++++|.+++...+ .+++..+..++.||+.||+|||+.|++|+||||+||+++.++..       ++++|||.+...
T Consensus        79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~  158 (258)
T cd05078          79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV  158 (258)
T ss_pred             ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence            9999999999997643 58999999999999999999999999999999999999877522       799999988654


Q ss_pred             ccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCCCccHHHHHHHHhcCCCCCC
Q 020657          202 CRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGH-FPFLQPGQRPDWATLMCAICFGDPPSL  280 (323)
Q Consensus       202 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~  280 (323)
                      ..    .....++..|+|||++..    ...++.++||||||+++|+|++|. .||..... ......     ......+
T Consensus       159 ~~----~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~-~~~~~~-----~~~~~~~  224 (258)
T cd05078         159 LP----KEILLERIPWVPPECIEN----PQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS-QKKLQF-----YEDRHQL  224 (258)
T ss_pred             CC----chhccccCCccCchhccC----CCCCCchhhHHHHHHHHHHHHcCCCCChhhccH-HHHHHH-----HHccccC
Confidence            32    223457788999998863    223456999999999999999985 55533221 111111     1223456


Q ss_pred             CCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          281 PDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       281 ~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      +...+.++.+|+.+||+.||++|||++++++.
T Consensus       225 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         225 PAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             CCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            66677899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=9e-40  Score=280.74  Aligned_cols=239  Identities=23%  Similarity=0.373  Sum_probs=186.9

Q ss_pred             eecccCCeEEEEEEecc------------------------cCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccce
Q 020657           58 VLGHGNGGTVYKVQHRC------------------------THKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ  113 (323)
Q Consensus        58 ~lg~G~~~~v~~~~~~~------------------------~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~  113 (323)
                      +||+|+||.||+|....                        ....|++|++.... ......+.+|+.+++.++||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence            69999999999997532                        12358888875432 234456788899999999999999


Q ss_pred             eceeEEcCCCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC-----
Q 020657          114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN-----  187 (323)
Q Consensus       114 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~-----  187 (323)
                      +++++.. ....++||||+++++|..++.. .+.+++..+..++.||++||.|||+.|++|+||||+||+++..+     
T Consensus        81 ~~~~~~~-~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~  159 (274)
T cd05076          81 VHGVCVR-GSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT  159 (274)
T ss_pred             EEEEEEe-CCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence            9999987 6788999999999999999865 45689999999999999999999999999999999999997643     


Q ss_pred             -CcEEEeecCcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCCCccH
Q 020657          188 -MQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELY-LGHFPFLQPGQRPDW  265 (323)
Q Consensus       188 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~ll-tg~~p~~~~~~~~~~  265 (323)
                       ..++++|||.+......    ....++..|+|||.+...    ...+.++||||||+++|+++ +|..||........ 
T Consensus       160 ~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~----~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-  230 (274)
T cd05076         160 SPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGG----NSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-  230 (274)
T ss_pred             cceeeecCCccccccccc----cccccCCcccCchhhcCC----CCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-
Confidence             14899999987543221    223467889999987532    33467999999999999995 79999965432211 


Q ss_pred             HHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          266 ATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      .....     ....++...+.++.+++.+||+.+|++|||+++++++
T Consensus       231 ~~~~~-----~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         231 ERFYE-----KKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHHHH-----hccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            11111     1223344456789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.8e-39  Score=276.87  Aligned_cols=252  Identities=20%  Similarity=0.302  Sum_probs=191.7

Q ss_pred             eeecccCCeEEEEEEeccc--CcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEeccCC
Q 020657           57 QVLGHGNGGTVYKVQHRCT--HKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDS  134 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~~--~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~  134 (323)
                      +.||+|+||.||+|....+  ...+++|.+...........+.+|+.+++.++||||+++++.+.. ....++||||+++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~   79 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE-AIPYLLVFEYCEL   79 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC-CCccEEEEecCCC
Confidence            3689999999999975432  335677777655545566788999999999999999999999987 6789999999999


Q ss_pred             CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC--cccc
Q 020657          135 GTLDTLLNKN----GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS--LDAC  208 (323)
Q Consensus       135 ~sL~~~l~~~----~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~--~~~~  208 (323)
                      ++|.+++.+.    ...+...+..++.||+.||.|||+.+++|+||||+||+++.++ .++|+|||++......  ....
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~-~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCc-cEEecccccccccCcchhhhcc
Confidence            9999998753    3467778889999999999999999999999999999999987 8999999987542211  1112


Q ss_pred             ccccccccccCCcccCCCCC--CCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhc-CCCCCCCCCC
Q 020657          209 NSYVGTCAYMSPERFDPDAY--GGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICF-GDPPSLPDGA  284 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  284 (323)
                      ....++..|+|||++.....  .....+.++||||||+++|+|++ |..||...........+...... ...+.++...
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY  238 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence            33457789999999853221  12345679999999999999996 56777544332222222221111 1223444567


Q ss_pred             ChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          285 SPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       285 ~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ++.+.+++..|| .+|.+|||++++++
T Consensus       239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         239 SERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            889999999999 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.6e-39  Score=277.34  Aligned_cols=240  Identities=20%  Similarity=0.353  Sum_probs=186.2

Q ss_pred             eeecccCCeEEEEEEecc------------cCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCe
Q 020657           57 QVLGHGNGGTVYKVQHRC------------THKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGD  124 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~------------~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  124 (323)
                      +.||+|++|.||+|....            ....+++|++.... ......+.+|+.+++.++||||+++++++.. +..
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~-~~~   78 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVR-DVE   78 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCC
Confidence            368999999999998532            22358888876443 2344567888999999999999999999887 577


Q ss_pred             EEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCC------cEEEeecCc
Q 020657          125 IAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNM------QVKIADFGV  197 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~------~~kl~Dfg~  197 (323)
                      .++||||+++++|..++.. ...+++..+..++.||++||.|||+.|++|+||+|+||+++.++.      .++++|||+
T Consensus        79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~  158 (262)
T cd05077          79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI  158 (262)
T ss_pred             CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence            8999999999999988875 456899999999999999999999999999999999999987641      289999999


Q ss_pred             chhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCCCccHHHHHHHHhcCC
Q 020657          198 SKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELY-LGHFPFLQPGQRPDWATLMCAICFGD  276 (323)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~ll-tg~~p~~~~~~~~~~~~~~~~~~~~~  276 (323)
                      +......    ....++..|+|||.+..    ...++.++||||||+++|+|+ +|..||.....    .......  ..
T Consensus       159 ~~~~~~~----~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~----~~~~~~~--~~  224 (262)
T cd05077         159 PITVLSR----QECVERIPWIAPECVED----SKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL----AEKERFY--EG  224 (262)
T ss_pred             CccccCc----ccccccccccChhhhcC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch----hHHHHHH--hc
Confidence            8654322    23456788999998752    233456999999999999998 68888744321    1111111  11


Q ss_pred             CCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          277 PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       277 ~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ........+.++.+|+.+||+.||++||++.+|+++
T Consensus       225 ~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         225 QCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             CccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            112223456789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.4e-39  Score=309.63  Aligned_cols=148  Identities=34%  Similarity=0.596  Sum_probs=135.6

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCC--CChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...  ........+..|+.+++.++|+||+++++++.. ...+++
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~~l   81 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS-ANNVYL   81 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE-CCEEEE
Confidence            57899999999999999999999989999999999643  234456778899999999999999999999887 678999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcch
Q 020657          128 LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                      ||||+.+++|.+++...+.+++..++.++.||+.||.|||..||+|+||||+|||++.++ .++|+|||++.
T Consensus        82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g-~vkL~DFGls~  152 (669)
T cd05610          82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEG-HIKLTDFGLSK  152 (669)
T ss_pred             EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCC-CEEEEeCCCCc
Confidence            999999999999998877899999999999999999999999999999999999999987 89999999885

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.3e-39  Score=275.70  Aligned_cols=238  Identities=23%  Similarity=0.360  Sum_probs=188.4

Q ss_pred             eeecccCCeEEEEEEecccC----------cEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEE
Q 020657           57 QVLGHGNGGTVYKVQHRCTH----------KIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIA  126 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~~~----------~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  126 (323)
                      +.||+|+||.||+|.+..++          ..+++|.+......  ...+.+|+.+++.++|+||+++++++..  ...+
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~   76 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR--DENI   76 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec--CCcE
Confidence            36899999999999997666          35777876544322  5778899999999999999999999876  5579


Q ss_pred             EEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCC------cEEEeecCcch
Q 020657          127 ILMEYMDSGTLDTLLNKNG-TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNM------QVKIADFGVSK  199 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~------~~kl~Dfg~~~  199 (323)
                      +||||+++++|.+++...+ .+++..+..++.||+.||.|||+.|++|+||||+||+++.++.      .++|+|||++.
T Consensus        77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~  156 (259)
T cd05037          77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI  156 (259)
T ss_pred             EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence            9999999999999998765 7899999999999999999999999999999999999987641      59999999987


Q ss_pred             hhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCC
Q 020657          200 IMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPP  278 (323)
Q Consensus       200 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  278 (323)
                      ....    .....++..|+|||++....   ...+.++||||||+++|+|++ |..||...... .......   .  ..
T Consensus       157 ~~~~----~~~~~~~~~y~aPE~~~~~~---~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-~~~~~~~---~--~~  223 (259)
T cd05037         157 TVLS----REERVERIPWIAPECIRNGQ---ASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS-EKERFYQ---D--QH  223 (259)
T ss_pred             cccc----ccccccCCCccChhhhcCCC---CCcchhhHHHHHHHHHHHHHhCCCCCcccCCch-hHHHHHh---c--CC
Confidence            6533    22344667899999986431   345679999999999999998 57777554321 1111111   1  11


Q ss_pred             CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          279 SLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       279 ~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ..+......+.+++.+||+.+|.+|||+.++++
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         224 RLPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             CCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            122223479999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=275.10  Aligned_cols=270  Identities=24%  Similarity=0.455  Sum_probs=230.8

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCC--CChHHHHHHHHHHHHHHcC-CCCccceeceeEE
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRT-DSPFIVQCFGIFE  119 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~  119 (323)
                      ...+.+...+|.++++||+|+++.|.+++...+.+.+|+|+++++  ++.+..+-++.|-.+.... +||.+|-+...|+
T Consensus       242 ~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfq  321 (593)
T KOG0695|consen  242 KISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ  321 (593)
T ss_pred             ccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhc
Confidence            356778889999999999999999999999999999999999866  3445566777888888775 7999999999999


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcch
Q 020657          120 KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       120 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                      + ++.+++|.||.+||+|--.+++.+.++++.++.+...|+-||.|||+.||++||||.+|+++|.+| .+||.|+|++.
T Consensus       322 t-esrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeg-hikltdygmck  399 (593)
T KOG0695|consen  322 T-ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEG-HIKLTDYGMCK  399 (593)
T ss_pred             c-cceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCC-ceeecccchhh
Confidence            8 789999999999999999999888999999999999999999999999999999999999999998 89999999998


Q ss_pred             hhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC--c-cHHHHHHHHhcCC
Q 020657          200 IMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQR--P-DWATLMCAICFGD  276 (323)
Q Consensus       200 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~--~-~~~~~~~~~~~~~  276 (323)
                      .--.+....++++||+.|.|||.+.+..++     ..+|+|+||++|+||+.|..||+-.+..  + ..+..+-++....
T Consensus       400 e~l~~gd~tstfcgtpnyiapeilrgeeyg-----fsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek  474 (593)
T KOG0695|consen  400 EGLGPGDTTSTFCGTPNYIAPEILRGEEYG-----FSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK  474 (593)
T ss_pred             cCCCCCcccccccCCCcccchhhhcccccC-----ceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh
Confidence            766677788899999999999999866554     5999999999999999999999643322  1 1122222222223


Q ss_pred             CCCCCCCCChhHHHHHHHhcccCcCCCC------CHHHHhcCcccccCC
Q 020657          277 PPSLPDGASPEFRSFIECCLQKEFSKRW------TASQLLTHPFLCKNR  319 (323)
Q Consensus       277 ~~~~~~~~~~~l~~ll~~~l~~~p~~Rp------t~~~~l~h~~f~~~~  319 (323)
                      -..+|..+|-....+++.-|+.||.+|.      .++++-+|+||+.+.
T Consensus       475 qiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~id  523 (593)
T KOG0695|consen  475 QIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSID  523 (593)
T ss_pred             cccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCC
Confidence            3456778888999999999999999998      589999999998653

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.3e-40  Score=312.79  Aligned_cols=258  Identities=31%  Similarity=0.507  Sum_probs=204.1

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEc---------
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEK---------  120 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---------  120 (323)
                      ..+|+.+..||+||||.||+++++-+|+.||||.+....+......+.+|+.++.+|+|||||.++..+..         
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            46788999999999999999999999999999999877677788899999999999999999998854321         


Q ss_pred             ---------------------------------------------CC---------------------------------
Q 020657          121 ---------------------------------------------PS---------------------------------  122 (323)
Q Consensus       121 ---------------------------------------------~~---------------------------------  122 (323)
                                                                   ..                                 
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                         00                                 


Q ss_pred             -------------------------------CeEEEEEeccCCCCHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhCC
Q 020657          123 -------------------------------GDIAILMEYMDSGTLDTLLNKNGTF-SEPKLAHIASQILKGLSYLHGHK  170 (323)
Q Consensus       123 -------------------------------~~~~lv~e~~~~~sL~~~l~~~~~~-~~~~~~~i~~~i~~~l~~Lh~~g  170 (323)
                                                     -.+||=||||+..++.+++..+... .....+.++.+|++||.|+|+.|
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g  717 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG  717 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence                                           1368899999997888888776554 57889999999999999999999


Q ss_pred             CeecCCCCCCeEEecCCCcEEEeecCcchhhc------------------cCccccccccccccccCCcccCCCCCCCCC
Q 020657          171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC------------------RSLDACNSYVGTCAYMSPERFDPDAYGGNY  232 (323)
Q Consensus       171 ivH~di~~~nil~~~~~~~~kl~Dfg~~~~~~------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  232 (323)
                      +|||||||.||++++.+ .|||+|||++....                  .+.....+.+||..|+|||++....  ...
T Consensus       718 iIHRDLKP~NIFLd~~~-~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~--~~~  794 (1351)
T KOG1035|consen  718 IIHRDLKPRNIFLDSRN-SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS--SNK  794 (1351)
T ss_pred             eeeccCCcceeEEcCCC-CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc--ccc
Confidence            99999999999999987 89999999998621                  0111233568999999999997443  245


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC---CCCCCCCCChhHHHHHHHhcccCcCCCCCHHHH
Q 020657          233 NGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD---PPSLPDGASPEFRSFIECCLQKEFSKRWTASQL  309 (323)
Q Consensus       233 ~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~  309 (323)
                      ++.|+|+||||++++||+.   ||...-+   ....+.....+.   +..+...--+.-..+|+.|++.||++|||+.|+
T Consensus       795 Yn~KiDmYSLGIVlFEM~y---PF~TsME---Ra~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eL  868 (1351)
T KOG1035|consen  795 YNSKIDMYSLGIVLFEMLY---PFGTSME---RASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATEL  868 (1351)
T ss_pred             ccchhhhHHHHHHHHHHhc---cCCchHH---HHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHH
Confidence            6789999999999999994   3522111   122222222222   222233334567899999999999999999999


Q ss_pred             hcCcccc
Q 020657          310 LTHPFLC  316 (323)
Q Consensus       310 l~h~~f~  316 (323)
                      |++.||.
T Consensus       869 L~s~llp  875 (1351)
T KOG1035|consen  869 LNSELLP  875 (1351)
T ss_pred             hhccCCC
Confidence            9999986

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=7.6e-41  Score=262.47  Aligned_cols=259  Identities=22%  Similarity=0.432  Sum_probs=209.3

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCC-CCccceeceeEEcCC-CeEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD-SPFIVQCFGIFEKPS-GDIA  126 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~-~~~~  126 (323)
                      ..++|++.+++|+|.+|.||.|....+++.++||+++    +-..+.+.+|+++++.|. ||||++++++..++. ....
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK----PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa  111 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK----PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS  111 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeec----hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence            6789999999999999999999988899999999985    344577889999999995 999999999987653 3567


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc
Q 020657          127 ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD  206 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~  206 (323)
                      +|+||.++.+...+-   +.++.-.++.++.+++.||.|+|+.||+|||+||.|+++|...-.++|+|||+|..+. +..
T Consensus       112 LiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH-p~~  187 (338)
T KOG0668|consen  112 LIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGK  187 (338)
T ss_pred             hHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC-CCc
Confidence            999999886666544   4688999999999999999999999999999999999999876689999999998774 445


Q ss_pred             ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-CccHHHHH------------HHHh
Q 020657          207 ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQ-RPDWATLM------------CAIC  273 (323)
Q Consensus       207 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~-~~~~~~~~------------~~~~  273 (323)
                      +....+.+..|.-||.+.    .-..++..-|+|||||++..|+..+.||+.... .+....+-            .+..
T Consensus       188 eYnVRVASRyfKGPELLV----dy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~  263 (338)
T KOG0668|consen  188 EYNVRVASRYFKGPELLV----DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ  263 (338)
T ss_pred             eeeeeeehhhcCCchhee----echhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence            566778888999999986    334456799999999999999999999865433 22211111            0000


Q ss_pred             cCCCC---------------C-CC----CCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          274 FGDPP---------------S-LP----DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       274 ~~~~~---------------~-~~----~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      ...++               . +.    .-.++++.||+.++|.+|-.+|+|+.|++.||||..++
T Consensus       264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~  329 (338)
T KOG0668|consen  264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR  329 (338)
T ss_pred             cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence            00011               0 11    12469999999999999999999999999999997654

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=7.6e-39  Score=277.75  Aligned_cols=258  Identities=20%  Similarity=0.256  Sum_probs=191.4

Q ss_pred             chhccccccceeeeecccCCeEEEEEEeccc---CcEEEEEeecCCCChHHH----------HHHHHHHHHHHcCCCCcc
Q 020657           45 TAAIAYSDLEKLQVLGHGNGGTVYKVQHRCT---HKIYALKVVHGDADPTVR----------RQVFREMEILRRTDSPFI  111 (323)
Q Consensus        45 ~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~---~~~v~iK~~~~~~~~~~~----------~~~~~e~~~l~~l~h~~i  111 (323)
                      ..++...+|++.+.||+|+||.||+|.+..+   +..+++|+..........          .....+...+..+.|+++
T Consensus         6 ~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i   85 (294)
T PHA02882          6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGI   85 (294)
T ss_pred             eeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCC
Confidence            4456678999999999999999999998766   667777775433221111          112233344556789999


Q ss_pred             ceeceeEEcCCC---eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCC
Q 020657          112 VQCFGIFEKPSG---DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNM  188 (323)
Q Consensus       112 ~~~~~~~~~~~~---~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~  188 (323)
                      +++++.+.....   ..+++++++.. ++.+.+......++..+..++.|++.||.|||+.|++||||||+||+++.++ 
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~-  163 (294)
T PHA02882         86 PKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN-  163 (294)
T ss_pred             CcEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-
Confidence            999987654322   34678888754 7777776655678899999999999999999999999999999999999887 


Q ss_pred             cEEEeecCcchhhccCc-------cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 020657          189 QVKIADFGVSKIMCRSL-------DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQ  261 (323)
Q Consensus       189 ~~kl~Dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~  261 (323)
                      .++|+|||++.......       .......+|..|+|||++.+.     .++.++||||||+++|+|++|..||.....
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~-----~~~~~~DiwSlG~~l~el~~g~~P~~~~~~  238 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA-----CVTRRGDLESLGYCMLKWAGIKLPWKGFGH  238 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC-----CCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence            89999999997653211       111234689999999988633     346699999999999999999999976643


Q ss_pred             CccHHH-----HHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          262 RPDWAT-----LMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       262 ~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ......     ....+..+  ......++.++.++++.||+.+|++||+++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        239 NGNLIHAAKCDFIKRLHEG--KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             chHHHHHhHHHHHHHhhhh--hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            322111     11222111  1123456899999999999999999999999875

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.2e-38  Score=273.49  Aligned_cols=250  Identities=21%  Similarity=0.352  Sum_probs=196.7

Q ss_pred             cceeeeecccCCeEEEEEEec---ccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCC-----
Q 020657           53 LEKLQVLGHGNGGTVYKVQHR---CTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG-----  123 (323)
Q Consensus        53 ~~~~~~lg~G~~~~v~~~~~~---~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----  123 (323)
                      |++.+.||+|++|.||+|.+.   .+++.+++|++.... .....+.+.+|+.+++.+.||||+++++++.....     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            677889999999999999864   357899999987553 34456778899999999999999999998764221     


Q ss_pred             eEEEEEeccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCc
Q 020657          124 DIAILMEYMDSGTLDTLLNKN------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGV  197 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~  197 (323)
                      ..+++++|+.+++|.+++...      ..++...+..++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||.
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~-~~kl~dfg~  159 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENM-TVCVADFGL  159 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCC-CEEECcccc
Confidence            247889999999998877432      2478999999999999999999999999999999999999886 899999999


Q ss_pred             chhhccCc--cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhc
Q 020657          198 SKIMCRSL--DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICF  274 (323)
Q Consensus       198 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~  274 (323)
                      +.......  .......++..|++||.+...     ..+.++||||||+++|+|++ |..||.....    ..+...+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-----~~~~~sDi~slG~il~el~~~g~~p~~~~~~----~~~~~~~~~  230 (273)
T cd05074         160 SKKIYSGDYYRQGCASKLPVKWLALESLADN-----VYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN----SEIYNYLIK  230 (273)
T ss_pred             cccccCCcceecCCCccCchhhcCHhHHhcC-----ccchhhhhHHHHHHHHHHhhCCCCCCCCCCH----HHHHHHHHc
Confidence            87653221  112223345679999987633     34569999999999999998 8888854322    333333333


Q ss_pred             CCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          275 GDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       275 ~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ......+...+..+.+++.+||+.+|++|||+.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         231 GNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            33444456678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-41  Score=289.48  Aligned_cols=264  Identities=27%  Similarity=0.427  Sum_probs=230.0

Q ss_pred             chhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCC--CChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC
Q 020657           45 TAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS  122 (323)
Q Consensus        45 ~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  122 (323)
                      ...+..++++++..||-|+||.|=++........+|+|++++.  -+....+.+..|-.+|.....|.||++|..|.+ +
T Consensus       414 ~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd-~  492 (732)
T KOG0614|consen  414 FAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD-S  492 (732)
T ss_pred             hcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc-c
Confidence            3456778899999999999999999998766556888888644  244556677889999999999999999999998 7


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          123 GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      .+.|++||-|-||.++.+++..+.+++...+.++..+++|++|||++|||+|||||+|.+++.+| -+||.|||+|..+.
T Consensus       493 kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~G-y~KLVDFGFAKki~  571 (732)
T KOG0614|consen  493 KYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRG-YLKLVDFGFAKKIG  571 (732)
T ss_pred             hhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCC-ceEEeehhhHHHhc
Confidence            88999999999999999999999999999999999999999999999999999999999999998 79999999999887


Q ss_pred             cCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCC
Q 020657          203 RSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPD  282 (323)
Q Consensus       203 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (323)
                      .+.. ..+++||+.|+|||++....+     +.++|.|+||+++|||++|..||.+.+.--....++..+.   ...+|.
T Consensus       572 ~g~K-TwTFcGTpEYVAPEIILnKGH-----D~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid---~i~~Pr  642 (732)
T KOG0614|consen  572 SGRK-TWTFCGTPEYVAPEIILNKGH-----DRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID---KIEFPR  642 (732)
T ss_pred             cCCc-eeeecCCcccccchhhhccCc-----chhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh---hhhccc
Confidence            6644 468999999999999985544     4599999999999999999999988766655555554433   355778


Q ss_pred             CCChhHHHHHHHhcccCcCCCCC-----HHHHhcCcccccCC
Q 020657          283 GASPEFRSFIECCLQKEFSKRWT-----ASQLLTHPFLCKNR  319 (323)
Q Consensus       283 ~~~~~l~~ll~~~l~~~p~~Rpt-----~~~~l~h~~f~~~~  319 (323)
                      .++....+||+.+...+|.+|..     +.+|-.|.||.+..
T Consensus       643 ~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfd  684 (732)
T KOG0614|consen  643 RITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFD  684 (732)
T ss_pred             ccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCC
Confidence            89999999999999999999995     89999999998753

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=266.70  Aligned_cols=266  Identities=33%  Similarity=0.545  Sum_probs=219.9

Q ss_pred             CccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHc-CCCCccceeceeEEc
Q 020657           42 TATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRR-TDSPFIVQCFGIFEK  120 (323)
Q Consensus        42 ~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~  120 (323)
                      ....+.+..++.+-+..||.|+||+|++..++.+|+..|||.++.........+++.|.+...+ -++||||+++|..-.
T Consensus        55 ~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~  134 (361)
T KOG1006|consen   55 DAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS  134 (361)
T ss_pred             cccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc
Confidence            3566677888889999999999999999999999999999999988877777888888887555 579999999999776


Q ss_pred             CCCeEEEEEeccCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCCeEEecCCCcEEEee
Q 020657          121 PSGDIAILMEYMDSGTLDTLLN-----KNGTFSEPKLAHIASQILKGLSYLHGH-KIIHRDIKPSNLLVNNNNMQVKIAD  194 (323)
Q Consensus       121 ~~~~~~lv~e~~~~~sL~~~l~-----~~~~~~~~~~~~i~~~i~~~l~~Lh~~-givH~di~~~nil~~~~~~~~kl~D  194 (323)
                       ++..++-||.|+- |+..+-.     +...++++.+-.|..-.+.||.||... .|+|||+||+|||++..| .+||||
T Consensus       135 -EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G-~vKLCD  211 (361)
T KOG1006|consen  135 -EGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG-DVKLCD  211 (361)
T ss_pred             -CCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC-CEeeec
Confidence             6788999999974 7765543     345799999999999999999999976 899999999999999998 899999


Q ss_pred             cCcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhc
Q 020657          195 FGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICF  274 (323)
Q Consensus       195 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~  274 (323)
                      ||.+....++.. .....|...|+|||.+.+..-   .++.+|||||||++|||+.||..||..  ....++.+.+ +-.
T Consensus       212 FGIcGqLv~SiA-kT~daGCrpYmAPERi~p~~~---gyDiRSDvWSLGITL~EvAtG~fPyr~--w~svfeql~~-Vv~  284 (361)
T KOG1006|consen  212 FGICGQLVDSIA-KTVDAGCRPYMAPERIDPSDK---GYDIRSDVWSLGITLYEVATGNFPYRK--WDSVFEQLCQ-VVI  284 (361)
T ss_pred             ccchHhHHHHHH-hhhccCCccccChhccCCccC---CcchhhhhhhhcceEeeeecCCCCcch--HHHHHHHHHH-HHc
Confidence            999977654432 234678999999999985543   467899999999999999999999943  2223333433 333


Q ss_pred             CCCCCCC-----CCCChhHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          275 GDPPSLP-----DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       275 ~~~~~~~-----~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                      ++++.+.     .+.+..+..++..||..|-+.||.+.+++++||+.-
T Consensus       285 gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~  332 (361)
T KOG1006|consen  285 GDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRM  332 (361)
T ss_pred             CCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhh
Confidence            4544332     247899999999999999999999999999999864

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=291.51  Aligned_cols=249  Identities=28%  Similarity=0.442  Sum_probs=199.5

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcC-----CCeE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP-----SGDI  125 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~  125 (323)
                      .-|...+.||+|+||.||+++++.+|+.||||.+.........+...+|++++++|+|+|||++.++=+..     ....
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            44666789999999999999999999999999998877677788899999999999999999999985432     1245


Q ss_pred             EEEEeccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC---CcEEEeecCcch
Q 020657          126 AILMEYMDSGTLDTLLNK---NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN---MQVKIADFGVSK  199 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~---~~~kl~Dfg~~~  199 (323)
                      .+|||||.||+|...+++   ...+++.+.+.++.+++.||.|||.+||+||||||.||++....   ...||+|||.|+
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar  172 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR  172 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence            799999999999999974   34699999999999999999999999999999999999986432   468999999998


Q ss_pred             hhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCC--
Q 020657          200 IMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP--  277 (323)
Q Consensus       200 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~--  277 (323)
                      ...+.. ...+.+||..|++||+...    +..++..+|.||||+++|+..||..||......-....+........+  
T Consensus       173 el~d~s-~~~S~vGT~~YLhPel~E~----q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~  247 (732)
T KOG4250|consen  173 ELDDNS-LFTSLVGTEEYLHPELYER----QKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG  247 (732)
T ss_pred             cCCCCC-eeeeecCchhhcChHHHhh----ccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence            876654 5667899999999999874    345566999999999999999999999766554322222211111111  


Q ss_pred             ------------------CCCCCCCChhH----HHHHHHhcccCcCCCC
Q 020657          278 ------------------PSLPDGASPEF----RSFIECCLQKEFSKRW  304 (323)
Q Consensus       278 ------------------~~~~~~~~~~l----~~ll~~~l~~~p~~Rp  304 (323)
                                        .+++.++++.+    -..+..+|+++|++|.
T Consensus       248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                              12344555544    4556678899999998

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.2e-41  Score=265.79  Aligned_cols=268  Identities=26%  Similarity=0.401  Sum_probs=211.8

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcCCCCccceeceeEEc---C
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-PTVRRQVFREMEILRRTDSPFIVQCFGIFEK---P  121 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~  121 (323)
                      .....+.|..+.++|+|.||.||+|+..++++.|++|++..++. ........+|++++..|+|+|++.+++++..   +
T Consensus        12 ~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp   91 (376)
T KOG0669|consen   12 FCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP   91 (376)
T ss_pred             ceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCC
Confidence            44567889999999999999999999999999999988754432 2334556799999999999999999987632   1


Q ss_pred             ----CCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecC
Q 020657          122 ----SGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFG  196 (323)
Q Consensus       122 ----~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg  196 (323)
                          ...+++||.+|+. +|.-++.+. ..++..++..++++++.+|.|+|+..|+|||+|+.|+|++.+| .+||.|||
T Consensus        92 ~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dg-ilklADFG  169 (376)
T KOG0669|consen   92 TNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDG-ILKLADFG  169 (376)
T ss_pred             cccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCc-eEEeeccc
Confidence                2348999999987 999888764 5799999999999999999999999999999999999999998 89999999


Q ss_pred             cchhhccCcc----ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHH
Q 020657          197 VSKIMCRSLD----ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAI  272 (323)
Q Consensus       197 ~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~  272 (323)
                      +++.+..+..    .+...+.|..|++||.+.    +...++.+.|||+.||++.||+|+...+.+..+...+..+. ..
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllL----G~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is-~L  244 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLL----GDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLIS-QL  244 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhh----cccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHH-HH
Confidence            9977654322    233456799999999986    44556679999999999999999999886655433222211 11


Q ss_pred             hcCCC------------------CCCC-------------CCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          273 CFGDP------------------PSLP-------------DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       273 ~~~~~------------------~~~~-------------~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                      +....                  ++++             -.-+++..+|+.++|..||.+|+++.++|.|.||-...-
T Consensus       245 cGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~  323 (376)
T KOG0669|consen  245 CGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPM  323 (376)
T ss_pred             hccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCc
Confidence            11110                  0011             012468899999999999999999999999999976543

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=9.2e-38  Score=262.67  Aligned_cols=242  Identities=38%  Similarity=0.608  Sum_probs=200.9

Q ss_pred             CCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEeccCCCCHHHHHH
Q 020657           63 NGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLN  142 (323)
Q Consensus        63 ~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~  142 (323)
                      ++|.||+|.+..+++.+++|++...........+.+|+..+++++|+|++++++.+.. ....++++|++.+++|.+++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-EDKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-CCEEEEEEeCCCCCCHHHHHH
Confidence            5789999999888999999999766543336788899999999999999999999887 578999999999999999998


Q ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccccccccccccCCcc
Q 020657          143 KNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER  222 (323)
Q Consensus       143 ~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~  222 (323)
                      ....++...+..++.+++.++.+||+.|++|+||+|+||+++.++ .++|+|||.+....... ......++..|++||.
T Consensus        80 ~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pE~  157 (244)
T smart00220       80 KRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDG-HVKLADFGLARQLDPGG-LLTTFVGTPEYMAPEV  157 (244)
T ss_pred             hccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC-cEEEccccceeeecccc-ccccccCCcCCCCHHH
Confidence            766689999999999999999999999999999999999999987 89999999997764432 2334567789999998


Q ss_pred             cCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCC--CChhHHHHHHHhcccCc
Q 020657          223 FDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDG--ASPEFRSFIECCLQKEF  300 (323)
Q Consensus       223 ~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~ll~~~l~~~p  300 (323)
                      +..     ...+.++|+|+||++++++++|..||....   ....+.+.............  ++.++.+++.+||..+|
T Consensus       158 ~~~-----~~~~~~~Di~slG~~l~~l~~~~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p  229 (244)
T smart00220      158 LLG-----KGYGKAVDVWSLGVILYELLTGKPPFPGDD---QLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDP  229 (244)
T ss_pred             Hcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCc
Confidence            863     334569999999999999999999995532   22333333332222222222  88999999999999999


Q ss_pred             CCCCCHHHHhcCccc
Q 020657          301 SKRWTASQLLTHPFL  315 (323)
Q Consensus       301 ~~Rpt~~~~l~h~~f  315 (323)
                      ++||++.++++||||
T Consensus       230 ~~Rp~~~~~~~~~~~  244 (244)
T smart00220      230 EKRLTAEEALQHPFF  244 (244)
T ss_pred             hhccCHHHHhhCCCC
Confidence            999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=5.1e-38  Score=292.28  Aligned_cols=269  Identities=20%  Similarity=0.222  Sum_probs=179.8

Q ss_pred             hhccccccceeeeecccCCeEEEEEEeccc----CcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeE---
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCT----HKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIF---  118 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~----~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~---  118 (323)
                      .....++|++.+.||+|+||.||+|.+..+    +..||+|.+......+.   ..++  .++...+.++..++..+   
T Consensus       127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~---~~~e--~l~~~~~~~~~~~~~~~~~~  201 (566)
T PLN03225        127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEI---WMNE--RVRRACPNSCADFVYGFLEP  201 (566)
T ss_pred             CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHH---HHHH--HHHhhchhhHHHHHHhhhcc
Confidence            344678999999999999999999999888    89999998764322111   1111  11222222222222111   


Q ss_pred             --EcCCCeEEEEEeccCCCCHHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCCeecCC
Q 020657          119 --EKPSGDIAILMEYMDSGTLDTLLNKNGT--------------------FSEPKLAHIASQILKGLSYLHGHKIIHRDI  176 (323)
Q Consensus       119 --~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------------------~~~~~~~~i~~~i~~~l~~Lh~~givH~di  176 (323)
                        .......++|+||+.+++|.+++.....                    .....+..++.||+.||.|||+.||+||||
T Consensus       202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL  281 (566)
T PLN03225        202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV  281 (566)
T ss_pred             cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence              1235678999999999999998864321                    123456789999999999999999999999


Q ss_pred             CCCCeEEecCCCcEEEeecCcchhhccC-ccccccccccccccCCcccCCCCCCC-----------------CCCCcchh
Q 020657          177 KPSNLLVNNNNMQVKIADFGVSKIMCRS-LDACNSYVGTCAYMSPERFDPDAYGG-----------------NYNGYAGD  238 (323)
Q Consensus       177 ~~~nil~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~-----------------~~~~~~~D  238 (323)
                      ||+|||++.+...+||+|||++...... ........+++.|+|||.+.......                 ..++.++|
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            9999999964338999999999755332 12234567889999999664222111                 12345679


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCC---------CCccHHHHHHHHhcCCCC------CCCCCCChhHHHHHHHhcccCcCCC
Q 020657          239 IWSLGLTLLELYLGHFPFLQPG---------QRPDWATLMCAICFGDPP------SLPDGASPEFRSFIECCLQKEFSKR  303 (323)
Q Consensus       239 v~slG~ll~~lltg~~p~~~~~---------~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~ll~~~l~~~p~~R  303 (323)
                      ||||||++|||+++..++....         .......+.........+      .+.........+||.+||+.||++|
T Consensus       362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR  441 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR  441 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence            9999999999999876652210         000011111110000000      0111223446699999999999999


Q ss_pred             CCHHHHhcCcccccCC
Q 020657          304 WTASQLLTHPFLCKNR  319 (323)
Q Consensus       304 pt~~~~l~h~~f~~~~  319 (323)
                      ||++++|+||||++..
T Consensus       442 ~ta~e~L~Hpff~~~~  457 (566)
T PLN03225        442 ISAKAALAHPYFDREG  457 (566)
T ss_pred             CCHHHHhCCcCcCCCC
Confidence            9999999999998754

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-38  Score=288.47  Aligned_cols=271  Identities=24%  Similarity=0.351  Sum_probs=223.0

Q ss_pred             CCCCCCCCCCCCCCccchhccccccceeeeecccCCeEEEEEEecccCc----EEEEEeecCCCChHHHHHHHHHHHHHH
Q 020657           29 ALPPTAPNTNNNTTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHK----IYALKVVHGDADPTVRRQVFREMEILR  104 (323)
Q Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~e~~~l~  104 (323)
                      ..++.+++.................+..++||+|+||+||+|.|-..|+    +|++|++......+....+.+|+-.|.
T Consensus       674 l~eplapS~~~~n~~~lrI~kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~ma  753 (1177)
T KOG1025|consen  674 LVEPLAPSGFAANLALLRILKETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMA  753 (1177)
T ss_pred             ccCccccccccchhhheeechhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHh
Confidence            3344444433332333333445567778999999999999999876555    689999987777778889999999999


Q ss_pred             cCCCCccceeceeEEcCCCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEE
Q 020657          105 RTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLV  183 (323)
Q Consensus       105 ~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~  183 (323)
                      ++.|||++++++++..  +.+.||++|++.|+|.++++.. ..+.....+.|+.||++||.|||.+++|||||.++||||
T Consensus       754 sldHpnl~RLLgvc~~--s~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV  831 (1177)
T KOG1025|consen  754 SLDHPNLLRLLGVCML--STLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV  831 (1177)
T ss_pred             cCCCchHHHHhhhccc--chHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee
Confidence            9999999999999986  4488999999999999999864 468999999999999999999999999999999999999


Q ss_pred             ecCCCcEEEeecCcchhhccCccccc--cccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 020657          184 NNNNMQVKIADFGVSKIMCRSLDACN--SYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPG  260 (323)
Q Consensus       184 ~~~~~~~kl~Dfg~~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~  260 (323)
                      ..-. .+|+.|||++........+..  .....+.|+|-|.+....+     +.++||||||+++||++| |..||++..
T Consensus       832 ksP~-hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~-----thqSDVWsfGVtiWElmTFGa~Py~gi~  905 (1177)
T KOG1025|consen  832 KSPN-HVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKY-----THQSDVWSFGVTIWELMTFGAKPYDGIP  905 (1177)
T ss_pred             cCCC-eEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCC-----CchhhhhhhhhhHHHHHhcCCCccCCCC
Confidence            9876 899999999988765554443  3445689999999875554     459999999999999996 999996654


Q ss_pred             CCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          261 QRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      .    +++......+.+...|..++.++..+|.+||..|++.||+++++..
T Consensus       906 ~----~eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  906 A----EEIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             H----HHhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence            4    4444455557778888999999999999999999999999998763

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=2.9e-39  Score=279.92  Aligned_cols=264  Identities=26%  Similarity=0.410  Sum_probs=214.9

Q ss_pred             CccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCC------Cccceec
Q 020657           42 TATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS------PFIVQCF  115 (323)
Q Consensus        42 ~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~  115 (323)
                      .....++...+|.+....|+|.||+|..|.|..-|..||||++...  ....+.=+.|+++|++|+.      -|++.++
T Consensus       423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN--E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~  500 (752)
T KOG0670|consen  423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN--EVMHKTGLKELEILKKLNDADPEDKFHCLRLF  500 (752)
T ss_pred             EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc--hHHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence            4667788999999999999999999999999999999999999744  3445556789999999863      4899999


Q ss_pred             eeEEcCCCeEEEEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEE
Q 020657          116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNG---TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKI  192 (323)
Q Consensus       116 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl  192 (323)
                      ..|.. .+++|||+|.+. .+|.+++.+.+   .+....|..++.|++-||..|..+|++|.||||+|||+++....+||
T Consensus       501 r~F~h-knHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKL  578 (752)
T KOG0670|consen  501 RHFKH-KNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKL  578 (752)
T ss_pred             HHhhh-cceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeee
Confidence            99887 789999999995 59999998644   48899999999999999999999999999999999999998779999


Q ss_pred             eecCcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHH
Q 020657          193 ADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAI  272 (323)
Q Consensus       193 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~  272 (323)
                      ||||.|.......  ...+..+..|.|||++.+.+|     +...|+||.||+||||+||+..|.+..+...+.-.+.-.
T Consensus       579 CDfGSA~~~~ene--itPYLVSRFYRaPEIiLG~~y-----d~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K  651 (752)
T KOG0670|consen  579 CDFGSASFASENE--ITPYLVSRFYRAPEIILGLPY-----DYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK  651 (752)
T ss_pred             ccCcccccccccc--ccHHHHHHhccCcceeecCcc-----cCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence            9999997654332  233456779999999985555     458999999999999999999998877654433222111


Q ss_pred             hcCCC-----------------------------------------C------------CCCC---CCChhHHHHHHHhc
Q 020657          273 CFGDP-----------------------------------------P------------SLPD---GASPEFRSFIECCL  296 (323)
Q Consensus       273 ~~~~~-----------------------------------------~------------~~~~---~~~~~l~~ll~~~l  296 (323)
                       ...+                                         +            .++.   .+-.+|.+|+.+||
T Consensus       652 -Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml  730 (752)
T KOG0670|consen  652 -GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKML  730 (752)
T ss_pred             -CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHh
Confidence             0000                                         0            0110   01156899999999


Q ss_pred             ccCcCCCCCHHHHhcCccccc
Q 020657          297 QKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       297 ~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                      ..||++|.|.+++|.||||.+
T Consensus       731 ~LdP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  731 ILDPEKRITVNQALKHPFITE  751 (752)
T ss_pred             ccChhhcCCHHHHhcCCcccC
Confidence            999999999999999999975

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-37  Score=289.72  Aligned_cols=257  Identities=25%  Similarity=0.390  Sum_probs=218.6

Q ss_pred             chhccccccceeeeecccCCeEEEEEEecc-------cCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceece
Q 020657           45 TAAIAYSDLEKLQVLGHGNGGTVYKVQHRC-------THKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFG  116 (323)
Q Consensus        45 ~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~  116 (323)
                      .|++...+.++...||+|.||.|++|.-..       ....||+|...........+.+..|+++|+.+ .|+||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            889999999999999999999999997431       14579999998777667788999999999998 5999999999


Q ss_pred             eEEcCCCeEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 020657          117 IFEKPSGDIAILMEYMDSGTLDTLLNKNG----------------TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSN  180 (323)
Q Consensus       117 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~n  180 (323)
                      .+.. ++.+++|+||+..|+|..+++..+                .++....+.++.||+.||+||++..++||||.++|
T Consensus       370 ~~t~-~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRN  448 (609)
T KOG0200|consen  370 ACTQ-DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARN  448 (609)
T ss_pred             eecc-CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhh
Confidence            9998 789999999999999999998655                48999999999999999999999999999999999


Q ss_pred             eEEecCCCcEEEeecCcchhhccCcccc-cccc--ccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 020657          181 LLVNNNNMQVKIADFGVSKIMCRSLDAC-NSYV--GTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPF  256 (323)
Q Consensus       181 il~~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~--~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~  256 (323)
                      ||++.+. .+||+|||+++......... ....  -...|+|||.+..     ..++.++||||||++||||+| |..||
T Consensus       449 VLi~~~~-~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-----~~ft~kSDVWSfGI~L~EifsLG~~PY  522 (609)
T KOG0200|consen  449 VLITKNK-VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-----RVFTSKSDVWSFGILLWEIFTLGGTPY  522 (609)
T ss_pred             EEecCCC-EEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-----CcccccchhhHHHHHHHHHhhCCCCCC
Confidence            9999986 89999999998654332221 2222  3567999999874     445669999999999999996 99999


Q ss_pred             CCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          257 LQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      .+..   ....+.+.+..+.+...|..++.+++++|+.||+.+|++||++.++.+
T Consensus       523 p~~~---~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  523 PGIP---PTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             CCCC---cHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            6522   134445567778888999999999999999999999999999998864

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-37  Score=282.44  Aligned_cols=264  Identities=32%  Similarity=0.553  Sum_probs=224.9

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceeceeEEc----
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFGIFEK----  120 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----  120 (323)
                      ...+.+.|++...+|.|.+|.||+++...+++.+|+|+.....+.+  ..+..|.++++.+ .|||++.++|+|..    
T Consensus        14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d--eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~   91 (953)
T KOG0587|consen   14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE--EEIELEYNMLKKYSHHPNVATFYGAFIKKDPG   91 (953)
T ss_pred             CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc--HHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence            3445688999999999999999999999999999999987665433  5566788888887 69999999999853    


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcc
Q 020657          121 PSGDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVS  198 (323)
Q Consensus       121 ~~~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~  198 (323)
                      .++.++||||||.+||+-+++++  +..+.+..+..|++.++.|+.+||...++|||||=.|||++.++ .|||+|||.+
T Consensus        92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~-~VKLvDFGvS  170 (953)
T KOG0587|consen   92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENA-EVKLVDFGVS  170 (953)
T ss_pred             CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccC-cEEEeeeeee
Confidence            35679999999999999999975  45799999999999999999999999999999999999999998 8999999999


Q ss_pred             hhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCC
Q 020657          199 KIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPP  278 (323)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~  278 (323)
                      ...........+.+||+.|+|||++.........++..+|+||||++..||-.|..|+..+-   .-..+...... .++
T Consensus       171 aQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH---PmraLF~IpRN-PPP  246 (953)
T KOG0587|consen  171 AQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH---PMRALFLIPRN-PPP  246 (953)
T ss_pred             eeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc---hhhhhccCCCC-CCc
Confidence            98888777788899999999999998777777888899999999999999999999994432   12223322222 222


Q ss_pred             CC--CCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccc
Q 020657          279 SL--PDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLC  316 (323)
Q Consensus       279 ~~--~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~  316 (323)
                      .+  ++.=+.++.+++..||..|-++||+..++|+|||..
T Consensus       247 kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~  286 (953)
T KOG0587|consen  247 KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT  286 (953)
T ss_pred             cccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence            22  345578899999999999999999999999999997

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-38  Score=269.58  Aligned_cols=267  Identities=27%  Similarity=0.413  Sum_probs=218.0

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC------hHHHHHHHHHHHHHHcCCCCccceeceeEEc
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD------PTVRRQVFREMEILRRTDSPFIVQCFGIFEK  120 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  120 (323)
                      ....++|-++..||+|+|+.||+|-|....++||+|+-....+      ....+...+|..+-+.|.||.||++|++|.-
T Consensus       459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl  538 (775)
T KOG1151|consen  459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL  538 (775)
T ss_pred             cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence            4556778899999999999999999998999999999764422      2245556789999999999999999999987


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--CCeecCCCCCCeEEecCC--CcEEEeecC
Q 020657          121 PSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH--KIIHRDIKPSNLLVNNNN--MQVKIADFG  196 (323)
Q Consensus       121 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~--givH~di~~~nil~~~~~--~~~kl~Dfg  196 (323)
                      +...+|.|.|||+|.+|.-+++..+.+++.+++.|+.||+.||.||...  .|+|-||||.|||+.+..  ..+||.|||
T Consensus       539 DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  539 DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence            7788999999999999999999999999999999999999999999987  699999999999996541  389999999


Q ss_pred             cchhhccCccc-------cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHH
Q 020657          197 VSKIMCRSLDA-------CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLM  269 (323)
Q Consensus       197 ~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~  269 (323)
                      ++....+....       .+...||-.|++||.+.-+. .....+.++||||+|+++|..+.|..||-..   .....++
T Consensus       619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgk-ePPKIsnKVDVWSvGVIFyQClYGrKPFGhn---qsQQdIL  694 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGK-EPPKISNKVDVWSVGVIFYQCLYGRKPFGHN---QSQQDIL  694 (775)
T ss_pred             hhhhccCCccCcccceeeecccCceeeecCcceeecCC-CCCccccceeeEeeehhhhhhhccCCCCCCc---hhHHHHH
Confidence            99887654332       34567999999999875222 1344567999999999999999999999432   2222222


Q ss_pred             HH-H-hcCCCCCCC--CCCChhHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          270 CA-I-CFGDPPSLP--DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       270 ~~-~-~~~~~~~~~--~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                      +. . .......+|  ..++.+..+||++||++--++|..+.++..||||..
T Consensus       695 qeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  695 QENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             hhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence            21 1 111222333  468999999999999999999999999999999964

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.5e-36  Score=274.67  Aligned_cols=269  Identities=23%  Similarity=0.249  Sum_probs=189.1

Q ss_pred             ccccccceeeeecccCCeEEEEEEec----------------ccCcEEEEEeecCCCChHHHHH--------------HH
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHR----------------CTHKIYALKVVHGDADPTVRRQ--------------VF   97 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~----------------~~~~~v~iK~~~~~~~~~~~~~--------------~~   97 (323)
                      ...++|++.++||+|+||+||+|.+.                ..++.||+|.+...... ....              ..
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~-~~~~fl~e~~~~~~~~e~~~  220 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQG-VRQDFLKTGTLAKGSAETGM  220 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchh-hHHHHHhhhhhhhcccchhH
Confidence            45789999999999999999999752                24567999998654321 1222              23


Q ss_pred             HHHHHHHcCCCCcc-----ceeceeEEcC-------CCeEEEEEeccCCCCHHHHHHhc---------------------
Q 020657           98 REMEILRRTDSPFI-----VQCFGIFEKP-------SGDIAILMEYMDSGTLDTLLNKN---------------------  144 (323)
Q Consensus        98 ~e~~~l~~l~h~~i-----~~~~~~~~~~-------~~~~~lv~e~~~~~sL~~~l~~~---------------------  144 (323)
                      .|+.++.+++|.++     +.+++++...       ++..++||||+++++|.+++...                     
T Consensus       221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~  300 (507)
T PLN03224        221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN  300 (507)
T ss_pred             HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence            46666666665543     5666765431       34689999999999999988631                     


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccc-cccccccccccCC
Q 020657          145 ---GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA-CNSYVGTCAYMSP  220 (323)
Q Consensus       145 ---~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~y~aP  220 (323)
                         ..+++..+..++.|++.+|.|||+.+++|+||||+||+++.++ .++|+|||++......... ......++.|+||
T Consensus       301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCC-cEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence               1235677889999999999999999999999999999999987 8999999999654332211 1123347899999


Q ss_pred             cccCCCCCCCC-----------------CCCcchhHHHHHHHHHHHHhCCC-CCCCCCCC--------ccHHHHHHHHhc
Q 020657          221 ERFDPDAYGGN-----------------YNGYAGDIWSLGLTLLELYLGHF-PFLQPGQR--------PDWATLMCAICF  274 (323)
Q Consensus       221 E~~~~~~~~~~-----------------~~~~~~Dv~slG~ll~~lltg~~-p~~~~~~~--------~~~~~~~~~~~~  274 (323)
                      |.+........                 ....+.||||+|+++++|++|.. ||......        .....+......
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~  459 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ  459 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence            98753321110                 11235799999999999999886 66432111        111111111111


Q ss_pred             CCCCCCCCCCChhHHHHHHHhcccCc---CCCCCHHHHhcCcccccC
Q 020657          275 GDPPSLPDGASPEFRSFIECCLQKEF---SKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       275 ~~~~~~~~~~~~~l~~ll~~~l~~~p---~~Rpt~~~~l~h~~f~~~  318 (323)
                      ..........++...+|+.+||..+|   .+|+|++|+|+||||...
T Consensus       460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~  506 (507)
T PLN03224        460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPE  506 (507)
T ss_pred             CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCC
Confidence            11222345678999999999999866   689999999999999753

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=259.66  Aligned_cols=260  Identities=26%  Similarity=0.429  Sum_probs=201.8

Q ss_pred             CccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHc--CCCCccceeceeEE
Q 020657           42 TATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRR--TDSPFIVQCFGIFE  119 (323)
Q Consensus        42 ~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~  119 (323)
                      +.-...-...+..+.+.||+|.||.||+|.|+  |+.||||++....    .+.+.+|.++.+.  |+|+||+.+++.-.
T Consensus       202 plLVQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd----E~SWfrEtEIYqTvmLRHENILgFIaaD~  275 (513)
T KOG2052|consen  202 PLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD----ERSWFRETEIYQTVMLRHENILGFIAADN  275 (513)
T ss_pred             hhHhHHhhhheeEEEEEecCccccceeecccc--CCceEEEEecccc----hhhhhhHHHHHHHHHhccchhhhhhhccc
Confidence            33344455678999999999999999999994  8999999996332    3567788888877  69999999998643


Q ss_pred             cCCC---eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CCeecCCCCCCeEEecCCC
Q 020657          120 KPSG---DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH--------KIIHRDIKPSNLLVNNNNM  188 (323)
Q Consensus       120 ~~~~---~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~--------givH~di~~~nil~~~~~~  188 (323)
                      .+.+   .++||++|.+.|||.|+++++ .++.+...+++..++.||++||..        .|+|||||..||+|..++ 
T Consensus       276 ~~~gs~TQLwLvTdYHe~GSL~DyL~r~-tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~-  353 (513)
T KOG2052|consen  276 KDNGSWTQLWLVTDYHEHGSLYDYLNRN-TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-  353 (513)
T ss_pred             cCCCceEEEEEeeecccCCcHHHHHhhc-cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC-
Confidence            2222   489999999999999999884 789999999999999999999964        499999999999999998 


Q ss_pred             cEEEeecCcchhhccCcc----ccccccccccccCCcccCCCCCCCCCCC-cchhHHHHHHHHHHHHh----C------C
Q 020657          189 QVKIADFGVSKIMCRSLD----ACNSYVGTCAYMSPERFDPDAYGGNYNG-YAGDIWSLGLTLLELYL----G------H  253 (323)
Q Consensus       189 ~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~Dv~slG~ll~~llt----g------~  253 (323)
                      ...|+|+|+|........    .....+||.+|+|||++...-...-..+ ..+||||||.++||+.-    |      +
T Consensus       354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~  433 (513)
T KOG2052|consen  354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ  433 (513)
T ss_pred             cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence            899999999987654422    2346789999999999974322211111 26999999999999983    2      6


Q ss_pred             CCCCCC-CCCccHHHHHHHHhcCC-CCCCCCCC-----ChhHHHHHHHhcccCcCCCCCHHHH
Q 020657          254 FPFLQP-GQRPDWATLMCAICFGD-PPSLPDGA-----SPEFRSFIECCLQKEFSKRWTASQL  309 (323)
Q Consensus       254 ~p~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~-----~~~l~~ll~~~l~~~p~~Rpt~~~~  309 (323)
                      .||... ..++.++++..-++... ++.+|..-     -..+.+||+.||..||..|.|+--+
T Consensus       434 ~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri  496 (513)
T KOG2052|consen  434 LPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRI  496 (513)
T ss_pred             CCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence            777553 45566777766555433 44554321     2457889999999999999987544

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.7e-37  Score=271.26  Aligned_cols=265  Identities=25%  Similarity=0.376  Sum_probs=209.7

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCe
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGD  124 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  124 (323)
                      .++-+-|..++.||-|+||.|.+++-..+...||.|.+.+..  .......+..|-.||.....+-||+++=.|++ ++.
T Consensus       625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD-kdn  703 (1034)
T KOG0608|consen  625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD-KDN  703 (1034)
T ss_pred             hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc-CCc
Confidence            344555888999999999999999987788899999986442  11233456678899999999999999999998 788


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC
Q 020657          125 IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS  204 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~  204 (323)
                      +|+||+|++||++-.++-+-+-+.+..++.++.++..|+++.|..|+|||||||+|||||.+| .+||.|||+++.+.-.
T Consensus       704 LYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdG-HIKLTDFGLCTGfRWT  782 (1034)
T KOG0608|consen  704 LYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGFRWT  782 (1034)
T ss_pred             eEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCC-ceeeeeccccccceec
Confidence            999999999999999998888999999999999999999999999999999999999999998 8999999999754110


Q ss_pred             ----c--------------------------------------cccccccccccccCCcccCCCCCCCCCCCcchhHHHH
Q 020657          205 ----L--------------------------------------DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSL  242 (323)
Q Consensus       205 ----~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl  242 (323)
                          .                                      ......+||..|+|||++....+     +...|+|+.
T Consensus       783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~-----~q~cdwws~  857 (1034)
T KOG0608|consen  783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGY-----TQLCDWWSV  857 (1034)
T ss_pred             cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCc-----cccchhhHh
Confidence                0                                      00113478999999999975444     458999999


Q ss_pred             HHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCC---CHHHHhcCcccccCC
Q 020657          243 GLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRW---TASQLLTHPFLCKNR  319 (323)
Q Consensus       243 G~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rp---t~~~~l~h~~f~~~~  319 (323)
                      |++||||+.|+.||....-......++.-.. .........++.+..+||.++. .+++.|.   -++++-.||||+++.
T Consensus       858 gvil~em~~g~~pf~~~tp~~tq~kv~nw~~-~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgID  935 (1034)
T KOG0608|consen  858 GVILYEMLVGQPPFLADTPGETQYKVINWRN-FLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGID  935 (1034)
T ss_pred             hHHHHHHhhCCCCccCCCCCcceeeeeehhh-ccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccc
Confidence            9999999999999966544333222211111 0112334678999999998754 3567787   467799999999886


Q ss_pred             C
Q 020657          320 R  320 (323)
Q Consensus       320 ~  320 (323)
                      =
T Consensus       936 f  936 (1034)
T KOG0608|consen  936 F  936 (1034)
T ss_pred             h
Confidence            3

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=255.96  Aligned_cols=133  Identities=26%  Similarity=0.403  Sum_probs=113.4

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCC--------CCccceeceeEEc
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD--------SPFIVQCFGIFEK  120 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~~~  120 (323)
                      ...+|.+.++||+|-|++||+|.|.++.+.||+|+++.-  ....+....|+++|++++        ..+||++++.|..
T Consensus        76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA--qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh  153 (590)
T KOG1290|consen   76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA--QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH  153 (590)
T ss_pred             cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh--hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence            348899999999999999999999999999999998633  345566778999998863        2479999999865


Q ss_pred             C---CCeEEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCCeEEe
Q 020657          121 P---SGDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHGH-KIIHRDIKPSNLLVN  184 (323)
Q Consensus       121 ~---~~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~-givH~di~~~nil~~  184 (323)
                      .   +.++|+|+|++.. +|..++..  .+.++...|.+|++||+.||.|||.. ||+|-||||+|||+.
T Consensus       154 sGpNG~HVCMVfEvLGd-nLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  154 SGPNGQHVCMVFEVLGD-NLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             cCCCCcEEEEEehhhhh-HHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence            2   4579999999954 78777764  45699999999999999999999986 999999999999994

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-36  Score=259.33  Aligned_cols=252  Identities=27%  Similarity=0.401  Sum_probs=199.3

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHc--CCCCccceeceeEEc---CC
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRR--TDSPFIVQCFGIFEK---PS  122 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~---~~  122 (323)
                      ......+..+.+|+|.||.||+|+.  +++.||||++.    ......+.+|-++.+.  ++|+||+++++.-..   ..
T Consensus       207 ~~l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~  280 (534)
T KOG3653|consen  207 LELDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFP----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR  280 (534)
T ss_pred             ccCCchhhHHHhhcCccceeehhhc--cCceeEEEecC----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence            3367788899999999999999998  57999999995    3446778888888877  589999999987432   13


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CCeecCCCCCCeEEecCCCcEEEe
Q 020657          123 GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH---------KIIHRDIKPSNLLVNNNNMQVKIA  193 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---------givH~di~~~nil~~~~~~~~kl~  193 (323)
                      ..++||++|.+.|+|.+++..+ .+++....+++..+++||+|||..         .|+|||||..|||+.++. +..|+
T Consensus       281 ~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl-TccIa  358 (534)
T KOG3653|consen  281 MEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL-TCCIA  358 (534)
T ss_pred             cceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC-cEEee
Confidence            4689999999999999999876 689999999999999999999963         599999999999999997 89999


Q ss_pred             ecCcchhhccCccc--cccccccccccCCcccCCCCCCC-CCCCcchhHHHHHHHHHHHHhC------------CCCCC-
Q 020657          194 DFGVSKIMCRSLDA--CNSYVGTCAYMSPERFDPDAYGG-NYNGYAGDIWSLGLTLLELYLG------------HFPFL-  257 (323)
Q Consensus       194 Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~-~~~~~~~Dv~slG~ll~~lltg------------~~p~~-  257 (323)
                      |||+|.++......  ...-+||.+|||||++.+...-. ...--+.||||+|.+||||++.            +.||. 
T Consensus       359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~  438 (534)
T KOG3653|consen  359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA  438 (534)
T ss_pred             ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence            99999887643322  33478999999999997443222 2222379999999999999953            23443 


Q ss_pred             CCCCCccHHHHHHHHh-cCCCCCCCC-----CCChhHHHHHHHhcccCcCCCCCHH
Q 020657          258 QPGQRPDWATLMCAIC-FGDPPSLPD-----GASPEFRSFIECCLQKEFSKRWTAS  307 (323)
Q Consensus       258 ~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~l~~ll~~~l~~~p~~Rpt~~  307 (323)
                      ..+..+.++.+...+- ...++.++.     .....+.+.++.||..|++.|.|+.
T Consensus       439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence            3455566666654443 334555553     2346689999999999999999975

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-36  Score=230.92  Aligned_cols=224  Identities=33%  Similarity=0.610  Sum_probs=187.8

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceeceeEEcC
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKP  121 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~  121 (323)
                      ....++..++..-+..||+|++|.|=+.++..+|...|+|.+...-+.+..++.++|+.+..+. .+|.+|.++|.+.. 
T Consensus        38 ~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r-  116 (282)
T KOG0984|consen   38 DRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR-  116 (282)
T ss_pred             cCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc-
Confidence            3346778888888999999999999999999999999999998777777788899999987774 79999999998776 


Q ss_pred             CCeEEEEEeccCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCCeEEecCCCcEEEeecC
Q 020657          122 SGDIAILMEYMDSGTLDTLL----NKNGTFSEPKLAHIASQILKGLSYLHGH-KIIHRDIKPSNLLVNNNNMQVKIADFG  196 (323)
Q Consensus       122 ~~~~~lv~e~~~~~sL~~~l----~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-givH~di~~~nil~~~~~~~~kl~Dfg  196 (323)
                      ++..++.||.|.. ||..+-    ..+..+++..+-+|+..+++||.|||++ .++|||+||.|||++.+| ++|+||||
T Consensus       117 egdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G-qVKiCDFG  194 (282)
T KOG0984|consen  117 EGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG-QVKICDFG  194 (282)
T ss_pred             cccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC-cEEEcccc
Confidence            7889999999975 776554    4677899999999999999999999987 999999999999999998 99999999


Q ss_pred             cchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHh
Q 020657          197 VSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAIC  273 (323)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~  273 (323)
                      .+....++-.. ....|...|+|||.+.++.. +..++.++||||||+++.||.++..||..  +...++.+.+.+.
T Consensus       195 IsG~L~dSiAk-t~daGCkpYmaPEri~~e~n-~~gY~vksDvWSLGItmiElA~lr~PY~~--w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  195 ISGYLVDSIAK-TMDAGCKPYMAPERINPELN-QKGYSVKSDVWSLGITMIEMAILRFPYES--WGTPFQQLKQVVE  267 (282)
T ss_pred             cceeehhhhHH-HHhcCCCccCChhhcCcccC-cccceeehhhhhhhhhhhhhhhccccccc--cCCHHHHHHHHhc
Confidence            99766443222 22568889999999987654 34788999999999999999999999942  3444555554443

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-36  Score=251.60  Aligned_cols=256  Identities=22%  Similarity=0.306  Sum_probs=216.9

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecc-----cCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEc
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRC-----THKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEK  120 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  120 (323)
                      ..+...+++....+-+|.||.||.|.|..     +.+.|.+|.+...-++.....+..|.-++..+.|||+.++.++...
T Consensus       279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie  358 (563)
T KOG1024|consen  279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE  358 (563)
T ss_pred             hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence            35566778888899999999999997653     3446778888777777778888999999999999999999999877


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEE
Q 020657          121 PSGDIAILMEYMDSGTLDTLLNK--------NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKI  192 (323)
Q Consensus       121 ~~~~~~lv~e~~~~~sL~~~l~~--------~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl  192 (323)
                      .....+.++.+++-|+|..++..        ...++..+.+.++.|++.|++|||+.|++|.||.++|+++|+. .++||
T Consensus       359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~-LqVkl  437 (563)
T KOG1024|consen  359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ-LQVKL  437 (563)
T ss_pred             ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh-eeEEe
Confidence            67788999999999999999972        2358889999999999999999999999999999999999987 59999


Q ss_pred             eecCcchhhccCcc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHH
Q 020657          193 ADFGVSKIMCRSLD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLM  269 (323)
Q Consensus       193 ~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~  269 (323)
                      +|=.+++.......  .....-....|++||.+...     .++.++|+||||++||||+| |+.||    ...+..++.
T Consensus       438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~-----~yssasDvWsfGVllWELmtlg~~Py----aeIDPfEm~  508 (563)
T KOG1024|consen  438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNS-----HYSSASDVWSFGVLLWELMTLGKLPY----AEIDPFEME  508 (563)
T ss_pred             ccchhccccCcccccccCCCCCCcccccCHHHHhhh-----hhcchhhhHHHHHHHHHHHhcCCCCc----cccCHHHHH
Confidence            99999986644322  22334467899999998744     44569999999999999997 99999    555667777


Q ss_pred             HHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          270 CAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ..++.+.+...|.++|+++..+|..||+..|++||+++++..
T Consensus       509 ~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  509 HYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             HHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            777888888899999999999999999999999999999863

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-36  Score=247.89  Aligned_cols=258  Identities=25%  Similarity=0.391  Sum_probs=206.5

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcCCCCccceeceeEEcCC----
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS----  122 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----  122 (323)
                      ....+|..+..+|.|+- .|..|-|.-.++.|++|....... ....++..+|..++..++|+||++++.+|.-..    
T Consensus        14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~   92 (369)
T KOG0665|consen   14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE   92 (369)
T ss_pred             eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence            34578999999999998 888899988999999999865532 233566779999999999999999999986422    


Q ss_pred             -CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhh
Q 020657          123 -GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM  201 (323)
Q Consensus       123 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~  201 (323)
                       ...|+|||+|.. +|.+.+.  -.++-..+..++.|++.|+.+||+.||+||||||+||++..++ .+|+.|||+++..
T Consensus        93 ~~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~-~lKi~dfg~ar~e  168 (369)
T KOG0665|consen   93 FQEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDC-TLKILDFGLARTE  168 (369)
T ss_pred             HHhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchh-heeeccchhhccc
Confidence             246899999975 9999887  3578889999999999999999999999999999999999997 8999999999775


Q ss_pred             ccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCC---
Q 020657          202 CRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPP---  278 (323)
Q Consensus       202 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~---  278 (323)
                      ... -.....+.+..|.|||++.+-.     +...+||||+||++.||++|...|.+.+.-+.+.++.+......+.   
T Consensus       169 ~~~-~~mtpyVvtRyyrapevil~~~-----~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~  242 (369)
T KOG0665|consen  169 DTD-FMMTPYVVTRYYRAPEVILGMG-----YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK  242 (369)
T ss_pred             Ccc-cccCchhheeeccCchheeccC-----CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence            443 2334567899999999997444     4559999999999999999999997665544444433332221110   


Q ss_pred             -----------------------CCC-----------CCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccc
Q 020657          279 -----------------------SLP-----------DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLC  316 (323)
Q Consensus       279 -----------------------~~~-----------~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~  316 (323)
                                             .++           ..-...+.+|+.+||-.||++|.+++++|.||||+
T Consensus       243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                                   011           11235689999999999999999999999999996

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=5.3e-35  Score=291.48  Aligned_cols=242  Identities=19%  Similarity=0.310  Sum_probs=184.3

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEe
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILME  130 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e  130 (323)
                      ..+.....||+|+||.||+|++..++..||+|.+......     ...|+..+++++||||+++++++.+ ....++|||
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~l~~l~HpnIv~~~~~~~~-~~~~~lv~E  763 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-----PSSEIADMGKLQHPNIVKLIGLCRS-EKGAYLIHE  763 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-----cHHHHHHHhhCCCCCcceEEEEEEc-CCCCEEEEe
Confidence            4566778999999999999999889999999998644321     1246888999999999999999987 577899999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccc
Q 020657          131 YMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH---GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA  207 (323)
Q Consensus       131 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~  207 (323)
                      |+++++|.+++.   .+++..+..++.|+++||+|||   +.+++||||||+||+++.++ ..++. ||.......    
T Consensus       764 y~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~-~~~~~-~~~~~~~~~----  834 (968)
T PLN00113        764 YIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD-EPHLR-LSLPGLLCT----  834 (968)
T ss_pred             CCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCC-ceEEE-ecccccccc----
Confidence            999999999995   3799999999999999999999   66999999999999999876 56654 555433211    


Q ss_pred             cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-CccHHHHHHHHhcC------CCCCC
Q 020657          208 CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQ-RPDWATLMCAICFG------DPPSL  280 (323)
Q Consensus       208 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~-~~~~~~~~~~~~~~------~~~~~  280 (323)
                      .....++..|+|||++...     .++.++||||||+++|||+||+.||..... ......+.......      ..+.+
T Consensus       835 ~~~~~~t~~y~aPE~~~~~-----~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  909 (968)
T PLN00113        835 DTKCFISSAYVAPETRETK-----DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSI  909 (968)
T ss_pred             CCCccccccccCcccccCC-----CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccc
Confidence            1223578899999998633     356699999999999999999999954322 12222221111000      00111


Q ss_pred             CC------CCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          281 PD------GASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       281 ~~------~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ..      ....++.+++.+||+.||++|||++++++.
T Consensus       910 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             cCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            11      112357789999999999999999999865

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-36  Score=271.86  Aligned_cols=245  Identities=27%  Similarity=0.392  Sum_probs=188.3

Q ss_pred             eeeecccCCeE-EEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceeceeEEcCCCeEEEEEeccC
Q 020657           56 LQVLGHGNGGT-VYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKPSGDIAILMEYMD  133 (323)
Q Consensus        56 ~~~lg~G~~~~-v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~lv~e~~~  133 (323)
                      .+.+|.|..|+ ||+|..  .++.||||.+-.    +......+|+..++.- .||||++.++.=.+ ....||..|.|.
T Consensus       514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d-~qF~YIalELC~  586 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLE----EFFDFAQREIQLLQESDEHPNVIRYYCSEQD-RQFLYIALELCA  586 (903)
T ss_pred             HHHcccCCCCcEEEEEee--CCceehHHHHhh----HhHHHHHHHHHHHHhccCCCceEEEEeeccC-CceEEEEehHhh
Confidence            46788888876 699998  688999999853    3345677999999886 79999999998665 788999999998


Q ss_pred             CCCHHHHHHhc-CC---CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEec---CC-CcEEEeecCcchhhccCc
Q 020657          134 SGTLDTLLNKN-GT---FSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNN---NN-MQVKIADFGVSKIMCRSL  205 (323)
Q Consensus       134 ~~sL~~~l~~~-~~---~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~---~~-~~~kl~Dfg~~~~~~~~~  205 (323)
                      . +|.+++... ..   ......+.++.|++.||++||+.+||||||||.|||++.   ++ ..++|+|||++.......
T Consensus       587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence            7 999999863 11   122456788999999999999999999999999999986   22 589999999998876543


Q ss_pred             c---ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCC
Q 020657          206 D---ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLP  281 (323)
Q Consensus       206 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (323)
                      .   ...+..||.+|.|||++......     .++|||+|||++|+.++ |..||.......  .++....  .....+.
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~~~~~-----~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~--~~L~~L~  736 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLREDRKT-----QAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGN--YTLVHLE  736 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhccccC-----cccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCc--cceeeec
Confidence            2   34567799999999999855543     39999999999999997 599993322211  1111100  0011111


Q ss_pred             CCCChhHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          282 DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       282 ~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                      .....+..+||.+|++++|..||++.++|.||||=+
T Consensus       737 ~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~  772 (903)
T KOG1027|consen  737 PLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD  772 (903)
T ss_pred             cCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence            111228999999999999999999999999999943

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-36  Score=243.26  Aligned_cols=261  Identities=29%  Similarity=0.427  Sum_probs=203.5

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCC----eEE
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG----DIA  126 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~~  126 (323)
                      +.+-.+.||.|+||.||.+.|..+|+.|++|.+..-. +-...+++.+|++++..++|.|++..+++.+-..-    .+|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            3445678999999999999999999999999886443 23457789999999999999999999987653211    257


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc
Q 020657          127 ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD  206 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~  206 (323)
                      .++|.|.. +|..++-....++...+.-+++||+++|.|||+.||.||||||.|.+++.+. .+||||||+++.......
T Consensus       134 V~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNC-vLKICDFGLARvee~d~~  211 (449)
T KOG0664|consen  134 VLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNC-ILKICDFGLARTWDQRDR  211 (449)
T ss_pred             HHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCc-eEEecccccccccchhhh
Confidence            88899864 9999988888899999999999999999999999999999999999999997 899999999987653322


Q ss_pred             -ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCcc------------HHHHHHHHh
Q 020657          207 -ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPD------------WATLMCAIC  273 (323)
Q Consensus       207 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~------------~~~~~~~~~  273 (323)
                       .....+.|..|+|||.+.    +...++.+.||||.||++.||+..+..|...+.-..            .+.+... +
T Consensus       212 ~hMTqEVVTQYYRAPEiLM----GaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A-C  286 (449)
T KOG0664|consen  212 LNMTHEVVTQYYRAPELLM----GARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA-C  286 (449)
T ss_pred             hhhHHHHHHHHhccHHHhh----cchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH-h
Confidence             223456789999999997    444567799999999999999998888844322111            1111110 0


Q ss_pred             cC----------CCCCCC--------CCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          274 FG----------DPPSLP--------DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       274 ~~----------~~~~~~--------~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      .+          ..+.++        ..-..+...++.+++..||..|.+.++++.|+|..+-|
T Consensus       287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R  350 (449)
T KOG0664|consen  287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR  350 (449)
T ss_pred             hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence            00          011111        13345678899999999999999999999999986543

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-35  Score=258.38  Aligned_cols=201  Identities=28%  Similarity=0.453  Sum_probs=175.3

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-------ChHHHHHHHHHHHHHHcCC---CCccceeceeE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-------DPTVRRQVFREMEILRRTD---SPFIVQCFGIF  118 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-------~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~  118 (323)
                      ...+|..++.+|+|+||.|++|.++.+...|++|.+.++.       .....-.+-.|+++|..|+   |+||++++++|
T Consensus       559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF  638 (772)
T KOG1152|consen  559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF  638 (772)
T ss_pred             ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence            4566899999999999999999999999999999997552       1111223557999999987   99999999999


Q ss_pred             EcCCCeEEEEEecc-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCc
Q 020657          119 EKPSGDIAILMEYM-DSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGV  197 (323)
Q Consensus       119 ~~~~~~~~lv~e~~-~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~  197 (323)
                      ++ +++++++||.. ++.+|.+++...+.+++.++..|++||+.|+++||+.||||||||-+|+.++.+| -+||+|||.
T Consensus       639 Ed-dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g-~~klidfgs  716 (772)
T KOG1152|consen  639 ED-DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNG-FVKLIDFGS  716 (772)
T ss_pred             ec-CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCC-eEEEeeccc
Confidence            98 78999999975 4668999999999999999999999999999999999999999999999999998 799999999


Q ss_pred             chhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 020657          198 SKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFL  257 (323)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~  257 (323)
                      +....+  .....++||..|.|||++.+..|.+.    .-|||++|++||.+...++||.
T Consensus       717 aa~~ks--gpfd~f~gtv~~aapevl~g~~y~gk----~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  717 AAYTKS--GPFDVFVGTVDYAAPEVLGGEKYLGK----PQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hhhhcC--CCcceeeeeccccchhhhCCCccCCC----cchhhhhhheeeEEEeccCCCc
Confidence            876433  33456889999999999998777653    6799999999999999999984

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5e-36  Score=266.62  Aligned_cols=262  Identities=34%  Similarity=0.515  Sum_probs=220.0

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      +.++|..++++|.|.+|.||+|+|..+++..++|+++.+.. +...-+.+|+-+++..+||||+.++|.+.. ...+++.
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~-dd~~~iqqei~~~~dc~h~nivay~gsylr-~dklwic   90 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG-DDFSGIQQEIGMLRDCRHPNIVAYFGSYLR-RDKLWIC   90 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCC-ccccccccceeeeecCCCcChHHHHhhhhh-hcCcEEE
Confidence            46899999999999999999999999999999999986643 334567789999999999999999999987 6779999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          129 MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      ||||.+|+|.++-.-.+++++.++...++..+++++|||+.|=+|||||=.||+++..| .+|+.|||.+..+...-...
T Consensus        91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~g-DvklaDfgvsaqitati~Kr  169 (829)
T KOG0576|consen   91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEG-DVKLADFGVSAQITATIAKR  169 (829)
T ss_pred             EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccC-ceeecccCchhhhhhhhhhh
Confidence            99999999999998889999999999999999999999999999999999999999998 89999999999887777777


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCC--CCCCh
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLP--DGASP  286 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  286 (323)
                      ..+.||+.|+|||+..=+.  ...+...+|||++|+...|+-.-+.|.+..-  +.....+.......++.+.  ..-++
T Consensus       170 ksfiGtpywmapEvaaver--kggynqlcdiwa~gitAiel~eLqpplfdlh--pmr~l~LmTkS~~qpp~lkDk~kws~  245 (829)
T KOG0576|consen  170 KSFIGTPYWMAPEVAAVER--KGGYNQLCDIWALGITAIELGELQPPLFDLH--PMRALFLMTKSGFQPPTLKDKTKWSE  245 (829)
T ss_pred             hcccCCccccchhHHHHHh--cccccccccccccccchhhhhhcCCcccccc--hHHHHHHhhccCCCCCcccCCccchH
Confidence            8899999999999874111  2234459999999999999988887764321  1112222222223333333  34578


Q ss_pred             hHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          287 EFRSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       287 ~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                      .+-+|++.+|..+|++|||++.+|+|||...
T Consensus       246 ~fh~fvK~altknpKkRptaeklL~h~fvs~  276 (829)
T KOG0576|consen  246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ  276 (829)
T ss_pred             HHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence            8999999999999999999999999999864

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=1.5e-32  Score=225.73  Aligned_cols=213  Identities=42%  Similarity=0.726  Sum_probs=185.3

Q ss_pred             ecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEeccCCCCHH
Q 020657           59 LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLD  138 (323)
Q Consensus        59 lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~sL~  138 (323)
                      ||+|.+|.||++.+..+++.+++|++...........+.+|+..++.++|++++++++++.. ....++++|++.+++|.
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~~~~e~~~~~~l~   79 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED-ENHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec-CCeEEEEEecCCCCcHH
Confidence            68999999999999877999999999866543345778899999999999999999999987 57899999999989999


Q ss_pred             HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEec-CCCcEEEeecCcchhhccCcccccccccccc
Q 020657          139 TLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNN-NNMQVKIADFGVSKIMCRSLDACNSYVGTCA  216 (323)
Q Consensus       139 ~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~  216 (323)
                      +++... ..++...+..++.+++.++.+||+.|++|+||+|.||+++. ++ .++|+|||.+..............+...
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (215)
T cd00180          80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNG-KVKLADFGLSKLLTSDKSLLKTIVGTPA  158 (215)
T ss_pred             HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCC-cEEEecCCceEEccCCcchhhcccCCCC
Confidence            999765 47899999999999999999999999999999999999998 66 8999999999765443222334567889


Q ss_pred             ccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhc
Q 020657          217 YMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCL  296 (323)
Q Consensus       217 y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l  296 (323)
                      |.+||.+...    ...+.++|+|++|++++++                                    ..+.+++..|+
T Consensus       159 ~~~pe~~~~~----~~~~~~~D~~~lg~~~~~l------------------------------------~~~~~~l~~~l  198 (215)
T cd00180         159 YMAPEVLLGK----GYYSEKSDIWSLGVILYEL------------------------------------PELKDLIRKML  198 (215)
T ss_pred             ccChhHhccc----CCCCchhhhHHHHHHHHHH------------------------------------HHHHHHHHHHh
Confidence            9999988643    2445699999999999999                                    57899999999


Q ss_pred             ccCcCCCCCHHHHhcCc
Q 020657          297 QKEFSKRWTASQLLTHP  313 (323)
Q Consensus       297 ~~~p~~Rpt~~~~l~h~  313 (323)
                      +.+|++||+++++++|+
T Consensus       199 ~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         199 QKDPEKRPSAKEILEHL  215 (215)
T ss_pred             hCCcccCcCHHHHhhCC
Confidence            99999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=1.4e-34  Score=245.50  Aligned_cols=258  Identities=27%  Similarity=0.432  Sum_probs=202.1

Q ss_pred             cccccceeeeecccCCeEEEEEEecc---cCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceeceeEEcCCCe
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRC---THKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKPSGD  124 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  124 (323)
                      ....|..+.+||+|.|++||+|.+..   ..+.|++|.+.....+   .++.+|+++|..+ ++.||+++.+.+.. .+.
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~rn-nd~  109 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCFRN-NDQ  109 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhhcc-CCe
Confidence            34568899999999999999999876   7889999999766544   4588999999998 68999999999887 678


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC
Q 020657          125 IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS  204 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~  204 (323)
                      .++|+||+++.+..++..   .++...+..+++.++.||.++|..|||||||||.|++.+.....-.|+|||++......
T Consensus       110 v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~  186 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY  186 (418)
T ss_pred             eEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhh
Confidence            999999999988888875   46789999999999999999999999999999999999887657899999999732100


Q ss_pred             c--------------c------------------------------ccccccccccccCCcccCCCCCCCCCCCcchhHH
Q 020657          205 L--------------D------------------------------ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIW  240 (323)
Q Consensus       205 ~--------------~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~  240 (323)
                      .              .                              ..-...||++|+|||++.    .....+.++|||
T Consensus       187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~----k~~~QttaiDiw  262 (418)
T KOG1167|consen  187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLF----RCPRQTTAIDIW  262 (418)
T ss_pred             hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHh----hccCcCCcccee
Confidence            0              0                              000135899999999997    334446799999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCCCcc-HHHHH---------------------H---------------HH----hcC----
Q 020657          241 SLGLTLLELYLGHFPFLQPGQRPD-WATLM---------------------C---------------AI----CFG----  275 (323)
Q Consensus       241 slG~ll~~lltg~~p~~~~~~~~~-~~~~~---------------------~---------------~~----~~~----  275 (323)
                      |.|+++.-++++..||+...+..+ +.++.                     +               ..    ...    
T Consensus       263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~  342 (418)
T KOG1167|consen  263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP  342 (418)
T ss_pred             eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence            999999999999999965443321 11100                     0               00    000    


Q ss_pred             --CCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          276 --DPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       276 --~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                        .........+..+.+|+.+||..||.+|.|++++|.||||..
T Consensus       343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~  386 (418)
T KOG1167|consen  343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE  386 (418)
T ss_pred             ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence              000011234558999999999999999999999999999974

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-33  Score=226.99  Aligned_cols=248  Identities=20%  Similarity=0.322  Sum_probs=196.0

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCC-CCccceeceeEEcCCCeEEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD-SPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~l  127 (323)
                      ..+.|.|.+.||+|.||.+-+++++++++.+++|.++...  ...+.|.+|...--.|+ |.||+.-+++.-+..+.+++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~--tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF   99 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ--TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF   99 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch--hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence            4578999999999999999999999999999999997654  45677888887766664 89999988774333778999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEec-CCCcEEEeecCcchhhccCcc
Q 020657          128 LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNN-NNMQVKIADFGVSKIMCRSLD  206 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~-~~~~~kl~Dfg~~~~~~~~~~  206 (323)
                      ++||++.|+|..-+..+ .+-+.....++.|+++|++|+|++++||||||.+|||+-. +-..+||||||..+..+....
T Consensus       100 ~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~  178 (378)
T KOG1345|consen  100 VQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK  178 (378)
T ss_pred             eeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceeh
Confidence            99999999999877654 4789999999999999999999999999999999999854 334899999999866543322


Q ss_pred             ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC----ccHHHHHHHHhcCCCCCCCC
Q 020657          207 ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQR----PDWATLMCAICFGDPPSLPD  282 (323)
Q Consensus       207 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~  282 (323)
                      .   .-....|.+||+............+.+|+|.||+++|.++||..||......    ..+..+...... ..+....
T Consensus       179 ~---~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~-~~P~~F~  254 (378)
T KOG1345|consen  179 Y---LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP-ALPKKFN  254 (378)
T ss_pred             h---hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc-cCchhhc
Confidence            1   2235578999988766555566678999999999999999999999532221    122333332222 2233335


Q ss_pred             CCChhHHHHHHHhcccCcCCC
Q 020657          283 GASPEFRSFIECCLQKEFSKR  303 (323)
Q Consensus       283 ~~~~~l~~ll~~~l~~~p~~R  303 (323)
                      ..++.+..+.++-|..++++|
T Consensus       255 ~fs~~a~r~Fkk~lt~~~~dr  275 (378)
T KOG1345|consen  255 PFSEKALRLFKKSLTPRFKDR  275 (378)
T ss_pred             ccCHHHHHHHHHhcCCccccc
Confidence            688999999999999999999

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.98  E-value=2.4e-30  Score=215.24  Aligned_cols=200  Identities=38%  Similarity=0.632  Sum_probs=172.6

Q ss_pred             cceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEecc
Q 020657           53 LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYM  132 (323)
Q Consensus        53 ~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~  132 (323)
                      |.+...||.|+++.||++.+..+++.+++|.+...........+.+|+..+++++|+|++++++.+.. ....++++|++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-~~~~~~v~e~~   79 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED-PEPLYLVMEYC   79 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec-CCceEEEEecc
Confidence            56789999999999999999888899999999866443356788899999999999999999999886 67899999999


Q ss_pred             CCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc-ccccc
Q 020657          133 DSGTLDTLLNKNGT-FSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL-DACNS  210 (323)
Q Consensus       133 ~~~sL~~~l~~~~~-~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~  210 (323)
                      ++++|.+++..... +++..+..++.+++.++.+||+.|++|+||++.||+++.++ .++|+|||.+....... .....
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~-~~~l~d~g~~~~~~~~~~~~~~~  158 (225)
T smart00221       80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG-LVKLADFGLARFIHRDLAALLKT  158 (225)
T ss_pred             CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeeCceeeEecCcccccccc
Confidence            99999999987666 89999999999999999999999999999999999999986 89999999997764432 12234


Q ss_pred             ccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 020657          211 YVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQ  258 (323)
Q Consensus       211 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~  258 (323)
                      ..++..|++||.+.    .....+.++|+|+||+++++|++|..||..
T Consensus       159 ~~~~~~~~~pe~~~----~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      159 VKGTPFYLAPEVLL----GGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             eeccCCcCCHhHhc----CCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            56778899999874    234455699999999999999999999943

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=4.5e-31  Score=257.12  Aligned_cols=201  Identities=20%  Similarity=0.215  Sum_probs=142.8

Q ss_pred             CCC-CccceeceeEEc------CCCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCC
Q 020657          106 TDS-PFIVQCFGIFEK------PSGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIK  177 (323)
Q Consensus       106 l~h-~~i~~~~~~~~~------~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~  177 (323)
                      ++| +||+.++++|..      ....+++++|++. ++|.+++.. ...+++..++.++.||++||.|||++||+|||||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK  107 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR  107 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence            445 577777776621      1245778899885 599999975 3469999999999999999999999999999999


Q ss_pred             CCCeEEecCC------------------CcEEEeecCcchhhccCc----------------cccccccccccccCCccc
Q 020657          178 PSNLLVNNNN------------------MQVKIADFGVSKIMCRSL----------------DACNSYVGTCAYMSPERF  223 (323)
Q Consensus       178 ~~nil~~~~~------------------~~~kl~Dfg~~~~~~~~~----------------~~~~~~~~~~~y~aPE~~  223 (323)
                      |+|||++..+                  ..+|++|||+++......                .......+|..|+|||++
T Consensus       108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~  187 (793)
T PLN00181        108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED  187 (793)
T ss_pred             chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence            9999996433                  245666666664321100                000113578889999998


Q ss_pred             CCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCC
Q 020657          224 DPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKR  303 (323)
Q Consensus       224 ~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~R  303 (323)
                      ....     ++.++|||||||+||||++|..|+....  .....+...    ..+.......+...+++..||+.+|.+|
T Consensus       188 ~~~~-----~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~L~~~P~~R  256 (793)
T PLN00181        188 NGSS-----SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHR----VLPPQILLNWPKEASFCLWLLHPEPSCR  256 (793)
T ss_pred             ccCC-----CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHh----hcChhhhhcCHHHHHHHHHhCCCChhhC
Confidence            7443     4569999999999999999988874221  111111111    1111111224567899999999999999


Q ss_pred             CCHHHHhcCcccccC
Q 020657          304 WTASQLLTHPFLCKN  318 (323)
Q Consensus       304 pt~~~~l~h~~f~~~  318 (323)
                      ||+.++++||||.+.
T Consensus       257 ps~~eil~h~~~~~~  271 (793)
T PLN00181        257 PSMSELLQSEFINEP  271 (793)
T ss_pred             cChHHHhhchhhhhh
Confidence            999999999999764

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=4.1e-29  Score=197.95  Aligned_cols=256  Identities=20%  Similarity=0.267  Sum_probs=204.3

Q ss_pred             cchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCC-CccceeceeEEcCC
Q 020657           44 TTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS-PFIVQCFGIFEKPS  122 (323)
Q Consensus        44 ~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~  122 (323)
                      ....+....|+++++||.|+||.+|+|....+|+.||||+-...   .....+.-|..+.+.|++ .+|..+..++.+ .
T Consensus         8 ~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~---a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e-~   83 (341)
T KOG1163|consen    8 LEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK---AKHPQLLYESKVYRILQGGVGIPHIRHYGTE-K   83 (341)
T ss_pred             hhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc---CCCcchhHHHHHHHHhccCCCCchhhhhccc-c
Confidence            34456788999999999999999999999999999999997543   233456678888888864 677777777766 6


Q ss_pred             CeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecC--CCcEEEeecCcch
Q 020657          123 GDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNN--NMQVKIADFGVSK  199 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~--~~~~kl~Dfg~~~  199 (323)
                      .+-.+||+.+ |.||+++.+- ++.++..+++.++-|++.-++|+|.++++||||||+|+|..-+  ...+.|+|||+|.
T Consensus        84 ~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK  162 (341)
T KOG1163|consen   84 DYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK  162 (341)
T ss_pred             ccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchh
Confidence            7889999999 5699999873 5579999999999999999999999999999999999998543  3489999999998


Q ss_pred             hhccC-------ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCc---cHHHHH
Q 020657          200 IMCRS-------LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRP---DWATLM  269 (323)
Q Consensus       200 ~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~---~~~~~~  269 (323)
                      .+-+.       ..+.....||.+|.+-..+.     +...+.++|+-|+|.+|..+.-|.+||.+.....   -.+.+.
T Consensus       163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~-----g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~  237 (341)
T KOG1163|consen  163 KYRDIRTRQHIPYREDRNLTGTARYASINAHL-----GIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKIS  237 (341)
T ss_pred             hhccccccccCccccCCccceeeeehhhhhhh-----hhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHH
Confidence            77542       33445567899998866554     3334568999999999999999999997654332   334455


Q ss_pred             HHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHH
Q 020657          270 CAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQL  309 (323)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~  309 (323)
                      +.........++++.|.++...+.-|-..-.++-|+..-+
T Consensus       238 EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~yl  277 (341)
T KOG1163|consen  238 EKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYL  277 (341)
T ss_pred             HhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHH
Confidence            5554445556778999999999999999888888876544

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=5.9e-28  Score=211.53  Aligned_cols=254  Identities=23%  Similarity=0.266  Sum_probs=197.5

Q ss_pred             ccceeeeecccCCeEEEEEEecccC-cEEEEEeecCCCChHHHHHHHHHHHHHHcCC----CCccceeceeEEcCCCeEE
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTH-KIYALKVVHGDADPTVRRQVFREMEILRRTD----SPFIVQCFGIFEKPSGDIA  126 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~-~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~----h~~i~~~~~~~~~~~~~~~  126 (323)
                      +|++.+.||+|+||.||+|.+..++ +.+|+|+.......... .+..|..++..+.    ..++..+++.+...+...+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence            8999999999999999999987664 67888988654322222 5667888888876    3689999988843367889


Q ss_pred             EEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC----CcEEEeecCcch-
Q 020657          127 ILMEYMDSGTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN----MQVKIADFGVSK-  199 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~----~~~kl~Dfg~~~-  199 (323)
                      +||+.+ |.+|.++....  +.++..++..++.|++.+|.+||+.|++||||||.|+++...+    ..+.|.|||+++ 
T Consensus        98 iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~  176 (322)
T KOG1164|consen   98 IVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR  176 (322)
T ss_pred             EEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence            999999 56999988643  5799999999999999999999999999999999999998653    379999999998 


Q ss_pred             -hhccCcc-------c-cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHH
Q 020657          200 -IMCRSLD-------A-CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMC  270 (323)
Q Consensus       200 -~~~~~~~-------~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~  270 (323)
                       .+.....       . .....||.+|.++..+.+...     +.+.|+||++.++.+++.|.+||.............+
T Consensus       177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-----~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~  251 (322)
T KOG1164|consen  177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-----GRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEK  251 (322)
T ss_pred             ccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-----CCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHH
Confidence             4322111       1 224569999999998874444     4599999999999999999999977665544444443


Q ss_pred             HHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          271 AICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ..............+.++..++..+-..+...+|....+...
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  252 DPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             HhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            333322222445567889999999988999999998877643

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=7.1e-29  Score=198.92  Aligned_cols=164  Identities=23%  Similarity=0.287  Sum_probs=126.0

Q ss_pred             CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccccccc
Q 020657          135 GTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVG  213 (323)
Q Consensus       135 ~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  213 (323)
                      |+|.+++.. +..+++..++.++.||+.||.|||+.+      ||+||+++.++ .+++  ||.+.......     ..+
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~-~~~~--fG~~~~~~~~~-----~~g   66 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDG-LLKL--DGSVAFKTPEQ-----SRV   66 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCcc-ceee--ccceEeecccc-----CCC
Confidence            589999976 456999999999999999999999999      99999999987 7888  99986653321     257


Q ss_pred             cccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCc-cHHHHHHHHhcCCCC--CCCCCCCh--hH
Q 020657          214 TCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRP-DWATLMCAICFGDPP--SLPDGASP--EF  288 (323)
Q Consensus       214 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~-~~~~~~~~~~~~~~~--~~~~~~~~--~l  288 (323)
                      +..|+|||++....     ++.++||||||+++|||+||..||....... ....+........+.  ..+..++.  ++
T Consensus        67 ~~~y~aPE~~~~~~-----~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  141 (176)
T smart00750       67 DPYFMAPEVIQGQS-----YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSF  141 (176)
T ss_pred             cccccChHHhcCCC-----CcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhH
Confidence            89999999987443     4569999999999999999999996543322 222222222211111  11122333  69


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          289 RSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       289 ~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                      .+++++||+.+|++|||+.++++|+|+..
T Consensus       142 ~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      142 ADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence            99999999999999999999999999753

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=2.2e-29  Score=234.03  Aligned_cols=259  Identities=27%  Similarity=0.394  Sum_probs=200.8

Q ss_pred             ceeeeecccCCeEEEEEEecccCcEEEEEeec-----CCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           54 EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH-----GDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        54 ~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~-----~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      .-...+|.|++|.++.+......+....|.+.     ..........+..|.-+-..+.|+|++..+..+.+..... -+
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~-~~  399 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGIL-QS  399 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccch-hh
Confidence            45678999999988888776566655555543     2222233334677777778899999988777766533333 33


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc---
Q 020657          129 MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL---  205 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~---  205 (323)
                      ||||++ +|..++.....++...+..+++|++.|+.|+|+.|+.|+|+|++|++++..| .+||+|||.+.....+.   
T Consensus       400 mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g-~lki~Dfg~~~vf~~~~e~~  477 (601)
T KOG0590|consen  400 MEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENG-ILKIIDFGAASVFRYPWEKN  477 (601)
T ss_pred             hhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCC-ceEEeecCcceeeccCcchh
Confidence            999999 9999998877899999999999999999999999999999999999999998 89999999997654332   


Q ss_pred             -cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHH-HH---HHHHhcCCCCCC
Q 020657          206 -DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWA-TL---MCAICFGDPPSL  280 (323)
Q Consensus       206 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~-~~---~~~~~~~~~~~~  280 (323)
                       ......+|...|+|||++.+..+..    ...||||.|++++.|.+|+.||.......... ..   .+......+..+
T Consensus       478 ~~~~~g~~gS~pY~apE~~~~~~ydp----r~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~  553 (601)
T KOG0590|consen  478 IHESSGIVGSDPYLAPEVLTGKEYDP----RAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRL  553 (601)
T ss_pred             hhhhcCcccCCcCcCcccccccccCc----chhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHH
Confidence             3345678999999999998666543    58999999999999999999997655443321 11   111111122233


Q ss_pred             CCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          281 PDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       281 ~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      ...++..-+.+|..||++||.+|.|+++|++.+||+.++
T Consensus       554 ~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~  592 (601)
T KOG0590|consen  554 LSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE  592 (601)
T ss_pred             HHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence            456788899999999999999999999999999999875

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=7.3e-27  Score=193.21  Aligned_cols=253  Identities=20%  Similarity=0.286  Sum_probs=200.4

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceeceeEEcCCCe
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKPSGD  124 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  124 (323)
                      ..+-+-.|++.++||+|+||.+++|.+.-+++.||||.-....+.   .++..|....+.| ..++|..++=+... +.+
T Consensus        23 ~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A---PQLrdEYr~YKlL~g~~GIP~vYYFGqe-G~~   98 (449)
T KOG1165|consen   23 VLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA---PQLRDEYRTYKLLGGTEGIPQVYYFGQE-GKY   98 (449)
T ss_pred             ceEecccceeccccccCcceeeecccccccCceEEEEeccccCCc---chHHHHHHHHHHHcCCCCCCceeeeccc-cch
Confidence            346778999999999999999999999999999999997655433   3345677777776 56889888866665 567


Q ss_pred             EEEEEeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC----CcEEEeecCcch
Q 020657          125 IAILMEYMDSGTLDTLLN-KNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN----MQVKIADFGVSK  199 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~----~~~kl~Dfg~~~  199 (323)
                      -.+|+|.+ |.+|+++.. .++.++...+..++.|++.-++++|++.+|+|||||+|+||..-+    ..+.++|||+|.
T Consensus        99 NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK  177 (449)
T KOG1165|consen   99 NILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK  177 (449)
T ss_pred             hhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence            78999999 569999987 566899999999999999999999999999999999999996432    379999999998


Q ss_pred             hhccC-------ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHH
Q 020657          200 IMCRS-------LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAI  272 (323)
Q Consensus       200 ~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~  272 (323)
                      .+.++       ..+.....||.+||+=-.+.     +...+.+.|+-|||-+++++|-|.+||.+...... ..-.+++
T Consensus       178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHl-----GrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn-K~kYeKI  251 (449)
T KOG1165|consen  178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHL-----GREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN-KEKYEKI  251 (449)
T ss_pred             hhcCccccccCccccccccccceeeeEeeccc-----cchhhhhhhHHHhhhhhhhhccCCCccccccCcch-HHHHHHh
Confidence            87654       33445677999999987766     34445699999999999999999999987644333 3333333


Q ss_pred             hcCCC----CCCCCCCChhHHHHHHHhcccCcCCCCCHHHH
Q 020657          273 CFGDP----PSLPDGASPEFRSFIECCLQKEFSKRWTASQL  309 (323)
Q Consensus       273 ~~~~~----~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~  309 (323)
                      .....    ..+..++|.++...|+-.-..+..+-|+.+-+
T Consensus       252 Ge~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdyl  292 (449)
T KOG1165|consen  252 GETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYL  292 (449)
T ss_pred             ccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHH
Confidence            33222    23456788999999999888888888886644

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=1.1e-26  Score=203.33  Aligned_cols=169  Identities=17%  Similarity=0.208  Sum_probs=132.1

Q ss_pred             hccccccceeeeecccCCeEEEEEEecc-cCcEEEEEeecCC----CChHHHHHHHHHHHHHHcCCCCccce-eceeEEc
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRC-THKIYALKVVHGD----ADPTVRRQVFREMEILRRTDSPFIVQ-CFGIFEK  120 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~-~~~~v~iK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~  120 (323)
                      ....++|.+.+.||+|+||+||+|++.. +++.+|+|+....    ........+.+|+.+++.++|+|+++ +++    
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----   89 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----   89 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----
Confidence            3456889999999999999999999875 6777899987533    12344667899999999999999985 433    


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCC-CCCCeEEecCCCcEEEeecCcch
Q 020657          121 PSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDI-KPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       121 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di-~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                       .+..++||||++|++|... ..   ..   ...++.+++++|.+||+.|++|||| ||+||+++.++ +++|+|||++.
T Consensus        90 -~~~~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~-~ikLiDFGlA~  160 (365)
T PRK09188         90 -TGKDGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDG-EAAVIDFQLAS  160 (365)
T ss_pred             -cCCcEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCC-CEEEEECccce
Confidence             2357999999999999732 11   11   2567899999999999999999999 99999998877 89999999998


Q ss_pred             hhccCcccc--------ccccccccccCCcccCCCCC
Q 020657          200 IMCRSLDAC--------NSYVGTCAYMSPERFDPDAY  228 (323)
Q Consensus       200 ~~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~  228 (323)
                      .........        ....++..|.|||.+.+...
T Consensus       161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~  197 (365)
T PRK09188        161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRER  197 (365)
T ss_pred             ecccCcchhhhhhhhhhhhhhccCccCCcccCChhhh
Confidence            664432111        23457788999999875543

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-27  Score=192.32  Aligned_cols=260  Identities=20%  Similarity=0.320  Sum_probs=202.5

Q ss_pred             CCCCCCCCccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCC-CChHHHHHHHHHHHHHHcCCCCccce
Q 020657           35 PNTNNNTTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIVQ  113 (323)
Q Consensus        35 ~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~  113 (323)
                      +.+...+...-.+++.++..++.+|.+...|..|+|+|+  |..+++|++... ......+.|..|.-.++-+.||||++
T Consensus       174 tr~rdatlsr~~gid~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilp  251 (448)
T KOG0195|consen  174 TRTRDATLSRYTGIDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILP  251 (448)
T ss_pred             ccccccccccccCcchhhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhh
Confidence            344455556666788888899999999999999999995  556667777533 34455677888988899999999999


Q ss_pred             eceeEEcCCCeEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC-C-eecCCCCCCeEEecCCCc
Q 020657          114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHK-I-IHRDIKPSNLLVNNNNMQ  189 (323)
Q Consensus       114 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~g-i-vH~di~~~nil~~~~~~~  189 (323)
                      +++.+.+ ...+.++..||+.++|...+....  ..+..++++++.+++++++|||+.. + ----+....+++|++- +
T Consensus       252 vlgacns-ppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedl-t  329 (448)
T KOG0195|consen  252 VLGACNS-PPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDL-T  329 (448)
T ss_pred             hhhhccC-CCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchh-h
Confidence            9999988 467899999999999999998654  3678899999999999999999973 3 3336788899999874 6


Q ss_pred             EEEe--ecCcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHH
Q 020657          190 VKIA--DFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWAT  267 (323)
Q Consensus       190 ~kl~--Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~  267 (323)
                      .+|.  |--++       -...+....+.|++||.+...+..  ..-.++|+|||++++|||.|.+.||..-..-   +-
T Consensus       330 arismad~kfs-------fqe~gr~y~pawmspealqrkped--~n~raadmwsfaillwel~trevpfadlspm---ec  397 (448)
T KOG0195|consen  330 ARISMADTKFS-------FQEVGRAYSPAWMSPEALQRKPED--LNIRAADMWSFAILLWELNTREVPFADLSPM---EC  397 (448)
T ss_pred             hheecccceee-------eeccccccCcccCCHHHHhcCchh--cchhhhhHHHHHHHHHHhhccccccccCCch---hh
Confidence            6654  22221       112334567899999999755432  2234899999999999999999999543322   22


Q ss_pred             HHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHh
Q 020657          268 LMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLL  310 (323)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l  310 (323)
                      -+.....+.+..+|.+++..+..|+.-|++.||.+||.+..++
T Consensus       398 gmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  398 GMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             hhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence            3344455778899999999999999999999999999998764

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=4.8e-24  Score=187.11  Aligned_cols=259  Identities=35%  Similarity=0.539  Sum_probs=202.9

Q ss_pred             cceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChH--HHHHHHHHHHHHHcCCCC-ccceeceeEEcCCCeEEEEE
Q 020657           53 LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT--VRRQVFREMEILRRTDSP-FIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        53 ~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~--~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~~lv~  129 (323)
                      |.+...||.|+|+.||++.+.   ..+++|.+.......  ....+.+|+.+++.+.|+ +++.+.+.+.. ....++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~   77 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD-EGSLYLVM   77 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec-CCEEEEEE
Confidence            788999999999999999996   778899987664433  577889999999999988 79999999965 55689999


Q ss_pred             eccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc
Q 020657          130 EYMDSGTLDTLLNKNG---TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD  206 (323)
Q Consensus       130 e~~~~~sL~~~l~~~~---~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~  206 (323)
                      +++.++++.+++....   .++...+..++.|++.++.++|+.|++|||+||+||+++..+..++++|||.+........
T Consensus        78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~  157 (384)
T COG0515          78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS  157 (384)
T ss_pred             ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence            9999999997777664   7999999999999999999999999999999999999998753599999999975543321


Q ss_pred             ------ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCC--
Q 020657          207 ------ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPP--  278 (323)
Q Consensus       207 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~--  278 (323)
                            ......++..|++||.+....  ....+...|+|++|++++++++|..||......................  
T Consensus       158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~--~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  235 (384)
T COG0515         158 TSSIPALPSTSVGTPGYMAPEVLLGLS--LAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL  235 (384)
T ss_pred             cccccccccccccccccCCHHHhcCCC--CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccc
Confidence                  245678999999999986321  1344569999999999999999999975554311122222222222211  


Q ss_pred             --CCCCCC----ChhHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          279 --SLPDGA----SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       279 --~~~~~~----~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                        ......    ...+.+++..++..+|..|.+..+...++|...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~  280 (384)
T COG0515         236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH  280 (384)
T ss_pred             ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence              111111    257999999999999999999999888866543

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.92  E-value=2e-25  Score=187.45  Aligned_cols=240  Identities=21%  Similarity=0.264  Sum_probs=155.8

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC--hHHHHHHHHHHHHHHcCC----------CCccceecee
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD--PTVRRQVFREMEILRRTD----------SPFIVQCFGI  117 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~e~~~l~~l~----------h~~i~~~~~~  117 (323)
                      ...+...+.||.|+++.||.++|..+++.+++|++....+  ....+.+.+|.-....+.          |-.++..++.
T Consensus        11 ~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~   90 (288)
T PF14531_consen   11 PRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL   90 (288)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred             ceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence            3466778999999999999999999999999999864432  234566666655444432          2233333333


Q ss_pred             EEcC--------C---C-----eEEEEEeccCCCCHHHHHHh---cC----CCCHHHHHHHHHHHHHHHHHHHhCCCeec
Q 020657          118 FEKP--------S---G-----DIAILMEYMDSGTLDTLLNK---NG----TFSEPKLAHIASQILKGLSYLHGHKIIHR  174 (323)
Q Consensus       118 ~~~~--------~---~-----~~~lv~e~~~~~sL~~~l~~---~~----~~~~~~~~~i~~~i~~~l~~Lh~~givH~  174 (323)
                      ....        .   .     ..+++|+-+.+ +|.+++..   ..    .+.......+..|+++.+++||+.|++|+
T Consensus        91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHg  169 (288)
T PF14531_consen   91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHG  169 (288)
T ss_dssp             EEETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred             EEEcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEec
Confidence            2211        1   1     24678888854 89888642   11    13344556677999999999999999999


Q ss_pred             CCCCCCeEEecCCCcEEEeecCcchhhccCccccccccccccccCCcccCCCCC---CCCCCCcchhHHHHHHHHHHHHh
Q 020657          175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAY---GGNYNGYAGDIWSLGLTLLELYL  251 (323)
Q Consensus       175 di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~~~~~~Dv~slG~ll~~llt  251 (323)
                      ||+|+|++++.+| .+.|+||+.....+.....   ...+..|.+||.......   .....+.+.|.|+||+++|.|++
T Consensus       170 di~~~nfll~~~G-~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  170 DIKPENFLLDQDG-GVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             T-SGGGEEE-TTS--EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCC-CEEEcChHHHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            9999999999998 8999999988766543322   334578899997643210   22345779999999999999999


Q ss_pred             CCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCC
Q 020657          252 GHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKR  303 (323)
Q Consensus       252 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~R  303 (323)
                      |..||...........         .-..+.++++.++.||+++|++||++|
T Consensus       246 ~~lPf~~~~~~~~~~~---------~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  246 GRLPFGLSSPEADPEW---------DFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             SS-STCCCGGGSTSGG---------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             ccCCCCCCCccccccc---------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence            9999964432211110         112234889999999999999999988

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=3.7e-24  Score=172.71  Aligned_cols=140  Identities=21%  Similarity=0.246  Sum_probs=110.9

Q ss_pred             eeeecccCCeEEEEEEecccCcEEEEEeecCCCCh--H-----------------------HHHHHHHHHHHHHcCCCCc
Q 020657           56 LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADP--T-----------------------VRRQVFREMEILRRTDSPF  110 (323)
Q Consensus        56 ~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~--~-----------------------~~~~~~~e~~~l~~l~h~~  110 (323)
                      .+.||+|++|.||+|.+. +|+.||+|+++.....  .                       ......+|+..+.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            468999999999999997 8999999999754211  0                       0122345999999998887


Q ss_pred             cceeceeEEcCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCCeecCCCCCCeEEecCCCc
Q 020657          111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL-HGHKIIHRDIKPSNLLVNNNNMQ  189 (323)
Q Consensus       111 i~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~L-h~~givH~di~~~nil~~~~~~~  189 (323)
                      +.....+...   ..++||||++++++.........++...+..++.|++.+|.++ |+.|++||||||+||++++ + .
T Consensus        81 v~~p~~~~~~---~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-~-~  155 (190)
T cd05147          81 IPCPEPILLK---SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-G-K  155 (190)
T ss_pred             CCCCcEEEec---CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-C-c
Confidence            7544433222   2389999999877766544456789999999999999999999 7999999999999999985 4 7


Q ss_pred             EEEeecCcchhh
Q 020657          190 VKIADFGVSKIM  201 (323)
Q Consensus       190 ~kl~Dfg~~~~~  201 (323)
                      ++|+|||++...
T Consensus       156 v~LiDFG~a~~~  167 (190)
T cd05147         156 LYIIDVSQSVEH  167 (190)
T ss_pred             EEEEEccccccC
Confidence            999999999654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.91  E-value=6.2e-25  Score=205.95  Aligned_cols=244  Identities=24%  Similarity=0.282  Sum_probs=182.6

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHH---HHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR---QVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~---~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ++...+.||.+.|=.|.+|++. .|. |++|++-+..+....+   +...|++ ...+++||.+++.-+-.. +...|+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t-~kAAylv   99 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVT-DKAAYLV   99 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHh-hHHHHHH
Confidence            7888999999999999999986 444 8899997664333333   3344444 555789999998887555 5667888


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhh--ccCcc
Q 020657          129 MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM--CRSLD  206 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~--~~~~~  206 (323)
                      -+|..+ +|+|.+.-.+-+...+.+.|+.||+.||..+|..||+|||||.+|||++.=+ =+.|.||..-...  ....+
T Consensus       100 Rqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWN-W~~LtDFAsFKPtYLPeDNP  177 (1431)
T KOG1240|consen  100 RQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWN-WLYLTDFASFKPTYLPEDNP  177 (1431)
T ss_pred             HHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeec-hhhhhcccccCCccCCCCCc
Confidence            889876 9999998888899999999999999999999999999999999999999865 4789999865321  11111


Q ss_pred             c-----cccccccccccCCcccCCCC------CCCCCCCcchhHHHHHHHHHHHHh-CCCCCC-------CCCCCccHHH
Q 020657          207 A-----CNSYVGTCAYMSPERFDPDA------YGGNYNGYAGDIWSLGLTLLELYL-GHFPFL-------QPGQRPDWAT  267 (323)
Q Consensus       207 ~-----~~~~~~~~~y~aPE~~~~~~------~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~-------~~~~~~~~~~  267 (323)
                      .     ..+.....+|+|||.+....      ......+++-||||+||+++||++ |..||.       ..++..+.+.
T Consensus       178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~  257 (1431)
T KOG1240|consen  178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQ  257 (1431)
T ss_pred             ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHH
Confidence            1     11233457999999886422      111225789999999999999996 677772       1112333333


Q ss_pred             HHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          268 LMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      +++.+           -+..+++|+..|++.||++|.++++.|+.
T Consensus       258 ~Le~I-----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  258 LLEKI-----------EDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHhC-----------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            33322           23478999999999999999999999976

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.91  E-value=6.2e-24  Score=173.39  Aligned_cols=176  Identities=17%  Similarity=0.223  Sum_probs=132.8

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC--hHHHHH------HHHHHHHHHcCCCCccceecee
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD--PTVRRQ------VFREMEILRRTDSPFIVQCFGI  117 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~------~~~e~~~l~~l~h~~i~~~~~~  117 (323)
                      ..+...+|++++.+|.|+||.||++.+  ++..+|+|++.....  +.....      +.+|+..+.++.|++|..+.++
T Consensus        26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~  103 (232)
T PRK10359         26 DDFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF  103 (232)
T ss_pred             HHHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence            456788999999999999999999766  466899999975532  222223      5789999999999999999988


Q ss_pred             EEcC-------CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcE
Q 020657          118 FEKP-------SGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQV  190 (323)
Q Consensus       118 ~~~~-------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~  190 (323)
                      +...       .+..+++|||++|.+|.++..    +++    ....+++.++..+|+.|++|||++|.||+++.+|  +
T Consensus       104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g--i  173 (232)
T PRK10359        104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG--L  173 (232)
T ss_pred             eeecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC--E
Confidence            6643       235789999999999988742    333    2456999999999999999999999999999876  9


Q ss_pred             EEeecCcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHH
Q 020657          191 KIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELY  250 (323)
Q Consensus       191 kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~ll  250 (323)
                      +|+|||........... ..           ......     +..++|+|+||+++..+.
T Consensus       174 ~liDfg~~~~~~e~~a~-d~-----------~vler~-----y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        174 RIIDLSGKRCTAQRKAK-DR-----------IDLERH-----YGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEECCCcccccchhhH-HH-----------HHHHhH-----hcccccccceeEeehHHH
Confidence            99999988654221111 00           111111     224899999999876544

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.90  E-value=4.5e-25  Score=197.01  Aligned_cols=240  Identities=28%  Similarity=0.430  Sum_probs=193.8

Q ss_pred             eecccCCeEEEEEEe---cccCcEEEEEeecCCCChH-HHHHHHHHHHHHHcCC-CCccceeceeEEcCCCeEEEEEecc
Q 020657           58 VLGHGNGGTVYKVQH---RCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTD-SPFIVQCFGIFEKPSGDIAILMEYM  132 (323)
Q Consensus        58 ~lg~G~~~~v~~~~~---~~~~~~v~iK~~~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~lv~e~~  132 (323)
                      .+|+|.+|.|++++-   ...+.-++.|+..+..... .......|..++...+ ||.++.+.-.++. +...+++.++.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt-~~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT-DGKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc-ccchhHhhhhc
Confidence            378999999998752   2356678888876442111 1113445777777775 9999999988887 78899999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccccccc
Q 020657          133 DSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYV  212 (323)
Q Consensus       133 ~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  212 (323)
                      .++.|...+.....+++..+..+...++-+++++|+.|++|+|+|++||+++.+| .+++.|||++...-.....    +
T Consensus        80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~G-hi~~tdfglske~v~~~~~----c  154 (612)
T KOG0603|consen   80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEG-HIKLTDFGLSKEAVKEKIA----C  154 (612)
T ss_pred             ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccC-ccccCCchhhhHhHhhhhc----c
Confidence            9999999998888899999999999999999999999999999999999999998 8999999999765433222    7


Q ss_pred             ccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHH
Q 020657          213 GTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFI  292 (323)
Q Consensus       213 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll  292 (323)
                      |+.-|+|||++++       .+..+|.|+||+++++|+||..||..       +.+.+..  .....+|..++..+.+++
T Consensus       155 gt~eymApEI~~g-------h~~a~D~ws~gvl~felltg~~pf~~-------~~~~~Il--~~~~~~p~~l~~~a~~~~  218 (612)
T KOG0603|consen  155 GTYEYRAPEIING-------HLSAADWWSFGVLAFELLTGTLPFGG-------DTMKRIL--KAELEMPRELSAEARSLF  218 (612)
T ss_pred             cchhhhhhHhhhc-------cCCcccchhhhhhHHHHhhCCCCCch-------HHHHHHh--hhccCCchhhhHHHHHHH
Confidence            8999999999871       23489999999999999999999955       1111111  223456778899999999


Q ss_pred             HHhcccCcCCCCC-----HHHHhcCcccccCC
Q 020657          293 ECCLQKEFSKRWT-----ASQLLTHPFLCKNR  319 (323)
Q Consensus       293 ~~~l~~~p~~Rpt-----~~~~l~h~~f~~~~  319 (323)
                      ++++..+|.+|.-     +.++++|+||+.+.
T Consensus       219 ~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~  250 (612)
T KOG0603|consen  219 RQLFKRNPENRLGAGPDGVDEIKQHEFFQSID  250 (612)
T ss_pred             HHHHhhCHHHHhccCcchhHHHhccchheeee
Confidence            9999999999985     58999999998874

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.90  E-value=9.7e-23  Score=165.02  Aligned_cols=142  Identities=16%  Similarity=0.170  Sum_probs=112.2

Q ss_pred             eeeeecccCCeEEEEEEecccCcEEEEEeecCCCCh-------------------------HHHHHHHHHHHHHHcCCCC
Q 020657           55 KLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADP-------------------------TVRRQVFREMEILRRTDSP  109 (323)
Q Consensus        55 ~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~-------------------------~~~~~~~~e~~~l~~l~h~  109 (323)
                      +.+.||+|++|.||+|.+. +|+.||+|++......                         .......+|...+.++.++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3578999999999999987 8999999999755211                         0122345788999999998


Q ss_pred             ccceeceeEEcCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCCeEEecCCC
Q 020657          110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG-HKIIHRDIKPSNLLVNNNNM  188 (323)
Q Consensus       110 ~i~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~givH~di~~~nil~~~~~~  188 (323)
                      ++.....+...   ..++||||++|+++.........++...+..++.+++.++.++|+ .|++|+||||+||+++ ++ 
T Consensus        80 ~i~~p~~~~~~---~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~-  154 (190)
T cd05145          80 GVPVPEPILLK---KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG-  154 (190)
T ss_pred             CCCCceEEEec---CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC-
Confidence            87554444332   238999999987554432234567889999999999999999999 9999999999999998 55 


Q ss_pred             cEEEeecCcchhhc
Q 020657          189 QVKIADFGVSKIMC  202 (323)
Q Consensus       189 ~~kl~Dfg~~~~~~  202 (323)
                      .++|+|||++....
T Consensus       155 ~~~liDFG~a~~~~  168 (190)
T cd05145         155 KPYIIDVSQAVELD  168 (190)
T ss_pred             CEEEEEcccceecC
Confidence            89999999997653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=3.3e-22  Score=159.89  Aligned_cols=190  Identities=13%  Similarity=0.058  Sum_probs=138.0

Q ss_pred             ceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC---hHHHHHHHHHHHHHHcCC-CCccceeceeEEcCCCeEEEEE
Q 020657           54 EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD---PTVRRQVFREMEILRRTD-SPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        54 ~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      .+...|++|+||+|+++..  .+..++.+.+.....   ......+.+|+++|++|. ++++++++++     +..+++|
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~-----~~~~lvm   77 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW-----DGRHLDR   77 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE-----cCEEEEE
Confidence            4567899999999998776  677787777754432   112335789999999995 5889999885     2368999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCC-CCCCeEEecCCCcEEEeecCcchhhccCccc-
Q 020657          130 EYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDI-KPSNLLVNNNNMQVKIADFGVSKIMCRSLDA-  207 (323)
Q Consensus       130 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di-~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~-  207 (323)
                      +|+.|.+|......       ....++.|++.+|.++|+.|++|+|| ||.||+++.++ .++|+|||++......... 
T Consensus        78 eyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g-~i~LIDFG~A~~~~~~~~~~  149 (218)
T PRK12274         78 SYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDG-SPAVIDFQLAVRGNPRARWM  149 (218)
T ss_pred             eeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCC-CEEEEECCCceecCCcchHH
Confidence            99999898754321       12457889999999999999999999 79999999887 8999999999754432211 


Q ss_pred             ---c---------ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 020657          208 ---C---------NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQ  261 (323)
Q Consensus       208 ---~---------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~  261 (323)
                         .         .-...++.|+.|+...-.   ....-...+.++.|..+|.++|+..++.+.++
T Consensus       150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l---~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        150 RLLAREDLRHLLKHKRMYCPAALTPVERRVL---KRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhh---ccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence               0         011235556666532211   11111478999999999999999999865443

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=2.7e-22  Score=170.12  Aligned_cols=196  Identities=24%  Similarity=0.301  Sum_probs=146.7

Q ss_pred             CCCccceeceeEEcC--------------------------CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHH
Q 020657          107 DSPFIVQCFGIFEKP--------------------------SGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQIL  160 (323)
Q Consensus       107 ~h~~i~~~~~~~~~~--------------------------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~  160 (323)
                      +||||+.+.+.|.+.                          ...+|+||..+++ ||..++..+ ..+.....-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHH
Confidence            599999999887541                          2257999999987 999999765 457778888999999


Q ss_pred             HHHHHHHhCCCeecCCCCCCeEEec--C-CCcEEEeecCcchhhcc-----Ccc-ccccccccccccCCcccCCCCCCCC
Q 020657          161 KGLSYLHGHKIIHRDIKPSNLLVNN--N-NMQVKIADFGVSKIMCR-----SLD-ACNSYVGTCAYMSPERFDPDAYGGN  231 (323)
Q Consensus       161 ~~l~~Lh~~givH~di~~~nil~~~--~-~~~~kl~Dfg~~~~~~~-----~~~-~~~~~~~~~~y~aPE~~~~~~~~~~  231 (323)
                      +|+.|||++|+.|||+|.+||++.-  + -..+.+.|||.+..-..     +.. ..-...|+..-+|||+..-.+....
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a  431 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA  431 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence            9999999999999999999999842  2 24789999998853322     011 1112357788999998863322111


Q ss_pred             C-CCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHH
Q 020657          232 Y-NGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTAS  307 (323)
Q Consensus       232 ~-~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~  307 (323)
                      . .-.++|.|+.|.+.||+++..+||...++-. .+.  ........+.++..+++.+++|+..+|+.||++|++.+
T Consensus       432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~~--r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LDT--RTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             eeccchhhhhhhhhhHHHHhccCCcccccchhe-ech--hhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence            1 1248999999999999999999997643321 111  11223446788899999999999999999999999864

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.88  E-value=1.8e-22  Score=192.15  Aligned_cols=202  Identities=25%  Similarity=0.292  Sum_probs=160.6

Q ss_pred             CccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCC---CCccceeceeE
Q 020657           42 TATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD---SPFIVQCFGIF  118 (323)
Q Consensus        42 ~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~  118 (323)
                      ......+....|.|-..+|+|++|.||.|...+ |+.||+|+-......+..    =-.+++.+|+   -+.|..+...+
T Consensus       689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfY----I~~q~~~RLk~~~~~~~~~~~~a~  763 (974)
T KOG1166|consen  689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFY----ICLQVMERLKPQMLPSIMHISSAH  763 (974)
T ss_pred             ccceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeee----ehHHHHHhhchhhhcchHHHHHHH
Confidence            455667788999999999999999999999875 999999998766554432    1123445554   23344444443


Q ss_pred             EcCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEec------CCCcEEE
Q 020657          119 EKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNN------NNMQVKI  192 (323)
Q Consensus       119 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~------~~~~~kl  192 (323)
                      .- .+.-++|++|.+.|||.++++..+.+++..+..++.|++..++.||..+||||||||+|+++..      +...++|
T Consensus       764 ~~-~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~l  842 (974)
T KOG1166|consen  764 VF-QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYL  842 (974)
T ss_pred             cc-CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEE
Confidence            33 3446899999999999999998889999999999999999999999999999999999999953      2246999


Q ss_pred             eecCcchhhcc--CccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCC
Q 020657          193 ADFGVSKIMCR--SLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHF  254 (323)
Q Consensus       193 ~Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~  254 (323)
                      +|||.+....-  ........+.|..+-++|+..     +..++.++|.|+|+.+++-||.|+.
T Consensus       843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~-----grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMRE-----GRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             EecccceeeeEcCCCcEEeeeeccccchhHHHhc-----CCCCchhhhhHHHHHHHHHHHHHHH
Confidence            99999975532  223455677899999999987     4555669999999999999999863

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.88  E-value=1.5e-22  Score=189.81  Aligned_cols=224  Identities=30%  Similarity=0.475  Sum_probs=165.3

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEE
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIA  126 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  126 (323)
                      .-.-++|..++.+..|++|.||+++++.+.+.+++|+-+ ++  .          +++.     |    ..|.+   ..+
T Consensus        79 ~p~e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~--l----------ilRn-----i----lt~a~---npf  133 (1205)
T KOG0606|consen   79 APSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QN--L----------ILRN-----I----LTFAG---NPF  133 (1205)
T ss_pred             CCCccccceeEeeccCCCCceeeeeccccccchhhcccc-cc--h----------hhhc-----c----ccccC---Ccc
Confidence            334578999999999999999999999889999985421 11  1          1111     1    11211   122


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc-
Q 020657          127 ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL-  205 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~-  205 (323)
                      .|      |+-...++..++++...        +.+++|||+.||+|+|+||+|.+++.-| .+|+.|||++....... 
T Consensus       134 vv------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mG-hiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  134 VV------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMG-HIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             ee------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecc-cccccchhhhhhhhhhcc
Confidence            22      34444445545555333        7899999999999999999999999998 89999999996542110 


Q ss_pred             --------------cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHH
Q 020657          206 --------------DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCA  271 (323)
Q Consensus       206 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~  271 (323)
                                    -..+..++|+.|+|||++....|+.     .+|+|++|+++||++-|..||++..-.+.+......
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygk-----pvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd  273 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGK-----PVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD  273 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCC-----CccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh
Confidence                          1123457999999999999777766     899999999999999999999877655555544433


Q ss_pred             HhcCCCCCCCCCCChhHHHHHHHhcccCcCCCC---CHHHHhcCccccc
Q 020657          272 ICFGDPPSLPDGASPEFRSFIECCLQKEFSKRW---TASQLLTHPFLCK  317 (323)
Q Consensus       272 ~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rp---t~~~~l~h~~f~~  317 (323)
                      ...  ++.-....++++++++.++|..+|..|.   .+-++-+|+||+.
T Consensus       274 ~i~--wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~  320 (1205)
T KOG0606|consen  274 DIE--WPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL  320 (1205)
T ss_pred             hcc--ccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence            221  2222456789999999999999999998   5678889999975

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.87  E-value=9.6e-22  Score=175.47  Aligned_cols=207  Identities=23%  Similarity=0.361  Sum_probs=162.8

Q ss_pred             HHcCCCCccceeceeEEcCCCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCC-eecCCCCCC
Q 020657          103 LRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKI-IHRDIKPSN  180 (323)
Q Consensus       103 l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~gi-vH~di~~~n  180 (323)
                      |+.+.|.|+.+++|.+.+ +...+.|.+||..|+|.+.+.. .-.++......++++|+.+|.|||...+ .|+.++..|
T Consensus         1 l~~l~h~n~~~f~g~~~~-~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n   79 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVD-GPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN   79 (484)
T ss_pred             CcccchhhhhhheeeEec-CCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence            356789999999999998 5889999999999999999987 4468899999999999999999999865 999999999


Q ss_pred             eEEecCCCcEEEeecCcchhhcc--CccccccccccccccCCcccCCCCCCC--CCCCcchhHHHHHHHHHHHHhCCCCC
Q 020657          181 LLVNNNNMQVKIADFGVSKIMCR--SLDACNSYVGTCAYMSPERFDPDAYGG--NYNGYAGDIWSLGLTLLELYLGHFPF  256 (323)
Q Consensus       181 il~~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~--~~~~~~~Dv~slG~ll~~lltg~~p~  256 (323)
                      +++|.. +.+||.|||+......  .............|.|||.+.......  ...+.+.|+||||++++|+++.+.||
T Consensus        80 Clvd~~-w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   80 CLVDSR-WVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             ceeeee-EEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            999998 5999999999876532  111122233557899999998543322  23567899999999999999999999


Q ss_pred             CCCCCCccHHHHHHHHhc-CCC---CCCC--CCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          257 LQPGQRPDWATLMCAICF-GDP---PSLP--DGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~-~~~---~~~~--~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ..........++...+.. +..   +.+.  ....+++..++++||..+|++||+++++-.
T Consensus       159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  159 DLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             ccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            775555554555444444 222   2222  145567999999999999999999988764

>smart00090 RIO RIO-like kinase

Probab=99.85  E-value=7.1e-21  Score=158.71  Aligned_cols=147  Identities=20%  Similarity=0.153  Sum_probs=114.0

Q ss_pred             ccccceeeeecccCCeEEEEEE-ecccCcEEEEEeecCCCCh-----------------------HHHHHHHHHHHHHHc
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQ-HRCTHKIYALKVVHGDADP-----------------------TVRRQVFREMEILRR  105 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~-~~~~~~~v~iK~~~~~~~~-----------------------~~~~~~~~e~~~l~~  105 (323)
                      ..-|++.+.||+|++|.||+|. +..+|+.||+|++......                       .....+.+|+..+.+
T Consensus        27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~  106 (237)
T smart00090       27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR  106 (237)
T ss_pred             CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            3458899999999999999999 6668999999999754210                       012345689999999


Q ss_pred             CCCCccceeceeEEcCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-CeecCCCCCCeEEe
Q 020657          106 TDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK-IIHRDIKPSNLLVN  184 (323)
Q Consensus       106 l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g-ivH~di~~~nil~~  184 (323)
                      +.+.+ +.+..++..  ...++||||+++.++.........+....+..++.||+.++.+||+.| ++|+||||+||+++
T Consensus       107 L~~~~-i~~p~~~~~--~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~  183 (237)
T smart00090      107 LYEAG-VPVPKPIAW--RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH  183 (237)
T ss_pred             HHhcC-CCCCeeeEe--cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence            86532 222222222  234899999999888766544456677778899999999999999999 99999999999999


Q ss_pred             cCCCcEEEeecCcchhh
Q 020657          185 NNNMQVKIADFGVSKIM  201 (323)
Q Consensus       185 ~~~~~~kl~Dfg~~~~~  201 (323)
                       ++ .++|+|||.+...
T Consensus       184 -~~-~i~LiDFg~a~~~  198 (237)
T smart00090      184 -DG-KVVIIDVSQSVEL  198 (237)
T ss_pred             -CC-CEEEEEChhhhcc
Confidence             55 8999999998654

>PRK10345 hypothetical protein; Provisional

Probab=99.85  E-value=3e-20  Score=151.34  Aligned_cols=139  Identities=23%  Similarity=0.344  Sum_probs=107.2

Q ss_pred             cceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-----CCCccceeceeEEcCC--CeE
Q 020657           53 LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT-----DSPFIVQCFGIFEKPS--GDI  125 (323)
Q Consensus        53 ~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~--~~~  125 (323)
                      +.-...||+|+++.||.  +..++.. +||++..... ...+.+.+|+.+++.+     .||||++++|++++..  +..
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~-~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v   79 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD-GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV   79 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCe-EEEEEecccc-chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence            34467899999999996  6556555 5888865432 2346789999999999     5799999999998853  233


Q ss_pred             E-EEEec--cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCCeecCCCCCCeEEecC---CCcEEEeecCcc
Q 020657          126 A-ILMEY--MDSGTLDTLLNKNGTFSEPKLAHIASQILKGL-SYLHGHKIIHRDIKPSNLLVNNN---NMQVKIADFGVS  198 (323)
Q Consensus       126 ~-lv~e~--~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l-~~Lh~~givH~di~~~nil~~~~---~~~~kl~Dfg~~  198 (323)
                      + +|+||  +.+++|.+++.+. .+++.  ..++.+++.++ .|||+++|+|+||||+||+++..   +.+++|+||+.+
T Consensus        80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            3 78999  4478999999764 46655  35677878777 99999999999999999999742   237999995433

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.83  E-value=2.1e-21  Score=170.44  Aligned_cols=176  Identities=32%  Similarity=0.415  Sum_probs=131.1

Q ss_pred             EEEEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhh
Q 020657          125 IAILMEYMDSGTLDTLLNKNG---TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM  201 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~  201 (323)
                      ++|.|++|...+|.+|+...+   ..+......++.|++.+++|   +|.+|+|+||.||++..++ ++||+|||+....
T Consensus       331 lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~-q~kIgDFgl~ts~  406 (516)
T KOG1033|consen  331 LYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDD-QLKIGDFGLVTSQ  406 (516)
T ss_pred             hhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccch-hhhhhhhhheeec
Confidence            568888999889999996432   46788899999999999999   9999999999999999887 8999999999765


Q ss_pred             ccCc------cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhc
Q 020657          202 CRSL------DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICF  274 (323)
Q Consensus       202 ~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~  274 (323)
                      ....      .......+|..|++||.+.+..++     .++|||+||++++|++. =.-+|..      ...+ ..+..
T Consensus       407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~-----~kvdIyaLGlil~EL~~~f~T~~er------~~t~-~d~r~  474 (516)
T KOG1033|consen  407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYS-----EKVDIYALGLILAELLIQFSTQFER------IATL-TDIRD  474 (516)
T ss_pred             ccCCcccchhhhhhhcccccccCCHHHHhhhhhh-----hhcchhhHHHHHHHHHHHhccHHHH------HHhh-hhhhc
Confidence            4322      122356799999999999855554     59999999999999996 2222311      1111 11111


Q ss_pred             CCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccc
Q 020657          275 GDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLC  316 (323)
Q Consensus       275 ~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~  316 (323)
                      +..++....--++-.+|+.+|+...|.+||++.+.--|.|.+
T Consensus       475 g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~  516 (516)
T KOG1033|consen  475 GIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ  516 (516)
T ss_pred             CCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence            222211122234567999999999999999888887777753

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=2.5e-19  Score=147.81  Aligned_cols=135  Identities=23%  Similarity=0.370  Sum_probs=111.5

Q ss_pred             eeecccCCeEEEEEEecccCcEEEEEeecCCCC--hH-----HHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           57 QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD--PT-----VRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      +.||+|++|.||+|.+  .+..+++|+......  ..     ....+.+|+.++..+.|+++.....++.. ....+++|
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-~~~~~lv~   78 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD-PENFIIVM   78 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe-CCCCEEEE
Confidence            5789999999999998  677889998653321  11     23457789999999999988777766655 45678999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchh
Q 020657          130 EYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       130 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                      ||++|++|.+++.....    .+..++.+++.+|.++|+.|++|+|++|.||+++ ++ .++|+|||.+..
T Consensus        79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~-~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GG-KIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CC-CEEEEECCcccC
Confidence            99999999999875432    8889999999999999999999999999999999 44 799999998854

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.80  E-value=4.3e-19  Score=144.99  Aligned_cols=131  Identities=20%  Similarity=0.330  Sum_probs=104.3

Q ss_pred             eecccCCeEEEEEEecccCcEEEEEeecCCC--Ch-----HHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEe
Q 020657           58 VLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DP-----TVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILME  130 (323)
Q Consensus        58 ~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e  130 (323)
                      .||+|++|.||+|.+  ++..+++|+.....  ..     ....++.+|+++++.+.|+++.....++.. ....++|||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-~~~~~lv~e   77 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD-PDNKTIVME   77 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE-CCCCEEEEE
Confidence            379999999999996  57889999865332  11     123567789999999988776554444444 455689999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchh
Q 020657          131 YMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       131 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                      |++|++|.+++.....       .++.+++.+|.+||+.|++|+|++|.||+++ ++ .++++|||++..
T Consensus        78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~-~~~liDfg~a~~  138 (199)
T TIGR03724        78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DD-KLYLIDFGLGKY  138 (199)
T ss_pred             EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CC-cEEEEECCCCcC
Confidence            9999999988765321       8889999999999999999999999999999 55 899999998854

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.79  E-value=1e-18  Score=142.62  Aligned_cols=137  Identities=20%  Similarity=0.204  Sum_probs=107.2

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCCh---------------------HHHHHHHHHHHHHHcCCCCc
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADP---------------------TVRRQVFREMEILRRTDSPF  110 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~---------------------~~~~~~~~e~~~l~~l~h~~  110 (323)
                      .|.+.+.||+|++|.||++.+. +|+.|++|++......                     ........|..++..+.+.+
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            3888899999999999999885 7999999987643210                     01123567888888887764


Q ss_pred             --cceeceeEEcCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCC
Q 020657          111 --IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNM  188 (323)
Q Consensus       111 --i~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~  188 (323)
                        ++..++     .+..++||||+++++|..+...      .....++.+++.++.++|+.|++|+||+|.||+++.++ 
T Consensus        95 i~v~~~~~-----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~-  162 (198)
T cd05144          95 FPVPKPID-----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE-  162 (198)
T ss_pred             CCCCceee-----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC-
Confidence              333333     2345899999999998765431      34567889999999999999999999999999999876 


Q ss_pred             cEEEeecCcchhh
Q 020657          189 QVKIADFGVSKIM  201 (323)
Q Consensus       189 ~~kl~Dfg~~~~~  201 (323)
                      .++|+|||++...
T Consensus       163 ~~~liDfg~~~~~  175 (198)
T cd05144         163 KIYIIDWPQMVST  175 (198)
T ss_pred             cEEEEECCccccC
Confidence            8999999998554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.78  E-value=3.4e-20  Score=172.87  Aligned_cols=263  Identities=22%  Similarity=0.313  Sum_probs=205.2

Q ss_pred             cccccceeeeecccCCeEEEEEEecc-cCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCC-CCccceeceeEEcCCCeE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRC-THKIYALKVVHGDA-DPTVRRQVFREMEILRRTD-SPFIVQCFGIFEKPSGDI  125 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~  125 (323)
                      ....|.+.+.||+|+++.+-++.... ....++.|.+.... .......+..|..+-+.+. |.|++..++...+ .+..
T Consensus        18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~-~~~~   96 (601)
T KOG0590|consen   18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS-PRSY   96 (601)
T ss_pred             ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC-Cccc
Confidence            45678888889999999998888743 33355566655442 3344555566777777776 9999999999887 6778


Q ss_pred             EEEEeccCCCCHHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          126 AILMEYMDSGTLDTLL-NKNG-TFSEPKLAHIASQILKGLSYLH-GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l-~~~~-~~~~~~~~~i~~~i~~~l~~Lh-~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      ++++++..|+++.+-+ .... ..+...+..++.|+..++.|+| ..++.|+|++|+|.+++..+..+++.|||+|..+.
T Consensus        97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen   97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            9999999999999888 5544 6788889999999999999999 99999999999999999886479999999998765


Q ss_pred             c-C--ccccccccc-cccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccH-HHHHHHHhcCCC
Q 020657          203 R-S--LDACNSYVG-TCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDW-ATLMCAICFGDP  277 (323)
Q Consensus       203 ~-~--~~~~~~~~~-~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~-~~~~~~~~~~~~  277 (323)
                      . .  .......++ +..|.|||...+..+    .....|+|+.|+++..+++|..||......... ..+.... ....
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~----~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~  251 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAY----RGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK-GRFT  251 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhh----cCCCcccccccccccccccCCCCccccccccccceeecccc-cccc
Confidence            5 2  222344567 999999999875433    335899999999999999999999766554422 2222211 1112


Q ss_pred             CCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          278 PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       278 ~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                      ......++....+++.+++..+|..|.+.+++-.++|+..
T Consensus       252 ~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  252 QLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             cCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence            3344678899999999999999999999999999999987

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.78  E-value=4e-18  Score=159.24  Aligned_cols=136  Identities=18%  Similarity=0.228  Sum_probs=108.0

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCC--CC-----hHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCe
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--AD-----PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGD  124 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~--~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  124 (323)
                      .|...+.||+|+||+||+|.+.  +..+++|+....  ..     ......+.+|+.+++.++|++++....+... ...
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-~~~  410 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD-PEE  410 (535)
T ss_pred             ccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe-CCC
Confidence            3456789999999999999885  333444433211  11     1224567899999999999999887766665 456


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchh
Q 020657          125 IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                      .++||||+++++|.+++.        ....++.+++++|.+||+.|++||||||+||+++ ++ .++|+|||++..
T Consensus       411 ~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~-~~~liDFGla~~  476 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD-RLYLIDFGLGKY  476 (535)
T ss_pred             CEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC-cEEEEeCccccc
Confidence            789999999999999885        3577899999999999999999999999999995 44 799999999865

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.74  E-value=4.2e-17  Score=136.29  Aligned_cols=136  Identities=21%  Similarity=0.295  Sum_probs=104.4

Q ss_pred             eeec-ccCCeEEEEEEecccCcEEEEEeecCCC------------ChHHHHHHHHHHHHHHcCCCCcc--ceeceeEEcC
Q 020657           57 QVLG-HGNGGTVYKVQHRCTHKIYALKVVHGDA------------DPTVRRQVFREMEILRRTDSPFI--VQCFGIFEKP  121 (323)
Q Consensus        57 ~~lg-~G~~~~v~~~~~~~~~~~v~iK~~~~~~------------~~~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~  121 (323)
                      ..|| .|+.|++|.+..  .+..+++|.+....            +.....++.+|+.++..|.|++|  +..+++....
T Consensus        37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4576 788899999887  47788898885321            11234567889999999988775  6666654332


Q ss_pred             CCe---EEEEEeccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCc
Q 020657          122 SGD---IAILMEYMDS-GTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGV  197 (323)
Q Consensus       122 ~~~---~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~  197 (323)
                      ...   .++|||+++| .+|.+++... .+++..    +.+|+.++.+||+.||+|+||||.||+++.++ .++|+|||.
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~-~v~LIDfg~  188 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA-PLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDG-KFWLIDFDR  188 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC-CCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC-CEEEEECCC
Confidence            232   2599999997 6899888653 455443    57899999999999999999999999999886 899999998


Q ss_pred             chh
Q 020657          198 SKI  200 (323)
Q Consensus       198 ~~~  200 (323)
                      +..
T Consensus       189 ~~~  191 (239)
T PRK01723        189 GEL  191 (239)
T ss_pred             ccc
Confidence            855

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.74  E-value=2.3e-17  Score=133.37  Aligned_cols=134  Identities=19%  Similarity=0.240  Sum_probs=96.5

Q ss_pred             eeeecccCCeEEEEEEecccCcEEEEEeecCCCChH-HHHH----------------------HHHHHHHHHcCCCCc--
Q 020657           56 LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQ----------------------VFREMEILRRTDSPF--  110 (323)
Q Consensus        56 ~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~----------------------~~~e~~~l~~l~h~~--  110 (323)
                      .+.||+|++|.||+|.+. +++.|++|++....... ....                      ...|...+..+.+.+  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            567999999999999987 79999999987542111 1111                      134555555553332  


Q ss_pred             cceeceeEEcCCCeEEEEEeccCCCC-----HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCCeEEe
Q 020657          111 IVQCFGIFEKPSGDIAILMEYMDSGT-----LDTLLNKNGTFSEPKLAHIASQILKGLSYLHG-HKIIHRDIKPSNLLVN  184 (323)
Q Consensus       111 i~~~~~~~~~~~~~~~lv~e~~~~~s-----L~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~givH~di~~~nil~~  184 (323)
                      +.++++.     ...++||||+++++     |.+...     . ..+..++.+++.++.++|. .|++|+||+|+||+++
T Consensus        81 ~~~~~~~-----~~~~lv~e~~~g~~~~~~~l~~~~~-----~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~  149 (187)
T cd05119          81 VPKPIDL-----NRHVLVMEFIGGDGIPAPRLKDVRL-----L-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD  149 (187)
T ss_pred             CCceEec-----CCCEEEEEEeCCCCccChhhhhhhh-----c-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE
Confidence            3333332     23589999999843     333221     1 6678999999999999999 9999999999999999


Q ss_pred             cCCCcEEEeecCcchhhcc
Q 020657          185 NNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       185 ~~~~~~kl~Dfg~~~~~~~  203 (323)
                       ++ .++|+|||.+.....
T Consensus       150 -~~-~~~liDfg~a~~~~~  166 (187)
T cd05119         150 -DG-KVYIIDVPQAVEIDH  166 (187)
T ss_pred             -CC-cEEEEECcccccccC
Confidence             55 899999999965433

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.71  E-value=6.1e-16  Score=140.12  Aligned_cols=170  Identities=20%  Similarity=0.316  Sum_probs=133.0

Q ss_pred             EEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEeccCCCCHHHHHHhcCCCC
Q 020657           69 KVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFS  148 (323)
Q Consensus        69 ~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~  148 (323)
                      .|..+.++.+|.+.++...+. .......+.++-++.++||+|+++++.++. ++.+|+|+|.+.  .|...+++-   +
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~-~~~~ylvTErV~--Pl~~~lk~l---~  102 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEE-EGTLYLVTERVR--PLETVLKEL---G  102 (690)
T ss_pred             ccceeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcc-cCceEEEeeccc--cHHHHHHHh---H
Confidence            355566788888888876655 445567788889999999999999999988 779999999985  677777653   4


Q ss_pred             HHHHHHHHHHHHHHHHHHH-hCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccccccccccccCCcccCCCC
Q 020657          149 EPKLAHIASQILKGLSYLH-GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDA  227 (323)
Q Consensus       149 ~~~~~~i~~~i~~~l~~Lh-~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  227 (323)
                      ...+..-+.||+.||.+|| +++++|++|+-+.|+++..| .+||++|.++..................|..|+.+.+..
T Consensus       103 ~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G-eWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  103 KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG-EWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC-cEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc
Confidence            7788888999999999998 56899999999999999998 899999999865543222122223334566777654332


Q ss_pred             CCCCCCCcchhHHHHHHHHHHHHhCC
Q 020657          228 YGGNYNGYAGDIWSLGLTLLELYLGH  253 (323)
Q Consensus       228 ~~~~~~~~~~Dv~slG~ll~~lltg~  253 (323)
                             ...|.|.||+++++++.|.
T Consensus       182 -------~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  182 -------WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             -------cchhhhhHHHHHHHHhCcc
Confidence                   2679999999999999993

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.70  E-value=2e-16  Score=123.05  Aligned_cols=132  Identities=27%  Similarity=0.370  Sum_probs=110.0

Q ss_pred             eeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCC--CccceeceeEEcCCCeEEEEEecc
Q 020657           55 KLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS--PFIVQCFGIFEKPSGDIAILMEYM  132 (323)
Q Consensus        55 ~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~~lv~e~~  132 (323)
                      +++.||+|.++.||++.+.  +..+++|.......   ...+.+|+..++.+++  .+++++++.... .+..++++||+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~-~~~~~~v~e~~   75 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGES-DGWSYLLMEWI   75 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC-CCccEEEEEec
Confidence            4678999999999999984  47889999865543   4567889999999876  588888887765 46789999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CCeecCCCCCCeEEecCCCcEEEeecCcchh
Q 020657          133 DSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH---KIIHRDIKPSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       133 ~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---givH~di~~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                      .+.++...       +......++.++++++..||..   +++|+|++|.||+++..+ .++++|||.+..
T Consensus        76 ~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~-~~~l~Df~~~~~  138 (155)
T cd05120          76 EGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK-ILGIIDWEYAGY  138 (155)
T ss_pred             CCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc-EEEEEecccccC
Confidence            98777643       5566778899999999999985   799999999999999866 899999998753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.67  E-value=2.3e-16  Score=141.42  Aligned_cols=260  Identities=23%  Similarity=0.291  Sum_probs=195.7

Q ss_pred             hhccccccceeeeecc--cCCeEEEEEEe--cccCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcC-CCCccceeceeEE
Q 020657           46 AAIAYSDLEKLQVLGH--GNGGTVYKVQH--RCTHKIYALKVVHGDAD-PTVRRQVFREMEILRRT-DSPFIVQCFGIFE  119 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~--G~~~~v~~~~~--~~~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~  119 (323)
                      .......+.+...+|.  |.+|.+|.+..  ..++..+++|.-+.... +.....-.+|+...+.+ .|++.++....+.
T Consensus       109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e  188 (524)
T KOG0601|consen  109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE  188 (524)
T ss_pred             cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc
Confidence            3444556778899999  99999999998  77888999988543322 22223334565555555 5899999888888


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHH----HHHHHHhCCCeecCCCCCCeEEecCCCcEEEee
Q 020657          120 KPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILK----GLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIAD  194 (323)
Q Consensus       120 ~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~----~l~~Lh~~givH~di~~~nil~~~~~~~~kl~D  194 (323)
                      . .+..++-+|++. .+|..+.... ..++...++..+.+..+    |+.++|+.+++|.|++|.||+...+....+++|
T Consensus       189 ~-~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~d  266 (524)
T KOG0601|consen  189 G-SGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTD  266 (524)
T ss_pred             c-CCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCC
Confidence            7 788999999996 4777777643 34888999999999999    999999999999999999999998833899999


Q ss_pred             cCcchhhccCccc-----cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHH
Q 020657          195 FGVSKIMCRSLDA-----CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLM  269 (323)
Q Consensus       195 fg~~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~  269 (323)
                      ||+...+....-.     .....+...|++||++.+      .++..+|+|++|.++.+..++..+...... ..|..+.
T Consensus       267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~------l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-~~W~~~r  339 (524)
T KOG0601|consen  267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG------LATFASDIFSLGEVILEAILGSHLPSVGKN-SSWSQLR  339 (524)
T ss_pred             cceeEEccCCccccceeeeecCCCCceEeChhhhcc------ccchHhhhcchhhhhHhhHhhcccccCCCC-CCccccc
Confidence            9999877654322     122367889999998853      345699999999999998887666533211 1111111


Q ss_pred             HHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          270 CAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                      +   .-.+..+..+.+..+...+.+|+..+|..|++++.++.|.+...
T Consensus       340 ~---~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s  384 (524)
T KOG0601|consen  340 Q---GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS  384 (524)
T ss_pred             c---ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence            1   11344556677888888999999999999999999999988753

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.60  E-value=1.8e-14  Score=115.37  Aligned_cols=140  Identities=16%  Similarity=0.219  Sum_probs=101.1

Q ss_pred             eeeecccCCeEEEEEEecc------cCcEEEEEeecCCC------------C---------hHHHHHH----HHHHHHHH
Q 020657           56 LQVLGHGNGGTVYKVQHRC------THKIYALKVVHGDA------------D---------PTVRRQV----FREMEILR  104 (323)
Q Consensus        56 ~~~lg~G~~~~v~~~~~~~------~~~~v~iK~~~~~~------------~---------~~~~~~~----~~e~~~l~  104 (323)
                      ...||.|-.+.||.|....      .+..+|+|+++...            +         ......+    .+|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4679999999999998753      35789999986220            0         1112223    37888888


Q ss_pred             cCC--CCccceeceeEEcCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCCeecCCCCCCe
Q 020657          105 RTD--SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL-HGHKIIHRDIKPSNL  181 (323)
Q Consensus       105 ~l~--h~~i~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~L-h~~givH~di~~~ni  181 (323)
                      ++.  .-+++.++++     ..-++||||+.+..+..-.-+...++......+..+++.+|..| |+.|++||||++.||
T Consensus        82 rl~~~Gv~vP~pi~~-----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI  156 (197)
T cd05146          82 RMQKAGIPCPEVVVL-----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM  156 (197)
T ss_pred             HHHHcCCCCCeEEEe-----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            874  3456667764     23489999997643322111222456667788889999999999 899999999999999


Q ss_pred             EEecCCCcEEEeecCcchhhc
Q 020657          182 LVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       182 l~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      +++++  .+.|+|||.+....
T Consensus       157 L~~~~--~v~iIDF~qav~~~  175 (197)
T cd05146         157 LWHDG--KVWFIDVSQSVEPT  175 (197)
T ss_pred             EEECC--cEEEEECCCceeCC
Confidence            99854  79999999986553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.58  E-value=1.9e-14  Score=130.42  Aligned_cols=142  Identities=17%  Similarity=0.243  Sum_probs=98.8

Q ss_pred             eeecccCCeEEEEEEecccCcEEEEEeecCCCChHHH---------------------------------H------HHH
Q 020657           57 QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR---------------------------------R------QVF   97 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~---------------------------------~------~~~   97 (323)
                      ..||.|++|.||+|+.. +|+.||||+.+........                                 .      .+.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            57999999999999986 7999999998654211110                                 0      133


Q ss_pred             HHHHHHHcC----CCCccceeceeEEcCCCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHhCCC
Q 020657           98 REMEILRRT----DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILK-GLSYLHGHKI  171 (323)
Q Consensus        98 ~e~~~l~~l----~h~~i~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~-~l~~Lh~~gi  171 (323)
                      +|+..+.++    ++.+-+.+-.++.+-....++||||++|.+|.++.... ...+   ...++..++. .+..+|..|+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~  278 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF  278 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence            344444443    23333333334433234568999999999998876532 1222   3445566665 4788999999


Q ss_pred             eecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       172 vH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      +|+|++|.||+++.++ +++++|||++.....
T Consensus       279 ~H~D~hPgNilv~~~g-~i~liDfG~~~~l~~  309 (437)
T TIGR01982       279 FHADLHPGNIFVLKDG-KIIALDFGIVGRLSE  309 (437)
T ss_pred             eeCCCCcccEEECCCC-cEEEEeCCCeeECCH
Confidence            9999999999999887 899999999976643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.57  E-value=1.8e-14  Score=120.18  Aligned_cols=201  Identities=21%  Similarity=0.300  Sum_probs=139.8

Q ss_pred             cCCCCccceeceeEEcC----CCeEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC--CCeec
Q 020657          105 RTDSPFIVQCFGIFEKP----SGDIAILMEYMDSGTLDTLLNK----NGTFSEPKLAHIASQILKGLSYLHGH--KIIHR  174 (323)
Q Consensus       105 ~l~h~~i~~~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~--givH~  174 (323)
                      .+-|.||++++.++.+.    .....+++||+..|++..++++    ...+....-.+|+-||+.||.|||+.  -++|+
T Consensus       123 qlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiihg  202 (458)
T KOG1266|consen  123 QLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHG  202 (458)
T ss_pred             HHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccC
Confidence            34588999999888653    3357899999999999999974    34688899999999999999999998  59999


Q ss_pred             CCCCCCeEEecCCCcEEEeecCcchhhc--c--CccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHH
Q 020657          175 DIKPSNLLVNNNNMQVKIADFGVSKIMC--R--SLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELY  250 (323)
Q Consensus       175 di~~~nil~~~~~~~~kl~Dfg~~~~~~--~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~ll  250 (323)
                      ++..+.|++..+| -+|++--.......  .  ...+.....+.++|.+||.=.     ....+.++|||+||....+|-
T Consensus       203 nlTc~tifiq~ng-LIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~-----~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  203 NLTCDTIFIQHNG-LIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGT-----TTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             CcchhheeecCCc-eEEecccCccccchhhhhhhHhhhhccccCCccccCCcCc-----ccccccchhhhhhhHHHHHHH
Confidence            9999999999887 56664211111000  0  011112233567888998532     223345899999999999998


Q ss_pred             hCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          251 LGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       251 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      -++..-.....+...+.-......+..       ...-++++..|++..|+.||++++++.||-+-+.
T Consensus       277 ilEiq~tnseS~~~~ee~ia~~i~~le-------n~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeV  337 (458)
T KOG1266|consen  277 ILEIQSTNSESKVEVEENIANVIIGLE-------NGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEV  337 (458)
T ss_pred             HheeccCCCcceeehhhhhhhheeecc-------CccccCcCcccccCCCCCCcchhhhhcCceeeec
Confidence            777654333333222222222222111       1123568899999999999999999999976543

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.56  E-value=6.3e-14  Score=108.52  Aligned_cols=132  Identities=19%  Similarity=0.290  Sum_probs=98.4

Q ss_pred             eeecccCCeEEEEEEecccCcEEEEEeecCC--CCh-----HHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           57 QVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADP-----TVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~--~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      ..+.+|+-+.++.+.+.  |..+++|.=...  ..+     -...+..+|+.+++.+.--+|.-.+-+..+ .....|+|
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD-~~~~~I~m   78 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD-PDNGLIVM   78 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc-CCCCEEEE
Confidence            45789999999999773  545666664322  112     235566789999988754444333333333 34567999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchh
Q 020657          130 EYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       130 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                      ||++|..|.+.+...       ...++..+-..+.-||..||+||||+++||++..+  ++.++|||++..
T Consensus        79 e~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~--~i~~IDfGLg~~  140 (204)
T COG3642          79 EYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG--RIYFIDFGLGEF  140 (204)
T ss_pred             EEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC--cEEEEECCcccc
Confidence            999999999888765       25677788888899999999999999999999876  599999999854

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.53  E-value=5.4e-14  Score=111.74  Aligned_cols=127  Identities=18%  Similarity=0.238  Sum_probs=94.8

Q ss_pred             eeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCcc-ceeceeEEcCCCeEEEEEeccCC
Q 020657           56 LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI-VQCFGIFEKPSGDIAILMEYMDS  134 (323)
Q Consensus        56 ~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~lv~e~~~~  134 (323)
                      ++.++.|.++.||++..  .++.+++|+......  ....+.+|+.+++.+.+.++ .+++....   ...++||||++|
T Consensus         3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~~---~~~~lv~e~i~G   75 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFDP---ETGVLITEFIEG   75 (170)
T ss_pred             eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEeC---CCCeEEEEecCC
Confidence            46789999999999987  477899999865432  12345678888888765444 44554432   234799999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC-----eecCCCCCCeEEecCCCcEEEeecCcch
Q 020657          135 GTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI-----IHRDIKPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       135 ~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~gi-----vH~di~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                      .++...     .   .....++.+++++|..||+.++     +|+|++|.||+++ ++ .++++|||.+.
T Consensus        76 ~~l~~~-----~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~-~~~liDf~~a~  135 (170)
T cd05151          76 SELLTE-----D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG-RLWLIDWEYAG  135 (170)
T ss_pred             Cccccc-----c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC-eEEEEeccccc
Confidence            887643     1   1123456799999999999985     9999999999999 44 79999999874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.53  E-value=2.4e-13  Score=104.93  Aligned_cols=144  Identities=23%  Similarity=0.325  Sum_probs=107.3

Q ss_pred             eeeeecccCCeEEEEEEecccCcEEEEEeecCC--C-----ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEE
Q 020657           55 KLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--A-----DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        55 ~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~--~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      .+..+.+|+.+.|+++.+  .|+.++||.-...  .     ..-...+..+|++.+.++.--+|.-..-++.+ ...-.+
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D-~~~~~i   87 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFID-TYGGQI   87 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEe-cCCCeE
Confidence            678899999999999999  6888778764322  1     12346677889999988754444443444443 344578


Q ss_pred             EEeccCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcE--EEeecCcchhh
Q 020657          128 LMEYMDS-GTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQV--KIADFGVSKIM  201 (323)
Q Consensus       128 v~e~~~~-~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~--kl~Dfg~~~~~  201 (323)
                      +|||++| .++.+++...  ..........++.+|-+.+.-||..+++||||+.+||++..++.++  .++|||++...
T Consensus        88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            9999987 4778877642  2334444478999999999999999999999999999998776554  89999998553

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.50  E-value=1.8e-14  Score=136.23  Aligned_cols=263  Identities=23%  Similarity=0.302  Sum_probs=188.8

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCCh--HHHHHHHHHHHHHHcCCCCccceeceeEEcCCC
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADP--TVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG  123 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  123 (323)
                      .....+.+.+..-+.+|.++.++.+.-..++....+|+......-  ...+....+-.+.-...+|.++...-.+. ...
T Consensus       799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~-~rs  877 (1205)
T KOG0606|consen  799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFP-CRS  877 (1205)
T ss_pred             ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCC-CCC
Confidence            456778888999999999999999987767755555554211100  00011111111111112233332222222 356


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          124 DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      ..+++++|.++++|...+++.+..+.+..+.....+..++++||...+.|+|++|.|.+....+ ..++.|||.......
T Consensus       878 P~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~g-h~~l~~~~t~~~vg~  956 (1205)
T KOG0606|consen  878 PLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDG-HRPLTDFGTLSKVGL  956 (1205)
T ss_pred             CcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccC-CcccCcccccccccc
Confidence            7899999999999999999888888888999999999999999999999999999999999987 799999984432110


Q ss_pred             C----------------------------c---cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhC
Q 020657          204 S----------------------------L---DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLG  252 (323)
Q Consensus       204 ~----------------------------~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg  252 (323)
                      -                            .   .......+++.|.+||.+.+...+.     .+|+|++|+++++.++|
T Consensus       957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs-----~ad~~~~g~~l~e~l~g 1031 (1205)
T KOG0606|consen  957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGS-----AADWWSSGVCLFEVLTG 1031 (1205)
T ss_pred             ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCC-----cchhhhhhhhhhhhhcC
Confidence            0                            0   0112346889999999988665544     89999999999999999


Q ss_pred             CCCCCCCCCCccHHHHHHHHhcCC--CCCCCCCCChhHHHHHHHhcccCcCCCCCHH---HHhcCcccccCC
Q 020657          253 HFPFLQPGQRPDWATLMCAICFGD--PPSLPDGASPEFRSFIECCLQKEFSKRWTAS---QLLTHPFLCKNR  319 (323)
Q Consensus       253 ~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~---~~l~h~~f~~~~  319 (323)
                      ..||..    +......+++....  ++.-+...+.+..+++...+..+|.+|..+.   ++-.|+||+...
T Consensus      1032 ~pp~na----~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1032 IPPFNA----ETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVD 1099 (1205)
T ss_pred             CCCCCC----cchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCC
Confidence            999944    44444444444433  3344567899999999999999999999988   888999998753

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.49  E-value=1.8e-13  Score=125.74  Aligned_cols=146  Identities=16%  Similarity=0.291  Sum_probs=96.6

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCCh---------------------------------HHHHHH
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADP---------------------------------TVRRQV   96 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~---------------------------------~~~~~~   96 (323)
                      ..+|.. ..||+|++|.||+|+.+.+|+.||||+.++....                                 +..+.+
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            456776 7899999999999999877999999999754211                                 112223


Q ss_pred             HHHHHHHH------cC----CCCccceeceeEEcCCCeEEEEEeccCCCCHHHHH--HhcC----CCCHHHHHHHHHHHH
Q 020657           97 FREMEILR------RT----DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLL--NKNG----TFSEPKLAHIASQIL  160 (323)
Q Consensus        97 ~~e~~~l~------~l----~h~~i~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l--~~~~----~~~~~~~~~i~~~i~  160 (323)
                      .+|+++.+      ++    .+...+.+-.++.+-....++||||+.|+++.++-  ...+    .+.+..+..++.|+ 
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-  276 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-  276 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence            33333332      22    23333333344433234568999999999998743  2222    23333444444444 


Q ss_pred             HHHHHHHhCCCeecCCCCCCeEEecCC---CcEEEeecCcchhhcc
Q 020657          161 KGLSYLHGHKIIHRDIKPSNLLVNNNN---MQVKIADFGVSKIMCR  203 (323)
Q Consensus       161 ~~l~~Lh~~givH~di~~~nil~~~~~---~~~kl~Dfg~~~~~~~  203 (323)
                            ...|++|+|++|.||+++.++   .+++++|||++...+.
T Consensus       277 ------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 ------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                  458999999999999998774   3799999999976643

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.38  E-value=2.2e-13  Score=124.22  Aligned_cols=154  Identities=22%  Similarity=0.314  Sum_probs=117.1

Q ss_pred             HHHHHHHHHHhC-CCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc----c-----cccccccccccCCcccCCCC
Q 020657          158 QILKGLSYLHGH-KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD----A-----CNSYVGTCAYMSPERFDPDA  227 (323)
Q Consensus       158 ~i~~~l~~Lh~~-givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~----~-----~~~~~~~~~y~aPE~~~~~~  227 (323)
                      +++.|+.++|+. ++||++|.|++|.++..+ .+||+.|+++.....+..    .     .........|.|||++..  
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~-~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~--  183 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANG-DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG--  183 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCc-ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc--
Confidence            344899999976 999999999999999998 899999999865443211    1     112235679999999874  


Q ss_pred             CCCCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCH
Q 020657          228 YGGNYNGYAGDIWSLGLTLLELY-LGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTA  306 (323)
Q Consensus       228 ~~~~~~~~~~Dv~slG~ll~~ll-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~  306 (323)
                         ...+.++|+||+|+++|.++ +|+..+...+. .................+...+++++.+=+.+++..++..||++
T Consensus       184 ---~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~-~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~  259 (700)
T KOG2137|consen  184 ---TTNTPASDVFSLGVLIYTIYNGGKSIIAANGG-LLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTL  259 (700)
T ss_pred             ---ccccccccceeeeeEEEEEecCCcchhhccCC-cchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcch
Confidence               44467999999999999999 56655544433 33333333333333445567899999999999999999999999


Q ss_pred             HHHhcCcccccC
Q 020657          307 SQLLTHPFLCKN  318 (323)
Q Consensus       307 ~~~l~h~~f~~~  318 (323)
                      ..++..+||.+-
T Consensus       260 ~~l~~~~ff~D~  271 (700)
T KOG2137|consen  260 DLLLSIPFFSDP  271 (700)
T ss_pred             hhhhcccccCCc
Confidence            999999999764

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.37  E-value=2e-11  Score=108.04  Aligned_cols=214  Identities=21%  Similarity=0.261  Sum_probs=155.5

Q ss_pred             CeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEc---CCCeEEEEEeccCCC-CHHH
Q 020657           64 GGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEK---PSGDIAILMEYMDSG-TLDT  139 (323)
Q Consensus        64 ~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~~lv~e~~~~~-sL~~  139 (323)
                      ..+.|++....+|..|++|.++...... ......-+++|+++.|.|++++.++|..   .+..+++|++|+++. +|.+
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~-~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQS-TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccC-cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            4678999998899999999996443221 1122345788999999999999998762   256789999999753 5766


Q ss_pred             HHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC
Q 020657          140 LLNK---------------NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS  204 (323)
Q Consensus       140 ~l~~---------------~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~  204 (323)
                      .-..               +...++..+|.++.||..||.++|+.|+...-|.+.+|+++.+. +++|...|........
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~-RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM-RIRISGCGIMDVLQED  446 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc-eEEEecccceeeecCC
Confidence            5531               23467899999999999999999999999999999999999885 8999888876443222


Q ss_pred             ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCC
Q 020657          205 LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA  284 (323)
Q Consensus       205 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (323)
                      .            .  |.+.     .   -.+-|.=.||.++..|.||..--..   .+......       ...+...+
T Consensus       447 ~------------~--~~le-----~---~Qq~D~~~lG~ll~aLAt~~~ns~~---~d~~~~s~-------~~~I~~~y  494 (655)
T KOG3741|consen  447 P------------T--EPLE-----S---QQQNDLRDLGLLLLALATGTENSNR---TDSTQSSH-------LTRITTTY  494 (655)
T ss_pred             C------------C--cchh-----H---HhhhhHHHHHHHHHHHhhccccccc---ccchHHHH-------HHHhhhhh
Confidence            1            0  1111     0   1278999999999999998533211   11111110       01233567


Q ss_pred             ChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          285 SPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       285 ~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      +.+++++|.-+...++++ -++.+++.+
T Consensus       495 S~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  495 STDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             hHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence            889999999999998887 788888865

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.36  E-value=3.8e-11  Score=101.60  Aligned_cols=141  Identities=15%  Similarity=0.171  Sum_probs=99.4

Q ss_pred             eeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHH----------HHHHHHHHHHcCCCCc--cceeceeEEcC---
Q 020657           57 QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR----------QVFREMEILRRTDSPF--IVQCFGIFEKP---  121 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~----------~~~~e~~~l~~l~h~~--i~~~~~~~~~~---  121 (323)
                      +.+.......|+.+..  .|+.+.+|...........+          ...+|...+..|..-+  .+.++.+++..   
T Consensus        28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~  105 (268)
T PRK15123         28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP  105 (268)
T ss_pred             cEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence            3344334445667655  57789999875443222112          3667888877774333  34455555432   


Q ss_pred             -CCeEEEEEeccCCC-CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEec------CCCcEE
Q 020657          122 -SGDIAILMEYMDSG-TLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNN------NNMQVK  191 (323)
Q Consensus       122 -~~~~~lv~e~~~~~-sL~~~l~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~------~~~~~k  191 (323)
                       ....++|||++++. +|.+++..  ..+.+......++.+++..+..||..|++|+|+++.||+++.      ++..+.
T Consensus       106 ~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~  185 (268)
T PRK15123        106 ATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLS  185 (268)
T ss_pred             ccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEE
Confidence             22468999999876 79998864  345667788899999999999999999999999999999985      234899


Q ss_pred             EeecCcch
Q 020657          192 IADFGVSK  199 (323)
Q Consensus       192 l~Dfg~~~  199 (323)
                      |+||+.+.
T Consensus       186 LIDl~r~~  193 (268)
T PRK15123        186 VIDLHRAQ  193 (268)
T ss_pred             EEECCccc
Confidence            99999874

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.35  E-value=6.8e-12  Score=104.09  Aligned_cols=142  Identities=21%  Similarity=0.298  Sum_probs=102.8

Q ss_pred             eeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCC--ccceeceeEEcCC--CeEEEEEec
Q 020657           56 LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSP--FIVQCFGIFEKPS--GDIAILMEY  131 (323)
Q Consensus        56 ~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~--~~~~lv~e~  131 (323)
                      .+.|+.|..+.+|++... +|+.+++|+............+..|+.+++.+.+.  .+.+++.+.....  +..++||||
T Consensus         3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~   81 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER   81 (223)
T ss_pred             ceecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence            357899999999999875 35789999986543222345678899999998653  4566666654321  356899999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 020657          132 MDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG-------------------------------------------  168 (323)
Q Consensus       132 ~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~-------------------------------------------  168 (323)
                      ++|.++.+.+.. ..++......++.+++++|..||+                                           
T Consensus        82 i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          82 VDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             eCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence            999888765432 245666666666777777766663                                           


Q ss_pred             -------------CCCeecCCCCCCeEEec--CCCcEEEeecCcchh
Q 020657          169 -------------HKIIHRDIKPSNLLVNN--NNMQVKIADFGVSKI  200 (323)
Q Consensus       169 -------------~givH~di~~~nil~~~--~~~~~kl~Dfg~~~~  200 (323)
                                   ..++|+|+++.||+++.  ++ .+.|+||+.+..
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~-~~~iID~e~~~~  206 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPR-VVAVLDWELATL  206 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCc-EEEEEecccccc
Confidence                         24699999999999998  44 689999998743

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.34  E-value=1.2e-11  Score=98.71  Aligned_cols=126  Identities=24%  Similarity=0.316  Sum_probs=84.5

Q ss_pred             EEEEEEecccCcEEEEEeecCC-------------------------CChHHHHHHHHHHHHHHcCCCC--ccceeceeE
Q 020657           66 TVYKVQHRCTHKIYALKVVHGD-------------------------ADPTVRRQVFREMEILRRTDSP--FIVQCFGIF  118 (323)
Q Consensus        66 ~v~~~~~~~~~~~v~iK~~~~~-------------------------~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~  118 (323)
                      .||.|... +|..+|+|+.+..                         ..........+|.+.|.++..-  +++.++.+.
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            48999885 6889999998522                         0011345667899999998654  466666553


Q ss_pred             EcCCCeEEEEEeccC--CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhCCCeecCCCCCCeEEecCCCcEEEeec
Q 020657          119 EKPSGDIAILMEYMD--SGTLDTLLNKNGTFSEPKLAHIASQILKGLSY-LHGHKIIHRDIKPSNLLVNNNNMQVKIADF  195 (323)
Q Consensus       119 ~~~~~~~~lv~e~~~--~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~-Lh~~givH~di~~~nil~~~~~~~~kl~Df  195 (323)
                      .     .++||||++  |..+..+....  ++......++.+++..+.. +|..|++|||+++.||+++++  .+.++||
T Consensus        80 ~-----~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~--~~~iIDf  150 (188)
T PF01163_consen   80 R-----NVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG--KVYIIDF  150 (188)
T ss_dssp             T-----TEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT--CEEE--G
T ss_pred             C-----CEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc--eEEEEec
Confidence            2     279999998  66665544332  2245567777888885444 679999999999999999986  6999999


Q ss_pred             Ccchhh
Q 020657          196 GVSKIM  201 (323)
Q Consensus       196 g~~~~~  201 (323)
                      |.+...
T Consensus       151 ~qav~~  156 (188)
T PF01163_consen  151 GQAVDS  156 (188)
T ss_dssp             TTEEET
T ss_pred             Ccceec
Confidence            988654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.32  E-value=1.4e-10  Score=100.45  Aligned_cols=243  Identities=17%  Similarity=0.250  Sum_probs=161.9

Q ss_pred             eeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHc-CCCCccce--------eceeEEcCCCeE
Q 020657           55 KLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRR-TDSPFIVQ--------CFGIFEKPSGDI  125 (323)
Q Consensus        55 ~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~--------~~~~~~~~~~~~  125 (323)
                      ....||+|+.+.+|..-.-  +. .+.|+++........+    -+..|.. -.||-+..        ++|  .+....+
T Consensus        15 ~gr~LgqGgea~ly~l~e~--~d-~VAKIYh~Pppa~~aq----k~a~la~~p~~p~~~~rvaWPqa~L~G--~~~~~~i   85 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV--RD-QVAKIYHAPPPAAQAQ----KVAELAATPDAPLLNYRVAWPQATLHG--GRRGKVI   85 (637)
T ss_pred             CCccccCCccceeeecchh--hc-hhheeecCCCchHHHH----HHHHhccCCCCcchhhhhcccHHHhhC--CCcccee
Confidence            4567999999999975432  22 3569988665443222    1222333 24553322        222  1223347


Q ss_pred             EEEEeccCCCC-HHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcc
Q 020657          126 AILMEYMDSGT-LDTLLN------KNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVS  198 (323)
Q Consensus       126 ~lv~e~~~~~s-L~~~l~------~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~  198 (323)
                      .++|..+.+.. ..++.+      ..+...+...+.....|+.+.+.||..|.+-||+.++|+++.+++ .|.|+|=+.-
T Consensus        86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~-~V~LVdsDsf  164 (637)
T COG4248          86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDS-KVVLVDSDSF  164 (637)
T ss_pred             EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCc-eEEEEcccce
Confidence            88999887652 333332      234478999999999999999999999999999999999999987 8999875543


Q ss_pred             hhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCCc----cHHHHH----
Q 020657          199 KIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLG-HFPFLQPGQRP----DWATLM----  269 (323)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg-~~p~~~~~~~~----~~~~~~----  269 (323)
                      .. +.........++...|++||.-.-..+.+...+...|.|+||+++++++.| ..||.+.....    ..+.-+    
T Consensus       165 qi-~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~  243 (637)
T COG4248         165 QI-NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR  243 (637)
T ss_pred             ee-ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence            22 233444556788999999998776667777778899999999999999965 99997643221    111110    


Q ss_pred             ------HHHhcC-CCCCCC-CCCChhHHHHHHHhccc--CcCCCCCHHH
Q 020657          270 ------CAICFG-DPPSLP-DGASPEFRSFIECCLQK--EFSKRWTASQ  308 (323)
Q Consensus       270 ------~~~~~~-~~~~~~-~~~~~~l~~ll~~~l~~--~p~~Rpt~~~  308 (323)
                            +..... .+...| .-+++.+.-|..+|+..  ++.-|||++.
T Consensus       244 f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         244 FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence                  000000 011122 34678999999999887  3568999764

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.31  E-value=3.4e-12  Score=114.84  Aligned_cols=255  Identities=21%  Similarity=0.232  Sum_probs=176.6

Q ss_pred             hccccccceeeeecccCCeEEEEEEec-ccCcEEEEEeecCCCChHH-HHHHHHHHHHHHcC-CCCccceeceeEEcCCC
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHR-CTHKIYALKVVHGDADPTV-RRQVFREMEILRRT-DSPFIVQCFGIFEKPSG  123 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~v~iK~~~~~~~~~~-~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~  123 (323)
                      .....+|..+..||.|.|+.++...-. .++..|++|.....-.... ...-..|+.+...+ .|.+++.....+.. ..
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~-~r  339 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ-LR  339 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc-cc
Confidence            345667899999999999999987744 4677888887764432221 12224455555555 57888887766655 34


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          124 DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      ..++=-|||.++++...+.-...+++...+.+..|++.++.++|+..++|+|++|.||++..++..-+++|||......-
T Consensus       340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~  419 (524)
T KOG0601|consen  340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF  419 (524)
T ss_pred             cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce
Confidence            56688899999888766644445788899999999999999999999999999999999998755789999998865322


Q ss_pred             Ccccccccccccccc-CCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCC
Q 020657          204 SLDACNSYVGTCAYM-SPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPD  282 (323)
Q Consensus       204 ~~~~~~~~~~~~~y~-aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (323)
                      ..   .......++. ..|.+..    ....-.+.|+|+||..+.+..++...-...   ..+..+.    .+..+. ..
T Consensus       420 ~~---~~~~~~~r~~p~~~~~~e----~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~---~~~~~i~----~~~~p~-~~  484 (524)
T KOG0601|consen  420 SS---GVFHHIDRLYPIAEILLE----DYPHLSKADIFSLGLSVDEAITGSPLSESG---VQSLTIR----SGDTPN-LP  484 (524)
T ss_pred             ec---ccccccccccccchhhcc----ccccccccccccccccccccccCcccCccc---ccceeee----cccccC-CC
Confidence            11   1122233444 2444432    222334999999999999999886443211   1111111    111222 23


Q ss_pred             CCChhHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          283 GASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       283 ~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                      +...++..+.+.+..+++..|+.+.++..|.=|..
T Consensus       485 ~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  485 GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             chHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence            34488999999999999999999999998866543

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.22  E-value=1.1e-10  Score=95.98  Aligned_cols=137  Identities=20%  Similarity=0.234  Sum_probs=104.9

Q ss_pred             cceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-------------------C--hHHHHHHHHHHHHHHcCCCC--
Q 020657           53 LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-------------------D--PTVRRQVFREMEILRRTDSP--  109 (323)
Q Consensus        53 ~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-------------------~--~~~~~~~~~e~~~l~~l~h~--  109 (323)
                      ..+...||-|--|.||.|.+. .|..+++|.-+...                   +  ...+....+|.+.|..|...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            446689999999999999997 78999999864221                   1  11344567888999988543  


Q ss_pred             ccceeceeEEcCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCc
Q 020657          110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQ  189 (323)
Q Consensus       110 ~i~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~  189 (323)
                      .+.+.+++     +..++|||+++|..|....     ++....-.++..|++-+..+-..|+||||+++-||+++++| .
T Consensus       172 ~VP~P~~~-----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg-~  240 (304)
T COG0478         172 KVPKPIAW-----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDG-D  240 (304)
T ss_pred             CCCCcccc-----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCC-C
Confidence            67777663     5668999999997776543     23455566667777777777789999999999999999998 8


Q ss_pred             EEEeecCcchhh
Q 020657          190 VKIADFGVSKIM  201 (323)
Q Consensus       190 ~kl~Dfg~~~~~  201 (323)
                      +.++||-.+...
T Consensus       241 ~~vIDwPQ~v~~  252 (304)
T COG0478         241 IVVIDWPQAVPI  252 (304)
T ss_pred             EEEEeCcccccC
Confidence            999999887544

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.11  E-value=1.9e-09  Score=88.29  Aligned_cols=107  Identities=19%  Similarity=0.249  Sum_probs=83.2

Q ss_pred             HHHHHHHHHHHcCCC--CccceeceeEEcCC---CeEEEEEeccCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 020657           94 RQVFREMEILRRTDS--PFIVQCFGIFEKPS---GDIAILMEYMDSG-TLDTLLNKNGTFSEPKLAHIASQILKGLSYLH  167 (323)
Q Consensus        94 ~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~---~~~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh  167 (323)
                      .+..+|...+..|..  -.++.++.+.+...   ...++|+|++++. +|.+++......+......++.++++.+.-||
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH  135 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH  135 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence            346677777766643  23455666555422   2358999999874 79999987555778888999999999999999


Q ss_pred             hCCCeecCCCCCCeEEecCC--CcEEEeecCcchh
Q 020657          168 GHKIIHRDIKPSNLLVNNNN--MQVKIADFGVSKI  200 (323)
Q Consensus       168 ~~givH~di~~~nil~~~~~--~~~kl~Dfg~~~~  200 (323)
                      ..|++|+|+++.|||++.++  ..+.|+||+.+..
T Consensus       136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99999999999999998874  4699999998754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=99.01  E-value=1.6e-08  Score=81.47  Aligned_cols=138  Identities=12%  Similarity=0.141  Sum_probs=98.2

Q ss_pred             cccCCeEEEEEEecccCcEEEEEeecCCC----C-hHHHHHHHHHHHHHHcCCCC--ccceeceeEEcC----CCeEEEE
Q 020657           60 GHGNGGTVYKVQHRCTHKIYALKVVHGDA----D-PTVRRQVFREMEILRRTDSP--FIVQCFGIFEKP----SGDIAIL  128 (323)
Q Consensus        60 g~G~~~~v~~~~~~~~~~~v~iK~~~~~~----~-~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~----~~~~~lv  128 (323)
                      |.||.|-|+.....  |+.+-+|......    . +--...+.+|...++.|..-  .+++++ ++...    .-..+||
T Consensus        27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            45788888887763  4467778764110    0 22356688898888887432  244444 22211    1235799


Q ss_pred             EeccCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC-CcEEEeecCcchh
Q 020657          129 MEYMDS-GTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN-MQVKIADFGVSKI  200 (323)
Q Consensus       129 ~e~~~~-~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~-~~~kl~Dfg~~~~  200 (323)
                      +|-+++ .+|.+++.+.  .+.+......++.+++.++.-||+.|+.|+|+.+.||+++.++ ..++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            997753 4898888653  2457788889999999999999999999999999999998555 3499999997754

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=99.01  E-value=5.8e-09  Score=85.15  Aligned_cols=139  Identities=14%  Similarity=0.211  Sum_probs=95.3

Q ss_pred             eeeecccCCeEEEEEEecccCcEEEEEeecCCCCh-----------------------HHHHHHHHHHHHHHcCC--CCc
Q 020657           56 LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADP-----------------------TVRRQVFREMEILRRTD--SPF  110 (323)
Q Consensus        56 ~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~-----------------------~~~~~~~~e~~~l~~l~--h~~  110 (323)
                      ...|+.|--+.||+|... ++..+|+|++......                       ....-..+|..-|+++.  +-.
T Consensus        53 ~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          53 VGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             EeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            457788999999999874 7889999999633110                       01112344666666652  455


Q ss_pred             cceeceeEEcCCCeEEEEEeccCCCC-HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCCeEEecCCC
Q 020657          111 IVQCFGIFEKPSGDIAILMEYMDSGT-LDTLLNKNGTFSEPKLAHIASQILKGLSYLHG-HKIIHRDIKPSNLLVNNNNM  188 (323)
Q Consensus       111 i~~~~~~~~~~~~~~~lv~e~~~~~s-L~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~givH~di~~~nil~~~~~~  188 (323)
                      +.+.+.+..     ..+|||++.... -.-.++ .-++.......+..++++.+.-|-. .|+||+||+.-|||+. ++ 
T Consensus       132 vP~Pi~~~~-----nVLvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~-  203 (268)
T COG1718         132 VPEPIAFRN-----NVLVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DG-  203 (268)
T ss_pred             CCCceeecC-----CeEEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CC-
Confidence            566666543     279999996531 011111 1123444688888999999988887 8999999999999999 44 


Q ss_pred             cEEEeecCcchhhcc
Q 020657          189 QVKIADFGVSKIMCR  203 (323)
Q Consensus       189 ~~kl~Dfg~~~~~~~  203 (323)
                      .+.+||||.|....+
T Consensus       204 ~p~iID~~QaV~~~h  218 (268)
T COG1718         204 EPYIIDVSQAVTIDH  218 (268)
T ss_pred             eEEEEECccccccCC
Confidence            799999999876543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=99.01  E-value=1.1e-08  Score=82.55  Aligned_cols=140  Identities=23%  Similarity=0.327  Sum_probs=91.6

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHH---------HHHHHHHHcC---CCCcccee
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQV---------FREMEILRRT---DSPFIVQC  114 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~---------~~e~~~l~~l---~h~~i~~~  114 (323)
                      .+...+|++.+.+-.....-|.+..-  +|+.+++|....... ...+.+         .+.+..+.++   +--....+
T Consensus        27 ~i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~-r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~  103 (229)
T PF06176_consen   27 KILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENR-RPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADP  103 (229)
T ss_pred             HHHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhh-hHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccc
Confidence            45667888889998888776766665  688999999875431 111111         1222222222   22223332


Q ss_pred             ceeEEcC----CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcE
Q 020657          115 FGIFEKP----SGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQV  190 (323)
Q Consensus       115 ~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~  190 (323)
                      +-+.+..    ....+++|||++|..|.+...    +++    .+...+++++.-||+.|++|||.+|.|++++++  .+
T Consensus       104 yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~--~i  173 (229)
T PF06176_consen  104 YLAAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN--GI  173 (229)
T ss_pred             eeeeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC--cE
Confidence            2222110    224568999999988876542    333    244567888999999999999999999999976  49


Q ss_pred             EEeecCcch
Q 020657          191 KIADFGVSK  199 (323)
Q Consensus       191 kl~Dfg~~~  199 (323)
                      +++||+...
T Consensus       174 ~iID~~~k~  182 (229)
T PF06176_consen  174 RIIDTQGKR  182 (229)
T ss_pred             EEEECcccc
Confidence            999998653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.81  E-value=1.1e-07  Score=78.94  Aligned_cols=133  Identities=17%  Similarity=0.275  Sum_probs=81.7

Q ss_pred             eeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCc--cceeceeEEcCCCeEEEEEeccCC
Q 020657           57 QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF--IVQCFGIFEKPSGDIAILMEYMDS  134 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~~lv~e~~~~  134 (323)
                      ..|++|..+.||+.    .+..+++|.......   ...+.+|.++++.+..-+  +.+++++... .+...+|||+++|
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~-~~~~glv~e~i~G   78 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFD---KETIKREFDASRKVFSLGIPTPHPFDLVED-GGRLGLIYELIVG   78 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCCC---HHHHHHHHHHHHHHHHcCCCCCceEEEEec-CCeeeeeeeecCC
Confidence            67899999999984    244678899865432   244678999998875433  4666777655 5667899999998


Q ss_pred             CC-HHHHH--------------H-------hc--CCCCHHHHH-HHHHH----------HHH-HHHHHH----hCCCeec
Q 020657          135 GT-LDTLL--------------N-------KN--GTFSEPKLA-HIASQ----------ILK-GLSYLH----GHKIIHR  174 (323)
Q Consensus       135 ~s-L~~~l--------------~-------~~--~~~~~~~~~-~i~~~----------i~~-~l~~Lh----~~givH~  174 (323)
                      .+ +...+              .       .-  ......... .+..+          +.+ ...+|.    ...++||
T Consensus        79 ~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg  158 (226)
T TIGR02172        79 KRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG  158 (226)
T ss_pred             ccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence            63 21111              0       00  011111100 01000          111 112222    1257899


Q ss_pred             CCCCCCeEEecCCCcEEEeecCcch
Q 020657          175 DIKPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       175 di~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                      |++|.||++++++  +.++||+.+.
T Consensus       159 D~~~~Nii~~~~~--~~iIDwe~a~  181 (226)
T TIGR02172       159 DFQIGNLITSGKG--TYWIDLGDFG  181 (226)
T ss_pred             CCCCCcEEEcCCC--cEEEechhcC
Confidence            9999999999875  8899999874

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.81  E-value=5.2e-08  Score=89.44  Aligned_cols=143  Identities=17%  Similarity=0.240  Sum_probs=92.0

Q ss_pred             eeecccCCeEEEEEEecccCcEEEEEeecCCCChH---------------------------------HHH------HHH
Q 020657           57 QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT---------------------------------VRR------QVF   97 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~---------------------------------~~~------~~~   97 (323)
                      ..++.++-|.||.|+.. +|+.||||+.++.-...                                 ..+      .+.
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            67889999999999997 69999999996442211                                 111      122


Q ss_pred             HHHHHHHcC----CCCccceeceeEEcCCCeEEEEEeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHH-HHHHHhCCC
Q 020657           98 REMEILRRT----DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLN-KNGTFSEPKLAHIASQILKG-LSYLHGHKI  171 (323)
Q Consensus        98 ~e~~~l~~l----~h~~i~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~-~~~~~~~~~~~~i~~~i~~~-l~~Lh~~gi  171 (323)
                      +|+..+.++    ....-+.+-.+|-+-.+.-.++|||+.|..+.++.. +...++...+.   ..++++ +..+=..|+
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia---~~~~~~f~~q~~~dgf  286 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELA---ELLVRAFLRQLLRDGF  286 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHH---HHHHHHHHHHHHhcCc
Confidence            333333332    222222222333222345689999999999988853 22344533333   333322 333445899


Q ss_pred             eecCCCCCCeEEecCCCcEEEeecCcchhhccC
Q 020657          172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS  204 (323)
Q Consensus       172 vH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~  204 (323)
                      .|.|.+|.||+++.+| .+.+.|||+...+...
T Consensus       287 fHaDpHpGNi~v~~~g-~i~~lDfGi~g~l~~~  318 (517)
T COG0661         287 FHADPHPGNILVRSDG-RIVLLDFGIVGRLDPK  318 (517)
T ss_pred             cccCCCccceEEecCC-cEEEEcCcceecCCHH
Confidence            9999999999999998 8999999999766443

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.69  E-value=1.4e-07  Score=73.00  Aligned_cols=131  Identities=25%  Similarity=0.279  Sum_probs=94.7

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccc-eeceeEEcCCCeEEEEEe
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIV-QCFGIFEKPSGDIAILME  130 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~~lv~e  130 (323)
                      ..+..+.|++|.+|.||++.+  .|..+++|+-+.+.   .+..+..|++++..+...++. .++.+..+     ++.||
T Consensus        23 ~~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds---~r~~l~kEakiLeil~g~~~~p~vy~yg~~-----~i~me   92 (201)
T COG2112          23 ELRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDS---PRRNLEKEAKILEILAGEGVTPEVYFYGED-----FIRME   92 (201)
T ss_pred             hhhhhhhhhcccccEEEEeec--cCceEEEEEecCCc---chhhHHHHHHHHHHhhhcCCCceEEEechh-----hhhhh
Confidence            345668899999999999999  46789999976553   456678899999988766654 35555332     46699


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCC-CCCeEEecCCCcEEEeecCcchh
Q 020657          131 YMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIK-PSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       131 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~-~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                      |+.|..|..+-...   +.    +-...+++.-.-|-..||-|+.|+ |..+++.+++ .+.|+||..|+.
T Consensus        93 ~i~G~~L~~~~~~~---~r----k~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~-~~~iIDFd~At~  155 (201)
T COG2112          93 YIDGRPLGKLEIGG---DR----KHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDR-DVYIIDFDSATF  155 (201)
T ss_pred             hhcCcchhhhhhcc---cH----HHHHHHHHHHHHHHHhccchhhhcCCceeEEecCC-cEEEEEccchhh
Confidence            99998887765432   32    333456666666778899999986 4444444554 799999998863

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.61  E-value=6.8e-07  Score=74.55  Aligned_cols=79  Identities=24%  Similarity=0.319  Sum_probs=56.1

Q ss_pred             eeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCC--ccceeceeEEc--CCCeEEEEEec
Q 020657           56 LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSP--FIVQCFGIFEK--PSGDIAILMEY  131 (323)
Q Consensus        56 ~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~--~~~~~~lv~e~  131 (323)
                      ++.++.|..+.+|++....  ..+++|.....   .....+.+|..+++.+...  .+..++.....  .....+++|++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~   76 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY   76 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence            5789999999999999853  58889997543   4556777888888887433  35566653322  23457899999


Q ss_pred             cCCCCHHH
Q 020657          132 MDSGTLDT  139 (323)
Q Consensus       132 ~~~~sL~~  139 (323)
                      ++|.++..
T Consensus        77 i~g~~~~~   84 (239)
T PF01636_consen   77 IPGRPLDD   84 (239)
T ss_dssp             ESSEEHHH
T ss_pred             eccccccc
Confidence            99987777

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.61  E-value=7.9e-07  Score=74.91  Aligned_cols=134  Identities=17%  Similarity=0.158  Sum_probs=81.0

Q ss_pred             eecccCC-eEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCC-CCccceeceeEEcCCCeEEEEEeccCCC
Q 020657           58 VLGHGNG-GTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD-SPFIVQCFGIFEKPSGDIAILMEYMDSG  135 (323)
Q Consensus        58 ~lg~G~~-~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~lv~e~~~~~  135 (323)
                      .|..|.+ +.||+....  +..+++|......    ...+.+|+.+++.+. +--+.++++.... .+..++|||+++|.
T Consensus         5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-~~~~~lv~e~i~G~   77 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSD-DGRAWLLTSAVPGV   77 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEec-CCccEEEEEeeCCc
Confidence            3445555 778998763  4678888875432    234567888887773 3446667776665 45678999999988


Q ss_pred             CHHHHHH-------------------hc----CCCCHH--HHHHHHH--------------------HHHHHHHHHH---
Q 020657          136 TLDTLLN-------------------KN----GTFSEP--KLAHIAS--------------------QILKGLSYLH---  167 (323)
Q Consensus       136 sL~~~l~-------------------~~----~~~~~~--~~~~i~~--------------------~i~~~l~~Lh---  167 (323)
                      ++.....                   .-    .++...  .......                    .+...+..|-   
T Consensus        78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  157 (244)
T cd05150          78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR  157 (244)
T ss_pred             cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence            7764320                   00    011100  0000000                    0111222221   


Q ss_pred             ----hCCCeecCCCCCCeEEecCCCcEEEeecCcch
Q 020657          168 ----GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       168 ----~~givH~di~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                          ...++|+|+.|.||++++++ .+.|+||+.+.
T Consensus       158 ~~~~~~~l~HgD~~~~Nil~~~~~-~~~iIDwe~a~  192 (244)
T cd05150         158 PAEEDLVVTHGDACLPNIIVDPGK-FSGFIDLGRLG  192 (244)
T ss_pred             CCcCceEEECCCCCCccEEEeCCc-EEEEEEccccc
Confidence                12489999999999999875 67899999874

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=98.55  E-value=1.3e-06  Score=86.20  Aligned_cols=147  Identities=20%  Similarity=0.335  Sum_probs=91.1

Q ss_pred             eeeeecccCCeEEEEEEecccC--cEEEEEeecCCCChHHHHHHHHHHHHHHcCC-CCcc--ceeceeEEcC--CCeEEE
Q 020657           55 KLQVLGHGNGGTVYKVQHRCTH--KIYALKVVHGDADPTVRRQVFREMEILRRTD-SPFI--VQCFGIFEKP--SGDIAI  127 (323)
Q Consensus        55 ~~~~lg~G~~~~v~~~~~~~~~--~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i--~~~~~~~~~~--~~~~~l  127 (323)
                      .+..++.|.++.+|+......+  ..+++|+............+.+|+.+++.+. |.++  .+++.++.+.  .+..++
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl  121 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY  121 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence            3677899999999998765322  4677887654332223356779999999985 6654  6677766542  246789


Q ss_pred             EEeccCCCCHHH--------------------HHH---h-c----------CC--CCHHHHHHHHHH-------------
Q 020657          128 LMEYMDSGTLDT--------------------LLN---K-N----------GT--FSEPKLAHIASQ-------------  158 (323)
Q Consensus       128 v~e~~~~~sL~~--------------------~l~---~-~----------~~--~~~~~~~~i~~~-------------  158 (323)
                      ||||++|..+.+                    .+.   . .          .+  .....+..|..+             
T Consensus       122 VME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~  201 (822)
T PLN02876        122 IMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRN  201 (822)
T ss_pred             EEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCC
Confidence            999998764321                    110   0 0          00  011223222221             


Q ss_pred             --HHHHHHHHHh-----------CCCeecCCCCCCeEEecCCC-cEEEeecCcchhh
Q 020657          159 --ILKGLSYLHG-----------HKIIHRDIKPSNLLVNNNNM-QVKIADFGVSKIM  201 (323)
Q Consensus       159 --i~~~l~~Lh~-----------~givH~di~~~nil~~~~~~-~~kl~Dfg~~~~~  201 (323)
                        +.+.+.+|..           ..+||+|+++.||+++.++. .+-++||+++..-
T Consensus       202 ~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G  258 (822)
T PLN02876        202 PKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG  258 (822)
T ss_pred             hhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence              2234556632           24999999999999986322 3579999998653

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.48  E-value=1.8e-06  Score=79.19  Aligned_cols=140  Identities=16%  Similarity=0.255  Sum_probs=90.6

Q ss_pred             eeecccCCeEEEEEEecccCcEEEEEeecCCCChH------------------------------HHH------HHHHHH
Q 020657           57 QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT------------------------------VRR------QVFREM  100 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~------------------------------~~~------~~~~e~  100 (323)
                      +.|+.-+.+.|++|+.+ +|+.||||+-+..-...                              ..+      ++.+|+
T Consensus       167 ~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            67899999999999998 59999999987442211                              111      223333


Q ss_pred             HHHHc----CCCCc------cceeceeEEcCCCeEEEEEeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHH-HHHh
Q 020657          101 EILRR----TDSPF------IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLN-KNGTFSEPKLAHIASQILKGLS-YLHG  168 (323)
Q Consensus       101 ~~l~~----l~h~~------i~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~-~~~~~~~~~~~~i~~~i~~~l~-~Lh~  168 (323)
                      +-..+    +.|-+      |.+++..+   .....++|||++|..+.+.-. ....++...+.   ..+.++.. -+=.
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~---st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~---~~l~~~~~~qIf~  319 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDL---STKRVLTMEYVDGIKINDLDAIDKRGISPHDIL---NKLVEAYLEQIFK  319 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhc---CcceEEEEEecCCccCCCHHHHHHcCCCHHHHH---HHHHHHHHHHHHh
Confidence            33222    23444      44444333   345789999999987766543 22245655443   44444322 2234


Q ss_pred             CCCeecCCCCCCeEEec---CCCcEEEeecCcchhhcc
Q 020657          169 HKIIHRDIKPSNLLVNN---NNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       169 ~givH~di~~~nil~~~---~~~~~kl~Dfg~~~~~~~  203 (323)
                      .|++|.|-+|.||++..   .+..+.+-|||+...+.+
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            68999999999999993   345899999999876644

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.47  E-value=8.7e-06  Score=65.26  Aligned_cols=127  Identities=30%  Similarity=0.451  Sum_probs=91.2

Q ss_pred             cccceeeeecccCC-eEEEEEEecccCcEEEEEeecC---CC-----------Ch------HHHHHHHHHHHHHHcC---
Q 020657           51 SDLEKLQVLGHGNG-GTVYKVQHRCTHKIYALKVVHG---DA-----------DP------TVRRQVFREMEILRRT---  106 (323)
Q Consensus        51 ~~~~~~~~lg~G~~-~~v~~~~~~~~~~~v~iK~~~~---~~-----------~~------~~~~~~~~e~~~l~~l---  106 (323)
                      ++++.++.||.|.. |.||+++-  .|+.+|+|++..   ..           ..      .....|..|.+...+|   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            89999999999999 99999998  688999999321   10           00      2234567788877665   


Q ss_pred             CCCcc--ceeceeEEcC-----------------CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 020657          107 DSPFI--VQCFGIFEKP-----------------SGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH  167 (323)
Q Consensus       107 ~h~~i--~~~~~~~~~~-----------------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh  167 (323)
                      ++.++  ++++|+..-.                 .....||.||.+...         .++...    +.+|.+-|..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHHHH
Confidence            45667  8999986321                 112468888876533         233333    356667777899


Q ss_pred             hCCCeecCCCCCCeEEecCCCcEEEeecCcc
Q 020657          168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVS  198 (323)
Q Consensus       168 ~~givH~di~~~nil~~~~~~~~kl~Dfg~~  198 (323)
                      ..||+-+|+++.|..   +|   +|+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~---~G---~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYR---GG---KLVDFSSS  206 (207)
T ss_pred             HCCeeeccCcccccc---CC---EEEecccC
Confidence            999999999999986   33   79999975

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.45  E-value=1.3e-06  Score=85.15  Aligned_cols=201  Identities=26%  Similarity=0.296  Sum_probs=139.3

Q ss_pred             HHHHHHHHcCCCCccceeceeEEcCCC---eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 020657           97 FREMEILRRTDSPFIVQCFGIFEKPSG---DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH  173 (323)
Q Consensus        97 ~~e~~~l~~l~h~~i~~~~~~~~~~~~---~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH  173 (323)
                      .-|...+....|+|+..++.+......   ...+..+++...++...++.-..++...++.+..++.+++.++|+....|
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~  309 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEH  309 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccce
Confidence            446666777899999999988654211   12345678888899999988888999999999999999999999997666


Q ss_pred             cCCCCC---CeEEecCCCcEEEe--ecCcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHH
Q 020657          174 RDIKPS---NLLVNNNNMQVKIA--DFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLE  248 (323)
Q Consensus       174 ~di~~~---nil~~~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~  248 (323)
                      .-+...   +...+.++ .+..+  ||+.+......... ........+.++|........   .....|+|.+|.+...
T Consensus       310 v~L~~s~~~~~~~~~e~-~~~~sl~~~~ss~~l~d~~~~-~~~~~~~~~~~~e~~~~~~~~---~~r~~dL~~lgll~~~  384 (1351)
T KOG1035|consen  310 VVLSASSSKESTVDGEG-VVAISLSDFDSSKPLPDNEKS-FSDLLAEIRNADEDLKENTAK---KSRLTDLWCLGLLLLQ  384 (1351)
T ss_pred             eEEecccccccccCccc-eeecchhhhcccccCCCcccc-hhhcCccccccccccccccch---hhhhhHHHHHHHHHhh
Confidence            655555   44444554 55666  88887665443222 233445566777766533222   2235799999999999


Q ss_pred             HHhCCCCCCCCCCCccHHHHHHHHhcCCCCCC-CCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          249 LYLGHFPFLQPGQRPDWATLMCAICFGDPPSL-PDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       249 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                      +..|..+-.....               +..+ +........+.+.+|+..++++|+++.+++.|+|..-
T Consensus       385 ~~~~~~i~~~~~~---------------~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~  439 (1351)
T KOG1035|consen  385 LSQGEDISEKSAV---------------PVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRF  439 (1351)
T ss_pred             hhhcCcccccccc---------------hhhhhccccchhhhhhhhhhcchhhhhccchhhhhhchhccc
Confidence            9877644311100               1111 1222227889999999999999999999999999854

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.38  E-value=3.2e-06  Score=70.79  Aligned_cols=74  Identities=12%  Similarity=0.118  Sum_probs=45.2

Q ss_pred             eeecccCCe-EEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCC---ccceeceeEEcCC--CeEEEEEe
Q 020657           57 QVLGHGNGG-TVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSP---FIVQCFGIFEKPS--GDIAILME  130 (323)
Q Consensus        57 ~~lg~G~~~-~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~~--~~~~lv~e  130 (323)
                      +.++.|+.. .||+..     ..+++|+.....   ....+.+|.++++.+...   .+..+++.....+  +..+++|+
T Consensus         3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~---~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~   74 (235)
T cd05155           3 EPVDSGGTDNATFRLG-----DDMSVRLPSAAG---YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYR   74 (235)
T ss_pred             eeccCCCcccceEEcC-----CceEEEcCCccc---hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEE
Confidence            456766665 488752     347788865422   345678899998887532   2344444332211  23578999


Q ss_pred             ccCCCCHH
Q 020657          131 YMDSGTLD  138 (323)
Q Consensus       131 ~~~~~sL~  138 (323)
                      +++|.++.
T Consensus        75 ~i~G~~l~   82 (235)
T cd05155          75 WLEGETAT   82 (235)
T ss_pred             eecCCCCC
Confidence            99987663

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.37  E-value=8.6e-08  Score=87.62  Aligned_cols=239  Identities=18%  Similarity=0.187  Sum_probs=156.4

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCc-cceeceeEEcCCCeEEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF-IVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~~lv  128 (323)
                      ..-+.....+++++++.+++.+...+...+ .+++...      ....-++++|.+++||| .+..++-++. +...+++
T Consensus       241 ~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~-E~~~~i~  312 (829)
T KOG0576|consen  241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDG-EDYLWIP  312 (829)
T ss_pred             ccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc------hhhHHHHHHHHHccCCCCcccccccCCc-ccccchh
Confidence            344566778899999999999986544444 6666433      33446788899999999 4555554443 6678899


Q ss_pred             EeccCCC-CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc
Q 020657          129 MEYMDSG-TLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD  206 (323)
Q Consensus       129 ~e~~~~~-sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~  206 (323)
                      ++++.++ +....+.. .-.+..-+...+...-.++++++|+.-=+|+|    ||+..++  ..++.||+....+.... 
T Consensus       313 ~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~--~~~~~~~~v~~~L~~~~-  385 (829)
T KOG0576|consen  313 MRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEE--EVKLLDFAVPPQLTRTM-  385 (829)
T ss_pred             hhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccccc--ccccccccCCcccCccc-
Confidence            9999876 22221111 11233344445566667889999988778888    8888775  68999999887665443 


Q ss_pred             ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-------CCccHHHHHHHHhcCCCCC
Q 020657          207 ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPG-------QRPDWATLMCAICFGDPPS  279 (323)
Q Consensus       207 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~-------~~~~~~~~~~~~~~~~~~~  279 (323)
                      ......+++.++|||+...+.+..     ..|.|++|.-..++--|..|-..+-       .......+...       .
T Consensus       386 ~~~t~~~~~~~~~pev~~~~~~~~-----~p~~~~~~~~~~~~ap~~pPr~~P~~~~~~~g~~p~s~~L~~~-------~  453 (829)
T KOG0576|consen  386 KPRTAIGTPEPLAPEVIQENTIDG-----CPDSGSLAVSAIQMAPGLPPRSSPPAVLPMIGNGPNSPMLTDK-------S  453 (829)
T ss_pred             ccccCCCCCCCCCchhhccccccc-----CCCccCCCcchhhcCCCCCCCCCCccccCCCCCCCCccccchh-------h
Confidence            345677899999999987555544     8899999986666666666653210       00000000000       0


Q ss_pred             CCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          280 LPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       280 ~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                        ..-+..-.++.+.|+.--|..|+....++-|.+|++
T Consensus       454 --aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfng  489 (829)
T KOG0576|consen  454 --AWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNG  489 (829)
T ss_pred             --hcCcccccCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence              000111124777888999999999999998888865

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.34  E-value=1.7e-05  Score=63.73  Aligned_cols=99  Identities=22%  Similarity=0.235  Sum_probs=78.7

Q ss_pred             HHHHHHHHcCCC-CccceeceeEEcCCCeEEEEEeccCCCCHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHhC---
Q 020657           97 FREMEILRRTDS-PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTL---LNKNGTFSEPKLAHIASQILKGLSYLHGH---  169 (323)
Q Consensus        97 ~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~lv~e~~~~~sL~~~---l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---  169 (323)
                      .+|.-+++.+.+ +++++++|++-.     ++|+||...+++...   +..--..++..+.+++.++++.+.+|+..   
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~-----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR-----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC-----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            357788888865 699999998743     689999987655421   11222458999999999999999999983   


Q ss_pred             CCeecCCCCCCeEEecCCCcEEEeecCcchhh
Q 020657          170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM  201 (323)
Q Consensus       170 givH~di~~~nil~~~~~~~~kl~Dfg~~~~~  201 (323)
                      .+.-.|++++|+-+++++ ++|++|.+.+...
T Consensus        82 ~~~lcDv~~~nfgv~~~~-~lk~iDld~v~~~  112 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDG-RLKLIDLDDVFVE  112 (188)
T ss_pred             cEEEeecchHHeEEeCCC-cEEEEechhcchh
Confidence            567779999999999887 8999999988654

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=98.22  E-value=1.8e-06  Score=73.36  Aligned_cols=138  Identities=15%  Similarity=0.186  Sum_probs=99.0

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-------------------ChH--HHHHHHHHHHHHHcCC-C-
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-------------------DPT--VRRQVFREMEILRRTD-S-  108 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-------------------~~~--~~~~~~~e~~~l~~l~-h-  108 (323)
                      -+.+...||-|--|.||.+-+. .|+..++|.-+...                   ++.  .+-...+|...|+.|. | 
T Consensus        93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            3567789999999999999986 68888888753110                   111  1223456777777773 2 


Q ss_pred             CccceeceeEEcCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCC
Q 020657          109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNM  188 (323)
Q Consensus       109 ~~i~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~  188 (323)
                      --+++.+++     +..++|||++.|.+|....+-      ...-.+...++..+--|-.+|+||+|+.--||++++++ 
T Consensus       172 fpVPkpiD~-----~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~-  239 (465)
T KOG2268|consen  172 FPVPKPIDH-----NRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDD-  239 (465)
T ss_pred             CCCCCcccc-----cceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCC-
Confidence            235555553     456899999999888765432      12334555677777788899999999999999999887 


Q ss_pred             cEEEeecCcchhhc
Q 020657          189 QVKIADFGVSKIMC  202 (323)
Q Consensus       189 ~~kl~Dfg~~~~~~  202 (323)
                      .+++|||-......
T Consensus       240 ~i~vIDFPQmvS~s  253 (465)
T KOG2268|consen  240 KIVVIDFPQMVSTS  253 (465)
T ss_pred             CEEEeechHhhccC
Confidence            89999998765443

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.21  E-value=2.2e-05  Score=65.64  Aligned_cols=75  Identities=15%  Similarity=0.227  Sum_probs=48.6

Q ss_pred             eeeecccCCeEEEEEEecc-cCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCc-cceeceeEEcCCCeEEEEEeccC
Q 020657           56 LQVLGHGNGGTVYKVQHRC-THKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF-IVQCFGIFEKPSGDIAILMEYMD  133 (323)
Q Consensus        56 ~~~lg~G~~~~v~~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~~lv~e~~~  133 (323)
                      ++.|..|-...+|++.... .++.+++|+.......  .....+|+.+++.+...+ .+++++...  .   .++|||++
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~--~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~---~~l~e~i~   75 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL--IIDRERELRIHKLLSKHGLAPKLYATFQ--N---GLIYEFIP   75 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc--eecHHHHHHHHHHHHhCCCCCeEEEEeC--C---cEEEEeeC
Confidence            4678888899999987642 2568889987543221  123347888888875433 344444332  2   48999999


Q ss_pred             CCCH
Q 020657          134 SGTL  137 (323)
Q Consensus       134 ~~sL  137 (323)
                      |.++
T Consensus        76 G~~l   79 (235)
T cd05157          76 GRTL   79 (235)
T ss_pred             CCcC
Confidence            8765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=98.19  E-value=2.2e-05  Score=68.09  Aligned_cols=144  Identities=21%  Similarity=0.270  Sum_probs=99.5

Q ss_pred             ceeeeecccCCeEEEEEEecccCcEEEEEeecCC------------------------CChH-HHHHHHHHHHHHHcCCC
Q 020657           54 EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD------------------------ADPT-VRRQVFREMEILRRTDS  108 (323)
Q Consensus        54 ~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~------------------------~~~~-~~~~~~~e~~~l~~l~h  108 (323)
                      .+-++|..|--+.||.|... +|..+|||+++..                        ++.. ..-....|++-|.++..
T Consensus       147 ~inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~  225 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN  225 (520)
T ss_pred             ecccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence            35578999999999999876 7888999998521                        1111 22233567777777765


Q ss_pred             CccceeceeEEcCCCeEEEEEeccCCCCH-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCCeEEecC
Q 020657          109 PFIVQCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSYLHG-HKIIHRDIKPSNLLVNNN  186 (323)
Q Consensus       109 ~~i~~~~~~~~~~~~~~~lv~e~~~~~sL-~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~givH~di~~~nil~~~~  186 (323)
                      -+|...--+...   ...|||+++..-.- .-.+ +.-.++...+..+-.+++.-|.-|-+ +++||.||.--|+|+..+
T Consensus       226 aGIP~PePIlLk---~hVLVM~FlGrdgw~aPkL-Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~LyhdG  301 (520)
T KOG2270|consen  226 AGIPCPEPILLK---NHVLVMEFLGRDGWAAPKL-KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHDG  301 (520)
T ss_pred             cCCCCCCceeee---cceEeeeeccCCCCcCccc-ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEECC
Confidence            554433222221   24799999963211 1111 23357888888888898888887765 599999999999999764


Q ss_pred             CCcEEEeecCcchhhccC
Q 020657          187 NMQVKIADFGVSKIMCRS  204 (323)
Q Consensus       187 ~~~~kl~Dfg~~~~~~~~  204 (323)
                        .+.++|.+.+.....+
T Consensus       302 --~lyiIDVSQSVE~DHP  317 (520)
T KOG2270|consen  302 --KLYIIDVSQSVEHDHP  317 (520)
T ss_pred             --EEEEEEccccccCCCh
Confidence              7999999988655443

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.19  E-value=7.5e-05  Score=60.34  Aligned_cols=130  Identities=22%  Similarity=0.390  Sum_probs=89.7

Q ss_pred             eeeecccCCeEEEEEEecccCcEEEEEeecCCC---------------ChHHHHHHHHHHHHHHcCC------CCcccee
Q 020657           56 LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA---------------DPTVRRQVFREMEILRRTD------SPFIVQC  114 (323)
Q Consensus        56 ~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~---------------~~~~~~~~~~e~~~l~~l~------h~~i~~~  114 (323)
                      ...||+|+.-.+|.--   .+....||+.....               .....+...+|+.....+.      +.+|.++
T Consensus         6 ~~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            4579999999999843   33446689887554               0112344555665555544      7889999


Q ss_pred             ceeEEcCCCeEEEEEeccC------CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC-
Q 020657          115 FGIFEKPSGDIAILMEYMD------SGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN-  187 (323)
Q Consensus       115 ~~~~~~~~~~~~lv~e~~~------~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~-  187 (323)
                      +|..++ +.-..+|+|.+.      ..||.+++..+ .+++ .   +...+-+-..+|-+.+|+.+|++|.||++...+ 
T Consensus        83 ~G~veT-~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~  156 (199)
T PF10707_consen   83 YGFVET-NLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS  156 (199)
T ss_pred             eEEEec-CCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence            999998 556788888763      33788888554 4555 3   334445556688899999999999999997542 


Q ss_pred             -C-cEEEee
Q 020657          188 -M-QVKIAD  194 (323)
Q Consensus       188 -~-~~kl~D  194 (323)
                       . .+.|+|
T Consensus       157 ~~~~lvlID  165 (199)
T PF10707_consen  157 GEFRLVLID  165 (199)
T ss_pred             CceEEEEEe
Confidence             2 566665

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PRK10593 hypothetical protein; Provisional

Probab=98.16  E-value=7.7e-05  Score=64.65  Aligned_cols=81  Identities=9%  Similarity=0.106  Sum_probs=57.6

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCC---CccceeceeEEcC--CCeEE
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS---PFIVQCFGIFEKP--SGDIA  126 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~~--~~~~~  126 (323)
                      ...-.+.||.|..+.||...+.  +..+++|..+....   ...+..|+..++.|..   ..++++++++...  .+..+
T Consensus        15 ~~~~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~   89 (297)
T PRK10593         15 KLSRVECISEQPYAALWALYDS--QGNPMPLMARSFST---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV   89 (297)
T ss_pred             hhheeeecCCccceeEEEEEcC--CCCEEEEEeccccc---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence            5566789999999999998763  23466788543212   2456788888888743   4677888776532  45689


Q ss_pred             EEEeccCCCCH
Q 020657          127 ILMEYMDSGTL  137 (323)
Q Consensus       127 lv~e~~~~~sL  137 (323)
                      +|||++++.++
T Consensus        90 LVmE~i~G~~~  100 (297)
T PRK10593         90 LLLERLRGVSV  100 (297)
T ss_pred             EEEeccCCEec
Confidence            99999998654

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=98.09  E-value=9.6e-05  Score=64.50  Aligned_cols=141  Identities=18%  Similarity=0.279  Sum_probs=81.2

Q ss_pred             cceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCc--cceecee-----EEcCCCeE
Q 020657           53 LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF--IVQCFGI-----FEKPSGDI  125 (323)
Q Consensus        53 ~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~-----~~~~~~~~  125 (323)
                      ...++.++.|....+|++...  +..+++|+.......   ..+..|..+++.|...+  +.+++..     +....+..
T Consensus        24 ~~~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~   98 (307)
T TIGR00938        24 LLSLKGIAEGVENSNYLLTTD--VGRYILTLYEKRVKA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP   98 (307)
T ss_pred             ceeccccCCccccceEEEEeC--CCcEEEEEecCCCCH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence            444677788888899998753  345778987653222   23445666666663222  3444432     11224567


Q ss_pred             EEEEeccCCCCHH-----------HHHH---h-cCCCCH-------HHHH----------------HHHHHHHHHHHHHH
Q 020657          126 AILMEYMDSGTLD-----------TLLN---K-NGTFSE-------PKLA----------------HIASQILKGLSYLH  167 (323)
Q Consensus       126 ~lv~e~~~~~sL~-----------~~l~---~-~~~~~~-------~~~~----------------~i~~~i~~~l~~Lh  167 (323)
                      +++++|++|..+.           ..+.   . ...++.       ...+                .....+...++++.
T Consensus        99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~  178 (307)
T TIGR00938        99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD  178 (307)
T ss_pred             EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence            8999999875431           1110   0 000000       0000                00112233455553


Q ss_pred             h-------CCCeecCCCCCCeEEecCCCcEEEeecCcch
Q 020657          168 G-------HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       168 ~-------~givH~di~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                      .       .+++|+|+++.||+++.++ .+.++||+.+.
T Consensus       179 ~~~~~~~~~~l~HgD~~~~Nvl~~~~~-~~~vIDfd~~~  216 (307)
T TIGR00938       179 KFWPRDLPRGVIHADLFPDNVLFDGDS-VKGVIDFYFAC  216 (307)
T ss_pred             hhhhhcCCCccCCCCCCcCcEEEECCc-eEEEeeccccc
Confidence            2       5899999999999999876 57899999884

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=98.04  E-value=0.00011  Score=63.71  Aligned_cols=141  Identities=16%  Similarity=0.187  Sum_probs=82.9

Q ss_pred             cceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCc--cceecee-----EEcCCCeE
Q 020657           53 LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF--IVQCFGI-----FEKPSGDI  125 (323)
Q Consensus        53 ~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~-----~~~~~~~~  125 (323)
                      ..-+..+..|....+|+...  ++..+++|++.. ..   ...+..|+.+++.+.+.+  +++++..     +....+..
T Consensus        16 ~~~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~   89 (296)
T cd05153          16 LLSFEGISAGIENTNYFVTT--DSGRYVLTLFEK-VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP   89 (296)
T ss_pred             hhheecccCccccceEEEEe--CCCcEEEEEcCC-CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence            33467788888889999875  345688898764 21   244566777777764322  4444432     11123456


Q ss_pred             EEEEeccCCCCHHH----HH-------H---h-cCCC----------CHHHH----------HHHHHHHHHHHHHHHh--
Q 020657          126 AILMEYMDSGTLDT----LL-------N---K-NGTF----------SEPKL----------AHIASQILKGLSYLHG--  168 (323)
Q Consensus       126 ~lv~e~~~~~sL~~----~l-------~---~-~~~~----------~~~~~----------~~i~~~i~~~l~~Lh~--  168 (323)
                      ++|+++++|.++..    ..       .   . ...+          .+...          ......+..++.++..  
T Consensus        90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~  169 (296)
T cd05153          90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD  169 (296)
T ss_pred             EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence            89999998866421    11       0   0 0000          00000          0011122334444443  


Q ss_pred             -----CCCeecCCCCCCeEEecCCCcEEEeecCcchh
Q 020657          169 -----HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       169 -----~givH~di~~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                           .+++|+|+.|.||++++++ .+.|+||+.+..
T Consensus       170 ~~~~~~~l~HgD~~~~Nil~~~~~-~~~iIDfe~a~~  205 (296)
T cd05153         170 PSDLPRGVIHADLFRDNVLFDGDE-LSGVIDFYFACT  205 (296)
T ss_pred             hhcCCCcCCccCcCcccEEEeCCc-eEEEeehhhhcC
Confidence                 3799999999999999875 568999998743

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.02  E-value=3.8e-05  Score=65.20  Aligned_cols=133  Identities=18%  Similarity=0.221  Sum_probs=77.5

Q ss_pred             eecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCcc-ceeceeEEcCCCeEEEEEeccCCCC
Q 020657           58 VLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI-VQCFGIFEKPSGDIAILMEYMDSGT  136 (323)
Q Consensus        58 ~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~lv~e~~~~~s  136 (323)
                      .+..|-.+.+|+...  +++.+++|........- .-...+|..+++.+...++ .+++....     -++|+||++|.+
T Consensus         3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~i~~~~-----~~~v~e~i~G~~   74 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCKAL-GVDRQREYQILQALSALGLAPKPILVNE-----HWLLVEWLEGEV   74 (256)
T ss_pred             cCCCcCcCCeEEEEe--CCccEEEeeCCcccccc-cCcHHHHHHHHHHHHhcCCCCceEEEeC-----CEEEEEeccCcc
Confidence            456788888998874  56788899865432211 0124678888888754333 33444322     268999999866


Q ss_pred             HHHH-------H-------H---h----cCCCCHH-HHHHHHHHH---------HHHHHHHHh--------CCCeecCCC
Q 020657          137 LDTL-------L-------N---K----NGTFSEP-KLAHIASQI---------LKGLSYLHG--------HKIIHRDIK  177 (323)
Q Consensus       137 L~~~-------l-------~---~----~~~~~~~-~~~~i~~~i---------~~~l~~Lh~--------~givH~di~  177 (323)
                      +...       .       .   .    ..+++.. .+..+..++         ...+..+..        ..++|+|+.
T Consensus        75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~  154 (256)
T TIGR02721        75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH  154 (256)
T ss_pred             cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence            5321       1       1   1    1112211 112222111         122222221        258999999


Q ss_pred             CCCeEEecCCCcEEEeecCcchh
Q 020657          178 PSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       178 ~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                      +.||++++++  +.|+||+.+..
T Consensus       155 ~~Nil~~~~~--~~lIDwE~a~~  175 (256)
T TIGR02721       155 AYNLVVTPQG--LKLIDWEYASD  175 (256)
T ss_pred             cCcEEEeCCC--CEEEeccccCc
Confidence            9999999875  78999998854

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK05231 homoserine kinase; Provisional

Probab=98.00  E-value=0.00026  Score=62.14  Aligned_cols=138  Identities=14%  Similarity=0.206  Sum_probs=74.7

Q ss_pred             eeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCc--cceecee-----EEcCCCeEEEE
Q 020657           56 LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF--IVQCFGI-----FEKPSGDIAIL  128 (323)
Q Consensus        56 ~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~-----~~~~~~~~~lv  128 (323)
                      ++.++.|....+|.....  +..+++|++. ..+.   ..+..|+.+++.|...+  +.+++..     +....+..+++
T Consensus        27 ~~~l~~G~~n~~y~v~t~--~g~~vLK~~~-~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l  100 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTT--QGEYVLTLFE-RLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAI  100 (319)
T ss_pred             cchhccccccceEEEEeC--CCcEEEEEec-cCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEE
Confidence            456777888889998763  3367889875 2222   22334555555542212  3333321     11124567899


Q ss_pred             EeccCCCCHH-----------HHHH---h-cCCC--------C--H-HHHH------------HHHHH-HHHHHHHHH--
Q 020657          129 MEYMDSGTLD-----------TLLN---K-NGTF--------S--E-PKLA------------HIASQ-ILKGLSYLH--  167 (323)
Q Consensus       129 ~e~~~~~sL~-----------~~l~---~-~~~~--------~--~-~~~~------------~i~~~-i~~~l~~Lh--  167 (323)
                      ++|++|..+.           ..+.   . ...+        .  . ....            ..+.+ +...+..+.  
T Consensus       101 ~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  180 (319)
T PRK05231        101 VTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASA  180 (319)
T ss_pred             EEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcc
Confidence            9999886431           1111   0 0000        0  0 0100            01111 112223332  


Q ss_pred             -----hCCCeecCCCCCCeEEecCCCcEEEeecCcchh
Q 020657          168 -----GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       168 -----~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                           ..|++|+|+.+.||+++.++ ..-++||+.+..
T Consensus       181 ~~~~lp~~liHgD~~~~Nil~~~~~-~~~iIDf~~~~~  217 (319)
T PRK05231        181 AWPALPRGVIHADLFRDNVLFEGDR-LSGFIDFYFACN  217 (319)
T ss_pred             ccccCCcccCCCCCCCCcEEEECCc-eEEEEecccccC
Confidence                 23899999999999998664 458999998853

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.98  E-value=0.00025  Score=63.49  Aligned_cols=78  Identities=17%  Similarity=0.132  Sum_probs=53.8

Q ss_pred             eeeecccCCeEEEEEEecccCcEEEEEeecCC-----C-ChHHHHHHHHHHHHHHcCC---CCccceeceeEEcCCCeEE
Q 020657           56 LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-----A-DPTVRRQVFREMEILRRTD---SPFIVQCFGIFEKPSGDIA  126 (323)
Q Consensus        56 ~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~-----~-~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~~  126 (323)
                      .+.||.|.+..||++.+...++.++||.....     . .+....+...|.+.|+.+.   ..++++++.+.   .+..+
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D---~~~~~  107 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD---EELAV  107 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC---CCCCE
Confidence            46799999999999998633358999985421     1 1234556677888887753   24566777762   34578


Q ss_pred             EEEeccCCCC
Q 020657          127 ILMEYMDSGT  136 (323)
Q Consensus       127 lv~e~~~~~s  136 (323)
                      +|||++++..
T Consensus       108 lVME~L~~~~  117 (401)
T PRK09550        108 TVMEDLSDHK  117 (401)
T ss_pred             EEEecCCCcc
Confidence            9999998644

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.90  E-value=9.6e-05  Score=64.34  Aligned_cols=76  Identities=22%  Similarity=0.316  Sum_probs=48.8

Q ss_pred             eeeecccCCeEEEEEEecc------cCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCcc-ceeceeEEcCCCeEEEE
Q 020657           56 LQVLGHGNGGTVYKVQHRC------THKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI-VQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        56 ~~~lg~G~~~~v~~~~~~~------~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~lv  128 (323)
                      ++.+..|-...+|++....      .++.+++|+......  ......+|..+++.+...++ .++++.+.  +   .+|
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~r~~E~~~~~~l~~~g~~P~~~~~~~--~---~~v   75 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE--LLIDRERELVVFARLSERNLGPKLYGIFP--N---GRI   75 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc--ceechHHHHHHHHHHHhCCCCCceEEEeC--C---Cch
Confidence            4567778888899987642      257899999765432  22345678888877743333 44555543  2   368


Q ss_pred             EeccCCCCHH
Q 020657          129 MEYMDSGTLD  138 (323)
Q Consensus       129 ~e~~~~~sL~  138 (323)
                      ++|++|.++.
T Consensus        76 ~e~i~G~~l~   85 (302)
T cd05156          76 EEFIPSRTLT   85 (302)
T ss_pred             hheeCCCcCC
Confidence            9998887654

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.77  E-value=0.00037  Score=60.29  Aligned_cols=147  Identities=14%  Similarity=0.281  Sum_probs=87.4

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCC--CccceeceeEEcCC-CeEEEE
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS--PFIVQCFGIFEKPS-GDIAIL  128 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~-~~~~lv  128 (323)
                      ...++..+..|-...+|...+.  ++.++++...............+|..+++.+.-  .-+...++.+.+.. +..+.|
T Consensus        26 ~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v  103 (321)
T COG3173          26 GLLIVEEISGGWSNDTFRLGDT--GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV  103 (321)
T ss_pred             CCceeeeccCCcccceEEEecC--CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence            3445556655666667777663  778888833223344556677788999888743  22344555555433 467999


Q ss_pred             EeccCCCCHH------------------HHHHh------------cC--CCCHHHHHHHHHHH--------------HHH
Q 020657          129 MEYMDSGTLD------------------TLLNK------------NG--TFSEPKLAHIASQI--------------LKG  162 (323)
Q Consensus       129 ~e~~~~~sL~------------------~~l~~------------~~--~~~~~~~~~i~~~i--------------~~~  162 (323)
                      |+|+.|..+.                  +++..            ..  .....++..+..+.              ...
T Consensus       104 ~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~  183 (321)
T COG3173         104 MEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL  183 (321)
T ss_pred             EEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence            9999873221                  11110            00  00111222222222              223


Q ss_pred             HHHHHhC--------CCeecCCCCCCeEEecCCCcEEEeecCcchhh
Q 020657          163 LSYLHGH--------KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM  201 (323)
Q Consensus       163 l~~Lh~~--------givH~di~~~nil~~~~~~~~kl~Dfg~~~~~  201 (323)
                      ..+|+..        .++|||+++.|+++++++ .+-++||+++..-
T Consensus       184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~-~~gVlDwe~~~lG  229 (321)
T COG3173         184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGR-PTGVLDWELATLG  229 (321)
T ss_pred             HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCC-eeEEEeccccccC
Confidence            4444432        489999999999999998 5999999998653

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.69  E-value=0.00067  Score=58.12  Aligned_cols=31  Identities=19%  Similarity=0.558  Sum_probs=25.3

Q ss_pred             CCeecCCCCCCeEEecCCCcEEEeecCcchh
Q 020657          170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       170 givH~di~~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                      .++|+|+++.||++++++...-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999997542356999998854

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02236 choline kinase

Probab=97.68  E-value=0.00073  Score=59.90  Aligned_cols=139  Identities=12%  Similarity=0.172  Sum_probs=81.5

Q ss_pred             eeeeecccCCeEEEEEEecc----cCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCcc-ceeceeEEcCCCeEEEEE
Q 020657           55 KLQVLGHGNGGTVYKVQHRC----THKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI-VQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        55 ~~~~lg~G~~~~v~~~~~~~----~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~lv~  129 (323)
                      -+..+..|-...+|++....    .++.+++|+...... .... ..+|..+++.+..-++ .++++.+..  +   .|+
T Consensus        40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~--g---~v~  112 (344)
T PLN02236         40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFFD-RDDEIRTFECMSRHGQGPRLLGRFPN--G---RVE  112 (344)
T ss_pred             EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eeec-hHHHHHHHHHHHHcCCCCceEEEECC--c---eEE
Confidence            34566668889999987532    246899998865432 2222 2578888888754444 345666543  2   578


Q ss_pred             eccCCCCHHHH-------H----------HhcC-C----C-CHHHHHHHHHHH-----------------HHHHHHH---
Q 020657          130 EYMDSGTLDTL-------L----------NKNG-T----F-SEPKLAHIASQI-----------------LKGLSYL---  166 (323)
Q Consensus       130 e~~~~~sL~~~-------l----------~~~~-~----~-~~~~~~~i~~~i-----------------~~~l~~L---  166 (323)
                      +|+++.++...       +          ++.. +    . ....+..+..++                 ...+..|   
T Consensus       113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~  192 (344)
T PLN02236        113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE  192 (344)
T ss_pred             EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence            99887666421       1          0000 0    1 122222332221                 1112222   


Q ss_pred             -H----hCCCeecCCCCCCeEEecCCCcEEEeecCcchh
Q 020657          167 -H----GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       167 -h----~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                       .    ...++|+|+++.||++++++..+.++||.++..
T Consensus       193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence             1    225899999999999987433799999999854

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.66  E-value=8.2e-05  Score=67.24  Aligned_cols=165  Identities=21%  Similarity=0.296  Sum_probs=102.6

Q ss_pred             HHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 020657           94 RQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH  173 (323)
Q Consensus        94 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH  173 (323)
                      ..+.....+++.+.|+|+...+++-.....+..+|+|++. .+|++.+..+. +-.....              .+|+.|
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~-l~~~s~~--------------~~~~~~   90 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN-LKDESLL--------------AHGVLH   90 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc-cchhhhc--------------ccccce
Confidence            4566778889999999999999987665667889999995 59999887553 2111111              222222


Q ss_pred             cCCCCCCeEEecCCCcEEEeecCcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCC
Q 020657          174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGH  253 (323)
Q Consensus       174 ~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~  253 (323)
                      -     |        .++.+| .++    +.            |  |-..     +     +|+|||++|.++.+++-|.
T Consensus        91 ~-----~--------~~~~td-~~~----t~------------~--~~~~-----~-----pKsdVwsl~~i~~el~L~~  128 (725)
T KOG1093|consen   91 L-----N--------IIYITD-HFL----TK------------Y--PSPI-----G-----PKSDVWSLGFIILELYLGI  128 (725)
T ss_pred             e-----h--------hhhccc-ccc----cc------------C--CCCC-----C-----cchhhhhHHHHHHHHHHhh
Confidence            1     1        233333 111    00            0  1100     1     3999999999999999887


Q ss_pred             CCCCCCCCCccHHHHHHHHhcCCCC--------CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          254 FPFLQPGQRPDWATLMCAICFGDPP--------SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       254 ~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                      ..+...........+. +.......        .+-..++..+..+...|+...|..||...++++++-|..
T Consensus       129 ~l~~~~~~s~~l~~i~-k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~e  199 (725)
T KOG1093|consen  129 SLEAELTESEYLEILL-KYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTE  199 (725)
T ss_pred             HHHHHHHHHHHHHHHH-HhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHH
Confidence            7663332221111111 11000000        122356778899999999999999999999999987754

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.58  E-value=0.0009  Score=58.98  Aligned_cols=138  Identities=14%  Similarity=0.225  Sum_probs=78.8

Q ss_pred             eeeecccCCeEEEEEEeccc---CcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCcc-ceeceeEEcCCCeEEEEEec
Q 020657           56 LQVLGHGNGGTVYKVQHRCT---HKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI-VQCFGIFEKPSGDIAILMEY  131 (323)
Q Consensus        56 ~~~lg~G~~~~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~lv~e~  131 (323)
                      +..|..|-...+|+......   +..|++|+.......  .-...+|..+++.+..-++ +++++++.  .+   +|.+|
T Consensus        19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~--~IdR~~E~~il~~l~~~gl~P~~l~~~~--~G---~i~~f   91 (330)
T PLN02421         19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY--VIDRERELQAIKYLSAAGFGAKLLGVFG--NG---MIQSF   91 (330)
T ss_pred             EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe--EechHHHHHHHHHHHhcCCCCceeEEeC--Cc---Eeehh
Confidence            34555588888999875422   337889988654321  1223477888887755444 34555553  23   58999


Q ss_pred             cCCCCHHH-------HH-------H---hcC-C----C-CHHHHHHHHHHH----------------------HHHHHHH
Q 020657          132 MDSGTLDT-------LL-------N---KNG-T----F-SEPKLAHIASQI----------------------LKGLSYL  166 (323)
Q Consensus       132 ~~~~sL~~-------~l-------~---~~~-~----~-~~~~~~~i~~~i----------------------~~~l~~L  166 (323)
                      +++.++..       .+       .   ... +    . -...+..+..++                      ..-+..+
T Consensus        92 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l  171 (330)
T PLN02421         92 INARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVEL  171 (330)
T ss_pred             hcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHH
Confidence            88766521       11       0   100 0    1 112222222221                      1112211


Q ss_pred             ----HhC----CCeecCCCCCCeEEecCCCcEEEeecCcchh
Q 020657          167 ----HGH----KIIHRDIKPSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       167 ----h~~----givH~di~~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                          ...    -++|+|+.+.||++++++..++++||++|..
T Consensus       172 ~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        172 KEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence                112    2799999999999986433799999999854

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.55  E-value=0.0013  Score=57.95  Aligned_cols=74  Identities=19%  Similarity=0.223  Sum_probs=47.9

Q ss_pred             eecccCCeEEEEEEecccCcEEEEEeecC------CCChHHHHHHHHHHHHHHcCC--CC-ccceeceeEEcCCCeEEEE
Q 020657           58 VLGHGNGGTVYKVQHRCTHKIYALKVVHG------DADPTVRRQVFREMEILRRTD--SP-FIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        58 ~lg~G~~~~v~~~~~~~~~~~v~iK~~~~------~~~~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~~~~~~~~~~lv  128 (323)
                      .+|.|....||++.+...++.++||.-..      ...+....+..-|...|+...  .| .+++++.+   +.+...+|
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~---D~e~~~~v   78 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF---DTEMAVTV   78 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE---ccccceeh
Confidence            47899999999999863336899987531      122334455556777776653  24 45555554   24556799


Q ss_pred             EeccCC
Q 020657          129 MEYMDS  134 (323)
Q Consensus       129 ~e~~~~  134 (323)
                      ||+++.
T Consensus        79 MEdL~~   84 (370)
T TIGR01767        79 MEDLSH   84 (370)
T ss_pred             HhhCcc
Confidence            999854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.46  E-value=2.2e-05  Score=78.92  Aligned_cols=217  Identities=15%  Similarity=0.031  Sum_probs=138.3

Q ss_pred             HHHHHHHHcCCCCccceeceeEE-cCCCeEEEEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC--
Q 020657           97 FREMEILRRTDSPFIVQCFGIFE-KPSGDIAILMEYMDSGTLDTLLNKN----GTFSEPKLAHIASQILKGLSYLHGH--  169 (323)
Q Consensus        97 ~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~~lv~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~~i~~~l~~Lh~~--  169 (323)
                      ..|....+...|+++.....-.. ..+...+..++++.+|.+.+++-++    +.+...-+....++.+....-+|+.  
T Consensus      1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred             hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence            33444455567877765443322 1133457899999999999998653    2344444444444446666666654  


Q ss_pred             ---CCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHH
Q 020657          170 ---KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTL  246 (323)
Q Consensus       170 ---givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll  246 (323)
                         --+|.++++.|.++..+- +++++++|+.+.............+++.|+.++..+.-.++     .++|+|..|+.+
T Consensus      1357 lg~T~v~~~Lkf~lpmIVtny-~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t-----~rsdilr~s~~l 1430 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNY-NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFT-----KRSDILRRSLSL 1430 (2724)
T ss_pred             CCccchhhhhhhhccceecCC-cccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhh-----hHHHHHHHHHHH
Confidence               268999999999999875 89999999998444444444556777888999887644443     369999999999


Q ss_pred             HHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCCCCC
Q 020657          247 LELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSDC  323 (323)
Q Consensus       247 ~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~~~  323 (323)
                      |....|..+|..    .....+...+.......++...|.+.......+|-+.-..||.-...++.+.|.--.+..|
T Consensus      1431 y~rs~~n~~fi~----flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~~~~d~~ 1503 (2724)
T KOG1826|consen 1431 YLRSDGNAYFIF----FLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAVGLRDIC 1503 (2724)
T ss_pred             HHHhcccHHHHH----HHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccccccccCcc
Confidence            999988877711    0111111111112222333333444444444455555578999999999888876655544

>PTZ00384 choline kinase; Provisional

Probab=97.34  E-value=0.0025  Score=57.16  Aligned_cols=77  Identities=12%  Similarity=0.146  Sum_probs=46.2

Q ss_pred             eeeeecccCCeEEEEEEecccC-c-----EEEEEeecCCCChHHHHHHHHHHHHHHcCCCCcc-ceeceeEEcCCCeEEE
Q 020657           55 KLQVLGHGNGGTVYKVQHRCTH-K-----IYALKVVHGDADPTVRRQVFREMEILRRTDSPFI-VQCFGIFEKPSGDIAI  127 (323)
Q Consensus        55 ~~~~lg~G~~~~v~~~~~~~~~-~-----~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~l  127 (323)
                      .+..|..|-...+|++...... .     .|+++.....  ....-.-.+|..+++.+...++ .++++.+..     ++
T Consensus        54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~--~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~-----g~  126 (383)
T PTZ00384         54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY--NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD-----FT  126 (383)
T ss_pred             EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCC--CceEeccHHHHHHHHHHHhCCCCCeEEEecCC-----EE
Confidence            3456666888999998754221 1     2445543222  1211223468888888865444 556666543     59


Q ss_pred             EEeccCCCCHH
Q 020657          128 LMEYMDSGTLD  138 (323)
Q Consensus       128 v~e~~~~~sL~  138 (323)
                      |.||++|.++.
T Consensus       127 l~efIeGr~l~  137 (383)
T PTZ00384        127 IQEWVEGNTMG  137 (383)
T ss_pred             EEEEeccccCC
Confidence            99999887664

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.27  E-value=0.0028  Score=56.55  Aligned_cols=76  Identities=17%  Similarity=0.198  Sum_probs=51.1

Q ss_pred             eeeecccCCeEEEEEEecccCcEEEEEeecC-----CCChHHHHHHHHHHHHHHcCC--CC-ccceeceeEEcCCCeEEE
Q 020657           56 LQVLGHGNGGTVYKVQHRCTHKIYALKVVHG-----DADPTVRRQVFREMEILRRTD--SP-FIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        56 ~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~-----~~~~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~~~~~~~~~~l  127 (323)
                      +..||.|....||++.+...++.|+||.-..     ...+....+..-|...|+.+.  .| .+++++.+-   .....+
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D---~e~~~~  110 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD---SVMNCC  110 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC---cHHhhH
Confidence            6788999999999999853356788887531     122344566667777777653  24 455566542   445678


Q ss_pred             EEeccCC
Q 020657          128 LMEYMDS  134 (323)
Q Consensus       128 v~e~~~~  134 (323)
                      |||+++.
T Consensus       111 vMEdL~~  117 (409)
T PRK12396        111 VMEDLSD  117 (409)
T ss_pred             HHHhCcc
Confidence            9999854

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.18  E-value=0.0093  Score=52.07  Aligned_cols=29  Identities=28%  Similarity=0.490  Sum_probs=25.3

Q ss_pred             CCCeecCCCCCCeEEecCCCcEEEeecCcch
Q 020657          169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       169 ~givH~di~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                      .+++|||+.+.||+++. + .+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~-~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-N-EVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-C-cEEEEECcccc
Confidence            47899999999999987 4 68999999763

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=97.12  E-value=0.0072  Score=52.84  Aligned_cols=88  Identities=14%  Similarity=0.165  Sum_probs=62.2

Q ss_pred             CCCCccceeceeEEcCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCCeEEe
Q 020657          106 TDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH-KIIHRDIKPSNLLVN  184 (323)
Q Consensus       106 l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-givH~di~~~nil~~  184 (323)
                      .+-++..+..-+-.+...+.+++|++- |+++..+-    -....++..++.+-+..++-+... ..-|||+..+||+++
T Consensus       282 ~g~~~~e~~~vv~~de~~y~yl~~kdh-gt~is~ik----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId  356 (488)
T COG5072         282 CGSVFLETLKVVSLDETLYLYLHFKDH-GTPISIIK----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID  356 (488)
T ss_pred             ccchhhhcceEEecCCceEEEEEEecC-Cceeeeee----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee
Confidence            333444433333223244567888886 33554321    236778899999998888888876 789999999999999


Q ss_pred             cCCCcEEEeecCcchh
Q 020657          185 NNNMQVKIADFGVSKI  200 (323)
Q Consensus       185 ~~~~~~kl~Dfg~~~~  200 (323)
                       +| ++.|+||-+++.
T Consensus       357 -~G-nvtLIDfklsRl  370 (488)
T COG5072         357 -EG-NVTLIDFKLSRL  370 (488)
T ss_pred             -cC-ceEEEEeeeeec
Confidence             66 899999999974

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=97.07  E-value=0.017  Score=50.48  Aligned_cols=30  Identities=13%  Similarity=0.282  Sum_probs=26.9

Q ss_pred             CCeecCCCCCCeEEecCCCcEEEeecCcchh
Q 020657          170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       170 givH~di~~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                      +++|+|+.++||+++.++ .+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~-~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETR-GGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCC-CEEEEEhhhccc
Confidence            799999999999999887 799999998743

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=97.05  E-value=0.0012  Score=54.31  Aligned_cols=30  Identities=33%  Similarity=0.679  Sum_probs=20.0

Q ss_pred             CCeecCCCCCCeEE-ecCCCcEEEeecCcchh
Q 020657          170 KIIHRDIKPSNLLV-NNNNMQVKIADFGVSKI  200 (323)
Q Consensus       170 givH~di~~~nil~-~~~~~~~kl~Dfg~~~~  200 (323)
                      .++|+|+.+.||++ +.++ .++|+||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~-~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDG-EVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSS-CEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCC-eEEEecHHHHhh
Confidence            58999999999999 5555 899999999853

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.02  E-value=0.026  Score=50.78  Aligned_cols=75  Identities=20%  Similarity=0.291  Sum_probs=50.3

Q ss_pred             eeeeecccCCeEEEEEEecccCcEEEEEeecCC-----C-ChHHHHHHHHHHHHHHcCC---CCccceeceeEEcCCCeE
Q 020657           55 KLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-----A-DPTVRRQVFREMEILRRTD---SPFIVQCFGIFEKPSGDI  125 (323)
Q Consensus        55 ~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~-----~-~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~  125 (323)
                      ..+.||.|....||+..+.  ++.++||.-...     . .+....+...|+..|+.+.   ..++++++.+..+   ..
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded---~~  110 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT---MA  110 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC---CC
Confidence            4778899999999999873  456889987522     1 0112344445566666553   2467778887653   45


Q ss_pred             EEEEeccCC
Q 020657          126 AILMEYMDS  134 (323)
Q Consensus       126 ~lv~e~~~~  134 (323)
                      +++||++++
T Consensus       111 vlvME~L~~  119 (418)
T PLN02756        111 LIGMRYLEP  119 (418)
T ss_pred             EEEEeecCC
Confidence            788999976

>PRK11768 serine/threonine protein kinase; Provisional

Probab=97.01  E-value=0.018  Score=50.72  Aligned_cols=70  Identities=14%  Similarity=0.117  Sum_probs=40.8

Q ss_pred             CCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCc--cceec---e--eEEcCCCeEEEEEeccCCC
Q 020657           63 NGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF--IVQCF---G--IFEKPSGDIAILMEYMDSG  135 (323)
Q Consensus        63 ~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~---~--~~~~~~~~~~lv~e~~~~~  135 (323)
                      ....||..... +++.+++|+.+....  ....+..|+..+..|....  ++...   |  +... ++..+.++++++|.
T Consensus        37 ~eN~vy~v~~~-~~~~~vlKv~r~~~~--~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~-~g~~~~l~~~~~G~  112 (325)
T PRK11768         37 YENRVYQFGDE-DGRRVVAKFYRPERW--SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEH-QGFRFALFPRRGGR  112 (325)
T ss_pred             ccceEEEEecC-CCCEEEEEEcCcccC--CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEE-CCEEEEEEeeeCCC
Confidence            34578988764 566799999864431  2344556777776653211  22212   2  1222 45678899998875


Q ss_pred             C
Q 020657          136 T  136 (323)
Q Consensus       136 s  136 (323)
                      .
T Consensus       113 ~  113 (325)
T PRK11768        113 A  113 (325)
T ss_pred             C
Confidence            4

>PTZ00296 choline kinase; Provisional

Probab=96.94  E-value=0.011  Score=54.23  Aligned_cols=76  Identities=14%  Similarity=0.241  Sum_probs=48.1

Q ss_pred             eeeeecccCCeEEEEEEecc--------cCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccc-eeceeEEcCCCeE
Q 020657           55 KLQVLGHGNGGTVYKVQHRC--------THKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIV-QCFGIFEKPSGDI  125 (323)
Q Consensus        55 ~~~~lg~G~~~~v~~~~~~~--------~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~  125 (323)
                      -+..|..|-...+|++....        .++.|++|++-.....- . ....|..+++.+..-+|- ++++.+..     
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~l-I-dR~~E~~v~~~ls~~gi~P~l~~~f~g-----  181 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDEL-Y-NPISEFEVYKTMSKYRIAPQLLNTFSG-----  181 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccce-e-CHHHHHHHHHHHHHCCCCCceEEEeCC-----
Confidence            56778888888999987542        14679999986543221 1 334677777776544443 45565532     


Q ss_pred             EEEEeccCCCCH
Q 020657          126 AILMEYMDSGTL  137 (323)
Q Consensus       126 ~lv~e~~~~~sL  137 (323)
                      +.|.+|++|.+|
T Consensus       182 g~I~efi~g~~l  193 (442)
T PTZ00296        182 GRIEEWLYGDPL  193 (442)
T ss_pred             CEEEEeeCCccC
Confidence            467899987644

>PRK06148 hypothetical protein; Provisional

Probab=96.63  E-value=0.098  Score=53.23  Aligned_cols=152  Identities=18%  Similarity=0.293  Sum_probs=80.9

Q ss_pred             cchhcccccccee---eeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCC-------CCccce
Q 020657           44 TTAAIAYSDLEKL---QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD-------SPFIVQ  113 (323)
Q Consensus        44 ~~~~~~~~~~~~~---~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~-------h~~i~~  113 (323)
                      ....+..+.|-+.   +.|+ |..-..|+.... +++.+++|+.......   .....|...+..|.       -|.+++
T Consensus        15 ~~~~~~~~~ygl~~~~~~L~-s~~d~nf~v~~~-~g~~yVLKi~~~~~~~---~~~~~q~~~L~hL~~~~~glpvP~~i~   89 (1013)
T PRK06148         15 DAEALLAQHFGISATATPLD-GERDLNFRLTTD-DGADYILKIVNPSEPR---VESDFQTAALDHLAAVAPDLPVPRLIP   89 (1013)
T ss_pred             HHHHHHHHHcCCceEEeecC-CcCCceEEEEeC-CCCeEEEEEcCCccch---hHHHHHHHHHHHHHhhCCCCCcCeeee
Confidence            3334444555443   4554 345678888754 5778999999755332   22334455555442       233333


Q ss_pred             ec-e----eEEcCCC--eEEEEEeccCCCCHHHH-------HH----------h------c----CCCCH----------
Q 020657          114 CF-G----IFEKPSG--DIAILMEYMDSGTLDTL-------LN----------K------N----GTFSE----------  149 (323)
Q Consensus       114 ~~-~----~~~~~~~--~~~lv~e~~~~~sL~~~-------l~----------~------~----~~~~~----------  149 (323)
                      -. |    .....++  ..+-+++|++|..+.+.       +.          .      .    ..+.+          
T Consensus        90 t~~G~~~~~v~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~  169 (1013)
T PRK06148         90 SLSGASLASAQDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARD  169 (1013)
T ss_pred             cCCCCeEEEeecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhh
Confidence            22 1    1111122  46778999998777551       10          0      0    00111          


Q ss_pred             -------HHHHHHHHHHHHHHH-----HHH--hCCCeecCCCCCCeEEecCC--CcEEEeecCcchh
Q 020657          150 -------PKLAHIASQILKGLS-----YLH--GHKIIHRDIKPSNLLVNNNN--MQVKIADFGVSKI  200 (323)
Q Consensus       150 -------~~~~~i~~~i~~~l~-----~Lh--~~givH~di~~~nil~~~~~--~~~kl~Dfg~~~~  200 (323)
                             ...+.++.++++.+.     .+.  ..++||+|+.+.||+++.++  ...-|+|||.+..
T Consensus       170 ~l~~i~d~~~r~~l~~~~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        170 RLHFIDDPEDRALVERFLARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             hhhhcCCHHHHHHHHHHHHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence                   111222333333222     122  24799999999999998763  2344999998853

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.60  E-value=0.059  Score=47.30  Aligned_cols=137  Identities=22%  Similarity=0.308  Sum_probs=77.6

Q ss_pred             eeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCc------cceeceeE-EcCCC--eEEE
Q 020657           57 QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF------IVQCFGIF-EKPSG--DIAI  127 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~~~-~~~~~--~~~l  127 (323)
                      ..|.+ ....+|+.... +|+. ++|++.....   ...+..|...++.|.-.+      +...-|-. ..-.+  ..+-
T Consensus        32 ~~l~s-~eN~~f~~~~~-~g~~-iLki~~~~~~---~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~  105 (331)
T COG2334          32 RGLNS-EENSNFRVQTE-DGRY-ILKIYRPGWT---RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAA  105 (331)
T ss_pred             ccccc-ccCceEEEEec-CCCe-EEEEecCCCC---HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEE
Confidence            34444 45678988875 3444 8999976622   344556777777763211      22222221 11123  7788


Q ss_pred             EEeccCCCCHHH-----HHH-------------hcC---------CCCHH----H---------HHHHHHHHHHHHHHHH
Q 020657          128 LMEYMDSGTLDT-----LLN-------------KNG---------TFSEP----K---------LAHIASQILKGLSYLH  167 (323)
Q Consensus       128 v~e~~~~~sL~~-----~l~-------------~~~---------~~~~~----~---------~~~i~~~i~~~l~~Lh  167 (323)
                      +++|++|..+..     .+.             ++-         ...+.    .         -.....++...+..+.
T Consensus       106 lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~  185 (331)
T COG2334         106 LFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLL  185 (331)
T ss_pred             EEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHH
Confidence            999999877762     110             000         01111    0         0012223334444444


Q ss_pred             h-------C-C--CeecCCCCCCeEEecCCCcEEEeecCcch
Q 020657          168 G-------H-K--IIHRDIKPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       168 ~-------~-g--ivH~di~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                      +       . +  +||+|+.++||+++.++....++||+.+.
T Consensus       186 ~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         186 ARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            3       2 3  99999999999999885238899999884

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.60  E-value=0.012  Score=50.53  Aligned_cols=76  Identities=18%  Similarity=0.263  Sum_probs=45.6

Q ss_pred             cceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcC---CCCccceeceeEEcCCCeEEEEE
Q 020657           53 LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT---DSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        53 ~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      .+..+.++.|..+.+|....  +++.+.+|+-...    ....+..|+.-|+.|   .--.+++++++... .+..++|+
T Consensus        19 i~~~~~v~GG~i~~a~~~~~--~~~~~FvK~~~~~----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~-~~~~fLll   91 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLDT--DGGSYFVKVNSES----GRDMFEGEAEGLKALAEANPIRVPKVIAWGEY-DDDAFLLL   91 (288)
T ss_dssp             --EEEEE--SSSSEEEEEET--TS-EEEEEEEEGG----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE--SSCCEEEE
T ss_pred             eeeeEecCCCChhheEEEEC--CCccEEEEecChh----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEee-cCCceEEE
Confidence            55667899999999999884  7788899987622    223455676666666   34567888888776 44569999


Q ss_pred             eccCCC
Q 020657          130 EYMDSG  135 (323)
Q Consensus       130 e~~~~~  135 (323)
                      ||++.+
T Consensus        92 e~l~~~   97 (288)
T PF03881_consen   92 EFLEMG   97 (288)
T ss_dssp             E-----
T ss_pred             EeecCC
Confidence            999765

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.28  E-value=0.023  Score=46.29  Aligned_cols=116  Identities=15%  Similarity=0.137  Sum_probs=68.4

Q ss_pred             cCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEeccCCCCHHHHH
Q 020657           62 GNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLL  141 (323)
Q Consensus        62 G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l  141 (323)
                      |+.++.-.+... -| ...+|.+....-......+.++.++++++.  +|+++..   +..-.+.++.|+|.....    
T Consensus        73 ~gNsTl~~~kt~-iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N---Dn~~~yGvIlE~Cy~~~i----  141 (308)
T PF07387_consen   73 NGNSTLLIGKTK-IG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN---DNNYKYGVILERCYKIKI----  141 (308)
T ss_pred             CCceEEEEeccc-cc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec---CCCceeEEEEeeccCccc----
Confidence            334444444433 13 344555543321112344567788877763  4666663   224457799999864211    


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHhC--CCeecCCCCCCeEEecCCCcEEEeecCcc
Q 020657          142 NKNGTFSEPKLAHIASQILKGLSYLHGH--KIIHRDIKPSNLLVNNNNMQVKIADFGVS  198 (323)
Q Consensus       142 ~~~~~~~~~~~~~i~~~i~~~l~~Lh~~--givH~di~~~nil~~~~~~~~kl~Dfg~~  198 (323)
                           ..   .-.+.. =+.+|...|+.  +.+|||..|+||+.|..| .+||.|=+..
T Consensus       142 -----~~---~N~i~a-gi~~L~~fH~~~~~~lHGD~np~NiM~D~~G-~lKlVDP~~L  190 (308)
T PF07387_consen  142 -----NF---SNFITA-GIKDLMDFHSENQHCLHGDCNPDNIMCDKFG-YLKLVDPVCL  190 (308)
T ss_pred             -----ch---hHHHHH-hHHHHHHhhccCCCeecCCCChhheeecCCC-CEEecChhhh
Confidence                 11   111111 14567778854  799999999999999998 8999987754

The function of this family is unknown.

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.84  E-value=0.1  Score=42.88  Aligned_cols=80  Identities=11%  Similarity=0.225  Sum_probs=55.9

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcC---CCCccceeceeEEcCCCeEEEE
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT---DSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      +.+..+.+..|.....|...+  ....+.+|+-.    ......+..|+.-|+.|   +--.+.+++.+..+ ..+.++|
T Consensus        17 ~i~er~~v~gG~inea~~v~d--g~~~~FvK~n~----~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~-~~~sylV   89 (286)
T COG3001          17 EIKEREEVSGGDINEAWRLRD--GTDPFFVKCNQ----REQLSMFTAEADGLELLARSNTITVPKVIAVGAS-RDHSYLV   89 (286)
T ss_pred             hhhcccccCCccccceeEeec--CCcceEEEecc----hhhHHHHHHHHHHHHHHHhcCCccccceEEecCC-CCeeEEE
Confidence            455566777777788888877  45677788753    23345566676666665   44567788887776 6789999


Q ss_pred             EeccCCCCHH
Q 020657          129 MEYMDSGTLD  138 (323)
Q Consensus       129 ~e~~~~~sL~  138 (323)
                      +||++-+.+.
T Consensus        90 le~L~~~~~d   99 (286)
T COG3001          90 LEYLPTGPLD   99 (286)
T ss_pred             EeeccCCCCC
Confidence            9999876554

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	323
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-48
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		6e-48
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-46
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-44
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-44
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-44
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-44
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-44
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		7e-44
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-41
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-32
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-32
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-32
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-32
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-32
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		7e-32
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		7e-31
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-30
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-30
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-29
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-29
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-29
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-29
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		6e-29
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-29
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-28
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-28
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-27
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-25
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-25
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-25
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-23
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		8e-23
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		9e-23
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-22
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-22
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-22
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-22
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-22
3g51_A	325	Structural Diversity Of The Active Conformation Of		6e-22
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-21
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-21
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-21
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-21
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-21
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-21
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-21
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-21
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-21
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-21
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-21
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-21
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-21
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-21
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-21
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-21
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-21
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-21
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-21
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-21
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-21
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-21
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		6e-21
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-21
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		6e-21
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		6e-21
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		7e-21
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		7e-21
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		7e-21
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		7e-21
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-21
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		8e-21
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-21
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		8e-21
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		8e-21
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		8e-21
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-20
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-20
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-20
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-20
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-20
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-20
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-20
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-20
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-20
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-20
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-20
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-20
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-20
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-20
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-20
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-20
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-20
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-20
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-20
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-20
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-20
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-20
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-20
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-20
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-20
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-20
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-20
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-20
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-20
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-20
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-20
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-20
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-20
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-20
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-20
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-20
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-20
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		6e-20
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-20
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		7e-20
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		8e-20
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		9e-20
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-19
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-19
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-19
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-19
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-19
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-19
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-19
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-19
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-19
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-19
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-19
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-19
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-19
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-19
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-19
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-19
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-19
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-19
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-19
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-19
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-19
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-19
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-19
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-19
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-19
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-19
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-19
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-19
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-19
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-19
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-19
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-19
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-19
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-19
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-19
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-19
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-19
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-19
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-19
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-19
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-19
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-19
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-19
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-19
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-19
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-19
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-19
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-19
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-19
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-19
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-19
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-19
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-19
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		4e-19
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-19
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-19
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		5e-19
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		6e-19
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		6e-19
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		6e-19
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		6e-19
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		6e-19
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		7e-19
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		7e-19
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		7e-19
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		8e-19
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		9e-19
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		9e-19
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		9e-19
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-18
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-18
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-18
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-18
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-18
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-18
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-18
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-18
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-18
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-18
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-18
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-18
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-18
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-18
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-18
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-18
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-18
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-18
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-18
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-18
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-18
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-18
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-18
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-18
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-18
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-18
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-18
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-18
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-18
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-18
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-18
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-18
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-18
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-18
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-18
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-18
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-18
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-18
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-18
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-18
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-18
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-18
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-18
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-18
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-18
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-18
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-18
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-18
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-18
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		5e-18
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		5e-18
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		6e-18
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		6e-18
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		7e-18
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		7e-18
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-18
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		7e-18
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		9e-18
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		9e-18
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		9e-18
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-17
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-17
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-17
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-17
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-17
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-17
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-17
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-17
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-17
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-17
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-17
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-17
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-17
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-17
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-17
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-17
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-17
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-17
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-17
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-17
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-17
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-17
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-17
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-17
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-17
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-17
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-17
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-17
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-17
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-17
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-17
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-17
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-17
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-17
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-17
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		4e-17
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		4e-17
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-17
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-17
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-17
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-17
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-17
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-17
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-17
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-17
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-17
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-17
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-17
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-17
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-17
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-17
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-17
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-17
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-17
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		5e-17
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		6e-17
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		7e-17
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		7e-17
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		7e-17
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		7e-17
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		7e-17
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-17
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		7e-17
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		8e-17
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-17
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-17
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		8e-17
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		8e-17
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-17
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		8e-17
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		8e-17
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		9e-17
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		9e-17
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-16
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-16
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-16
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-16
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-16
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-16
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-16
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-16
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-16
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-16
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-16
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-16
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-16
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-16
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-16
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		3e-16
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-16
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		4e-16
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-16
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-16
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-16
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		5e-16
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-16
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		5e-16
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-16
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		6e-16
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		6e-16
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		6e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		7e-16
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		7e-16
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-16
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		8e-16
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		8e-16
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		8e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		8e-16
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		8e-16
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-16
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-16
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-15
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-15
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-15
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-15
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-15
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-15
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-15
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-15
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-15
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-15
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-15
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-15
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-15
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-15
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-15
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-15
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-15
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-15
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-15
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-15
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-15
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-15
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-15
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-15
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-15
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-15
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-15
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-15
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-15
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-15
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-15
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-15
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-15
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-15
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-15
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-15
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-15
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		5e-15
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-15
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-15
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		6e-15
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		6e-15
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		8e-15
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		8e-15
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-14
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-14
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-14
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-14
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-14
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-14
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-14
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-14
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-14
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-14
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-14
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-14
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-14
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-14
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-14
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-14
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		2e-14
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-14
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-14
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-14
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-14
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-14
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-14
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-14
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-14
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		5e-14
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-14
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-14
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		6e-14
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-14
3soa_A	444	Full-Length Human Camkii Length = 444		6e-14
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-14
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-14
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		8e-14
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		9e-14
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-13
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-13
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-13
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-13
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-13
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-13
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-13
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-13
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-13
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-13
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-13
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-13
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-13
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-13
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-13
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-13
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-13
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-13
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-13
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-13
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-13
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-13
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-13
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-13
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-13
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-13
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-13
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-13
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-13
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-13
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-13
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-13
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-13
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-13
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-13
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-13
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-13
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-13
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		6e-13
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-13
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		6e-13
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		6e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-13
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-13
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		7e-13
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		7e-13
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		7e-13
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		8e-13
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		8e-13
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		8e-13
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		8e-13
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		9e-13
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		9e-13
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		9e-13
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		9e-13
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		9e-13
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-12
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-12
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-12
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-12
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-12
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-12
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-12
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-12
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-12
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-12
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-12
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-12
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-12
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-12
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-12
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-12
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-12
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-12
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-12
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-12
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-12
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-12
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-12
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-12
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-12
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-12
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-12
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-12
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-12
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-12
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-12
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-12
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-12
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-12
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-12
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-12
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-12
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-12
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-12
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-12
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-12
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-12
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		4e-12
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		4e-12
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-12
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-12
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-12
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		5e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		5e-12
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		5e-12
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-12
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-12
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		6e-12
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		6e-12
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-12
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-12
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		7e-12
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		7e-12
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-12
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		7e-12
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		7e-12
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		7e-12
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		7e-12
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		7e-12
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		7e-12
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		7e-12
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		8e-12
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		8e-12
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-12
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		8e-12
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		9e-12
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		9e-12
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		9e-12
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-11
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-11
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-11
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-11
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-11
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-11
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-11
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-11
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-11
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-11
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-11
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-11
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-11
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-11
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-11
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-11
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-11
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-11
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-11
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-11
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-11
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-11
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-11
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-11
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-11
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-11
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-11
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-11
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-11
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-11
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-11
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-11
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-11
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-11
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-11
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-11
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-11
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-11
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-11
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-11
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-11
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-11
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-11
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-11
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-11
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-11
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-11
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-11
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		5e-11
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-11
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		6e-11
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		6e-11
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-11
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		6e-11
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		6e-11
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		6e-11
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		7e-11
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		7e-11
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		7e-11
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		8e-11
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		8e-11
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		8e-11
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-11
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-11
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		8e-11
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		8e-11
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		8e-11
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		8e-11
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		9e-11
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		9e-11
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		9e-11
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-11
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		9e-11
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		9e-11
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		9e-11
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		9e-11
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		9e-11
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-10
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-10
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-10
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-10
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-10
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-10
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-10
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-10
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-10
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-10
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-10
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-10
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-10
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-10
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-10
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-10
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-10
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-10
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-10
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-10
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-10
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-10
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-10
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-10
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-10
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-10
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-10
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-10
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-10
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-10
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-10
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-10
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-10
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-10
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-10
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-10
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-10
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-10
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-10
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-10
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-10
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-10
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-10
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-10
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-10
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-10
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-10
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-10
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-10
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-10
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-10
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-10
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-10
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-10
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-10
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-10
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-10
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-10
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-10
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-10
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-10
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-10
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-10
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-10
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-10
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-10
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-10
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-10
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-10
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-10
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-10
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-10
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-10
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-10
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-10
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-10
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-10
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-10
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-10
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-10
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-10
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-10
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-10
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-10
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-10
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-10
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		4e-10
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-10
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		4e-10
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-10
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		4e-10
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		4e-10
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-10
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-10
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		5e-10
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-10
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		5e-10
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-10
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-10
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		5e-10
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		5e-10
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-10
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-10
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		5e-10
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-10
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-10
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		5e-10
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		5e-10
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		5e-10
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		6e-10
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		7e-10
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		7e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-10
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-10
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-10
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		9e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-09
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-09
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-09
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-09
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-09
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-09
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-09
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-09
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-09
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-09
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-09
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-09
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-09
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-09
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-09
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-09
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-09
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-09
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-09
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-09
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-09
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-09
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-09
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-09
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-09
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-09
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-09
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-09
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-09
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-09
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-09
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-09
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-09
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-09
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-09
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-09
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-09
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-09
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-09
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-09
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-09
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-09
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-09
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-09
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		4e-09
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-09
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		4e-09
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		4e-09
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-09
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		4e-09
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-09
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		5e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		5e-09
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		5e-09
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		5e-09
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		5e-09
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		5e-09
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		5e-09
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		5e-09
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		6e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-09
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		7e-09
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		7e-09
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		8e-09
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		8e-09
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		8e-09
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		8e-09
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		8e-09
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		8e-09
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		8e-09
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-09
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		8e-09
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		8e-09
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		8e-09
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-09
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		8e-09
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-09
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		8e-09
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		8e-09
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		9e-09
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		9e-09
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-09
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		9e-09
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-09
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-08
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-08
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-08
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-08
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-08
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-08
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-08
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-08
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-08
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-08
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-08
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-08
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-08
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-08
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-08
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-08
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-08
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-08
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-08
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		5e-08
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		5e-08
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		6e-08
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		6e-08
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		6e-08
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		6e-08
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		6e-08
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		6e-08
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		6e-08
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		6e-08
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		7e-08
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		7e-08
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		7e-08
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		8e-08
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		9e-08
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		1e-07
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-07
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-07
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-07
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-07
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-07
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-07
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-07
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-07
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-07
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-07
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		2e-07
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-07
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-07
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-07
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-07
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-07
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-07
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-07
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-07
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-07
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-07
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-07
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		3e-07
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-07
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-07
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-07
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-07
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		6e-07
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		6e-07
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		6e-07
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-07
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		6e-07
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		6e-07
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		7e-07
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		7e-07
3b2t_A	311	Structure Of Phosphotransferase Length = 311		8e-07
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		8e-07
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-07
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-07
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		8e-07
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		8e-07
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-07
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-07
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		9e-07
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-07
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-06
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-06
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-06
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-06
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-06
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-06
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-06
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-06

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score =  188 bits (477), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 109/280 (38%), Positives = 155/280 (55%), Gaps = 20/280 (7%)
Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
           D EK+  LG GNGG V+KV H+ +  + A K++H +  P +R Q+ RE+++L   +SP+I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL-HGHK 170
           V  +G F    G+I+I ME+MD G+LD +L K G   E  L  ++  ++KGL+YL   HK
Sbjct: 67  VGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
           I+HRD+KPSN+LVN+   ++K+ DFGVS  +  S+   NS+VGT +YMSPER        
Sbjct: 126 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQ-----G 177
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGD------PPSLPDGA 284
                  DIWS          G +P   P  + D    M      D      PP LP G 
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGV 237
Query: 285 -SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSDC 323
            S EF+ F+  CL K  ++R    QL+ H F+   +RSD 
Sbjct: 238 FSLEFQDFVNKCLIKNPAERADLKQLMVHAFI---KRSDA 274

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score =  187 bits (475), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 107/274 (39%), Positives = 153/274 (55%), Gaps = 14/274 (5%)
Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
           D EK+  LG GNGG V+KV H+ +  + A K++H +  P +R Q+ RE+++L   +SP+I
Sbjct: 26  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 85
Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL-HGHK 170
           V  +G F    G+I+I ME+MD G+LD +L K G   E  L  ++  ++KGL+YL   HK
Sbjct: 86  VGFYGAF-YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 144
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
           I+HRD+KPSN+LVN+   ++K+ DFGVS  +  S+   NS+VGT +YMSPER        
Sbjct: 145 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQ-----G 196
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA-SPEFR 289
                  DIWS          G +P            L+  I    PP LP G  S EF+
Sbjct: 197 THYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQ 256
Query: 290 SFIECCLQKEFSKRWTASQLLTHPFLCKNRRSDC 323
            F+  CL K  ++R    QL+ H F+   +RSD 
Sbjct: 257 DFVNKCLIKNPAERADLKQLMVHAFI---KRSDA 287

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score =  181 bits (460), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 107/276 (38%), Positives = 153/276 (55%), Gaps = 22/276 (7%)
Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
           D EK+  LG GNGG V+KV H+ +  + A K++H +  P +R Q+ RE+++L   +SP+I
Sbjct: 10  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 69
Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL-HGHK 170
           V  +G F    G+I+I ME+MD G+LD +L K G   E  L  ++  ++KGL+YL   HK
Sbjct: 70  VGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 128
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
           I+HRD+KPSN+LVN+   ++K+ DFGVS  +   +   N +VGT +YMSPER        
Sbjct: 129 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDEM--ANEFVGTRSYMSPERLQ-----G 180
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWAT--LMCAICFGDPPSLPDGA-SPE 287
                  DIWS          G +P      RP  A   L+  I    PP LP    S E
Sbjct: 181 THYSVQSDIWSMGLSLVEMAVGRYP------RPPMAIFELLDYIVNEPPPKLPSAVFSLE 234
Query: 288 FRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSDC 323
           F+ F+  CL K  ++R    QL+ H F+   +RSD 
Sbjct: 235 FQDFVNKCLIKNPAERADLKQLMVHAFI---KRSDA 267

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score =  176 bits (445), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 111/312 (35%), Positives = 157/312 (50%), Gaps = 52/312 (16%)
Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
           D EK+  LG GNGG V+KV H+ +  + A K++H +  P +R Q+ RE+++L   +SP+I
Sbjct: 34  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 93
Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL-HGHK 170
           V  +G F    G+I+I ME+MD G+LD +L K G   E  L  ++  ++KGL+YL   HK
Sbjct: 94  VGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 152
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
           I+HRD+KPSN+LVN+   ++K+ DFGVS  +  S+   NS+VGT +YMSPER        
Sbjct: 153 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQ-----G 204
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQP------------------------------- 259
                  DIWS          G +P   P                               
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264
Query: 260 -----GQRPDWAT--LMCAICFGDPPSLPDGA-SPEFRSFIECCLQKEFSKRWTASQLLT 311
                  RP  A   L+  I    PP LP G  S EF+ F+  CL K  ++R    QL+ 
Sbjct: 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324
Query: 312 HPFLCKNRRSDC 323
           H F+   +RSD 
Sbjct: 325 HAFI---KRSDA 333

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score =  176 bits (445), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 111/312 (35%), Positives = 157/312 (50%), Gaps = 52/312 (16%)
Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
           D EK+  LG GNGG V+KV H+ +  + A K++H +  P +R Q+ RE+++L   +SP+I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL-HGHK 170
           V  +G F    G+I+I ME+MD G+LD +L K G   E  L  ++  ++KGL+YL   HK
Sbjct: 67  VGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
           I+HRD+KPSN+LVN+   ++K+ DFGVS  +  S+   NS+VGT +YMSPER        
Sbjct: 126 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQ-----G 177
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQP------------------------------- 259
                  DIWS          G +P   P                               
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237
Query: 260 -----GQRPDWAT--LMCAICFGDPPSLPDGA-SPEFRSFIECCLQKEFSKRWTASQLLT 311
                  RP  A   L+  I    PP LP G  S EF+ F+  CL K  ++R    QL+ 
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297
Query: 312 HPFLCKNRRSDC 323
           H F+   +RSD 
Sbjct: 298 HAFI---KRSDA 306

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score =  175 bits (444), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 111/312 (35%), Positives = 157/312 (50%), Gaps = 52/312 (16%)
Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
           D EK+  LG GNGG V+KV H+ +  + A K++H +  P +R Q+ RE+++L   +SP+I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL-HGHK 170
           V  +G F    G+I+I ME+MD G+LD +L K G   E  L  ++  ++KGL+YL   HK
Sbjct: 67  VGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
           I+HRD+KPSN+LVN+   ++K+ DFGVS  +  S+   NS+VGT +YMSPER        
Sbjct: 126 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQ-----G 177
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQP------------------------------- 259
                  DIWS          G +P   P                               
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237
Query: 260 -----GQRPDWAT--LMCAICFGDPPSLPDGA-SPEFRSFIECCLQKEFSKRWTASQLLT 311
                  RP  A   L+  I    PP LP G  S EF+ F+  CL K  ++R    QL+ 
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297
Query: 312 HPFLCKNRRSDC 323
           H F+   +RSD 
Sbjct: 298 HAFI---KRSDA 306

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 111/312 (35%), Positives = 157/312 (50%), Gaps = 52/312 (16%)
Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
           D EK+  LG GNGG V+KV H+ +  + A K++H +  P +R Q+ RE+++L   +SP+I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL-HGHK 170
           V  +G F    G+I+I ME+MD G+LD +L K G   E  L  ++  ++KGL+YL   HK
Sbjct: 67  VGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
           I+HRD+KPSN+LVN+   ++K+ DFGVS  +  S+   NS+VGT +YMSPER        
Sbjct: 126 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQ-----G 177
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQP------------------------------- 259
                  DIWS          G +P   P                               
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237
Query: 260 -----GQRPDWAT--LMCAICFGDPPSLPDGA-SPEFRSFIECCLQKEFSKRWTASQLLT 311
                  RP  A   L+  I    PP LP G  S EF+ F+  CL K  ++R    QL+ 
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297
Query: 312 HPFLCKNRRSDC 323
           H F+   +RSD 
Sbjct: 298 HAFI---KRSDA 306

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 111/312 (35%), Positives = 157/312 (50%), Gaps = 52/312 (16%)
Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
           D EK+  LG GNGG V+KV H+ +  + A K++H +  P +R Q+ RE+++L   +SP+I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL-HGHK 170
           V  +G F    G+I+I ME+MD G+LD +L K G   E  L  ++  ++KGL+YL   HK
Sbjct: 67  VGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
           I+HRD+KPSN+LVN+   ++K+ DFGVS  +  S+   NS+VGT +YMSPER        
Sbjct: 126 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQ-----G 177
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQP------------------------------- 259
                  DIWS          G +P   P                               
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237
Query: 260 -----GQRPDWAT--LMCAICFGDPPSLPDGA-SPEFRSFIECCLQKEFSKRWTASQLLT 311
                  RP  A   L+  I    PP LP G  S EF+ F+  CL K  ++R    QL+ 
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297
Query: 312 HPFLCKNRRSDC 323
           H F+   +RSD 
Sbjct: 298 HAFI---KRSDA 306

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score =  174 bits (440), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 110/312 (35%), Positives = 156/312 (50%), Gaps = 52/312 (16%)
Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
           D EK+  LG GNGG V+KV H+ +  + A K++H +  P +R Q+ RE+++L   +SP+I
Sbjct: 69  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 128
Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL-HGHK 170
           V  +G F    G+I+I ME+MD G+LD +L K G   E  L  ++  ++KGL+YL   HK
Sbjct: 129 VGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 187
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
           I+HRD+KPSN+LVN+   ++K+ DFGVS  +  S+   NS+VGT +YMSPER        
Sbjct: 188 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQ-----G 239
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQP------------------------------- 259
                  DIWS          G +P   P                               
Sbjct: 240 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 299
Query: 260 -----GQRPDWAT--LMCAICFGDPPSLPDGA-SPEFRSFIECCLQKEFSKRWTASQLLT 311
                  RP  A   L+  I    PP LP    S EF+ F+  CL K  ++R    QL+ 
Sbjct: 300 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMV 359
Query: 312 HPFLCKNRRSDC 323
           H F+   +RSD 
Sbjct: 360 HAFI---KRSDA 368

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 104/312 (33%), Positives = 154/312 (49%), Gaps = 53/312 (16%)
Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
           D E++  LG GNGG V KVQHR +  I A K++H +  P +R Q+ RE+++L   +SP+I
Sbjct: 17  DFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 76
Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL-HGHK 170
           V  +G F    G+I+I ME+MD G+LD +L +     E  L  ++  +L+GL+YL   H+
Sbjct: 77  VGFYGAFYS-DGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ 135
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
           I+HRD+KPSN+LVN+   ++K+ DFGVS  +  S+   NS+VGT +YM+PER        
Sbjct: 136 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSM--ANSFVGTRSYMAPERLQ-----G 187
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQP------------------------------- 259
                  DIWS          G +P   P                               
Sbjct: 188 THYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 247
Query: 260 ---------GQRPDWAT--LMCAICFGDPPSLPDGA-SPEFRSFIECCLQKEFSKRWTAS 307
                      RP  A   L+  I    PP LP+G  +P+F+ F+  CL K  ++R    
Sbjct: 248 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLK 307
Query: 308 QLLTHPFLCKNR 319
            L  H F+ ++ 
Sbjct: 308 MLTNHTFIKRSE 319

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 90/263 (34%), Positives = 140/263 (53%), Gaps = 17/263 (6%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           L+ LG G+ G+VYK  H+ T +I A+K V  ++D    +++ +E+ I+++ DSP +V+ +
Sbjct: 34  LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD---LQEIIKEISIMQQCDSPHVVKYY 90
Query: 116 GIFEKPSGDIAILMEYMDSGTLDTLLN-KNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
           G + K + D+ I+MEY  +G++  ++  +N T +E ++A I    LKGL YLH  + IHR
Sbjct: 91  GSYFK-NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHR 149
Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXX 234
           DIK  N+L+N      K+ADFGV+  +   +   N  +GT  +M+PE             
Sbjct: 150 DIKAGNILLNTEG-HAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQ-----EIGYN 203
Query: 235 XXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSL--PDGASPEFRSFI 292
              DIWS          G  P+      P  A  M  I    PP+   P+  S  F  F+
Sbjct: 204 CVADIWSLGITAIEMAEGKPPYADI--HPMRAIFM--IPTNPPPTFRKPELWSDNFTDFV 259
Query: 293 ECCLQKEFSKRWTASQLLTHPFL 315
           + CL K   +R TA+QLL HPF+
Sbjct: 260 KQCLVKSPEQRATATQLLQHPFV 282

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  135 bits (341), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 88/268 (32%), Positives = 141/268 (52%), Gaps = 16/268 (5%)
Query: 55  KLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQC 114
           KL+ +G G+ G V+K     T K+ A+K++  +        + +E+ +L + DSP++ + 
Sbjct: 11  KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 70
Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
           +G + K +  + I+MEY+  G+   LL + G   E ++A I  +ILKGL YLH  K IHR
Sbjct: 71  YGSYLKDT-KLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLDYLHSEKKIHR 128
Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXX 234
           DIK +N+L++ +  +VK+ADFGV+  +  +    N++VGT  +M+PE             
Sbjct: 129 DIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-----VIKQSAYD 182
Query: 235 XXXDIWSXXXXXXXXXXGHFPF--LQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFI 292
              DIWS          G  P   L P +      ++  I   +PP+L    S   + F+
Sbjct: 183 SKADIWSLGITAIELARGEPPHSELHPMK------VLFLIPKNNPPTLEGNYSKPLKEFV 236
Query: 293 ECCLQKEFSKRWTASQLLTHPFLCKNRR 320
           E CL KE S R TA +LL H F+ +N +
Sbjct: 237 EACLNKEPSFRPTAKELLKHKFILRNAK 264

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 88/268 (32%), Positives = 141/268 (52%), Gaps = 16/268 (5%)
Query: 55  KLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQC 114
           KL+ +G G+ G V+K     T K+ A+K++  +        + +E+ +L + DSP++ + 
Sbjct: 31  KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 90
Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
           +G + K +  + I+MEY+  G+   LL + G   E ++A I  +ILKGL YLH  K IHR
Sbjct: 91  YGSYLKDT-KLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLDYLHSEKKIHR 148
Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXX 234
           DIK +N+L++ +  +VK+ADFGV+  +  +    N++VGT  +M+PE             
Sbjct: 149 DIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-----KQSAYD 202
Query: 235 XXXDIWSXXXXXXXXXXGHFPF--LQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFI 292
              DIWS          G  P   L P +      ++  I   +PP+L    S   + F+
Sbjct: 203 SKADIWSLGITAIELARGEPPHSELHPMK------VLFLIPKNNPPTLEGNYSKPLKEFV 256
Query: 293 ECCLQKEFSKRWTASQLLTHPFLCKNRR 320
           E CL KE S R TA +LL H F+ +N +
Sbjct: 257 EACLNKEPSFRPTAKELLKHKFILRNAK 284

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 88/268 (32%), Positives = 139/268 (51%), Gaps = 16/268 (5%)
Query: 55  KLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQC 114
           KL+ +G G+ G V+K     T K+ A+K++  +        + +E+ +L + DSP++ + 
Sbjct: 26  KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 85
Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
           +G + K +  + I+MEY+  G+   LL + G   E ++A I  +ILKGL YLH  K IHR
Sbjct: 86  YGSYLKDT-KLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLDYLHSEKKIHR 143
Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXX 234
           DIK +N+L++ +  +VK+ADFGV+  +  +    N +VGT  +M+PE             
Sbjct: 144 DIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-----KQSAYD 197
Query: 235 XXXDIWSXXXXXXXXXXGHFPF--LQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFI 292
              DIWS          G  P   L P        ++  I   +PP+L    S   + F+
Sbjct: 198 SKADIWSLGITAIELARGEPPHSELHP------MKVLFLIPKNNPPTLEGNYSKPLKEFV 251
Query: 293 ECCLQKEFSKRWTASQLLTHPFLCKNRR 320
           E CL KE S R TA +LL H F+ +N +
Sbjct: 252 EACLNKEPSFRPTAKELLKHKFILRNAK 279

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 88/268 (32%), Positives = 140/268 (52%), Gaps = 16/268 (5%)
Query: 55  KLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQC 114
           KL+ +G G+ G V+K     T K+ A+K++  +        + +E+ +L + DSP++ + 
Sbjct: 11  KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 70
Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
           +G + K +  + I+MEY+  G+   LL + G   E ++A I  +ILKGL YLH  K IHR
Sbjct: 71  YGSYLKDT-KLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLDYLHSEKKIHR 128
Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXX 234
           DIK +N+L++ +  +VK+ADFGV+  +  +    N +VGT  +M+PE             
Sbjct: 129 DIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE-----VIKQSAYD 182
Query: 235 XXXDIWSXXXXXXXXXXGHFPF--LQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFI 292
              DIWS          G  P   L P +      ++  I   +PP+L    S   + F+
Sbjct: 183 SKADIWSLGITAIELARGEPPHSELHPMK------VLFLIPKNNPPTLEGNYSKPLKEFV 236
Query: 293 ECCLQKEFSKRWTASQLLTHPFLCKNRR 320
           E CL KE S R TA +LL H F+ +N +
Sbjct: 237 EACLNKEPSFRPTAKELLKHKFILRNAK 264

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score =  134 bits (337), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 92/271 (33%), Positives = 139/271 (51%), Gaps = 14/271 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEI-LRRTDSP 109
           +DLE L  +G G  G V+K++ R T  + A+K +    +    +++  ++++ L+  D P
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYL- 166
           +IVQCFG F   + D+ I ME M  GT    L K   G   E  L  +   I+K L YL 
Sbjct: 85  YIVQCFGTFITNT-DVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK 141
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPD 226
             H +IHRD+KPSN+L++    Q+K+ DFG+S  +     A +   G  AYM+PER DP 
Sbjct: 142 EKHGVIHRDVKPSNILLDERG-QIKLCDFGISGRLVDD-KAKDRSAGCAAYMAPERIDPP 199
Query: 227 XXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPD--GA 284
                      D+WS          G FP+     + D+  L   +   +PP LP   G 
Sbjct: 200 DPTKPDYDIRADVWSLGISLVELATGQFPY--KNCKTDFEVL-TKVLQEEPPLLPGHMGF 256
Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
           S +F+SF++ CL K+  KR   ++LL H F+
Sbjct: 257 SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFI 287

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  130 bits (328), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 138/266 (51%), Gaps = 12/266 (4%)
Query: 55  KLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQC 114
           KL+ +G G+ G V+K     T ++ A+K++  +        + +E+ +L + DS ++ + 
Sbjct: 27  KLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKY 86
Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
           +G + K S  + I+MEY+  G+   LL + G F E ++A +  +ILKGL YLH  K IHR
Sbjct: 87  YGSYLKGS-KLWIIMEYLGGGSALDLL-RAGPFDEFQIATMLKEILKGLDYLHSEKKIHR 144
Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXX 234
           DIK +N+L++     VK+ADFGV+  +  +    N++VGT  +M+PE             
Sbjct: 145 DIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-----VIQQSAYD 198
Query: 235 XXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIEC 294
              DIWS          G  P       P    ++  I   +PP+L    +  F+ FI+ 
Sbjct: 199 SKADIWSLGITAIELAKGEPP--NSDMHP--MRVLFLIPKNNPPTLVGDFTKSFKEFIDA 254
Query: 295 CLQKEFSKRWTASQLLTHPFLCKNRR 320
           CL K+ S R TA +LL H F+ KN +
Sbjct: 255 CLNKDPSFRPTAKELLKHKFIVKNSK 280

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 90/278 (32%), Positives = 139/278 (50%), Gaps = 25/278 (8%)
Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEI-LRRTDSPF 110
           DL+ L  +G G  G+V K+ H+ + +I A+K +    D   ++Q+  ++++ +R +D P+
Sbjct: 23  DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPY 82
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK-----NGTFSEPKLAHIASQILKGLSY 165
           IVQ +G   +  GD  I ME M S + D          +    E  L  I    +K L++
Sbjct: 83  IVQFYGALFR-EGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140
Query: 166 LHGH-KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD 224
           L  + KIIHRDIKPSN+L++ +   +K+ DFG+S  +  S+ A     G   YM+PER D
Sbjct: 141 LKENLKIIHRDIKPSNILLDRSG-NIKLCDFGISGQLVDSI-AKTRDAGCRPYMAPERID 198
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATL---MCAICFGDPPSLP 281
           P            D+WS          G FP+      P W ++   +  +  GDPP L 
Sbjct: 199 P-SASRQGYDVRSDVWSLGITLYELATGRFPY------PKWNSVFDQLTQVVKGDPPQLS 251
Query: 282 DGA----SPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
           +      SP F +F+  CL K+ SKR    +LL HPF+
Sbjct: 252 NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  128 bits (321), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 89/265 (33%), Positives = 133/265 (50%), Gaps = 16/265 (6%)
Query: 55  KLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQC 114
           KL  +G G+ G VYK     T ++ A+K++  +        + +E+ +L + DSP+I + 
Sbjct: 23  KLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRY 82
Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
           FG + K S  + I+MEY+  G+   LL K G   E  +A I  +ILKGL YLH  + IHR
Sbjct: 83  FGSYLK-STKLWIIMEYLGGGSALDLL-KPGPLEETYIATILREILKGLDYLHSERKIHR 140
Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXX 234
           DIK +N+L++     VK+ADFGV+  +  +    N +VGT  +M+PE             
Sbjct: 141 DIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE-----VIKQSAYD 194
Query: 235 XXXDIWSXXXXXXXXXXGHFPF--LQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFI 292
              DIWS          G  P   L P +      ++  I    PP+L    S  F+ F+
Sbjct: 195 FKADIWSLGITAIELAKGEPPNSDLHPMR------VLFLIPKNSPPTLEGQHSKPFKEFV 248
Query: 293 ECCLQKEFSKRWTASQLLTHPFLCK 317
           E CL K+   R TA +LL H F+ +
Sbjct: 249 EACLNKDPRFRPTAKELLKHKFITR 273

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 143/274 (52%), Gaps = 20/274 (7%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKV--VHGDADPTVRRQVFREMEILRR-TDSP 109
            E ++++G+G  G VYK +H  T ++ A+KV  V GD +  +++    E+ +L++ +   
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ----EINMLKKYSHHR 81
Query: 110 FIVQCFGIFEK--PSG---DIAILMEYMDSGTLDTLL--NKNGTFSEPKLAHIASQILKG 162
            I   +G F K  P G    + ++ME+  +G++  L+   K  T  E  +A+I  +IL+G
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
           LS+LH HK+IHRDIK  N+L+   N +VK+ DFGVS  + R++   N+++GT  +M+PE 
Sbjct: 142 LSHLHQHKVIHRDIKGQNVLL-TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 200
Query: 223 FDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPD 282
              D           D+WS          G  P       P  A  +  I     P L  
Sbjct: 201 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD--MHPMRALFL--IPRNPAPRLKS 256
Query: 283 GA-SPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
              S +F+SFIE CL K  S+R    QL+ HPF+
Sbjct: 257 KKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFI 290

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 134/263 (50%), Gaps = 14/263 (5%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIF 118
           LG G  G VYK +++ T  + A KV+   ++  +   +  E+EIL   D P+IV+  G +
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIV-EIEILATCDHPYIVKLLGAY 85
Query: 119 EKPSGDIAILMEYMDSGTLDT-LLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIK 177
               G + I++E+   G +D  +L  +   +EP++  +  Q+L+ L++LH  +IIHRD+K
Sbjct: 86  YH-DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLK 144
Query: 178 PSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXXXXX 237
             N+L+      +++ADFGVS    ++L   +S++GT  +M+PE    +           
Sbjct: 145 AGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKA 203
Query: 238 DIWSXXXXXXXXXXGHFPF--LQPGQRPDWATLMCAICFGDPPSL--PDGASPEFRSFIE 293
           DIWS             P   L P +      ++  I   DPP+L  P   S EFR F++
Sbjct: 204 DIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSDPPTLLTPSKWSVEFRDFLK 257
Query: 294 CCLQKEFSKRWTASQLLTHPFLC 316
             L K    R +A+QLL HPF+ 
Sbjct: 258 IALDKNPETRPSAAQLLEHPFVS 280

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 134/263 (50%), Gaps = 14/263 (5%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIF 118
           LG G  G VYK +++ T  + A KV+   ++  +   +  E+EIL   D P+IV+  G +
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIV-EIEILATCDHPYIVKLLGAY 77
Query: 119 EKPSGDIAILMEYMDSGTLDT-LLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIK 177
               G + I++E+   G +D  +L  +   +EP++  +  Q+L+ L++LH  +IIHRD+K
Sbjct: 78  YH-DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLK 136
Query: 178 PSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXXXXX 237
             N+L+      +++ADFGVS    ++L   +S++GT  +M+PE    +           
Sbjct: 137 AGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKA 195
Query: 238 DIWSXXXXXXXXXXGHFPF--LQPGQRPDWATLMCAICFGDPPSL--PDGASPEFRSFIE 293
           DIWS             P   L P +      ++  I   DPP+L  P   S EFR F++
Sbjct: 196 DIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSDPPTLLTPSKWSVEFRDFLK 249
Query: 294 CCLQKEFSKRWTASQLLTHPFLC 316
             L K    R +A+QLL HPF+ 
Sbjct: 250 IALDKNPETRPSAAQLLEHPFVS 272

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 130/263 (49%), Gaps = 14/263 (5%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIF 118
           LG G  G VYK Q++ T  + A KV+   ++  +   +  E++IL   D P IV+    F
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMV-EIDILASCDHPNIVKLLDAF 103
Query: 119 EKPSGDIAILMEYMDSGTLD-TLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIK 177
                ++ IL+E+   G +D  +L      +E ++  +  Q L  L+YLH +KIIHRD+K
Sbjct: 104 YY-ENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLK 162
Query: 178 PSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXXXXX 237
             N+L   +   +K+ADFGVS    R++   +S++GT  +M+PE    +           
Sbjct: 163 AGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKA 221
Query: 238 DIWSXXXXXXXXXXGHFPF--LQPGQRPDWATLMCAICFGDPPSL--PDGASPEFRSFIE 293
           D+WS             P   L P +      ++  I   +PP+L  P   S  F+ F++
Sbjct: 222 DVWSLGITLIEMAEIEPPHHELNPMR------VLLKIAKSEPPTLAQPSRWSSNFKDFLK 275
Query: 294 CCLQKEFSKRWTASQLLTHPFLC 316
            CL+K    RWT SQLL HPF+ 
Sbjct: 276 KCLEKNVDARWTTSQLLQHPFVT 298

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 91/279 (32%), Positives = 136/279 (48%), Gaps = 21/279 (7%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEI-LRRT 106
           +   DLE +  LG G  G V K++H  + +I A+K +    +   ++++  +++I +R  
Sbjct: 48  VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTV 107
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDT----LLNKNGTFSEPKLAHIASQILKG 162
           D PF V  +G   +  GD+ I ME MD+ +LD     +++K  T  E  L  IA  I+K 
Sbjct: 108 DCPFTVTFYGALFR-EGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 165
Query: 163 LSYLHGH-KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
           L +LH    +IHRD+KPSN+L+N    QVK+ DFG+S  +  S+ A     G   YM+PE
Sbjct: 166 LEHLHSKLSVIHRDVKPSNVLINALG-QVKMCDFGISGYLVDSV-AKTIDAGCKPYMAPE 223
Query: 222 RFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWAT---LMCAICFGDPP 278
           R +P+           DIWS            FP+        W T    +  +     P
Sbjct: 224 RINPE-LNQKGYSVKSDIWSLGITMIELAILRFPY------DSWGTPFQQLKQVVEEPSP 276
Query: 279 SLP-DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLC 316
            LP D  S EF  F   CL+K   +R T  +L+ HPF  
Sbjct: 277 QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFT 315

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  124 bits (311), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 129/263 (49%), Gaps = 14/263 (5%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIF 118
           LG G  G VYK Q++ T  + A KV+   ++  +   +  E++IL   D P IV+    F
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMV-EIDILASCDHPNIVKLLDAF 103
Query: 119 EKPSGDIAILMEYMDSGTLD-TLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIK 177
                ++ IL+E+   G +D  +L      +E ++  +  Q L  L+YLH +KIIHRD+K
Sbjct: 104 YY-ENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLK 162
Query: 178 PSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXXXXX 237
             N+L   +   +K+ADFGVS    R +   +S++GT  +M+PE    +           
Sbjct: 163 AGNILFTLDG-DIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKA 221
Query: 238 DIWSXXXXXXXXXXGHFPF--LQPGQRPDWATLMCAICFGDPPSL--PDGASPEFRSFIE 293
           D+WS             P   L P +      ++  I   +PP+L  P   S  F+ F++
Sbjct: 222 DVWSLGITLIEMAEIEPPHHELNPMR------VLLKIAKSEPPTLAQPSRWSSNFKDFLK 275
Query: 294 CCLQKEFSKRWTASQLLTHPFLC 316
            CL+K    RWT SQLL HPF+ 
Sbjct: 276 KCLEKNVDARWTTSQLLQHPFVT 298

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score =  123 bits (308), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 90/279 (32%), Positives = 136/279 (48%), Gaps = 21/279 (7%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEI-LRRT 106
           +   DLE +  LG G  G V K++H  + +I A+K +    +   ++++  +++I +R  
Sbjct: 4   VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTV 63
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDT----LLNKNGTFSEPKLAHIASQILKG 162
           D PF V  +G   +  GD+ I ME MD+ +LD     +++K  T  E  L  IA  I+K 
Sbjct: 64  DCPFTVTFYGALFR-EGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 163 LSYLHGH-KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
           L +LH    +IHRD+KPSN+L+N    QVK+ DFG+S  +   + A +   G   YM+PE
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALG-QVKMCDFGISGYLVDDV-AKDIDAGCKPYMAPE 179
Query: 222 RFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWAT---LMCAICFGDPP 278
           R +P+           DIWS            FP+        W T    +  +     P
Sbjct: 180 RINPE-LNQKGYSVKSDIWSLGITMIELAILRFPY------DSWGTPFQQLKQVVEEPSP 232
Query: 279 SLP-DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLC 316
            LP D  S EF  F   CL+K   +R T  +L+ HPF  
Sbjct: 233 QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFT 271

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 128/263 (48%), Gaps = 14/263 (5%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIF 118
           LG G  G VYK Q++ T  + A KV+   ++  +   +  E++IL   D P IV+    F
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMV-EIDILASCDHPNIVKLLDAF 103
Query: 119 EKPSGDIAILMEYMDSGTLD-TLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIK 177
                ++ IL+E+   G +D  +L      +E ++  +  Q L  L+YLH +KIIHRD+K
Sbjct: 104 YY-ENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLK 162
Query: 178 PSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXXXXX 237
             N+L   +   +K+ADFGVS    R +   + ++GT  +M+PE    +           
Sbjct: 163 AGNILFTLDG-DIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKA 221
Query: 238 DIWSXXXXXXXXXXGHFPF--LQPGQRPDWATLMCAICFGDPPSL--PDGASPEFRSFIE 293
           D+WS             P   L P +      ++  I   +PP+L  P   S  F+ F++
Sbjct: 222 DVWSLGITLIEMAEIEPPHHELNPMR------VLLKIAKSEPPTLAQPSRWSSNFKDFLK 275
Query: 294 CCLQKEFSKRWTASQLLTHPFLC 316
            CL+K    RWT SQLL HPF+ 
Sbjct: 276 KCLEKNVDARWTTSQLLQHPFVT 298

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 89/279 (31%), Positives = 131/279 (46%), Gaps = 21/279 (7%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT- 106
           +   DLE +  LG G  G V K +H  + +I A+K +    +   ++++  +++I  RT 
Sbjct: 31  VKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTV 90
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDT----LLNKNGTFSEPKLAHIASQILKG 162
           D PF V  +G   +  GD+ I  E  D+ +LD     +++K  T  E  L  IA  I+K 
Sbjct: 91  DCPFTVTFYGALFR-EGDVWICXELXDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 148
Query: 163 LSYLHGH-KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
           L +LH    +IHRD+KPSN+L+N    QVK  DFG+S  +   + A +   G   Y +PE
Sbjct: 149 LEHLHSKLSVIHRDVKPSNVLINALG-QVKXCDFGISGYLVDDV-AKDIDAGCKPYXAPE 206
Query: 222 RFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWAT---LMCAICFGDPP 278
           R +P+           DIWS            FP+        W T    +  +     P
Sbjct: 207 RINPE-LNQKGYSVKSDIWSLGITXIELAILRFPY------DSWGTPFQQLKQVVEEPSP 259
Query: 279 SLP-DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLC 316
            LP D  S EF  F   CL+K   +R T  +L  HPF  
Sbjct: 260 QLPADKFSAEFVDFTSQCLKKNSKERPTYPELXQHPFFT 298

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 84/261 (32%), Positives = 123/261 (47%), Gaps = 10/261 (3%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGI 117
           VLG G  G VY  +        A+K +  + D    + +  E+ + +      IVQ  G 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIP-ERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 118 FEKPSGDIAILMEYMDSGTLDTLL-NKNGTF--SEPKLAHIASQILKGLSYLHGHKIIHR 174
           F + +G I I ME +  G+L  LL +K G    +E  +     QIL+GL YLH ++I+HR
Sbjct: 88  FSE-NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 146
Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXX 234
           DIK  N+L+N  +  +KI+DFG SK +        ++ GT  YM+PE  D          
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIID---KGPRGYG 203
Query: 235 XXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIEC 294
              DIWS          G  PF + G+ P  A     + F   P +P+  S E ++FI  
Sbjct: 204 KAADIWSLGCTIIEMATGKPPFYELGE-PQAAMFKVGM-FKVHPEIPESMSAEAKAFILK 261
Query: 295 CLQKEFSKRWTASQLLTHPFL 315
           C + +  KR  A+ LL   FL
Sbjct: 262 CFEPDPDKRACANDLLVDEFL 282

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  111 bits (278), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 84/261 (32%), Positives = 123/261 (47%), Gaps = 10/261 (3%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGI 117
           VLG G  G VY  +        A+K +  + D    + +  E+ + +      IVQ  G 
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIP-ERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 73
Query: 118 FEKPSGDIAILMEYMDSGTLDTLL-NKNGTF--SEPKLAHIASQILKGLSYLHGHKIIHR 174
           F + +G I I ME +  G+L  LL +K G    +E  +     QIL+GL YLH ++I+HR
Sbjct: 74  FSE-NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 132
Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXX 234
           DIK  N+L+N  +  +KI+DFG SK +        ++ GT  YM+PE  D          
Sbjct: 133 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIID---KGPRGYG 189
Query: 235 XXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIEC 294
              DIWS          G  PF + G+ P  A     + F   P +P+  S E ++FI  
Sbjct: 190 KAADIWSLGCTIIEMATGKPPFYELGE-PQAAMFKVGM-FKVHPEIPESMSAEAKAFILK 247
Query: 295 CLQKEFSKRWTASQLLTHPFL 315
           C + +  KR  A+ LL   FL
Sbjct: 248 CFEPDPDKRACANDLLVDEFL 268

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 78/263 (29%), Positives = 118/263 (44%), Gaps = 12/263 (4%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           +LG G+ G V K + R T + YA+KV++   A       + RE+E+L++ D P I++ F 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 117 IFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDI 176
           I E  S    I+ E    G L   + K   FSE   A I  Q+  G++Y+H H I+HRD+
Sbjct: 89  ILEDSSS-FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDL 147
Query: 177 KPSNLLVNNNNM--QVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXX 234
           KP N+L+ +      +KI DFG+S    ++       +GT  Y++PE             
Sbjct: 148 KPENILLESKEKDCDIKIIDFGLSTCFQQNT-KMKDRIGTAYYIAPE------VLRGTYD 200
Query: 235 XXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIEC 294
              D+WS          G  PF    +      +       D P      S + +  I  
Sbjct: 201 EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR-TISDDAKDLIRK 259
Query: 295 CLQKEFSKRWTASQLLTHPFLCK 317
            L    S R TA+Q L HP++ K
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQK 282

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 78/263 (29%), Positives = 120/263 (45%), Gaps = 12/263 (4%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           +LG G+ G V K + R T + YA+KV++   A       + RE+E+L++ D P I++ F 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 117 IFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDI 176
           I E  S    I+ E    G L   + K   FSE   A I  Q+  G++Y+H H I+HRD+
Sbjct: 89  ILEDSSS-FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDL 147
Query: 177 KPSNLLVNN--NNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXX 234
           KP N+L+ +   +  +KI DFG+S    ++    +  +GT  Y++PE             
Sbjct: 148 KPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR-IGTAYYIAPE------VLRGTYD 200
Query: 235 XXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIEC 294
              D+WS          G  PF    +      +       D P      S + +  I  
Sbjct: 201 EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR-TISDDAKDLIRK 259
Query: 295 CLQKEFSKRWTASQLLTHPFLCK 317
            L    S R TA+Q L HP++ K
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQK 282

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  103 bits (258), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 78/263 (29%), Positives = 120/263 (45%), Gaps = 12/263 (4%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           +LG G+ G V K + R T + YA+KV++   A       + RE+E+L++ D P I++ F 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 117 IFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDI 176
           I E  S    I+ E    G L   + K   FSE   A I  Q+  G++Y+H H I+HRD+
Sbjct: 89  ILEDSSS-FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDL 147
Query: 177 KPSNLLVNN--NNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXX 234
           KP N+L+ +   +  +KI DFG+S    ++    +  +GT  Y++PE             
Sbjct: 148 KPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR-IGTAYYIAPE------VLRGTYD 200
Query: 235 XXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIEC 294
              D+WS          G  PF    +      +       D P      S + +  I  
Sbjct: 201 EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR-TISDDAKDLIRK 259
Query: 295 CLQKEFSKRWTASQLLTHPFLCK 317
            L    S R TA+Q L HP++ K
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQK 282

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 133/297 (44%), Gaps = 32/297 (10%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           I   D E  +V+G G    V         +  A+K ++ +   T   ++ +E++ + +  
Sbjct: 12  INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 71
Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLL--------NKNGTFSEPKLAHIASQI 159
            P IV  +  F     ++ ++M+ +  G++  ++        +K+G   E  +A I  ++
Sbjct: 72  HPNIVSYYTSF-VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 160 LKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC-----NSYVGT 214
           L+GL YLH +  IHRD+K  N+L+  +   V+IADFGVS  +    D        ++VGT
Sbjct: 131 LEGLEYLHKNGQIHRDVKAGNILLGEDG-SVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 215 CAYMSPERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICF 274
             +M+PE  +             DIWS          G  P+    + P    LM  +  
Sbjct: 190 PCWMAPEVME----QVRGYDFKADIWSFGITAIELATGAAPY---HKYPPMKVLMLTLQ- 241
Query: 275 GDPPSLPDGASPE---------FRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSD 322
            DPPSL  G   +         FR  I  CLQK+  KR TA++LL H F  K +  +
Sbjct: 242 NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKE 298

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 132/294 (44%), Gaps = 32/294 (10%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           I   D E  +V+G G    V         +  A+K ++ +   T   ++ +E++ + +  
Sbjct: 7   INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 66
Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLL--------NKNGTFSEPKLAHIASQI 159
            P IV  +  F     ++ ++M+ +  G++  ++        +K+G   E  +A I  ++
Sbjct: 67  HPNIVSYYTSF-VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 125
Query: 160 LKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC-----NSYVGT 214
           L+GL YLH +  IHRD+K  N+L+  +   V+IADFGVS  +    D        ++VGT
Sbjct: 126 LEGLEYLHKNGQIHRDVKAGNILLGEDG-SVQIADFGVSAFLATGGDITRNKVRKTFVGT 184
Query: 215 CAYMSPERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICF 274
             +M+PE  +             DIWS          G  P+    + P    LM  +  
Sbjct: 185 PCWMAPEVME----QVRGYDFKADIWSFGITAIELATGAAPY---HKYPPMKVLMLTLQ- 236
Query: 275 GDPPSLPDGASPE---------FRSFIECCLQKEFSKRWTASQLLTHPFLCKNR 319
            DPPSL  G   +         FR  I  CLQK+  KR TA++LL H F  K +
Sbjct: 237 NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 290

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 82/269 (30%), Positives = 124/269 (46%), Gaps = 30/269 (11%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIF 118
           LG G    VY+ + + T K YALKV+    D  + R    E+ +L R   P I++   IF
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRT---EIGVLLRLSHPNIIKLKEIF 117
Query: 119 EKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKP 178
           E P+ +I++++E +  G L   + + G +SE   A    QIL+ ++YLH + I+HRD+KP
Sbjct: 118 ETPT-EISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKP 176
Query: 179 SNLLVNN--NNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE-----RFDPDXXXXX 231
            NLL      +  +KIADFG+SKI+   +    +  GT  Y +PE      + P+     
Sbjct: 177 ENLLYATPAPDAPLKIADFGLSKIVEHQV-LMKTVCGTPGYCAPEILRGCAYGPE----- 230
Query: 232 XXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDW----ATLMCAICFGDPPSLPDGASPE 287
                 D+WS          G  PF    +R D       L C   F  P    D  S  
Sbjct: 231 -----VDMWSVGIITYILLCGFEPFYD--ERGDQFMFRRILNCEYYFISP--WWDEVSLN 281
Query: 288 FRSFIECCLQKEFSKRWTASQLLTHPFLC 316
            +  +   +  +  KR T  Q L HP++ 
Sbjct: 282 AKDLVRKLIVLDPKKRLTTFQALQHPWVT 310

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 123/262 (46%), Gaps = 18/262 (6%)
Query: 51  SDLEKLQVLGHGNGGTVY---KVQHRCTHKIYALKVVHGDADPTVRRQVFREME--ILRR 105
           S  E L+VLG G+ G V+   K+      ++YA+KV+   A   VR +V  +ME  IL  
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK-KATLKVRDRVRTKMERDILVE 83
Query: 106 TDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
            + PFIV+    F+   G + ++++++  G L T L+K   F+E  +    +++   L +
Sbjct: 84  VNHPFIVKLHYAFQ-TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDH 142
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDP 225
           LH   II+RD+KP N+L++     +K+ DFG+SK          S+ GT  YM+PE  + 
Sbjct: 143 LHSLGIIYRDLKPENILLDEEG-HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN- 200
Query: 226 DXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS 285
                       D WS          G  PF Q   R +  T++     G P  L    S
Sbjct: 201 ----RRGHTQSADWWSFGVLMFEMLTGTLPF-QGKDRKETMTMILKAKLGMPQFL----S 251
Query: 286 PEFRSFIECCLQKEFSKRWTAS 307
           PE +S +    ++  + R  A 
Sbjct: 252 PEAQSLLRMLFKRNPANRLGAG 273

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 123/262 (46%), Gaps = 18/262 (6%)
Query: 51  SDLEKLQVLGHGNGGTVY---KVQHRCTHKIYALKVVHGDADPTVRRQVFREME--ILRR 105
           S  E L+VLG G+ G V+   K+      ++YA+KV+   A   VR +V  +ME  IL  
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK-KATLKVRDRVRTKMERDILVE 82
Query: 106 TDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
            + PFIV+    F+   G + ++++++  G L T L+K   F+E  +    +++   L +
Sbjct: 83  VNHPFIVKLHYAFQ-TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDH 141
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDP 225
           LH   II+RD+KP N+L++     +K+ DFG+SK          S+ GT  YM+PE  + 
Sbjct: 142 LHSLGIIYRDLKPENILLDEEG-HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN- 199
Query: 226 DXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS 285
                       D WS          G  PF Q   R +  T++     G P  L    S
Sbjct: 200 ----RRGHTQSADWWSFGVLMFEMLTGTLPF-QGKDRKETMTMILKAKLGMPQFL----S 250
Query: 286 PEFRSFIECCLQKEFSKRWTAS 307
           PE +S +    ++  + R  A 
Sbjct: 251 PEAQSLLRMLFKRNPANRLGAG 272

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  101 bits (251), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 123/262 (46%), Gaps = 18/262 (6%)
Query: 51  SDLEKLQVLGHGNGGTVY---KVQHRCTHKIYALKVVHGDADPTVRRQVFREME--ILRR 105
           S  E L+VLG G+ G V+   K+      ++YA+KV+   A   VR +V  +ME  IL  
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK-KATLKVRDRVRTKMERDILVE 82
Query: 106 TDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
            + PFIV+    F+   G + ++++++  G L T L+K   F+E  +    +++   L +
Sbjct: 83  VNHPFIVKLHYAFQ-TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDH 141
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDP 225
           LH   II+RD+KP N+L++     +K+ DFG+SK          S+ GT  YM+PE  + 
Sbjct: 142 LHSLGIIYRDLKPENILLDEEG-HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN- 199
Query: 226 DXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS 285
                       D WS          G  PF Q   R +  T++     G    +P   S
Sbjct: 200 ----RRGHTQSADWWSFGVLMFEMLTGTLPF-QGKDRKETMTMILKAKLG----MPQFLS 250
Query: 286 PEFRSFIECCLQKEFSKRWTAS 307
           PE +S +    ++  + R  A 
Sbjct: 251 PEAQSLLRMLFKRNPANRLGAG 272

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 80/264 (30%), Positives = 120/264 (45%), Gaps = 20/264 (7%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           LG G  G VY  + R +  I ALKV+         V  Q+ RE+EI      P I++ +G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 117 IFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDI 176
            F   +  + +++EY   GT+   L K   F E + A   +++   LSY H  ++IHRDI
Sbjct: 80  YFHDAT-RVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIHRDI 138
Query: 177 KPSNLLVNNNNMQVKIADFG--VSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXX 234
           KP NLL+ +N  ++KIADFG  V     R    C    GT  Y+ PE  +          
Sbjct: 139 KPENLLLGSNG-ELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIE-----GRMHD 188
Query: 235 XXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIEC 294
              D+WS          G  PF     +  +  +   + F  P  + +GA    R  I  
Sbjct: 189 EKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRI-SRVEFTFPDFVTEGA----RDLISR 243
Query: 295 CLQKEFSKRWTASQLLTHPFLCKN 318
            L+   S+R T +++L HP++  N
Sbjct: 244 LLKHNASQRLTLAEVLEHPWIKAN 267

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 131/284 (46%), Gaps = 37/284 (13%)
Query: 55  KLQVLGHGNGGTVYKVQHRCTHKIYALKVV---------HGDADPTVRR---QVFREMEI 102
           K++ LG G  G V   + +  H   A+KV+         + D +  + +   +++ E+ +
Sbjct: 40  KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 103 LRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILK 161
           L+  D P I++ F +FE       ++ E+ + G L + ++N++  F E   A+I  QIL 
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKY-FYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILS 157
Query: 162 GLSYLHGHKIIHRDIKPSNLLVNNNN--MQVKIADFGVSKIMCRSLDACNSYVGTCAYMS 219
           G+ YLH H I+HRDIKP N+L+ N N  + +KI DFG+S    +        +GT  Y++
Sbjct: 158 GICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY-KLRDRLGTAYYIA 216
Query: 220 PERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCA------IC 273
           PE                D+WS          G+ PF   G + D   +           
Sbjct: 217 PEVLKK------KYNEKCDVWSCGVIMYILLCGYPPF---GGQNDQDIIKKVEKGKYYFD 267
Query: 274 FGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK 317
           F D  ++ D A    +  I+  L  +++KR TA + L   ++ K
Sbjct: 268 FNDWKNISDEA----KELIKLMLTYDYNKRCTAEEALNSRWIKK 307

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 122/275 (44%), Gaps = 22/275 (8%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR--QVFREMEILRRTDS 108
            D +  ++LG G+  TV   +   T + YA+K++         +   V RE +++ R D 
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF V+ +  F+     +   + Y  +G L   + K G+F E       ++I+  L YLHG
Sbjct: 92  PFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC-RSLDA-CNSYVGTCAYMSPERFDPD 226
             IIHRD+KP N+L+ N +M ++I DFG +K++   S  A  N +VGT  Y+SPE     
Sbjct: 151 KGIIHRDLKPENILL-NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL--- 206
Query: 227 XXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP 286
                      D+W+          G  PF     R     L+ A         P+   P
Sbjct: 207 --TEKSAXKSSDLWALGCIIYQLVAGLPPF-----RAGNEGLIFAKIIKLEYDFPEKFFP 259
Query: 287 EFRSFIECCLQKEFSKRWTASQ------LLTHPFL 315
           + R  +E  L  + +KR    +      L  HPF 
Sbjct: 260 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 131/275 (47%), Gaps = 15/275 (5%)
Query: 49  AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVV--HGDADPTVRRQVFREMEILRRT 106
           ++  + K ++LG G  G V+K +   T    A K++   G  D   + +V  E+ ++ + 
Sbjct: 87  SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD---KEEVKNEISVMNQL 143
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSY 165
           D   ++Q +  FE  + DI ++MEY+D G L D +++++   +E        QI +G+ +
Sbjct: 144 DHANLIQLYDAFESKN-DIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRH 202
Query: 166 LHGHKIIHRDIKPSNLL-VNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD 224
           +H   I+H D+KP N+L VN +  Q+KI DFG+++   +  +      GT  +++PE  +
Sbjct: 203 MHQMYILHLDLKPENILCVNRDAKQIKIIDFGLAR-RYKPREKLKVNFGTPEFLAPEVVN 261
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
            D           D+WS          G  PFL          ++      +     D  
Sbjct: 262 YD-----FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQD-I 315
Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR 319
           S E + FI   L KE S R +AS+ L HP+L  ++
Sbjct: 316 SEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK 350

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 121/262 (46%), Gaps = 16/262 (6%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           LG G  G VY  + R +  I ALKV+         V  Q+ RE+EI      P I++ +G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 117 IFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDI 176
            F   +  + +++EY   GT+   L K   F E + A   +++   LSY H  ++IHRDI
Sbjct: 80  YFHDAT-RVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIHRDI 138
Query: 177 KPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXXXX 236
           KP NLL+ +N  ++KIADFG S     S    ++  GT  Y+ PE  +            
Sbjct: 139 KPENLLLGSNG-ELKIADFGWSVHAPSS--RRDTLCGTLDYLPPEMIE-----GRMHDEK 190
Query: 237 XDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCL 296
            D+WS          G  PF     +  +  +   + F  P  + +GA    R  I   L
Sbjct: 191 VDLWSLGVLCYEFLVGMPPFEAHTYQETYRRI-SRVEFTFPDFVTEGA----RDLISRLL 245
Query: 297 QKEFSKRWTASQLLTHPFLCKN 318
           +   S+R T +++L HP++  N
Sbjct: 246 KHNASQRLTLAEVLEHPWIKAN 267

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 122/268 (45%), Gaps = 20/268 (7%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR-----QVFREMEILRRTDSPFIVQ 113
           LG G    V K + + T   YA K +        RR     ++ RE+ ILR+   P I+ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
              ++E  + D+ +++E +  G L   L +  + SE +      QIL G++YLH  KI H
Sbjct: 80  LHDVYENRT-DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAH 138
Query: 174 RDIKPSNLLVNNNNM---QVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE--RFDPDXX 228
            D+KP N+++ + N+    +K+ DFG++  +   ++  N + GT  +++PE   ++P   
Sbjct: 139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVAPEIVNYEP--- 194
Query: 229 XXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEF 288
                    D+WS          G  PFL   ++   A +  A+ +          S   
Sbjct: 195 ----LGLEADMWSIGVITYILLSGASPFLGDTKQETLANI-TAVSYDFDEEFFSQTSELA 249
Query: 289 RSFIECCLQKEFSKRWTASQLLTHPFLC 316
           + FI   L KE  KR T  + L HP++ 
Sbjct: 250 KDFIRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/272 (30%), Positives = 122/272 (44%), Gaps = 16/272 (5%)
Query: 49  AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRT 106
           A  D E  + LG G  G VY  + + +  I ALKV+         V  Q+ RE+EI    
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
             P I++ +G F   S  + +++EY   GT+   L K   F E + A   +++   LSY 
Sbjct: 66  RHPNILRLYGYFHD-STRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPD 226
           H  K+IHRDIKP NLL+ +   ++KIADFG S     S  A  +  GT  Y+ PE  +  
Sbjct: 125 HSKKVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSSRRA--ALCGTLDYLPPEMIE-- 179
Query: 227 XXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP 286
                      D+WS          G  PF +     D    +  + F  P  + +GA  
Sbjct: 180 ---GRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQDTYKRISRVEFTFPDFVTEGA-- 233
Query: 287 EFRSFIECCLQKEFSKRWTASQLLTHPFLCKN 318
             R  I   L+   S+R    ++L HP++  N
Sbjct: 234 --RDLISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 77/275 (28%), Positives = 121/275 (44%), Gaps = 22/275 (8%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR--QVFREMEILRRTDS 108
            D +  ++LG G+  TV   +   T + YA+K++         +   V RE +++ R D 
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF V+ +  F+     +   + Y  +G L   + K G+F E       ++I+  L YLHG
Sbjct: 92  PFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC-RSLDA-CNSYVGTCAYMSPERFDPD 226
             IIHRD+KP N+L+ N +M ++I DFG +K++   S  A  N +VGT  Y+SPE     
Sbjct: 151 KGIIHRDLKPENILL-NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL--- 206
Query: 227 XXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP 286
                      D+W+          G  PF     R     L+ A         P+   P
Sbjct: 207 --TEKSACKSSDLWALGCIIYQLVAGLPPF-----RAGNEGLIFAKIIKLEYDFPEKFFP 259
Query: 287 EFRSFIECCLQKEFSKRWTASQ------LLTHPFL 315
           + R  +E  L  + +KR    +      L  HPF 
Sbjct: 260 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 77/275 (28%), Positives = 121/275 (44%), Gaps = 22/275 (8%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR--QVFREMEILRRTDS 108
            D +  ++LG G+  TV   +   T + YA+K++         +   V RE +++ R D 
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF V+ +  F+     +   + Y  +G L   + K G+F E       ++I+  L YLHG
Sbjct: 92  PFFVKLYFTFQDDE-KLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC-RSLDA-CNSYVGTCAYMSPERFDPD 226
             IIHRD+KP N+L+ N +M ++I DFG +K++   S  A  NS+VGT  Y+SPE     
Sbjct: 151 KGIIHRDLKPENILL-NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL--- 206
Query: 227 XXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP 286
                      D+W+          G  PF     R     L+           P+   P
Sbjct: 207 --TEKSASKSSDLWALGCIIYQLVAGLPPF-----RAGNEYLIFQKIIKLEYDFPEKFFP 259
Query: 287 EFRSFIECCLQKEFSKRWTASQ------LLTHPFL 315
           + R  +E  L  + +KR    +      L  HPF 
Sbjct: 260 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/248 (30%), Positives = 117/248 (47%), Gaps = 14/248 (5%)
Query: 51  SDLEKLQVLGHGNGGTVY---KVQHRCTHKIYALKVVHGDADPTVRRQVFREME--ILRR 105
           S  E L+VLG G+ G V+   KV    +  +YA+KV+   A   VR +V  +ME  IL  
Sbjct: 28  SHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLK-KATLKVRDRVRTKMERDILAD 86
Query: 106 TDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
            + PF+V+    F+   G + ++++++  G L T L+K   F+E  +    +++  GL +
Sbjct: 87  VNHPFVVKLHYAFQ-TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDH 145
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDP 225
           LH   II+RD+KP N+L++     +K+ DFG+SK          S+ GT  YM+PE  + 
Sbjct: 146 LHSLGIIYRDLKPENILLDEEG-HIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVN- 203
Query: 226 DXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS 285
                       D WS          G  PF Q   R +  TL+     G P  L   A 
Sbjct: 204 ----RQGHSHSADWWSYGVLMFEMLTGSLPF-QGKDRKETMTLILKAKLGMPQFLSTEAQ 258
Query: 286 PEFRSFIE 293
              R+  +
Sbjct: 259 SLLRALFK 266

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 77/275 (28%), Positives = 121/275 (44%), Gaps = 22/275 (8%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR--QVFREMEILRRTDS 108
            D +  ++LG G+  TV   +   T + YA+K++         +   V RE +++ R D 
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF V+ +  F+     +   + Y  +G L   + K G+F E       ++I+  L YLHG
Sbjct: 89  PFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 147
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC-RSLDA-CNSYVGTCAYMSPERFDPD 226
             IIHRD+KP N+L+ N +M ++I DFG +K++   S  A  NS+VGT  Y+SPE     
Sbjct: 148 KGIIHRDLKPENILL-NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE----- 201
Query: 227 XXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP 286
                      D+W+          G  PF     R     L+           P+   P
Sbjct: 202 LLTEKSACKSSDLWALGCIIYQLVAGLPPF-----RAGNEYLIFQKIIKLEYDFPEKFFP 256
Query: 287 EFRSFIECCLQKEFSKRWTASQ------LLTHPFL 315
           + R  +E  L  + +KR    +      L  HPF 
Sbjct: 257 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 291

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 121/266 (45%), Gaps = 14/266 (5%)
Query: 50  YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSP 109
           Y+  EK+   G G  GTVY      T +  A++ ++    P  +  +  E+ ++R   +P
Sbjct: 22  YTRFEKI---GQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNP 77
Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
            IV     +     ++ ++MEY+  G+L  ++ +     E ++A +  + L+ L +LH +
Sbjct: 78  NIVNYLDSY-LVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN 135
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
           ++IHRDIK  N+L+  +   VK+ DFG    +       +  VGT  +M+PE        
Sbjct: 136 QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPE-----VVT 189
Query: 230 XXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFR 289
                   DIWS          G  P+L   + P  A  + A         P+  S  FR
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPELQNPEKLSAIFR 247
Query: 290 SFIECCLQKEFSKRWTASQLLTHPFL 315
            F+  CL+ +  KR +A +LL H FL
Sbjct: 248 DFLNRCLEMDVEKRGSAKELLQHQFL 273

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 121/266 (45%), Gaps = 14/266 (5%)
Query: 50  YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSP 109
           Y+  EK+   G G  GTVY      T +  A++ ++    P  +  +  E+ ++R   +P
Sbjct: 22  YTRFEKI---GQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNP 77
Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
            IV     +     ++ ++MEY+  G+L  ++ +     E ++A +  + L+ L +LH +
Sbjct: 78  NIVNYLDSY-LVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN 135
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
           ++IHRDIK  N+L+  +   VK+ DFG    +       ++ VGT  +M+PE        
Sbjct: 136 QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-----VVT 189
Query: 230 XXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFR 289
                   DIWS          G  P+L   + P  A  + A         P+  S  FR
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPELQNPEKLSAIFR 247
Query: 290 SFIECCLQKEFSKRWTASQLLTHPFL 315
            F+  CL  +  KR +A +LL H FL
Sbjct: 248 DFLNRCLDMDVEKRGSAKELLQHQFL 273

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 77/275 (28%), Positives = 121/275 (44%), Gaps = 22/275 (8%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR--QVFREMEILRRTDS 108
            D +  ++LG G+  TV   +   T + YA+K++         +   V RE +++ R D 
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF V+ +  F+     +   + Y  +G L   + K G+F E       ++I+  L YLHG
Sbjct: 93  PFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 151
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC-RSLDA-CNSYVGTCAYMSPERFDPD 226
             IIHRD+KP N+L+ N +M ++I DFG +K++   S  A  NS+VGT  Y+SPE     
Sbjct: 152 KGIIHRDLKPENILL-NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL--- 207
Query: 227 XXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP 286
                      D+W+          G  PF     R     L+           P+   P
Sbjct: 208 --TEKSACKSSDLWALGCIIYQLVAGLPPF-----RAGNEYLIFQKIIKLEYDFPEKFFP 260
Query: 287 EFRSFIECCLQKEFSKRWTASQ------LLTHPFL 315
           + R  +E  L  + +KR    +      L  HPF 
Sbjct: 261 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 295

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 121/266 (45%), Gaps = 14/266 (5%)
Query: 50  YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSP 109
           Y+  EK+   G G  GTVY      T +  A++ ++    P  +  +  E+ ++R   +P
Sbjct: 23  YTRFEKI---GQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNP 78
Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
            IV     +     ++ ++MEY+  G+L  ++ +     E ++A +  + L+ L +LH +
Sbjct: 79  NIVNYLDSY-LVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN 136
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
           ++IHRDIK  N+L+  +   VK+ DFG    +       +  VGT  +M+PE        
Sbjct: 137 QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPE-----VVT 190
Query: 230 XXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFR 289
                   DIWS          G  P+L   + P  A  + A         P+  S  FR
Sbjct: 191 RKAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPELQNPEKLSAIFR 248
Query: 290 SFIECCLQKEFSKRWTASQLLTHPFL 315
            F+  CL+ +  KR +A +L+ H FL
Sbjct: 249 DFLNRCLEMDVEKRGSAKELIQHQFL 274

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 120/266 (45%), Gaps = 14/266 (5%)
Query: 50  YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSP 109
           Y+  EK+   G G  GTVY      T +  A++ ++    P  +  +  E+ ++R   +P
Sbjct: 22  YTRFEKI---GQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNP 77
Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
            IV     +     ++ ++MEY+  G+L  ++ +     E ++A +  + L+ L +LH +
Sbjct: 78  NIVNYLDSY-LVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN 135
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
           ++IHRDIK  N+L+  +   VK+ DFG    +       +  VGT  +M+PE        
Sbjct: 136 QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPE-----VVT 189
Query: 230 XXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFR 289
                   DIWS          G  P+L   + P  A  + A         P+  S  FR
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPELQNPEKLSAIFR 247
Query: 290 SFIECCLQKEFSKRWTASQLLTHPFL 315
            F+  CL  +  KR +A +LL H FL
Sbjct: 248 DFLNRCLDMDVEKRGSAKELLQHQFL 273

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 122/273 (44%), Gaps = 16/273 (5%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR-----QVFREMEILRRTDSPFIVQ 113
           LG G    V K + + T K YA K +      + RR     ++ RE+ ILR    P I+ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
              IFE  + D+ +++E +  G L   L +  + +E +      QIL G+ YLH  +I H
Sbjct: 73  LHDIFENKT-DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAH 131
Query: 174 RDIKPSNLLVNNNNM---QVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
            D+KP N+++ + N+   ++K+ DFG+       ++A N +     + +PE   P+    
Sbjct: 132 FDLKPENIMLLDKNVPNPRIKLIDFGI----AHKIEAGNEF--KNIFGTPEFVAPEIVNY 185
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                  D+WS          G  PFL   ++ +  T + A+ +          S   + 
Sbjct: 186 EPLGLEADMWSIGVITYILLSGASPFLGETKQ-ETLTNISAVNYDFDEEYFSNTSELAKD 244
Query: 291 FIECCLQKEFSKRWTASQLLTHPFLCKNRRSDC 323
           FI   L K+  +R T +Q L H ++   RR + 
Sbjct: 245 FIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 126/281 (44%), Gaps = 22/281 (7%)
Query: 49  AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRT 106
           A  D E  + LG G  G VY  + + +  I ALKV+         V  Q+ RE+EI    
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
             P I++ +G F   +  + +++EY   GT+   L K   F E + A   +++   LSY 
Sbjct: 66  RHPNILRLYGYFHDAT-RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFG--VSKIMCRSLDACNSYVGTCAYMSPERFD 224
           H  ++IHRDIKP NLL+ +   ++KIADFG  V     R  D C    GT  Y+ PE  +
Sbjct: 125 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIE 179
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
                        D+WS          G  PF +     +    +  + F  P  + +GA
Sbjct: 180 -----GRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGA 233
Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN--RRSDC 323
               R  I   L+   S+R    ++L HP++  N  + S+C
Sbjct: 234 ----RDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 270

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 81/274 (29%), Positives = 122/274 (44%), Gaps = 20/274 (7%)
Query: 49  AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRT 106
           A  D E  + LG G  G VY  + + +  I ALKV+         V  Q+ RE+EI    
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
             P I++ +G F   +  + +++EY   GT+   L K   F E + A   +++   LSY 
Sbjct: 67  RHPNILRLYGYFHDAT-RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 125
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFG--VSKIMCRSLDACNSYVGTCAYMSPERFD 224
           H  ++IHRDIKP NLL+ +   ++KIADFG  V     R  D C    GT  Y+ PE  +
Sbjct: 126 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIE 180
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
                        D+WS          G  PF +     +    +  + F  P  + +GA
Sbjct: 181 -----GRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGA 234
Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN 318
               R  I   L+   S+R    ++L HP++  N
Sbjct: 235 ----RDLISRLLKHNPSQRPMLREVLEHPWITAN 264

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 81/274 (29%), Positives = 122/274 (44%), Gaps = 20/274 (7%)
Query: 49  AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRT 106
           A  D E  + LG G  G VY  + + +  I ALKV+         V  Q+ RE+EI    
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
             P I++ +G F   +  + +++EY   GT+   L K   F E + A   +++   LSY 
Sbjct: 66  RHPNILRLYGYFHDAT-RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFG--VSKIMCRSLDACNSYVGTCAYMSPERFD 224
           H  ++IHRDIKP NLL+ +   ++KIADFG  V     R  D C    GT  Y+ PE  +
Sbjct: 125 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIE 179
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
                        D+WS          G  PF +     +    +  + F  P  + +GA
Sbjct: 180 -----GRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGA 233
Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN 318
               R  I   L+   S+R    ++L HP++  N
Sbjct: 234 ----RDLISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 121/275 (44%), Gaps = 22/275 (8%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR--QVFREMEILRRTDS 108
            D +  ++LG G+  TV   +   T + YA+K++         +   V RE +++ R D 
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF V+ +  F+     +   + Y  +G L   + K G+F E       ++I+  L YLHG
Sbjct: 90  PFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC-RSLDA-CNSYVGTCAYMSPERFDPD 226
             IIHRD+KP N+L+ N +M ++I DFG +K++   S  A  N++VGT  Y+SPE     
Sbjct: 149 KGIIHRDLKPENILL-NEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELL--- 204
Query: 227 XXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP 286
                      D+W+          G  PF     R     L+           P+   P
Sbjct: 205 --TEKSACKSSDLWALGCIIYQLVAGLPPF-----RAGNEYLIFQKIIKLEYDFPEKFFP 257
Query: 287 EFRSFIECCLQKEFSKRWTASQ------LLTHPFL 315
           + R  +E  L  + +KR    +      L  HPF 
Sbjct: 258 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 98.2 bits (243), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 126/281 (44%), Gaps = 22/281 (7%)
Query: 49  AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRT 106
           A  D E  + LG G  G VY  + + +  I ALKV+         V  Q+ RE+EI    
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
             P I++ +G F   +  + +++EY   GT+   L K   F E + A   +++   LSY 
Sbjct: 71  RHPNILRLYGYFHDAT-RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 129
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFG--VSKIMCRSLDACNSYVGTCAYMSPERFD 224
           H  ++IHRDIKP NLL+ +   ++KIADFG  V     R  D C    GT  Y+ PE  +
Sbjct: 130 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIE 184
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
                        D+WS          G  PF +     +    +  + F  P  + +GA
Sbjct: 185 -----GRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGA 238
Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN--RRSDC 323
               R  I   L+   S+R    ++L HP++  N  + S+C
Sbjct: 239 ----RDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 275

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 120/270 (44%), Gaps = 24/270 (8%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVV---HGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           ++LG G+  TV   +   T + YA+K++   H   +  V   V RE +++ R D PF V+
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVP-YVTRERDVMSRLDHPFFVK 72
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
            +  F+     +   + Y  +G L   + K G+F E       ++I+  L YLHG  IIH
Sbjct: 73  LYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIH 131
Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMC-RSLDA-CNSYVGTCAYMSPERFDPDXXXXX 231
           RD+KP N+L+ N +M ++I DFG +K++   S  A  N +VGT  Y+SPE          
Sbjct: 132 RDLKPENILL-NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-----LLTEK 185
Query: 232 XXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSF 291
                 D+W+          G  PF     R     L+           P+   P+ R  
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPF-----RAGNEYLIFQKIIKLEYDFPEKFFPKARDL 240
Query: 292 IECCLQKEFSKRWTASQ------LLTHPFL 315
           +E  L  + +KR    +      L  HPF 
Sbjct: 241 VEKLLVLDATKRLGCEEMEGYGPLKAHPFF 270

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 122/276 (44%), Gaps = 24/276 (8%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVV---HGDADPTVRRQVFREMEILRRTD 107
            D +  ++LG G+  TV   +   T + YA+K++   H   +  V   V RE +++ R D
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVP-YVTRERDVMSRLD 67
Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
            PF V+ +  F+     +   + Y  +G L   + K G+F E       ++I+  L YLH
Sbjct: 68  HPFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 126
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC-RSLDA-CNSYVGTCAYMSPERFDP 225
           G  IIHRD+KP N+L+ N +M ++I DFG +K++   S  A  N +VGT  Y+SPE    
Sbjct: 127 GKGIIHRDLKPENILL-NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE---- 181
Query: 226 DXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS 285
                       D+W+          G  PF     R     L+           P+   
Sbjct: 182 -LLTEKSACKSSDLWALGCIIYQLVAGLPPF-----RAGNEYLIFQKIIKLEYDFPEKFF 235
Query: 286 PEFRSFIECCLQKEFSKRWTASQ------LLTHPFL 315
           P+ R  +E  L  + +KR    +      L  HPF 
Sbjct: 236 PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 271

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 120/270 (44%), Gaps = 24/270 (8%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVV---HGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           ++LG G+  TV   +   T + YA+K++   H   +  V   V RE +++ R D PF V+
Sbjct: 13  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVP-YVTRERDVMSRLDHPFFVK 71
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
            +  F+     +   + Y  +G L   + K G+F E       ++I+  L YLHG  IIH
Sbjct: 72  LYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIH 130
Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMC-RSLDA-CNSYVGTCAYMSPERFDPDXXXXX 231
           RD+KP N+L+ N +M ++I DFG +K++   S  A  N +VGT  Y+SPE          
Sbjct: 131 RDLKPENILL-NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-----LLTEK 184
Query: 232 XXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSF 291
                 D+W+          G  PF     R     L+           P+   P+ R  
Sbjct: 185 SACKSSDLWALGCIIYQLVAGLPPF-----RAGNEYLIFQKIIKLEYDFPEKFFPKARDL 239
Query: 292 IECCLQKEFSKRWTASQ------LLTHPFL 315
           +E  L  + +KR    +      L  HPF 
Sbjct: 240 VEKLLVLDATKRLGCEEMEGYGPLKAHPFF 269

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 120/275 (43%), Gaps = 22/275 (8%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR--QVFREMEILRRTDS 108
            D +  ++LG G+  TV   +   T + YA+K++         +   V RE +++ R D 
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF V+ +  F+     +   + Y  +G L   + K G+F E       ++I+  L YLHG
Sbjct: 89  PFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 147
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC-RSLDA-CNSYVGTCAYMSPERFDPD 226
             IIHRD+KP N+L+ N +M ++I DFG +K++   S  A  N +VGT  Y+SPE     
Sbjct: 148 KGIIHRDLKPENILL-NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE----- 201
Query: 227 XXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP 286
                      D+W+          G  PF     R     L+           P+   P
Sbjct: 202 LLTEKSACKSSDLWALGCIIYQLVAGLPPF-----RAGNEYLIFQKIIKLEYDFPEKFFP 256
Query: 287 EFRSFIECCLQKEFSKRWTASQ------LLTHPFL 315
           + R  +E  L  + +KR    +      L  HPF 
Sbjct: 257 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 291

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 122/266 (45%), Gaps = 14/266 (5%)
Query: 50  YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSP 109
           Y+  EK+   G G  GTVY      T +  A++ ++    P  +  +  E+ ++R   +P
Sbjct: 23  YTRFEKI---GQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNP 78
Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
            IV     +     ++ ++MEY+  G+L  ++ +     E ++A +  + L+ L +LH +
Sbjct: 79  NIVNYLDSY-LVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN 136
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
           ++IHR+IK  N+L+  +   VK+ DFG    +       ++ VGT  +M+PE        
Sbjct: 137 QVIHRNIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-----VVT 190
Query: 230 XXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFR 289
                   DIWS          G  P+L   + P  A  + A         P+  S  FR
Sbjct: 191 RKAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPELQNPEKLSAIFR 248
Query: 290 SFIECCLQKEFSKRWTASQLLTHPFL 315
            F+  CL+ +  KR +A +L+ H FL
Sbjct: 249 DFLNRCLEMDVEKRGSAKELIQHQFL 274

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 120/275 (43%), Gaps = 22/275 (8%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR--QVFREMEILRRTDS 108
            D +  ++LG G+  TV   +   T + YA+K++         +   V RE +++ R D 
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF V+ +  F+     +   + Y  +G L   + K G+F E       ++I+  L YLHG
Sbjct: 92  PFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC-RSLDA-CNSYVGTCAYMSPERFDPD 226
             IIHRD+KP N+L+ N +M ++I DFG +K++   S  A  N +VGT  Y+SPE     
Sbjct: 151 KGIIHRDLKPENILL-NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL--- 206
Query: 227 XXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP 286
                      D+W+          G  PF     R     L+           P+   P
Sbjct: 207 --TEKSACKSSDLWALGCIIYQLVAGLPPF-----RAGNEYLIFQKIIKLEYDFPEKFFP 259
Query: 287 EFRSFIECCLQKEFSKRWTASQ------LLTHPFL 315
           + R  +E  L  + +KR    +      L  HPF 
Sbjct: 260 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 122/276 (44%), Gaps = 24/276 (8%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVV---HGDADPTVRRQVFREMEILRRTD 107
            D +  ++LG G+  TV   +   T + YA+K++   H   +  V   V RE +++ R D
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVP-YVTRERDVMSRLD 68
Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
            PF V+ +  F+     +   + Y  +G L   + K G+F E       ++I+  L YLH
Sbjct: 69  HPFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 127
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC-RSLDA-CNSYVGTCAYMSPERFDP 225
           G  IIHRD+KP N+L+ N +M ++I DFG +K++   S  A  N +VGT  Y+SPE    
Sbjct: 128 GKGIIHRDLKPENILL-NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE---- 182
Query: 226 DXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS 285
                       D+W+          G  PF     R     L+           P+   
Sbjct: 183 -LLTEKSACKSSDLWALGCIIYQLVAGLPPF-----RAGNEYLIFQKIIKLEYDFPEKFF 236
Query: 286 PEFRSFIECCLQKEFSKRWTASQ------LLTHPFL 315
           P+ R  +E  L  + +KR    +      L  HPF 
Sbjct: 237 PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 272

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 120/275 (43%), Gaps = 22/275 (8%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR--QVFREMEILRRTDS 108
            D +  ++LG G+  TV   +   T + YA+K++         +   V RE +++ R D 
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF V+ +  F+     +   + Y  +G L   + K G+F E       ++I+  L YLHG
Sbjct: 74  PFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 132
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC-RSLDA-CNSYVGTCAYMSPERFDPD 226
             IIHRD+KP N+L+ N +M ++I DFG +K++   S  A  N +VGT  Y+SPE     
Sbjct: 133 KGIIHRDLKPENILL-NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE----- 186
Query: 227 XXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP 286
                      D+W+          G  PF     R     L+           P+   P
Sbjct: 187 LLTEKSACKSSDLWALGCIIYQLVAGLPPF-----RAGNEYLIFQKIIKLEYDFPEKFFP 241
Query: 287 EFRSFIECCLQKEFSKRWTASQ------LLTHPFL 315
           + R  +E  L  + +KR    +      L  HPF 
Sbjct: 242 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 276

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 120/275 (43%), Gaps = 22/275 (8%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR--QVFREMEILRRTDS 108
            D +  ++LG G+  TV   +   T + YA+K++         +   V RE +++ R D 
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF V+ +  F+     +   + Y  +G L   + K G+F E       ++I+  L YLHG
Sbjct: 90  PFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC-RSLDA-CNSYVGTCAYMSPERFDPD 226
             IIHRD+KP N+L+ N +M ++I DFG +K++   S  A  N +VGT  Y+SPE     
Sbjct: 149 KGIIHRDLKPENILL-NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL--- 204
Query: 227 XXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP 286
                      D+W+          G  PF     R     L+           P+   P
Sbjct: 205 --TEKSACKSSDLWALGCIIYQLVAGLPPF-----RAGNEYLIFQKIIKLEYDFPEKFFP 257
Query: 287 EFRSFIECCLQKEFSKRWTASQ------LLTHPFL 315
           + R  +E  L  + +KR    +      L  HPF 
Sbjct: 258 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 81/274 (29%), Positives = 122/274 (44%), Gaps = 20/274 (7%)
Query: 49  AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRT 106
           A  D E  + LG G  G VY  + + +  I ALKV+         V  Q+ RE+EI    
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
             P I++ +G F   +  + +++EY   GT+   L K   F E + A   +++   LSY 
Sbjct: 69  RHPNILRLYGYFHDAT-RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFG--VSKIMCRSLDACNSYVGTCAYMSPERFD 224
           H  ++IHRDIKP NLL+ +   ++KIADFG  V     R  D C    GT  Y+ PE  +
Sbjct: 128 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSSRRDDLC----GTLDYLPPEMIE 182
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
                        D+WS          G  PF +     +    +  + F  P  + +GA
Sbjct: 183 -----GRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGA 236
Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN 318
               R  I   L+   S+R    ++L HP++  N
Sbjct: 237 ----RDLISRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 120/275 (43%), Gaps = 22/275 (8%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR--QVFREMEILRRTDS 108
            D +  ++LG G+  TV   +   T + YA+K++         +   V RE +++ R D 
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF V+ +  F+     +   + Y  +G L   + K G+F E       ++I+  L YLHG
Sbjct: 90  PFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC-RSLDA-CNSYVGTCAYMSPERFDPD 226
             IIHRD+KP N+L+ N +M ++I DFG +K++   S  A  N +VGT  Y+SPE     
Sbjct: 149 KGIIHRDLKPENILL-NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL--- 204
Query: 227 XXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP 286
                      D+W+          G  PF     R     L+           P+   P
Sbjct: 205 --TEKSACKSSDLWALGCIIYQLVAGLPPF-----RAGNEYLIFQKIIKLEYDFPEKFFP 257
Query: 287 EFRSFIECCLQKEFSKRWTASQ------LLTHPFL 315
           + R  +E  L  + +KR    +      L  HPF 
Sbjct: 258 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 97.4 bits (241), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 120/275 (43%), Gaps = 22/275 (8%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR--QVFREMEILRRTDS 108
            D +  ++LG G+  TV   +   T + YA+K++         +   V RE +++ R D 
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF V+ +  F+     +   + Y  +G L   + K G+F E       ++I+  L YLHG
Sbjct: 92  PFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC-RSLDA-CNSYVGTCAYMSPERFDPD 226
             IIHRD+KP N+L+ N +M ++I DFG +K++   S  A  N +VGT  Y+SPE     
Sbjct: 151 KGIIHRDLKPENILL-NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL--- 206
Query: 227 XXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP 286
                      D+W+          G  PF     R     L+           P+   P
Sbjct: 207 --TEKSACKSSDLWALGCIIYQLVAGLPPF-----RAGNEYLIFQKIIKLEYDFPEKFFP 259
Query: 287 EFRSFIECCLQKEFSKRWTASQ------LLTHPFL 315
           + R  +E  L  + +KR    +      L  HPF 
Sbjct: 260 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 97.4 bits (241), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 120/275 (43%), Gaps = 22/275 (8%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR--QVFREMEILRRTDS 108
            D +  ++LG G+  TV   +   T + YA+K++         +   V RE +++ R D 
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF V+ +  F+     +   + Y  +G L   + K G+F E       ++I+  L YLHG
Sbjct: 92  PFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC-RSLDA-CNSYVGTCAYMSPERFDPD 226
             IIHRD+KP N+L+ N +M ++I DFG +K++   S  A  N +VGT  Y+SPE     
Sbjct: 151 KGIIHRDLKPENILL-NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL--- 206
Query: 227 XXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP 286
                      D+W+          G  PF     R     L+           P+   P
Sbjct: 207 --TEKSACKSSDLWALGCIIYQLVAGLPPF-----RAGNEYLIFQKIIKLEYDFPEKFFP 259
Query: 287 EFRSFIECCLQKEFSKRWTASQ------LLTHPFL 315
           + R  +E  L  + +KR    +      L  HPF 
Sbjct: 260 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 97.4 bits (241), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 120/275 (43%), Gaps = 22/275 (8%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR--QVFREMEILRRTDS 108
            D +  ++LG G+  TV   +   T + YA+K++         +   V RE +++ R D 
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF V+ +  F+     +   + Y  +G L   + K G+F E       ++I+  L YLHG
Sbjct: 93  PFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 151
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC-RSLDA-CNSYVGTCAYMSPERFDPD 226
             IIHRD+KP N+L+ N +M ++I DFG +K++   S  A  N +VGT  Y+SPE     
Sbjct: 152 KGIIHRDLKPENILL-NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL--- 207
Query: 227 XXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP 286
                      D+W+          G  PF     R     L+           P+   P
Sbjct: 208 --TEKSACKSSDLWALGCIIYQLVAGLPPF-----RAGNEYLIFQKIIKLEYDFPEKFFP 260
Query: 287 EFRSFIECCLQKEFSKRWTASQ------LLTHPFL 315
           + R  +E  L  + +KR    +      L  HPF 
Sbjct: 261 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 295

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 126/281 (44%), Gaps = 22/281 (7%)
Query: 49  AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRT 106
           A  D E  + LG G  G VY  + + +  I ALKV+         V  Q+ RE+EI    
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
             P I++ +G F   +  + +++EY   GT+   L K   F E + A   +++   LSY 
Sbjct: 92  RHPNILRLYGYFHDAT-RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 150
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFG--VSKIMCRSLDACNSYVGTCAYMSPERFD 224
           H  ++IHRDIKP NLL+ +   ++KIADFG  V     R  D C    GT  Y+ PE  +
Sbjct: 151 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSSRRDDLC----GTLDYLPPEMIE 205
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
                        D+WS          G  PF +     +    +  + F  P  + +GA
Sbjct: 206 -----GRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGA 259
Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN--RRSDC 323
               R  I   L+   S+R    ++L HP++  N  + S+C
Sbjct: 260 ----RDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 296

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/281 (29%), Positives = 126/281 (44%), Gaps = 22/281 (7%)
Query: 49  AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRT 106
           A  D E  + LG G  G VY  + + +  I ALKV+         V  Q+ RE+EI    
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
             P I++ +G F   +  + +++EY   GT+   L K   F E + A   +++   LSY 
Sbjct: 66  RHPNILRLYGYFHDAT-RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFG--VSKIMCRSLDACNSYVGTCAYMSPERFD 224
           H  ++IHRDIKP NLL+ +   ++KIADFG  V     R  + C    GT  Y+ PE  +
Sbjct: 125 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSSRRTELC----GTLDYLPPEMIE 179
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
                        D+WS          G  PF +     +    +  + F  P  + +GA
Sbjct: 180 -----GRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGA 233
Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN--RRSDC 323
               R  I   L+   S+R    ++L HP++  N  + S+C
Sbjct: 234 ----RDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 270

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 58/175 (33%), Positives = 93/175 (53%), Gaps = 6/175 (3%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR--QVFREMEILRRTDS 108
            D +  ++LG G+  TV   +   T + YA+K++         +   V RE +++ R D 
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF V+ +  F+     +   + Y  +G L   + K G+F E       ++I+  L YLHG
Sbjct: 95  PFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 153
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC-RSLDA-CNSYVGTCAYMSPE 221
             IIHRD+KP N+L+ N +M ++I DFG +K++   S  A  N +VGT  Y+SPE
Sbjct: 154 KGIIHRDLKPENILL-NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 207

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 120/275 (43%), Gaps = 22/275 (8%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR--QVFREMEILRRTDS 108
            D +  ++LG G+  TV   +   T + YA+K++         +   V RE +++ R D 
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF V+ +  F+     +   + Y  +G L   + K G+F E       ++I+  L YLHG
Sbjct: 97  PFFVKLYFCFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 155
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC-RSLDA-CNSYVGTCAYMSPERFDPD 226
             IIHRD+KP N+L+ N +M ++I DFG +K++   S  A  N +VGT  Y+SPE     
Sbjct: 156 KGIIHRDLKPENILL-NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL--- 211
Query: 227 XXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP 286
                      D+W+          G  PF     R     L+           P+   P
Sbjct: 212 --TEKSACKSSDLWALGCIIYQLVAGLPPF-----RAGNEYLIFQKIIKLEYDFPEKFFP 264
Query: 287 EFRSFIECCLQKEFSKRWTASQ------LLTHPFL 315
           + R  +E  L  + +KR    +      L  HPF 
Sbjct: 265 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 299

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 128/269 (47%), Gaps = 31/269 (11%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVV--------HGDADPTVRRQVFRE 99
           +  +D    +++G G  G VY  +   T K+YA+K +         G+      R +   
Sbjct: 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM--- 242
Query: 100 MEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQI 159
           + ++   D PFIV     F  P   ++ +++ M+ G L   L+++G FSE  +   A++I
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPD-KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI 301
Query: 160 LKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR-SLDACNSYVGTCAYM 218
           + GL ++H   +++RD+KP+N+L++ +   V+I+D G++   C  S    ++ VGT  YM
Sbjct: 302 ILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLA---CDFSKKKPHASVGTHGYM 357
Query: 219 SPERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRP----DWATLMCAICF 274
           +PE                D +S          GH PF Q   +     D  TL  A+  
Sbjct: 358 APEVLQ----KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-- 411
Query: 275 GDPPSLPDGASPEFRSFIECCLQKEFSKR 303
                LPD  SPE RS +E  LQ++ ++R
Sbjct: 412 ----ELPDSFSPELRSLLEGLLQRDVNRR 436

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 128/269 (47%), Gaps = 31/269 (11%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVV--------HGDADPTVRRQVFRE 99
           +  +D    +++G G  G VY  +   T K+YA+K +         G+      R +   
Sbjct: 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM--- 242
Query: 100 MEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQI 159
           + ++   D PFIV     F  P   ++ +++ M+ G L   L+++G FSE  +   A++I
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPD-KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI 301
Query: 160 LKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR-SLDACNSYVGTCAYM 218
           + GL ++H   +++RD+KP+N+L++ +   V+I+D G++   C  S    ++ VGT  YM
Sbjct: 302 ILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLA---CDFSKKKPHASVGTHGYM 357
Query: 219 SPERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRP----DWATLMCAICF 274
           +PE                D +S          GH PF Q   +     D  TL  A+  
Sbjct: 358 APEVLQ----KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-- 411
Query: 275 GDPPSLPDGASPEFRSFIECCLQKEFSKR 303
                LPD  SPE RS +E  LQ++ ++R
Sbjct: 412 ----ELPDSFSPELRSLLEGLLQRDVNRR 436

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 128/269 (47%), Gaps = 31/269 (11%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVV--------HGDADPTVRRQVFRE 99
           +  +D    +++G G  G VY  +   T K+YA+K +         G+      R +   
Sbjct: 185 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM--- 241
Query: 100 MEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQI 159
           + ++   D PFIV     F  P   ++ +++ M+ G L   L+++G FSE  +   A++I
Sbjct: 242 LSLVSTGDCPFIVCMSYAFHTPD-KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI 300
Query: 160 LKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR-SLDACNSYVGTCAYM 218
           + GL ++H   +++RD+KP+N+L++ +   V+I+D G++   C  S    ++ VGT  YM
Sbjct: 301 ILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLA---CDFSKKKPHASVGTHGYM 356
Query: 219 SPERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRP----DWATLMCAICF 274
           +PE                D +S          GH PF Q   +     D  TL  A+  
Sbjct: 357 APEVLQ----KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-- 410
Query: 275 GDPPSLPDGASPEFRSFIECCLQKEFSKR 303
                LPD  SPE RS +E  LQ++ ++R
Sbjct: 411 ----ELPDSFSPELRSLLEGLLQRDVNRR 435

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 128/269 (47%), Gaps = 31/269 (11%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVV--------HGDADPTVRRQVFRE 99
           +  +D    +++G G  G VY  +   T K+YA+K +         G+      R +   
Sbjct: 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM--- 242
Query: 100 MEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQI 159
           + ++   D PFIV     F  P   ++ +++ M+ G L   L+++G FSE  +   A++I
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPD-KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI 301
Query: 160 LKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR-SLDACNSYVGTCAYM 218
           + GL ++H   +++RD+KP+N+L++ +   V+I+D G++   C  S    ++ VGT  YM
Sbjct: 302 ILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLA---CDFSKKKPHASVGTHGYM 357
Query: 219 SPERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRP----DWATLMCAICF 274
           +PE                D +S          GH PF Q   +     D  TL  A+  
Sbjct: 358 APEVLQ----KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-- 411
Query: 275 GDPPSLPDGASPEFRSFIECCLQKEFSKR 303
                LPD  SPE RS +E  LQ++ ++R
Sbjct: 412 ----ELPDSFSPELRSLLEGLLQRDVNRR 436

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/262 (26%), Positives = 120/262 (45%), Gaps = 10/262 (3%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           + LG G    V   + + T K++A+K +   A       +  E+ +LR+     IV    
Sbjct: 28  ETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALED 87
Query: 117 IFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDI 176
           I+E P+  + ++M+ +  G L   + + G ++E   + +  Q+L  + YLH   I+HRD+
Sbjct: 88  IYESPN-HLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVHRDL 146
Query: 177 KPSNLLVNNNNMQVK--IADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXX 234
           KP NLL  + + + K  I+DFG+SK+  +  D  ++  GT  Y++PE             
Sbjct: 147 KPENLLYYSQDEESKIMISDFGLSKMEGKG-DVMSTACGTPGYVAPEVL-----AQKPYS 200
Query: 235 XXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIEC 294
              D WS          G+ PF        +  ++ A    D P   D  S   + FI  
Sbjct: 201 KAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDD-ISDSAKDFIRN 259
Query: 295 CLQKEFSKRWTASQLLTHPFLC 316
            ++K+ +KR+T  Q   HP++ 
Sbjct: 260 LMEKDPNKRYTCEQAARHPWIA 281

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 122/272 (44%), Gaps = 16/272 (5%)
Query: 49  AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRT 106
           A  D E  + LG G  G VY  + + +  I ALKV+         V  Q+ RE+EI    
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
             P I++ +G F   +  + +++EY   GT+   L K   F E + A   +++   LSY 
Sbjct: 66  RHPNILRLYGYFHDAT-RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPD 226
           H  ++IHRDIKP NLL+ +   ++KIADFG S     S  A  +  GT  Y+ PE  +  
Sbjct: 125 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSSRRA--ALCGTLDYLPPEMIE-- 179
Query: 227 XXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP 286
                      D+WS          G  PF +     +    +  + F  P  + +GA  
Sbjct: 180 ---GRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGA-- 233
Query: 287 EFRSFIECCLQKEFSKRWTASQLLTHPFLCKN 318
             R  I   L+   S+R    ++L HP++  N
Sbjct: 234 --RDLISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 120/273 (43%), Gaps = 16/273 (5%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR-----QVFREMEILRRTDSPFIVQ 113
           LG G    V K + + T K YA K +      + RR     ++ RE+ ILR    P I+ 
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIIT 93
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
              IFE  + D+ +++E +  G L   L +  + +E +      QIL G+ YLH  +I H
Sbjct: 94  LHDIFENKT-DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAH 152
Query: 174 RDIKPSNLLVNNNNM---QVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
            D+KP N+++ + N+   ++K+ DFG+       ++A N +     + +PE   P+    
Sbjct: 153 FDLKPENIMLLDKNVPNPRIKLIDFGI----AHKIEAGNEF--KNIFGTPEFVAPEIVNY 206
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                  D+WS          G  PFL    + +  T + A+ +          S   + 
Sbjct: 207 EPLGLEADMWSIGVITYILLSGASPFLGE-TKQETLTNISAVNYDFDEEYFSNTSELAKD 265
Query: 291 FIECCLQKEFSKRWTASQLLTHPFLCKNRRSDC 323
           FI   L K+  +R   +Q L H ++   RR + 
Sbjct: 266 FIRRLLVKDPKRRMXIAQSLEHSWIKAIRRRNV 298

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 126/279 (45%), Gaps = 18/279 (6%)
Query: 49  AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRT 106
           A  D E  + LG G  G VY  + + +  I ALKV+         V  Q+ RE+EI    
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
             P I++ +G F   +  + +++EY   GT+   L K   F E + A   +++   LSY 
Sbjct: 69  RHPNILRLYGYFHDAT-RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPD 226
           H  ++IHRDIKP NLL+ +   ++KIADFG S     S  A  +  GT  Y+ PE  +  
Sbjct: 128 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSSRRA--ALCGTLDYLPPEMIE-- 182
Query: 227 XXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP 286
                      D+WS          G  PF +     +    +  + F  P  + +GA  
Sbjct: 183 ---GRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGA-- 236
Query: 287 EFRSFIECCLQKEFSKRWTASQLLTHPFLCKN--RRSDC 323
             R  I   L+   S+R    ++L HP++  N  + S+C
Sbjct: 237 --RDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 273

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/259 (28%), Positives = 120/259 (46%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            E+++ +G G+ G V  V+H  T   YA+K++  D    V+         E  IL+  + 
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEYM  G + + L + G FSEP     A+QI+    YLH 
Sbjct: 101 PFLVKLEFSF-KDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NLL++     +K+ADFG +K +  R+   C    GT  Y++PE      
Sbjct: 160 LDLIYRDLKPENLLIDQQGY-IKVADFGFAKRVKGRTWXLC----GTPEYLAPE-----I 209
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 262
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 263 SDLKDLLRNLLQVDLTKRF 281

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/274 (29%), Positives = 121/274 (44%), Gaps = 20/274 (7%)
Query: 49  AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRT 106
           A  D E  + LG G  G VY  + + +  I ALKV+         V  Q+ RE+EI    
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
             P I++ +G F   +  + +++EY   GT+   L K   F E + A   +++   LSY 
Sbjct: 69  RHPNILRLYGYFHDAT-RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFG--VSKIMCRSLDACNSYVGTCAYMSPERFD 224
           H  ++IHRDIKP NLL+ +   ++KIADFG  V     R    C    GT  Y+ PE  +
Sbjct: 128 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIE 182
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
                        D+WS          G  PF +     +    +  + F  P  + +GA
Sbjct: 183 -----GRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGA 236
Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN 318
               R  I   L+   S+R    ++L HP++  N
Sbjct: 237 ----RDLISRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/274 (29%), Positives = 121/274 (44%), Gaps = 20/274 (7%)
Query: 49  AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRT 106
           A  D E  + LG G  G VY  + + +  I ALKV+         V  Q+ RE+EI    
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
             P I++ +G F   +  + +++EY   GT+   L K   F E + A   +++   LSY 
Sbjct: 65  RHPNILRLYGYFHDAT-RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 123
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFG--VSKIMCRSLDACNSYVGTCAYMSPERFD 224
           H  ++IHRDIKP NLL+ +   ++KIADFG  V     R    C    GT  Y+ PE  +
Sbjct: 124 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIE 178
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
                        D+WS          G  PF +     +    +  + F  P  + +GA
Sbjct: 179 -----GRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGA 232
Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN 318
               R  I   L+   S+R    ++L HP++  N
Sbjct: 233 ----RDLISRLLKHNPSQRPMLREVLEHPWITAN 262

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 119/275 (43%), Gaps = 22/275 (8%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR--QVFREMEILRRTDS 108
            D +  ++LG G+  T    +   T + YA+K++         +   V RE +++ R D 
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF V+ +  F+     +   + Y  +G L   + K G+F E       ++I+  L YLHG
Sbjct: 90  PFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC-RSLDA-CNSYVGTCAYMSPERFDPD 226
             IIHRD+KP N+L+ N +M ++I DFG +K++   S  A  N +VGT  Y+SPE     
Sbjct: 149 KGIIHRDLKPENILL-NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL--- 204
Query: 227 XXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP 286
                      D+W+          G  PF     R     L+           P+   P
Sbjct: 205 --TEKSACKSSDLWALGCIIYQLVAGLPPF-----RAGNEYLIFQKIIKLEYDFPEKFFP 257
Query: 287 EFRSFIECCLQKEFSKRWTASQ------LLTHPFL 315
           + R  +E  L  + +KR    +      L  HPF 
Sbjct: 258 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 82/281 (29%), Positives = 125/281 (44%), Gaps = 22/281 (7%)
Query: 49  AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRT 106
           A  D E  + LG G  G VY  + + +  I ALKV+         V  Q+ RE+EI    
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
             P I++ +G F   +  + +++EY   GT+   L K   F E + A   +++   LSY 
Sbjct: 66  RHPNILRLYGYFHDAT-RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFG--VSKIMCRSLDACNSYVGTCAYMSPERFD 224
           H  ++IHRDIKP NLL+ +   ++KIADFG  V     R    C    GT  Y+ PE  +
Sbjct: 125 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIE 179
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
                        D+WS          G  PF +     +    +  + F  P  + +GA
Sbjct: 180 -----GRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGA 233
Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN--RRSDC 323
               R  I   L+   S+R    ++L HP++  N  + S+C
Sbjct: 234 ----RDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 270

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 80/274 (29%), Positives = 121/274 (44%), Gaps = 20/274 (7%)
Query: 49  AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRT 106
           A  D E  + LG G  G VY  + + +  I ALKV+         V  Q+ RE+EI    
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
             P I++ +G F   +  + +++EY   GT+   L K   F E + A   +++   LSY 
Sbjct: 70  RHPNILRLYGYFHDAT-RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 128
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFG--VSKIMCRSLDACNSYVGTCAYMSPERFD 224
           H  ++IHRDIKP NLL+ +   ++KIADFG  V     R    C    GT  Y+ PE  +
Sbjct: 129 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIE 183
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
                        D+WS          G  PF +     +    +  + F  P  + +GA
Sbjct: 184 -----GRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGA 237
Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN 318
               R  I   L+   S+R    ++L HP++  N
Sbjct: 238 ----RDLISRLLKHNPSQRPMLREVLEHPWITAN 267

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 124/273 (45%), Gaps = 18/273 (6%)
Query: 49  AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRT 106
           A  D E  + LG G  G VY  + + +  I ALKV+         V  Q+ RE+EI    
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
             P I++ +G F   +  + +++EY   GT+   L K   F E + A   +++   LSY 
Sbjct: 67  RHPNILRLYGYFHDAT-RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 125
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYV-GTCAYMSPERFDP 225
           H  ++IHRDIKP NLL+ +   ++KIADFG S   C +  +  + + GT  Y+ PE  + 
Sbjct: 126 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWS---CHAPSSRRTTLSGTLDYLPPEMIE- 180
Query: 226 DXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS 285
                       D+WS          G  PF +     +    +  + F  P  + +GA 
Sbjct: 181 ----GRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGA- 234
Query: 286 PEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN 318
              R  I   L+   S+R    ++L HP++  N
Sbjct: 235 ---RDLISRLLKHNPSQRPMLREVLEHPWITAN 264

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/259 (28%), Positives = 120/259 (46%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            E+++ +G G+ G V  V+H  T   YA+K++  D    V+         E  IL+  + 
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEYM  G + + L + G FSEP     A+QI+    YLH 
Sbjct: 101 PFLVKLEFSF-KDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NLL++     +K+ADFG +K +  R+   C    GT  Y++PE      
Sbjct: 160 LDLIYRDLKPENLLIDQQGY-IKVADFGFAKRVKGRTWXLC----GTPEYLAPE-----I 209
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 262
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 263 SDLKDLLRNLLQVDLTKRF 281

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 80/274 (29%), Positives = 121/274 (44%), Gaps = 20/274 (7%)
Query: 49  AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRT 106
           A  D E  + LG G  G VY  + + +  I ALKV+         V  Q+ RE+EI    
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
             P I++ +G F   +  + +++EY   GT+   L K   F E + A   +++   LSY 
Sbjct: 69  RHPNILRLYGYFHDAT-RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFG--VSKIMCRSLDACNSYVGTCAYMSPERFD 224
           H  ++IHRDIKP NLL+ +   ++KIADFG  V     R    C    GT  Y+ PE  +
Sbjct: 128 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSSRRXXLC----GTLDYLPPEMIE 182
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
                        D+WS          G  PF +     +    +  + F  P  + +GA
Sbjct: 183 -----GRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGA 236
Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN 318
               R  I   L+   S+R    ++L HP++  N
Sbjct: 237 ----RDLISRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 80/274 (29%), Positives = 121/274 (44%), Gaps = 20/274 (7%)
Query: 49  AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRT 106
           A  D E  + LG G  G VY  + + +  I ALKV+         V  Q+ RE+EI    
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
             P I++ +G F   +  + +++EY   GT+   L K   F E + A   +++   LSY 
Sbjct: 66  RHPNILRLYGYFHDAT-RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFG--VSKIMCRSLDACNSYVGTCAYMSPERFD 224
           H  ++IHRDIKP NLL+ +   ++KIADFG  V     R    C    GT  Y+ PE  +
Sbjct: 125 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSSRRXXLC----GTLDYLPPEMIE 179
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
                        D+WS          G  PF +     +    +  + F  P  + +GA
Sbjct: 180 -----GRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGA 233
Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN 318
               R  I   L+   S+R    ++L HP++  N
Sbjct: 234 ----RDLISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 80/274 (29%), Positives = 121/274 (44%), Gaps = 20/274 (7%)
Query: 49  AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRT 106
           A  D E  + LG G  G VY  + + +  I ALKV+         V  Q+ RE+EI    
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
             P I++ +G F   +  + +++EY   GT+   L K   F E + A   +++   LSY 
Sbjct: 66  RHPNILRLYGYFHDAT-RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFG--VSKIMCRSLDACNSYVGTCAYMSPERFD 224
           H  ++IHRDIKP NLL+ +   ++KIADFG  V     R    C    GT  Y+ PE  +
Sbjct: 125 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSSRRTXLC----GTLDYLPPEMIE 179
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
                        D+WS          G  PF +     +    +  + F  P  + +GA
Sbjct: 180 -----GRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGA 233
Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN 318
               R  I   L+   S+R    ++L HP++  N
Sbjct: 234 ----RDLISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/274 (29%), Positives = 122/274 (44%), Gaps = 20/274 (7%)
Query: 49  AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRT 106
           A  D E  + LG G  G VY  + + +  I ALKV+         V  Q+ RE+EI    
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
             P I++ +G F   +  + +++EY   GT+   L K   F E + A   +++   LSY 
Sbjct: 71  RHPNILRLYGYFHDAT-RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 129
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFG--VSKIMCRSLDACNSYVGTCAYMSPERFD 224
           H  ++IHRDIKP NLL+ +   ++KIADFG  V     R    C    GT  Y+ PE  +
Sbjct: 130 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEXIE 184
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
                        D+WS          G  PF +     +    +  + F  P  + +GA
Sbjct: 185 -----GRXHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGA 238
Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN 318
               R  I   L+   S+R    ++L HP++  N
Sbjct: 239 ----RDLISRLLKHNPSQRPXLREVLEHPWITAN 268

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 122/273 (44%), Gaps = 18/273 (6%)
Query: 50  YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH--GDADPTVRRQVFREMEILRRTD 107
           +SDL ++   GHG+ G VY  +     ++ A+K +   G       + + +E+  L++  
Sbjct: 56  FSDLREI---GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
            P  +Q  G + +      ++MEY      D L        E ++A +    L+GL+YLH
Sbjct: 113 HPNTIQYRGCYLR-EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDX 227
            H +IHRD+K  N+L++   + VK+ DFG + IM       N +VGT  +M+PE      
Sbjct: 172 SHNMIHRDVKAGNILLSEPGL-VKLGDFGSASIMA----PANXFVGTPYWMAPEVI--LA 224
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPE 287
                     D+WS             P           + +  I   + P+L  G   E
Sbjct: 225 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYHIAQNESPALQSGHWSE 280
Query: 288 -FRSFIECCLQKEFSKRWTASQLLTHPFLCKNR 319
            FR+F++ CLQK    R T+  LL H F+ + R
Sbjct: 281 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 313

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 82/281 (29%), Positives = 125/281 (44%), Gaps = 22/281 (7%)
Query: 49  AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRT 106
           A  D E  + LG G  G VY  + + +  I ALKV+         V  Q+ RE+EI    
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
             P I++ +G F   +  + +++EY   GT+   L K   F E + A   +++   LSY 
Sbjct: 71  RHPNILRLYGYFHDAT-RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 129
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFG--VSKIMCRSLDACNSYVGTCAYMSPERFD 224
           H  ++IHRDIKP NLL+ +   ++KIADFG  V     R    C    GT  Y+ PE  +
Sbjct: 130 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIE 184
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
                        D+WS          G  PF +     +    +  + F  P  + +GA
Sbjct: 185 -----GRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGA 238
Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN--RRSDC 323
               R  I   L+   S+R    ++L HP++  N  + S+C
Sbjct: 239 ----RDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 275

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 121/268 (45%), Gaps = 20/268 (7%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR-----QVFREMEILRRTDSPFIVQ 113
           LG G    V K + + T   YA K +        RR     ++ RE+ ILR+     ++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
              ++E  + D+ +++E +  G L   L +  + SE +      QIL G++YLH  KI H
Sbjct: 80  LHDVYENRT-DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAH 138
Query: 174 RDIKPSNLLVNNNNM---QVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE--RFDPDXX 228
            D+KP N+++ + N+    +K+ DFG++  +   ++  N + GT  +++PE   ++P   
Sbjct: 139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVAPEIVNYEP--- 194
Query: 229 XXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEF 288
                    D+WS          G  PFL   ++   A +  A+ +          S   
Sbjct: 195 ----LGLEADMWSIGVITYILLSGASPFLGDTKQETLANI-TAVSYDFDEEFFSQTSELA 249
Query: 289 RSFIECCLQKEFSKRWTASQLLTHPFLC 316
           + FI   L KE  KR T  + L HP++ 
Sbjct: 250 KDFIRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 122/273 (44%), Gaps = 18/273 (6%)
Query: 50  YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH--GDADPTVRRQVFREMEILRRTD 107
           +SDL ++   GHG+ G VY  +     ++ A+K +   G       + + +E+  L++  
Sbjct: 17  FSDLREI---GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
            P  +Q  G + +      ++MEY      D L        E ++A +    L+GL+YLH
Sbjct: 74  HPNTIQYRGCYLR-EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDX 227
            H +IHRD+K  N+L++   + VK+ DFG + IM       N +VGT  +M+PE      
Sbjct: 133 SHNMIHRDVKAGNILLSEPGL-VKLGDFGSASIMA----PANXFVGTPYWMAPEVI--LA 185
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPE 287
                     D+WS             P           + +  I   + P+L  G   E
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYHIAQNESPALQSGHWSE 241
Query: 288 -FRSFIECCLQKEFSKRWTASQLLTHPFLCKNR 319
            FR+F++ CLQK    R T+  LL H F+ + R
Sbjct: 242 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 82/281 (29%), Positives = 125/281 (44%), Gaps = 22/281 (7%)
Query: 49  AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRT 106
           A  D E  + LG G  G VY  + + +  I ALKV+         V  Q+ RE+EI    
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
             P I++ +G F   +  + +++EY   GT+   L K   F E + A   +++   LSY 
Sbjct: 69  RHPNILRLYGYFHDAT-RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFG--VSKIMCRSLDACNSYVGTCAYMSPERFD 224
           H  ++IHRDIKP NLL+ +   ++KIADFG  V     R    C    GT  Y+ PE  +
Sbjct: 128 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIE 182
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
                        D+WS          G  PF +     +    +  + F  P  + +GA
Sbjct: 183 -----GRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGA 236
Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN--RRSDC 323
               R  I   L+   S+R    ++L HP++  N  + S+C
Sbjct: 237 ----RDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 273

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 121/268 (45%), Gaps = 20/268 (7%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR-----QVFREMEILRRTDSPFIVQ 113
           LG G    V K + + T   YA K +        RR     ++ RE+ ILR+     ++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
              ++E  + D+ +++E +  G L   L +  + SE +      QIL G++YLH  KI H
Sbjct: 80  LHDVYENRT-DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAH 138
Query: 174 RDIKPSNLLVNNNNM---QVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE--RFDPDXX 228
            D+KP N+++ + N+    +K+ DFG++  +   ++  N + GT  +++PE   ++P   
Sbjct: 139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVAPEIVNYEP--- 194
Query: 229 XXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEF 288
                    D+WS          G  PFL   ++   A +  A+ +          S   
Sbjct: 195 ----LGLEADMWSIGVITYILLSGASPFLGDTKQETLANI-TAVSYDFDEEFFSQTSELA 249
Query: 289 RSFIECCLQKEFSKRWTASQLLTHPFLC 316
           + FI   L KE  KR T  + L HP++ 
Sbjct: 250 KDFIRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 82/281 (29%), Positives = 125/281 (44%), Gaps = 22/281 (7%)
Query: 49  AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRT 106
           A  D E  + LG G  G VY  + + +  I ALKV+         V  Q+ RE+EI    
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
             P I++ +G F   +  + +++EY   GT+   L K   F E + A   +++   LSY 
Sbjct: 68  RHPNILRLYGYFHDAT-RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 126
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFG--VSKIMCRSLDACNSYVGTCAYMSPERFD 224
           H  ++IHRDIKP NLL+ +   ++KIADFG  V     R    C    GT  Y+ PE  +
Sbjct: 127 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSSRRXXLC----GTLDYLPPEMIE 181
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
                        D+WS          G  PF +     +    +  + F  P  + +GA
Sbjct: 182 -----GRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGA 235
Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN--RRSDC 323
               R  I   L+   S+R    ++L HP++  N  + S+C
Sbjct: 236 ----RDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 272

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 82/281 (29%), Positives = 125/281 (44%), Gaps = 22/281 (7%)
Query: 49  AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRT 106
           A  D E  + LG G  G VY  + + +  I ALKV+         V  Q+ RE+EI    
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
             P I++ +G F   +  + +++EY   GT+   L K   F E + A   +++   LSY 
Sbjct: 83  RHPNILRLYGYFHDAT-RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 141
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFG--VSKIMCRSLDACNSYVGTCAYMSPERFD 224
           H  ++IHRDIKP NLL+ +   ++KIADFG  V     R    C    GT  Y+ PE  +
Sbjct: 142 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIE 196
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
                        D+WS          G  PF +     +    +  + F  P  + +GA
Sbjct: 197 -----GRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGA 250
Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN--RRSDC 323
               R  I   L+   S+R    ++L HP++  N  + S+C
Sbjct: 251 ----RDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 287

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 82/281 (29%), Positives = 125/281 (44%), Gaps = 22/281 (7%)
Query: 49  AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRT 106
           A  D E  + LG G  G VY  + + +  I ALKV+         V  Q+ RE+EI    
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
             P I++ +G F   +  + +++EY   GT+   L K   F E + A   +++   LSY 
Sbjct: 92  RHPNILRLYGYFHDAT-RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 150
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFG--VSKIMCRSLDACNSYVGTCAYMSPERFD 224
           H  ++IHRDIKP NLL+ +   ++KIADFG  V     R    C    GT  Y+ PE  +
Sbjct: 151 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIE 205
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
                        D+WS          G  PF +     +    +  + F  P  + +GA
Sbjct: 206 -----GRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGA 259
Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN--RRSDC 323
               R  I   L+   S+R    ++L HP++  N  + S+C
Sbjct: 260 ----RDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 296

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 122/272 (44%), Gaps = 16/272 (5%)
Query: 49  AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRT 106
           A  D E  + LG G  G VY  + + +  I ALKV+         V  Q+ RE+EI    
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
             P I++ +G F   +  + +++EY   GT+   L K   F E + A   +++   LSY 
Sbjct: 67  RHPNILRLYGYFHDAT-RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 125
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPD 226
           H  ++IHRDIKP NLL+ +   ++KIADFG S     S    ++  GT  Y+ PE  +  
Sbjct: 126 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSSRR--DTLCGTLDYLPPEMIE-- 180
Query: 227 XXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP 286
                      D+WS          G  PF +     +    +  + F  P  + +GA  
Sbjct: 181 ---GRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGA-- 234
Query: 287 EFRSFIECCLQKEFSKRWTASQLLTHPFLCKN 318
             R  I   L+   S+R    ++L HP++  N
Sbjct: 235 --RDLISRLLKHNPSQRPMLREVLEHPWITAN 264

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 118/265 (44%), Gaps = 11/265 (4%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVF-REMEILRRTDSPFIVQCFGI 117
           LG G    V +  H+ T   +A K+++         Q   RE  I R+   P IV+    
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 118 FEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIK 177
            ++ S    ++ + +  G L   +     +SE   +H   QIL+ ++Y H + I+HR++K
Sbjct: 74  IQEESFHY-LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLK 132
Query: 178 PSNLLVNN--NNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXXX 235
           P NLL+ +      VK+ADFG++ I     +A + + GT  Y+SPE    D         
Sbjct: 133 PENLLLASKAKGAAVKLADFGLA-IEVNDSEAWHGFAGTPGYLSPEVLKKD-----PYSK 186
Query: 236 XXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECC 295
             DIW+          G+ PF    Q   +A +  A  +  P    D  +PE +S I+  
Sbjct: 187 PVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK-AGAYDYPSPEWDTVTPEAKSLIDSM 245
Query: 296 LQKEFSKRWTASQLLTHPFLCKNRR 320
           L     KR TA Q L  P++C   R
Sbjct: 246 LTVNPKKRITADQALKVPWICNRER 270

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 118/265 (44%), Gaps = 11/265 (4%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVF-REMEILRRTDSPFIVQCFGI 117
           LG G    V +  H+ T   +A K+++         Q   RE  I R+   P IV+    
Sbjct: 13  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 72
Query: 118 FEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIK 177
            ++ S    ++ + +  G L   +     +SE   +H   QIL+ ++Y H + I+HR++K
Sbjct: 73  IQEESFHY-LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLK 131
Query: 178 PSNLLVNN--NNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXXX 235
           P NLL+ +      VK+ADFG++ I     +A + + GT  Y+SPE    D         
Sbjct: 132 PENLLLASKAKGAAVKLADFGLA-IEVNDSEAWHGFAGTPGYLSPEVLKKD-----PYSK 185
Query: 236 XXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECC 295
             DIW+          G+ PF    Q   +A +  A  +  P    D  +PE +S I+  
Sbjct: 186 PVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK-AGAYDYPSPEWDTVTPEAKSLIDSM 244
Query: 296 LQKEFSKRWTASQLLTHPFLCKNRR 320
           L     KR TA Q L  P++C   R
Sbjct: 245 LTVNPKKRITADQALKVPWICNRER 269

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 80/274 (29%), Positives = 120/274 (43%), Gaps = 20/274 (7%)
Query: 49  AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRT 106
           A  D E  + LG G  G VY  + +    I ALKV+         V  Q+ RE+EI    
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
             P I++ +G F   +  + +++EY   GT+   L K   F E + A   +++   LSY 
Sbjct: 63  RHPNILRLYGYFHDAT-RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 121
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFG--VSKIMCRSLDACNSYVGTCAYMSPERFD 224
           H  ++IHRDIKP NLL+ +   ++KIADFG  V     R    C    GT  Y+ PE  +
Sbjct: 122 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIE 176
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
                        D+WS          G  PF +     +    +  + F  P  + +GA
Sbjct: 177 -----GRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGA 230
Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN 318
               R  I   L+   S+R    ++L HP++  N
Sbjct: 231 ----RDLISRLLKHNPSQRPMLREVLEHPWITAN 260

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 130/284 (45%), Gaps = 35/284 (12%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR-QVFREMEILRRTDSPFIV 112
           ++++ LG G  G V   + + TH   A+K++   +  T    ++  E+ +L+  D P I+
Sbjct: 40  QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
           + +  FE    +  ++ME    G L   +     F+E   A I  Q+L G++YLH H I+
Sbjct: 100 KLYDFFEDKR-NYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIV 158
Query: 173 HRDIKPSNLLVNNNNMQ--VKIADFGVSKIMCRSLDACNSYVGTCAYMSPE----RFDPD 226
           HRD+KP NLL+ +      +KI DFG+S +   +       +GT  Y++PE    ++D  
Sbjct: 159 HRDLKPENLLLESKEKDALIKIVDFGLSAVF-ENQKKMKERLGTAYYIAPEVLRKKYDE- 216
Query: 227 XXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATL----MCAICFGDPP--SL 280
                      D+WS          G+ PF   G + D   L         F  P   ++
Sbjct: 217 ---------KCDVWSIGVILFILLAGYPPF---GGQTDQEILRKVEKGKYTFDSPEWKNV 264
Query: 281 PDGASPEFRSFIECCLQKEFSKRWTASQLLTHPF---LCKNRRS 321
            +GA    +  I+  LQ +  +R +A Q L HP+   +C  + S
Sbjct: 265 SEGA----KDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKES 304

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 120/265 (45%), Gaps = 17/265 (6%)
Query: 64  GGTVYKVQHRCTHKI----YALKVVHGDADPTVR--RQVFREMEILRRTDSPFIVQCFGI 117
           G   + V  RC HK     +A K+++     + R  +++ RE  I R+   P IV+    
Sbjct: 38  GKGAFSVVRRCVHKTTGLEFAAKIIN-TKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 118 FEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIK 177
            ++ S    ++ + +  G L   +     +SE   +H   QIL+ ++Y H + I+HR++K
Sbjct: 97  IQEESFHY-LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLK 155
Query: 178 PSNLLVNN--NNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXXX 235
           P NLL+ +      VK+ADFG++ I     +A + + GT  Y+SPE    D         
Sbjct: 156 PENLLLASKAKGAAVKLADFGLA-IEVNDSEAWHGFAGTPGYLSPEVLKKD-----PYSK 209
Query: 236 XXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECC 295
             DIW+          G+ PF    Q   +A +     +  P    D  +PE +S I+  
Sbjct: 210 PVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG-AYDYPSPEWDTVTPEAKSLIDSM 268
Query: 296 LQKEFSKRWTASQLLTHPFLCKNRR 320
           L     KR TA Q L  P++C   R
Sbjct: 269 LTVNPKKRITADQALKVPWICNRER 293

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 94.4 bits (233), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 124/281 (44%), Gaps = 22/281 (7%)
Query: 49  AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRT 106
           A  D E  + LG G  G VY  + + +  I ALKV+         V  Q+ RE+EI    
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
             P I++ +G F   +  + +++EY   G +   L K   F E + A   +++   LSY 
Sbjct: 71  RHPNILRLYGYFHDAT-RVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYC 129
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFG--VSKIMCRSLDACNSYVGTCAYMSPERFD 224
           H  ++IHRDIKP NLL+ +   ++KIADFG  V     R    C    GT  Y+ PE  +
Sbjct: 130 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIE 184
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
                        D+WS          G  PF +     +    +  + F  P  + +GA
Sbjct: 185 -----GRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGA 238
Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN--RRSDC 323
               R  I   L+   S+R    ++L HP++  N  + S+C
Sbjct: 239 ----RDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 275

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 120/259 (46%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            E+++ +G G+ G V  V+H  T   YA+K++  D    V+         E  IL+  + 
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G FSEP     A+QI+    YLH 
Sbjct: 101 PFLVKLEFSF-KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NLL++     +K+ADFG +K +  R+   C    GT  Y++PE      
Sbjct: 160 LDLIYRDLKPENLLIDQQGY-IKVADFGFAKRVKGRTWXLC----GTPEYLAPE-----I 209
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 262
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 263 SDLKDLLRNLLQVDLTKRF 281

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 94.0 bits (232), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 121/274 (44%), Gaps = 20/274 (7%)
Query: 49  AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRT 106
           A  D E  + LG G  G VY  + + +  I ALKV+         V  Q+ RE+EI    
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
             P I++ +G F   +  + +++EY   GT+   L K   F E + A   +++   LSY 
Sbjct: 69  RHPNILRLYGYFHDAT-RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFG--VSKIMCRSLDACNSYVGTCAYMSPERFD 224
           H  ++IHRDIKP NLL+ +   ++KIA+FG  V     R    C    GT  Y+ PE  +
Sbjct: 128 HSKRVIHRDIKPENLLLGSAG-ELKIANFGWSVHAPSSRRTTLC----GTLDYLPPEMIE 182
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
                        D+WS          G  PF +     +    +  + F  P  + +GA
Sbjct: 183 -----GRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGA 236
Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN 318
               R  I   L+   S+R    ++L HP++  N
Sbjct: 237 ----RDLISRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 121/268 (45%), Gaps = 20/268 (7%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR-----QVFREMEILRRTDSPFIVQ 113
           LG G    V K + + T   YA K +        RR     ++ RE+ ILR+     ++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
              ++E  + D+ +++E +  G L   L +  + SE +      QIL G++YLH  KI H
Sbjct: 80  LHDVYENRT-DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAH 138
Query: 174 RDIKPSNLLVNNNNM---QVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE--RFDPDXX 228
            D+KP N+++ + N+    +K+ DFG++  +   ++  N + GT  +++PE   ++P   
Sbjct: 139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVAPEIVNYEP--- 194
Query: 229 XXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEF 288
                    D+WS          G  PFL   ++   A +  ++ +          S   
Sbjct: 195 ----LGLEADMWSIGVITYILLSGASPFLGDTKQETLANI-TSVSYDFDEEFFSHTSELA 249
Query: 289 RSFIECCLQKEFSKRWTASQLLTHPFLC 316
           + FI   L KE  KR T  + L HP++ 
Sbjct: 250 KDFIRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 118/263 (44%), Gaps = 14/263 (5%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT--VRRQVFREMEILRRTDSPFIVQCF 115
            LG G  G V   +H  T    A+K+++     +  V  ++ RE++ L+    P I++ +
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRD 175
            +   PS DI ++MEY+  G L   + KNG   E +   +  QIL G+ Y H H ++HRD
Sbjct: 83  QVISTPS-DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRD 141
Query: 176 IKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXXX 235
           +KP N+L+ + +M  KIADFG+S +M    +      G+  Y +PE              
Sbjct: 142 LKPENVLL-DAHMNAKIADFGLSNMMSDG-EFLRXSCGSPNYAAPEVI----SGRLYAGP 195
Query: 236 XXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECC 295
             DIWS          G  PF      P     +C   F  P  L    +P   S ++  
Sbjct: 196 EVDIWSSGVILYALLCGTLPF-DDDHVPTLFKKICDGIFYTPQYL----NPSVISLLKHM 250
Query: 296 LQKEFSKRWTASQLLTHPFLCKN 318
           LQ +  KR T   +  H +  ++
Sbjct: 251 LQVDPMKRATIKDIREHEWFKQD 273

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 121/268 (45%), Gaps = 20/268 (7%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR-----QVFREMEILRRTDSPFIVQ 113
           LG G    V K + + T   YA K +        RR     ++ RE+ ILR+     ++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
              ++E  + D+ +++E +  G L   L +  + SE +      QIL G++YLH  KI H
Sbjct: 80  LHDVYENRT-DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAH 138
Query: 174 RDIKPSNLLVNNNNM---QVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE--RFDPDXX 228
            D+KP N+++ + N+    +K+ DFG++  +   ++  N + GT  +++PE   ++P   
Sbjct: 139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVAPEIVNYEP--- 194
Query: 229 XXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEF 288
                    D+WS          G  PFL   ++   A +  ++ +          S   
Sbjct: 195 ----LGLEADMWSIGVITYILLSGASPFLGDTKQETLANI-TSVSYDFDEEFFSHTSELA 249
Query: 289 RSFIECCLQKEFSKRWTASQLLTHPFLC 316
           + FI   L KE  KR T  + L HP++ 
Sbjct: 250 KDFIRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 118/265 (44%), Gaps = 16/265 (6%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR-----QVFREMEILRRTDSPFIVQ 113
           LG G    V K + + T K YA K +      + RR     ++ RE+ ILR    P I+ 
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 79
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
              IFE  + D+ +++E +  G L   L +  + +E +      QIL G+ YLH  +I H
Sbjct: 80  LHDIFENKT-DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAH 138
Query: 174 RDIKPSNLLVNNNNM---QVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
            D+KP N+++ + N+   ++K+ DFG+       ++A N +     + +PE   P+    
Sbjct: 139 FDLKPENIMLLDKNVPNPRIKLIDFGI----AHKIEAGNEF--KNIFGTPEFVAPEIVNY 192
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                  D+WS          G  PFL   ++ +  T + A+ +          S   + 
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFLGETKQ-ETLTNISAVNYDFDEEYFSNTSELAKD 251
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
           FI   L K+  +R   +Q L H ++
Sbjct: 252 FIRRLLVKDPKRRMXIAQSLEHSWI 276

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 120/259 (46%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            E+++ LG G+ G V  V+H+ T   YA+K++  D    V+         E  IL+  + 
Sbjct: 36  FERIKTLGTGSFGRVMLVKHKETGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G FSEP     A+QI+    YLH 
Sbjct: 94  PFLVKLEFSF-KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 152
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NLL++     +++ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 153 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWXLC----GTPEYLAPE-----I 202
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 203 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 255
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 256 SDLKDLLRNLLQVDLTKRF 274

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 125/281 (44%), Gaps = 22/281 (7%)
Query: 49  AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRT 106
           A  D E  + LG G  G VY  + + +  I ALKV+         V  Q+ RE+EI    
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
             P I++ +G F   +  + +++EY   GT+   L K   F E + A   +++   LSY 
Sbjct: 68  RHPNILRLYGYFHDAT-RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 126
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFG--VSKIMCRSLDACNSYVGTCAYMSPERFD 224
           H  ++IHRDIKP NLL+ +   ++KIA+FG  V     R    C    GT  Y+ PE  +
Sbjct: 127 HSKRVIHRDIKPENLLLGSAG-ELKIANFGWSVHAPSSRRTTLC----GTLDYLPPEMIE 181
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
                        D+WS          G  PF +     +    +  + F  P  + +GA
Sbjct: 182 -----GRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGA 235
Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN--RRSDC 323
               R  I   L+   S+R    ++L HP++  N  + S+C
Sbjct: 236 ----RDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 272

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 120/259 (46%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            E+++ LG G+ G V  V+H+ T   YA+K++  D    V+         E  IL+  + 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G FSEP     A+QI+    YLH 
Sbjct: 102 PFLVKLEFSF-KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NLL++     +++ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 161 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWXLC----GTPEYLAPE-----I 210
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 263
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 264 SDLKDLLRNLLQVDLTKRF 282

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 120/259 (46%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            E+++ LG G+ G V  V+H+ T   YA+K++  D    V+         E  IL+  + 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G FSEP     A+QI+    YLH 
Sbjct: 102 PFLVKLEFSF-KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NLL++     +++ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 161 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWXLC----GTPEYLAPE-----I 210
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 263
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 264 SDLKDLLRNLLQVDLTKRF 282

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 120/259 (46%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            E+++ LG G+ G V  V+H+ T   YA+K++  D    V+         E  IL+  + 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G FSEP     A+QI+    YLH 
Sbjct: 102 PFLVKLEFSF-KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NLL++     +++ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 161 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWXLC----GTPEYLAPE-----I 210
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 263
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 264 SDLKDLLRNLLQVDLTKRF 282

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 128/268 (47%), Gaps = 17/268 (6%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQV-FREMEILRRTDSPFIVQCFGI 117
           +G G+ G V   + + + +  A+K++  D     RR++ F E+ I+R      +V+ +  
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 118 FEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIK 177
           +     ++ +LME++  G L  ++++    +E ++A +   +L+ L+YLH   +IHRDIK
Sbjct: 111 Y-LVGEELWVLMEFLQGGALTDIVSQV-RLNEEQIATVCEAVLQALAYLHAQGVIHRDIK 168
Query: 178 PSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXXXXX 237
             ++L+  +  +VK++DFG    + + +      VGT  +M+PE                
Sbjct: 169 SDSILLTLDG-RVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPE-----VISRSLYATEV 222
Query: 238 DIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDG--ASPEFRSFIECC 295
           DIWS          G  P+      P  A  M  +    PP L +    SP  R F+E  
Sbjct: 223 DIWSLGIMVIEMVDGEPPYF--SDSPVQA--MKRLRDSPPPKLKNSHKVSPVLRDFLERM 278
Query: 296 LQKEFSKRWTASQLLTHPFLCKNRRSDC 323
           L ++  +R TA +LL HPFL +    +C
Sbjct: 279 LVRDPQERATAQELLDHPFLLQTGLPEC 306

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 119/267 (44%), Gaps = 10/267 (3%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGI 117
           VLG G    V   + + T K+ A+K +  +A       +  E+ +L +   P IV    I
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 118 FEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIK 177
           +E   G + ++M+ +  G L   + + G ++E   + +  Q+L  + YLH   I+HRD+K
Sbjct: 85  YES-GGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLK 143
Query: 178 PSNLLVN--NNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXXX 235
           P NLL    + + ++ I+DFG+SK M       ++  GT  Y++PE              
Sbjct: 144 PENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTACGTPGYVAPEVL-----AQKPYSK 197
Query: 236 XXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECC 295
             D WS          G+ PF        +  ++ A    D P   D  S   + FI   
Sbjct: 198 AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW-DDISDSAKDFIRHL 256
Query: 296 LQKEFSKRWTASQLLTHPFLCKNRRSD 322
           ++K+  KR+T  Q L HP++  +   D
Sbjct: 257 MEKDPEKRFTCEQALQHPWIAGDTALD 283

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 121/268 (45%), Gaps = 20/268 (7%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR-----QVFREMEILRRTDSPFIVQ 113
           LG G    V K + + T   YA K +        RR     ++ RE+ ILR+     ++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
              ++E  + D+ +++E +  G L   L +  + SE +      QIL G++YLH  KI H
Sbjct: 80  LHDVYENRT-DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAH 138
Query: 174 RDIKPSNLLVNNNNM---QVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE--RFDPDXX 228
            D+KP N+++ + N+    +K+ DFG++  +   ++  N + GT  +++PE   ++P   
Sbjct: 139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVAPEIVNYEP--- 194
Query: 229 XXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEF 288
                    D+WS          G  PFL   ++   A +  ++ +          S   
Sbjct: 195 ----LGLEADMWSIGVITYILLSGASPFLGDTKQETLANI-TSVSYDFDEEFFSHTSELA 249
Query: 289 RSFIECCLQKEFSKRWTASQLLTHPFLC 316
           + FI   L KE  KR T  + L HP++ 
Sbjct: 250 KDFIRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 119/259 (45%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            E+++ LG G+ G V  V+H+ T   YA+K++  D    V+         E  IL+  + 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY   G + + L + G FSEP     A+QI+    YLH 
Sbjct: 102 PFLVKLEFSF-KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NL+++     +K+ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 161 LDLIYRDLKPENLMIDQQGY-IKVTDFGFAKRVKGRTWXLC----GTPEYLAPE-----I 210
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 263
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 264 SDLKDLLRNLLQVDLTKRF 282

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 120/259 (46%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            E+++ LG G+ G V  V+H+ T   YA+K++  D    V+         E  IL+  + 
Sbjct: 64  FERIKTLGTGSFGRVMLVKHKETGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G FSEP     A+QI+    YLH 
Sbjct: 122 PFLVKLEFSF-KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 180
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NLL++     +++ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 181 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWXLC----GTPEYLAPE-----I 230
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 231 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSGK-VRFPSHFS 283
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 284 SDLKDLLRNLLQVDLTKRF 302

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 123/277 (44%), Gaps = 23/277 (8%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD---ADPTVRRQVFREMEILR 104
           +  +D + L++LG G  G V  V+ + T + YA+K++  +   A   V   V  E  +L+
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV-TESRVLQ 60
Query: 105 RTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLS 164
            T  PF+      F+     +  +MEY + G L   L++   F+E +     ++I+  L 
Sbjct: 61  NTRHPFLTALKYAFQ-THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119
Query: 165 YLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD 224
           YLH   +++RDIK  NL+++ +   +KI DFG+ K          ++ GT  Y++PE  +
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFL-QPGQRPDWATLMCAICFGDPPSLPDG 283
            +           D W           G  PF  Q  +R     LM  I F      P  
Sbjct: 179 DN-----DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF------PRT 227
Query: 284 ASPEFRSFIECCLQKEFSKRW-----TASQLLTHPFL 315
            SPE +S +   L+K+  +R       A +++ H F 
Sbjct: 228 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 121/272 (44%), Gaps = 21/272 (7%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQ--VFREMEILRRTDSPFI 111
           ++++ LG G  G V   + + T    A+K++   +  T      +  E+ +L++ D P I
Sbjct: 24  QRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNI 83
Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
           ++ +  FE    +  ++ME    G L   +     FSE   A I  Q+L G +YLH H I
Sbjct: 84  MKLYEFFEDKR-NYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNI 142
Query: 172 IHRDIKPSNLLVNNNNMQ--VKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
           +HRD+KP NLL+ + +    +KI DFG+S             +GT  Y++PE        
Sbjct: 143 VHRDLKPENLLLESKSRDALIKIVDFGLSA-HFEVGGKMKERLGTAYYIAPEVL------ 195
Query: 230 XXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATL----MCAICFGDPPSLPDGAS 285
                   D+WS          G+ PF   G + D   L         F DPP      S
Sbjct: 196 RKKYDEKCDVWSCGVILYILLCGYPPF---GGQTDQEILKRVEKGKFSF-DPPDWTQ-VS 250
Query: 286 PEFRSFIECCLQKEFSKRWTASQLLTHPFLCK 317
            E +  ++  L  E SKR +A + L HP++ K
Sbjct: 251 DEAKQLVKLMLTYEPSKRISAEEALNHPWIVK 282

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 123/278 (44%), Gaps = 23/278 (8%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD---ADPTVRRQVFREMEILR 104
           +  +D + L++LG G  G V  V+ + T + YA+K++  +   A   V   V  E  +L+
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV-TESRVLQ 60
Query: 105 RTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLS 164
            T  PF+      F+     +  +MEY + G L   L++   F+E +     ++I+  L 
Sbjct: 61  NTRHPFLTALKYAFQ-THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119
Query: 165 YLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD 224
           YLH   +++RDIK  NL+++ +   +KI DFG+ K          ++ GT  Y++PE  +
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFL-QPGQRPDWATLMCAICFGDPPSLPDG 283
            +           D W           G  PF  Q  +R     LM  I F      P  
Sbjct: 179 DN-----DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF------PRT 227
Query: 284 ASPEFRSFIECCLQKEFSKRW-----TASQLLTHPFLC 316
            SPE +S +   L+K+  +R       A +++ H F  
Sbjct: 228 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 124/276 (44%), Gaps = 29/276 (10%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQ--VFREMEILRRTDSPFI 111
           ++++ LG G  G V   + + T    A+K++   +  T      +  E+ +L++ D P I
Sbjct: 7   QRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNI 66
Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
           ++ +  FE    +  ++ME    G L   +     FSE   A I  Q+L G +YLH H I
Sbjct: 67  MKLYEFFEDKR-NYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNI 125
Query: 172 IHRDIKPSNLLVNNNNMQ--VKIADFGVSKIMCRSLDACNSYVGTCAYMSPE----RFDP 225
           +HRD+KP NLL+ + +    +KI DFG+S             +GT  Y++PE    ++D 
Sbjct: 126 VHRDLKPENLLLESKSRDALIKIVDFGLS-AHFEVGGKMKERLGTAYYIAPEVLRKKYDE 184
Query: 226 DXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATL----MCAICFGDPPSLP 281
                       D+WS          G+ PF   G + D   L         F DPP   
Sbjct: 185 ----------KCDVWSCGVILYILLCGYPPF---GGQTDQEILKRVEKGKFSF-DPPDWT 230
Query: 282 DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK 317
              S E +  ++  L  E SKR +A + L HP++ K
Sbjct: 231 Q-VSDEAKQLVKLMLTYEPSKRISAEEALNHPWIVK 265

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 116/261 (44%), Gaps = 11/261 (4%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVF-REMEILRRTDSPFIVQCFGI 117
           LG G    V +  H+ T   +A K+++         Q   RE  I R+   P IV+    
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 118 FEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIK 177
            ++ S    ++ + +  G L   +     +SE   +H   QIL+ ++Y H + I+HR++K
Sbjct: 74  IQEESFHY-LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLK 132
Query: 178 PSNLLVNN--NNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXXX 235
           P NLL+ +      VK+ADFG++ I     +A + + GT  Y+SPE    D         
Sbjct: 133 PENLLLASKAKGAAVKLADFGLA-IEVNDSEAWHGFAGTPGYLSPEVLKKD-----PYSK 186
Query: 236 XXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECC 295
             DIW+          G+ PF    Q   +A +     +  P    D  +PE +S I+  
Sbjct: 187 PVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG-AYDYPSPEWDTVTPEAKSLIDSM 245
Query: 296 LQKEFSKRWTASQLLTHPFLC 316
           L     KR TA Q L  P++C
Sbjct: 246 LTVNPKKRITADQALKVPWIC 266

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 123/278 (44%), Gaps = 23/278 (8%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD---ADPTVRRQVFREMEILR 104
           +  +D + L++LG G  G V  V+ + T + YA+K++  +   A   V   V  E  +L+
Sbjct: 5   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV-TESRVLQ 63
Query: 105 RTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLS 164
            T  PF+      F+     +  +MEY + G L   L++   F+E +     ++I+  L 
Sbjct: 64  NTRHPFLTALKYAFQ-THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 122
Query: 165 YLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD 224
           YLH   +++RDIK  NL+++ +   +KI DFG+ K          ++ GT  Y++PE  +
Sbjct: 123 YLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 181
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFL-QPGQRPDWATLMCAICFGDPPSLPDG 283
            +           D W           G  PF  Q  +R     LM  I F      P  
Sbjct: 182 DN-----DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF------PRT 230
Query: 284 ASPEFRSFIECCLQKEFSKRW-----TASQLLTHPFLC 316
            SPE +S +   L+K+  +R       A +++ H F  
Sbjct: 231 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 268

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 119/267 (44%), Gaps = 10/267 (3%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGI 117
           VLG G    V   + + T K+ A+K +  +A       +  E+ +L +   P IV    I
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 118 FEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIK 177
           +E   G + ++M+ +  G L   + + G ++E   + +  Q+L  + YLH   I+HRD+K
Sbjct: 85  YES-GGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLK 143
Query: 178 PSNLLVN--NNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXXX 235
           P NLL    + + ++ I+DFG+SK M       ++  GT  Y++PE              
Sbjct: 144 PENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTACGTPGYVAPEVL-----AQKPYSK 197
Query: 236 XXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECC 295
             D WS          G+ PF        +  ++ A    D P   D  S   + FI   
Sbjct: 198 AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW-DDISDSAKDFIRHL 256
Query: 296 LQKEFSKRWTASQLLTHPFLCKNRRSD 322
           ++K+  KR+T  Q L HP++  +   D
Sbjct: 257 MEKDPEKRFTCEQALQHPWIAGDTALD 283

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 59/175 (33%), Positives = 98/175 (56%), Gaps = 12/175 (6%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVV----HGDADPTVRRQVFREMEILRRTDSP 109
           EKL  LG G   TVYK + + T++I A+K +      +A   + R   RE+++L+    P
Sbjct: 13  EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 72
Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQIL---KGLSYL 166
            I+     F   S +I+++ ++M++  L+ ++  N     P  +HI + +L   +GL YL
Sbjct: 73  NIIGLLDAFGHKS-NISLVFDFMET-DLEVIIKDNSLVLTP--SHIKAYMLMTLQGLEYL 128
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
           H H I+HRD+KP+NLL++ N + +K+ADFG++K       A    V T  Y +PE
Sbjct: 129 HQHWILHRDLKPNNLLLDENGV-LKLADFGLAKSFGSPNRAYXHQVVTRWYRAPE 182

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 131/270 (48%), Gaps = 17/270 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQV-FREMEILRRTDSP 109
           S L+    +G G+ G V     R + K+ A+K +  D     RR++ F E+ I+R     
Sbjct: 29  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHE 86
Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
            +V+ +  +     ++ ++ME+++ G L  ++  +   +E ++A +   +L+ LS LH  
Sbjct: 87  NVVEMYNSYLV-GDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQ 144
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
            +IHRDIK  ++L+ ++  +VK++DFG    + + +      VGT  +M+PE        
Sbjct: 145 GVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS----- 198
Query: 230 XXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPD--GASPE 287
                   DIWS          G  P+    + P  A  M  I    PP L +    SP 
Sbjct: 199 RLPYGPEVDIWSLGIMVIEMVDGEPPYF--NEPPLKA--MKMIRDNLPPRLKNLHKVSPS 254
Query: 288 FRSFIECCLQKEFSKRWTASQLLTHPFLCK 317
            + F++  L ++ ++R TA++LL HPFL K
Sbjct: 255 LKGFLDRLLVRDPAQRATAAELLKHPFLAK 284

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 123/268 (45%), Gaps = 18/268 (6%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFR-EMEILRRTDSPFIVQC 114
           ++VLG G    V+ V+ R T K++ALK +     P  R      E+ +L++     IV  
Sbjct: 14  MEVLGSGAFSEVFLVKQRLTGKLFALKCI--KKSPAFRDSSLENEIAVLKKIKHENIVTL 71
Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
             I+E  +    ++M+ +  G L   + + G ++E   + +  Q+L  + YLH + I+HR
Sbjct: 72  EDIYESTT-HYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHR 130
Query: 175 DIKPSNL--LVNNNNMQVKIADFGVSKIMCRSL--DACNSYVGTCAYMSPERFDPDXXXX 230
           D+KP NL  L    N ++ I DFG+SK+    +   AC    GT  Y++PE         
Sbjct: 131 DLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC----GTPGYVAPEVL-----AQ 181
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                  D WS          G+ PF +  +   +  +       + P   D  S   + 
Sbjct: 182 KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESP-FWDDISESAKD 240
Query: 291 FIECCLQKEFSKRWTASQLLTHPFLCKN 318
           FI   L+K+ ++R+T  + L+HP++  N
Sbjct: 241 FICHLLEKDPNERYTCEKALSHPWIDGN 268

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 119/267 (44%), Gaps = 10/267 (3%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGI 117
           VLG G    V   + + T K+ A+K +  +A       +  E+ +L +   P IV    I
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 118 FEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIK 177
           +E   G + ++M+ +  G L   + + G ++E   + +  Q+L  + YLH   I+HRD+K
Sbjct: 85  YE-SGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLK 143
Query: 178 PSNLLVN--NNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXXX 235
           P NLL    + + ++ I+DFG+SK M       ++  GT  Y++PE              
Sbjct: 144 PENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTACGTPGYVAPEVL-----AQKPYSK 197
Query: 236 XXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECC 295
             D WS          G+ PF        +  ++ A    D P   D  S   + FI   
Sbjct: 198 AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW-DDISDSAKDFIRHL 256
Query: 296 LQKEFSKRWTASQLLTHPFLCKNRRSD 322
           ++K+  KR+T  Q L HP++  +   D
Sbjct: 257 MEKDPEKRFTCEQALQHPWIAGDTALD 283

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 130/270 (48%), Gaps = 17/270 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQV-FREMEILRRTDSP 109
           S L+    +G G+ G V     R + K+ A+K +  D     RR++ F E+ I+R     
Sbjct: 74  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHE 131
Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
            +V+ +  +     ++ ++ME+++ G L  ++      +E ++A +   +L+ LS LH  
Sbjct: 132 NVVEMYNSYLV-GDELWVVMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQ 189
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
            +IHRDIK  ++L+ ++  +VK++DFG    + + +      VGT  +M+PE        
Sbjct: 190 GVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS----- 243
Query: 230 XXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPD--GASPE 287
                   DIWS          G  P+    + P  A  M  I    PP L +    SP 
Sbjct: 244 RLPYGPEVDIWSLGIMVIEMVDGEPPYFN--EPPLKA--MKMIRDNLPPRLKNLHKVSPS 299
Query: 288 FRSFIECCLQKEFSKRWTASQLLTHPFLCK 317
            + F++  L ++ ++R TA++LL HPFL K
Sbjct: 300 LKGFLDRLLVRDPAQRATAAELLKHPFLAK 329

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 131/270 (48%), Gaps = 17/270 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQV-FREMEILRRTDSP 109
           S L+    +G G+ G V     R + K+ A+K +  D     RR++ F E+ I+R     
Sbjct: 31  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHE 88
Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
            +V+ +  +     ++ ++ME+++ G L  ++  +   +E ++A +   +L+ LS LH  
Sbjct: 89  NVVEMYNSYLV-GDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQ 146
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
            +IHRDIK  ++L+ ++  +VK++DFG    + + +      VGT  +M+PE        
Sbjct: 147 GVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS----- 200
Query: 230 XXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPD--GASPE 287
                   DIWS          G  P+    + P  A  M  I    PP L +    SP 
Sbjct: 201 RLPYGPEVDIWSLGIMVIEMVDGEPPYF--NEPPLKA--MKMIRDNLPPRLKNLHKVSPS 256
Query: 288 FRSFIECCLQKEFSKRWTASQLLTHPFLCK 317
            + F++  L ++ ++R TA++LL HPFL K
Sbjct: 257 LKGFLDRLLVRDPAQRATAAELLKHPFLAK 286

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 123/279 (44%), Gaps = 18/279 (6%)
Query: 49  AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRT 106
           A  D E  + LG G  G VY  + + +  I ALKV+         V  Q+ RE+EI    
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
             P I++ +G F   +  + +++EY   G +   L K   F E + A   +++   LSY 
Sbjct: 71  RHPNILRLYGYFHDAT-RVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYC 129
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPD 226
           H  ++IHRDIKP NLL+ +   ++KIADFG S     S        GT  Y+ PE  +  
Sbjct: 130 HSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSSRRX--XLXGTLDYLPPEMIE-- 184
Query: 227 XXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP 286
                      D+WS          G  PF +     +    +  + F  P  + +GA  
Sbjct: 185 ---GRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGA-- 238
Query: 287 EFRSFIECCLQKEFSKRWTASQLLTHPFLCKN--RRSDC 323
             R  I   L+   S+R    ++L HP++  N  + S+C
Sbjct: 239 --RDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 275

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 131/270 (48%), Gaps = 17/270 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQV-FREMEILRRTDSP 109
           S L+    +G G+ G V     R + K+ A+K +  D     RR++ F E+ I+R     
Sbjct: 24  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHE 81
Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
            +V+ +  +     ++ ++ME+++ G L  ++  +   +E ++A +   +L+ LS LH  
Sbjct: 82  NVVEMYNSYLV-GDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQ 139
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
            +IHRDIK  ++L+ ++  +VK++DFG    + + +      VGT  +M+PE        
Sbjct: 140 GVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS----- 193
Query: 230 XXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPD--GASPE 287
                   DIWS          G  P+    + P  A  M  I    PP L +    SP 
Sbjct: 194 RLPYGPEVDIWSLGIMVIEMVDGEPPYFN--EPPLKA--MKMIRDNLPPRLKNLHKVSPS 249
Query: 288 FRSFIECCLQKEFSKRWTASQLLTHPFLCK 317
            + F++  L ++ ++R TA++LL HPFL K
Sbjct: 250 LKGFLDRLLVRDPAQRATAAELLKHPFLAK 279

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 12/222 (5%)
Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR--QVFREMEILRRTDSP 109
           D + L+ LG G+ G V+ ++ R   + YA+KV+  +    +++      E  +L     P
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 66
Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           FI++ +G F+  +  I ++M+Y++ G L +LL K+  F  P     A+++   L YLH  
Sbjct: 67  FIIRMWGTFQD-AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 125
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
            II+RD+KP N+L++ N   +KI DFG +K +    D      GT  Y++PE        
Sbjct: 126 DIIYRDLKPENILLDKNG-HIKITDFGFAKYVP---DVTYXLCGTPDYIAPE-----VVS 176
Query: 230 XXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCA 271
                   D WS          G+ PF        +  ++ A
Sbjct: 177 TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA 218

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 125/270 (46%), Gaps = 15/270 (5%)
Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSP 109
           D +   +LG G+   VY+ +   T    A+K++   A     + ++V  E++I  +   P
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQILKGLSYLHG 168
            I++ +  FE  S  + +++E   +G ++  L N+   FSE +  H   QI+ G+ YLH 
Sbjct: 72  SILELYNYFED-SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXX 228
           H I+HRD+  SNLL+   NM +KIADFG++  +    +   +  GT  Y+SPE       
Sbjct: 131 HGILHRDLTLSNLLL-TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPE-----IA 184
Query: 229 XXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEF 288
                    D+WS          G  PF     +     ++ A        +P   S E 
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA-----DYEMPSFLSIEA 239
Query: 289 RSFIECCLQKEFSKRWTASQLLTHPFLCKN 318
           +  I   L++  + R + S +L HPF+ +N
Sbjct: 240 KDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 119/259 (45%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            E+++ LG G+ G V  V+H  T   YA+K++  D    V+         E  IL+  + 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY   G + + L + G FSEP     A+QI+    YLH 
Sbjct: 101 PFLVKLEFSF-KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NL+++     +K+ DFG++K +  R+   C    GT  Y++PE      
Sbjct: 160 LDLIYRDLKPENLMIDQQGY-IKVTDFGLAKRVKGRTWXLC----GTPEYLAPE-----I 209
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 262
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 263 SDLKDLLRNLLQVDLTKRF 281

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 131/270 (48%), Gaps = 17/270 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQV-FREMEILRRTDSP 109
           S L+    +G G+ G V     R + K+ A+K +  D     RR++ F E+ I+R     
Sbjct: 20  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHE 77
Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
            +V+ +  +     ++ ++ME+++ G L  ++  +   +E ++A +   +L+ LS LH  
Sbjct: 78  NVVEMYNSYLV-GDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQ 135
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
            +IHRDIK  ++L+ ++  +VK++DFG    + + +      VGT  +M+PE        
Sbjct: 136 GVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS----- 189
Query: 230 XXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPD--GASPE 287
                   DIWS          G  P+    + P  A  M  I    PP L +    SP 
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDGEPPYFN--EPPLKA--MKMIRDNLPPRLKNLHKVSPS 245
Query: 288 FRSFIECCLQKEFSKRWTASQLLTHPFLCK 317
            + F++  L ++ ++R TA++LL HPFL K
Sbjct: 246 LKGFLDRLLVRDPAQRATAAELLKHPFLAK 275

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 119/259 (45%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            E+++ LG G+ G V  V+H  T   YA+K++  D    V+         E  IL+  + 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G FSEP     A+QI+    YLH 
Sbjct: 101 PFLVKLEFSF-KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NLL++     +++ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 160 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWXLC----GTPEYLAPE-----I 209
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 262
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 263 SDLKDLLRNLLQVDLTKRF 281

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 119/259 (45%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            E+++ LG G+ G V  V+H  T   YA+K++  D    V+         E  IL+  + 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G FSEP     A+QI+    YLH 
Sbjct: 102 PFLVKLEFSF-KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NLL++     +++ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 161 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWTLC----GTPEYLAPE-----I 210
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 263
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 264 SDLKDLLRNLLQVDLTKRF 282

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 122/278 (43%), Gaps = 23/278 (8%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD---ADPTVRRQVFREMEILR 104
           +  +D + L++LG G  G V  V+ + T + YA+K++  +   A   V   V  E  +L+
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV-TESRVLQ 60
Query: 105 RTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLS 164
            T  PF+      F+     +  +MEY + G L   L++   F+E +     ++I+  L 
Sbjct: 61  NTRHPFLTALKYAFQ-THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119
Query: 165 YLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD 224
           YLH   +++RDIK  NL+++ +   +KI DFG+ K           + GT  Y++PE  +
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLE 178
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFL-QPGQRPDWATLMCAICFGDPPSLPDG 283
            +           D W           G  PF  Q  +R     LM  I F      P  
Sbjct: 179 DN-----DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF------PRT 227
Query: 284 ASPEFRSFIECCLQKEFSKRW-----TASQLLTHPFLC 316
            SPE +S +   L+K+  +R       A +++ H F  
Sbjct: 228 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 122/278 (43%), Gaps = 23/278 (8%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD---ADPTVRRQVFREMEILR 104
           +  +D + L++LG G  G V  V+ + T + YA+K++  +   A   V   V  E  +L+
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV-TESRVLQ 60
Query: 105 RTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLS 164
            T  PF+      F+     +  +MEY + G L   L++   F+E +     ++I+  L 
Sbjct: 61  NTRHPFLTALKYAFQ-THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119
Query: 165 YLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD 224
           YLH   +++RDIK  NL+++ +   +KI DFG+ K           + GT  Y++PE  +
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLE 178
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFL-QPGQRPDWATLMCAICFGDPPSLPDG 283
            +           D W           G  PF  Q  +R     LM  I F      P  
Sbjct: 179 DN-----DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF------PRT 227
Query: 284 ASPEFRSFIECCLQKEFSKRW-----TASQLLTHPFLC 316
            SPE +S +   L+K+  +R       A +++ H F  
Sbjct: 228 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 119/259 (45%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            E+++ LG G+ G V  V+H  T   YA+K++  D    V+         E  IL+  + 
Sbjct: 29  FERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G FSEP     A+QI+    YLH 
Sbjct: 87  PFLVKLEFSF-KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 145
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NLL++     +++ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 146 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWTLC----GTPEYLAPE-----I 195
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 196 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 248
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 249 SDLKDLLRNLLQVDLTKRF 267

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 122/278 (43%), Gaps = 23/278 (8%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD---ADPTVRRQVFREMEILR 104
           +  +D + L++LG G  G V  V+ + T + YA+K++  +   A   V   V  E  +L+
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV-TESRVLQ 60
Query: 105 RTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLS 164
            T  PF+      F+     +  +MEY + G L   L++   F+E +     ++I+  L 
Sbjct: 61  NTRHPFLTALKYAFQ-THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119
Query: 165 YLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD 224
           YLH   +++RDIK  NL+++ +   +KI DFG+ K           + GT  Y++PE  +
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLE 178
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFL-QPGQRPDWATLMCAICFGDPPSLPDG 283
            +           D W           G  PF  Q  +R     LM  I F      P  
Sbjct: 179 DN-----DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF------PRT 227
Query: 284 ASPEFRSFIECCLQKEFSKRW-----TASQLLTHPFLC 316
            SPE +S +   L+K+  +R       A +++ H F  
Sbjct: 228 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 120/259 (46%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            E+++ LG G+ G V  V+H+ T   +A+K++  D    V+         E  IL+  + 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G FSEP     A+QI+    YLH 
Sbjct: 101 PFLVKLEYSF-KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NLL++     +++ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 160 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWXLC----GTPEYLAPE-----I 209
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 262
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 263 SDLKDLLRNLLQVDLTKRF 281

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 119/259 (45%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            E+++ LG G+ G V  V+H  T   YA+K++  D    V+         E  IL+  + 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G FSEP     A+QI+    YLH 
Sbjct: 102 PFLVKLEFSF-KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NLL++     +++ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 161 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWXLC----GTPEYLAPE-----I 210
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 263
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 264 SDLKDLLRNLLQVDLTKRF 282

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 119/259 (45%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            E+++ LG G+ G V  V+H  T   YA+K++  D    V+         E  IL+  + 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G FSEP     A+QI+    YLH 
Sbjct: 101 PFLVKLEFSF-KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NLL++     +++ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 160 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWXLC----GTPEYLAPE-----I 209
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 262
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 263 SDLKDLLRNLLQVDLTKRF 281

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 119/259 (45%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            E+++ LG G+ G V  V+H  T   YA+K++  D    V+         E  IL+  + 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G FSEP     A+QI+    YLH 
Sbjct: 101 PFLVKLEFSF-KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NLL++     +++ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 160 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWXLC----GTPEYLAPE-----I 209
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 262
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 263 SDLKDLLRNLLQVDLTKRF 281

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 119/259 (45%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            E+++ LG G+ G V  V+H  T   YA+K++  D    V+         E  IL+  + 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G FSEP     A+QI+    YLH 
Sbjct: 101 PFLVKLEFSF-KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NLL++     +++ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 160 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWXLC----GTPEYLAPE-----I 209
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 262
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 263 SDLKDLLRNLLQVDLTKRF 281

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 119/259 (45%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            E+++ LG G+ G V  V+H+ T   YA+K++  D    V+         E  IL+  + 
Sbjct: 36  FERIKTLGTGSFGRVMLVKHKETGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G F EP     A+QI+    YLH 
Sbjct: 94  PFLVKLEFSF-KDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 152
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NLL++     +++ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 153 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWXLC----GTPEYLAPE-----I 202
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 203 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 255
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 256 SDLKDLLRNLLQVDLTKRF 274

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 122/278 (43%), Gaps = 23/278 (8%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD---ADPTVRRQVFREMEILR 104
           +  +D + L++LG G  G V  V+ + T + YA+K++  +   A   V   V  E  +L+
Sbjct: 7   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV-TESRVLQ 65
Query: 105 RTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLS 164
            T  PF+      F+     +  +MEY + G L   L++   F+E +     ++I+  L 
Sbjct: 66  NTRHPFLTALKYAFQ-THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 124
Query: 165 YLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD 224
           YLH   +++RDIK  NL+++ +   +KI DFG+ K           + GT  Y++PE  +
Sbjct: 125 YLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLE 183
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFL-QPGQRPDWATLMCAICFGDPPSLPDG 283
            +           D W           G  PF  Q  +R     LM  I F      P  
Sbjct: 184 DN-----DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF------PRT 232
Query: 284 ASPEFRSFIECCLQKEFSKRW-----TASQLLTHPFLC 316
            SPE +S +   L+K+  +R       A +++ H F  
Sbjct: 233 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 270

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 120/259 (46%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            E+++ LG G+ G V  V+H+ T   +A+K++  D    V+         E  IL+  + 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G FSEP     A+QI+    YLH 
Sbjct: 101 PFLVKLEYSF-KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NLL++     +++ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 160 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWXLC----GTPEYLAPE-----I 209
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 262
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 263 SDLKDLLRNLLQVDLTKRF 281

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 120/259 (46%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            E+++ LG G+ G V  V+H+ T   +A+K++  D    V+         E  IL+  + 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G FSEP     A+QI+    YLH 
Sbjct: 101 PFLVKLEYSF-KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NLL++     +++ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 160 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWXLC----GTPEYLAPE-----I 209
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 262
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 263 SDLKDLLRNLLQVDLTKRF 281

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 121/265 (45%), Gaps = 20/265 (7%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIF 118
           LG G  G V+ V+ R +     +K ++ D       Q+  E+E+L+  D P I++ F +F
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 119 EKPSGDIAILMEYMDSGTLDTLL----NKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
           E    ++ I+ME  + G L   +     +    SE  +A +  Q++  L+Y H   ++H+
Sbjct: 90  ED-YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHK 148
Query: 175 DIKPSNLLVNNNNMQ--VKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXX 232
           D+KP N+L  + +    +KI DFG++++  +S +   +  GT  YM+PE F  D      
Sbjct: 149 DLKPENILFQDTSPHSPIKIIDFGLAELF-KSDEHSTNAAGTALYMAPEVFKRD------ 201
Query: 233 XXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPD--GASPEFRS 290
                DIWS          G  PF           +     + +P    +    +P+   
Sbjct: 202 VTFKCDIWSAGVVMYFLLTGCLPFTGTS----LEEVQQKATYKEPNYAVECRPLTPQAVD 257
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
            ++  L K+  +R +A+Q+L H + 
Sbjct: 258 LLKQMLTKDPERRPSAAQVLHHEWF 282

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 131/270 (48%), Gaps = 17/270 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQV-FREMEILRRTDSP 109
           S L+    +G G+ G V     R + K+ A+K +  D     RR++ F E+ I+R     
Sbjct: 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHE 208
Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
            +V+ +  +     ++ ++ME+++ G L  ++  +   +E ++A +   +L+ LS LH  
Sbjct: 209 NVVEMYNSYLV-GDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQ 266
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
            +IHRDIK  ++L+ ++  +VK++DFG    + + +      VGT  +M+PE        
Sbjct: 267 GVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS----- 320
Query: 230 XXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPD--GASPE 287
                   DIWS          G  P+    + P  A  M  I    PP L +    SP 
Sbjct: 321 RLPYGPEVDIWSLGIMVIEMVDGEPPYF--NEPPLKA--MKMIRDNLPPRLKNLHKVSPS 376
Query: 288 FRSFIECCLQKEFSKRWTASQLLTHPFLCK 317
            + F++  L ++ ++R TA++LL HPFL K
Sbjct: 377 LKGFLDRLLVRDPAQRATAAELLKHPFLAK 406

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 118/277 (42%), Gaps = 29/277 (10%)
Query: 53  LEKLQVLGHGNGGTVY---KVQHRCTHKIYALKVVHG-----DADPTVRRQVFREMEILR 104
            E L+VLG G  G V+   KV    T KI+A+KV+       +A  T   +   E  IL 
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA--ERNILE 76
Query: 105 RTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLS 164
               PFIV     F+   G + +++EY+  G L   L + G F E       ++I   L 
Sbjct: 77  EVKHPFIVDLIYAFQT-GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG 135
Query: 165 YLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD 224
           +LH   II+RD+KP N+++N+    VK+ DFG+ K         +++ GT  YM+PE   
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQG-HVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPE--- 191
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDW-ATLMCAICFGDPPSLPDG 283
                        D WS          G  PF    ++      L C +      +LP  
Sbjct: 192 --ILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL------NLPPY 243
Query: 284 ASPEFRSFIECCLQKEFSKRW-----TASQLLTHPFL 315
            + E R  ++  L++  + R       A ++  HPF 
Sbjct: 244 LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 118/259 (45%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            E+++ LG G+ G V  V+H  T   YA+K++  D    V+         E  IL+  + 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY   G + + L + G FSEP     A+QI+    YLH 
Sbjct: 101 PFLVKLEFSF-KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NL+++     +K+ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 160 LDLIYRDLKPENLMIDQQGY-IKVTDFGFAKRVKGRTWXLC----GTPEYLAPE-----I 209
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 262
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 263 SDLKDLLRNLLQVDLTKRF 281

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 82/271 (30%), Positives = 121/271 (44%), Gaps = 16/271 (5%)
Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSP 109
           D E  + LG G  G VY  + + +H I ALKV+         V  Q+ RE+EI      P
Sbjct: 24  DFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHP 83
Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
            I++ +  F      I +++EY   G L   L K+ TF E + A I  ++   L Y HG 
Sbjct: 84  NILRLYNYFYD-RRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGK 142
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
           K+IHRDIKP N L+     ++KIADFG S +   SL    +  GT  Y+ PE  +     
Sbjct: 143 KVIHRDIKPEN-LLLGLKGELKIADFGWS-VHAPSLRR-KTMCGTLDYLPPEMIE----- 194
Query: 230 XXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFR 289
                   D+W           G+ PF        +  ++  +    P S+P GA    +
Sbjct: 195 GRMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIV-KVDLKFPASVPTGA----Q 249
Query: 290 SFIECCLQKEFSKRWTASQLLTHPFLCKNRR 320
             I   L+   S+R   +Q+  HP++  N R
Sbjct: 250 DLISKLLRHNPSERLPLAQVSAHPWVRANSR 280

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 119/259 (45%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            E+++ LG G+ G V  V+H+ T   YA+K++  D    V+         E  I +  + 
Sbjct: 44  FERIRTLGTGSFGRVMLVKHKETGNHYAMKIL--DKQKVVKLKQIEHTLNEKRIQQAVNF 101
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ +++EY   G + + L + G FSEP     A+QI+    YLH 
Sbjct: 102 PFLVKLEFSF-KDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NLL++     +K+ADFG +K +  R+   C    GT  Y++PE      
Sbjct: 161 LDLIYRDLKPENLLIDQQGY-IKVADFGFAKRVKGRTWXLC----GTPEYLAPE-----I 210
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 263
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 264 SDLKDLLRNLLQVDLTKRF 282

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 118/267 (44%), Gaps = 10/267 (3%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGI 117
           VLG G    V   + + T K+ A+K +   A       +  E+ +L +   P IV    I
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 118 FEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIK 177
           +E   G + ++M+ +  G L   + + G ++E   + +  Q+L  + YLH   I+HRD+K
Sbjct: 85  YES-GGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLK 143
Query: 178 PSNLLVN--NNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXXX 235
           P NLL    + + ++ I+DFG+SK M       ++  GT  Y++PE              
Sbjct: 144 PENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTACGTPGYVAPEVL-----AQKPYSK 197
Query: 236 XXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECC 295
             D WS          G+ PF        +  ++ A    D P   D  S   + FI   
Sbjct: 198 AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDD-ISDSAKDFIRHL 256
Query: 296 LQKEFSKRWTASQLLTHPFLCKNRRSD 322
           ++K+  KR+T  Q L HP++  +   D
Sbjct: 257 MEKDPEKRFTCEQALQHPWIAGDTALD 283

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 119/271 (43%), Gaps = 14/271 (5%)
Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVF-REMEILRRTDSPF 110
           D +  + LG G    V +   +   + YA K+++         Q   RE  I R    P 
Sbjct: 32  DYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPN 91
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           IV+      +  G   ++ + +  G L   +     +SE   +H   QIL+ ++++H H 
Sbjct: 92  IVRLHDSISE-EGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQHD 150
Query: 171 IIHRDIKPSNLLVNN--NNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE--RFDPD 226
           I+HRD+KP NLL+ +      VK+ADFG++  +     A   + GT  Y+SPE  R DP 
Sbjct: 151 IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDP- 209
Query: 227 XXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP 286
                      DIW+          G+ PF    Q   +  +  A  +  P    D  +P
Sbjct: 210 ------YGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIK-AGAYDFPSPEWDTVTP 262
Query: 287 EFRSFIECCLQKEFSKRWTASQLLTHPFLCK 317
           E ++ I   L    +KR TA Q L HP++C+
Sbjct: 263 EAKNLINQMLTINPAKRITADQALKHPWVCQ 293

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 119/270 (44%), Gaps = 26/270 (9%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFRE-----MEILRRTDSPFIVQ 113
           LG G    V K + + T   YA K +      + RR V RE     + IL+    P ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
              ++E  + D+ +++E +  G L   L +  + +E +      QIL G+ YLH  +I H
Sbjct: 79  LHEVYENKT-DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137
Query: 174 RDIKPSNLLVNNNNM---QVKIADFGVSKIMCRSLDACNSY---VGTCAYMSPE--RFDP 225
            D+KP N+++ + N+   ++KI DFG    +   +D  N +    GT A+++PE   ++P
Sbjct: 138 FDLKPENIMLLDRNVPKPRIKIIDFG----LAHKIDFGNEFKNIFGTPAFVAPEIVNYEP 193
Query: 226 DXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS 285
                       D+WS          G  PFL   ++   A  + A+ +          S
Sbjct: 194 -------LGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-VSAVNYEFEDEYFSNTS 245
Query: 286 PEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
              + FI   L K+  KR T    L HP++
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 120/259 (46%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            ++++ LG G+ G V  V+H+ +   YA+K++  D    V+         E  IL+  + 
Sbjct: 44  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G FSEP     A+QI+    YLH 
Sbjct: 102 PFLVKLEFSF-KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NLL++     +++ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 161 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWXLC----GTPEYLAPE-----I 210
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 263
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 264 SDLKDLLRNLLQVDLTKRF 282

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 120/259 (46%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            ++++ LG G+ G V  V+H+ +   YA+K++  D    V+         E  IL+  + 
Sbjct: 30  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G FSEP     A+QI+    YLH 
Sbjct: 88  PFLVKLEFSF-KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 146
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NLL++     +++ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 147 LDLIYRDLKPENLLIDEQGY-IQVTDFGFAKRVKGRTWXLC----GTPEYLAPE-----I 196
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 197 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 249
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 250 SDLKDLLRNLLQVDLTKRF 268

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 117/277 (42%), Gaps = 29/277 (10%)
Query: 53  LEKLQVLGHGNGGTVY---KVQHRCTHKIYALKVVHG-----DADPTVRRQVFREMEILR 104
            E L+VLG G  G V+   KV    T KI+A+KV+       +A  T   +   E  IL 
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA--ERNILE 76
Query: 105 RTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLS 164
               PFIV     F+   G + +++EY+  G L   L + G F E       ++I   L 
Sbjct: 77  EVKHPFIVDLIYAFQT-GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG 135
Query: 165 YLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD 224
           +LH   II+RD+KP N+++N+    VK+ DFG+ K         + + GT  YM+PE   
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQG-HVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPE--- 191
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDW-ATLMCAICFGDPPSLPDG 283
                        D WS          G  PF    ++      L C +      +LP  
Sbjct: 192 --ILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL------NLPPY 243
Query: 284 ASPEFRSFIECCLQKEFSKRW-----TASQLLTHPFL 315
            + E R  ++  L++  + R       A ++  HPF 
Sbjct: 244 LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 119/259 (45%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            E+++ LG G+ G V  V+H  T   YA+K++  D    V+         E  IL+  + 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY   G + + L + G FSEP     A+QI+    YLH 
Sbjct: 101 PFLVKLEFSF-KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NL+++     +++ DFG++K +  R+   C    GT  Y++PE      
Sbjct: 160 LDLIYRDLKPENLMIDQQGY-IQVTDFGLAKRVKGRTWXLC----GTPEYLAPE-----I 209
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 262
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 263 SDLKDLLRNLLQVDLTKRF 281

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 120/259 (46%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            ++++ LG G+ G V  V+H+ +   YA+K++  D    V+         E  IL+  + 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G FSEP     A+QI+    YLH 
Sbjct: 101 PFLVKLEFSF-KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NLL++     +++ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 160 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWXLC----GTPEYLAPE-----I 209
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 210 ILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 262
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 263 SDLKDLLRNLLQVDLTKRF 281

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 120/259 (46%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            ++++ LG G+ G V  V+H+ +   YA+K++  D    V+         E  IL+  + 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G FSEP     A+QI+    YLH 
Sbjct: 101 PFLVKLEFSF-KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NLL++     +++ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 160 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWXLC----GTPEYLAPE-----I 209
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 262
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 263 SDLKDLLRNLLQVDLTKRF 281

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 120/259 (46%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            ++++ LG G+ G V  V+H+ +   YA+K++  D    V+         E  IL+  + 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G FSEP     A+QI+    YLH 
Sbjct: 101 PFLVKLEFSF-KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NLL++     +++ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 160 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWXLC----GTPEYLAPE-----I 209
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 262
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 263 SDLKDLLRNLLQVDLTKRF 281

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 120/259 (46%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            ++++ LG G+ G V  V+H+ +   YA+K++  D    V+         E  IL+  + 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G FSEP     A+QI+    YLH 
Sbjct: 101 PFLVKLEFSF-KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NLL++     +++ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 160 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWXLC----GTPEYLAPE-----I 209
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 262
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 263 SDLKDLLRNLLQVDLTKRF 281

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 90.9 bits (224), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 107/233 (45%), Gaps = 24/233 (10%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFEKPSGD-IAILMEYMDSGTLDTLLNKNGTFSEPKL 152
            QV++E+ IL++ D P +V+   + + P+ D + ++ E ++ G +  +       SE + 
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK-PLSEDQA 139
Query: 153 AHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYV 212
                 ++KG+ YLH  KIIHRDIKPSNLLV  +   +KIADFGVS     S    ++ V
Sbjct: 140 RFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDG-HIKIADFGVSNEFKGSDALLSNTV 198
Query: 213 GTCAYMSPERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMC-- 270
           GT A+M+PE                D+W+          G  PF+          +MC  
Sbjct: 199 GTPAFMAPESL--SETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-------ERIMCLH 249
Query: 271 ------AICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK 317
                 A+ F D P + +    + +  I   L K    R    ++  HP++ +
Sbjct: 250 SKIKSQALEFPDQPDIAE----DLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 118/259 (45%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            ++++ LG G+ G V  V+H+ +   YA+K++  D    V+         E  IL+  + 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G FSEP     A+QI+    YLH 
Sbjct: 101 PFLVKLEFSF-KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NLL++     +++ DFG +K +  R+   C          +PE   P+ 
Sbjct: 160 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWXLCG---------TPEALAPEI 209
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 262
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 263 SDLKDLLRNLLQVDLTKRF 281

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 123/260 (47%), Gaps = 17/260 (6%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQV-FREMEILRRTDSPFIVQCFGI 117
           +G G+ G V     + T K  A+K +  D     RR++ F E+ I+R      +V  +  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIMRDYHHDNVVDMYSS 110
Query: 118 FEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIK 177
           +     ++ ++ME+++ G L  ++      +E ++A +   +L+ LSYLH   +IHRDIK
Sbjct: 111 Y-LVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 168
Query: 178 PSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXXXXX 237
             ++L+ ++  ++K++DFG    + + +      VGT  +M+PE                
Sbjct: 169 SDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVIS-----RLPYGTEV 222
Query: 238 DIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPD--GASPEFRSFIECC 295
           DIWS          G  P+    + P  A  M  I    PP + D    S   R F++  
Sbjct: 223 DIWSLGIMVIEMIDGEPPYFN--EPPLQA--MRRIRDSLPPRVKDLHKVSSVLRGFLDLM 278
Query: 296 LQKEFSKRWTASQLLTHPFL 315
           L +E S+R TA +LL HPFL
Sbjct: 279 LVREPSQRATAQELLGHPFL 298

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 119/258 (46%), Gaps = 25/258 (9%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            ++++ LG G+ G V  V+H+ +   YA+K++  D    V+         E  IL+  + 
Sbjct: 64  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G FSEP     A+QI+    YLH 
Sbjct: 122 PFLVKLEFSF-KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 180
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXX 228
             +I+RD+KP NLL++     +++ DFG +K   R   A  +  GT  Y++PE       
Sbjct: 181 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAK---RVKGATWTLCGTPEYLAPE-----II 231
Query: 229 XXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGASP 286
                    D W+          G+ PF   QP Q      +   I  G     P   S 
Sbjct: 232 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFSS 284
Query: 287 EFRSFIECCLQKEFSKRW 304
           + +  +   LQ + +KR+
Sbjct: 285 DLKDLLRNLLQVDLTKRF 302

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 118/259 (45%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            E+++ LG G+ G V  V+H  T   YA+K++  D    V+         E  IL+  + 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY   G + + L + G FSEP     A+QI+    YLH 
Sbjct: 101 PFLVKLEFSF-KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NL+++     +++ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 160 LDLIYRDLKPENLMIDQQGY-IQVTDFGFAKRVKGRTWXLC----GTPEYLAPE-----I 209
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 262
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 263 SDLKDLLRNLLQVDLTKRF 281

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 95/178 (53%), Gaps = 5/178 (2%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRR 105
           + +   E L+ +G G+ G V  VQ   T K+YA+K ++     +    R VF+E++I++ 
Sbjct: 12  VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQG 71
Query: 106 TDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
            + PF+V  +  F+    D+ ++++ +  G L   L +N  F E  +     +++  L Y
Sbjct: 72  LEHPFLVNLWYSFQDEE-DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDY 130
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF 223
           L   +IIHRD+KP N+L++ +   V I DF ++ ++ R      +  GT  YM+PE F
Sbjct: 131 LQNQRIIHRDMKPDNILLDEHG-HVHITDFNIAAMLPRET-QITTMAGTKPYMAPEMF 186

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 118/259 (45%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            E+++ LG G+ G V  V+H  T   YA+K++  D    V+         E  IL+  + 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G F EP     A+QI+    YLH 
Sbjct: 102 PFLVKLEFSF-KDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 160
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NLL++     +++ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 161 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWXLC----GTPEYLAPE-----I 210
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 263
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 264 SDLKDLLRNLLQVDLTKRF 282

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 118/259 (45%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            E+++ LG G+ G V  V+H  T   YA+K++  D    V+         E  IL+  + 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G F EP     A+QI+    YLH 
Sbjct: 101 PFLVKLEFSF-KDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NLL++     +++ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 160 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWXLC----GTPEYLAPE-----I 209
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 262
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 263 SDLKDLLRNLLQVDLTKRF 281

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 118/259 (45%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            E+++ LG G+ G V  V+H  T   YA+K++  D    V+         E  IL+  + 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G F EP     A+QI+    YLH 
Sbjct: 101 PFLVKLEFSF-KDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NLL++     +++ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 160 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWXLC----GTPEYLAPE-----I 209
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 262
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 263 SDLKDLLRNLLQVDLTKRF 281

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 117/259 (45%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            E+++ LG G+ G V  V+H  T   YA+K++  D    V+         E  IL+  + 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+ +    F K + ++ ++MEY   G + + L + G FSEP     A+QI+    YLH 
Sbjct: 102 PFLTKLEFSF-KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NL+++     +K+ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 161 LDLIYRDLKPENLMIDQQGY-IKVTDFGFAKRVKGRTWXLC----GTPEYLAPE-----I 210
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 263
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 264 SDLKDLLRNLLQVDLTKRF 282

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 117/259 (45%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            E+++ LG G+ G V  V+H  T   YA+K++  D    V+         E  IL+  + 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+ +    F K + ++ ++MEY   G + + L + G FSEP     A+QI+    YLH 
Sbjct: 102 PFLTKLEFSF-KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NL+++     +K+ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 161 LDLIYRDLKPENLMIDQQGY-IKVTDFGFAKRVKGRTWXLC----GTPEYLAPE-----I 210
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 263
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 264 SDLKDLLRNLLQVDLTKRF 282

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 114/265 (43%), Gaps = 16/265 (6%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFRE-----MEILRRTDSPFIVQ 113
           LG G    V K + + T   YA K +      + RR V RE     + IL+    P ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
              ++E  + D+ +++E +  G L   L +  + +E +      QIL G+ YLH  +I H
Sbjct: 79  LHEVYENKT-DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137
Query: 174 RDIKPSNLLVNNNNM---QVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
            D+KP N+++ + N+   ++KI DFG    +   +D  N +     + +PE   P+    
Sbjct: 138 FDLKPENIMLLDRNVPKPRIKIIDFG----LAHKIDFGNEFKNI--FGTPEFVAPEIVNY 191
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                  D+WS          G  PFL   ++   A  + A+ +          S   + 
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-VSAVNYEFEDEYFSNTSALAKD 250
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
           FI   L K+  KR T    L HP++
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 117/259 (45%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            E+++ LG G+ G V  V+H  T   YA+K++  D    V+         E  IL+  + 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY   G + + L + G F EP     A+QI+    YLH 
Sbjct: 101 PFLVKLEFSF-KDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NL+++     +K+ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 160 LDLIYRDLKPENLMIDQQGY-IKVTDFGFAKRVKGRTWXLC----GTPEYLAPE-----I 209
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 262
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 263 SDLKDLLRNLLQVDLTKRF 281

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 120/259 (46%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            ++++ LG G+ G V  V+H+ +   YA+K++  D    V+         E  IL+  + 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G FSEP     A+QI+    YLH 
Sbjct: 101 PFLVKLEFSF-KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NL+++     +++ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 160 LDLIYRDLKPENLIIDQQGY-IQVTDFGFAKRVKGRTWXLC----GTPEYLAPE-----I 209
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 210 IISKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 262
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 263 SDLKDLLRNLLQVDLTKRF 281

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 124/263 (47%), Gaps = 18/263 (6%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSPFIVQC 114
           ++LG G    V+  +    H+  A+KV+  D   DP+   +  RE +     + P IV  
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 115 F--GIFEKPSGDIA-ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
           +  G  E P+G +  I+MEY+D  TL  +++  G  +  +   + +   + L++ H + I
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGI 137
Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN---SYVGTCAYMSPERFDPDXX 228
           IHRD+KP+N++++  N  VK+ DFG+++ +  S ++     + +GT  Y+SPE+   D  
Sbjct: 138 IHRDVKPANIMISATNA-VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-- 194
Query: 229 XXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLP-DGASPE 287
                    D++S          G  PF   G  PD            PPS   +G S +
Sbjct: 195 ---SVDARSDVYSLGCVLYEVLTGEPPFT--GDSPDSVAYQHVREDPIPPSARHEGLSAD 249
Query: 288 FRSFIECCLQKEFSKRW-TASQL 309
             + +   L K    R+ TA+++
Sbjct: 250 LDAVVLKALAKNPENRYQTAAEM 272

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 114/265 (43%), Gaps = 16/265 (6%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFRE-----MEILRRTDSPFIVQ 113
           LG G    V K + + T   YA K +      + RR V RE     + IL+    P ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
              ++E  + D+ +++E +  G L   L +  + +E +      QIL G+ YLH  +I H
Sbjct: 79  LHEVYENKT-DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137
Query: 174 RDIKPSNLLVNNNNM---QVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
            D+KP N+++ + N+   ++KI DFG    +   +D  N +     + +PE   P+    
Sbjct: 138 FDLKPENIMLLDRNVPKPRIKIIDFG----LAHKIDFGNEF--KNIFGTPEFVAPEIVNY 191
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                  D+WS          G  PFL   ++   A +  A+ +          S   + 
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-SAVNYEFEDEYFSNTSALAKD 250
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
           FI   L K+  KR T    L HP++
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 116/257 (45%), Gaps = 23/257 (8%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            ++++ LG G+ G V  V+H+ +   YA+K++  D    V+         E  IL+  + 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G FSEP     A+QI+    YLH 
Sbjct: 101 PFLVKLEFSF-KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NLL++     +++ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 160 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWXLC----GTPEYLAPE-----I 209
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPE 287
                     D W+          G+ PF       D    +           P   S +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFF-----ADEPIQIYEKIVSGKVRFPSHFSSD 264
Query: 288 FRSFIECCLQKEFSKRW 304
            +  +   LQ + +KR+
Sbjct: 265 LKDLLRNLLQVDLTKRF 281

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 120/259 (46%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            ++++ LG G+ G V  V+H+ +   YA+K++  D    V+         E  IL+  + 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G F+EP     A+QI+    YLH 
Sbjct: 101 PFLVKLEFSF-KDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHS 159
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NLL++     +++ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 160 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWXLC----GTPEYLAPE-----I 209
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 262
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 263 SDLKDLLRNLLQVDLTKRF 281

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 114/265 (43%), Gaps = 16/265 (6%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFRE-----MEILRRTDSPFIVQ 113
           LG G    V K + + T   YA K +      + RR V RE     + IL+    P ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
              ++E  + D+ +++E +  G L   L +  + +E +      QIL G+ YLH  +I H
Sbjct: 79  LHEVYENKT-DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137
Query: 174 RDIKPSNLLVNNNNM---QVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
            D+KP N+++ + N+   ++KI DFG    +   +D  N +     + +PE   P+    
Sbjct: 138 FDLKPENIMLLDRNVPKPRIKIIDFG----LAHKIDFGNEF--KNIFGTPEFVAPEIVNY 191
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                  D+WS          G  PFL   ++   A  + A+ +          S   + 
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-VSAVNYEFEDEYFSNTSALAKD 250
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
           FI   L K+  KR T    L HP++
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 114/265 (43%), Gaps = 16/265 (6%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFRE-----MEILRRTDSPFIVQ 113
           LG G    V K + + T   YA K +      + RR V RE     + IL+    P ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
              ++E  + D+ +++E +  G L   L +  + +E +      QIL G+ YLH  +I H
Sbjct: 79  LHEVYENKT-DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137
Query: 174 RDIKPSNLLVNNNNM---QVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
            D+KP N+++ + N+   ++KI DFG    +   +D  N +     + +PE   P+    
Sbjct: 138 FDLKPENIMLLDRNVPKPRIKIIDFG----LAHKIDFGNEF--KNIFGTPEFVAPEIVNY 191
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                  D+WS          G  PFL   ++   A  + A+ +          S   + 
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-VSAVNYEFEDEYFSNTSALAKD 250
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
           FI   L K+  KR T    L HP++
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 114/265 (43%), Gaps = 16/265 (6%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFRE-----MEILRRTDSPFIVQ 113
           LG G    V K + + T   YA K +      + RR V RE     + IL+    P ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
              ++E  + D+ +++E +  G L   L +  + +E +      QIL G+ YLH  +I H
Sbjct: 79  LHEVYENKT-DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137
Query: 174 RDIKPSNLLVNNNNM---QVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
            D+KP N+++ + N+   ++KI DFG    +   +D  N +     + +PE   P+    
Sbjct: 138 FDLKPENIMLLDRNVPKPRIKIIDFG----LAHKIDFGNEF--KNIFGTPEFVAPEIVNY 191
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                  D+WS          G  PFL   ++   A  + A+ +          S   + 
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-VSAVNYEFEDEYFSNTSALAKD 250
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
           FI   L K+  KR T    L HP++
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 91/169 (53%), Gaps = 3/169 (1%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALK-VVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           EK+  +G G+ G V+K ++R T +I A+K  +  + DP +++   RE+ +L++   P +V
Sbjct: 6   EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLV 65
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
               +F +    + ++ EY D   L  L        E  +  I  Q L+ +++ H H  I
Sbjct: 66  NLLEVFRR-KRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCI 124
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
           HRD+KP N+L+  +++ +K+ DFG ++++    D  +  V T  Y SPE
Sbjct: 125 HRDVKPENILITKHSV-IKLCDFGFARLLTGPSDYYDDEVATRWYRSPE 172

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 114/265 (43%), Gaps = 16/265 (6%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFRE-----MEILRRTDSPFIVQ 113
           LG G    V K + + T   YA K +      + RR V RE     + IL+    P ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
              ++E  + D+ +++E +  G L   L +  + +E +      QIL G+ YLH  +I H
Sbjct: 79  LHEVYENKT-DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137
Query: 174 RDIKPSNLLVNNNNM---QVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
            D+KP N+++ + N+   ++KI DFG    +   +D  N +     + +PE   P+    
Sbjct: 138 FDLKPENIMLLDRNVPKPRIKIIDFG----LAHKIDFGNEF--KNIFGTPEFVAPEIVNY 191
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                  D+WS          G  PFL   ++   A  + A+ +          S   + 
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-VSAVNYEFEDEYFSNTSALAKD 250
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
           FI   L K+  KR T    L HP++
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 114/273 (41%), Gaps = 20/273 (7%)
Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSP 109
           D + ++ LG G  G VY  + +    I ALKV+         V  Q+ RE+EI      P
Sbjct: 15  DFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 74
Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
            I++ +  F      I +++E+   G L   L K+G F E + A    ++   L Y H  
Sbjct: 75  NILRMYNYFHD-RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER 133
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFG--VSKIMCRSLDACNSYVGTCAYMSPERFDPDX 227
           K+IHRDIKP NLL+     ++KIADFG  V     R    C    GT  Y+ PE  +   
Sbjct: 134 KVIHRDIKPENLLMGYKG-ELKIADFGWSVHAPSLRRRXMC----GTLDYLPPEMIE--- 185
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPE 287
                     D+W           G  PF  P    +    +  +    PP L DG+   
Sbjct: 186 --GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH-TETHRRIVNVDLKFPPFLSDGS--- 239
Query: 288 FRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR 320
            +  I   L+    +R     ++ HP++  N R
Sbjct: 240 -KDLISKLLRYHPPQRLPLKGVMEHPWVKANSR 271

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 119/259 (45%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            ++++ LG G+ G V  V+H+ +   YA+K++  D    V+         E  IL+  + 
Sbjct: 38  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G F EP     A+QI+    YLH 
Sbjct: 96  PFLVKLEFSF-KDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 154
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NLL++     +++ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 155 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWXLC----GTPEYLAPE-----I 204
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 205 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 257
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 258 SDLKDLLRNLLQVDLTKRF 276

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 114/265 (43%), Gaps = 16/265 (6%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFRE-----MEILRRTDSPFIVQ 113
           LG G    V K + + T   YA K +      + RR V RE     + IL+    P ++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
              ++E  + D+ +++E +  G L   L +  + +E +      QIL G+ YLH  +I H
Sbjct: 78  LHEVYENKT-DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 136
Query: 174 RDIKPSNLLVNNNNM---QVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
            D+KP N+++ + N+   ++KI DFG    +   +D  N +     + +PE   P+    
Sbjct: 137 FDLKPENIMLLDRNVPKPRIKIIDFG----LAHKIDFGNEF--KNIFGTPEFVAPEIVNY 190
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                  D+WS          G  PFL   ++   A  + A+ +          S   + 
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-VSAVNYEFEDEYFSNTSALAKD 249
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
           FI   L K+  KR T    L HP++
Sbjct: 250 FIRRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 114/265 (43%), Gaps = 16/265 (6%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFRE-----MEILRRTDSPFIVQ 113
           LG G    V K + + T   YA K +      + RR V RE     + IL+    P ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
              ++E  + D+ +++E +  G L   L +  + +E +      QIL G+ YLH  +I H
Sbjct: 79  LHEVYENKT-DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137
Query: 174 RDIKPSNLLVNNNNM---QVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
            D+KP N+++ + N+   ++KI DFG    +   +D  N +     + +PE   P+    
Sbjct: 138 FDLKPENIMLLDRNVPKPRIKIIDFG----LAHKIDFGNEF--KNIFGTPEFVAPEIVNY 191
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                  D+WS          G  PFL   ++   A  + A+ +          S   + 
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-VSAVNYEFEDEYFSNTSALAKD 250
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
           FI   L K+  KR T    L HP++
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 114/265 (43%), Gaps = 16/265 (6%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFRE-----MEILRRTDSPFIVQ 113
           LG G    V K + + T   YA K +      + RR V RE     + IL+    P ++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
              ++E  + D+ +++E +  G L   L +  + +E +      QIL G+ YLH  +I H
Sbjct: 78  LHEVYENKT-DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 136
Query: 174 RDIKPSNLLVNNNNM---QVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
            D+KP N+++ + N+   ++KI DFG    +   +D  N +     + +PE   P+    
Sbjct: 137 FDLKPENIMLLDRNVPKPRIKIIDFG----LAHKIDFGNEF--KNIFGTPEFVAPEIVNY 190
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                  D+WS          G  PFL   ++   A  + A+ +          S   + 
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-VSAVNYEFEDEYFSNTSALAKD 249
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
           FI   L K+  KR T    L HP++
Sbjct: 250 FIRRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 114/265 (43%), Gaps = 16/265 (6%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFRE-----MEILRRTDSPFIVQ 113
           LG G    V K + + T   YA K +      + RR V RE     + IL+    P ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
              ++E  + D+ +++E +  G L   L +  + +E +      QIL G+ YLH  +I H
Sbjct: 79  LHEVYENKT-DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137
Query: 174 RDIKPSNLLVNNNNM---QVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
            D+KP N+++ + N+   ++KI DFG    +   +D  N +     + +PE   P+    
Sbjct: 138 FDLKPENIMLLDRNVPKPRIKIIDFG----LAHKIDFGNEF--KNIFGTPEFVAPEIVNY 191
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                  D+WS          G  PFL   ++   A  + A+ +          S   + 
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-VSAVNYEFEDEYFSNTSALAKD 250
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
           FI   L K+  KR T    L HP++
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 114/265 (43%), Gaps = 16/265 (6%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFRE-----MEILRRTDSPFIVQ 113
           LG G    V K + + T   YA K +      + RR V RE     + IL+    P ++ 
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
              ++E  + D+ +++E +  G L   L +  + +E +      QIL G+ YLH  +I H
Sbjct: 79  LHEVYENKT-DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137
Query: 174 RDIKPSNLLVNNNNM---QVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
            D+KP N+++ + N+   ++KI DFG    +   +D  N +     + +PE   P+    
Sbjct: 138 FDLKPENIMLLDRNVPKPRIKIIDFG----LAHKIDFGNEF--KNIFGTPEFVAPEIVNY 191
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                  D+WS          G  PFL   ++   A  + A+ +          S   + 
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-VSAVNYEFEDEYFSNTSALAKD 250
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
           FI   L K+  KR T    L HP++
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 55/174 (31%), Positives = 95/174 (54%), Gaps = 13/174 (7%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            ++++ LG G+ G V  V+H+ +   YA+K++  D    V+         E  IL+  + 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G FSEP     A+QI+    YLH 
Sbjct: 101 PFLVKLEFSF-KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPE 221
             +I+RD+KP NLL++     +++ DFG +K +  R+   C    GT  Y++PE
Sbjct: 160 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWXLC----GTPEYLAPE 208

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 119/259 (45%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            ++++ LG G+ G V  V+H+ +   YA+K++  D    V+         E  IL+  + 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G F EP     A+QI+    YLH 
Sbjct: 101 PFLVKLEFSF-KDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NLL++     +++ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 160 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWXLC----GTPEYLAPE-----I 209
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 262
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 263 SDLKDLLRNLLQVDLTKRF 281

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 119/259 (45%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            ++++ LG G+ G V  V+H+ +   YA+K++  D    V+         E  IL+  + 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G F EP     A+QI+    YLH 
Sbjct: 101 PFLVKLEFSF-KDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NLL++     +++ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 160 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWXLC----GTPEYLAPE-----I 209
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 262
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 263 SDLKDLLRNLLQVDLTKRF 281

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 119/259 (45%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            ++++ LG G+ G V  V+H+ +   YA+K++  D    V+         E  IL+  + 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G F EP     A+QI+    YLH 
Sbjct: 101 PFLVKLEFSF-KDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NLL++     +++ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 160 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWXLC----GTPEYLAPE-----I 209
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 262
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 263 SDLKDLLRNLLQVDLTKRF 281

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 117/259 (45%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            ++++ LG G+ G V  V+H+ +   YA+K++  D    V+         E  IL+  + 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G FSEP     A+QI+    YLH 
Sbjct: 101 PFLVKLEFSF-KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NLL++     +++ DFG +K +  R+   C          +PE   P  
Sbjct: 160 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWXLCG---------TPEYLAPAI 209
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 262
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 263 SDLKDLLRNLLQVDLTKRF 281

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 119/259 (45%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            ++++ LG G+ G V  V+H+ +   YA+K++  D    V+         E  IL+  + 
Sbjct: 64  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G F EP     A+QI+    YLH 
Sbjct: 122 PFLVKLEFSF-KDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 180
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NLL++     +++ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 181 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWXLC----GTPEYLAPE-----I 230
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 231 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 283
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 284 SDLKDLLRNLLQVDLTKRF 302

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 115/275 (41%), Gaps = 13/275 (4%)
Query: 50  YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-------PTVRRQVFREMEI 102
           Y   +   V+G G    V +  HR T   +A+K++   A+         VR    RE  I
Sbjct: 93  YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 103 LRRTDS-PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILK 161
           LR+    P I+     +E  S  + ++ + M  G L   L +    SE +   I   +L+
Sbjct: 153 LRQVAGHPHIITLIDSYES-SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLE 211
Query: 162 GLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
            +S+LH + I+HRD+KP N+L+ ++NMQ++++DFG S       +      GT  Y++PE
Sbjct: 212 AVSFLHANNIVHRDLKPENILL-DDNMQIRLSDFGFS-CHLEPGEKLRELCGTPGYLAPE 269
Query: 222 RFDPDXXXXX-XXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSL 280
                            D+W+          G  PF    Q      +M        P  
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW 329
Query: 281 PDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
            D +S   +  I   LQ +   R TA Q L HPF 
Sbjct: 330 DDRSST-VKDLISRLLQVDPEARLTAEQALQHPFF 363

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 123/265 (46%), Gaps = 24/265 (9%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVV-HGDADPTVRRQVFREMEILRRT 106
           I + DL   + +G G+ GTV++ +   +    A+K++   D       +  RE+ I++R 
Sbjct: 34  IPWCDLNIKEKIGAGSFGTVHRAEWHGSD--VAVKILMEQDFHAERVNEFLREVAIMKRL 91
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGT---FSEPKLAHIASQILKGL 163
             P IV   G   +P  +++I+ EY+  G+L  LL+K+G      E +   +A  + KG+
Sbjct: 92  RHPNIVLFMGAVTQPP-NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 150
Query: 164 SYLHGHK--IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
           +YLH     I+HR++K  NLLV+     VK+ DFG+S++   +  +  S  GT  +M+PE
Sbjct: 151 NYLHNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPE 209
Query: 222 --RFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFG-DPP 278
             R +P             +W                 QP    + A ++ A+ F     
Sbjct: 210 VLRDEPSNEKSDVYSFGVILWELAT-----------LQQPWGNLNPAQVVAAVGFKCKRL 258
Query: 279 SLPDGASPEFRSFIECCLQKEFSKR 303
            +P   +P+  + IE C   E  KR
Sbjct: 259 EIPRNLNPQVAAIIEGCWTNEPWKR 283

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 8/202 (3%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVV-HGDADPTVRRQVFREMEILRRTDSPFIVQC 114
           L+ +G GN   V   +H  T +  A+K++     +PT  +++FRE+ I++  + P IV+ 
Sbjct: 17  LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 76
Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
           F + E     + ++MEY   G +   L  +G   E +      QI+  + Y H  +I+HR
Sbjct: 77  FEVIETEK-TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHR 135
Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXX 234
           D+K  NLL+ + +M +KIADFG S          +++ G+  Y +PE F           
Sbjct: 136 DLKAENLLL-DADMNIKIADFGFSNEFTVG-GKLDTFCGSPPYAAPELFQ----GKKYDG 189
Query: 235 XXXDIWSXXXXXXXXXXGHFPF 256
              D+WS          G  PF
Sbjct: 190 PEVDVWSLGVILYTLVSGSLPF 211

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 117/258 (45%), Gaps = 25/258 (9%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            ++++ LG G+ G V  V+H+ +   YA+K++  D    V+         E  IL+  + 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G FSEP     A+QI+    YLH 
Sbjct: 101 PFLVKLEFSF-KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXX 228
             +I+RD+KP NLL++     +++ DFG +K   R         GT  Y++PE       
Sbjct: 160 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAK---RVKGRTWXLAGTPEYLAPE-----II 210
Query: 229 XXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGASP 286
                    D W+          G+ PF   QP Q      +   I  G     P   S 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFSS 263
Query: 287 EFRSFIECCLQKEFSKRW 304
           + +  +   LQ + +KR+
Sbjct: 264 DLKDLLRNLLQVDLTKRF 281

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 87/169 (51%), Gaps = 3/169 (1%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTDSPFIV 112
           EKL+ +G G  GTV+K ++R TH+I ALK V   D D  V     RE+ +L+      IV
Sbjct: 5   EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
           +   +       + ++ E+ D        + NG      +     Q+LKGL + H   ++
Sbjct: 65  RLHDVLHS-DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVL 123
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
           HRD+KP NLL+N N  ++K+ADFG+++     +   ++ V T  Y  P+
Sbjct: 124 HRDLKPQNLLINRNG-ELKLADFGLARAFGIPVRCYSAEVVTLWYRPPD 171

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 120/277 (43%), Gaps = 16/277 (5%)
Query: 50  YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVV--------HGDADPTVRRQVFREME 101
           Y + E  ++LG G    V +  H+ T K YA+K++          +    +R    +E++
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 102 ILRRTDS-PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQIL 160
           ILR+    P I+Q    +E  +    ++ + M  G L   L +  T SE +   I   +L
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTF-FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL 134
Query: 161 KGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSP 220
           + +  LH   I+HRD+KP N+L+ +++M +K+ DFG S       +   S  GT +Y++P
Sbjct: 135 EVICALHKLNIVHRDLKPENILL-DDDMNIKLTDFGFS-CQLDPGEKLRSVCGTPSYLAP 192
Query: 221 ERFDPDXXXXX-XXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCA-ICFGDPP 278
           E  +              D+WS          G  PF    Q      +M     FG P 
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 252
Query: 279 SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
              D  S   +  +   L  +  KR+TA + L HPF 
Sbjct: 253 W--DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 12/204 (5%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVV-HGDADPTVRRQVFREMEILRRTDSPFIVQC 114
           L+ +G GN   V   +H  T +  A+K++     +PT  +++FRE+ I++  + P IV+ 
Sbjct: 20  LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
           F + E     + ++MEY   G +   L  +G   E +      QI+  + Y H  +I+HR
Sbjct: 80  FEVIETEK-TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHR 138
Query: 175 DIKPSNLLVNNNNMQVKIADFGVSK--IMCRSLDACNSYVGTCAYMSPERFDPDXXXXXX 232
           D+K  NLL+ + +M +KIADFG S    +   LDA   + G   Y +PE F         
Sbjct: 139 DLKAENLLL-DADMNIKIADFGFSNEFTVGGKLDA---FCGAPPYAAPELFQ----GKKY 190
Query: 233 XXXXXDIWSXXXXXXXXXXGHFPF 256
                D+WS          G  PF
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPF 214

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 116/259 (44%), Gaps = 27/259 (10%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            E+++ LG G+ G V  V+H  T   YA+K++  D    V+         E  IL+  + 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+ +    F K + ++ ++MEY   G + + L + G F EP     A+QI+    YLH 
Sbjct: 102 PFLTKLEFSF-KDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 160
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPDX 227
             +I+RD+KP NL+++     +K+ DFG +K +  R+   C    GT  Y++PE      
Sbjct: 161 LDLIYRDLKPENLMIDQQGY-IKVTDFGFAKRVKGRTWXLC----GTPEYLAPE-----I 210
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGAS 285
                     D W+          G+ PF   QP Q      +   I  G     P   S
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFS 263
Query: 286 PEFRSFIECCLQKEFSKRW 304
            + +  +   LQ + +KR+
Sbjct: 264 SDLKDLLRNLLQVDLTKRF 282

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/176 (31%), Positives = 96/176 (54%), Gaps = 10/176 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQ----VFREMEILRRT 106
            D E ++V+G G  G V  V+H+ T K+YA+K++       ++R      + E +I+   
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS--KFEMIKRSDSAFFWEERDIMAFA 126
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
           +SP++VQ F  F+     + ++MEYM  G L  L++ N    E       ++++  L  +
Sbjct: 127 NSPWVVQLFYAFQDDRY-LYMVMEYMPGGDLVNLMS-NYDVPEKWARFYTAEVVLALDAI 184
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGV-SKIMCRSLDACNSYVGTCAYMSPE 221
           H    IHRD+KP N+L++ +   +K+ADFG   K+    +  C++ VGT  Y+SPE
Sbjct: 185 HSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE 239

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/176 (31%), Positives = 96/176 (54%), Gaps = 10/176 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQ----VFREMEILRRT 106
            D E ++V+G G  G V  V+H+ T K+YA+K++       ++R      + E +I+   
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS--KFEMIKRSDSAFFWEERDIMAFA 131
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
           +SP++VQ F  F+     + ++MEYM  G L  L++ N    E       ++++  L  +
Sbjct: 132 NSPWVVQLFYAFQDDRY-LYMVMEYMPGGDLVNLMS-NYDVPEKWARFYTAEVVLALDAI 189
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGV-SKIMCRSLDACNSYVGTCAYMSPE 221
           H    IHRD+KP N+L++ +   +K+ADFG   K+    +  C++ VGT  Y+SPE
Sbjct: 190 HSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE 244

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 117/258 (45%), Gaps = 25/258 (9%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR----RQVFREMEILRRTDS 108
            ++++ LG G+ G V  V+H+ +   YA+K++  D    V+         E  IL+  + 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+V+    F K + ++ ++MEY+  G + + L + G FSEP     A+QI+    YLH 
Sbjct: 101 PFLVKLEFSF-KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXX 228
             +I+RD+KP NLL++     +++ DFG +K   R         GT  Y++PE       
Sbjct: 160 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAK---RVKGRTWXLXGTPEYLAPE-----II 210
Query: 229 XXXXXXXXXDIWSXXXXXXXXXXGHFPFL--QPGQRPDWATLMCAICFGDPPSLPDGASP 286
                    D W+          G+ PF   QP Q      +   I  G     P   S 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSG-KVRFPSHFSS 263
Query: 287 EFRSFIECCLQKEFSKRW 304
           + +  +   LQ + +KR+
Sbjct: 264 DLKDLLRNLLQVDLTKRF 281

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 118/271 (43%), Gaps = 19/271 (7%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR--RQVFREMEILRRTDSPFIVQ 113
            +VLG G  G V+  Q + T K+YA K ++       +  +    E +IL +  S FIV 
Sbjct: 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLD----TLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
               FE  + D+ ++M  M+ G +      +   N  F EP+     +QI+ GL +LH  
Sbjct: 250 LAYAFETKT-DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
            II+RD+KP N+L++++   V+I+D G++  +         Y GT  +M+PE        
Sbjct: 309 NIIYRDLKPENVLLDDDG-NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL-----L 362
Query: 230 XXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFR 289
                   D ++             PF   G++ +   L   +      + PD  SP  +
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV-LEQAVTYPDKFSPASK 421
Query: 290 SFIECCLQKEFSKRW-----TASQLLTHPFL 315
            F E  LQK+  KR      +   L THP  
Sbjct: 422 DFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 114/265 (43%), Gaps = 16/265 (6%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFRE-----MEILRRTDSPFIVQ 113
           LG G    V K + + T   YA K +      + RR V RE     + IL+    P ++ 
Sbjct: 19  LGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
              ++E  + D+ +++E +  G L   L +  + +E +      QIL G+ YLH  +I H
Sbjct: 79  LHEVYENKT-DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137
Query: 174 RDIKPSNLLVNNNNM---QVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
            D+KP N+++ + N+   ++KI DFG    +   +D  N +     + +PE   P+    
Sbjct: 138 FDLKPENIMLLDRNVPKPRIKIIDFG----LAHKIDFGNEF--KNIFGTPEFVAPEIVNY 191
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                  D+WS          G  PFL   ++   A  + A+ +          S   + 
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-VSAVNYEFEDEYFSNTSALAKD 250
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
           FI   L K+  KR T    L HP++
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 118/271 (43%), Gaps = 19/271 (7%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR--RQVFREMEILRRTDSPFIVQ 113
            +VLG G  G V+  Q + T K+YA K ++       +  +    E +IL +  S FIV 
Sbjct: 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLD----TLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
               FE  + D+ ++M  M+ G +      +   N  F EP+     +QI+ GL +LH  
Sbjct: 250 LAYAFETKT-DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
            II+RD+KP N+L++++   V+I+D G++  +         Y GT  +M+PE        
Sbjct: 309 NIIYRDLKPENVLLDDDG-NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL-----L 362
Query: 230 XXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFR 289
                   D ++             PF   G++ +   L   +      + PD  SP  +
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV-LEQAVTYPDKFSPASK 421
Query: 290 SFIECCLQKEFSKRW-----TASQLLTHPFL 315
            F E  LQK+  KR      +   L THP  
Sbjct: 422 DFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 118/271 (43%), Gaps = 19/271 (7%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR--RQVFREMEILRRTDSPFIVQ 113
            +VLG G  G V+  Q + T K+YA K ++       +  +    E +IL +  S FIV 
Sbjct: 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLD----TLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
               FE  + D+ ++M  M+ G +      +   N  F EP+     +QI+ GL +LH  
Sbjct: 250 LAYAFETKT-DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
            II+RD+KP N+L++++   V+I+D G++  +         Y GT  +M+PE        
Sbjct: 309 NIIYRDLKPENVLLDDDG-NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPE-----LLL 362
Query: 230 XXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFR 289
                   D ++             PF   G++ +   L   +      + PD  SP  +
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV-LEQAVTYPDKFSPASK 421
Query: 290 SFIECCLQKEFSKRW-----TASQLLTHPFL 315
            F E  LQK+  KR      +   L THP  
Sbjct: 422 DFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 118/271 (43%), Gaps = 19/271 (7%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR--RQVFREMEILRRTDSPFIVQ 113
            +VLG G  G V+  Q + T K+YA K ++       +  +    E +IL +  S FIV 
Sbjct: 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLD----TLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
               FE  + D+ ++M  M+ G +      +   N  F EP+     +QI+ GL +LH  
Sbjct: 250 LAYAFETKT-DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
            II+RD+KP N+L++++   V+I+D G++  +         Y GT  +M+PE        
Sbjct: 309 NIIYRDLKPENVLLDDDG-NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPE-----LLL 362
Query: 230 XXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFR 289
                   D ++             PF   G++ +   L   +      + PD  SP  +
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV-LEQAVTYPDKFSPASK 421
Query: 290 SFIECCLQKEFSKRW-----TASQLLTHPFL 315
            F E  LQK+  KR      +   L THP  
Sbjct: 422 DFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 118/267 (44%), Gaps = 12/267 (4%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIF 118
           +G GN G    ++ + T ++ A+K +   A   +   V RE+   R    P IV+   + 
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGA--AIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 119 EKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKP 178
             P+  +AI+MEY   G L   +   G FSE +      Q+L G+SY H  +I HRD+K 
Sbjct: 86  LTPT-HLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKL 144
Query: 179 SNLLVNNNNM-QVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXXXXX 237
            N L++ +   ++KI DFG SK          S VGT AY++PE                
Sbjct: 145 ENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVL----LRQEYDGKIA 199
Query: 238 DIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDG--ASPEFRSFIECC 295
           D+WS          G +PF  P +  D+   +  I      S+PD    SPE    I   
Sbjct: 200 DVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRI-LSVKYSIPDDIRISPECCHLISRI 258
Query: 296 LQKEFSKRWTASQLLTHPFLCKNRRSD 322
              + + R +  ++ TH +  KN  +D
Sbjct: 259 FVADPATRISIPEIKTHSWFLKNLPAD 285

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 56/176 (31%), Positives = 96/176 (54%), Gaps = 10/176 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQ----VFREMEILRRT 106
            D E ++V+G G  G V  V+H+ T K+YA+K++       ++R      + E +I+   
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS--KFEMIKRSDSAFFWEERDIMAFA 131
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
           +SP++VQ F  F+     + ++MEYM  G L  L++ N    E       ++++  L  +
Sbjct: 132 NSPWVVQLFYAFQDDRY-LYMVMEYMPGGDLVNLMS-NYDVPEKWARFYTAEVVLALDAI 189
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGV-SKIMCRSLDACNSYVGTCAYMSPE 221
           H    IHRD+KP N+L++ +   +K+ADFG   K+    +  C++ VGT  Y+SPE
Sbjct: 190 HSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE 244

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 130/285 (45%), Gaps = 23/285 (8%)
Query: 48  IAYSDLEKLQVLGHGNGGTVY---KVQHRCTHKIYALKVVHG-----DADPTVRRQVFRE 99
           +   + E L+VLG G  G V+   K+    T K+YA+KV+        A  T   +  R+
Sbjct: 51  VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 110
Query: 100 -MEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQ 158
            +E +R+  SPF+V     F+  +  + ++++Y++ G L T L++   F+E ++     +
Sbjct: 111 VLEHIRQ--SPFLVTLHYAFQTET-KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE 167
Query: 159 ILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAY 217
           I+  L +LH   II+RDIK  N+L+++N   V + DFG+SK  +    +    + GT  Y
Sbjct: 168 IVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKEFVADETERAYDFCGTIEY 226
Query: 218 MSPERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDP 277
           M+P   D             D WS          G  PF   G++   A +   I   +P
Sbjct: 227 MAP---DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 283
Query: 278 PSLPDGASPEFRSFIECCLQKEFSKRW-----TASQLLTHPFLCK 317
           P  P   S   +  I+  L K+  KR       A ++  H F  K
Sbjct: 284 P-YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 118/264 (44%), Gaps = 15/264 (5%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSPFIVQC 114
           + LG G+ G V    H  T +  ALK +         +  +V RE+  L+    P I++ 
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
           + +   P+ DI +++EY      D ++ K    +E +      QI+  + Y H HKI+HR
Sbjct: 75  YDVITTPT-DIVMVIEYAGGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRHKIVHR 132
Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXX 234
           D+KP NLL+ ++N+ VKIADFG+S IM    +   +  G+  Y +PE  +          
Sbjct: 133 DLKPENLLL-DDNLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVIN----GKLYAG 186
Query: 235 XXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIEC 294
              D+WS          G  PF      P+    + +  +     +PD  SP  +S I  
Sbjct: 187 PEVDVWSCGIVLYVMLVGRLPF-DDEFIPNLFKKVNSCVY----VMPDFLSPGAQSLIRR 241
Query: 295 CLQKEFSKRWTASQLLTHPFLCKN 318
            +  +  +R T  ++   P+   N
Sbjct: 242 MIVADPMQRITIQEIRRDPWFNVN 265

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 123/274 (44%), Gaps = 16/274 (5%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH--GDADPTVRRQVFREMEILRRTDSPFI 111
           E ++ +G GN G    ++ +  +++ A+K +      D  V+R++       R    P I
Sbjct: 22  ELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINH----RSLRHPNI 77
Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
           V+   +   P+  +AI+MEY   G L   +   G FSE +      Q++ G+SY H  ++
Sbjct: 78  VRFKEVILTPT-HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQV 136
Query: 172 IHRDIKPSNLLVNNNNM-QVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
            HRD+K  N L++ +   ++KIADFG SK          S VGT AY++PE         
Sbjct: 137 AHRDLKLENTLLDGSPAPRLKIADFGYSKASVLH-SQPKSAVGTPAYIAPEVL----LKK 191
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA--SPEF 288
                  D+WS          G +PF  P +  ++   +  I      ++PD    SPE 
Sbjct: 192 EYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-LNVQYAIPDYVHISPEC 250
Query: 289 RSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSD 322
           R  I      + +KR +  ++  H +  KN  +D
Sbjct: 251 RHLISRIFVADPAKRISIPEIRNHEWFLKNLPAD 284

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 110/266 (41%), Gaps = 20/266 (7%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           LG G  G VY  + +    I ALKV+         V  Q+ RE+EI      P I++ + 
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 117 IFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDI 176
            F      I +++E+   G L   L K+G F E + A    ++   L Y H  K+IHRDI
Sbjct: 83  YFHD-RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDI 141
Query: 177 KPSNLLVNNNNMQVKIADFG--VSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXX 234
           KP NLL+     ++KIADFG  V     R    C    GT  Y+ PE  +          
Sbjct: 142 KPENLLMGYKG-ELKIADFGWSVHAPSLRRRXMC----GTLDYLPPEMIE-----GKTHD 191
Query: 235 XXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIEC 294
              D+W           G  PF  P    +    +  +    PP L DG+    +  I  
Sbjct: 192 EKVDLWCAGVLCYEFLVGMPPFDSPSH-TETHRRIVNVDLKFPPFLSDGS----KDLISK 246
Query: 295 CLQKEFSKRWTASQLLTHPFLCKNRR 320
            L+    +R     ++ HP++  N R
Sbjct: 247 LLRYHPPQRLPLKGVMEHPWVKANSR 272

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 123/279 (44%), Gaps = 23/279 (8%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVV-HGDADPTVRRQVFREMEILRRTDSP 109
            D E L  +G G+ G   K++ +   KI   K + +G      ++ +  E+ +LR    P
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 110 FIVQCFG-IFEKPSGDIAILMEYMDSGTLDTLLNKNGT-----FSEPKLAHIASQILKGL 163
            IV+ +  I ++ +  + I+MEY + G L +++ K GT       E  +  + +Q+   L
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK-GTKERQYLDEEFVLRVMTQLTLAL 124
Query: 164 SYLH-----GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYM 218
              H     GH ++HRD+KP+N+ ++     VK+ DFG+++I+    D    +VGT  YM
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGLARILNHDEDFAKEFVGTPYYM 183
Query: 219 SPERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPP 278
           SPE+ +             DIWS             PF    Q+     L   I  G   
Sbjct: 184 SPEQMN-----RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE----LAGKIREGKFR 234
Query: 279 SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK 317
            +P   S E    I   L  +   R +  ++L +P + +
Sbjct: 235 RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 119/277 (42%), Gaps = 16/277 (5%)
Query: 50  YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVV--------HGDADPTVRRQVFREME 101
           Y + E  ++LG G    V +  H+ T K YA+K++          +    +R    +E++
Sbjct: 3   YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 62
Query: 102 ILRRTDS-PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQIL 160
           ILR+    P I+Q    +E  +    ++ + M  G L   L +  T SE +   I   +L
Sbjct: 63  ILRKVSGHPNIIQLKDTYETNTF-FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL 121
Query: 161 KGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSP 220
           + +  LH   I+HRD+KP N+L+ +++M +K+ DFG S       +      GT +Y++P
Sbjct: 122 EVICALHKLNIVHRDLKPENILL-DDDMNIKLTDFGFS-CQLDPGEKLREVCGTPSYLAP 179
Query: 221 ERFDPDXXXXX-XXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCA-ICFGDPP 278
           E  +              D+WS          G  PF    Q      +M     FG P 
Sbjct: 180 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 239
Query: 279 SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
              D  S   +  +   L  +  KR+TA + L HPF 
Sbjct: 240 W--DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 274

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 120/265 (45%), Gaps = 24/265 (9%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVV-HGDADPTVRRQVFREMEILRRT 106
           I + DL   + +G G+ GTV++ +   +    A+K++   D       +  RE+ I++R 
Sbjct: 34  IPWCDLNIKEKIGAGSFGTVHRAEWHGSD--VAVKILMEQDFHAERVNEFLREVAIMKRL 91
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGT---FSEPKLAHIASQILKGL 163
             P IV   G   +P  +++I+ EY+  G+L  LL+K+G      E +   +A  + KG+
Sbjct: 92  RHPNIVLFMGAVTQPP-NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 150
Query: 164 SYLHGHK--IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
           +YLH     I+HRD+K  NLLV+     VK+ DFG+S++            GT  +M+PE
Sbjct: 151 NYLHNRNPPIVHRDLKSPNLLVDKK-YTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPE 209
Query: 222 --RFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFG-DPP 278
             R +P             +W                 QP    + A ++ A+ F     
Sbjct: 210 VLRDEPSNEKSDVYSFGVILWELAT-----------LQQPWGNLNPAQVVAAVGFKCKRL 258
Query: 279 SLPDGASPEFRSFIECCLQKEFSKR 303
            +P   +P+  + IE C   E  KR
Sbjct: 259 EIPRNLNPQVAAIIEGCWTNEPWKR 283

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 122/263 (46%), Gaps = 18/263 (6%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQC 114
           ++LG G    V+  +    H+  A+KV+  D   DP+   +  RE +     + P IV  
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 115 F--GIFEKPSGDIA-ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
           +  G  E P+G +  I+MEY+D  TL  +++  G  +  +   + +   + L++ H + I
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGI 137
Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMC---RSLDACNSYVGTCAYMSPERFDPDXX 228
           IHRD+KP+N+L++  N  VK+ DFG+++ +     S+    + +GT  Y+SPE+   D  
Sbjct: 138 IHRDVKPANILISATNA-VKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGD-- 194
Query: 229 XXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLP-DGASPE 287
                    D++S          G  PF   G  P             PPS   +G S +
Sbjct: 195 ---SVDARSDVYSLGCVLYEVLTGEPPFT--GDSPVSVAYQHVREDPIPPSARHEGLSAD 249
Query: 288 FRSFIECCLQKEFSKRW-TASQL 309
             + +   L K    R+ TA+++
Sbjct: 250 LDAVVLKALAKNPENRYQTAAEM 272

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 113/265 (42%), Gaps = 16/265 (6%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFRE-----MEILRRTDSPFIVQ 113
           LG G    V K + + T   YA K +      + RR V RE     + IL+    P ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
              ++E  + D+ ++ E +  G L   L +  + +E +      QIL G+ YLH  +I H
Sbjct: 79  LHEVYENKT-DVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137
Query: 174 RDIKPSNLLVNNNNM---QVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
            D+KP N+++ + N+   ++KI DFG    +   +D  N +     + +PE   P+    
Sbjct: 138 FDLKPENIMLLDRNVPKPRIKIIDFG----LAHKIDFGNEF--KNIFGTPEFVAPEIVNY 191
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                  D+WS          G  PFL   ++   A  + A+ +          S   + 
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-VSAVNYEFEDEYFSNTSALAKD 250
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
           FI   L K+  KR T    L HP++
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 119/277 (42%), Gaps = 16/277 (5%)
Query: 50  YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVV--------HGDADPTVRRQVFREME 101
           Y + E  ++LG G    V +  H+ T K YA+K++          +    +R    +E++
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 102 ILRRTDS-PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQIL 160
           ILR+    P I+Q    +E  +    ++ + M  G L   L +  T SE +   I   +L
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTF-FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL 134
Query: 161 KGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSP 220
           + +  LH   I+HRD+KP N+L+ +++M +K+ DFG S       +      GT +Y++P
Sbjct: 135 EVICALHKLNIVHRDLKPENILL-DDDMNIKLTDFGFS-CQLDPGEKLREVCGTPSYLAP 192
Query: 221 ERFDPDXXXXX-XXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCA-ICFGDPP 278
           E  +              D+WS          G  PF    Q      +M     FG P 
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 252
Query: 279 SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
              D  S   +  +   L  +  KR+TA + L HPF 
Sbjct: 253 W--DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 119/277 (42%), Gaps = 27/277 (9%)
Query: 49  AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS 108
            Y   + L+ LG G  G V++   + T +++  K ++    P  +  V  E+ I+ +   
Sbjct: 49  VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHH 107
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
           P ++     FE    ++ +++E++  G L D +  ++   SE ++ +   Q  +GL ++H
Sbjct: 108 PKLINLHDAFED-KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 166
Query: 168 GHKIIHRDIKPSNLLVNNNNM-QVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPD 226
            H I+H DIKP N++        VKI DFG++  +    +       T  + +PE  D +
Sbjct: 167 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDRE 225
Query: 227 XXXXXXXXXXXDIWSXXXXXXXXXXGHFPF--------LQPGQRPDWATLMCAICFGDPP 278
                      D+W+          G  PF        LQ  +R DW     A       
Sbjct: 226 -----PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS----- 275
Query: 279 SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
                 SPE + FI+  LQKE  KR T    L HP+L
Sbjct: 276 ----SVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL 308

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 87/169 (51%), Gaps = 3/169 (1%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTDSPFIV 112
           EKL+ +G G  GTV+K ++R TH+I ALK V   D D  V     RE+ +L+      IV
Sbjct: 5   EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
           +   +       + ++ E+ D        + NG      +     Q+LKGL + H   ++
Sbjct: 65  RLHDVLHS-DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVL 123
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
           HRD+KP NLL+N N  ++K+A+FG+++     +   ++ V T  Y  P+
Sbjct: 124 HRDLKPQNLLINRNG-ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPD 171

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 125/292 (42%), Gaps = 37/292 (12%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           SD E++ VLG G  G V K ++    + YA+K +    +      +  E+ +L   +  +
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL--STILSEVMLLASLNHQY 63
Query: 111 IVQCFGI------FEKP------SGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIAS 157
           +V+ +        F KP         + I MEY ++GTL D + ++N      +   +  
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 158 QILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA---------- 207
           QIL+ LSY+H   IIHRD+KP N+ ++ +   VKI DFG++K + RSLD           
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESR-NVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 208 ----CNSYVGTCAYMSPERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRP 263
                 S +GT  Y++ E  D             D++S            +PF    +R 
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDG----TGHYNEKIDMYSLGIIFFEMI---YPFSTGMERV 235
Query: 264 DWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
           +    + ++    PP   D      +  I   +  + +KR  A  LL   +L
Sbjct: 236 NILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 123/263 (46%), Gaps = 18/263 (6%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQC 114
           ++LG G    V+  +    H+  A+KV+  D   DP+   +  RE +     + P IV  
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 115 F--GIFEKPSGDIA-ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
           +  G  E P+G +  I+MEY+D  TL  +++  G  +  +   + +   + L++ H + I
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGI 137
Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN---SYVGTCAYMSPERFDPDXX 228
           IHRD+KP+N++++  N  VK+ DFG+++ +  S ++     + +GT  Y+SPE+   D  
Sbjct: 138 IHRDVKPANIMISATNA-VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-- 194
Query: 229 XXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLP-DGASPE 287
                    D++S          G  PF   G  P             PPS   +G S +
Sbjct: 195 ---SVDARSDVYSLGCVLYEVLTGEPPFT--GDSPVSVAYQHVREDPIPPSARHEGLSAD 249
Query: 288 FRSFIECCLQKEFSKRW-TASQL 309
             + +   L K    R+ TA+++
Sbjct: 250 LDAVVLKALAKNPENRYQTAAEM 272

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 123/263 (46%), Gaps = 18/263 (6%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQC 114
           ++LG G    V+  +    H+  A+KV+  D   DP+   +  RE +     + P IV  
Sbjct: 18  EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 115 F--GIFEKPSGDIA-ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
           +  G  E P+G +  I+MEY+D  TL  +++  G  +  +   + +   + L++ H + I
Sbjct: 78  YATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGI 137
Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN---SYVGTCAYMSPERFDPDXX 228
           IHRD+KP+N++++  N  VK+ DFG+++ +  S ++     + +GT  Y+SPE+   D  
Sbjct: 138 IHRDVKPANIMISATN-AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-- 194
Query: 229 XXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLP-DGASPE 287
                    D++S          G  PF   G  P             PPS   +G S +
Sbjct: 195 ---SVDARSDVYSLGCVLYEVLTGEPPFT--GDSPVSVAYQHVREDPIPPSARHEGLSAD 249
Query: 288 FRSFIECCLQKEFSKRW-TASQL 309
             + +   L K    R+ TA+++
Sbjct: 250 LDAVVLKALAKNPENRYQTAAEM 272

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 123/279 (44%), Gaps = 23/279 (8%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVV-HGDADPTVRRQVFREMEILRRTDSP 109
            D E L  +G G+ G   K++ +   KI   K + +G      ++ +  E+ +LR    P
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 110 FIVQCFG-IFEKPSGDIAILMEYMDSGTLDTLLNKNGT-----FSEPKLAHIASQILKGL 163
            IV+ +  I ++ +  + I+MEY + G L +++ K GT       E  +  + +Q+   L
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK-GTKERQYLDEEFVLRVMTQLTLAL 124
Query: 164 SYLH-----GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYM 218
              H     GH ++HRD+KP+N+ ++     VK+ DFG+++I+        ++VGT  YM
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 219 SPERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPP 278
           SPE+ +             DIWS             PF    Q+     L   I  G   
Sbjct: 184 SPEQMN-----RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE----LAGKIREGKFR 234
Query: 279 SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK 317
            +P   S E    I   L  +   R +  ++L +P + +
Sbjct: 235 RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 8/201 (3%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVV-HGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           + +G GN   V   +H  T +  A+K++     +PT  +++FRE+ I++  + P IV+ F
Sbjct: 21  KTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRD 175
            + E     + ++MEY   G +   L  +G   E +      QI+  + Y H   I+HRD
Sbjct: 81  EVIETEK-TLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKYIVHRD 139
Query: 176 IKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXXX 235
           +K  NLL+ + +M +KIADFG S       +  +++ G+  Y +PE F            
Sbjct: 140 LKAENLLL-DGDMNIKIADFGFSNEFTVG-NKLDTFCGSPPYAAPELFQ----GKKYDGP 193
Query: 236 XXDIWSXXXXXXXXXXGHFPF 256
             D+WS          G  PF
Sbjct: 194 EVDVWSLGVILYTLVSGSLPF 214

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 123/263 (46%), Gaps = 18/263 (6%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQC 114
           ++LG G    V+  +    H+  A+KV+  D   DP+   +  RE +     + P IV  
Sbjct: 18  EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 115 F--GIFEKPSGDIA-ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
           +  G  E P+G +  I+MEY+D  TL  +++  G  +  +   + +   + L++ H + I
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGI 137
Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN---SYVGTCAYMSPERFDPDXX 228
           IHRD+KP+N++++  N  VK+ DFG+++ +  S ++     + +GT  Y+SPE+   D  
Sbjct: 138 IHRDVKPANIMISATNA-VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-- 194
Query: 229 XXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLP-DGASPE 287
                    D++S          G  PF   G  P             PPS   +G S +
Sbjct: 195 ---SVDARSDVYSLGCVLYEVLTGEPPFT--GDSPVSVAYQHVREDPIPPSARHEGLSAD 249
Query: 288 FRSFIECCLQKEFSKRW-TASQL 309
             + +   L K    R+ TA+++
Sbjct: 250 LDAVVLKALAKNPENRYQTAAEM 272

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 123/263 (46%), Gaps = 18/263 (6%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQC 114
           ++LG G    V+  +    H+  A+KV+  D   DP+   +  RE +     + P IV  
Sbjct: 35  EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 94
Query: 115 F--GIFEKPSGDIA-ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
           +  G  E P+G +  I+MEY+D  TL  +++  G  +  +   + +   + L++ H + I
Sbjct: 95  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGI 154
Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN---SYVGTCAYMSPERFDPDXX 228
           IHRD+KP+N++++  N  VK+ DFG+++ +  S ++     + +GT  Y+SPE+   D  
Sbjct: 155 IHRDVKPANIMISATN-AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-- 211
Query: 229 XXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLP-DGASPE 287
                    D++S          G  PF   G  P             PPS   +G S +
Sbjct: 212 ---SVDARSDVYSLGCVLYEVLTGEPPFT--GDSPVSVAYQHVREDPIPPSARHEGLSAD 266
Query: 288 FRSFIECCLQKEFSKRW-TASQL 309
             + +   L K    R+ TA+++
Sbjct: 267 LDAVVLKALAKNPENRYQTAAEM 289

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 123/279 (44%), Gaps = 23/279 (8%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVV-HGDADPTVRRQVFREMEILRRTDSP 109
            D E L  +G G+ G   K++ +   KI   K + +G      ++ +  E+ +LR    P
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 110 FIVQCFG-IFEKPSGDIAILMEYMDSGTLDTLLNKNGT-----FSEPKLAHIASQILKGL 163
            IV+ +  I ++ +  + I+MEY + G L +++ K GT       E  +  + +Q+   L
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK-GTKERQYLDEEFVLRVMTQLTLAL 124
Query: 164 SYLH-----GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYM 218
              H     GH ++HRD+KP+N+ ++     VK+ DFG+++I+        ++VGT  YM
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGLARILNHDTSFAKAFVGTPYYM 183
Query: 219 SPERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPP 278
           SPE+ +             DIWS             PF    Q+     L   I  G   
Sbjct: 184 SPEQMN-----RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE----LAGKIREGKFR 234
Query: 279 SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK 317
            +P   S E    I   L  +   R +  ++L +P + +
Sbjct: 235 RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 97/180 (53%), Gaps = 18/180 (10%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQ----VFREMEILRRT 106
            D + ++V+G G  G V  V+H+ + K+YA+K++       ++R      + E +I+   
Sbjct: 75  EDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLS--KFEMIKRSDSAFFWEERDIMAFA 132
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
           +SP++VQ F  F+     + ++MEYM  G L  L++ N    E       ++++  L  +
Sbjct: 133 NSPWVVQLFCAFQDDKY-LYMVMEYMPGGDLVNLMS-NYDVPEKWAKFYTAEVVLALDAI 190
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA-----CNSYVGTCAYMSPE 221
           H   +IHRD+KP N+L++ +   +K+ADFG     C  +D      C++ VGT  Y+SPE
Sbjct: 191 HSMGLIHRDVKPDNMLLDKHG-HLKLADFGT----CMKMDETGMVHCDTAVGTPDYISPE 245

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 123/279 (44%), Gaps = 24/279 (8%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD---ADPTVRRQVFREMEILR 104
           +  ++ E L++LG G  G V  V+ + T + YA+K++  +   A   V      E  +L+
Sbjct: 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVA-HTLTENRVLQ 203
Query: 105 RTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLS 164
            +  PF+      F+     +  +MEY + G L   L++   FSE +     ++I+  L 
Sbjct: 204 NSRHPFLTALKYSFQ-THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD 262
Query: 165 YLHGHK-IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF 223
           YLH  K +++RD+K  NL+++ +   +KI DFG+ K   +      ++ GT  Y++PE  
Sbjct: 263 YLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL 321
Query: 224 DPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFL-QPGQRPDWATLMCAICFGDPPSLPD 282
           + +           D W           G  PF  Q  ++     LM  I F      P 
Sbjct: 322 EDN-----DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF------PR 370
Query: 283 GASPEFRSFIECCLQKEFSKRW-----TASQLLTHPFLC 316
              PE +S +   L+K+  +R       A +++ H F  
Sbjct: 371 TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 409

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 123/279 (44%), Gaps = 24/279 (8%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD---ADPTVRRQVFREMEILR 104
           +  ++ E L++LG G  G V  V+ + T + YA+K++  +   A   V      E  +L+
Sbjct: 148 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVA-HTLTENRVLQ 206
Query: 105 RTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLS 164
            +  PF+      F+     +  +MEY + G L   L++   FSE +     ++I+  L 
Sbjct: 207 NSRHPFLTALKYSFQ-THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD 265
Query: 165 YLHGHK-IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF 223
           YLH  K +++RD+K  NL+++ +   +KI DFG+ K   +      ++ GT  Y++PE  
Sbjct: 266 YLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL 324
Query: 224 DPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFL-QPGQRPDWATLMCAICFGDPPSLPD 282
           + +           D W           G  PF  Q  ++     LM  I F      P 
Sbjct: 325 EDN-----DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF------PR 373
Query: 283 GASPEFRSFIECCLQKEFSKRW-----TASQLLTHPFLC 316
              PE +S +   L+K+  +R       A +++ H F  
Sbjct: 374 TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 412

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 128/278 (46%), Gaps = 29/278 (10%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           QVLG G  G V ++ ++ T + +ALK++     P  RR+V  E+   R +  P IV+   
Sbjct: 68  QVLGLGINGKVLQIFNKRTQEKFALKMLQDC--PKARREV--ELH-WRASQCPHIVRIVD 122
Query: 117 IFEKPSGD---IAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKI 171
           ++E        + I+ME +D G L + +   G   F+E + + I   I + + YLH   I
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 182
Query: 172 IHRDIKPSNLLVNNN--NMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
            HRD+KP NLL  +   N  +K+ DFG +K    S ++  +   T  Y++PE   P+   
Sbjct: 183 AHRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPE--- 238
Query: 230 XXXXXXXXDIWSXXXXXXXXXXGHFPF-------LQPGQRPDWATLMCAICFGDPPSLPD 282
                   D+WS          G+ PF       + PG +      M    F +P     
Sbjct: 239 --KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT--RIRMGQYEFPNPEW--S 292
Query: 283 GASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR 320
             S E +  I   L+ E ++R T ++ + HP++ ++ +
Sbjct: 293 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 330

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 128/278 (46%), Gaps = 29/278 (10%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           QVLG G  G V ++ ++ T + +ALK++     P  RR+V  E+   R +  P IV+   
Sbjct: 23  QVLGLGINGKVLQIFNKRTQEKFALKMLQDC--PKARREV--ELH-WRASQCPHIVRIVD 77
Query: 117 IFEKPSGD---IAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKI 171
           ++E        + I+ME +D G L + +   G   F+E + + I   I + + YLH   I
Sbjct: 78  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 137
Query: 172 IHRDIKPSNLLVNNN--NMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
            HRD+KP NLL  +   N  +K+ DFG +K    S ++  +   T  Y++PE   P+   
Sbjct: 138 AHRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPE--- 193
Query: 230 XXXXXXXXDIWSXXXXXXXXXXGHFPF-------LQPGQRPDWATLMCAICFGDPPSLPD 282
                   D+WS          G+ PF       + PG +      M    F +P     
Sbjct: 194 --KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT--RIRMGQYEFPNPEW--S 247
Query: 283 GASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR 320
             S E +  I   L+ E ++R T ++ + HP++ ++ +
Sbjct: 248 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 285

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 128/278 (46%), Gaps = 29/278 (10%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           QVLG G  G V ++ ++ T + +ALK++     P  RR+V  E+   R +  P IV+   
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALKMLQDC--PKARREV--ELH-WRASQCPHIVRIVD 78
Query: 117 IFEKPSGD---IAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKI 171
           ++E        + I+ME +D G L + +   G   F+E + + I   I + + YLH   I
Sbjct: 79  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 138
Query: 172 IHRDIKPSNLLVNNN--NMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
            HRD+KP NLL  +   N  +K+ DFG +K    S ++  +   T  Y++PE   P+   
Sbjct: 139 AHRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPE--- 194
Query: 230 XXXXXXXXDIWSXXXXXXXXXXGHFPF-------LQPGQRPDWATLMCAICFGDPPSLPD 282
                   D+WS          G+ PF       + PG +      M    F +P     
Sbjct: 195 --KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT--RIRMGQYEFPNPEW--S 248
Query: 283 GASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR 320
             S E +  I   L+ E ++R T ++ + HP++ ++ +
Sbjct: 249 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 286

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 120/297 (40%), Gaps = 44/297 (14%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSP 109
            + +K++ +G G  G VYK +++ T ++ ALK +  D +   V     RE+ +L+  + P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 110 FIVQCFGIFEKPSGDIAI-------LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
            IV+   +    +    +       L ++MD+  L  +         P +     Q+L+G
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI-------PLPLIKSYLFQLLQG 115
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
           LS+ H H+++HRD+KP NLL+N     +K+ADFG+++     +      V T  Y +PE 
Sbjct: 116 LSFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 174
Query: 223 FDPDXXXXXXXXXXXDIWSX--XXXXXXXXXGHFP----------FLQPGQRPDWATLMC 270
                          DIWS              FP            +    PD      
Sbjct: 175 L----LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230
Query: 271 AICFGD-PPSLPDGASPEF-----------RSFIECCLQKEFSKRWTASQLLTHPFL 315
                D  PS P  A  +F           RS +   L  + +KR +A   L HPF 
Sbjct: 231 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 121/297 (40%), Gaps = 44/297 (14%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSP 109
            + +K++ +G G  G VYK +++ T ++ ALK +  D +   V     RE+ +L+  + P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 110 FIVQCFGIFEKPSGDIAI-------LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
            IV+   +    +    +       L ++MD+  L  +         P +     Q+L+G
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI-------PLPLIKSYLFQLLQG 115
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
           L++ H H+++HRD+KP NLL+N     +K+ADFG+++     +      V T  Y +PE 
Sbjct: 116 LAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 174
Query: 223 FDPDXXXXXXXXXXXDIWSX--XXXXXXXXXGHFP----------FLQPGQRPDWATLMC 270
                          DIWS              FP            +    PD      
Sbjct: 175 L----LGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230
Query: 271 AICFGD-PPSLPDGASPEF-----------RSFIECCLQKEFSKRWTASQLLTHPFL 315
                D  PS P  A  +F           RS +   L  + +KR +A   L HPF 
Sbjct: 231 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 128/278 (46%), Gaps = 29/278 (10%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           QVLG G  G V ++ ++ T + +ALK++     P  RR+V  E+   R +  P IV+   
Sbjct: 22  QVLGLGINGKVLQIFNKRTQEKFALKMLQDC--PKARREV--ELH-WRASQCPHIVRIVD 76
Query: 117 IFEKPSGD---IAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKI 171
           ++E        + I+ME +D G L + +   G   F+E + + I   I + + YLH   I
Sbjct: 77  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 136
Query: 172 IHRDIKPSNLLVNNN--NMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
            HRD+KP NLL  +   N  +K+ DFG +K    S ++  +   T  Y++PE   P+   
Sbjct: 137 AHRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPE--- 192
Query: 230 XXXXXXXXDIWSXXXXXXXXXXGHFPF-------LQPGQRPDWATLMCAICFGDPPSLPD 282
                   D+WS          G+ PF       + PG +      M    F +P     
Sbjct: 193 --KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT--RIRMGQYEFPNPEW--S 246
Query: 283 GASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR 320
             S E +  I   L+ E ++R T ++ + HP++ ++ +
Sbjct: 247 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 284

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 123/300 (41%), Gaps = 50/300 (16%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSP 109
            + +K++ +G G  G VYK +++ T ++ ALK +  D +   V     RE+ +L+  + P
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 110 FIVQC----------FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQI 159
            IV+           + +FE  S D   L ++MD+  L  +         P +     Q+
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLSMD---LKDFMDASALTGI-------PLPLIKSYLFQL 115
Query: 160 LKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMS 219
           L+GL++ H H+++HRD+KP NLL+N     +K+ADFG+++     +      V T  Y +
Sbjct: 116 LQGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 220 PERFDPDXXXXXXXXXXXDIWSX--XXXXXXXXXGHFP----------FLQPGQRPDWAT 267
           PE                DIWS              FP            +    PD   
Sbjct: 175 PEIL----LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 230
Query: 268 LMCAICFGD-PPSLPDGASPEF-----------RSFIECCLQKEFSKRWTASQLLTHPFL 315
                   D  PS P  A  +F           RS +   L  + +KR +A   L HPF 
Sbjct: 231 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 128/278 (46%), Gaps = 29/278 (10%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           QVLG G  G V ++ ++ T + +ALK++     P  RR+V  E+   R +  P IV+   
Sbjct: 28  QVLGLGINGKVLQIFNKRTQEKFALKMLQDC--PKARREV--ELH-WRASQCPHIVRIVD 82
Query: 117 IFEKPSGD---IAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKI 171
           ++E        + I+ME +D G L + +   G   F+E + + I   I + + YLH   I
Sbjct: 83  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 142
Query: 172 IHRDIKPSNLLVNNN--NMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
            HRD+KP NLL  +   N  +K+ DFG +K    S ++  +   T  Y++PE   P+   
Sbjct: 143 AHRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPE--- 198
Query: 230 XXXXXXXXDIWSXXXXXXXXXXGHFPF-------LQPGQRPDWATLMCAICFGDPPSLPD 282
                   D+WS          G+ PF       + PG +      M    F +P     
Sbjct: 199 --KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT--RIRMGQYEFPNPEW--S 252
Query: 283 GASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR 320
             S E +  I   L+ E ++R T ++ + HP++ ++ +
Sbjct: 253 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 290

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 128/278 (46%), Gaps = 29/278 (10%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           QVLG G  G V ++ ++ T + +ALK++     P  RR+V  E+   R +  P IV+   
Sbjct: 30  QVLGLGINGKVLQIFNKRTQEKFALKMLQDC--PKARREV--ELH-WRASQCPHIVRIVD 84
Query: 117 IFEKPSGD---IAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKI 171
           ++E        + I+ME +D G L + +   G   F+E + + I   I + + YLH   I
Sbjct: 85  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 144
Query: 172 IHRDIKPSNLLVNNN--NMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
            HRD+KP NLL  +   N  +K+ DFG +K    S ++  +   T  Y++PE   P+   
Sbjct: 145 AHRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPE--- 200
Query: 230 XXXXXXXXDIWSXXXXXXXXXXGHFPF-------LQPGQRPDWATLMCAICFGDPPSLPD 282
                   D+WS          G+ PF       + PG +      M    F +P     
Sbjct: 201 --KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT--RIRMGQYEFPNPEW--S 254
Query: 283 GASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR 320
             S E +  I   L+ E ++R T ++ + HP++ ++ +
Sbjct: 255 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 292

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 128/278 (46%), Gaps = 29/278 (10%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           QVLG G  G V ++ ++ T + +ALK++     P  RR+V  E+   R +  P IV+   
Sbjct: 29  QVLGLGINGKVLQIFNKRTQEKFALKMLQDC--PKARREV--ELH-WRASQCPHIVRIVD 83
Query: 117 IFEKPSGD---IAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKI 171
           ++E        + I+ME +D G L + +   G   F+E + + I   I + + YLH   I
Sbjct: 84  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 143
Query: 172 IHRDIKPSNLLVNNN--NMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
            HRD+KP NLL  +   N  +K+ DFG +K    S ++  +   T  Y++PE   P+   
Sbjct: 144 AHRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPE--- 199
Query: 230 XXXXXXXXDIWSXXXXXXXXXXGHFPF-------LQPGQRPDWATLMCAICFGDPPSLPD 282
                   D+WS          G+ PF       + PG +      M    F +P     
Sbjct: 200 --KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT--RIRMGQYEFPNPEW--S 253
Query: 283 GASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR 320
             S E +  I   L+ E ++R T ++ + HP++ ++ +
Sbjct: 254 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 291

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 94/177 (53%), Gaps = 7/177 (3%)
Query: 50  YSDLEKLQ-VLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRT 106
           +SD  K Q VLG G+ G V   + + T +  A+KV+        T +  + RE+++L++ 
Sbjct: 30  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 89
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
           D P I++ +  FE   G   ++ E    G L   +     FSE   A I  Q+L G++Y+
Sbjct: 90  DHPNIMKLYEFFE-DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYM 148
Query: 167 HGHKIIHRDIKPSNLLVN--NNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
           H +KI+HRD+KP NLL+   + +  ++I DFG+S     S       +GT  Y++PE
Sbjct: 149 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPE 204

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 84/161 (52%), Gaps = 20/161 (12%)
Query: 56  LQVLGHGNGGTVYK-VQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQC 114
           L+ LG G  G V+  V + C  ++   K+V    DP   +   RE++I+RR D   IV+ 
Sbjct: 16  LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVL--TDPQSVKHALREIKIIRRLDHDNIVKV 73
Query: 115 FGIFEKPSGD--------------IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQIL 160
           F I   PSG               + I+ EYM++   + L  + G   E        Q+L
Sbjct: 74  FEIL-GPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVL--EQGPLLEEHARLFMYQLL 130
Query: 161 KGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           +GL Y+H   ++HRD+KP+NL +N  ++ +KI DFG+++IM
Sbjct: 131 RGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIM 171

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 123/300 (41%), Gaps = 50/300 (16%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSP 109
            + +K++ +G G  G VYK +++ T ++ ALK +  D +   V     RE+ +L+  + P
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 110 FIVQC----------FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQI 159
            IV+           + +FE  S D   L ++MD+  L  +         P +     Q+
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLSMD---LKDFMDASALTGI-------PLPLIKSYLFQL 114
Query: 160 LKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMS 219
           L+GL++ H H+++HRD+KP NLL+N     +K+ADFG+++     +      V T  Y +
Sbjct: 115 LQGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRA 173
Query: 220 PERFDPDXXXXXXXXXXXDIWSX--XXXXXXXXXGHFP----------FLQPGQRPDWAT 267
           PE                DIWS              FP            +    PD   
Sbjct: 174 PEIL----LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 229
Query: 268 LMCAICFGD-PPSLPDGASPEF-----------RSFIECCLQKEFSKRWTASQLLTHPFL 315
                   D  PS P  A  +F           RS +   L  + +KR +A   L HPF 
Sbjct: 230 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 128/278 (46%), Gaps = 29/278 (10%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           QVLG G  G V ++ ++ T + +ALK++     P  RR+V  E+   R +  P IV+   
Sbjct: 74  QVLGLGINGKVLQIFNKRTQEKFALKMLQDC--PKARREV--ELH-WRASQCPHIVRIVD 128
Query: 117 IFEKPSGD---IAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKI 171
           ++E        + I+ME +D G L + +   G   F+E + + I   I + + YLH   I
Sbjct: 129 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 188
Query: 172 IHRDIKPSNLLVNNN--NMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
            HRD+KP NLL  +   N  +K+ DFG +K    S ++  +   T  Y++PE   P+   
Sbjct: 189 AHRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPE--- 244
Query: 230 XXXXXXXXDIWSXXXXXXXXXXGHFPF-------LQPGQRPDWATLMCAICFGDPPSLPD 282
                   D+WS          G+ PF       + PG +      M    F +P     
Sbjct: 245 --KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT--RIRMGQYEFPNPEW--S 298
Query: 283 GASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR 320
             S E +  I   L+ E ++R T ++ + HP++ ++ +
Sbjct: 299 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 336

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 123/300 (41%), Gaps = 50/300 (16%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSP 109
            + +K++ +G G  G VYK +++ T ++ ALK +  D +   V     RE+ +L+  + P
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 110 FIVQC----------FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQI 159
            IV+           + +FE  S D   L ++MD+  L  +         P +     Q+
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLSMD---LKKFMDASALTGI-------PLPLIKSYLFQL 113
Query: 160 LKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMS 219
           L+GL++ H H+++HRD+KP NLL+N     +K+ADFG+++     +      V T  Y +
Sbjct: 114 LQGLAFCHSHRVLHRDLKPENLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRA 172
Query: 220 PERFDPDXXXXXXXXXXXDIWSX--XXXXXXXXXGHFP----------FLQPGQRPDWAT 267
           PE                DIWS              FP            +    PD   
Sbjct: 173 PEIL----LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 228
Query: 268 LMCAICFGD-PPSLPDGASPEF-----------RSFIECCLQKEFSKRWTASQLLTHPFL 315
                   D  PS P  A  +F           RS +   L  + +KR +A   L HPF 
Sbjct: 229 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 123/293 (41%), Gaps = 36/293 (12%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSP 109
            + +K++ +G G  G VYK +++ T ++ ALK +  D +   V     RE+ +L+  + P
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIAS---QILKGLSYL 166
            IV+   +       + ++ E++    L T ++ +     P L  I S   Q+L+GL++ 
Sbjct: 66  NIVKLLDVIHT-ENKLYLVFEFLHQD-LKTFMDASALTGIP-LPLIKSYLFQLLQGLAFC 122
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPD 226
           H H+++HRD+KP NLL+N     +K+ADFG+++     +      V T  Y +PE     
Sbjct: 123 HSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL--- 178
Query: 227 XXXXXXXXXXXDIWSX--XXXXXXXXXGHFP----------FLQPGQRPDWATLMCAICF 274
                      DIWS              FP            +    PD          
Sbjct: 179 -LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 237
Query: 275 GD-PPSLPDGASPEF-----------RSFIECCLQKEFSKRWTASQLLTHPFL 315
            D  PS P  A  +F           RS +   L  + +KR +A   L HPF 
Sbjct: 238 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 128/278 (46%), Gaps = 29/278 (10%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           QVLG G  G V ++ ++ T + +ALK++     P  RR+V  E+   R +  P IV+   
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALKMLQDC--PKARREV--ELH-WRASQCPHIVRIVD 78
Query: 117 IFEKPSGD---IAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKI 171
           ++E        + I+ME +D G L + +   G   F+E + + I   I + + YLH   I
Sbjct: 79  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 138
Query: 172 IHRDIKPSNLLVNNN--NMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
            HRD+KP NLL  +   N  +K+ DFG +K    S ++  +   T  Y++PE   P+   
Sbjct: 139 AHRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPE--- 194
Query: 230 XXXXXXXXDIWSXXXXXXXXXXGHFPF-------LQPGQRPDWATLMCAICFGDPPSLPD 282
                   D+WS          G+ PF       + PG +      M    F +P     
Sbjct: 195 --KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT--RIRMGQYEFPNPEW--S 248
Query: 283 GASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR 320
             S E +  I   L+ E ++R T ++ + HP++ ++ +
Sbjct: 249 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 286

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 123/300 (41%), Gaps = 50/300 (16%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSP 109
            + +K++ +G G  G VYK +++ T ++ ALK +  D +   V     RE+ +L+  + P
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 110 FIVQC----------FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQI 159
            IV+           + +FE  S D   L ++MD+  L  +         P +     Q+
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLSMD---LKKFMDASALTGI-------PLPLIKSYLFQL 115
Query: 160 LKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMS 219
           L+GL++ H H+++HRD+KP NLL+N     +K+ADFG+++     +      V T  Y +
Sbjct: 116 LQGLAFCHSHRVLHRDLKPENLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 220 PERFDPDXXXXXXXXXXXDIWSX--XXXXXXXXXGHFP----------FLQPGQRPDWAT 267
           PE                DIWS              FP            +    PD   
Sbjct: 175 PEIL----LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 230
Query: 268 LMCAICFGD-PPSLPDGASPEF-----------RSFIECCLQKEFSKRWTASQLLTHPFL 315
                   D  PS P  A  +F           RS +   L  + +KR +A   L HPF 
Sbjct: 231 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 121/297 (40%), Gaps = 44/297 (14%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSP 109
            + +K++ +G G  G VYK +++ T ++ ALK +  D +   V     RE+ +L+  + P
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 110 FIVQCFGIFEKPSGDIAI-------LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
            IV+   +    +    +       L ++MD+  L  +         P +     Q+L+G
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI-------PLPLIKSYLFQLLQG 122
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
           L++ H H+++HRD+KP NLL+N     +K+ADFG+++     +      V T  Y +PE 
Sbjct: 123 LAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 181
Query: 223 FDPDXXXXXXXXXXXDIWSX--XXXXXXXXXGHFP----------FLQPGQRPDWATLMC 270
                          DIWS              FP            +    PD      
Sbjct: 182 L----LGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 237
Query: 271 AICFGD-PPSLPDGASPEF-----------RSFIECCLQKEFSKRWTASQLLTHPFL 315
                D  PS P  A  +F           RS +   L  + +KR +A   L HPF 
Sbjct: 238 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 294

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 123/293 (41%), Gaps = 36/293 (12%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSP 109
            + +K++ +G G  G VYK +++ T ++ ALK +  D +   V     RE+ +L+  + P
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIAS---QILKGLSYL 166
            IV+   +       + ++ E++D   L   ++ +     P L  I S   Q+L+GL++ 
Sbjct: 66  NIVKLLDVIHT-ENKLYLVFEHVDQD-LKKFMDASALTGIP-LPLIKSYLFQLLQGLAFC 122
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPD 226
           H H+++HRD+KP NLL+N     +K+ADFG+++     +      V T  Y +PE     
Sbjct: 123 HSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL--- 178
Query: 227 XXXXXXXXXXXDIWSX--XXXXXXXXXGHFP----------FLQPGQRPDWATLMCAICF 274
                      DIWS              FP            +    PD          
Sbjct: 179 -LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 237
Query: 275 GD-PPSLPDGASPEF-----------RSFIECCLQKEFSKRWTASQLLTHPFL 315
            D  PS P  A  +F           RS +   L  + +KR +A   L HPF 
Sbjct: 238 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 94/177 (53%), Gaps = 7/177 (3%)
Query: 50  YSDLEKLQ-VLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRT 106
           +SD  K Q VLG G+ G V   + + T +  A+KV+        T +  + RE+++L++ 
Sbjct: 24  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
           D P I++ +  FE   G   ++ E    G L   +     FSE   A I  Q+L G++Y+
Sbjct: 84  DHPNIMKLYEFFE-DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYM 142
Query: 167 HGHKIIHRDIKPSNLLVN--NNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
           H +KI+HRD+KP NLL+   + +  ++I DFG+S     S       +GT  Y++PE
Sbjct: 143 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPE 198

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 127/281 (45%), Gaps = 35/281 (12%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           QVLG G  G V ++ ++ T + +ALK++     P  RR+V  E+   R +  P IV+   
Sbjct: 22  QVLGLGINGKVLQIFNKRTQEKFALKMLQDC--PKARREV--ELH-WRASQCPHIVRIVD 76
Query: 117 IFEKPSGD---IAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKI 171
           ++E        + I+ME +D G L + +   G   F+E + + I   I + + YLH   I
Sbjct: 77  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 136
Query: 172 IHRDIKPSNLLVNNN--NMQVKIADFGVSKIMCRSLDACNSYVGTC---AYMSPERFDPD 226
            HRD+KP NLL  +   N  +K+ DFG +K       + NS    C    Y++PE   P+
Sbjct: 137 AHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSHNSLTEPCYTPYYVAPEVLGPE 192
Query: 227 XXXXXXXXXXXDIWSXXXXXXXXXXGHFPF-------LQPGQRPDWATLMCAICFGDPPS 279
                      D+WS          G+ PF       + PG +      M    F +P  
Sbjct: 193 -----KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT--RIRMGQYEFPNPEW 245
Query: 280 LPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR 320
                S E +  I   L+ E ++R T ++ + HP++ ++ +
Sbjct: 246 --SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 284

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 128/278 (46%), Gaps = 29/278 (10%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           QVLG G  G V ++ ++ T + +ALK++     P  RR+V  E+   R +  P IV+   
Sbjct: 38  QVLGLGINGKVLQIFNKRTQEKFALKMLQDC--PKARREV--ELH-WRASQCPHIVRIVD 92
Query: 117 IFEKPSGD---IAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKI 171
           ++E        + I+ME +D G L + +   G   F+E + + I   I + + YLH   I
Sbjct: 93  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 152
Query: 172 IHRDIKPSNLLVNNN--NMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
            HRD+KP NLL  +   N  +K+ DFG +K    S ++  +   T  Y++PE   P+   
Sbjct: 153 AHRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPE--- 208
Query: 230 XXXXXXXXDIWSXXXXXXXXXXGHFPF-------LQPGQRPDWATLMCAICFGDPPSLPD 282
                   D+WS          G+ PF       + PG +      M    F +P     
Sbjct: 209 --KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT--RIRMGQYEFPNPEW--S 262
Query: 283 GASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR 320
             S E +  I   L+ E ++R T ++ + HP++ ++ +
Sbjct: 263 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 300

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 123/293 (41%), Gaps = 36/293 (12%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSP 109
            + +K++ +G G  G VYK +++ T ++ ALK +  D +   V     RE+ +L+  + P
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIAS---QILKGLSYL 166
            IV+   +       + ++ E++    L T ++ +     P L  I S   Q+L+GL++ 
Sbjct: 62  NIVKLLDVIHT-ENKLYLVFEHVHQD-LKTFMDASALTGIP-LPLIKSYLFQLLQGLAFC 118
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPD 226
           H H+++HRD+KP NLL+N     +K+ADFG+++     +      V T  Y +PE     
Sbjct: 119 HSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL--- 174
Query: 227 XXXXXXXXXXXDIWSX--XXXXXXXXXGHFP----------FLQPGQRPDWATLMCAICF 274
                      DIWS              FP            +    PD          
Sbjct: 175 -LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 275 GD-PPSLPDGASPEF-----------RSFIECCLQKEFSKRWTASQLLTHPFL 315
            D  PS P  A  +F           RS +   L  + +KR +A   L HPF 
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 122/279 (43%), Gaps = 24/279 (8%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD---ADPTVRRQVFREMEILR 104
           +  ++ E L++LG G  G V  V+ + T + YA+K++  +   A   V      E  +L+
Sbjct: 6   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVA-HTLTENRVLQ 64
Query: 105 RTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLS 164
            +  PF+      F+     +  +MEY + G L   L++   FSE +     ++I+  L 
Sbjct: 65  NSRHPFLTALKYSFQ-THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD 123
Query: 165 YLHGHK-IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF 223
           YLH  K +++RD+K  NL+++ +   +KI DFG+ K   +       + GT  Y++PE  
Sbjct: 124 YLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVL 182
Query: 224 DPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFL-QPGQRPDWATLMCAICFGDPPSLPD 282
           + +           D W           G  PF  Q  ++     LM  I F      P 
Sbjct: 183 EDN-----DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF------PR 231
Query: 283 GASPEFRSFIECCLQKEFSKRW-----TASQLLTHPFLC 316
              PE +S +   L+K+  +R       A +++ H F  
Sbjct: 232 TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 270

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 119/291 (40%), Gaps = 32/291 (10%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSP 109
            + +K++ +G G  G VYK +++ T ++ ALK +  D +   V     RE+ +L+  + P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILKGLSYLHG 168
            IV+   +       + ++ E++     D +     T    P +     Q+L+GL++ H 
Sbjct: 63  NIVKLLDVIHT-ENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXX 228
           H+++HRD+KP NLL+N     +K+ADFG+++     +      V T  Y +PE       
Sbjct: 122 HRVLHRDLKPENLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL----L 176
Query: 229 XXXXXXXXXDIWSX--XXXXXXXXXGHFP----------FLQPGQRPDWATLMCAICFGD 276
                    DIWS              FP            +    PD           D
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 236
Query: 277 -PPSLPDGASPEF-----------RSFIECCLQKEFSKRWTASQLLTHPFL 315
             PS P  A  +F           RS +   L  + +KR +A   L HPF 
Sbjct: 237 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 94/177 (53%), Gaps = 7/177 (3%)
Query: 50  YSDLEKLQ-VLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRT 106
           +SD  K Q VLG G+ G V   + + T +  A+KV+        T +  + RE+++L++ 
Sbjct: 47  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 106
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
           D P I++ +  FE   G   ++ E    G L   +     FSE   A I  Q+L G++Y+
Sbjct: 107 DHPNIMKLYEFFE-DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYM 165
Query: 167 HGHKIIHRDIKPSNLLVN--NNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
           H +KI+HRD+KP NLL+   + +  ++I DFG+S     S       +GT  Y++PE
Sbjct: 166 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPE 221

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 92/168 (54%), Gaps = 6/168 (3%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSPFIVQ 113
           ++ LG G+ G V    H  T +  ALK+++    A   ++ ++ RE+  LR    P I++
Sbjct: 9   VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIK 68
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
            + +  K   +I +++EY  +   D ++ ++   SE +      QI+  + Y H HKI+H
Sbjct: 69  LYDVI-KSKDEIIMVIEYAGNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKIVH 126
Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
           RD+KP NLL+ + ++ VKIADFG+S IM    +   +  G+  Y +PE
Sbjct: 127 RDLKPENLLL-DEHLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPE 172

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 92/168 (54%), Gaps = 6/168 (3%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSPFIVQ 113
           ++ LG G+ G V    H  T +  ALK+++    A   ++ ++ RE+  LR    P I++
Sbjct: 18  VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIK 77
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
            + +  K   +I +++EY  +   D ++ ++   SE +      QI+  + Y H HKI+H
Sbjct: 78  LYDVI-KSKDEIIMVIEYAGNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKIVH 135
Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
           RD+KP NLL+ + ++ VKIADFG+S IM    +   +  G+  Y +PE
Sbjct: 136 RDLKPENLLL-DEHLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPE 181

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 92/168 (54%), Gaps = 6/168 (3%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSPFIVQ 113
           ++ LG G+ G V    H  T +  ALK+++    A   ++ ++ RE+  LR    P I++
Sbjct: 19  VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIK 78
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
            + +  K   +I +++EY  +   D ++ ++   SE +      QI+  + Y H HKI+H
Sbjct: 79  LYDVI-KSKDEIIMVIEYAGNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKIVH 136
Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
           RD+KP NLL+ + ++ VKIADFG+S IM    +   +  G+  Y +PE
Sbjct: 137 RDLKPENLLL-DEHLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPE 182

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/178 (33%), Positives = 98/178 (55%), Gaps = 9/178 (5%)
Query: 50  YSDLEKLQ-VLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRT 106
           +SD  K Q VLG G+ G V   + + T +  A+KV+        T +  + RE+++L++ 
Sbjct: 48  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 107
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSY 165
           D P I++ +  FE   G   ++ E    G L D ++++   FSE   A I  Q+L G++Y
Sbjct: 108 DHPNIMKLYEFFE-DKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITY 165
Query: 166 LHGHKIIHRDIKPSNLLVN--NNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
           +H +KI+HRD+KP NLL+   + +  ++I DFG+S     S       +GT  Y++PE
Sbjct: 166 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPE 222

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 122/279 (43%), Gaps = 24/279 (8%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD---ADPTVRRQVFREMEILR 104
           +  ++ E L++LG G  G V  V+ + T + YA+K++  +   A   V      E  +L+
Sbjct: 7   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVA-HTLTENRVLQ 65
Query: 105 RTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLS 164
            +  PF+      F+     +  +MEY + G L   L++   FSE +     ++I+  L 
Sbjct: 66  NSRHPFLTALKYSFQ-THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD 124
Query: 165 YLHGHK-IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF 223
           YLH  K +++RD+K  NL+++ +   +KI DFG+ K   +       + GT  Y++PE  
Sbjct: 125 YLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVL 183
Query: 224 DPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFL-QPGQRPDWATLMCAICFGDPPSLPD 282
           + +           D W           G  PF  Q  ++     LM  I F      P 
Sbjct: 184 EDN-----DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF------PR 232
Query: 283 GASPEFRSFIECCLQKEFSKRW-----TASQLLTHPFLC 316
              PE +S +   L+K+  +R       A +++ H F  
Sbjct: 233 TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 271

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 122/279 (43%), Gaps = 24/279 (8%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD---ADPTVRRQVFREMEILR 104
           +  ++ E L++LG G  G V  V+ + T + YA+K++  +   A   V      E  +L+
Sbjct: 5   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVA-HTLTENRVLQ 63
Query: 105 RTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLS 164
            +  PF+      F+     +  +MEY + G L   L++   FSE +     ++I+  L 
Sbjct: 64  NSRHPFLTALKYSFQ-THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD 122
Query: 165 YLHGHK-IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF 223
           YLH  K +++RD+K  NL+++ +   +KI DFG+ K   +       + GT  Y++PE  
Sbjct: 123 YLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVL 181
Query: 224 DPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFL-QPGQRPDWATLMCAICFGDPPSLPD 282
           + +           D W           G  PF  Q  ++     LM  I F      P 
Sbjct: 182 EDN-----DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF------PR 230
Query: 283 GASPEFRSFIECCLQKEFSKRW-----TASQLLTHPFLC 316
              PE +S +   L+K+  +R       A +++ H F  
Sbjct: 231 TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 269

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 92/168 (54%), Gaps = 6/168 (3%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSPFIVQ 113
           ++ LG G+ G V    H  T +  ALK+++    A   ++ ++ RE+  LR    P I++
Sbjct: 13  VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIK 72
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
            + +  K   +I +++EY  +   D ++ ++   SE +      QI+  + Y H HKI+H
Sbjct: 73  LYDVI-KSKDEIIMVIEYAGNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKIVH 130
Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
           RD+KP NLL+ + ++ VKIADFG+S IM    +   +  G+  Y +PE
Sbjct: 131 RDLKPENLLL-DEHLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPE 176

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 120/297 (40%), Gaps = 44/297 (14%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSP 109
            + +K++ +G G  G VYK +++ T ++ ALK +  D +   V     RE+ +L+  + P
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 110 FIVQCFGIFEKPSGDIAI-------LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
            IV+   +    +    +       L ++MD+  L  +         P +     Q+L+G
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI-------PLPLIKSYLFQLLQG 122
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
           L++ H H+++HRD+KP NLL+N     +K+ADFG+++     +      V T  Y +PE 
Sbjct: 123 LAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 181
Query: 223 FDPDXXXXXXXXXXXDIWSX--XXXXXXXXXGHFP----------FLQPGQRPDWATLMC 270
                          DIWS              FP            +    PD      
Sbjct: 182 L----LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 237
Query: 271 AICFGD-PPSLPDGASPEF-----------RSFIECCLQKEFSKRWTASQLLTHPFL 315
                D  PS P  A  +F           RS +   L  + +KR +A   L HPF 
Sbjct: 238 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 294

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 120/297 (40%), Gaps = 44/297 (14%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSP 109
            + +K++ +G G  G VYK +++ T ++ ALK +  D +   V     RE+ +L+  + P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 110 FIVQCFGIFEKPSGDIAI-------LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
            IV+   +    +    +       L ++MD+  L  +         P +     Q+L+G
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI-------PLPLIKSYLFQLLQG 115
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
           L++ H H+++HRD+KP NLL+N     +K+ADFG+++     +      V T  Y +PE 
Sbjct: 116 LAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 174
Query: 223 FDPDXXXXXXXXXXXDIWSX--XXXXXXXXXGHFP----------FLQPGQRPDWATLMC 270
                          DIWS              FP            +    PD      
Sbjct: 175 L----LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230
Query: 271 AICFGD-PPSLPDGASPEF-----------RSFIECCLQKEFSKRWTASQLLTHPFL 315
                D  PS P  A  +F           RS +   L  + +KR +A   L HPF 
Sbjct: 231 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 120/297 (40%), Gaps = 44/297 (14%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSP 109
            + +K++ +G G  G VYK +++ T ++ ALK +  D +   V     RE+ +L+  + P
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 110 FIVQCFGIFEKPSGDIAI-------LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
            IV+   +    +    +       L ++MD+  L  +         P +     Q+L+G
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI-------PLPLIKSYLFQLLQG 114
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
           L++ H H+++HRD+KP NLL+N     +K+ADFG+++     +      V T  Y +PE 
Sbjct: 115 LAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 173
Query: 223 FDPDXXXXXXXXXXXDIWSX--XXXXXXXXXGHFP----------FLQPGQRPDWATLMC 270
                          DIWS              FP            +    PD      
Sbjct: 174 L----LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229
Query: 271 AICFGD-PPSLPDGASPEF-----------RSFIECCLQKEFSKRWTASQLLTHPFL 315
                D  PS P  A  +F           RS +   L  + +KR +A   L HPF 
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 120/297 (40%), Gaps = 44/297 (14%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSP 109
            + +K++ +G G  G VYK +++ T ++ ALK +  D +   V     RE+ +L+  + P
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 110 FIVQCFGIFEKPSGDIAI-------LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
            IV+   +    +    +       L ++MD+  L  +         P +     Q+L+G
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI-------PLPLIKSYLFQLLQG 114
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
           L++ H H+++HRD+KP NLL+N     +K+ADFG+++     +      V T  Y +PE 
Sbjct: 115 LAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 173
Query: 223 FDPDXXXXXXXXXXXDIWSX--XXXXXXXXXGHFP----------FLQPGQRPDWATLMC 270
                          DIWS              FP            +    PD      
Sbjct: 174 L----LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229
Query: 271 AICFGD-PPSLPDGASPEF-----------RSFIECCLQKEFSKRWTASQLLTHPFL 315
                D  PS P  A  +F           RS +   L  + +KR +A   L HPF 
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 120/297 (40%), Gaps = 44/297 (14%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSP 109
            + +K++ +G G  G VYK +++ T ++ ALK +  D +   V     RE+ +L+  + P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 110 FIVQCFGIFEKPSGDIAI-------LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
            IV+   +    +    +       L ++MD+  L  +         P +     Q+L+G
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI-------PLPLIKSYLFQLLQG 115
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
           L++ H H+++HRD+KP NLL+N     +K+ADFG+++     +      V T  Y +PE 
Sbjct: 116 LAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 174
Query: 223 FDPDXXXXXXXXXXXDIWSX--XXXXXXXXXGHFP----------FLQPGQRPDWATLMC 270
                          DIWS              FP            +    PD      
Sbjct: 175 L----LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230
Query: 271 AICFGD-PPSLPDGASPEF-----------RSFIECCLQKEFSKRWTASQLLTHPFL 315
                D  PS P  A  +F           RS +   L  + +KR +A   L HPF 
Sbjct: 231 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 121/300 (40%), Gaps = 44/300 (14%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRT 106
           +   + +K++ +G G  G VYK +++ T ++ ALK +  D +   V     RE+ +L+  
Sbjct: 4   VDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 107 DSPFIVQCFGIFEKPSGDIAI-------LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQI 159
           + P IV+   +    +    +       L ++MD+  L  +         P +     Q+
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI-------PLPLIKSYLFQL 116
Query: 160 LKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMS 219
           L+GL++ H H+++HRD+KP NLL+N     +K+ADFG+++     +      V T  Y +
Sbjct: 117 LQGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRA 175
Query: 220 PERFDPDXXXXXXXXXXXDIWSX--XXXXXXXXXGHFP----------FLQPGQRPDWAT 267
           PE                DIWS              FP            +    PD   
Sbjct: 176 PEIL----LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 231
Query: 268 LMCAICFGD-PPSLPDGASPEF-----------RSFIECCLQKEFSKRWTASQLLTHPFL 315
                   D  PS P  A  +F           RS +   L  + +KR +A   L HPF 
Sbjct: 232 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 291

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 123/274 (44%), Gaps = 16/274 (5%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH--GDADPTVRRQVFREMEILRRTDSPFI 111
           E ++ +G GN G    ++ + ++++ A+K +      D  V+R++       R    P I
Sbjct: 21  ELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINH----RSLRHPNI 76
Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
           V+   +   P+  +AI+MEY   G L   +   G FSE +      Q++ G+SY H  ++
Sbjct: 77  VRFKEVILTPT-HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 135
Query: 172 IHRDIKPSNLLVNNNNM-QVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
            HRD+K  N L++ +   ++KI DFG SK          S VGT AY++PE         
Sbjct: 136 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVL----LKK 190
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA--SPEF 288
                  D+WS          G +PF  P +  ++   +  I      ++PD    SPE 
Sbjct: 191 EYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-LNVQYAIPDYVHISPEC 249
Query: 289 RSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSD 322
           R  I      + +KR +  ++  H +  KN  +D
Sbjct: 250 RHLISRIFVADPAKRISIPEIRNHEWFLKNLPAD 283

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 120/297 (40%), Gaps = 44/297 (14%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSP 109
            + +K++ +G G  G VYK +++ T ++ ALK +  D +   V     RE+ +L+  + P
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 110 FIVQCFGIFEKPSGDIAI-------LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
            IV+   +    +    +       L ++MD+  L  +         P +     Q+L+G
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI-------PLPLIKSYLFQLLQG 116
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
           L++ H H+++HRD+KP NLL+N     +K+ADFG+++     +      V T  Y +PE 
Sbjct: 117 LAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 175
Query: 223 FDPDXXXXXXXXXXXDIWSX--XXXXXXXXXGHFP----------FLQPGQRPDWATLMC 270
                          DIWS              FP            +    PD      
Sbjct: 176 L----LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 231
Query: 271 AICFGD-PPSLPDGASPEF-----------RSFIECCLQKEFSKRWTASQLLTHPFL 315
                D  PS P  A  +F           RS +   L  + +KR +A   L HPF 
Sbjct: 232 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 120/297 (40%), Gaps = 44/297 (14%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSP 109
            + +K++ +G G  G VYK +++ T ++ ALK +  D +   V     RE+ +L+  + P
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 110 FIVQCFGIFEKPSGDIAI-------LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
            IV+   +    +    +       L ++MD+  L  +         P +     Q+L+G
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI-------PLPLIKSYLFQLLQG 114
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
           L++ H H+++HRD+KP NLL+N     +K+ADFG+++     +      V T  Y +PE 
Sbjct: 115 LAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 173
Query: 223 FDPDXXXXXXXXXXXDIWSX--XXXXXXXXXGHFP----------FLQPGQRPDWATLMC 270
                          DIWS              FP            +    PD      
Sbjct: 174 L----LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229
Query: 271 AICFGD-PPSLPDGASPEF-----------RSFIECCLQKEFSKRWTASQLLTHPFL 315
                D  PS P  A  +F           RS +   L  + +KR +A   L HPF 
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 123/272 (45%), Gaps = 12/272 (4%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           E ++ +G GN G    ++ + ++++ A+K +  +    +   V RE+   R    P IV+
Sbjct: 22  ELVKDIGSGNFGVARLMRDKQSNELVAVKYI--ERGEKIAANVKREIINHRSLRHPNIVR 79
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
              +   P+  +AI+MEY   G L   +   G FSE +      Q++ G+SY H  ++ H
Sbjct: 80  FKEVILTPT-HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 138
Query: 174 RDIKPSNLLVNNNNM-QVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXX 232
           RD+K  N L++ +   ++KI DFG SK          S VGT AY++PE           
Sbjct: 139 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVL----LKKEY 193
Query: 233 XXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA--SPEFRS 290
                D+WS          G +PF  P +  ++   +  I      ++PD    SPE R 
Sbjct: 194 DGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-LNVQYAIPDYVHISPECRH 252
Query: 291 FIECCLQKEFSKRWTASQLLTHPFLCKNRRSD 322
            I      + +KR +  ++  H +  KN  +D
Sbjct: 253 LISRIFVADPAKRISIPEIRNHEWFLKNLPAD 284

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 120/297 (40%), Gaps = 44/297 (14%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSP 109
            + +K++ +G G  G VYK +++ T ++ ALK +  D +   V     RE+ +L+  + P
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 110 FIVQCFGIFEKPSGDIAI-------LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
            IV+   +    +    +       L ++MD+  L  +         P +     Q+L+G
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI-------PLPLIKSYLFQLLQG 116
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
           L++ H H+++HRD+KP NLL+N     +K+ADFG+++     +      V T  Y +PE 
Sbjct: 117 LAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 175
Query: 223 FDPDXXXXXXXXXXXDIWSX--XXXXXXXXXGHFP----------FLQPGQRPDWATLMC 270
                          DIWS              FP            +    PD      
Sbjct: 176 L----LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 231
Query: 271 AICFGD-PPSLPDGASPEF-----------RSFIECCLQKEFSKRWTASQLLTHPFL 315
                D  PS P  A  +F           RS +   L  + +KR +A   L HPF 
Sbjct: 232 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 120/297 (40%), Gaps = 44/297 (14%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSP 109
            + +K++ +G G  G VYK +++ T ++ ALK +  D +   V     RE+ +L+  + P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 110 FIVQCFGIFEKPSGDIAI-------LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
            IV+   +    +    +       L ++MD+  L  +         P +     Q+L+G
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI-------PLPLIKSYLFQLLQG 115
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
           L++ H H+++HRD+KP NLL+N     +K+ADFG+++     +      V T  Y +PE 
Sbjct: 116 LAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 223 FDPDXXXXXXXXXXXDIWSX--XXXXXXXXXGHFP----------FLQPGQRPDWATLMC 270
                          DIWS              FP            +    PD      
Sbjct: 175 L----LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230
Query: 271 AICFGD-PPSLPDGASPEF-----------RSFIECCLQKEFSKRWTASQLLTHPFL 315
                D  PS P  A  +F           RS +   L  + +KR +A   L HPF 
Sbjct: 231 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 120/297 (40%), Gaps = 44/297 (14%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSP 109
            + +K++ +G G  G VYK +++ T ++ ALK +  D +   V     RE+ +L+  + P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 110 FIVQCFGIFEKPSGDIAI-------LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
            IV+   +    +    +       L ++MD+  L  +         P +     Q+L+G
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI-------PLPLIKSYLFQLLQG 115
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
           L++ H H+++HRD+KP NLL+N     +K+ADFG+++     +      V T  Y +PE 
Sbjct: 116 LAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 223 FDPDXXXXXXXXXXXDIWSX--XXXXXXXXXGHFP----------FLQPGQRPDWATLMC 270
                          DIWS              FP            +    PD      
Sbjct: 175 L----LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230
Query: 271 AICFGD-PPSLPDGASPEF-----------RSFIECCLQKEFSKRWTASQLLTHPFL 315
                D  PS P  A  +F           RS +   L  + +KR +A   L HPF 
Sbjct: 231 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 120/297 (40%), Gaps = 44/297 (14%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSP 109
            + +K++ +G G  G VYK +++ T ++ ALK +  D +   V     RE+ +L+  + P
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 110 FIVQCFGIFEKPSGDIAI-------LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
            IV+   +    +    +       L ++MD+  L  +         P +     Q+L+G
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI-------PLPLIKSYLFQLLQG 116
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
           L++ H H+++HRD+KP NLL+N     +K+ADFG+++     +      V T  Y +PE 
Sbjct: 117 LAFCHSHRVLHRDLKPENLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 175
Query: 223 FDPDXXXXXXXXXXXDIWSX--XXXXXXXXXGHFP----------FLQPGQRPDWATLMC 270
                          DIWS              FP            +    PD      
Sbjct: 176 L----LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 231
Query: 271 AICFGD-PPSLPDGASPEF-----------RSFIECCLQKEFSKRWTASQLLTHPFL 315
                D  PS P  A  +F           RS +   L  + +KR +A   L HPF 
Sbjct: 232 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 120/297 (40%), Gaps = 44/297 (14%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSP 109
            + +K++ +G G  G VYK +++ T ++ ALK +  D +   V     RE+ +L+  + P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 110 FIVQCFGIFEKPSGDIAI-------LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
            IV+   +    +    +       L ++MD+  L  +         P +     Q+L+G
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI-------PLPLIKSYLFQLLQG 115
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
           L++ H H+++HRD+KP NLL+N     +K+ADFG+++     +      V T  Y +PE 
Sbjct: 116 LAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 223 FDPDXXXXXXXXXXXDIWSX--XXXXXXXXXGHFP----------FLQPGQRPDWATLMC 270
                          DIWS              FP            +    PD      
Sbjct: 175 L----LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230
Query: 271 AICFGD-PPSLPDGASPEF-----------RSFIECCLQKEFSKRWTASQLLTHPFL 315
                D  PS P  A  +F           RS +   L  + +KR +A   L HPF 
Sbjct: 231 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 120/297 (40%), Gaps = 44/297 (14%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSP 109
            + +K++ +G G  G VYK +++ T ++ ALK +  D +   V     RE+ +L+  + P
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 110 FIVQCFGIFEKPSGDIAI-------LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
            IV+   +    +    +       L ++MD+  L  +         P +     Q+L+G
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI-------PLPLIKSYLFQLLQG 114
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
           L++ H H+++HRD+KP NLL+N     +K+ADFG+++     +      V T  Y +PE 
Sbjct: 115 LAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 173
Query: 223 FDPDXXXXXXXXXXXDIWSX--XXXXXXXXXGHFP----------FLQPGQRPDWATLMC 270
                          DIWS              FP            +    PD      
Sbjct: 174 L----LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229
Query: 271 AICFGD-PPSLPDGASPEF-----------RSFIECCLQKEFSKRWTASQLLTHPFL 315
                D  PS P  A  +F           RS +   L  + +KR +A   L HPF 
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 120/297 (40%), Gaps = 44/297 (14%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSP 109
            + +K++ +G G  G VYK +++ T ++ ALK +  D +   V     RE+ +L+  + P
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 110 FIVQCFGIFEKPSGDIAI-------LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
            IV+   +    +    +       L ++MD+  L  +         P +     Q+L+G
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI-------PLPLIKSYLFQLLQG 117
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
           L++ H H+++HRD+KP NLL+N     +K+ADFG+++     +      V T  Y +PE 
Sbjct: 118 LAFCHSHRVLHRDLKPENLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 223 FDPDXXXXXXXXXXXDIWSX--XXXXXXXXXGHFP----------FLQPGQRPDWATLMC 270
                          DIWS              FP            +    PD      
Sbjct: 177 L----LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 232
Query: 271 AICFGD-PPSLPDGASPEF-----------RSFIECCLQKEFSKRWTASQLLTHPFL 315
                D  PS P  A  +F           RS +   L  + +KR +A   L HPF 
Sbjct: 233 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 120/297 (40%), Gaps = 44/297 (14%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSP 109
            + +K++ +G G  G VYK +++ T ++ ALK +  D +   V     RE+ +L+  + P
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 110 FIVQCFGIFEKPSGDIAI-------LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
            IV+   +    +    +       L ++MD+  L  +         P +     Q+L+G
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI-------PLPLIKSYLFQLLQG 117
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
           L++ H H+++HRD+KP NLL+N     +K+ADFG+++     +      V T  Y +PE 
Sbjct: 118 LAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 223 FDPDXXXXXXXXXXXDIWSX--XXXXXXXXXGHFP----------FLQPGQRPDWATLMC 270
                          DIWS              FP            +    PD      
Sbjct: 177 L----LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 232
Query: 271 AICFGD-PPSLPDGASPEF-----------RSFIECCLQKEFSKRWTASQLLTHPFL 315
                D  PS P  A  +F           RS +   L  + +KR +A   L HPF 
Sbjct: 233 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 120/297 (40%), Gaps = 44/297 (14%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSP 109
            + +K++ +G G  G VYK +++ T ++ ALK +  D +   V     RE+ +L+  + P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 110 FIVQCFGIFEKPSGDIAI-------LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
            IV+   +    +    +       L ++MD+  L  +         P +     Q+L+G
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI-------PLPLIKSYLFQLLQG 115
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
           L++ H H+++HRD+KP NLL+N     +K+ADFG+++     +      V T  Y +PE 
Sbjct: 116 LAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 223 FDPDXXXXXXXXXXXDIWSX--XXXXXXXXXGHFP----------FLQPGQRPDWATLMC 270
                          DIWS              FP            +    PD      
Sbjct: 175 L----LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230
Query: 271 AICFGD-PPSLPDGASPEF-----------RSFIECCLQKEFSKRWTASQLLTHPFL 315
                D  PS P  A  +F           RS +   L  + +KR +A   L HPF 
Sbjct: 231 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 120/297 (40%), Gaps = 44/297 (14%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSP 109
            + +K++ +G G  G VYK +++ T ++ ALK +  D +   V     RE+ +L+  + P
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 110 FIVQCFGIFEKPSGDIAI-------LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
            IV+   +    +    +       L ++MD+  L  +         P +     Q+L+G
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI-------PLPLIKSYLFQLLQG 118
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
           L++ H H+++HRD+KP NLL+N     +K+ADFG+++     +      V T  Y +PE 
Sbjct: 119 LAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 223 FDPDXXXXXXXXXXXDIWSX--XXXXXXXXXGHFP----------FLQPGQRPDWATLMC 270
                          DIWS              FP            +    PD      
Sbjct: 178 L----LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 233
Query: 271 AICFGD-PPSLPDGASPEF-----------RSFIECCLQKEFSKRWTASQLLTHPFL 315
                D  PS P  A  +F           RS +   L  + +KR +A   L HPF 
Sbjct: 234 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 120/297 (40%), Gaps = 44/297 (14%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSP 109
            + +K++ +G G  G VYK +++ T ++ ALK +  D +   V     RE+ +L+  + P
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 110 FIVQCFGIFEKPSGDIAI-------LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
            IV+   +    +    +       L ++MD+  L  +         P +     Q+L+G
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI-------PLPLIKSYLFQLLQG 118
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
           L++ H H+++HRD+KP NLL+N     +K+ADFG+++     +      V T  Y +PE 
Sbjct: 119 LAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 223 FDPDXXXXXXXXXXXDIWSX--XXXXXXXXXGHFP----------FLQPGQRPDWATLMC 270
                          DIWS              FP            +    PD      
Sbjct: 178 L----LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 233
Query: 271 AICFGD-PPSLPDGASPEF-----------RSFIECCLQKEFSKRWTASQLLTHPFL 315
                D  PS P  A  +F           RS +   L  + +KR +A   L HPF 
Sbjct: 234 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 120/297 (40%), Gaps = 44/297 (14%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSP 109
            + +K++ +G G  G VYK +++ T ++ ALK +  D +   V     RE+ +L+  + P
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 110 FIVQCFGIFEKPSGDIAI-------LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
            IV+   +    +    +       L ++MD+  L  +         P +     Q+L+G
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI-------PLPLIKSYLFQLLQG 117
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
           L++ H H+++HRD+KP NLL+N     +K+ADFG+++     +      V T  Y +PE 
Sbjct: 118 LAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 223 FDPDXXXXXXXXXXXDIWSX--XXXXXXXXXGHFP----------FLQPGQRPDWATLMC 270
                          DIWS              FP            +    PD      
Sbjct: 177 L----LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 232
Query: 271 AICFGD-PPSLPDGASPEF-----------RSFIECCLQKEFSKRWTASQLLTHPFL 315
                D  PS P  A  +F           RS +   L  + +KR +A   L HPF 
Sbjct: 233 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 115/267 (43%), Gaps = 14/267 (5%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVF-REMEILRRTDSPFIVQC 114
            + LG G    V +     T + YA K+++         Q   RE  I R    P IV+ 
Sbjct: 9   FEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRL 68
Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
                +  G   ++ + +  G L   +     +SE   +H   QIL+ +++ H + I+HR
Sbjct: 69  HDSISE-EGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHR 127
Query: 175 DIKPSNLLV--NNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE--RFDPDXXXX 230
           D+KP NLL+   +    VK+ADFG++  +     A   + GT  Y+SPE  R DP     
Sbjct: 128 DLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDP----- 182
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                  D+W+          G+ PF    Q   +  +     +  P    D  +PE + 
Sbjct: 183 --YGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAG-AYDFPSPEWDTVTPEAKD 239
Query: 291 FIECCLQKEFSKRWTASQLLTHPFLCK 317
            I   L    +KR TAS+ L HP++C+
Sbjct: 240 LINKMLTINPAKRITASEALKHPWICQ 266

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 120/297 (40%), Gaps = 44/297 (14%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSP 109
            + +K++ +G G  G VYK +++ T ++ ALK +  D +   V     RE+ +L+  + P
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 110 FIVQCFGIFEKPSGDIAI-------LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
            IV+   +    +    +       L ++MD+  L  +         P +     Q+L+G
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI-------PLPLIKSYLFQLLQG 119
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
           L++ H H+++HRD+KP NLL+N     +K+ADFG+++     +      V T  Y +PE 
Sbjct: 120 LAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 178
Query: 223 FDPDXXXXXXXXXXXDIWSX--XXXXXXXXXGHFP----------FLQPGQRPDWATLMC 270
                          DIWS              FP            +    PD      
Sbjct: 179 L----LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 234
Query: 271 AICFGD-PPSLPDGASPEF-----------RSFIECCLQKEFSKRWTASQLLTHPFL 315
                D  PS P  A  +F           RS +   L  + +KR +A   L HPF 
Sbjct: 235 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 291

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 120/297 (40%), Gaps = 44/297 (14%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSP 109
            + +K++ +G G  G VYK +++ T ++ ALK +  D +   V     RE+ +L+  + P
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 110 FIVQCFGIFEKPSGDIAI-------LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
            IV+   +    +    +       L ++MD+  L  +         P +     Q+L+G
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI-------PLPLIKSYLFQLLQG 116
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
           L++ H H+++HRD+KP NLL+N     +K+ADFG+++     +      V T  Y +PE 
Sbjct: 117 LAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 175
Query: 223 FDPDXXXXXXXXXXXDIWSX--XXXXXXXXXGHFP----------FLQPGQRPDWATLMC 270
                          DIWS              FP            +    PD      
Sbjct: 176 L----LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 231
Query: 271 AICFGD-PPSLPDGASPEF-----------RSFIECCLQKEFSKRWTASQLLTHPFL 315
                D  PS P  A  +F           RS +   L  + +KR +A   L HPF 
Sbjct: 232 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 98/197 (49%), Gaps = 13/197 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           S  ++L+ LG+G   TVYK  ++ T    ALK V  D++        RE+ +++      
Sbjct: 5   SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHEN 64
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPK------LAHIASQILKGLS 164
           IV+ + +       + ++ E+MD+  L   ++     + P+      + +   Q+L+GL+
Sbjct: 65  IVRLYDVIHT-ENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122
Query: 165 YLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD 224
           + H +KI+HRD+KP NLL+N    Q+K+ DFG+++     ++  +S V T  Y +P+   
Sbjct: 123 FCHENKILHRDLKPQNLLINKRG-QLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVL- 180
Query: 225 PDXXXXXXXXXXXDIWS 241
                        DIWS
Sbjct: 181 ---MGSRTYSTSIDIWS 194

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 8/202 (3%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVV-HGDADPTVRRQVFREMEILRRTDSPFIVQC 114
           L+ +G GN   V   +H  T K  A+K++     + +  +++FRE+ I++  + P IV+ 
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
           F + E     + ++MEY   G +   L  +G   E +      QI+  + Y H   I+HR
Sbjct: 79  FEVIETEK-TLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHR 137
Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXX 234
           D+K  NLL+ + +M +KIADFG S       +  +++ G+  Y +PE F           
Sbjct: 138 DLKAENLLL-DADMNIKIADFGFSNEFTFG-NKLDTFCGSPPYAAPELFQ----GKKYDG 191
Query: 235 XXXDIWSXXXXXXXXXXGHFPF 256
              D+WS          G  PF
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPF 213

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 115/266 (43%), Gaps = 19/266 (7%)
Query: 48  IAYSDLEKLQV---LGHGNGGTVYKVQHRCTHKIYALKVVH--GDADPTVRRQVFREMEI 102
           + Y+ L   ++   +G G    VY+          ALK V      D   R    +E+++
Sbjct: 26  MGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDL 85
Query: 103 LRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLN----KNGTFSEPKLAHIASQ 158
           L++ + P +++ +  F +   ++ I++E  D+G L  ++     +     E  +     Q
Sbjct: 86  LKQLNHPNVIKYYASFIE-DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ 144
Query: 159 ILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYM 218
           +   L ++H  +++HRDIKP+N+ +    + VK+ D G+ +       A +S VGT  YM
Sbjct: 145 LCSALEHMHSRRVMHRDIKPANVFITATGV-VKLGDLGLGRFFSSKTTAAHSLVGTPYYM 203
Query: 219 SPERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPP 278
           SPER   +           DIWS             PF   G + +  +L   I   D P
Sbjct: 204 SPERIHEN-----GYNFKSDIWSLGCLLYEMAALQSPFY--GDKMNLYSLCKKIEQCDYP 256
Query: 279 SLP-DGASPEFRSFIECCLQKEFSKR 303
            LP D  S E R  +  C+  +  KR
Sbjct: 257 PLPSDHYSEELRQLVNMCINPDPEKR 282

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 115/263 (43%), Gaps = 18/263 (6%)
Query: 64  GGTVYKVQHRC----THKIYALKVVHGDADPTVRRQVF-REMEILRRTDSPFIVQCFGIF 118
           G   + V  RC    T + YA K+++         Q   RE  I R    P IV+     
Sbjct: 13  GKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI 72
Query: 119 EKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKP 178
            +  G   ++ + +  G L   +     +SE   +H   QIL+ +++ H + I+HRD+KP
Sbjct: 73  SE-EGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKP 131
Query: 179 SNLLV--NNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE--RFDPDXXXXXXXX 234
            NLL+   +    VK+ADFG++  +     A   + GT  Y+SPE  R DP         
Sbjct: 132 ENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDP-------YG 184
Query: 235 XXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIEC 294
              D+W+          G+ PF    Q   +  +  A  +  P    D  +PE +  I  
Sbjct: 185 KPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIK-AGAYDFPSPEWDTVTPEAKDLINK 243
Query: 295 CLQKEFSKRWTASQLLTHPFLCK 317
            L    +KR TAS+ L HP++C+
Sbjct: 244 MLTINPAKRITASEALKHPWICQ 266

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 8/202 (3%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVV-HGDADPTVRRQVFREMEILRRTDSPFIVQC 114
           L+ +G GN   V   +H  T K  A+K++     + +  +++FRE+ I++  + P IV+ 
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
           F + E     + ++MEY   G +   L  +G   E +      QI+  + Y H   I+HR
Sbjct: 79  FEVIETEK-TLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHR 137
Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXX 234
           D+K  NLL+ + +M +KIADFG S       +  +++ G+  Y +PE F           
Sbjct: 138 DLKAENLLL-DADMNIKIADFGFSNEFTFG-NKLDTFCGSPPYAAPELFQ----GKKYDG 191
Query: 235 XXXDIWSXXXXXXXXXXGHFPF 256
              D+WS          G  PF
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPF 213

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 93/177 (52%), Gaps = 7/177 (3%)
Query: 50  YSDLEKLQ-VLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRT 106
           +SD  K Q VLG G+ G V   + + T +  A+KV+        T +  + RE+++L++ 
Sbjct: 24  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
           D P I + +  FE   G   ++ E    G L   +     FSE   A I  Q+L G++Y 
Sbjct: 84  DHPNIXKLYEFFE-DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYX 142
Query: 167 HGHKIIHRDIKPSNLLVN--NNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
           H +KI+HRD+KP NLL+   + +  ++I DFG+S     S    +  +GT  Y++PE
Sbjct: 143 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDK-IGTAYYIAPE 198

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 8/202 (3%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVV-HGDADPTVRRQVFREMEILRRTDSPFIVQC 114
           L+ +G GN   V   +H  T K  A+K++     + +  +++FRE+ I++  + P IV+ 
Sbjct: 12  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 71
Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
           F + E     + ++MEY   G +   L  +G   E +      QI+  + Y H   I+HR
Sbjct: 72  FEVIETEK-TLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKFIVHR 130
Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXX 234
           D+K  NLL+ + +M +KIADFG S       +  +++ G+  Y +PE F           
Sbjct: 131 DLKAENLLL-DADMNIKIADFGFSNEFTFG-NKLDTFCGSPPYAAPELFQ----GKKYDG 184
Query: 235 XXXDIWSXXXXXXXXXXGHFPF 256
              D+WS          G  PF
Sbjct: 185 PEVDVWSLGVILYTLVSGSLPF 206

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/259 (24%), Positives = 110/259 (42%), Gaps = 15/259 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEIL-RRTD 107
           SD   L+V+G G+ G V   +H+     YA+KV+   A       + +  E  +L +   
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
            PF+V     F+  +  +  +++Y++ G L   L +   F EP+    A++I   L YLH
Sbjct: 98  HPFLVGLHFSFQT-ADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH 156
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDX 227
              I++RD+KP N+L+++    + + DFG+ K         +++ GT  Y++PE      
Sbjct: 157 SLNIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPE-----V 210
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPE 287
                     D W           G  PF        +  ++       P  L    +  
Sbjct: 211 LHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL-----NKPLQLKPNITNS 265
Query: 288 FRSFIECCLQKEFSKRWTA 306
            R  +E  LQK+ +KR  A
Sbjct: 266 ARHLLEGLLQKDRTKRLGA 284

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 124/292 (42%), Gaps = 37/292 (12%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           SD E++ VLG G  G V K ++    + YA+K +    +      +  E+ +L   +  +
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL--STILSEVMLLASLNHQY 63
Query: 111 IVQCFGI------FEKP------SGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIAS 157
           +V+ +        F KP         + I MEY ++ TL D + ++N      +   +  
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFR 123
Query: 158 QILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA---------- 207
           QIL+ LSY+H   IIHRD+KP N+ ++ +   VKI DFG++K + RSLD           
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESR-NVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 208 ----CNSYVGTCAYMSPERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRP 263
                 S +GT  Y++ E  D             D++S            +PF    +R 
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDG----TGHYNEKIDMYSLGIIFFEMI---YPFSTGMERV 235
Query: 264 DWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
           +    + ++    PP   D      +  I   +  + +KR  A  LL   +L
Sbjct: 236 NILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 8/202 (3%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVV-HGDADPTVRRQVFREMEILRRTDSPFIVQC 114
           L+ +G GN   V   +H  T K  A+K++     + +  +++FRE+ I++  + P IV+ 
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
           F + E     + ++MEY   G +   L  +G   E +      QI+  + Y H   I+HR
Sbjct: 79  FEVIETEK-TLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHR 137
Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXX 234
           D+K  NLL+ + +M +KIADFG S       +  +++ G   Y +PE F           
Sbjct: 138 DLKAENLLL-DADMNIKIADFGFSNEFTFG-NKLDAFCGAPPYAAPELFQ----GKKYDG 191
Query: 235 XXXDIWSXXXXXXXXXXGHFPF 256
              D+WS          G  PF
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPF 213

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 119/297 (40%), Gaps = 44/297 (14%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSP 109
            + +K++ +G G  G VYK +++ T ++ AL  +  D +   V     RE+ +L+  + P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 110 FIVQCFGIFEKPSGDIAI-------LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
            IV+   +    +    +       L ++MD+  L  +         P +     Q+L+G
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI-------PLPLIKSYLFQLLQG 115
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
           L++ H H+++HRD+KP NLL+N     +K+ADFG+++     +      V T  Y +PE 
Sbjct: 116 LAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 174
Query: 223 FDPDXXXXXXXXXXXDIWSX--XXXXXXXXXGHFP----------FLQPGQRPDWATLMC 270
                          DIWS              FP            +    PD      
Sbjct: 175 L----LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230
Query: 271 AICFGD-PPSLPDGASPEF-----------RSFIECCLQKEFSKRWTASQLLTHPFL 315
                D  PS P  A  +F           RS +   L  + +KR +A   L HPF 
Sbjct: 231 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 119/297 (40%), Gaps = 44/297 (14%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSP 109
            + +K++ +G G  G VYK +++ T ++ AL  +  D +   V     RE+ +L+  + P
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 110 FIVQCFGIFEKPSGDIAI-------LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
            IV+   +    +    +       L ++MD+  L  +         P +     Q+L+G
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI-------PLPLIKSYLFQLLQG 114
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
           L++ H H+++HRD+KP NLL+N     +K+ADFG+++     +      V T  Y +PE 
Sbjct: 115 LAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 173
Query: 223 FDPDXXXXXXXXXXXDIWSX--XXXXXXXXXGHFP----------FLQPGQRPDWATLMC 270
                          DIWS              FP            +    PD      
Sbjct: 174 L----LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229
Query: 271 AICFGD-PPSLPDGASPEF-----------RSFIECCLQKEFSKRWTASQLLTHPFL 315
                D  PS P  A  +F           RS +   L  + +KR +A   L HPF 
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 90/180 (50%), Gaps = 11/180 (6%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA---DPTVRRQVFREMEILR 104
           +  +D   L VLG G+ G V     + T ++YA+K++  D    D  V   +  +  +  
Sbjct: 16  VKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLAL 75
Query: 105 RTDSPFIVQ---CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILK 161
               PF+ Q   CF   ++    +  +MEY++ G L   + + G F EP+    A++I  
Sbjct: 76  LDKPPFLTQLHSCFQTVDR----LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISI 131
Query: 162 GLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
           GL +LH   II+RD+K  N+++++    +KIADFG+ K           + GT  Y++PE
Sbjct: 132 GLFFLHKRGIIYRDLKLDNVMLDSEG-HIKIADFGMCKEHMMDGVTTREFCGTPDYIAPE 190

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 8/202 (3%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVV-HGDADPTVRRQVFREMEILRRTDSPFIVQC 114
           L+ +G GN   V   +H  T K  A++++     + +  +++FRE+ I++  + P IV+ 
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
           F + E     + ++MEY   G +   L  +G   E +      QI+  + Y H   I+HR
Sbjct: 79  FEVIETEK-TLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHR 137
Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXX 234
           D+K  NLL+ + +M +KIADFG S       +  +++ G+  Y +PE F           
Sbjct: 138 DLKAENLLL-DADMNIKIADFGFSNEFTFG-NKLDTFCGSPPYAAPELFQ----GKKYDG 191
Query: 235 XXXDIWSXXXXXXXXXXGHFPF 256
              D+WS          G  PF
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPF 213

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 8/202 (3%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVV-HGDADPTVRRQVFREMEILRRTDSPFIVQC 114
           L+ +G GN   V   +H  T K  A++++     + +  +++FRE+ I++  + P IV+ 
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
           F + E     + ++MEY   G +   L  +G   E +      QI+  + Y H   I+HR
Sbjct: 79  FEVIETEK-TLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHR 137
Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXX 234
           D+K  NLL+ + +M +KIADFG S       +  + + G+  Y +PE F           
Sbjct: 138 DLKAENLLL-DADMNIKIADFGFSNEFTFG-NKLDEFCGSPPYAAPELFQ----GKKYDG 191
Query: 235 XXXDIWSXXXXXXXXXXGHFPF 256
              D+WS          G  PF
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPF 213

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 120/269 (44%), Gaps = 22/269 (8%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           QVLG G  G V +  HR T +  ALK+++    P  R++V    +    +  P IV    
Sbjct: 16  QVLGLGVNGKVLECFHRRTGQKCALKLLYDS--PKARQEVDHHWQA---SGGPHIVCILD 70
Query: 117 IFEKPSGD---IAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKI 171
           ++E        + I+ME M+ G L + + + G   F+E + A I   I   + +LH H I
Sbjct: 71  VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNI 130
Query: 172 IHRDIKPSNLLVNN--NNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
            HRD+KP NLL  +   +  +K+ DFG +K   +  +A  +   T  Y++PE   P+   
Sbjct: 131 AHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ--NALQTPCYTPYYVAPEVLGPE--- 185
Query: 230 XXXXXXXXDIWSXXXXXXXXXXGHFPFL-QPGQ--RPDWATLMCAICFGDPPSLPDGASP 286
                   D+WS          G  PF    GQ   P     +    +G P       S 
Sbjct: 186 --KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSE 243
Query: 287 EFRSFIECCLQKEFSKRWTASQLLTHPFL 315
           + +  I   L+ + ++R T +Q + HP++
Sbjct: 244 DAKQLIRLLLKTDPTERLTITQFMNHPWI 272

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 122/274 (44%), Gaps = 16/274 (5%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH--GDADPTVRRQVFREMEILRRTDSPFI 111
           E ++ +G GN G    ++ + ++++ A+K +      D  V+R++       R    P I
Sbjct: 22  ELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINH----RSLRHPNI 77
Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
           V+   +   P+  +AI+MEY   G L   +   G FSE +      Q++ G+SY H  ++
Sbjct: 78  VRFKEVILTPT-HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 136
Query: 172 IHRDIKPSNLLVNNNNM-QVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
            HRD+K  N L++ +   ++KI  FG SK          S VGT AY++PE         
Sbjct: 137 CHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLH-SQPKSTVGTPAYIAPEVL----LKK 191
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA--SPEF 288
                  D+WS          G +PF  P +  ++   +  I      ++PD    SPE 
Sbjct: 192 EYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-LNVQYAIPDYVHISPEC 250
Query: 289 RSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSD 322
           R  I      + +KR +  ++  H +  KN  +D
Sbjct: 251 RHLISRIFVADPAKRISIPEIRNHEWFLKNLPAD 284

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 120/269 (44%), Gaps = 22/269 (8%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           QVLG G  G V +  HR T +  ALK+++    P  R++V    +    +  P IV    
Sbjct: 35  QVLGLGVNGKVLECFHRRTGQKCALKLLYDS--PKARQEVDHHWQA---SGGPHIVCILD 89
Query: 117 IFEKPSGD---IAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKI 171
           ++E        + I+ME M+ G L + + + G   F+E + A I   I   + +LH H I
Sbjct: 90  VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNI 149
Query: 172 IHRDIKPSNLLVNN--NNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
            HRD+KP NLL  +   +  +K+ DFG +K   +  +A  +   T  Y++PE   P+   
Sbjct: 150 AHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ--NALQTPCYTPYYVAPEVLGPE--- 204
Query: 230 XXXXXXXXDIWSXXXXXXXXXXGHFPFL-QPGQ--RPDWATLMCAICFGDPPSLPDGASP 286
                   D+WS          G  PF    GQ   P     +    +G P       S 
Sbjct: 205 --KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSE 262
Query: 287 EFRSFIECCLQKEFSKRWTASQLLTHPFL 315
           + +  I   L+ + ++R T +Q + HP++
Sbjct: 263 DAKQLIRLLLKTDPTERLTITQFMNHPWI 291

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 80/309 (25%), Positives = 131/309 (42%), Gaps = 46/309 (14%)
Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADP-TVRRQVFREMEILRRTDSPF 110
           + E ++ +G+G  G V   + R T +  A+K +    D  T  ++  RE++IL+      
Sbjct: 55  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDN 114
Query: 111 IVQCFGIFEK--PSGD---IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
           I+    I     P G+   + ++++ M+S  L  +++ +   +   + +   Q+L+GL Y
Sbjct: 115 IIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKY 173
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA----CNSYVGTCAYMSPE 221
           +H  ++IHRD+KPSNLLV N N ++KI DFG+++ +C S          YV T  Y +PE
Sbjct: 174 MHSAQVIHRDLKPSNLLV-NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPE 232
Query: 222 RFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPP--- 278
                           D+WS              F  PG+       +  +  G P    
Sbjct: 233 LM----LSLHEYTQAIDLWSVGCIFGEMLARRQLF--PGKNYVHQLQLIMMVLGTPSPAV 286
Query: 279 --------------SLP-----------DGASPEFRSFIECCLQKEFSKRWTASQLLTHP 313
                         SLP            GA  +  S +   L+ E S R +A+  L HP
Sbjct: 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHP 346
Query: 314 FLCKNRRSD 322
           FL K    D
Sbjct: 347 FLAKYHDPD 355

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 117/270 (43%), Gaps = 18/270 (6%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHG---------DADPTVRRQVFREMEILRRTD 107
           + LG G  G V     R T K  A+K++           +ADP +   V  E+EIL++ +
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL--NVETEIEILKKLN 73
Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
            P I++    F+  + D  I++E M+ G L   +  N    E        Q+L  + YLH
Sbjct: 74  HPCIIKIKNFFD--AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH 131
Query: 168 GHKIIHRDIKPSNLLVNNNNMQ--VKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDP 225
            + IIHRD+KP N+L+++      +KI DFG SKI+  +     +  GT  Y++PE    
Sbjct: 132 ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVL-- 188
Query: 226 DXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS 285
                       D WS          G+ PF +   +      + +  +   P +    S
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 248
Query: 286 PEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
            +    ++  L  +   R+T  + L HP+L
Sbjct: 249 EKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 117/270 (43%), Gaps = 18/270 (6%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHG---------DADPTVRRQVFREMEILRRTD 107
           + LG G  G V     R T K  A+K++           +ADP +   V  E+EIL++ +
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL--NVETEIEILKKLN 73
Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
            P I++    F+  + D  I++E M+ G L   +  N    E        Q+L  + YLH
Sbjct: 74  HPCIIKIKNFFD--AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH 131
Query: 168 GHKIIHRDIKPSNLLVNNNNMQ--VKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDP 225
            + IIHRD+KP N+L+++      +KI DFG SKI+  +     +  GT  Y++PE    
Sbjct: 132 ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVL-- 188
Query: 226 DXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS 285
                       D WS          G+ PF +   +      + +  +   P +    S
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 248
Query: 286 PEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
            +    ++  L  +   R+T  + L HP+L
Sbjct: 249 EKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 117/270 (43%), Gaps = 18/270 (6%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHG---------DADPTVRRQVFREMEILRRTD 107
           + LG G  G V     R T K  A+K++           +ADP +   V  E+EIL++ +
Sbjct: 15  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL--NVETEIEILKKLN 72
Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
            P I++    F+  + D  I++E M+ G L   +  N    E        Q+L  + YLH
Sbjct: 73  HPCIIKIKNFFD--AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH 130
Query: 168 GHKIIHRDIKPSNLLVNNNNMQ--VKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDP 225
            + IIHRD+KP N+L+++      +KI DFG SKI+  +     +  GT  Y++PE    
Sbjct: 131 ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVL-- 187
Query: 226 DXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS 285
                       D WS          G+ PF +   +      + +  +   P +    S
Sbjct: 188 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 247
Query: 286 PEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
            +    ++  L  +   R+T  + L HP+L
Sbjct: 248 EKALDLVKKLLVVDPKARFTTEEALRHPWL 277

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 117/270 (43%), Gaps = 18/270 (6%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHG---------DADPTVRRQVFREMEILRRTD 107
           + LG G  G V     R T K  A+K++           +ADP +   V  E+EIL++ +
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL--NVETEIEILKKLN 73
Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
            P I++    F+  + D  I++E M+ G L   +  N    E        Q+L  + YLH
Sbjct: 74  HPCIIKIKNFFD--AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH 131
Query: 168 GHKIIHRDIKPSNLLVNNNNMQ--VKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDP 225
            + IIHRD+KP N+L+++      +KI DFG SKI+  +     +  GT  Y++PE    
Sbjct: 132 ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVL-- 188
Query: 226 DXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS 285
                       D WS          G+ PF +   +      + +  +   P +    S
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 248
Query: 286 PEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
            +    ++  L  +   R+T  + L HP+L
Sbjct: 249 EKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 96/180 (53%), Gaps = 12/180 (6%)
Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADP-TVRRQVFREMEILRRTDSPF 110
           + E ++ +G+G  G V   + R T +  A+K +    D  T  ++  RE++IL+      
Sbjct: 56  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDN 115
Query: 111 IVQCFGIFEK--PSGD---IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
           I+    I     P G+   + ++++ M+S  L  +++ +   +   + +   Q+L+GL Y
Sbjct: 116 IIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKY 174
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA----CNSYVGTCAYMSPE 221
           +H  ++IHRD+KPSNLLV N N ++KI DFG+++ +C S          YV T  Y +PE
Sbjct: 175 MHSAQVIHRDLKPSNLLV-NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPE 233

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 14/222 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
            D + +Q LG G  G V    +R T +  A+K+V           + +E+ I +  +   
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHEN 66
Query: 111 IVQCFGIFEKPSGDIAIL-MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           +V+ +G   +  G+I  L +EY   G L   +  +    EP       Q++ G+ YLHG 
Sbjct: 67  VVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM--CRSLDACNSYVGTCAYMSPERFDPDX 227
            I HRDIKP NLL++  +  +KI+DFG++ +          N   GT  Y++PE      
Sbjct: 125 GITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL---- 179
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPG----QRPDW 265
                     D+WS          G  P+ QP     +  DW
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 221

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 117/270 (43%), Gaps = 18/270 (6%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHG---------DADPTVRRQVFREMEILRRTD 107
           + LG G  G V     R T K  A+K++           +ADP +   V  E+EIL++ +
Sbjct: 22  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL--NVETEIEILKKLN 79
Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
            P I++    F+  + D  I++E M+ G L   +  N    E        Q+L  + YLH
Sbjct: 80  HPCIIKIKNFFD--AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH 137
Query: 168 GHKIIHRDIKPSNLLVNNNNMQ--VKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDP 225
            + IIHRD+KP N+L+++      +KI DFG SKI+  +     +  GT  Y++PE    
Sbjct: 138 ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVL-- 194
Query: 226 DXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS 285
                       D WS          G+ PF +   +      + +  +   P +    S
Sbjct: 195 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 254
Query: 286 PEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
            +    ++  L  +   R+T  + L HP+L
Sbjct: 255 EKALDLVKKLLVVDPKARFTTEEALRHPWL 284

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 123/274 (44%), Gaps = 16/274 (5%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH--GDADPTVRRQVFREMEILRRTDSPFI 111
           E ++ +G GN G    ++ + ++++ A+K +      D  V+R++       R    P I
Sbjct: 22  ELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINH----RSLRHPNI 77
Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
           V+   +   P+  +AI+MEY   G L   +   G FSE +      Q++ G+SY H  ++
Sbjct: 78  VRFKEVILTPT-HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 136
Query: 172 IHRDIKPSNLLVNNNNM-QVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
            HRD+K  N L++ +   ++KI  FG SK         ++ VGT AY++PE         
Sbjct: 137 CHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDT-VGTPAYIAPEVL----LKK 191
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA--SPEF 288
                  D+WS          G +PF  P +  ++   +  I      ++PD    SPE 
Sbjct: 192 EYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-LNVQYAIPDYVHISPEC 250
Query: 289 RSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSD 322
           R  I      + +KR +  ++  H +  KN  +D
Sbjct: 251 RHLISRIFVADPAKRISIPEIRNHEWFLKNLPAD 284

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 14/222 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
            D + +Q LG G  G V    +R T +  A+K+V           + +E+ I +  +   
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHEN 65
Query: 111 IVQCFGIFEKPSGDIAIL-MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           +V+ +G   +  G+I  L +EY   G L   +  +    EP       Q++ G+ YLHG 
Sbjct: 66  VVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM--CRSLDACNSYVGTCAYMSPERFDPDX 227
            I HRDIKP NLL++  +  +KI+DFG++ +          N   GT  Y++PE      
Sbjct: 124 GITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL---- 178
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPG----QRPDW 265
                     D+WS          G  P+ QP     +  DW
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 220

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/183 (31%), Positives = 93/183 (50%), Gaps = 17/183 (9%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           I Y ++E  +V+G G  G V K + R   K  A+K +  +++   R+    E+  L R +
Sbjct: 6   IDYKEIEVEEVVGRGAFGVVCKAKWRA--KDVAIKQIESESE---RKAFIVELRQLSRVN 60
Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILK---GLS 164
            P IV+ +G    P   + ++MEY + G+L  +L+          AH  S  L+   G++
Sbjct: 61  HPNIVKLYGACLNP---VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 117
Query: 165 YLHGHK---IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
           YLH  +   +IHRD+KP NLL+      +KI DFG +   C       +  G+ A+M+PE
Sbjct: 118 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA---CDIQTHMTNNKGSAAWMAPE 174
Query: 222 RFD 224
            F+
Sbjct: 175 VFE 177

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 14/222 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
            D + +Q LG G  G V    +R T +  A+K+V           + +E+ I +  +   
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHEN 65
Query: 111 IVQCFGIFEKPSGDIAIL-MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           +V+ +G   +  G+I  L +EY   G L   +  +    EP       Q++ G+ YLHG 
Sbjct: 66  VVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM--CRSLDACNSYVGTCAYMSPERFDPDX 227
            I HRDIKP NLL++  +  +KI+DFG++ +          N   GT  Y++PE      
Sbjct: 124 GITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL---- 178
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPG----QRPDW 265
                     D+WS          G  P+ QP     +  DW
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 220

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 115/261 (44%), Gaps = 14/261 (5%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQC 114
           + LG G     Y++    T +++A KVV       P  + ++  E+ I +  D+P +V  
Sbjct: 32  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF 91
Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
            G FE     + +++E     +L  L  +    +EP+  +   Q ++G+ YLH +++IHR
Sbjct: 92  HGFFED-DDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHR 150
Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXX 234
           D+K  NL + N++M VKI DFG++  +    +      GT  Y++PE             
Sbjct: 151 DLKLGNLFL-NDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPE-----VLCKKGHS 204
Query: 235 XXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIEC 294
              DIWS          G  PF     +  +  +       +  S+P   +P   + I  
Sbjct: 205 FEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIK-----KNEYSVPRHINPVASALIRR 259
Query: 295 CLQKEFSKRWTASQLLTHPFL 315
            L  + + R + ++LLT  F 
Sbjct: 260 MLHADPTLRPSVAELLTDEFF 280

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 9/200 (4%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT--VRRQVFREMEILRRTDSPFIVQCFG 116
           LG G  G V   +H+ T    A+K+++     +  V  ++ RE++ L+    P I++ + 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 117 IFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDI 176
           +   P+ D  ++MEY+  G L   + K+G   E +   +  QIL  + Y H H ++HRD+
Sbjct: 79  VISTPT-DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDL 137
Query: 177 KPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXXXX 236
           KP N+L+ + +M  KIADFG+S +M    +   +  G+  Y +PE               
Sbjct: 138 KPENVLL-DAHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVIS----GRLYAGPE 191
Query: 237 XDIWSXXXXXXXXXXGHFPF 256
            DIWS          G  PF
Sbjct: 192 VDIWSCGVILYALLCGTLPF 211

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 116/261 (44%), Gaps = 14/261 (5%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQC 114
           + LG G     Y++    T +++A KVV       P  + ++  E+ I +  D+P +V  
Sbjct: 48  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF 107
Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
            G FE     + +++E     +L  L  +    +EP+  +   Q ++G+ YLH +++IHR
Sbjct: 108 HGFFED-DDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHR 166
Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXX 234
           D+K  NL + N++M VKI DFG++  +    +   +  GT  Y++PE             
Sbjct: 167 DLKLGNLFL-NDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPE-----VLCKKGHS 220
Query: 235 XXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIEC 294
              DIWS          G  PF     +  +  +       +  S+P   +P   + I  
Sbjct: 221 FEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIK-----KNEYSVPRHINPVASALIRR 275
Query: 295 CLQKEFSKRWTASQLLTHPFL 315
            L  + + R + ++LLT  F 
Sbjct: 276 MLHADPTLRPSVAELLTDEFF 296

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 14/222 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
            D + +Q LG G  G V    +R T +  A+K+V           + +E+ I +  +   
Sbjct: 6   EDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 111 IVQCFGIFEKPSGDIAIL-MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           +V+ +G   +  G+I  L +EY   G L   +  +    EP       Q++ G+ YLHG 
Sbjct: 66  VVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM--CRSLDACNSYVGTCAYMSPERFDPDX 227
            I HRDIKP NLL++  +  +KI+DFG++ +          N   GT  Y++PE      
Sbjct: 124 GITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL---- 178
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPG----QRPDW 265
                     D+WS          G  P+ QP     +  DW
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 220

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 57/183 (31%), Positives = 93/183 (50%), Gaps = 17/183 (9%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           I Y ++E  +V+G G  G V K + R   K  A+K +  +++   R+    E+  L R +
Sbjct: 5   IDYKEIEVEEVVGRGAFGVVCKAKWRA--KDVAIKQIESESE---RKAFIVELRQLSRVN 59
Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILK---GLS 164
            P IV+ +G    P   + ++MEY + G+L  +L+          AH  S  L+   G++
Sbjct: 60  HPNIVKLYGACLNP---VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116
Query: 165 YLHGHK---IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
           YLH  +   +IHRD+KP NLL+      +KI DFG +   C       +  G+ A+M+PE
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA---CDIQTHMTNNKGSAAWMAPE 173
Query: 222 RFD 224
            F+
Sbjct: 174 VFE 176

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT--VRRQVFREMEILRRTDSPFIVQCFG 116
           LG G  G V   +H+ T    A+K+++     +  V  ++ RE++ L+    P I++ + 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 117 IFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDI 176
           +   P+ D  ++MEY+  G L   + K+G   E +   +  QIL  + Y H H ++HRD+
Sbjct: 79  VISTPT-DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDL 137
Query: 177 KPSNLLVNNNNMQVKIADFGVSKIMCRS---LDACNSYVGTCAYMSPERFDPDXXXXXXX 233
           KP N+L+ + +M  KIADFG+S +M       D+C    G+  Y +PE            
Sbjct: 138 KPENVLL-DAHMNAKIADFGLSNMMSDGEFLRDSC----GSPNYAAPEVIS----GRLYA 188
Query: 234 XXXXDIWSXXXXXXXXXXGHFPF 256
               DIWS          G  PF
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPF 211

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 97/190 (51%), Gaps = 10/190 (5%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIV 112
           +KL+ +G G  G VYK +     +I ALK +  DA D  +     RE+ +L+    P IV
Sbjct: 24  QKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIV 82
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILKGLSYLHGHKI 171
               +       + ++ E+M+   L  +L++N T   + ++     Q+L+G+++ H H+I
Sbjct: 83  SLIDVIHSERC-LTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRI 140
Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXX 231
           +HRD+KP NLL+N++   +K+ADFG+++     + +    V T  Y +P+          
Sbjct: 141 LHRDLKPQNLLINSDG-ALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVL----MGSK 195
Query: 232 XXXXXXDIWS 241
                 DIWS
Sbjct: 196 KYSTSVDIWS 205

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 97/190 (51%), Gaps = 10/190 (5%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIV 112
           +KL+ +G G  G VYK +     +I ALK +  DA D  +     RE+ +L+    P IV
Sbjct: 24  QKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIV 82
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILKGLSYLHGHKI 171
               +       + ++ E+M+   L  +L++N T   + ++     Q+L+G+++ H H+I
Sbjct: 83  SLIDVIHSERC-LTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRI 140
Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXX 231
           +HRD+KP NLL+N++   +K+ADFG+++     + +    V T  Y +P+          
Sbjct: 141 LHRDLKPQNLLINSDGA-LKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVL----MGSK 195
Query: 232 XXXXXXDIWS 241
                 DIWS
Sbjct: 196 KYSTSVDIWS 205

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 116/259 (44%), Gaps = 25/259 (9%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILR--RTDSPFIVQCFG 116
           LG G+ G V++++ + T    A+K         VR +VFR  E++      SP IV  +G
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVK--------KVRLEVFRAEELMACAGLTSPRIVPLYG 152
Query: 117 -IFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRD 175
            + E P   + I ME ++ G+L  L+ + G   E +  +   Q L+GL YLH  +I+H D
Sbjct: 153 AVREGPW--VNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGD 210
Query: 176 IKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYM--SPERFDPDXXXXXXX 233
           +K  N+L++++     + DFG    +C   D     + T  Y+  +     P+       
Sbjct: 211 VKADNVLLSSDGSHAALCDFG--HAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSC 268
Query: 234 XXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPP---SLPDGASPEFRS 290
               D+WS          G  P+ Q  + P     +C     +PP    +P   +P    
Sbjct: 269 DAKVDVWSSCCMMLHMLNGCHPWTQFFRGP-----LCLKIASEPPPVREIPPSCAPLTAQ 323
Query: 291 FIECCLQKEFSKRWTASQL 309
            I+  L+KE   R +A++L
Sbjct: 324 AIQEGLRKEPIHRVSAAEL 342

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 115/261 (44%), Gaps = 14/261 (5%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQC 114
           + LG G     Y++    T +++A KVV       P  + ++  E+ I +  D+P +V  
Sbjct: 48  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF 107
Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
            G FE     + +++E     +L  L  +    +EP+  +   Q ++G+ YLH +++IHR
Sbjct: 108 HGFFED-DDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHR 166
Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXX 234
           D+K  NL + N++M VKI DFG++  +    +      GT  Y++PE             
Sbjct: 167 DLKLGNLFL-NDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPE-----VLCKKGHS 220
Query: 235 XXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIEC 294
              DIWS          G  PF     +  +  +       +  S+P   +P   + I  
Sbjct: 221 FEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIK-----KNEYSVPRHINPVASALIRR 275
Query: 295 CLQKEFSKRWTASQLLTHPFL 315
            L  + + R + ++LLT  F 
Sbjct: 276 MLHADPTLRPSVAELLTDEFF 296

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 117/270 (43%), Gaps = 18/270 (6%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHG---------DADPTVRRQVFREMEILRRTD 107
           + LG G  G V     R T K  A++++           +ADP +   V  E+EIL++ +
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPAL--NVETEIEILKKLN 198
Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
            P I++    F+  + D  I++E M+ G L   +  N    E        Q+L  + YLH
Sbjct: 199 HPCIIKIKNFFD--AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH 256
Query: 168 GHKIIHRDIKPSNLLVNNNNMQ--VKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDP 225
            + IIHRD+KP N+L+++      +KI DFG SKI+  +     +  GT  Y++PE    
Sbjct: 257 ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVL-- 313
Query: 226 DXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS 285
                       D WS          G+ PF +   +      + +  +   P +    S
Sbjct: 314 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 373
Query: 286 PEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
            +    ++  L  +   R+T  + L HP+L
Sbjct: 374 EKALDLVKKLLVVDPKARFTTEEALRHPWL 403

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 117/270 (43%), Gaps = 18/270 (6%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHG---------DADPTVRRQVFREMEILRRTD 107
           + LG G  G V     R T K  A++++           +ADP +   V  E+EIL++ +
Sbjct: 155 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPAL--NVETEIEILKKLN 212
Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
            P I++    F+  + D  I++E M+ G L   +  N    E        Q+L  + YLH
Sbjct: 213 HPCIIKIKNFFD--AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH 270
Query: 168 GHKIIHRDIKPSNLLVNNNNMQ--VKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDP 225
            + IIHRD+KP N+L+++      +KI DFG SKI+  +     +  GT  Y++PE    
Sbjct: 271 ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVL-- 327
Query: 226 DXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS 285
                       D WS          G+ PF +   +      + +  +   P +    S
Sbjct: 328 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 387
Query: 286 PEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
            +    ++  L  +   R+T  + L HP+L
Sbjct: 388 EKALDLVKKLLVVDPKARFTTEEALRHPWL 417

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 115/261 (44%), Gaps = 14/261 (5%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQC 114
           + LG G     Y++    T +++A KVV       P  + ++  E+ I +  D+P +V  
Sbjct: 48  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF 107
Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
            G FE     + +++E     +L  L  +    +EP+  +   Q ++G+ YLH +++IHR
Sbjct: 108 HGFFED-DDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHR 166
Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXX 234
           D+K  NL + N++M VKI DFG++  +    +      GT  Y++PE             
Sbjct: 167 DLKLGNLFL-NDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPE-----VLCKKGHS 220
Query: 235 XXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIEC 294
              DIWS          G  PF     +  +  +       +  S+P   +P   + I  
Sbjct: 221 FEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIK-----KNEYSVPRHINPVASALIRR 275
Query: 295 CLQKEFSKRWTASQLLTHPFL 315
            L  + + R + ++LLT  F 
Sbjct: 276 MLHADPTLRPSVAELLTDEFF 296

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/309 (25%), Positives = 124/309 (40%), Gaps = 54/309 (17%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           SD +   +LG G  G V    H+ T +I A+K +     P    +  RE++IL+      
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHEN 70
Query: 111 IVQCFGIFEKPSG-----DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
           I+  F I ++P       ++ I+ E M +     +  +    S+  + +   Q L+ +  
Sbjct: 71  IITIFNI-QRPDSFENFNEVYIIQELMQTDLHRVISTQ--MLSDDHIQYFIYQTLRAVKV 127
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL----------DACNSYVGTC 215
           LHG  +IHRD+KPSNLL+ N+N  +K+ DFG+++I+  S                YV T 
Sbjct: 128 LHGSNVIHRDLKPSNLLI-NSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATR 186
Query: 216 AYMSPERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFG 275
            Y +PE                D+WS              F  PG+      L+     G
Sbjct: 187 WYRAPEVM----LTSAKYSRAMDVWSCGCILAELFLRRPIF--PGRDYRHQLLLIFGIIG 240
Query: 276 DPPSLPD---GASPEFRSFIECC-------LQKEF-------------------SKRWTA 306
            P S  D     SP  R +I+         L+K F                   +KR TA
Sbjct: 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITA 300
Query: 307 SQLLTHPFL 315
            + L HP+L
Sbjct: 301 KEALEHPYL 309

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 116/259 (44%), Gaps = 25/259 (9%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILR--RTDSPFIVQCFG 116
           LG G+ G V++++ + T    A+K         VR +VFR  E++      SP IV  +G
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVK--------KVRLEVFRAEELMACAGLTSPRIVPLYG 133
Query: 117 -IFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRD 175
            + E P   + I ME ++ G+L  L+ + G   E +  +   Q L+GL YLH  +I+H D
Sbjct: 134 AVREGPW--VNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGD 191
Query: 176 IKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYM--SPERFDPDXXXXXXX 233
           +K  N+L++++     + DFG    +C   D     + T  Y+  +     P+       
Sbjct: 192 VKADNVLLSSDGSHAALCDFG--HAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSC 249
Query: 234 XXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPP---SLPDGASPEFRS 290
               D+WS          G  P+ Q  + P     +C     +PP    +P   +P    
Sbjct: 250 DAKVDVWSSCCMMLHMLNGCHPWTQFFRGP-----LCLKIASEPPPVREIPPSCAPLTAQ 304
Query: 291 FIECCLQKEFSKRWTASQL 309
            I+  L+KE   R +A++L
Sbjct: 305 AIQEGLRKEPIHRVSAAEL 323

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 94/188 (50%), Gaps = 24/188 (12%)
Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
           D ++++++G G  G V+K +HR   K Y +K V  + +     +  RE++ L + D   I
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE-----KAEREVKALAKLDHVNI 66
Query: 112 VQCFGIFEKPSGD---------------IAILMEYMDSGTLDTLLNKN-GTFSEPKLA-H 154
           V   G ++    D               + I ME+ D GTL+  + K  G   +  LA  
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 155 IASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGT 214
           +  QI KG+ Y+H  K+I+RD+KPSN+ + +   QVKI DFG+   +        S  GT
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK-QVKIGDFGLVTSLKNDGKRXRSK-GT 184
Query: 215 CAYMSPER 222
             YMSPE+
Sbjct: 185 LRYMSPEQ 192

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 14/222 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
            D + +Q LG G  G V    +R T +  A+K+V           + +E+ I +  +   
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 111 IVQCFGIFEKPSGDIAIL-MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           +V+ +G   +  G+I  L +EY   G L   +  +    EP       Q++ G+ YLHG 
Sbjct: 66  VVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM--CRSLDACNSYVGTCAYMSPERFDPDX 227
            I HRDIKP NLL++  +  +KI+DFG++ +          N   GT  Y++PE      
Sbjct: 124 GITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL---- 178
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPG----QRPDW 265
                     D+WS          G  P+ QP     +  DW
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 220

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 14/222 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
            D + +Q LG G  G V    +R T +  A+K+V           + +E+ I +  +   
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 111 IVQCFGIFEKPSGDIAIL-MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           +V+ +G   +  G+I  L +EY   G L   +  +    EP       Q++ G+ YLHG 
Sbjct: 66  VVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM--CRSLDACNSYVGTCAYMSPERFDPDX 227
            I HRDIKP NLL++  +  +KI+DFG++ +          N   GT  Y++PE      
Sbjct: 124 GITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL---- 178
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPG----QRPDW 265
                     D+WS          G  P+ QP     +  DW
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 220

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 14/222 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
            D + +Q LG G  G V    +R T +  A+K+V           + +E+ I +  +   
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 111 IVQCFGIFEKPSGDIAIL-MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           +V+ +G   +  G+I  L +EY   G L   +  +    EP       Q++ G+ YLHG 
Sbjct: 67  VVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM--CRSLDACNSYVGTCAYMSPERFDPDX 227
            I HRDIKP NLL++  +  +KI+DFG++ +          N   GT  Y++PE      
Sbjct: 125 GITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL---- 179
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPG----QRPDW 265
                     D+WS          G  P+ QP     +  DW
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 221

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 110/262 (41%), Gaps = 10/262 (3%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVF-REMEILRRTDSPFIVQCFGI 117
           +G G    V +    CT   YA K+++         Q   RE  I R      IV+    
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 118 FEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIK 177
             +  G   ++ + +  G L   +     +SE   +H   QIL+ + + H   ++HRD+K
Sbjct: 72  ISE-EGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLK 130
Query: 178 PSNLLVNN--NNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXXX 235
           P NLL+ +      VK+ADFG++  +     A   + GT  Y+SPE    +         
Sbjct: 131 PENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKE-----AYGK 185
Query: 236 XXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECC 295
             DIW+          G+ PF    Q   +  +  A  +  P    D  +PE ++ I   
Sbjct: 186 PVDIWACGVILYILLVGYPPFWDEDQHKLYQQIK-AGAYDFPSPEWDTVTPEAKNLINQM 244
Query: 296 LQKEFSKRWTASQLLTHPFLCK 317
           L    +KR TA + L HP++C+
Sbjct: 245 LTINPAKRITAHEALKHPWVCQ 266

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 98/190 (51%), Gaps = 9/190 (4%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALK-VVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           E L ++G G+ G V K +++ T +I A+K  +  D D  V++   RE+++L++     +V
Sbjct: 28  ENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLV 87
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTL-LNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
               + +K      ++ E++D   LD L L  NG   +    ++  QI+ G+ + H H I
Sbjct: 88  NLLEVCKKKK-RWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLF-QIINGIGFCHSHNI 145
Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXX 231
           IHRDIKP N+LV+ + + VK+ DFG ++ +    +  +  V T  Y +PE    D     
Sbjct: 146 IHRDIKPENILVSQSGV-VKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGD----V 200
Query: 232 XXXXXXDIWS 241
                 D+W+
Sbjct: 201 KYGKAVDVWA 210

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 16/217 (7%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF--- 115
           LG G  G V +  H+ T +  A+K    +  P  R +   E++I+++ + P +V      
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 82
Query: 116 -GIFEKPSGDIAIL-MEYMDSGTLDTLLNKNGT---FSEPKLAHIASQILKGLSYLHGHK 170
            G+ +    D+ +L MEY + G L   LN+        E  +  + S I   L YLH ++
Sbjct: 83  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR 142
Query: 171 IIHRDIKPSNLLVNNNNMQV--KIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXX 228
           IIHRD+KP N+++     ++  KI D G +K + +  + C  +VGT  Y++PE  +    
Sbjct: 143 IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFVGTLQYLAPELLE---- 197
Query: 229 XXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDW 265
                    D WS          G  PFL   Q   W
Sbjct: 198 -QKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQW 233

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 14/222 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
            D + +Q LG G  G V    +R T +  A+K+V           + +E+ I +  +   
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 111 IVQCFGIFEKPSGDIAIL-MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           +V+ +G   +  G+I  L +EY   G L   +  +    EP       Q++ G+ YLHG 
Sbjct: 66  VVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM--CRSLDACNSYVGTCAYMSPERFDPDX 227
            I HRDIKP NLL++  +  +KI+DFG++ +          N   GT  Y++PE      
Sbjct: 124 GITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL---- 178
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPG----QRPDW 265
                     D+WS          G  P+ QP     +  DW
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 220

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 14/222 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
            D + +Q LG G  G V    +R T +  A+K+V           + +E+ I +  +   
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 111 IVQCFGIFEKPSGDIAIL-MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           +V+ +G   +  G+I  L +EY   G L   +  +    EP       Q++ G+ YLHG 
Sbjct: 66  VVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM--CRSLDACNSYVGTCAYMSPERFDPDX 227
            I HRDIKP NLL++  +  +KI+DFG++ +          N   GT  Y++PE      
Sbjct: 124 GITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL---- 178
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPG----QRPDW 265
                     D+WS          G  P+ QP     +  DW
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 220

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 14/222 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
            D + +Q LG G  G V    +R T +  A+K+V           + +E+ I +  +   
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 111 IVQCFGIFEKPSGDIAIL-MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           +V+ +G   +  G+I  L +EY   G L   +  +    EP       Q++ G+ YLHG 
Sbjct: 66  VVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM--CRSLDACNSYVGTCAYMSPERFDPDX 227
            I HRDIKP NLL++  +  +KI+DFG++ +          N   GT  Y++PE      
Sbjct: 124 GITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL---- 178
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPG----QRPDW 265
                     D+WS          G  P+ QP     +  DW
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 220

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 123/292 (42%), Gaps = 37/292 (12%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           SD E++ VLG G  G V K ++    + YA+K +    +      +  E+ +L   +  +
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL--STILSEVXLLASLNHQY 63
Query: 111 IVQCFGI------FEKPSGDIA------ILMEYMDSGTL-DTLLNKNGTFSEPKLAHIAS 157
           +V+ +        F KP   +       I  EY ++ TL D + ++N      +   +  
Sbjct: 64  VVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFR 123
Query: 158 QILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA---------- 207
           QIL+ LSY+H   IIHR++KP N+ ++ +   VKI DFG++K + RSLD           
Sbjct: 124 QILEALSYIHSQGIIHRNLKPXNIFIDESR-NVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 208 ----CNSYVGTCAYMSPERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRP 263
                 S +GT  Y++ E  D             D +S            +PF    +R 
Sbjct: 183 SSDNLTSAIGTAXYVATEVLDG----TGHYNEKIDXYSLGIIFFEXI---YPFSTGXERV 235
Query: 264 DWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
           +    + ++    PP   D      +  I   +  + +KR  A  LL   +L
Sbjct: 236 NILKKLRSVSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 14/222 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
            D + +Q LG G  G V    +R T +  A+K+V           + +E+ I +  +   
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 111 IVQCFGIFEKPSGDIAIL-MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           +V+ +G   +  G+I  L +EY   G L   +  +    EP       Q++ G+ YLHG 
Sbjct: 66  VVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM--CRSLDACNSYVGTCAYMSPERFDPDX 227
            I HRDIKP NLL++  +  +KI+DFG++ +          N   GT  Y++PE      
Sbjct: 124 GITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL---- 178
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPG----QRPDW 265
                     D+WS          G  P+ QP     +  DW
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 220

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 16/217 (7%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF--- 115
           LG G  G V +  H+ T +  A+K    +  P  R +   E++I+++ + P +V      
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 116 -GIFEKPSGDIAIL-MEYMDSGTLDTLLNKNGT---FSEPKLAHIASQILKGLSYLHGHK 170
            G+ +    D+ +L MEY + G L   LN+        E  +  + S I   L YLH ++
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR 141
Query: 171 IIHRDIKPSNLLVNNNNMQV--KIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXX 228
           IIHRD+KP N+++     ++  KI D G +K + +  + C  +VGT  Y++PE  +    
Sbjct: 142 IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFVGTLQYLAPELLE---- 196
Query: 229 XXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDW 265
                    D WS          G  PFL   Q   W
Sbjct: 197 -QKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQW 232

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 14/222 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
            D + +Q LG G  G V    +R T +  A+K+V           + +E+ I +  +   
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 111 IVQCFGIFEKPSGDIAIL-MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           +V+ +G   +  G+I  L +EY   G L   +  +    EP       Q++ G+ YLHG 
Sbjct: 67  VVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM--CRSLDACNSYVGTCAYMSPERFDPDX 227
            I HRDIKP NLL++  +  +KI+DFG++ +          N   GT  Y++PE      
Sbjct: 125 GITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL---- 179
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPG----QRPDW 265
                     D+WS          G  P+ QP     +  DW
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 221

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 14/222 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
            D + +Q LG G  G V    +R T +  A+K+V           + +E+ I +  +   
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 111 IVQCFGIFEKPSGDIAIL-MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           +V+ +G   +  G+I  L +EY   G L   +  +    EP       Q++ G+ YLHG 
Sbjct: 66  VVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM--CRSLDACNSYVGTCAYMSPERFDPDX 227
            I HRDIKP NLL++  +  +KI+DFG++ +          N   GT  Y++PE      
Sbjct: 124 GITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL---- 178
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPG----QRPDW 265
                     D+WS          G  P+ QP     +  DW
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDW 220

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 14/222 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
            D + +Q LG G  G V    +R T +  A+K+V           + +E+ I +  +   
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 111 IVQCFGIFEKPSGDIAIL-MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           +V+ +G   +  G+I  L +EY   G L   +  +    EP       Q++ G+ YLHG 
Sbjct: 65  VVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM--CRSLDACNSYVGTCAYMSPERFDPDX 227
            I HRDIKP NLL++  +  +KI+DFG++ +          N   GT  Y++PE      
Sbjct: 123 GITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL---- 177
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPG----QRPDW 265
                     D+WS          G  P+ QP     +  DW
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 219

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 14/222 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
            D + +Q LG G  G V    +R T +  A+K+V           + +E+ I +  +   
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 111 IVQCFGIFEKPSGDIAIL-MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           +V+ +G   +  G+I  L +EY   G L   +  +    EP       Q++ G+ YLHG 
Sbjct: 66  VVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM--CRSLDACNSYVGTCAYMSPERFDPDX 227
            I HRDIKP NLL++  +  +KI+DFG++ +          N   GT  Y++PE      
Sbjct: 124 GITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL---- 178
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPG----QRPDW 265
                     D+WS          G  P+ QP     +  DW
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 220

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 14/222 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
            D + +Q LG G  G V    +R T +  A+K+V           + +E+ I +  +   
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 111 IVQCFGIFEKPSGDIAIL-MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           +V+ +G   +  G+I  L +EY   G L   +  +    EP       Q++ G+ YLHG 
Sbjct: 67  VVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM--CRSLDACNSYVGTCAYMSPERFDPDX 227
            I HRDIKP NLL++  +  +KI+DFG++ +          N   GT  Y++PE      
Sbjct: 125 GITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL---- 179
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPG----QRPDW 265
                     D+WS          G  P+ QP     +  DW
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 221

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 14/222 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
            D + +Q LG G  G V    +R T +  A+K+V           + +E+ I +  +   
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 111 IVQCFGIFEKPSGDIAIL-MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           +V+ +G   +  G+I  L +EY   G L   +  +    EP       Q++ G+ YLHG 
Sbjct: 67  VVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM--CRSLDACNSYVGTCAYMSPERFDPDX 227
            I HRDIKP NLL++  +  +KI+DFG++ +          N   GT  Y++PE      
Sbjct: 125 GITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL---- 179
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPG----QRPDW 265
                     D+WS          G  P+ QP     +  DW
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 221

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 14/222 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
            D + +Q LG G  G V    +R T +  A+K+V           + +E+ I +  +   
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 111 IVQCFGIFEKPSGDIAIL-MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           +V+ +G   +  G+I  L +EY   G L   +  +    EP       Q++ G+ YLHG 
Sbjct: 67  VVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM--CRSLDACNSYVGTCAYMSPERFDPDX 227
            I HRDIKP NLL++  +  +KI+DFG++ +          N   GT  Y++PE      
Sbjct: 125 GITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL---- 179
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPG----QRPDW 265
                     D+WS          G  P+ QP     +  DW
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 221

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 125/278 (44%), Gaps = 29/278 (10%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           QVLG G  G V ++ ++ T + +ALK +     P  RR+V  E+   R +  P IV+   
Sbjct: 68  QVLGLGINGKVLQIFNKRTQEKFALKXLQDC--PKARREV--ELH-WRASQCPHIVRIVD 122
Query: 117 IFEKPSGD---IAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKI 171
           ++E        + I+ E +D G L + +   G   F+E + + I   I + + YLH   I
Sbjct: 123 VYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSINI 182
Query: 172 IHRDIKPSNLLVNNN--NMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
            HRD+KP NLL  +   N  +K+ DFG +K    S ++  +   T  Y++PE   P+   
Sbjct: 183 AHRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPE--- 238
Query: 230 XXXXXXXXDIWSXXXXXXXXXXGHFPF-------LQPGQRPDWATLMCAICFGDPPSLPD 282
                   D WS          G+ PF       + PG +    T +    +  P     
Sbjct: 239 --KYDKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXK----TRIRXGQYEFPNPEWS 292
Query: 283 GASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR 320
             S E +  I   L+ E ++R T ++   HP++ ++ +
Sbjct: 293 EVSEEVKXLIRNLLKTEPTQRXTITEFXNHPWIXQSTK 330

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 10/212 (4%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA---DPTVRRQVFREMEILR 104
           +   + E ++VLG G+ G V   + + T  +YA+KV+  D    D  V   +  +  +  
Sbjct: 20  LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79
Query: 105 RTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLS 164
             + PF+ Q F  F+ P   +  +ME+++ G L   + K+  F E +    A++I+  L 
Sbjct: 80  ARNHPFLTQLFCCFQTPD-RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALM 138
Query: 165 YLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD 224
           +LH   II+RD+K  N+L+++     K+ADFG    MC+    CN         +P+   
Sbjct: 139 FLHDKGIIYRDLKLDNVLLDHEG-HCKLADFG----MCKE-GICNGVTTATFCGTPDYIA 192
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPF 256
           P+           D W+          GH PF
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCGHAPF 224

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 89/177 (50%), Gaps = 5/177 (2%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA---DPTVRRQVFREMEILR 104
           +   D E  ++LG G+ G V+  + + T++ +A+K +  D    D  V   +  +  +  
Sbjct: 15  LKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 74
Query: 105 RTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLS 164
             + PF+   F  F+    ++  +MEY++ G L   +     F   +    A++I+ GL 
Sbjct: 75  AWEHPFLTHMFCTFQTKE-NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 133
Query: 165 YLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
           +LH   I++RD+K  N+L++ +   +KIADFG+ K         N + GT  Y++PE
Sbjct: 134 FLHSKGIVYRDLKLDNILLDKDG-HIKIADFGMCKENMLGDAKTNEFCGTPDYIAPE 189

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 14/222 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
            D + +Q LG G  G V    +R T +  A+K+V           + +E+ I +  +   
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 111 IVQCFGIFEKPSGDIAIL-MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           +V+ +G   +  G+I  L +EY   G L   +  +    EP       Q++ G+ YLHG 
Sbjct: 66  VVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM--CRSLDACNSYVGTCAYMSPERFDPDX 227
            I HRDIKP NLL++  +  +KI+DFG++ +          N   GT  Y++PE      
Sbjct: 124 GITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL---- 178
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPG----QRPDW 265
                     D+WS          G  P+ QP     +  DW
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 220

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 116/264 (43%), Gaps = 18/264 (6%)
Query: 59  LGHGNGGTVYK-VQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGI 117
           +G G+  TVYK +    T ++   ++       + R++   E E L+    P IV+ +  
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 118 FE---KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK--II 172
           +E   K    I ++ E   SGTL T L +        L     QILKGL +LH     II
Sbjct: 94  WESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTPPII 153
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXX 232
           HRD+K  N+ +      VKI D G++ +   S     + +GT  + +PE ++        
Sbjct: 154 HRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFXAPEXYEE------K 205
Query: 233 XXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFG-DPPSLPDGASPEFRSF 291
                D+++            +P+    +  + A +   +  G  P S    A PE +  
Sbjct: 206 YDESVDVYAFGXCXLEXATSEYPY---SECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 262
Query: 292 IECCLQKEFSKRWTASQLLTHPFL 315
           IE C+++   +R++   LL H F 
Sbjct: 263 IEGCIRQNKDERYSIKDLLNHAFF 286

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 14/222 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
            D + +Q LG G  G V    +R T +  A+K+V           + +E+ I +  +   
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 111 IVQCFGIFEKPSGDIAIL-MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           +V+ +G   +  G+I  L +EY   G L   +  +    EP       Q++ G+ YLHG 
Sbjct: 67  VVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM--CRSLDACNSYVGTCAYMSPERFDPDX 227
            I HRDIKP NLL++  +  +KI+DFG++ +          N   GT  Y++PE      
Sbjct: 125 GITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL---- 179
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPG----QRPDW 265
                     D+WS          G  P+ QP     +  DW
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 221

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 110/261 (42%), Gaps = 18/261 (6%)
Query: 64  GGTVYKVQHRCTHKI----YALKVVHGDADPTVRRQVF-REMEILRRTDSPFIVQCFGIF 118
           G   + V  RC   +    YA K+++         Q   RE  I R    P IV+     
Sbjct: 31  GKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI 90
Query: 119 EKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKP 178
            +  G   ++ + +  G L   +     +SE   +H   QIL+ + + H   ++HRD+KP
Sbjct: 91  SE-EGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLKP 149
Query: 179 SNLLVNN--NNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE--RFDPDXXXXXXXX 234
            NLL+ +      VK+ADFG++  +     A   + GT  Y+SPE  R DP         
Sbjct: 150 ENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP-------YG 202
Query: 235 XXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIEC 294
              D+W+          G+ PF    Q   +  +  A  +  P    D  +PE +  I  
Sbjct: 203 KPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIK-AGAYDFPSPEWDTVTPEAKDLINK 261
Query: 295 CLQKEFSKRWTASQLLTHPFL 315
            L    SKR TA++ L HP++
Sbjct: 262 MLTINPSKRITAAEALKHPWI 282

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 119/294 (40%), Gaps = 53/294 (18%)
Query: 59  LGHGNGGTV-YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGI 117
           +G G  G+V   +  R   K+   K+          ++ +RE+ +L+      ++    +
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 118 FEKPSG-----DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
           F   S      D  ++M +M +  L  ++     FSE K+ ++  Q+LKGL Y+H   ++
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQTD-LQKIMGME--FSEEKIQYLVYQMLKGLKYIHSAGVV 166
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA-CNSYVGTCAYMSPERFDPDXXXXX 231
           HRD+KP NL V N + ++KI DFG    + R  DA    YV T  Y +PE          
Sbjct: 167 HRDLKPGNLAV-NEDCELKILDFG----LARHADAEMTGYVVTRWYRAPEVI----LSWM 217
Query: 232 XXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAI--CFGDP------------ 277
                 DIWS          G   F    +  D+   +  I    G P            
Sbjct: 218 HYNQTVDIWSVGCIMAEMLTGKTLF----KGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 273
Query: 278 -----PSLPDG-----------ASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
                 SLP             ASP+    +E  L+ +  KR TA+Q LTHPF 
Sbjct: 274 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 327

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 118/294 (40%), Gaps = 53/294 (18%)
Query: 59  LGHGNGGTV-YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGI 117
           +G G  G+V   +  R   K+   K+          ++ +RE+ +L+      ++    +
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 118 FEKPSG-----DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
           F   S      D  ++M +M +     +  K   FSE K+ ++  Q+LKGL Y+H   ++
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTDLQKIMGLK---FSEEKIQYLVYQMLKGLKYIHSAGVV 148
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA-CNSYVGTCAYMSPERFDPDXXXXX 231
           HRD+KP NL V N + ++KI DFG    + R  DA    YV T  Y +PE          
Sbjct: 149 HRDLKPGNLAV-NEDCELKILDFG----LARHADAEMTGYVVTRWYRAPEVI----LSWM 199
Query: 232 XXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAI--CFGDP------------ 277
                 DIWS          G   F    +  D+   +  I    G P            
Sbjct: 200 HYNQTVDIWSVGCIMAEMLTGKTLF----KGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255
Query: 278 -----PSLPDG-----------ASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
                 SLP             ASP+    +E  L+ +  KR TA+Q LTHPF 
Sbjct: 256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 95/222 (42%), Gaps = 14/222 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
            D + +Q LG G  G V    +R T +  A+K+V           + +E+ I    +   
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHEN 66
Query: 111 IVQCFGIFEKPSGDIAIL-MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           +V+ +G   +  G+I  L +EY   G L   +  +    EP       Q++ G+ YLHG 
Sbjct: 67  VVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM--CRSLDACNSYVGTCAYMSPERFDPDX 227
            I HRDIKP NLL++  +  +KI+DFG++ +          N   GT  Y++PE      
Sbjct: 125 GITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL---- 179
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPG----QRPDW 265
                     D+WS          G  P+ QP     +  DW
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 221

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 88/177 (49%), Gaps = 11/177 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA---DPTVRRQVFREMEILRRTD 107
           +D   L VLG G+ G V   + + T ++YA+K++  D    D  V   +  +  +     
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 108 SPFIVQ---CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLS 164
            PF+ Q   CF   ++    +  +MEY++ G L   + + G F EP     A++I  GL 
Sbjct: 401 PPFLTQLHSCFQTMDR----LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF 456
Query: 165 YLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
           +L    II+RD+K  N+++++    +KIADFG+ K           + GT  Y++PE
Sbjct: 457 FLQSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENIWDGVTTKXFCGTPDYIAPE 512

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 82/310 (26%), Positives = 127/310 (40%), Gaps = 56/310 (18%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           SD +   +LG G  G V    H+ T +I A+K +     P    +  RE++IL+      
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHEN 70
Query: 111 IVQCFGIFEKPSG-----DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
           I+  F I ++P       ++ I+ E M +     +  +    S+  + +   Q L+ +  
Sbjct: 71  IITIFNI-QRPDSFENFNEVYIIQELMQTDLHRVISTQ--MLSDDHIQYFIYQTLRAVKV 127
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNS-----------YVGT 214
           LHG  +IHRD+KPSNLL+ N+N  +K+ DFG+++I+  S  A NS           +V T
Sbjct: 128 LHGSNVIHRDLKPSNLLI-NSNCDLKVCDFGLARIIDESA-ADNSEPTGQQSGMVEFVAT 185
Query: 215 CAYMSPERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICF 274
             Y +PE                D+WS              F  PG+      L+     
Sbjct: 186 RWYRAPEVM----LTSAKYSRAMDVWSCGCILAELFLRRPIF--PGRDYRHQLLLIFGII 239
Query: 275 GDPPSLPD---GASPEFRSFIECC-------LQKEF-------------------SKRWT 305
           G P S  D     SP  R +I+         L+K F                   +KR T
Sbjct: 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRIT 299
Query: 306 ASQLLTHPFL 315
           A + L HP+L
Sbjct: 300 AKEALEHPYL 309

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 89/170 (52%), Gaps = 5/170 (2%)
Query: 55  KLQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +LQ +G G+ G    V+     + Y +K ++        R +  RE+ +L     P IVQ
Sbjct: 28  RLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQ 87
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLN--KNGTFSEPKLAHIASQILKGLSYLHGHKI 171
               FE+ +G + I+M+Y + G L   +N  K   F E ++     QI   L ++H  KI
Sbjct: 88  YRESFEE-NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKI 146
Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
           +HRDIK  N+ +  +   V++ DFG+++++  +++   + +GT  Y+SPE
Sbjct: 147 LHRDIKSQNIFLTKDGT-VQLGDFGIARVLNSTVELARACIGTPYYLSPE 195

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 88/177 (49%), Gaps = 11/177 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA---DPTVRRQVFREMEILRRTD 107
           +D   L VLG G+ G V   + + T ++YA+K++  D    D  V   +  +  +     
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 108 SPFIVQ---CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLS 164
            PF+ Q   CF   ++    +  +MEY++ G L   + + G F EP     A++I  GL 
Sbjct: 80  PPFLTQLHSCFQTMDR----LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF 135
Query: 165 YLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
           +L    II+RD+K  N+++++    +KIADFG+ K           + GT  Y++PE
Sbjct: 136 FLQSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENIWDGVTTKXFCGTPDYIAPE 191

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 121/287 (42%), Gaps = 25/287 (8%)
Query: 48  IAYSDLEKL-QVLGHGNGGTVYKVQHRCTHKIYALKVV---HGDADPTVRRQ-VFREMEI 102
           + + D+ +L +V+G G    V +  +R T + +A+K+V      + P +  + + RE  I
Sbjct: 20  VLFEDVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASI 79
Query: 103 LRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNG----TFSEPKLAHIASQ 158
                 P IV+    +    G + ++ E+MD   L   + K       +SE   +H   Q
Sbjct: 80  CHMLKHPHIVELLETYSS-DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQ 138
Query: 159 ILKGLSYLHGHKIIHRDIKPSNLLV--NNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA 216
           IL+ L Y H + IIHRD+KP N+L+    N+  VK+ DFGV+  +  S       VGT  
Sbjct: 139 ILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPH 198
Query: 217 YMSPERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGD 276
           +M+PE                D+W           G  PF    +R     L   I  G 
Sbjct: 199 FMAPE-----VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-----LFEGIIKGK 248
Query: 277 ---PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR 320
               P      S   +  +   L  + ++R T  + L HP+L +  R
Sbjct: 249 YKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDR 295

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 97/202 (48%), Gaps = 37/202 (18%)
Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
           D ++++++G G  G V+K +HR   K Y ++ V  + +     +  RE++ L + D   I
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNE-----KAEREVKALAKLDHVNI 67
Query: 112 VQ---CFGIFE---KPSGD----------------------IAILMEYMDSGTLDTLLNK 143
           V    C+  F+   + S D                      + I ME+ D GTL+  + K
Sbjct: 68  VHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 127
Query: 144 N-GTFSEPKLA-HIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
             G   +  LA  +  QI KG+ Y+H  K+IHRD+KPSN+ + +   QVKI DFG+   +
Sbjct: 128 RRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTK-QVKIGDFGLVTSL 186
Query: 202 CRSLDACNSYVGTCAYMSPERF 223
                   S  GT  YMSPE+ 
Sbjct: 187 KNDGKRTRSK-GTLRYMSPEQI 207

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/169 (33%), Positives = 91/169 (53%), Gaps = 10/169 (5%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFR-EMEILRRTDSPFIVQCF 115
           Q +G G+ GTVYK +    H   A+K+++  A    + Q F+ E+ +LR+T    I+   
Sbjct: 18  QRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 74
Query: 116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILKGLSYLHGHKIIHR 174
           G   KP   +AI+ ++ +  +L   L+ + T F   KL  IA Q  +G+ YLH   IIHR
Sbjct: 75  GYSTKPQ--LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHR 132
Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCR--SLDACNSYVGTCAYMSPE 221
           D+K +N+ ++ +N  VKI DFG++ +  R           G+  +M+PE
Sbjct: 133 DLKSNNIFLHEDNT-VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 180

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 117/272 (43%), Gaps = 31/272 (11%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVV---HGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           + LG G  G V++V  R T   +A K V   H     TVR+++ + M +LR    P +V 
Sbjct: 57  EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEI-QTMSVLRH---PTLVN 112
Query: 114 CFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
               FE    ++ ++ E+M  G L + + +++   SE +      Q+ KGL ++H +  +
Sbjct: 113 LHDAFED-DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 171
Query: 173 HRDIKPSNLL-VNNNNMQVKIADFGVSKIMCRSLDACNSY---VGTCAYMSPERFDPDXX 228
           H D+KP N++     + ++K+ DFG++      LD   S     GT  + +PE       
Sbjct: 172 HLDLKPENIMFTTKRSNELKLIDFGLTA----HLDPKQSVKVTTGTAEFAAPE-----VA 222
Query: 229 XXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLM----CAICFGDPPSLPDGA 284
                    D+WS          G  PF   G   D  TL     C     D  S   G 
Sbjct: 223 EGKPVGYYTDMWSVGVLSYILLSGLSPF---GGENDDETLRNVKSCDWNMDD--SAFSGI 277
Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLC 316
           S + + FI   L  + + R T  Q L HP+L 
Sbjct: 278 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 309

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 23/217 (10%)
Query: 57  QVLGHGNGGTVYKVQHRCTHK------IYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           +V+G G  G V   + +   K      I  LKV + +     RR    E  I+ + D P 
Sbjct: 28  RVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQ---RRDFLGEASIMGQFDHPN 84
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGH 169
           I+   G+  K S  + I+ EYM++G+LDT L KN G F+  +L  +   I  G+ YL   
Sbjct: 85  IIHLEGVVTK-SKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDM 143
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDXX 228
             +HRD+   N+L+ N+N+  K++DFG+S+++    +A  +  G      P R+  P+  
Sbjct: 144 GYVHRDLAARNILI-NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI---PIRWTAPEAI 199
Query: 229 XXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDW 265
                    D+WS            +  +  G+RP W
Sbjct: 200 AFRKFTSASDVWSYGIVM-------WEVVSYGERPYW 229

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 84/155 (54%), Gaps = 8/155 (5%)
Query: 53  LEKLQVLGHGNGGTV----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS 108
           L+ +  LG GN G+V    Y      T  + A+K +   + P  +R   RE++IL+   S
Sbjct: 9   LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-HSGPDQQRDFQREIQILKALHS 67
Query: 109 PFIVQCFGIFEKPS-GDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYL 166
            FIV+  G+   P   ++ ++MEY+ SG L   L ++       +L   +SQI KG+ YL
Sbjct: 68  DFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL 127
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
              + +HRD+   N+LV  +   VKIADFG++K++
Sbjct: 128 GSRRCVHRDLAARNILV-ESEAHVKIADFGLAKLL 161

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 91/186 (48%), Gaps = 18/186 (9%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           SDL   +VLG G  G   KV HR T ++  +K +    D   +R   +E++++R  + P 
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELI-RFDEETQRTFLKEVKVMRCLEHPN 68
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGH 169
           +++  G+  K    +  + EY+  GTL  ++   +  +   +    A  I  G++YLH  
Sbjct: 69  VLKFIGVLYK-DKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM 127
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC---------RSLDACN-----SYVGTC 215
            IIHRD+   N LV  N   V +ADFG++++M          RSL   +     + VG  
Sbjct: 128 NIIHRDLNSHNCLVRENK-NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 216 AYMSPE 221
            +M+PE
Sbjct: 187 YWMAPE 192

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/309 (25%), Positives = 123/309 (39%), Gaps = 54/309 (17%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           SD +   +LG G  G V    H+ T +I A+K +     P    +  RE++IL+      
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHEN 70
Query: 111 IVQCFGIFEKPSG-----DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
           I+  F I ++P       ++ I+ E M +     +  +    S+  + +   Q L+ +  
Sbjct: 71  IITIFNI-QRPDSFENFNEVYIIQELMQTDLHRVISTQ--MLSDDHIQYFIYQTLRAVKV 127
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL----------DACNSYVGTC 215
           LHG  +IHRD+KPSNLL+ N+N  +K+ DFG+++I+  S                 V T 
Sbjct: 128 LHGSNVIHRDLKPSNLLI-NSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATR 186
Query: 216 AYMSPERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFG 275
            Y +PE                D+WS              F  PG+      L+     G
Sbjct: 187 WYRAPEVM----LTSAKYSRAMDVWSCGCILAELFLRRPIF--PGRDYRHQLLLIFGIIG 240
Query: 276 DPPSLPD---GASPEFRSFIECC-------LQKEF-------------------SKRWTA 306
            P S  D     SP  R +I+         L+K F                   +KR TA
Sbjct: 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITA 300
Query: 307 SQLLTHPFL 315
            + L HP+L
Sbjct: 301 KEALEHPYL 309

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/259 (24%), Positives = 113/259 (43%), Gaps = 14/259 (5%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFG 116
           LG G     +++    T +++A K+V       P  R ++  E+ I R      +V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 117 IFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDI 176
            FE  +  + +++E     +L  L  +    +EP+  +   QI+ G  YLH +++IHRD+
Sbjct: 85  FFED-NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 143
Query: 177 KPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXXXX 236
           K  NL + N +++VKI DFG++  +    +   +  GT  Y++PE               
Sbjct: 144 KLGNLFL-NEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLS-----KKGHSFE 197
Query: 237 XDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCL 296
            D+WS          G  PF     +  +  +       +  S+P   +P   S I+  L
Sbjct: 198 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK-----KNEYSIPKHINPVAASLIQKML 252
Query: 297 QKEFSKRWTASQLLTHPFL 315
           Q + + R T ++LL   F 
Sbjct: 253 QTDPTARPTINELLNDEFF 271

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 86/168 (51%), Gaps = 5/168 (2%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA---DPTVRRQVFREMEILRRTDSPFIVQ 113
           ++LG G+ G V+  + + T++ +A+K +  D    D  V   +  +  +    + PF+  
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
            F  F+    ++  +MEY++ G L   +     F   +    A++I+ GL +LH   I++
Sbjct: 83  MFCTFQTKE-NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVY 141
Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
           RD+K  N+L++ +   +KIADFG+ K         N + GT  Y++PE
Sbjct: 142 RDLKLDNILLDKDG-HIKIADFGMCKENMLGDAKTNXFCGTPDYIAPE 188

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/259 (24%), Positives = 113/259 (43%), Gaps = 14/259 (5%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFG 116
           LG G     +++    T +++A K+V       P  R ++  E+ I R      +V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 117 IFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDI 176
            FE  +  + +++E     +L  L  +    +EP+  +   QI+ G  YLH +++IHRD+
Sbjct: 85  FFED-NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 143
Query: 177 KPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXXXX 236
           K  NL + N +++VKI DFG++  +    +   +  GT  Y++PE               
Sbjct: 144 KLGNLFL-NEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLS-----KKGHSFE 197
Query: 237 XDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCL 296
            D+WS          G  PF     +  +  +       +  S+P   +P   S I+  L
Sbjct: 198 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK-----KNEYSIPKHINPVAASLIQKML 252
Query: 297 QKEFSKRWTASQLLTHPFL 315
           Q + + R T ++LL   F 
Sbjct: 253 QTDPTARPTINELLNDEFF 271

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/155 (34%), Positives = 83/155 (53%), Gaps = 8/155 (5%)
Query: 53  LEKLQVLGHGNGGTV----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS 108
           L+ LQ LG GN G+V    Y      T ++ A+K +    +  +R    RE+EIL+    
Sbjct: 12  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQH 70
Query: 109 PFIVQCFGI-FEKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILKGLSYL 166
             IV+  G+ +     ++ ++MEY+  G+L   L K+       KL    SQI KG+ YL
Sbjct: 71  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
              + IHRD+   N+LV N N +VKI DFG++K++
Sbjct: 131 GTKRYIHRDLATRNILVENEN-RVKIGDFGLTKVL 164

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/155 (34%), Positives = 83/155 (53%), Gaps = 8/155 (5%)
Query: 53  LEKLQVLGHGNGGTV----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS 108
           L+ LQ LG GN G+V    Y      T ++ A+K +    +  +R    RE+EIL+    
Sbjct: 43  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQH 101
Query: 109 PFIVQCFGI-FEKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILKGLSYL 166
             IV+  G+ +     ++ ++MEY+  G+L   L K+       KL    SQI KG+ YL
Sbjct: 102 DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 161
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
              + IHRD+   N+LV N N +VKI DFG++K++
Sbjct: 162 GTKRYIHRDLATRNILVENEN-RVKIGDFGLTKVL 195

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/155 (34%), Positives = 83/155 (53%), Gaps = 8/155 (5%)
Query: 53  LEKLQVLGHGNGGTV----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS 108
           L+ LQ LG GN G+V    Y      T ++ A+K +    +  +R    RE+EIL+    
Sbjct: 16  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQH 74
Query: 109 PFIVQCFGI-FEKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILKGLSYL 166
             IV+  G+ +     ++ ++MEY+  G+L   L K+       KL    SQI KG+ YL
Sbjct: 75  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 134
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
              + IHRD+   N+LV N N +VKI DFG++K++
Sbjct: 135 GTKRYIHRDLATRNILVENEN-RVKIGDFGLTKVL 168

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/155 (34%), Positives = 83/155 (53%), Gaps = 8/155 (5%)
Query: 53  LEKLQVLGHGNGGTV----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS 108
           L+ LQ LG GN G+V    Y      T ++ A+K +    +  +R    RE+EIL+    
Sbjct: 17  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQH 75
Query: 109 PFIVQCFGI-FEKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILKGLSYL 166
             IV+  G+ +     ++ ++MEY+  G+L   L K+       KL    SQI KG+ YL
Sbjct: 76  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 135
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
              + IHRD+   N+LV N N +VKI DFG++K++
Sbjct: 136 GTKRYIHRDLATRNILVENEN-RVKIGDFGLTKVL 169

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/155 (34%), Positives = 83/155 (53%), Gaps = 8/155 (5%)
Query: 53  LEKLQVLGHGNGGTV----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS 108
           L+ LQ LG GN G+V    Y      T ++ A+K +    +  +R    RE+EIL+    
Sbjct: 18  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQH 76
Query: 109 PFIVQCFGI-FEKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILKGLSYL 166
             IV+  G+ +     ++ ++MEY+  G+L   L K+       KL    SQI KG+ YL
Sbjct: 77  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 136
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
              + IHRD+   N+LV N N +VKI DFG++K++
Sbjct: 137 GTKRYIHRDLATRNILVENEN-RVKIGDFGLTKVL 170

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/155 (34%), Positives = 83/155 (53%), Gaps = 8/155 (5%)
Query: 53  LEKLQVLGHGNGGTV----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS 108
           L+ LQ LG GN G+V    Y      T ++ A+K +    +  +R    RE+EIL+    
Sbjct: 12  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQH 70
Query: 109 PFIVQCFGI-FEKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILKGLSYL 166
             IV+  G+ +     ++ ++MEY+  G+L   L K+       KL    SQI KG+ YL
Sbjct: 71  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
              + IHRD+   N+LV N N +VKI DFG++K++
Sbjct: 131 GTKRYIHRDLATRNILVENEN-RVKIGDFGLTKVL 164

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/155 (34%), Positives = 83/155 (53%), Gaps = 8/155 (5%)
Query: 53  LEKLQVLGHGNGGTV----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS 108
           L+ LQ LG GN G+V    Y      T ++ A+K +    +  +R    RE+EIL+    
Sbjct: 10  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQH 68
Query: 109 PFIVQCFGI-FEKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILKGLSYL 166
             IV+  G+ +     ++ ++MEY+  G+L   L K+       KL    SQI KG+ YL
Sbjct: 69  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 128
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
              + IHRD+   N+LV N N +VKI DFG++K++
Sbjct: 129 GTKRYIHRDLATRNILVENEN-RVKIGDFGLTKVL 162

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 117/272 (43%), Gaps = 31/272 (11%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVV---HGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           + LG G  G V++V  R T   +A K V   H     TVR+++ + M +LR    P +V 
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEI-QTMSVLRH---PTLVN 218
Query: 114 CFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
               FE    ++ ++ E+M  G L + + +++   SE +      Q+ KGL ++H +  +
Sbjct: 219 LHDAFED-DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 277
Query: 173 HRDIKPSNLL-VNNNNMQVKIADFGVSKIMCRSLDACNSY---VGTCAYMSPERFDPDXX 228
           H D+KP N++     + ++K+ DFG++      LD   S     GT  + +PE       
Sbjct: 278 HLDLKPENIMFTTKRSNELKLIDFGLTA----HLDPKQSVKVTTGTAEFAAPE-----VA 328
Query: 229 XXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATL----MCAICFGDPPSLPDGA 284
                    D+WS          G  PF   G   D  TL     C     D  S   G 
Sbjct: 329 EGKPVGYYTDMWSVGVLSYILLSGLSPF---GGENDDETLRNVKSCDWNMDD--SAFSGI 383
Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLC 316
           S + + FI   L  + + R T  Q L HP+L 
Sbjct: 384 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 415

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/155 (34%), Positives = 83/155 (53%), Gaps = 8/155 (5%)
Query: 53  LEKLQVLGHGNGGTV----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS 108
           L+ LQ LG GN G+V    Y      T ++ A+K +    +  +R    RE+EIL+    
Sbjct: 11  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQH 69
Query: 109 PFIVQCFGI-FEKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILKGLSYL 166
             IV+  G+ +     ++ ++MEY+  G+L   L K+       KL    SQI KG+ YL
Sbjct: 70  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 129
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
              + IHRD+   N+LV N N +VKI DFG++K++
Sbjct: 130 GTKRYIHRDLATRNILVENEN-RVKIGDFGLTKVL 163

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/259 (24%), Positives = 113/259 (43%), Gaps = 14/259 (5%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFG 116
           LG G     +++    T +++A K+V       P  R ++  E+ I R      +V   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 117 IFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDI 176
            FE  +  + +++E     +L  L  +    +EP+  +   QI+ G  YLH +++IHRD+
Sbjct: 89  FFED-NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 147
Query: 177 KPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXXXX 236
           K  NL + N +++VKI DFG++  +    +   +  GT  Y++PE               
Sbjct: 148 KLGNLFL-NEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLS-----KKGHSFE 201
Query: 237 XDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCL 296
            D+WS          G  PF     +  +  +       +  S+P   +P   S I+  L
Sbjct: 202 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK-----KNEYSIPKHINPVAASLIQKML 256
Query: 297 QKEFSKRWTASQLLTHPFL 315
           Q + + R T ++LL   F 
Sbjct: 257 QTDPTARPTINELLNDEFF 275

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/155 (34%), Positives = 83/155 (53%), Gaps = 8/155 (5%)
Query: 53  LEKLQVLGHGNGGTV----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS 108
           L+ LQ LG GN G+V    Y      T ++ A+K +    +  +R    RE+EIL+    
Sbjct: 15  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQH 73
Query: 109 PFIVQCFGI-FEKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILKGLSYL 166
             IV+  G+ +     ++ ++MEY+  G+L   L K+       KL    SQI KG+ YL
Sbjct: 74  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 133
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
              + IHRD+   N+LV N N +VKI DFG++K++
Sbjct: 134 GTKRYIHRDLATRNILVENEN-RVKIGDFGLTKVL 167

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/155 (34%), Positives = 83/155 (53%), Gaps = 8/155 (5%)
Query: 53  LEKLQVLGHGNGGTV----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS 108
           L+ LQ LG GN G+V    Y      T ++ A+K +    +  +R    RE+EIL+    
Sbjct: 12  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQH 70
Query: 109 PFIVQCFGI-FEKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILKGLSYL 166
             IV+  G+ +     ++ ++MEY+  G+L   L K+       KL    SQI KG+ YL
Sbjct: 71  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
              + IHRD+   N+LV N N +VKI DFG++K++
Sbjct: 131 GTKRYIHRDLATRNILVENEN-RVKIGDFGLTKVL 164

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/155 (34%), Positives = 83/155 (53%), Gaps = 8/155 (5%)
Query: 53  LEKLQVLGHGNGGTV----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS 108
           L+ LQ LG GN G+V    Y      T ++ A+K +    +  +R    RE+EIL+    
Sbjct: 19  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQH 77
Query: 109 PFIVQCFGI-FEKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILKGLSYL 166
             IV+  G+ +     ++ ++MEY+  G+L   L K+       KL    SQI KG+ YL
Sbjct: 78  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 137
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
              + IHRD+   N+LV N N +VKI DFG++K++
Sbjct: 138 GTKRYIHRDLATRNILVENEN-RVKIGDFGLTKVL 171

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 8/202 (3%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVV-HGDADPTVRRQVFREMEILRRTDSPFIVQC 114
           L+ +G GN   V   +H  T K  A+K++     + +  +++FRE+ I +  + P IV+ 
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKL 78
Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
           F + E     + ++ EY   G +   L  +G   E +      QI+  + Y H   I+HR
Sbjct: 79  FEVIETEK-TLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKFIVHR 137
Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXX 234
           D+K  NLL+ + +  +KIADFG S       +  +++ G   Y +PE F           
Sbjct: 138 DLKAENLLL-DADXNIKIADFGFSNEFTFG-NKLDAFCGAPPYAAPELFQ----GKKYDG 191
Query: 235 XXXDIWSXXXXXXXXXXGHFPF 256
              D+WS          G  PF
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPF 213

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/155 (34%), Positives = 83/155 (53%), Gaps = 8/155 (5%)
Query: 53  LEKLQVLGHGNGGTV----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS 108
           L+ LQ LG GN G+V    Y      T ++ A+K +    +  +R    RE+EIL+    
Sbjct: 30  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQH 88
Query: 109 PFIVQCFGI-FEKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILKGLSYL 166
             IV+  G+ +     ++ ++MEY+  G+L   L K+       KL    SQI KG+ YL
Sbjct: 89  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 148
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
              + IHRD+   N+LV N N +VKI DFG++K++
Sbjct: 149 GTKRYIHRDLATRNILVENEN-RVKIGDFGLTKVL 182

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 97/196 (49%), Gaps = 12/196 (6%)
Query: 53  LEKLQVLGHGNGGTV----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS 108
           L+ +  LG GN G+V    Y      T  + A+K +   + P  +R   RE++IL+   S
Sbjct: 12  LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-HSGPDQQRDFQREIQILKALHS 70
Query: 109 PFIVQCFGIFEKPS-GDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYL 166
            FIV+  G+   P    + ++MEY+ SG L   L ++       +L   +SQI KG+ YL
Sbjct: 71  DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL 130
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE-RFDP 225
              + +HRD+   N+LV  +   VKIADFG++K++   LD  + YV      SP   + P
Sbjct: 131 GSRRCVHRDLAARNILV-ESEAHVKIADFGLAKLL--PLDK-DYYVVREPGQSPIFWYAP 186
Query: 226 DXXXXXXXXXXXDIWS 241
           +           D+WS
Sbjct: 187 ESLSDNIFSRQSDVWS 202

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 97/196 (49%), Gaps = 12/196 (6%)
Query: 53  LEKLQVLGHGNGGTV----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS 108
           L+ +  LG GN G+V    Y      T  + A+K +   + P  +R   RE++IL+   S
Sbjct: 13  LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-HSGPDQQRDFQREIQILKALHS 71
Query: 109 PFIVQCFGIFEKPS-GDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYL 166
            FIV+  G+   P    + ++MEY+ SG L   L ++       +L   +SQI KG+ YL
Sbjct: 72  DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL 131
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE-RFDP 225
              + +HRD+   N+LV  +   VKIADFG++K++   LD  + YV      SP   + P
Sbjct: 132 GSRRCVHRDLAARNILV-ESEAHVKIADFGLAKLL--PLDK-DYYVVREPGQSPIFWYAP 187
Query: 226 DXXXXXXXXXXXDIWS 241
           +           D+WS
Sbjct: 188 ESLSDNIFSRQSDVWS 203

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 97/196 (49%), Gaps = 12/196 (6%)
Query: 53  LEKLQVLGHGNGGTV----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS 108
           L+ +  LG GN G+V    Y      T  + A+K +   + P  +R   RE++IL+   S
Sbjct: 25  LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-HSGPDQQRDFQREIQILKALHS 83
Query: 109 PFIVQCFGIFEKPS-GDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYL 166
            FIV+  G+   P    + ++MEY+ SG L   L ++       +L   +SQI KG+ YL
Sbjct: 84  DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL 143
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE-RFDP 225
              + +HRD+   N+LV  +   VKIADFG++K++   LD  + YV      SP   + P
Sbjct: 144 GSRRCVHRDLAARNILV-ESEAHVKIADFGLAKLL--PLDK-DYYVVREPGQSPIFWYAP 199
Query: 226 DXXXXXXXXXXXDIWS 241
           +           D+WS
Sbjct: 200 ESLSDNIFSRQSDVWS 215

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/155 (34%), Positives = 83/155 (53%), Gaps = 8/155 (5%)
Query: 53  LEKLQVLGHGNGGTV----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS 108
           L+ LQ LG GN G+V    Y      T ++ A+K +    +  +R    RE+EIL+    
Sbjct: 30  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQH 88
Query: 109 PFIVQCFGI-FEKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILKGLSYL 166
             IV+  G+ +     ++ ++MEY+  G+L   L K+       KL    SQI KG+ YL
Sbjct: 89  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 148
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
              + IHRD+   N+LV N N +VKI DFG++K++
Sbjct: 149 GTKRYIHRDLATRNILVENEN-RVKIGDFGLTKVL 182

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 17/223 (7%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILR 104
           ++Y  +E  +V+G G  G V + + +   K     A+K + G      RR+   E  I+ 
Sbjct: 13  VSYVKIE--EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMG 70
Query: 105 RTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGL 163
           + + P I++  G+    S  + IL E+M++G LD+ L  N G F+  +L  +   I  G+
Sbjct: 71  QFEHPNIIRLEGVVTN-SMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGM 129
Query: 164 SYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF 223
            YL     +HRD+   N+LV N+N+  K++DFG+S+ +  +  +  +Y  +     P R+
Sbjct: 130 RYLAEMSYVHRDLAARNILV-NSNLVCKVSDFGLSRFLEEN-SSDPTYTSSLGGKIPIRW 187
Query: 224 D-PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDW 265
             P+           D WS            +  +  G+RP W
Sbjct: 188 TAPEAIAFRKFTSASDAWSYGIVM-------WEVMSFGERPYW 223

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 15/214 (7%)
Query: 57  QVLGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           QV+G G  G V     +   K     A+K +        RR    E  I+ + D P ++ 
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 98
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKII 172
             G+  K S  + I+ E+M++G+LD+ L +N G F+  +L  +   I  G+ YL     +
Sbjct: 99  LEGVVTK-STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYV 157
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDXXXXX 231
           HRD+   N+LV N+N+  K++DFG+S+ +     +  +Y        P R+  P+     
Sbjct: 158 HRDLAARNILV-NSNLVCKVSDFGLSRFL-EDDTSDPTYTSALGGKIPIRWTAPEAIQYR 215
Query: 232 XXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDW 265
                 D+WS            +  +  G+RP W
Sbjct: 216 KFTSASDVWSYGIVM-------WEVMSYGERPYW 242

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 121/278 (43%), Gaps = 50/278 (17%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           QVLG G  G V ++ ++ T + +ALK++     P  RR+V  E+   R +  P IV+   
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALKMLQDC--PKARREV--ELH-WRASQCPHIVRIVD 78
Query: 117 IFEKPSGD---IAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKI 171
           ++E        + I+ME +D G L + +   G   F+E + + I   I + + YLH   I
Sbjct: 79  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 138
Query: 172 IHRDIKPSNLLVNNN--NMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
            HRD+KP NLL  +   N  +K+ DFG +K                   + E++D     
Sbjct: 139 AHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------------ETTGEKYDKS--- 178
Query: 230 XXXXXXXXDIWSXXXXXXXXXXGHFPF-------LQPGQRPDWATLMCAICFGDPPSLPD 282
                   D+WS          G+ PF       + PG +      M    F +P     
Sbjct: 179 -------CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT--RIRMGQYEFPNPEW--S 227
Query: 283 GASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR 320
             S E +  I   L+ E ++R T ++ + HP++ ++ +
Sbjct: 228 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/259 (24%), Positives = 112/259 (43%), Gaps = 14/259 (5%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFG 116
           LG G     +++    T +++A K+V       P  R ++  E+ I R      +V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 117 IFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDI 176
            FE  +  + +++E     +L  L  +    +EP+  +   QI+ G  YLH +++IHRD+
Sbjct: 83  FFED-NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 141
Query: 177 KPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXXXX 236
           K  NL + N +++VKI DFG++  +    +      GT  Y++PE               
Sbjct: 142 KLGNLFL-NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS-----KKGHSFE 195
Query: 237 XDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCL 296
            D+WS          G  PF     +  +  +       +  S+P   +P   S I+  L
Sbjct: 196 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK-----KNEYSIPKHINPVAASLIQKML 250
Query: 297 QKEFSKRWTASQLLTHPFL 315
           Q + + R T ++LL   F 
Sbjct: 251 QTDPTARPTINELLNDEFF 269

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/259 (24%), Positives = 112/259 (43%), Gaps = 14/259 (5%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFG 116
           LG G     +++    T +++A K+V       P  R ++  E+ I R      +V   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 117 IFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDI 176
            FE  +  + +++E     +L  L  +    +EP+  +   QI+ G  YLH +++IHRD+
Sbjct: 107 FFED-NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 165
Query: 177 KPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXXXX 236
           K  NL + N +++VKI DFG++  +    +      GT  Y++PE               
Sbjct: 166 KLGNLFL-NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS-----KKGHSFE 219
Query: 237 XDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCL 296
            D+WS          G  PF     +  +  +       +  S+P   +P   S I+  L
Sbjct: 220 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK-----KNEYSIPKHINPVAASLIQKML 274
Query: 297 QKEFSKRWTASQLLTHPFL 315
           Q + + R T ++LL   F 
Sbjct: 275 QTDPTARPTINELLNDEFF 293

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 121/274 (44%), Gaps = 14/274 (5%)
Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQV--FRE-MEILRRTDS 108
           D E L+V+G G    V  V+ + T ++YA+K+++   D   R +V  FRE  ++L   D 
Sbjct: 62  DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMN-KWDMLKRGEVSCFREERDVLVNGDR 120
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHI-ASQILKGLSYLH 167
            +I Q    F+  +  + ++MEY   G L TLL+K G     ++A    ++I+  +  +H
Sbjct: 121 RWITQLHFAFQDENY-LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH 179
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSY--VGTCAYMSPERFDP 225
               +HRDIKP N+L++     +++ADFG S +  R+     S   VGT  Y+SPE    
Sbjct: 180 RLGYVHRDIKPDNILLDRCG-HIRLADFG-SCLKLRADGTVRSLVAVGTPDYLSPEILQA 237
Query: 226 --DXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDG 283
                         D W+          G  PF        +  ++        P + +G
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEG 297
Query: 284 ASPEFRSFIE--CCLQKEFSKRWTASQLLTHPFL 315
              E R FI+   C  +    R  A    THPF 
Sbjct: 298 VPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFF 331

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 86/154 (55%), Gaps = 7/154 (4%)
Query: 53  LEKLQVLGHGNGGTV----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS 108
           L+K++ LG G+ G V    Y   +  T ++ A+K +  DA P  R    +E++ILR    
Sbjct: 33  LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYH 92
Query: 109 PFIVQCFGIFEKP-SGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
             I++  G  E   +  + ++MEY+  G+L   L ++ +    +L   A QI +G++YLH
Sbjct: 93  EHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLH 151
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
               IHRD+   N+L++N+ + VKI DFG++K +
Sbjct: 152 AQHYIHRDLAARNVLLDNDRL-VKIGDFGLAKAV 184

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 17/214 (7%)
Query: 57  QVLGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +V+G G  G V   + +   K     A+K +        RR    E  I+ + D P I+ 
Sbjct: 35  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 94
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKII 172
             G+  K    + I+ EYM++G+LD  L KN G F+  +L  +   I  G+ YL     +
Sbjct: 95  LEGVVTK-CKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSAV 153
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDXXXXX 231
           HRD+   N+LV N+N+  K++DFG+S+++    +A  +  G      P R+  P+     
Sbjct: 154 HRDLAARNILV-NSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI---PIRWTAPEAIAYR 209
Query: 232 XXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDW 265
                 D+WS            +  +  G+RP W
Sbjct: 210 KFTSASDVWSYGIVM-------WEVMSYGERPYW 236

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 113/264 (42%), Gaps = 21/264 (7%)
Query: 57  QVLGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +V+G G  G V   + +   K     A+K +        RR    E  I+ + D P I+ 
Sbjct: 20  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 79
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKII 172
             G+  K    + I+ EYM++G+LD  L KN G F+  +L  +   I  G+ YL     +
Sbjct: 80  LEGVVTK-CKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYV 138
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDXXXXX 231
           HRD+   N+LV N+N+  K++DFG+S+++    +A  +  G      P R+  P+     
Sbjct: 139 HRDLAARNILV-NSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI---PIRWTAPEAIAYR 194
Query: 232 XXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDW----ATLMCAICFGDPPSLPDGASPE 287
                 D+WS            +  +  G+RP W      ++ AI  G     P      
Sbjct: 195 KFTSASDVWSYGIVM-------WEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIA 247
Query: 288 FRSFIECCLQKEFSKRWTASQLLT 311
               +  C QKE S R    Q++ 
Sbjct: 248 LHQLMLDCWQKERSDRPKFGQIVN 271

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/259 (24%), Positives = 112/259 (43%), Gaps = 14/259 (5%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFG 116
           LG G     +++    T +++A K+V       P  R ++  E+ I R      +V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 117 IFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDI 176
            FE  +  + +++E     +L  L  +    +EP+  +   QI+ G  YLH +++IHRD+
Sbjct: 109 FFED-NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 167
Query: 177 KPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXXXX 236
           K  NL + N +++VKI DFG++  +    +      GT  Y++PE               
Sbjct: 168 KLGNLFL-NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS-----KKGHSFE 221
Query: 237 XDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCL 296
            D+WS          G  PF     +  +  +       +  S+P   +P   S I+  L
Sbjct: 222 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK-----KNEYSIPKHINPVAASLIQKML 276
Query: 297 QKEFSKRWTASQLLTHPFL 315
           Q + + R T ++LL   F 
Sbjct: 277 QTDPTARPTINELLNDEFF 295

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/155 (34%), Positives = 82/155 (52%), Gaps = 8/155 (5%)
Query: 53  LEKLQVLGHGNGGTV----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS 108
           L+ LQ LG GN G+V    Y      T ++ A+K +    +  +R    RE+EIL+    
Sbjct: 15  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQH 73
Query: 109 PFIVQCFGI-FEKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILKGLSYL 166
             IV+  G+ +     ++ ++MEY+  G+L   L  +       KL    SQI KG+ YL
Sbjct: 74  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYL 133
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
              + IHRD+   N+LV N N +VKI DFG++K++
Sbjct: 134 GTKRYIHRDLATRNILVENEN-RVKIGDFGLTKVL 167

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 80/167 (47%), Gaps = 2/167 (1%)
Query: 55  KLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQC 114
           KL  LG G   TVYK + + T  + ALK +  + +        RE+ +L+      IV  
Sbjct: 6   KLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 65
Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
             I       + ++ EY+D      L +     +   +     Q+L+GL+Y H  K++HR
Sbjct: 66  HDIIHTEKS-LTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHR 124
Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
           D+KP NLL+N    ++K+ADFG+++         ++ V T  Y  P+
Sbjct: 125 DLKPQNLLINERG-ELKLADFGLARAKSIPTKTYDNEVVTLWYRPPD 170

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 17/214 (7%)
Query: 57  QVLGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +V+G G  G V   + +   K     A+K +        RR    E  I+ + D P I+ 
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 73
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKII 172
             G+  K    + I+ EYM++G+LD  L KN G F+  +L  +   I  G+ YL     +
Sbjct: 74  LEGVVTK-CKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYV 132
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDXXXXX 231
           HRD+   N+LV N+N+  K++DFG+S+++    +A  +  G      P R+  P+     
Sbjct: 133 HRDLAARNILV-NSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI---PIRWTAPEAIAYR 188
Query: 232 XXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDW 265
                 D+WS            +  +  G+RP W
Sbjct: 189 KFTSASDVWSYGIVM-------WEVMSYGERPYW 215

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/169 (33%), Positives = 90/169 (53%), Gaps = 10/169 (5%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFR-EMEILRRTDSPFIVQCF 115
           Q +G G+ GTVYK +    H   A+K+++  A    + Q F+ E+ +LR+T    I+   
Sbjct: 30  QRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILKGLSYLHGHKIIHR 174
           G   KP   +AI+ ++ +  +L   L+ + T F   KL  IA Q  +G+ YLH   IIHR
Sbjct: 87  GYSTKPQ--LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHR 144
Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCR--SLDACNSYVGTCAYMSPE 221
           D+K +N+ ++ +N  VKI DFG++    R           G+  +M+PE
Sbjct: 145 DLKSNNIFLHEDNT-VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 122/273 (44%), Gaps = 21/273 (7%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKI---YALKVVHGDADPTVRRQVFREMEILR 104
           I  S +   +++G G+ G V   + R   +     A+K +        RR    E  I+ 
Sbjct: 46  IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMG 105
Query: 105 RTDSPFIVQCFGIFEKPSGDIA-ILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQILKG 162
           + D P I++  G+  +  G +A I+ EYM++G+LDT L   +G F+  +L  +   +  G
Sbjct: 106 QFDHPNIIRLEGVVTR--GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAG 163
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
           + YL     +HRD+   N+LV ++N+  K++DFG+S+++    DA  +Y  T   +    
Sbjct: 164 MRYLSDLGYVHRDLAARNVLV-DSNLVCKVSDFGLSRVLEDDPDA--AYTTTGGKIPIRW 220
Query: 223 FDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWAT----LMCAICFGDPP 278
             P+           D+WS            +  L  G+RP W      ++ ++  G   
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVM-------WEVLAYGERPYWNMTNRDVISSVEEGYRL 273
Query: 279 SLPDGASPEFRSFIECCLQKEFSKRWTASQLLT 311
             P G        +  C  K+ ++R   SQ+++
Sbjct: 274 PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 27/198 (13%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           +D E +Q LG G  G V++ +++     YA+K +        R +V RE++ L + + P 
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 111 IVQCFGIF-----------EKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLA---HIA 156
           IV+ F  +             P   + I M+      L   +N   T  E + +   HI 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 157 SQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS------LDACNS 210
            QI + + +LH   ++HRD+KPSN+    +++ VK+ DFG+   M +       L    +
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV-VKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 211 Y------VGTCAYMSPER 222
           Y      VGT  YMSPE+
Sbjct: 184 YARHTGQVGTKLYMSPEQ 201

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 83/156 (53%), Gaps = 8/156 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRT 106
           ++L K++VLG G  GTVYK   +      KI  A+KV+  +  P   +++  E  ++   
Sbjct: 17  TELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV 76
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSG-TLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
            SP++ +  GI    +  + ++ + M  G  LD +    G      L +   QI KG+SY
Sbjct: 77  GSPYVSRLLGICL--TSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSY 134
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           L   +++HRD+   N+LV + N  VKI DFG+++++
Sbjct: 135 LEDVRLVHRDLAARNVLVKSPN-HVKITDFGLARLL 169

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/155 (34%), Positives = 83/155 (53%), Gaps = 8/155 (5%)
Query: 53  LEKLQVLGHGNGGTV----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS 108
           L+ LQ LG GN G+V    Y      T ++ A+K +    +  +R    RE+EIL+    
Sbjct: 13  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQH 71
Query: 109 PFIVQCFGI-FEKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILKGLSYL 166
             IV+  G+ +     ++ ++MEY+  G+L   L K+       KL    SQI KG+ YL
Sbjct: 72  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 131
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
              + IHR++   N+LV N N +VKI DFG++K++
Sbjct: 132 GTKRYIHRNLATRNILVENEN-RVKIGDFGLTKVL 165

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/182 (32%), Positives = 94/182 (51%), Gaps = 17/182 (9%)
Query: 50  YSDLEKLQVL-----GHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR-QVFR-EMEI 102
           Y ++E  +V+     G G+ GTVYK +      +  LKVV    DPT  + Q FR E+ +
Sbjct: 30  YWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVV----DPTPEQFQAFRNEVAV 85
Query: 103 LRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILK 161
           LR+T    I+   G   K   ++AI+ ++ +  +L   L+   T F   +L  IA Q  +
Sbjct: 86  LRKTRHVNILLFMGYMTKD--NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQ 143
Query: 162 GLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR--SLDACNSYVGTCAYMS 219
           G+ YLH   IIHRD+K +N+ + +  + VKI DFG++ +  R           G+  +M+
Sbjct: 144 GMDYLHAKNIIHRDMKSNNIFL-HEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMA 202
Query: 220 PE 221
           PE
Sbjct: 203 PE 204

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/274 (24%), Positives = 123/274 (44%), Gaps = 23/274 (8%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKI---YALKVVHGDADPTVRRQVFREMEILR 104
           I  S +   +++G G+ G V   + R   +     A+K +        RR    E  I+ 
Sbjct: 46  IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMG 105
Query: 105 RTDSPFIVQCFGIFEKPSGDIA-ILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQILKG 162
           + D P I++  G+  +  G +A I+ EYM++G+LDT L   +G F+  +L  +   +  G
Sbjct: 106 QFDHPNIIRLEGVVTR--GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAG 163
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
           + YL     +HRD+   N+LV ++N+  K++DFG+S+++    DA  +  G      P R
Sbjct: 164 MRYLSDLGYVHRDLAARNVLV-DSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKI---PIR 219
Query: 223 FD-PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWAT----LMCAICFGDP 277
           +  P+           D+WS            +  L  G+RP W      ++ ++  G  
Sbjct: 220 WTAPEAIAFRTFSSASDVWSFGVVM-------WEVLAYGERPYWNMTNRDVISSVEEGYR 272
Query: 278 PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT 311
              P G        +  C  K+ ++R   SQ+++
Sbjct: 273 LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 96/222 (43%), Gaps = 13/222 (5%)
Query: 98  REMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIAS 157
           RE  I R    P IV+      +  G   ++ + +  G L   +     +SE   +H   
Sbjct: 59  REARICRLLKHPNIVRLHDSISE-EGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ 117
Query: 158 QILKGLSYLHGHKIIHRDIKPSNLLVNN--NNMQVKIADFGVSKIMCRSLDACNSYVGTC 215
           QIL+ + + H   ++HR++KP NLL+ +      VK+ADFG++  +     A   + GT 
Sbjct: 118 QILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTP 177
Query: 216 AYMSPE--RFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAIC 273
            Y+SPE  R DP            D+W+          G+ PF    Q   +  +     
Sbjct: 178 GYLSPEVLRKDP-------YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAG-A 229
Query: 274 FGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
           +  P    D  +PE +  I   L    SKR TA++ L HP++
Sbjct: 230 YDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWI 271

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 86/168 (51%), Gaps = 7/168 (4%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVH---GDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           LG G   TVY  +    +   A+K +     + + T++R   RE+    +     IV   
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKR-FEREVHNSSQLSHQNIVSMI 77
Query: 116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRD 175
            + E+      ++MEY++  TL   +  +G  S     +  +QIL G+ + H  +I+HRD
Sbjct: 78  DVDEEDDC-YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRD 136
Query: 176 IKPSNLLVNNNNMQVKIADFGVSKIMCR-SLDACNSYVGTCAYMSPER 222
           IKP N+L+++N   +KI DFG++K +   SL   N  +GT  Y SPE+
Sbjct: 137 IKPQNILIDSNKT-LKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQ 183

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 13/184 (7%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRT 106
           +A S  E +  +G G  GTVYK +   +    ALK V   + +  +     RE+ +LRR 
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 107 DS---PFIVQCFGIFEKPSGD----IAILMEYMDSGTLDTLLNKNGTFSEPK--LAHIAS 157
           ++   P +V+   +      D    + ++ E++D   L T L+K      P   +  +  
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMR 119
Query: 158 QILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAY 217
           Q L+GL +LH + I+HRD+KP N+LV +    VK+ADFG+++I    + A +  V T  Y
Sbjct: 120 QFLRGLDFLHANCIVHRDLKPENILVTSGG-TVKLADFGLARIYSYQM-ALDPVVVTLWY 177
Query: 218 MSPE 221
            +PE
Sbjct: 178 RAPE 181

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 73/308 (23%), Positives = 125/308 (40%), Gaps = 60/308 (19%)
Query: 50  YSDLEKLQ--VLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           + D+ +LQ  VLG G    V    +  T + YA+K++       +R +VFRE+E+L +  
Sbjct: 10  FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG-HIRSRVFREVEMLYQCQ 68
Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               V     F +      ++ E M  G++ + ++K   F+E + + +   +   L +LH
Sbjct: 69  GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH 128
Query: 168 GHKIIHRDIKPSNLLVNNNNM--QVKIADFGVSKIMCRSLDACN--------SYVGTCAY 217
              I HRD+KP N+L  + N    VKI DFG+   +  + D C+        +  G+  Y
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGD-CSPISTPELLTPCGSAEY 187
Query: 218 MSPERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPF--------------------- 256
           M+PE  +             D+WS          G+ PF                     
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247
Query: 257 -----LQPGQRP----DWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTAS 307
                +Q G+      DWA + CA                 +  I   L ++  +R +A+
Sbjct: 248 MLFESIQEGKYEFPDKDWAHISCAA----------------KDLISKLLVRDAKQRLSAA 291
Query: 308 QLLTHPFL 315
           Q+L HP++
Sbjct: 292 QVLQHPWV 299

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/259 (24%), Positives = 107/259 (41%), Gaps = 12/259 (4%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIF 118
           LG G  G V++     + K Y  K V       V   V +E+ IL       I+     F
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV--LVKKEISILNIARHRNILHLHESF 70
Query: 119 EKPSGDIAILMEYMDSGTLDTLLNKNG-TFSEPKLAHIASQILKGLSYLHGHKIIHRDIK 177
           E    ++ ++ E++    +   +N +    +E ++     Q+ + L +LH H I H DI+
Sbjct: 71  ESME-ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIR 129
Query: 178 PSNLLVNN-NNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXXXX 236
           P N++     +  +KI +FG      R L   +++     + +PE + P+          
Sbjct: 130 PENIIYQTRRSSTIKIIEFG----QARQLKPGDNF--RLLFTAPEYYAPEVHQHDVVSTA 183
Query: 237 XDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCL 296
            D+WS          G  PFL    +     +M A    D  +  +  S E   F++  L
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKE-ISIEAMDFVDRLL 242
Query: 297 QKEFSKRWTASQLLTHPFL 315
            KE   R TAS+ L HP+L
Sbjct: 243 VKERKSRMTASEALQHPWL 261

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 92/182 (50%), Gaps = 15/182 (8%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVV-----HGDAD---PTVRRQVFRE 99
           +   D + L+V+G G+   V  V+ + T +IYA+KVV     + D D       + VF +
Sbjct: 17  LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 76
Query: 100 MEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQI 159
                 ++ PF+V     F+  S  +  ++EY++ G L   + +     E      +++I
Sbjct: 77  A-----SNHPFLVGLHSCFQTESR-LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI 130
Query: 160 LKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMS 219
              L+YLH   II+RD+K  N+L+++    +K+ D+G+ K   R  D  + + GT  Y++
Sbjct: 131 SLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPGDTTSXFCGTPNYIA 189
Query: 220 PE 221
           PE
Sbjct: 190 PE 191

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 92/182 (50%), Gaps = 15/182 (8%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVV-----HGDAD---PTVRRQVFRE 99
           +   D + L+V+G G+   V  V+ + T +IYA+KVV     + D D       + VF +
Sbjct: 6   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 100 MEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQI 159
                 ++ PF+V     F+  S  +  ++EY++ G L   + +     E      +++I
Sbjct: 66  A-----SNHPFLVGLHSCFQTESR-LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI 119
Query: 160 LKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMS 219
              L+YLH   II+RD+K  N+L+++    +K+ D+G+ K   R  D  + + GT  Y++
Sbjct: 120 SLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPGDTTSXFCGTPNYIA 178
Query: 220 PE 221
           PE
Sbjct: 179 PE 180

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 92/182 (50%), Gaps = 15/182 (8%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVV-----HGDAD---PTVRRQVFRE 99
           +   D + L+V+G G+   V  V+ + T +IYA+KVV     + D D       + VF +
Sbjct: 2   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 61
Query: 100 MEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQI 159
                 ++ PF+V     F+  S  +  ++EY++ G L   + +     E      +++I
Sbjct: 62  A-----SNHPFLVGLHSCFQTESR-LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI 115
Query: 160 LKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMS 219
              L+YLH   II+RD+K  N+L+++    +K+ D+G+ K   R  D  + + GT  Y++
Sbjct: 116 SLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPGDTTSXFCGTPNYIA 174
Query: 220 PE 221
           PE
Sbjct: 175 PE 176

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 93/184 (50%), Gaps = 13/184 (7%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRT 106
           +A S  E +  +G G  GTVYK +   +    ALK V   + +  +     RE+ +LRR 
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 107 DS---PFIVQCFGIFEKPSGD----IAILMEYMDSGTLDTLLNKNGTFSEPK--LAHIAS 157
           ++   P +V+   +      D    + ++ E++D   L T L+K      P   +  +  
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMR 119
Query: 158 QILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAY 217
           Q L+GL +LH + I+HRD+KP N+LV +    VK+ADFG+++I    + A    V T  Y
Sbjct: 120 QFLRGLDFLHANCIVHRDLKPENILVTSGG-TVKLADFGLARIYSYQM-ALAPVVVTLWY 177
Query: 218 MSPE 221
            +PE
Sbjct: 178 RAPE 181

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 84/158 (53%), Gaps = 8/158 (5%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILR 104
           ++Y  +E  +V+G G  G V + + +   K     A+K + G      RR+   E  I+ 
Sbjct: 15  VSYVKIE--EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMG 72
Query: 105 RTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGL 163
           + + P I++  G+    S  + IL E+M++G LD+ L  N G F+  +L  +   I  G+
Sbjct: 73  QFEHPNIIRLEGVVTN-SMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGM 131
Query: 164 SYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
            YL     +HRD+   N+LV N+N+  K++DFG+S+ +
Sbjct: 132 RYLAEMSYVHRDLAARNILV-NSNLVCKVSDFGLSRFL 168

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 83/155 (53%), Gaps = 8/155 (5%)
Query: 53  LEKLQVLGHGNGGTV----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS 108
           L+ L+ LG GN G+V    Y      T ++ A+K +    +  +R    RE+EIL+    
Sbjct: 15  LKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQH 73
Query: 109 PFIVQCFGI-FEKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILKGLSYL 166
             IV+  G+ +     ++ ++ME++  G+L   L K+       KL    SQI KG+ YL
Sbjct: 74  DNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYL 133
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
              + IHRD+   N+LV N N +VKI DFG++K++
Sbjct: 134 GTKRYIHRDLATRNILVENEN-RVKIGDFGLTKVL 167

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 17/205 (8%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILR--RTDSPFIVQCFG 116
           LG G+ G V++++ + T    A+K         VR +VFR  E++      SP IV  +G
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVK--------KVRLEVFRVEELVACAGLSSPRIVPLYG 131
Query: 117 -IFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRD 175
            + E P   + I ME ++ G+L  L+ + G   E +  +   Q L+GL YLH  +I+H D
Sbjct: 132 AVREGPW--VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGD 189
Query: 176 IKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYM--SPERFDPDXXXXXXX 233
           +K  N+L++++  +  + DFG    +C   D     + T  Y+  +     P+       
Sbjct: 190 VKADNVLLSSDGSRAALCDFG--HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 247
Query: 234 XXXXDIWSXXXXXXXXXXGHFPFLQ 258
               DIWS          G  P+ Q
Sbjct: 248 DAKVDIWSSCCMMLHMLNGCHPWTQ 272

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 15/214 (7%)
Query: 57  QVLGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           QV+G G  G V     +   K     A+K +        RR    E  I+ + D P ++ 
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 72
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKII 172
             G+  K S  + I+ E+M++G+LD+ L +N G F+  +L  +   I  G+ YL     +
Sbjct: 73  LEGVVTK-STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYV 131
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDXXXXX 231
           HR +   N+LV N+N+  K++DFG+S+ +     +  +Y        P R+  P+     
Sbjct: 132 HRALAARNILV-NSNLVCKVSDFGLSRFL-EDDTSDPTYTSALGGKIPIRWTAPEAIQYR 189
Query: 232 XXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDW 265
                 D+WS            +  +  G+RP W
Sbjct: 190 KFTSASDVWSYGIVM-------WEVMSYGERPYW 216

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 93/182 (51%), Gaps = 15/182 (8%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVV-----HGDAD---PTVRRQVFRE 99
           +   D + L+V+G G+   V  V+ + T +IYA++VV     + D D       + VF +
Sbjct: 49  LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQ 108
Query: 100 MEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQI 159
                 ++ PF+V     F+  S  +  ++EY++ G L   + +     E      +++I
Sbjct: 109 A-----SNHPFLVGLHSCFQTES-RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI 162
Query: 160 LKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMS 219
              L+YLH   II+RD+K  N+L+++    +K+ D+G+ K   R  D  +++ GT  Y++
Sbjct: 163 SLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 221
Query: 220 PE 221
           PE
Sbjct: 222 PE 223

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/293 (24%), Positives = 125/293 (42%), Gaps = 30/293 (10%)
Query: 50  YSDLEKL--QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRR-T 106
           + D+ KL  ++LG G    V         K YA+K++   A  + R +VFRE+E L +  
Sbjct: 10  FEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHS-RSRVFREVETLYQCQ 68
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
            +  I++    FE  +    ++ E +  G++   + K   F+E + + +   +   L +L
Sbjct: 69  GNKNILELIEFFEDDT-RFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFL 127
Query: 167 HGHKIIHRDIKPSNLLVNNNNM--QVKIADFGVSKIMCRSLDACNSYV--------GTCA 216
           H   I HRD+KP N+L  +      VKI DF +   M +  ++C            G+  
Sbjct: 128 HTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGM-KLNNSCTPITTPELTTPCGSAE 186
Query: 217 YMSPERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFL-QPGQRPDW-ATLMCAICF 274
           YM+PE  +             D+WS          G+ PF+   G    W    +C +C 
Sbjct: 187 YMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ 246
Query: 275 GDP-PSLPDGA-----------SPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
                S+ +G            S E +  I   L ++  +R +A+Q+L HP++
Sbjct: 247 NKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 90/169 (53%), Gaps = 10/169 (5%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFR-EMEILRRTDSPFIVQCF 115
           Q +G G+ GTVYK +    H   A+K+++  A    + Q F+ E+ +LR+T    I+   
Sbjct: 30  QRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILKGLSYLHGHKIIHR 174
           G    P   +AI+ ++ +  +L   L+ + T F   KL  IA Q  +G+ YLH   IIHR
Sbjct: 87  GYSTAPQ--LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHR 144
Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA--CNSYVGTCAYMSPE 221
           D+K +N+ ++ +N  VKI DFG++    R   +       G+  +M+PE
Sbjct: 145 DLKSNNIFLHEDNT-VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 15/213 (7%)
Query: 57  QVLGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +V+G G  G V   + +   K     A+K +        RR    E  I+ + D P I++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKII 172
             G+  K S  + I+ EYM++G+LD+ L K +  F+  +L  +   I  G+ YL     +
Sbjct: 111 LEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGFV 169
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXX 232
           HRD+   N+L+ N+N+  K++DFG+S+++    +A  +Y      +      P+      
Sbjct: 170 HRDLAARNILI-NSNLVCKVSDFGLSRVLEDDPEA--AYTTRGGKIPIRWTSPEAIAYRK 226
Query: 233 XXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDW 265
                D+WS            +  +  G+RP W
Sbjct: 227 FTSASDVWSYGIVL-------WEVMSYGERPYW 252

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 23/217 (10%)
Query: 57  QVLGHGNGGTVYKVQHRCTHK------IYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           +V+G G  G V   + +   K      I  LKV + +     RR    E  I+ + D P 
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDFLGEASIMGQFDHPN 78
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGH 169
           I++  G+  K S  + I+ EYM++G+LD+ L K +  F+  +L  +   I  G+ YL   
Sbjct: 79  IIRLEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 137
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF-DPDXX 228
             +HRD+   N+L+ N+N+  K++DFG+S+++    +A  +  G      P R+  P+  
Sbjct: 138 GYVHRDLAARNILI-NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI---PIRWTSPEAI 193
Query: 229 XXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDW 265
                    D+WS            +  +  G+RP W
Sbjct: 194 AYRKFTSASDVWSYGIVL-------WEVMSYGERPYW 223

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 99/214 (46%), Gaps = 17/214 (7%)
Query: 57  QVLGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +V+G G  G V   + +   K     A+K +        RR    E  I+ + D P I++
Sbjct: 39  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 98
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKII 172
             G+  K S  + I+ EYM++G+LD+ L K +  F+  +L  +   I  G+ YL     +
Sbjct: 99  LEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 157
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF-DPDXXXXX 231
           HRD+   N+L+ N+N+  K++DFG+S+++    +A  +  G      P R+  P+     
Sbjct: 158 HRDLAARNILI-NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI---PIRWTSPEAIAYR 213
Query: 232 XXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDW 265
                 D+WS            +  +  G+RP W
Sbjct: 214 KFTSASDVWSYGIVL-------WEVMSYGERPYW 240

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 93/184 (50%), Gaps = 13/184 (7%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRT 106
           +A S  E +  +G G  GTVYK +   +    ALK V   + +  +     RE+ +LRR 
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 107 DS---PFIVQCFGIFEKPSGD----IAILMEYMDSGTLDTLLNKNGTFSEPK--LAHIAS 157
           ++   P +V+   +      D    + ++ E++D   L T L+K      P   +  +  
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMR 119
Query: 158 QILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAY 217
           Q L+GL +LH + I+HRD+KP N+LV +    VK+ADFG+++I    + A    V T  Y
Sbjct: 120 QFLRGLDFLHANCIVHRDLKPENILVTSGG-TVKLADFGLARIYSYQM-ALFPVVVTLWY 177
Query: 218 MSPE 221
            +PE
Sbjct: 178 RAPE 181

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 15/213 (7%)
Query: 57  QVLGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +V+G G  G V   + +   K     A+K +        RR    E  I+ + D P I++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKII 172
             G+  K S  + I+ EYM++G+LD+ L K +  F+  +L  +   I  G+ YL     +
Sbjct: 111 LEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXX 232
           HRD+   N+L+ N+N+  K++DFG+S+++    +A  +Y      +      P+      
Sbjct: 170 HRDLAARNILI-NSNLVCKVSDFGLSRVLEDDPEA--AYTTRGGKIPIRWTSPEAIAYRK 226
Query: 233 XXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDW 265
                D+WS            +  +  G+RP W
Sbjct: 227 FTSASDVWSYGIVL-------WEVMSYGERPYW 252

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 92/174 (52%), Gaps = 14/174 (8%)
Query: 59  LGHGNGGTVYKVQH-RCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTDS---PFIVQ 113
           +G G  G V+K +  +   +  ALK V     +  +     RE+ +LR  ++   P +V+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 114 CFGIFEKPSGD----IAILMEYMDSGTLDTLLNKNGTFSEPK--LAHIASQILKGLSYLH 167
            F +      D    + ++ E++D   L T L+K      P   +  +  Q+L+GL +LH
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
            H+++HRD+KP N+LV ++  Q+K+ADFG+++I    + A  S V T  Y +PE
Sbjct: 138 SHRVVHRDLKPQNILVTSSG-QIKLADFGLARIYSFQM-ALTSVVVTLWYRAPE 189

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 99/214 (46%), Gaps = 17/214 (7%)
Query: 57  QVLGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +V+G G  G V   + +   K     A+K +        RR    E  I+ + D P I++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKII 172
             G+  K S  + I+ EYM++G+LD+ L K +  F+  +L  +   I  G+ YL     +
Sbjct: 111 LEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF-DPDXXXXX 231
           HRD+   N+L+ N+N+  K++DFG+S+++    +A  +  G      P R+  P+     
Sbjct: 170 HRDLAARNILI-NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI---PIRWTSPEAIAYR 225
Query: 232 XXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDW 265
                 D+WS            +  +  G+RP W
Sbjct: 226 KFTSASDVWSYGIVL-------WEVMSYGERPYW 252

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 99/214 (46%), Gaps = 17/214 (7%)
Query: 57  QVLGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +V+G G  G V   + +   K     A+K +        RR    E  I+ + D P I++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKII 172
             G+  K S  + I+ EYM++G+LD+ L K +  F+  +L  +   I  G+ YL     +
Sbjct: 111 LEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF-DPDXXXXX 231
           HRD+   N+L+ N+N+  K++DFG+S+++    +A  +  G      P R+  P+     
Sbjct: 170 HRDLAARNILI-NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI---PIRWTSPEAIAYR 225
Query: 232 XXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDW 265
                 D+WS            +  +  G+RP W
Sbjct: 226 KFTSASDVWSYGIVL-------WEVMSYGERPYW 252

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 99/214 (46%), Gaps = 17/214 (7%)
Query: 57  QVLGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +V+G G  G V   + +   K     A+K +        RR    E  I+ + D P I++
Sbjct: 49  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 108
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKII 172
             G+  K S  + I+ EYM++G+LD+ L K +  F+  +L  +   I  G+ YL     +
Sbjct: 109 LEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 167
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF-DPDXXXXX 231
           HRD+   N+L+ N+N+  K++DFG+S+++    +A  +  G      P R+  P+     
Sbjct: 168 HRDLAARNILI-NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI---PIRWTSPEAIAYR 223
Query: 232 XXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDW 265
                 D+WS            +  +  G+RP W
Sbjct: 224 KFTSASDVWSYGIVL-------WEVMSYGERPYW 250

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 99/214 (46%), Gaps = 17/214 (7%)
Query: 57  QVLGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +V+G G  G V   + +   K     A+K +        RR    E  I+ + D P I++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKII 172
             G+  K S  + I+ EYM++G+LD+ L K +  F+  +L  +   I  G+ YL     +
Sbjct: 111 LEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF-DPDXXXXX 231
           HRD+   N+L+ N+N+  K++DFG+S+++    +A  +  G      P R+  P+     
Sbjct: 170 HRDLAARNILI-NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI---PIRWTSPEAIAYR 225
Query: 232 XXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDW 265
                 D+WS            +  +  G+RP W
Sbjct: 226 KFTSASDVWSYGIVL-------WEVMSYGERPYW 252

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 92/174 (52%), Gaps = 14/174 (8%)
Query: 59  LGHGNGGTVYKVQH-RCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTDS---PFIVQ 113
           +G G  G V+K +  +   +  ALK V     +  +     RE+ +LR  ++   P +V+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 114 CFGIFEKPSGD----IAILMEYMDSGTLDTLLNKNGTFSEPK--LAHIASQILKGLSYLH 167
            F +      D    + ++ E++D   L T L+K      P   +  +  Q+L+GL +LH
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
            H+++HRD+KP N+LV ++  Q+K+ADFG+++I    + A  S V T  Y +PE
Sbjct: 138 SHRVVHRDLKPQNILVTSSG-QIKLADFGLARIYSFQM-ALTSVVVTLWYRAPE 189

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 91/169 (53%), Gaps = 10/169 (5%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFR-EMEILRRTDSPFIVQCF 115
           Q +G G+ GTVYK +    H   A+K+++  A    + Q F+ E+ +LR+T    I+   
Sbjct: 14  QRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILKGLSYLHGHKIIHR 174
           G   KP   +AI+ ++ +  +L   L+   T F   KL  IA Q  +G+ YLH   IIHR
Sbjct: 71  GYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHR 128
Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA--CNSYVGTCAYMSPE 221
           D+K +N+ + + ++ VKI DFG++ +  R   +       G+  +M+PE
Sbjct: 129 DLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 176

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 91/169 (53%), Gaps = 10/169 (5%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFR-EMEILRRTDSPFIVQCF 115
           Q +G G+ GTVYK +    H   A+K+++  A    + Q F+ E+ +LR+T    I+   
Sbjct: 16  QRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 72
Query: 116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILKGLSYLHGHKIIHR 174
           G   KP   +AI+ ++ +  +L   L+   T F   KL  IA Q  +G+ YLH   IIHR
Sbjct: 73  GYSTKP--QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHR 130
Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA--CNSYVGTCAYMSPE 221
           D+K +N+ + + ++ VKI DFG++ +  R   +       G+  +M+PE
Sbjct: 131 DLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 178

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 92/174 (52%), Gaps = 14/174 (8%)
Query: 59  LGHGNGGTVYKVQH-RCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTDS---PFIVQ 113
           +G G  G V+K +  +   +  ALK V     +  +     RE+ +LR  ++   P +V+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 114 CFGIFEKPSGD----IAILMEYMDSGTLDTLLNKNGTFSEPK--LAHIASQILKGLSYLH 167
            F +      D    + ++ E++D   L T L+K      P   +  +  Q+L+GL +LH
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
            H+++HRD+KP N+LV ++  Q+K+ADFG+++I    + A  S V T  Y +PE
Sbjct: 138 SHRVVHRDLKPQNILVTSSG-QIKLADFGLARIYSFQM-ALTSVVVTLWYRAPE 189

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 17/205 (8%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILR--RTDSPFIVQCFG 116
           +G G+ G V++++ + T    A+K         VR +VFR  E++      SP IV  +G
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVK--------KVRLEVFRVEELVACAGLSSPRIVPLYG 117
Query: 117 -IFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRD 175
            + E P   + I ME ++ G+L  L+ + G   E +  +   Q L+GL YLH  +I+H D
Sbjct: 118 AVREGPW--VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGD 175
Query: 176 IKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYM--SPERFDPDXXXXXXX 233
           +K  N+L++++  +  + DFG    +C   D     + T  Y+  +     P+       
Sbjct: 176 VKADNVLLSSDGSRAALCDFG--HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 233
Query: 234 XXXXDIWSXXXXXXXXXXGHFPFLQ 258
               DIWS          G  P+ Q
Sbjct: 234 DAKVDIWSSCCMMLHMLNGCHPWTQ 258

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 90/169 (53%), Gaps = 10/169 (5%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFR-EMEILRRTDSPFIVQCF 115
           Q +G G+ GTVYK +    H   A+K+++  A    + Q F+ E+ +LR+T    I+   
Sbjct: 19  QRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 75
Query: 116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILKGLSYLHGHKIIHR 174
           G   KP   +AI+ ++ +  +L   L+   T F   KL  IA Q  +G+ YLH   IIHR
Sbjct: 76  GYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHR 133
Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCR--SLDACNSYVGTCAYMSPE 221
           D+K +N+ + + ++ VKI DFG++ +  R           G+  +M+PE
Sbjct: 134 DLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 181

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 90/169 (53%), Gaps = 10/169 (5%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFR-EMEILRRTDSPFIVQCF 115
           Q +G G+ GTVYK +    H   A+K+++  A    + Q F+ E+ +LR+T    I+   
Sbjct: 41  QRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 97
Query: 116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILKGLSYLHGHKIIHR 174
           G   KP   +AI+ ++ +  +L   L+   T F   KL  IA Q  +G+ YLH   IIHR
Sbjct: 98  GYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHR 155
Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCR--SLDACNSYVGTCAYMSPE 221
           D+K +N+ + + ++ VKI DFG++ +  R           G+  +M+PE
Sbjct: 156 DLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 203

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 17/205 (8%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILR--RTDSPFIVQCFG 116
           +G G+ G V++++ + T    A+K         VR +VFR  E++      SP IV  +G
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVK--------KVRLEVFRVEELVACAGLSSPRIVPLYG 133
Query: 117 -IFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRD 175
            + E P   + I ME ++ G+L  L+ + G   E +  +   Q L+GL YLH  +I+H D
Sbjct: 134 AVREGPW--VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGD 191
Query: 176 IKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYM--SPERFDPDXXXXXXX 233
           +K  N+L++++  +  + DFG    +C   D     + T  Y+  +     P+       
Sbjct: 192 VKADNVLLSSDGSRAALCDFG--HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 249
Query: 234 XXXXDIWSXXXXXXXXXXGHFPFLQ 258
               DIWS          G  P+ Q
Sbjct: 250 DAKVDIWSSCCMMLHMLNGCHPWTQ 274

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 90/169 (53%), Gaps = 10/169 (5%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFR-EMEILRRTDSPFIVQCF 115
           Q +G G+ GTVYK +    H   A+K+++  A    + Q F+ E+ +LR+T    I+   
Sbjct: 42  QRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 98
Query: 116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILKGLSYLHGHKIIHR 174
           G   KP   +AI+ ++ +  +L   L+   T F   KL  IA Q  +G+ YLH   IIHR
Sbjct: 99  GYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHR 156
Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCR--SLDACNSYVGTCAYMSPE 221
           D+K +N+ + + ++ VKI DFG++ +  R           G+  +M+PE
Sbjct: 157 DLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 204

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 113/263 (42%), Gaps = 29/263 (11%)
Query: 68  YKVQHRCTHKI----YALKVV-HGDADPTVRRQVFREMEIL-RRTDSPFIVQCFGIFEKP 121
           Y V  RC HK     +A+K++     DPT       E+EIL R    P I+    +++  
Sbjct: 35  YSVCKRCIHKATNMEFAVKIIDKSKRDPT------EEIEILLRYGQHPNIITLKDVYDD- 87
Query: 122 SGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNL 181
              + ++ E M  G L   + +   FSE + + +   I K + YLH   ++HRD+KPSN+
Sbjct: 88  GKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNI 147
Query: 182 LV---NNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXXXXXD 238
           L    + N   ++I DFG +K     L A N  + T  Y +     P+           D
Sbjct: 148 LYVDESGNPESIRICDFGFAK----QLRAENGLLMTPCY-TANFVAPEVLERQGYDAACD 202
Query: 239 IWSXXXXXXXXXXGHFPFLQ-PGQRPDWATLMCAICFGDPPSLPDG----ASPEFRSFIE 293
           IWS          G+ PF   P   P+   ++  I  G   SL  G     S   +  + 
Sbjct: 203 IWSLGVLLYTMLTGYTPFANGPDDTPE--EILARIGSGK-FSLSGGYWNSVSDTAKDLVS 259
Query: 294 CCLQKEFSKRWTASQLLTHPFLC 316
             L  +  +R TA+ +L HP++ 
Sbjct: 260 KMLHVDPHQRLTAALVLRHPWIV 282

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 91/169 (53%), Gaps = 10/169 (5%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFR-EMEILRRTDSPFIVQCF 115
           Q +G G+ GTVYK +    H   A+K+++  A    + Q F+ E+ +LR+T    I+   
Sbjct: 19  QRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 75
Query: 116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILKGLSYLHGHKIIHR 174
           G   KP   +AI+ ++ +  +L   L+   T F   KL  IA Q  +G+ YLH   IIHR
Sbjct: 76  GYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHR 133
Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA--CNSYVGTCAYMSPE 221
           D+K +N+ + + ++ VKI DFG++ +  R   +       G+  +M+PE
Sbjct: 134 DLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 181

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/262 (24%), Positives = 112/262 (42%), Gaps = 19/262 (7%)
Query: 57  QVLGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +V+G G  G V   + +   K     A+K +        RR    E  I+ + D P +V 
Sbjct: 49  RVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVH 108
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKII 172
             G+  +    + I++E+M++G LD  L K +G F+  +L  +   I  G+ YL     +
Sbjct: 109 LEGVVTR-GKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGYV 167
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXX 232
           HRD+   N+LV N+N+  K++DFG+S+++    +A   Y  T   +      P+      
Sbjct: 168 HRDLAARNILV-NSNLVCKVSDFGLSRVIEDDPEAV--YTTTGGKIPVRWTAPEAIQYRK 224
Query: 233 XXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDW----ATLMCAICFGDPPSLPDGASPEF 288
                D+WS            +  +  G+RP W      ++ AI  G     P       
Sbjct: 225 FTSASDVWSYGIVM-------WEVMSYGERPYWDMSNQDVIKAIEEGYRLPAPMDCPAGL 277
Query: 289 RSFIECCLQKEFSKRWTASQLL 310
              +  C QKE ++R    Q++
Sbjct: 278 HQLMLDCWQKERAERPKFEQIV 299

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 120/282 (42%), Gaps = 24/282 (8%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQV--FREMEILRR 105
           +  +   + +VLG G  G V   Q R T K+YA K +        + +     E +IL +
Sbjct: 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK 240
Query: 106 TDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGT--FSEPKLAHIASQILKGL 163
            +S F+V     +E     + +++  M+ G L   +   G   F E +    A++I  GL
Sbjct: 241 VNSRFVVSLAYAYETKDA-LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGL 299
Query: 164 SYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF 223
             LH  +I++RD+KP N+L++++   ++I+D G++ +           VGT  YM+PE  
Sbjct: 300 EDLHRERIVYRDLKPENILLDDHG-HIRISDLGLA-VHVPEGQTIKGRVGTVGYMAPE-- 355
Query: 224 DPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPG---QRPDWATLMCAICFGDPPSL 280
                         D W+          G  PF Q     +R +   L+  +    P   
Sbjct: 356 ---VVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV----PEEY 408
Query: 281 PDGASPEFRSFIECCLQKEFSKRW-----TASQLLTHPFLCK 317
            +  SP+ RS     L K+ ++R      +A ++  HP   K
Sbjct: 409 SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 81/192 (42%), Gaps = 9/192 (4%)
Query: 50  YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSP 109
           Y  LEK+   G G  G VYK Q+         K+     D  +     RE+ IL+     
Sbjct: 4   YHGLEKI---GEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
            IV+ + +       + ++ E++D      L    G            Q+L G++Y H  
Sbjct: 61  NIVKLYDVIHTKK-RLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
           +++HRD+KP NLL+N    ++KIADFG+++     +      V T  Y +P+        
Sbjct: 120 RVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVL----MG 174
Query: 230 XXXXXXXXDIWS 241
                   DIWS
Sbjct: 175 SKKYSTTIDIWS 186

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 108/256 (42%), Gaps = 20/256 (7%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKI----YALKVVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           +V+G G  G VYK   + +        A+K +        R     E  I+ +     I+
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
           +  G+  K    + I+ EYM++G LD  L  K+G FS  +L  +   I  G+ YL     
Sbjct: 110 RLEGVISKYK-PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY 168
Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXX 231
           +HRD+   N+LV N+N+  K++DFG+S+++    +A  +Y  +   +      P+     
Sbjct: 169 VHRDLAARNILV-NSNLVCKVSDFGLSRVLEDDPEA--TYTTSGGKIPIRWTAPEAISYR 225
Query: 232 XXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWA----TLMCAICFGDPPSLPDGASPE 287
                 D+WS            +  +  G+RP W      +M AI  G     P      
Sbjct: 226 KFTSASDVWSFGIVM-------WEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA 278
Query: 288 FRSFIECCLQKEFSKR 303
               +  C Q+E ++R
Sbjct: 279 IYQLMMQCWQQERARR 294

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 81/192 (42%), Gaps = 9/192 (4%)
Query: 50  YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSP 109
           Y  LEK+   G G  G VYK Q+         K+     D  +     RE+ IL+     
Sbjct: 4   YHGLEKI---GEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
            IV+ + +       + ++ E++D      L    G            Q+L G++Y H  
Sbjct: 61  NIVKLYDVIHTKK-RLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
           +++HRD+KP NLL+N    ++KIADFG+++     +      V T  Y +P+        
Sbjct: 120 RVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVL----MG 174
Query: 230 XXXXXXXXDIWS 241
                   DIWS
Sbjct: 175 SKKYSTTIDIWS 186

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 120/282 (42%), Gaps = 24/282 (8%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQV--FREMEILRR 105
           +  +   + +VLG G  G V   Q R T K+YA K +        + +     E +IL +
Sbjct: 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK 240
Query: 106 TDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGT--FSEPKLAHIASQILKGL 163
            +S F+V     +E     + +++  M+ G L   +   G   F E +    A++I  GL
Sbjct: 241 VNSRFVVSLAYAYETKDA-LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGL 299
Query: 164 SYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF 223
             LH  +I++RD+KP N+L++++   ++I+D G++ +           VGT  YM+PE  
Sbjct: 300 EDLHRERIVYRDLKPENILLDDHG-HIRISDLGLA-VHVPEGQTIKGRVGTVGYMAPE-- 355
Query: 224 DPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPG---QRPDWATLMCAICFGDPPSL 280
                         D W+          G  PF Q     +R +   L+  +    P   
Sbjct: 356 ---VVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV----PEEY 408
Query: 281 PDGASPEFRSFIECCLQKEFSKRW-----TASQLLTHPFLCK 317
            +  SP+ RS     L K+ ++R      +A ++  HP   K
Sbjct: 409 SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS-PFIVQCFGI 117
           LG G+     K  H+ +++ +A+K++    +   ++    E+  L+  +  P IV+   +
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK----EITALKLCEGHPNIVKLHEV 74
Query: 118 FEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIK 177
           F        ++ME ++ G L   + K   FSE + ++I  +++  +S++H   ++HRD+K
Sbjct: 75  FHDQLHTF-LVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLK 133
Query: 178 PSNLLVN--NNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXXX 235
           P NLL    N+N+++KI DFG +++         +   T  Y +PE  + +         
Sbjct: 134 PENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN-----GYDE 188
Query: 236 XXDIWSXXXXXXXXXXGHFPF 256
             D+WS          G  PF
Sbjct: 189 SCDLWSLGVILYTMLSGQVPF 209

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 17/214 (7%)
Query: 57  QVLGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +V+G G  G V   + +   K     A+K +        RR    E  I+ + D P I++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKII 172
             G+  K S  + I+ EYM++G+LD+ L K +  F+  +L  +   I  G+ YL     +
Sbjct: 111 LEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF-DPDXXXXX 231
           HRD+   N+L+ N+N+  K++DFG+++++    +A  +  G      P R+  P+     
Sbjct: 170 HRDLAARNILI-NSNLVCKVSDFGLARVLEDDPEAAYTTRGGKI---PIRWTSPEAIAYR 225
Query: 232 XXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDW 265
                 D+WS            +  +  G+RP W
Sbjct: 226 KFTSASDVWSYGIVL-------WEVMSYGERPYW 252

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 72/308 (23%), Positives = 124/308 (40%), Gaps = 60/308 (19%)
Query: 50  YSDLEKLQ--VLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           + D+ +LQ  VLG G    V    +  T + YA+K++       +R +VFRE+E+L +  
Sbjct: 10  FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG-HIRSRVFREVEMLYQCQ 68
Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               V     F +      ++ E M  G++ + ++K   F+E + + +   +   L +LH
Sbjct: 69  GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH 128
Query: 168 GHKIIHRDIKPSNLLVNNNNM--QVKIADFGVSKIMCRSLDACN--------SYVGTCAY 217
              I HRD+KP N+L  + N    VKI DF +   +  + D C+        +  G+  Y
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD-CSPISTPELLTPCGSAEY 187
Query: 218 MSPERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPF--------------------- 256
           M+PE  +             D+WS          G+ PF                     
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247
Query: 257 -----LQPGQRP----DWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTAS 307
                +Q G+      DWA + CA                 +  I   L ++  +R +A+
Sbjct: 248 MLFESIQEGKYEFPDKDWAHISCAA----------------KDLISKLLVRDAKQRLSAA 291
Query: 308 QLLTHPFL 315
           Q+L HP++
Sbjct: 292 QVLQHPWV 299

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 81/192 (42%), Gaps = 9/192 (4%)
Query: 50  YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSP 109
           Y  LEK+   G G  G VYK Q+         K+     D  +     RE+ IL+     
Sbjct: 4   YHGLEKI---GEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
            IV+ + +       + ++ E++D      L    G            Q+L G++Y H  
Sbjct: 61  NIVKLYDVIHTKK-RLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
           +++HRD+KP NLL+N    ++KIADFG+++     +      + T  Y +P+        
Sbjct: 120 RVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL----MG 174
Query: 230 XXXXXXXXDIWS 241
                   DIWS
Sbjct: 175 SKKYSTTIDIWS 186

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 118/273 (43%), Gaps = 23/273 (8%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEIL-RRTDSPFIVQCF 115
           + +G G+     +  H+ T+  YA+KV+        +R    E+EIL R    P I+   
Sbjct: 33  ETIGVGSYSECKRCVHKATNMEYAVKVIDKS-----KRDPSEEIEILLRYGQHPNIITLK 87
Query: 116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRD 175
            +++     + ++ E M  G L   + +   FSE + + +   I K + YLH   ++HRD
Sbjct: 88  DVYDD-GKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRD 146
Query: 176 IKPSNLLV---NNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXX 232
           +KPSN+L    + N   ++I DFG +K     L A N  + T  Y +     P+      
Sbjct: 147 LKPSNILYVDESGNPECLRICDFGFAK----QLRAENGLLMTPCY-TANFVAPEVLKRQG 201
Query: 233 XXXXXDIWSXXXXXXXXXXGHFPFLQ-PGQRPDWATLMCAICFGDPPSLPDG----ASPE 287
                DIWS          G+ PF   P   P+   ++  I  G   +L  G     S  
Sbjct: 202 YDEGCDIWSLGILLYTMLAGYTPFANGPSDTPE--EILTRIGSGK-FTLSGGNWNTVSET 258
Query: 288 FRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR 320
            +  +   L  +  +R TA Q+L HP++ +  +
Sbjct: 259 AKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDK 291

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 91/183 (49%), Gaps = 13/183 (7%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALK-VVHGDADPTVRRQVFREMEILRRTDSP 109
           S  EKL  +G G  G V+K +HR T +  ALK V+  +          RE++IL+     
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 76
Query: 110 FIVQCFGI-------FEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
            +V    I       + +  G I ++ ++ +      L N    F+  ++  +   +L G
Sbjct: 77  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 136
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC-NSY---VGTCAYM 218
           L Y+H +KI+HRD+K +N+L+  + + +K+ADFG+++    + ++  N Y   V T  Y 
Sbjct: 137 LYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 195
Query: 219 SPE 221
            PE
Sbjct: 196 PPE 198

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 83/154 (53%), Gaps = 7/154 (4%)
Query: 53  LEKLQVLGHGNGGTV----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS 108
           L+K++ LG G+ G V    Y   +  T ++ A+K +     P +R    RE+EILR    
Sbjct: 10  LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYH 69
Query: 109 PFIVQCFGIFE-KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
             IV+  G  E +    + ++MEY+  G+L   L ++      +L   A QI +G++YLH
Sbjct: 70  EHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRH-CVGLAQLLLFAQQICEGMAYLH 128
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
               IHR +   N+L++N+ + VKI DFG++K +
Sbjct: 129 AQHYIHRALAARNVLLDNDRL-VKIGDFGLAKAV 161

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 96/213 (45%), Gaps = 15/213 (7%)
Query: 57  QVLGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +V+G G  G V   + +   K     A+K +        RR    E  I+ + D P I++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKII 172
             G+  K S  + I+ EYM++G+LD+ L K +  F+  +L  +   I  G+ YL     +
Sbjct: 111 LEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXX 232
           HRD+   N+L+ N+N+  K++DFG+ +++    +A  +Y      +      P+      
Sbjct: 170 HRDLAARNILI-NSNLVCKVSDFGLGRVLEDDPEA--AYTTRGGKIPIRWTSPEAIAYRK 226
Query: 233 XXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDW 265
                D+WS            +  +  G+RP W
Sbjct: 227 FTSASDVWSYGIVL-------WEVMSYGERPYW 252

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 83/154 (53%), Gaps = 7/154 (4%)
Query: 53  LEKLQVLGHGNGGTV----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS 108
           L+K++ LG G+ G V    Y   +  T ++ A+K +     P +R    RE+EILR    
Sbjct: 11  LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYH 70
Query: 109 PFIVQCFGIFE-KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
             IV+  G  E +    + ++MEY+  G+L   L ++      +L   A QI +G++YLH
Sbjct: 71  EHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRH-CVGLAQLLLFAQQICEGMAYLH 129
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
               IHR +   N+L++N+ + VKI DFG++K +
Sbjct: 130 AQHYIHRALAARNVLLDNDRL-VKIGDFGLAKAV 162

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 91/183 (49%), Gaps = 13/183 (7%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALK-VVHGDADPTVRRQVFREMEILRRTDSP 109
           S  EKL  +G G  G V+K +HR T +  ALK V+  +          RE++IL+     
Sbjct: 18  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 77
Query: 110 FIVQCFGI-------FEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
            +V    I       + +  G I ++ ++ +      L N    F+  ++  +   +L G
Sbjct: 78  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 137
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC-NSY---VGTCAYM 218
           L Y+H +KI+HRD+K +N+L+  + + +K+ADFG+++    + ++  N Y   V T  Y 
Sbjct: 138 LYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 196
Query: 219 SPE 221
            PE
Sbjct: 197 PPE 199

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 119/287 (41%), Gaps = 25/287 (8%)
Query: 48  IAYSDLEKL-QVLGHGNGGTVYKVQHRCTHKIYALKVV---HGDADPTVRRQ-VFREMEI 102
           + + D+ +L +V+G G    V +  +R T + +A+K+V      + P +  + + RE  I
Sbjct: 20  VLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASI 79
Query: 103 LRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNG----TFSEPKLAHIASQ 158
                 P IV+    +    G + ++ E+MD   L   + K       +SE   +H   Q
Sbjct: 80  CHMLKHPHIVELLETYSS-DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQ 138
Query: 159 ILKGLSYLHGHKIIHRDIKPSNLLV--NNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA 216
           IL+ L Y H + IIHRD+KP  +L+    N+  VK+  FGV+  +  S       VGT  
Sbjct: 139 ILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPH 198
Query: 217 YMSPERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGD 276
           +M+PE                D+W           G  PF    +R     L   I  G 
Sbjct: 199 FMAPE-----VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-----LFEGIIKGK 248
Query: 277 ---PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR 320
               P      S   +  +   L  + ++R T  + L HP+L +  R
Sbjct: 249 YKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDR 295

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 118/273 (43%), Gaps = 23/273 (8%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEIL-RRTDSPFIVQCF 115
           + +G G+     +  H+ T+  YA+KV+        +R    E+EIL R    P I+   
Sbjct: 33  ETIGVGSYSECKRCVHKATNMEYAVKVIDKS-----KRDPSEEIEILLRYGQHPNIITLK 87
Query: 116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRD 175
            +++     + ++ E M  G L   + +   FSE + + +   I K + YLH   ++HRD
Sbjct: 88  DVYDD-GKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRD 146
Query: 176 IKPSNLLV---NNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXX 232
           +KPSN+L    + N   ++I DFG +K     L A N  + T  Y +     P+      
Sbjct: 147 LKPSNILYVDESGNPECLRICDFGFAK----QLRAENGLLMTPCY-TANFVAPEVLKRQG 201
Query: 233 XXXXXDIWSXXXXXXXXXXGHFPFLQ-PGQRPDWATLMCAICFGDPPSLPDG----ASPE 287
                DIWS          G+ PF   P   P+   ++  I  G   +L  G     S  
Sbjct: 202 YDEGCDIWSLGILLYTMLAGYTPFANGPSDTPE--EILTRIGSGK-FTLSGGNWNTVSET 258
Query: 288 FRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR 320
            +  +   L  +  +R TA Q+L HP++ +  +
Sbjct: 259 AKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDK 291

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 85/154 (55%), Gaps = 7/154 (4%)
Query: 53  LEKLQVLGHGNGGTV----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS 108
           L+K++ LG G+ G V    Y   +  T ++ A+K +  D  P  R    +E++ILR    
Sbjct: 16  LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYH 75
Query: 109 PFIVQCFGIFE-KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
             I++  G  E +    + ++MEY+  G+L   L ++ +    +L   A QI +G++YLH
Sbjct: 76  EHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLH 134
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
               IHR++   N+L++N+ + VKI DFG++K +
Sbjct: 135 AQHYIHRNLAARNVLLDNDRL-VKIGDFGLAKAV 167

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 91/183 (49%), Gaps = 13/183 (7%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALK-VVHGDADPTVRRQVFREMEILRRTDSP 109
           S  EKL  +G G  G V+K +HR T +  ALK V+  +          RE++IL+     
Sbjct: 18  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 77
Query: 110 FIVQCFGI-------FEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
            +V    I       + +  G I ++ ++ +      L N    F+  ++  +   +L G
Sbjct: 78  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 137
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC-NSY---VGTCAYM 218
           L Y+H +KI+HRD+K +N+L+  + + +K+ADFG+++    + ++  N Y   V T  Y 
Sbjct: 138 LYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 196
Query: 219 SPE 221
            PE
Sbjct: 197 PPE 199

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           L  +G G  G V            A+K +      T  ++  RE++IL R     I+   
Sbjct: 32  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGIN 91
Query: 116 GIFEKPS----GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
            I   P+     D+ I+ + M++     L  K    S   + +   QIL+GL Y+H   +
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLL--KTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC---NSYVGTCAYMSPE 221
           +HRD+KPSNLL+ N    +KI DFG++++     D       YV T  Y +PE
Sbjct: 150 LHRDLKPSNLLL-NTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/187 (31%), Positives = 92/187 (49%), Gaps = 16/187 (8%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH----GDADPTVRRQVFREMEIL 103
           +A S  E +  +G G  GTVYK +   +    ALK V     G     +     RE+ +L
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 104 RRTDS---PFIVQCFGIFEKPSGD----IAILMEYMDSGTLDTLLNKNGTFSEPK--LAH 154
           RR ++   P +V+   +      D    + ++ E++D   L T L+K      P   +  
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKD 124
Query: 155 IASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGT 214
           +  Q L+GL +LH + I+HRD+KP N+LV +    VK+ADFG+++I    + A    V T
Sbjct: 125 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGG-TVKLADFGLARIYSYQM-ALTPVVVT 182
Query: 215 CAYMSPE 221
             Y +PE
Sbjct: 183 LWYRAPE 189

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 80/146 (54%), Gaps = 6/146 (4%)
Query: 59  LGHGNGGTVYK--VQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCF 115
           LG GN GTV K   Q +   K  A+K++  +A DP ++ ++  E  ++++ D+P+IV+  
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRD 175
           GI E  S    ++ME  + G L+  L +N    +  +  +  Q+  G+ YL     +HRD
Sbjct: 95  GICEAES--WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRD 152
Query: 176 IKPSNLLVNNNNMQVKIADFGVSKIM 201
           +   N+L+   +   KI+DFG+SK +
Sbjct: 153 LAARNVLLVTQHY-AKISDFGLSKAL 177

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 6/223 (2%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHG-DADPTVRRQVFRE-MEILRRTDS 108
            D E L+V+G G  G V  V+ +   K++A+K+++  +         FRE  ++L   DS
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLH 167
            +I      F+    ++ ++M+Y   G L TLL+K      E       ++++  +  +H
Sbjct: 134 KWITTLHYAFQD-DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH 192
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVS-KIMCRSLDACNSYVGTCAYMSPERFDPD 226
               +HRDIKP N+L++ N   +++ADFG   K+M       +  VGT  Y+SPE     
Sbjct: 193 QLHYVHRDIKPDNILMDMNG-HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 251
Query: 227 XXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLM 269
                      D WS          G  PF        +  +M
Sbjct: 252 EGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 294

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 80/146 (54%), Gaps = 6/146 (4%)
Query: 59  LGHGNGGTVYK--VQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCF 115
           LG GN GTV K   Q +   K  A+K++  +A DP ++ ++  E  ++++ D+P+IV+  
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRD 175
           GI E  S    ++ME  + G L+  L +N    +  +  +  Q+  G+ YL     +HRD
Sbjct: 95  GICEAES--WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRD 152
Query: 176 IKPSNLLVNNNNMQVKIADFGVSKIM 201
           +   N+L+   +   KI+DFG+SK +
Sbjct: 153 LAARNVLLVTQHY-AKISDFGLSKAL 177

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 119/287 (41%), Gaps = 25/287 (8%)
Query: 48  IAYSDLEKL-QVLGHGNGGTVYKVQHRCTHKIYALKVV---HGDADPTVRRQ-VFREMEI 102
           + + D+ +L +V+G G    V +  +R T + +A+K+V      + P +  + + RE  I
Sbjct: 22  VLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASI 81
Query: 103 LRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNG----TFSEPKLAHIASQ 158
                 P IV+    +    G + ++ E+MD   L   + K       +SE   +H   Q
Sbjct: 82  CHMLKHPHIVELLETYSS-DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQ 140
Query: 159 ILKGLSYLHGHKIIHRDIKPSNLLV--NNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA 216
           IL+ L Y H + IIHRD+KP  +L+    N+  VK+  FGV+  +  S       VGT  
Sbjct: 141 ILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPH 200
Query: 217 YMSPERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGD 276
           +M+PE                D+W           G  PF    +R     L   I  G 
Sbjct: 201 FMAPE-----VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-----LFEGIIKGK 250
Query: 277 ---PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR 320
               P      S   +  +   L  + ++R T  + L HP+L +  R
Sbjct: 251 YKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDR 297

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 85/154 (55%), Gaps = 7/154 (4%)
Query: 53  LEKLQVLGHGNGGTV----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS 108
           L+K++ LG G+ G V    Y   +  T ++ A+K +  D  P  R    +E++ILR    
Sbjct: 16  LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYH 75
Query: 109 PFIVQCFGIFE-KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
             I++  G  E +    + ++MEY+  G+L   L ++ +    +L   A QI +G++YLH
Sbjct: 76  EHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLH 134
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
               IHR++   N+L++N+ + VKI DFG++K +
Sbjct: 135 SQHYIHRNLAARNVLLDNDRL-VKIGDFGLAKAV 167

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 80/146 (54%), Gaps = 6/146 (4%)
Query: 59  LGHGNGGTVYK--VQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCF 115
           LG GN GTV K   Q +   K  A+K++  +A DP ++ ++  E  ++++ D+P+IV+  
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRD 175
           GI E  S    ++ME  + G L+  L +N    +  +  +  Q+  G+ YL     +HRD
Sbjct: 85  GICEAES--WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRD 142
Query: 176 IKPSNLLVNNNNMQVKIADFGVSKIM 201
           +   N+L+   +   KI+DFG+SK +
Sbjct: 143 LAARNVLLVTQHY-AKISDFGLSKAL 167

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 80/146 (54%), Gaps = 6/146 (4%)
Query: 59  LGHGNGGTVYK--VQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCF 115
           LG GN GTV K   Q +   K  A+K++  +A DP ++ ++  E  ++++ D+P+IV+  
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRD 175
           GI E  S    ++ME  + G L+  L +N    +  +  +  Q+  G+ YL     +HRD
Sbjct: 79  GICEAES--WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRD 136
Query: 176 IKPSNLLVNNNNMQVKIADFGVSKIM 201
           +   N+L+   +   KI+DFG+SK +
Sbjct: 137 LAARNVLLVTQHY-AKISDFGLSKAL 161

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 80/146 (54%), Gaps = 6/146 (4%)
Query: 59  LGHGNGGTVYK--VQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCF 115
           LG GN GTV K   Q +   K  A+K++  +A DP ++ ++  E  ++++ D+P+IV+  
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRD 175
           GI E  S    ++ME  + G L+  L +N    +  +  +  Q+  G+ YL     +HRD
Sbjct: 79  GICEAES--WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRD 136
Query: 176 IKPSNLLVNNNNMQVKIADFGVSKIM 201
           +   N+L+   +   KI+DFG+SK +
Sbjct: 137 LAARNVLLVTQHY-AKISDFGLSKAL 161

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 112/277 (40%), Gaps = 20/277 (7%)
Query: 50  YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSP 109
           Y  LE    +G G+ G V     + T    A K +       V R   +E+EI++  D P
Sbjct: 10  YYTLE--NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR-FKQEIEIMKSLDHP 66
Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
            I++ +  FE  + DI ++ME    G L   +     F E   A I   +L  ++Y H  
Sbjct: 67  NIIRLYETFED-NTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125
Query: 170 KIIHRDIKPSN--LLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDX 227
            + HRD+KP N   L ++ +  +K+ DFG++    +      + VGT  Y+SP+  +   
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA-RFKPGKMMRTKVGTPYYVSPQVLE--- 181
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAI---CFGDPPSLPDGA 284
                     D WS          G+ PF  P        +M  I    F  P       
Sbjct: 182 ---GLYGPECDEWSAGVMMYVLLCGYPPFSAPTD----XEVMLKIREGTFTFPEKDWLNV 234
Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS 321
           SP+  S I   L K   +R T+ Q L H +  K   S
Sbjct: 235 SPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSS 271

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 80/146 (54%), Gaps = 6/146 (4%)
Query: 59  LGHGNGGTVYK--VQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCF 115
           LG GN GTV K   Q +   K  A+K++  +A DP ++ ++  E  ++++ D+P+IV+  
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRD 175
           GI E  S    ++ME  + G L+  L +N    +  +  +  Q+  G+ YL     +HRD
Sbjct: 93  GICEAES--WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRD 150
Query: 176 IKPSNLLVNNNNMQVKIADFGVSKIM 201
           +   N+L+   +   KI+DFG+SK +
Sbjct: 151 LAARNVLLVTQHY-AKISDFGLSKAL 175

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 112/277 (40%), Gaps = 20/277 (7%)
Query: 50  YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSP 109
           Y  LE    +G G+ G V     + T    A K +       V R   +E+EI++  D P
Sbjct: 27  YYTLE--NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR-FKQEIEIMKSLDHP 83
Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
            I++ +  FE  + DI ++ME    G L   +     F E   A I   +L  ++Y H  
Sbjct: 84  NIIRLYETFED-NTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 142
Query: 170 KIIHRDIKPSN--LLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDX 227
            + HRD+KP N   L ++ +  +K+ DFG++    +      + VGT  Y+SP+  +   
Sbjct: 143 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA-RFKPGKMMRTKVGTPYYVSPQVLE--- 198
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAI---CFGDPPSLPDGA 284
                     D WS          G+ PF  P        +M  I    F  P       
Sbjct: 199 ---GLYGPECDEWSAGVMMYVLLCGYPPFSAPTD----XEVMLKIREGTFTFPEKDWLNV 251
Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS 321
           SP+  S I   L K   +R T+ Q L H +  K   S
Sbjct: 252 SPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSS 288

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 80/146 (54%), Gaps = 6/146 (4%)
Query: 59  LGHGNGGTVYK--VQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCF 115
           LG GN GTV K   Q +   K  A+K++  +A DP ++ ++  E  ++++ D+P+IV+  
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRD 175
           GI E  S    ++ME  + G L+  L +N    +  +  +  Q+  G+ YL     +HRD
Sbjct: 75  GICEAES--WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRD 132
Query: 176 IKPSNLLVNNNNMQVKIADFGVSKIM 201
           +   N+L+   +   KI+DFG+SK +
Sbjct: 133 LAARNVLLVTQHY-AKISDFGLSKAL 157

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 80/146 (54%), Gaps = 6/146 (4%)
Query: 59  LGHGNGGTVYK--VQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCF 115
           LG GN GTV K   Q +   K  A+K++  +A DP ++ ++  E  ++++ D+P+IV+  
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRD 175
           GI E  S    ++ME  + G L+  L +N    +  +  +  Q+  G+ YL     +HRD
Sbjct: 73  GICEAES--WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRD 130
Query: 176 IKPSNLLVNNNNMQVKIADFGVSKIM 201
           +   N+L+   +   KI+DFG+SK +
Sbjct: 131 LAARNVLLVTQHY-AKISDFGLSKAL 155

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 90/169 (53%), Gaps = 10/169 (5%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFR-EMEILRRTDSPFIVQCF 115
           Q +G G+ GTVYK +    H   A+K+++  A    + Q F+ E+ +LR+T    I+   
Sbjct: 14  QRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILKGLSYLHGHKIIHR 174
           G    P   +AI+ ++ +  +L   L+   T F   KL  IA Q  +G+ YLH   IIHR
Sbjct: 71  GYSTAPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHR 128
Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA--CNSYVGTCAYMSPE 221
           D+K +N+ + + ++ VKI DFG++ +  R   +       G+  +M+PE
Sbjct: 129 DLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 176

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 89/169 (52%), Gaps = 10/169 (5%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFR-EMEILRRTDSPFIVQCF 115
           Q +G G+ GTVYK +    H   A+K+++  A    + Q F+ E+ +LR+T    I+   
Sbjct: 34  QRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 90
Query: 116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILKGLSYLHGHKIIHR 174
           G   KP   +AI+ ++ +  +L   L+   T F   KL  IA Q  +G+ YLH   IIHR
Sbjct: 91  GYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHR 148
Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCR--SLDACNSYVGTCAYMSPE 221
           D+K +N+ + + ++ VKI DFG++    R           G+  +M+PE
Sbjct: 149 DLKSNNIFL-HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 196

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 89/169 (52%), Gaps = 10/169 (5%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFR-EMEILRRTDSPFIVQCF 115
           Q +G G+ GTVYK +    H   A+K+++  A    + Q F+ E+ +LR+T    I+   
Sbjct: 42  QRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 98
Query: 116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILKGLSYLHGHKIIHR 174
           G   KP   +AI+ ++ +  +L   L+   T F   KL  IA Q  +G+ YLH   IIHR
Sbjct: 99  GYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHR 156
Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCR--SLDACNSYVGTCAYMSPE 221
           D+K +N+ + + ++ VKI DFG++    R           G+  +M+PE
Sbjct: 157 DLKSNNIFL-HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 204

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 90/169 (53%), Gaps = 10/169 (5%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFR-EMEILRRTDSPFIVQCF 115
           Q +G G+ GTVYK +    H   A+K+++  A    + Q F+ E+ +LR+T    I+   
Sbjct: 14  QRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILKGLSYLHGHKIIHR 174
           G   KP   +AI+ ++ +  +L   L+   T F   KL  IA Q  +G+ YLH   IIHR
Sbjct: 71  GYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHR 128
Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA--CNSYVGTCAYMSPE 221
           D+K +N+ + + ++ VKI DFG++    R   +       G+  +M+PE
Sbjct: 129 DLKSNNIFL-HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 176

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 93/188 (49%), Gaps = 12/188 (6%)
Query: 59  LGHGNGGTVYK--VQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCF 115
           LG GN GTV K   Q +   K  A+K++  +A DP ++ ++  E  ++++ D+P+IV+  
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRD 175
           GI E  S    ++ME  + G L+  L +N    +  +  +  Q+  G+ YL     +HRD
Sbjct: 437 GICEAES--WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRD 494
Query: 176 IKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSY--VGTCAYMSPERFDPDXXXXXXX 233
           +   N+L+   +   KI+DFG+SK    +L A  +Y    T      + + P+       
Sbjct: 495 LAARNVLLVTQHY-AKISDFGLSK----ALRADENYYKAQTHGKWPVKWYAPECINYYKF 549
Query: 234 XXXXDIWS 241
               D+WS
Sbjct: 550 SSKSDVWS 557

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           L  +G G  G V            A+K +      T  ++  RE++IL R     I+   
Sbjct: 28  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 116 GIFEKPS----GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
            I   P+     D+ I+ + M++     L  K    S   + +   QIL+GL Y+H   +
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLL--KTQHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC---NSYVGTCAYMSPE 221
           +HRD+KPSNLL+ N    +KI DFG++++     D       YV T  Y +PE
Sbjct: 146 LHRDLKPSNLLL-NTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           L  +G G  G V            A+K +      T  ++  RE++IL R     I+   
Sbjct: 28  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 116 GIFEKPS----GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
            I   P+     D+ I+ + M++     L  K    S   + +   QIL+GL Y+H   +
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLL--KTQHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC---NSYVGTCAYMSPE 221
           +HRD+KPSNLL+ N    +KI DFG++++     D       YV T  Y +PE
Sbjct: 146 LHRDLKPSNLLL-NTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 21/216 (9%)
Query: 57  QVLGHGNGGTVYKVQHRCTHK------IYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           +V+G G  G V   + +   K      I  LKV + +     RR    E  I+ + D P 
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDFLGEASIMGQFDHPN 78
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGH 169
           I++  G+  K S  + I+ E M++G+LD+ L K +  F+  +L  +   I  G+ YL   
Sbjct: 79  IIRLEGVVTK-SKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 137
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
             +HRD+   N+L+ N+N+  K++DFG+S+++    +A  +Y      +      P+   
Sbjct: 138 GYVHRDLAARNILI-NSNLVCKVSDFGLSRVLEDDPEA--AYTTRGGKIPIRWTSPEAIA 194
Query: 230 XXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDW 265
                   D+WS            +  +  G+RP W
Sbjct: 195 YRKFTSASDVWSYGIVL-------WEVMSYGERPYW 223

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 82/156 (52%), Gaps = 8/156 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRT 106
           ++L++++VLG G  GTVYK   V    T KI  A+K+++    P    +   E  I+   
Sbjct: 38  TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM 97
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSG-TLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
           D P +V+  G+   P+  I ++ + M  G  L+ +           L +   QI KG+ Y
Sbjct: 98  DHPHLVRLLGVCLSPT--IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMY 155
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           L   +++HRD+   N+LV + N  VKI DFG+++++
Sbjct: 156 LEERRLVHRDLAARNVLVKSPN-HVKITDFGLARLL 190

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 96/213 (45%), Gaps = 15/213 (7%)
Query: 57  QVLGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +V+G G  G V   + +   K     A+K +        RR    E  I+ + D P I++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKII 172
             G+  K S  + I+ E M++G+LD+ L K +  F+  +L  +   I  G+ YL     +
Sbjct: 111 LEGVVTK-SKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGAV 169
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXX 232
           HRD+   N+L+ N+N+  K++DFG+S+++    +A  +Y      +      P+      
Sbjct: 170 HRDLAARNILI-NSNLVCKVSDFGLSRVLEDDPEA--AYTTRGGKIPIRWTSPEAIAYRK 226
Query: 233 XXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDW 265
                D+WS            +  +  G+RP W
Sbjct: 227 FTSASDVWSYGIVL-------WEVMSYGERPYW 252

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           L  +G G  G V            A+K +      T  ++  RE++IL R     I+   
Sbjct: 28  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 116 GIFEKPS----GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
            I   P+     D+ I+ + M++     L  K    S   + +   QIL+GL Y+H   +
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLL--KTQHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC---NSYVGTCAYMSPE 221
           +HRD+KPSNLL+ N    +KI DFG++++     D       YV T  Y +PE
Sbjct: 146 LHRDLKPSNLLL-NTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 93/188 (49%), Gaps = 12/188 (6%)
Query: 59  LGHGNGGTVYK--VQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCF 115
           LG GN GTV K   Q +   K  A+K++  +A DP ++ ++  E  ++++ D+P+IV+  
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRD 175
           GI E  S    ++ME  + G L+  L +N    +  +  +  Q+  G+ YL     +HRD
Sbjct: 438 GICEAES--WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRD 495
Query: 176 IKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSY--VGTCAYMSPERFDPDXXXXXXX 233
           +   N+L+   +   KI+DFG+SK    +L A  +Y    T      + + P+       
Sbjct: 496 LAARNVLLVTQHY-AKISDFGLSK----ALRADENYYKAQTHGKWPVKWYAPECINYYKF 550
Query: 234 XXXXDIWS 241
               D+WS
Sbjct: 551 SSKSDVWS 558

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 82/156 (52%), Gaps = 8/156 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRT 106
           ++L++++VLG G  GTVYK   V    T KI  A+K+++    P    +   E  I+   
Sbjct: 15  TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM 74
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSG-TLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
           D P +V+  G+   P+  I ++ + M  G  L+ +           L +   QI KG+ Y
Sbjct: 75  DHPHLVRLLGVCLSPT--IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMY 132
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           L   +++HRD+   N+LV + N  VKI DFG+++++
Sbjct: 133 LEERRLVHRDLAARNVLVKSPN-HVKITDFGLARLL 167

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 116/270 (42%), Gaps = 20/270 (7%)
Query: 58  VLGHGNGGTVYKV---QHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQC 114
           +LG G+ G V +V   +  C   +  LK       P     V +E+++LRR     ++Q 
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 115 FGI-FEKPSGDIAILMEYMDSGT---LDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
             + + +    + ++MEY   G    LD++  K   F   +      Q++ GL YLH   
Sbjct: 72  VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR--FPVCQAHGYFCQLIDGLEYLHSQG 129
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIM--CRSLDACNSYVGTCAYMSPERFDPDXX 228
           I+H+DIKP NLL+      +KI+  GV++ +    + D C +  G+ A+  PE  +    
Sbjct: 130 IVHKDIKPGNLLLTTGGT-LKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN---G 185
Query: 229 XXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEF 288
                    DIWS          G +PF    +  +   L   I  G   ++P    P  
Sbjct: 186 LDTFSGFKVDIWSAGVTLYNITTGLYPF----EGDNIYKLFENIGKGS-YAIPGDCGPPL 240
Query: 289 RSFIECCLQKEFSKRWTASQLLTHPFLCKN 318
              ++  L+ E +KR++  Q+  H +  K 
Sbjct: 241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 113/263 (42%), Gaps = 29/263 (11%)
Query: 68  YKVQHRCTHKI----YALKVV-HGDADPTVRRQVFREMEIL-RRTDSPFIVQCFGIFEKP 121
           Y V  RC HK     +A+K++     DPT       E+EIL R    P I+    +++  
Sbjct: 35  YSVCKRCIHKATNXEFAVKIIDKSKRDPT------EEIEILLRYGQHPNIITLKDVYDD- 87
Query: 122 SGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNL 181
              + ++ E    G L   + +   FSE + + +   I K + YLH   ++HRD+KPSN+
Sbjct: 88  GKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNI 147
Query: 182 LV---NNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXXXXXXD 238
           L    + N   ++I DFG +K     L A N  + T  Y +     P+           D
Sbjct: 148 LYVDESGNPESIRICDFGFAK----QLRAENGLLXTPCYTA-NFVAPEVLERQGYDAACD 202
Query: 239 IWSXXXXXXXXXXGHFPFLQ-PGQRPDWATLMCAICFGDPPSLPDG----ASPEFRSFIE 293
           IWS          G+ PF   P   P+   ++  I  G   SL  G     S   +  + 
Sbjct: 203 IWSLGVLLYTXLTGYTPFANGPDDTPE--EILARIGSGK-FSLSGGYWNSVSDTAKDLVS 259
Query: 294 CCLQKEFSKRWTASQLLTHPFLC 316
             L  +  +R TA+ +L HP++ 
Sbjct: 260 KXLHVDPHQRLTAALVLRHPWIV 282

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           L  +G G  G V            A+K +      T  ++  RE++IL R     I+   
Sbjct: 32  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 116 GIFEKPS----GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
            I   P+     D+ I+ + M++     L  K    S   + +   QIL+GL Y+H   +
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLL--KTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC---NSYVGTCAYMSPE 221
           +HRD+KPSNLL+ N    +KI DFG++++     D       YV T  Y +PE
Sbjct: 150 LHRDLKPSNLLL-NTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 96/213 (45%), Gaps = 15/213 (7%)
Query: 57  QVLGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +V+G G  G V   + +   K     A+K +        RR    E  I+ + D P I++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKII 172
             G+  K S  + I+ E M++G+LD+ L K +  F+  +L  +   I  G+ YL     +
Sbjct: 111 LEGVVTK-SKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXX 232
           HRD+   N+L+ N+N+  K++DFG+S+++    +A  +Y      +      P+      
Sbjct: 170 HRDLAARNILI-NSNLVCKVSDFGLSRVLEDDPEA--AYTTRGGKIPIRWTSPEAIAYRK 226
Query: 233 XXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDW 265
                D+WS            +  +  G+RP W
Sbjct: 227 FTSASDVWSYGIVL-------WEVMSYGERPYW 252

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 104/261 (39%), Gaps = 43/261 (16%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFEKPSG----DIAILMEYMDSGTLDTLLNKNGTFSE 149
           ++ +RE+ +L+      ++    +F   +     +   L+ ++    L+ ++ K    ++
Sbjct: 95  KRTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIV-KCQKLTD 153
Query: 150 PKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN 209
             +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D   
Sbjct: 154 DHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEMT 209
Query: 210 SYVGTCAYMSPERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLM 269
            YV T  Y +PE                DIWS          G   F  PG         
Sbjct: 210 GYVATRWYRAPEIM----LNWMHYNMTVDIWSVGCIMAELLTGRTLF--PGTDHINQLQQ 263
Query: 270 CAICFGDPP-----------------SLPD-----------GASPEFRSFIECCLQKEFS 301
                G PP                 SLP            GA+P     +E  L  +  
Sbjct: 264 IMRLTGTPPASVISRMPSHEARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTD 323
Query: 302 KRWTASQLLTHPFLCKNRRSD 322
           KR TAS+ L HP+  +    D
Sbjct: 324 KRITASEALAHPYFSQYHDPD 344

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 118/271 (43%), Gaps = 18/271 (6%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTD--SPFIV 112
           L+ +G G    V++V +    +IYA+K V+  +AD         E+  L +    S  I+
Sbjct: 13  LKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 71
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
           + +  +E     I ++ME   +  L++ L K  +    +       +L+ +  +H H I+
Sbjct: 72  RLYD-YEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIV 129
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC--NSYVGTCAYMSPERFD------ 224
           H D+KP+N L+ +    +K+ DFG++  M     +   +S VGT  YM PE         
Sbjct: 130 HSDLKPANFLIVDG--MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 187
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
            +           D+WS          G  PF Q   +   + L   I        PD  
Sbjct: 188 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHAIIDPNHEIEFPDIP 245
Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
             + +  ++CCL+++  +R +  +LL HP++
Sbjct: 246 EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 276

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           L  +G G  G V            A+K +      T  ++  RE++IL R     I+   
Sbjct: 28  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 116 GIFEKPS----GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
            I   P+     D+ I+ + M++     L  K    S   + +   QIL+GL Y+H   +
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLL--KTQHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC---NSYVGTCAYMSPE 221
           +HRD+KPSNLL+ N    +KI DFG++++     D       YV T  Y +PE
Sbjct: 146 LHRDLKPSNLLL-NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 118/271 (43%), Gaps = 18/271 (6%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTD--SPFIV 112
           L+ +G G    V++V +    +IYA+K V+  +AD         E+  L +    S  I+
Sbjct: 17  LKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 75
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
           + +  +E     I ++ME   +  L++ L K  +    +       +L+ +  +H H I+
Sbjct: 76  RLYD-YEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIV 133
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC--NSYVGTCAYMSPERFD------ 224
           H D+KP+N L+ +    +K+ DFG++  M     +   +S VGT  YM PE         
Sbjct: 134 HSDLKPANFLIVDG--MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 191
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
            +           D+WS          G  PF Q   +   + L   I        PD  
Sbjct: 192 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHAIIDPNHEIEFPDIP 249
Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
             + +  ++CCL+++  +R +  +LL HP++
Sbjct: 250 EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 280

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 118/271 (43%), Gaps = 18/271 (6%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTD--SPFIV 112
           L+ +G G    V++V +    +IYA+K V+  +AD         E+  L +    S  I+
Sbjct: 33  LKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 91
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
           + +  +E     I ++ME   +  L++ L K  +    +       +L+ +  +H H I+
Sbjct: 92  RLYD-YEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIV 149
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC--NSYVGTCAYMSPERFD------ 224
           H D+KP+N L+ +    +K+ DFG++  M     +   +S VGT  YM PE         
Sbjct: 150 HSDLKPANFLIVDG--MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 207
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
            +           D+WS          G  PF Q   +   + L   I        PD  
Sbjct: 208 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--SKLHAIIDPNHEIEFPDIP 265
Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
             + +  ++CCL+++  +R +  +LL HP++
Sbjct: 266 EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           L  +G G  G V            A+K +      T  ++  RE++IL R     I+   
Sbjct: 30  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 89
Query: 116 GIFEKPS----GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
            I   P+     D+ I+ + M++     L  K    S   + +   QIL+GL Y+H   +
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLMETDLYKLL--KTQHLSNDHICYFLYQILRGLKYIHSANV 147
Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC---NSYVGTCAYMSPE 221
           +HRD+KPSNLL+ N    +KI DFG++++     D       YV T  Y +PE
Sbjct: 148 LHRDLKPSNLLL-NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 199

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 118/273 (43%), Gaps = 22/273 (8%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTD--SPFIV 112
           L+ +G G    V++V +    +IYA+K V+  +AD         E+  L +    S  I+
Sbjct: 61  LKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 119
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLD--TLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           + +  +E     I ++ME    G +D  + L K  +    +       +L+ +  +H H 
Sbjct: 120 RLYD-YEITDQYIYMVME---CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 175
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC--NSYVGTCAYMSPERFD---- 224
           I+H D+KP+N L+ +    +K+ DFG++  M     +   +S VGT  YM PE       
Sbjct: 176 IVHSDLKPANFLIVDG--MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 233
Query: 225 --PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPD 282
              +           D+WS          G  PF Q   +   + L   I        PD
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHAIIDPNHEIEFPD 291
Query: 283 GASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
               + +  ++CCL+++  +R +  +LL HP++
Sbjct: 292 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           L  +G G  G V            A+K +      T  ++  RE++IL R     I+   
Sbjct: 36  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 95
Query: 116 GIFEKPS----GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
            I   P+     D+ I+ + M++     L  K    S   + +   QIL+GL Y+H   +
Sbjct: 96  DIIRAPTIEQMKDVYIVQDLMETDLYKLL--KTQHLSNDHICYFLYQILRGLKYIHSANV 153
Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC---NSYVGTCAYMSPE 221
           +HRD+KPSNLL+ N    +KI DFG++++     D       YV T  Y +PE
Sbjct: 154 LHRDLKPSNLLL-NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 205

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           L  +G G  G V            A+K +      T  ++  RE++IL R     I+   
Sbjct: 28  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 116 GIFEKPS----GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
            I   P+     D+ I+ + M++     L  K    S   + +   QIL+GL Y+H   +
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLL--KTQHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC---NSYVGTCAYMSPE 221
           +HRD+KPSNLL+ N    +KI DFG++++     D       YV T  Y +PE
Sbjct: 146 LHRDLKPSNLLL-NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 84/195 (43%), Gaps = 6/195 (3%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           + + DL   + +G GN G V+  + R  + + A+K       P ++ +  +E  IL++  
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS 170
Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPK-LAHIASQILKGLSYL 166
            P IV+  G+  +    I I+ME +  G   T L   G     K L  +      G+ YL
Sbjct: 171 HPNIVRLIGVCTQKQ-PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL 229
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPD 226
                IHRD+   N LV   N+ +KI+DFG+S+      D   +  G    +  +   P+
Sbjct: 230 ESKCCIHRDLAARNCLVTEKNV-LKISDFGMSR---EEADGVXAASGGLRQVPVKWTAPE 285
Query: 227 XXXXXXXXXXXDIWS 241
                      D+WS
Sbjct: 286 ALNYGRYSSESDVWS 300

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 88/174 (50%), Gaps = 10/174 (5%)
Query: 53  LEKLQVLGHGNGGTV-YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
           L+ L+ +G G  G+V      R   K+   K+          R+ +RE+ +L+      +
Sbjct: 30  LQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENV 89
Query: 112 VQCFGIFEKPSGDIAILME-YMDSGTLDTLLN---KNGTFSEPKLAHIASQILKGLSYLH 167
           +    +F  P+  I    E Y+ +  +   LN   K+   S+  +  +  Q+L+GL Y+H
Sbjct: 90  IGLLDVF-TPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIH 148
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
              IIHRD+KPSN+ VN ++ +++I DFG+++   ++ +    YV T  Y +PE
Sbjct: 149 SAGIIHRDLKPSNVAVNEDS-ELRILDFGLAR---QADEEMTGYVATRWYRAPE 198

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 90/183 (49%), Gaps = 13/183 (7%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALK-VVHGDADPTVRRQVFREMEILRRTDSP 109
           S  EKL  +G G  G V+K +HR T +  ALK V+  +          RE++IL+     
Sbjct: 18  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 77
Query: 110 FIVQCFGI-------FEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
            +V    I       + +    I ++ ++ +      L N    F+  ++  +   +L G
Sbjct: 78  NVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 137
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC-NSY---VGTCAYM 218
           L Y+H +KI+HRD+K +N+L+  + + +K+ADFG+++    + ++  N Y   V T  Y 
Sbjct: 138 LYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 196
Query: 219 SPE 221
            PE
Sbjct: 197 PPE 199

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 110/254 (43%), Gaps = 23/254 (9%)
Query: 59  LGHGNGGTVYKVQHRCTHKI--YALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           LG GN G+V +  +R   K    A+KV+    +     ++ RE +I+ + D+P+IV+  G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 117 IFEKPSGDIAILMEYMDSGTLDT-LLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRD 175
           + +  +  + ++ME    G L   L+ K        +A +  Q+  G+ YL     +HRD
Sbjct: 78  VCQAEA--LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRD 135
Query: 176 IKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNS-YVGTCAYMSPER-FDPDXXXXXXX 233
           +   N+L+ N +   KI+DFG+SK    +L A +S Y    A   P + + P+       
Sbjct: 136 LAARNVLLVNRHY-AKISDFGLSK----ALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 234 XXXXDIWSXXXXXXXXXXGHFPFLQPGQRP----DWATLMCAICFGDPPSLPDGASPEFR 289
               D+WS            +  L  GQ+P        +M  I  G     P    PE  
Sbjct: 191 SSRSDVWSYGVTM-------WEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY 243
Query: 290 SFIECCLQKEFSKR 303
           + +  C   ++  R
Sbjct: 244 ALMSDCWIYKWEDR 257

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           L  +G G  G V            A+K +      T  ++  RE++IL R     I+   
Sbjct: 26  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 85
Query: 116 GIFEKPS----GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
            I   P+     D+ I+ + M++     L  K    S   + +   QIL+GL Y+H   +
Sbjct: 86  DIIRAPTIEQMKDVYIVQDLMETDLYKLL--KTQHLSNDHICYFLYQILRGLKYIHSANV 143
Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC---NSYVGTCAYMSPE 221
           +HRD+KPSNLL+ N    +KI DFG++++     D       YV T  Y +PE
Sbjct: 144 LHRDLKPSNLLL-NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 195

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           L  +G G  G V            A+K +      T  ++  RE++IL R     I+   
Sbjct: 48  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 107
Query: 116 GIFEKPS----GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
            I   P+     D+ I+ + M++     L  K    S   + +   QIL+GL Y+H   +
Sbjct: 108 DIIRAPTIEQMKDVYIVQDLMETDLYKLL--KTQHLSNDHICYFLYQILRGLKYIHSANV 165
Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC---NSYVGTCAYMSPE 221
           +HRD+KPSNLL+ N    +KI DFG++++     D       YV T  Y +PE
Sbjct: 166 LHRDLKPSNLLL-NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 217

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           L  +G G  G V            A+K +      T  ++  RE++IL R     I+   
Sbjct: 33  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 92
Query: 116 GIFEKPS----GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
            I   P+     D+ I+ + M++     L  K    S   + +   QIL+GL Y+H   +
Sbjct: 93  DIIRAPTIEQMKDVYIVQDLMETDLYKLL--KTQHLSNDHICYFLYQILRGLKYIHSANV 150
Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC---NSYVGTCAYMSPE 221
           +HRD+KPSNLL+ N    +KI DFG++++     D       YV T  Y +PE
Sbjct: 151 LHRDLKPSNLLL-NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 202

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           L  +G G  G V            A+K +      T  ++  RE++IL R     I+   
Sbjct: 34  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 93
Query: 116 GIFEKPS----GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
            I   P+     D+ I+ + M++     L  K    S   + +   QIL+GL Y+H   +
Sbjct: 94  DIIRAPTIEQMKDVYIVQDLMETDLYKLL--KTQHLSNDHICYFLYQILRGLKYIHSANV 151
Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC---NSYVGTCAYMSPE 221
           +HRD+KPSNLL+ N    +KI DFG++++     D       YV T  Y +PE
Sbjct: 152 LHRDLKPSNLLL-NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 203

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           L  +G G  G V            A+K +      T  ++  RE++IL R     I+   
Sbjct: 25  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 84
Query: 116 GIFEKPS----GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
            I   P+     D+ I+ + M++     L  K    S   + +   QIL+GL Y+H   +
Sbjct: 85  DIIRAPTIEQMKDVYIVQDLMETDLYKLL--KTQHLSNDHICYFLYQILRGLKYIHSANV 142
Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC---NSYVGTCAYMSPE 221
           +HRD+KPSNLL+ N    +KI DFG++++     D       YV T  Y +PE
Sbjct: 143 LHRDLKPSNLLL-NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 194

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           L  +G G  G V            A+K +      T  ++  RE++IL R     I+   
Sbjct: 32  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 116 GIFEKPS----GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
            I   P+     D+ I+ + M++     L  K    S   + +   QIL+GL Y+H   +
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLL--KTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC---NSYVGTCAYMSPE 221
           +HRD+KPSNLL+ N    +KI DFG++++     D       YV T  Y +PE
Sbjct: 150 LHRDLKPSNLLL-NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           L  +G G  G V            A+K +      T  ++  RE++IL R     I+   
Sbjct: 26  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 85
Query: 116 GIFEKPS----GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
            I   P+     D+ I+ + M++     L  K    S   + +   QIL+GL Y+H   +
Sbjct: 86  DIIRAPTIEQMKDVYIVQDLMETDLYKLL--KTQHLSNDHICYFLYQILRGLKYIHSANV 143
Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC---NSYVGTCAYMSPE 221
           +HRD+KPSNLL+ N    +KI DFG++++     D       YV T  Y +PE
Sbjct: 144 LHRDLKPSNLLL-NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 195

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 118/271 (43%), Gaps = 18/271 (6%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTD--SPFIV 112
           L+ +G G    V++V +    +IYA+K V+  +AD         E+  L +    S  I+
Sbjct: 14  LKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 72
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
           + +  +E     I ++ME   +  L++ L K  +    +       +L+ +  +H H I+
Sbjct: 73  RLYD-YEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIV 130
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC--NSYVGTCAYMSPERFD------ 224
           H D+KP+N L+ +    +K+ DFG++  M     +   +S VGT  YM PE         
Sbjct: 131 HSDLKPANFLIVDG--MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 188
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
            +           D+WS          G  PF Q   +   + L   I        PD  
Sbjct: 189 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHAIIDPNHEIEFPDIP 246
Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
             + +  ++CCL+++  +R +  +LL HP++
Sbjct: 247 EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 108/241 (44%), Gaps = 19/241 (7%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGI 117
           +LG G    V++ +H+ T  ++A+KV +  +         RE E+L++ +   IV+ F I
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 118 FEKPSGDIAIL-MEYMDSGTLDTLLNKNGT---FSEPKLAHIASQILKGLSYLHGHKIIH 173
            E+ +    +L ME+   G+L T+L +        E +   +   ++ G+++L  + I+H
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVH 135
Query: 174 RDIKPSNLL--VNNNNMQV-KIADFGVSKIMCRSLDACNSYV---GTCAYMSPERFDPDX 227
           R+IKP N++  +  +   V K+ DFG +    R L+    +V   GT  Y+ P+ ++   
Sbjct: 136 RNIKPGNIMRVIGEDGQSVYKLTDFGAA----RELEDDEQFVSLYGTEEYLHPDMYERAV 191
Query: 228 XX---XXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDW-ATLMCAICFGDPPSLPDG 283
                        D+WS          G  PF +P + P     +M  I  G P     G
Sbjct: 192 LRKDHQKKYGATVDLWSIGVTFYHAATGSLPF-RPFEGPRRNKEVMYKIITGKPSGAISG 250
Query: 284 A 284
Sbjct: 251 V 251

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/265 (24%), Positives = 114/265 (43%), Gaps = 18/265 (6%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDS-PFIVQCFG 116
           LG G    V +   + T + YA K +         R ++  E+ +L    S P ++    
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 117 IFEKPSGDIAILMEYMDSGTLDTLL--NKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
           ++E  S +I +++EY   G + +L         SE  +  +  QIL+G+ YLH + I+H 
Sbjct: 97  VYENTS-EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHL 155
Query: 175 DIKPSNLLVNNNN--MQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE--RFDPDXXXX 230
           D+KP N+L+++      +KI DFG+S+ +  + +     +GT  Y++PE   +DP     
Sbjct: 156 DLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTPEYLAPEILNYDP----- 209
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                  D+W+             PF+    +  +  +   +            S     
Sbjct: 210 --ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI-SQVNVDYSEETFSSVSQLATD 266
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
           FI+  L K   KR TA   L+H +L
Sbjct: 267 FIQSLLVKNPEKRPTAEICLSHSWL 291

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 93/192 (48%), Gaps = 17/192 (8%)
Query: 55  KLQV-LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +L+V LG G  G V+      T ++    +  G   P       +E +++++     +VQ
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQ 77
Query: 114 CFGIF-EKPSGDIAILMEYMDSG-TLDTLLNKNGTFSE-PKLAHIASQILKGLSYLHGHK 170
            + +  E+P   I I+MEYM  G  LD L  + G +   P+L  +A+QI  G++Y+    
Sbjct: 78  LYAVVSEEP---IYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDXXX 229
            +HRD++ +N+LV   N+  K+ADFG+++++       N Y        P ++  P+   
Sbjct: 135 YVHRDLRAANILV-GENLVCKVADFGLARLI-----EDNEYTARQGAKFPIKWTAPEAAL 188
Query: 230 XXXXXXXXDIWS 241
                   D+WS
Sbjct: 189 YGRFTIKSDVWS 200

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 84/195 (43%), Gaps = 6/195 (3%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           + + DL   + +G GN G V+  + R  + + A+K       P ++ +  +E  IL++  
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS 170
Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPK-LAHIASQILKGLSYL 166
            P IV+  G+  +    I I+ME +  G   T L   G     K L  +      G+ YL
Sbjct: 171 HPNIVRLIGVCTQKQ-PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL 229
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPD 226
                IHRD+   N LV   N+ +KI+DFG+S+      D   +  G    +  +   P+
Sbjct: 230 ESKCCIHRDLAARNCLVTEKNV-LKISDFGMSR---EEADGVYAASGGLRQVPVKWTAPE 285
Query: 227 XXXXXXXXXXXDIWS 241
                      D+WS
Sbjct: 286 ALNYGRYSSESDVWS 300

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 117/271 (43%), Gaps = 18/271 (6%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTD--SPFIV 112
           L+ +G G    V++V +    +IYA+K V+  +AD         E+  L +    S  I+
Sbjct: 33  LKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 91
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
           + +  +E     I ++ME   +  L++ L K  +    +       +L+ +  +H H I+
Sbjct: 92  RLYD-YEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIV 149
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC--NSYVGTCAYMSPERFD------ 224
           H D+KP+N L+ +    +K+ DFG++  M         +S VGT  YM PE         
Sbjct: 150 HSDLKPANFLIVDG--MLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSSR 207
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
            +           D+WS          G  PF Q   +   + L   I        PD  
Sbjct: 208 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--SKLHAIIDPNHEIEFPDIP 265
Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
             + +  ++CCL+++  +R +  +LL HP++
Sbjct: 266 EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 87/156 (55%), Gaps = 9/156 (5%)
Query: 53  LEKLQVLGHGNGGTV----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS 108
           L++++ LG G+ G V    Y  +   T +  A+K +  ++       + +E+EILR    
Sbjct: 11  LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH 70
Query: 109 PFIVQCFGIFEKPSGD-IAILMEYMDSGTLDTLL--NKNGTFSEPKLAHIASQILKGLSY 165
             IV+  GI  +  G+ I ++ME++ SG+L   L  NKN    + +L + A QI KG+ Y
Sbjct: 71  ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY-AVQICKGMDY 129
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           L   + +HRD+   N+LV + + QVKI DFG++K +
Sbjct: 130 LGSRQYVHRDLAARNVLVESEH-QVKIGDFGLTKAI 164

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 87/156 (55%), Gaps = 9/156 (5%)
Query: 53  LEKLQVLGHGNGGTV----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS 108
           L++++ LG G+ G V    Y  +   T +  A+K +  ++       + +E+EILR    
Sbjct: 23  LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH 82
Query: 109 PFIVQCFGIFEKPSGD-IAILMEYMDSGTLDTLL--NKNGTFSEPKLAHIASQILKGLSY 165
             IV+  GI  +  G+ I ++ME++ SG+L   L  NKN    + +L + A QI KG+ Y
Sbjct: 83  ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY-AVQICKGMDY 141
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           L   + +HRD+   N+LV + + QVKI DFG++K +
Sbjct: 142 LGSRQYVHRDLAARNVLVESEH-QVKIGDFGLTKAI 176

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 108/241 (44%), Gaps = 19/241 (7%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGI 117
           +LG G    V++ +H+ T  ++A+KV +  +         RE E+L++ +   IV+ F I
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 118 FEKPSGDIAIL-MEYMDSGTLDTLLNKNGT---FSEPKLAHIASQILKGLSYLHGHKIIH 173
            E+ +    +L ME+   G+L T+L +        E +   +   ++ G+++L  + I+H
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVH 135
Query: 174 RDIKPSNLL--VNNNNMQV-KIADFGVSKIMCRSLDACNSYV---GTCAYMSPERFDPDX 227
           R+IKP N++  +  +   V K+ DFG +    R L+    +V   GT  Y+ P+ ++   
Sbjct: 136 RNIKPGNIMRVIGEDGQSVYKLTDFGAA----RELEDDEQFVXLYGTEEYLHPDMYERAV 191
Query: 228 XX---XXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDW-ATLMCAICFGDPPSLPDG 283
                        D+WS          G  PF +P + P     +M  I  G P     G
Sbjct: 192 LRKDHQKKYGATVDLWSIGVTFYHAATGSLPF-RPFEGPRRNKEVMYKIITGKPSGAISG 250
Query: 284 A 284
Sbjct: 251 V 251

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 71/292 (24%), Positives = 114/292 (39%), Gaps = 42/292 (14%)
Query: 56  LQVLGHGNGGTV-YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQC 114
           LQ +G G  G V   V  R   K+   K+          ++ +RE+ +L+      ++  
Sbjct: 30  LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGL 89
Query: 115 FGIFEKPSG-----DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
             +F          D  ++M +M  GT    L K+    E ++  +  Q+LKGL Y+H  
Sbjct: 90  LDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA 147
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
            IIHRD+KP NL V N + ++KI DFG+++   ++       V T  Y +PE        
Sbjct: 148 GIIHRDLKPGNLAV-NEDCELKILDFGLAR---QADSEMXGXVVTRWYRAPEVI----LN 199
Query: 230 XXXXXXXXDIWSXXXXXXXXXXGHFPF--------------------------LQPGQRP 263
                   DIWS          G   F                          LQ  +  
Sbjct: 200 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 259
Query: 264 DWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
           ++   +  +   D  S+   ASP   + +E  L  +  +R TA + L HP+ 
Sbjct: 260 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 93/192 (48%), Gaps = 17/192 (8%)
Query: 55  KLQV-LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +L+V LG G  G V+      T ++    +  G   P       +E +++++     +VQ
Sbjct: 14  RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQ 70
Query: 114 CFGIF-EKPSGDIAILMEYMDSGTL-DTLLNKNGTFSE-PKLAHIASQILKGLSYLHGHK 170
            + +  E+P   I I+ EYM  G+L D L  + G +   P+L  +A+QI  G++Y+    
Sbjct: 71  LYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 127
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDXXX 229
            +HRD++ +N+LV   N+  K+ADFG+++++       N Y        P ++  P+   
Sbjct: 128 YVHRDLRAANILV-GENLVCKVADFGLARLI-----EDNEYTARQGAKFPIKWTAPEAAL 181
Query: 230 XXXXXXXXDIWS 241
                   D+WS
Sbjct: 182 YGRFTIKSDVWS 193

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 118/271 (43%), Gaps = 18/271 (6%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTD--SPFIV 112
           L+ +G G    V++V +    +IYA+K V+  +AD         E+  L +    S  I+
Sbjct: 61  LKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 119
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
           + +  +E     I ++ME   +  L++ L K  +    +       +L+ +  +H H I+
Sbjct: 120 RLYD-YEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIV 177
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC--NSYVGTCAYMSPERFD------ 224
           H D+KP+N L+ +    +K+ DFG++  M     +   +S VGT  YM PE         
Sbjct: 178 HSDLKPANFLIVDG--MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 235
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
            +           D+WS          G  PF Q   +   + L   I        PD  
Sbjct: 236 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHAIIDPNHEIEFPDIP 293
Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
             + +  ++CCL+++  +R +  +LL HP++
Sbjct: 294 EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 79/156 (50%), Gaps = 8/156 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRT 106
           ++ +K++VLG G  GTVYK   +      KI  A+K +     P   +++  E  ++   
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSG-TLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
           D+P + +  GI    +  + ++M+ M  G  LD +           L +   QI KG++Y
Sbjct: 79  DNPHVCRLLGICL--TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 136
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           L   +++HRD+   N+LV      VKI DFG++K++
Sbjct: 137 LEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLL 171

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 79/156 (50%), Gaps = 8/156 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRT 106
           ++ +K++VLG G  GTVYK   +      KI  A+K +     P   +++  E  ++   
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSY 165
           D+P + +  GI    +  + ++M+ M  G L D +           L +   QI KG++Y
Sbjct: 76  DNPHVCRLLGICL--TSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 133
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           L   +++HRD+   N+LV      VKI DFG++K++
Sbjct: 134 LEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLL 168

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 79/156 (50%), Gaps = 8/156 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRT 106
           ++ +K++VLG G  GTVYK   +      KI  A+K +     P   +++  E  ++   
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSG-TLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
           D+P + +  GI    +  + ++M+ M  G  LD +           L +   QI KG++Y
Sbjct: 76  DNPHVCRLLGICL--TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 133
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           L   +++HRD+   N+LV      VKI DFG++K++
Sbjct: 134 LEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLL 168

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           L  +G G  G V            A++ +      T  ++  RE++IL R     I+   
Sbjct: 32  LSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 116 GIFEKPS----GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
            I   P+     D+ I+ + M++     L  K    S   + +   QIL+GL Y+H   +
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLL--KTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC---NSYVGTCAYMSPE 221
           +HRD+KPSNLL+ N    +KI DFG++++     D       YV T  Y +PE
Sbjct: 150 LHRDLKPSNLLL-NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 94/192 (48%), Gaps = 17/192 (8%)
Query: 55  KLQV-LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +L+V LG G  G V+      T ++    +  G   P       +E +++++     +VQ
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQ 77
Query: 114 CFGIF-EKPSGDIAILMEYMDSGTL-DTLLNKNGTFSE-PKLAHIASQILKGLSYLHGHK 170
            + +  E+P   I I++EYM  G+L D L  + G +   P+L  +A+QI  G++Y+    
Sbjct: 78  LYAVVSEEP---IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDXXX 229
            +HRD++ +N+LV   N+  K+ADFG+++++       N Y        P ++  P+   
Sbjct: 135 YVHRDLRAANILV-GENLVCKVADFGLARLI-----EDNEYTARQGAKFPIKWTAPEAAL 188
Query: 230 XXXXXXXXDIWS 241
                   D+WS
Sbjct: 189 YGRFTIKSDVWS 200

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 79/156 (50%), Gaps = 8/156 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRT 106
           ++ +K++VLG G  GTVYK   +      KI  A+K +     P   +++  E  ++   
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSG-TLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
           D+P + +  GI    +  + ++M+ M  G  LD +           L +   QI KG++Y
Sbjct: 75  DNPHVCRLLGICL--TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           L   +++HRD+   N+LV      VKI DFG++K++
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLL 167

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 79/156 (50%), Gaps = 8/156 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRT 106
           ++ +K++VLG G  GTVYK   +      KI  A+K +     P   +++  E  ++   
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSG-TLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
           D+P + +  GI    +  + ++M+ M  G  LD +           L +   QI KG++Y
Sbjct: 77  DNPHVCRLLGICL--TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           L   +++HRD+   N+LV      VKI DFG++K++
Sbjct: 135 LEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLL 169

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 82/151 (54%), Gaps = 11/151 (7%)
Query: 55  KLQV-LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +L+V LG G  G V+      T ++    +  G   P       +E +++++     +VQ
Sbjct: 11  RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQ 67
Query: 114 CFGIF-EKPSGDIAILMEYMDSGTL-DTLLNKNGTFSE-PKLAHIASQILKGLSYLHGHK 170
            + +  E+P   I I+ EYM  G+L D L  + G +   P+L  +A+QI  G++Y+    
Sbjct: 68  LYAVVSEEP---IXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 124
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
            +HRD++ +N+LV   N+  K+ADFG+++++
Sbjct: 125 YVHRDLRAANILV-GENLVCKVADFGLARLI 154

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 93/192 (48%), Gaps = 17/192 (8%)
Query: 55  KLQV-LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +L+V LG G  G V+      T ++    +  G   P       +E +++++     +VQ
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQ 243
Query: 114 CFGIF-EKPSGDIAILMEYMDSGTL-DTLLNKNGTFSE-PKLAHIASQILKGLSYLHGHK 170
            + +  E+P   I I+ EYM  G+L D L  + G +   P+L  +A+QI  G++Y+    
Sbjct: 244 LYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 300
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDXXX 229
            +HRD++ +N+LV   N+  K+ADFG+++++       N Y        P ++  P+   
Sbjct: 301 YVHRDLRAANILV-GENLVCKVADFGLARLI-----EDNEYTARQGAKFPIKWTAPEAAL 354
Query: 230 XXXXXXXXDIWS 241
                   D+WS
Sbjct: 355 YGRFTIKSDVWS 366

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 79/156 (50%), Gaps = 8/156 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRT 106
           ++ +K++VLG G  GTVYK   +      KI  A+K +     P   +++  E  ++   
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSG-TLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
           D+P + +  GI    +  + ++M+ M  G  LD +           L +   QI KG++Y
Sbjct: 78  DNPHVCRLLGIC--LTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           L   +++HRD+   N+LV      VKI DFG++K++
Sbjct: 136 LEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLL 170

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 93/192 (48%), Gaps = 17/192 (8%)
Query: 55  KLQV-LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +L+V LG G  G V+      T ++    +  G   P       +E +++++     +VQ
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQ 243
Query: 114 CFGIF-EKPSGDIAILMEYMDSGTL-DTLLNKNGTFSE-PKLAHIASQILKGLSYLHGHK 170
            + +  E+P   I I+ EYM  G+L D L  + G +   P+L  +A+QI  G++Y+    
Sbjct: 244 LYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 300
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDXXX 229
            +HRD++ +N+LV   N+  K+ADFG+++++       N Y        P ++  P+   
Sbjct: 301 YVHRDLRAANILV-GENLVCKVADFGLARLI-----EDNEYTARQGAKFPIKWTAPEAAL 354
Query: 230 XXXXXXXXDIWS 241
                   D+WS
Sbjct: 355 YGRFTIKSDVWS 366

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 90/203 (44%), Gaps = 28/203 (13%)
Query: 59  LGHGNGGTVYKVQ--HRCTHK---IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           LG G  G V+  +  + C  +   + A+K +  DA    R+   RE E+L       IV+
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLK-DASDNARKDFHREAELLTNLQHEHIVK 79
Query: 114 CFGIFEKPSGD-IAILMEYMDSGTLDTLLNKNG-------------TFSEPKLAHIASQI 159
            +G+  +  GD + ++ EYM  G L+  L  +G               ++ ++ HIA QI
Sbjct: 80  FYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQI 137
Query: 160 LKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMS 219
             G+ YL     +HRD+   N LV   N+ VKI DFG    M R + + + Y      M 
Sbjct: 138 AAGMVYLASQHFVHRDLATRNCLV-GENLLVKIGDFG----MSRDVYSTDYYRVGGHTML 192
Query: 220 PERF-DPDXXXXXXXXXXXDIWS 241
           P R+  P+           D+WS
Sbjct: 193 PIRWMPPESIMYRKFTTESDVWS 215

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 10/174 (5%)
Query: 55  KLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQC 114
           +LQ +G G  G V            A+K +      T  ++  RE++IL R     ++  
Sbjct: 47  QLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGI 106
Query: 115 FGIFEKPS----GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
             I    +     D+ I+ + M++     L  K+   S   + +   QIL+GL Y+H   
Sbjct: 107 RDILRASTLEAMRDVYIVQDLMETDLYKLL--KSQQLSNDHICYFLYQILRGLKYIHSAN 164
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC---NSYVGTCAYMSPE 221
           ++HRD+KPSNLL+ N    +KI DFG+++I     D        V T  Y +PE
Sbjct: 165 VLHRDLKPSNLLI-NTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPE 217

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 94/192 (48%), Gaps = 17/192 (8%)
Query: 55  KLQV-LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +L+V LG G  G V+      T ++    +  G   P       +E +++++     +VQ
Sbjct: 18  RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQ 74
Query: 114 CFGIF-EKPSGDIAILMEYMDSGTL-DTLLNKNGTFSE-PKLAHIASQILKGLSYLHGHK 170
            + +  E+P   I I+ EYM+ G+L D L  + G +   P+L  +++QI  G++Y+    
Sbjct: 75  LYAVVSEEP---IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN 131
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDXXX 229
            +HRD++ +N+LV   N+  K+ADFG+++++       N Y        P ++  P+   
Sbjct: 132 YVHRDLRAANILV-GENLVCKVADFGLARLI-----EDNEYTARQGAKFPIKWTAPEAAL 185
Query: 230 XXXXXXXXDIWS 241
                   D+WS
Sbjct: 186 YGRFTIKSDVWS 197

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 114/268 (42%), Gaps = 28/268 (10%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGD--------ADPTVRRQVFREMEILRRTDSPF 110
           LG G  G V+    +  +K   +K +  +         DP + + V  E+ IL R +   
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGK-VTLEIAILSRVEHAN 90
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGT-LDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           I++   IFE   G   ++ME   SG  L   ++++    EP  ++I  Q++  + YL   
Sbjct: 91  IIKVLDIFEN-QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK 149
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
            IIHRDIK  N+++   +  +K+ DFG +  + R      ++ GT  Y +PE        
Sbjct: 150 DIIHRDIKDENIVI-AEDFTIKLIDFGSAAYLERG-KLFYTFCGTIEYCAPEVL----MG 203
Query: 230 XXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFR 289
                   ++WS             PF +  +     T+  AI    PP L    S E  
Sbjct: 204 NPYRGPELEMWSLGVTLYTLVFEENPFCELEE-----TVEAAI---HPPYL---VSKELM 252
Query: 290 SFIECCLQKEFSKRWTASQLLTHPFLCK 317
           S +   LQ    +R T  +L+T P++ +
Sbjct: 253 SLVSGLLQPVPERRTTLEKLVTDPWVTQ 280

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 81/157 (51%), Gaps = 10/157 (6%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           I    L+ ++ LG+G  G V+        K+    +  G   P        E +I+++  
Sbjct: 6   IPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSP---ESFLEEAQIMKKLK 62
Query: 108 SPFIVQCFGIF-EKPSGDIAILMEYMDSGTL-DTLLNKNG-TFSEPKLAHIASQILKGLS 164
              +VQ + +  E+P   I I+ EYM+ G+L D L +  G     P L  +A+Q+  G++
Sbjct: 63  HDKLVQLYAVVSEEP---IYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMA 119
Query: 165 YLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           Y+     IHRD++ +N+LV  N +  KIADFG+++++
Sbjct: 120 YIERMNYIHRDLRSANILV-GNGLICKIADFGLARLI 155

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           L  +G G  G V            A+K +      T  ++  RE++IL R     I+   
Sbjct: 32  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 116 GIFEKPS----GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
            I   P+     D+ I+ + M++     L  K    S   + +   QIL+GL Y+H   +
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLL--KCQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC---NSYVGTCAYMSPE 221
           +HRD+KPSNLL+ N    +KI DFG++++     D       YV T  Y +PE
Sbjct: 150 LHRDLKPSNLLL-NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 93/192 (48%), Gaps = 17/192 (8%)
Query: 55  KLQV-LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +L+V LG G  G V+      T ++    +  G   P       +E +++++     +VQ
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQ 326
Query: 114 CFGIF-EKPSGDIAILMEYMDSGTL-DTLLNKNGTFSE-PKLAHIASQILKGLSYLHGHK 170
            + +  E+P   I I+ EYM  G+L D L  + G +   P+L  +A+QI  G++Y+    
Sbjct: 327 LYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 383
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDXXX 229
            +HRD++ +N+LV   N+  K+ADFG+++++       N Y        P ++  P+   
Sbjct: 384 YVHRDLRAANILV-GENLVCKVADFGLARLI-----EDNEYTARQGAKFPIKWTAPEAAL 437
Query: 230 XXXXXXXXDIWS 241
                   D+WS
Sbjct: 438 YGRFTIKSDVWS 449

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 93/192 (48%), Gaps = 17/192 (8%)
Query: 55  KLQV-LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +L+V LG G  G V+      T ++    +  G   P       +E +++++     +VQ
Sbjct: 10  RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQ 66
Query: 114 CFGIF-EKPSGDIAILMEYMDSGTL-DTLLNKNGTFSE-PKLAHIASQILKGLSYLHGHK 170
            + +  E+P   I I+ EYM  G+L D L  + G +   P+L  +A+QI  G++Y+    
Sbjct: 67  LYAVVSEEP---IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 123
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDXXX 229
            +HRD++ +N+LV   N+  K+ADFG+++++       N Y        P ++  P+   
Sbjct: 124 YVHRDLRAANILV-GENLVCKVADFGLARLI-----EDNEYTARQGAKFPIKWTAPEAAL 177
Query: 230 XXXXXXXXDIWS 241
                   D+WS
Sbjct: 178 YGRFTIKSDVWS 189

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 96/223 (43%), Gaps = 6/223 (2%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHG-DADPTVRRQVFRE-MEILRRTDS 108
            D E ++V+G G  G V  V+ + T +IYA+K+++  +         FRE  ++L   D 
Sbjct: 90  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 149
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLH 167
            +I      F+  +  + ++M+Y   G L TLL+K      E        +++  +  +H
Sbjct: 150 QWITALHYAFQDEN-HLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIH 208
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSY-VGTCAYMSPERFDPD 226
               +HRDIKP N+L++ N   +++ADFG    M       +S  VGT  Y+SPE     
Sbjct: 209 QLHYVHRDIKPDNVLLDVNG-HIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAM 267
Query: 227 XXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLM 269
                      D WS          G  PF        +  +M
Sbjct: 268 EDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 310

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 116/274 (42%), Gaps = 28/274 (10%)
Query: 59  LGHGNGGTV-----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF-IV 112
           LG G  G V     + +    T +  A+K++   A  +  R +  E++IL        +V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPK--------LAHI---ASQIL 160
              G   KP G + +++E+   G L T L +K   F   K        L H+   + Q+ 
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 161 KGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSP 220
           KG+ +L   K IHRD+   N+L++  N+ VKI DFG+++ + +  D    YV       P
Sbjct: 155 KGMEFLASRKXIHRDLAARNILLSEKNV-VKIXDFGLARDIYKDPD----YVRKGDARLP 209
Query: 221 ERF-DPDXXXXXXXXXXXDIWSXXXXX-XXXXXGHFPFLQPGQRPDWATLMCAICFGDPP 278
            ++  P+           D+WS           G  P+  PG + D       +  G   
Sbjct: 210 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--PGVKID-EEFXRRLKEGTRM 266
Query: 279 SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH 312
             PD  +PE    +  C   E S+R T S+L+ H
Sbjct: 267 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 300

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 96/223 (43%), Gaps = 6/223 (2%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHG-DADPTVRRQVFRE-MEILRRTDS 108
            D E ++V+G G  G V  V+ + T +IYA+K+++  +         FRE  ++L   D 
Sbjct: 74  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 133
Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLH 167
            +I      F+  +  + ++M+Y   G L TLL+K      E        +++  +  +H
Sbjct: 134 QWITALHYAFQDEN-HLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIH 192
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSY-VGTCAYMSPERFDPD 226
               +HRDIKP N+L++ N   +++ADFG    M       +S  VGT  Y+SPE     
Sbjct: 193 QLHYVHRDIKPDNVLLDVNG-HIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAM 251
Query: 227 XXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLM 269
                      D WS          G  PF        +  +M
Sbjct: 252 EDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 294

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 93/192 (48%), Gaps = 17/192 (8%)
Query: 55  KLQV-LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +L+V LG G  G V+      T ++    +  G   P       +E +++++     +VQ
Sbjct: 12  RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQ 68
Query: 114 CFGIF-EKPSGDIAILMEYMDSGTL-DTLLNKNGTFSE-PKLAHIASQILKGLSYLHGHK 170
            + +  E+P   I I+ EYM  G+L D L  + G +   P+L  +A+QI  G++Y+    
Sbjct: 69  LYAVVSEEP---IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 125
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDXXX 229
            +HRD++ +N+LV   N+  K+ADFG+++++       N Y        P ++  P+   
Sbjct: 126 YVHRDLRAANILV-GENLVCKVADFGLARLI-----EDNEYTARQGAKFPIKWTAPEAAL 179
Query: 230 XXXXXXXXDIWS 241
                   D+WS
Sbjct: 180 YGRFTIKSDVWS 191

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 93/192 (48%), Gaps = 17/192 (8%)
Query: 55  KLQV-LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +L+V LG G  G V+      T ++    +  G   P       +E +++++     +VQ
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKIRHEKLVQ 77
Query: 114 CFGIF-EKPSGDIAILMEYMDSGTL-DTLLNKNGTFSE-PKLAHIASQILKGLSYLHGHK 170
            + +  E+P   I I+ EYM  G+L D L  + G +   P+L  +A+QI  G++Y+    
Sbjct: 78  LYAVVSEEP---IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDXXX 229
            +HRD++ +N+LV   N+  K+ADFG+++++       N Y        P ++  P+   
Sbjct: 135 YVHRDLRAANILV-GENLVCKVADFGLARLI-----EDNEYTARQGAKFPIKWTAPEAAL 188
Query: 230 XXXXXXXXDIWS 241
                   D+WS
Sbjct: 189 YGRFTIKSDVWS 200

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 79/173 (45%), Gaps = 10/173 (5%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           L  +G G  G V            A+K +      T  ++  RE++IL       I+   
Sbjct: 30  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGIN 89
Query: 116 GIFEKPS----GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
            I   P+     D+ I+ + M++     L  K    S   + +   QIL+GL Y+H   +
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLMETDLYKLL--KTQHLSNDHICYFLYQILRGLKYIHSANV 147
Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC---NSYVGTCAYMSPE 221
           +HRD+KPSNLL+N  +  +KI DFG++++     D       YV T  Y +PE
Sbjct: 148 LHRDLKPSNLLLNTTS-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 199

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 93/192 (48%), Gaps = 17/192 (8%)
Query: 55  KLQV-LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +L+V LG G  G V+      T ++    +  G   P       +E +++++     +VQ
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQ 77
Query: 114 CFGIF-EKPSGDIAILMEYMDSGTL-DTLLNKNGTFSE-PKLAHIASQILKGLSYLHGHK 170
            + +  E+P   I I+ EYM  G+L D L  + G +   P+L  +A+QI  G++Y+    
Sbjct: 78  LYAVVSEEP---IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDXXX 229
            +HRD++ +N+LV   N+  K+ADFG+++++       N Y        P ++  P+   
Sbjct: 135 YVHRDLRAANILV-GENLVCKVADFGLARLI-----EDNEYTARQGAKFPIKWTAPEAAL 188
Query: 230 XXXXXXXXDIWS 241
                   D+WS
Sbjct: 189 YGRFTIKSDVWS 200

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 87/174 (50%), Gaps = 10/174 (5%)
Query: 53  LEKLQVLGHGNGGTV-YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
           L+ L+ +G G  G+V      R   K+   K+          R+ +RE+ +L+      +
Sbjct: 30  LQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENV 89
Query: 112 VQCFGIFEKPSGDIAILME-YMDSGTLDTLLN---KNGTFSEPKLAHIASQILKGLSYLH 167
           +    +F  P+  I    E Y+ +  +   LN   K    S+  +  +  Q+L+GL Y+H
Sbjct: 90  IGLLDVF-TPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH 148
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
              IIHRD+KPSN+ VN ++ +++I DFG+++   ++ +    YV T  Y +PE
Sbjct: 149 SAGIIHRDLKPSNVAVNEDS-ELRILDFGLAR---QADEEMTGYVATRWYRAPE 198

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 93/192 (48%), Gaps = 17/192 (8%)
Query: 55  KLQV-LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +L+V LG G  G V+      T ++    +  G+  P       +E +++++     +VQ
Sbjct: 188 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEA---FLQEAQVMKKLRHEKLVQ 244
Query: 114 CFGIF-EKPSGDIAILMEYMDSGTL-DTLLNKNGTFSE-PKLAHIASQILKGLSYLHGHK 170
            + +  E+P   I I+ EYM  G+L D L  + G +   P+L  +A+QI  G++Y+    
Sbjct: 245 LYAVVSEEP---IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 301
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDXXX 229
            +HRD++ +N+LV   N+  K+ADFG+ +++       N Y        P ++  P+   
Sbjct: 302 YVHRDLRAANILV-GENLVCKVADFGLGRLI-----EDNEYTARQGAKFPIKWTAPEAAL 355
Query: 230 XXXXXXXXDIWS 241
                   D+WS
Sbjct: 356 YGRFTIKSDVWS 367

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 93/192 (48%), Gaps = 17/192 (8%)
Query: 55  KLQV-LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +L+V LG G  G V+      T ++    +  G   P       +E +++++     +VQ
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQ 243
Query: 114 CFGIF-EKPSGDIAILMEYMDSGTL-DTLLNKNGTFSE-PKLAHIASQILKGLSYLHGHK 170
            + +  E+P   I I+ EYM  G+L D L  + G +   P+L  +A+QI  G++Y+    
Sbjct: 244 LYAVVSEEP---IYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 300
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDXXX 229
            +HRD++ +N+LV   N+  K+ADFG+++++       N Y        P ++  P+   
Sbjct: 301 YVHRDLRAANILV-GENLVCKVADFGLARLI-----EDNEYTARQGAKFPIKWTAPEAAL 354
Query: 230 XXXXXXXXDIWS 241
                   D+WS
Sbjct: 355 YGRFTIKSDVWS 366

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 91/195 (46%), Gaps = 16/195 (8%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           S+L  +Q +G G  G V+        K+ A+K +   A          E E++ +   P 
Sbjct: 7   SELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGA--MSEEDFIEEAEVMMKLSHPK 63
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           +VQ +G+  + +  I ++ E+M+ G L D L  + G F+   L  +   + +G++YL   
Sbjct: 64  LVQLYGVCLEQA-PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 122
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGT---CAYMSPERFDPD 226
            +IHRD+   N LV  N + +K++DFG+++ +    D   S  GT     + SPE F   
Sbjct: 123 SVIHRDLAARNCLVGENQV-IKVSDFGMTRFVLD--DQYTSSTGTKFPVKWASPEVFS-- 177
Query: 227 XXXXXXXXXXXDIWS 241
                      D+WS
Sbjct: 178 ---FSRYSSKSDVWS 189

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 91/188 (48%), Gaps = 12/188 (6%)
Query: 59  LGHGNGGTVYKVQHRCTHKI--YALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           LG GN G+V +  +R   K    A+KV+    +     ++ RE +I+ + D+P+IV+  G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 117 IFEKPSGDIAILMEYMDSGTLDT-LLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRD 175
           + +  +  + ++ME    G L   L+ K        +A +  Q+  G+ YL     +HR+
Sbjct: 404 VCQAEA--LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRN 461
Query: 176 IKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNS-YVGTCAYMSPER-FDPDXXXXXXX 233
           +   N+L+ N +   KI+DFG+SK    +L A +S Y    A   P + + P+       
Sbjct: 462 LAARNVLLVNRHY-AKISDFGLSK----ALGADDSYYTARSAGKWPLKWYAPECINFRKF 516
Query: 234 XXXXDIWS 241
               D+WS
Sbjct: 517 SSRSDVWS 524

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 116/274 (42%), Gaps = 28/274 (10%)
Query: 59  LGHGNGGTV-----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF-IV 112
           LG G  G V     + +    T +  A+K++   A  +  R +  E++IL        +V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPK--------LAHI---ASQIL 160
              G   KP G + +++E+   G L T L +K   F   K        L H+   + Q+ 
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 161 KGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSP 220
           KG+ +L   K IHRD+   N+L++  N+ VKI DFG+++ + +  D    YV       P
Sbjct: 155 KGMEFLASRKXIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPD----YVRKGDARLP 209
Query: 221 ERF-DPDXXXXXXXXXXXDIWSXXXXX-XXXXXGHFPFLQPGQRPDWATLMCAICFGDPP 278
            ++  P+           D+WS           G  P+  PG + D       +  G   
Sbjct: 210 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--PGVKID-EEFCRRLKEGTRM 266
Query: 279 SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH 312
             PD  +PE    +  C   E S+R T S+L+ H
Sbjct: 267 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 300

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 83/151 (54%), Gaps = 11/151 (7%)
Query: 55  KLQV-LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +L+V LG G  G V+      T ++    +  G   P       +E +++++     +VQ
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQ 77
Query: 114 CFGIF-EKPSGDIAILMEYMDSGTL-DTLLNKNGTFSE-PKLAHIASQILKGLSYLHGHK 170
            + +  E+P   I I++EYM  G+L D L  + G +   P+L  +A+QI  G++Y+    
Sbjct: 78  LYAVVSEEP---IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
            +HRD++ +N+LV   N+  K+ADFG+++++
Sbjct: 135 YVHRDLRAANILV-GENLVCKVADFGLARLI 164

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 8/156 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRT 106
           ++ +K++VLG G  GTVYK   +      KI  A+K +     P   +++  E  ++   
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSG-TLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
           D+P + +  GI    +  + ++M+ M  G  LD +           L +   QI KG++Y
Sbjct: 79  DNPHVCRLLGICL--TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 136
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           L   +++HRD+   N+LV      VKI DFG +K++
Sbjct: 137 LEDRRLVHRDLAARNVLVKTPQ-HVKITDFGRAKLL 171

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 83/151 (54%), Gaps = 11/151 (7%)
Query: 55  KLQV-LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +L+V LG G  G V+      T ++    +  G   P       +E +++++     +VQ
Sbjct: 18  RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQ 74
Query: 114 CFGIF-EKPSGDIAILMEYMDSGTL-DTLLNKNGTFSE-PKLAHIASQILKGLSYLHGHK 170
            + +  E+P   I I+ EYM+ G+L D L  + G +   P+L  +++QI  G++Y+    
Sbjct: 75  LYAVVSEEP---IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN 131
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
            +HRD++ +N+LV   N+  K+ADFG+++++
Sbjct: 132 YVHRDLRAANILV-GENLVCKVADFGLARLI 161

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 8/156 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRT 106
           ++ +K++VLG G  GTVYK   +      KI  A+K +     P   +++  E  ++   
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSG-TLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
           D+P + +  GI    +  + ++M+ M  G  LD +           L +   QI KG++Y
Sbjct: 77  DNPHVCRLLGICL--TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           L   +++HRD+   N+LV      VKI DFG +K++
Sbjct: 135 LEDRRLVHRDLAARNVLVKTPQ-HVKITDFGRAKLL 169

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 103/247 (41%), Gaps = 19/247 (7%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIV 112
           + L+ +G G  G V         +  A+K +     + T  ++ +RE+ +++  +   I+
Sbjct: 27  QNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNII 86
Query: 113 QCFGIFEKPSG-----DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F          D+ I+ME MD+     +          +++++  Q+L G+ +LH
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMDANLSQVI---QMELDHERMSYLLYQMLVGIKHLH 143
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDX 227
              IIHRD+KPSN++V  ++  +KI DFG+++    S      YV T  Y +PE      
Sbjct: 144 SAGIIHRDLKPSNIVV-KSDATLKILDFGLARTAGTSF-MMTPYVVTRYYRAPE-----V 196
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDP-PSLPDGASP 286
                     DIWS          G   F        W  ++  +  G P P       P
Sbjct: 197 ILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQL--GTPSPEFMKKLQP 254
Query: 287 EFRSFIE 293
             R+++E
Sbjct: 255 TVRTYVE 261

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 93/192 (48%), Gaps = 17/192 (8%)
Query: 55  KLQV-LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +L+V LG G  G V+      T ++    +  G   P       +E +++++     +VQ
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQ 77
Query: 114 CFGIF-EKPSGDIAILMEYMDSGTL-DTLLNKNGTFSE-PKLAHIASQILKGLSYLHGHK 170
            + +  E+P   I I+ EYM  G+L D L  + G +   P+L  +A+QI  G++Y+    
Sbjct: 78  LYAVVSEEP---IYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDXXX 229
            +HRD++ +N+LV   N+  K+ADFG+++++       N Y        P ++  P+   
Sbjct: 135 YVHRDLRAANILV-GENLVCKVADFGLARLI-----EDNEYTARQGAKFPIKWTAPEAAL 188
Query: 230 XXXXXXXXDIWS 241
                   D+WS
Sbjct: 189 YGRFTIKSDVWS 200

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 78/173 (45%), Gaps = 10/173 (5%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           L  +G G  G V            A+K +      T  ++  RE++IL       I+   
Sbjct: 30  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGIN 89
Query: 116 GIFEKPS----GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
            I   P+     D+ I+ + M++     L  K    S   + +   QIL+GL Y+H   +
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLMETDLYKLL--KTQHLSNDHICYFLYQILRGLKYIHSANV 147
Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC---NSYVGTCAYMSPE 221
           +HRD+KPSNLL+ N    +KI DFG++++     D       YV T  Y +PE
Sbjct: 148 LHRDLKPSNLLL-NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 199

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 77/173 (44%), Gaps = 10/173 (5%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           L  +G G  G V            A+K +      T  ++  RE++IL R     I+   
Sbjct: 48  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 107
Query: 116 GIFEKPS----GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
            I   P+     D+ ++   M +     L  K    S   + +   QIL+GL Y+H   +
Sbjct: 108 DIIRAPTIEQMKDVYLVTHLMGADLYKLL--KTQHLSNDHICYFLYQILRGLKYIHSANV 165
Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC---NSYVGTCAYMSPE 221
           +HRD+KPSNLL+ N    +KI DFG++++     D       YV T  Y +PE
Sbjct: 166 LHRDLKPSNLLL-NTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 217

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 8/156 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRT 106
           ++ +K++VLG G  GTVYK   +      KI  A+K +     P   +++  E  ++   
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSG-TLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
           D+P + +  GI    +  + ++M+ M  G  LD +           L +   QI KG++Y
Sbjct: 77  DNPHVCRLLGIC--LTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           L   +++HRD+   N+LV      VKI DFG +K++
Sbjct: 135 LEDRRLVHRDLAARNVLVKTPQ-HVKITDFGRAKLL 169

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 117/271 (43%), Gaps = 18/271 (6%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTD--SPFIV 112
           L+ +G G    V++V +    +IYA+K V+  +AD         E+  L +    S  I+
Sbjct: 61  LKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 119
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
           + +  +E     I ++ME   +  L++ L K  +    +       +L+ +  +H H I+
Sbjct: 120 RLYD-YEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIV 177
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC--NSYVGTCAYMSPERFD------ 224
           H D+KP+N L+ +    +K+ DFG++  M     +   +S VG   YM PE         
Sbjct: 178 HSDLKPANFLIVDG--MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSR 235
Query: 225 PDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
            +           D+WS          G  PF Q   +   + L   I        PD  
Sbjct: 236 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHAIIDPNHEIEFPDIP 293
Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
             + +  ++CCL+++  +R +  +LL HP++
Sbjct: 294 EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 92/192 (47%), Gaps = 17/192 (8%)
Query: 55  KLQV-LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +L+V LG G  G V+      T ++    +  G   P       +E +++++     +VQ
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQ 77
Query: 114 CFGIF-EKPSGDIAILMEYMDSG-TLDTLLNKNGTFSE-PKLAHIASQILKGLSYLHGHK 170
            + +  E+P   I I+ EYM  G  LD L  + G +   P+L  +A+QI  G++Y+    
Sbjct: 78  LYAVVSEEP---IYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDXXX 229
            +HRD++ +N+LV   N+  K+ADFG+++++       N Y        P ++  P+   
Sbjct: 135 YVHRDLRAANILV-GENLVCKVADFGLARLI-----EDNEYTARQGAKFPIKWTAPEAAL 188
Query: 230 XXXXXXXXDIWS 241
                   D+WS
Sbjct: 189 YGRFTIKSDVWS 200

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 92/192 (47%), Gaps = 17/192 (8%)
Query: 55  KLQV-LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +L+V LG G  G V+      T ++    +  G   P       +E +++++     +VQ
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQ 77
Query: 114 CFGIF-EKPSGDIAILMEYMDSGTL-DTLLNKNGTFSE-PKLAHIASQILKGLSYLHGHK 170
            + +  E+P   I I+ EYM  G+L D L  + G +   P+L  +A+QI  G++Y+    
Sbjct: 78  LYAVVSEEP---IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 134
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDXXX 229
            +HRD+  +N+LV   N+  K+ADFG+++++       N Y        P ++  P+   
Sbjct: 135 YVHRDLAAANILV-GENLVCKVADFGLARLI-----EDNEYTARQGAKFPIKWTAPEAAL 188
Query: 230 XXXXXXXXDIWS 241
                   D+WS
Sbjct: 189 YGRFTIKSDVWS 200

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/312 (22%), Positives = 119/312 (38%), Gaps = 60/312 (19%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGDA----DPTVRRQVFREMEILRRTDSPFIVQ 113
            +G G+ G V       T  I A+K+++ +     +P    ++  E+ ++++   P I +
Sbjct: 33  AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNK-----------------------------N 144
            + ++E     I ++ME    G L   LN                              N
Sbjct: 93  LYEVYEDEQY-ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151
Query: 145 GTF-----------SEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNN-NMQVKI 192
           G+             E  +++I  QI   L YLH   I HRDIKP N L + N + ++K+
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKL 211
Query: 193 ADFGVSKIMCR----SLDACNSYVGTCAYMSPERFDPDXXXXXXXXXXXDIWSXXXXXXX 248
            DFG+SK   +          +  GT  +++PE  +             D WS       
Sbjct: 212 VDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLN---TTNESYGPKCDAWSAGVLLHL 268
Query: 249 XXXGHFPFLQPGQRPD---WATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWT 305
              G  PF  PG          L   +CF +P    +  SP  R  +   L +   +R+ 
Sbjct: 269 LLMGAVPF--PGVNDADTISQVLNKKLCFENPNY--NVLSPLARDLLSNLLNRNVDERFD 324
Query: 306 ASQLLTHPFLCK 317
           A + L HP++ +
Sbjct: 325 AMRALQHPWISQ 336

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 72/134 (53%), Gaps = 13/134 (9%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K+   +
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KSQKLT 123
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR-SLDA 207
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL VN ++ ++KI DFG    +CR + D 
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDS-ELKILDFG----LCRHTDDE 178
Query: 208 CNSYVGTCAYMSPE 221
              YV T  Y +PE
Sbjct: 179 MTGYVATRWYRAPE 192

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 86/174 (49%), Gaps = 10/174 (5%)
Query: 53  LEKLQVLGHGNGGTV-YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
           L+ L+ +G G  G+V      R   K+   K+          R+ +RE+ +L+      +
Sbjct: 22  LQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENV 81
Query: 112 VQCFGIFEKPSGDIAILME-YMDSGTLDTLLN---KNGTFSEPKLAHIASQILKGLSYLH 167
           +    +F  P+  I    E Y+ +  +   LN   K    S+  +  +  Q+L+GL Y+H
Sbjct: 82  IGLLDVF-TPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH 140
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
              IIHRD+KPSN+ V N + +++I DFG+++   ++ +    YV T  Y +PE
Sbjct: 141 SAGIIHRDLKPSNVAV-NEDCELRILDFGLAR---QADEEMTGYVATRWYRAPE 190

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 91/195 (46%), Gaps = 16/195 (8%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           S+L  +Q +G G  G V+ + +       A+K +   A          E E++ +   P 
Sbjct: 10  SELTFVQEIGSGQFGLVH-LGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPK 66
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           +VQ +G+  + +  I ++ E+M+ G L D L  + G F+   L  +   + +G++YL   
Sbjct: 67  LVQLYGVCLEQA-PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 125
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGT---CAYMSPERFDPD 226
            +IHRD+   N LV  N + +K++DFG+++ +    D   S  GT     + SPE F   
Sbjct: 126 CVIHRDLAARNCLVGENQV-IKVSDFGMTRFVLD--DQYTSSTGTKFPVKWASPEVFS-- 180
Query: 227 XXXXXXXXXXXDIWS 241
                      D+WS
Sbjct: 181 ---FSRYSSKSDVWS 192

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 91/195 (46%), Gaps = 16/195 (8%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           S+L  +Q +G G  G V+        K+ A+K +   A          E E++ +   P 
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGA--MSEEDFIEEAEVMMKLSHPK 61
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           +VQ +G+  + +  I ++ E+M+ G L D L  + G F+   L  +   + +G++YL   
Sbjct: 62  LVQLYGVCLEQA-PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGT---CAYMSPERFDPD 226
            +IHRD+   N LV  N + +K++DFG+++ +    D   S  GT     + SPE F   
Sbjct: 121 CVIHRDLAARNCLVGENQV-IKVSDFGMTRFVLD--DQYTSSTGTKFPVKWASPEVFS-- 175
Query: 227 XXXXXXXXXXXDIWS 241
                      D+WS
Sbjct: 176 ---FSRYSSKSDVWS 187

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 8/156 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRT 106
           ++ +K++VLG G  GTVYK   +      KI  A+K +     P   +++  E  ++   
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSG-TLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
           D+P + +  GI    +  + ++ + M  G  LD +           L +   QI KG++Y
Sbjct: 85  DNPHVCRLLGIC--LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 142
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           L   +++HRD+   N+LV      VKI DFG++K++
Sbjct: 143 LEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLL 177

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 91/195 (46%), Gaps = 16/195 (8%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           S+L  +Q +G G  G V+ + +       A+K +   A          E E++ +   P 
Sbjct: 7   SELTFVQEIGSGQFGLVH-LGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPK 63
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           +VQ +G+  + +  I ++ E+M+ G L D L  + G F+   L  +   + +G++YL   
Sbjct: 64  LVQLYGVCLEQA-PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 122
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGT---CAYMSPERFDPD 226
            +IHRD+   N LV  N + +K++DFG+++ +    D   S  GT     + SPE F   
Sbjct: 123 CVIHRDLAARNCLVGENQV-IKVSDFGMTRFVLD--DQYTSSTGTKFPVKWASPEVFS-- 177
Query: 227 XXXXXXXXXXXDIWS 241
                      D+WS
Sbjct: 178 ---FSRYSSKSDVWS 189

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 116/278 (41%), Gaps = 34/278 (12%)
Query: 59  LGHGNGGTV-----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF-IV 112
           LG G  G V     + +    T +  A+K++   A  +  R +  E++IL        +V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPK----------LAHI---ASQ 158
              G   KP G + +++E+   G L T L +K   F   K          L H+   + Q
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 159 ILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGT--CA 216
           + KG+ +L   K IHRD+   N+L++  N+ VKI DFG+++ + +  D            
Sbjct: 157 VAKGMEFLASRKXIHRDLAARNILLSEKNV-VKICDFGLARDIXKDPDXVRKGDARLPLK 215
Query: 217 YMSPER-FDPDXXXXXXXXXXXDIWSXXXXX-XXXXXGHFPFLQPGQRPDWATLMCAICF 274
           +M+PE  FD             D+WS           G  P+  PG + D       +  
Sbjct: 216 WMAPETIFD------RVYTIQSDVWSFGVLLWEIFSLGASPY--PGVKID-EEFCRRLKE 266
Query: 275 GDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH 312
           G     PD  +PE    +  C   E S+R T S+L+ H
Sbjct: 267 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 8/156 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRT 106
           ++ +K++VLG G  GTVYK   +      KI  A+K +     P   +++  E  ++   
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSY 165
           D+P + +  GI    +  + ++ + M  G L D +           L +   QI KG++Y
Sbjct: 75  DNPHVCRLLGICL--TSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           L   +++HRD+   N+LV      VKI DFG++K++
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLL 167

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 8/156 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRT 106
           ++ +K++VLG G  GTVYK   +      KI  A+K +     P   +++  E  ++   
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSG-TLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
           D+P + +  GI    +  + ++ + M  G  LD +           L +   QI KG++Y
Sbjct: 75  DNPHVCRLLGIC--LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           L   +++HRD+   N+LV      VKI DFG++K++
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLL 167

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 78/173 (45%), Gaps = 10/173 (5%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           L  +G G  G V            A+K +      T  ++  RE++IL R     I+   
Sbjct: 32  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 116 GIFEKPS----GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
            I   P+     D+ I+ + M++     L  K    S   + +   QIL+GL Y+H   +
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLL--KTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN---SYVGTCAYMSPE 221
           +HRD+KPSNLL+ N    +KI DFG++++     D        V T  Y +PE
Sbjct: 150 LHRDLKPSNLLL-NTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPE 201

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 91/195 (46%), Gaps = 16/195 (8%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           S+L  +Q +G G  G V+ + +       A+K +   A          E E++ +   P 
Sbjct: 8   SELTFVQEIGSGQFGLVH-LGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPK 64
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           +VQ +G+  + +  I ++ E+M+ G L D L  + G F+   L  +   + +G++YL   
Sbjct: 65  LVQLYGVCLEQA-PICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 123
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGT---CAYMSPERFDPD 226
            +IHRD+   N LV  N + +K++DFG+++ +    D   S  GT     + SPE F   
Sbjct: 124 CVIHRDLAARNCLVGENQV-IKVSDFGMTRFVLD--DQYTSSTGTKFPVKWASPEVFS-- 178
Query: 227 XXXXXXXXXXXDIWS 241
                      D+WS
Sbjct: 179 ---FSRYSSKSDVWS 190

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 8/156 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRT 106
           ++ +K++VLG G  GTVYK   +      KI  A+K +     P   +++  E  ++   
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSG-TLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
           D+P + +  GI    +  + ++ + M  G  LD +           L +   QI KG++Y
Sbjct: 75  DNPHVCRLLGIC--LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           L   +++HRD+   N+LV      VKI DFG++K++
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLL 167

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 78/173 (45%), Gaps = 10/173 (5%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           L  +G G  G V            A+K +      T  ++  RE++IL R     I+   
Sbjct: 33  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 92
Query: 116 GIFEKPS----GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
            I   P+     D+ I+ + M++     L  K    S   + +   QIL+GL Y+H   +
Sbjct: 93  DIIRAPTIEQMKDVYIVQDLMETDLYKLL--KTQHLSNDHICYFLYQILRGLKYIHSANV 150
Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN---SYVGTCAYMSPE 221
           +HRD+KPSNLL+ N    +KI DFG++++     D        V T  Y +PE
Sbjct: 151 LHRDLKPSNLLL-NTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPE 202

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 8/156 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRT 106
           ++ +K++VLG G  GTVYK   +      KI  A+K +     P   +++  E  ++   
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSG-TLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
           D+P + +  GI    +  + ++ + M  G  LD +           L +   QI KG++Y
Sbjct: 77  DNPHVCRLLGIC--LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           L   +++HRD+   N+LV      VKI DFG++K++
Sbjct: 135 LEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLL 169

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 8/156 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRT 106
           ++ +K++VLG G  GTVYK   +      KI  A+K +     P   +++  E  ++   
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSG-TLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
           D+P + +  GI    +  + ++ + M  G  LD +           L +   QI KG++Y
Sbjct: 78  DNPHVCRLLGIC--LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           L   +++HRD+   N+LV      VKI DFG++K++
Sbjct: 136 LEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLL 170

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 8/156 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRT 106
           ++ +K++VL  G  GTVYK   +      KI  A+K +     P   +++  E  ++   
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSG-TLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
           D+P + +  GI    +  + ++M+ M  G  LD +           L +   QI KG++Y
Sbjct: 82  DNPHVCRLLGIC--LTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           L   +++HRD+   N+LV      VKI DFG++K++
Sbjct: 140 LEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLL 174

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 8/156 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRT 106
           ++ +K++VLG G  GTVYK   +      KI  A+K +     P   +++  E  ++   
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSG-TLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
           D+P + +  GI    +  + ++ + M  G  LD +           L +   QI KG++Y
Sbjct: 78  DNPHVCRLLGICL--TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           L   +++HRD+   N+LV      VKI DFG++K++
Sbjct: 136 LEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLL 170

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 8/156 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRT 106
           ++ +K++VLG G  GTVYK   +      KI  A+K +     P   +++  E  ++   
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSG-TLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
           D+P + +  GI    +  + ++ + M  G  LD +           L +   QI KG++Y
Sbjct: 69  DNPHVCRLLGIC--LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           L   +++HRD+   N+LV      VKI DFG++K++
Sbjct: 127 LEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLL 161

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 103/247 (41%), Gaps = 19/247 (7%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIV 112
           + L+ +G G  G V         +  A+K +     + T  ++ +RE+ +++  +   I+
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNII 86
Query: 113 QCFGIFEKPSG-----DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F          D+ I+ME MD+     +          +++++  Q+L G+ +LH
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMDANLSQVI---QMELDHERMSYLLYQMLVGIKHLH 143
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDX 227
              IIHRD+KPSN++V  ++  +KI DFG+++    S      YV T  Y +PE      
Sbjct: 144 SAGIIHRDLKPSNIVV-KSDATLKILDFGLARTAGTSF-MMTPYVVTRYYRAPE-----V 196
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDP-PSLPDGASP 286
                     DIWS          G   F        W  ++  +  G P P       P
Sbjct: 197 ILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQL--GTPSPEFMKKLQP 254
Query: 287 EFRSFIE 293
             R+++E
Sbjct: 255 TVRTYVE 261

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 8/156 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRT 106
           ++ +K++VLG G  GTVYK   +      KI  A+K +     P   +++  E  ++   
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSG-TLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
           D+P + +  GI    +  + ++ + M  G  LD +           L +   QI KG++Y
Sbjct: 78  DNPHVCRLLGICL--TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           L   +++HRD+   N+LV      VKI DFG++K++
Sbjct: 136 LEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLL 170

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 8/156 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRT 106
           ++ +K++VLG G  GTVYK   +      KI  A+K +     P   +++  E  ++   
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSG-TLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
           D+P + +  GI    +  + ++ + M  G  LD +           L +   QI KG++Y
Sbjct: 82  DNPHVCRLLGIC--LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           L   +++HRD+   N+LV      VKI DFG++K++
Sbjct: 140 LEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLL 174

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 8/156 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRT 106
           ++ +K++VLG G  GTVYK   +      KI  A+K +     P   +++  E  ++   
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSG-TLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
           D+P + +  GI    +  + ++ + M  G  LD +           L +   QI KG++Y
Sbjct: 81  DNPHVCRLLGIC--LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 138
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           L   +++HRD+   N+LV      VKI DFG++K++
Sbjct: 139 LEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLL 173

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 8/156 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRT 106
           ++ +K++VLG G  GTVYK   +      KI  A+K +     P   +++  E  ++   
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 99
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSG-TLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
           D+P + +  GI    +  + ++ + M  G  LD +           L +   QI KG++Y
Sbjct: 100 DNPHVCRLLGIC--LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 157
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           L   +++HRD+   N+LV      VKI DFG++K++
Sbjct: 158 LEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLL 192

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KXQKLT 123
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDXELKILDFGLAR---HTDDEM 179
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 180 TGYVATRWYRAPE 192

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/278 (23%), Positives = 114/278 (41%), Gaps = 41/278 (14%)
Query: 57  QVLGHGNGGTVYK-----VQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
           + LG G  G V K     ++ R  +   A+K++  +A P+  R +  E  +L++ + P +
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNG------------------------TF 147
           ++ +G   +  G + +++EY   G+L   L ++                           
Sbjct: 89  IKLYGACSQ-DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 148 SEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA 207
           +   L   A QI +G+ YL   K++HRD+   N+LV     ++KI+DFG+S    R +  
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGR-KMKISDFGLS----RDVYE 202
Query: 208 CNSYVGTCAYMSPERFDP-DXXXXXXXXXXXDIWS-XXXXXXXXXXGHFPFLQPGQRPDW 265
            +SYV       P ++   +           D+WS           G  P+  PG  P+ 
Sbjct: 203 EDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY--PGIPPE- 259
Query: 266 ATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKR 303
             L   +  G     PD  S E    +  C ++E  KR
Sbjct: 260 -RLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKR 296

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 115/277 (41%), Gaps = 30/277 (10%)
Query: 59  LGHGNGGTV-----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF-IV 112
           LG G  G V     + +    T +  A+K++   A  +  R +  E++IL        +V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLA------------HI---A 156
              G   KP G + +++E+   G L T L +K   F   K+A            H+   +
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 157 SQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA 216
            Q+ KG+ +L   K IHRD+   N+L++  N+ VKI DFG+++ + +  D         A
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIXKDPDXVRK---GDA 201
Query: 217 YMSPERFDPDXXXXXXXXXXXDIWSXXXXX-XXXXXGHFPFLQPGQRPDWATLMCAICFG 275
            +  +   P+           D+WS           G  P+  PG + D       +  G
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--PGVKID-EEFCRRLKEG 258
Query: 276 DPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH 312
                PD  +PE    +  C   E S+R T S+L+ H
Sbjct: 259 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 88/205 (42%), Gaps = 29/205 (14%)
Query: 59  LGHGNGGTVYKVQ--HRCTHKIYALKVVHGDADPTV--RRQVFREMEILRRTDSPFIVQC 114
           LG G  G V+  +  +    K   L  V    DPT+  R+   RE E+L       IV+ 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 115 FGIFEKPSGD-IAILMEYMDSGTLDTLLNKNG------TFSEPKLA----------HIAS 157
           +G+     GD + ++ EYM  G L+  L  +G         +P+ A          HIAS
Sbjct: 83  YGVC--GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 158 QILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAY 217
           QI  G+ YL     +HRD+   N LV   N+ VKI DFG    M R + + + Y      
Sbjct: 141 QIASGMVYLASQHFVHRDLATRNCLV-GANLLVKIGDFG----MSRDVYSTDYYRVGGHT 195
Query: 218 MSPERF-DPDXXXXXXXXXXXDIWS 241
           M P R+  P+           D+WS
Sbjct: 196 MLPIRWMPPESIMYRKFTTESDVWS 220

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 115/277 (41%), Gaps = 30/277 (10%)
Query: 59  LGHGNGGTV-----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF-IV 112
           LG G  G V     + +    T +  A+K++   A  +  R +  E++IL        +V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLA------------HI---A 156
              G   KP G + +++E+   G L T L +K   F   K+A            H+   +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 157 SQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA 216
            Q+ KG+ +L   K IHRD+   N+L++  N+ VKI DFG+++ + +  D         A
Sbjct: 155 FQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIXKDPDXVRK---GDA 210
Query: 217 YMSPERFDPDXXXXXXXXXXXDIWSXXXXX-XXXXXGHFPFLQPGQRPDWATLMCAICFG 275
            +  +   P+           D+WS           G  P+  PG + D       +  G
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--PGVKID-EEFCRRLKEG 267
Query: 276 DPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH 312
                PD  +PE    +  C   E S+R T S+L+ H
Sbjct: 268 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 117/278 (42%), Gaps = 32/278 (11%)
Query: 59  LGHGNGGTV-----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF-IV 112
           LG G  G V     + +    T +  A+K++   A  +  R +  E++IL        +V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLA------------HI---A 156
              G   KP G + +++E+   G L T L +K   F   K+A            H+   +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 157 SQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA 216
            Q+ KG+ +L   K IHRD+   N+L++  N+ VKI DFG+++ + +  D    YV    
Sbjct: 155 FQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPD----YVRKGD 209
Query: 217 YMSPERF-DPDXXXXXXXXXXXDIWSXXXXX-XXXXXGHFPFLQPGQRPDWATLMCAICF 274
              P ++  P+           D+WS           G  P+  PG + D       +  
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--PGVKID-EEFCRRLKE 266
Query: 275 GDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH 312
           G     PD  +PE    +  C   E S+R T S+L+ H
Sbjct: 267 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 117/278 (42%), Gaps = 32/278 (11%)
Query: 59  LGHGNGGTV-----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF-IV 112
           LG G  G V     + +    T +  A+K++   A  +  R +  E++IL        +V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLA------------HI---A 156
              G   KP G + +++E+   G L T L +K   F   K+A            H+   +
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 157 SQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA 216
            Q+ KG+ +L   K IHRD+   N+L++  N+ VKI DFG+++ + +  D    YV    
Sbjct: 192 FQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPD----YVRKGD 246
Query: 217 YMSPERF-DPDXXXXXXXXXXXDIWSXXXXX-XXXXXGHFPFLQPGQRPDWATLMCAICF 274
              P ++  P+           D+WS           G  P+  PG + D       +  
Sbjct: 247 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--PGVKID-EEFCRRLKE 303
Query: 275 GDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH 312
           G     PD  +PE    +  C   E S+R T S+L+ H
Sbjct: 304 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 103/247 (41%), Gaps = 19/247 (7%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIV 112
           + L+ +G G  G V         +  A+K +     + T  ++ +RE+ +++  +   I+
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNII 86
Query: 113 QCFGIFEKPSG-----DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F          D+ I+ME MD+     +          +++++  Q+L G+ +LH
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMDANLSQVI---QMELDHERMSYLLYQMLVGIKHLH 143
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDX 227
              IIHRD+KPSN++V  ++  +KI DFG+++    S      YV T  Y +PE      
Sbjct: 144 SAGIIHRDLKPSNIVV-KSDATLKILDFGLARTAGTSF-MMTPYVVTRYYRAPE-----V 196
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDP-PSLPDGASP 286
                     DIWS          G   F        W  ++  +  G P P       P
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL--GTPSPEFMKKLQP 254
Query: 287 EFRSFIE 293
             R+++E
Sbjct: 255 TVRTYVE 261

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 84/174 (48%), Gaps = 12/174 (6%)
Query: 54  EKLQVLGHGNGGTV-YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           + L  +G G  G+V      +  H++   K+          ++ +RE+ +L+      ++
Sbjct: 21  QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 80
Query: 113 QCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F      +   D+ ++   M    L+ ++ K    ++  +  +  QIL+GL Y+H
Sbjct: 81  GLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCAKLTDDHVQFLIYQILRGLKYIH 138
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
              IIHRD+KPSNL V N + ++KI DFG+++    + D    YV T  Y +PE
Sbjct: 139 SADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPE 188

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 115/276 (41%), Gaps = 29/276 (10%)
Query: 59  LGHGNGGTV-----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF-IV 112
           LG G  G V     + +    T +  A+K++   A  +  R +  E++IL        +V
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLL----NKNGTFSEPK--------LAHI---AS 157
              G   KP G + +++E+   G L T L    N+   +  P+        L H+   + 
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 158 QILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAY 217
           Q+ KG+ +L   K IHRD+   N+L++  N+ VKI DFG+++ + +  D         A 
Sbjct: 156 QVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIXKDPDXVRK---GDAR 211
Query: 218 MSPERFDPDXXXXXXXXXXXDIWSXXXXX-XXXXXGHFPFLQPGQRPDWATLMCAICFGD 276
           +  +   P+           D+WS           G  P+  PG + D       +  G 
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--PGVKID-EEFCRRLKEGT 268
Query: 277 PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH 312
               PD  +PE    +  C   E S+R T S+L+ H
Sbjct: 269 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 28/224 (12%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR---QVFREMEILR 104
           I +++L   +++G G  G VY+          A+K    D D  + +    V +E ++  
Sbjct: 4   IDFAELTLEEIIGIGGFGKVYRAFWIGDE--VAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 105 RTDSPFIVQCFGI-FEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPK-LAHIASQILKG 162
               P I+   G+  ++P  ++ ++ME+   G L+ +L+  G    P  L + A QI +G
Sbjct: 62  MLKHPNIIALRGVCLKEP--NLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARG 117
Query: 163 LSYLHGHKI---IHRDIKPSNLLV-------NNNNMQVKIADFGVSKIMCRSLDACNSYV 212
           ++YLH   I   IHRD+K SN+L+       + +N  +KI DFG+++   R+     S  
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM--SAA 175
Query: 213 GTCAYMSPERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPF 256
           G  A+M+PE                D+WS          G  PF
Sbjct: 176 GAYAWMAPEVI-----RASMFSKGSDVWSYGVLLWELLTGEVPF 214

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 82/192 (42%), Gaps = 16/192 (8%)
Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
           +L+ LQ +G G  G V    +R      A+K +  DA     +    E  ++ +     +
Sbjct: 13  ELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDA---TAQAFLAEASVMTQLRHSNL 67
Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGH 169
           VQ  G+  +  G + I+ EYM  G+L   L   G        L   +  + + + YL G+
Sbjct: 68  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 127
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
             +HRD+   N+LV+ +N+  K++DFG++K    + D     V   A        P+   
Sbjct: 128 NFVHRDLAARNVLVSEDNV-AKVSDFGLTKEASSTQDTGKLPVKWTA--------PEALR 178
Query: 230 XXXXXXXXDIWS 241
                   D+WS
Sbjct: 179 EAAFSTKSDVWS 190

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 85/194 (43%), Gaps = 12/194 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           +D+     LG G  G VY+   +      A+K +  D       +  +E  +++    P 
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPN 70
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHG 168
           +VQ  G+  +      I++E+M  G L   L +      S   L ++A+QI   + YL  
Sbjct: 71  LVQLLGVCTREP-PFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDX 227
              IHRD+   N LV  N++ VK+ADFG+S++M       ++Y        P ++  P+ 
Sbjct: 130 KNFIHRDLAARNCLVGENHL-VKVADFGLSRLMT-----GDTYTAHAGAKFPIKWTAPES 183
Query: 228 XXXXXXXXXXDIWS 241
                     D+W+
Sbjct: 184 LAYNKFSIKSDVWA 197

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 85/194 (43%), Gaps = 12/194 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           +D+     LG G  G VY+   +      A+K +  D       +  +E  +++    P 
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPN 70
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHG 168
           +VQ  G+  +      I++E+M  G L   L +      S   L ++A+QI   + YL  
Sbjct: 71  LVQLLGVCTREP-PFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDX 227
              IHRD+   N LV  N++ VK+ADFG+S++M       ++Y        P ++  P+ 
Sbjct: 130 KNFIHRDLAARNCLVGENHL-VKVADFGLSRLMT-----GDTYTAHAGAKFPIKWTAPES 183
Query: 228 XXXXXXXXXXDIWS 241
                     D+W+
Sbjct: 184 LAYNKFSIKSDVWA 197

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 115/277 (41%), Gaps = 30/277 (10%)
Query: 59  LGHGNGGTV-----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF-IV 112
           LG G  G V     + +    T +  A+K++   A  +  R +  E++IL        +V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLA------------HI---A 156
              G   KP G + +++E+   G L T L +K   F   K+A            H+   +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 157 SQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA 216
            Q+ KG+ +L   K IHRD+   N+L++  N+ VKI DFG+++ + +  D         A
Sbjct: 155 FQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPDXVRK---GDA 210
Query: 217 YMSPERFDPDXXXXXXXXXXXDIWSXXXXX-XXXXXGHFPFLQPGQRPDWATLMCAICFG 275
            +  +   P+           D+WS           G  P+  PG + D       +  G
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--PGVKID-EEFCRRLKEG 267
Query: 276 DPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH 312
                PD  +PE    +  C   E S+R T S+L+ H
Sbjct: 268 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 116/278 (41%), Gaps = 32/278 (11%)
Query: 59  LGHGNGGTV-----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF-IV 112
           LG G  G V     + +    T +  A+K++   A  +  R +  E++IL        +V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLA------------HI---A 156
              G   KP G + ++ E+   G L T L +K   F   K+A            H+   +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 157 SQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA 216
            Q+ KG+ +L   K IHRD+   N+L++  N+ VKI DFG+++ + +  D    YV    
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPD----YVRKGD 200
Query: 217 YMSPERF-DPDXXXXXXXXXXXDIWSXXXXX-XXXXXGHFPFLQPGQRPDWATLMCAICF 274
              P ++  P+           D+WS           G  P+  PG + D       +  
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--PGVKID-EEFCRRLKE 257
Query: 275 GDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH 312
           G     PD  +PE    +  C   E S+R T S+L+ H
Sbjct: 258 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 116/278 (41%), Gaps = 32/278 (11%)
Query: 59  LGHGNGGTV-----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF-IV 112
           LG G  G V     + +    T +  A+K++   A  +  R +  E++IL        +V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLA------------HI---A 156
              G   KP G + ++ E+   G L T L +K   F   K+A            H+   +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 157 SQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA 216
            Q+ KG+ +L   K IHRD+   N+L++  N+ VKI DFG+++ + +  D    YV    
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPD----YVRKGD 200
Query: 217 YMSPERF-DPDXXXXXXXXXXXDIWSXXXXX-XXXXXGHFPFLQPGQRPDWATLMCAICF 274
              P ++  P+           D+WS           G  P+  PG + D       +  
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--PGVKID-EEFCRRLKE 257
Query: 275 GDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH 312
           G     PD  +PE    +  C   E S+R T S+L+ H
Sbjct: 258 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/261 (23%), Positives = 103/261 (39%), Gaps = 21/261 (8%)
Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
           +L+ LQ +G G  G V    +R      A+K +  DA     +    E  ++ +     +
Sbjct: 194 ELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDA---TAQAFLAEASVMTQLRHSNL 248
Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGH 169
           VQ  G+  +  G + I+ EYM  G+L   L   G        L   +  + + + YL G+
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
             +HRD+   N+LV+ +N+  K++DFG++K    + D     V   A        P+   
Sbjct: 309 NFVHRDLAARNVLVSEDNV-AKVSDFGLTKEASSTQDTGKLPVKWTA--------PEALR 359
Query: 230 XXXXXXXXDIWS-XXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEF 288
                   D+WS           G  P+     R     ++  +  G     PDG  P  
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGRVPY----PRIPLKDVVPRVEKGYKMDAPDGCPPAV 415
Query: 289 RSFIECCLQKEFSKRWTASQL 309
              ++ C   + + R T  QL
Sbjct: 416 YDVMKNCWHLDAATRPTFLQL 436

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 71/133 (53%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 72  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 129
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL VN ++ ++KI DFG+++    + D  
Sbjct: 130 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDS-ELKILDFGLAR---HTDDEM 185
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 186 TGYVATRWYRAPE 198

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 71/133 (53%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 68  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 125
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL VN ++ ++KI DFG+++    + D  
Sbjct: 126 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDS-ELKILDFGLAR---HTDDEM 181
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 182 TGYVATRWYRAPE 194

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 8/156 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRT 106
           ++ +K++VLG G  GTVYK   +      KI  A+K +     P   +++  E  ++   
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSG-TLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
           D+P + +  GI    +  + ++ + M  G  LD +           L +   QI KG++Y
Sbjct: 77  DNPHVCRLLGIC--LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           L   +++HRD+   N+LV      VKI DFG +K++
Sbjct: 135 LEDRRLVHRDLAARNVLVKTPQ-HVKITDFGRAKLL 169

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 85/174 (48%), Gaps = 11/174 (6%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIV 112
           + L+ +G G  G V         +  A+K +     + T  ++ +RE+ +++  +   I+
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNII 86
Query: 113 QCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F      +   D+ ++ME MD+     +          +++++  Q+L G+ +LH
Sbjct: 87  SLLNVFTPQKTLEEFQDVYLVMELMDANLXQVI---QMELDHERMSYLLYQMLXGIKHLH 143
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
              IIHRD+KPSN++V  ++  +KI DFG+++    S      YV T  Y +PE
Sbjct: 144 SAGIIHRDLKPSNIVV-KSDXTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPE 195

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 8/156 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRT 106
           ++ +K++VLG G  GTVYK   +      KI  A+K +     P   +++  E  ++   
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSG-TLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
           D+P + +  GI    +  + ++ + M  G  LD +           L +   QI KG++Y
Sbjct: 75  DNPHVCRLLGICL--TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           L   +++HRD+   N+LV      VKI DFG +K++
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQ-HVKITDFGRAKLL 167

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 6/154 (3%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           +D+     LG G  G VY+   +      A+K +  D       +  +E  +++    P 
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPN 68
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHG 168
           +VQ  G+  +      I++E+M  G L   L +      S   L ++A+QI   + YL  
Sbjct: 69  LVQLLGVCTREP-PFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 127
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC 202
              IHRD+   N LV  N++ VK+ADFG+S++M 
Sbjct: 128 KNFIHRDLAARNCLVGENHL-VKVADFGLSRLMT 160

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 90/177 (50%), Gaps = 9/177 (5%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALK-VVHGDADPTVRRQVFREMEILRR-TDSPFI 111
           E ++ LG G  G V+K   R T ++ A+K +     + T  ++ FRE+ IL   +    I
Sbjct: 12  ELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENI 71
Query: 112 VQCFGIFEKPSG-DIAILMEYMDSGTLDTLLNKNGTFSEP-KLAHIASQILKGLSYLHGH 169
           V    +    +  D+ ++ +YM++  L  ++  N    EP    ++  Q++K + YLH  
Sbjct: 72  VNLLNVLRADNDRDVYLVFDYMETD-LHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSG 128
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPD 226
            ++HRD+KPSN+L+ N    VK+ADFG+S+         N+ +      + E FD D
Sbjct: 129 GLLHRDMKPSNILL-NAECHVKVADFGLSRSFVNIRRVTNN-IPLSINENTENFDDD 183

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 114/277 (41%), Gaps = 30/277 (10%)
Query: 59  LGHGNGGTV-----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF-IV 112
           LG G  G V     + +    T +  A+K++   A  +  R +  E++IL        +V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLA------------HI---A 156
              G   KP G + ++ E+   G L T L +K   F   K+A            H+   +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 157 SQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA 216
            Q+ KG+ +L   K IHRD+   N+L++  N+ VKI DFG+++ + +  D         A
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIXKDPDXVRK---GDA 201
Query: 217 YMSPERFDPDXXXXXXXXXXXDIWSXXXXX-XXXXXGHFPFLQPGQRPDWATLMCAICFG 275
            +  +   P+           D+WS           G  P+  PG + D       +  G
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--PGVKID-EEFCRRLKEG 258
Query: 276 DPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH 312
                PD  +PE    +  C   E S+R T S+L+ H
Sbjct: 259 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 88/195 (45%), Gaps = 16/195 (8%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           S+L  +Q +G G  G V+        K+    +  G            E E++ +   P 
Sbjct: 27  SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMS---EDDFIEEAEVMMKLSHPK 83
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           +VQ +G+  + +  I ++ E+M+ G L D L  + G F+   L  +   + +G++YL   
Sbjct: 84  LVQLYGVCLEQA-PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 142
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGT---CAYMSPERFDPD 226
            +IHRD+   N LV  N + +K++DFG+++ +    D   S  GT     + SPE F   
Sbjct: 143 CVIHRDLAARNCLVGENQV-IKVSDFGMTRFVLD--DQYTSSTGTKFPVKWASPEVFS-- 197
Query: 227 XXXXXXXXXXXDIWS 241
                      D+WS
Sbjct: 198 ---FSRYSSKSDVWS 209

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 84/197 (42%), Gaps = 11/197 (5%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYK---VQHRCTHKIYALKVVHGDADPTVRRQVFREMEILR 104
           IA  D+   ++LG G  G VY+     H+      A+K    D     + +   E  I++
Sbjct: 5   IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 64
Query: 105 RTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGL 163
             D P IV+  GI E+      I+ME    G L   L +N  +     L   + QI K +
Sbjct: 65  NLDHPHIVKLIGIIEEEP--TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAM 122
Query: 164 SYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF 223
           +YL     +HRDI   N+LV +    VK+ DFG+S    R ++  + Y  +   +  +  
Sbjct: 123 AYLESINCVHRDIAVRNILVASPEC-VKLGDFGLS----RYIEDEDYYKASVTRLPIKWM 177
Query: 224 DPDXXXXXXXXXXXDIW 240
            P+           D+W
Sbjct: 178 SPESINFRRFTTASDVW 194

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KXQKLT 123
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEM 179
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 180 TGYVATRWYRAPE 192

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 82/192 (42%), Gaps = 16/192 (8%)
Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
           +L+ LQ +G G  G V    +R      A+K +  DA     +    E  ++ +     +
Sbjct: 7   ELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATA---QAFLAEASVMTQLRHSNL 61
Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGH 169
           VQ  G+  +  G + I+ EYM  G+L   L   G        L   +  + + + YL G+
Sbjct: 62  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 121
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
             +HRD+   N+LV+ +N+  K++DFG++K    + D     V   A        P+   
Sbjct: 122 NFVHRDLAARNVLVSEDNV-AKVSDFGLTKEASSTQDTGKLPVKWTA--------PEALR 172
Query: 230 XXXXXXXXDIWS 241
                   D+WS
Sbjct: 173 EKKFSTKSDVWS 184

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 82/192 (42%), Gaps = 16/192 (8%)
Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
           +L+ LQ +G G  G V    +R      A+K +  DA     +    E  ++ +     +
Sbjct: 22  ELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATA---QAFLAEASVMTQLRHSNL 76
Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGH 169
           VQ  G+  +  G + I+ EYM  G+L   L   G        L   +  + + + YL G+
Sbjct: 77  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXX 229
             +HRD+   N+LV+ +N+  K++DFG++K    + D     V   A        P+   
Sbjct: 137 NFVHRDLAARNVLVSEDNV-AKVSDFGLTKEASSTQDTGKLPVKWTA--------PEALR 187
Query: 230 XXXXXXXXDIWS 241
                   D+WS
Sbjct: 188 EKKFSTKSDVWS 199

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 116/278 (41%), Gaps = 32/278 (11%)
Query: 59  LGHGNGGTV-----YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF-IV 112
           LG G  G V     + +    T +  A+K++   A  +  R +  E++IL        +V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPK------------LAHI---A 156
              G   KP G + +++E+   G L T L +K   F   K            L H+   +
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 157 SQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA 216
            Q+ KG+ +L   K IHRD+   N+L++  N+ VKI DFG+++ + +  D    YV    
Sbjct: 157 FQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPD----YVRKGD 211
Query: 217 YMSPERF-DPDXXXXXXXXXXXDIWSXXXXX-XXXXXGHFPFLQPGQRPDWATLMCAICF 274
              P ++  P+           D+WS           G  P+  PG + D       +  
Sbjct: 212 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--PGVKID-EEFCRRLKE 268
Query: 275 GDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH 312
           G     PD  +PE    +  C   E S+R T S+L+ H
Sbjct: 269 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 306

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 78/156 (50%), Gaps = 8/156 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRT 106
           ++ +K++VLG G  GTVYK   +      KI  A+K +     P   +++  E  ++   
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSG-TLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
           D+P + +  GI    +  + ++ + M  G  LD +           L +   QI +G++Y
Sbjct: 72  DNPHVCRLLGIC--LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNY 129
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           L   +++HRD+   N+LV      VKI DFG++K++
Sbjct: 130 LEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLL 164

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 84/197 (42%), Gaps = 11/197 (5%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYK---VQHRCTHKIYALKVVHGDADPTVRRQVFREMEILR 104
           IA  D+   ++LG G  G VY+     H+      A+K    D     + +   E  I++
Sbjct: 9   IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 68
Query: 105 RTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGL 163
             D P IV+  GI E+      I+ME    G L   L +N  +     L   + QI K +
Sbjct: 69  NLDHPHIVKLIGIIEEEP--TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAM 126
Query: 164 SYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF 223
           +YL     +HRDI   N+LV +    VK+ DFG+S    R ++  + Y  +   +  +  
Sbjct: 127 AYLESINCVHRDIAVRNILVASPEC-VKLGDFGLS----RYIEDEDYYKASVTRLPIKWM 181
Query: 224 DPDXXXXXXXXXXXDIW 240
            P+           D+W
Sbjct: 182 SPESINFRRFTTASDVW 198

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 84/197 (42%), Gaps = 11/197 (5%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYK---VQHRCTHKIYALKVVHGDADPTVRRQVFREMEILR 104
           IA  D+   ++LG G  G VY+     H+      A+K    D     + +   E  I++
Sbjct: 21  IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 80
Query: 105 RTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGL 163
             D P IV+  GI E+      I+ME    G L   L +N  +     L   + QI K +
Sbjct: 81  NLDHPHIVKLIGIIEEEP--TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAM 138
Query: 164 SYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF 223
           +YL     +HRDI   N+LV +    VK+ DFG+S    R ++  + Y  +   +  +  
Sbjct: 139 AYLESINCVHRDIAVRNILVASPEC-VKLGDFGLS----RYIEDEDYYKASVTRLPIKWM 193
Query: 224 DPDXXXXXXXXXXXDIW 240
            P+           D+W
Sbjct: 194 SPESINFRRFTTASDVW 210

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 8/156 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRT 106
           ++ +K++VLG G  GTVYK   +      KI  A+K +     P   +++  E  ++   
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSG-TLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
           D+P + +  GI    +  + ++ + M  G  LD +           L +   QI KG++Y
Sbjct: 82  DNPHVCRLLGIC--LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           L   +++HRD+   N+LV      VKI DFG +K++
Sbjct: 140 LEDRRLVHRDLAARNVLVKTPQ-HVKITDFGRAKLL 174

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 94/182 (51%), Gaps = 17/182 (9%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           ++Y+D    +V+G+G+ G VY+ +   + ++ A+K V  D     +R   RE++I+R+ D
Sbjct: 20  VSYTDT---KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLD 71
Query: 108 SPFIVQCFGIF-----EKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIA---SQI 159
              IV+    F     +K    + ++++Y+         + +       + ++     Q+
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 160 LKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMS 219
            + L+Y+H   I HRDIKP NLL++ +   +K+ DFG +K + R  +   SY+ +  Y +
Sbjct: 132 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRA 190
Query: 220 PE 221
           PE
Sbjct: 191 PE 192

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 73  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 130
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D  
Sbjct: 131 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTADEM 186
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 187 TGYVATRWYRAPE 199

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 80/156 (51%), Gaps = 7/156 (4%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR-RQVFREMEILRRTDSPFIVQCF 115
            ++G G+ G VY    + T K  A+K V+   +  +  +++ RE+ IL R  S +I++ +
Sbjct: 32  HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLY 91
Query: 116 GIFEKPS----GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
            +          ++ I++E  DS  L  L       +E  +  I   +L G +++H   I
Sbjct: 92  DLIIPDDLLKFDELYIVLEIADSD-LKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGI 150
Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA 207
           IHRD+KP+N L+ N +  VK+ DFG+++ +    D 
Sbjct: 151 IHRDLKPANCLL-NQDCSVKVCDFGLARTINSEKDT 185

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 103/247 (41%), Gaps = 19/247 (7%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIV 112
           + L+ +G G  G V         +  A+K +     + T  ++ +RE+ +++  +   I+
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNII 86
Query: 113 QCFGIFEKPSG-----DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F          D+ I+ME MD+     +          +++++  Q+L G+ +LH
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMDANLSQVI---QMELDHERMSYLLYQMLCGIKHLH 143
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDX 227
              IIHRD+KPSN++V  ++  +KI DFG+++    S      YV T  Y +PE      
Sbjct: 144 SAGIIHRDLKPSNIVV-KSDATLKILDFGLARTAGTSF-MMTPYVVTRYYRAPE-----V 196
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDP-PSLPDGASP 286
                     DIWS          G   F        W  ++  +  G P P       P
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL--GTPSPEFMKKLQP 254
Query: 287 EFRSFIE 293
             R+++E
Sbjct: 255 TVRTYVE 261

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 71  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 128
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D  
Sbjct: 129 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDXELKILDFGLAR---HTDDEM 184
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 185 TGYVATRWYRAPE 197

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 77  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 134
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D  
Sbjct: 135 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDXELKILDFGLAR---HTDDEM 190
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 191 TGYVATRWYRAPE 203

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 71/133 (53%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFEKPSGDI-----AILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F  P+  +       L+ ++    L+ ++ K    +
Sbjct: 73  KRTYRELRLLKHMKHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLT 130
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D  
Sbjct: 131 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTADEM 186
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 187 TGYVATRWYRAPE 199

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 71  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 128
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D  
Sbjct: 129 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDXELKILDFGLAR---HTDDEM 184
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 185 TGYVATRWYRAPE 197

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 84/174 (48%), Gaps = 12/174 (6%)
Query: 54  EKLQVLGHGNGGTV-YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           + L  +G G  G+V      +  H++   K+          ++ +RE+ +L+      ++
Sbjct: 21  QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 80
Query: 113 QCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F      +   D+ ++   M    L+ ++ K    ++  +  +  QIL+GL Y+H
Sbjct: 81  GLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIH 138
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
              IIHRD+KPSNL V N + ++KI DFG+++    + D    YV T  Y +PE
Sbjct: 139 SADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPE 188

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 84/174 (48%), Gaps = 12/174 (6%)
Query: 54  EKLQVLGHGNGGTV-YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           + L  +G G  G+V      +  H++   K+          ++ +RE+ +L+      ++
Sbjct: 25  QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 84
Query: 113 QCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F      +   D+ ++   M    L+ ++ K    ++  +  +  QIL+GL Y+H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
              IIHRD+KPSNL V N + ++KI DFG+++    + D    YV T  Y +PE
Sbjct: 143 SADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPE 192

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 71/133 (53%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFEKPSGDI-----AILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F  P+  +       L+ ++    L+ ++ K    +
Sbjct: 73  KRTYRELRLLKHMKHENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLT 130
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D  
Sbjct: 131 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTADEM 186
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 187 TGYVATRWYRAPE 199

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 84/194 (43%), Gaps = 12/194 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           +D+     LG G  G VY+   +      A+K +  D       +  +E  +++    P 
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPN 70
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHG 168
           +VQ  G+  +      I+ E+M  G L   L +      S   L ++A+QI   + YL  
Sbjct: 71  LVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDX 227
              IHRD+   N LV  N++ VK+ADFG+S++M       ++Y        P ++  P+ 
Sbjct: 130 KNFIHRDLAARNCLVGENHL-VKVADFGLSRLMT-----GDTYTAHAGAKFPIKWTAPES 183
Query: 228 XXXXXXXXXXDIWS 241
                     D+W+
Sbjct: 184 LAYNKFSIKSDVWA 197

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 84/194 (43%), Gaps = 12/194 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           +D+     LG G  G VY+   +      A+K +  D       +  +E  +++    P 
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPN 70
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHG 168
           +VQ  G+  +      I+ E+M  G L   L +      S   L ++A+QI   + YL  
Sbjct: 71  LVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDX 227
              IHRD+   N LV  N++ VK+ADFG+S++M       ++Y        P ++  P+ 
Sbjct: 130 KNFIHRDLAARNCLVGENHL-VKVADFGLSRLMT-----GDTYTAHAGAKFPIKWTAPES 183
Query: 228 XXXXXXXXXXDIWS 241
                     D+W+
Sbjct: 184 LAYNKFSIKSDVWA 197

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 84/194 (43%), Gaps = 12/194 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           +D+     LG G  G VY+   +      A+K +  D       +  +E  +++    P 
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPN 75
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHG 168
           +VQ  G+  +      I+ E+M  G L   L +      S   L ++A+QI   + YL  
Sbjct: 76  LVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 134
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDX 227
              IHRD+   N LV  N++ VK+ADFG+S++M       ++Y        P ++  P+ 
Sbjct: 135 KNFIHRDLAARNCLVGENHL-VKVADFGLSRLMT-----GDTYTAHAGAKFPIKWTAPES 188
Query: 228 XXXXXXXXXXDIWS 241
                     D+W+
Sbjct: 189 LAYNKFSIKSDVWA 202

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 84/174 (48%), Gaps = 12/174 (6%)
Query: 54  EKLQVLGHGNGGTV-YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           + L  +G G  G+V      +  H++   K+          ++ +RE+ +L+      ++
Sbjct: 35  QNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 94
Query: 113 QCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F      +   D+ ++   M    L+ ++ K    ++  +  +  QIL+GL Y+H
Sbjct: 95  GLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIH 152
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
              IIHRD+KPSNL V N + ++KI DFG+++    + D    YV T  Y +PE
Sbjct: 153 SADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPE 202

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 94/182 (51%), Gaps = 17/182 (9%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           ++Y+D    +V+G+G+ G VY+ +   + ++ A+K V  D     +R   RE++I+R+ D
Sbjct: 33  VSYTDT---KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLD 84
Query: 108 SPFIVQCFGIF-----EKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIA---SQI 159
              IV+    F     +K    + ++++Y+         + +       + ++     Q+
Sbjct: 85  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 144
Query: 160 LKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMS 219
            + L+Y+H   I HRDIKP NLL++ +   +K+ DFG +K + R  +   SY+ +  Y +
Sbjct: 145 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRA 203
Query: 220 PE 221
           PE
Sbjct: 204 PE 205

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 84/174 (48%), Gaps = 12/174 (6%)
Query: 54  EKLQVLGHGNGGTV-YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           + L  +G G  G+V      +  H++   K+          ++ +RE+ +L+      ++
Sbjct: 44  QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 103
Query: 113 QCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F      +   D+ ++   M    L+ ++ K    ++  +  +  QIL+GL Y+H
Sbjct: 104 GLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIH 161
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
              IIHRD+KPSNL V N + ++KI DFG+++    + D    YV T  Y +PE
Sbjct: 162 SADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPE 211

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 8/156 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRT 106
           ++ +K++VLG G  GTVYK   +      KI  A+  +     P   +++  E  ++   
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSG-TLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
           D+P + +  GI    +  + ++ + M  G  LD +           L +   QI KG++Y
Sbjct: 109 DNPHVCRLLGICL--TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 166
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           L   +++HRD+   N+LV      VKI DFG++K++
Sbjct: 167 LEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLL 201

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 82/180 (45%), Gaps = 35/180 (19%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCT-----HKIYALKVVHGDADPTVRRQVFREMEILRR 105
           +++E ++ +G G  G V++ +           + A+K++  +A   ++    RE  ++  
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 106 TDSPFIVQCFGI--FEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAH--------- 154
            D+P IV+  G+    KP   + +L EYM  G L+  L      +   L+H         
Sbjct: 107 FDNPNIVKLLGVCAVGKP---MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 155 ---------------IASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK 199
                          IA Q+  G++YL   K +HRD+   N LV   NM VKIADFG+S+
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV-GENMVVKIADFGLSR 222

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 84/174 (48%), Gaps = 12/174 (6%)
Query: 54  EKLQVLGHGNGGTV-YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           + L  +G G  G+V      +  H++   K+          ++ +RE+ +L+      ++
Sbjct: 45  QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 104
Query: 113 QCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F      +   D+ ++   M    L+ ++ K    ++  +  +  QIL+GL Y+H
Sbjct: 105 GLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIH 162
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
              IIHRD+KPSNL V N + ++KI DFG+++    + D    YV T  Y +PE
Sbjct: 163 SADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPE 212

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 103/247 (41%), Gaps = 19/247 (7%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIV 112
           + L+ +G G  G V         +  A+K +     + T  ++ +RE+ +++  +   I+
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 113 QCFGIFEKPSG-----DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F          D+ I+ME MD+     +          +++++  Q+L G+ +LH
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLH 143
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDX 227
              IIHRD+KPSN++V  ++  +KI DFG+++    S      YV T  Y +PE      
Sbjct: 144 SAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPE-----V 196
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDP-PSLPDGASP 286
                     DIWS          G   F        W  ++  +  G P P       P
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL--GTPCPEFMKKLQP 254
Query: 287 EFRSFIE 293
             R+++E
Sbjct: 255 TVRTYVE 261

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 6/154 (3%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           +D+     LG G  G VY+   +      A+K +  D       +  +E  +++    P 
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPN 68
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHG 168
           +VQ  G+  +      I+ E+M  G L   L +      S   L ++A+QI   + YL  
Sbjct: 69  LVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 127
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC 202
              IHRD+   N LV  N++ VK+ADFG+S++M 
Sbjct: 128 KNFIHRDLAARNCLVGENHL-VKVADFGLSRLMT 160

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 96/186 (51%), Gaps = 25/186 (13%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           ++Y+D    +V+G+G+ G VY+ +   + ++ A+K V  D     +R   RE++I+R+ D
Sbjct: 48  VSYTDT---KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLD 99
Query: 108 SPFIVQCFGIF-----EKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPK-------LAHI 155
              IV+    F     +K    + ++++Y+     +T+      +S  K       +   
Sbjct: 100 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLY 155
Query: 156 ASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTC 215
             Q+ + L+Y+H   I HRDIKP NLL++ +   +K+ DFG +K + R  +   SY+ + 
Sbjct: 156 MYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSR 214
Query: 216 AYMSPE 221
            Y +PE
Sbjct: 215 YYRAPE 220

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 84/174 (48%), Gaps = 12/174 (6%)
Query: 54  EKLQVLGHGNGGTV-YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           + L  +G G  G+V      +  H++   K+          ++ +RE+ +L+      ++
Sbjct: 31  QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 90
Query: 113 QCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F      +   D+ ++   M    L+ ++ K    ++  +  +  QIL+GL Y+H
Sbjct: 91  GLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIH 148
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
              IIHRD+KPSNL V N + ++KI DFG+++    + D    YV T  Y +PE
Sbjct: 149 SADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPE 198

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 96/186 (51%), Gaps = 25/186 (13%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           ++Y+D    +V+G+G+ G VY+ +   + ++ A+K V  D     +R   RE++I+R+ D
Sbjct: 54  VSYTDT---KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLD 105
Query: 108 SPFIVQCFGIF-----EKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPK-------LAHI 155
              IV+    F     +K    + ++++Y+     +T+      +S  K       +   
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLY 161
Query: 156 ASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTC 215
             Q+ + L+Y+H   I HRDIKP NLL++ +   +K+ DFG +K + R  +   SY+ + 
Sbjct: 162 MYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSR 220
Query: 216 AYMSPE 221
            Y +PE
Sbjct: 221 YYRAPE 226

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 91/188 (48%), Gaps = 12/188 (6%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           L+ LG G  G V   + +  + +    +  G        + F+E + + +   P +V+ +
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFY 69
Query: 116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEP-KLAHIASQILKGLSYLHGHKIIHR 174
           G+  K    I I+ EY+ +G L   L  +G   EP +L  +   + +G+++L  H+ IHR
Sbjct: 70  GVCSKEY-PIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHR 128
Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDXXXXXXX 233
           D+   N LV + ++ VK++DFG+++ +   LD  + YV +     P ++  P+       
Sbjct: 129 DLAARNCLV-DRDLCVKVSDFGMTRYV---LD--DQYVSSVGTKFPVKWSAPEVFHYFKY 182
Query: 234 XXXXDIWS 241
               D+W+
Sbjct: 183 SSKSDVWA 190

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 8/156 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRT 106
           ++ +K++VL  G  GTVYK   +      KI  A+K +     P   +++  E  ++   
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSG-TLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
           D+P + +  GI    +  + ++ + M  G  LD +           L +   QI KG++Y
Sbjct: 75  DNPHVCRLLGIC--LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           L   +++HRD+   N+LV      VKI DFG++K++
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLL 167

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 97/187 (51%), Gaps = 27/187 (14%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           ++Y+D    +V+G+G+ G VY+ +   + ++ A+K V  D     +R   RE++I+R+ D
Sbjct: 56  VSYTDT---KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLD 107
Query: 108 SPFIVQCFGIFEKPSGD------IAILMEYMDSGTLDTLLNKNGTFSEPK-------LAH 154
              IV+    F   SG+      + ++++Y+     +T+      +S  K       +  
Sbjct: 108 HCNIVRLRYFFYS-SGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKL 162
Query: 155 IASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGT 214
              Q+ + L+Y+H   I HRDIKP NLL++ +   +K+ DFG +K + R  +   SY+ +
Sbjct: 163 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICS 221
Query: 215 CAYMSPE 221
             Y +PE
Sbjct: 222 RYYRAPE 228

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/263 (24%), Positives = 106/263 (40%), Gaps = 47/263 (17%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 123
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEM 179
Query: 209 NSYVGTCAYMSPERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPG-QRPDWAT 267
             YV T  Y +PE                DIWS          G   F  PG    D   
Sbjct: 180 TGYVATRWYRAPEIM----LNAMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLK 233
Query: 268 LMCAICFGDPPS--------------------LPD--------GASPEFRSFIECCLQKE 299
           L+  +  G P +                    +P         GA+P     +E  L  +
Sbjct: 234 LILRLV-GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 292
Query: 300 FSKRWTASQLLTHPFLCKNRRSD 322
             KR TA+Q L H +  +    D
Sbjct: 293 SDKRITAAQALAHAYFAQYHDPD 315

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 103/247 (41%), Gaps = 19/247 (7%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIV 112
           + L+ +G G  G V         +  A+K +     + T  ++ +RE+ +++  +   I+
Sbjct: 28  QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 87
Query: 113 QCFGIFEKPSG-----DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F          D+ I+ME MD+     +          +++++  Q+L G+ +LH
Sbjct: 88  GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLH 144
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDX 227
              IIHRD+KPSN++V  ++  +KI DFG+++    S      YV T  Y +PE      
Sbjct: 145 SAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPE-----V 197
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDP-PSLPDGASP 286
                     DIWS          G   F        W  ++  +  G P P       P
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL--GTPCPEFMKKLQP 255
Query: 287 EFRSFIE 293
             R+++E
Sbjct: 256 TVRTYVE 262

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 6/154 (3%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           +D+     LG G  G VY+   +      A+K +  D       +  +E  +++    P 
Sbjct: 11  TDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPN 68
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHG 168
           +VQ  G+  +      I+ E+M  G L   L +      S   L ++A+QI   + YL  
Sbjct: 69  LVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 127
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC 202
              IHRD+   N LV  N++ VK+ADFG+S++M 
Sbjct: 128 KNFIHRDLAARNCLVGENHL-VKVADFGLSRLMT 160

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 96/186 (51%), Gaps = 25/186 (13%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           ++Y+D    +V+G+G+ G VY+ +   + ++ A+K V  D     +R   RE++I+R+ D
Sbjct: 58  VSYTDT---KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLD 109
Query: 108 SPFIVQCFGIF-----EKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPK-------LAHI 155
              IV+    F     +K    + ++++Y+     +T+      +S  K       +   
Sbjct: 110 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLY 165
Query: 156 ASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTC 215
             Q+ + L+Y+H   I HRDIKP NLL++ +   +K+ DFG +K + R  +   SY+ + 
Sbjct: 166 MYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSR 224
Query: 216 AYMSPE 221
            Y +PE
Sbjct: 225 YYRAPE 230

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 85/194 (43%), Gaps = 12/194 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           +D+     LG G  G VY+   +      A+K +  D       +  +E  +++    P 
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPN 75
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHG 168
           +VQ  G+  +      I++E+M  G L   L +      +   L ++A+QI   + YL  
Sbjct: 76  LVQLLGVCTREP-PFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDX 227
              IHRD+   N LV  N++ VK+ADFG+S++M       ++Y        P ++  P+ 
Sbjct: 135 KNFIHRDLAARNCLVGENHL-VKVADFGLSRLM-----TGDTYTAHAGAKFPIKWTAPES 188
Query: 228 XXXXXXXXXXDIWS 241
                     D+W+
Sbjct: 189 LAYNKFSIKSDVWA 202

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 73/136 (53%), Gaps = 10/136 (7%)
Query: 91  TVRRQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNG 145
           T  ++ +RE+ +L+  +   I+    +F      +   D+ ++ME MD+     +   + 
Sbjct: 65  THAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---HM 121
Query: 146 TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL 205
                +++++  Q+L G+ +LH   IIHRD+KPSN++V  ++  +KI DFG+++  C + 
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTACTNF 180
Query: 206 DACNSYVGTCAYMSPE 221
                YV T  Y +PE
Sbjct: 181 -MMTPYVVTRYYRAPE 195

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 96/186 (51%), Gaps = 25/186 (13%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           ++Y+D    +V+G+G+ G VY+ +   + ++ A+K V  D     +R   RE++I+R+ D
Sbjct: 25  VSYTDT---KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLD 76
Query: 108 SPFIVQCFGIF-----EKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPK-------LAHI 155
              IV+    F     +K    + ++++Y+     +T+      +S  K       +   
Sbjct: 77  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLY 132
Query: 156 ASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTC 215
             Q+ + L+Y+H   I HRDIKP NLL++ +   +K+ DFG +K + R  +   SY+ + 
Sbjct: 133 MYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSR 191
Query: 216 AYMSPE 221
            Y +PE
Sbjct: 192 YYRAPE 197

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 103/247 (41%), Gaps = 19/247 (7%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIV 112
           + L+ +G G  G V         +  A+K +     + T  ++ +RE+ +++  +   I+
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 113 QCFGIFEKPSG-----DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F          D+ I+ME MD+     +          +++++  Q+L G+ +LH
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMDANLSQVI---QMELDHERMSYLLYQMLCGIKHLH 143
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDX 227
              IIHRD+KPSN++V  ++  +KI DFG+++    S      YV T  Y +PE      
Sbjct: 144 SAGIIHRDLKPSNIVV-KSDATLKILDFGLARTAGTSF-MMTPYVVTRYYRAPE-----V 196
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDP-PSLPDGASP 286
                     DIWS          G   F        W  ++  +  G P P       P
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL--GTPSPEFMKKLQP 254
Query: 287 EFRSFIE 293
             R+++E
Sbjct: 255 TVRTYVE 261

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           L+ ++ LG G  G V+   +    K+    +  G   P        E  ++++     +V
Sbjct: 15  LKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLV 71
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGT-FSEPKLAHIASQILKGLSYLHGHK 170
           + + +  +    I I+ EYM++G+L D L   +G   +  KL  +A+QI +G++++    
Sbjct: 72  RLYAVVTQEP--IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
            IHRD++ +N+LV ++ +  KIADFG+++++
Sbjct: 130 YIHRDLRAANILV-SDTLSCKIADFGLARLI 159

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 72  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 129
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D  
Sbjct: 130 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEM 185
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 186 TGYVATRWYRAPE 198

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 123
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEM 179
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 180 TGYVATRWYRAPE 192

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 84/196 (42%), Gaps = 16/196 (8%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           +D+     LG G  G VY    +      A+K +  D       +  +E  +++    P 
Sbjct: 32  TDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPN 89
Query: 111 IVQCFGI--FEKPSGDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYL 166
           +VQ  G+   E P     I+ EYM  G L   L +      +   L ++A+QI   + YL
Sbjct: 90  LVQLLGVCTLEPP---FYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYL 146
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-P 225
                IHRD+   N LV  N++ VK+ADFG+S++M       ++Y        P ++  P
Sbjct: 147 EKKNFIHRDLAARNCLVGENHV-VKVADFGLSRLMT-----GDTYTAHAGAKFPIKWTAP 200
Query: 226 DXXXXXXXXXXXDIWS 241
           +           D+W+
Sbjct: 201 ESLAYNTFSIKSDVWA 216

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 8/156 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRT 106
           ++ +K++VL  G  GTVYK   +      KI  A+K +     P   +++  E  ++   
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSG-TLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
           D+P + +  GI    +  + ++ + M  G  LD +           L +   QI KG++Y
Sbjct: 82  DNPHVCRLLGIC--LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           L   +++HRD+   N+LV      VKI DFG++K++
Sbjct: 140 LEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLL 174

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 63  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 120
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D  
Sbjct: 121 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEM 176
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 177 TGYVATRWYRAPE 189

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 73  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 130
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D  
Sbjct: 131 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEM 186
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 187 TGYVATRWYRAPE 199

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 123
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEM 179
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 180 TGYVATRWYRAPE 192

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 68  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 125
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D  
Sbjct: 126 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEM 181
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 182 TGYVATRWYRAPE 194

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 71  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 128
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D  
Sbjct: 129 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEM 184
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 185 TGYVATRWYRAPE 197

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 65  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 122
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D  
Sbjct: 123 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEM 178
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 179 TGYVATRWYRAPE 191

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 72  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 129
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D  
Sbjct: 130 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEM 185
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 186 TGYVATRWYRAPE 198

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 123
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEM 179
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 180 TGYVATRWYRAPE 192

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 64  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 121
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D  
Sbjct: 122 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEM 177
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 178 TGYVATRWYRAPE 190

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 103/247 (41%), Gaps = 19/247 (7%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIV 112
           + L+ +G G  G V         +  A+K +     + T  ++ +RE+ +++  +   I+
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 113 QCFGIFEKPSG-----DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F          D+ I+ME MD+     +          +++++  Q+L G+ +LH
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLH 143
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDX 227
              IIHRD+KPSN++V  ++  +KI DFG+++    S      YV T  Y +PE      
Sbjct: 144 SAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPE-----V 196
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDP-PSLPDGASP 286
                     DIWS          G   F        W  ++  +  G P P       P
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL--GTPSPEFMKKLQP 254
Query: 287 EFRSFIE 293
             R+++E
Sbjct: 255 TVRTYVE 261

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 71  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 128
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D  
Sbjct: 129 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEM 184
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 185 TGYVATRWYRAPE 197

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 68  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 125
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D  
Sbjct: 126 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEM 181
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 182 TGYVATRWYRAPE 194

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 63  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 120
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D  
Sbjct: 121 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEM 176
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 177 TGYVATRWYRAPE 189

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 123
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEM 179
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 180 TGYVATRWYRAPE 192

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 68  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 125
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D  
Sbjct: 126 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEM 181
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 182 TGYVATRWYRAPE 194

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 96/186 (51%), Gaps = 25/186 (13%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           ++Y+D    +V+G+G+ G VY+ +   + ++ A+K V  D     +R   RE++I+R+ D
Sbjct: 99  VSYTDT---KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLD 150
Query: 108 SPFIVQCFGIF-----EKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPK-------LAHI 155
              IV+    F     +K    + ++++Y+     +T+      +S  K       +   
Sbjct: 151 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLY 206
Query: 156 ASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTC 215
             Q+ + L+Y+H   I HRDIKP NLL++ +   +K+ DFG +K + R  +   SY+ + 
Sbjct: 207 MYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSR 265
Query: 216 AYMSPE 221
            Y +PE
Sbjct: 266 YYRAPE 271

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 123
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEM 179
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 180 TGYVATRWYRAPE 192

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 119
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D  
Sbjct: 120 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEM 175
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 176 TGYVATRWYRAPE 188

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 77  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 134
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D  
Sbjct: 135 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEM 190
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 191 TGYVATRWYRAPE 203

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 123
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEM 179
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 180 TGYVATRWYRAPE 192

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/280 (23%), Positives = 113/280 (40%), Gaps = 45/280 (16%)
Query: 57  QVLGHGNGGTVYK-----VQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
           + LG G  G V K     ++ R  +   A+K++  +A P+  R +  E  +L++ + P +
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNG------------------------TF 147
           ++ +G   +  G + +++EY   G+L   L ++                           
Sbjct: 89  IKLYGACSQ-DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 148 SEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA 207
           +   L   A QI +G+ YL   K++HRD+   N+LV     ++KI+DFG+S+ +      
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGR-KMKISDFGLSRDVYEEDSX 206
Query: 208 CNSYVGT--CAYMSPER-FDPDXXXXXXXXXXXDIWS-XXXXXXXXXXGHFPFLQPGQRP 263
                G     +M+ E  FD             D+WS           G  P+  PG  P
Sbjct: 207 VKRSQGRIPVKWMAIESLFD------HIYTTQSDVWSFGVLLWEIVTLGGNPY--PGIPP 258
Query: 264 DWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKR 303
           +   L   +  G     PD  S E    +  C ++E  KR
Sbjct: 259 E--RLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKR 296

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 123
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEM 179
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 180 TGYVATRWYRAPE 192

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 86  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 143
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D  
Sbjct: 144 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEM 199
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 200 TGYVATRWYRAPE 212

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 78  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 135
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D  
Sbjct: 136 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEM 191
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 192 TGYVATRWYRAPE 204

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 78  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 135
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D  
Sbjct: 136 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEM 191
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 192 TGYVATRWYRAPE 204

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 85  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 142
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D  
Sbjct: 143 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEM 198
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 199 TGYVATRWYRAPE 211

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 78  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 135
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D  
Sbjct: 136 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEM 191
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 192 TGYVATRWYRAPE 204

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 85/174 (48%), Gaps = 11/174 (6%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIV 112
           + L+ +G G  G V         +  A+K +     + T  ++ +RE+ +++  +   I+
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 113 QCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F      +   D+ ++ME MD+     +          +++++  Q+L G+ +LH
Sbjct: 87  SLLNVFTPQKTLEEFQDVYLVMELMDANLXQVI---QMELDHERMSYLLYQMLXGIKHLH 143
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
              IIHRD+KPSN++V  ++  +KI DFG+++    S      YV T  Y +PE
Sbjct: 144 SAGIIHRDLKPSNIVV-KSDXTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPE 195

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 89  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 146
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D  
Sbjct: 147 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEM 202
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 203 TGYVATRWYRAPE 215

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 92/192 (47%), Gaps = 14/192 (7%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           L+ ++ LG G  G V+   +    K+    +  G   P        E  ++++     +V
Sbjct: 21  LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLV 77
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGT-FSEPKLAHIASQILKGLSYLHGHK 170
           + + +  +    I I+ EYM++G+L D L   +G   +  KL  +A+QI +G++++    
Sbjct: 78  RLYAVVTQEP--IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 135
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDXXX 229
            IHRD++ +N+LV ++ +  KIADFG+++++       N Y        P ++  P+   
Sbjct: 136 YIHRDLRAANILV-SDTLSCKIADFGLARLI-----EDNEYTAREGAKFPIKWTAPEAIN 189
Query: 230 XXXXXXXXDIWS 241
                   D+WS
Sbjct: 190 YGTFTIKSDVWS 201

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 85/174 (48%), Gaps = 11/174 (6%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIV 112
           + L+ +G G  G V         +  A+K +     + T  ++ +RE+ +++  +   I+
Sbjct: 20  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79
Query: 113 QCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F      +   D+ ++ME MD+     +          +++++  Q+L G+ +LH
Sbjct: 80  SLLNVFTPQKTLEEFQDVYLVMELMDANLXQVI---QMELDHERMSYLLYQMLXGIKHLH 136
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
              IIHRD+KPSN++V  ++  +KI DFG+++    S      YV T  Y +PE
Sbjct: 137 SAGIIHRDLKPSNIVV-KSDXTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPE 188

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/252 (24%), Positives = 112/252 (44%), Gaps = 24/252 (9%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVF-REMEILRRTDSPFIVQCFGI 117
           LG G  G V+   +  + K+    +  G    T+  Q F  E  +++      +V+ + +
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPG----TMSVQAFLEEANLMKTLQHDKLVRLYAV 76
Query: 118 F--EKPSGDIAILMEYMDSGTLDTLL--NKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
              E+P   I I+ EYM  G+L   L  ++ G    PKL   ++QI +G++Y+     IH
Sbjct: 77  VTREEP---IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIH 133
Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDXXXXXX 232
           RD++ +N+LV+ + M  KIADFG+++++       N Y        P ++  P+      
Sbjct: 134 RDLRAANVLVSESLM-CKIADFGLARVI-----EDNEYTAREGAKFPIKWTAPEAINFGC 187
Query: 233 XXXXXDIWS-XXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSF 291
                D+WS           G  P+  PG+    A +M A+  G      +    E    
Sbjct: 188 FTIKSDVWSFGILLYEIVTYGKIPY--PGRTN--ADVMTALSQGYRMPRVENCPDELYDI 243
Query: 292 IECCLQKEFSKR 303
           ++ C +++  +R
Sbjct: 244 MKMCWKEKAEER 255

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 84/194 (43%), Gaps = 12/194 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           +D+     LG G  G VY+   +      A+K +  D       +  +E  +++    P 
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPN 70
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHG 168
           +VQ  G+  +      I+ E+M  G L   L +      +   L ++A+QI   + YL  
Sbjct: 71  LVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 129
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDX 227
              IHRD+   N LV  N++ VK+ADFG+S++M       ++Y        P ++  P+ 
Sbjct: 130 KNFIHRDLAARNCLVGENHL-VKVADFGLSRLM-----TGDTYTAHAGAKFPIKWTAPES 183
Query: 228 XXXXXXXXXXDIWS 241
                     D+W+
Sbjct: 184 LAYNKFSIKSDVWA 197

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 84/194 (43%), Gaps = 12/194 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           +D+     LG G  G VY+   +      A+K +  D       +  +E  +++    P 
Sbjct: 14  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPN 71
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHG 168
           +VQ  G+  +      I+ E+M  G L   L +      +   L ++A+QI   + YL  
Sbjct: 72  LVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 130
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDX 227
              IHRD+   N LV  N++ VK+ADFG+S++M       ++Y        P ++  P+ 
Sbjct: 131 KNFIHRDLAARNCLVGENHL-VKVADFGLSRLMT-----GDTYTAPAGAKFPIKWTAPES 184
Query: 228 XXXXXXXXXXDIWS 241
                     D+W+
Sbjct: 185 LAYNKFSIKSDVWA 198

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 92/192 (47%), Gaps = 14/192 (7%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           L+ ++ LG G  G V+   +    K+    +  G   P        E  ++++     +V
Sbjct: 20  LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLV 76
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGT-FSEPKLAHIASQILKGLSYLHGHK 170
           + + +  +    I I+ EYM++G+L D L   +G   +  KL  +A+QI +G++++    
Sbjct: 77  RLYAVVTQEP--IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 134
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDXXX 229
            IHRD++ +N+LV ++ +  KIADFG+++++       N Y        P ++  P+   
Sbjct: 135 YIHRDLRAANILV-SDTLSCKIADFGLARLI-----EDNEYTAREGAKFPIKWTAPEAIN 188
Query: 230 XXXXXXXXDIWS 241
                   D+WS
Sbjct: 189 YGTFTIKSDVWS 200

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 93/190 (48%), Gaps = 27/190 (14%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFR---EMEILRRTDSP 109
           L+ L+V   G  G V+K Q    ++  A+K+      P   +Q ++   E+  L      
Sbjct: 26  LQLLEVKARGRFGCVWKAQ--LLNEYVAVKIF-----PIQDKQSWQNEYEVYSLPGMKHE 78
Query: 110 FIVQCFGIFEKPSG---DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
            I+Q  G  ++ +    D+ ++  + + G+L   L  N   S  +L HIA  + +GL+YL
Sbjct: 79  NILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYL 137
Query: 167 H--------GHK--IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSY--VGT 214
           H        GHK  I HRDIK  N+L+  NN+   IADFG++        A +++  VGT
Sbjct: 138 HEDIPGLKDGHKPAISHRDIKSKNVLL-KNNLTACIADFGLALKFEAGKSAGDTHGQVGT 196
Query: 215 CAYMSPERFD 224
             YM+PE  +
Sbjct: 197 RRYMAPEVLE 206

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 84/194 (43%), Gaps = 12/194 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           +D+     LG G  G VY+   +      A+K +  D       +  +E  +++    P 
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPN 70
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHG 168
           +VQ  G+  +      I+ E+M  G L   L +      +   L ++A+QI   + YL  
Sbjct: 71  LVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 129
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDX 227
              IHRD+   N LV  N++ VK+ADFG+S++M       ++Y        P ++  P+ 
Sbjct: 130 KNFIHRDLAARNCLVGENHL-VKVADFGLSRLM-----TGDTYTAHAGAKFPIKWTAPES 183
Query: 228 XXXXXXXXXXDIWS 241
                     D+W+
Sbjct: 184 LAYNKFSIKSDVWA 197

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 92/192 (47%), Gaps = 14/192 (7%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           L+ ++ LG G  G V+   +    K+    +  G   P        E  ++++     +V
Sbjct: 25  LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLV 81
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGT-FSEPKLAHIASQILKGLSYLHGHK 170
           + + +  +    I I+ EYM++G+L D L   +G   +  KL  +A+QI +G++++    
Sbjct: 82  RLYAVVTQEP--IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 139
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDXXX 229
            IHRD++ +N+LV ++ +  KIADFG+++++       N Y        P ++  P+   
Sbjct: 140 YIHRDLRAANILV-SDTLSCKIADFGLARLI-----EDNEYTAREGAKFPIKWTAPEAIN 193
Query: 230 XXXXXXXXDIWS 241
                   D+WS
Sbjct: 194 YGTFTIKSDVWS 205

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 73/154 (47%), Gaps = 6/154 (3%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           +D+     LG G  G VY+   +      A+K +  D       +  +E  +++    P 
Sbjct: 14  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPN 71
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHG 168
           +VQ  G+  +      I++E+M  G L   L +      +   L ++A+QI   + YL  
Sbjct: 72  LVQLLGVCTREP-PFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 130
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC 202
              IHRD+   N LV  N++ VK+ADFG+S++M 
Sbjct: 131 KNFIHRDLAARNCLVGENHL-VKVADFGLSRLMT 163

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 103/247 (41%), Gaps = 19/247 (7%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIV 112
           + L+ +G G  G V         +  A+K +     + T  ++ +RE+ +++  +   I+
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 113 QCFGIFEKPSG-----DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F          D+ I+ME MD+     +          +++++  Q+L G+ +LH
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMDANLSQVI---QMELDHERMSYLLYQMLCGIKHLH 143
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDX 227
              IIHRD+KPSN++V  ++  +KI DFG+++    S      YV T  Y +PE      
Sbjct: 144 SAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPE-----V 196
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDP-PSLPDGASP 286
                     DIWS          G   F        W  ++  +  G P P       P
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL--GTPSPEFMKKLQP 254
Query: 287 EFRSFIE 293
             R+++E
Sbjct: 255 TVRTYVE 261

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 92/192 (47%), Gaps = 14/192 (7%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           L+ ++ LG G  G V+   +    K+    +  G   P        E  ++++     +V
Sbjct: 15  LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLV 71
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGT-FSEPKLAHIASQILKGLSYLHGHK 170
           + + +  +    I I+ EYM++G+L D L   +G   +  KL  +A+QI +G++++    
Sbjct: 72  RLYAVVTQEP--IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDXXX 229
            IHRD++ +N+LV ++ +  KIADFG+++++       N Y        P ++  P+   
Sbjct: 130 YIHRDLRAANILV-SDTLSCKIADFGLARLI-----EDNEYTAREGAKFPIKWTAPEAIN 183
Query: 230 XXXXXXXXDIWS 241
                   D+WS
Sbjct: 184 YGTFTIKSDVWS 195

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 84/194 (43%), Gaps = 12/194 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           +D+     LG G  G VY+   +      A+K +  D       +  +E  +++    P 
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPN 74
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHG 168
           +VQ  G+  +      I+ E+M  G L   L +      +   L ++A+QI   + YL  
Sbjct: 75  LVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 133
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDX 227
              IHRD+   N LV  N++ VK+ADFG+S++M       ++Y        P ++  P+ 
Sbjct: 134 KNFIHRDLAARNCLVGENHL-VKVADFGLSRLMT-----GDTYTAHAGAKFPIKWTAPES 187
Query: 228 XXXXXXXXXXDIWS 241
                     D+W+
Sbjct: 188 LAYNKFSIKSDVWA 201

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 85/174 (48%), Gaps = 11/174 (6%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIV 112
           + L+ +G G  G V         +  A+K +     + T  ++ +RE+ +++  +   I+
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNII 86
Query: 113 QCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F      +   D+ ++ME MD+     +          +++++  Q+L G+ +LH
Sbjct: 87  SLLNVFTPQKTLEEFQDVYLVMELMDANLXQVI---QMELDHERMSYLLYQMLCGIKHLH 143
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
              IIHRD+KPSN++V  ++  +KI DFG+++    S      YV T  Y +PE
Sbjct: 144 SAGIIHRDLKPSNIVV-KSDXTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPE 195

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 84/194 (43%), Gaps = 12/194 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           +D+     LG G  G VY+   +      A+K +  D       +  +E  +++    P 
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPN 75
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHG 168
           +VQ  G+  +      I+ E+M  G L   L +      +   L ++A+QI   + YL  
Sbjct: 76  LVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDX 227
              IHRD+   N LV  N++ VK+ADFG+S++M       ++Y        P ++  P+ 
Sbjct: 135 KNFIHRDLAARNCLVGENHL-VKVADFGLSRLM-----TGDTYTAHAGAKFPIKWTAPES 188
Query: 228 XXXXXXXXXXDIWS 241
                     D+W+
Sbjct: 189 LAYNKFSIKSDVWA 202

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 84/194 (43%), Gaps = 12/194 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           +D+     LG G  G VY+   +      A+K +  D       +  +E  +++    P 
Sbjct: 26  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPN 83
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHG 168
           +VQ  G+  +      I+ E+M  G L   L +      +   L ++A+QI   + YL  
Sbjct: 84  LVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 142
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDX 227
              IHRD+   N LV  N++ VK+ADFG+S++M       ++Y        P ++  P+ 
Sbjct: 143 KNFIHRDLAARNCLVGENHL-VKVADFGLSRLMT-----GDTYTAHAGAKFPIKWTAPES 196
Query: 228 XXXXXXXXXXDIWS 241
                     D+W+
Sbjct: 197 LAYNKFSIKSDVWA 210

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 92/192 (47%), Gaps = 14/192 (7%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           L+ ++ LG G  G V+   +    K+    +  G   P        E  ++++     +V
Sbjct: 10  LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLV 66
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGT-FSEPKLAHIASQILKGLSYLHGHK 170
           + + +  +    I I+ EYM++G+L D L   +G   +  KL  +A+QI +G++++    
Sbjct: 67  RLYAVVTQEP--IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 124
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDXXX 229
            IHRD++ +N+LV ++ +  KIADFG+++++       N Y        P ++  P+   
Sbjct: 125 YIHRDLRAANILV-SDTLSCKIADFGLARLI-----EDNEYTAREGAKFPIKWTAPEAIN 178
Query: 230 XXXXXXXXDIWS 241
                   D+WS
Sbjct: 179 YGTFTIKSDVWS 190

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 84/194 (43%), Gaps = 12/194 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           +D+     LG G  G VY+   +      A+K +  D       +  +E  +++    P 
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPN 75
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHG 168
           +VQ  G+  +      I+ E+M  G L   L +      +   L ++A+QI   + YL  
Sbjct: 76  LVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDX 227
              IHRD+   N LV  N++ VK+ADFG+S++M       ++Y        P ++  P+ 
Sbjct: 135 KNFIHRDLAARNCLVGENHL-VKVADFGLSRLMT-----GDTYTAHAGAKFPIKWTAPES 188
Query: 228 XXXXXXXXXXDIWS 241
                     D+W+
Sbjct: 189 LAYNKFSIKSDVWA 202

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 84/194 (43%), Gaps = 12/194 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           +D+     LG G  G VY+   +      A+K +  D       +  +E  +++    P 
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPN 72
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHG 168
           +VQ  G+  +      I+ E+M  G L   L +      +   L ++A+QI   + YL  
Sbjct: 73  LVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 131
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDX 227
              IHRD+   N LV  N++ VK+ADFG+S++M       ++Y        P ++  P+ 
Sbjct: 132 KNFIHRDLAARNCLVGENHL-VKVADFGLSRLMT-----GDTYTAPAGAKFPIKWTAPES 185
Query: 228 XXXXXXXXXXDIWS 241
                     D+W+
Sbjct: 186 LAYNKFSIKSDVWA 199

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 89  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 146
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D  
Sbjct: 147 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEM 202
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 203 XGYVATRWYRAPE 215

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 81/156 (51%), Gaps = 8/156 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRT 106
           ++L KL+VLG G  GTV+K   +    + KI   +KV+   +     + V   M  +   
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSY 165
           D   IV+  G+   P   + ++ +Y+  G+L D +    G      L +   QI KG+ Y
Sbjct: 73  DHAHIVRLLGLC--PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYY 130
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           L  H ++HR++   N+L+ + + QV++ADFGV+ ++
Sbjct: 131 LEEHGMVHRNLAARNVLLKSPS-QVQVADFGVADLL 165

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 84/194 (43%), Gaps = 12/194 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           +D+     LG G  G VY+   +      A+K +  D       +  +E  +++    P 
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPN 72
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHG 168
           +VQ  G+  +      I+ E+M  G L   L +      +   L ++A+QI   + YL  
Sbjct: 73  LVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 131
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDX 227
              IHRD+   N LV  N++ VK+ADFG+S++M       ++Y        P ++  P+ 
Sbjct: 132 KNFIHRDLAARNCLVGENHL-VKVADFGLSRLMT-----GDTYTAHAGAKFPIKWTAPES 185
Query: 228 XXXXXXXXXXDIWS 241
                     D+W+
Sbjct: 186 LAYNKFSIKSDVWA 199

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 89/174 (51%), Gaps = 18/174 (10%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT---VRRQVFREMEILRRTDSPFIVQCF 115
           +G G  G VYK      +   A+K +    D T   +++Q  +E++++ +     +V+  
Sbjct: 39  MGEGGFGVVYK--GYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 116 GIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLA-----HIASQILKGLSYLHGH 169
           G F     D+ ++  YM +G+L D L   +GT   P L+      IA     G+++LH +
Sbjct: 97  G-FSSDGDDLCLVYVYMPNGSLLDRLSCLDGT---PPLSWHMRCKIAQGAANGINFLHEN 152
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC--NSYVGTCAYMSPE 221
             IHRDIK +N+L+ +     KI+DFG+++   +       +  VGT AYM+PE
Sbjct: 153 HHIHRDIKSANILL-DEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPE 205

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 107/274 (39%), Gaps = 47/274 (17%)
Query: 59  LGHGNGGTVYKV--------QHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           LG G  G V+          Q +    + ALK    +A  + R+   RE E+L       
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK----EASESARQDFQREAELLTMLQHQH 81
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSE---------------PKLAHI 155
           IV+ FG+  +    + ++ EYM  G L+  L  +G  ++                +L  +
Sbjct: 82  IVRFFGVCTE-GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 140
Query: 156 ASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTC 215
           ASQ+  G+ YL G   +HRD+   N LV    + VKI DFG    M R + + + Y    
Sbjct: 141 ASQVAAGMVYLAGLHFVHRDLATRNCLV-GQGLVVKIGDFG----MSRDIYSTDYYRVGG 195
Query: 216 AYMSPERF-DPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATL-----M 269
             M P R+  P+           D+WS            +     G++P W  L     +
Sbjct: 196 RTMLPIRWMPPESILYRKFTTESDVWSFGVVL-------WEIFTYGKQP-WYQLSNTEAI 247
Query: 270 CAICFGDPPSLPDGASPEFRSFIECCLQKEFSKR 303
             I  G     P    PE  + +  C Q+E  +R
Sbjct: 248 DCITQGRELERPRACPPEVYAIMRGCWQREPQQR 281

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 84/194 (43%), Gaps = 12/194 (6%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           +D+     LG G  G VY+   +      A+K +  D       +  +E  +++    P 
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPN 72
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHG 168
           +VQ  G+  +      I+ E+M  G L   L +      +   L ++A+QI   + YL  
Sbjct: 73  LVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 131
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDX 227
              IHRD+   N LV  N++ VK+ADFG+S++M       ++Y        P ++  P+ 
Sbjct: 132 KNFIHRDLAARNCLVGENHL-VKVADFGLSRLMT-----GDTYTAHAGAKFPIKWTAPES 185
Query: 228 XXXXXXXXXXDIWS 241
                     D+W+
Sbjct: 186 LAYNKFSIKSDVWA 199

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 81/156 (51%), Gaps = 8/156 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKI-YALKVVHGDADPTVRRQVFREMEILRRT 106
           ++L KL+VLG G  GTV+K   +    + KI   +KV+   +     + V   M  +   
Sbjct: 31  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 90
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSY 165
           D   IV+  G+   P   + ++ +Y+  G+L D +    G      L +   QI KG+ Y
Sbjct: 91  DHAHIVRLLGLC--PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYY 148
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           L  H ++HR++   N+L+ + + QV++ADFGV+ ++
Sbjct: 149 LEEHGMVHRNLAARNVLLKSPS-QVQVADFGVADLL 183

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 6/154 (3%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           +D+     LG G  G VY+   +      A+K +  D       +  +E  +++    P 
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPN 75
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHG 168
           +VQ  G+  +      I+ E+M  G L   L +      +   L ++A+QI   + YL  
Sbjct: 76  LVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC 202
              IHRD+   N LV  N++ VK+ADFG+S++M 
Sbjct: 135 KNFIHRDLAARNCLVGENHL-VKVADFGLSRLMT 167

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 72/148 (48%), Gaps = 9/148 (6%)
Query: 59  LGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           +G G  G V++  +          A+K        +VR +  +E   +R+ D P IV+  
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 116 GIF-EKPSGDIAILMEYMDSGTLDTLLN-KNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
           G+  E P   + I+ME    G L + L  +  +     L   A Q+   L+YL   + +H
Sbjct: 80  GVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVH 136
Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           RDI   N+LV++N+  VK+ DFG+S+ M
Sbjct: 137 RDIAARNVLVSSNDC-VKLGDFGLSRYM 163

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 72/148 (48%), Gaps = 9/148 (6%)
Query: 59  LGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           +G G  G V++  +          A+K        +VR +  +E   +R+ D P IV+  
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 116 GIF-EKPSGDIAILMEYMDSGTLDTLLN-KNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
           G+  E P   + I+ME    G L + L  +  +     L   A Q+   L+YL   + +H
Sbjct: 75  GVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVH 131
Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           RDI   N+LV++N+  VK+ DFG+S+ M
Sbjct: 132 RDIAARNVLVSSNDC-VKLGDFGLSRYM 158

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 70/160 (43%), Gaps = 5/160 (3%)
Query: 67  VYKVQHRCTHKIYALKVVHG--DADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGD 124
           VY+ +     +I ALK+      +DP  R +  RE     R   P +V     F +  G 
Sbjct: 50  VYEAEDTVRERIVALKLXSETLSSDPVFRTRXQREARTAGRLQEPHVVPIHD-FGEIDGQ 108
Query: 125 IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVN 184
           + +    ++   L   L + G  + P+   I  QI   L   H     HRD+KP N+LV+
Sbjct: 109 LYVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS 168
Query: 185 NNNMQVKIADFGV-SKIMCRSLDACNSYVGTCAYMSPERF 223
            ++    + DFG+ S      L    + VGT  Y +PERF
Sbjct: 169 ADDF-AYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERF 207

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 107/274 (39%), Gaps = 47/274 (17%)
Query: 59  LGHGNGGTVYKV--------QHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           LG G  G V+          Q +    + ALK    +A  + R+   RE E+L       
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK----EASESARQDFQREAELLTMLQHQH 75
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSE---------------PKLAHI 155
           IV+ FG+  +    + ++ EYM  G L+  L  +G  ++                +L  +
Sbjct: 76  IVRFFGVCTEGR-PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 134
Query: 156 ASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTC 215
           ASQ+  G+ YL G   +HRD+   N LV    + VKI DFG    M R + + + Y    
Sbjct: 135 ASQVAAGMVYLAGLHFVHRDLATRNCLV-GQGLVVKIGDFG----MSRDIYSTDYYRVGG 189
Query: 216 AYMSPERF-DPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATL-----M 269
             M P R+  P+           D+WS            +     G++P W  L     +
Sbjct: 190 RTMLPIRWMPPESILYRKFTTESDVWSFGVVL-------WEIFTYGKQP-WYQLSNTEAI 241
Query: 270 CAICFGDPPSLPDGASPEFRSFIECCLQKEFSKR 303
             I  G     P    PE  + +  C Q+E  +R
Sbjct: 242 DCITQGRELERPRACPPEVYAIMRGCWQREPQQR 275

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 82/187 (43%), Gaps = 13/187 (6%)
Query: 59  LGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           +G G  G V++  +          A+K        +VR +  +E   +R+ D P IV+  
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 116 GIF-EKPSGDIAILMEYMDSGTLDTLLN-KNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
           G+  E P   + I+ME    G L + L  +  +     L   A Q+   L+YL   + +H
Sbjct: 78  GVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVH 134
Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXX 233
           RDI   N+LV++N+  VK+ DFG+S+ M    +    Y  +   +  +   P+       
Sbjct: 135 RDIAARNVLVSSNDC-VKLGDFGLSRYM----EDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 234 XXXXDIW 240
               D+W
Sbjct: 190 TSASDVW 196

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 72/148 (48%), Gaps = 9/148 (6%)
Query: 59  LGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           +G G  G V++  +          A+K        +VR +  +E   +R+ D P IV+  
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 116 GIF-EKPSGDIAILMEYMDSGTLDTLLN-KNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
           G+  E P   + I+ME    G L + L  +  +     L   A Q+   L+YL   + +H
Sbjct: 81  GVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVH 137
Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           RDI   N+LV++N+  VK+ DFG+S+ M
Sbjct: 138 RDIAARNVLVSSNDC-VKLGDFGLSRYM 164

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 76/159 (47%), Gaps = 9/159 (5%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILR 104
           I    +E  + +G G  G V++  +          A+K        +VR +  +E   +R
Sbjct: 7   IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMR 66
Query: 105 RTDSPFIVQCFGIF-EKPSGDIAILMEYMDSGTLDTLLN-KNGTFSEPKLAHIASQILKG 162
           + D P IV+  G+  E P   + I+ME    G L + L  +  +     L   A Q+   
Sbjct: 67  QFDHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA 123
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           L+YL   + +HRDI   N+LV++N+  VK+ DFG+S+ M
Sbjct: 124 LAYLESKRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM 161

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 85/174 (48%), Gaps = 11/174 (6%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIV 112
           + L+ +G G  G V         +  A+K +     + T  ++ +RE+ +++  +   I+
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNII 86
Query: 113 QCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F      +   D+ ++ME MD+     +          +++++  Q+L G+ +LH
Sbjct: 87  SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLH 143
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
              IIHRD+KPSN++V  ++  +KI DFG+++    S      YV T  Y +PE
Sbjct: 144 SAGIIHRDLKPSNIVV-KSDXTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPE 195

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 82/187 (43%), Gaps = 13/187 (6%)
Query: 59  LGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           +G G  G V++  +          A+K        +VR +  +E   +R+ D P IV+  
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 116 GIF-EKPSGDIAILMEYMDSGTLDTLLN-KNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
           G+  E P   + I+ME    G L + L  +  +     L   A Q+   L+YL   + +H
Sbjct: 78  GVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVH 134
Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXX 233
           RDI   N+LV++N+  VK+ DFG+S+ M    +    Y  +   +  +   P+       
Sbjct: 135 RDIAARNVLVSSNDC-VKLGDFGLSRYM----EDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 234 XXXXDIW 240
               D+W
Sbjct: 190 TSASDVW 196

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 85/193 (44%), Gaps = 13/193 (6%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILRRTDSP 109
           +E  + +G G  G V++  +          A+K        +VR +  +E   +R+ D P
Sbjct: 17  IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 76
Query: 110 FIVQCFGIF-EKPSGDIAILMEYMDSGTLDTLLN-KNGTFSEPKLAHIASQILKGLSYLH 167
            IV+  G+  E P   + I+ME    G L + L  +  +     L   A Q+   L+YL 
Sbjct: 77  HIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 133
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDX 227
             + +HRDI   N+LV++N+  VK+ DFG+S+ M    +    Y  +   +  +   P+ 
Sbjct: 134 SKRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM----EDSTYYKASKGKLPIKWMAPES 188
Query: 228 XXXXXXXXXXDIW 240
                     D+W
Sbjct: 189 INFRRFTSASDVW 201

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 72/148 (48%), Gaps = 9/148 (6%)
Query: 59  LGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           +G G  G V++  +          A+K        +VR +  +E   +R+ D P IV+  
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 116 GIF-EKPSGDIAILMEYMDSGTLDTLLN-KNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
           G+  E P   + I+ME    G L + L  +  +     L   A Q+   L+YL   + +H
Sbjct: 106 GVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVH 162
Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           RDI   N+LV++N+  VK+ DFG+S+ M
Sbjct: 163 RDIAARNVLVSSNDC-VKLGDFGLSRYM 189

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 77/146 (52%), Gaps = 9/146 (6%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVF-REMEILRRTDSPFIVQCFGI 117
           LG G  G V+   +  + K+    +  G    T+  Q F  E  +++      +V+ + +
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPG----TMSVQAFLEEANLMKTLQHDKLVRLYAV 75
Query: 118 FEKPSGDIAILMEYMDSGTLDTLL--NKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRD 175
             K    I I+ E+M  G+L   L  ++ G    PKL   ++QI +G++Y+     IHRD
Sbjct: 76  VTKEE-PIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRD 134
Query: 176 IKPSNLLVNNNNMQVKIADFGVSKIM 201
           ++ +N+LV+ + M  KIADFG+++++
Sbjct: 135 LRAANVLVSESLM-CKIADFGLARVI 159

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 84/174 (48%), Gaps = 12/174 (6%)
Query: 54  EKLQVLGHGNGGTV-YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           + L  +G G  G+V      +  H++   K+          ++ +RE+ +L+      ++
Sbjct: 25  QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 84
Query: 113 QCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F      +   D+ ++   M    L+ ++ K    ++  +  +  QIL+GL Y+H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
              IIHRD+KPSNL V N + ++KI DFG+++    + D    +V T  Y +PE
Sbjct: 143 SADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEMAGFVATRWYRAPE 192

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 84/174 (48%), Gaps = 12/174 (6%)
Query: 54  EKLQVLGHGNGGTV-YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           + L  +G G  G+V      +  H++   K+          ++ +RE+ +L+      ++
Sbjct: 25  QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 84
Query: 113 QCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F      +   D+ ++   M    L+ ++ K    ++  +  +  QIL+GL Y+H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
              IIHRD+KPSNL V N + ++KI DFG+++    + D    +V T  Y +PE
Sbjct: 143 SADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEMAGFVATRWYRAPE 192

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           L+ ++ LG G  G V+   +    K+    +  G   P        E  ++++     +V
Sbjct: 21  LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLV 77
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGT-FSEPKLAHIASQILKGLSYLHGHK 170
           + + +  +    I I+ EYM++G+L D L   +G   +  KL  +A+QI +G++++    
Sbjct: 78  RLYAVVTQEP--IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 135
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
            IHRD++ +N+LV ++ +  KIADFG+++++
Sbjct: 136 YIHRDLRAANILV-SDTLSCKIADFGLARLI 165

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 70/133 (52%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 123
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI D+G+++    + D  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDYGLAR---HTDDEM 179
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 180 TGYVATRWYRAPE 192

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/252 (23%), Positives = 105/252 (41%), Gaps = 29/252 (11%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIV 112
           + L+ +G G  G V         +  A+K +     + T  ++ +RE+ +++  +   I+
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 113 QCFGIFEKPSG-----DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F          D+ I+ME MD+     +          +++++  Q+L G+ +LH
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLH 143
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE---RF- 223
              IIHRD+KPSN++V  ++  +KI DFG+++             GT   M+PE   R+ 
Sbjct: 144 SAGIIHRDLKPSNIVV-KSDCTLKILDFGLART-----------AGTSFMMTPEVVTRYY 191
Query: 224 -DPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDP-PSLP 281
             P+           DIWS          G   F        W  ++  +  G P P   
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL--GTPCPEFM 249
Query: 282 DGASPEFRSFIE 293
               P  R+++E
Sbjct: 250 KKLQPTVRTYVE 261

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 107/274 (39%), Gaps = 47/274 (17%)
Query: 59  LGHGNGGTVYKV--------QHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           LG G  G V+          Q +    + ALK    +A  + R+   RE E+L       
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK----EASESARQDFQREAELLTMLQHQH 104
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSE---------------PKLAHI 155
           IV+ FG+  +    + ++ EYM  G L+  L  +G  ++                +L  +
Sbjct: 105 IVRFFGVCTEGR-PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 156 ASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTC 215
           ASQ+  G+ YL G   +HRD+   N LV    + VKI DFG    M R + + + Y    
Sbjct: 164 ASQVAAGMVYLAGLHFVHRDLATRNCLV-GQGLVVKIGDFG----MSRDIYSTDYYRVGG 218
Query: 216 AYMSPERF-DPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATL-----M 269
             M P R+  P+           D+WS            +     G++P W  L     +
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVL-------WEIFTYGKQP-WYQLSNTEAI 270
Query: 270 CAICFGDPPSLPDGASPEFRSFIECCLQKEFSKR 303
             I  G     P    PE  + +  C Q+E  +R
Sbjct: 271 DCITQGRELERPRACPPEVYAIMRGCWQREPQQR 304

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           L+ ++ LG G  G V+   +    K+    +  G   P        E  ++++     +V
Sbjct: 24  LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLV 80
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGT-FSEPKLAHIASQILKGLSYLHGHK 170
           + + +  +    I I+ EYM++G+L D L   +G   +  KL  +A+QI +G++++    
Sbjct: 81  RLYAVVTQEP--IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 138
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
            IHRD++ +N+LV ++ +  KIADFG+++++
Sbjct: 139 YIHRDLRAANILV-SDTLSCKIADFGLARLI 168

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           L+ ++ LG G  G V+   +    K+    +  G   P        E  ++++     +V
Sbjct: 16  LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLV 72
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGT-FSEPKLAHIASQILKGLSYLHGHK 170
           + + +  +    I I+ EYM++G+L D L   +G   +  KL  +A+QI +G++++    
Sbjct: 73  RLYAVVTQEP--IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 130
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
            IHRD++ +N+LV ++ +  KIADFG+++++
Sbjct: 131 YIHRDLRAANILV-SDTLSCKIADFGLARLI 160

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           L+ ++ LG G  G V+   +    K+    +  G   P        E  ++++     +V
Sbjct: 15  LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLV 71
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGT-FSEPKLAHIASQILKGLSYLHGHK 170
           + + +  +    I I+ EYM++G+L D L   +G   +  KL  +A+QI +G++++    
Sbjct: 72  RLYAVVTQEP--IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
            IHRD++ +N+LV ++ +  KIADFG+++++
Sbjct: 130 YIHRDLRAANILV-SDTLSCKIADFGLARLI 159

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           L+ ++ LG G  G V+   +    K+    +  G   P        E  ++++     +V
Sbjct: 17  LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLV 73
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGT-FSEPKLAHIASQILKGLSYLHGHK 170
           + + +  +    I I+ EYM++G+L D L   +G   +  KL  +A+QI +G++++    
Sbjct: 74  RLYAVVTQEP--IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 131
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
            IHRD++ +N+LV ++ +  KIADFG+++++
Sbjct: 132 YIHRDLRAANILV-SDTLSCKIADFGLARLI 161

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 94/183 (51%), Gaps = 19/183 (10%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALK-VVHGDADPTVRRQVFREMEILRRT 106
           ++Y+D    +V+G+G+ G VY+ +   + ++ A+K V+ G A         RE++I+R+ 
Sbjct: 20  VSYTDT---KVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN------RELQIMRKL 70
Query: 107 DSPFIVQCFGIF-----EKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIA---SQ 158
           D   IV+    F     +K    + ++++Y+         + +       + ++     Q
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 159 ILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYM 218
           + + L+Y+H   I HRDIKP NLL++ +   +K+ DFG +K + R  +   SY+ +  Y 
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYR 189
Query: 219 SPE 221
           +PE
Sbjct: 190 APE 192

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           L+ ++ LG G  G V+   +    K+    +  G   P        E  ++++     +V
Sbjct: 15  LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLV 71
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGT-FSEPKLAHIASQILKGLSYLHGHK 170
           + + +  +    I I+ EYM++G+L D L   +G   +  KL  +A+QI +G++++    
Sbjct: 72  RLYAVVTQEP--IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
            IHRD++ +N+LV ++ +  KIADFG+++++
Sbjct: 130 YIHRDLRAANILV-SDTLSCKIADFGLARLI 159

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           L+ ++ LG G  G V+   +    K+    +  G   P        E  ++++     +V
Sbjct: 23  LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLV 79
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGT-FSEPKLAHIASQILKGLSYLHGHK 170
           + + +  +    I I+ EYM++G+L D L   +G   +  KL  +A+QI +G++++    
Sbjct: 80  RLYAVVTQEP--IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 137
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
            IHRD++ +N+LV ++ +  KIADFG+++++
Sbjct: 138 YIHRDLRAANILV-SDTLSCKIADFGLARLI 167

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 84/174 (48%), Gaps = 12/174 (6%)
Query: 54  EKLQVLGHGNGGTV-YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           + L  +G G  G+V      +  H++   K+          ++ +RE+ +L+      ++
Sbjct: 21  QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 80
Query: 113 QCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F      +   D+ ++   M    L+ ++ K    ++  +  +  QIL+GL Y+H
Sbjct: 81  GLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIH 138
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
              IIHRD+KPSNL V N + ++KI DFG+++    + D    +V T  Y +PE
Sbjct: 139 SADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEMAGFVATRWYRAPE 188

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 94/183 (51%), Gaps = 19/183 (10%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALK-VVHGDADPTVRRQVFREMEILRRT 106
           ++Y+D    +V+G+G+ G VY+ +   + ++ A+K V+ G A         RE++I+R+ 
Sbjct: 20  VSYTDT---KVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN------RELQIMRKL 70
Query: 107 DSPFIVQCFGIF-----EKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIA---SQ 158
           D   IV+    F     +K    + ++++Y+         + +       + ++     Q
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 159 ILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYM 218
           + + L+Y+H   I HRDIKP NLL++ +   +K+ DFG +K + R  +   SY+ +  Y 
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYR 189
Query: 219 SPE 221
           +PE
Sbjct: 190 APE 192

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 88/174 (50%), Gaps = 18/174 (10%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT---VRRQVFREMEILRRTDSPFIVQCF 115
           +G G  G VYK      +   A+K +    D T   +++Q  +E++++ +     +V+  
Sbjct: 39  MGEGGFGVVYK--GYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 116 GIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLA-----HIASQILKGLSYLHGH 169
           G F     D+ ++  YM +G+L D L   +GT   P L+      IA     G+++LH +
Sbjct: 97  G-FSSDGDDLCLVYVYMPNGSLLDRLSCLDGT---PPLSWHMRCKIAQGAANGINFLHEN 152
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC--NSYVGTCAYMSPE 221
             IHRDIK +N+L+ +     KI+DFG+++   +          VGT AYM+PE
Sbjct: 153 HHIHRDIKSANILL-DEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPE 205

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 88/174 (50%), Gaps = 18/174 (10%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT---VRRQVFREMEILRRTDSPFIVQCF 115
           +G G  G VYK      +   A+K +    D T   +++Q  +E++++ +     +V+  
Sbjct: 33  MGEGGFGVVYK--GYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 90
Query: 116 GIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLA-----HIASQILKGLSYLHGH 169
           G F     D+ ++  YM +G+L D L   +GT   P L+      IA     G+++LH +
Sbjct: 91  G-FSSDGDDLCLVYVYMPNGSLLDRLSCLDGT---PPLSWHMRCKIAQGAANGINFLHEN 146
Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC--NSYVGTCAYMSPE 221
             IHRDIK +N+L+ +     KI+DFG+++   +          VGT AYM+PE
Sbjct: 147 HHIHRDIKSANILL-DEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPE 199

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 84/174 (48%), Gaps = 11/174 (6%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIV 112
           + L+ +G G  G V         +  A+K +     + T  ++ +RE+ +++  +   I+
Sbjct: 21  QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 80
Query: 113 QCFGIFEKPSG-----DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F          D+ I+ME MD+     +          +++++  Q+L G+ +LH
Sbjct: 81  GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLH 137
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
              IIHRD+KPSN++V  ++  +KI DFG+++    S      YV T  Y +PE
Sbjct: 138 SAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPE 189

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 84/174 (48%), Gaps = 11/174 (6%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIV 112
           + L+ +G G  G V         +  A+K +     + T  ++ +RE+ +++  +   I+
Sbjct: 32  QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 91
Query: 113 QCFGIFEKPSG-----DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F          D+ I+ME MD+     +          +++++  Q+L G+ +LH
Sbjct: 92  GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLH 148
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
              IIHRD+KPSN++V  ++  +KI DFG+++    S      YV T  Y +PE
Sbjct: 149 SAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPE 200

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 82/187 (43%), Gaps = 13/187 (6%)
Query: 59  LGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           +G G  G V++  +          A+K        +VR +  +E   +R+ D P IV+  
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 116 GIF-EKPSGDIAILMEYMDSGTLDTLLN-KNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
           G+  E P   + I+ME    G L + L  +  +     L   A Q+   L+YL   + +H
Sbjct: 458 GVITENP---VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVH 514
Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXX 233
           RDI   N+LV++N+  VK+ DFG+S+ M    +    Y  +   +  +   P+       
Sbjct: 515 RDIAARNVLVSSNDC-VKLGDFGLSRYM----EDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 234 XXXXDIW 240
               D+W
Sbjct: 570 TSASDVW 576

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 85/196 (43%), Gaps = 16/196 (8%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           +D+     LG G  G VY+   +      A+K +  D       +  +E  +++    P 
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPN 277
Query: 111 IVQCFGI--FEKPSGDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYL 166
           +VQ  G+   E P     I+ E+M  G L   L +      S   L ++A+QI   + YL
Sbjct: 278 LVQLLGVCTREPP---FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 334
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-P 225
                IHR++   N LV  N++ VK+ADFG+S++M       ++Y        P ++  P
Sbjct: 335 EKKNFIHRNLAARNCLVGENHL-VKVADFGLSRLMT-----GDTYTAHAGAKFPIKWTAP 388
Query: 226 DXXXXXXXXXXXDIWS 241
           +           D+W+
Sbjct: 389 ESLAYNKFSIKSDVWA 404

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 64/280 (22%), Positives = 112/280 (40%), Gaps = 45/280 (16%)
Query: 57  QVLGHGNGGTVYK-----VQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
           + LG G  G V K     ++ R  +   A+K++  +A P+  R +  E  +L++ + P +
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNG------------------------TF 147
           ++ +G   +  G + +++EY   G+L   L ++                           
Sbjct: 89  IKLYGACSQ-DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 148 SEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA 207
           +   L   A QI +G+ YL    ++HRD+   N+LV     ++KI+DFG+S+ +      
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGR-KMKISDFGLSRDVYEEDSX 206
Query: 208 CNSYVGT--CAYMSPER-FDPDXXXXXXXXXXXDIWS-XXXXXXXXXXGHFPFLQPGQRP 263
                G     +M+ E  FD             D+WS           G  P+  PG  P
Sbjct: 207 VKRSQGRIPVKWMAIESLFD------HIYTTQSDVWSFGVLLWEIVTLGGNPY--PGIPP 258
Query: 264 DWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKR 303
           +   L   +  G     PD  S E    +  C ++E  KR
Sbjct: 259 E--RLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKR 296

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 107/253 (42%), Gaps = 22/253 (8%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEIL---R 104
           +AY   E L+V+G G+ G V K      H+  ALK+V  +      RQ   E+ IL   R
Sbjct: 95  VAYR-YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLR 151
Query: 105 RTDSPFIVQCFGIFEKPSGDIAILMEY-MDSGTLDTLLNKNG--TFSEPKLAHIASQILK 161
           + D    +    + E  +    I M + + S  L  L+ KN    FS P +   A  IL+
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQ 211
Query: 162 GLSYLHGHKIIHRDIKPSNLLVNNNNMQ-VKIADFGVSKIMCRSLDACNSYVGTCAYMSP 220
            L  LH ++IIH D+KP N+L+       +K+ DFG S   C       + + +  Y +P
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYTXIQSRFYRAP 268
Query: 221 ERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAI-CFGDPPS 279
           E                D+WS          G +P L PG+  +   L C I   G P  
Sbjct: 269 E-----VILGARYGMPIDMWSLGCILAELLTG-YPLL-PGE-DEGDQLACMIELLGMPSQ 320
Query: 280 LPDGASPEFRSFI 292
               AS   ++F+
Sbjct: 321 KLLDASKRAKNFV 333

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 93/182 (51%), Gaps = 17/182 (9%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           ++Y+D    +V+G+G+ G VY+ +   + ++ A+K V  D     +R   RE++I+R+ D
Sbjct: 20  VSYTDT---KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLD 71
Query: 108 SPFIVQCFGIF-----EKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIA---SQI 159
              IV+    F     +K    + ++++Y+         + +       + ++     Q+
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 160 LKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMS 219
            + L+Y+H   I HRDIKP NLL++ +   +K+ DFG +K + R  +   S + +  Y +
Sbjct: 132 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRA 190
Query: 220 PE 221
           PE
Sbjct: 191 PE 192

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 93/182 (51%), Gaps = 17/182 (9%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           ++Y+D    +V+G+G+ G VY+ +   + ++ A+K V  D     +R   RE++I+R+ D
Sbjct: 21  VSYTDT---KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLD 72
Query: 108 SPFIVQCFGIF-----EKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIA---SQI 159
              IV+    F     +K    + ++++Y+         + +       + ++     Q+
Sbjct: 73  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 132
Query: 160 LKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMS 219
            + L+Y+H   I HRDIKP NLL++ +   +K+ DFG +K + R  +   S + +  Y +
Sbjct: 133 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRA 191
Query: 220 PE 221
           PE
Sbjct: 192 PE 193

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 93/182 (51%), Gaps = 17/182 (9%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           ++Y+D    +V+G+G+ G VY+ +   + ++ A+K V  D     +R   RE++I+R+ D
Sbjct: 20  VSYTDT---KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLD 71
Query: 108 SPFIVQCFGIF-----EKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIA---SQI 159
              IV+    F     +K    + ++++Y+         + +       + ++     Q+
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 160 LKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMS 219
            + L+Y+H   I HRDIKP NLL++ +   +K+ DFG +K + R  +   S + +  Y +
Sbjct: 132 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRA 190
Query: 220 PE 221
           PE
Sbjct: 191 PE 192

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 21/169 (12%)
Query: 50  YSDLEKLQVLGHGNGGTVYK--VQHRCTHKIYALKVVHGDADPTVRRQVFREMEIL-RRT 106
           ++D++   V+G GN G V K  ++        A+K +   A     R    E+E+L +  
Sbjct: 14  WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 73
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN----------------GTFSEP 150
             P I+   G  E   G + + +EY   G L   L K+                 T S  
Sbjct: 74  HHPNIINLLGACEH-RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 132
Query: 151 KLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK 199
           +L H A+ + +G+ YL   + IHRD+   N+LV  N +  KIADFG+S+
Sbjct: 133 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV-AKIADFGLSR 180

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 93/184 (50%), Gaps = 21/184 (11%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           ++Y+D    +V+G+G+ G VY+ +   + ++ A+K V  D     +R   RE++I+R+ D
Sbjct: 20  VSYTDT---KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLD 71
Query: 108 SPFIVQCFGIFEKPSG---DIAILMEYMDSGTLDTLLNKNGTFSEPK-------LAHIAS 157
              IV+    F   SG   D+  L   +D    +T+      +S  K       +     
Sbjct: 72  HCNIVRLRYFFYS-SGEKKDVVYLNLVLDY-VPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 158 QILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAY 217
           Q+ + L+Y+H   I HRDIKP NLL++ +   +K+ DFG +K + R  +   S + +  Y
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYY 188
Query: 218 MSPE 221
            +PE
Sbjct: 189 RAPE 192

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 24/200 (12%)
Query: 59  LGHGNGGTVYK------VQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           LG G+ G VY+      V+     ++ A+K V+  A    R +   E  +++  +   +V
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLL-------NKNGTFSEP---KLAHIASQILKG 162
           +  G+  +    + ++ME M  G L + L         N   + P   K+  +A +I  G
Sbjct: 92  RLLGVVSQGQPTL-VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 150
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
           ++YL+ +K +HRD+   N +V   +  VKI DFG    M R +   + Y      + P R
Sbjct: 151 MAYLNANKFVHRDLAARNCMV-AEDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPVR 205
Query: 223 F-DPDXXXXXXXXXXXDIWS 241
           +  P+           D+WS
Sbjct: 206 WMSPESLKDGVFTTYSDVWS 225

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 86/199 (43%), Gaps = 22/199 (11%)
Query: 59  LGHGNGGTVYKVQHRCTHKI-----YALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           LG G+ G VY+   +   K       A+K V+  A    R +   E  +++  +   +V+
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 83
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLL-------NKNGTFSEP---KLAHIASQILKGL 163
             G+  +    + ++ME M  G L + L         N   + P   K+  +A +I  G+
Sbjct: 84  LLGVVSQGQPTL-VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 142
Query: 164 SYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF 223
           +YL+ +K +HRD+   N +V   +  VKI DFG    M R +   + Y      + P R+
Sbjct: 143 AYLNANKFVHRDLAARNCMV-AEDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPVRW 197
Query: 224 -DPDXXXXXXXXXXXDIWS 241
             P+           D+WS
Sbjct: 198 MSPESLKDGVFTTYSDVWS 216

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/192 (23%), Positives = 92/192 (47%), Gaps = 14/192 (7%)
Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           L+ ++ LG G  G V+   +    K+    +  G   P        E  ++++     +V
Sbjct: 11  LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLV 67
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGT-FSEPKLAHIASQILKGLSYLHGHK 170
           + + +  +    I I+ EYM++G+L D L   +G   +  KL  +A+QI +G++++    
Sbjct: 68  RLYAVVTQEP--IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 125
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDXXX 229
            IHR+++ +N+LV ++ +  KIADFG+++++       N Y        P ++  P+   
Sbjct: 126 YIHRNLRAANILV-SDTLSCKIADFGLARLI-----EDNEYTAREGAKFPIKWTAPEAIN 179
Query: 230 XXXXXXXXDIWS 241
                   D+WS
Sbjct: 180 YGTFTIKSDVWS 191

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 107/253 (42%), Gaps = 22/253 (8%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEIL---R 104
           +AY   E L+V+G G+ G V K      H+  ALK+V  +      RQ   E+ IL   R
Sbjct: 95  VAYR-YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLR 151
Query: 105 RTDSPFIVQCFGIFEKPSGDIAILMEY-MDSGTLDTLLNKNG--TFSEPKLAHIASQILK 161
           + D    +    + E  +    I M + + S  L  L+ KN    FS P +   A  IL+
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQ 211
Query: 162 GLSYLHGHKIIHRDIKPSNLLVNNNNMQ-VKIADFGVSKIMCRSLDACNSYVGTCAYMSP 220
            L  LH ++IIH D+KP N+L+       +K+ DFG S   C       + + +  Y +P
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYTXIQSRFYRAP 268
Query: 221 ERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAI-CFGDPPS 279
           E                D+WS          G +P L PG+  +   L C I   G P  
Sbjct: 269 E-----VILGARYGMPIDMWSLGCILAELLTG-YPLL-PGE-DEGDQLACMIELLGMPSQ 320
Query: 280 LPDGASPEFRSFI 292
               AS   ++F+
Sbjct: 321 KLLDASKRAKNFV 333

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 21/169 (12%)
Query: 50  YSDLEKLQVLGHGNGGTVYK--VQHRCTHKIYALKVVHGDADPTVRRQVFREMEIL-RRT 106
           ++D++   V+G GN G V K  ++        A+K +   A     R    E+E+L +  
Sbjct: 24  WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 83
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN----------------GTFSEP 150
             P I+   G  E   G + + +EY   G L   L K+                 T S  
Sbjct: 84  HHPNIINLLGACEH-RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 151 KLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK 199
           +L H A+ + +G+ YL   + IHRD+   N+LV  N +  KIADFG+S+
Sbjct: 143 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV-AKIADFGLSR 190

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 93/182 (51%), Gaps = 17/182 (9%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           ++Y+D    +V+G+G+ G VY+ +   + ++ A+K V  D     +R   RE++I+R+ D
Sbjct: 28  VSYTDT---KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLD 79
Query: 108 SPFIVQCFGIF-----EKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIA---SQI 159
              IV+    F     +K    + ++++Y+         + +       + ++     Q+
Sbjct: 80  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 139
Query: 160 LKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMS 219
            + L+Y+H   I HRDIKP NLL++ +   +K+ DFG +K + R  +   S + +  Y +
Sbjct: 140 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRA 198
Query: 220 PE 221
           PE
Sbjct: 199 PE 200

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 103/247 (41%), Gaps = 19/247 (7%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIV 112
           + L+ +G G  G V         +  A+K +     + T  ++ +RE+ +++  +   I+
Sbjct: 29  QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 88
Query: 113 QCFGIFEKPSG-----DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F          D+ I+ME MD+     +          +++++  Q+L G+ +LH
Sbjct: 89  GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLH 145
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDX 227
              IIHRD+KPSN++V  ++  +KI DFG+++    S      +V T  Y +PE      
Sbjct: 146 SAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFMMV-PFVVTRYYRAPE-----V 198
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDP-PSLPDGASP 286
                     DIWS          G   F        W  ++  +  G P P       P
Sbjct: 199 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL--GTPCPEFMKKLQP 256
Query: 287 EFRSFIE 293
             R+++E
Sbjct: 257 TVRTYVE 263

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 86/199 (43%), Gaps = 22/199 (11%)
Query: 59  LGHGNGGTVYKVQHRCTHKI-----YALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           LG G+ G VY+   +   K       A+K V+  A    R +   E  +++  +   +V+
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLL-------NKNGTFSEP---KLAHIASQILKGL 163
             G+  +    + ++ME M  G L + L         N   + P   K+  +A +I  G+
Sbjct: 80  LLGVVSQGQPTL-VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 138
Query: 164 SYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF 223
           +YL+ +K +HRD+   N +V   +  VKI DFG    M R +   + Y      + P R+
Sbjct: 139 AYLNANKFVHRDLAARNCMV-AEDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPVRW 193
Query: 224 -DPDXXXXXXXXXXXDIWS 241
             P+           D+WS
Sbjct: 194 MSPESLKDGVFTTYSDVWS 212

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 86/199 (43%), Gaps = 22/199 (11%)
Query: 59  LGHGNGGTVYKVQHRCTHKI-----YALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           LG G+ G VY+   +   K       A+K V+  A    R +   E  +++  +   +V+
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLL-------NKNGTFSEP---KLAHIASQILKGL 163
             G+  +    + ++ME M  G L + L         N   + P   K+  +A +I  G+
Sbjct: 86  LLGVVSQGQPTL-VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 144
Query: 164 SYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF 223
           +YL+ +K +HRD+   N +V   +  VKI DFG    M R +   + Y      + P R+
Sbjct: 145 AYLNANKFVHRDLAARNCMV-AEDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPVRW 199
Query: 224 -DPDXXXXXXXXXXXDIWS 241
             P+           D+WS
Sbjct: 200 MSPESLKDGVFTTYSDVWS 218

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 86/199 (43%), Gaps = 22/199 (11%)
Query: 59  LGHGNGGTVYKVQHRCTHKI-----YALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           LG G+ G VY+   +   K       A+K V+  A    R +   E  +++  +   +V+
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLL-------NKNGTFSEP---KLAHIASQILKGL 163
             G+  +    + ++ME M  G L + L         N   + P   K+  +A +I  G+
Sbjct: 87  LLGVVSQGQPTL-VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 145
Query: 164 SYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF 223
           +YL+ +K +HRD+   N +V   +  VKI DFG    M R +   + Y      + P R+
Sbjct: 146 AYLNANKFVHRDLAARNCMV-AEDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPVRW 200
Query: 224 -DPDXXXXXXXXXXXDIWS 241
             P+           D+WS
Sbjct: 201 MSPESLKDGVFTTYSDVWS 219

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 93/182 (51%), Gaps = 17/182 (9%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           ++Y+D    +V+G+G+ G VY+ +   + ++ A+K V  D     +R   RE++I+R+ D
Sbjct: 24  VSYTDT---KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLD 75
Query: 108 SPFIVQCFGIF-----EKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIA---SQI 159
              IV+    F     +K    + ++++Y+         + +       + ++     Q+
Sbjct: 76  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 135
Query: 160 LKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMS 219
            + L+Y+H   I HRDIKP NLL++ +   +K+ DFG +K + R  +   S + +  Y +
Sbjct: 136 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRA 194
Query: 220 PE 221
           PE
Sbjct: 195 PE 196

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 93/182 (51%), Gaps = 17/182 (9%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           ++Y+D    +V+G+G+ G VY+ +   + ++ A+K V  D     +R   RE++I+R+ D
Sbjct: 39  VSYTDT---KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLD 90
Query: 108 SPFIVQCFGIF-----EKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIA---SQI 159
              IV+    F     +K    + ++++Y+         + +       + ++     Q+
Sbjct: 91  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 150
Query: 160 LKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMS 219
            + L+Y+H   I HRDIKP NLL++ +   +K+ DFG +K + R  +   S + +  Y +
Sbjct: 151 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRA 209
Query: 220 PE 221
           PE
Sbjct: 210 PE 211

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 83/174 (47%), Gaps = 12/174 (6%)
Query: 54  EKLQVLGHGNGGTV-YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           + L  +G G  G+V      +  H++   K+          ++ +RE+ +L+      ++
Sbjct: 25  QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 84
Query: 113 QCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F      +   D+ ++   M    L+ ++ K    ++  +  +  QIL+GL Y+H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIH 142
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
              IIHRD+KPSNL V N + ++KI DF +++    + D    YV T  Y +PE
Sbjct: 143 SADIIHRDLKPSNLAV-NEDCELKILDFYLAR---HTDDEMTGYVATRWYRAPE 192

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 86/199 (43%), Gaps = 22/199 (11%)
Query: 59  LGHGNGGTVYKVQHRCTHKI-----YALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           LG G+ G VY+   +   K       A+K V+  A    R +   E  +++  +   +V+
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLN-------KNGTFSEP---KLAHIASQILKGL 163
             G+  +    + ++ME M  G L + L         N   + P   K+  +A +I  G+
Sbjct: 83  LLGVVSQGQPTL-VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 141
Query: 164 SYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF 223
           +YL+ +K +HRD+   N +V   +  VKI DFG    M R +   + Y      + P R+
Sbjct: 142 AYLNANKFVHRDLAARNCMV-AEDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPVRW 196
Query: 224 -DPDXXXXXXXXXXXDIWS 241
             P+           D+WS
Sbjct: 197 MSPESLKDGVFTTYSDVWS 215

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 24/200 (12%)
Query: 59  LGHGNGGTVYK------VQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           LG G+ G VY+      V+     ++ A+K V+  A    R +   E  +++  +   +V
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLN-------KNGTFSEP---KLAHIASQILKG 162
           +  G+  +    + ++ME M  G L + L         N   + P   K+  +A +I  G
Sbjct: 92  RLLGVVSQGQPTL-VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
           ++YL+ +K +HRD+   N +V   +  VKI DFG    M R +   + Y      + P R
Sbjct: 151 MAYLNANKFVHRDLAARNCMV-AEDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPVR 205
Query: 223 F-DPDXXXXXXXXXXXDIWS 241
           +  P+           D+WS
Sbjct: 206 WMSPESLKDGVFTTYSDVWS 225

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 93/182 (51%), Gaps = 17/182 (9%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           ++Y+D    +V+G+G+ G VY+ +   + ++ A+K V  D     +R   RE++I+R+ D
Sbjct: 32  VSYTDT---KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLD 83
Query: 108 SPFIVQCFGIF-----EKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIA---SQI 159
              IV+    F     +K    + ++++Y+         + +       + ++     Q+
Sbjct: 84  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 143
Query: 160 LKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMS 219
            + L+Y+H   I HRDIKP NLL++ +   +K+ DFG +K + R  +   S + +  Y +
Sbjct: 144 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRA 202
Query: 220 PE 221
           PE
Sbjct: 203 PE 204

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 86/199 (43%), Gaps = 22/199 (11%)
Query: 59  LGHGNGGTVYKVQHRCTHKI-----YALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           LG G+ G VY+   +   K       A+K V+  A    R +   E  +++  +   +V+
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLL-------NKNGTFSEP---KLAHIASQILKGL 163
             G+  +    + ++ME M  G L + L         N   + P   K+  +A +I  G+
Sbjct: 86  LLGVVSQGQPTL-VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 144
Query: 164 SYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF 223
           +YL+ +K +HRD+   N +V   +  VKI DFG    M R +   + Y      + P R+
Sbjct: 145 AYLNANKFVHRDLAARNCMV-AEDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPVRW 199
Query: 224 -DPDXXXXXXXXXXXDIWS 241
             P+           D+WS
Sbjct: 200 MSPESLKDGVFTTYSDVWS 218

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 85/174 (48%), Gaps = 11/174 (6%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIV 112
           + L+ +G G  G V         +  A+K +     + T  ++ +RE+ +++  +   I+
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 113 QCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F      +   D+ ++ME MD+     +          +++++  Q+L G+ +LH
Sbjct: 87  SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLH 143
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
              IIHRD+KPSN++V  ++  +KI DFG+++    S      YV T  Y +PE
Sbjct: 144 SAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPE 195

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 85/174 (48%), Gaps = 11/174 (6%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIV 112
           + L+ +G G  G V         +  A+K +     + T  ++ +RE+ +++  +   I+
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 113 QCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F      +   D+ ++ME MD+     +          +++++  Q+L G+ +LH
Sbjct: 87  SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLH 143
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
              IIHRD+KPSN++V  ++  +KI DFG+++    S      YV T  Y +PE
Sbjct: 144 SAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPE 195

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 85/174 (48%), Gaps = 11/174 (6%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIV 112
           + L+ +G G  G V         +  A+K +     + T  ++ +RE+ +++  +   I+
Sbjct: 28  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 87
Query: 113 QCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F      +   D+ ++ME MD+     +          +++++  Q+L G+ +LH
Sbjct: 88  SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLH 144
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
              IIHRD+KPSN++V  ++  +KI DFG+++    S      YV T  Y +PE
Sbjct: 145 SAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPE 196

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 95/186 (51%), Gaps = 25/186 (13%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           ++Y+D    +V+G+G+ G VY+ +   + ++ A+K V  D     +R   RE++I+R+ D
Sbjct: 32  VSYTDT---KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLD 83
Query: 108 SPFIVQCFGIF-----EKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPK-------LAHI 155
              IV+    F     +K    + ++++Y+     +T+      +S  K       +   
Sbjct: 84  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLY 139
Query: 156 ASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTC 215
             Q+ + L+Y+H   I HRDIKP NLL++ +   +K+ DFG +K + R  +   S + + 
Sbjct: 140 MYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSR 198
Query: 216 AYMSPE 221
            Y +PE
Sbjct: 199 YYRAPE 204

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 85/174 (48%), Gaps = 11/174 (6%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIV 112
           + L+ +G G  G V         +  A+K +     + T  ++ +RE+ +++  +   I+
Sbjct: 26  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 85
Query: 113 QCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F      +   D+ ++ME MD+     +          +++++  Q+L G+ +LH
Sbjct: 86  SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLH 142
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
              IIHRD+KPSN++V  ++  +KI DFG+++    S      YV T  Y +PE
Sbjct: 143 SAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPE 194

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 86/199 (43%), Gaps = 22/199 (11%)
Query: 59  LGHGNGGTVYKVQHRCTHKI-----YALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           LG G+ G VY+   +   K       A+K V+  A    R +   E  +++  +   +V+
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLL-------NKNGTFSEP---KLAHIASQILKGL 163
             G+  +    + ++ME M  G L + L         N   + P   K+  +A +I  G+
Sbjct: 115 LLGVVSQGQPTL-VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 173
Query: 164 SYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF 223
           +YL+ +K +HRD+   N +V   +  VKI DFG    M R +   + Y      + P R+
Sbjct: 174 AYLNANKFVHRDLAARNCMV-AEDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPVRW 228
Query: 224 -DPDXXXXXXXXXXXDIWS 241
             P+           D+WS
Sbjct: 229 MSPESLKDGVFTTYSDVWS 247

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 85/174 (48%), Gaps = 11/174 (6%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIV 112
           + L+ +G G  G V         +  A+K +     + T  ++ +RE+ +++  +   I+
Sbjct: 21  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 80
Query: 113 QCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F      +   D+ ++ME MD+     +          +++++  Q+L G+ +LH
Sbjct: 81  SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLH 137
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
              IIHRD+KPSN++V  ++  +KI DFG+++    S      YV T  Y +PE
Sbjct: 138 SAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPE 189

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 85/174 (48%), Gaps = 11/174 (6%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIV 112
           + L+ +G G  G V         +  A+K +     + T  ++ +RE+ +++  +   I+
Sbjct: 20  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79
Query: 113 QCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F      +   D+ ++ME MD+     +          +++++  Q+L G+ +LH
Sbjct: 80  SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLH 136
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
              IIHRD+KPSN++V  ++  +KI DFG+++    S      YV T  Y +PE
Sbjct: 137 SAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPE 188

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 85/174 (48%), Gaps = 11/174 (6%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIV 112
           + L+ +G G  G V         +  A+K +     + T  ++ +RE+ +++  +   I+
Sbjct: 21  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 80
Query: 113 QCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F      +   D+ ++ME MD+     +          +++++  Q+L G+ +LH
Sbjct: 81  SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLH 137
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
              IIHRD+KPSN++V  ++  +KI DFG+++    S      YV T  Y +PE
Sbjct: 138 SAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPE 189

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 95/186 (51%), Gaps = 25/186 (13%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           ++Y+D    +V+G+G+ G VY+ +   + ++ A+K V  D     +R   RE++I+R+ D
Sbjct: 54  VSYTDT---KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLD 105
Query: 108 SPFIVQCFGIF-----EKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPK-------LAHI 155
              IV+    F     +K    + ++++Y+     +T+      +S  K       +   
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLY 161
Query: 156 ASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTC 215
             Q+ + L+Y+H   I HRDIKP NLL++ +   +K+ DFG +K + R  +   S + + 
Sbjct: 162 MYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSR 220
Query: 216 AYMSPE 221
            Y +PE
Sbjct: 221 YYRAPE 226

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 85/174 (48%), Gaps = 11/174 (6%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIV 112
           + L+ +G G  G V         +  A+K +     + T  ++ +RE+ +++  +   I+
Sbjct: 28  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 87
Query: 113 QCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F      +   D+ ++ME MD+     +          +++++  Q+L G+ +LH
Sbjct: 88  SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLH 144
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
              IIHRD+KPSN++V  ++  +KI DFG+++    S      YV T  Y +PE
Sbjct: 145 SAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPE 196

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 85/174 (48%), Gaps = 11/174 (6%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIV 112
           + L+ +G G  G V         +  A+K +     + T  ++ +RE+ +++  +   I+
Sbjct: 65  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 124
Query: 113 QCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F      +   D+ ++ME MD+     +          +++++  Q+L G+ +LH
Sbjct: 125 SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLH 181
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
              IIHRD+KPSN++V  ++  +KI DFG+++    S      YV T  Y +PE
Sbjct: 182 SAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPE 233

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 83/174 (47%), Gaps = 12/174 (6%)
Query: 54  EKLQVLGHGNGGTV-YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           + L  +G G  G+V      +  H++   K+          ++ +RE+ +L+      ++
Sbjct: 45  QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 104
Query: 113 QCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F      +   D+ ++   M    L+ ++ K    ++  +  +  QIL+GL Y+H
Sbjct: 105 GLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIH 162
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
              IIHRD+KPSNL V N + ++KI DFG+++    + D     V T  Y +PE
Sbjct: 163 SADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEMXGXVATRWYRAPE 212

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 69/133 (51%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 123
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI  FG+++    + D  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILGFGLAR---HTDDEM 179
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 180 TGYVATRWYRAPE 192

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 85/174 (48%), Gaps = 11/174 (6%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIV 112
           + L+ +G G  G V         +  A+K +     + T  ++ +RE+ +++  +   I+
Sbjct: 65  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 124
Query: 113 QCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F      +   D+ ++ME MD+     +          +++++  Q+L G+ +LH
Sbjct: 125 SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLH 181
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
              IIHRD+KPSN++V  ++  +KI DFG+++    S      YV T  Y +PE
Sbjct: 182 SAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPE 233

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 85/196 (43%), Gaps = 16/196 (8%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           +D+     LG G  G VY+   +      A+K +  D       +  +E  +++    P 
Sbjct: 259 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPN 316
Query: 111 IVQCFGI--FEKPSGDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYL 166
           +VQ  G+   E P     I+ E+M  G L   L +      +   L ++A+QI   + YL
Sbjct: 317 LVQLLGVCTREPP---FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 373
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-P 225
                IHR++   N LV  N++ VK+ADFG+S++M       ++Y        P ++  P
Sbjct: 374 EKKNFIHRNLAARNCLVGENHL-VKVADFGLSRLMT-----GDTYTAHAGAKFPIKWTAP 427
Query: 226 DXXXXXXXXXXXDIWS 241
           +           D+W+
Sbjct: 428 ESLAYNKFSIKSDVWA 443

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 78/155 (50%), Gaps = 7/155 (4%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVR-RQVFREMEILRRTDSPFIVQCF 115
            ++G G+ G VY    +  +K  A+K V+   +  +  +++ RE+ IL R  S +I++  
Sbjct: 34  HLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLH 93
Query: 116 GIFEKPS----GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
            +          ++ I++E  DS  L  L       +E  +  I   +L G  ++H   I
Sbjct: 94  DLIIPEDLLKFDELYIVLEIADSD-LKKLFKTPIFLTEQHVKTILYNLLLGEKFIHESGI 152
Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD 206
           IHRD+KP+N L+ N +  VKI DFG+++ +    D
Sbjct: 153 IHRDLKPANCLL-NQDCSVKICDFGLARTINSDKD 186

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 91  TVRRQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNG 145
           T  ++ +RE+ +L+  +   I+    +F      +   D+ ++ME MD+     +   + 
Sbjct: 63  THAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---HM 119
Query: 146 TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL 205
                +++++  Q+L G+ +LH   IIHRD+KPSN++V  ++  +KI DFG+++    + 
Sbjct: 120 ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTASTNF 178
Query: 206 DACNSYVGTCAYMSPERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDW 265
                YV T  Y +PE                DIWS          G   F        W
Sbjct: 179 -MMTPYVVTRYYRAPE-----VILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQW 232
Query: 266 ATLMCAICFGDPPS-LPDGASPEFRSFIE 293
             ++  +  G P +       P  R+++E
Sbjct: 233 NKVIEQL--GTPSAEFMAALQPTVRNYVE 259

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 69/133 (51%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 123
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI DFG+++    + D  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDFGLAR---HTDDEM 179
Query: 209 NSYVGTCAYMSPE 221
              V T  Y +PE
Sbjct: 180 TGXVATRWYRAPE 192

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 69/133 (51%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 123
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI D G+++    + D  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDAGLAR---HTDDEM 179
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 180 TGYVATRWYRAPE 192

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 88/192 (45%), Gaps = 12/192 (6%)
Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
           DL  L+ LG G  G V   + R  + + A+K++   +      +   E +++       +
Sbjct: 9   DLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGS--MSEDEFIEEAKVMMNLSHEKL 65
Query: 112 VQCFGIFEKPSGDIAILMEYMDSG-TLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           VQ +G+  K    I I+ EYM +G  L+ L      F   +L  +   + + + YL   +
Sbjct: 66  VQLYGVCTKQR-PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 124
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDXXX 229
            +HRD+   N LVN+  + VK++DFG+S+ +   LD  + Y  +     P R+  P+   
Sbjct: 125 FLHRDLAARNCLVNDQGV-VKVSDFGLSRYV---LD--DEYTSSVGSKFPVRWSPPEVLM 178
Query: 230 XXXXXXXXDIWS 241
                   DIW+
Sbjct: 179 YSKFSSKSDIWA 190

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 88/192 (45%), Gaps = 12/192 (6%)
Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
           DL  L+ LG G  G V   + R  + + A+K++   +      +   E +++       +
Sbjct: 25  DLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGS--MSEDEFIEEAKVMMNLSHEKL 81
Query: 112 VQCFGIFEKPSGDIAILMEYMDSG-TLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           VQ +G+  K    I I+ EYM +G  L+ L      F   +L  +   + + + YL   +
Sbjct: 82  VQLYGVCTKQR-PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 140
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDXXX 229
            +HRD+   N LVN+  + VK++DFG+S+ +   LD  + Y  +     P R+  P+   
Sbjct: 141 FLHRDLAARNCLVNDQGV-VKVSDFGLSRYV---LD--DEYTSSVGSKFPVRWSPPEVLM 194
Query: 230 XXXXXXXXDIWS 241
                   DIW+
Sbjct: 195 YSKFSSKSDIWA 206

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 88/192 (45%), Gaps = 12/192 (6%)
Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
           DL  L+ LG G  G V   + R  + + A+K++   +      +   E +++       +
Sbjct: 5   DLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGS--MSEDEFIEEAKVMMNLSHEKL 61
Query: 112 VQCFGIFEKPSGDIAILMEYMDSG-TLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           VQ +G+  K    I I+ EYM +G  L+ L      F   +L  +   + + + YL   +
Sbjct: 62  VQLYGVCTKQR-PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDXXX 229
            +HRD+   N LVN+  + VK++DFG+S+ +   LD  + Y  +     P R+  P+   
Sbjct: 121 FLHRDLAARNCLVNDQGV-VKVSDFGLSRYV---LD--DEYTSSVGSKFPVRWSPPEVLM 174
Query: 230 XXXXXXXXDIWS 241
                   DIW+
Sbjct: 175 YSKFSSKSDIWA 186

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 88/192 (45%), Gaps = 12/192 (6%)
Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
           DL  L+ LG G  G V   + R  + + A+K++   +      +   E +++       +
Sbjct: 16  DLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGS--MSEDEFIEEAKVMMNLSHEKL 72
Query: 112 VQCFGIFEKPSGDIAILMEYMDSG-TLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           VQ +G+  K    I I+ EYM +G  L+ L      F   +L  +   + + + YL   +
Sbjct: 73  VQLYGVCTKQR-PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 131
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDXXX 229
            +HRD+   N LVN+  + VK++DFG+S+ +   LD  + Y  +     P R+  P+   
Sbjct: 132 FLHRDLAARNCLVNDQGV-VKVSDFGLSRYV---LD--DEYTSSVGSKFPVRWSPPEVLM 185
Query: 230 XXXXXXXXDIWS 241
                   DIW+
Sbjct: 186 YSKFSSKSDIWA 197

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 88/192 (45%), Gaps = 12/192 (6%)
Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
           DL  L+ LG G  G V   + R  + + A+K++   +      +   E +++       +
Sbjct: 10  DLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGS--MSEDEFIEEAKVMMNLSHEKL 66
Query: 112 VQCFGIFEKPSGDIAILMEYMDSG-TLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           VQ +G+  K    I I+ EYM +G  L+ L      F   +L  +   + + + YL   +
Sbjct: 67  VQLYGVCTKQR-PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 125
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDXXX 229
            +HRD+   N LVN+  + VK++DFG+S+ +   LD  + Y  +     P R+  P+   
Sbjct: 126 FLHRDLAARNCLVNDQGV-VKVSDFGLSRYV---LD--DEYTSSVGSKFPVRWSPPEVLM 179
Query: 230 XXXXXXXXDIWS 241
                   DIW+
Sbjct: 180 YSKFSSKSDIWA 191

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 69/133 (51%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 123
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI D G+++    + D  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDRGLAR---HTDDEM 179
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 180 TGYVATRWYRAPE 192

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 69/133 (51%), Gaps = 11/133 (8%)
Query: 94  RQVFREMEILRRTDSPFIVQCFGIFE-----KPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
           ++ +RE+ +L+      ++    +F      +   D+ ++   M    L+ ++ K    +
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLT 123
Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           +  +  +  QIL+GL Y+H   IIHRD+KPSNL V N + ++KI D G+++    + D  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKILDGGLAR---HTDDEM 179
Query: 209 NSYVGTCAYMSPE 221
             YV T  Y +PE
Sbjct: 180 TGYVATRWYRAPE 192

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 85/199 (42%), Gaps = 22/199 (11%)
Query: 59  LGHGNGGTVYKVQHRCTHKI-----YALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           LG G+ G VY+   +   K       A+K V+  A    R +   E  +++  +   +V+
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLL-------NKNGTFSEP---KLAHIASQILKGL 163
             G+  +    + ++ME M  G L + L         N   + P   K+  +A +I  G+
Sbjct: 80  LLGVVSQGQPTL-VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 138
Query: 164 SYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF 223
           +YL+ +K +HRD+   N  V   +  VKI DFG    M R +   + Y      + P R+
Sbjct: 139 AYLNANKFVHRDLAARNCXV-AEDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPVRW 193
Query: 224 -DPDXXXXXXXXXXXDIWS 241
             P+           D+WS
Sbjct: 194 MSPESLKDGVFTTYSDVWS 212

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 82/181 (45%), Gaps = 13/181 (7%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEIL---R 104
           +AY   E L+V+G G  G V K      H+  ALK+V  +      RQ   E+ IL   R
Sbjct: 95  VAYR-YEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLR 151
Query: 105 RTDSPFIVQCFGIFEKPSGDIAILMEY-MDSGTLDTLLNKNG--TFSEPKLAHIASQILK 161
           + D    +    + E  +    I M + + S  L  L+ KN    FS P +   A  IL+
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQ 211
Query: 162 GLSYLHGHKIIHRDIKPSNLLVNNNNMQ-VKIADFGVSKIMCRSLDACNSYVGTCAYMSP 220
            L  LH ++IIH D+KP N+L+       +K+ DFG S   C         + +  Y +P
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYXXIQSRFYRAP 268
Query: 221 E 221
           E
Sbjct: 269 E 269

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/269 (23%), Positives = 116/269 (43%), Gaps = 23/269 (8%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALK-VVHGDADPTVR-----RQVFREME 101
           +A +++E  + +G G  G V+K +      + A+K ++ GD++         ++  RE+ 
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 102 ILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQIL 160
           I+   + P IV+ +G+   P     ++ME++  G L   LL+K           +   I 
Sbjct: 76  IMSNLNHPNIVKLYGLMHNPP---RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIA 132
Query: 161 KGLSYLHGHK--IIHRDIKPSNLLV----NNNNMQVKIADFGVSKIMCRSLDACNSYVGT 214
            G+ Y+      I+HRD++  N+ +     N  +  K+ADFG+S+   +S+ + +  +G 
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ---QSVHSVSGLLGN 189
Query: 215 CAYMSPERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICF 274
             +M+PE    +           D +S          G  PF +          M     
Sbjct: 190 FQWMAPETIGAE---EESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR-EE 245
Query: 275 GDPPSLPDGASPEFRSFIECCLQKEFSKR 303
           G  P++P+   P  R+ IE C   +  KR
Sbjct: 246 GLRPTIPEDCPPRLRNVIELCWSGDPKKR 274

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 94/183 (51%), Gaps = 19/183 (10%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALK-VVHGDADPTVRRQVFREMEILRRT 106
           ++Y+D    +V+G+G+ G VY+ +   + ++ A+K V+ G A         RE++I+R+ 
Sbjct: 20  VSYTDT---KVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN------RELQIMRKL 70
Query: 107 DSPFIVQCFGIF-----EKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIA---SQ 158
           D   IV+    F     +K    + ++++Y+ +       + +       + ++     Q
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 159 ILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYM 218
           + + L+Y+H   I HRDIKP NLL++ +   +K+ DFG +K + R  +   S + +  Y 
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYR 189
Query: 219 SPE 221
           +PE
Sbjct: 190 APE 192

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 70/148 (47%), Gaps = 9/148 (6%)
Query: 59  LGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           +G G  G V++  +          A+K        +VR +  +E   +R+ D P IV+  
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 116 GIF-EKPSGDIAILMEYMDSGTLDTLLN-KNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
           G+  E P   + I+ME    G L + L  +  +     L   A Q+   L+YL   + +H
Sbjct: 78  GVITENP---VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVH 134
Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           RDI   N+LV+  +  VK+ DFG+S+ M
Sbjct: 135 RDIAARNVLVSATDC-VKLGDFGLSRYM 161

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 89/199 (44%), Gaps = 26/199 (13%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIV 112
           + L+ +G G  G V         +  A+K +     + T  ++ +RE+ +++  +   I+
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 113 QCFGIFEKPSG-----DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F          D+ I+ME MD+     +          +++++  Q+L G+ +LH
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLH 143
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE---RF- 223
              IIHRD+KPSN++V  ++  +KI DFG+++             GT   M PE   R+ 
Sbjct: 144 SAGIIHRDLKPSNIVV-KSDCTLKILDFGLART-----------AGTSFMMEPEVVTRYY 191
Query: 224 -DPDXXXXXXXXXXXDIWS 241
             P+           DIWS
Sbjct: 192 RAPEVILGMGYKENVDIWS 210

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 75/164 (45%), Gaps = 7/164 (4%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHK---IYALKVVHGD--ADPTVRRQVFREMEI 102
           I   DL  L+ LG G+ G V + +           A+K +  D  + P       RE+  
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 74
Query: 103 LRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
           +   D   +++ +G+   P   +   +  + S  LD L    G F    L+  A Q+ +G
Sbjct: 75  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGS-LLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD 206
           + YL   + IHRD+   NLL+   ++ VKI DFG+ + + ++ D
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDD 176

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/272 (22%), Positives = 115/272 (42%), Gaps = 29/272 (10%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALK-VVHGDADPTVR-----RQVFREME 101
           +A +++E  + +G G  G V+K +      + A+K ++ GD++         ++  RE+ 
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 102 ILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQIL 160
           I+   + P IV+ +G+   P     ++ME++  G L   LL+K           +   I 
Sbjct: 76  IMSNLNHPNIVKLYGLMHNPP---RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIA 132
Query: 161 KGLSYLHGHK--IIHRDIKPSNLLV----NNNNMQVKIADFGVSKIMCRSLDACNSYVGT 214
            G+ Y+      I+HRD++  N+ +     N  +  K+ADFG S+   +S+ + +  +G 
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ---QSVHSVSGLLGN 189
Query: 215 CAYMSPERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICF 274
             +M+PE    +           D +S          G  PF        +  +      
Sbjct: 190 FQWMAPETIGAE---EESYTEKADTYSFAMILYTILTGEGPF----DEYSYGKIKFINMI 242
Query: 275 ---GDPPSLPDGASPEFRSFIECCLQKEFSKR 303
              G  P++P+   P  R+ IE C   +  KR
Sbjct: 243 REEGLRPTIPEDCPPRLRNVIELCWSGDPKKR 274

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 77/169 (45%), Gaps = 21/169 (12%)
Query: 50  YSDLEKLQVLGHGNGGTVYK--VQHRCTHKIYALKVVHGDADPTVRRQVFREMEIL-RRT 106
           ++D++   V+G GN G V K  ++        A+K +   A     R    E+E+L +  
Sbjct: 21  WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 80
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN----------------GTFSEP 150
             P I+   G  E   G + + +EY   G L   L K+                 T S  
Sbjct: 81  HHPNIINLLGACEH-RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 139
Query: 151 KLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK 199
           +L H A+ + +G+ YL   + IHR++   N+LV  N +  KIADFG+S+
Sbjct: 140 QLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYV-AKIADFGLSR 187

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 75/152 (49%), Gaps = 16/152 (10%)
Query: 99  EMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDT------LLNKNGTFSEP-- 150
           E++I+    + + + C GI      ++ I+ EYM++ ++        +L+KN T   P  
Sbjct: 93  ELQIITDIKNEYCLTCEGIITN-YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQ 151
Query: 151 KLAHIASQILKGLSYLHGHK-IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN 209
            +  I   +L   SY+H  K I HRD+KPSN+L++ N  +VK++DFG S+ M        
Sbjct: 152 VIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNG-RVKLSDFGESEYMVDK--KIK 208
Query: 210 SYVGTCAYMSPERFDPDXXXXXXXXXXXDIWS 241
              GT  +M PE F  +           DIWS
Sbjct: 209 GSRGTYEFMPPEFFSNE---SSYNGAKVDIWS 237

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 75/164 (45%), Gaps = 7/164 (4%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHK---IYALKVVHGD--ADPTVRRQVFREMEI 102
           I   DL  L+ LG G+ G V + +           A+K +  D  + P       RE+  
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 74
Query: 103 LRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
           +   D   +++ +G+   P   +   +  + S  LD L    G F    L+  A Q+ +G
Sbjct: 75  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGS-LLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD 206
           + YL   + IHRD+   NLL+   ++ VKI DFG+ + + ++ D
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDD 176

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 85/199 (42%), Gaps = 22/199 (11%)
Query: 59  LGHGNGGTVYKVQHRCTHKI-----YALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           LG G+ G VY+   +   K       A+K V+  A    R +   E  +++  +   +V+
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLL-------NKNGTFSEP---KLAHIASQILKGL 163
             G+  +    + ++ME M  G L + L         N   + P   K+  +A +I  G+
Sbjct: 87  LLGVVSQGQPTL-VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 145
Query: 164 SYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF 223
           +YL+ +K +HRD+   N +V   +  VKI DFG    M R +   +        + P R+
Sbjct: 146 AYLNANKFVHRDLAARNCMV-AEDFTVKIGDFG----MTRDIXETDXXRKGGKGLLPVRW 200
Query: 224 -DPDXXXXXXXXXXXDIWS 241
             P+           D+WS
Sbjct: 201 MSPESLKDGVFTTYSDVWS 219

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 114/276 (41%), Gaps = 24/276 (8%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVF-REMEILRRT 106
           I +  LE  +++G G  G VY   H   H   A++++  + D   + + F RE+   R+T
Sbjct: 30  IPFEQLEIGELIGKGRFGQVY---HGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQT 86
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQILKGLSY 165
               +V   G    P   +AI+       TL +++ +        K   IA +I+KG+ Y
Sbjct: 87  RHENVVLFMGACMSPP-HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGY 145
Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKI-----MCRSLDACNSYVGTCAYMSP 220
           LH   I+H+D+K  N+  +N   +V I DFG+  I       R  D      G   +++P
Sbjct: 146 LHAKGILHKDLKSKNVFYDNG--KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203
Query: 221 E---RFDPDXXXXXX-XXXXXDIWSXXXXXXXXXXGHFPF-LQPGQRPDWATLMCAICFG 275
           E   +  PD            D+++            +PF  QP +   W      +  G
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW-----QMGTG 258
Query: 276 DPPSLPD-GASPEFRSFIECCLQKEFSKRWTASQLL 310
             P+L   G   E    +  C   E  +R T ++L+
Sbjct: 259 MKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLM 294

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 86/182 (47%), Gaps = 11/182 (6%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           +A  +     +LG G  G VYK        + A+K +  +       Q   E+E++    
Sbjct: 35  VASDNFSNKNILGRGGFGKVYK-GRLADGTLVAVKRLKEERXQGGELQFQTEVEMISMAV 93
Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGT----FSEPKLAHIASQILKGL 163
              +++  G    P+  + ++  YM +G++ + L +          PK   IA    +GL
Sbjct: 94  HRNLLRLRGFCMTPTERL-LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGL 152
Query: 164 SYLHGH---KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM-CRSLDACNSYVGTCAYMS 219
           +YLH H   KIIHRD+K +N+L+ +   +  + DFG++K+M  +      +  GT  +++
Sbjct: 153 AYLHDHCDPKIIHRDVKAANILL-DEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIA 211
Query: 220 PE 221
           PE
Sbjct: 212 PE 213

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/265 (22%), Positives = 102/265 (38%), Gaps = 24/265 (9%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGD-----ADPTVRRQVFREMEILRRTDSPF-- 110
           +LG G  G+VY       +   A+K V  D      +     +V  E+ +L++  S F  
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           +++    FE+P   + IL        L   + + G   E        Q+L+ + + H   
Sbjct: 75  VIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 134
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
           ++HRDIK  N+L++ N  ++K+ DFG   ++  ++     + GT  Y  PE         
Sbjct: 135 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI----RYH 188
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                   +WS          G  PF       D   +   + F          S E + 
Sbjct: 189 RYHGRSAAVWSLGILLYDMVCGDIPFEH-----DEEIIRGQVFF------RQRVSSECQH 237
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
            I  CL    S R T  ++  HP++
Sbjct: 238 LIRWCLALRPSDRPTFEEIQNHPWM 262

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 75/164 (45%), Gaps = 7/164 (4%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHK---IYALKVVHGD--ADPTVRRQVFREMEI 102
           I   DL  L+ LG G+ G V + +           A+K +  D  + P       RE+  
Sbjct: 9   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 68
Query: 103 LRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
           +   D   +++ +G+   P   +   +  + S  LD L    G F    L+  A Q+ +G
Sbjct: 69  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGS-LLDRLRKHQGHFLLGTLSRYAVQVAEG 127
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD 206
           + YL   + IHRD+   NLL+   ++ VKI DFG+ + + ++ D
Sbjct: 128 MGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDD 170

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 85/199 (42%), Gaps = 22/199 (11%)
Query: 59  LGHGNGGTVYKVQHRCTHKI-----YALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           LG G+ G VY+   +   K       A+K V+  A    R +   E  +++  +   +V+
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLL-------NKNGTFSEP---KLAHIASQILKGL 163
             G+  +    + ++ME M  G L + L         N   + P   K+  +A +I  G+
Sbjct: 78  LLGVVSQGQPTL-VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 136
Query: 164 SYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF 223
           +YL+ +K +HRD+   N +V   +  VKI DFG    M R +   +        + P R+
Sbjct: 137 AYLNANKFVHRDLAARNCMV-AEDFTVKIGDFG----MTRDIXETDXXRKGGKGLLPVRW 191
Query: 224 -DPDXXXXXXXXXXXDIWS 241
             P+           D+WS
Sbjct: 192 MSPESLKDGVFTTYSDVWS 210

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 88/192 (45%), Gaps = 12/192 (6%)
Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
           DL  L+ LG G  G V   + R  + + A+K++   +      +   E +++       +
Sbjct: 10  DLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGS--MSEDEFIEEAKVMMNLSHEKL 66
Query: 112 VQCFGIFEKPSGDIAILMEYMDSG-TLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           VQ +G+  K    I I+ EYM +G  L+ L      F   +L  +   + + + YL   +
Sbjct: 67  VQLYGVCTKQR-PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 125
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDXXX 229
            +HRD+   N LVN+  + VK++DFG+S+ +   LD  + Y  +     P R+  P+   
Sbjct: 126 FLHRDLAARNCLVNDQGV-VKVSDFGLSRYV---LD--DEYTSSRGSKFPVRWSPPEVLM 179
Query: 230 XXXXXXXXDIWS 241
                   DIW+
Sbjct: 180 YSKFSSKSDIWA 191

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 75/164 (45%), Gaps = 7/164 (4%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHK---IYALKVVHGD--ADPTVRRQVFREMEI 102
           I   DL  L+ LG G+ G V + +           A+K +  D  + P       RE+  
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 103 LRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
           +   D   +++ +G+   P   +   +  + S  LD L    G F    L+  A Q+ +G
Sbjct: 65  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGS-LLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD 206
           + YL   + IHRD+   NLL+   ++ VKI DFG+ + + ++ D
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDD 166

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 77/171 (45%), Gaps = 9/171 (5%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGD-----ADPTVRRQVFREMEILRRTDSPF-- 110
           +LG G  G+VY       +   A+K V  D      +     +V  E+ +L++  S F  
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           +++    FE+P   + IL        L   + + G   E        Q+L+ + + H   
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNXG 130
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
           ++HRDIK  N+L++ N  ++K+ DFG   ++  ++     + GT  Y  PE
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPE 179

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 75/164 (45%), Gaps = 7/164 (4%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHK---IYALKVVHGD--ADPTVRRQVFREMEI 102
           I   DL  L+ LG G+ G V + +           A+K +  D  + P       RE+  
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 103 LRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
           +   D   +++ +G+   P   +   +  + S  LD L    G F    L+  A Q+ +G
Sbjct: 65  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGS-LLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD 206
           + YL   + IHRD+   NLL+   ++ VKI DFG+ + + ++ D
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDD 166

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 75/164 (45%), Gaps = 7/164 (4%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHK---IYALKVVHGD--ADPTVRRQVFREMEI 102
           I   DL  L+ LG G+ G V + +           A+K +  D  + P       RE+  
Sbjct: 9   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 68
Query: 103 LRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
           +   D   +++ +G+   P   +   +  + S  LD L    G F    L+  A Q+ +G
Sbjct: 69  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGS-LLDRLRKHQGHFLLGTLSRYAVQVAEG 127
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD 206
           + YL   + IHRD+   NLL+   ++ VKI DFG+ + + ++ D
Sbjct: 128 MGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDD 170

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 75/164 (45%), Gaps = 7/164 (4%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHK---IYALKVVHGD--ADPTVRRQVFREMEI 102
           I   DL  L+ LG G+ G V + +           A+K +  D  + P       RE+  
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 103 LRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
           +   D   +++ +G+   P   +   +  + S  LD L    G F    L+  A Q+ +G
Sbjct: 65  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGS-LLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD 206
           + YL   + IHRD+   NLL+   ++ VKI DFG+ + + ++ D
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDD 166

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/172 (23%), Positives = 82/172 (47%), Gaps = 7/172 (4%)
Query: 55  KLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIVQ 113
           ++  LG G  G VYK     T++  A+K +  +  +  V     RE+ +L+      I++
Sbjct: 38  RITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIE 97
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
              +    +  + ++ EY ++  L   ++KN   S   +     Q++ G+++ H  + +H
Sbjct: 98  LKSVIHH-NHRLHLIFEYAEND-LKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLH 155
Query: 174 RDIKPSNLLVNNNNMQ----VKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
           RD+KP NLL++ ++      +KI DFG+++     +      + T  Y  PE
Sbjct: 156 RDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPE 207

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 88/192 (45%), Gaps = 12/192 (6%)
Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
           DL  L+ LG G  G V   + R  + + A+K++   +      +   E +++       +
Sbjct: 25  DLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGS--MSEDEFIEEAKVMMNLSHEKL 81
Query: 112 VQCFGIFEKPSGDIAILMEYMDSG-TLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           VQ +G+  K    I I+ EYM +G  L+ L      F   +L  +   + + + YL   +
Sbjct: 82  VQLYGVCTKQR-PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 140
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDXXX 229
            +HRD+   N LVN+  + VK++DFG+S+ +    D   S VG+     P R+  P+   
Sbjct: 141 FLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLD--DEETSSVGS---KFPVRWSPPEVLM 194
Query: 230 XXXXXXXXDIWS 241
                   DIW+
Sbjct: 195 YSKFSSKSDIWA 206

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 80/187 (42%), Gaps = 13/187 (6%)
Query: 59  LGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           +G G  G V++  +          A+K        +VR +  +E   +R+ D P IV+  
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 116 GIF-EKPSGDIAILMEYMDSGTLDTLLN-KNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
           G+  E P   + I+ME    G L + L  +  +     L   A Q+   L+YL   + +H
Sbjct: 458 GVITENP---VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVH 514
Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXXXXX 233
           RDI   N+LV+  +  VK+ DFG+S+ M    +    Y  +   +  +   P+       
Sbjct: 515 RDIAARNVLVSATDC-VKLGDFGLSRYM----EDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 234 XXXXDIW 240
               D+W
Sbjct: 570 TSASDVW 576

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/265 (22%), Positives = 102/265 (38%), Gaps = 24/265 (9%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGD-----ADPTVRRQVFREMEILRRTDSPF-- 110
           +LG G  G+VY       +   A+K V  D      +     +V  E+ +L++  S F  
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           +++    FE+P   + IL        L   + + G   E        Q+L+ + + H   
Sbjct: 90  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 149
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
           ++HRDIK  N+L++ N  ++K+ DFG   ++  ++     + GT  Y  PE         
Sbjct: 150 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI----RYH 203
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                   +WS          G  PF       D   +   + F          S E + 
Sbjct: 204 RYHGRSAAVWSLGILLYDMVCGDIPFEH-----DEEIIRGQVFFR------QRVSSECQH 252
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
            I  CL    S R T  ++  HP++
Sbjct: 253 LIRWCLALRPSDRPTFEEIQNHPWM 277

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/265 (22%), Positives = 100/265 (37%), Gaps = 24/265 (9%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGD-----ADPTVRRQVFREMEILRRTDSPF-- 110
           +LG G  G+VY       +   A+K V  D      +     +V  E+ +L++  S F  
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           +++    FE+P   + IL        L   + + G   E        Q+L+ + + H   
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 130
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
           ++HRDIK  N+L++ N  ++K+ DFG   ++  ++     + GT  Y  PE         
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI----RYH 184
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                   +WS          G  PF    +             G         S E + 
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----------IIGGQVFFRQRVSSECQH 233
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
            I  CL    S R T  ++  HP++
Sbjct: 234 LIRWCLALRPSDRPTFEEIQNHPWM 258

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/265 (22%), Positives = 100/265 (37%), Gaps = 24/265 (9%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGD-----ADPTVRRQVFREMEILRRTDSPF-- 110
           +LG G  G+VY       +   A+K V  D      +     +V  E+ +L++  S F  
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           +++    FE+P   + IL        L   + + G   E        Q+L+ + + H   
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 162
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
           ++HRDIK  N+L++ N  ++K+ DFG   ++  ++     + GT  Y  PE         
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI----RYH 216
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                   +WS          G  PF    +             G         S E + 
Sbjct: 217 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----------IIGGQVFFRQRVSSECQH 265
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
            I  CL    S R T  ++  HP++
Sbjct: 266 LIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 73/315 (23%), Positives = 128/315 (40%), Gaps = 60/315 (19%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           IAY++    +V+G+G+ G V++ +   + ++   KV+        +R   RE++I+R   
Sbjct: 40  IAYTNC---KVIGNGSFGVVFQAKLVESDEVAIKKVLQD------KRFKNRELQIMRIVK 90
Query: 108 SPFIVQCFGIFEKPSGD------IAILMEYMDSGTLDTLLNKNGTFSEPK-------LAH 154
            P +V     F   +GD      + +++EY+     +T+   +  +++ K       +  
Sbjct: 91  HPNVVDLKAFFYS-NGDKKDEVFLNLVLEYVP----ETVYRASRHYAKLKQTMPMLLIKL 145
Query: 155 IASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGT 214
              Q+L+ L+Y+H   I HRDIKP NLL++  +  +K+ DFG +KI+    +   S + +
Sbjct: 146 YMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG-EPNVSXICS 204
Query: 215 CAYMSPERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICF 274
             Y +PE                DIWS          G   F  PG+      +      
Sbjct: 205 RYYRAPELI----FGATNYTTNIDIWSTGCVMAELMQGQPLF--PGESGIDQLVEIIKVL 258
Query: 275 GDP---------PSLPDGASPEFR-----------------SFIECCLQKEFSKRWTASQ 308
           G P         P+  +   P+ R                   I   L+   S R TA +
Sbjct: 259 GTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIE 318
Query: 309 LLTHPFLCKNRRSDC 323
            L HPF  + R  + 
Sbjct: 319 ALCHPFFDELRTGEA 333

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/265 (22%), Positives = 102/265 (38%), Gaps = 24/265 (9%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGD-----ADPTVRRQVFREMEILRRTDSPF-- 110
           +LG G  G+VY       +   A+K V  D      +     +V  E+ +L++  S F  
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           +++    FE+P   + IL        L   + + G   E        Q+L+ + + H   
Sbjct: 91  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 150
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
           ++HRDIK  N+L++ N  ++K+ DFG   ++  ++     + GT  Y  PE         
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI----RYH 204
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                   +WS          G  PF       D   +   + F          S E + 
Sbjct: 205 RYHGRSAAVWSLGILLYDMVCGDIPFEH-----DEEIIRGQVFFR------QRVSSECQH 253
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
            I  CL    S R T  ++  HP++
Sbjct: 254 LIRWCLALRPSDRPTFEEIQNHPWM 278

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/265 (22%), Positives = 102/265 (38%), Gaps = 24/265 (9%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGD-----ADPTVRRQVFREMEILRRTDSPF-- 110
           +LG G  G+VY       +   A+K V  D      +     +V  E+ +L++  S F  
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           +++    FE+P   + IL        L   + + G   E        Q+L+ + + H   
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 135
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
           ++HRDIK  N+L++ N  ++K+ DFG   ++  ++     + GT  Y  PE         
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI----RYH 189
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                   +WS          G  PF       D   +   + F          S E + 
Sbjct: 190 RYHGRSAAVWSLGILLYDMVCGDIPFEH-----DEEIIRGQVFFR------QRVSSECQH 238
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
            I  CL    S R T  ++  HP++
Sbjct: 239 LIRWCLALRPSDRPTFEEIQNHPWM 263

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/265 (22%), Positives = 102/265 (38%), Gaps = 24/265 (9%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGD-----ADPTVRRQVFREMEILRRTDSPF-- 110
           +LG G  G+VY       +   A+K V  D      +     +V  E+ +L++  S F  
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           +++    FE+P   + IL        L   + + G   E        Q+L+ + + H   
Sbjct: 75  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 134
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
           ++HRDIK  N+L++ N  ++K+ DFG   ++  ++     + GT  Y  PE         
Sbjct: 135 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI----RYH 188
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                   +WS          G  PF       D   +   + F          S E + 
Sbjct: 189 RYHGRSAAVWSLGILLYDMVCGDIPFEH-----DEEIIRGQVFFR------QRVSSECQH 237
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
            I  CL    S R T  ++  HP++
Sbjct: 238 LIRWCLALRPSDRPTFEEIQNHPWM 262

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 115/277 (41%), Gaps = 39/277 (14%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR---QVF----REMEILRRTDS-P 109
           VLGHG  GT+              + +  + D  V+R   + F    RE+++LR +D  P
Sbjct: 31  VLGHGAEGTI------------VYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHP 78
Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
            +++ F   EK      I +E   +   + +  K+      +   +  Q   GL++LH  
Sbjct: 79  NVIRYFCT-EKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL 137
Query: 170 KIIHRDIKPSNLLVNNNNMQVK----IADFGVSKIMC---RSLDACNSYVGTCAYMSPER 222
            I+HRD+KP N+L++  N   K    I+DFG+ K +     S    +   GT  +++PE 
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 223 FDPDXXXXXXXXXXXDIWSXX-XXXXXXXXGHFPFLQPGQRPDWATLMCAICFGD---PP 278
              D           DI+S           G  PF +  QR   A ++   C  D   P 
Sbjct: 198 LSED--CKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR--QANILLGACSLDCLHPE 253
Query: 279 SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
              D  +   R  IE  +  +  KR +A  +L HPF 
Sbjct: 254 KHEDVIA---RELIEKMIAMDPQKRPSAKHVLKHPFF 287

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 89/199 (44%), Gaps = 26/199 (13%)
Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIV 112
           + L+ +G G  G V         +  A+K +     + T  ++ +RE+ +++  +   I+
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 113 QCFGIFEKPSG-----DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F          D+ I+ME MD+     +          +++++  Q+L G+ +LH
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLH 143
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE---RF- 223
              IIHRD+KPSN++V  ++  +KI DFG+++             GT   M PE   R+ 
Sbjct: 144 SAGIIHRDLKPSNIVV-KSDCTLKILDFGLART-----------AGTSFMMEPEVVTRYY 191
Query: 224 -DPDXXXXXXXXXXXDIWS 241
             P+           D+WS
Sbjct: 192 RAPEVILGMGYKENVDLWS 210

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/265 (22%), Positives = 100/265 (37%), Gaps = 24/265 (9%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGD-----ADPTVRRQVFREMEILRRTDSPF-- 110
           +LG G  G+VY       +   A+K V  D      +     +V  E+ +L++  S F  
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           +++    FE+P   + IL        L   + + G   E        Q+L+ + + H   
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 163
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
           ++HRDIK  N+L++ N  ++K+ DFG   ++  ++     + GT  Y  PE         
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI----RYH 217
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                   +WS          G  PF    +             G         S E + 
Sbjct: 218 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----------IIGGQVFFRQRVSSECQH 266
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
            I  CL    S R T  ++  HP++
Sbjct: 267 LIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/265 (22%), Positives = 102/265 (38%), Gaps = 24/265 (9%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGD-----ADPTVRRQVFREMEILRRTDSPF-- 110
           +LG G  G+VY       +   A+K V  D      +     +V  E+ +L++  S F  
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           +++    FE+P   + IL        L   + + G   E        Q+L+ + + H   
Sbjct: 91  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 150
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
           ++HRDIK  N+L++ N  ++K+ DFG   ++  ++     + GT  Y  PE         
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI----RYH 204
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                   +WS          G  PF       D   +   + F          S E + 
Sbjct: 205 RYHGRSAAVWSLGILLYDMVCGDIPFEH-----DEEIIRGQVFFR------QRVSXECQH 253
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
            I  CL    S R T  ++  HP++
Sbjct: 254 LIRWCLALRPSDRPTFEEIQNHPWM 278

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/265 (22%), Positives = 102/265 (38%), Gaps = 24/265 (9%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGD-----ADPTVRRQVFREMEILRRTDSPF-- 110
           +LG G  G+VY       +   A+K V  D      +     +V  E+ +L++  S F  
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           +++    FE+P   + IL        L   + + G   E        Q+L+ + + H   
Sbjct: 90  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 149
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
           ++HRDIK  N+L++ N  ++K+ DFG   ++  ++     + GT  Y  PE         
Sbjct: 150 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI----RYH 203
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                   +WS          G  PF       D   +   + F          S E + 
Sbjct: 204 RYHGRSAAVWSLGILLYDMVCGDIPFEH-----DEEIIRGQVFFR------QRVSXECQH 252
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
            I  CL    S R T  ++  HP++
Sbjct: 253 LIRWCLALRPSDRPTFEEIQNHPWM 277

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/265 (22%), Positives = 100/265 (37%), Gaps = 24/265 (9%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGD-----ADPTVRRQVFREMEILRRTDSPF-- 110
           +LG G  G+VY       +   A+K V  D      +     +V  E+ +L++  S F  
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           +++    FE+P   + IL        L   + + G   E        Q+L+ + + H   
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 162
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
           ++HRDIK  N+L++ N  ++K+ DFG   ++  ++     + GT  Y  PE         
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI----RYH 216
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                   +WS          G  PF    +             G         S E + 
Sbjct: 217 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----------IIGGQVFFRQRVSSECQH 265
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
            I  CL    S R T  ++  HP++
Sbjct: 266 LIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 22/202 (10%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHK-----IYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           L+ LG G+ G VY+   R   K       A+K V+  A    R +   E  +++      
Sbjct: 22  LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH 81
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLN------KNGTFSEP----KLAHIASQIL 160
           +V+  G+  K    + ++ME M  G L + L       +N     P    ++  +A++I 
Sbjct: 82  VVRLLGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 161 KGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSP 220
            G++YL+  K +HRD+   N +V  ++  VKI DFG    M R +   + Y      + P
Sbjct: 141 DGMAYLNAKKFVHRDLAARNCMV-AHDFTVKIGDFG----MTRDIYETDYYRKGGKGLLP 195
Query: 221 ERF-DPDXXXXXXXXXXXDIWS 241
            R+  P+           D+WS
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWS 217

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/265 (22%), Positives = 102/265 (38%), Gaps = 24/265 (9%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGD-----ADPTVRRQVFREMEILRRTDSPF-- 110
           +LG G  G+VY       +   A+K V  D      +     +V  E+ +L++  S F  
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           +++    FE+P   + IL        L   + + G   E        Q+L+ + + H   
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 162
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
           ++HRDIK  N+L++ N  ++K+ DFG   ++  ++     + GT  Y  PE         
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI----RYH 216
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                   +WS          G  PF       D   +   + F          S E + 
Sbjct: 217 RYHGRSAAVWSLGILLYDMVCGDIPFEH-----DEEIIRGQVFFR------QRVSSECQH 265
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
            I  CL    S R T  ++  HP++
Sbjct: 266 LIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/265 (22%), Positives = 100/265 (37%), Gaps = 24/265 (9%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGD-----ADPTVRRQVFREMEILRRTDSPF-- 110
           +LG G  G+VY       +   A+K V  D      +     +V  E+ +L++  S F  
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           +++    FE+P   + IL        L   + + G   E        Q+L+ + + H   
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 163
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
           ++HRDIK  N+L++ N  ++K+ DFG   ++  ++     + GT  Y  PE         
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI----RYH 217
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                   +WS          G  PF    +             G         S E + 
Sbjct: 218 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----------IIGGQVFFRQRVSSECQH 266
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
            I  CL    S R T  ++  HP++
Sbjct: 267 LIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/265 (22%), Positives = 100/265 (37%), Gaps = 24/265 (9%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGD-----ADPTVRRQVFREMEILRRTDSPF-- 110
           +LG G  G+VY       +   A+K V  D      +     +V  E+ +L++  S F  
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           +++    FE+P   + IL        L   + + G   E        Q+L+ + + H   
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 162
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
           ++HRDIK  N+L++ N  ++K+ DFG   ++  ++     + GT  Y  PE         
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI----RYH 216
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                   +WS          G  PF    +             G         S E + 
Sbjct: 217 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----------IIGGQVFFRQRVSXECQH 265
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
            I  CL    S R T  ++  HP++
Sbjct: 266 LIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/265 (22%), Positives = 102/265 (38%), Gaps = 24/265 (9%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGD-----ADPTVRRQVFREMEILRRTDSPF-- 110
           +LG G  G+VY       +   A+K V  D      +     +V  E+ +L++  S F  
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           +++    FE+P   + IL        L   + + G   E        Q+L+ + + H   
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 169
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
           ++HRDIK  N+L++ N  ++K+ DFG   ++  ++     + GT  Y  PE         
Sbjct: 170 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI----RYH 223
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                   +WS          G  PF       D   +   + F          S E + 
Sbjct: 224 RYHGRSAAVWSLGILLYDMVCGDIPFEH-----DEEIIRGQVFFR------QRVSSECQH 272
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
            I  CL    S R T  ++  HP++
Sbjct: 273 LIRWCLALRPSDRPTFEEIQNHPWM 297

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/265 (22%), Positives = 102/265 (38%), Gaps = 24/265 (9%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGD-----ADPTVRRQVFREMEILRRTDSPF-- 110
           +LG G  G+VY       +   A+K V  D      +     +V  E+ +L++  S F  
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           +++    FE+P   + IL        L   + + G   E        Q+L+ + + H   
Sbjct: 118 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 177
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
           ++HRDIK  N+L++ N  ++K+ DFG   ++  ++     + GT  Y  PE         
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI----RYH 231
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                   +WS          G  PF       D   +   + F          S E + 
Sbjct: 232 RYHGRSAAVWSLGILLYDMVCGDIPFEH-----DEEIIRGQVFFR------QRVSXECQH 280
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
            I  CL    S R T  ++  HP++
Sbjct: 281 LIRWCLALRPSDRPTFEEIQNHPWM 305

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/265 (22%), Positives = 102/265 (38%), Gaps = 24/265 (9%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGD-----ADPTVRRQVFREMEILRRTDSPF-- 110
           +LG G  G+VY       +   A+K V  D      +     +V  E+ +L++  S F  
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           +++    FE+P   + IL        L   + + G   E        Q+L+ + + H   
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 135
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
           ++HRDIK  N+L++ N  ++K+ DFG   ++  ++     + GT  Y  PE         
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI----RYH 189
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                   +WS          G  PF       D   +   + F          S E + 
Sbjct: 190 RYHGRSAAVWSLGILLYDMVCGDIPFEH-----DEEIIRGQVFFR------QRVSSECQH 238
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
            I  CL    S R T  ++  HP++
Sbjct: 239 LIRWCLALRPSDRPTFEEIQNHPWM 263

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/265 (22%), Positives = 100/265 (37%), Gaps = 24/265 (9%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGD-----ADPTVRRQVFREMEILRRTDSPF-- 110
           +LG G  G+VY       +   A+K V  D      +     +V  E+ +L++  S F  
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           +++    FE+P   + IL        L   + + G   E        Q+L+ + + H   
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 163
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
           ++HRDIK  N+L++ N  ++K+ DFG   ++  ++     + GT  Y  PE         
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI----RYH 217
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                   +WS          G  PF    +             G         S E + 
Sbjct: 218 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----------IIGGQVFFRQRVSXECQH 266
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
            I  CL    S R T  ++  HP++
Sbjct: 267 LIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/265 (22%), Positives = 102/265 (38%), Gaps = 24/265 (9%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGD-----ADPTVRRQVFREMEILRRTDSPF-- 110
           +LG G  G+VY       +   A+K V  D      +     +V  E+ +L++  S F  
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           +++    FE+P   + IL        L   + + G   E        Q+L+ + + H   
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 135
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
           ++HRDIK  N+L++ N  ++K+ DFG   ++  ++     + GT  Y  PE         
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI----RYH 189
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                   +WS          G  PF       D   +   + F          S E + 
Sbjct: 190 RYHGRSAAVWSLGILLYDMVCGDIPFEH-----DEEIIRGQVFFR------QRVSSECQH 238
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
            I  CL    S R T  ++  HP++
Sbjct: 239 LIRWCLALRPSDRPTFEEIQNHPWM 263

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/265 (22%), Positives = 100/265 (37%), Gaps = 24/265 (9%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGD-----ADPTVRRQVFREMEILRRTDSPF-- 110
           +LG G  G+VY       +   A+K V  D      +     +V  E+ +L++  S F  
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           +++    FE+P   + IL        L   + + G   E        Q+L+ + + H   
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 163
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
           ++HRDIK  N+L++ N  ++K+ DFG   ++  ++     + GT  Y  PE         
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI----RYH 217
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                   +WS          G  PF    +             G         S E + 
Sbjct: 218 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----------IIGGQVFFRQRVSXECQH 266
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
            I  CL    S R T  ++  HP++
Sbjct: 267 LIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/265 (22%), Positives = 102/265 (38%), Gaps = 24/265 (9%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGD-----ADPTVRRQVFREMEILRRTDSPF-- 110
           +LG G  G+VY       +   A+K V  D      +     +V  E+ +L++  S F  
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           +++    FE+P   + IL        L   + + G   E        Q+L+ + + H   
Sbjct: 118 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 177
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
           ++HRDIK  N+L++ N  ++K+ DFG   ++  ++     + GT  Y  PE         
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI----RYH 231
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                   +WS          G  PF       D   +   + F          S E + 
Sbjct: 232 RYHGRSAAVWSLGILLYDMVCGDIPFEH-----DEEIIRGQVFFR------QRVSSECQH 280
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
            I  CL    S R T  ++  HP++
Sbjct: 281 LIRWCLALRPSDRPTFEEIQNHPWM 305

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/265 (22%), Positives = 102/265 (38%), Gaps = 24/265 (9%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGD-----ADPTVRRQVFREMEILRRTDSPF-- 110
           +LG G  G+VY       +   A+K V  D      +     +V  E+ +L++  S F  
Sbjct: 14  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 73
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           +++    FE+P   + IL        L   + + G   E        Q+L+ + + H   
Sbjct: 74  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 133
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
           ++HRDIK  N+L++ N  ++K+ DFG   ++  ++     + GT  Y  PE         
Sbjct: 134 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI----RYH 187
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                   +WS          G  PF       D   +   + F          S E + 
Sbjct: 188 RYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFF------RQRVSSECQH 236
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
            I  CL    S R T  ++  HP++
Sbjct: 237 LIRWCLALRPSDRPTFEEIQNHPWM 261

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/265 (22%), Positives = 102/265 (38%), Gaps = 24/265 (9%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGD-----ADPTVRRQVFREMEILRRTDSPF-- 110
           +LG G  G+VY       +   A+K V  D      +     +V  E+ +L++  S F  
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           +++    FE+P   + IL        L   + + G   E        Q+L+ + + H   
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 130
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
           ++HRDIK  N+L++ N  ++K+ DFG   ++  ++     + GT  Y  PE         
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI----RYH 184
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                   +WS          G  PF       D   +   + F          S E + 
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFF------RQRVSSECQH 233
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
            I  CL    S R T  ++  HP++
Sbjct: 234 LIRWCLALRPSDRPTFEEIQNHPWM 258

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 77/171 (45%), Gaps = 9/171 (5%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGD-----ADPTVRRQVFREMEILRRTDSPF-- 110
           +LG G  G+VY       +   A+K V  D      +     +V  E+ +L++  S F  
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           +++    FE+P   + IL        L   + + G   E        Q+L+ + + H   
Sbjct: 91  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 150
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
           ++HRDIK  N+L++ N  ++K+ DFG   ++  ++     + GT  Y  PE
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPE 199

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 22/202 (10%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHK-----IYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           L+ LG G+ G VY+   R   K       A+K V+  A    R +   E  +++      
Sbjct: 21  LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH 80
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLN------KNGTFSEP----KLAHIASQIL 160
           +V+  G+  K    + ++ME M  G L + L       +N     P    ++  +A++I 
Sbjct: 81  VVRLLGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 139
Query: 161 KGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSP 220
            G++YL+  K +HRD+   N +V  ++  VKI DFG    M R +   + Y      + P
Sbjct: 140 DGMAYLNAKKFVHRDLAARNCMV-AHDFTVKIGDFG----MTRDIYETDYYRKGGKGLLP 194
Query: 221 ERF-DPDXXXXXXXXXXXDIWS 241
            R+  P+           D+WS
Sbjct: 195 VRWMAPESLKDGVFTTSSDMWS 216

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/265 (22%), Positives = 102/265 (38%), Gaps = 24/265 (9%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGD-----ADPTVRRQVFREMEILRRTDSPF-- 110
           +LG G  G+VY       +   A+K V  D      +     +V  E+ +L++  S F  
Sbjct: 63  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 122
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           +++    FE+P   + IL        L   + + G   E        Q+L+ + + H   
Sbjct: 123 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 182
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
           ++HRDIK  N+L++ N  ++K+ DFG   ++  ++     + GT  Y  PE         
Sbjct: 183 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI----RYH 236
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                   +WS          G  PF       D   +   + F          S E + 
Sbjct: 237 RYHGRSAAVWSLGILLYDMVCGDIPFEH-----DEEIIRGQVFFR------QRVSXECQH 285
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
            I  CL    S R T  ++  HP++
Sbjct: 286 LIRWCLALRPSDRPTFEEIQNHPWM 310

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/265 (22%), Positives = 102/265 (38%), Gaps = 24/265 (9%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGD-----ADPTVRRQVFREMEILRRTDSPF-- 110
           +LG G  G+VY       +   A+K V  D      +     +V  E+ +L++  S F  
Sbjct: 38  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 97
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           +++    FE+P   + IL        L   + + G   E        Q+L+ + + H   
Sbjct: 98  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 157
Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDXXXX 230
           ++HRDIK  N+L++ N  ++K+ DFG   ++  ++     + GT  Y  PE         
Sbjct: 158 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI----RYH 211
Query: 231 XXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                   +WS          G  PF       D   +   + F          S E + 
Sbjct: 212 RYHGRSAAVWSLGILLYDMVCGDIPFEH-----DEEIIRGQVFFR------QRVSXECQH 260
Query: 291 FIECCLQKEFSKRWTASQLLTHPFL 315
            I  CL    S R T  ++  HP++
Sbjct: 261 LIRWCLALRPSDRPTFEEIQNHPWM 285

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 86/216 (39%), Gaps = 28/216 (12%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYK------VQHRCTHKIYALKVVHGDADPTVRRQVFREME 101
           I+ S +  ++ LG    G VYK           T  + A+K +   A+  +R +   E  
Sbjct: 23  ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAV-AIKTLKDKAEGPLREEFRHEAM 81
Query: 102 ILRRTDSPFIVQCFGIFEKPS-----------GDIAILM----EYMDSGTLDTLLNKNGT 146
           +  R   P +V   G+  K             GD+   +     + D G+ D        
Sbjct: 82  LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 141
Query: 147 FSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD 206
              P   H+ +QI  G+ YL  H ++H+D+   N+LV  + + VKI+D G    + R + 
Sbjct: 142 LEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV-YDKLNVKISDLG----LFREVY 196
Query: 207 ACNSYVGTCAYMSPERF-DPDXXXXXXXXXXXDIWS 241
           A + Y      + P R+  P+           DIWS
Sbjct: 197 AADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWS 232

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/269 (22%), Positives = 115/269 (42%), Gaps = 23/269 (8%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALK-VVHGDADPTVR-----RQVFREME 101
           +A +++E  + +G G  G V+K +      + A+K ++ GD++         ++  RE+ 
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 102 ILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQIL 160
           I+   + P IV+ +G+   P     ++ME++  G L   LL+K           +   I 
Sbjct: 76  IMSNLNHPNIVKLYGLMHNPP---RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIA 132
Query: 161 KGLSYLHGHK--IIHRDIKPSNLLV----NNNNMQVKIADFGVSKIMCRSLDACNSYVGT 214
            G+ Y+      I+HRD++  N+ +     N  +  K+ADF +S+   +S+ + +  +G 
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ---QSVHSVSGLLGN 189
Query: 215 CAYMSPERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICF 274
             +M+PE    +           D +S          G  PF +          M     
Sbjct: 190 FQWMAPETIGAE---EESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR-EE 245
Query: 275 GDPPSLPDGASPEFRSFIECCLQKEFSKR 303
           G  P++P+   P  R+ IE C   +  KR
Sbjct: 246 GLRPTIPEDCPPRLRNVIELCWSGDPKKR 274

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 87/202 (43%), Gaps = 22/202 (10%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHK-----IYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           L+ LG G+ G VY+   R   K       A+K V+  A    R +   E  +++      
Sbjct: 22  LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH 81
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLN------KNGTFSEP----KLAHIASQIL 160
           +V+  G+  K    + ++ME M  G L + L       +N     P    ++  +A++I 
Sbjct: 82  VVRLLGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 161 KGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSP 220
            G++YL+  K +HRD+   N +V  ++  VKI DFG    M R +     Y      + P
Sbjct: 141 DGMAYLNAKKFVHRDLAARNCMV-AHDFTVKIGDFG----MTRDIYETAYYRKGGKGLLP 195
Query: 221 ERF-DPDXXXXXXXXXXXDIWS 241
            R+  P+           D+WS
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWS 217

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 86/216 (39%), Gaps = 28/216 (12%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYK------VQHRCTHKIYALKVVHGDADPTVRRQVFREME 101
           I+ S +  ++ LG    G VYK           T  + A+K +   A+  +R +   E  
Sbjct: 6   ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAV-AIKTLKDKAEGPLREEFRHEAM 64
Query: 102 ILRRTDSPFIVQCFGIFEKPS-----------GDIAILM----EYMDSGTLDTLLNKNGT 146
           +  R   P +V   G+  K             GD+   +     + D G+ D        
Sbjct: 65  LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124
Query: 147 FSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD 206
              P   H+ +QI  G+ YL  H ++H+D+   N+LV  + + VKI+D G    + R + 
Sbjct: 125 LEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV-YDKLNVKISDLG----LFREVY 179
Query: 207 ACNSYVGTCAYMSPERF-DPDXXXXXXXXXXXDIWS 241
           A + Y      + P R+  P+           DIWS
Sbjct: 180 AADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWS 215

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 85/182 (46%), Gaps = 11/182 (6%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           +A  +     +LG G  G VYK        + A+K +  +       Q   E+E++    
Sbjct: 27  VASDNFXNKNILGRGGFGKVYK-GRLADGXLVAVKRLKEERTQGGELQFQTEVEMISMAV 85
Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGT----FSEPKLAHIASQILKGL 163
              +++  G    P+  + ++  YM +G++ + L +          PK   IA    +GL
Sbjct: 86  HRNLLRLRGFCMTPTERL-LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGL 144
Query: 164 SYLHGH---KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM-CRSLDACNSYVGTCAYMS 219
           +YLH H   KIIHRD+K +N+L+ +   +  + DFG++K+M  +      +  G   +++
Sbjct: 145 AYLHDHCDPKIIHRDVKAANILL-DEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIA 203
Query: 220 PE 221
           PE
Sbjct: 204 PE 205

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 80/180 (44%), Gaps = 20/180 (11%)
Query: 59  LGHGNGGTVYKVQHRCTHKI--YALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           +G G  G VYK + +       YALK + G     +     RE+ +LR    P ++    
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQK 85
Query: 117 IF-EKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPK--------LAHIASQILKGLSYLH 167
           +F       + +L +Y +      +     + +  K        +  +  QIL G+ YLH
Sbjct: 86  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 168 GHKIIHRDIKPSNLLVNNNNMQ---VKIADFGVSKIM---CRSLDACNSYVGTCAYMSPE 221
            + ++HRD+KP+N+LV     +   VKIAD G +++     + L   +  V T  Y +PE
Sbjct: 146 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 205

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 21/155 (13%)
Query: 57  QVLGHGNGGTVY------KVQHRCTHKIYALKVVHGDADPTVRRQV---FREMEILRRTD 107
           +V+G G+ G VY      + Q+R    I +L  +      T  +QV    RE  ++R  +
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI------TEMQQVEAFLREGLLMRGLN 80
Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLL---NKNGTFSEPKLAHIASQILKGLS 164
            P ++   GI   P G   +L+ YM  G L   +    +N T  +  L     Q+ +G+ 
Sbjct: 81  HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKD--LISFGLQVARGME 138
Query: 165 YLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK 199
           YL   K +HRD+   N ++ + +  VK+ADFG+++
Sbjct: 139 YLAEQKFVHRDLAARNCML-DESFTVKVADFGLAR 172

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 22/210 (10%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHK-----IYALKVVHGDADPTVRRQVFREMEI 102
           ++   +  L+ LG G+ G VY+   R   K       A+K V+  A    R +   E  +
Sbjct: 14  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 103 LRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLN------KNGTFSEP----KL 152
           ++      +V+  G+  K    + ++ME M  G L + L       +N     P    ++
Sbjct: 74  MKGFTCHHVVRLLGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 153 AHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYV 212
             +A++I  G++YL+  K +HRD+   N +V  ++  VKI DFG    M R +   +   
Sbjct: 133 IQMAAEIADGMAYLNAKKFVHRDLAARNCMV-AHDFTVKIGDFG----MTRDIXETDXXR 187
Query: 213 GTCAYMSPERF-DPDXXXXXXXXXXXDIWS 241
                + P R+  P+           D+WS
Sbjct: 188 KGGKGLLPVRWMAPESLKDGVFTTSSDMWS 217

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 87/202 (43%), Gaps = 22/202 (10%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHK-----IYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           L+ LG G+ G VY+   R   K       A+K V+  A    R +   E  +++      
Sbjct: 19  LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH 78
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLN------KNGTFSEP----KLAHIASQIL 160
           +V+  G+  K    + ++ME M  G L + L       +N     P    ++  +A++I 
Sbjct: 79  VVRLLGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 137
Query: 161 KGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSP 220
            G++YL+  K +HRD+   N +V  ++  VKI DFG    M R +   +        + P
Sbjct: 138 DGMAYLNAKKFVHRDLAARNCMV-AHDFTVKIGDFG----MTRDIXETDXXRKGGKGLLP 192
Query: 221 ERF-DPDXXXXXXXXXXXDIWS 241
            R+  P+           D+WS
Sbjct: 193 VRWMAPESLKDGVFTTSSDMWS 214

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 88/202 (43%), Gaps = 22/202 (10%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHK-----IYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           L+ LG G+ G VY+   R   K       A+K V+  A    R +   E  +++      
Sbjct: 22  LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH 81
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLN------KNGTFSEP----KLAHIASQIL 160
           +V+  G+  K    + ++ME M  G L + L       +N     P    ++  +A++I 
Sbjct: 82  VVRLLGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 161 KGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSP 220
            G++YL+  K +HR++   N +V  ++  VKI DFG    M R +   + Y      + P
Sbjct: 141 DGMAYLNAKKFVHRNLAARNCMV-AHDFTVKIGDFG----MTRDIYETDYYRKGGKGLLP 195
Query: 221 ERF-DPDXXXXXXXXXXXDIWS 241
            R+  P+           D+WS
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWS 217

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 87/202 (43%), Gaps = 22/202 (10%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHK-----IYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           L+ LG G+ G VY+   R   K       A+K V+  A    R +   E  +++      
Sbjct: 22  LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH 81
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLN------KNGTFSEP----KLAHIASQIL 160
           +V+  G+  K    + ++ME M  G L + L       +N     P    ++  +A++I 
Sbjct: 82  VVRLLGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 161 KGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSP 220
            G++YL+  K +HRD+   N +V  ++  VKI DFG    M R +   +        + P
Sbjct: 141 DGMAYLNAKKFVHRDLAARNCMV-AHDFTVKIGDFG----MTRDIXETDXXRKGGKGLLP 195
Query: 221 ERF-DPDXXXXXXXXXXXDIWS 241
            R+  P+           D+WS
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWS 217

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 88/202 (43%), Gaps = 22/202 (10%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHK-----IYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           L+ LG G+ G VY+   R   K       A+K V+  A    R +   E  +++      
Sbjct: 23  LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH 82
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLN------KNGTFSEP----KLAHIASQIL 160
           +V+  G+  K    + ++ME M  G L + L       +N     P    ++  +A++I 
Sbjct: 83  VVRLLGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 141
Query: 161 KGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSP 220
            G++YL+  K +HR++   N +V  ++  VKI DFG    M R +   + Y      + P
Sbjct: 142 DGMAYLNAKKFVHRNLAARNCMV-AHDFTVKIGDFG----MTRDIYETDYYRKGGKGLLP 196
Query: 221 ERF-DPDXXXXXXXXXXXDIWS 241
            R+  P+           D+WS
Sbjct: 197 VRWMAPESLKDGVFTTSSDMWS 218

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 83/170 (48%), Gaps = 12/170 (7%)
Query: 60  GHGNGGTVYKVQHRCTHKIYALKVVHGDADPT---VRRQVFREMEILRRTDSPFIVQCFG 116
           G G  G VYK      +   A+K +    D T   +++Q  +E+++  +     +V+  G
Sbjct: 31  GEGGFGVVYK--GYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLG 88
Query: 117 IFEKPSGDIAILMEYMDSGTL-DTLLNKNGT--FSEPKLAHIASQILKGLSYLHGHKIIH 173
            F     D+ ++  Y  +G+L D L   +GT   S      IA     G+++LH +  IH
Sbjct: 89  -FSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHHIH 147
Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC--NSYVGTCAYMSPE 221
           RDIK +N+L+ +     KI+DFG+++   +       +  VGT AY +PE
Sbjct: 148 RDIKSANILL-DEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPE 196

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 76/150 (50%), Gaps = 7/150 (4%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALK-VVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
            ++G G+ G V +   +   ++ A+K ++    D    +++ RE+ IL R +   +V+  
Sbjct: 59  HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVL 118
Query: 116 GIF----EKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
            I      +   ++ +++E  DS     L       +E  +  +   +L G+ Y+H   I
Sbjct: 119 DIVIPKDVEKFDELYVVLEIADSD-FKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGI 177
Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           +HRD+KP+N LV N +  VK+ DFG+++ +
Sbjct: 178 LHRDLKPANCLV-NQDCSVKVCDFGLARTV 206

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 71/149 (47%), Gaps = 5/149 (3%)
Query: 57  QVLGHGNGGTVY--KVQHRCTHKIY-ALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +V+G G+ G VY   +      KI+ A+K ++   D     Q   E  I++    P ++ 
Sbjct: 28  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 87
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
             GI  +  G   +++ YM  G L   + N+    +   L     Q+ KG+ YL   K +
Sbjct: 88  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 147
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           HRD+   N ++ +    VK+ADFG+++ M
Sbjct: 148 HRDLAARNCML-DEKFTVKVADFGLARDM 175

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 71/149 (47%), Gaps = 5/149 (3%)
Query: 57  QVLGHGNGGTVY--KVQHRCTHKIY-ALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +V+G G+ G VY   +      KI+ A+K ++   D     Q   E  I++    P ++ 
Sbjct: 55  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 114
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
             GI  +  G   +++ YM  G L   + N+    +   L     Q+ KG+ YL   K +
Sbjct: 115 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 174
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           HRD+   N ++ +    VK+ADFG+++ M
Sbjct: 175 HRDLAARNCML-DEKFTVKVADFGLARDM 202

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 71/149 (47%), Gaps = 5/149 (3%)
Query: 57  QVLGHGNGGTVY--KVQHRCTHKIY-ALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +V+G G+ G VY   +      KI+ A+K ++   D     Q   E  I++    P ++ 
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
             GI  +  G   +++ YM  G L   + N+    +   L     Q+ KG+ YL   K +
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 154
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           HRD+   N ++ +    VK+ADFG+++ M
Sbjct: 155 HRDLAARNCML-DEKFTVKVADFGLARDM 182

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/219 (22%), Positives = 85/219 (38%), Gaps = 19/219 (8%)
Query: 99  EMEILRRTDSPF--IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIA 156
           E+ +L++  S F  +++    FE+P   + IL        L   + + G   E       
Sbjct: 104 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 163
Query: 157 SQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA 216
            Q+L+ + + H   ++HRDIK  N+L++ N  ++K+ DFG   ++  ++     + GT  
Sbjct: 164 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRV 221
Query: 217 YMSPERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGD 276
           Y  PE                 +WS          G  PF       D   +   + F  
Sbjct: 222 YSPPEWI----RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-----DEEIIRGQVFFR- 271
Query: 277 PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
                   S E +  I  CL    S R T  ++  HP++
Sbjct: 272 -----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 305

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 71/149 (47%), Gaps = 5/149 (3%)
Query: 57  QVLGHGNGGTVY--KVQHRCTHKIY-ALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +V+G G+ G VY   +      KI+ A+K ++   D     Q   E  I++    P ++ 
Sbjct: 54  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 113
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
             GI  +  G   +++ YM  G L   + N+    +   L     Q+ KG+ YL   K +
Sbjct: 114 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 173
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           HRD+   N ++ +    VK+ADFG+++ M
Sbjct: 174 HRDLAARNCML-DEKFTVKVADFGLARDM 201

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 71/149 (47%), Gaps = 5/149 (3%)
Query: 57  QVLGHGNGGTVY--KVQHRCTHKIY-ALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +V+G G+ G VY   +      KI+ A+K ++   D     Q   E  I++    P ++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
             GI  +  G   +++ YM  G L   + N+    +   L     Q+ KG+ YL   K +
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 150
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           HRD+   N ++ +    VK+ADFG+++ M
Sbjct: 151 HRDLAARNCML-DEKFTVKVADFGLARDM 178

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 71/149 (47%), Gaps = 5/149 (3%)
Query: 57  QVLGHGNGGTVY--KVQHRCTHKIY-ALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +V+G G+ G VY   +      KI+ A+K ++   D     Q   E  I++    P ++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
             GI  +  G   +++ YM  G L   + N+    +   L     Q+ KG+ YL   K +
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 155
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           HRD+   N ++ +    VK+ADFG+++ M
Sbjct: 156 HRDLAARNCML-DEKFTVKVADFGLARDM 183

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 71/149 (47%), Gaps = 5/149 (3%)
Query: 57  QVLGHGNGGTVY--KVQHRCTHKIY-ALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +V+G G+ G VY   +      KI+ A+K ++   D     Q   E  I++    P ++ 
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
             GI  +  G   +++ YM  G L   + N+    +   L     Q+ KG+ YL   K +
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 153
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           HRD+   N ++ +    VK+ADFG+++ M
Sbjct: 154 HRDLAARNCML-DEKFTVKVADFGLARDM 181

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 71/149 (47%), Gaps = 5/149 (3%)
Query: 57  QVLGHGNGGTVY--KVQHRCTHKIY-ALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +V+G G+ G VY   +      KI+ A+K ++   D     Q   E  I++    P ++ 
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
             GI  +  G   +++ YM  G L   + N+    +   L     Q+ KG+ YL   K +
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 152
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           HRD+   N ++ +    VK+ADFG+++ M
Sbjct: 153 HRDLAARNCML-DEKFTVKVADFGLARDM 180

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 71/149 (47%), Gaps = 5/149 (3%)
Query: 57  QVLGHGNGGTVY--KVQHRCTHKIY-ALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +V+G G+ G VY   +      KI+ A+K ++   D     Q   E  I++    P ++ 
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
             GI  +  G   +++ YM  G L   + N+    +   L     Q+ KG+ YL   K +
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 154
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           HRD+   N ++ +    VK+ADFG+++ M
Sbjct: 155 HRDLAARNCML-DEKFTVKVADFGLARDM 182

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 71/149 (47%), Gaps = 5/149 (3%)
Query: 57  QVLGHGNGGTVY--KVQHRCTHKIY-ALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +V+G G+ G VY   +      KI+ A+K ++   D     Q   E  I++    P ++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
             GI  +  G   +++ YM  G L   + N+    +   L     Q+ KG+ YL   K +
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 155
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIM 201
           HRD+   N ++ +    VK+ADFG+++ M
Sbjct: 156 HRDLAARNCML-DEKFTVKVADFGLARDM 183

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/186 (24%), Positives = 83/186 (44%), Gaps = 14/186 (7%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIF 118
           LG G  G V+   +    K+    +  G            E  +++      +V+   + 
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA---FLAEANVMKTLQHDKLVKLHAVV 79
Query: 119 EKPSGDIAILMEYMDSGTL-DTLLNKNGTFSE-PKLAHIASQILKGLSYLHGHKIIHRDI 176
            K    I I+ E+M  G+L D L +  G+    PKL   ++QI +G++++     IHRD+
Sbjct: 80  TKEP--IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 137
Query: 177 KPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDXXXXXXXXX 235
           + +N+LV + ++  KIADFG+++++       N Y        P ++  P+         
Sbjct: 138 RAANILV-SASLVCKIADFGLARVI-----EDNEYTAREGAKFPIKWTAPEAINFGSFTI 191
Query: 236 XXDIWS 241
             D+WS
Sbjct: 192 KSDVWS 197

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/190 (24%), Positives = 85/190 (44%), Gaps = 8/190 (4%)
Query: 57  QVLGHGNGGTVY--KVQHRCTHKIY-ALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +V+G G+ G VY   +      KI+ A+K ++   D     Q   E  I++    P ++ 
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
             GI  +  G   +++ YM  G L   + N+    +   L     Q+ KG+ +L   K +
Sbjct: 97  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 156
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMC-RSLDACNSYVGTCAYMSPERFDPDXXXXX 231
           HRD+   N ++ +    VK+ADFG+++ M  +  D+ ++  G  A +  +    +     
Sbjct: 157 HRDLAARNCML-DEKFTVKVADFGLARDMLDKEFDSVHNKTG--AKLPVKWMALESLQTQ 213
Query: 232 XXXXXXDIWS 241
                 D+WS
Sbjct: 214 KFTTKSDVWS 223

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/298 (22%), Positives = 123/298 (41%), Gaps = 48/298 (16%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKV----VHGDADP-TVRRQVFREMEILRR 105
           ++  +L+ +G G  G+V+K   R    IYA+K     + G  D     R+V+    + + 
Sbjct: 7   TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 66
Query: 106 TDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN----GTFSEPKLAHIASQILK 161
           +    +V+ F  + +    + I  EY + G+L   +++N      F E +L  +  Q+ +
Sbjct: 67  S---HVVRYFSAWAE-DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 122
Query: 162 GLSYLHGHKIIHRDIKPSNLLVN------------------NNNMQVKIADFG-VSKIMC 202
           GL Y+H   ++H DIKPSN+ ++                  +N +  KI D G V++I  
Sbjct: 123 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 182
Query: 203 RSLDACNSYVGTCAYMSPERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQR 262
             ++      G   +++ E    +           DI++          G  P  + G +
Sbjct: 183 PQVEE-----GDSRFLANEVLQEN----YTHLPKADIFA-LALTVVXAAGAEPLPRNGDQ 232
Query: 263 PDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR 320
             W      I  G  P +P   S EF   ++  +  +  +R +A  L+ H  L    R
Sbjct: 233 --WHE----IRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 284

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/151 (23%), Positives = 79/151 (52%), Gaps = 9/151 (5%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRR-TDSP 109
            D + ++ LG G    V++  +   ++   +K++     P  + ++ RE++IL      P
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL----KPVKKNKIKREIKILENLRGGP 92
Query: 110 FIVQCFGIFEKP-SGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
            I+    I + P S   A++ E++++     L     T ++  +     +ILK L Y H 
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHS 149
Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK 199
             I+HRD+KP N+++++ + ++++ D+G+++
Sbjct: 150 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 180

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/268 (22%), Positives = 105/268 (39%), Gaps = 28/268 (10%)
Query: 58  VLGHGNGGTVYKVQHRCTHKI-YALKV-----VHGDADPTVRRQVFREMEILRRTDS--- 108
           +LG G  GTV+   HR T ++  A+KV     V G +  +       E+ +L +  +   
Sbjct: 38  LLGKGGFGTVF-AGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 109 -PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
            P +++    FE   G + +L   + +  L   + + G   E        Q++  + + H
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCH 156
Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDX 227
              ++HRDIK  N+L++      K+ DFG   ++    +    + GT  Y  PE      
Sbjct: 157 SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD--EPYTDFDGTRVYSPPEWIS--- 211
Query: 228 XXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPE 287
                      +WS          G  PF +     D   L   + F      P   SP+
Sbjct: 212 -RHQYHALPATVWSLGILLYDMVCGDIPFER-----DQEILEAELHF------PAHVSPD 259
Query: 288 FRSFIECCLQKEFSKRWTASQLLTHPFL 315
             + I  CL  + S R +  ++L  P++
Sbjct: 260 CCALIRRCLAPKPSSRPSLEEILLDPWM 287

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/186 (24%), Positives = 83/186 (44%), Gaps = 14/186 (7%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIF 118
           LG G  G V+   +    K+    +  G            E  +++      +V+   + 
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA---FLAEANVMKTLQHDKLVKLHAVV 252
Query: 119 EKPSGDIAILMEYMDSGTL-DTLLNKNGTFSE-PKLAHIASQILKGLSYLHGHKIIHRDI 176
            K    I I+ E+M  G+L D L +  G+    PKL   ++QI +G++++     IHRD+
Sbjct: 253 TKEP--IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 310
Query: 177 KPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PDXXXXXXXXX 235
           + +N+LV + ++  KIADFG+++++       N Y        P ++  P+         
Sbjct: 311 RAANILV-SASLVCKIADFGLARVI-----EDNEYTAREGAKFPIKWTAPEAINFGSFTI 364
Query: 236 XXDIWS 241
             D+WS
Sbjct: 365 KSDVWS 370

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/190 (24%), Positives = 85/190 (44%), Gaps = 8/190 (4%)
Query: 57  QVLGHGNGGTVY--KVQHRCTHKIY-ALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +V+G G+ G VY   +      KI+ A+K ++   D     Q   E  I++    P ++ 
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
             GI  +  G   +++ YM  G L   + N+    +   L     Q+ KG+ +L   K +
Sbjct: 97  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 156
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMC-RSLDACNSYVGTCAYMSPERFDPDXXXXX 231
           HRD+   N ++ +    VK+ADFG+++ M  +  D+ ++  G  A +  +    +     
Sbjct: 157 HRDLAARNCML-DEKFTVKVADFGLARDMYDKEFDSVHNKTG--AKLPVKWMALESLQTQ 213
Query: 232 XXXXXXDIWS 241
                 D+WS
Sbjct: 214 KFTTKSDVWS 223

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/190 (24%), Positives = 85/190 (44%), Gaps = 8/190 (4%)
Query: 57  QVLGHGNGGTVY--KVQHRCTHKIY-ALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +V+G G+ G VY   +      KI+ A+K ++   D     Q   E  I++    P ++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
             GI  +  G   +++ YM  G L   + N+    +   L     Q+ KG+ +L   K +
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 155
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMC-RSLDACNSYVGTCAYMSPERFDPDXXXXX 231
           HRD+   N ++ +    VK+ADFG+++ M  +  D+ ++  G  A +  +    +     
Sbjct: 156 HRDLAARNCML-DEKFTVKVADFGLARDMYDKEFDSVHNKTG--AKLPVKWMALESLQTQ 212
Query: 232 XXXXXXDIWS 241
                 D+WS
Sbjct: 213 KFTTKSDVWS 222

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/190 (24%), Positives = 85/190 (44%), Gaps = 8/190 (4%)
Query: 57  QVLGHGNGGTVY--KVQHRCTHKIY-ALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +V+G G+ G VY   +      KI+ A+K ++   D     Q   E  I++    P ++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
             GI  +  G   +++ YM  G L   + N+    +   L     Q+ KG+ +L   K +
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 155
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMC-RSLDACNSYVGTCAYMSPERFDPDXXXXX 231
           HRD+   N ++ +    VK+ADFG+++ M  +  D+ ++  G  A +  +    +     
Sbjct: 156 HRDLAARNCML-DEKFTVKVADFGLARDMYDKEFDSVHNKTG--AKLPVKWMALESLQTQ 212
Query: 232 XXXXXXDIWS 241
                 D+WS
Sbjct: 213 KFTTKSDVWS 222

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/190 (24%), Positives = 85/190 (44%), Gaps = 8/190 (4%)
Query: 57  QVLGHGNGGTVY--KVQHRCTHKIY-ALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +V+G G+ G VY   +      KI+ A+K ++   D     Q   E  I++    P ++ 
Sbjct: 41  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 100
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
             GI  +  G   +++ YM  G L   + N+    +   L     Q+ KG+ +L   K +
Sbjct: 101 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 160
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMC-RSLDACNSYVGTCAYMSPERFDPDXXXXX 231
           HRD+   N ++ +    VK+ADFG+++ M  +  D+ ++  G  A +  +    +     
Sbjct: 161 HRDLAARNCML-DEKFTVKVADFGLARDMYDKEFDSVHNKTG--AKLPVKWMALESLQTQ 217
Query: 232 XXXXXXDIWS 241
                 D+WS
Sbjct: 218 KFTTKSDVWS 227

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 77/163 (47%), Gaps = 6/163 (3%)
Query: 57  QVLGHGNGGTVY--KVQHRCTHKIY-ALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +V+G G+ G VY   +      KI+ A+K ++   D     Q   E  I++    P ++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
             GI  +  G   +++ YM  G L   + N+    +   L     Q+ KG+ +L   K +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 214
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMC-RSLDACNSYVGT 214
           HRD+   N ++ +    VK+ADFG+++ M  +  D+ ++  G 
Sbjct: 215 HRDLAARNCML-DEKFTVKVADFGLARDMYDKEFDSVHNKTGA 256

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/190 (24%), Positives = 85/190 (44%), Gaps = 8/190 (4%)
Query: 57  QVLGHGNGGTVY--KVQHRCTHKIY-ALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +V+G G+ G VY   +      KI+ A+K ++   D     Q   E  I++    P ++ 
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
             GI  +  G   +++ YM  G L   + N+    +   L     Q+ KG+ +L   K +
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 153
Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMC-RSLDACNSYVGTCAYMSPERFDPDXXXXX 231
           HRD+   N ++ +    VK+ADFG+++ M  +  D+ ++  G  A +  +    +     
Sbjct: 154 HRDLAARNCML-DEKFTVKVADFGLARDMYDKEFDSVHNKTG--AKLPVKWMALESLQTQ 210
Query: 232 XXXXXXDIWS 241
                 D+WS
Sbjct: 211 KFTTKSDVWS 220

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 74/180 (41%), Gaps = 24/180 (13%)
Query: 80  ALKVVHGDADPTVRRQVFREMEILRRTDS-PFIVQCFGIFEKPSGDIAILMEYMDSGTLD 138
           A+K++  DA       +  EME+++       I+   G   +  G + +++EY   G L 
Sbjct: 49  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASKGNLR 107
Query: 139 TLL----------------NKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLL 182
             L                N     S   L   A Q+ +G+ YL   K IHRD+   N+L
Sbjct: 108 EYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 167
Query: 183 VNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF-DPDXXXXXXXXXXXDIWS 241
           V  +N+ +KIADFG    + R +   + Y  T     P ++  P+           D+WS
Sbjct: 168 VTEDNV-MKIADFG----LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 222

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/298 (22%), Positives = 122/298 (40%), Gaps = 48/298 (16%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKV----VHGDADP-TVRRQVFREMEILRR 105
           ++  +L+ +G G  G+V+K   R    IYA+K     + G  D     R+V+    + + 
Sbjct: 9   TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 68
Query: 106 TDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN----GTFSEPKLAHIASQILK 161
           +    +V+ F  + +    + I  EY + G+L   +++N      F E +L  +  Q+ +
Sbjct: 69  S---HVVRYFSAWAE-DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 124
Query: 162 GLSYLHGHKIIHRDIKPSNLLVN------------------NNNMQVKIADFG-VSKIMC 202
           GL Y+H   ++H DIKPSN+ ++                  +N +  KI D G V++I  
Sbjct: 125 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 184
Query: 203 RSLDACNSYVGTCAYMSPERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQR 262
             ++      G   +++ E    +           DI++          G  P  + G +
Sbjct: 185 PQVEE-----GDSRFLANEVLQEN----YTHLPKADIFA-LALTVVCAAGAEPLPRNGDQ 234
Query: 263 PDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR 320
             W      I  G  P +P   S EF   ++  +  +  +R +A  L+ H  L    R
Sbjct: 235 --WHE----IRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 286

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/298 (22%), Positives = 122/298 (40%), Gaps = 48/298 (16%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKV----VHGDADP-TVRRQVFREMEILRR 105
           ++  +L+ +G G  G+V+K   R    IYA+K     + G  D     R+V+    + + 
Sbjct: 9   TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 68
Query: 106 TDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN----GTFSEPKLAHIASQILK 161
           +    +V+ F  + +    + I  EY + G+L   +++N      F E +L  +  Q+ +
Sbjct: 69  S---HVVRYFSAWAE-DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 124
Query: 162 GLSYLHGHKIIHRDIKPSNLLVN------------------NNNMQVKIADFG-VSKIMC 202
           GL Y+H   ++H DIKPSN+ ++                  +N +  KI D G V++I  
Sbjct: 125 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 184
Query: 203 RSLDACNSYVGTCAYMSPERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQR 262
             ++      G   +++ E    +           DI++          G  P  + G +
Sbjct: 185 PQVEE-----GDSRFLANEVLQEN----YTHLPKADIFA-LALTVVCAAGAEPLPRNGDQ 234
Query: 263 PDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR 320
             W      I  G  P +P   S EF   ++  +  +  +R +A  L+ H  L    R
Sbjct: 235 --WHE----IRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 286

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 74/180 (41%), Gaps = 24/180 (13%)
Query: 80  ALKVVHGDADPTVRRQVFREMEILRRTDS-PFIVQCFGIFEKPSGDIAILMEYMDSGTLD 138
           A+K++  DA       +  EME+++       I+   G   +  G + +++EY   G L 
Sbjct: 64  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASKGNLR 122
Query: 139 TLL----------------NKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLL 182
             L                N     S   L   A Q+ +G+ YL   K IHRD+   N+L
Sbjct: 123 EYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 182
Query: 183 VNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF-DPDXXXXXXXXXXXDIWS 241
           V  +N+ +KIADFG    + R +   + Y  T     P ++  P+           D+WS
Sbjct: 183 VTEDNV-MKIADFG----LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 237

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 74/180 (41%), Gaps = 24/180 (13%)
Query: 80  ALKVVHGDADPTVRRQVFREMEILRRTDS-PFIVQCFGIFEKPSGDIAILMEYMDSGTLD 138
           A+K++  DA       +  EME+++       I+   G   +  G + +++EY   G L 
Sbjct: 57  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASKGNLR 115
Query: 139 TLL----------------NKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLL 182
             L                N     S   L   A Q+ +G+ YL   K IHRD+   N+L
Sbjct: 116 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 175
Query: 183 VNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF-DPDXXXXXXXXXXXDIWS 241
           V  +N+ +KIADFG    + R +   + Y  T     P ++  P+           D+WS
Sbjct: 176 VTEDNV-MKIADFG----LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 230

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 74/180 (41%), Gaps = 24/180 (13%)
Query: 80  ALKVVHGDADPTVRRQVFREMEILRRTDS-PFIVQCFGIFEKPSGDIAILMEYMDSGTLD 138
           A+K++  DA       +  EME+++       I+   G   +  G + +++EY   G L 
Sbjct: 53  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASKGNLR 111
Query: 139 TLL----------------NKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLL 182
             L                N     S   L   A Q+ +G+ YL   K IHRD+   N+L
Sbjct: 112 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 171
Query: 183 VNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF-DPDXXXXXXXXXXXDIWS 241
           V  +N+ +KIADFG    + R +   + Y  T     P ++  P+           D+WS
Sbjct: 172 VTEDNV-MKIADFG----LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 226

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/298 (22%), Positives = 122/298 (40%), Gaps = 48/298 (16%)
Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKV----VHGDADP-TVRRQVFREMEILRR 105
           ++  +L+ +G G  G+V+K   R    IYA+K     + G  D     R+V+    + + 
Sbjct: 11  TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70
Query: 106 TDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN----GTFSEPKLAHIASQILK 161
           +    +V+ F  + +    + I  EY + G+L   +++N      F E +L  +  Q+ +
Sbjct: 71  S---HVVRYFSAWAEDD-HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 162 GLSYLHGHKIIHRDIKPSNLLVN------------------NNNMQVKIADFG-VSKIMC 202
           GL Y+H   ++H DIKPSN+ ++                  +N +  KI D G V++I  
Sbjct: 127 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 203 RSLDACNSYVGTCAYMSPERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQR 262
             ++      G   +++ E    +           DI++          G  P  + G +
Sbjct: 187 PQVEE-----GDSRFLANEVLQEN----YTHLPKADIFA-LALTVVCAAGAEPLPRNGDQ 236
Query: 263 PDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR 320
             W      I  G  P +P   S EF   ++  +  +  +R +A  L+ H  L    R
Sbjct: 237 --WHE----IRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 288

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 74/180 (41%), Gaps = 24/180 (13%)
Query: 80  ALKVVHGDADPTVRRQVFREMEILRRTDS-PFIVQCFGIFEKPSGDIAILMEYMDSGTLD 138
           A+K++  DA       +  EME+++       I+   G   +  G + +++EY   G L 
Sbjct: 64  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASKGNLR 122
Query: 139 TLL----------------NKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLL 182
             L                N     S   L   A Q+ +G+ YL   K IHRD+   N+L
Sbjct: 123 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 182
Query: 183 VNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF-DPDXXXXXXXXXXXDIWS 241
           V  +N+ +KIADFG    + R +   + Y  T     P ++  P+           D+WS
Sbjct: 183 VTEDNV-MKIADFG----LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 237

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 74/180 (41%), Gaps = 24/180 (13%)
Query: 80  ALKVVHGDADPTVRRQVFREMEILRRTDS-PFIVQCFGIFEKPSGDIAILMEYMDSGTLD 138
           A+K++  DA       +  EME+++       I+   G   +  G + +++EY   G L 
Sbjct: 56  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASKGNLR 114
Query: 139 TLL----------------NKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLL 182
             L                N     S   L   A Q+ +G+ YL   K IHRD+   N+L
Sbjct: 115 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 174
Query: 183 VNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF-DPDXXXXXXXXXXXDIWS 241
           V  +N+ +KIADFG    + R +   + Y  T     P ++  P+           D+WS
Sbjct: 175 VTEDNV-MKIADFG----LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 229

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 74/180 (41%), Gaps = 24/180 (13%)
Query: 80  ALKVVHGDADPTVRRQVFREMEILRRTDS-PFIVQCFGIFEKPSGDIAILMEYMDSGTLD 138
           A+K++  DA       +  EME+++       I+   G   +  G + +++EY   G L 
Sbjct: 64  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASKGNLR 122
Query: 139 TLL----------------NKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLL 182
             L                N     S   L   A Q+ +G+ YL   K IHRD+   N+L
Sbjct: 123 EYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 182
Query: 183 VNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF-DPDXXXXXXXXXXXDIWS 241
           V  +N+ +KIADFG    + R +   + Y  T     P ++  P+           D+WS
Sbjct: 183 VTEDNV-MKIADFG----LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 237

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 72/147 (48%), Gaps = 8/147 (5%)
Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIF 118
           LG G  G V+   +    K+    +  G            E  +++      +V+   + 
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA---FLAEANVMKTLQHDKLVKLHAVV 246
Query: 119 EKPSGDIAILMEYMDSGTL-DTLLNKNGTFSE-PKLAHIASQILKGLSYLHGHKIIHRDI 176
            K    I I+ E+M  G+L D L +  G+    PKL   ++QI +G++++     IHRD+
Sbjct: 247 TKEP--IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 304
Query: 177 KPSNLLVNNNNMQVKIADFGVSKIMCR 203
           + +N+LV + ++  KIADFG++++  +
Sbjct: 305 RAANILV-SASLVCKIADFGLARVGAK 330

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 74/180 (41%), Gaps = 24/180 (13%)
Query: 80  ALKVVHGDADPTVRRQVFREMEILRRTDS-PFIVQCFGIFEKPSGDIAILMEYMDSGTLD 138
           A+K++  DA       +  EME+++       I+   G   +  G + +++EY   G L 
Sbjct: 105 AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASKGNLR 163
Query: 139 TLL----------------NKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLL 182
             L                N     S   L   A Q+ +G+ YL   K IHRD+   N+L
Sbjct: 164 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 223
Query: 183 VNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF-DPDXXXXXXXXXXXDIWS 241
           V  +N+ +KIADFG    + R +   + Y  T     P ++  P+           D+WS
Sbjct: 224 VTEDNV-MKIADFG----LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 278

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 85/210 (40%), Gaps = 22/210 (10%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQ-----HRCTHKIYALKVVHGDADPTVRRQVFREMEI 102
           +   ++  ++ LGHG  G VY+ Q     +  +    A+K +              E  I
Sbjct: 27  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 86
Query: 103 LRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-------GTFSEPKLAHI 155
           + + +   IV+C G+  + S    ILME M  G L + L +         + +   L H+
Sbjct: 87  ISKFNHQNIVRCIGVSLQ-SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 156 ASQILKGLSYLHGHKIIHRDIKPSNLLVN--NNNMQVKIADFGVSKIMCRSLDACNSYV- 212
           A  I  G  YL  +  IHRDI   N L+         KI DFG+++ + R+     SY  
Sbjct: 146 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-----SYYR 200
Query: 213 -GTCAYMSPERFDPDXXXXXXXXXXXDIWS 241
            G CA +  +   P+           D WS
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWS 230

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/173 (31%), Positives = 82/173 (47%), Gaps = 12/173 (6%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGI 117
           ++GHG  G VYK   R   K+ ALK    ++   +      E+E L     P +V   G 
Sbjct: 46  LIGHGVFGKVYKGVLRDGAKV-ALKRRTPESSQGIEEFE-TEIETLSFCRHPHLVSLIG- 102
Query: 118 FEKPSGDIAILMEYMDSGTLDTLLNKNG----TFSEPKLAHIASQILKGLSYLHGHKIIH 173
           F     ++ ++ +YM++G L   L  +     + S  +   I     +GL YLH   IIH
Sbjct: 103 FCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIH 162
Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYV---GTCAYMSPERF 223
           RD+K  N+L++ N +  KI DFG+SK     LD  +      GT  Y+ PE F
Sbjct: 163 RDVKSINILLDENFVP-KITDFGISK-KGTELDQTHLXXVVKGTLGYIDPEYF 213

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 85/193 (44%), Gaps = 30/193 (15%)
Query: 54  EKLQVLGHGNGGTVYK-VQHRCTHKIYALKVVHG-DADPTVRRQVFREMEILRRTDSPFI 111
           E +  LG G  G V + + H+   +  A+K+V   D      R   + +E L  TD    
Sbjct: 17  EIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNST 76
Query: 112 VQCFGIFE--KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHI---ASQILKGLSYL 166
            +C  + E  +  G I I+ E +   T D  + +NG F   +L HI   A QI K +++L
Sbjct: 77  FRCVQMLEWFEHHGHICIVFELLGLSTYD-FIKENG-FLPFRLDHIRKMAYQICKSVNFL 134
Query: 167 HGHKIIHRDIKPSNLLVNNN------------------NMQVKIADFGVSKIMCRSLDAC 208
           H +K+ H D+KP N+L   +                  N  +K+ DFG +       +  
Sbjct: 135 HSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY---DDEHH 191
Query: 209 NSYVGTCAYMSPE 221
           ++ V T  Y +PE
Sbjct: 192 STLVSTRHYRAPE 204

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 84/206 (40%), Gaps = 22/206 (10%)
Query: 52  DLEKLQVLGHGNGGTVYKVQ-----HRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT 106
           ++  ++ LGHG  G VY+ Q     +  +    A+K +              E  I+ + 
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 105
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-------GTFSEPKLAHIASQI 159
           +   IV+C G+  + S    ILME M  G L + L +         + +   L H+A  I
Sbjct: 106 NHQNIVRCIGVSLQ-SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 164
Query: 160 LKGLSYLHGHKIIHRDIKPSNLLVN--NNNMQVKIADFGVSKIMCRSLDACNSYV--GTC 215
             G  YL  +  IHRDI   N L+         KI DFG+++ + R+     SY   G C
Sbjct: 165 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-----SYYRKGGC 219
Query: 216 AYMSPERFDPDXXXXXXXXXXXDIWS 241
           A +  +   P+           D WS
Sbjct: 220 AMLPVKWMPPEAFMEGIFTSKTDTWS 245

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 62/137 (45%), Gaps = 19/137 (13%)
Query: 80  ALKVVHGDADPTVRRQVFREMEILRRTDS-PFIVQCFGIFEKPSGDIAILMEYMDSGTLD 138
           A+K++  DA       +  EME+++       I+   G   +  G + +++EY   G L 
Sbjct: 64  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASKGNLR 122
Query: 139 TLL----------------NKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLL 182
             L                N     S   L   A Q+ +G+ YL   K IHRD+   N+L
Sbjct: 123 EYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 182
Query: 183 VNNNNMQVKIADFGVSK 199
           V  +N+ +KIADFG+++
Sbjct: 183 VTEDNV-MKIADFGLAR 198

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 93/220 (42%), Gaps = 36/220 (16%)
Query: 52  DLEKLQVLGHGNGG-----TVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT 106
           +LE  +VLG G  G     T Y +         A+K++   AD + R  +  E++++ + 
Sbjct: 46  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 105
Query: 107 DS-PFIVQCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAH---------- 154
            S   IV   G     SG I ++ EY   G L + L +K   FSE ++ +          
Sbjct: 106 GSHENIVNLLGAC-TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 155 ------------IASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IM 201
                        A Q+ KG+ +L     +HRD+   N+LV +  + VKI DFG+++ IM
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV-VKICDFGLARDIM 223
Query: 202 CRSLDACNSYVGTCAYMSPERFDPDXXXXXXXXXXXDIWS 241
             S    N  V   A +  +   P+           D+WS
Sbjct: 224 SDS----NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWS 259

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 84/209 (40%), Gaps = 28/209 (13%)
Query: 52  DLEKLQVLGHGNGGTVYKVQ--------HRCTHKIYALKVVHGDADPTVRRQVFREMEIL 103
           ++  ++ LGHG  G VY+ Q              +  L  V+ + D         E  I+
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQD---ELDFLMEALII 102
Query: 104 RRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-------GTFSEPKLAHIA 156
            + +   IV+C G+  + S    IL+E M  G L + L +         + +   L H+A
Sbjct: 103 SKFNHQNIVRCIGVSLQ-SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 161
Query: 157 SQILKGLSYLHGHKIIHRDIKPSNLLVN--NNNMQVKIADFGVSKIMCRSLDACNSYV-- 212
             I  G  YL  +  IHRDI   N L+         KI DFG+++ + R+     SY   
Sbjct: 162 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-----SYYRK 216
Query: 213 GTCAYMSPERFDPDXXXXXXXXXXXDIWS 241
           G CA +  +   P+           D WS
Sbjct: 217 GGCAMLPVKWMPPEAFMEGIFTSKTDTWS 245

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 84/175 (48%), Gaps = 16/175 (9%)
Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGI 117
           ++GHG  G VYK   R   K+ ALK    ++   +      E+E L     P +V   G 
Sbjct: 46  LIGHGVFGKVYKGVLRDGAKV-ALKRRTPESSQGIEEFE-TEIETLSFCRHPHLVSLIG- 102
Query: 118 FEKPSGDIAILMEYMDSGTLDTLLNKNG----TFSEPKLAHIASQILKGLSYLHGHKIIH 173
           F     ++ ++ +YM++G L   L  +     + S  +   I     +GL YLH   IIH
Sbjct: 103 FCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIH 162
Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYV-----GTCAYMSPERF 223
           RD+K  N+L++ N +  KI DFG+SK   +  +   +++     GT  Y+ PE F
Sbjct: 163 RDVKSINILLDENFVP-KITDFGISK---KGTELGQTHLXXVVKGTLGYIDPEYF 213

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 84/208 (40%), Gaps = 29/208 (13%)
Query: 49  AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS 108
           A+  + +    G G    V KV         A+K++   A    +  +  E++I+     
Sbjct: 58  AFGKVVEATAFGLGKEDAVLKV---------AVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 109 -PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK--------------NGTFSEPKLA 153
              IV   G      G + ++ EY   G L   L +              N T S   L 
Sbjct: 109 HENIVNLLGACTH-GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLL 167
Query: 154 HIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVG 213
           H +SQ+ +G+++L     IHRD+   N+L+ N ++  KI DFG+++ +   ++  N  V 
Sbjct: 168 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV-AKIGDFGLARDI---MNDSNYIVK 223
Query: 214 TCAYMSPERFDPDXXXXXXXXXXXDIWS 241
             A +  +   P+           D+WS
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWS 251

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 87/191 (45%), Gaps = 27/191 (14%)
Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH--GDADPTVRRQVFREMEILRRTDSP 109
           +L+ L+++G G  G VYK       +  A+KV       +    + ++R   +     + 
Sbjct: 14  NLKLLELIGRGRYGAVYK--GSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIAR 71
Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGT--FSEPKLAHIASQILKGLSYLH 167
           FIV    +      +  ++MEY  +G+L   L+ + +   S  +LAH    + +GL+YLH
Sbjct: 72  FIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAH---SVTRGLAYLH 128
Query: 168 GH---------KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC--------RSLDACNS 210
                       I HRD+   N+LV N+   V I+DFG+S  +            +A  S
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCV-ISDFGLSMRLTGNRLVRPGEEDNAAIS 187
Query: 211 YVGTCAYMSPE 221
            VGT  YM+PE
Sbjct: 188 EVGTIRYMAPE 198

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 84/206 (40%), Gaps = 22/206 (10%)
Query: 52  DLEKLQVLGHGNGGTVYKVQ-----HRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT 106
           ++  ++ LGHG  G VY+ Q     +  +    A+K +              E  I+ + 
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKL 105
Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-------GTFSEPKLAHIASQI 159
           +   IV+C G+  + S    IL+E M  G L + L +         + +   L H+A  I
Sbjct: 106 NHQNIVRCIGVSLQ-SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 164
Query: 160 LKGLSYLHGHKIIHRDIKPSNLLVN--NNNMQVKIADFGVSKIMCRSLDACNSYV--GTC 215
             G  YL  +  IHRDI   N L+         KI DFG+++ + R+     SY   G C
Sbjct: 165 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-----SYYRKGGC 219
Query: 216 AYMSPERFDPDXXXXXXXXXXXDIWS 241
           A +  +   P+           D WS
Sbjct: 220 AMLPVKWMPPEAFMEGIFTSKTDTWS 245

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 83/210 (39%), Gaps = 35/210 (16%)
Query: 59  LGHGNGGTVYKVQHRCTHK-------IYALKVVHGDADPTVRRQVFREMEILRRTDS-PF 110
           LG G  G V   +     K         A+K++  DA       +  EME+++       
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLL------------------NKNGTFSEPKL 152
           I+   G   +  G + +++EY   G L   L                   +  TF +  L
Sbjct: 103 IINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD--L 159
Query: 153 AHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYV 212
                Q+ +G+ YL   K IHRD+   N+LV  NN+ +KIADFG    + R ++  + Y 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV-MKIADFG----LARDINNIDYYK 214
Query: 213 GTCAYMSPERF-DPDXXXXXXXXXXXDIWS 241
            T     P ++  P+           D+WS
Sbjct: 215 NTTNGRLPVKWMAPEALFDRVYTHQSDVWS 244

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 85/210 (40%), Gaps = 22/210 (10%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQ-----HRCTHKIYALKVVHGDADPTVRRQVFREMEI 102
           +   ++  ++ LGHG  G VY+ Q     +  +    A+K +              E  I
Sbjct: 19  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 78
Query: 103 LRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-------GTFSEPKLAHI 155
           + + +   IV+C G+  + S    IL+E M  G L + L +         + +   L H+
Sbjct: 79  ISKFNHQNIVRCIGVSLQ-SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 137
Query: 156 ASQILKGLSYLHGHKIIHRDIKPSNLLVN--NNNMQVKIADFGVSKIMCRSLDACNSYV- 212
           A  I  G  YL  +  IHRDI   N L+         KI DFG+++ + R+     SY  
Sbjct: 138 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-----SYYR 192
Query: 213 -GTCAYMSPERFDPDXXXXXXXXXXXDIWS 241
            G CA +  +   P+           D WS
Sbjct: 193 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWS 222

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 85/210 (40%), Gaps = 22/210 (10%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQ-----HRCTHKIYALKVVHGDADPTVRRQVFREMEI 102
           +   ++  ++ LGHG  G VY+ Q     +  +    A+K +              E  I
Sbjct: 27  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 86
Query: 103 LRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-------GTFSEPKLAHI 155
           + + +   IV+C G+  + S    IL+E M  G L + L +         + +   L H+
Sbjct: 87  ISKFNHQNIVRCIGVSLQ-SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 156 ASQILKGLSYLHGHKIIHRDIKPSNLLVN--NNNMQVKIADFGVSKIMCRSLDACNSYV- 212
           A  I  G  YL  +  IHRDI   N L+         KI DFG+++ + R+     SY  
Sbjct: 146 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-----SYYR 200
Query: 213 -GTCAYMSPERFDPDXXXXXXXXXXXDIWS 241
            G CA +  +   P+           D WS
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWS 230

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 80/199 (40%), Gaps = 22/199 (11%)
Query: 59  LGHGNGGTVYKVQ-----HRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           LGHG  G VY+ Q     +  +    A+K +              E  I+ + +   IV+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-------GTFSEPKLAHIASQILKGLSYL 166
           C G+  + S    IL+E M  G L + L +         + +   L H+A  I  G  YL
Sbjct: 99  CIGVSLQ-SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 167 HGHKIIHRDIKPSNLLVN--NNNMQVKIADFGVSKIMCRSLDACNSYV--GTCAYMSPER 222
             +  IHRDI   N L+         KI DFG+++ + R+     SY   G CA +  + 
Sbjct: 158 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-----SYYRKGGCAMLPVKW 212
Query: 223 FDPDXXXXXXXXXXXDIWS 241
             P+           D WS
Sbjct: 213 MPPEAFMEGIFTSKTDTWS 231

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 75/168 (44%), Gaps = 27/168 (16%)
Query: 54  EKLQVLGHGNGGTVYK-VQHRCTHKIYALKVVHG-DADPTVRRQVFREMEILRRTDSPFI 111
           E +  LG G  G V + + H+   +  A+K+V   D      R   + +E L  TD    
Sbjct: 17  EIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNST 76
Query: 112 VQCFGIFE--KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHI---ASQILKGLSYL 166
            +C  + E  +  G I I+ E +   T D  + +NG F   +L HI   A QI K +++L
Sbjct: 77  FRCVQMLEWFEHHGHICIVFELLGLSTYD-FIKENG-FLPFRLDHIRKMAYQICKSVNFL 134
Query: 167 HGHKIIHRDIKPSNLLVNNN------------------NMQVKIADFG 196
           H +K+ H D+KP N+L   +                  N  +K+ DFG
Sbjct: 135 HSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 77/182 (42%), Gaps = 28/182 (15%)
Query: 80  ALKVVHGDADPTVRRQVFREMEILRRTDS-PFIVQCFGIFEKPSGDIAILMEYMDSGTLD 138
           A+K++  DA       +  EME+++       I+   G   +  G + +++EY   G L 
Sbjct: 58  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASKGNLR 116
Query: 139 TLL------------------NKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSN 180
             L                   +  TF +  L     Q+ +G+ YL   K IHRD+   N
Sbjct: 117 EYLRARRPPGMEYSYDINRVPEEQMTFKD--LVSCTYQLARGMEYLASQKCIHRDLTARN 174
Query: 181 LLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF-DPDXXXXXXXXXXXDI 239
           +LV  NN+ +KIADFG++    R ++  + Y  T     P ++  P+           D+
Sbjct: 175 VLVTENNV-MKIADFGLA----RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 229
Query: 240 WS 241
           WS
Sbjct: 230 WS 231

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 76/182 (41%), Gaps = 28/182 (15%)
Query: 80  ALKVVHGDADPTVRRQVFREMEILRRTDS-PFIVQCFGIFEKPSGDIAILMEYMDSGTLD 138
           A+K++  DA       +  EME+++       I+   G   +  G + +++EY   G L 
Sbjct: 117 AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASKGNLR 175
Query: 139 TLL------------------NKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSN 180
             L                   +  TF +  L     Q+ +G+ YL   K IHRD+   N
Sbjct: 176 EYLRARRPPGMEYSYDINRVPEEQMTFKD--LVSCTYQLARGMEYLASQKCIHRDLAARN 233
Query: 181 LLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF-DPDXXXXXXXXXXXDI 239
           +LV  NN+ +KIADFG    + R ++  + Y  T     P ++  P+           D+
Sbjct: 234 VLVTENNV-MKIADFG----LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 288
Query: 240 WS 241
           WS
Sbjct: 289 WS 290

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 83/210 (39%), Gaps = 35/210 (16%)
Query: 59  LGHGNGGTVYKVQHRCTHK-------IYALKVVHGDADPTVRRQVFREMEILRRTDS-PF 110
           LG G  G V   +     K         A+K++  DA       +  EME+++       
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLL------------------NKNGTFSEPKL 152
           I+   G   +  G + +++EY   G L   L                   +  TF +  L
Sbjct: 103 IINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD--L 159
Query: 153 AHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYV 212
                Q+ +G+ YL   K IHRD+   N+LV  NN+ +KIADFG    + R ++  + Y 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV-MKIADFG----LARDINNIDYYK 214
Query: 213 GTCAYMSPERF-DPDXXXXXXXXXXXDIWS 241
            T     P ++  P+           D+WS
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWS 244

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 83/210 (39%), Gaps = 35/210 (16%)
Query: 59  LGHGNGGTVYKVQHRCTHK-------IYALKVVHGDADPTVRRQVFREMEILRRTDS-PF 110
           LG G  G V   +     K         A+K++  DA       +  EME+++       
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLL------------------NKNGTFSEPKL 152
           I+   G   +  G + +++EY   G L   L                   +  TF +  L
Sbjct: 103 IIHLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD--L 159
Query: 153 AHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYV 212
                Q+ +G+ YL   K IHRD+   N+LV  NN+ +KIADFG    + R ++  + Y 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV-MKIADFG----LARDINNIDYYK 214
Query: 213 GTCAYMSPERF-DPDXXXXXXXXXXXDIWS 241
            T     P ++  P+           D+WS
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWS 244

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 77/182 (42%), Gaps = 28/182 (15%)
Query: 80  ALKVVHGDADPTVRRQVFREMEILRRTDS-PFIVQCFGIFEKPSGDIAILMEYMDSGTLD 138
           A+K++  DA       +  EME+++       I+   G   +  G + +++EY   G L 
Sbjct: 60  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASKGNLR 118
Query: 139 TLL------------------NKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSN 180
             L                   +  TF +  L     Q+ +G+ YL   K IHRD+   N
Sbjct: 119 EYLRARRPPGMEYSYDINRVPEEQMTFKD--LVSCTYQLARGMEYLASQKCIHRDLAARN 176
Query: 181 LLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF-DPDXXXXXXXXXXXDI 239
           +LV  NN+ +KIADFG++    R ++  + Y  T     P ++  P+           D+
Sbjct: 177 VLVTENNV-MKIADFGLA----RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 231
Query: 240 WS 241
           WS
Sbjct: 232 WS 233

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 80/199 (40%), Gaps = 22/199 (11%)
Query: 59  LGHGNGGTVYKVQ-----HRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           LGHG  G VY+ Q     +  +    A+K +              E  I+ + +   IV+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-------GTFSEPKLAHIASQILKGLSYL 166
           C G+  + S    IL+E M  G L + L +         + +   L H+A  I  G  YL
Sbjct: 115 CIGVSLQ-SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 173
Query: 167 HGHKIIHRDIKPSNLLVN--NNNMQVKIADFGVSKIMCRSLDACNSYV--GTCAYMSPER 222
             +  IHRDI   N L+         KI DFG+++ + R+     SY   G CA +  + 
Sbjct: 174 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-----SYYRKGGCAMLPVKW 228
Query: 223 FDPDXXXXXXXXXXXDIWS 241
             P+           D WS
Sbjct: 229 MPPEAFMEGIFTSKTDTWS 247

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 83/210 (39%), Gaps = 35/210 (16%)
Query: 59  LGHGNGGTVYKVQHRCTHK-------IYALKVVHGDADPTVRRQVFREMEILRRTDS-PF 110
           LG G  G V   +     K         A+K++  DA       +  EME+++       
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLL------------------NKNGTFSEPKL 152
           I+   G   +  G + +++EY   G L   L                   +  TF +  L
Sbjct: 103 IITLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD--L 159
Query: 153 AHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYV 212
                Q+ +G+ YL   K IHRD+   N+LV  NN+ +KIADFG    + R ++  + Y 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV-MKIADFG----LARDINNIDYYK 214
Query: 213 GTCAYMSPERF-DPDXXXXXXXXXXXDIWS 241
            T     P ++  P+           D+WS
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWS 244

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 85/210 (40%), Gaps = 22/210 (10%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQ-----HRCTHKIYALKVVHGDADPTVRRQVFREMEI 102
           +   ++  ++ LGHG  G VY+ Q     +  +    A+K +              E  I
Sbjct: 28  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 87
Query: 103 LRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-------GTFSEPKLAHI 155
           + + +   IV+C G+  + S    IL+E M  G L + L +         + +   L H+
Sbjct: 88  ISKFNHQNIVRCIGVSLQ-SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 146
Query: 156 ASQILKGLSYLHGHKIIHRDIKPSNLLVN--NNNMQVKIADFGVSKIMCRSLDACNSYV- 212
           A  I  G  YL  +  IHRDI   N L+         KI DFG+++ + R+     SY  
Sbjct: 147 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-----SYYR 201
Query: 213 -GTCAYMSPERFDPDXXXXXXXXXXXDIWS 241
            G CA +  +   P+           D WS
Sbjct: 202 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWS 231

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 77/182 (42%), Gaps = 28/182 (15%)
Query: 80  ALKVVHGDADPTVRRQVFREMEILRRTDS-PFIVQCFGIFEKPSGDIAILMEYMDSGTLD 138
           A+K++  DA       +  EME+++       I+   G   +  G + +++EY   G L 
Sbjct: 63  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASKGNLR 121
Query: 139 TLL------------------NKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSN 180
             L                   +  TF +  L     Q+ +G+ YL   K IHRD+   N
Sbjct: 122 EYLRARRPPGMEYSYDINRVPEEQMTFKD--LVSCTYQLARGMEYLASQKCIHRDLAARN 179
Query: 181 LLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF-DPDXXXXXXXXXXXDI 239
           +LV  NN+ +KIADFG++    R ++  + Y  T     P ++  P+           D+
Sbjct: 180 VLVTENNV-MKIADFGLA----RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 234
Query: 240 WS 241
           WS
Sbjct: 235 WS 236

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 78/197 (39%), Gaps = 18/197 (9%)
Query: 59  LGHGNGGTVYKVQ-----HRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           LGHG  G VY+ Q     +  +    A+K +              E  I+ + +   IV+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-------GTFSEPKLAHIASQILKGLSYL 166
           C G+  + S    IL+E M  G L + L +         + +   L H+A  I  G  YL
Sbjct: 125 CIGVSLQ-SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 183
Query: 167 HGHKIIHRDIKPSNLLVN--NNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD 224
             +  IHRDI   N L+         KI DFG+++ + R   A     G CA +  +   
Sbjct: 184 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR---ASYYRKGGCAMLPVKWMP 240
Query: 225 PDXXXXXXXXXXXDIWS 241
           P+           D WS
Sbjct: 241 PEAFMEGIFTSKTDTWS 257

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 87/191 (45%), Gaps = 35/191 (18%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           ++LG+G+ GTV   Q     +  A+K +  D           E+++L  +D    V  + 
Sbjct: 39  KILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCDIA----LMEIKLLTESDDHPNVIRYY 93
Query: 117 IFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAH------IASQILKGLSYLHGHK 170
             E     + I +E  +    D + +KN +    KL        +  QI  G+++LH  K
Sbjct: 94  CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK 153
Query: 171 IIHRDIKPSNLLVNNN------------NMQVKIADFGVSKIMCRSLDA--------CNS 210
           IIHRD+KP N+LV+ +            N+++ I+DFG    +C+ LD+         N+
Sbjct: 154 IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG----LCKKLDSGQXXFRXNLNN 209
Query: 211 YVGTCAYMSPE 221
             GT  + +PE
Sbjct: 210 PSGTSGWRAPE 220

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 80/199 (40%), Gaps = 22/199 (11%)
Query: 59  LGHGNGGTVYKVQ-----HRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           LGHG  G VY+ Q     +  +    A+K +              E  I+ + +   IV+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-------GTFSEPKLAHIASQILKGLSYL 166
           C G+  + S    IL+E M  G L + L +         + +   L H+A  I  G  YL
Sbjct: 105 CIGVSLQ-SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 163
Query: 167 HGHKIIHRDIKPSNLLVN--NNNMQVKIADFGVSKIMCRSLDACNSYV--GTCAYMSPER 222
             +  IHRDI   N L+         KI DFG+++ + R+     SY   G CA +  + 
Sbjct: 164 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-----SYYRKGGCAMLPVKW 218
Query: 223 FDPDXXXXXXXXXXXDIWS 241
             P+           D WS
Sbjct: 219 MPPEAFMEGIFTSKTDTWS 237

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 80/199 (40%), Gaps = 22/199 (11%)
Query: 59  LGHGNGGTVYKVQ-----HRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           LGHG  G VY+ Q     +  +    A+K +              E  I+ + +   IV+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-------GTFSEPKLAHIASQILKGLSYL 166
           C G+  + S    IL+E M  G L + L +         + +   L H+A  I  G  YL
Sbjct: 99  CIGVSLQ-SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 167 HGHKIIHRDIKPSNLLVN--NNNMQVKIADFGVSKIMCRSLDACNSYV--GTCAYMSPER 222
             +  IHRDI   N L+         KI DFG+++ + R+     SY   G CA +  + 
Sbjct: 158 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRA-----SYYRKGGCAMLPVKW 212
Query: 223 FDPDXXXXXXXXXXXDIWS 241
             P+           D WS
Sbjct: 213 MPPEAFMEGIFTSKTDTWS 231

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 87/191 (45%), Gaps = 35/191 (18%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           ++LG+G+ GTV   Q     +  A+K +  D           E+++L  +D    V  + 
Sbjct: 39  KILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCDIA----LMEIKLLTESDDHPNVIRYY 93
Query: 117 IFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAH------IASQILKGLSYLHGHK 170
             E     + I +E  +    D + +KN +    KL        +  QI  G+++LH  K
Sbjct: 94  CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK 153
Query: 171 IIHRDIKPSNLLVNNN------------NMQVKIADFGVSKIMCRSLDA--------CNS 210
           IIHRD+KP N+LV+ +            N+++ I+DFG    +C+ LD+         N+
Sbjct: 154 IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG----LCKKLDSGQXXFRXNLNN 209
Query: 211 YVGTCAYMSPE 221
             GT  + +PE
Sbjct: 210 PSGTSGWRAPE 220

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 84/208 (40%), Gaps = 29/208 (13%)
Query: 49  AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS 108
           A+  + +    G G    V KV         A+K++   A    +  +  E++I+     
Sbjct: 58  AFGKVVEATAFGLGKEDAVLKV---------AVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 109 -PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK--------------NGTFSEPKLA 153
              IV   G      G + ++ EY   G L   L +              N T S   L 
Sbjct: 109 HENIVNLLGACTH-GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 154 HIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVG 213
           H +SQ+ +G+++L     IHRD+   N+L+ N ++  KI DFG+++ +   ++  N  V 
Sbjct: 168 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV-AKIGDFGLARDI---MNDSNYIVK 223
Query: 214 TCAYMSPERFDPDXXXXXXXXXXXDIWS 241
             A +  +   P+           D+WS
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWS 251

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 87/191 (45%), Gaps = 35/191 (18%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           ++LG+G+ GTV   Q     +  A+K +  D           E+++L  +D    V  + 
Sbjct: 21  KILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCDIA----LMEIKLLTESDDHPNVIRYY 75
Query: 117 IFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAH------IASQILKGLSYLHGHK 170
             E     + I +E  +    D + +KN +    KL        +  QI  G+++LH  K
Sbjct: 76  CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK 135
Query: 171 IIHRDIKPSNLLVNNN------------NMQVKIADFGVSKIMCRSLDA--------CNS 210
           IIHRD+KP N+LV+ +            N+++ I+DFG    +C+ LD+         N+
Sbjct: 136 IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG----LCKKLDSGQXXFRXNLNN 191
Query: 211 YVGTCAYMSPE 221
             GT  + +PE
Sbjct: 192 PSGTSGWRAPE 202

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 87/191 (45%), Gaps = 35/191 (18%)
Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           ++LG+G+ GTV   Q     +  A+K +  D           E+++L  +D    V  + 
Sbjct: 21  KILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCDIA----LMEIKLLTESDDHPNVIRYY 75
Query: 117 IFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAH------IASQILKGLSYLHGHK 170
             E     + I +E  +    D + +KN +    KL        +  QI  G+++LH  K
Sbjct: 76  CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK 135
Query: 171 IIHRDIKPSNLLVNNN------------NMQVKIADFGVSKIMCRSLDA--------CNS 210
           IIHRD+KP N+LV+ +            N+++ I+DFG    +C+ LD+         N+
Sbjct: 136 IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG----LCKKLDSGQSSFRTNLNN 191
Query: 211 YVGTCAYMSPE 221
             GT  + +PE
Sbjct: 192 PSGTSGWRAPE 202

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 83/208 (39%), Gaps = 18/208 (8%)
Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQ-----HRCTHKIYALKVVHGDADPTVRRQVFREMEI 102
           +   ++  ++ LGHG  G VY+ Q     +  +    A+K +              E  I
Sbjct: 45  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 104
Query: 103 LRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-------GTFSEPKLAHI 155
           + + +   IV+C G+  + S    IL+E M  G L + L +         + +   L H+
Sbjct: 105 ISKFNHQNIVRCIGVSLQ-SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 163
Query: 156 ASQILKGLSYLHGHKIIHRDIKPSNLLVN--NNNMQVKIADFGVSKIMCRSLDACNSYVG 213
           A  I  G  YL  +  IHRDI   N L+         KI DFG+++ + R   A     G
Sbjct: 164 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR---AGYYRKG 220
Query: 214 TCAYMSPERFDPDXXXXXXXXXXXDIWS 241
            CA +  +   P+           D WS
Sbjct: 221 GCAMLPVKWMPPEAFMEGIFTSKTDTWS 248

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 78/197 (39%), Gaps = 18/197 (9%)
Query: 59  LGHGNGGTVYKVQ-----HRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           LGHG  G VY+ Q     +  +    A+K +              E  I+ + +   IV+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-------GTFSEPKLAHIASQILKGLSYL 166
           C G+  + S    IL+E M  G L + L +         + +   L H+A  I  G  YL
Sbjct: 139 CIGVSLQ-SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 167 HGHKIIHRDIKPSNLLVN--NNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD 224
             +  IHRDI   N L+         KI DFG+++ + R   A     G CA +  +   
Sbjct: 198 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR---AGYYRKGGCAMLPVKWMP 254
Query: 225 PDXXXXXXXXXXXDIWS 241
           P+           D WS
Sbjct: 255 PEAFMEGIFTSKTDTWS 271

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 66/133 (49%), Gaps = 8/133 (6%)
Query: 94  RQVFREMEILRRTDSPFIV---QCFGIFEKPS-GDIAILMEYMDSGTLDTLLNKNGTFSE 149
           ++V RE+ +L     P I+     F  FE+P+   + ++ E M +     + ++    S 
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISP 133
Query: 150 PKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN 209
             + +    IL GL  LH   ++HRD+ P N+L+ +NN  + I DF +++    + DA  
Sbjct: 134 QHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN-DITICDFNLAR--EDTADANK 190
Query: 210 S-YVGTCAYMSPE 221
           + YV    Y +PE
Sbjct: 191 THYVTHRWYRAPE 203

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 92/242 (38%), Gaps = 24/242 (9%)
Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVV--HGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +Q LG G    V  V+       YALK +  H   D   R +  RE ++ R  + P I++
Sbjct: 34  IQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD---REEAQREADMHRLFNHPNILR 90
Query: 114 CFGIFEKPSG---DIAILMEYMDSGTL----DTLLNKNGTFSEPKLAHIASQILKGLSYL 166
                 +  G   +  +L+ +   GTL    + L +K    +E ++  +   I +GL  +
Sbjct: 91  LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVG---------TCAY 217
           H     HRD+KP+N+L+ +    V + D G     C  ++     +          T +Y
Sbjct: 151 HAKGYAHRDLKPTNILLGDEGQPV-LMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 218 MSPERFDPDXXXXXXXXXXXDIWSXXXXXXXXXXGHFPFLQPGQRPDWATLMCAICFGDP 277
            +PE F              D+WS          G  P+    Q+ D   L        P
Sbjct: 210 RAPELF--SVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIP 267
Query: 278 PS 279
            S
Sbjct: 268 QS 269

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 66/133 (49%), Gaps = 8/133 (6%)
Query: 94  RQVFREMEILRRTDSPFIV---QCFGIFEKPS-GDIAILMEYMDSGTLDTLLNKNGTFSE 149
           ++V RE+ +L     P I+     F  FE+P+   + ++ E M +     + ++    S 
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISP 133
Query: 150 PKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN 209
             + +    IL GL  LH   ++HRD+ P N+L+ +NN  + I DF +++    + DA  
Sbjct: 134 QHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN-DITICDFNLAR--EDTADANK 190
Query: 210 S-YVGTCAYMSPE 221
           + YV    Y +PE
Sbjct: 191 THYVTHRWYRAPE 203
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	323
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-124
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-124
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-119
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-117
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-116
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	6e-84
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-82
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-81
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-80
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-79
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-79
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-78
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-77
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-77
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	6e-77
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-77
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-76
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-76
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-74
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	6e-74
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	7e-74
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	6e-73
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-72
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	6e-72
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-71
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-71
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-70
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-66
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-66
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	9e-63
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-62
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-61
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	8e-61
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-59
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	5e-58
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	5e-58
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-57
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-57
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-57
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-57
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-56
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-56
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-56
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-56
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-56
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	6e-56
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-56
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-55
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-55
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-55
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-55
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-55
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-55
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-55
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-54
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-54
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-54
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-54
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-54
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-54
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-54
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-54
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-54
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-54
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	7e-54
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	9e-54
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-53
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-53
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	9e-53
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-52
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-52
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-52
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-52
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-52
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	5e-52
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-51
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-11
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-51
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-51
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-51
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-51
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	8e-51
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	9e-51
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-50
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-50
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-49
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-49
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-49
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-48
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-48
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-48
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-48
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	6e-48
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-47
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-47
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-46
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-46
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	5e-46
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	6e-46
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-45
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	7e-45
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-44
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-44
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-44
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	9e-44
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-43
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-43
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-43
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-43
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	6e-43
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-42
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-42
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	6e-42
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	9e-42
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-41
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-41
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-41
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-41
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-41
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-41
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-41
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-41
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	7e-41
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	8e-41
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-40
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-40
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-39
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-39
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-39
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-39
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-39
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-38
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-38
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-38
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-38
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	7e-38
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-37
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-37
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-37
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-37
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-36
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-36
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-35
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-35
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-35
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-35
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	7e-35
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-34
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-34
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-34
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-34
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-34
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-34
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-34
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-34
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	6e-34
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	8e-34
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-33
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-33
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	5e-33
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	6e-33
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	7e-33
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-32
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-32
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	7e-32
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	7e-32
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-31
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-31
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-31
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-31
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-31
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-31
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-31
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-31
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	5e-31
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	6e-31
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	8e-31
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-30
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-30
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-30
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-30
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	8e-30
3uqc_A	286	Probable conserved transmembrane protein; structur	9e-30
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-29
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-29
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-29
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-29
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	5e-29
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-29
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	7e-29
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-28
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-28
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-28
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-28
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-28
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-28
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-28
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-28
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-27
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-27
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-27
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-27
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-27
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-26
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-26
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-26
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-26
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-26
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-26
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-26
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-26
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	8e-26
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	9e-26
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-25
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-25
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-25
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-24
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-24
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-23
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-23
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	9e-23
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-22
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-22
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-22
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-21
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	8e-21
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-20
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	9e-20
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	9e-20
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-19
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	5e-19
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	9e-19
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-18
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-18
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-17
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	9e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-04

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  355 bits (914), Expect = e-124
 Identities = 96/286 (33%), Positives = 144/286 (50%), Gaps = 21/286 (7%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT- 106
           +   DLE +  LG G  G V K++H  + +I A+K +    +   ++++  +++I  RT 
Sbjct: 4   VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTV 63

Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLL----NKNGTFSEPKLAHIASQILKG 162
           D PF V  +G   +  GD+ I ME MD  +LD       +K  T  E  L  IA  I+K 
Sbjct: 64  DCPFTVTFYGALFRE-GDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121

Query: 163 LSYLHG-HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
           L +LH    +IHRD+KPSN+L+ N   QVK+ DFG+S  +   + A +   G   YM+PE
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLI-NALGQVKMCDFGISGYLVDDV-AKDIDAGCKPYMAPE 179

Query: 222 RFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWAT---LMCAICFGDPP 278
           R +P+     Y+    DIWSLG+T++EL +  FP+        W T    +  +     P
Sbjct: 180 RINPELNQKGYS-VKSDIWSLGITMIELAILRFPY------DSWGTPFQQLKQVVEEPSP 232

Query: 279 SLPDGA-SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSDC 323
            LP    S EF  F   CL+K   +R T  +L+ HPF   +     
Sbjct: 233 QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGT 278

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  345 bits (886), Expect = e-119
 Identities = 91/276 (32%), Positives = 146/276 (52%), Gaps = 10/276 (3%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT-DSP 109
           +DLE L  +G G  G V+K++ R T  + A+K +    +    +++  +++++ ++ D P
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84

Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG- 168
           +IVQCFG F   + D+ I ME M +          G   E  L  +   I+K L YL   
Sbjct: 85  YIVQCFGTFIT-NTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143

Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAY 228
           H +IHRD+KPSN+L++    Q+K+ DFG+S  +     A +   G  AYM+PER DP   
Sbjct: 144 HGVIHRDVKPSNILLDER-GQIKLCDFGISGRLVDDK-AKDRSAGCAAYMAPERIDPPDP 201

Query: 229 GGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA--SP 286
                    D+WSLG++L+EL  G FP+     + D+  L   +   +PP LP     S 
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQFPY--KNCKTDFEVLT-KVLQEEPPLLPGHMGFSG 258

Query: 287 EFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSD 322
           +F+SF++ CL K+  KR   ++LL H F+ +    +
Sbjct: 259 DFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLE 294

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  341 bits (876), Expect = e-117
 Identities = 110/312 (35%), Positives = 164/312 (52%), Gaps = 49/312 (15%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
            D EK+  LG GNGG V+KV H+ +  + A K++H +  P +R Q+ RE+++L   +SP+
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92

Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG-H 169
           IV  +G F    G+I+I ME+MD G+LD +L K G   E  L  ++  ++KGL+YL   H
Sbjct: 93  IVGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 151

Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYG 229
           KI+HRD+KPSN+LVN+   ++K+ DFGVS  +  S+   NS+VGT +YMSPER     Y 
Sbjct: 152 KIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQGTHY- 207

Query: 230 GNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWAT---------------------- 267
                   DIWS+GL+L+E+ +G +P   P  +                           
Sbjct: 208 ----SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263

Query: 268 ----------------LMCAICFGDPPSLPDGA-SPEFRSFIECCLQKEFSKRWTASQLL 310
                           L+  I    PP LP G  S EF+ F+  CL K  ++R    QL+
Sbjct: 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 323

Query: 311 THPFLCKNRRSD 322
            H F+ ++   +
Sbjct: 324 VHAFIKRSDAEE 335

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  338 bits (870), Expect = e-116
 Identities = 96/289 (33%), Positives = 145/289 (50%), Gaps = 25/289 (8%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT- 106
               DL+ L  +G G  G+V K+ H+ + +I A+K +    D   ++Q+  +++++ R+ 
Sbjct: 19  FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSS 78

Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLL-----NKNGTFSEPKLAHIASQILK 161
           D P+IVQ +G   +  GD  I ME M   + D          +    E  L  I    +K
Sbjct: 79  DCPYIVQFYGALFRE-GDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVK 136

Query: 162 GLSYLHG-HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSP 220
            L++L    KIIHRDIKPSN+L+ + +  +K+ DFG+S  +  S+       G   YM+P
Sbjct: 137 ALNHLKENLKIIHRDIKPSNILL-DRSGNIKLCDFGISGQLVDSIAKTRD-AGCRPYMAP 194

Query: 221 ERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWAT---LMCAICFGDP 277
           ER DP A    Y+    D+WSLG+TL EL  G FP+      P W +    +  +  GDP
Sbjct: 195 ERIDPSASRQGYD-VRSDVWSLGITLYELATGRFPY------PKWNSVFDQLTQVVKGDP 247

Query: 278 PSLPDGA----SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSD 322
           P L +      SP F +F+  CL K+ SKR    +LL HPF+       
Sbjct: 248 PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERA 296

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  256 bits (656), Expect = 6e-84
 Identities = 71/271 (26%), Positives = 123/271 (45%), Gaps = 14/271 (5%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTDSPFIV 112
            +LQ +G G+ G    V+     + Y +K ++        R +  RE+ +L     P IV
Sbjct: 27  VRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIV 86

Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLN--KNGTFSEPKLAHIASQILKGLSYLHGHK 170
           Q    FE+ +G + I+M+Y + G L   +N  K   F E ++     QI   L ++H  K
Sbjct: 87  QYRESFEE-NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK 145

Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGG 230
           I+HRDIK  N+ +  +   V++ DFG+++++  +++   + +GT  Y+SPE  +   Y  
Sbjct: 146 ILHRDIKSQNIFLTKDGT-VQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPY-- 202

Query: 231 NYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                  DIW+LG  L EL      F    +      L+  I  G  P +    S + RS
Sbjct: 203 ---NNKSDIWALGCVLYELCTLKHAF----EAGSMKNLVLKIISGSFPPVSLHYSYDLRS 255

Query: 291 FIECCLQKEFSKRWTASQLLTHPFLCKNRRS 321
            +    ++    R + + +L   F+ K    
Sbjct: 256 LVSQLFKRNPRDRPSVNSILEKGFIAKRIEK 286

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  251 bits (642), Expect = 2e-82
 Identities = 71/303 (23%), Positives = 123/303 (40%), Gaps = 18/303 (5%)

Query: 27  PLALPPTAPNTNNNTTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVV-- 84
              +P   P            +  ++    + +G G    VY+          ALK V  
Sbjct: 10  GPPVPQFQPQKALRPDMGYNTL--ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQI 67

Query: 85  HGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK- 143
               D   R    +E+++L++ + P +++ +  F +   ++ I++E  D+G L  ++   
Sbjct: 68  FDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-DNELNIVLELADAGDLSRMIKHF 126

Query: 144 ---NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKI 200
                   E  +     Q+   L ++H  +++HRDIKP+N+ +      VK+ D G+ + 
Sbjct: 127 KKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRF 185

Query: 201 MCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPG 260
                 A +S VGT  YMSPER   + Y      +  DIWSLG  L E+     PF   G
Sbjct: 186 FSSKTTAAHSLVGTPYYMSPERIHENGY-----NFKSDIWSLGCLLYEMAALQSPFY--G 238

Query: 261 QRPDWATLMCAICFGDPPSLPDGA-SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR 319
            + +  +L   I   D P LP    S E R  +  C+  +  KR   + +          
Sbjct: 239 DKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC 298

Query: 320 RSD 322
            + 
Sbjct: 299 TAS 301

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  248 bits (636), Expect = 1e-81
 Identities = 89/293 (30%), Positives = 135/293 (46%), Gaps = 10/293 (3%)

Query: 33  TAPNTNNNTTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTV 92
           +    +  +        Y +     VLG G  G VY  +        A+K +        
Sbjct: 4   STEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS 63

Query: 93  RRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTF--SE 149
           +  +  E+ + +      IVQ  G F +    I I ME +  G+L  LL +K G    +E
Sbjct: 64  Q-PLHEEIALHKHLKHKNIVQYLGSFSENG-FIKIFMEQVPGGSLSALLRSKWGPLKDNE 121

Query: 150 PKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN 209
             +     QIL+GL YLH ++I+HRDIK  N+L+N  +  +KI+DFG SK +        
Sbjct: 122 QTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE 181

Query: 210 SYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLM 269
           ++ GT  YM+PE  D    G  Y   A DIWSLG T++E+  G  PF + G+    A + 
Sbjct: 182 TFTGTLQYMAPEIIDKGPRG--YGKAA-DIWSLGCTIIEMATGKPPFYELGEP--QAAMF 236

Query: 270 CAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSD 322
               F   P +P+  S E ++FI  C + +  KR  A+ LL   FL  + +  
Sbjct: 237 KVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKK 289

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  243 bits (623), Expect = 5e-80
 Identities = 72/279 (25%), Positives = 124/279 (44%), Gaps = 21/279 (7%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTDSPFIV 112
           E L  +G G+ G   K++ +   KI   K +  G      ++ +  E+ +LR    P IV
Sbjct: 9   EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 68

Query: 113 QCFGIF-EKPSGDIAILMEYMDSGTLDTLLNK----NGTFSEPKLAHIASQILKGLSYLH 167
           + +    ++ +  + I+MEY + G L +++ K         E  +  + +Q+   L   H
Sbjct: 69  RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 128

Query: 168 -----GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
                GH ++HRD+KP+N+ ++     VK+ DFG+++I+        ++VGT  YMSPE+
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQ 187

Query: 223 FDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPD 282
            +  +Y         DIWSLG  L EL     PF           L   I  G    +P 
Sbjct: 188 MNRMSYN-----EKSDIWSLGCLLYELCALMPPF----TAFSQKELAGKIREGKFRRIPY 238

Query: 283 GASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS 321
             S E    I   L  +   R +  ++L +P + ++   
Sbjct: 239 RYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHH 277

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  244 bits (624), Expect = 1e-79
 Identities = 71/270 (26%), Positives = 114/270 (42%), Gaps = 19/270 (7%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRR-TDS 108
              ++L  LGHG+ G V+KV+ +   ++YA+K        P  R +   E+    +    
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116

Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILKGLSYLH 167
           P  V+    +E+  G + +  E     +L       G    E ++       L  L++LH
Sbjct: 117 PCCVRLEQAWEEG-GILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH 174

Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDA 227
              ++H D+KP+N+ +     + K+ DFG+   +  +  A     G   YM+PE      
Sbjct: 175 SQGLVHLDVKPANIFLGPRG-RCKLGDFGLLVEL-GTAGAGEVQEGDPRYMAPELLQ--- 229

Query: 228 YGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPE 287
             G+Y   A D++SLGLT+LE+         P     W  L        PP    G S E
Sbjct: 230 --GSYG-TAADVFSLGLTILEVACNMEL---PHGGEGWQQLRQGYL---PPEFTAGLSSE 280

Query: 288 FRSFIECCLQKEFSKRWTASQLLTHPFLCK 317
            RS +   L+ +   R TA  LL  P L +
Sbjct: 281 LRSVLVMMLEPDPKLRATAEALLALPVLRQ 310

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  243 bits (621), Expect = 1e-79
 Identities = 61/294 (20%), Positives = 112/294 (38%), Gaps = 40/294 (13%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVV-HGDADPTVRRQVFREMEILRR-TDS 108
           ++  +L+ +G G  G+V+K   R    IYA+K      A     +   RE+         
Sbjct: 11  TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70

Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN----GTFSEPKLAHIASQILKGLS 164
             +V+ F  + +    + I  EY + G+L   +++N      F E +L  +  Q+ +GL 
Sbjct: 71  SHVVRYFSAWAE-DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 165 YLHGHKIIHRDIKPSNLLVNNNN------------------MQVKIADFGVSKIMCRSLD 206
           Y+H   ++H DIKPSN+ ++  +                  +  KI D G        + 
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT----RIS 185

Query: 207 ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWA 266
           +     G   +++ E    +     +     DI++L LT++                   
Sbjct: 186 SPQVEEGDSRFLANEVLQENY---THL-PKADIFALALTVVCAAGAEPLPRN-------G 234

Query: 267 TLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR 320
                I  G  P +P   S EF   ++  +  +  +R +A  L+ H  L    R
Sbjct: 235 DQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 288

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  238 bits (610), Expect = 5e-78
 Identities = 71/287 (24%), Positives = 121/287 (42%), Gaps = 38/287 (13%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
            D ++++++G G  G V+K +HR   K Y +K V  +       +  RE++ L + D   
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN-----NEKAEREVKALAKLDHVN 65

Query: 111 IVQCFGIFE---------------KPSGDIAILMEYMDSGTLDTLLNK--NGTFSEPKLA 153
           IV   G ++                 +  + I ME+ D GTL+  + K       +    
Sbjct: 66  IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125

Query: 154 HIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVG 213
            +  QI KG+ Y+H  K+I+RD+KPSN+ + +   QVKI DFG+   +           G
Sbjct: 126 ELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK-QVKIGDFGLVTSLKNDGKR-TRSKG 183

Query: 214 TCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAIC 273
           T  YMSPE+     Y     G   D+++LGL L EL              + +     + 
Sbjct: 184 TLRYMSPEQISSQDY-----GKEVDLYALGLILAELLHVCDTA------FETSKFFTDLR 232

Query: 274 FGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR 320
                 + D    + ++ ++  L K+   R   S++L    + K   
Sbjct: 233 ---DGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  237 bits (607), Expect = 3e-77
 Identities = 94/268 (35%), Positives = 147/268 (54%), Gaps = 12/268 (4%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
            KL+ +G G+ G V+K     T K+ A+K++  +        + +E+ +L + DSP++ +
Sbjct: 25  TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 84

Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
            +G + K    + I+MEY+  G+   LL + G   E ++A I  +ILKGL YLH  K IH
Sbjct: 85  YYGSYLK-DTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLDYLHSEKKIH 142

Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYN 233
           RDIK +N+L++ +  +VK+ADFGV+  +  +    N++VGT  +M+PE     AY     
Sbjct: 143 RDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD---- 197

Query: 234 GYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIE 293
               DIWSLG+T +EL  G  P  +    P     +  I   +PP+L    S   + F+E
Sbjct: 198 -SKADIWSLGITAIELARGEPPHSE--LHPMKVLFL--IPKNNPPTLEGNYSKPLKEFVE 252

Query: 294 CCLQKEFSKRWTASQLLTHPFLCKNRRS 321
            CL KE S R TA +LL H F+ +N + 
Sbjct: 253 ACLNKEPSFRPTAKELLKHKFILRNAKK 280

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  237 bits (607), Expect = 3e-77
 Identities = 67/296 (22%), Positives = 123/296 (41%), Gaps = 18/296 (6%)

Query: 31  PPTAPNTNNNTTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDAD 89
                    N    + ++       L+ +G G    V++V +    +IYA+K V+  +AD
Sbjct: 8   SSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEAD 66

Query: 90  PTVRRQVFREMEILRRTD--SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTF 147
                    E+  L +    S  I++ +         I ++ME  +   L++ L K  + 
Sbjct: 67  NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ-YIYMVMECGN-IDLNSWLKKKKSI 124

Query: 148 SEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM--CRSL 205
              +       +L+ +  +H H I+H D+KP+N L+ +    +K+ DFG++  M    + 
Sbjct: 125 DPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTS 182

Query: 206 DACNSYVGTCAYMSPE------RFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQP 259
              +S VGT  YM PE          +    +      D+WSLG  L  +  G  PF   
Sbjct: 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--Q 240

Query: 260 GQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
                 + L   I        PD    + +  ++CCL+++  +R +  +LL HP++
Sbjct: 241 QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  239 bits (612), Expect = 6e-77
 Identities = 66/303 (21%), Positives = 125/303 (41%), Gaps = 18/303 (5%)

Query: 30  LPPTAPNTNNNTTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDA 88
           L     +  +++     ++       L+ +G G    V++V +    +IYA+K V+  +A
Sbjct: 35  LGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA 93

Query: 89  DPTVRRQVFREMEILRRTD--SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGT 146
           D         E+  L +    S  I++ +         I ++ME  +   L++ L K  +
Sbjct: 94  DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ-YIYMVMECGN-IDLNSWLKKKKS 151

Query: 147 FSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD 206
               +       +L+ +  +H H I+H D+KP+N L+ +    +K+ DFG++  M     
Sbjct: 152 IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTT 209

Query: 207 AC--NSYVGTCAYMSPE------RFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQ 258
           +   +S VG   YM PE          +    +      D+WSLG  L  +  G  PF  
Sbjct: 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-- 267

Query: 259 PGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN 318
                  + L   I        PD    + +  ++CCL+++  +R +  +LL HP++   
Sbjct: 268 QQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327

Query: 319 RRS 321
              
Sbjct: 328 THP 330

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  237 bits (607), Expect = 6e-77
 Identities = 65/268 (24%), Positives = 112/268 (41%), Gaps = 23/268 (8%)

Query: 55  KLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQC 114
               +G G+ G V++++ + T    A+K V       +      E+       SP IV  
Sbjct: 62  HQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPL 115

Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
           +G   +    + I ME ++ G+L  L+ + G   E +  +   Q L+GL YLH  +I+H 
Sbjct: 116 YGAVREGP-WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHG 174

Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIM-----CRSLDACNSYVGTCAYMSPERFDPDAYG 229
           D+K  N+L++++  +  + DFG +  +      +SL   +   GT  +M+PE        
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC- 233

Query: 230 GNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSL--PDGASPE 287
                   DIWS    +L +  G  P+ Q  +       +  I    PP    P   +P 
Sbjct: 234 ----DAKVDIWSSCCMMLHMLNGCHPWTQYFR---GPLCL-KIASEPPPIREIPPSCAPL 285

Query: 288 FRSFIECCLQKEFSKRWTASQLLTHPFL 315
               I+  L+KE   R +A +L      
Sbjct: 286 TAQAIQEGLRKEPVHRASAMELRRKVGK 313

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  236 bits (604), Expect = 2e-76
 Identities = 66/279 (23%), Positives = 118/279 (42%), Gaps = 18/279 (6%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTD--SPF 110
             L+ +G G    V++V +    +IYA+K V+  +AD         E+  L +    S  
Sbjct: 12  SILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70

Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           I++ +         I ++ME  +   L++ L K  +    +       +L+ +  +H H 
Sbjct: 71  IIRLYDYEITDQ-YIYMVMECGN-IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 128

Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIM--CRSLDACNSYVGTCAYMSPERFDPDAY 228
           I+H D+KP+N L+ +    +K+ DFG++  M    +    +S VGT  YM PE     + 
Sbjct: 129 IVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186

Query: 229 GGNYN------GYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPD 282
                          D+WSLG  L  +  G  PF         + L   I        PD
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQISKLHAIIDPNHEIEFPD 244

Query: 283 GASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS 321
               + +  ++CCL+++  +R +  +LL HP++      
Sbjct: 245 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 283

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  234 bits (599), Expect = 3e-76
 Identities = 73/268 (27%), Positives = 120/268 (44%), Gaps = 18/268 (6%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTDSPFIVQCF 115
             +G G+  TVYK     T    A   +       + R++   E E+L+    P IV+ +
Sbjct: 32  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91

Query: 116 GIFEKPSGD---IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK-- 170
             +E        I ++ E M SGTL T L +        L     QILKGL +LH     
Sbjct: 92  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 151

Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGG 230
           IIHRD+K  N+ +      VKI D G++ +         + +GT  +M+PE      Y  
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKAVIGTPEFMAPE-----MYEE 204

Query: 231 NYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPP-SLPDGASPEFR 289
            Y+  + D+++ G+ +LE+    +P+    +  + A +   +  G  P S    A PE +
Sbjct: 205 KYD-ESVDVYAFGMCMLEMATSEYPYS---ECQNAAQIYRRVTSGVKPASFDKVAIPEVK 260

Query: 290 SFIECCLQKEFSKRWTASQLLTHPFLCK 317
             IE C+++   +R++   LL H F  +
Sbjct: 261 EIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  231 bits (590), Expect = 1e-74
 Identities = 87/273 (31%), Positives = 142/273 (52%), Gaps = 10/273 (3%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           E +  LG G  G VYK +++ T  + A KV+   ++  +      E+EIL   D P+IV+
Sbjct: 22  EIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE-DYIVEIEILATCDHPYIVK 80

Query: 114 CFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
             G +    G + I++E+   G +   +L  +   +EP++  +  Q+L+ L++LH  +II
Sbjct: 81  LLGAYYH-DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRII 139

Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNY 232
           HRD+K  N+L+      +++ADFGVS    ++L   +S++GT  +M+PE    +      
Sbjct: 140 HRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTP 198

Query: 233 NGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA--SPEFRS 290
             Y  DIWSLG+TL+E+     P  +    P    L   I   DPP+L   +  S EFR 
Sbjct: 199 YDYKADIWSLGITLIEMAQIEPPHHE--LNPMRVLLK--IAKSDPPTLLTPSKWSVEFRD 254

Query: 291 FIECCLQKEFSKRWTASQLLTHPFLCKNRRSDC 323
           F++  L K    R +A+QLL HPF+     +  
Sbjct: 255 FLKIALDKNPETRPSAAQLLEHPFVSSITSNKA 287

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  228 bits (584), Expect = 6e-74
 Identities = 73/293 (24%), Positives = 119/293 (40%), Gaps = 38/293 (12%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           +D E +Q LG G  G V++ +++     YA+K +        R +V RE++ L + + P 
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 111 IVQCFGIFE-----------KPSGDIAILMEYMDSGTLDTLLNKNGT---FSEPKLAHIA 156
           IV+ F  +             P   + I M+      L   +N   T          HI 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 157 SQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN------- 209
            QI + + +LH   ++HRD+KPSN+     +  VK+ DFG+   M +  +          
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFF-TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 210 -----SYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPD 264
                  VGT  YMSPE+      G +Y+ +  DI+SLGL L EL    +PF    +R  
Sbjct: 184 YARHTGQVGTKLYMSPEQIH----GNSYS-HKVDIFSLGLILFELL---YPFSTQMER-- 233

Query: 265 WATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK 317
               +  +     P L     P     ++  L     +R  A  ++ +     
Sbjct: 234 -VRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  229 bits (587), Expect = 7e-74
 Identities = 91/278 (32%), Positives = 149/278 (53%), Gaps = 18/278 (6%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIV 112
           E ++++G+G  G VYK +H  T ++ A+KV+    D     ++ +E+ +L++      I 
Sbjct: 27  ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE--EEEIKQEINMLKKYSHHRNIA 84

Query: 113 QCFGIFEKPS-----GDIAILMEYMDSGTLDTLLN--KNGTFSEPKLAHIASQILKGLSY 165
             +G F K +       + ++ME+  +G++  L+   K  T  E  +A+I  +IL+GLS+
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 144

Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE-RFD 224
           LH HK+IHRDIK  N+L+  N  +VK+ DFGVS  + R++   N+++GT  +M+PE    
Sbjct: 145 LHQHKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 203

Query: 225 PDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSL-PDG 283
            +     Y+  + D+WSLG+T +E+  G  P       P  A  +  I     P L    
Sbjct: 204 DENPDATYDFKS-DLWSLGITAIEMAEGAPPLCD--MHPMRALFL--IPRNPAPRLKSKK 258

Query: 284 ASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS 321
            S +F+SFIE CL K  S+R    QL+ HPF+      
Sbjct: 259 WSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNE 296

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  226 bits (579), Expect = 6e-73
 Identities = 96/272 (35%), Positives = 152/272 (55%), Gaps = 17/272 (6%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           + L+ LG G+ G+VYK  H+ T +I A+K V  ++D    +++ +E+ I+++ DSP +V+
Sbjct: 32  DVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL---QEIIKEISIMQQCDSPHVVK 88

Query: 114 CFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
            +G + K + D+ I+MEY  +G++ D +  +N T +E ++A I    LKGL YLH  + I
Sbjct: 89  YYGSYFK-NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKI 147

Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNY 232
           HRDIK  N+L+N      K+ADFGV+  +  ++   N+ +GT  +M+PE      Y    
Sbjct: 148 HRDIKAGNILLNTEG-HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY---- 202

Query: 233 NGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSL--PDGASPEFRS 290
                DIWSLG+T +E+  G  P+      P  A  M  I    PP+   P+  S  F  
Sbjct: 203 -NCVADIWSLGITAIEMAEGKPPYAD--IHPMRAIFM--IPTNPPPTFRKPELWSDNFTD 257

Query: 291 FIECCLQKEFSKRWTASQLLTHPFLCKNRRSD 322
           F++ CL K   +R TA+QLL HPF+   +   
Sbjct: 258 FVKQCLVKSPEQRATATQLLQHPFVRSAKGVS 289

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  226 bits (579), Expect = 2e-72
 Identities = 82/271 (30%), Positives = 130/271 (47%), Gaps = 15/271 (5%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT--VRRQVFREMEILRRTDSPFI 111
             L+ +GHG+ G VY  +     ++ A+K +      +    + + +E+  L++   P  
Sbjct: 57  SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 116

Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
           +Q  G + +      ++MEY      D L        E ++A +    L+GL+YLH H +
Sbjct: 117 IQYRGCYLREH-TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 175

Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGN 231
           IHRD+K  N+L++     VK+ DFG + IM  +    NS+VGT  +M+PE       G  
Sbjct: 176 IHRDVKAGNILLSEPG-LVKLGDFGSASIMAPA----NSFVGTPYWMAPEVILAMDEGQ- 229

Query: 232 YNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA-SPEFRS 290
           Y+G   D+WSLG+T +EL     P          A     I   + P+L  G  S  FR+
Sbjct: 230 YDGKV-DVWSLGITCIELAERKPPLFN--MNAMSALYH--IAQNESPALQSGHWSEYFRN 284

Query: 291 FIECCLQKEFSKRWTASQLLTHPFLCKNRRS 321
           F++ CLQK    R T+  LL H F+ + R  
Sbjct: 285 FVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 315

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  223 bits (571), Expect = 6e-72
 Identities = 77/275 (28%), Positives = 131/275 (47%), Gaps = 15/275 (5%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
               + + +G G  GTVY      T +  A++ ++    P  +  +  E+ ++R   +P 
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPN 78

Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           IV     +     ++ ++MEY+  G+L  ++       E ++A +  + L+ L +LH ++
Sbjct: 79  IVNYLDSYLV-GDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQ 136

Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGG 230
           +IHRDIK  N+L+  +   VK+ DFG    +       ++ VGT  +M+PE     AY  
Sbjct: 137 VIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-- 193

Query: 231 NYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSL--PDGASPEF 288
              G   DIWSLG+  +E+  G  P+L   + P  A  +  I     P L  P+  S  F
Sbjct: 194 ---GPKVDIWSLGIMAIEMIEGEPPYLN--ENPLRALYL--IATNGTPELQNPEKLSAIF 246

Query: 289 RSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSDC 323
           R F+  CL+ +  KR +A +LL H FL   +    
Sbjct: 247 RDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSS 281

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  222 bits (569), Expect = 2e-71
 Identities = 86/305 (28%), Positives = 145/305 (47%), Gaps = 32/305 (10%)

Query: 40  NTTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFRE 99
           +++A   +I   D E  +V+G G    V         +  A+K ++ +   T   ++ +E
Sbjct: 4   DSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKE 63

Query: 100 MEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLL--------NKNGTFSEPK 151
           ++ + +   P IV  +  F     ++ ++M+ +  G++  ++        +K+G   E  
Sbjct: 64  IQAMSQCHHPNIVSYYTSFVVKD-ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122

Query: 152 LAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC--- 208
           +A I  ++L+GL YLH +  IHRD+K  N+L+  +   V+IADFGVS  +    D     
Sbjct: 123 IATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG-SVQIADFGVSAFLATGGDITRNK 181

Query: 209 --NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWA 266
              ++VGT  +M+PE  +       Y+  A DIWS G+T +EL  G  P+ +    P   
Sbjct: 182 VRKTFVGTPCWMAPEVMEQ---VRGYDFKA-DIWSFGITAIELATGAAPYHK--YPPMKV 235

Query: 267 TLMCAICFGDPPSLPDGA---------SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK 317
            ++      DPPSL  G             FR  I  CLQK+  KR TA++LL H F  K
Sbjct: 236 LML--TLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293

Query: 318 NRRSD 322
            +  +
Sbjct: 294 AKNKE 298

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  222 bits (568), Expect = 2e-71
 Identities = 74/295 (25%), Positives = 126/295 (42%), Gaps = 43/295 (14%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           SD E++ VLG G  G V K ++    + YA+K +           +  E+ +L   +  +
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI--RHTEEKLSTILSEVMLLASLNHQY 63

Query: 111 IVQCFGIFEKPSGDIA------------ILMEYMDSGTL-DTLLNKNGTFSEPKLAHIAS 157
           +V+ +  + +    +             I MEY ++GTL D + ++N      +   +  
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123

Query: 158 QILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC--------- 208
           QIL+ LSY+H   IIHRD+KP N+ ++ +   VKI DFG++K + RSLD           
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESR-NVKIGDFGLAKNVHRSLDILKLDSQNLPG 182

Query: 209 -----NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRP 263
                 S +GT  Y++ E        G+YN    D++SLG+   E+              
Sbjct: 183 SSDNLTSAIGTAMYVATEVL---DGTGHYN-EKIDMYSLGIIFFEMIYPFSTG------M 232

Query: 264 DWATLMCAICFGD---PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
           +   ++  +       PP   D      +  I   +  + +KR  A  LL   +L
Sbjct: 233 ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  221 bits (565), Expect = 1e-70
 Identities = 75/273 (27%), Positives = 132/273 (48%), Gaps = 15/273 (5%)

Query: 53  LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIV 112
           L+    +G G+ G V   + + + +  A+K++        R  +F E+ I+R      +V
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR-RELLFNEVVIMRDYQHFNVV 105

Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
           + +  +     ++ +LME++  G L  ++      +E ++A +   +L+ L+YLH   +I
Sbjct: 106 EMYKSYLV-GEELWVLMEFLQGGALTDIV-SQVRLNEEQIATVCEAVLQALAYLHAQGVI 163

Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNY 232
           HRDIK  ++L+  +  +VK++DFG    + + +    S VGT  +M+PE      Y    
Sbjct: 164 HRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLY---- 218

Query: 233 NGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSL--PDGASPEFRS 290
                DIWSLG+ ++E+  G  P+      P  A     +    PP L      SP  R 
Sbjct: 219 -ATEVDIWSLGIMVIEMVDGEPPYFS--DSPVQAMKR--LRDSPPPKLKNSHKVSPVLRD 273

Query: 291 FIECCLQKEFSKRWTASQLLTHPFLCKNRRSDC 323
           F+E  L ++  +R TA +LL HPFL +    +C
Sbjct: 274 FLERMLVRDPQERATAQELLDHPFLLQTGLPEC 306

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  210 bits (537), Expect = 2e-66
 Identities = 60/306 (19%), Positives = 106/306 (34%), Gaps = 22/306 (7%)

Query: 31  PPTAPNTNNNTTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADP 90
             ++   N         I       +Q LG G    V  V+       YALK +    + 
Sbjct: 9   HHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC-HEQ 67

Query: 91  TVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGD---IAILMEYMDSGTLDTLLN----K 143
             R +  RE ++ R  + P I++      +  G      +L+ +   GTL   +     K
Sbjct: 68  QDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDK 127

Query: 144 NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM-- 201
               +E ++  +   I +GL  +H     HRD+KP+N+L+ +   Q  + D G       
Sbjct: 128 GNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEG-QPVLMDLGSMNQACI 186

Query: 202 -------CRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHF 254
                    +L    +   T +Y +PE F              D+WSLG  L  +  G  
Sbjct: 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSV--QSHCVIDERTDVWSLGCVLYAMMFGEG 244

Query: 255 PFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPF 314
           P+    Q+ D  ++  A+            S      +   +  +  +R     LL+   
Sbjct: 245 PYDMVFQKGD--SVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE 302

Query: 315 LCKNRR 320
             +   
Sbjct: 303 ALQPPA 308

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  209 bits (534), Expect = 3e-66
 Identities = 65/301 (21%), Positives = 115/301 (38%), Gaps = 35/301 (11%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
               +LG G    V++ +H+ T  ++A+KV +  +         RE E+L++ +   IV+
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 114 CFGIFEKPSGD-IAILMEYMDSGTLDTLLNKNGT---FSEPKLAHIASQILKGLSYLHGH 169
            F I E+ +     ++ME+   G+L T+L +        E +   +   ++ G+++L  +
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131

Query: 170 KIIHRDIKPSNLLVNNN---NMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE---RF 223
            I+HR+IKP N++           K+ DFG ++ +    +   S  GT  Y+ P+   R 
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVSLYGTEEYLHPDMYERA 190

Query: 224 DPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP------ 277
                     G   D+WS+G+T      G  PF           +M  I  G P      
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250

Query: 278 ------------------PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR 319
                              SL  G        +   L+ +  K W   Q         +R
Sbjct: 251 VQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310

Query: 320 R 320
            
Sbjct: 311 G 311

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  203 bits (517), Expect = 9e-63
 Identities = 65/301 (21%), Positives = 116/301 (38%), Gaps = 35/301 (11%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
               +LG G    V++ +H+ T  ++A+KV +  +         RE E+L++ +   IV+
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 114 CFGIFEKPSGD-IAILMEYMDSGTLDTLLNKNGT---FSEPKLAHIASQILKGLSYLHGH 169
            F I E+ +     ++ME+   G+L T+L +        E +   +   ++ G+++L  +
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131

Query: 170 KIIHRDIKPSNLLV---NNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE---RF 223
            I+HR+IKP N++     +     K+ DFG ++ +    +   S  GT  Y+ P+   R 
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVSLYGTEEYLHPDMYERA 190

Query: 224 DPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPP----- 278
                     G   D+WS+G+T      G  PF           +M  I  G P      
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250

Query: 279 -------------------SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR 319
                              SL  G        +   L+ +  K W   Q         +R
Sbjct: 251 VQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310

Query: 320 R 320
            
Sbjct: 311 M 311

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  202 bits (514), Expect = 2e-62
 Identities = 73/331 (22%), Positives = 126/331 (38%), Gaps = 68/331 (20%)

Query: 51  SDLEKLQVLGHGNG--GTVYKVQHRCTHKIYALKVVHGDADPTVRRQ-VFREMEILRRTD 107
              E L V+G G     TV   +++ T +   ++ ++ +A        +  E+ + +  +
Sbjct: 25  GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84

Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLL--NKNGTFSEPKLAHIASQILKGLSY 165
            P IV     F   + ++ ++  +M  G+   L+  +     +E  +A+I   +LK L Y
Sbjct: 85  HPNIVPYRATFIADN-ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143

Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL-------DACNSYVGTCAYM 218
           +H    +HR +K S++L++ +  +V ++    +  M           D     V    ++
Sbjct: 144 IHHMGYVHRSVKASHILISVDG-KVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202

Query: 219 SPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPP 278
           SPE    +  G  Y+  + DI+S+G+T  EL  GH PF           L      G  P
Sbjct: 203 SPEVLQQNLQG--YDAKS-DIYSVGITACELANGHVPFKD--MPATQMLLE--KLNGTVP 255

Query: 279 SLPDGA---------------------------------------------SPEFRSFIE 293
            L D +                                             SP F  F+E
Sbjct: 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVE 315

Query: 294 CCLQKEFSKRWTASQLLTHPFL--CKNRRSD 322
            CLQ+    R +AS LL H F    K R S+
Sbjct: 316 QCLQRNPDARPSASTLLNHSFFKQIKRRASE 346

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  201 bits (512), Expect = 2e-61
 Identities = 68/274 (24%), Positives = 115/274 (41%), Gaps = 21/274 (7%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS-PFIVQCF 115
            VLGHG  GT+   +    ++  A+K +  +      R    E+++LR +D  P +++ F
Sbjct: 30  DVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADR----EVQLLRESDEHPNVIRYF 84

Query: 116 GIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
              +       I +E     TL + +  K+      +   +  Q   GL++LH   I+HR
Sbjct: 85  CTEKDRQ-FQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHR 142

Query: 175 DIKPSNLLV----NNNNMQVKIADFGVSKIMC---RSLDACNSYVGTCAYMSPERFDPDA 227
           D+KP N+L+     +  ++  I+DFG+ K +     S    +   GT  +++PE    D 
Sbjct: 143 DLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDC 202

Query: 228 YGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP 286
                  Y  DI+S G     +   G  PF +  QR   A ++   C  D          
Sbjct: 203 KEN-P-TYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ--ANILLGACSLDCLHPEKHEDV 258

Query: 287 EFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR 320
             R  IE  +  +  KR +A  +L HPF     +
Sbjct: 259 IARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK 292

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  194 bits (496), Expect = 8e-61
 Identities = 82/272 (30%), Positives = 125/272 (45%), Gaps = 20/272 (7%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDS 108
            D E  + LG G  G VY  + + +  I ALKV+         V  Q+ RE+EI      
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           P I++ +G F   +  + +++EY   GT+   L K   F E + A   +++   LSY H 
Sbjct: 69  PNILRLYGYFHDAT-RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127

Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM--CRSLDACNSYVGTCAYMSPERFDPD 226
            ++IHRDIKP NLL+  +  ++KIADFG S      R  D C    GT  Y+ PE  +  
Sbjct: 128 KRVIHRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIEGR 182

Query: 227 AYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP 286
            +         D+WSLG+   E  +G  PF    +   +      I   +  + PD  + 
Sbjct: 183 MH-----DEKVDLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVE-FTFPDFVTE 232

Query: 287 EFRSFIECCLQKEFSKRWTASQLLTHPFLCKN 318
             R  I   L+   S+R    ++L HP++  N
Sbjct: 233 GARDLISRLLKHNPSQRPMLREVLEHPWITAN 264

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  190 bits (486), Expect = 3e-59
 Identities = 78/280 (27%), Positives = 113/280 (40%), Gaps = 32/280 (11%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDS 108
            D +  + LG G  G VY  + +    I ALKV+         V  Q+ RE+EI      
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           P I++ +  F      I +++E+   G L   L K+G F E + A    ++   L Y H 
Sbjct: 74  PNILRMYNYFHDRK-RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 132

Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKI--------MCRSLDACNSYVGTCAYMSP 220
            K+IHRDIKP NLL+     ++KIADFG S          MC          GT  Y+ P
Sbjct: 133 RKVIHRDIKPENLLM-GYKGELKIADFGWSVHAPSLRRRTMC----------GTLDYLPP 181

Query: 221 ERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSL 280
           E  +   +         D+W  G+   E  +G  PF      P        I   D    
Sbjct: 182 EMIEGKTHDE-----KVDLWCAGVLCYEFLVGMPPF----DSPSHTETHRRIVNVD-LKF 231

Query: 281 PDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR 320
           P   S   +  I   L+    +R     ++ HP++  N R
Sbjct: 232 PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR 271

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  193 bits (493), Expect = 5e-58
 Identities = 74/271 (27%), Positives = 123/271 (45%), Gaps = 18/271 (6%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQ-VFREMEILRRTDSPFIVQCF 115
           + LG G  G V   + + TH   A+K++   +  T     +  E+ +L+  D P I++ +
Sbjct: 43  KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102

Query: 116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRD 175
             FE       ++ME    G L   +     F+E   A I  Q+L G++YLH H I+HRD
Sbjct: 103 DFFEDKRN-YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRD 161

Query: 176 IKPSNLLVNNN--NMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYN 233
           +KP NLL+ +   +  +KI DFG+S +   +       +GT  Y++PE          Y 
Sbjct: 162 LKPENLLLESKEKDALIKIVDFGLSAVF-ENQKKMKERLGTAYYIAPEVLR-----KKY- 214

Query: 234 GYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP--PSLP-DGASPEFRS 290
               D+WS+G+ L  L  G+ PF     +     ++  +  G     S      S   + 
Sbjct: 215 DEKCDVWSIGVILFILLAGYPPFGGQTDQ----EILRKVEKGKYTFDSPEWKNVSEGAKD 270

Query: 291 FIECCLQKEFSKRWTASQLLTHPFLCKNRRS 321
            I+  LQ +  +R +A Q L HP++ +    
Sbjct: 271 LIKQMLQFDSQRRISAQQALEHPWIKEMCSK 301

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  191 bits (488), Expect = 5e-58
 Identities = 76/278 (27%), Positives = 119/278 (42%), Gaps = 20/278 (7%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVH-------GDADPTVRRQVFREMEILRRTDSP 109
           + LG G  G V     R T K  A++++           +      V  E+EIL++ + P
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200

Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
            I++    F+    D  I++E M+ G L   +  N    E        Q+L  + YLH +
Sbjct: 201 CIIKIKNFFDAE--DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN 258

Query: 170 KIIHRDIKPSNLLVNN--NNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDA 227
            IIHRD+KP N+L+++   +  +KI DFG SKI+        +  GT  Y++PE      
Sbjct: 259 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLCGTPTYLAPEVLVSVG 317

Query: 228 YGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD---PPSLPDGA 284
             G Y   A D WSLG+ L     G+ PF +   +     L   I  G     P +    
Sbjct: 318 TAG-Y-NRAVDCWSLGVILFICLSGYPPFSEHRTQVS---LKDQITSGKYNFIPEVWAEV 372

Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSD 322
           S +    ++  L  +   R+T  + L HP+L       
Sbjct: 373 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKR 410

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  186 bits (475), Expect = 1e-57
 Identities = 78/280 (27%), Positives = 128/280 (45%), Gaps = 35/280 (12%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSP 109
           D +   +LG G+   VY+ +   T    A+K++         + ++V  E++I  +   P
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71

Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
            I++ +  FE  +  + +++E   +G +   L N+   FSE +  H   QI+ G+ YLH 
Sbjct: 72  SILELYNYFEDSN-YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130

Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVS----------KIMCRSLDACNSYVGTCAYM 218
           H I+HRD+  SNLL+   NM +KIADFG++            +C          GT  Y+
Sbjct: 131 HGILHRDLTLSNLLL-TRNMNIKIADFGLATQLKMPHEKHYTLC----------GTPNYI 179

Query: 219 SPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPP 278
           SPE     A+     G   D+WSLG     L +G  PF            +  +   D  
Sbjct: 180 SPEIATRSAH-----GLESDVWSLGCMFYTLLIGRPPF----DTDTVKNTLNKVVLAD-Y 229

Query: 279 SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN 318
            +P   S E +  I   L++  + R + S +L HPF+ +N
Sbjct: 230 EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  187 bits (478), Expect = 1e-57
 Identities = 78/275 (28%), Positives = 120/275 (43%), Gaps = 22/275 (8%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVH-------GDADPTVRRQVFREMEILRRTDSP 109
           + LG G  G V     R T K  A+K++           +      V  E+EIL++ + P
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75

Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
            I++    F+    D  I++E M+ G L D ++       E        Q+L  + YLH 
Sbjct: 76  CIIKIKNFFDAE--DYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHE 132

Query: 169 HKIIHRDIKPSNLLVNNN--NMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPD 226
           + IIHRD+KP N+L+++   +  +KI DFG SKI+        +  GT  Y++PE     
Sbjct: 133 NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLCGTPTYLAPEVLVSV 191

Query: 227 AYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD---PPSLPDG 283
              G Y   A D WSLG+ L     G+ PF     R    +L   I  G     P +   
Sbjct: 192 GTAG-Y-NRAVDCWSLGVILFICLSGYPPF--SEHRTQ-VSLKDQITSGKYNFIPEVWAE 246

Query: 284 ASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN 318
            S +    ++  L  +   R+T  + L HP+L   
Sbjct: 247 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  191 bits (486), Expect = 4e-57
 Identities = 72/273 (26%), Positives = 120/273 (43%), Gaps = 19/273 (6%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVV--HGDADPTVRRQVFREMEILRRTDSPFIVQC 114
           +VLG G+ G V   + + T +  A+KV+        T +  + RE+++L++ D P I++ 
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91

Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
           +  FE       ++ E    G L   +     FSE   A I  Q+L G++Y+H +KI+HR
Sbjct: 92  YEFFEDKGY-FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHR 150

Query: 175 DIKPSNLLVNNN--NMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNY 232
           D+KP NLL+ +   +  ++I DFG+S     +       +GT  Y++PE        G Y
Sbjct: 151 DLKPENLLLESKSKDANIRIIDFGLSTHF-EASKKMKDKIGTAYYIAPEVLH-----GTY 204

Query: 233 NGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP--PSLP-DGASPEFR 289
                D+WS G+ L  L  G  PF    +      ++  +  G            S   +
Sbjct: 205 -DEKCDVWSTGVILYILLSGCPPFNGANEY----DILKKVEKGKYTFELPQWKKVSESAK 259

Query: 290 SFIECCLQKEFSKRWTASQLLTHPFLCKNRRSD 322
             I   L    S R +A   L H ++    +  
Sbjct: 260 DLIRKMLTYVPSMRISARDALDHEWIQTYTKEQ 292

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  187 bits (476), Expect = 5e-57
 Identities = 73/278 (26%), Positives = 118/278 (42%), Gaps = 24/278 (8%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVH----GDADPTVRRQVFREMEILRRTDSPFIV 112
           +V+G G    V +  +R T + +A+K+V       +       + RE  I      P IV
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89

Query: 113 QCFGIFEKPSGDIAILMEYMDSGTL-DTLLNK---NGTFSEPKLAHIASQILKGLSYLHG 168
           +    +    G + ++ E+MD   L   ++ +      +SE   +H   QIL+ L Y H 
Sbjct: 90  ELLETYSSD-GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148

Query: 169 HKIIHRDIKPSNLLVNN--NNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPD 226
           + IIHRD+KP  +L+ +  N+  VK+  FGV+  +  S       VGT  +M+PE    +
Sbjct: 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKRE 208

Query: 227 AYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP--PSLP-DG 283
            Y     G   D+W  G+ L  L  G  PF    +R     L   I  G           
Sbjct: 209 PY-----GKPVDVWGCGVILFILLSGCLPFYGTKER-----LFEGIIKGKYKMNPRQWSH 258

Query: 284 ASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS 321
            S   +  +   L  + ++R T  + L HP+L +  R 
Sbjct: 259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRY 296

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  184 bits (470), Expect = 1e-56
 Identities = 73/262 (27%), Positives = 123/262 (46%), Gaps = 24/262 (9%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           I Y ++E  +V+G G  G V K + R   K  A+K +  +++   R+    E+  L R +
Sbjct: 5   IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESE---RKAFIVELRQLSRVN 59

Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNG---TFSEPKLAHIASQILKGLS 164
            P IV+ +G    P   + ++MEY + G+L  +L+       ++         Q  +G++
Sbjct: 60  HPNIVKLYGACLNP---VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116

Query: 165 YLHGHK---IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
           YLH  +   +IHRD+KP NLL+      +KI DFG +  +   +    +  G+ A+M+PE
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM---TNNKGSAAWMAPE 173

Query: 222 RFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLP 281
            F+    G NY+    D++S G+ L E+     PF           +M A+  G  P L 
Sbjct: 174 VFE----GSNYSEKC-DVFSWGIILWEVITRRKPF--DEIGGPAFRIMWAVHNGTRPPLI 226

Query: 282 DGASPEFRSFIECCLQKEFSKR 303
                   S +  C  K+ S+R
Sbjct: 227 KNLPKPIESLMTRCWSKDPSQR 248

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  184 bits (469), Expect = 1e-56
 Identities = 68/269 (25%), Positives = 127/269 (47%), Gaps = 20/269 (7%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           + LG G  G V+ V+ R +     +K ++ D       Q+  E+E+L+  D P I++ F 
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87

Query: 117 IFEKPSGDIAILMEYMDSGTL----DTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
           +FE    ++ I+ME  + G L     +   +    SE  +A +  Q++  L+Y H   ++
Sbjct: 88  VFEDYH-NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVV 146

Query: 173 HRDIKPSNLLVNNN--NMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGG 230
           H+D+KP N+L  +   +  +KI DFG++++  +S +   +  GT  YM+PE F       
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAELF-KSDEHSTNAAGTALYMAPEVFK-----R 200

Query: 231 NYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP--PSLPDGASPEF 288
           +   +  DIWS G+ +  L  G  PF           +     + +P         +P+ 
Sbjct: 201 DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSL----EEVQQKATYKEPNYAVECRPLTPQA 255

Query: 289 RSFIECCLQKEFSKRWTASQLLTHPFLCK 317
              ++  L K+  +R +A+Q+L H +  +
Sbjct: 256 VDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  183 bits (468), Expect = 2e-56
 Identities = 69/277 (24%), Positives = 121/277 (43%), Gaps = 34/277 (12%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSPFI 111
            + + LG G     +++    T +++A K+V       P  R ++  E+ I R      +
Sbjct: 18  VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHV 77

Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
           V   G FE     + +++E     +L  L  +    +EP+  +   QI+ G  YLH +++
Sbjct: 78  VGFHGFFEDND-FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRV 136

Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVS----------KIMCRSLDACNSYVGTCAYMSPE 221
           IHRD+K  NL + N +++VKI DFG++          K++C          GT  Y++PE
Sbjct: 137 IHRDLKLGNLFL-NEDLEVKIGDFGLATKVEYDGERKKVLC----------GTPNYIAPE 185

Query: 222 RFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLP 281
                 +      +  D+WS+G  +  L +G  PF    +          I   +  S+P
Sbjct: 186 VLSKKGH-----SFEVDVWSIGCIMYTLLVGKPPF----ETSCLKETYLRIKKNE-YSIP 235

Query: 282 DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN 318
              +P   S I+  LQ + + R T ++LL   F    
Sbjct: 236 KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  182 bits (465), Expect = 4e-56
 Identities = 79/273 (28%), Positives = 126/273 (46%), Gaps = 19/273 (6%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQ-VFREMEILRRTDSPFIVQCF 115
           + LG G    V +  H+ T   +A K+++         Q + RE  I R+   P IV+  
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71

Query: 116 GIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
              ++      ++ + +  G L + ++ +   +SE   +H   QIL+ ++Y H + I+HR
Sbjct: 72  DSIQEE-SFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHR 129

Query: 175 DIKPSNLLV--NNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNY 232
           ++KP NLL+        VK+ADFG++  +    +A + + GT  Y+SPE    D Y    
Sbjct: 130 NLKPENLLLASKAKGAAVKLADFGLAIEV-NDSEAWHGFAGTPGYLSPEVLKKDPY---- 184

Query: 233 NGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP--PSLP-DGASPEFR 289
                DIW+ G+ L  L +G+ PF    Q      L   I  G    PS   D  +PE +
Sbjct: 185 -SKPVDIWACGVILYILLVGYPPFWDEDQH----RLYAQIKAGAYDYPSPEWDTVTPEAK 239

Query: 290 SFIECCLQKEFSKRWTASQLLTHPFLCKNRRSD 322
           S I+  L     KR TA Q L  P++C   R  
Sbjct: 240 SLIDSMLTVNPKKRITADQALKVPWICNRERVA 272

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  184 bits (469), Expect = 4e-56
 Identities = 69/309 (22%), Positives = 117/309 (37%), Gaps = 53/309 (17%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH----------------GDADPTVRRQ 95
           D   ++ L  G    +   +    +K YALK                     +  +    
Sbjct: 32  DYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 96  VFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGT--------F 147
              E++I+    + + + C GI      ++ I+ EYM++ ++                  
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYD-EVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148

Query: 148 SEPKLAHIASQILKGLSYLHGHK-IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL- 205
               +  I   +L   SY+H  K I HRD+KPSN+L++ N  +VK++DFG S+ M     
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNG-RVKLSDFGESEYMVDKKI 207

Query: 206 -DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRP- 263
             +     GT  +M PE F  +    +YNG   DIWSLG+ L  ++    PF        
Sbjct: 208 KGSR----GTYEFMPPEFFSNE---SSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260

Query: 264 --------------DWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQL 309
                         D    +  +         +  S E   F++  L+K  ++R T+   
Sbjct: 261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDA 320

Query: 310 LTHPFLCKN 318
           L H +L   
Sbjct: 321 LKHEWLADT 329

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  187 bits (478), Expect = 6e-56
 Identities = 82/275 (29%), Positives = 126/275 (45%), Gaps = 24/275 (8%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVH----GDADPTVRRQVFREMEILRRTDSPFIV 112
            +LG G+ G V K + R T + YA+KV++     + D      + RE+E+L++ D P I+
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD---TSTILREVELLKKLDHPNIM 84

Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
           + F I E  S    I+ E    G L   + K   FSE   A I  Q+  G++Y+H H I+
Sbjct: 85  KLFEILEDSSS-FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIV 143

Query: 173 HRDIKPSNLLVNNN--NMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGG 230
           HRD+KP N+L+ +   +  +KI DFG+S    +        +GT  Y++PE        G
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKMKDRIGTAYYIAPEVLR-----G 197

Query: 231 NYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP--PSLP-DGASPE 287
            Y     D+WS G+ L  L  G  PF    +      ++  +  G            S +
Sbjct: 198 TY-DEKCDVWSAGVILYILLSGTPPFYGKNEY----DILKRVETGKYAFDLPQWRTISDD 252

Query: 288 FRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSD 322
            +  I   L    S R TA+Q L HP++ K     
Sbjct: 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSET 287

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  183 bits (466), Expect = 8e-56
 Identities = 69/277 (24%), Positives = 121/277 (43%), Gaps = 34/277 (12%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSPFI 111
            + + LG G     +++    T +++A K+V       P  R ++  E+ I R      +
Sbjct: 44  VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHV 103

Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
           V   G FE     + +++E     +L  L  +    +EP+  +   QI+ G  YLH +++
Sbjct: 104 VGFHGFFEDND-FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRV 162

Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVS----------KIMCRSLDACNSYVGTCAYMSPE 221
           IHRD+K  NL + N +++VKI DFG++          K++C          GT  Y++PE
Sbjct: 163 IHRDLKLGNLFL-NEDLEVKIGDFGLATKVEYDGERKKVLC----------GTPNYIAPE 211

Query: 222 RFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLP 281
                      + +  D+WS+G  +  L +G  PF    +          I   +  S+P
Sbjct: 212 VLS-----KKGHSFEVDVWSIGCIMYTLLVGKPPF----ETSCLKETYLRIKKNE-YSIP 261

Query: 282 DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN 318
              +P   S I+  LQ + + R T ++LL   F    
Sbjct: 262 KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 298

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  184 bits (468), Expect = 1e-55
 Identities = 90/312 (28%), Positives = 151/312 (48%), Gaps = 21/312 (6%)

Query: 15  PMPELSERCLRFPLALP-PTAPNTNNNTTATTAAI-AYSDLEKLQVLGHGNGGTVYKVQH 72
            MP  S+R     + +P P AP  +   TA   A+ ++  + K ++LG G  G V+K + 
Sbjct: 51  RMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEE 110

Query: 73  RCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYM 132
             T    A K++        + +V  E+ ++ + D   ++Q +  FE  + DI ++MEY+
Sbjct: 111 TATGLKLAAKIIKTRG-MKDKEEVKNEISVMNQLDHANLIQLYDAFESKN-DIVLVMEYV 168

Query: 133 DSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLL-VNNNNMQV 190
           D G L D +++++   +E        QI +G+ ++H   I+H D+KP N+L VN +  Q+
Sbjct: 169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQI 228

Query: 191 KIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELY 250
           KI DFG+++      +      GT  +++PE  +      ++  +  D+WS+G+    L 
Sbjct: 229 KIIDFGLARRYKPR-EKLKVNFGTPEFLAPEVVN-----YDFVSFPTDMWSVGVIAYMLL 282

Query: 251 LGHFPFLQPGQRPDWATL----MCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTA 306
            G  PFL  G   D  TL     C     D        S E + FI   L KE S R +A
Sbjct: 283 SGLSPFL--GDN-DAETLNNILACRWDLEDEEF--QDISEEAKEFISKLLIKEKSWRISA 337

Query: 307 SQLLTHPFLCKN 318
           S+ L HP+L  +
Sbjct: 338 SEALKHPWLSDH 349

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  183 bits (466), Expect = 2e-55
 Identities = 83/306 (27%), Positives = 133/306 (43%), Gaps = 26/306 (8%)

Query: 31  PPTAPNTNNNTTATTAAIAYSDLEKL-------QVLGHGNGGTVYKVQHRCTHKIYALKV 83
           P  A  T        +    +   K        + LG G    V +  H+ T   +A K+
Sbjct: 2   PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61

Query: 84  VHGDADPTVRRQ-VFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTL-DTLL 141
           ++         Q + RE  I R+   P IV+     ++      ++ + +  G L + ++
Sbjct: 62  INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-SFHYLVFDLVTGGELFEDIV 120

Query: 142 NKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNN--NNMQVKIADFGVSK 199
            +   +SE   +H   QIL+ ++Y H + I+HR++KP NLL+ +      VK+ADFG++ 
Sbjct: 121 AR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179

Query: 200 IMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQP 259
            +    +A + + GT  Y+SPE    D Y         DIW+ G+ L  L +G+ PF   
Sbjct: 180 EV-NDSEAWHGFAGTPGYLSPEVLKKDPY-----SKPVDIWACGVILYILLVGYPPFWDE 233

Query: 260 GQRPDWATLMCAICFGDP--PSLP-DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLC 316
            Q      L   I  G    PS   D  +PE +S I+  L     KR TA Q L  P++C
Sbjct: 234 DQ----HRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWIC 289

Query: 317 KNRRSD 322
              R  
Sbjct: 290 NRERVA 295

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  180 bits (459), Expect = 3e-55
 Identities = 81/273 (29%), Positives = 128/273 (46%), Gaps = 20/273 (7%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQ-VFREMEILRRTDSPFIVQCF 115
            +LG G+ G V K + R T + YA+KV++  +        + RE+E+L++ D P I++ F
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 116 GIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
            I E  S    I+ E    G L D ++ +   FSE   A I  Q+  G++Y+H H I+HR
Sbjct: 88  EILEDSS-SFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHR 145

Query: 175 DIKPSNLLVNNN--NMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNY 232
           D+KP N+L+ +   +  +KI DFG+S    +        +GT  Y++PE        G Y
Sbjct: 146 DLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKMKDRIGTAYYIAPEVLR-----GTY 199

Query: 233 NGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP--PSLP-DGASPEFR 289
                D+WS G+ L  L  G  PF    +      ++  +  G            S + +
Sbjct: 200 -DEKCDVWSAGVILYILLSGTPPFYGKNE----YDILKRVETGKYAFDLPQWRTISDDAK 254

Query: 290 SFIECCLQKEFSKRWTASQLLTHPFLCKNRRSD 322
             I   L    S R TA+Q L HP++ K    +
Sbjct: 255 DLIRKMLTFHPSLRITATQCLEHPWIQKYSSEE 287

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  180 bits (458), Expect = 4e-55
 Identities = 66/279 (23%), Positives = 120/279 (43%), Gaps = 25/279 (8%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH-----GDADPTVRRQVF-REME 101
           +A +++E  + +G G  G V+K +      + A+K +      G+ +   + Q F RE+ 
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75

Query: 102 ILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQIL 160
           I+   + P IV+ +G+   P     ++ME++  G L   LL+K           +   I 
Sbjct: 76  IMSNLNHPNIVKLYGLMHNP---PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIA 132

Query: 161 KGLSYLHGHK--IIHRDIKPSNLLVN----NNNMQVKIADFGVSKIMCRSLDACNSYVGT 214
            G+ Y+      I+HRD++  N+ +     N  +  K+ADFG+S+    S+      +G 
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGL---LGN 189

Query: 215 CAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICF 274
             +M+PE    +    +Y   A D +S  + L  +  G  PF            +  I  
Sbjct: 190 FQWMAPETIGAE--EESYTEKA-DTYSFAMILYTILTGEGPF--DEYSYGKIKFINMIRE 244

Query: 275 GDP-PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH 312
               P++P+   P  R+ IE C   +  KR   S ++  
Sbjct: 245 EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  186 bits (473), Expect = 4e-55
 Identities = 73/282 (25%), Positives = 120/282 (42%), Gaps = 29/282 (10%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVH------------GDADPTVRRQVFREMEILR 104
           + LG G  G V   + +  H   A+KV+                      +++ E+ +L+
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 105 RTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLS 164
             D P I++ F +FE       ++ E+ + G L   +     F E   A+I  QIL G+ 
Sbjct: 102 SLDHPNIIKLFDVFEDKKY-FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGIC 160

Query: 165 YLHGHKIIHRDIKPSNLLVNNN--NMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
           YLH H I+HRDIKP N+L+ N    + +KI DFG+S             +GT  Y++PE 
Sbjct: 161 YLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF-SKDYKLRDRLGTAYYIAPEV 219

Query: 223 FDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP--PSL 280
                    Y     D+WS G+ +  L  G+ PF     +     ++  +  G       
Sbjct: 220 LK-----KKY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQ----DIIKKVEKGKYYFDFN 269

Query: 281 P-DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS 321
                S E +  I+  L  +++KR TA + L   ++ K   +
Sbjct: 270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANN 311

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  181 bits (461), Expect = 5e-55
 Identities = 67/279 (24%), Positives = 125/279 (44%), Gaps = 21/279 (7%)

Query: 50  YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS- 108
           Y    K + LG G+     K  H+ +++ +A+K++       +     +E+  L+  +  
Sbjct: 10  YDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKII----SKRMEANTQKEITALKLCEGH 65

Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
           P IV+   +F        ++ME ++ G L + +  K   FSE + ++I  +++  +S++H
Sbjct: 66  PNIVKLHEVFHDQL-HTFLVMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMH 123

Query: 168 GHKIIHRDIKPSNLLVNNN--NMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDP 225
              ++HRD+KP NLL  +   N+++KI DFG +++         +   T  Y +PE  + 
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQ 183

Query: 226 DAYGGNYNGYAGDIWSLGLTLLELYLGHFPF---LQPGQRPDWATLMCAICFGDP--PSL 280
           + Y       + D+WSLG+ L  +  G  PF    +         +M  I  GD      
Sbjct: 184 NGY-----DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE 238

Query: 281 P-DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN 318
                S E +  I+  L  + +KR   S L  + +L   
Sbjct: 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  181 bits (461), Expect = 6e-55
 Identities = 70/322 (21%), Positives = 121/322 (37%), Gaps = 76/322 (23%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVH----GDADPTVRRQVFREMEILRRTDSPFIV 112
             +G G+ G V       T  I A+K+++       +P    ++  E+ ++++   P I 
Sbjct: 32  GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91

Query: 113 QCFGIFEKPSGDIAILMEYMDSGTL----------------------------------- 137
           + + ++E     I ++ME    G L                                   
Sbjct: 92  RLYEVYEDEQ-YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150

Query: 138 -----DTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSN-LLVNNNNMQVK 191
                    + +    E  +++I  QI   L YLH   I HRDIKP N L   N + ++K
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIK 210

Query: 192 IADFGVSKIMCRSLDA----CNSYVGTCAYMSPE--RFDPDAYGGNYNGYAGDIWSLGLT 245
           + DFG+SK   +  +       +  GT  +++PE      ++Y     G   D WS G+ 
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY-----GPKCDAWSAGVL 265

Query: 246 LLELYLGHFPFLQPGQRPDWAT---------LMCAICFGDPPSLPDGASPEFRSFIECCL 296
           L  L +G  PF                    L   +CF +P    +  SP  R  +   L
Sbjct: 266 LHLLLMGAVPF--------PGVNDADTISQVLNKKLCFENPNY--NVLSPLARDLLSNLL 315

Query: 297 QKEFSKRWTASQLLTHPFLCKN 318
            +   +R+ A + L HP++ + 
Sbjct: 316 NRNVDERFDAMRALQHPWISQF 337

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  179 bits (456), Expect = 1e-54
 Identities = 76/281 (27%), Positives = 126/281 (44%), Gaps = 24/281 (8%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKV--------VHGDADPTVRRQVFREMEILRRTDS 108
           ++LG G    V +  H+ T K YA+K+           +    +R    +E++ILR+   
Sbjct: 23  EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82

Query: 109 -PFIVQCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSYL 166
            P I+Q    +E  +    ++ + M  G L D L  K  T SE +   I   +L+ +  L
Sbjct: 83  HPNIIQLKDTYETNT-FFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICAL 140

Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE--RFD 224
           H   I+HRD+KP N+L+ +++M +K+ DFG S  +    +      GT +Y++PE     
Sbjct: 141 HKLNIVHRDLKPENILL-DDDMNIKLTDFGFSCQL-DPGEKLREVCGTPSYLAPEIIECS 198

Query: 225 PDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP--PSLP- 281
            +     Y G   D+WS G+ +  L  G  PF    Q      ++  I  G+    S   
Sbjct: 199 MNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQ----MLMLRMIMSGNYQFGSPEW 253

Query: 282 DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSD 322
           D  S   +  +   L  +  KR+TA + L HPF  +    +
Sbjct: 254 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEE 294

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  187 bits (477), Expect = 1e-54
 Identities = 73/291 (25%), Positives = 116/291 (39%), Gaps = 35/291 (12%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           E  + LG G  G V +  H+ T +  A+K    +  P  R +   E++I+++ + P +V 
Sbjct: 17  EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 76

Query: 114 CFGIFEKPSGDIA-----ILMEYMDSGTLDTLLNKNGT---FSEPKLAHIASQILKGLSY 165
              + +            + MEY + G L   LN+        E  +  + S I   L Y
Sbjct: 77  AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRY 136

Query: 166 LHGHKIIHRDIKPSNLLV--NNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF 223
           LH ++IIHRD+KP N+++      +  KI D G +K +    + C  +VGT  Y++PE  
Sbjct: 137 LHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL-DQGELCTEFVGTLQYLAPELL 195

Query: 224 DPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFL---QPGQR------------PDWATL 268
           +   Y         D WS G    E   G  PFL   QP Q               +  L
Sbjct: 196 EQKKY-----TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL 250

Query: 269 MCAICFG----DPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
             A+ F      P  L    + +   +++C L     +R T  Q       
Sbjct: 251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCF 301

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  183 bits (465), Expect = 1e-54
 Identities = 64/287 (22%), Positives = 111/287 (38%), Gaps = 36/287 (12%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS-PFIVQCF 115
           ++LG+G+ GTV   Q     +  A+K +  D           E+++L  +D  P +++ +
Sbjct: 21  KILGYGSSGTVVF-QGSFQGRPVAVKRMLIDFCDIALM----EIKLLTESDDHPNVIRYY 75

Query: 116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFS-------EPKLAHIASQILKGLSYLHG 168
                    + I +E  +   L  L+              E     +  QI  G+++LH 
Sbjct: 76  CSETTDR-FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133

Query: 169 HKIIHRDIKPSNLLVNN------------NNMQVKIADFGVSKIM----CRSLDACNSYV 212
            KIIHRD+KP N+LV+              N+++ I+DFG+ K +           N+  
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193

Query: 213 GTCAYMSPERFDPDAYGGNYNGY--AGDIWSLGLTLLELY-LGHFPFLQPGQRPDWATLM 269
           GT  + +PE  +             + DI+S+G     +   G  PF     R +   + 
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR-ESNIIR 252

Query: 270 CAICFGDPPSLP-DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
                 +   L       E    I   +  +  KR TA ++L HP  
Sbjct: 253 GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  179 bits (456), Expect = 1e-54
 Identities = 79/274 (28%), Positives = 131/274 (47%), Gaps = 24/274 (8%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           +VLG G    V+ V+ R T K++ALK +   +       +  E+ +L++     IV    
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIK-KSPAFRDSSLENEIAVLKKIKHENIVTLED 73

Query: 117 IFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRD 175
           I+E  +    ++M+ +  G L D +L + G ++E   + +  Q+L  + YLH + I+HRD
Sbjct: 74  IYESTT-HYYLVMQLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENGIVHRD 131

Query: 176 IKPSNLLVNNN--NMQVKIADFGVSKIMCRSL--DACNSYVGTCAYMSPERFDPDAYGGN 231
           +KP NLL      N ++ I DFG+SK+    +   AC    GT  Y++PE      Y   
Sbjct: 132 LKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC----GTPGYVAPEVLAQKPY--- 184

Query: 232 YNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP--PSLP-DGASPEF 288
               A D WS+G+    L  G+ PF +  +    + L   I  G     S   D  S   
Sbjct: 185 --SKAVDCWSIGVITYILLCGYPPFYEETE----SKLFEKIKEGYYEFESPFWDDISESA 238

Query: 289 RSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSD 322
           + FI   L+K+ ++R+T  + L+HP++  N    
Sbjct: 239 KDFICHLLEKDPNERYTCEKALSHPWIDGNTALH 272

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  178 bits (453), Expect = 2e-54
 Identities = 76/268 (28%), Positives = 119/268 (44%), Gaps = 20/268 (7%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
             +G G+ G V     + T    A K +       V R   +E+EI++  D P I++ + 
Sbjct: 15  NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR-FKQEIEIMKSLDHPNIIRLYE 73

Query: 117 IFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRD 175
            FE  + DI ++ME    G L + +++K   F E   A I   +L  ++Y H   + HRD
Sbjct: 74  TFEDNT-DIYLVMELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLNVAHRD 131

Query: 176 IKPSNLLVNNN--NMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYN 233
           +KP N L   +  +  +K+ DFG++    +      + VGT  Y+SP+  +     G Y 
Sbjct: 132 LKPENFLFLTDSPDSPLKLIDFGLAARF-KPGKMMRTKVGTPYYVSPQVLE-----GLY- 184

Query: 234 GYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP--PSLP-DGASPEFRS 290
           G   D WS G+ +  L  G+ PF  P      + +M  I  G    P       SP+  S
Sbjct: 185 GPECDEWSAGVMMYVLLCGYPPFSAPTD----SEVMLKIREGTFTFPEKDWLNVSPQAES 240

Query: 291 FIECCLQKEFSKRWTASQLLTHPFLCKN 318
            I   L K   +R T+ Q L H +  K 
Sbjct: 241 LIRRLLTKSPKQRITSLQALEHEWFEKQ 268

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  178 bits (455), Expect = 3e-54
 Identities = 64/270 (23%), Positives = 107/270 (39%), Gaps = 18/270 (6%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           + LG G  G V++     + K Y  K V        +  V +E+ IL       I+    
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD--QVLVKKEISILNIARHRNILHLHE 68

Query: 117 IFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRD 175
            FE    ++ ++ E++    + + +       +E ++     Q+ + L +LH H I H D
Sbjct: 69  SFESME-ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFD 127

Query: 176 IKPSNLL-VNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNG 234
           I+P N++     +  +KI +FG ++ +    D          Y +PE    D        
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQHDVV-----S 181

Query: 235 YAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP--PSLP-DGASPEFRSF 291
            A D+WSLG  +  L  G  PFL          ++  I   +           S E   F
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETN----QQIIENIMNAEYTFDEEAFKEISIEAMDF 237

Query: 292 IECCLQKEFSKRWTASQLLTHPFLCKNRRS 321
           ++  L KE   R TAS+ L HP+L +    
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWLKQKIER 267

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  178 bits (455), Expect = 3e-54
 Identities = 71/276 (25%), Positives = 119/276 (43%), Gaps = 20/276 (7%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVH-----GDADPTVRRQVFREMEILRRTDSPFI 111
           + LG G    V K + + T   YA K +             R ++ RE+ ILR+     +
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77

Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           +    ++E  + D+ +++E +  G L D L  K  + SE +      QIL G++YLH  K
Sbjct: 78  ITLHDVYENRT-DVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKK 135

Query: 171 IIHRDIKPSNLLV---NNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDA 227
           I H D+KP N+++   N     +K+ DFG++  +        +  GT  +++PE  + + 
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIVNYEP 194

Query: 228 YGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDW-ATLMCAICFGDPPSLPDGASP 286
                 G   D+WS+G+    L  G  PFL   ++         +  F +        S 
Sbjct: 195 L-----GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFF--SHTSE 247

Query: 287 EFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSD 322
             + FI   L KE  KR T  + L HP++       
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQ 283

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  182 bits (463), Expect = 4e-54
 Identities = 74/273 (27%), Positives = 119/273 (43%), Gaps = 18/273 (6%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQ-VFREMEILRRTDSPFIVQCF 115
           + LG G    V +       + YA  +++         Q + RE  I R    P IV+  
Sbjct: 17  EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76

Query: 116 GIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
               +  G   ++ + +  G L + ++ +   +SE   +H   QIL+ + + H   ++HR
Sbjct: 77  DSISEE-GHHYLIFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMGVVHR 134

Query: 175 DIKPSNLLVNN--NNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNY 232
           ++KP NLL+ +      VK+ADFG++  +     A   + GT  Y+SPE    D Y    
Sbjct: 135 NLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY---- 190

Query: 233 NGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP--PSLP-DGASPEFR 289
            G   D+W+ G+ L  L +G+ PF    Q      L   I  G    PS   D  +PE +
Sbjct: 191 -GKPVDLWACGVILYILLVGYPPFWDEDQ----HRLYQQIKAGAYDFPSPEWDTVTPEAK 245

Query: 290 SFIECCLQKEFSKRWTASQLLTHPFLCKNRRSD 322
             I   L    SKR TA++ L HP++       
Sbjct: 246 DLINKMLTINPSKRITAAEALKHPWISHRSTVA 278

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  179 bits (455), Expect = 4e-54
 Identities = 70/315 (22%), Positives = 114/315 (36%), Gaps = 41/315 (13%)

Query: 27  PLALPPTAPNTNNNTTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHG 86
           P +L   +    ++    T  +    L   +VL  G    VY+ Q   + + YALK +  
Sbjct: 4   PGSLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS 63

Query: 87  DADPTVRRQVFREMEILRR-TDSPFIVQCFGIFEKPSGDIA-------ILMEYMDSGTLD 138
             +    R + +E+  +++ +  P IVQ          +         +L E      ++
Sbjct: 64  -NEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVE 122

Query: 139 TLLNK--NGTFSEPKLAHIASQILKGLSYLHGHK--IIHRDIKPSNLLVNNNNMQVKIAD 194
            L      G  S   +  I  Q  + + ++H  K  IIHRD+K  NLL+ +N   +K+ D
Sbjct: 123 FLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL-SNQGTIKLCD 181

Query: 195 FGVSKIMCRSLDACNS------------YVGTCAYMSPERFDPDAYGGNYNGYAGDIWSL 242
           FG +  +    D   S               T  Y +PE  D   Y     G   DIW+L
Sbjct: 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDL--YSNFPIGEKQDIWAL 239

Query: 243 GLTLLELYLGHFPFLQPGQRPDWATLMCAIC---FGDPPSLPDGASPEFRSFIECCLQKE 299
           G  L  L     PF    +          I    +  PP         F S I   LQ  
Sbjct: 240 GCILYLLCFRQHPFEDGAKL--------RIVNGKYSIPPHDT--QYTVFHSLIRAMLQVN 289

Query: 300 FSKRWTASQLLTHPF 314
             +R + ++++    
Sbjct: 290 PEERLSIAEVVHQLQ 304

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  179 bits (456), Expect = 5e-54
 Identities = 46/355 (12%), Positives = 101/355 (28%), Gaps = 44/355 (12%)

Query: 3   VVKQRRQLNLRLPMPELSERCLRFPLALPPTAPNTNNNTTATTAAIAYSDLEKLQVLGHG 62
           ++K+  +L        L E             P     T  +  +     L+ ++ L  G
Sbjct: 14  LLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVG 73

Query: 63  NGGTVYKVQHRCTHKIYALKVVH--GDADPTVRRQVFREMEILRRTDSPFIVQCFGIF-- 118
           +   V+ V+     + +ALKV     +   +   ++        R       +       
Sbjct: 74  DRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRL 133

Query: 119 -----------------------EKPSGDIAILMEYMDS------GTLDTLLNKNGTFSE 149
                                  +    +  +LM            TLD +    G    
Sbjct: 134 LLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGI 193

Query: 150 PKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN 209
             L  + +Q+++  + L    ++H    P NL +   + ++ + D      +     A  
Sbjct: 194 LALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI-MPDGRLMLGDVSALWKVGTRGPAS- 251

Query: 210 SYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLM 269
                  Y   E  +          +A + W LGL++  ++    PF         +   
Sbjct: 252 --SVPVTYAPREFLNASTATF---THALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKR 306

Query: 270 CAICFGDPPSLP----DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR 320
            ++      SL            ++ I   L  +  +R    + +  P   + + 
Sbjct: 307 PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQN 361

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  179 bits (455), Expect = 7e-54
 Identities = 74/276 (26%), Positives = 121/276 (43%), Gaps = 20/276 (7%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVH-----GDADPTVRRQVFREMEILRRTDSPFI 111
           + LG G    V K + + T   YA K +             R ++ RE+ ILR+   P I
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77

Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           +    ++E  + D+ +++E +  G L D L  K  + SE +      QIL G++YLH  K
Sbjct: 78  ITLHDVYENRT-DVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKK 135

Query: 171 IIHRDIKPSNLLV---NNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDA 227
           I H D+KP N+++   N     +K+ DFG++  +        +  GT  +++PE  + + 
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIVNYEP 194

Query: 228 YGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWAT-LMCAICFGDPPSLPDGASP 286
                 G   D+WS+G+    L  G  PFL   ++   A     +  F +        S 
Sbjct: 195 L-----GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF--SQTSE 247

Query: 287 EFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSD 322
             + FI   L KE  KR T  + L HP++       
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQ 283

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  179 bits (456), Expect = 9e-54
 Identities = 68/270 (25%), Positives = 120/270 (44%), Gaps = 13/270 (4%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           + LG G  G V++   + T +++  K ++    P  +  V  E+ I+ +   P ++    
Sbjct: 57  EELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHD 115

Query: 117 IFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRD 175
            FE    ++ +++E++  G L D +  ++   SE ++ +   Q  +GL ++H H I+H D
Sbjct: 116 AFEDKY-EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLD 174

Query: 176 IKPSNLL-VNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNG 234
           IKP N++        VKI DFG++  +    +       T  + +PE  D +       G
Sbjct: 175 IKPENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDREPV-----G 228

Query: 235 YAGDIWSLGLTLLELYLGHFPFLQPGQRPDWAT-LMCAICFGDPPSLPDGASPEFRSFIE 293
           +  D+W++G+    L  G  PF              C   F +        SPE + FI+
Sbjct: 229 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF--SSVSPEAKDFIK 286

Query: 294 CCLQKEFSKRWTASQLLTHPFLCKNRRSDC 323
             LQKE  KR T    L HP+L  +  +  
Sbjct: 287 NLLQKEPRKRLTVHDALEHPWLKGDHSNLT 316

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  182 bits (464), Expect = 3e-53
 Identities = 64/270 (23%), Positives = 114/270 (42%), Gaps = 17/270 (6%)

Query: 58  VLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGI 117
            LG G  G V++V  R T   +A K V      + +  V +E++ +     P +V     
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDA 222

Query: 118 FEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDI 176
           FE  + ++ ++ E+M  G L + + +++   SE +      Q+ KGL ++H +  +H D+
Sbjct: 223 FEDDN-EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDL 281

Query: 177 KPSNLL-VNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGY 235
           KP N++     + ++K+ DFG++        +     GT  + +PE  +         GY
Sbjct: 282 KPENIMFTTKRSNELKLIDFGLTA-HLDPKQSVKVTTGTAEFAAPEVAEGKPV-----GY 335

Query: 236 AGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP--PSLP-DGASPEFRSFI 292
             D+WS+G+    L  G  PF            +  +   D         G S + + FI
Sbjct: 336 YTDMWSVGVLSYILLSGLSPFGGEND----DETLRNVKSCDWNMDDSAFSGISEDGKDFI 391

Query: 293 ECCLQKEFSKRWTASQLLTHPFLCKNRRSD 322
              L  + + R T  Q L HP+L       
Sbjct: 392 RKLLLADPNTRMTIHQALEHPWLTPGNAPG 421

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  178 bits (453), Expect = 4e-53
 Identities = 38/322 (11%), Positives = 93/322 (28%), Gaps = 45/322 (13%)

Query: 35  PNTNNNTTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT--- 91
                    +        L +  VLG  +     +   + T + + + V +    P    
Sbjct: 62  NTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNA 121

Query: 92  ---VRRQVFRE---------------------MEILRRTDSPFIVQCFGIFEKPS-GDIA 126
              ++ +V R                       ++++      +++              
Sbjct: 122 IKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRF 181

Query: 127 ILMEYMDS------GTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSN 180
            L   M S        L +  + + +        +  Q+++ L+ LH + ++H  ++P +
Sbjct: 182 FLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVD 241

Query: 181 LLVNNNNMQVKIADFGVSKIM-CRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDI 239
           +++ +    V +  F         ++             +        +      +A D 
Sbjct: 242 IVL-DQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDT 300

Query: 240 WSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKE 299
           W+LGL +  ++    P                I F    ++P       R+ +E  L+  
Sbjct: 301 WTLGLAIYWIWCADLPN----TDDAALGGSEWI-FRSCKNIP----QPVRALLEGFLRYP 351

Query: 300 FSKRWTASQLLTHPFLCKNRRS 321
              R    Q +  P   + R  
Sbjct: 352 KEDRLLPLQAMETPEYEQLRTE 373

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  176 bits (448), Expect = 9e-53
 Identities = 81/277 (29%), Positives = 123/277 (44%), Gaps = 31/277 (11%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVV-------HGDADPTVRRQVFREMEILRR-TDS 108
            V+G G    V +  HR T   +A+K++         +    VR    RE  ILR+    
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159

Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
           P I+     +E  S  + ++ + M  G L D L  K    SE +   I   +L+ +S+LH
Sbjct: 160 PHIITLIDSYESSS-FMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLH 217

Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE--RFDP 225
            + I+HRD+KP N+L+ ++NMQ++++DFG S  +    +      GT  Y++PE  +   
Sbjct: 218 ANNIVHRDLKPENILL-DDNMQIRLSDFGFSCHL-EPGEKLRELCGTPGYLAPEILKCSM 275

Query: 226 DAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWA----TLMCAICFGDP--PS 279
           D     Y G   D+W+ G+ L  L  G  PF        W      ++  I  G     S
Sbjct: 276 DETHPGY-GKEVDLWACGVILFTLLAGSPPF--------WHRRQILMLRMIMEGQYQFSS 326

Query: 280 LP-DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
              D  S   +  I   LQ +   R TA Q L HPF 
Sbjct: 327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  174 bits (443), Expect = 2e-52
 Identities = 71/278 (25%), Positives = 116/278 (41%), Gaps = 24/278 (8%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVH-----GDADPTVRRQVFREMEILRRTDSPFI 111
           + LG G    V K + + T   YA K +             R  + RE+ IL+    P +
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76

Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           +    ++E  + D+ +++E +  G L D L  K  + +E +      QIL G+ YLH  +
Sbjct: 77  ITLHEVYENKT-DVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQ 134

Query: 171 IIHRDIKPSNLLV---NNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDA 227
           I H D+KP N+++   N    ++KI DFG++  +    +   +  GT  +++PE  + + 
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAPEIVNYEP 193

Query: 228 YGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPD---WATLMCAICFGDPPSLPDGA 284
                 G   D+WS+G+    L  G  PFL  G                F D        
Sbjct: 194 L-----GLEADMWSIGVITYILLSGASPFL--GDTKQETLANVSAVNYEFEDEYF--SNT 244

Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSD 322
           S   + FI   L K+  KR T    L HP++       
Sbjct: 245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  174 bits (442), Expect = 2e-52
 Identities = 65/277 (23%), Positives = 112/277 (40%), Gaps = 22/277 (7%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVF-REMEILRRT 106
           I +  LE  +++G G  G VY  +        A++++  + D   + + F RE+   R+T
Sbjct: 30  IPFEQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQT 86

Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQILKGLSY 165
               +V   G    P   +AI+       TL +++ +        K   IA +I+KG+ Y
Sbjct: 87  RHENVVLFMGACMSP-PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGY 145

Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSY-----VGTCAYMSP 220
           LH   I+H+D+K  N+  +N    V I DFG+  I                 G   +++P
Sbjct: 146 LHAKGILHKDLKSKNVFYDNGK--VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203

Query: 221 E--RFDPDAYGGNYNGY--AGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD 276
           E  R        +   +    D+++LG    EL+   +PF    Q  +          G 
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF--KTQPAEAIIWQMG--TGM 259

Query: 277 PPSLPD-GASPEFRSFIECCLQKEFSKRWTASQLLTH 312
            P+L   G   E    +  C   E  +R T ++L+  
Sbjct: 260 KPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  173 bits (441), Expect = 3e-52
 Identities = 78/265 (29%), Positives = 129/265 (48%), Gaps = 24/265 (9%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVF-REMEILRRT 106
           I + DL   + +G G+ GTV++ +        A+K++        R   F RE+ I++R 
Sbjct: 34  IPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRL 91

Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGT---FSEPKLAHIASQILKGL 163
             P IV   G   +P  +++I+ EY+  G+L  LL+K+G      E +   +A  + KG+
Sbjct: 92  RHPNIVLFMGAVTQPP-NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 150

Query: 164 SYLHGHK--IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
           +YLH     I+HR++K  NLLV+     VK+ DFG+S++   +  +  S  GT  +M+PE
Sbjct: 151 NYLHNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPE 209

Query: 222 RFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPF--LQPGQRPDWATLMCAICFGDP-P 278
                      N  + D++S G+ L EL     P+  L P Q      ++ A+ F     
Sbjct: 210 VLR----DEPSNEKS-DVYSFGVILWELATLQQPWGNLNPAQ------VVAAVGFKCKRL 258

Query: 279 SLPDGASPEFRSFIECCLQKEFSKR 303
            +P   +P+  + IE C   E  KR
Sbjct: 259 EIPRNLNPQVAAIIEGCWTNEPWKR 283

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  174 bits (443), Expect = 3e-52
 Identities = 67/270 (24%), Positives = 120/270 (44%), Gaps = 21/270 (7%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRR-TDSPFIVQCF 115
           + +G G+     +  H+ T+  +A+K++        +R    E+EIL R    P I+   
Sbjct: 28  EDIGVGSYSVCKRCIHKATNMEFAVKII-----DKSKRDPTEEIEILLRYGQHPNIITLK 82

Query: 116 GIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
            +++     + ++ E M  G L D +L +   FSE + + +   I K + YLH   ++HR
Sbjct: 83  DVYDDGK-YVYVVTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQGVVHR 140

Query: 175 DIKPSNLLVNN---NNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGN 231
           D+KPSN+L  +   N   ++I DFG +K +        +   T  +++PE  +   Y   
Sbjct: 141 DLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGY--- 197

Query: 232 YNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFG--DPPSLP-DGASPEF 288
               A DIWSLG+ L  +  G+ PF           ++  I  G         +  S   
Sbjct: 198 --DAACDIWSLGVLLYTMLTGYTPFANGPDDTP-EEILARIGSGKFSLSGGYWNSVSDTA 254

Query: 289 RSFIECCLQKEFSKRWTASQLLTHPFLCKN 318
           +  +   L  +  +R TA+ +L HP++   
Sbjct: 255 KDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  171 bits (437), Expect = 5e-52
 Identities = 77/288 (26%), Positives = 127/288 (44%), Gaps = 28/288 (9%)

Query: 51  SDLEKL----QVLGHGNGGTVYKVQHRCTHKIYALKVVH-----GDADPTVRRQVFREME 101
           S +E      + LG G    V K + + T K YA K +             R ++ RE+ 
Sbjct: 1   SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60

Query: 102 ILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQIL 160
           ILR    P I+    IFE  + D+ +++E +  G L D L  K  + +E +      QIL
Sbjct: 61  ILREIRHPNIITLHDIFENKT-DVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQIL 118

Query: 161 KGLSYLHGHKIIHRDIKPSNLLV---NNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAY 217
            G+ YLH  +I H D+KP N+++   N  N ++K+ DFG++  +    +   +  GT  +
Sbjct: 119 DGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG-NEFKNIFGTPEF 177

Query: 218 MSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP 277
           ++PE  + +       G   D+WS+G+    L  G  PFL   +       +  I   + 
Sbjct: 178 VAPEIVNYEPL-----GLEADMWSIGVITYILLSGASPFLGETK----QETLTNISAVNY 228

Query: 278 --PSLP-DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSD 322
                     S   + FI   L K+  +R T +Q L H ++   RR +
Sbjct: 229 DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  173 bits (441), Expect = 5e-52
 Identities = 73/273 (26%), Positives = 127/273 (46%), Gaps = 24/273 (8%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRR-TDSPFIVQCF 115
           QVLG G  G V +  HR T +  ALK+++         +  +E++   + +  P IV   
Sbjct: 35  QVLGLGVNGKVLECFHRRTGQKCALKLLYD------SPKARQEVDHHWQASGGPHIVCIL 88

Query: 116 GIFE---KPSGDIAILMEYMDSGTL-DTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHK 170
            ++E        + I+ME M+ G L   +  + +  F+E + A I   I   + +LH H 
Sbjct: 89  DVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN 148

Query: 171 IIHRDIKPSNLLVNNN--NMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAY 228
           I HRD+KP NLL  +   +  +K+ DFG +K    + +A  +   T  Y++PE   P+ Y
Sbjct: 149 IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNALQTPCYTPYYVAPEVLGPEKY 206

Query: 229 GGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP--PSLP-DGAS 285
                  + D+WSLG+ +  L  G  PF     +     +   I  G    P+      S
Sbjct: 207 -----DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVS 261

Query: 286 PEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN 318
            + +  I   L+ + ++R T +Q + HP++ ++
Sbjct: 262 EDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  172 bits (437), Expect = 2e-51
 Identities = 54/263 (20%), Positives = 100/263 (38%), Gaps = 28/263 (10%)

Query: 68  YKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAI 127
              +      +         + P+       ++  +    +   V        P   + I
Sbjct: 80  KWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSS-PKVYLYI 138

Query: 128 LMEYMDSGTLDTLLNKNGTFSEPKLA---HIASQILKGLSYLHGHKIIHRDIKPSNLLVN 184
            M+      L   +N+  +  + +     HI  QI + + +LH   ++HRD+KPSN+   
Sbjct: 139 QMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT 198

Query: 185 NNNMQVKIADFGVSKIMCRSLDACN------------SYVGTCAYMSPERFDPDAYGGNY 232
            ++  VK+ DFG+   M +  +                 VGT  YMSPE+      G NY
Sbjct: 199 MDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIH----GNNY 253

Query: 233 NGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFI 292
           + +  DI+SLGL L EL    + F    +R     ++  +     P L     P+    +
Sbjct: 254 S-HKVDIFSLGLILFELL---YSFSTQMER---VRIITDVRNLKFPLLFTQKYPQEHMMV 306

Query: 293 ECCLQKEFSKRWTASQLLTHPFL 315
           +  L    ++R  A+ ++ +   
Sbjct: 307 QDMLSPSPTERPEATDIIENAIF 329

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 63.7 bits (155), Expect = 1e-11
 Identities = 22/131 (16%), Positives = 49/131 (37%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
           +D E +Q +G G  G V++ +++     YA+K +        R +V RE++ L + + P 
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           IV+ F  + +   +             ++      + S      +  + +   S  +   
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 171 IIHRDIKPSNL 181
            +        L
Sbjct: 126 QLQPSSPKVYL 136

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  170 bits (434), Expect = 3e-51
 Identities = 78/296 (26%), Positives = 130/296 (43%), Gaps = 26/296 (8%)

Query: 31  PPTAPNTNNNTTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADP 90
           P      +             D +  ++LG G+  TV   +   T + YA+K++  +   
Sbjct: 10  PGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRH 67

Query: 91  TVRRQ----VFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGT 146
            ++      V RE +++ R D PF V+ +  F+     +   + Y  +G L   + K G+
Sbjct: 68  IIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGS 126

Query: 147 FSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD 206
           F E       ++I+  L YLHG  IIHRD+KP N+L+ N +M ++I DFG +K++     
Sbjct: 127 FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL-NEDMHIQITDFGTAKVLSPESK 185

Query: 207 A--CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPD 264
               NS+VGT  Y+SPE     +        + D+W+LG  + +L  G  PF    +  +
Sbjct: 186 QARANSFVGTAQYVSPELLTEKSA-----CKSSDLWALGCIIYQLVAGLPPF----RAGN 236

Query: 265 WATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWT------ASQLLTHPF 314
              +   I        P+   P+ R  +E  L  + +KR           L  HPF
Sbjct: 237 EYLIFQKIIKL-EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  170 bits (434), Expect = 3e-51
 Identities = 67/271 (24%), Positives = 112/271 (41%), Gaps = 25/271 (9%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
              SDL   +VLG G  G   KV HR T ++  +K +    D   +R   +E++++R  +
Sbjct: 7   FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELI-RFDEETQRTFLKEVKVMRCLE 65

Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQILKGLSYL 166
            P +++  G+  K    +  + EY+  GTL  ++ + +  +   +    A  I  G++YL
Sbjct: 66  HPNVLKFIGVLYKD-KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL 124

Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN--------------SYV 212
           H   IIHRD+   N LV  N   V +ADFG++++M                      + V
Sbjct: 125 HSMNIIHRDLNSHNCLVRENKN-VVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183

Query: 213 GTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAI 272
           G   +M+PE  +    G +Y+    D++S G+ L E+         P   P        +
Sbjct: 184 GNPYWMAPEMIN----GRSYD-EKVDVFSFGIVLCEIIGRVNAD--PDYLPRTMDFGLNV 236

Query: 273 CFGDPPSLPDGASPEFRSFIECCLQKEFSKR 303
                   P    P F      C   +  KR
Sbjct: 237 RGFLDRYCPPNCPPSFFPITVRCCDLDPEKR 267

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  171 bits (436), Expect = 4e-51
 Identities = 86/272 (31%), Positives = 131/272 (48%), Gaps = 20/272 (7%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
             LG G    VY+ + + T K YALKV+    D   ++ V  E+ +L R   P I++   
Sbjct: 59  SELGRGATSIVYRCKQKGTQKPYALKVLKKTVD---KKIVRTEIGVLLRLSHPNIIKLKE 115

Query: 117 IFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRD 175
           IFE P+ +I++++E +  G L D ++ K G +SE   A    QIL+ ++YLH + I+HRD
Sbjct: 116 IFETPT-EISLVLELVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENGIVHRD 173

Query: 176 IKPSNLLVNNN--NMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYN 233
           +KP NLL      +  +KIADFG+SKI+        +  GT  Y +PE     AY     
Sbjct: 174 LKPENLLYATPAPDAPLKIADFGLSKIV-EHQVLMKTVCGTPGYCAPEILRGCAY----- 227

Query: 234 GYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP--PSLP-DGASPEFRS 290
           G   D+WS+G+    L  G  PF    +R D   +   I   +    S   D  S   + 
Sbjct: 228 GPEVDMWSVGIITYILLCGFEPFY--DERGD-QFMFRRILNCEYYFISPWWDEVSLNAKD 284

Query: 291 FIECCLQKEFSKRWTASQLLTHPFLCKNRRSD 322
            +   +  +  KR T  Q L HP++     + 
Sbjct: 285 LVRKLIVLDPKKRLTTFQALQHPWVTGKAANF 316

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  170 bits (434), Expect = 5e-51
 Identities = 68/275 (24%), Positives = 117/275 (42%), Gaps = 20/275 (7%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQ-VFREMEILRRTDS-PFIVQC 114
           + LG G    V +   + T + YA K +         R  +  E+ +L    S P ++  
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94

Query: 115 FGIFEKPSGDIAILMEYMDSGTL-DTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKII 172
             ++E  S +I +++EY   G +    L +     SE  +  +  QIL+G+ YLH + I+
Sbjct: 95  HEVYENTS-EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIV 153

Query: 173 HRDIKPSNLLVNNN--NMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGG 230
           H D+KP N+L+++      +KI DFG+S+ +  +       +GT  Y++PE  + D    
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA-CELREIMGTPEYLAPEILNYDPI-- 210

Query: 231 NYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP--PSLP-DGASPE 287
                A D+W++G+    L     PF+              I   +           S  
Sbjct: 211 ---TTATDMWNIGIIAYMLLTHTSPFVGEDN----QETYLNISQVNVDYSEETFSSVSQL 263

Query: 288 FRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSD 322
              FI+  L K   KR TA   L+H +L +    +
Sbjct: 264 ATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN 298

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  171 bits (435), Expect = 8e-51
 Identities = 39/308 (12%), Positives = 95/308 (30%), Gaps = 54/308 (17%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT------VRRQVFR------- 98
            L +  VLG  +     +   + T + + + V +    P       ++ +V R       
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 99  --------------EMEILRRTDSPFIVQCFGIFEKPS-GDIAILMEYMDS------GTL 137
                           ++++      +++               L   M S        L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 138 DTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGV 197
            +  + + +        +  Q+++ L+ LH + ++H  ++P ++++ +    V +  F  
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL-DQRGGVFLTGFEH 252

Query: 198 SKIMCRSLDACNSYVGTCAYMSPERFDP------DAYGGNYNGYAGDIWSLGLTLLELYL 251
                  + +      +  +  PE                   ++ D W+LGL +  ++ 
Sbjct: 253 LVRDGARVVSS----VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308

Query: 252 GHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT 311
              P      +         I F    ++P       R+ +E  L+     R    Q + 
Sbjct: 309 ADLPI----TKDAALGGSEWI-FRSCKNIP----QPVRALLEGFLRYPKEDRLLPLQAME 359

Query: 312 HPFLCKNR 319
            P   + R
Sbjct: 360 TPEYEQLR 367

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  171 bits (436), Expect = 9e-51
 Identities = 74/270 (27%), Positives = 127/270 (47%), Gaps = 14/270 (5%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQ----VFREMEILRRT 106
              E L+ +G G+ G V  VQ   T K+YA+K ++      V R     VF+E++I++  
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQK--CVERNEVRNVFKELQIMQGL 72

Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
           + PF+V  +  F+    D+ ++++ +  G L   L +N  F E  +     +++  L YL
Sbjct: 73  EHPFLVNLWYSFQDEE-DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYL 131

Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPD 226
              +IIHRD+KP N+L++ +   V I DF ++ ++        +  GT  YM+PE F   
Sbjct: 132 QNQRIIHRDMKPDNILLDEHG-HVHITDFNIAAML-PRETQITTMAGTKPYMAPEMFSSR 189

Query: 227 AYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP 286
              G Y  +A D WSLG+T  EL  G  P+           ++         + P   S 
Sbjct: 190 KGAG-Y-SFAVDWWSLGVTAYELLRGRRPY-HIRSSTSSKEIVHTFETT-VVTYPSAWSQ 245

Query: 287 EFRSFIECCLQKEFSKRW-TASQLLTHPFL 315
           E  S ++  L+    +R+   S +   P++
Sbjct: 246 EMVSLLKKLLEPNPDQRFSQLSDVQNFPYM 275

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  171 bits (436), Expect = 1e-50
 Identities = 75/273 (27%), Positives = 130/273 (47%), Gaps = 23/273 (8%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRR-TDSPFIVQCF 115
           QVLG G  G V ++ ++ T + +ALK++             RE+E+  R +  P IV+  
Sbjct: 68  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK------ARREVELHWRASQCPHIVRIV 121

Query: 116 GIFE---KPSGDIAILMEYMDSGTL-DTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHK 170
            ++E        + I+ME +D G L   + ++ +  F+E + + I   I + + YLH   
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 181

Query: 171 IIHRDIKPSNLLVNNN--NMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAY 228
           I HRD+KP NLL  +   N  +K+ DFG +K    S ++  +   T  Y++PE   P+ Y
Sbjct: 182 IAHRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKY 240

Query: 229 GGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP--PSLP-DGAS 285
                  + D+WSLG+ +  L  G+ PF           +   I  G    P+      S
Sbjct: 241 -----DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 295

Query: 286 PEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN 318
            E +  I   L+ E ++R T ++ + HP++ ++
Sbjct: 296 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  168 bits (427), Expect = 2e-50
 Identities = 78/287 (27%), Positives = 125/287 (43%), Gaps = 37/287 (12%)

Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVV-------------------------HGDADPTVR 93
           +G G+ G V    +   +  YA+KV+                                  
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 94  RQVFREMEILRRTDSPFIVQCFGIFEKPSGD-IAILMEYMDSGTLDTLLNKNGTFSEPKL 152
            QV++E+ IL++ D P +V+   + + P+ D + ++ E ++ G +  +       SE + 
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-KPLSEDQA 139

Query: 153 AHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYV 212
                 ++KG+ YLH  KIIHRDIKPSNLLV  +   +KIADFGVS     S    ++ V
Sbjct: 140 RFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDG-HIKIADFGVSNEFKGSDALLSNTV 198

Query: 213 GTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAI 272
           GT A+M+PE          ++G A D+W++G+TL     G  PF           L   I
Sbjct: 199 GTPAFMAPESL--SETRKIFSGKALDVWAMGVTLYCFVFGQCPF----MDERIMCLHSKI 252

Query: 273 CFGDP--PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK 317
                  P  PD  + + +  I   L K    R    ++  HP++ +
Sbjct: 253 KSQALEFPDQPD-IAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  165 bits (420), Expect = 2e-49
 Identities = 68/281 (24%), Positives = 116/281 (41%), Gaps = 35/281 (12%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYK------VQHRCTHKIYALKVVH-GDADPTVRRQVFREM 100
           I    +   Q +G G+ GTVYK      V         A+K+++     P   +    E+
Sbjct: 21  IPDGQITVGQRIGSGSFGTVYKGKWHGDV---------AVKMLNVTAPTPQQLQAFKNEV 71

Query: 101 EILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQI 159
            +LR+T    I+   G    P   +AI+ ++ +  +L   L      F   KL  IA Q 
Sbjct: 72  GVLRKTRHVNILLFMGYSTAP--QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQT 129

Query: 160 LKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM--CRSLDACNSYVGTCAY 217
            +G+ YLH   IIHRD+K +N+ ++ +N  VKI DFG++                G+  +
Sbjct: 130 ARGMDYLHAKSIIHRDLKSNNIFLHEDNT-VKIGDFGLATEKSRWSGSHQFEQLSGSILW 188

Query: 218 MSPERFDPDAYGGNYNGY--AGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFG 275
           M+PE         + N Y    D+++ G+ L EL  G  P+           +   +  G
Sbjct: 189 MAPEVIR----MQDSNPYSFQSDVYAFGIVLYELMTGQLPY--SNINNRDQIIE-MVGRG 241

Query: 276 ----DPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH 312
               D   +        +  +  CL+K+  +R +  ++L  
Sbjct: 242 SLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE 282

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  166 bits (422), Expect = 2e-49
 Identities = 72/283 (25%), Positives = 124/283 (43%), Gaps = 26/283 (9%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRR-TDSPFIVQCF 115
            VLG G    V    +  T + YA+K++       +R +VFRE+E+L +      +++  
Sbjct: 19  DVLGEGAHARVQTCINLITSQEYAVKIIE-KQPGHIRSRVFREVEMLYQCQGHRNVLELI 77

Query: 116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRD 175
             FE+      ++ E M  G++ + ++K   F+E + + +   +   L +LH   I HRD
Sbjct: 78  EFFEEED-RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRD 136

Query: 176 IKPSNLLV--NNNNMQVKIADFGVSKIMCRSLDACNSY-------VGTCAYMSPERFDPD 226
           +KP N+L    N    VKI DF +   +  + D             G+  YM+PE  +  
Sbjct: 137 LKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAF 196

Query: 227 AYGGNYNGYAGDIWSLGLTLLELYLGHFPFL-QPGQRPDWAT----------LMCAICFG 275
           +   +      D+WSLG+ L  L  G+ PF+ + G    W            L  +I  G
Sbjct: 197 SEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEG 256

Query: 276 DP--PSLP-DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
               P       S   +  I   L ++  +R +A+Q+L HP++
Sbjct: 257 KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  164 bits (417), Expect = 1e-48
 Identities = 62/272 (22%), Positives = 111/272 (40%), Gaps = 30/272 (11%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVV-----HGDADPTVRRQVFREMEILR--RT 106
           +   +LG G  G+VY       +   A+K V         +     +V  E+ +L+   +
Sbjct: 46  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 105

Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMD-SGTLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
               +++    FE+P     +++E  +    L   + + G   E        Q+L+ + +
Sbjct: 106 GFSGVIRLLDWFERPD-SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 164

Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL--DACNSYVGTCAYMSPERF 223
            H   ++HRDIK  N+L++ N  ++K+ DFG   ++  ++  D      GT  Y  PE  
Sbjct: 165 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWI 220

Query: 224 DPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDG 283
                   Y+G +  +WSLG+ L ++  G  PF    +          I  G        
Sbjct: 221 ----RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQ-VFFRQR 265

Query: 284 ASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
            S E +  I  CL    S R T  ++  HP++
Sbjct: 266 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 297

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  163 bits (414), Expect = 1e-48
 Identities = 53/264 (20%), Positives = 101/264 (38%), Gaps = 23/264 (8%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRT 106
           I +  L  L  L   + G ++K   R       +KV+   D      R    E   LR  
Sbjct: 7   IDFKQLNFLTKLNENHSGELWKG--RWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64

Query: 107 DSPFIVQCFGI-FEKPSGDIAILMEYMDSGTLDTLL--NKNGTFSEPKLAHIASQILKGL 163
             P ++   G     P+    ++  +M  G+L  +L    N    + +    A  + +G+
Sbjct: 65  SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGM 124

Query: 164 SYLHGHK--IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
           ++LH  +  I    +   ++++ + +M  +I+   V              +   A+++PE
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMI-DEDMTARISMADVKFSF-----QSPGRMYAPAWVAPE 178

Query: 222 RFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPF--LQPGQRPDWATLMCAICFGDPPS 279
                    + N  + D+WS  + L EL     PF  L   +       M     G  P+
Sbjct: 179 ALQKKPE--DTNRRSADMWSFAVLLWELVTREVPFADLSNME-----IGMKVALEGLRPT 231

Query: 280 LPDGASPEFRSFIECCLQKEFSKR 303
           +P G SP     ++ C+ ++ +KR
Sbjct: 232 IPPGISPHVSKLMKICMNEDPAKR 255

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  165 bits (419), Expect = 1e-48
 Identities = 80/268 (29%), Positives = 127/268 (47%), Gaps = 12/268 (4%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           + ++ +G GN G    ++ + T ++ A+K +  +    +   V RE+   R    P IV+
Sbjct: 23  DFVKDIGSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDENVQREIINHRSLRHPNIVR 80

Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
              +   P+  +AI+MEY   G L   +   G FSE +      Q+L G+SY H  +I H
Sbjct: 81  FKEVILTPT-HLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICH 139

Query: 174 RDIKPSNLLV-NNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNY 232
           RD+K  N L+  +   ++KI DFG SK          S VGT AY++PE          Y
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKSTVGTPAYIAPEVLL----RQEY 194

Query: 233 NGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA--SPEFRS 290
           +G   D+WS G+TL  + +G +PF  P +  D+   +  I      S+PD    SPE   
Sbjct: 195 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK-YSIPDDIRISPECCH 253

Query: 291 FIECCLQKEFSKRWTASQLLTHPFLCKN 318
            I      + + R +  ++ TH +  KN
Sbjct: 254 LISRIFVADPATRISIPEIKTHSWFLKN 281

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  162 bits (412), Expect = 3e-48
 Identities = 64/265 (24%), Positives = 105/265 (39%), Gaps = 12/265 (4%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           Q LG G  G V    +R T +  A+K+V           + +E+ I +  +   +V+ +G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 117 IFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDI 176
              + +    + +EY   G L   +  +    EP       Q++ G+ YLHG  I HRDI
Sbjct: 73  HRREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDI 131

Query: 177 KPSNLLVNNNNMQVKIADFGVSKIM--CRSLDACNSYVGTCAYMSPERFDPDAYGGNYNG 234
           KP NLL+ +    +KI+DFG++ +          N   GT  Y++PE          ++ 
Sbjct: 132 KPENLLL-DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL----KRREFHA 186

Query: 235 YAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA-SPEFRSFIE 293
              D+WS G+ L  +  G  P+ QP    D                P         + + 
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPS---DSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243

Query: 294 CCLQKEFSKRWTASQLLTHPFLCKN 318
             L +  S R T   +    +  K 
Sbjct: 244 KILVENPSARITIPDIKKDRWYNKP 268

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  162 bits (412), Expect = 6e-48
 Identities = 64/300 (21%), Positives = 107/300 (35%), Gaps = 33/300 (11%)

Query: 27  PLALPPTAPNTNNNTTATTAAIAYSDL-EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH 85
           PL  PP  P T           A+        +LG G  GTV+           A+KV+ 
Sbjct: 6   PLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIP 65

Query: 86  GDADPTVRR-----QVFREMEILRRTDS----PFIVQCFGIFEKPSGDIAILMEYMDSGT 136
            +                E+ +L +  +    P +++    FE       +++E      
Sbjct: 66  RNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQE-GFMLVLERPLPAQ 124

Query: 137 -LDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADF 195
            L   + + G   E        Q++  + + H   ++HRDIK  N+L++      K+ DF
Sbjct: 125 DLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF 184

Query: 196 GVSKIMCRSL--DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGH 253
           G   ++      D      GT  Y  PE          Y+     +WSLG+ L ++  G 
Sbjct: 185 GSGALLHDEPYTDFD----GTRVYSPPEWIS----RHQYHALPATVWSLGILLYDMVCGD 236

Query: 254 FPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHP 313
            PF     +         I   +    P   SP+  + I  CL  + S R +  ++L  P
Sbjct: 237 IPF--ERDQ--------EILEAE-LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDP 285

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  162 bits (411), Expect = 1e-47
 Identities = 74/264 (28%), Positives = 124/264 (46%), Gaps = 13/264 (4%)

Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQC 114
           L+ +G GN   V   +H  T +  A+K++     +PT  +++FRE+ I++  + P IV+ 
Sbjct: 20  LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79

Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
           F + E     + ++MEY   G +   L  +G   E +      QI+  + Y H  +I+HR
Sbjct: 80  FEVIETEK-TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHR 138

Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNG 234
           D+K  NLL+ + +M +KIADFG S          +++ G   Y +PE F     G  Y+G
Sbjct: 139 DLKAENLLL-DADMNIKIADFGFSNEFTVG-GKLDAFCGAPPYAAPELFQ----GKKYDG 192

Query: 235 YAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIEC 294
              D+WSLG+ L  L  G  PF       +   L   +  G    +P   S +  + ++ 
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPF----DGQNLKELRERVLRGKYR-IPFYMSTDCENLLKR 247

Query: 295 CLQKEFSKRWTASQLLTHPFLCKN 318
            L     KR T  Q++   ++   
Sbjct: 248 FLVLNPIKRGTLEQIMKDRWINAG 271

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  161 bits (410), Expect = 1e-47
 Identities = 64/265 (24%), Positives = 105/265 (39%), Gaps = 12/265 (4%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           Q LG G  G V    +R T +  A+K+V           + +E+ I +  +   +V+ +G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 117 IFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDI 176
              + +    + +EY   G L   +  +    EP       Q++ G+ YLHG  I HRDI
Sbjct: 73  HRREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDI 131

Query: 177 KPSNLLVNNNNMQVKIADFGVSKIM--CRSLDACNSYVGTCAYMSPERFDPDAYGGNYNG 234
           KP NLL+ +    +KI+DFG++ +          N   GT  Y++PE          ++ 
Sbjct: 132 KPENLLL-DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL----KRREFHA 186

Query: 235 YAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA-SPEFRSFIE 293
              D+WS G+ L  +  G  P+ QP    D                P         + + 
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPS---DSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243

Query: 294 CCLQKEFSKRWTASQLLTHPFLCKN 318
             L +  S R T   +    +  K 
Sbjct: 244 KILVENPSARITIPDIKKDRWYNKP 268

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  157 bits (399), Expect = 5e-46
 Identities = 70/270 (25%), Positives = 122/270 (45%), Gaps = 18/270 (6%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGD---ADPTVRRQVFREMEILRRTDSPFIVQ 113
            +LG G+ G V +V    T    A+K++        P     V +E+++LRR     ++Q
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70

Query: 114 CFGIFEKPS-GDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHGHK 170
              +        + ++MEY   G  + +L+      F   +      Q++ GL YLH   
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGMQE-MLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG 129

Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIM--CRSLDACNSYVGTCAYMSPERFDPDAY 228
           I+H+DIKP NLL+      +KI+  GV++ +    + D C +  G+ A+  PE       
Sbjct: 130 IVHKDIKPGNLLL-TTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA---NG 185

Query: 229 GGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEF 288
              ++G+  DIWS G+TL  +  G +PF    +  +   L   I  G   ++P    P  
Sbjct: 186 LDTFSGFKVDIWSAGVTLYNITTGLYPF----EGDNIYKLFENIGKGS-YAIPGDCGPPL 240

Query: 289 RSFIECCLQKEFSKRWTASQLLTHPFLCKN 318
              ++  L+ E +KR++  Q+  H +  K 
Sbjct: 241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  157 bits (400), Expect = 5e-46
 Identities = 70/296 (23%), Positives = 115/296 (38%), Gaps = 28/296 (9%)

Query: 31  PPTAPNTNNNTTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVV------ 84
           PP A                        LG G  G V+    +  +K   +K +      
Sbjct: 6   PPKAVELEGLAACEGEYSQKYSTMSP--LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVL 63

Query: 85  -HGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGT-LDTLLN 142
                +     +V  E+ IL R +   I++   IFE       ++ME   SG  L   ++
Sbjct: 64  EDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG-FFQLVMEKHGSGLDLFAFID 122

Query: 143 KNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC 202
           ++    EP  ++I  Q++  + YL    IIHRDIK  N+++   +  +K+ DFG +  + 
Sbjct: 123 RHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI-AEDFTIKLIDFGSAAYL- 180

Query: 203 RSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQR 262
                  ++ GT  Y +PE       G  Y G   ++WSLG+TL  L     PF +  + 
Sbjct: 181 ERGKLFYTFCGTIEYCAPEVLM----GNPYRGPELEMWSLGVTLYTLVFEENPFCELEE- 235

Query: 263 PDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN 318
                             P   S E  S +   LQ    +R T  +L+T P++ + 
Sbjct: 236 ---------TVEAA-IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  156 bits (396), Expect = 5e-46
 Identities = 67/272 (24%), Positives = 113/272 (41%), Gaps = 33/272 (12%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADP---TVRRQVFREMEILR 104
           I +++L   +++G G  G VY+          A+K    D D         V +E ++  
Sbjct: 4   IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61

Query: 105 RTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLS 164
               P I+   G+  K   ++ ++ME+   G L+ +L+         L + A QI +G++
Sbjct: 62  MLKHPNIIALRGVCLKEP-NLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMN 119

Query: 165 YLHGHK---IIHRDIKPSNLLVNN-------NNMQVKIADFGVSKIMCRSLDACNSYVGT 214
           YLH      IIHRD+K SN+L+         +N  +KI DFG+++   R      S  G 
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR--TTKMSAAGA 177

Query: 215 CAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPF--LQPGQRPDWATLMCAI 272
            A+M+PE          ++  + D+WS G+ L EL  G  PF  +          +   +
Sbjct: 178 YAWMAPEVIR----ASMFSKGS-DVWSYGVLLWELLTGEVPFRGIDGLA------VAYGV 226

Query: 273 CF-GDPPSLPDGASPEFRSFIECCLQKEFSKR 303
                   +P      F   +E C   +   R
Sbjct: 227 AMNKLALPIPSTCPEPFAKLMEDCWNPDPHSR 258

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  162 bits (411), Expect = 6e-46
 Identities = 80/277 (28%), Positives = 130/277 (46%), Gaps = 23/277 (8%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQ----VFREMEILRRT 106
                 +VLG G  G V+  Q + T K+YA K +  +     +R+       E +IL + 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKL--NKKRLKKRKGYQGAMVEKKILAKV 242

Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTL----DTLLNKNGTFSEPKLAHIASQILKG 162
            S FIV     FE  + D+ ++M  M+ G +      +   N  F EP+     +QI+ G
Sbjct: 243 HSRFIVSLAYAFETKT-DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301

Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
           L +LH   II+RD+KP N+L++++   V+I+D G++  +         Y GT  +M+PE 
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDG-NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360

Query: 223 FDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPD 282
              + Y      ++ D ++LG+TL E+     PF   G++ +   L   +      + PD
Sbjct: 361 LLGEEY-----DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE-QAVTYPD 414

Query: 283 GASPEFRSFIECCLQKEFSKR-----WTASQLLTHPF 314
             SP  + F E  LQK+  KR      +   L THP 
Sbjct: 415 KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  155 bits (393), Expect = 1e-45
 Identities = 75/262 (28%), Positives = 123/262 (46%), Gaps = 14/262 (5%)

Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFG 116
           LG G  G V   +H+ T    A+K+++        V  ++ RE++ L+    P I++ + 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 117 IFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDI 176
           +   P+ D  ++MEY+  G L   + K+G   E +   +  QIL  + Y H H ++HRD+
Sbjct: 79  VISTPT-DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDL 137

Query: 177 KPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYA 236
           KP N+L+ + +M  KIADFG+S +M    +   +  G+  Y +PE       G  Y G  
Sbjct: 138 KPENVLL-DAHMNAKIADFGLSNMM-SDGEFLRTSCGSPNYAAPEVIS----GRLYAGPE 191

Query: 237 GDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCL 296
            DIWS G+ L  L  G  PF          TL   I  G    +P+  +    + +   L
Sbjct: 192 VDIWSCGVILYALLCGTLPF----DDEHVPTLFKKIRGGV-FYIPEYLNRSVATLLMHML 246

Query: 297 QKEFSKRWTASQLLTHPFLCKN 318
           Q +  KR T   +  H +  ++
Sbjct: 247 QVDPLKRATIKDIREHEWFKQD 268

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  159 bits (405), Expect = 7e-45
 Identities = 72/275 (26%), Positives = 127/275 (46%), Gaps = 22/275 (8%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQ----VFREMEILRRT 106
           +   + +VLG G  G V   Q R T K+YA K +  +     +R+       E +IL + 
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKL--EKKRIKKRKGEAMALNEKQILEKV 241

Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGT--FSEPKLAHIASQILKGLS 164
           +S F+V     +E     + +++  M+ G L   +   G   F E +    A++I  GL 
Sbjct: 242 NSRFVVSLAYAYETKD-ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE 300

Query: 165 YLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD 224
            LH  +I++RD+KP N+L++++   ++I+D G++  +          VGT  YM+PE   
Sbjct: 301 DLHRERIVYRDLKPENILLDDHG-HIRISDLGLAVHVPEG-QTIKGRVGTVGYMAPEVVK 358

Query: 225 PDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
            + Y      ++ D W+LG  L E+  G  PF Q  ++     +   +    P    +  
Sbjct: 359 NERY-----TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VPEEYSERF 412

Query: 285 SPEFRSFIECCLQKEFSKR-----WTASQLLTHPF 314
           SP+ RS     L K+ ++R      +A ++  HP 
Sbjct: 413 SPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL 447

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  152 bits (386), Expect = 3e-44
 Identities = 70/273 (25%), Positives = 119/273 (43%), Gaps = 44/273 (16%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRR-TDSPFIVQCF 115
           QVLG G  G V ++ ++ T + +ALK++             RE+E+  R +  P IV+  
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK------ARREVELHWRASQCPHIVRIV 77

Query: 116 GIFEKPSGD---IAILMEYMDSGTL-DTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHK 170
            ++E        + I+ME +D G L   + ++ +  F+E + + I   I + + YLH   
Sbjct: 78  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 137

Query: 171 IIHRDIKPSNLLVNNN--NMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAY 228
           I HRD+KP NLL  +   N  +K+ DFG +K                             
Sbjct: 138 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET--------------------------T 171

Query: 229 GGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP--PSLP-DGAS 285
           G  Y   + D+WSLG+ +  L  G+ PF           +   I  G    P+      S
Sbjct: 172 GEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 230

Query: 286 PEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN 318
            E +  I   L+ E ++R T ++ + HP++ ++
Sbjct: 231 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  153 bits (389), Expect = 3e-44
 Identities = 78/265 (29%), Positives = 123/265 (46%), Gaps = 21/265 (7%)

Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           LG G+ G V    H  T +  ALK +         +  +V RE+  L+    P I++ + 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 117 IFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDI 176
           +   P+ DI +++EY   G L   + +    +E +      QI+  + Y H HKI+HRD+
Sbjct: 77  VITTPT-DIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDL 134

Query: 177 KPSNLLVNNNNMQVKIADFGVSKIMCRS--LD-ACNSYVGTCAYMSPERFDPDAYGGNYN 233
           KP NLL+ ++N+ VKIADFG+S IM     L  +C    G+  Y +PE  +    G  Y 
Sbjct: 135 KPENLLL-DDNLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVIN----GKLYA 185

Query: 234 GYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIE 293
           G   D+WS G+ L  + +G  PF           L   +       +PD  SP  +S I 
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPF----DDEFIPNLFKKVNSCV-YVMPDFLSPGAQSLIR 240

Query: 294 CCLQKEFSKRWTASQLLTHPFLCKN 318
             +  +  +R T  ++   P+   N
Sbjct: 241 RMIVADPMQRITIQEIRRDPWFNVN 265

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  153 bits (390), Expect = 3e-44
 Identities = 79/277 (28%), Positives = 130/277 (46%), Gaps = 19/277 (6%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRC---THKIYALKVVHGDADPTVRRQVFR---EMEILR 104
            + E L+VLG G  G V+ V+      T K+YA+KV+         +       E ++L 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113

Query: 105 RTD-SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGL 163
               SPF+V     F+  +  + ++++Y++ G L T L++   F+E ++     +I+  L
Sbjct: 114 HIRQSPFLVTLHYAFQTET-KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 172

Query: 164 SYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKI-MCRSLDACNSYVGTCAYMSPER 222
            +LH   II+RDIK  N+L+++N   V + DFG+SK  +    +    + GT  YM+P+ 
Sbjct: 173 EHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 231

Query: 223 FDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPD 282
                 G   +  A D WSLG+ + EL  G  PF   G++   A +   I     P  P 
Sbjct: 232 VRGGDSG---HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYPQ 287

Query: 283 GASPEFRSFIECCLQKEFSKR-----WTASQLLTHPF 314
             S   +  I+  L K+  KR       A ++  H F
Sbjct: 288 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  154 bits (392), Expect = 1e-43
 Identities = 85/287 (29%), Positives = 129/287 (44%), Gaps = 16/287 (5%)

Query: 34  APNTNNNTTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPT 91
            P            I +  L     LG G  G V   +H  T    A+K+++        
Sbjct: 1   GPMAEKQKHDGRVKIGHYILGDT--LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLD 58

Query: 92  VRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPK 151
           V  ++ RE++ L+    P I++ + +   PS DI ++MEY+  G L   + KNG   E +
Sbjct: 59  VVGKIRREIQNLKLFRHPHIIKLYQVISTPS-DIFMVMEYVSGGELFDYICKNGRLDEKE 117

Query: 152 LAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSY 211
              +  QIL G+ Y H H ++HRD+KP N+L+ + +M  KIADFG+S +M    +   + 
Sbjct: 118 SRRLFQQILSGVDYCHRHMVVHRDLKPENVLL-DAHMNAKIADFGLSNMM-SDGEFLRTS 175

Query: 212 VGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCA 271
            G+  Y +PE       G  Y G   DIWS G+ L  L  G  PF          TL   
Sbjct: 176 CGSPNYAAPEVI----SGRLYAGPEVDIWSSGVILYALLCGTLPF----DDDHVPTLFKK 227

Query: 272 ICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN 318
           IC G     P   +P   S ++  LQ +  KR T   +  H +  ++
Sbjct: 228 ICDGI-FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  152 bits (387), Expect = 3e-43
 Identities = 68/276 (24%), Positives = 111/276 (40%), Gaps = 20/276 (7%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREME---ILRRTD 107
            D E L+V+G G  G V  V+ +   K++A+K+++   +   R +     E   +L   D
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN-KWEMLKRAETACFREERDVLVNGD 132

Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYL 166
           S +I      F+    ++ ++M+Y   G L TLL+K      E       ++++  +  +
Sbjct: 133 SKWITTLHYAFQDD-NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSV 191

Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA-CNSYVGTCAYMSPERFDP 225
           H    +HRDIKP N+L++ N   +++ADFG    +        +  VGT  Y+SPE    
Sbjct: 192 HQLHYVHRDIKPDNILMDMNG-HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250

Query: 226 DAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP----PSLP 281
              G    G   D WSLG+ + E+  G  PF               I         P+  
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETPF----YAESLVETYGKIMNHKERFQFPTQV 306

Query: 282 DGASPEFRSFIECCLQKEFSKRWT---ASQLLTHPF 314
              S   +  I   +      R           HPF
Sbjct: 307 TDVSENAKDLIRRLICSR-EHRLGQNGIEDFKKHPF 341

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  156 bits (397), Expect = 3e-43
 Identities = 79/277 (28%), Positives = 135/277 (48%), Gaps = 26/277 (9%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVV--------HGDADPTVRRQVFREMEI 102
           +D    +++G G  G VY  +   T K+YA+K +         G+      R +     +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML---SL 245

Query: 103 LRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
           +   D PFIV     F  P   ++ +++ M+ G L   L+++G FSE  +   A++I+ G
Sbjct: 246 VSTGDCPFIVCMSYAFHTPD-KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 304

Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPER 222
           L ++H   +++RD+KP+N+L++ +   V+I+D G++    +     ++ VGT  YM+PE 
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSK--KKPHASVGTHGYMAPEV 361

Query: 223 FDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPD 282
                 G  Y   + D +SLG  L +L  GH PF Q   + D   +           LPD
Sbjct: 362 L---QKGVAY-DSSADWFSLGCMLFKLLRGHSPFRQHKTK-DKHEIDRMTLT-MAVELPD 415

Query: 283 GASPEFRSFIECCLQKEFSKR-----WTASQLLTHPF 314
             SPE RS +E  LQ++ ++R       A ++   PF
Sbjct: 416 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 452

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  152 bits (385), Expect = 5e-43
 Identities = 76/280 (27%), Positives = 119/280 (42%), Gaps = 26/280 (9%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR----QVFREMEILRRT 106
            D E L+V+G G    V  V+ + T ++YA+K+++      ++R        E ++L   
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWD--MLKRGEVSCFREERDVLVNG 118

Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILKGLSY 165
           D  +I Q    F+  +  + ++MEY   G L TLL+K G            ++I+  +  
Sbjct: 119 DRRWITQLHFAFQDEN-YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDS 177

Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPE--- 221
           +H    +HRDIKP N+L++     +++ADFG    +           VGT  Y+SPE   
Sbjct: 178 VHRLGYVHRDIKPDNILLDRCG-HIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ 236

Query: 222 RFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP---- 277
                   G+Y G   D W+LG+   E++ G  PF         A     I         
Sbjct: 237 AVGGGPGTGSY-GPECDWWALGVFAYEMFYGQTPF----YADSTAETYGKIVHYKEHLSL 291

Query: 278 PSLPDGASPEFRSFIECCLQKEFSKRWT---ASQLLTHPF 314
           P + +G   E R FI+  L      R     A    THPF
Sbjct: 292 PLVDEGVPEEARDFIQRLLCPP-ETRLGRGGAGDFRTHPF 330

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  149 bits (379), Expect = 6e-43
 Identities = 79/274 (28%), Positives = 130/274 (47%), Gaps = 23/274 (8%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRC---THKIYALKVVHGDADPTVRRQVFREME--ILRR 105
           S  E L+VLG G+ G V+ V+        ++YA+KV+   A   VR +V  +ME  IL  
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK-KATLKVRDRVRTKMERDILVE 82

Query: 106 TDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
            + PFIV+    F+   G + ++++++  G L T L+K   F+E  +    +++   L +
Sbjct: 83  VNHPFIVKLHYAFQTE-GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDH 141

Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDP 225
           LH   II+RD+KP N+L++     +K+ DFG+SK          S+ GT  YM+PE  + 
Sbjct: 142 LHSLGIIYRDLKPENILLDEEG-HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 200

Query: 226 DAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS 285
             +       + D WS G+ + E+  G  PF    Q  D    M  I       +P   S
Sbjct: 201 RGH-----TQSADWWSFGVLMFEMLTGTLPF----QGKDRKETMTMILK-AKLGMPQFLS 250

Query: 286 PEFRSFIECCLQKEFSKR-----WTASQLLTHPF 314
           PE +S +    ++  + R         ++  H F
Sbjct: 251 PEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  148 bits (377), Expect = 1e-42
 Identities = 78/290 (26%), Positives = 127/290 (43%), Gaps = 23/290 (7%)

Query: 36  NTNNNTTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRC---THKIYALKVVHGDADPTV 92
           ++  +       I     E L+VLG G  G V++V+      T KI+A+KV+        
Sbjct: 2   SSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN 61

Query: 93  RRQVFR---EMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSE 149
            +       E  IL     PFIV     F+   G + +++EY+  G L   L + G F E
Sbjct: 62  AKDTAHTKAERNILEEVKHPFIVDLIYAFQTG-GKLYLILEYLSGGELFMQLEREGIFME 120

Query: 150 PKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN 209
                  ++I   L +LH   II+RD+KP N+++N+    VK+ DFG+ K         +
Sbjct: 121 DTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG-HVKLTDFGLCKESIHDGTVTH 179

Query: 210 SYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLM 269
           ++ GT  YM+PE      +       A D WSLG  + ++  G  PF   G+  +    +
Sbjct: 180 TFCGTIEYMAPEILMRSGH-----NRAVDWWSLGALMYDMLTGAPPF--TGE--NRKKTI 230

Query: 270 CAICFGDPPSLPDGASPEFRSFIECCLQKEFSKR-----WTASQLLTHPF 314
             I      +LP   + E R  ++  L++  + R       A ++  HPF
Sbjct: 231 DKILK-CKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  148 bits (377), Expect = 2e-42
 Identities = 72/273 (26%), Positives = 127/273 (46%), Gaps = 26/273 (9%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQ----VFREMEILRRT 106
              ++++ LG G+ G V  V+H+ +   YA+K++  D    V+ +       E  IL+  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAV 98

Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
           + PF+V+    F+  S ++ ++MEY+  G + + L + G FSEP     A+QI+    YL
Sbjct: 99  NFPFLVKLEFSFKDNS-NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157

Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPD 226
           H   +I+RD+KP NLL++     +++ DFG +K   R      +  GT   ++PE     
Sbjct: 158 HSLDLIYRDLKPENLLIDQQG-YIQVTDFGFAK---RVKGRTWTLCGTPEALAPEIILSK 213

Query: 227 AYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP 286
            Y       A D W+LG+ + E+  G+ PF           +   I  G     P   S 
Sbjct: 214 GY-----NKAVDWWALGVLIYEMAAGYPPFFA----DQPIQIYEKIVSG-KVRFPSHFSS 263

Query: 287 EFRSFIECCLQKEFSKRW-----TASQLLTHPF 314
           + +  +   LQ + +KR+       + +  H +
Sbjct: 264 DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  147 bits (373), Expect = 6e-42
 Identities = 74/285 (25%), Positives = 126/285 (44%), Gaps = 18/285 (6%)

Query: 35  PNTNNNTTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR 94
           P  N    +    +   D    ++LG G+ G V+  + + T++ +A+K +  D    +  
Sbjct: 1   PELNKERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKD-VVLMDD 59

Query: 95  QV---FREMEILRR-TDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEP 150
            V     E  +L    + PF+   F  F+    ++  +MEY++ G L   +     F   
Sbjct: 60  DVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE-NLFFVMEYLNGGDLMYHIQSCHKFDLS 118

Query: 151 KLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNS 210
           +    A++I+ GL +LH   I++RD+K  N+L++ +   +KIADFG+ K         N+
Sbjct: 119 RATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG-HIKIADFGMCKENMLGDAKTNT 177

Query: 211 YVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMC 270
           + GT  Y++PE      Y      ++ D WS G+ L E+ +G  PF   GQ  D   L  
Sbjct: 178 FCGTPDYIAPEILLGQKY-----NHSVDWWSFGVLLYEMLIGQSPF--HGQ--DEEELFH 228

Query: 271 AICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTA-SQLLTHPF 314
           +I   D P  P     E +  +     +E  KR      +  HP 
Sbjct: 229 SIRM-DNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPL 272

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  147 bits (373), Expect = 9e-42
 Identities = 47/281 (16%), Positives = 87/281 (30%), Gaps = 38/281 (13%)

Query: 56  LQVLGHGNGGTVYKVQHRC-----THKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
             +LG G    VY+            + + LKV    A+P       + ME L+ +    
Sbjct: 70  HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK-PANPWEFYIGTQLMERLKPSMQHM 128

Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNK-----NGTFSEPKLAHIASQILKGLSY 165
            ++ +      +G   ++ E    GTL   +N           +  +   A ++L  +  
Sbjct: 129 FMKFYSAHLFQNG-SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQ 187

Query: 166 LHGHKIIHRDIKPSNLLVNN----------NNMQVKIADFGVSKIM--CRSLDACNSYVG 213
           +H  +IIH DIKP N ++ N           +  + + D G S  M          +   
Sbjct: 188 VHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCE 247

Query: 214 TCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAIC 273
           T  +   E      +      Y  D + +  T+  +  G +  +    + +         
Sbjct: 248 TSGFQCVEMLSNKPW-----NYQIDYFGVAATVYCMLFGTYMKV----KNEGGECKPEGL 298

Query: 274 FGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPF 314
           F   P         +  F    L         +  LL    
Sbjct: 299 FRRLPH-----LDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  146 bits (371), Expect = 1e-41
 Identities = 71/290 (24%), Positives = 119/290 (41%), Gaps = 37/290 (12%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTDSPFIV 112
           E L ++G G+ G V K +++ T +I A+K     D D  V++   RE+++L++     +V
Sbjct: 28  ENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLV 87

Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
               +  K      ++ E++D   LD L           +     QI+ G+ + H H II
Sbjct: 88  NLLEVC-KKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNII 146

Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNY 232
           HRDIKP N+LV+ +   VK+ DFG ++ +    +  +  V T  Y +PE       G   
Sbjct: 147 HRDIKPENILVSQSG-VVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELL----VGDVK 201

Query: 233 NGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPP--------SLPD-- 282
            G A D+W++G  + E+++G  P        D    +     G+            P   
Sbjct: 202 YGKAVDVWAIGCLVTEMFMGE-PLFPGDSDIDQLYHIMMCL-GNLIPRHQELFNKNPVFA 259

Query: 283 ------------------GASPEFRSFIECCLQKEFSKRWTASQLLTHPF 314
                               S       + CL  +  KR   ++LL H F
Sbjct: 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  149 bits (377), Expect = 1e-41
 Identities = 75/294 (25%), Positives = 132/294 (44%), Gaps = 24/294 (8%)

Query: 31  PPTAPNTNNNTTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADP 90
              A     +       +  ++ E L++LG G  G V  V+ + T + YA+K++  +   
Sbjct: 128 NSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEV-- 185

Query: 91  TVRR----QVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGT 146
            V +        E  +L+ +  PF+      F+     +  +MEY + G L   L++   
Sbjct: 186 IVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD-RLCFVMEYANGGELFFHLSRERV 244

Query: 147 FSEPKLAHIASQILKGLSYLHGHK-IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL 205
           FSE +     ++I+  L YLH  K +++RD+K  NL++ + +  +KI DFG+ K   +  
Sbjct: 245 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML-DKDGHIKITDFGLCKEGIKDG 303

Query: 206 DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDW 265
               ++ GT  Y++PE  + + Y     G A D W LG+ + E+  G  PF    Q  D 
Sbjct: 304 ATMKTFCGTPEYLAPEVLEDNDY-----GRAVDWWGLGVVMYEMMCGRLPF--YNQ--DH 354

Query: 266 ATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKR-----WTASQLLTHPF 314
             L   I   +    P    PE +S +   L+K+  +R       A +++ H F
Sbjct: 355 EKLFELILM-EEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  145 bits (368), Expect = 1e-41
 Identities = 67/295 (22%), Positives = 108/295 (36%), Gaps = 45/295 (15%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEI--LRRTDSP 109
           D+  L+ +G G  G V++   +  +   A+K+          +  FRE E+         
Sbjct: 9   DITLLECVGKGRYGEVWRGSWQGEN--VAVKIF----SSRDEKSWFRETELYNTVMLRHE 62

Query: 110 FIVQCFGIFEKPSGD---IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
            I+               + ++  Y + G+L   L    T        I   I  GL++L
Sbjct: 63  NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHL 121

Query: 167 HG--------HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD----ACNSYVGT 214
           H           I HRD+K  N+LV   N Q  IAD G++ +  +S +      N  VGT
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILV-KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180

Query: 215 CAYMSPERFD--PDAYGGNYNGYAGDIWSLGLTLLELY-----LGHFPFLQP------GQ 261
             YM+PE  D        +      DIW+ GL L E+       G     +P        
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRV-DIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239

Query: 262 RPDWATLMCAICFGDP-PSLP-----DGASPEFRSFIECCLQKEFSKRWTASQLL 310
            P +  +   +C     P++P     D         ++ C  +  S R TA ++ 
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  146 bits (370), Expect = 1e-41
 Identities = 66/298 (22%), Positives = 106/298 (35%), Gaps = 43/298 (14%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEI--LRR 105
                ++ ++ +G G  G V+  + R      A+KV       T     FRE EI     
Sbjct: 34  TIAKQIQMVKQIGKGRYGEVWMGKWRGEK--VAVKVFF----TTEEASWFRETEIYQTVL 87

Query: 106 TDSPFIVQCFGIFEKPSGD---IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
                I+       K +G    + ++ +Y ++G+L   L    T     +  +A   + G
Sbjct: 88  MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSG 146

Query: 163 LSYLHGH--------KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD----ACNS 210
           L +LH           I HRD+K  N+LV   N    IAD G++       +      N+
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILV-KKNGTCCIADLGLAVKFISDTNEVDIPPNT 205

Query: 211 YVGTCAYMSPERFDPDAYGGNYNGY-AGDIWSLGLTLLELYLGHFPFLQP---------- 259
            VGT  YM PE  D      ++  Y   D++S GL L E+                    
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265

Query: 260 -GQRPDWATLMCAICF-GDPPSLP-----DGASPEFRSFIECCLQKEFSKRWTASQLL 310
               P +  +   +C     PS P     D    +    +  C     + R TA ++ 
Sbjct: 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  146 bits (370), Expect = 2e-41
 Identities = 75/272 (27%), Positives = 129/272 (47%), Gaps = 21/272 (7%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFR---EMEILRRTD 107
           +D + L++LG G  G V  V+ + T + YA+K++  +     + +V     E  +L+ T 
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKE-VIIAKDEVAHTVTESRVLQNTR 63

Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
            PF+      F+     +  +MEY + G L   L++   F+E +     ++I+  L YLH
Sbjct: 64  HPFLTALKYAFQTHD-RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122

Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDA 227
              +++RDIK  NL+++ +   +KI DFG+ K          ++ GT  Y++PE  + + 
Sbjct: 123 SRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181

Query: 228 YGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPE 287
           Y     G A D W LG+ + E+  G  PF    Q  D   L   I   +    P   SPE
Sbjct: 182 Y-----GRAVDWWGLGVVMYEMMCGRLPF--YNQ--DHERLFELILM-EEIRFPRTLSPE 231

Query: 288 FRSFIECCLQKEFSKR-----WTASQLLTHPF 314
            +S +   L+K+  +R       A +++ H F
Sbjct: 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  145 bits (368), Expect = 2e-41
 Identities = 69/263 (26%), Positives = 108/263 (41%), Gaps = 21/263 (7%)

Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSPFIVQ 113
            +++G G  G VY+ +     +I ALK++     +DP  R ++ RE     R   P +V 
Sbjct: 39  RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 114 CFGIFEKPSGDIA-ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
                E        + M  ++   L  +L + G  + P+   I  QI   L   H     
Sbjct: 99  IHDFGE--IDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGAT 156

Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS-LDACNSYVGTCAYMSPERFDPDAYGGN 231
           HRD+KP N+LV+ ++    + DFG++       L    + VGT  YM+PERF       +
Sbjct: 157 HRDVKPENILVSADD-FAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFS-----ES 210

Query: 232 YNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPD---GASPEF 288
           +  Y  DI++L   L E   G  P+   G   D  ++M A      P       G    F
Sbjct: 211 HATYRADIYALTCVLYECLTGSPPY--QG---DQLSVMGAHINQAIPRPSTVRPGIPVAF 265

Query: 289 RSFIECCLQKEFSKRW-TASQLL 310
            + I   + K    R+ T   L 
Sbjct: 266 DAVIARGMAKNPEDRYVTCGDLS 288

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  145 bits (367), Expect = 3e-41
 Identities = 73/292 (25%), Positives = 127/292 (43%), Gaps = 41/292 (14%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTDSPFIV 112
           EK+  +G G+ G V+K ++R T +I A+K     + DP +++   RE+ +L++   P +V
Sbjct: 6   EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLV 65

Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
               +F +    + ++ EY D   L  L        E  +  I  Q L+ +++ H H  I
Sbjct: 66  NLLEVF-RRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCI 124

Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNY 232
           HRD+KP N+L+  ++  +K+ DFG ++++    D  +  V T  Y SPE       G   
Sbjct: 125 HRDVKPENILITKHS-VIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELL----VGDTQ 179

Query: 233 NGYAGDIWSLGLTLLELYLGH--FP--------FL------------QPG--QRPDWATL 268
            G   D+W++G    EL  G   +P        +L            Q        ++  
Sbjct: 180 YGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG- 238

Query: 269 MCAICFGDPPSLPD------GASPEFRSFIECCLQKEFSKRWTASQLLTHPF 314
              +   DP  +          S      ++ CL  + ++R T  QLL HP+
Sbjct: 239 ---VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  146 bits (371), Expect = 5e-41
 Identities = 76/274 (27%), Positives = 125/274 (45%), Gaps = 20/274 (7%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFR---EMEILRRTD 107
            D E ++V+G G  G V  V+H+ T K+YA+K++    +   R        E +I+   +
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS-KFEMIKRSDSAFFWEERDIMAFAN 127

Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
           SP++VQ F  F+     + ++MEYM  G L  L++      E       ++++  L  +H
Sbjct: 128 SPWVVQLFYAFQDDR-YLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIH 185

Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK-IMCRSLDACNSYVGTCAYMSPERFDPD 226
               IHRD+KP N+L++ +   +K+ADFG    +    +  C++ VGT  Y+SPE     
Sbjct: 186 SMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 244

Query: 227 AYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFG-DPPSLPDGA- 284
              G Y G   D WS+G+ L E+ +G  PF               I    +  + PD   
Sbjct: 245 GGDGYY-GRECDWWSVGVFLYEMLVGDTPFYA----DSLVGTYSKIMNHKNSLTFPDDND 299

Query: 285 -SPEFRSFIECCLQKEFSKRWT---ASQLLTHPF 314
            S E ++ I C    +   R       ++  H F
Sbjct: 300 ISKEAKNLI-CAFLTDREVRLGRNGVEEIKRHLF 332

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  150 bits (380), Expect = 7e-41
 Identities = 53/262 (20%), Positives = 93/262 (35%), Gaps = 31/262 (11%)

Query: 56  LQVLGHGNGGTVYK-VQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQC 114
              + HG  G +Y  +      +   LK +    D   +     E + L     P IVQ 
Sbjct: 85  KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144

Query: 115 FGIFEKPSGDIA----ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
           F   E           I+MEY+   +L             +      +IL  LSYLH   
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPALSYLHSIG 202

Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGG 230
           +++ D+KP N+++     Q+K+ D G        +++     GT  + +PE        G
Sbjct: 203 LVYNDLKPENIMLTEE--QLKLIDLGAV----SRINSFGYLYGTPGFQAPEI----VRTG 252

Query: 231 NYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                A DI+++G TL  L L        G+  D           +   +       +  
Sbjct: 253 --PTVATDIYTVGRTLAALTLDLPTR--NGRYVDGLP--------EDDPVLK-TYDSYGR 299

Query: 291 FIECCLQKEFSKRW-TASQLLT 311
            +   +  +  +R+ TA ++  
Sbjct: 300 LLRRAIDPDPRQRFTTAEEMSA 321

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  143 bits (362), Expect = 2e-40
 Identities = 74/273 (27%), Positives = 125/273 (45%), Gaps = 26/273 (9%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRR-QV---FREMEILRRT 106
            D + L+ LG G+ G V+ ++ R   + YA+KV+  +    VR  QV     E  +L   
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEI--VVRLKQVEHTNDERLMLSIV 63

Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
             PFI++ +G F + +  I ++M+Y++ G L +LL K+  F  P     A+++   L YL
Sbjct: 64  THPFIIRMWGTF-QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 122

Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPD 226
           H   II+RD+KP N+L++ N   +KI DFG +K      D   +  GT  Y++PE     
Sbjct: 123 HSKDIIYRDLKPENILLDKNG-HIKITDFGFAK---YVPDVTYTLCGTPDYIAPEVVSTK 178

Query: 227 AYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP 286
            Y       + D WS G+ + E+  G+ PF               I        P   + 
Sbjct: 179 PY-----NKSIDWWSFGILIYEMLAGYTPFY--DSNTM--KTYEKILNA-ELRFPPFFNE 228

Query: 287 EFRSFIECCLQKEFSKRW-----TASQLLTHPF 314
           + +  +   + ++ S+R          +  HP+
Sbjct: 229 DVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  142 bits (359), Expect = 4e-40
 Identities = 71/298 (23%), Positives = 111/298 (37%), Gaps = 43/298 (14%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEI--LRR 105
                L+ L+V   G  G V+K Q    +   A+K+         ++    E E+  L  
Sbjct: 21  FQSMPLQLLEVKARGRFGCVWKAQLLNEY--VAVKIF----PIQDKQSWQNEYEVYSLPG 74

Query: 106 TDSPFIVQCFGIFEKPSGDIA---ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
                I+Q  G  ++ +       ++  + + G+L   L  N   S  +L HIA  + +G
Sbjct: 75  MKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARG 133

Query: 163 LSYLHGH----------KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM--CRSLDACNS 210
           L+YLH             I HRDIK  N+L+  NN+   IADFG++      +S    + 
Sbjct: 134 LAYLHEDIPGLKDGHKPAISHRDIKSKNVLL-KNNLTACIADFGLALKFEAGKSAGDTHG 192

Query: 211 YVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQP----------- 259
            VGT  YM+PE  +             D++++GL L EL         P           
Sbjct: 193 QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252

Query: 260 -GQRPDWATLMCAICFGDP-PSLPDGASPE-----FRSFIECCLQKEFSKRWTASQLL 310
            GQ P    +   +      P L D              IE C   +   R +A  + 
Sbjct: 253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  141 bits (358), Expect = 1e-39
 Identities = 66/295 (22%), Positives = 111/295 (37%), Gaps = 43/295 (14%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEI--LRRTDS 108
             +   + +G G  G V++ + R      A+K+          R  FRE EI        
Sbjct: 42  RTIVLQESIGKGRFGEVWRGKWRGEE--VAVKIFSSRE----ERSWFREAEIYQTVMLRH 95

Query: 109 PFIVQCFGIFEKPSGD---IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
             I+       K +G    + ++ +Y + G+L   LN+  T +   +  +A     GL++
Sbjct: 96  ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAH 154

Query: 166 LHGH--------KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD----ACNSYVG 213
           LH           I HRD+K  N+LV   N    IAD G++     + D    A N  VG
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILV-KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 213

Query: 214 TCAYMSPERFDPDAYGGNYNGY-AGDIWSLGLTLLELYLG----------HFPF-LQPGQ 261
           T  YM+PE  D      ++  +   DI+++GL   E+               P+      
Sbjct: 214 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 273

Query: 262 RPDWATLMCAICF-GDPPSLPDG-----ASPEFRSFIECCLQKEFSKRWTASQLL 310
            P    +   +C     P++P+      A       +  C     + R TA ++ 
Sbjct: 274 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  141 bits (358), Expect = 2e-39
 Identities = 75/296 (25%), Positives = 124/296 (41%), Gaps = 29/296 (9%)

Query: 31  PPTAPNTNNNTTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVV------ 84
           PP      N   ++      SD   L+V+G G+ G V   +H+     YA+KV+      
Sbjct: 18  PPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAIL 77

Query: 85  -HGDADPT-VRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLN 142
              +       R V      L+    PF+V     F+     +  +++Y++ G L   L 
Sbjct: 78  KKKEEKHIMSERNVL-----LKNVKHPFLVGLHFSFQTAD-KLYFVLDYINGGELFYHLQ 131

Query: 143 KNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC 202
           +   F EP+    A++I   L YLH   I++RD+KP N+L+++    + + DFG+ K   
Sbjct: 132 RERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG-HIVLTDFGLCKENI 190

Query: 203 RSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQR 262
                 +++ GT  Y++PE      Y         D W LG  L E+  G  PF    + 
Sbjct: 191 EHNSTTSTFCGTPEYLAPEVLHKQPY-----DRTVDWWCLGAVLYEMLYGLPPF--YSR- 242

Query: 263 PDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKR----WTASQLLTHPF 314
            + A +   I    P  L    +   R  +E  LQK+ +KR        ++ +H F
Sbjct: 243 -NTAEMYDNILN-KPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVF 296

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  140 bits (355), Expect = 3e-39
 Identities = 72/279 (25%), Positives = 129/279 (46%), Gaps = 24/279 (8%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD---ADPTVRRQVFREMEILRR-T 106
            D + L+V+G G+   V  V+ + T +IYA+KVV  +    D  +   V  E  +  + +
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDW-VQTEKHVFEQAS 67

Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
           + PF+V     F+  S  +  ++EY++ G L   + +     E      +++I   L+YL
Sbjct: 68  NHPFLVGLHSCFQTES-RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 126

Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPD 226
           H   II+RD+K  N+L+++    +K+ D+G+ K   R  D  +++ GT  Y++PE    +
Sbjct: 127 HERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE 185

Query: 227 AYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRP-----DWATLMCAICFGDPPSLP 281
            Y     G++ D W+LG+ + E+  G  PF   G            L   I       +P
Sbjct: 186 DY-----GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQIRIP 239

Query: 282 DGASPEFRSFIECCLQKEFSKR------WTASQLLTHPF 314
              S +  S ++  L K+  +R         + +  HPF
Sbjct: 240 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  141 bits (358), Expect = 3e-39
 Identities = 71/279 (25%), Positives = 129/279 (46%), Gaps = 24/279 (8%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD---ADPTVRRQVFREMEILRR-T 106
            D + L+V+G G+   V  V+ + T +IYA++VV  +    D  +   V  E  +  + +
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDW-VQTEKHVFEQAS 110

Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
           + PF+V     F+  S  +  ++EY++ G L   + +     E      +++I   L+YL
Sbjct: 111 NHPFLVGLHSCFQTES-RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 169

Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPD 226
           H   II+RD+K  N+L+++    +K+ D+G+ K   R  D  +++ GT  Y++PE    +
Sbjct: 170 HERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE 228

Query: 227 AYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRP-----DWATLMCAICFGDPPSLP 281
            Y     G++ D W+LG+ + E+  G  PF   G            L   I       +P
Sbjct: 229 DY-----GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQIRIP 282

Query: 282 DGASPEFRSFIECCLQKEFSKR------WTASQLLTHPF 314
              S +  S ++  L K+  +R         + +  HPF
Sbjct: 283 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  140 bits (355), Expect = 4e-39
 Identities = 76/291 (26%), Positives = 124/291 (42%), Gaps = 22/291 (7%)

Query: 33  TAPNTNNNTTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD---AD 89
           T   +  +       +  +D   L VLG G+ G V   + + T ++YA+K++  D    D
Sbjct: 2   TNTVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD 61

Query: 90  PTVRRQVFREMEILRRTDS-PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFS 148
             V      E  +L      PF+ Q    F+     +  +MEY++ G L   + + G F 
Sbjct: 62  DDVEC-TMVEKRVLALPGKPPFLTQLHSCFQTMD-RLYFVMEYVNGGDLMYHIQQVGRFK 119

Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
           EP     A++I  GL +L    II+RD+K  N+++++    +KIADFG+ K         
Sbjct: 120 EPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENIWDGVTT 178

Query: 209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATL 268
            ++ GT  Y++PE      Y     G + D W+ G+ L E+  G  PF   G+  D   L
Sbjct: 179 KTFCGTPDYIAPEIIAYQPY-----GKSVDWWAFGVLLYEMLAGQAPF--EGE--DEDEL 229

Query: 269 MCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKR-----WTASQLLTHPF 314
             +I      + P   S E  +  +  + K   KR          +  H F
Sbjct: 230 FQSIME-HNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 279

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  138 bits (351), Expect = 1e-38
 Identities = 77/294 (26%), Positives = 131/294 (44%), Gaps = 23/294 (7%)

Query: 31  PPTAPNTNNNTTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADP 90
             ++   N     ++  +   + E ++VLG G+ G V   + + T  +YA+KV+  D   
Sbjct: 3   KESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKD-VI 61

Query: 91  TVRRQV---FREMEILRR-TDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGT 146
                V     E  IL    + PF+ Q F  F+ P   +  +ME+++ G L   + K+  
Sbjct: 62  LQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD-RLFFVMEFVNGGDLMFHIQKSRR 120

Query: 147 FSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD 206
           F E +    A++I+  L +LH   II+RD+K  N+L+++     K+ADFG+ K    +  
Sbjct: 121 FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGICNGV 179

Query: 207 ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWA 266
              ++ GT  Y++PE      Y     G A D W++G+ L E+  GH PF    +  +  
Sbjct: 180 TTATFCGTPDYIAPEILQEMLY-----GPAVDWWAMGVLLYEMLCGHAPF--EAE--NED 230

Query: 267 TLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKR------WTASQLLTHPF 314
            L  AI   D    P     +    ++  + K  + R           +L HPF
Sbjct: 231 DLFEAILN-DEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPF 283

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  138 bits (350), Expect = 1e-38
 Identities = 68/305 (22%), Positives = 121/305 (39%), Gaps = 54/305 (17%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSPFIV 112
           EKL  +G G  G V+K +HR T +  ALK V  + +         RE++IL+      +V
Sbjct: 20  EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 79

Query: 113 QCFGI-------FEKPSGDIAILMEYMD---SGTLDTLLNKNGTFSEPKLAHIASQILKG 162
               I       + +  G I ++ ++ +   +G L    N    F+  ++  +   +L G
Sbjct: 80  NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNG 136

Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA-CNSY---VGTCAYM 218
           L Y+H +KI+HRD+K +N+L+  +   +K+ADFG+++    + ++  N Y   V T  Y 
Sbjct: 137 LYYIHRNKILHRDMKAANVLITRDG-VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 195

Query: 219 SPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPP 278
            PE       G    G   D+W  G  + E++    P +Q         L+  +C G   
Sbjct: 196 PPELL----LGERDYGPPIDLWGAGCIMAEMWTRS-PIMQGNTEQHQLALISQLC-GSIT 249

Query: 279 --------SLPDGASPEFRSFIECCLQKEF---------------------SKRWTASQL 309
                   +       E     +  ++                        ++R  +   
Sbjct: 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 309

Query: 310 LTHPF 314
           L H F
Sbjct: 310 LNHDF 314

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  139 bits (353), Expect = 2e-38
 Identities = 73/317 (23%), Positives = 123/317 (38%), Gaps = 49/317 (15%)

Query: 33  TAPNTNNNTTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTV 92
           T   T          ++Y+D +   V+G+G+ G VY+ +   + ++ A+K V  D     
Sbjct: 39  TVVATPGQGPDRPQEVSYTDTK---VIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---- 91

Query: 93  RRQVFREMEILRRTDSPFIVQCFGIFEKPSG-----DIAILMEYMDSGTL----DTLLNK 143
            R   RE++I+R+ D   IV+    F           + ++++Y+   T+          
Sbjct: 92  -RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRA 149

Query: 144 NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR 203
             T     +     Q+ + L+Y+H   I HRDIKP NLL++ +   +K+ DFG +K +  
Sbjct: 150 KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-V 208

Query: 204 SLDACNSYVGTCAYMSPER-FDPDAYGGNYNGYAGDIWSLGLTLLELYLGH--FP----F 256
             +   SY+ +  Y +PE  F    Y       + D+WS G  L EL LG   FP     
Sbjct: 209 RGEPNVSYICSRYYRAPELIFGATDYTS-----SIDVWSAGCVLAELLLGQPIFPGDSGV 263

Query: 257 LQ----------------PGQRPDWATLMCAICFGDPPS--LPDGASPEFRSFIECCLQK 298
            Q                    P++           P +        PE  +     L+ 
Sbjct: 264 DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEY 323

Query: 299 EFSKRWTASQLLTHPFL 315
             + R T  +   H F 
Sbjct: 324 TPTARLTPLEACAHSFF 340

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  137 bits (347), Expect = 3e-38
 Identities = 68/310 (21%), Positives = 115/310 (37%), Gaps = 54/310 (17%)

Query: 47  AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEI--LR 104
           ++   +L+ L+++G G  G VYK       +  A+KV         R+    E  I  + 
Sbjct: 9   SLDLDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVF----SFANRQNFINEKNIYRVP 62

Query: 105 RTDSPFIVQCFGIFEKPSGDIA----ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQIL 160
             +   I +     E+ + D      ++MEY  +G+L   L+ + T        +A  + 
Sbjct: 63  LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVT 121

Query: 161 KGLSYLHG---------HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD----- 206
           +GL+YLH            I HRD+   N+LV  N+    I+DFG+S  +  +       
Sbjct: 122 RGLAYLHTELPRGDHYKPAISHRDLNSRNVLV-KNDGTCVISDFGLSMRLTGNRLVRPGE 180

Query: 207 ---ACNSYVGTCAYMSPERFDPDAYGGNYNGY--AGDIWSLGLTLLEL---------YLG 252
              A  S VGT  YM+PE  +      +        D+++LGL   E+            
Sbjct: 181 EDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240

Query: 253 HFPFLQP-----GQRPDWATLMCAICF-GDPPSLPD------GASPEFRSFIECCLQKEF 300
              +        G  P +  +   +      P  P+       A    +  IE C  ++ 
Sbjct: 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDA 300

Query: 301 SKRWTASQLL 310
             R TA    
Sbjct: 301 EARLTAQXAE 310

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  137 bits (347), Expect = 7e-38
 Identities = 74/326 (22%), Positives = 118/326 (36%), Gaps = 78/326 (23%)

Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRR---------- 105
           ++ LG G+  TV+  +    +   A+K+V    D         E+++L+R          
Sbjct: 24  VRKLGWGHFSTVWLAKDMVNNTHVAMKIV--RGDKVYTEAAEDEIKLLQRVNDADNTKED 81

Query: 106 -TDSPFIVQCFGIFE--KPSGD-IAILMEYMDSGTLDTL-LNKNGTFSEPKLAHIASQIL 160
              +  I++    F    P+G  + ++ E +    L  +   ++       +  I+ Q+L
Sbjct: 82  SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 141

Query: 161 KGLSYLHGH-KIIHRDIKPSNLLV-----NNNNMQVKIADFGVSKIMCRSLDACNSYVGT 214
            GL Y+H    IIH DIKP N+L+       N +Q+KIAD G +   C   +   + + T
Sbjct: 142 LGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWYDEHYTNSIQT 198

Query: 215 CAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWAT-----LM 269
             Y SPE       G  + G   DIWS    + EL  G F F          T     + 
Sbjct: 199 REYRSPEVL----LGAPW-GCGADIWSTACLIFELITGDFLF--EPDEGHSYTKDDDHIA 251

Query: 270 CAI-CFGDPPS---------------------------------------LPDGASPEFR 289
             I   G+ PS                                            + E  
Sbjct: 252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 311

Query: 290 SFIECCLQKEFSKRWTASQLLTHPFL 315
            F+   LQ +  KR  A  L+ HP+L
Sbjct: 312 DFLSPMLQLDPRKRADAGGLVNHPWL 337

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  134 bits (340), Expect = 2e-37
 Identities = 73/271 (26%), Positives = 129/271 (47%), Gaps = 30/271 (11%)

Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSPFIVQ 113
            ++LG G    V+  +    H+  A+KV+  D   DP+   +  RE +     + P IV 
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 114 CF--GIFEKPSGDIA-ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
            +  G  E P+G +  I+MEY+D  TL  +++  G  +  +   + +   + L++ H + 
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG 136

Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS---LDACNSYVGTCAYMSPERFDPDA 227
           IIHRD+KP+N++++  N  VK+ DFG+++ +  S   +    + +GT  Y+SPE+    A
Sbjct: 137 IIHRDVKPANIMISATN-AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ----A 191

Query: 228 YGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICF----GDPPSLPD- 282
            G        D++SLG  L E+  G  PF   G  P       ++ +     DP      
Sbjct: 192 RGD-SVDARSDVYSLGCVLYEVLTGEPPFT--GDSP------VSVAYQHVREDPIPPSAR 242

Query: 283 --GASPEFRSFIECCLQKEFSKRW-TASQLL 310
             G S +  + +   L K    R+ TA+++ 
Sbjct: 243 HEGLSADLDAVVLKALAKNPENRYQTAAEMR 273

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  140 bits (354), Expect = 2e-37
 Identities = 74/293 (25%), Positives = 122/293 (41%), Gaps = 22/293 (7%)

Query: 31  PPTAPNTNNNTTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADP 90
                 +  +       +  +D   L VLG G+ G V   + + T ++YA+K++  D   
Sbjct: 321 KTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKD-VV 379

Query: 91  TVRRQV---FREMEILRRTDS-PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGT 146
                V     E  +L      PF+ Q    F+     +  +MEY++ G L   + + G 
Sbjct: 380 IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD-RLYFVMEYVNGGDLMYHIQQVGR 438

Query: 147 FSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD 206
           F EP     A++I  GL +L    II+RD+K  N+++++    +KIADFG+ K       
Sbjct: 439 FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENIWDGV 497

Query: 207 ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWA 266
              ++ GT  Y++PE      Y     G + D W+ G+ L E+  G  PF   G+  D  
Sbjct: 498 TTKTFCGTPDYIAPEIIAYQPY-----GKSVDWWAFGVLLYEMLAGQAPF--EGE--DED 548

Query: 267 TLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKR-----WTASQLLTHPF 314
            L  +I      + P   S E  +  +  + K   KR          +  H F
Sbjct: 549 ELFQSIME-HNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 600

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  134 bits (339), Expect = 2e-37
 Identities = 68/268 (25%), Positives = 117/268 (43%), Gaps = 29/268 (10%)

Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSPFIVQ 113
           +  LG G   TVY  +    +   A+K +           ++  RE+    +     IV 
Sbjct: 16  VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 114 CFGIFEKPSGDIA-ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
              + E    D   ++MEY++  TL   +  +G  S     +  +QIL G+ + H  +I+
Sbjct: 76  MIDVDE--EDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIV 133

Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS-LDACNSYVGTCAYMSPERFDPDAYGGN 231
           HRDIKP N+L+++N   +KI DFG++K +  + L   N  +GT  Y SPE+    A G  
Sbjct: 134 HRDIKPQNILIDSNK-TLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQ----AKGE- 187

Query: 232 YNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICF----GDPPSLP----DG 283
                 DI+S+G+ L E+ +G  PF   G+         +I         P++       
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEPPF--NGETA------VSIAIKHIQDSVPNVTTDVRKD 239

Query: 284 ASPEFRSFIECCLQKEFSKRW-TASQLL 310
                 + I    +K+ + R+ T  ++ 
Sbjct: 240 IPQSLSNVILRATEKDKANRYKTIQEMK 267

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  134 bits (340), Expect = 5e-37
 Identities = 81/294 (27%), Positives = 131/294 (44%), Gaps = 45/294 (15%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT----VRRQVFREMEILRRTDSP 109
           EKL  LG G   TVYK + + T++I A+K +           + R   RE+++L+    P
Sbjct: 13  EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 72

Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQILKGLSYLHG 168
            I+     F   S +I+++ ++M++  L+ ++ + +   +   +       L+GL YLH 
Sbjct: 73  NIIGLLDAFGHKS-NISLVFDFMETD-LEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 130

Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSY---VGTCAYMSPERFDP 225
           H I+HRD+KP+NLL++ N   +K+ADFG++K          +Y   V T  Y +PE    
Sbjct: 131 HWILHRDLKPNNLLLDENG-VLKLADFGLAKSFG---SPNRAYTHQVVTRWYRAPELL-- 184

Query: 226 DAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQR--------------------PDW 265
             +G    G   D+W++G  L EL L   PFL PG                      PD 
Sbjct: 185 --FGARMYGVGVDMWAVGCILAELLLRV-PFL-PGDSDLDQLTRIFETLGTPTEEQWPDM 240

Query: 266 ATLMCAICFGDPPSLP-----DGASPEFRSFIECCLQKEFSKRWTASQLLTHPF 314
            +L   + F   P +P       A  +    I+         R TA+Q L   +
Sbjct: 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  134 bits (339), Expect = 1e-36
 Identities = 76/315 (24%), Positives = 124/315 (39%), Gaps = 54/315 (17%)

Query: 37  TNNNTTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQV 96
            ++  T     IAY++ + +   G+G+ G V++ +   + ++ A+K V  D      R  
Sbjct: 29  ASDGKTGEQREIAYTNCKVI---GNGSFGVVFQAKLVESDEV-AIKKVLQDK-----RFK 79

Query: 97  FREMEILRRTDSPFIVQCFGIFEKPSG-----DIAILMEYMDSGTL----DTLLNKNGTF 147
            RE++I+R    P +V     F           + +++EY+   T+            T 
Sbjct: 80  NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTM 138

Query: 148 SEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA 207
               +     Q+L+ L+Y+H   I HRDIKP NLL++  +  +K+ DFG +KI+  + + 
Sbjct: 139 PMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL-IAGEP 197

Query: 208 CNSYVGTCAYMSPER-FDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQ----- 261
             SY+ +  Y +PE  F    Y         DIWS G  + EL  G   F  PG+     
Sbjct: 198 NVSYICSRYYRAPELIFGATNYTT-----NIDIWSTGCVMAELMQGQPLF--PGESGIDQ 250

Query: 262 ---------RPDWATLMCAICFGDPPSLPD------------GASPEFRSFIECCLQKEF 300
                     P    +            P                P+    I   L+   
Sbjct: 251 LVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTP 310

Query: 301 SKRWTASQLLTHPFL 315
           S R TA + L HPF 
Sbjct: 311 SARLTAIEALCHPFF 325

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  132 bits (333), Expect = 2e-36
 Identities = 77/306 (25%), Positives = 119/306 (38%), Gaps = 58/306 (18%)

Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           L+ LG G  G V+        K  A+K +    DP   +   RE++I+RR D   IV+ F
Sbjct: 16  LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVF 74

Query: 116 GIFEKPSG-------------DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
            I                    + I+ EYM++  L  +L + G   E        Q+L+G
Sbjct: 75  EILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVL-EQGPLLEEHARLFMYQLLRG 132

Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNS---YVGTCAYMS 219
           L Y+H   ++HRD+KP+NL +N  ++ +KI DFG+++IM             + T  Y S
Sbjct: 133 LKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRS 192

Query: 220 PERFDPDAYGGNYNGY--AGDIWSLGLTLLELYLGHFPFLQPGQRP-DWATLMCAICFGD 276
           P          + N Y  A D+W+ G    E+  G   F   G    +   L+       
Sbjct: 193 PRLL------LSPNNYTKAIDMWAAGCIFAEMLTGKTLF--AGAHELEQMQLILESI-PV 243

Query: 277 PP----------------SLPD-----------GASPEFRSFIECCLQKEFSKRWTASQL 309
                             +              G S E   F+E  L      R TA + 
Sbjct: 244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEA 303

Query: 310 LTHPFL 315
           L+HP++
Sbjct: 304 LSHPYM 309

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  129 bits (326), Expect = 1e-35
 Identities = 74/291 (25%), Positives = 123/291 (42%), Gaps = 40/291 (13%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSPFIV 112
           EKL+ +G G  GTV+K ++R TH+I ALK V  D D   V     RE+ +L+      IV
Sbjct: 5   EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64

Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
           +   +       + ++ E+ D   L     + NG      +     Q+LKGL + H   +
Sbjct: 65  RLHDVLHSDK-KLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV 122

Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGN 231
           +HRD+KP NLL+ N N ++K+A+FG+++     +   ++ V T  Y  P+      +G  
Sbjct: 123 LHRDLKPQNLLI-NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL----FGAK 177

Query: 232 YNGYAGDIWSLGLTLLELYLGHFPFLQ-----------------------PG--QRPDWA 266
               + D+WS G    EL     P                          P   + PD+ 
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237

Query: 267 TLMCAICFGDPPSLPD---GASPEFRSFIECCLQKEFSKRWTASQLLTHPF 314
                  +    SL +     +   R  ++  L+    +R +A + L HP+
Sbjct: 238 PYP---MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  130 bits (329), Expect = 2e-35
 Identities = 78/298 (26%), Positives = 129/298 (43%), Gaps = 55/298 (18%)

Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQ 113
              +G G  G+V     + + +  A+K +           ++ +RE+ +L+      ++ 
Sbjct: 29  PTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-RPFQSEIFAKRAYRELLLLKHMQHENVIG 87

Query: 114 CFGIFEKPSG-----DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
              +F   S      D  ++M +M +  L  ++     FSE K+ ++  Q+LKGL Y+H 
Sbjct: 88  LLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLK--FSEEKIQYLVYQMLKGLKYIHS 144

Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAY 228
             ++HRD+KP NL VN +  ++KI DFG+++     +     YV T  Y +PE       
Sbjct: 145 AGVVHRDLKPGNLAVNEDC-ELKILDFGLARHADAEM---TGYVVTRWYRAPEVI----- 195

Query: 229 GGNYNGY--AGDIWSLGLTLLELYLGHFPFLQPGQRP-DWATLMCAICFGDPP------- 278
             ++  Y    DIWS+G  + E+  G   F   G+   D  T +  +  G P        
Sbjct: 196 -LSWMHYNQTVDIWSVGCIMAEMLTGKTLF--KGKDYLDQLTQILKVT-GVPGTEFVQKL 251

Query: 279 ----------SLPD-----------GASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
                     SLP             ASP+    +E  L+ +  KR TA+Q LTHPF 
Sbjct: 252 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  129 bits (327), Expect = 2e-35
 Identities = 63/297 (21%), Positives = 112/297 (37%), Gaps = 48/297 (16%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSPFIV 112
            ++  LG G  G VYK     T++  A+K +  + +   V     RE+ +L+      I+
Sbjct: 37  RRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNII 96

Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
           +   +    +  + ++ EY ++  L   ++KN   S   +     Q++ G+++ H  + +
Sbjct: 97  ELKSVIHH-NHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCL 154

Query: 173 HRDIKPSNLLVNN----NNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAY 228
           HRD+KP NLL++         +KI DFG+++     +      + T  Y  PE       
Sbjct: 155 HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEIL----L 210

Query: 229 GGNYNGYAGDIWSLGLTLLELYLGHFPFLQ-----------------------PG--QRP 263
           G  +   + DIWS+     E+ +   P                          PG    P
Sbjct: 211 GSRHYSTSVDIWSIACIWAEMLMKT-PLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALP 269

Query: 264 DWATLMCAICFGDPPS------LPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPF 314
           DW        F           L      E    +   L+ +  KR +A   L HP+
Sbjct: 270 DWKQS-----FPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  129 bits (326), Expect = 7e-35
 Identities = 81/298 (27%), Positives = 118/298 (39%), Gaps = 50/298 (16%)

Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
           L  +G G  G V            A+K +      T  ++  RE++IL R     I+   
Sbjct: 32  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91

Query: 116 GIFEKPS----GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
            I   P+     D+ I+ + M++  L  LL      S   + +   QIL+GL Y+H   +
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANV 149

Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNS---YVGTCAYMSPERFDPDAY 228
           +HRD+KPSNLL+N     +KI DFG++++     D       YV T  Y +PE       
Sbjct: 150 LHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM----- 203

Query: 229 GGNYNGY--AGDIWSLGLTLLELYLGHFPFLQPGQRP-DWATLMCAICFGDPP------- 278
             N  GY  + DIWS+G  L E+      F  PG+   D    +  I  G P        
Sbjct: 204 -LNSKGYTKSIDIWSVGCILAEMLSNRPIF--PGKHYLDQLNHILGIL-GSPSQEDLNCI 259

Query: 279 ----------SLPD-----------GASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
                     SLP             A  +    ++  L     KR    Q L HP+L
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  127 bits (321), Expect = 1e-34
 Identities = 70/290 (24%), Positives = 122/290 (42%), Gaps = 39/290 (13%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSPFIV 112
           +KL+ +G G  G VYK +     +I ALK +  DA+   +     RE+ +L+    P IV
Sbjct: 24  QKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIV 82

Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
               +       + ++ E+M+   L  +L        + ++     Q+L+G+++ H H+I
Sbjct: 83  SLIDVIHSER-CLTLVFEFMEKD-LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRI 140

Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGN 231
           +HRD+KP NLL+ N++  +K+ADFG+++     + +    V T  Y +P+       G  
Sbjct: 141 LHRDLKPQNLLI-NSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVL----MGSK 195

Query: 232 YNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP--------PSLPDG 283
               + DIWS+G    E+  G  P        D    + +I  G P          LP  
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGK-PLFPGVTDDDQLPKIFSIL-GTPNPREWPQVQELPLW 253

Query: 284 ASPEFRSFIECCLQKEF-------------------SKRWTASQLLTHPF 314
               F+ F +                          +KR +A   + HP+
Sbjct: 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  126 bits (320), Expect = 2e-34
 Identities = 67/292 (22%), Positives = 109/292 (37%), Gaps = 43/292 (14%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
            KL  LG G   TVYK + + T  + ALK +  + +        RE+ +L+      IV 
Sbjct: 5   IKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVT 64

Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
              I       + ++ EY+D   L   L +     +   +     Q+L+GL+Y H  K++
Sbjct: 65  LHDIIHTEK-SLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVL 122

Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSY---VGTCAYMSPERFDPDAYG 229
           HRD+KP NLL+N    ++K+ADFG+++          +Y   V T  Y  P+       G
Sbjct: 123 HRDLKPQNLLINERG-ELKLADFGLARAKS---IPTKTYDNEVVTLWYRPPDIL----LG 174

Query: 230 GNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP--------PSLP 281
                   D+W +G    E+  G  P        +    +  I  G P         S  
Sbjct: 175 STDYSTQIDMWGVGCIFYEMATGR-PLFPGSTVEEQLHFIFRIL-GTPTEETWPGILSNE 232

Query: 282 DGASPEFRSFIECCLQKEF-------------------SKRWTASQLLTHPF 314
           +  +  +  +    L                         R +A   + HPF
Sbjct: 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  128 bits (323), Expect = 2e-34
 Identities = 70/309 (22%), Positives = 123/309 (39%), Gaps = 61/309 (19%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFI 111
           + L+ +G G  G V         +  A+K +      + T  ++ +RE+ +++  +   I
Sbjct: 28  QNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNI 86

Query: 112 VQCFGIFEKPSG-----DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
           +    +F          D+ I+ME MD+  L  ++         +++++  Q+L G+ +L
Sbjct: 87  IGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHL 143

Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNS---YVGTCAYMSPERF 223
           H   IIHRD+KPSN++V ++   +KI DFG++    R+         YV T  Y +PE  
Sbjct: 144 HSAGIIHRDLKPSNIVVKSDC-TLKILDFGLA----RTAGTSFMMTPYVVTRYYRAPEVI 198

Query: 224 DPDAYGGNYNGYAGDIWSLGLTLLELYLGH--FP------------------------FL 257
                G  Y     DIWS+G  + E+  G   FP                         L
Sbjct: 199 ----LGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253

Query: 258 QPG-----------QRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTA 306
           QP                +  L   + F          + + R  +   L  + SKR + 
Sbjct: 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 313

Query: 307 SQLLTHPFL 315
            + L HP++
Sbjct: 314 DEALQHPYI 322

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  126 bits (319), Expect = 2e-34
 Identities = 74/304 (24%), Positives = 114/304 (37%), Gaps = 59/304 (19%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQV----FREMEILRR---T 106
           E +  +G G  GTVYK +   +    ALK V           +     RE+ +LRR    
Sbjct: 12  EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAF 71

Query: 107 DSPFIVQCFGIFEKPSGD----IAILMEYMDSGTLDTLLNKNGT--FSEPKLAHIASQIL 160
           + P +V+   +      D    + ++ E++D   L T L+K          +  +  Q L
Sbjct: 72  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFL 130

Query: 161 KGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSY---VGTCAY 217
           +GL +LH + I+HRD+KP N+LV +    VK+ADFG    + R      +    V T  Y
Sbjct: 131 RGLDFLHANCIVHRDLKPENILVTSGG-TVKLADFG----LARIYSYQMALTPVVVTLWY 185

Query: 218 MSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP 277
            +PE          Y     D+WS+G    E++    P        D    +  +  G P
Sbjct: 186 RAPEVL----LQSTY-ATPVDMWSVGCIFAEMFRRK-PLFCGNSEADQLGKIFDLI-GLP 238

Query: 278 P--------SLPDGASPEFRSFIECCLQKEF-------------------SKRWTASQLL 310
           P        SLP      F       +Q                       KR +A + L
Sbjct: 239 PEDDWPRDVSLPR---GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL 295

Query: 311 THPF 314
            H +
Sbjct: 296 QHSY 299

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  126 bits (319), Expect = 3e-34
 Identities = 74/298 (24%), Positives = 126/298 (42%), Gaps = 46/298 (15%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           ++L+ LG+G   TVYK  ++ T    ALK V  D++        RE+ +++      IV+
Sbjct: 8   KQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVR 67

Query: 114 CFGIFEKPSGDIAILMEYMDS---GTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHG 168
            + +       + ++ E+MD+     +D+    N         + +   Q+L+GL++ H 
Sbjct: 68  LYDVIHT-ENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE 126

Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAY 228
           +KI+HRD+KP NLL+N    Q+K+ DFG+++     ++  +S V T  Y +P+       
Sbjct: 127 NKILHRDLKPQNLLINKRG-QLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVL----M 181

Query: 229 GGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP-----P---SL 280
           G      + DIWS G  L E+  G  P        +   L+  I  G P     P    L
Sbjct: 182 GSRTYSTSIDIWSCGCILAEMITGK-PLFPGTNDEEQLKLIFDIM-GTPNESLWPSVTKL 239

Query: 281 PDGASPEFRSFIECCLQKEF------------------------SKRWTASQLLTHPF 314
           P   +P  +      L++                            R +A Q L HP+
Sbjct: 240 PK-YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  125 bits (316), Expect = 4e-34
 Identities = 69/290 (23%), Positives = 113/290 (38%), Gaps = 40/290 (13%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPT-VRRQVFREMEILRRTDSPFIV 112
             L+ +G G  G VYK Q+    + +ALK +  + +   +     RE+ IL+      IV
Sbjct: 5   HGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63

Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
           + + +       + ++ E++D   L  LL    G            Q+L G++Y H  ++
Sbjct: 64  KLYDVIHTKK-RLVLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121

Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGN 231
           +HRD+KP NLL+N    ++KIADFG+++     +      + T  Y +P+       G  
Sbjct: 122 LHRDLKPQNLLINREG-ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL----MGSK 176

Query: 232 YNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP--------PSLPDG 283
                 DIWS+G    E+  G  P        D    +  I  G P          LP  
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGT-PLFPGVSEADQLMRIFRIL-GTPNSKNWPNVTELPK- 233

Query: 284 ASPEFRSFIECCLQKEF-------------------SKRWTASQLLTHPF 314
             P F  +     +                      ++R TA Q L H +
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  126 bits (318), Expect = 5e-34
 Identities = 56/223 (25%), Positives = 99/223 (44%), Gaps = 28/223 (12%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYK---VQHRCTHKIY-ALKVVHGDADPTVRRQVFREMEIL 103
           +  ++ +K++VLG G  GTVYK   +      KI  A+K +     P   +++  E  ++
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71

Query: 104 RRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKG 162
              D+P + +  GI    +  + ++ + M  G L   + ++        L +   QI KG
Sbjct: 72  ASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129

Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA------ 216
           ++YL   +++HRD+   N+LV      VKI DFG++    + L A               
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLA----KLLGAEEKEYHAEGGKVPIK 184

Query: 217 YMSPERFDPDAYGGNYNGY--AGDIWSLGLTLLELY-LGHFPF 256
           +M+ E          +  Y    D+WS G+T+ EL   G  P+
Sbjct: 185 WMALESI-------LHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  126 bits (319), Expect = 6e-34
 Identities = 82/306 (26%), Positives = 128/306 (41%), Gaps = 58/306 (18%)

Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF 115
             +LG G  G V    H+ T +I A+K +     P    +  RE++IL+      I+  F
Sbjct: 16  KSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIF 75

Query: 116 GIFEKPS----GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
            I    S     ++ I+ E M +  L  ++      S+  + +   Q L+ +  LHG  +
Sbjct: 76  NIQRPDSFENFNEVYIIQELMQT-DLHRVI-STQMLSDDHIQYFIYQTLRAVKVLHGSNV 133

Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNS----------YVGTCAYMSPE 221
           IHRD+KPSNLL+ N+N  +K+ DFG+++I+  S    +           +V T  Y +PE
Sbjct: 134 IHRDLKPSNLLI-NSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPE 192

Query: 222 RFDPDAYGGNYNGY--AGDIWSLGLTLLELYLGHFPFLQPGQRP-DWATLMCAICFGDPP 278
                        Y  A D+WS G  L EL+L    F  PG+       L+  I  G P 
Sbjct: 193 VM------LTSAKYSRAMDVWSCGCILAELFLRRPIF--PGRDYRHQLLLIFGII-GTPH 243

Query: 279 ------------------SLPD-----------GASPEFRSFIECCLQKEFSKRWTASQL 309
                             SLP              +P+    ++  L  + +KR TA + 
Sbjct: 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEA 303

Query: 310 LTHPFL 315
           L HP+L
Sbjct: 304 LEHPYL 309

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  126 bits (319), Expect = 6e-34
 Identities = 77/298 (25%), Positives = 123/298 (41%), Gaps = 54/298 (18%)

Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQ 113
           LQ +G G  G V       T    A+K ++          ++ +RE+ +L+      ++ 
Sbjct: 30  LQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-RPFQSELFAKRAYRELRLLKHMRHENVIG 88

Query: 114 CFGIFEKPSG-----DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
              +F          D  ++M +M +  L  L+ K+    E ++  +  Q+LKGL Y+H 
Sbjct: 89  LLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHA 146

Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAY 228
             IIHRD+KP NL VN +  ++KI DFG+++     +     YV T  Y +PE       
Sbjct: 147 AGIIHRDLKPGNLAVNEDC-ELKILDFGLARQADSEM---TGYVVTRWYRAPEVI----- 197

Query: 229 GGNYNGY--AGDIWSLGLTLLELYLGHFPFLQPGQRP-DWATLMCAICFGDPP------- 278
             N+  Y    DIWS+G  + E+  G   F   G    D    +  +  G PP       
Sbjct: 198 -LNWMRYTQTVDIWSVGCIMAEMITGKTLF--KGSDHLDQLKEIMKVT-GTPPAEFVQRL 253

Query: 279 ----------SLPD-----------GASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
                      LP+            ASP   + +E  L  +  +R TA + L HP+ 
Sbjct: 254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  126 bits (318), Expect = 8e-34
 Identities = 77/297 (25%), Positives = 122/297 (41%), Gaps = 52/297 (17%)

Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIVQC 114
           L  +G G  G+V       T    A+K +          ++ +RE+ +L+      ++  
Sbjct: 34  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 93

Query: 115 FGIFEKPSG-----DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
             +F          D+ ++   M +  L+ ++ K    ++  +  +  QIL+GL Y+H  
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLMGA-DLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSA 151

Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYG 229
            IIHRD+KPSNL VN +  ++KI DFG+++     +     YV T  Y +PE        
Sbjct: 152 DIIHRDLKPSNLAVNEDC-ELKILDFGLARHTADEMT---GYVATRWYRAPEIM------ 201

Query: 230 GNYNGY--AGDIWSLGLTLLELYLGHFPFLQPGQRP-DWATLMCAICFGDPP-------- 278
            N+  Y    DIWS+G  + EL  G   F  PG    D   L+  +  G P         
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLKLILRLV-GTPGAELLKKIS 258

Query: 279 ---------SLPD-----------GASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
                    SL             GA+P     +E  L  +  KR TA+Q L H + 
Sbjct: 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  124 bits (313), Expect = 1e-33
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 37/223 (16%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYK----VQHRCTHKIYALKVVHGDADPTVRRQVFREMEIL 103
                L++++ LG G+ G V       +   T +  A+K +  ++       + +E+EIL
Sbjct: 18  FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEIL 77

Query: 104 RRTDSPFIVQCFGIFEKPSGD-IAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILK 161
           R      IV+  GI  +  G+ I ++ME++ SG+L   L KN    +  +    A QI K
Sbjct: 78  RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICK 137

Query: 162 GLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAY---- 217
           G+ YL   + +HRD+   N+LV + +  VKI DFG++K +               Y    
Sbjct: 138 GMDYLGSRQYVHRDLAARNVLVESEHQ-VKIGDFGLTKAI---------ETDKEYYTVKD 187

Query: 218 --------MSPERFDPDAYGGNYNGY--AGDIWSLGLTLLELY 250
                    +PE           + +  A D+WS G+TL EL 
Sbjct: 188 DRDSPVFWYAPECL-------MQSKFYIASDVWSFGVTLHELL 223

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  123 bits (312), Expect = 3e-33
 Identities = 64/302 (21%), Positives = 122/302 (40%), Gaps = 51/302 (16%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRR-TDSP 109
            D + ++ LG G    V++  +   ++   +K++     P  ++++ RE++IL      P
Sbjct: 36  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK----PVKKKKIKREIKILENLRGGP 91

Query: 110 FIVQCFGIFEKP-SGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
            I+    I + P S   A++ E++++     L     T ++  +     +ILK L Y H 
Sbjct: 92  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHS 148

Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE-RFDPDA 227
             I+HRD+KP N+++++ + ++++ D+G+++         N  V +  +  PE   D   
Sbjct: 149 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLVDYQM 207

Query: 228 YGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQ--------------RPDWATLMCAIC 273
           Y      Y+ D+WSLG  L  +     PF   G                 D    +    
Sbjct: 208 Y-----DYSLDMWSLGCMLASMIFRKEPFF-HGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261

Query: 274 FGDPP----SLP----------------DGASPEFRSFIECCLQKEFSKRWTASQLLTHP 313
               P     L                    SPE   F++  L+ +   R TA + + HP
Sbjct: 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 321

Query: 314 FL 315
           + 
Sbjct: 322 YF 323

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  123 bits (310), Expect = 5e-33
 Identities = 62/229 (27%), Positives = 103/229 (44%), Gaps = 26/229 (11%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIY----ALKVVHGDADPTVRRQVFREMEILRRT 106
             L+K++ LG G+ G V    +  T+       A+K +  DA P  R    +E++ILR  
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90

Query: 107 DSPFIVQCFGIFEKPSGD-IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
               I++  G  E      + ++MEY+  G+L   L ++ +    +L   A QI +G++Y
Sbjct: 91  YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAY 149

Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA------YMS 219
           LH    IHRD+   N+L++N+   VKI DFG++K +    +    Y           + +
Sbjct: 150 LHAQHYIHRDLAARNVLLDNDR-LVKIGDFGLAKAVPEGHEY---YRVREDGDSPVFWYA 205

Query: 220 PERFDPDAYGGNYNGY--AGDIWSLGLTLLELY-LGHFPFLQPGQRPDW 265
           PE             +  A D+WS G+TL EL          P +  + 
Sbjct: 206 PECL-------KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL 247

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  123 bits (312), Expect = 6e-33
 Identities = 69/310 (22%), Positives = 108/310 (34%), Gaps = 65/310 (20%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +  ++ G G  GTV   + + T    A+K V    DP  R +  + M+ L     P IVQ
Sbjct: 26  QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI--QDPRFRNRELQIMQDLAVLHHPNIVQ 83

Query: 114 CFGIFEKPSGD------IAILMEYMDSGTLDTLLNKNGTFSEP-KLAHIAS---QILKGL 163
               F            + ++MEY+   TL                  I     Q+++ +
Sbjct: 84  LQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSI 142

Query: 164 SYLH--GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPE 221
             LH     + HRDIKP N+LVN  +  +K+ DFG +K +    +   +Y+ +  Y +PE
Sbjct: 143 GCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL-SPSEPNVAYICSRYYRAPE 201

Query: 222 R-FDPDAYGGNYNGYAGDIWSLGLTLLELYLGH--FP----------------------- 255
             F    Y       A DIWS+G    E+ LG   F                        
Sbjct: 202 LIFGNQHYTT-----AVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256

Query: 256 -FLQPG---------QRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWT 305
             L P          +   W+ +                + E    +   LQ    +R  
Sbjct: 257 RKLNPSHTDVDLYNSKGIPWSNVF--------SDHSLKDAKEAYDLLSALLQYLPEERMK 308

Query: 306 ASQLLTHPFL 315
             + L HP+ 
Sbjct: 309 PYEALCHPYF 318

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  125 bits (316), Expect = 7e-33
 Identities = 67/307 (21%), Positives = 119/307 (38%), Gaps = 61/307 (19%)

Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQ 113
           L+ +G G  G V         +  A+K +      + T  ++ +RE+ +++  +   I+ 
Sbjct: 67  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIS 125

Query: 114 CFGIFEKPSG-----DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
              +F          D+ ++ME MD+  L  ++         +++++  Q+L G+ +LH 
Sbjct: 126 LLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHS 182

Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNS---YVGTCAYMSPERFDP 225
             IIHRD+KPSN++V ++   +KI DFG++    R+         YV T  Y +PE    
Sbjct: 183 AGIIHRDLKPSNIVVKSDC-TLKILDFGLA----RTAGTSFMMTPYVVTRYYRAPEVI-- 235

Query: 226 DAYGGNYNGYAGDIWSLGLTLLELYLGH--FP------------------------FLQP 259
              G  Y     DIWS+G  + E+      FP                         LQP
Sbjct: 236 --LGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292

Query: 260 G-----------QRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQ 308
                           +  L     F          + + R  +   L  + +KR +   
Sbjct: 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 352

Query: 309 LLTHPFL 315
            L HP++
Sbjct: 353 ALQHPYI 359

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  122 bits (309), Expect = 2e-32
 Identities = 61/311 (19%), Positives = 103/311 (33%), Gaps = 64/311 (20%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVF----------REMEIL 103
              + +  G+ G V          + A+K V           +           RE+ +L
Sbjct: 25  TVQRFISSGSYGAVCAGVDSEGIPV-AIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83

Query: 104 RRTDSPFIVQCFGIFEKPS----GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQI 159
                P I+    IF          + ++ E M +     + ++    S   + +    I
Sbjct: 84  NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHI 143

Query: 160 LKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNS---YVGTCA 216
           L GL  LH   ++HRD+ P N+L+ +NN  + I DF     + R   A  +   YV    
Sbjct: 144 LLGLHVLHEAGVVHRDLHPGNILLADNN-DITICDFN----LAREDTADANKTHYVTHRW 198

Query: 217 YMSPERFDPDAYGGNYNGY--AGDIWSLGLTLLELYLGHFPFLQPGQRP-DWATLMCAIC 273
           Y +PE          + G+    D+WS G  + E++     F   G    +    +  + 
Sbjct: 199 YRAPELV------MQFKGFTKLVDMWSAGCVMAEMFNRKALF--RGSTFYNQLNKIVEVV 250

Query: 274 FGDPP------------------SLPD-----------GASPEFRSFIECCLQKEFSKRW 304
            G P                   SL +            A P     I   L+    +R 
Sbjct: 251 -GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRI 309

Query: 305 TASQLLTHPFL 315
           +  Q L HP+ 
Sbjct: 310 STEQALRHPYF 320

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  120 bits (303), Expect = 5e-32
 Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 28/220 (12%)

Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKIY-ALKVVHGDADPTVRRQVFREMEILRRT 106
           ++ +K++VLG G  GTVYK   +      KI  A+K +     P   +++  E  ++   
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSY 165
           D+P + +  GI    +  + ++ + M  G L   + ++        L +   QI KG++Y
Sbjct: 75  DNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132

Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA------YMS 219
           L   +++HRD+   N+LV      VKI DFG++    + L A               +M+
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLA----KLLGAEEKEYHAEGGKVPIKWMA 187

Query: 220 PERFDPDAYGGNYNGY--AGDIWSLGLTLLELY-LGHFPF 256
            E          +  Y    D+WS G+T+ EL   G  P+
Sbjct: 188 LESI-------LHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  121 bits (306), Expect = 7e-32
 Identities = 71/339 (20%), Positives = 115/339 (33%), Gaps = 100/339 (29%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
              + LG G+ G V +V    + K +ALK V  D      R   RE++I++  D   I++
Sbjct: 10  SLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVLDHVNIIK 64

Query: 114 CFGIFEKPSG-------------------------------------DIAILMEYMDSGT 136
               F                                           + ++MEY+   T
Sbjct: 65  LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-T 123

Query: 137 LDTLLNKNGTFSEP-KLAHIAS---QILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKI 192
           L  +L           +  I+    Q+ + + ++H   I HRDIKP NLLVN+ +  +K+
Sbjct: 124 LHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKL 183

Query: 193 ADFGVSKIMCRSLDACNSYVGTCAYMSPE-RFDPDAYGGNYNGYAGDIWSLGLTLLELYL 251
            DFG +K +    +   +Y+ +  Y +PE       Y       + D+WS+G    EL L
Sbjct: 184 CDFGSAKKL-IPSEPSVAYICSRFYRAPELMLGATEYTP-----SIDLWSIGCVFGELIL 237

Query: 252 GH--FP---------------------------------FLQPGQRPDWATLMCAICFGD 276
           G   F                                       +  DW  +        
Sbjct: 238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKI-------- 289

Query: 277 PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
              LP+G        +E  L+ E   R    + + HPF 
Sbjct: 290 ---LPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF 325

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  119 bits (301), Expect = 7e-32
 Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 26/214 (12%)

Query: 51  SDLEKLQVLGHGNGGTVYK----VQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT 106
             L+ LQ LG GN G+V           T ++ A+K +    +    R   RE+EIL+  
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH-LRDFEREIEILKSL 68

Query: 107 DSPFIVQCFGIFEKPSGD-IAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLS 164
               IV+  G+        + ++MEY+  G+L   L K+       KL    SQI KG+ 
Sbjct: 69  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 128

Query: 165 YLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA------YM 218
           YL   + IHRD+   N+LV N N  VKI DFG++K++ +  +    +           + 
Sbjct: 129 YLGTKRYIHRDLATRNILVENENR-VKIGDFGLTKVLPQDKEF---FKVKEPGESPIFWY 184

Query: 219 SPERFDPDAYGGNYNGY--AGDIWSLGLTLLELY 250
           +PE           + +  A D+WS G+ L EL+
Sbjct: 185 APESL-------TESKFSVASDVWSFGVVLYELF 211

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  120 bits (302), Expect = 1e-31
 Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 27/226 (11%)

Query: 51  SDLEKLQVLGHGNGGTVYK----VQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT 106
             L+ +  LG GN G+V           T  + A+K +     P  +R   RE++IL+  
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKAL 81

Query: 107 DSPFIVQCFGIFEKPSGD-IAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLS 164
            S FIV+  G+   P    + ++MEY+ SG L   L ++       +L   +SQI KG+ 
Sbjct: 82  HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGME 141

Query: 165 YLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA------YM 218
           YL   + +HRD+   N+LV +    VKIADFG++K++    D    YV          + 
Sbjct: 142 YLGSRRCVHRDLAARNILVESEAH-VKIADFGLAKLLPLDKDY---YVVREPGQSPIFWY 197

Query: 219 SPERFDPDAYGGNYNGY--AGDIWSLGLTLLELY-LGHFPFLQPGQ 261
           +PE         + N +    D+WS G+ L EL+           +
Sbjct: 198 APESL-------SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE 236

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  120 bits (304), Expect = 1e-31
 Identities = 68/273 (24%), Positives = 112/273 (41%), Gaps = 27/273 (9%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           + + DL   + +G GN G V+  + R  + + A+K       P ++ +  +E  IL++  
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS 170

Query: 108 SPFIVQCFGI--FEKPSGDIAILMEYMDSGTLDTLLNKNG-TFSEPKLAHIASQILKGLS 164
            P IV+  G+   ++P   I I+ME +  G   T L   G       L  +      G+ 
Sbjct: 171 HPNIVRLIGVCTQKQP---IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGME 227

Query: 165 YLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAY--MSPER 222
           YL     IHRD+   N LV   N+ +KI+DFG+S+     + A +  +        +PE 
Sbjct: 228 YLESKCCIHRDLAARNCLVTEKNV-LKISDFGMSREEADGVYAASGGLRQVPVKWTAPEA 286

Query: 223 FDPDAYGGNYNGY--AGDIWSLGLTLLELY-LGHFPFLQPGQRPDW--ATLMCAICFGDP 277
                   NY  Y    D+WS G+ L E + LG  P+      P+         +  G  
Sbjct: 287 L-------NYGRYSSESDVWSFGILLWETFSLGASPY------PNLSNQQTREFVEKGGR 333

Query: 278 PSLPDGASPEFRSFIECCLQKEFSKRWTASQLL 310
              P+         +E C   E  +R + S + 
Sbjct: 334 LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIY 366

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  119 bits (299), Expect = 3e-31
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 26/214 (12%)

Query: 51  SDLEKLQVLGHGNGGTVYK----VQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT 106
             L+ LQ LG GN G+V           T ++ A+K +    +    R   RE+EIL+  
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH-LRDFEREIEILKSL 99

Query: 107 DSPFIVQCFGIFEKPSGD-IAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLS 164
               IV+  G+        + ++MEY+  G+L   L K+       KL    SQI KG+ 
Sbjct: 100 QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 159

Query: 165 YLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA------YM 218
           YL   + IHRD+   N+LV N N  VKI DFG++K++ +  +    Y           + 
Sbjct: 160 YLGTKRYIHRDLATRNILVENENR-VKIGDFGLTKVLPQDKEY---YKVKEPGESPIFWY 215

Query: 219 SPERFDPDAYGGNYNGY--AGDIWSLGLTLLELY 250
           +PE           + +  A D+WS G+ L EL+
Sbjct: 216 APESL-------TESKFSVASDVWSFGVVLYELF 242

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  120 bits (303), Expect = 3e-31
 Identities = 71/342 (20%), Positives = 115/342 (33%), Gaps = 89/342 (26%)

Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQ 113
             ++G G+ G VY    + T K  A+K V+     D    +++ RE+ IL R  S +I++
Sbjct: 31  KHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-RMFEDLIDCKRILREITILNRLKSDYIIR 89

Query: 114 CFGIFEKPSG----DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
            + +          ++ I++E  DS  L  L       +E  +  I   +L G +++H  
Sbjct: 90  LYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES 148

Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYG 229
            IIHRD+KP+N L+ N +  VK+ DFG    + R++++             E   P    
Sbjct: 149 GIIHRDLKPANCLL-NQDCSVKVCDFG----LARTINSEKDTNIVNDLEENEEPGPHNKN 203

Query: 230 G--------------------NYNGY--AGDIWSLGLTLLELYLGHFPFLQ--------- 258
                                    Y  + DIWS G    EL       +          
Sbjct: 204 LKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLF 263

Query: 259 PGQRPDWATLMCAICF-----------------GDPP-----------------SLPD-- 282
           PG      +                        G P                    P   
Sbjct: 264 PGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRK 323

Query: 283 ---------GASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
                      S +  + +E  L+   +KR T  Q L HP+L
Sbjct: 324 PINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYL 365

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  120 bits (302), Expect = 3e-31
 Identities = 67/316 (21%), Positives = 109/316 (34%), Gaps = 68/316 (21%)

Query: 59  LGHGNGGTVYKVQHR--CTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           +G G  G VYK + +     K YALK + G           RE+ +LR    P ++    
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM---SACREIALLRELKHPNVISLQK 85

Query: 117 IF-EKPSGDIAILMEY--------MDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
           +F       + +L +Y        +          K        +  +  QIL G+ YLH
Sbjct: 86  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145

Query: 168 GHKIIHRDIKPSNLLVN---NNNMQVKIADFGVSK---IMCRSLDACNSYVGTCAYMSPE 221
            + ++HRD+KP+N+LV        +VKIAD G ++      + L   +  V T  Y +PE
Sbjct: 146 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 205

Query: 222 RFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQ----------------------- 258
                  G  +   A DIW++G    EL     P                          
Sbjct: 206 LL----LGARHYTKAIDIWAIGCIFAELLTSE-PIFHCRQEDIKTSNPYHHDQLDRIFNV 260

Query: 259 ---------PG--QRPDWATLMCAICFGDPPSLP---------DGASPEFRSFIECCLQK 298
                        + P+ +TLM         +                +    ++  L  
Sbjct: 261 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTM 320

Query: 299 EFSKRWTASQLLTHPF 314
           +  KR T+ Q +  P+
Sbjct: 321 DPIKRITSEQAMQDPY 336

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  117 bits (295), Expect = 4e-31
 Identities = 53/209 (25%), Positives = 98/209 (46%), Gaps = 19/209 (9%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIY--ALKVVHGDADPTVRRQVF-REMEILRRTDSPFIVQ 113
           + LG GN GTV K  ++    +   A+K++  +A+    +     E  ++++ D+P+IV+
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82

Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
             GI E  S    ++ME  + G L+  L +N    +  +  +  Q+  G+ YL     +H
Sbjct: 83  MIGICEAES--WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 140

Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGT---CAYMSPERFDPDAYGG 230
           RD+   N+L+   +   KI+DFG+SK +    +   +         + +PE         
Sbjct: 141 RDLAARNVLLVTQHY-AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI------- 192

Query: 231 NYNGY--AGDIWSLGLTLLELY-LGHFPF 256
           NY  +    D+WS G+ + E +  G  P+
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKPY 221

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  117 bits (295), Expect = 4e-31
 Identities = 62/221 (28%), Positives = 96/221 (43%), Gaps = 26/221 (11%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYK--VQHRCTHKIY-ALKVVHGDADPTVRRQVFREMEILR 104
           IA  D+   ++LG G  G VY+    +    KI  A+K    D     + +   E  I++
Sbjct: 9   IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 68

Query: 105 RTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGL 163
             D P IV+  GI E+      I+ME    G L   L +N  +     L   + QI K +
Sbjct: 69  NLDHPHIVKLIGIIEEEP--TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAM 126

Query: 164 SYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA-----YM 218
           +YL     +HRDI   N+LV +    VK+ DFG    + R ++  + Y  +       +M
Sbjct: 127 AYLESINCVHRDIAVRNILVASPEC-VKLGDFG----LSRYIEDEDYYKASVTRLPIKWM 181

Query: 219 SPERFDPDAYGGNYNGY--AGDIWSLGLTLLELY-LGHFPF 256
           SPE         N+  +  A D+W   + + E+   G  PF
Sbjct: 182 SPESI-------NFRRFTTASDVWMFAVCMWEILSFGKQPF 215

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  116 bits (294), Expect = 5e-31
 Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 26/221 (11%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIY---ALKVVHGDADPTVRRQVFREMEILR 104
           I    +E  + +G G  G V++  +          A+K        +VR +  +E   +R
Sbjct: 12  IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 71

Query: 105 RTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGL 163
           + D P IV+  G+  +    + I+ME    G L + L     +     L   A Q+   L
Sbjct: 72  QFDHPHIVKLIGVITENP--VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 129

Query: 164 SYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA-----YM 218
           +YL   + +HRDI   N+LV++N+  VK+ DFG    + R ++    Y  +       +M
Sbjct: 130 AYLESKRFVHRDIAARNVLVSSNDC-VKLGDFG----LSRYMEDSTYYKASKGKLPIKWM 184

Query: 219 SPERFDPDAYGGNYNGY--AGDIWSLGLTLLELY-LGHFPF 256
           +PE         N+  +  A D+W  G+ + E+   G  PF
Sbjct: 185 APESI-------NFRRFTSASDVWMFGVCMWEILMHGVKPF 218

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  117 bits (296), Expect = 5e-31
 Identities = 58/223 (26%), Positives = 103/223 (46%), Gaps = 28/223 (12%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYK---VQHRCTHKIY-ALKVVHGDADPTVRRQVFREMEIL 103
              ++L KL+VLG G  GTV+K   +    + KI   +KV+   +     + V   M  +
Sbjct: 10  FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAI 69

Query: 104 RRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKG 162
              D   IV+  G+    S  + ++ +Y+  G+L   + ++ G      L +   QI KG
Sbjct: 70  GSLDHAHIVRLLGLCPGSS--LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKG 127

Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA------ 216
           + YL  H ++HR++   N+L+ + + QV++ADFGV+      L   +  +          
Sbjct: 128 MYYLEEHGMVHRNLAARNVLLKSPS-QVQVADFGVA----DLLPPDDKQLLYSEAKTPIK 182

Query: 217 YMSPERFDPDAYGGNYNGY--AGDIWSLGLTLLELY-LGHFPF 256
           +M+ E         ++  Y    D+WS G+T+ EL   G  P+
Sbjct: 183 WMALESI-------HFGKYTHQSDVWSYGVTVWELMTFGAEPY 218

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  119 bits (301), Expect = 6e-31
 Identities = 85/325 (26%), Positives = 122/325 (37%), Gaps = 75/325 (23%)

Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRR------TDSP 109
           L+V+G G+ G V K      H+  ALK+V    +    RQ   E+ IL         ++ 
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVR--NEKRFHRQAAEEIRILEHLRKQDKDNTM 159

Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGT--FSEPKLAHIASQILKGLSYLH 167
            ++     F      I +  E + S  L  L+ KN    FS P +   A  IL+ L  LH
Sbjct: 160 NVIHMLENFTF-RNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217

Query: 168 GHKIIHRDIKPSN-LLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPD 226
            ++IIH D+KP N LL       +K+ DFG S   C       +Y+ +  Y +PE     
Sbjct: 218 KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYTYIQSRFYRAPEVI--- 271

Query: 227 AYGGNYNGYAGDIWSLGLTLLELY---------------------LGHFP--FLQPGQR- 262
             G  Y G   D+WSLG  L EL                      LG      L   +R 
Sbjct: 272 -LGARY-GMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRA 329

Query: 263 ------------------PDWATLMCA------ICFGDPPS------LPDGASPEFRSFI 292
                              D + ++           G P S      L     P F  F+
Sbjct: 330 KNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFL 389

Query: 293 ECCLQKEFSKRWTASQLLTHPFLCK 317
           + CL+ + + R T  Q L HP+L +
Sbjct: 390 KQCLEWDPAVRMTPGQALRHPWLRR 414

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  118 bits (298), Expect = 8e-31
 Identities = 66/327 (20%), Positives = 116/327 (35%), Gaps = 75/327 (22%)

Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRR-TDSPFIV 112
           ++ LG G  G V+K   R T ++ A+K +  DA  + T  ++ FRE+ IL   +    IV
Sbjct: 14  VKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-DAFQNSTDAQRTFREIMILTELSGHENIV 72

Query: 113 QCFGIFEKPS-GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
               +    +  D+ ++ +YM++  L  ++ +          ++  Q++K + YLH   +
Sbjct: 73  NLLNVLRADNDRDVYLVFDYMET-DLHAVI-RANILEPVHKQYVVYQLIKVIKYLHSGGL 130

Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGG- 230
           +HRD+KPSN+L+N     VK+ADFG    + RS                E  +       
Sbjct: 131 LHRDMKPSNILLNAEC-HVKVADFG----LSRSFVNIRRVTNNIPLSINENTENFDDDQP 185

Query: 231 ------------------NYNGY--AGDIWSLGLTLLEL--------------------- 249
                                 Y    D+WSLG  L E+                     
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245

Query: 250 --------------------YLGHFPFLQPGQRPDWATLMCAICFGDPPSLPD-GASPEF 288
                                +         ++ +   +            P    + E 
Sbjct: 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEA 305

Query: 289 RSFIECCLQKEFSKRWTASQLLTHPFL 315
              ++  LQ   +KR +A+  L HPF+
Sbjct: 306 LDLLDKLLQFNPNKRISANDALKHPFV 332

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  117 bits (295), Expect = 1e-30
 Identities = 69/307 (22%), Positives = 120/307 (39%), Gaps = 67/307 (21%)

Query: 54  EKLQVLGHGNGGTVYKVQH-RCTHKIYALKVVHGDAD-----PTVRRQVFREMEILR--- 104
           E +  +G G  G V+K +  +   +  ALK V           +      RE+ +LR   
Sbjct: 14  ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST----IREVAVLRHLE 69

Query: 105 RTDSPFIVQ----CFGIFEKPSGDIAILMEYMD---SGTLDTLLNKNGTFSEPKLAHIAS 157
             + P +V+    C          + ++ E++D   +  LD +           +  +  
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMF 127

Query: 158 QILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSY---VGT 214
           Q+L+GL +LH H+++HRD+KP N+LV ++  Q+K+ADFG    + R      +    V T
Sbjct: 128 QLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFG----LARIYSFQMALTSVVVT 182

Query: 215 CAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICF 274
             Y +PE         +Y     D+WS+G    E++    P  +     D    +  +  
Sbjct: 183 LWYRAPEVL----LQSSY-ATPVDLWSVGCIFAEMFRRK-PLFRGSSDVDQLGKILDVI- 235

Query: 275 GDPP--------SLPDGASPEFRSFIECCLQKEF-------------------SKRWTAS 307
           G P         +LP      F S     ++K                     +KR +A 
Sbjct: 236 GLPGEEDWPRDVALPR---QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 292

Query: 308 QLLTHPF 314
             L+HP+
Sbjct: 293 SALSHPY 299

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  118 bits (298), Expect = 2e-30
 Identities = 47/226 (20%), Positives = 88/226 (38%), Gaps = 30/226 (13%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIV 112
           E   ++G G+ G V +   +   ++ A+K +     D    +++ RE+ IL R +   +V
Sbjct: 56  EIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVV 115

Query: 113 QCFGIFEKPS----GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           +   I          ++ +++E  DS     L       +E  +  +   +L G+ Y+H 
Sbjct: 116 KVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHS 174

Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAY 228
             I+HRD+KP+N LVN +   VK+ DFG+++ +    +  +    +              
Sbjct: 175 AGILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHT 233

Query: 229 GG---------------------NYNGY--AGDIWSLGLTLLELYL 251
                                      Y  A D+WS+G    EL  
Sbjct: 234 KNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  119 bits (300), Expect = 3e-30
 Identities = 57/221 (25%), Positives = 97/221 (43%), Gaps = 26/221 (11%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYK--VQHRCTHKIY-ALKVVHGDADPTVRRQVFREMEILR 104
           I    +E  + +G G  G V++          +  A+K        +VR +  +E   +R
Sbjct: 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMR 446

Query: 105 RTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGL 163
           + D P IV+  G+  +    + I+ME    G L + L     +     L   A Q+   L
Sbjct: 447 QFDHPHIVKLIGVITENP--VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTAL 504

Query: 164 SYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA-----YM 218
           +YL   + +HRDI   N+LV++N+  VK+ DFG+S    R ++    Y  +       +M
Sbjct: 505 AYLESKRFVHRDIAARNVLVSSNDC-VKLGDFGLS----RYMEDSTYYKASKGKLPIKWM 559

Query: 219 SPERFDPDAYGGNYNGY--AGDIWSLGLTLLELY-LGHFPF 256
           +PE         N+  +  A D+W  G+ + E+   G  PF
Sbjct: 560 APESI-------NFRRFTSASDVWMFGVCMWEILMHGVKPF 593

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  114 bits (288), Expect = 5e-30
 Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 24/222 (10%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYK----VQHRCTHKIYALKVVH-GDADPTVRRQVF-REME 101
           I   DL  L+ LG G+ G V +         T  + A+K +             F RE+ 
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAMDDFIREVN 73

Query: 102 ILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQIL 160
            +   D   +++ +G+   P   + ++ E    G+L   L K+ G F    L+  A Q+ 
Sbjct: 74  AMHSLDHRNLIRLYGVVLTPP--MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 131

Query: 161 KGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGT---CAY 217
           +G+ YL   + IHRD+   NLL+   ++ VKI DFG+ + + ++ D            A+
Sbjct: 132 EGMGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190

Query: 218 MSPERFDPDAYGGNYNGY--AGDIWSLGLTLLELY-LGHFPF 256
            +PE             +  A D W  G+TL E++  G  P+
Sbjct: 191 CAPESL-------KTRTFSHASDTWMFGVTLWEMFTYGQEPW 225

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  114 bits (287), Expect = 8e-30
 Identities = 50/221 (22%), Positives = 85/221 (38%), Gaps = 27/221 (12%)

Query: 51  SDLEKLQVLGHGNGGTVYK---VQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
             +   +V+G G+ G VY    + +       A+K ++   D     Q   E  I++   
Sbjct: 25  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 84

Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYL 166
            P ++   GI  +  G   +++ YM  G L   +       +   L     Q+ KG+ YL
Sbjct: 85  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 144

Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAY--------M 218
              K +HRD+   N +++     VK+ADFG++    R +     Y              M
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFT-VKVADFGLA----RDMYDKEYYSVHNKTGAKLPVKWM 199

Query: 219 SPERFDPDAYGGNYNGY--AGDIWSLGLTLLELY-LGHFPF 256
           + E             +    D+WS G+ L EL   G  P+
Sbjct: 200 ALESL-------QTQKFTTKSDVWSFGVLLWELMTRGAPPY 233

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  113 bits (285), Expect = 9e-30
 Identities = 33/249 (13%), Positives = 65/249 (26%), Gaps = 42/249 (16%)

Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSPFIVQ 113
           L   G       ++       +  AL  V         V ++       L R D P + +
Sbjct: 36  LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
              +         ++ E++  G+L  + +   + S          +       H   +  
Sbjct: 96  VLDVVH-TRAGGLVVAEWIRGGSLQEVAD--TSPSPVGAIRAMQSLAAAADAAHRAGVAL 152

Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYN 233
               PS + V+ +   V +A                        M               
Sbjct: 153 SIDHPSRVRVSIDG-DVVLAYPA--------------------TMPDA------------ 179

Query: 234 GYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPP---SLPDGASPEFRS 290
               DI  +G +L  L +  +P  + G R   A        G P     +      +  +
Sbjct: 180 NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE-RDTAGQPIEPADIDRDIPFQISA 238

Query: 291 FIECCLQKE 299
                +Q +
Sbjct: 239 VAARSVQGD 247

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  115 bits (290), Expect = 1e-29
 Identities = 71/332 (21%), Positives = 101/332 (30%), Gaps = 82/332 (24%)

Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRR------TDSP 109
             ++G G+ G V K   R   +  A+K++          Q   E+ +L            
Sbjct: 59  DSLIGKGSFGQVVKAYDRVEQEWVAIKIIK--NKKAFLNQAQIEVRLLELMNKHDTEMKY 116

Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGT--FSEPKLAHIASQILKGLSYLH 167
           +IV     F      + ++ E + S  L  LL        S       A Q+   L +L 
Sbjct: 117 YIVHLKRHFMF-RNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174

Query: 168 GHK--IIHRDIKPSN-LLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD 224
             +  IIH D+KP N LL N     +KI DFG S   C+       Y+ +  Y SPE   
Sbjct: 175 TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS---CQLGQRIYQYIQSRFYRSPEVL- 230

Query: 225 PDAYGGNYNGYAGDIWSLGLTLLELY---------------------LGHFP--FLQPGQ 261
               G  Y   A D+WSLG  L+E++                     LG  P   L    
Sbjct: 231 ---LGMPY-DLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAP 286

Query: 262 R---------------------------PDWATLMCAICFGD-PPSLPDGASPE------ 287
           +                           P    L   +      P               
Sbjct: 287 KARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADY 346

Query: 288 --FRSFIECCLQKEFSKRWTASQLLTHPFLCK 317
             F+  I   L  +   R      L H F  K
Sbjct: 347 LKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 378

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  113 bits (285), Expect = 1e-29
 Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 19/207 (9%)

Query: 59  LGHGNGGTVYKVQHRCTHKIY--ALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           LG GN G+V +  +R   K    A+KV+    +     ++ RE +I+ + D+P+IV+  G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 117 IFEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRD 175
           + +  +  + ++ME    G L   L           +A +  Q+  G+ YL     +HRD
Sbjct: 78  VCQAEA--LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRD 135

Query: 176 IKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGT---CAYMSPERFDPDAYGGNY 232
           +   N+L+ N +   KI+DFG+SK +        +         + +PE         N+
Sbjct: 136 LAARNVLLVNRHY-AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI-------NF 187

Query: 233 NGY--AGDIWSLGLTLLELY-LGHFPF 256
             +    D+WS G+T+ E    G  P+
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKPY 214

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  113 bits (286), Expect = 2e-29
 Identities = 61/263 (23%), Positives = 112/263 (42%), Gaps = 24/263 (9%)

Query: 6   QRRQLNLRLPMPELSERCLRFPLALPPTAPNTNNNTTATTAAIAYSDLEKLQVLGHGNGG 65
                       +      +F  A P T         + T  I  S +   +++G G+ G
Sbjct: 5   HHHSSGRENLYFQGKLPEPQFY-AEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSG 63

Query: 66  TVYK--VQHRCTHKIY-ALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGI--FEK 120
            V    ++      +  A+K +        RR    E  I+ + D P I++  G+    +
Sbjct: 64  EVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR 123

Query: 121 PSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPS 179
                 I+ EYM++G+LDT L  + G F+  +L  +   +  G+ YL     +HRD+   
Sbjct: 124 L---AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAAR 180

Query: 180 NLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGT---CAYMSPERFDPDAYGGNYNGY- 235
           N+LV++N +  K++DFG+S+++    DA  +  G      + +PE          +  + 
Sbjct: 181 NVLVDSNLV-CKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAI-------AFRTFS 232

Query: 236 -AGDIWSLGLTLLELY-LGHFPF 256
            A D+WS G+ + E+   G  P+
Sbjct: 233 SASDVWSFGVVMWEVLAYGERPY 255

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  114 bits (288), Expect = 2e-29
 Identities = 59/223 (26%), Positives = 105/223 (47%), Gaps = 27/223 (12%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYK--VQHRCTHKIY-ALKVVHGDADPTVRRQVFREMEILR 104
           +  +++   +V+G G  G V    ++     +I  A+K +        RR    E  I+ 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101

Query: 105 RTDSPFIVQCFGI--FEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILK 161
           + D P I++  G+    KP   + I+ EYM++G+LD+ L K+   F+  +L  +   I  
Sbjct: 102 QFDHPNIIRLEGVVTKSKP---VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158

Query: 162 GLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA----- 216
           G+ YL     +HRD+   N+L+N+N +  K++DFG+ +++    D   +Y          
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLV-CKVSDFGLGRVL--EDDPEAAYTTRGGKIPIR 215

Query: 217 YMSPERFDPDAYGGNYNGY--AGDIWSLGLTLLELY-LGHFPF 256
           + SPE          Y  +  A D+WS G+ L E+   G  P+
Sbjct: 216 WTSPEAI-------AYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  113 bits (285), Expect = 5e-29
 Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 21/218 (9%)

Query: 51  SDLEKLQVLGHGNGGTVYK--VQHRCTHKIY-ALKVVHGDADPTVRRQVFREMEILRRTD 107
             +   +V+G G+ G VY   +      KI+ A+K ++   D     Q   E  I++   
Sbjct: 89  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 148

Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYL 166
            P ++   GI  +  G   +++ YM  G L   +       +   L     Q+ KG+ +L
Sbjct: 149 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 208

Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA-----YMSPE 221
              K +HRD+   N +++     VK+ADFG+++ M    +  + +  T A     +M+ E
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFT-VKVADFGLARDMYDK-EFDSVHNKTGAKLPVKWMALE 266

Query: 222 RFDPDAYGGNYNGY--AGDIWSLGLTLLELY-LGHFPF 256
                        +    D+WS G+ L EL   G  P+
Sbjct: 267 SL-------QTQKFTTKSDVWSFGVLLWELMTRGAPPY 297

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  112 bits (283), Expect = 5e-29
 Identities = 60/222 (27%), Positives = 103/222 (46%), Gaps = 24/222 (10%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYK---VQHRCTHKIY-ALKVVHGDADPTVRRQVFREMEIL 103
           I  S + + +V+G G  G VYK          ++  A+K +        R     E  I+
Sbjct: 41  IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 100

Query: 104 RRTDSPFIVQCFGI--FEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQIL 160
            +     I++  G+    KP   + I+ EYM++G LD  L +  G FS  +L  +   I 
Sbjct: 101 GQFSHHNIIRLEGVISKYKP---MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 157

Query: 161 KGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGT---CAY 217
            G+ YL     +HRD+   N+LVN+N +  K++DFG+S+++    +A  +  G      +
Sbjct: 158 AGMKYLANMNYVHRDLAARNILVNSNLV-CKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 216

Query: 218 MSPERFDPDAYGGNYNGY--AGDIWSLGLTLLELY-LGHFPF 256
            +PE         +Y  +  A D+WS G+ + E+   G  P+
Sbjct: 217 TAPEAI-------SYRKFTSASDVWSFGIVMWEVMTYGERPY 251

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  110 bits (278), Expect = 7e-29
 Identities = 55/219 (25%), Positives = 103/219 (47%), Gaps = 33/219 (15%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVF-REMEILRRTDSP 109
           S+L  +Q +G G  G V+        K+ A+K +       +  + F  E E++ +   P
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREG---AMSEEDFIEEAEVMMKLSHP 63

Query: 110 FIVQCFGI--FEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYL 166
            +VQ +G+   + P   I ++ E+M+ G L   L    G F+   L  +   + +G++YL
Sbjct: 64  KLVQLYGVCLEQAP---ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120

Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA------YMSP 220
               +IHRD+   N LV  N + +K++DFG+++ +       + Y  +        + SP
Sbjct: 121 EEACVIHRDLAARNCLVGENQV-IKVSDFGMTRFVLD-----DQYTSSTGTKFPVKWASP 174

Query: 221 ERFDPDAYGGNYNGY--AGDIWSLGLTLLELY-LGHFPF 256
           E F       +++ Y    D+WS G+ + E++  G  P+
Sbjct: 175 EVF-------SFSRYSSKSDVWSFGVLMWEVFSEGKIPY 206

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  110 bits (278), Expect = 1e-28
 Identities = 53/221 (23%), Positives = 107/221 (48%), Gaps = 31/221 (14%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           +   ++  L+ LG G  G V   + +  + + A+K++   +      + F+E + + +  
Sbjct: 5   LKREEITLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKEGS--MSEDEFFQEAQTMMKLS 61

Query: 108 SPFIVQCFGI--FEKPSGDIAILMEYMDSGTLDTLLNKNG-TFSEPKLAHIASQILKGLS 164
            P +V+ +G+   E P   I I+ EY+ +G L   L  +G      +L  +   + +G++
Sbjct: 62  HPKLVKFYGVCSKEYP---IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMA 118

Query: 165 YLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA------YM 218
           +L  H+ IHRD+   N LV+ +   VK++DFG+++ +       + YV +        + 
Sbjct: 119 FLESHQFIHRDLAARNCLVDRDLC-VKVSDFGMTRYVLD-----DQYVSSVGTKFPVKWS 172

Query: 219 SPERFDPDAYGGNYNGY--AGDIWSLGLTLLELY-LGHFPF 256
           +PE F       +Y  Y    D+W+ G+ + E++ LG  P+
Sbjct: 173 APEVF-------HYFKYSSKSDVWAFGILMWEVFSLGKMPY 206

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  110 bits (278), Expect = 1e-28
 Identities = 48/222 (21%), Positives = 89/222 (40%), Gaps = 23/222 (10%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIY---ALKVVHGDADPTVRRQVFREMEILRRTD 107
                 +V+G G+ G VY  ++    +     A+K +    +        RE  ++R  +
Sbjct: 21  VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN 80

Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDT-LLNKNGTFSEPKLAHIASQILKGLSYL 166
            P ++   GI   P G   +L+ YM  G L   + +     +   L     Q+ +G+ YL
Sbjct: 81  HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL 140

Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA-----YMSPE 221
              K +HRD+   N +++ +   VK+ADFG+++ +    +  +      A     + + E
Sbjct: 141 AEQKFVHRDLAARNCMLDESFT-VKVADFGLARDI-LDREYYSVQQHRHARLPVKWTALE 198

Query: 222 RFDPDAYGGNYNGY--AGDIWSLGLTLLELY-LGHFPFLQPG 260
                        +    D+WS G+ L EL   G  P+    
Sbjct: 199 SL-------QTYRFTTKSDVWSFGVLLWELLTRGAPPY--RH 231

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  110 bits (277), Expect = 2e-28
 Identities = 48/227 (21%), Positives = 86/227 (37%), Gaps = 30/227 (13%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYK------VQHRCTHKIY-ALKVVHGDADPTVRRQVFREM 100
           I   DL   + LG G    ++K        +   H+    LKV+   A        F   
Sbjct: 5   IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD-KAHRNYSESFFEAA 63

Query: 101 EILRRTDSPFIVQCFGI--FEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIAS 157
            ++ +     +V  +G+           ++ E++  G+LDT L KN    +      +A 
Sbjct: 64  SMMSKLSHKHLVLNYGVCVCGDE---NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK 120

Query: 158 QILKGLSYLHGHKIIHRDIKPSNLLVNN-------NNMQVKIADFGVSKIMCRSLDACNS 210
           Q+   + +L  + +IH ++   N+L+         N   +K++D G    +  ++   + 
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG----ISITVLPKDI 176

Query: 211 YVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELY-LGHFPF 256
                 ++ PE         N N  A D WS G TL E+   G  P 
Sbjct: 177 LQERIPWVPPECI---ENPKNLNL-ATDKWSFGTTLWEICSGGDKPL 219

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  111 bits (280), Expect = 2e-28
 Identities = 68/273 (24%), Positives = 104/273 (38%), Gaps = 43/273 (15%)

Query: 13  RLPMPELSERCLRFPLALPPTAPNTNNNTTATTAA----IAYSDLEKLQVLGHGNGGTVY 68
            L  PE     LR    +    PN       ++ +    +   ++  ++ LGHG  G VY
Sbjct: 29  ELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVY 88

Query: 69  K-----VQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGI--FEKP 121
           +     + +  +    A+K +              E  I+ + +   IV+C G+     P
Sbjct: 89  EGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148

Query: 122 SGDIAILMEYMDSGTLDTLL-------NKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
                IL+E M  G L + L       ++  + +   L H+A  I  G  YL  +  IHR
Sbjct: 149 ---RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHR 205

Query: 175 DIKPSNLLVNNN--NMQVKIADFGVSKIMCRSLDACNSY-VGTCAY-----MSPERFDPD 226
           DI   N L+         KI DFG    M R +     Y  G CA      M PE F   
Sbjct: 206 DIAARNCLLTCPGPGRVAKIGDFG----MARDIYRAGYYRKGGCAMLPVKWMPPEAF--- 258

Query: 227 AYGGNYNGY--AGDIWSLGLTLLELY-LGHFPF 256
                   +    D WS G+ L E++ LG+ P+
Sbjct: 259 ----MEGIFTSKTDTWSFGVLLWEIFSLGYMPY 287

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  112 bits (283), Expect = 2e-28
 Identities = 65/265 (24%), Positives = 112/265 (42%), Gaps = 21/265 (7%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
             L     LG G  G V+      T ++ A+K +             +E +++++     
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGT--MSPEAFLQEAQVMKKLRHEK 240

Query: 111 IVQCFG-IFEKPSGDIAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLH 167
           +VQ +  + E+P   I I+ EYM  G+L   L          P+L  +A+QI  G++Y+ 
Sbjct: 241 LVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 297

Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PD 226
               +HRD++ +N+LV  N +  K+ADFG+++++       N Y        P ++  P+
Sbjct: 298 RMNYVHRDLRAANILVGENLV-CKVADFGLARLI-----EDNEYTARQGAKFPIKWTAPE 351

Query: 227 AYGGNYNGYAGDIWSLGLTLLELY-LGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS 285
           A          D+WS G+ L EL   G  P+  PG       ++  +  G     P    
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPY--PGM--VNREVLDQVERGYRMPCPPECP 407

Query: 286 PEFRSFIECCLQKEFSKRWTASQLL 310
                 +  C +KE  +R T   L 
Sbjct: 408 ESLHDLMCQCWRKEPEERPTFEYLQ 432

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  110 bits (276), Expect = 4e-28
 Identities = 49/237 (20%), Positives = 89/237 (37%), Gaps = 38/237 (16%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYK---VQHRCTHKIYALKVVHGDADPTVRRQVF-REMEIL 103
           I        ++LG G  G+V +    Q   +    A+K++  D   +   + F RE   +
Sbjct: 20  IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACM 79

Query: 104 RRTDSPFIVQCFGI-----FEKPSGDIAILMEYMDSGTLDTLL------NKNGTFSEPKL 152
           +  D P + +  G+      +       +++ +M  G L   L                L
Sbjct: 80  KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTL 139

Query: 153 AHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSY- 211
                 I  G+ YL     IHRD+   N ++  +   V +ADFG    + R + + + Y 
Sbjct: 140 VRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT-VCVADFG----LSRKIYSGDYYR 194

Query: 212 VGTCA-----YMSPERFDPDAYGGNYNGY--AGDIWSLGLTLLELY-LGHFPFLQPG 260
            G  +     +++ E           N Y    D+W+ G+T+ E+   G  P+   G
Sbjct: 195 QGCASKLPVKWLALESL-------ADNLYTVHSDVWAFGVTMWEIMTRGQTPY--AG 242

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  113 bits (284), Expect = 4e-28
 Identities = 52/209 (24%), Positives = 94/209 (44%), Gaps = 19/209 (9%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIY--ALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQC 114
             LG GN G+V +  +R   K    A+KV+    +     ++ RE +I+ + D+P+IV+ 
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401

Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIH 173
            G+ +  +  + ++ME    G L   L           +A +  Q+  G+ YL     +H
Sbjct: 402 IGVCQAEA--LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 459

Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGT---CAYMSPERFDPDAYGG 230
           R++   N+L+ N +   KI+DFG+SK +        +         + +PE         
Sbjct: 460 RNLAARNVLLVNRHY-AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI------- 511

Query: 231 NYNGY--AGDIWSLGLTLLELY-LGHFPF 256
           N+  +    D+WS G+T+ E    G  P+
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQKPY 540

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  112 bits (282), Expect = 5e-28
 Identities = 66/271 (24%), Positives = 117/271 (43%), Gaps = 25/271 (9%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           +  +D+     LG G  G VY+   +      A+K +  D       +  +E  +++   
Sbjct: 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIK 274

Query: 108 SPFIVQCFGI--FEKPSGDIAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGL 163
            P +VQ  G+   E P     I+ E+M  G L   L +      S   L ++A+QI   +
Sbjct: 275 HPNLVQLLGVCTREPP---FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 331

Query: 164 SYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF 223
            YL     IHR++   N LV  N++ VK+ADFG+S++M       ++Y        P ++
Sbjct: 332 EYLEKKNFIHRNLAARNCLVGENHL-VKVADFGLSRLM-----TGDTYTAHAGAKFPIKW 385

Query: 224 D-PDAYGGNYNGY--AGDIWSLGLTLLELY-LGHFPFLQPGQRPDWATLMCAICFGDPPS 279
             P++    YN +    D+W+ G+ L E+   G  P+  PG   D + +   +       
Sbjct: 386 TAPESL--AYNKFSIKSDVWAFGVLLWEIATYGMSPY--PGI--DLSQVYELLEKDYRME 439

Query: 280 LPDGASPEFRSFIECCLQKEFSKRWTASQLL 310
            P+G   +    +  C Q   S R + +++ 
Sbjct: 440 RPEGCPEKVYELMRACWQWNPSDRPSFAEIH 470

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  111 bits (280), Expect = 1e-27
 Identities = 65/265 (24%), Positives = 112/265 (42%), Gaps = 21/265 (7%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
             L     LG G  G V+      T ++ A+K +             +E +++++     
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGT--MSPEAFLQEAQVMKKLRHEK 323

Query: 111 IVQCFG-IFEKPSGDIAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLH 167
           +VQ +  + E+P   I I+ EYM  G+L   L          P+L  +A+QI  G++Y+ 
Sbjct: 324 LVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 380

Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD-PD 226
               +HRD++ +N+LV  N +  K+ADFG+++++       N Y        P ++  P+
Sbjct: 381 RMNYVHRDLRAANILVGENLV-CKVADFGLARLI-----EDNEYTARQGAKFPIKWTAPE 434

Query: 227 AYGGNYNGYAGDIWSLGLTLLELY-LGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS 285
           A          D+WS G+ L EL   G  P+  PG       ++  +  G     P    
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGRVPY--PGM--VNREVLDQVERGYRMPCPPECP 490

Query: 286 PEFRSFIECCLQKEFSKRWTASQLL 310
                 +  C +KE  +R T   L 
Sbjct: 491 ESLHDLMCQCWRKEPEERPTFEYLQ 515

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  107 bits (270), Expect = 2e-27
 Identities = 55/219 (25%), Positives = 100/219 (45%), Gaps = 33/219 (15%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVF-REMEILRRTDSP 109
            DL  L+ LG G  G V   + R  + + A+K++      ++    F  E +++      
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEG---SMSEDEFIEEAKVMMNLSHE 79

Query: 110 FIVQCFGI--FEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYL 166
            +VQ +G+   ++P   I I+ EYM +G L   L +    F   +L  +   + + + YL
Sbjct: 80  KLVQLYGVCTKQRP---IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 136

Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA------YMSP 220
              + +HRD+   N LVN+  + VK++DFG+S+ +       + Y  +        +  P
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLD-----DEYTSSVGSKFPVRWSPP 190

Query: 221 ERFDPDAYGGNYNGY--AGDIWSLGLTLLELY-LGHFPF 256
           E          Y+ +    DIW+ G+ + E+Y LG  P+
Sbjct: 191 EVL-------MYSKFSSKSDIWAFGVLMWEIYSLGKMPY 222

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  107 bits (270), Expect = 2e-27
 Identities = 56/241 (23%), Positives = 97/241 (40%), Gaps = 47/241 (19%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYK-----VQHRCTHKIYALKVVHGDADPTVRRQVFREMEI 102
           I+ S +  ++ LG    G VYK            +  A+K +   A+  +R +   E  +
Sbjct: 6   ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAML 65

Query: 103 LRRTDSPFIVQCFGI--FEKPSGDIAILMEYMDSGTLDTLLNKN---------------- 144
             R   P +V   G+   ++P   ++++  Y   G L   L                   
Sbjct: 66  RARLQHPNVVCLLGVVTKDQP---LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122

Query: 145 GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS 204
                P   H+ +QI  G+ YL  H ++H+D+   N+LV +    VKI+D G    + R 
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN-VKISDLG----LFRE 177

Query: 205 LDACNSY-VGTCA-----YMSPERFDPDAYGGNYNGY--AGDIWSLGLTLLELY-LGHFP 255
           + A + Y +   +     +M+PE          Y  +    DIWS G+ L E++  G  P
Sbjct: 178 VYAADYYKLLGNSLLPIRWMAPEAI-------MYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

Query: 256 F 256
           +
Sbjct: 231 Y 231

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  107 bits (270), Expect = 3e-27
 Identities = 59/239 (24%), Positives = 96/239 (40%), Gaps = 43/239 (17%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYK-----VQHRCTHKIYALKVVHGDADPTVRRQVFREMEI 102
           +A   +   + LG G+ G VY+     V         A+K V+  A    R +   E  +
Sbjct: 22  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81

Query: 103 LRRTDSPFIVQCFGI--FEKPSGDIAILMEYMDSGTLDTLL----------NKNGTFSEP 150
           ++  +   +V+  G+    +P     ++ME M  G L + L                S  
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQP---TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 138

Query: 151 KLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNS 210
           K+  +A +I  G++YL+ +K +HRD+   N +V  +   VKI DFG    M R +   + 
Sbjct: 139 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT-VKIGDFG----MTRDIYETDY 193

Query: 211 Y-VGTCAY-----MSPERFDPDAYGGNYNGY--AGDIWSLGLTLLELY-LGHFPFLQPG 260
           Y  G         MSPE             +    D+WS G+ L E+  L   P+   G
Sbjct: 194 YRKGGKGLLPVRWMSPESL-------KDGVFTTYSDVWSFGVVLWEIATLAEQPY--QG 243

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  107 bits (270), Expect = 3e-27
 Identities = 65/257 (25%), Positives = 99/257 (38%), Gaps = 45/257 (17%)

Query: 31  PPTAPNTNNNTTATTAA------IAYSDLEKLQVLGHGNGGTVYK-----VQHRCTHKIY 79
                N N      T++      +   ++  ++ LGHG  G VY+     + +  +    
Sbjct: 4   HHHHHNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQV 63

Query: 80  ALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGI--FEKPSGDIAILMEYMDSGTL 137
           A+K +              E  I+ + +   IV+C G+     P     ILME M  G L
Sbjct: 64  AVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP---RFILMELMAGGDL 120

Query: 138 DTLL-------NKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNN--NM 188
            + L       ++  + +   L H+A  I  G  YL  +  IHRDI   N L+       
Sbjct: 121 KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 180

Query: 189 QVKIADFGVSKIMCRSLDACNSY-VGTCAY-----MSPERFDPDAYGGNYNGY--AGDIW 240
             KI DFG    M R +   + Y  G CA      M PE F           +    D W
Sbjct: 181 VAKIGDFG----MARDIYRASYYRKGGCAMLPVKWMPPEAF-------MEGIFTSKTDTW 229

Query: 241 SLGLTLLELY-LGHFPF 256
           S G+ L E++ LG+ P+
Sbjct: 230 SFGVLLWEIFSLGYMPY 246

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  106 bits (266), Expect = 1e-26
 Identities = 50/236 (21%), Positives = 90/236 (38%), Gaps = 37/236 (15%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYK---VQHRCTHKIYALKVVHGDADPTVRRQVF-REMEIL 103
           I  + L   ++LG G  G+V +    Q   T    A+K +  D       + F  E   +
Sbjct: 31  IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACM 90

Query: 104 RRTDSPFIVQCFGI--FEKPSGDIA--ILMEYMDSGTLDTLL------NKNGTFSEPKLA 153
           +    P +++  G+       G     +++ +M  G L T L                L 
Sbjct: 91  KDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLL 150

Query: 154 HIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSY-V 212
                I  G+ YL     +HRD+   N ++ ++   V +ADFG    + + + + + Y  
Sbjct: 151 KFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT-VCVADFG----LSKKIYSGDYYRQ 205

Query: 213 GTCA-----YMSPERFDPDAYGGNYNGY--AGDIWSLGLTLLELY-LGHFPFLQPG 260
           G  A     +++ E             Y    D+W+ G+T+ E+   G  P+  PG
Sbjct: 206 GRIAKMPVKWIAIESL-------ADRVYTSKSDVWAFGVTMWEIATRGMTPY--PG 252

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  108 bits (271), Expect = 1e-26
 Identities = 66/304 (21%), Positives = 111/304 (36%), Gaps = 48/304 (15%)

Query: 27  PLALPPTAPNTNNNTTATTAAIAY-------SDLEKLQVLGHGNGGTVYKVQHRCTHKIY 79
            L      P     T A               +L+ LQ +G G  G V            
Sbjct: 162 GLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVML--GDYRGNKV 219

Query: 80  ALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDT 139
           A+K +  DA     +    E  ++ +     +VQ  G+  +  G + I+ EYM  G+L  
Sbjct: 220 AVKCIKNDATA---QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD 276

Query: 140 LLNKNG--TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGV 197
            L   G        L   +  + + + YL G+  +HRD+   N+LV+ +N+  K++DFG+
Sbjct: 277 YLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV-AKVSDFGL 335

Query: 198 SKIMCRSLDACNSYVGTCA------YMSPERFDPDAYGGNYNGY--AGDIWSLGLTLLEL 249
           +K          +            + +PE             +    D+WS G+ L E+
Sbjct: 336 TK---------EASSTQDTGKLPVKWTAPEAL-------REKKFSTKSDVWSFGILLWEI 379

Query: 250 Y-LGHFPFLQPGQRPDWATLMCAICFGD--PPSLPDGASPEFRSFIECCLQKEFSKRWTA 306
           Y  G  P+  P        ++  +  G       PDG  P     ++ C   + + R T 
Sbjct: 380 YSFGRVPY--PRI--PLKDVVPRVEKGYKMDA--PDGCPPAVYDVMKNCWHLDAATRPTF 433

Query: 307 SQLL 310
            QL 
Sbjct: 434 LQLR 437

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  107 bits (270), Expect = 1e-26
 Identities = 51/218 (23%), Positives = 100/218 (45%), Gaps = 31/218 (14%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
             L+  + LG G  G V+   +    K+ A+K +   +          E  +++      
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGS--MSVEAFLAEANVMKTLQHDK 244

Query: 111 IVQCFGI-FEKPSGDIAILMEYMDSGTLDTLL--NKNGTFSEPKLAHIASQILKGLSYLH 167
           +V+   +  ++P   I I+ E+M  G+L   L  ++      PKL   ++QI +G++++ 
Sbjct: 245 LVKLHAVVTKEP---IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 301

Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA------YMSPE 221
               IHRD++ +N+LV+ + +  KIADFG+++++       N Y           + +PE
Sbjct: 302 QRNYIHRDLRAANILVSASLV-CKIADFGLARVI-----EDNEYTAREGAKFPIKWTAPE 355

Query: 222 RFDPDAYGGNYNGY--AGDIWSLGLTLLELY-LGHFPF 256
                    N+  +    D+WS G+ L+E+   G  P+
Sbjct: 356 AI-------NFGSFTIKSDVWSFGILLMEIVTYGRIPY 386

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  106 bits (267), Expect = 1e-26
 Identities = 69/332 (20%), Positives = 113/332 (34%), Gaps = 84/332 (25%)

Query: 56  LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRR-----TDSPF 110
           ++ +G G  G V   QH    K YA+KVV         R    E +IL++      ++  
Sbjct: 40  IRKMGDGTFGRVLLCQHIDNKKYYAVKVVR--NIKKYTRSAKIEADILKKIQNDDINNNN 97

Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHG 168
           IV+  G F      + ++ E +     + ++ +N    F    +     +ILK L+YL  
Sbjct: 98  IVKYHGKFMY-YDHMCLIFEPLGPSLYE-IITRNNYNGFHIEDIKLYCIEILKALNYLRK 155

Query: 169 HKIIHRDIKPSNLLVNNNNMQ------------------------VKIADFGVSKIMCRS 204
             + H D+KP N+L+++   +                        +K+ DFG +      
Sbjct: 156 MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA---TFK 212

Query: 205 LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGH--FP------- 255
            D   S + T  Y +PE          +   + D+WS G  L ELY G   F        
Sbjct: 213 SDYHGSIINTRQYRAPEVI----LNLGW-DVSSDMWSFGCVLAELYTGSLLFRTHEHMEH 267

Query: 256 --------------FLQPGQRP--------DWATLMCAICFGDPPSLPDGAS-------- 285
                          L    +         D   L          S+             
Sbjct: 268 LAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKII 327

Query: 286 --PEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
               F  F+   LQ + + R + ++LL H FL
Sbjct: 328 KHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  104 bits (263), Expect = 2e-26
 Identities = 52/220 (23%), Positives = 92/220 (41%), Gaps = 33/220 (15%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           +   +L+ LQ +G G  G V    +R      A+K +  DA     +    E  ++ +  
Sbjct: 18  LNMKELKLLQTIGKGEFGDVMLGDYRGN--KVAVKCIKNDATA---QAFLAEASVMTQLR 72

Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSY 165
              +VQ  G+  +  G + I+ EYM  G+L   L   G        L   +  + + + Y
Sbjct: 73  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 132

Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA------YMS 219
           L G+  +HRD+   N+LV+ +N+  K++DFG++K          +            + +
Sbjct: 133 LEGNNFVHRDLAARNVLVSEDNV-AKVSDFGLTK---------EASSTQDTGKLPVKWTA 182

Query: 220 PERFDPDAYGGNYNGY--AGDIWSLGLTLLELY-LGHFPF 256
           PE             +    D+WS G+ L E+Y  G  P+
Sbjct: 183 PEAL-------REKKFSTKSDVWSFGILLWEIYSFGRVPY 215

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  104 bits (262), Expect = 2e-26
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 33/223 (14%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVF-REMEILRRT 106
           +  +D+     LG G  G VY+   +      A+K +  D   T+  + F +E  +++  
Sbjct: 10  MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEI 66

Query: 107 DSPFIVQCFGI--FEKPSGDIAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKG 162
             P +VQ  G+   E P     I+ E+M  G L   L +      S   L ++A+QI   
Sbjct: 67  KHPNLVQLLGVCTREPP---FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123

Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA------ 216
           + YL     IHRD+   N LV  N++ VK+ADFG+S++M       ++Y           
Sbjct: 124 MEYLEKKNFIHRDLAARNCLVGENHL-VKVADFGLSRLM-----TGDTYTAHAGAKFPIK 177

Query: 217 YMSPERFDPDAYGGNYNGY--AGDIWSLGLTLLELY-LGHFPF 256
           + +PE          YN +    D+W+ G+ L E+   G  P+
Sbjct: 178 WTAPESL-------AYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  105 bits (263), Expect = 4e-26
 Identities = 66/257 (25%), Positives = 101/257 (39%), Gaps = 47/257 (18%)

Query: 31  PPTAPNTNNNTTATTAAIAYSDLEKLQVLGHGNGGTVYK-----VQHRCTHKIYALKVVH 85
                N    + A    I   D+     LG G  G V+      +       + A+K + 
Sbjct: 21  GHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK 80

Query: 86  GDADPTVRRQVFREMEILRRTDSPFIVQCFGI--FEKPSGDIAILMEYMDSGTLDTLL-- 141
            +A  + R+   RE E+L       IV+ FG+    +P   + ++ EYM  G L+  L  
Sbjct: 81  -EASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP---LLMVFEYMRHGDLNRFLRS 136

Query: 142 -------------NKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNM 188
                           G     +L  +ASQ+  G+ YL G   +HRD+   N LV    +
Sbjct: 137 HGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV 196

Query: 189 QVKIADFGVSKIMCRSLDACNSY-VGTCA-----YMSPERFDPDAYGGNYNGY--AGDIW 240
            VKI DFG    M R + + + Y VG        +M PE          Y  +    D+W
Sbjct: 197 -VKIGDFG----MSRDIYSTDYYRVGGRTMLPIRWMPPESI-------LYRKFTTESDVW 244

Query: 241 SLGLTLLELY-LGHFPF 256
           S G+ L E++  G  P+
Sbjct: 245 SFGVVLWEIFTYGKQPW 261

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  103 bits (260), Expect = 4e-26
 Identities = 53/218 (24%), Positives = 102/218 (46%), Gaps = 31/218 (14%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
             L+ ++ LG G  G V+   +    K+ A+K +   +          E  ++++     
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGS--MSPDAFLAEANLMKQLQHQR 69

Query: 111 IVQCFGI-FEKPSGDIAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLH 167
           +V+ + +  ++P   I I+ EYM++G+L   L        +  KL  +A+QI +G++++ 
Sbjct: 70  LVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126

Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCA------YMSPE 221
               IHRD++ +N+LV++     KIADFG+++++       N Y           + +PE
Sbjct: 127 ERNYIHRDLRAANILVSDTLS-CKIADFGLARLI-----EDNEYTAREGAKFPIKWTAPE 180

Query: 222 RFDPDAYGGNYNGY--AGDIWSLGLTLLELY-LGHFPF 256
                    NY  +    D+WS G+ L E+   G  P+
Sbjct: 181 AI-------NYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  104 bits (261), Expect = 8e-26
 Identities = 61/327 (18%), Positives = 107/327 (32%), Gaps = 76/327 (23%)

Query: 56  LQVLGHGNGGTVYKV-QHRCTHKIYALKVVHGDADPTVRRQVFREMEILRR------TDS 108
           +  LG G  G V +   H       ALK++        R     E+ +L++       + 
Sbjct: 24  VGNLGEGTFGKVVECLDHARGKSQVALKIIR--NVGKYREAARLEINVLKKIKEKDKENK 81

Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTL-LNKNGTFSEPKLAHIASQILKGLSYLH 167
              V     F    G + I  E +   T + L  N    +  P + H+A Q+   L +LH
Sbjct: 82  FLCVLMSDWFNF-HGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH 140

Query: 168 GHKIIHRDIKPSNLLVNNNNMQ------------------VKIADFGVSKIMCRSLDACN 209
            +++ H D+KP N+L  N+  +                  +++ADFG +       +   
Sbjct: 141 ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA---TFDHEHHT 197

Query: 210 SYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGH--FP------------ 255
           + V T  Y  PE          +     D+WS+G  L E Y G   F             
Sbjct: 198 TIVATRHYRPPEVI----LELGW-AQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMME 252

Query: 256 ---------FLQPGQR--------PDWATLMCAICFGDPPSLPDGAS--------PEFRS 290
                     +   ++          W        +      P  +          +   
Sbjct: 253 KILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFD 312

Query: 291 FIECCLQKEFSKRWTASQLLTHPFLCK 317
            +   L+ + ++R T ++ L HPF   
Sbjct: 313 LMRRMLEFDPAQRITLAEALLHPFFAG 339

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  103 bits (258), Expect = 9e-26
 Identities = 65/241 (26%), Positives = 97/241 (40%), Gaps = 48/241 (19%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYK-----VQHRCTHKIYALKVVHGDADPTVRRQVFREMEI 102
           I   D+   + LG G  G V+      +       + A+K +  D     R+   RE E+
Sbjct: 12  IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-DPTLAARKDFQREAEL 70

Query: 103 LRRTDSPFIVQCFGI--FEKPSGDIAILMEYMDSGTLDTLL----------------NKN 144
           L       IV+ +G+     P   + ++ EYM  G L+  L                   
Sbjct: 71  LTNLQHEHIVKFYGVCGDGDP---LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK 127

Query: 145 GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS 204
           G     ++ HIASQI  G+ YL     +HRD+   N LV  N + VKI DFG    M R 
Sbjct: 128 GELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL-VKIGDFG----MSRD 182

Query: 205 LDACNSY-VGTCA-----YMSPERFDPDAYGGNYNGY--AGDIWSLGLTLLELY-LGHFP 255
           + + + Y VG        +M PE          Y  +    D+WS G+ L E++  G  P
Sbjct: 183 VYSTDYYRVGGHTMLPIRWMPPESI-------MYRKFTTESDVWSFGVILWEIFTYGKQP 235

Query: 256 F 256
           +
Sbjct: 236 W 236

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  103 bits (259), Expect = 2e-25
 Identities = 64/290 (22%), Positives = 110/290 (37%), Gaps = 60/290 (20%)

Query: 13  RLPMPELSERCLRFPLALPPTAPNTNNNTTATTAA-------IAYSDLEKLQVLGHGNGG 65
            +    ++   L   L L    PN                     +++E ++ +G G  G
Sbjct: 2   AMESAAVTLTTLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFG 61

Query: 66  TVYK------VQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFE 119
            V++      + +     + A+K++  +A   ++    RE  ++   D+P IV+  G+  
Sbjct: 62  RVFQARAPGLLPYEPFTMV-AVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120

Query: 120 KPSGDIAILMEYMDSGTLDTLLNKN------------------------GTFSEPKLAHI 155
                + +L EYM  G L+  L                              S  +   I
Sbjct: 121 V-GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCI 179

Query: 156 ASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSY-VGT 214
           A Q+  G++YL   K +HRD+   N LV  N + VKIADFG    + R++ + + Y    
Sbjct: 180 ARQVAAGMAYLSERKFVHRDLATRNCLVGENMV-VKIADFG----LSRNIYSADYYKADG 234

Query: 215 CAY-----MSPERFDPDAYGGNYNGY--AGDIWSLGLTLLELY-LGHFPF 256
                   M PE          YN Y    D+W+ G+ L E++  G  P+
Sbjct: 235 NDAIPIRWMPPESI-------FYNRYTTESDVWAYGVVLWEIFSYGLQPY 277

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  103 bits (258), Expect = 2e-25
 Identities = 71/332 (21%), Positives = 119/332 (35%), Gaps = 78/332 (23%)

Query: 56  LQVLGHGNGGTVYKVQ-HRCTHKIYALKVVHGDADPTVRRQVFREMEILRR------TDS 108
           +  LG G  G V +   H+   +  A+K+V              E+++L          +
Sbjct: 19  VDTLGEGAFGKVVECIDHKAGGRHVAVKIVK--NVDRYCEAARSEIQVLEHLNTTDPNST 76

Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGT--FSEPKLAHIASQILKGLSYL 166
              VQ    FE   G I I+ E +   +    + +NG   F    +  +A QI K +++L
Sbjct: 77  FRCVQMLEWFEH-HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFL 134

Query: 167 HGHKIIHRDIKPSNLLVNNNNM------------------QVKIADFGVSKIMCRSLDAC 208
           H +K+ H D+KP N+L   ++                    +K+ DFG +       +  
Sbjct: 135 HSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA---TYDDEHH 191

Query: 209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGH--FP----------- 255
           ++ V T  Y +PE          +     D+WS+G  L+E YLG   FP           
Sbjct: 192 STLVSTRHYRAPEVI----LALGW-SQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMM 246

Query: 256 ----------FLQPGQR--------PDWATLMCAICFGDPPSLP--------DGASPEFR 289
                      +Q  ++         DW     A  +      P        D       
Sbjct: 247 ERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLF 306

Query: 290 SFIECCLQKEFSKRWTASQLLTHPFLCKNRRS 321
             I+  L+ + +KR T  + L HPF    ++S
Sbjct: 307 DLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score =  102 bits (257), Expect = 2e-25
 Identities = 57/277 (20%), Positives = 97/277 (35%), Gaps = 56/277 (20%)

Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQC---- 114
           +G G  G +Y        +  A  VV    +      +F E++  +R      ++     
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVK--VEYQENGPLFSELKFYQRVAKKDCIKKWIER 102

Query: 115 -------------FGIFEKPSGDIAIL-MEYMDSGTLDTLLNKNGTFSEPKLAHIASQIL 160
                         G+ E        + ME +    L  +  +NGTF +  +  +  ++L
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNGTFKKSTVLQLGIRML 161

Query: 161 KGLSYLHGHKIIHRDIKPSNLLVNNNNM-QVKIADFGVSKIMCRS-------LDACNSYV 212
             L Y+H ++ +H DIK +NLL+   N  QV +AD+G+S   C +        +    + 
Sbjct: 162 DVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHN 221

Query: 213 GTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDW------- 265
           GT  + S      DA+ G       D+  LG  +L    G  P+ Q  + P         
Sbjct: 222 GTIEFTS-----LDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTN 276

Query: 266 -------ATLMCAICFGDPPSLPDGASPEFRSFIECC 295
                  + L  A               E   F+ C 
Sbjct: 277 LLDELPQSVLKWAPSGSSC--------CEIAQFLVCA 305

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  100 bits (251), Expect = 1e-24
 Identities = 62/244 (25%), Positives = 99/244 (40%), Gaps = 45/244 (18%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYK-----VQHRCTHKIYALKVVHGDADPTVRRQVFREMEI 102
                L+  + LG G  G V +     +    T +  A+K++   A  +  R +  E++I
Sbjct: 24  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 83

Query: 103 LRRTDS-PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLL----------------NKNG 145
           L        +V   G   KP G + +++E+   G L T L                    
Sbjct: 84  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143

Query: 146 TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL 205
             +   L   + Q+ KG+ +L   K IHRD+   N+L++  N+ VKI DFG    + R +
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFG----LARDI 198

Query: 206 DACNSYV-GTCA-----YMSPERFDPDAYGGNYNGY--AGDIWSLGLTLLELY-LGHFPF 256
                YV    A     +M+PE             Y    D+WS G+ L E++ LG  P+
Sbjct: 199 YKDPDYVRKGDARLPLKWMAPETI-------FDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

Query: 257 LQPG 260
             PG
Sbjct: 252 --PG 253

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  101 bits (254), Expect = 1e-24
 Identities = 74/364 (20%), Positives = 112/364 (30%), Gaps = 120/364 (32%)

Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRR---TDS-----PF 110
           LG G+  TV+        K  A+KVV   +          E+ +L+    +D        
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVK--SAEHYTETALDEIRLLKSVRNSDPNDPNREM 102

Query: 111 IVQCFGIFE--KPSGD-IAILMEYMDSGTLDTLL--NKNGTFSEPKLAHIASQILKGLSY 165
           +VQ    F+    +G  I ++ E +    L   +  +       P +  I  Q+L+GL Y
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDY 161

Query: 166 LHGH-KIIHRDIKPSNLLVNNNNM------------------------------------ 188
           LH   +IIH DIKP N+L++ N                                      
Sbjct: 162 LHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFL 221

Query: 189 ------------QVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYA 236
                       +VKIAD G +   C         + T  Y S E      Y        
Sbjct: 222 VNPLEPKNAEKLKVKIADLGNA---CWVHKHFTEDIQTRQYRSLEVLIGSGY-----NTP 273

Query: 237 GDIWSLGLTLLELYLGHFPFLQPGQRPDWAT------LMCAICFGDPPS----------- 279
            DIWS      EL  G + F +P    ++        L+  +  G  P            
Sbjct: 274 ADIWSTACMAFELATGDYLF-EPHSGEEYTRDEDHIALIIEL-LGKVPRKLIVAGKYSKE 331

Query: 280 ----------------------------LPDGASPEFRSFIECCLQKEFSKRWTASQLLT 311
                                            +  F  F+   L+    KR TA++ L 
Sbjct: 332 FFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391

Query: 312 HPFL 315
           HP+L
Sbjct: 392 HPWL 395

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 97.8 bits (244), Expect = 2e-23
 Identities = 69/306 (22%), Positives = 109/306 (35%), Gaps = 72/306 (23%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYK------VQHRCTHKIY-ALKVVHGDADPTVRRQVFREM 100
                L   + LG G  G V         + +    +  A+K++  DA       +  EM
Sbjct: 78  FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 137

Query: 101 EILRRTDS-PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLL----------------NK 143
           E+++       I+   G   +  G + +++EY   G L   L                  
Sbjct: 138 EMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196

Query: 144 NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR 203
               +   L     Q+ +G+ YL   K IHRD+   N+LV  NN+ +KIADFG    + R
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV-MKIADFG----LAR 251

Query: 204 SLDACNSY-VGTCA-----YMSPERFDPDAYGGNYNGY--AGDIWSLGLTLLELY-LGHF 254
            ++  + Y   T       +M+PE             Y    D+WS G+ + E++ LG  
Sbjct: 252 DINNIDYYKKTTNGRLPVKWMAPEAL-------FDRVYTHQSDVWSFGVLMWEIFTLGGS 304

Query: 255 P-----------FLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKR 303
           P            L+ G R D                P   + E    +  C     S+R
Sbjct: 305 PYPGIPVEELFKLLKEGHRMD---------------KPANCTNELYMMMRDCWHAVPSQR 349

Query: 304 WTASQL 309
            T  QL
Sbjct: 350 PTFKQL 355

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 96.2 bits (240), Expect = 6e-23
 Identities = 65/236 (27%), Positives = 100/236 (42%), Gaps = 44/236 (18%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYK--VQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRR 105
           + ++D++   V+G GN G V K  ++        A+K +   A     R    E+E+L +
Sbjct: 22  LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 81

Query: 106 TDS-PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN----------------GTFS 148
               P I+   G  E   G + + +EY   G L   L K+                 T S
Sbjct: 82  LGHHPNIINLLGACEH-RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140

Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
             +L H A+ + +G+ YL   + IHRD+   N+LV  N +  KIADFG    + R  +  
Sbjct: 141 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV-AKIADFG----LSRGQEV- 194

Query: 209 NSYVGTCA------YMSPERFDPDAYGGNYNGY--AGDIWSLGLTLLELY-LGHFP 255
             YV          +M+ E         NY+ Y    D+WS G+ L E+  LG  P
Sbjct: 195 --YVKKTMGRLPVRWMAIESL-------NYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 95.4 bits (238), Expect = 9e-23
 Identities = 60/253 (23%), Positives = 105/253 (41%), Gaps = 57/253 (22%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYK-----VQHRCTHKIYALKVVHGDADPTVRRQVFREMEI 102
               +L   + LG G  G V K     ++ R  +   A+K++  +A P+  R +  E  +
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNV 79

Query: 103 LRRTDSPFIVQCFGI--FEKPSGDIAILMEYMDSGTLDTLL------------------- 141
           L++ + P +++ +G    + P   + +++EY   G+L   L                   
Sbjct: 80  LKQVNHPHVIKLYGACSQDGP---LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136

Query: 142 -----NKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFG 196
                      +   L   A QI +G+ YL   K++HRD+   N+LV      +KI+DFG
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK-MKISDFG 195

Query: 197 VSKIMCRSLDACNSYV-GTCA-----YMSPERFDPDAYGGNYNGY--AGDIWSLGLTLLE 248
               + R +   +SYV  +       +M+ E           + Y    D+WS G+ L E
Sbjct: 196 ----LSRDVYEEDSYVKRSQGRIPVKWMAIESL-------FDHIYTTQSDVWSFGVLLWE 244

Query: 249 LY-LGHFPFLQPG 260
           +  LG  P+  PG
Sbjct: 245 IVTLGGNPY--PG 255

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 95.0 bits (237), Expect = 1e-22
 Identities = 69/298 (23%), Positives = 111/298 (37%), Gaps = 49/298 (16%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYK-----VQHRCTHKIYALKVVHGDADPTVRRQVFREMEI 102
              + L   + LG G  G V +     +         A+K++   A  T R  +  E+++
Sbjct: 20  FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79

Query: 103 LRRTDS-PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLL------------------NK 143
           L    +   IV   G      G   ++ EY   G L   L                  + 
Sbjct: 80  LSYLGNHMNIVNLLGACTI-GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138

Query: 144 NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR 203
                   L   + Q+ KG+++L     IHRD+   N+L+ +  +  KI DFG    + R
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI-TKICDFG----LAR 193

Query: 204 SLDACNSYV-GTCA-----YMSPERFDPDAYGGNYNGY--AGDIWSLGLTLLELY-LGHF 254
            +   ++YV    A     +M+PE             Y    D+WS G+ L EL+ LG  
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESI-------FNCVYTFESDVWSYGIFLWELFSLGSS 246

Query: 255 PFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH 312
           P+  PG  P  +     I  G     P+ A  E    ++ C   +  KR T  Q++  
Sbjct: 247 PY--PG-MPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 95.4 bits (238), Expect = 1e-22
 Identities = 59/246 (23%), Positives = 96/246 (39%), Gaps = 48/246 (19%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYK------VQHRCTHKIY-ALKVVHGDADPTVRRQVFREM 100
                L   + LG G  G V         + +    +  A+K++  DA       +  EM
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91

Query: 101 EILRRTDS-PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLL----------------NK 143
           E+++       I+   G   +  G + +++EY   G L   L                  
Sbjct: 92  EMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150

Query: 144 NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR 203
               +   L     Q+ +G+ YL   K IHRD+   N+LV  NN+ +KIADFG    + R
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV-MKIADFG----LAR 205

Query: 204 SLDACNSYVGTCA------YMSPERFDPDAYGGNYNGY--AGDIWSLGLTLLELY-LGHF 254
            ++  + Y  T        +M+PE             Y    D+WS G+ + E++ LG  
Sbjct: 206 DINNIDYYKKTTNGRLPVKWMAPEAL-------FDRVYTHQSDVWSFGVLMWEIFTLGGS 258

Query: 255 PFLQPG 260
           P+  PG
Sbjct: 259 PY--PG 262

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 94.6 bits (236), Expect = 2e-22
 Identities = 68/294 (23%), Positives = 115/294 (39%), Gaps = 45/294 (15%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYK-----VQHRCTHKIYALKVVHGDADPTVRRQVFREMEI 102
              ++L+  + LG G  G V +     +         A+K++   A    +  +  E++I
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102

Query: 103 LRRTDS-PFIVQCFGIFEKPSGDIAILMEYMDSGTL--------------DTLLNKNGTF 147
           +        IV   G      G + ++ EY   G L                    N T 
Sbjct: 103 MSHLGQHENIVNLLGACTH-GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161

Query: 148 SEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA 207
           S   L H +SQ+ +G+++L     IHRD+   N+L+ N ++  KI DFG    + R +  
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV-AKIGDFG----LARDIMN 216

Query: 208 CNSY-VGTCA-----YMSPERFDPDAYGGNYNGY--AGDIWSLGLTLLELY-LGHFPFLQ 258
            ++Y V   A     +M+PE             Y    D+WS G+ L E++ LG  P+  
Sbjct: 217 DSNYIVKGNARLPVKWMAPESI-------FDCVYTVQSDVWSYGILLWEIFSLGLNPY-- 267

Query: 259 PGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH 312
           PG     +     +  G   + P  A     S ++ C   E + R T  Q+ + 
Sbjct: 268 PG-ILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 92.8 bits (231), Expect = 2e-21
 Identities = 61/246 (24%), Positives = 95/246 (38%), Gaps = 48/246 (19%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYK-------VQHRCTHKIYALKVVHGDADPTVRRQVFREM 100
           +    L   + LG G  G V                   A+K++  DA       +  EM
Sbjct: 66  LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 125

Query: 101 EILRRTDS-PFIVQCFGIFEKPSGDIAILMEYMDSGTL----------------DTLLNK 143
           E+++       I+   G   +  G + +++EY   G L                +   N 
Sbjct: 126 EMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184

Query: 144 NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR 203
               S   L   A Q+ +G+ YL   K IHRD+   N+LV  +N+ +KIADFG    + R
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV-MKIADFG----LAR 239

Query: 204 SLDACNSYV-GTCA-----YMSPERFDPDAYGGNYNGY--AGDIWSLGLTLLELY-LGHF 254
            +   + Y   T       +M+PE             Y    D+WS G+ L E++ LG  
Sbjct: 240 DIHHIDYYKKTTNGRLPVKWMAPEAL-------FDRIYTHQSDVWSFGVLLWEIFTLGGS 292

Query: 255 PFLQPG 260
           P+  PG
Sbjct: 293 PY--PG 296

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 90.4 bits (225), Expect = 8e-21
 Identities = 62/253 (24%), Positives = 98/253 (38%), Gaps = 57/253 (22%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYK-----VQHRCTHKIYALKVVHGDADPTVRRQVFREMEI 102
               +LE  +VLG G  G V       +         A+K++   AD + R  +  E+++
Sbjct: 42  FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 101

Query: 103 LRRTDS-PFIVQCFGI--FEKPSGDIAILMEYMDSGTLDTLLNKN--------------- 144
           + +  S   IV   G      P   I ++ EY   G L   L                  
Sbjct: 102 MTQLGSHENIVNLLGACTLSGP---IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 158

Query: 145 --------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFG 196
                      +   L   A Q+ KG+ +L     +HRD+   N+LV +  + VKI DFG
Sbjct: 159 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV-VKICDFG 217

Query: 197 VSKIMCRSLDACNSYV-GTCA-----YMSPERFDPDAYGGNYNGY--AGDIWSLGLTLLE 248
               + R + + ++YV    A     +M+PE             Y    D+WS G+ L E
Sbjct: 218 ----LARDIMSDSNYVVRGNARLPVKWMAPESL-------FEGIYTIKSDVWSYGILLWE 266

Query: 249 LY-LGHFPFLQPG 260
           ++ LG  P+  PG
Sbjct: 267 IFSLGVNPY--PG 277

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 88.2 bits (219), Expect = 4e-20
 Identities = 50/215 (23%), Positives = 87/215 (40%), Gaps = 29/215 (13%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD-SPFIVQC- 114
           + +G GN G +   ++  T++  A+K+    +      Q+  E    ++      I Q  
Sbjct: 15  KKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVY 71

Query: 115 -FGIFEKPSGDIAIL-MEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKI 171
            FG    P G    + +E +   +L+ L +  + TFS   +  IA Q++  + Y+H   +
Sbjct: 72  YFG----PCGKYNAMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNL 126

Query: 172 IHRDIKPSNLLV----NNNNMQVKIADFGVSKIMCRS-------LDACNSYVGTCAYMSP 220
           I+RD+KP N L+    N     + I DF ++K                 S  GT  YMS 
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMS- 185

Query: 221 ERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFP 255
                + + G       D+ +LG   +    G  P
Sbjct: 186 ----INTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 87.5 bits (217), Expect = 9e-20
 Identities = 61/280 (21%), Positives = 101/280 (36%), Gaps = 59/280 (21%)

Query: 59  LGHGNGGTVYKVQHRCTHKI-----YALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +G G  G +Y      +  +       +KV   D        +F E++  +R   P  +Q
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN-----GPLFTELKFYQRAAKPEQIQ 97

Query: 114 -----------------CFGIFEKPSGDIAIL-MEYMDSGTLDTLLNKNG-TFSEPKLAH 154
                              G+ +K       + M+   S  L  +   N   FS   +  
Sbjct: 98  KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKRFSRKTVLQ 156

Query: 155 IASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNM-QVKIADFGVSKIMCRS-------LD 206
           ++ +IL  L Y+H H+ +H DIK SNLL+N  N  QV + D+G++   C          D
Sbjct: 157 LSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAAD 216

Query: 207 ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDW- 265
               + GT  + S      DA+ G      GD+  LG  +++   GH P+    + P + 
Sbjct: 217 PKRCHDGTIEFTS-----IDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271

Query: 266 ----------ATLMCAICFGDPPSLPDGASPEFRSFIECC 295
                        +   CF         A  E   ++E  
Sbjct: 272 RDSKIRYRENIASLMDKCFP-----AANAPGEIAKYMETV 306

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 86.6 bits (215), Expect = 9e-20
 Identities = 49/218 (22%), Positives = 87/218 (39%), Gaps = 35/218 (16%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILR-RTDSPFI--VQ 113
           + +G G+ G +++  +   ++  A+K     +D     Q+  E    +       I  V 
Sbjct: 16  RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVY 72

Query: 114 CFGIFEKPSGDIAIL-MEYMDSGTLDTLLNKNG-TFSEPKLAHIASQILKGLSYLHGHKI 171
            FG      G   +L ++ +   +L+ LL+  G  FS   +A  A Q+L  +  +H   +
Sbjct: 73  YFG----QEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL 127

Query: 172 IHRDIKPSNLLV----NNNNMQVKIADFGVSKIMCRSLDACN----------SYVGTCAY 217
           ++RDIKP N L+    + N   + + DFG+ K      D             +  GT  Y
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK---FYRDPVTKQHIPYREKKNLSGTARY 184

Query: 218 MSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFP 255
           MS      + + G       D+ +LG   +    G  P
Sbjct: 185 MS-----INTHLGREQSRRDDLEALGHVFMYFLRGSLP 217

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 85.5 bits (212), Expect = 2e-19
 Identities = 49/210 (23%), Positives = 81/210 (38%), Gaps = 25/210 (11%)

Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRR-TDSPFI--VQCF 115
           +G G+ G +Y        +  A+K+           Q+  E +I +       I  ++  
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWC 73

Query: 116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNG-TFSEPKLAHIASQILKGLSYLHGHKIIHR 174
           G     +    ++ME +   +L+ L N     FS   +  +A Q++  + Y+H    IHR
Sbjct: 74  GAEGDYN---VMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHR 129

Query: 175 DIKPSNLLV--NNNNMQVKIADFGVSKI-------MCRSLDACNSYVGTCAYMSPERFDP 225
           D+KP N L+        V I DFG++K                 +  GT  Y S      
Sbjct: 130 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS-----I 184

Query: 226 DAYGGNYNGYAGDIWSLGLTLLELYLGHFP 255
           + + G       D+ SLG  L+   LG  P
Sbjct: 185 NTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 84.9 bits (211), Expect = 5e-19
 Identities = 46/169 (27%), Positives = 73/169 (43%), Gaps = 49/169 (28%)

Query: 130 EYMDSGTLD-TLLNKNGTFSEPKL-----AHIASQILKGLSYLHGH---KIIHRDIKPSN 180
            YM +G++   L  +    S+P L       IA    +GL+YLH H   KIIHRD+K +N
Sbjct: 107 PYMANGSVASCLRERPE--SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAAN 164

Query: 181 LLVNNNNMQVKIADFGVSKIMCRSLDACNSYV-----GTCAYMSPERFDPDAYGGNYNGY 235
           +L+ +   +  + DFG++K+M    D  +++V     GT  +++PE             Y
Sbjct: 165 ILL-DEEFEAVVGDFGLAKLM----DYKDTHVTTAVRGTIGHIAPE-------------Y 206

Query: 236 A--------GDIWSLGLTLLELYLGHFPF---LQPGQR----PDWATLM 269
                     D++  G+ LLEL  G   F              DW   +
Sbjct: 207 LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 85.4 bits (211), Expect = 9e-19
 Identities = 53/211 (25%), Positives = 87/211 (41%), Gaps = 27/211 (12%)

Query: 59  LGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRR-TDSPFI--VQCF 115
           +G G+ G +Y   +  T++  A+K+ +         Q+  E +I R       I  V+ F
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKIYRILQGGTGIPNVRWF 71

Query: 116 GIFEKPSGDIAIL-MEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
           G      GD  +L M+ +   +L+ L N  +   S   +  +A Q++  + ++H    +H
Sbjct: 72  G----VEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126

Query: 174 RDIKPSNLLVNNNNM--QVKIADFGVSKI-------MCRSLDACNSYVGTCAYMSPERFD 224
           RDIKP N L+       QV I DFG++K                 +  GT  Y S     
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS----- 181

Query: 225 PDAYGGNYNGYAGDIWSLGLTLLELYLGHFP 255
            + + G       D+ SLG  L+    G  P
Sbjct: 182 VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 83.4 bits (207), Expect = 2e-18
 Identities = 78/319 (24%), Positives = 118/319 (36%), Gaps = 76/319 (23%)

Query: 31  PPTAPNTNNNTTATTAAIAYSDLE-------KLQVLGHGNGGTVYKVQHRCTHKIYALKV 83
              A +++      +  +   DLE          ++GHG  G VYK   R   K+ ALK 
Sbjct: 12  INDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV-ALKR 70

Query: 84  VHGDADPTVRRQVFR----EMEILRRTDSPFIVQCFGIFEKPSGDIAILM-EYMDSGTLD 138
              +       Q       E+E L     P +V   G  +    +  IL+ +YM++G L 
Sbjct: 71  RTPE-----SSQGIEEFETEIETLSFCRHPHLVSLIGFCD--ERNEMILIYKYMENGNLK 123

Query: 139 TLLNKNGTFSEPKLA-----HIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIA 193
             L  +   +   ++      I     +GL YLH   IIHRD+K  N+L+ + N   KI 
Sbjct: 124 RHLYGSDLPTMS-MSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL-DENFVPKIT 181

Query: 194 DFGVSKIMCRSLDACNSYV-----GTCAYMSPERFDPDAYGGNYNGYAG--------DIW 240
           DFG+SK      +   +++     GT  Y+ PE             Y          D++
Sbjct: 182 DFGISKKG---TELDQTHLSTVVKGTLGYIDPE-------------YFIKGRLTEKSDVY 225

Query: 241 SLGLTLLELYLGHFPFLQPGQRP-------DWATLMCAICFGDP-----PSLPDGASPE- 287
           S G+ L E+       +Q    P       +WA        G       P+L D   PE 
Sbjct: 226 SFGVVLFEVLCARSAIVQ--SLPREMVNLAEWAVESHN--NGQLEQIVDPNLADKIRPES 281

Query: 288 FRSFIEC---CLQKEFSKR 303
            R F +    CL      R
Sbjct: 282 LRKFGDTAVKCLALSSEDR 300

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 83.3 bits (206), Expect = 3e-18
 Identities = 47/281 (16%), Positives = 91/281 (32%), Gaps = 61/281 (21%)

Query: 59  LGHGNGGTVYKVQHRCTHKI--------YALKVVHGDADPTVRRQVFREMEILRRTDSPF 110
               N G +Y+     T           ++LK+   D       ++F E    +R   P 
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDG------RLFNEQNFFQRAAKPL 103

Query: 111 IVQ---------CFGI-----FEKPSGDIAIL-MEYMDSGTLDTLLNKNG--TFSEPKLA 153
            V             I     F         L +  +   +L + L+ +     SE  + 
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSVL 162

Query: 154 HIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNM-QVKIADFGVSKIMCRS-------L 205
            +A ++L  L +LH ++ +H ++   N+ V+  +  QV +A +G +   C S        
Sbjct: 163 QVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVE 222

Query: 206 DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPF--LQPGQRP 263
            + + + G   ++S      D + G       D+ SLG  +L+   G  P+    P    
Sbjct: 223 GSRSPHEGDLEFIS-----MDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTED 277

Query: 264 DW---------ATLMCAICFGDPPSLPDGASPEFRSFIECC 295
                             C           S   + +++  
Sbjct: 278 IMKQKQKFVDKPGPFVGPCGHWIRP-----SETLQKYLKVV 313

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 79.9 bits (198), Expect = 2e-17
 Identities = 52/207 (25%), Positives = 83/207 (40%), Gaps = 58/207 (28%)

Query: 130 EYMDSGTLDT-LLNKNGTFSEPKLA-----HIASQILKGLSYLHGHKIIHRDIKPSNLLV 183
            YM +G+L   L   +GT   P L+      IA     G+++LH +  IHRDIK +N+L+
Sbjct: 110 VYMPNGSLLDRLSCLDGT---PPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL 166

Query: 184 NNNNMQVKIADFGVSKIMCRSLDACNSYV-----GTCAYMSPERFDPDAYGGNYNGYA-G 237
            +     KI+DFG+++    S     + +     GT AYM+PE                G
Sbjct: 167 -DEAFTAKISDFGLARA---SEKFAQTVMTSRIVGTTAYMAPE-------------ALRG 209

Query: 238 ------DIWSLGLTLLELYLGHFPFLQPGQRP----DWATLMCAICFGDP--------PS 279
                 DI+S G+ LLE+  G    +   + P    D    +      +           
Sbjct: 210 EITPKSDIYSFGVVLLEIITGLPA-VDEHREPQLLLDIKEEI----EDEEKTIEDYIDKK 264

Query: 280 LPDGASPEFRSFIEC---CLQKEFSKR 303
           + D  S    +       CL ++ +KR
Sbjct: 265 MNDADSTSVEAMYSVASQCLHEKKNKR 291

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 71.8 bits (175), Expect = 2e-14
 Identities = 43/328 (13%), Positives = 87/328 (26%), Gaps = 66/328 (20%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-------PTVRRQVFREM 100
           +    L++ + +G G  G V++      H   A+K++  +              ++  E+
Sbjct: 17  LPTEKLQRCEKIGEGVFGEVFQT--IADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74

Query: 101 EILR---------RTDSPFIVQCFGIF-----------------------------EKPS 122
            I +            +   +    +                                  
Sbjct: 75  IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134

Query: 123 GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH-GHKIIHRDIKPSNL 181
             + I++E+   G  D    +    S      I  Q+   L+      +  HRD+   N+
Sbjct: 135 DQLFIVLEFEFGGI-DLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNV 193

Query: 182 LVNN----------NNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGN 231
           L+            N     I   G+   +     +     G   +      D D + G+
Sbjct: 194 LLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSM-DEDLFTGD 252

Query: 232 YNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSF 291
            + Y  DI+ L         G +    P     W   +               +P  +  
Sbjct: 253 GD-YQFDIYRLMKKENNNRWGEY---HPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQI 308

Query: 292 IE--CCLQKEFSKRWTASQLLTHPFLCK 317
                   +      +A+ LL    L K
Sbjct: 309 KRKIQEFHRTMLNFSSATDLLCQHSLFK 336

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 69.6 bits (170), Expect = 2e-13
 Identities = 49/174 (28%), Positives = 74/174 (42%), Gaps = 20/174 (11%)

Query: 144 NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR 203
               +   L   + Q+ KG+ +L   K IHRD+   N+L++  N+ VKI DFG    + R
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFG----LAR 241

Query: 204 SLDACNSYVGTCA------YMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELY-LGHFPF 256
            +     YV          +M+PE      Y         D+WS G+ L E++ LG  P+
Sbjct: 242 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQS-----DVWSFGVLLWEIFSLGASPY 296

Query: 257 LQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLL 310
             PG           +  G     PD  +PE    +  C   E S+R T S+L+
Sbjct: 297 --PGV-KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 347

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 48.8 bits (116), Expect = 9e-07
 Identities = 31/146 (21%), Positives = 56/146 (38%), Gaps = 10/146 (6%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYK-----VQHRCTHKIYALKVVHGDADPTVRRQVFREMEI 102
                L+  + LG G  G V +     +    T +  A+K++   A  +  R +  E++I
Sbjct: 19  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 78

Query: 103 LRRTDS-PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILK 161
           L        +V   G   KP G + +++E+   G L T L        P     A +  +
Sbjct: 79  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGA-RFRQ 137

Query: 162 GLSYLHGHKIIHRDIKPSNLLVNNNN 187
           G  Y+     I  D+K     + ++ 
Sbjct: 138 GKDYVG---AIPVDLKRRLDSITSSQ 160

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 53.7 bits (128), Expect = 4e-08
 Identities = 42/333 (12%), Positives = 90/333 (27%), Gaps = 105/333 (31%)

Query: 12  LRLPMPEL-SERCLRFPLALPPTA------PNTNNNTTATTAAIAYSDLEKLQVLGHGNG 64
           L     +L  E     P  L   A        T +N         + + +KL        
Sbjct: 311 LDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNW-------KHVNCDKLT------- 356

Query: 65  GTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEK---- 120
                +       +  L       +P   R++F                   +F      
Sbjct: 357 ----TIIESS---LNVL-------EPAEYRKMFDR---------------LSVFPPSAHI 387

Query: 121 PSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSN 180
           P+  ++++   +    +  ++NK     +  L  +  Q  +    +     I+ ++K   
Sbjct: 388 PTILLSLIWFDVIKSDVMVVVNK---LHKYSL--VEKQPKESTISIPS---IYLELKVKL 439

Query: 181 LLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDP--DAYGGNYNGY--- 235
              N   +   I D                Y     + S +   P  D Y  ++ G+   
Sbjct: 440 E--NEYALHRSIVD---------------HYNIPKTFDSDDLIPPYLDQYFYSHIGHHLK 482

Query: 236 ---AGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPD---------G 283
                +  +L      ++L  F FL+  Q+    +           +L            
Sbjct: 483 NIEHPERMTL---FRMVFL-DFRFLE--QKIRHDSTAWNASGSILNTLQQLKFYKPYICD 536

Query: 284 ASPEFRSFIECCLQKEFSKRWTASQLLTHPFLC 316
             P++   +   L  +F  +     L+   +  
Sbjct: 537 NDPKYERLVNAIL--DFLPK-IEENLICSKYTD 566

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 41.4 bits (96), Expect = 3e-04
 Identities = 42/286 (14%), Positives = 70/286 (24%), Gaps = 100/286 (34%)

Query: 78  IYALKVVHGDADPTVRRQVFREMEI--LRR-----TDSPFI------------------- 111
           I     ++ D     +  V R      LR+       +  +                   
Sbjct: 113 IEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCL 172

Query: 112 ---VQC---FGIF-------EKPSGDIAILMEYMDSGTLDTLLNKNGT------FSEPKL 152
              VQC   F IF         P   + +L        L   ++ N T       +    
Sbjct: 173 SYKVQCKMDFKIFWLNLKNCNSPETVLEMLQ------KLLYQIDPNWTSRSDHSSNIKLR 226

Query: 153 AHIASQILKGLSYLHGHK---IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL---- 205
            H     L+ L     ++   ++  +       V N         F +S   C+ L    
Sbjct: 227 IHSIQAELRRLLKSKPYENCLLVLLN-------VQNAKA---WNAFNLS---CKILLTTR 273

Query: 206 -----DACNSYVGTCAYMSPER--FDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQ 258
                D  ++   T   +        PD                  +LL  YL   P   
Sbjct: 274 FKQVTDFLSAATTTHISLDHHSMTLTPDE---------------VKSLLLKYLDCRPQDL 318

Query: 259 PGQRPDWATLMCAIC---FGDPPSLPDG----ASPEFRSFIECCLQ 297
           P +         +I      D  +  D        +  + IE  L 
Sbjct: 319 PREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLN 364

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	323
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.86
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.79
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.49
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.36
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.35
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.15
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	99.04
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.95
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.89
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.79
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.6
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.51
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.48
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.4
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.24
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.18
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	98.09
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.08
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.99
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.88
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.83
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.82
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.78
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.68
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.6
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.59
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.5
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.44
3mes_A	424	Choline kinase; malaria, structural genomics, stru	97.01
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.86
1cja_A	342	Protein (actin-fragmin kinase); transferase; HET:	89.34
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	82.25
2x6h_A	696	GH13170P, VPS34, phosphotidylinositol 3 kinase 59F	81.35

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.8e-64  Score=438.41  Aligned_cols=259  Identities=27%  Similarity=0.437  Sum_probs=222.1

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      ..++|++++.||+|+||+||+|++..+|+.||+|++.... .......+.+|+.++++++||||+++++++.+ ++.+||
T Consensus        22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~-~~~~yi  100 (350)
T 4b9d_A           22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE-NGSLYI  100 (350)
T ss_dssp             CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEE
T ss_pred             cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE-CCEEEE
Confidence            3579999999999999999999999999999999997553 44567789999999999999999999999998 788999


Q ss_pred             EEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc
Q 020657          128 LMEYMDSGTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL  205 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~  205 (323)
                      |||||+||+|.+++...  ..+++..++.|+.||+.||.|||++||+||||||+|||++.+| .+||+|||+|+......
T Consensus       101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-TVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTC-CEEECSTTEESCCCHHH
T ss_pred             EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC-CEEEcccccceeecCCc
Confidence            99999999999999643  3579999999999999999999999999999999999999998 89999999998765443


Q ss_pred             cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCC
Q 020657          206 DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS  285 (323)
Q Consensus       206 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (323)
                      ......+||+.|+|||++.+.     .++.++|||||||++|||+||..||.+.    ....+...+..+..+.++..+|
T Consensus       180 ~~~~~~~GT~~YmAPE~l~~~-----~y~~~~DiwSlGvilyemltG~~PF~~~----~~~~~~~~i~~~~~~~~~~~~s  250 (350)
T 4b9d_A          180 ELARACIGTPYYLSPEICENK-----PYNNKSDIWALGCVLYELCTLKHAFEAG----SMKNLVLKIISGSFPPVSLHYS  250 (350)
T ss_dssp             HHHHHHHSCCTTCCHHHHTTC-----CCCHHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHTCCCCCCTTSC
T ss_pred             ccccccCCCccccCHHHHCCC-----CCCcHHHHHHHHHHHHHHHHCCCCCCCc----CHHHHHHHHHcCCCCCCCccCC
Confidence            344556899999999999744     3466999999999999999999999543    3445555555666677888999


Q ss_pred             hhHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          286 PEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       286 ~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      +++.+||.+||+.||++|||++|+|+||||++.
T Consensus       251 ~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          251 YDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence            999999999999999999999999999999764

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.4e-64  Score=434.76  Aligned_cols=259  Identities=29%  Similarity=0.496  Sum_probs=224.2

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIA  126 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  126 (323)
                      ..++|++.+.||+|+||+||+|++..+++.||+|++....  +....+.+.+|+++++.++||||++++++|++ ++.+|
T Consensus        30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~y  108 (311)
T 4aw0_A           30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-DEKLY  108 (311)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEE
T ss_pred             CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEE
Confidence            3478999999999999999999999999999999996431  12235678899999999999999999999998 78899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC--
Q 020657          127 ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS--  204 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~--  204 (323)
                      +||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|......  
T Consensus       109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g-~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECCTTTT
T ss_pred             EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCC-CEEEEEcCCceecCCCCC
Confidence            9999999999999999888999999999999999999999999999999999999999998 8999999999876432  


Q ss_pred             ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCC
Q 020657          205 LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA  284 (323)
Q Consensus       205 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (323)
                      .......+||+.|+|||++.+..     ++.++|||||||++|+|+||..||.+.+    ...+...+... ...++..+
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~-----y~~~~DiWSlGvilyeml~G~~PF~~~~----~~~~~~~i~~~-~~~~p~~~  257 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKS-----ACKSSDLWALGCIIYQLVAGLPPFRAGN----EGLIFAKIIKL-EYDFPEKF  257 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSC-----BCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHT-CCCCCTTC
T ss_pred             cccccCcccCcccCCHHHHcCCC-----CCcHHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHcC-CCCCCccc
Confidence            22345678999999999997444     4569999999999999999999996543    33444444333 34677889


Q ss_pred             ChhHHHHHHHhcccCcCCCCCHHH------HhcCcccccCC
Q 020657          285 SPEFRSFIECCLQKEFSKRWTASQ------LLTHPFLCKNR  319 (323)
Q Consensus       285 ~~~l~~ll~~~l~~~p~~Rpt~~~------~l~h~~f~~~~  319 (323)
                      ++++.+||++||+.||++|||++|      |++||||+++.
T Consensus       258 s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id  298 (311)
T 4aw0_A          258 FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT  298 (311)
T ss_dssp             CHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred             CHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence            999999999999999999999988      58999998864

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=7e-63  Score=430.41  Aligned_cols=257  Identities=29%  Similarity=0.502  Sum_probs=222.1

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      ...|++++.||+|+||+||+|++..+|+.||+|++..... ...+.+.+|+.+++.++||||++++++|.+ ++.+||||
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-~~~~~ivm  150 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVM  150 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-SSGGGGHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEE
Confidence            4679999999999999999999999999999999964432 223557899999999999999999999998 78899999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccc
Q 020657          130 EYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN  209 (323)
Q Consensus       130 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~  209 (323)
                      |||+||+|.+++.+. .+++..+..++.||+.||+|||++||+||||||+|||++.+| .+||+|||+|...........
T Consensus       151 Ey~~gg~L~~~l~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~~~~~~~~  228 (346)
T 4fih_A          151 EFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRK  228 (346)
T ss_dssp             CCCTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSSSCCBC
T ss_pred             eCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCC-CEEEecCcCceecCCCCCccc
Confidence            999999999999764 699999999999999999999999999999999999999998 899999999987766555566


Q ss_pred             cccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCC--CCCCCChh
Q 020657          210 SYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPS--LPDGASPE  287 (323)
Q Consensus       210 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  287 (323)
                      ..+||+.|+|||++....     ++.++|||||||++|||++|..||.+...    ......+....++.  .+..++++
T Consensus       229 ~~~GTp~YmAPEvl~~~~-----y~~~~DiWSlGvilyeml~G~~PF~~~~~----~~~~~~i~~~~~~~~~~~~~~s~~  299 (346)
T 4fih_A          229 SLVGTPYWMAPELISRLP-----YGPEVDIWSLGIMVIEMVDGEPPYFNEPP----LKAMKMIRDNLPPRLKNLHKVSPS  299 (346)
T ss_dssp             CCCSCGGGCCHHHHTTCC-----BCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHHSSCCCCSCGGGSCHH
T ss_pred             ccccCcCcCCHHHHCCCC-----CCcHHHHHHHHHHHHHHHHCCCCCCCcCH----HHHHHHHHcCCCCCCCccccCCHH
Confidence            789999999999997444     45699999999999999999999965432    33333333333333  33578999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          288 FRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       288 l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      +.+||.+||+.||++|||++|+|+||||++..
T Consensus       300 ~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          300 LKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence            99999999999999999999999999998754

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.1e-62  Score=417.39  Aligned_cols=255  Identities=27%  Similarity=0.462  Sum_probs=207.5

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      .++|++.+.||+|+||+||+|++..+|+.||+|++....  .......+.+|+.+++.++||||+++++++.+ ++.+++
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~i   90 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS-KDEIIM   90 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCEEEE
Confidence            468999999999999999999999999999999997553  23445678999999999999999999999998 788999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccc
Q 020657          128 LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA  207 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~  207 (323)
                      ||||+ +|+|.+.+.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.++ ++||+|||+|...... ..
T Consensus        91 vmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~~~~~-~~  167 (275)
T 3hyh_A           91 VIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHL-NVKIADFGLSNIMTDG-NF  167 (275)
T ss_dssp             EEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTC-CEEECCSSCC---------
T ss_pred             EEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCC-CEEEeecCCCeecCCC-Cc
Confidence            99999 569999998888999999999999999999999999999999999999999987 8999999999765432 23


Q ss_pred             cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChh
Q 020657          208 CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPE  287 (323)
Q Consensus       208 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (323)
                      ....+||+.|+|||++.+..+    .+.++|||||||++|+|+||+.||.+.    ....+.+.+..+ ...++..+|++
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~y----~~~~~DiwSlGvily~lltg~~PF~~~----~~~~~~~~i~~~-~~~~p~~~s~~  238 (275)
T 3hyh_A          168 LKTSCGSPNYAAPEVISGKLY----AGPEVDVWSCGVILYVMLCRRLPFDDE----SIPVLFKNISNG-VYTLPKFLSPG  238 (275)
T ss_dssp             -------CTTSCHHHHSSSSC----CCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHT-CCCCCTTSCHH
T ss_pred             cCCeeECcccCChhhhcCCCC----CCChhhhHHHHHHHHHHHHCCCCCCCC----CHHHHHHHHHcC-CCCCCCCCCHH
Confidence            345789999999999974432    346999999999999999999999543    334444444433 34577889999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          288 FRSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       288 l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                      +.+||++||+.||++|||++|+++||||+.
T Consensus       239 ~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          239 AAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             HHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence            999999999999999999999999999975

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=6.6e-62  Score=434.27  Aligned_cols=257  Identities=29%  Similarity=0.502  Sum_probs=222.8

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      ...|++++.||+|+||.||+|++..+|+.||||++...... ..+.+.+|+.+|+.++||||++++++|.+ ++.+||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-~~~~~iVm  227 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVM  227 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS-SGGGHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh-HHHHHHHHHHHHHhCCCCCCCceEEEEEE-CCEEEEEE
Confidence            46799999999999999999999999999999999755332 24567899999999999999999999998 68899999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccc
Q 020657          130 EYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN  209 (323)
Q Consensus       130 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~  209 (323)
                      |||+||+|.+++... .+++..+..|+.||+.||+|||++||+||||||+|||++.+| .+||+|||+|...........
T Consensus       228 Ey~~gG~L~~~i~~~-~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g-~vKl~DFGla~~~~~~~~~~~  305 (423)
T 4fie_A          228 EFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRK  305 (423)
T ss_dssp             ECCTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTC-CEEECCCTTCEECCSSCCCBC
T ss_pred             eCCCCCcHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC-CEEEecCccceECCCCCcccc
Confidence            999999999999764 699999999999999999999999999999999999999998 899999999987766555566


Q ss_pred             cccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCC--CCCCCCChh
Q 020657          210 SYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPP--SLPDGASPE  287 (323)
Q Consensus       210 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  287 (323)
                      ..+||+.|+|||++....     ++.++|||||||++|||++|+.||.+...    ..+...+.....+  ..+..++++
T Consensus       306 ~~~GTp~YmAPEvl~~~~-----y~~~~DiWSlGvilyeml~G~~PF~~~~~----~~~~~~i~~~~~~~~~~~~~~s~~  376 (423)
T 4fie_A          306 SLVGTPYWMAPELISRLP-----YGPEVDIWSLGIMVIEMVDGEPPYFNEPP----LKAMKMIRDNLPPRLKNLHKVSPS  376 (423)
T ss_dssp             CCEECTTTCCHHHHTTCC-----BCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHHSCCCCCSCTTSSCHH
T ss_pred             ccccCcCcCCHHHHCCCC-----CCcHHHHHHHHHHHHHHHHCCCCCCCcCH----HHHHHHHHcCCCCCCcccccCCHH
Confidence            789999999999997544     45699999999999999999999965432    3333333333333  334678999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          288 FRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       288 l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      +.+||.+||+.||++|||++|+|+||||++..
T Consensus       377 ~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          377 LKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence            99999999999999999999999999998754

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.5e-61  Score=411.72  Aligned_cols=253  Identities=28%  Similarity=0.459  Sum_probs=215.4

Q ss_pred             cceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcC---CCeEEEE
Q 020657           53 LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP---SGDIAIL  128 (323)
Q Consensus        53 ~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~~lv  128 (323)
                      |++...||+|+||+||+|.+..++..||+|++.... .......+.+|+.++++++||||+++++++.+.   +..+++|
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            477788999999999999999999999999996543 445567899999999999999999999998642   3568999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCCeEEec-CCCcEEEeecCcchhhccCc
Q 020657          129 MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK--IIHRDIKPSNLLVNN-NNMQVKIADFGVSKIMCRSL  205 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g--ivH~di~~~nil~~~-~~~~~kl~Dfg~~~~~~~~~  205 (323)
                      ||||++|+|.+++.+.+.+++..+..|+.||+.||.|||++|  |+||||||+|||++. ++ .+||+|||+|+....  
T Consensus       108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g-~vKl~DFGla~~~~~--  184 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG-SVKIGDLGLATLKRA--  184 (290)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTS-CEEECCTTGGGGCCT--
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCC-CEEEEeCcCCEeCCC--
Confidence            999999999999998889999999999999999999999998  999999999999985 55 899999999975433  


Q ss_pred             cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC-CCCCCCCC
Q 020657          206 DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD-PPSLPDGA  284 (323)
Q Consensus       206 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  284 (323)
                      ......+||+.|+|||++.+      .++.++|||||||++|||+||..||.+...   ...+...+..+. +..++..+
T Consensus       185 ~~~~~~~GTp~YmAPE~~~~------~y~~~~DiwSlGvilyelltg~~Pf~~~~~---~~~~~~~i~~~~~~~~~~~~~  255 (290)
T 3fpq_A          185 SFAKAVIGTPEFMAPEMYEE------KYDESVDVYAFGMCMLEMATSEYPYSECQN---AAQIYRRVTSGVKPASFDKVA  255 (290)
T ss_dssp             TSBEESCSSCCCCCGGGGGT------CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS---HHHHHHHHTTTCCCGGGGGCC
T ss_pred             CccCCcccCccccCHHHcCC------CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc---HHHHHHHHHcCCCCCCCCccC
Confidence            23345689999999998852      256799999999999999999999965432   334444444333 33456778


Q ss_pred             ChhHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       285 ~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                      ++++.+||.+||+.||++|||++++|+||||++
T Consensus       256 ~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          256 IPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            999999999999999999999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=6.2e-63  Score=424.55  Aligned_cols=259  Identities=28%  Similarity=0.489  Sum_probs=214.3

Q ss_pred             cccccceeeeecccCCeEEEEEEec---ccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCe
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHR---CTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGD  124 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~---~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  124 (323)
                      ..++|++++.||+|+||+||+|++.   .+++.||+|++.... .......+.+|+.++++++||||+++++++.+ ++.
T Consensus        22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~  100 (304)
T 3ubd_A           22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT-EGK  100 (304)
T ss_dssp             CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE-TTE
T ss_pred             CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCE
Confidence            3478999999999999999999874   467899999996442 11122357789999999999999999999998 789


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC
Q 020657          125 IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS  204 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~  204 (323)
                      +++||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+| .+||+|||+|+.....
T Consensus       101 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          101 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG-HIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTS-CEEEESSEEEEC----
T ss_pred             EEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCC-CEEecccccceeccCC
Confidence            999999999999999999888999999999999999999999999999999999999999998 8999999999876555


Q ss_pred             ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCC
Q 020657          205 LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA  284 (323)
Q Consensus       205 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (323)
                      .......+||+.|+|||++....     ++.++|||||||++|||+||..||.+.+.    ..+...+... ...++..+
T Consensus       180 ~~~~~~~~GT~~YmAPE~~~~~~-----y~~~~DiwSlGvilyemltG~~PF~~~~~----~~~~~~i~~~-~~~~p~~~  249 (304)
T 3ubd_A          180 EKKAYSFCGTVEYMAPEVVNRRG-----HTQSADWWSFGVLMFEMLTGTLPFQGKDR----KETMTMILKA-KLGMPQFL  249 (304)
T ss_dssp             -CCCCSCCCCGGGCCHHHHHTSC-----CCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHC-CCCCCTTS
T ss_pred             CccccccccCcccCCHHHhccCC-----CCCCCcccchHHHHHHHHhCCCCCCCcCH----HHHHHHHHcC-CCCCCCcC
Confidence            45556678999999999997444     45699999999999999999999965433    3333333333 34677889


Q ss_pred             ChhHHHHHHHhcccCcCCCCC-----HHHHhcCcccccCC
Q 020657          285 SPEFRSFIECCLQKEFSKRWT-----ASQLLTHPFLCKNR  319 (323)
Q Consensus       285 ~~~l~~ll~~~l~~~p~~Rpt-----~~~~l~h~~f~~~~  319 (323)
                      |+++.+||++||+.||++|||     ++|+++||||+++.
T Consensus       250 s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~id  289 (304)
T 3ubd_A          250 SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID  289 (304)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence            999999999999999999998     58999999998763

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=7.8e-61  Score=416.31  Aligned_cols=260  Identities=24%  Similarity=0.321  Sum_probs=221.6

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ..+.|++.++||+|+||.||+|++..+|+.||+|+++....      ..+|+.+++.++||||+++++++.+ ++.+|||
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~-~~~~~iv  128 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVRE-GPWVNIF  128 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEE
Confidence            45678999999999999999999999999999999975532      2479999999999999999999998 7889999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc--
Q 020657          129 MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD--  206 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~--  206 (323)
                      ||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|..+||+|||+|+.......  
T Consensus       129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~  208 (336)
T 4g3f_A          129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK  208 (336)
T ss_dssp             ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred             EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence            999999999999998889999999999999999999999999999999999999998875699999999986643211  


Q ss_pred             ---ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCC
Q 020657          207 ---ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDG  283 (323)
Q Consensus       207 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (323)
                         .....+||+.|+|||++.+..     ++.++|||||||++|||+||..||.+.........+....  .....++..
T Consensus       209 ~~~~~~~~~GT~~YmAPE~~~~~~-----y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~  281 (336)
T 4g3f_A          209 SLLTGDYIPGTETHMAPEVVMGKP-----CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP--PPIREIPPS  281 (336)
T ss_dssp             -----CCCCCCGGGCCHHHHTTCC-----CCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC--CGGGGSCTT
T ss_pred             ceecCCccccCccccCHHHHCCCC-----CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC--CCchhcCcc
Confidence               223457999999999997443     4569999999999999999999998776665555544321  111246778


Q ss_pred             CChhHHHHHHHhcccCcCCCCCHHHH-------------hcCcccccCCCCC
Q 020657          284 ASPEFRSFIECCLQKEFSKRWTASQL-------------LTHPFLCKNRRSD  322 (323)
Q Consensus       284 ~~~~l~~ll~~~l~~~p~~Rpt~~~~-------------l~h~~f~~~~~~~  322 (323)
                      +++++.+||.+||+.||++|||+.|+             |+|||+.+.+.|+
T Consensus       282 ~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr  333 (336)
T 4g3f_A          282 CAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPR  333 (336)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCC
T ss_pred             CCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCC
Confidence            99999999999999999999999997             6899999988775

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.1e-59  Score=417.53  Aligned_cols=265  Identities=28%  Similarity=0.420  Sum_probs=219.5

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcC-----CC
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP-----SG  123 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~  123 (323)
                      .++|++++.||+|+||+||+|++..+|+.||||++.... .....+.+.+|+.+|+.++||||+++++++...     .+
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            368999999999999999999999999999999997553 344567788999999999999999999987642     35


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          124 DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      .+|+|||||+ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~-~~Ki~DFGla~~~~~  210 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENC-ELKIGDFGMARGLCT  210 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC-CEEECCCTTCBCC--
T ss_pred             EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCC-CEEEeecceeeeccc
Confidence            7899999996 58999999888999999999999999999999999999999999999999998 899999999976543


Q ss_pred             C----ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC---
Q 020657          204 S----LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD---  276 (323)
Q Consensus       204 ~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~---  276 (323)
                      .    .......+||+.|+|||++.+.    .+++.++||||+||++|||++|..||.+.+.......+........   
T Consensus       211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~----~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~  286 (398)
T 4b99_A          211 SPAEHQYFMTEYVATRWYRAPELMLSL----HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV  286 (398)
T ss_dssp             -----CCCCCSSCCCCTTCCHHHHTTC----SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             CccccccccccceeChHhcCHHHhcCC----CCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence            2    2233467899999999998632    3456799999999999999999999976654444444333221111   


Q ss_pred             ----------------CCC-------CCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          277 ----------------PPS-------LPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       277 ----------------~~~-------~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                                      +..       +...+++++.+||.+||+.||++|||++|+|+||||++.+.
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  353 (398)
T 4b99_A          287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD  353 (398)
T ss_dssp             TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred             hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence                            000       12357899999999999999999999999999999988654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.2e-59  Score=403.79  Aligned_cols=257  Identities=27%  Similarity=0.390  Sum_probs=203.0

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCC-------
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG-------  123 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-------  123 (323)
                      ++|++++.||+|+||+||+|++..+|+.||+|++.........+.+.+|+.+++.++||||+++++++.+.+.       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            5799999999999999999999999999999999877666677889999999999999999999999875322       


Q ss_pred             ----eEEEEEeccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecC
Q 020657          124 ----DIAILMEYMDSGTLDTLLNKNGT---FSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFG  196 (323)
Q Consensus       124 ----~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg  196 (323)
                          .+|+|||||++++|.+++.....   .++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~-~vKl~DFG  163 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVGDFG  163 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCCC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCC-cEEEccCc
Confidence                47999999999999999986544   45567899999999999999999999999999999999998 89999999


Q ss_pred             cchhhccCcc------------ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCcc
Q 020657          197 VSKIMCRSLD------------ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPD  264 (323)
Q Consensus       197 ~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~  264 (323)
                      +|+.......            .....+||+.|+|||++.+.     .++.++|||||||++|||++   ||...   ..
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-----~y~~~~DiwSlGvilyell~---Pf~~~---~~  232 (299)
T 4g31_A          164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-----SYSHKVDIFSLGLILFELLY---PFSTQ---ME  232 (299)
T ss_dssp             CC--------------------------CCCTTSCHHHHTTC-----CCCTHHHHHHHHHHHHHHHS---CCSSH---HH
T ss_pred             cceecCCCccccccccccccccccCCcccCccccCHHHHcCC-----CCCCHHHHHHHHHHHHHHcc---CCCCc---cH
Confidence            9987643321            12245799999999999744     34569999999999999996   77321   11


Q ss_pred             HHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          265 WATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      .............+......++.+.+|+++||+.||++|||++++|+||||++..
T Consensus       233 ~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~  287 (299)
T 4g31_A          233 RVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD  287 (299)
T ss_dssp             HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred             HHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence            1222233333333333345677889999999999999999999999999998764

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2e-58  Score=397.38  Aligned_cols=261  Identities=26%  Similarity=0.403  Sum_probs=210.5

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCC-CChHHHHHHHHHHHHHHcCCCCccceeceeEEcC
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP  121 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  121 (323)
                      ...|++..+++++.+.||+|+||+||+|++..   .||||+++.. .+....+.+.+|+.++++++||||++++|++.. 
T Consensus        28 ~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-  103 (307)
T 3omv_A           28 SYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-  103 (307)
T ss_dssp             -CCCBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred             CcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-
Confidence            45689999999999999999999999998753   5899998744 345667889999999999999999999998764 


Q ss_pred             CCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchh
Q 020657          122 SGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       122 ~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                       +.+++|||||++|+|.+++.. ...+++..+..|+.||+.||+|||++||+||||||+|||++.++ ++||+|||+|+.
T Consensus       104 -~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~-~~Ki~DFGla~~  181 (307)
T 3omv_A          104 -DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGL-TVKIGDFGLATV  181 (307)
T ss_dssp             -SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTE-EEEECCCSSCBC
T ss_pred             -CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCC-cEEEeeccCcee
Confidence             568999999999999999975 45799999999999999999999999999999999999999987 999999999976


Q ss_pred             hccC--ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHH-HhcCCC
Q 020657          201 MCRS--LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCA-ICFGDP  277 (323)
Q Consensus       201 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~-~~~~~~  277 (323)
                      ....  ........||+.|+|||++....  ...++.++||||||+++|||+||+.||.+............. ......
T Consensus       182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~--~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~  259 (307)
T 3omv_A          182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQD--NNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDL  259 (307)
T ss_dssp             ------------CCCCTTSCCHHHHHCCS--SCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCS
T ss_pred             cccCCcceeecccccCCCccCHHHhhccC--CCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCc
Confidence            5432  22334568999999999986332  234677999999999999999999999765443222222211 111122


Q ss_pred             CCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          278 PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       278 ~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ..++..+++++.+|+.+||+.||++|||+.++++
T Consensus       260 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~  293 (307)
T 3omv_A          260 SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS  293 (307)
T ss_dssp             TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred             ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            3456788999999999999999999999998753

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.6e-58  Score=399.57  Aligned_cols=257  Identities=23%  Similarity=0.364  Sum_probs=219.7

Q ss_pred             chhccccccceeeeecccCCeEEEEEEec-----ccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEE
Q 020657           45 TAAIAYSDLEKLQVLGHGNGGTVYKVQHR-----CTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFE  119 (323)
Q Consensus        45 ~~~~~~~~~~~~~~lg~G~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  119 (323)
                      ..++..+++++.+.||+|+||+||+|.+.     .+++.||||++....+....+.+.+|+.++++++||||++++|++.
T Consensus        20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~   99 (308)
T 4gt4_A           20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT   99 (308)
T ss_dssp             CCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence            44677889999999999999999999863     3678999999986665566788999999999999999999999998


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEE
Q 020657          120 KPSGDIAILMEYMDSGTLDTLLNKN----------------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLV  183 (323)
Q Consensus       120 ~~~~~~~lv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~  183 (323)
                      + ++.+++|||||++|+|.+++...                ..+++..+..++.||+.||.|||+++|+||||||+|||+
T Consensus       100 ~-~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl  178 (308)
T 4gt4_A          100 K-DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV  178 (308)
T ss_dssp             S-SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             E-CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence            7 67899999999999999999642                358999999999999999999999999999999999999


Q ss_pred             ecCCCcEEEeecCcchhhccCc--cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 020657          184 NNNNMQVKIADFGVSKIMCRSL--DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPG  260 (323)
Q Consensus       184 ~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~  260 (323)
                      +.++ ++||+|||+++......  .......+|+.|+|||++...     .++.++||||||+++|||+| |..||.+..
T Consensus       179 ~~~~-~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-----~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~  252 (308)
T 4gt4_A          179 YDKL-NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-----KFSIDSDIWSYGVVLWEVFSYGLQPYCGYS  252 (308)
T ss_dssp             CGGG-CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-----CCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred             CCCC-CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC-----CCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence            9987 89999999998654332  223456789999999998744     45679999999999999998 899996543


Q ss_pred             CCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          261 QRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                          ...+...+..+...+.+..++.++.+|+.+||+.||++|||+.+|+++
T Consensus       253 ----~~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          253 ----NQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             ----HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----HHHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                345555666677778889999999999999999999999999999876

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.4e-58  Score=396.77  Aligned_cols=258  Identities=26%  Similarity=0.415  Sum_probs=218.5

Q ss_pred             hhccccccceeeeecccCCeEEEEEEec-----ccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEc
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHR-----CTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEK  120 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  120 (323)
                      ..+..++|.+.+.||+|+||+||+|++.     .++..||||++... +....+.+.+|++++++++||||++++|++.+
T Consensus         8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~   86 (299)
T 4asz_A            8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVE   86 (299)
T ss_dssp             CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence            4577889999999999999999999864     35788999999754 45567789999999999999999999999987


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC
Q 020657          121 PSGDIAILMEYMDSGTLDTLLNKN-------------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN  187 (323)
Q Consensus       121 ~~~~~~lv~e~~~~~sL~~~l~~~-------------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~  187 (323)
                       ++.+++|||||++|+|.+++...             ..+++..+..++.||+.||.|||+++|+||||||+|||++.++
T Consensus        87 -~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           87 -GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             -SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred             -CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence             67899999999999999999753             3699999999999999999999999999999999999999987


Q ss_pred             CcEEEeecCcchhhccCcc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCcc
Q 020657          188 MQVKIADFGVSKIMCRSLD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPD  264 (323)
Q Consensus       188 ~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~  264 (323)
                       .+||+|||+|+.......  ......+|+.|+|||++...     .++.++||||||+++|||+| |+.||.+..    
T Consensus       166 -~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-----~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~----  235 (299)
T 4asz_A          166 -LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-----KFTTESDVWSLGVVLWEIFTYGKQPWYQLS----  235 (299)
T ss_dssp             -CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC-----CCCHHHHHHHHHHHHHHHHTTTCCTTTTSC----
T ss_pred             -cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCCC----
Confidence             899999999986644322  22345689999999999744     35679999999999999998 899996543    


Q ss_pred             HHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          265 WATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                      ...+...+..+.....|..+++++.+|+.+||+.||++|||+++++  +|+++
T Consensus       236 ~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~  286 (299)
T 4asz_A          236 NNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQN  286 (299)
T ss_dssp             HHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHH
T ss_pred             HHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHH
Confidence            3455566666777788899999999999999999999999999994  45543

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.1e-57  Score=397.94  Aligned_cols=257  Identities=26%  Similarity=0.427  Sum_probs=212.5

Q ss_pred             cchhccccccceeeeecccCCeEEEEEEec-----ccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeE
Q 020657           44 TTAAIAYSDLEKLQVLGHGNGGTVYKVQHR-----CTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIF  118 (323)
Q Consensus        44 ~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~  118 (323)
                      ....+..++|.+.+.||+|+||+||+|++.     .+++.||||++... +....+.+.+|+.+|++++||||++++|++
T Consensus        34 ~~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~  112 (329)
T 4aoj_A           34 CVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVRFFGVC  112 (329)
T ss_dssp             CSCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             hhcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            345577789999999999999999999864     36789999999754 455677899999999999999999999999


Q ss_pred             EcCCCeEEEEEeccCCCCHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEE
Q 020657          119 EKPSGDIAILMEYMDSGTLDTLLNKN---------------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLV  183 (323)
Q Consensus       119 ~~~~~~~~lv~e~~~~~sL~~~l~~~---------------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~  183 (323)
                      .+ .+.+++|||||++|+|.+++...               .++++..++.|+.||+.||.|||+.+|+||||||+|||+
T Consensus       113 ~~-~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl  191 (329)
T 4aoj_A          113 TE-GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV  191 (329)
T ss_dssp             CS-SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             EE-CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE
Confidence            87 67899999999999999999643               358999999999999999999999999999999999999


Q ss_pred             ecCCCcEEEeecCcchhhccCc--cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 020657          184 NNNNMQVKIADFGVSKIMCRSL--DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPG  260 (323)
Q Consensus       184 ~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~  260 (323)
                      +.++ .+||+|||+++......  .......+|+.|+|||++...     .++.++||||||+++|||+| |+.||.+..
T Consensus       192 ~~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-----~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~  265 (329)
T 4aoj_A          192 GQGL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-----KFTTESDVWSFGVVLWEIFTYGKQPWYQLS  265 (329)
T ss_dssp             ETTT-EEEECCCC----------------CCCCGGGCCHHHHTTC-----CCCHHHHHHHHHHHHHHHHTTSCCTTCSSC
T ss_pred             CCCC-cEEEcccccceeccCCCcceecCcccccccccChhhhcCC-----CCCccccccchHHHHHHHHcCCCCCCCCCC
Confidence            9987 99999999998654332  223346789999999998744     45679999999999999998 899996543


Q ss_pred             CCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          261 QRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                          ...+...+..+.+...|..+++++.+|+.+||+.||++|||+++|+++
T Consensus       266 ----~~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          266 ----NTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             ----HHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             ----HHHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence                344455555666778889999999999999999999999999999864

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4e-58  Score=403.78  Aligned_cols=261  Identities=26%  Similarity=0.392  Sum_probs=224.5

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEeccc-----CcEEEEEeecCCCChHHHHHHHHHHHHHHcCCC-Cccceece
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCT-----HKIYALKVVHGDADPTVRRQVFREMEILRRTDS-PFIVQCFG  116 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~-----~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~  116 (323)
                      ...|+++.++|++.+.||+|+||+||+|.+..+     ++.||+|.+.........+.+.+|+.++.+++| |||++++|
T Consensus        56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g  135 (353)
T 4ase_A           56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG  135 (353)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence            456899999999999999999999999997643     368999999877666677889999999999976 89999999


Q ss_pred             eEEcCCCeEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 020657          117 IFEKPSGDIAILMEYMDSGTLDTLLNKN----------------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSN  180 (323)
Q Consensus       117 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~n  180 (323)
                      ++...++.+++|||||++|+|.++++..                ..+++..+..++.||+.||.|||+++|+||||||+|
T Consensus       136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~N  215 (353)
T 4ase_A          136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN  215 (353)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccc
Confidence            9977567799999999999999999742                348999999999999999999999999999999999


Q ss_pred             eEEecCCCcEEEeecCcchhhccCcc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 020657          181 LLVNNNNMQVKIADFGVSKIMCRSLD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFL  257 (323)
Q Consensus       181 il~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~  257 (323)
                      ||++.++ .+||+|||+|+.......  ......+|+.|+|||++...     .++.++|||||||++|||+| |..||.
T Consensus       216 ILl~~~~-~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-----~y~~ksDVwS~Gv~l~El~t~G~~Pf~  289 (353)
T 4ase_A          216 ILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-----VYTIQSDVWSFGVLLWEIFSLGASPYP  289 (353)
T ss_dssp             EEECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-----CCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             eeeCCCC-CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-----CCCCcccEeehHHHHHHHHhCCCCCCC
Confidence            9999987 899999999986543322  23345789999999999744     45679999999999999998 999997


Q ss_pred             CCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          258 QPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      +....   ..+...+..+.++..|..+++++.+|+.+||+.||++|||+.+|++|
T Consensus       290 ~~~~~---~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          290 GVKID---EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             TCCCS---HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHH---HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            65443   33444455566778888999999999999999999999999999988

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.7e-56  Score=416.67  Aligned_cols=263  Identities=29%  Similarity=0.492  Sum_probs=222.5

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCC-----CChHHHHHHHHHHHHHHcCCCCccceeceeEEcC
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-----ADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP  121 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  121 (323)
                      .+..++|++++.||+|+||.||+|++..+|+.||+|++.+.     ...........++.+++.++||||++++++|++ 
T Consensus       185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~-  263 (689)
T 3v5w_A          185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-  263 (689)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-
T ss_pred             CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE-
Confidence            35578999999999999999999999999999999998632     222233334455677788899999999999998 


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhh
Q 020657          122 SGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM  201 (323)
Q Consensus       122 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~  201 (323)
                      .+.+|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++|||||||||+|||++.+| .+||+|||+|...
T Consensus       264 ~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G-~vKL~DFGlA~~~  342 (689)
T 3v5w_A          264 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDF  342 (689)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCC-CEEecccceeeec
Confidence            789999999999999999999888999999999999999999999999999999999999999998 8999999999776


Q ss_pred             ccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCC
Q 020657          202 CRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLP  281 (323)
Q Consensus       202 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (323)
                      ...  ...+.+||+.|+|||++..    +..++.++|||||||++|||++|..||.+...... ..+...+. .....++
T Consensus       343 ~~~--~~~t~~GTp~YmAPEvl~~----~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~-~~i~~~i~-~~~~~~p  414 (689)
T 3v5w_A          343 SKK--KPHASVGTHGYMAPEVLQK----GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTL-TMAVELP  414 (689)
T ss_dssp             SSC--CCCSCCSCGGGCCHHHHST----TCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH-HHHHHHHH-HCCCCCC
T ss_pred             CCC--CCCCccCCcCccCHHHHhC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhhc-CCCCCCC
Confidence            433  3356789999999999862    23345699999999999999999999976544333 23333332 2345677


Q ss_pred             CCCChhHHHHHHHhcccCcCCCCC-----HHHHhcCcccccCC
Q 020657          282 DGASPEFRSFIECCLQKEFSKRWT-----ASQLLTHPFLCKNR  319 (323)
Q Consensus       282 ~~~~~~l~~ll~~~l~~~p~~Rpt-----~~~~l~h~~f~~~~  319 (323)
                      ..+|+++.+||++||+.||++|++     +++|++||||+++.
T Consensus       415 ~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id  457 (689)
T 3v5w_A          415 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD  457 (689)
T ss_dssp             TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred             ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence            889999999999999999999998     79999999999863

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=5.7e-56  Score=392.37  Aligned_cols=259  Identities=22%  Similarity=0.317  Sum_probs=206.5

Q ss_pred             ccccceeeeecccCCeEEEEEEec---ccCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceeceeEEcCCCeE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHR---CTHKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKPSGDI  125 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~  125 (323)
                      .++|++.+.||+|+||+||+|+++   .+++.||+|.+.....   ..++.+|+++++.+ +||||++++++|.+ .+.+
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~-~~~~   95 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH---PIRIAAELQCLTVAGGQDNVMGVKYCFRK-NDHV   95 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC---HHHHHHHHHHHHHTCSBTTBCCCSEEEEE-TTEE
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC---HHHHHHHHHHHHHhcCCCCCceEEEEEEE-CCEE
Confidence            478999999999999999999875   4678999999865543   24577899999998 69999999999998 7899


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc
Q 020657          126 AILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL  205 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~  205 (323)
                      ++||||+++++|.+++.   .+++..++.++.||+.||+|||++||+||||||+|||++.+...+||+|||+|+......
T Consensus        96 ~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~  172 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK  172 (361)
T ss_dssp             EEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred             EEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence            99999999999999984   589999999999999999999999999999999999999873389999999997543221


Q ss_pred             ----------------------------cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 020657          206 ----------------------------DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFL  257 (323)
Q Consensus       206 ----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~  257 (323)
                                                  ......+||+.|+|||++.+.    ..++.++||||+||++|+|+||+.||.
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~----~~y~~~~DiWSlG~il~ell~G~~Pf~  248 (361)
T 4f9c_A          173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC----PNQTTAIDMWSAGVIFLSLLSGRYPFY  248 (361)
T ss_dssp             CGGGGGC--------------------------CCCCGGGCCHHHHTTC----SCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCC----CCCCCccchhhhHHHHHHHHHCCCCCC
Confidence                                        112235799999999998632    335669999999999999999999997


Q ss_pred             CCCCCcc-HHHHH----------------------------------HHHhcC---------------CCCCCCCCCChh
Q 020657          258 QPGQRPD-WATLM----------------------------------CAICFG---------------DPPSLPDGASPE  287 (323)
Q Consensus       258 ~~~~~~~-~~~~~----------------------------------~~~~~~---------------~~~~~~~~~~~~  287 (323)
                      ....... ...+.                                  +.....               ........+|++
T Consensus       249 ~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~  328 (361)
T 4f9c_A          249 KASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDE  328 (361)
T ss_dssp             CCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHH
T ss_pred             CCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHH
Confidence            5443211 11111                                  000000               001123468899


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          288 FRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       288 l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      +.|||++||+.||++|+|++|+|+||||++..
T Consensus       329 a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          329 AYDLLDKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             HHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            99999999999999999999999999999863

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.6e-54  Score=404.75  Aligned_cols=258  Identities=26%  Similarity=0.411  Sum_probs=219.9

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|++.... ......+.+|+.+|+.++||||++++++|.+ .+.+++||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~iv~  233 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFED-DNEMVMIY  233 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEE
Confidence            478999999999999999999999999999999997553 3345678899999999999999999999998 78999999


Q ss_pred             eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecC--CCcEEEeecCcchhhccCcc
Q 020657          130 EYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNN--NMQVKIADFGVSKIMCRSLD  206 (323)
Q Consensus       130 e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~--~~~~kl~Dfg~~~~~~~~~~  206 (323)
                      |||+||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+  + .+||+|||+|...... .
T Consensus       234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~-~vKl~DFG~a~~~~~~-~  311 (573)
T 3uto_A          234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSN-ELKLIDFGLTAHLDPK-Q  311 (573)
T ss_dssp             ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCC-CEEECCCSSCEECCTT-S
T ss_pred             eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCC-CEEEeeccceeEccCC-C
Confidence            99999999998864 4579999999999999999999999999999999999999864  5 8999999999876433 2


Q ss_pred             ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC---CCCCCCC
Q 020657          207 ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD---PPSLPDG  283 (323)
Q Consensus       207 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  283 (323)
                      .....+||+.|+|||++.+..     ++.++|||||||++|+|++|..||.+...    ......+....   +......
T Consensus       312 ~~~~~~GT~~y~APEv~~~~~-----y~~~~DiWSlGvilyeml~G~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~  382 (573)
T 3uto_A          312 SVKVTTGTAEFAAPEVAEGKP-----VGYYTDMWSVGVLSYILLSGLSPFGGEND----DETLRNVKSCDWNMDDSAFSG  382 (573)
T ss_dssp             EEEEECSSGGGCCHHHHTTCC-----BCHHHHHHHHHHHHHHHHHSCCSSCCSSH----HHHHHHHHTTCCCCCSGGGTT
T ss_pred             ceeeeEECccccCHHHhCCCC-----CCcHHHHHHHHHHHHHHHHCCCCCCCcCH----HHHHHHHHhCCCCCCcccccC
Confidence            334568999999999997544     45699999999999999999999965433    23333333222   2334467


Q ss_pred             CChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          284 ASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       284 ~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                      +++++.+||++||+.||++|||++|+|+||||+....
T Consensus       383 ~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~  419 (573)
T 3uto_A          383 ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA  419 (573)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence            8999999999999999999999999999999987543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1e-52  Score=368.54  Aligned_cols=262  Identities=27%  Similarity=0.460  Sum_probs=225.0

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCe
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGD  124 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  124 (323)
                      .....++|++.+.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++++.. .+.
T Consensus        10 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~   88 (328)
T 3fe3_A           10 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET-EKT   88 (328)
T ss_dssp             -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSE
T ss_pred             cCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCE
Confidence            3345688999999999999999999999899999999996543 44566788899999999999999999999987 688


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC
Q 020657          125 IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS  204 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~  204 (323)
                      .++||||+++++|.+++...+.+++..++.++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++......
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           89 LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADM-NIKIADFGFSNEFTVG  167 (328)
T ss_dssp             EEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSTTCCGGGSSS
T ss_pred             EEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCC-CEEEeeccCceecCCC
Confidence            999999999999999998888899999999999999999999999999999999999999987 8999999999766433


Q ss_pred             ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCC
Q 020657          205 LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA  284 (323)
Q Consensus       205 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (323)
                       .......+++.|+|||++.+..+    .+.++||||||+++|+|++|..||.+..    ...+...+..+ ...++..+
T Consensus       168 -~~~~~~~gt~~y~aPE~~~~~~~----~~~~~DiwslG~il~ell~g~~pf~~~~----~~~~~~~i~~~-~~~~p~~~  237 (328)
T 3fe3_A          168 -GKLDAFCGAPPYAAPELFQGKKY----DGPEVDVWSLGVILYTLVSGSLPFDGQN----LKELRERVLRG-KYRIPFYM  237 (328)
T ss_dssp             -CGGGTTSSSGGGCCHHHHHTCCC----CSHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHC-CCCCCTTS
T ss_pred             -CccccccCCcceeCcccccCCCc----CCchhhhhhhHHHHHHHHhCCCCCCCCC----HHHHHHHHHhC-CCCCCCCC
Confidence             23345679999999999864332    3468999999999999999999995543    33333333333 34566788


Q ss_pred             ChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       285 ~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      ++++.+|+++||+.||++|||++++++||||+...
T Consensus       238 s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          238 STDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             CHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence            99999999999999999999999999999998654

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=7.2e-53  Score=370.58  Aligned_cols=260  Identities=27%  Similarity=0.515  Sum_probs=223.0

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeE
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDI  125 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  125 (323)
                      +..++|++++.||+|+||.||+|++..+++.||+|++....  .......+.+|+.+++.++||||+++++++.+ .+.+
T Consensus         2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~   80 (337)
T 1o6l_A            2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-HDRL   80 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-SSEE
T ss_pred             CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe-CCEE
Confidence            45689999999999999999999999999999999996431  11234567889999999999999999999997 6789


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc
Q 020657          126 AILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL  205 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~  205 (323)
                      ++||||+++++|..++...+.+++..++.++.||+.||.|||++|++||||||+||+++.++ .+||+|||++.......
T Consensus        81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~  159 (337)
T 1o6l_A           81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCSCCTT
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCC-CEEEeeccchhhcccCC
Confidence            99999999999999998888899999999999999999999999999999999999999998 89999999997644444


Q ss_pred             cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCC
Q 020657          206 DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS  285 (323)
Q Consensus       206 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (323)
                      .......+|+.|+|||++....     ++.++||||||+++|+|++|..||.....    ..+...+... ...++..++
T Consensus       160 ~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~ell~g~~Pf~~~~~----~~~~~~i~~~-~~~~p~~~s  229 (337)
T 1o6l_A          160 ATMKTFCGTPEYLAPEVLEDND-----YGRAVDWWGLGVVMYEMMCGRLPFYNQDH----ERLFELILME-EIRFPRTLS  229 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSSSC-----BCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHC-CCCCCTTSC
T ss_pred             CcccccccChhhCChhhhcCCC-----CCchhhcccchhHHHHHhcCCCCCCCCCH----HHHHHHHHcC-CCCCCCCCC
Confidence            4455678999999999987443     45699999999999999999999965432    3333333322 345677899


Q ss_pred             hhHHHHHHHhcccCcCCCC-----CHHHHhcCcccccCC
Q 020657          286 PEFRSFIECCLQKEFSKRW-----TASQLLTHPFLCKNR  319 (323)
Q Consensus       286 ~~l~~ll~~~l~~~p~~Rp-----t~~~~l~h~~f~~~~  319 (323)
                      +++.+|+++||+.||++||     +++++++||||.++.
T Consensus       230 ~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~  268 (337)
T 1o6l_A          230 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  268 (337)
T ss_dssp             HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             HHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence            9999999999999999999     999999999998753

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.9e-53  Score=375.44  Aligned_cols=264  Identities=27%  Similarity=0.455  Sum_probs=215.8

Q ss_pred             cchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcC-CCCccceeceeEEc
Q 020657           44 TTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRT-DSPFIVQCFGIFEK  120 (323)
Q Consensus        44 ~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~  120 (323)
                      ....+..++|++.+.||+|+||.||+|++..+++.||+|++....  .......+.+|..+++.+ +||||+++++++.+
T Consensus        16 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~   95 (353)
T 3txo_A           16 SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT   95 (353)
T ss_dssp             -------CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             CcCCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe
Confidence            334567899999999999999999999999999999999996431  122345677899999987 79999999999998


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchh
Q 020657          121 PSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       121 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                       .+.+++||||+.+++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+||+++.++ .+||+|||++..
T Consensus        96 -~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g-~ikL~DFG~a~~  173 (353)
T 3txo_A           96 -PDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG-HCKLADFGMCKE  173 (353)
T ss_dssp             -SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBC
T ss_pred             -CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCC-CEEEccccceee
Confidence             678999999999999999999888999999999999999999999999999999999999999998 899999999976


Q ss_pred             hccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCC
Q 020657          201 MCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSL  280 (323)
Q Consensus       201 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  280 (323)
                      ...........++|+.|+|||++....     ++.++||||||+++|+|++|..||.....    ..+...+... ...+
T Consensus       174 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~ell~G~~Pf~~~~~----~~~~~~i~~~-~~~~  243 (353)
T 3txo_A          174 GICNGVTTATFCGTPDYIAPEILQEML-----YGPAVDWWAMGVLLYEMLCGHAPFEAENE----DDLFEAILND-EVVY  243 (353)
T ss_dssp             SCC---------CCGGGCCHHHHHHHH-----CTTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHC-CCCC
T ss_pred             cccCCccccccCCCcCeEChhhcCCCC-----cCCccCCCcchHHHHHHHhCCCCCCCCCH----HHHHHHHHcC-CCCC
Confidence            444444455678999999999986443     45699999999999999999999965433    3333333332 3456


Q ss_pred             CCCCChhHHHHHHHhcccCcCCCCCH------HHHhcCcccccCC
Q 020657          281 PDGASPEFRSFIECCLQKEFSKRWTA------SQLLTHPFLCKNR  319 (323)
Q Consensus       281 ~~~~~~~l~~ll~~~l~~~p~~Rpt~------~~~l~h~~f~~~~  319 (323)
                      +..++.++.+|+++||+.||++||++      +++++||||++..
T Consensus       244 p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~  288 (353)
T 3txo_A          244 PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID  288 (353)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCC
T ss_pred             CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCC
Confidence            77899999999999999999999999      8999999998753

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=4e-52  Score=362.62  Aligned_cols=269  Identities=25%  Similarity=0.417  Sum_probs=220.7

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcC
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP  121 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  121 (323)
                      +.......++|++.+.||+|+||+||+|++. +++.||+|++.... .......+.+|+.+++.++||||+++++++.+ 
T Consensus        13 ~~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-   90 (311)
T 3niz_A           13 NLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS-   90 (311)
T ss_dssp             --CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC-
T ss_pred             ceeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc-
Confidence            3344556799999999999999999999996 68999999997553 23345678899999999999999999999987 


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchh
Q 020657          122 SGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       122 ~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                      ....++||||+++ +|.+.+... ..+++..++.++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++..
T Consensus        91 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~  168 (311)
T 3niz_A           91 ERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG-ALKLADFGLARA  168 (311)
T ss_dssp             SSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             CCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCC-CEEEccCcCcee
Confidence            6789999999986 787777654 4599999999999999999999999999999999999999987 899999999987


Q ss_pred             hccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCC-
Q 020657          201 MCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPS-  279 (323)
Q Consensus       201 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-  279 (323)
                      ............++..|+|||++.+    ...++.++||||||+++|+|++|..||.+.........+........+.. 
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  244 (311)
T 3niz_A          169 FGIPVRSYTHEVVTLWYRAPDVLMG----SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREW  244 (311)
T ss_dssp             TTSCCC---CCCCCCTTCCHHHHTT----CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTS
T ss_pred             cCCCcccccCCcccCCcCCHHHhcC----CCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHh
Confidence            6555444555678999999999863    23456799999999999999999999988777766666655433222211 


Q ss_pred             ------------------------CCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          280 ------------------------LPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       280 ------------------------~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                                              +...+++++.+|+++||+.||++|||++++|+||||++..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          245 PQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             GGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             hhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence                                    1235678999999999999999999999999999999875

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.9e-52  Score=373.31  Aligned_cols=267  Identities=26%  Similarity=0.472  Sum_probs=223.3

Q ss_pred             chhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcC-CCCccceeceeEEcC
Q 020657           45 TAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKP  121 (323)
Q Consensus        45 ~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~  121 (323)
                      ...+..++|++++.||+|+||.||+|++..+++.||+|++....  .......+.+|..+++.+ +||||+++++++.+ 
T Consensus        46 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-  124 (396)
T 4dc2_A           46 SSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-  124 (396)
T ss_dssp             ---CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC-
T ss_pred             ccCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE-
Confidence            34567889999999999999999999999999999999997542  223345577899998886 89999999999997 


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhh
Q 020657          122 SGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM  201 (323)
Q Consensus       122 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~  201 (323)
                      .+.+++||||+++++|..++...+.+++..++.++.||+.||.|||+.||+||||||+||+++.++ .+||+|||++...
T Consensus       125 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g-~ikL~DFGla~~~  203 (396)
T 4dc2_A          125 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEG  203 (396)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCC-CEEEeecceeeec
Confidence            688999999999999999999888999999999999999999999999999999999999999998 8999999999764


Q ss_pred             ccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCc-----cHHHHHHHHhcCC
Q 020657          202 CRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRP-----DWATLMCAICFGD  276 (323)
Q Consensus       202 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~-----~~~~~~~~~~~~~  276 (323)
                      ..........+||+.|+|||++.+..     ++.++||||||+++|+|++|..||.......     ....+.+.+. ..
T Consensus       204 ~~~~~~~~~~~gt~~Y~aPE~l~~~~-----~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~-~~  277 (396)
T 4dc2_A          204 LRPGDTTSTFCGTPNYIAPEILRGED-----YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL-EK  277 (396)
T ss_dssp             CCTTCCBCCCCBCGGGCCHHHHTTCC-----BCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHH-HC
T ss_pred             ccCCCccccccCCcccCCchhhcCCC-----CChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHh-cc
Confidence            44444556678999999999997544     4569999999999999999999996543221     2222333333 33


Q ss_pred             CCCCCCCCChhHHHHHHHhcccCcCCCCCH------HHHhcCcccccCC
Q 020657          277 PPSLPDGASPEFRSFIECCLQKEFSKRWTA------SQLLTHPFLCKNR  319 (323)
Q Consensus       277 ~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~------~~~l~h~~f~~~~  319 (323)
                      ...++..++.++.+||++||+.||++||++      +++++||||+++.
T Consensus       278 ~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~  326 (396)
T 4dc2_A          278 QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  326 (396)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred             ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCC
Confidence            456778899999999999999999999984      8999999998763

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=5.5e-52  Score=359.46  Aligned_cols=260  Identities=27%  Similarity=0.502  Sum_probs=219.9

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ...+|++.+.||+|+||.||+|.+..+++.||+|++....... ...+.+|+.+++.++||||+++++++.. .+..++|
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv   95 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLV-GDELWVV   95 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC-HHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH-HHHHHHHHHHHhcCCCCCCCeEeEEEEE-CCEEEEE
Confidence            4678999999999999999999999999999999986543322 4567899999999999999999999987 6789999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          129 MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      |||+.+++|.+++... .+++..+..++.|++.||.|||+.|++||||||+||+++.++ .+||+|||++..........
T Consensus        96 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~  173 (297)
T 3fxz_A           96 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKR  173 (297)
T ss_dssp             EECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSTTCCB
T ss_pred             EECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCC-CEEEeeCCCceecCCccccc
Confidence            9999999999999765 689999999999999999999999999999999999999987 89999999997765555555


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhH
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEF  288 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (323)
                      ....++..|+|||++.+..     ++.++||||||+++|+|++|..||...........+.  .........+..++..+
T Consensus       174 ~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  246 (297)
T 3fxz_A          174 STMVGTPYWMAPEVVTRKA-----YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA--TNGTPELQNPEKLSAIF  246 (297)
T ss_dssp             CCCCSCGGGCCHHHHHCSC-----BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH--HHCSCCCSCGGGSCHHH
T ss_pred             CCccCCcCccChhhhcCCC-----CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCCccccCHHH
Confidence            5678999999999987443     4569999999999999999999996543222222111  11122233456789999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          289 RSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       289 ~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      .+|+.+||+.||++|||++++++||||+..+
T Consensus       247 ~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  277 (297)
T 3fxz_A          247 RDFLNRCLEMDVEKRGSAKELLQHQFLKIAK  277 (297)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence            9999999999999999999999999998654

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=8.6e-52  Score=365.16  Aligned_cols=264  Identities=27%  Similarity=0.470  Sum_probs=224.9

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCC--CChHHHHHHHHHHHHHHcC-CCCccceeceeEEcCCCe
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKPSGD  124 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  124 (323)
                      +..++|++.+.||+|+||.||+|++..+++.||+|++...  ........+.+|..+++.+ +||||+++++++.+ .+.
T Consensus         6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-~~~   84 (345)
T 3a8x_A            6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ESR   84 (345)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSE
T ss_pred             CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe-CCE
Confidence            4578999999999999999999999999999999999754  2445567788999999987 89999999999987 688


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC
Q 020657          125 IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS  204 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~  204 (323)
                      +++||||+++++|.+++...+.+++..++.++.||+.||.|||++|++||||||+||+++.++ .+||+|||++......
T Consensus        85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCGGGCBCSCCT
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC-CEEEEeccccccccCC
Confidence            999999999999999998888899999999999999999999999999999999999999987 8999999999764444


Q ss_pred             ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC-----ccHHHHHHHHhcCCCCC
Q 020657          205 LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQR-----PDWATLMCAICFGDPPS  279 (323)
Q Consensus       205 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~  279 (323)
                      ........+|+.|+|||++....     ++.++||||||+++|+|++|..||...+..     .....+.+.+.. ....
T Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~-~~~~  237 (345)
T 3a8x_A          164 GDTTSTFCGTPNYIAPEILRGED-----YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQIR  237 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCC-----BCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH-CCCC
T ss_pred             CCcccccCCCccccCccccCCCC-----CChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc-CCCC
Confidence            44455678999999999987443     456999999999999999999999654322     122233333332 3455


Q ss_pred             CCCCCChhHHHHHHHhcccCcCCCCCH------HHHhcCcccccCC
Q 020657          280 LPDGASPEFRSFIECCLQKEFSKRWTA------SQLLTHPFLCKNR  319 (323)
Q Consensus       280 ~~~~~~~~l~~ll~~~l~~~p~~Rpt~------~~~l~h~~f~~~~  319 (323)
                      ++..++.++.+|+++||+.||++||++      +++++||||++..
T Consensus       238 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~  283 (345)
T 3a8x_A          238 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  283 (345)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred             CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence            778899999999999999999999995      8999999998753

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1e-52  Score=363.73  Aligned_cols=256  Identities=23%  Similarity=0.267  Sum_probs=196.9

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCC---eEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG---DIAI  127 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---~~~l  127 (323)
                      ++|.+.+.||+|+||+||+|++  +|+.||||++....  ........|+..+.+++||||+++++++.....   .+++
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l   78 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc--hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence            5789999999999999999998  68999999986432  222223346666677899999999999876432   5899


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CCeecCCCCCCeEEecCCCcEEEeecCcch
Q 020657          128 LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH--------KIIHRDIKPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~--------givH~di~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                      ||||+++|+|.++++.. ++++..+..++.|++.||+|||++        ||+||||||+|||++.++ ++||+|||+++
T Consensus        79 V~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~-~~Ki~DFGla~  156 (303)
T 3hmm_A           79 VSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAV  156 (303)
T ss_dssp             EEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCCTTCE
T ss_pred             EecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC-CEEEEeCCCCc
Confidence            99999999999999765 689999999999999999999987        999999999999999997 89999999997


Q ss_pred             hhccCccc----cccccccccccCCcccCCCCC-CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----------CCc
Q 020657          200 IMCRSLDA----CNSYVGTCAYMSPERFDPDAY-GGNYNGYAGDIWSLGLTLLELYLGHFPFLQPG-----------QRP  263 (323)
Q Consensus       200 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~-----------~~~  263 (323)
                      ........    ....+||+.|+|||++.+... ....++.++||||||+++|||+||..||....           ...
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~  236 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence            66543222    234579999999999975432 12235679999999999999999976653221           122


Q ss_pred             cHHHHHHHHhc-CCCCCCCCC-----CChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          264 DWATLMCAICF-GDPPSLPDG-----ASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       264 ~~~~~~~~~~~-~~~~~~~~~-----~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ....+...+.. ..++.++..     .+..+.+|+.+||+.||++|||+.++++.
T Consensus       237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            33444443332 234444432     23578999999999999999999999864

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=8.4e-52  Score=357.49  Aligned_cols=263  Identities=26%  Similarity=0.406  Sum_probs=215.2

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++.... .......+.+|+.++++++||||+++++++.+ ++..++||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~   80 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-DKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe-CCEEEEEE
Confidence            68999999999999999999999999999999997553 34456778899999999999999999999987 68899999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccc
Q 020657          130 EYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN  209 (323)
Q Consensus       130 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~  209 (323)
                      ||++++.+..+....+.+++..++.++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++...........
T Consensus        81 e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~  159 (292)
T 3o0g_A           81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG-ELKLANFGLARAFGIPVRCYS  159 (292)
T ss_dssp             ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCSCCSCCC
T ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeecccceecCCcccccc
Confidence            9998744444444567899999999999999999999999999999999999999987 899999999987655555555


Q ss_pred             cccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCcc-HHHHHHHHhcCCC-----------
Q 020657          210 SYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPD-WATLMCAICFGDP-----------  277 (323)
Q Consensus       210 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~-~~~~~~~~~~~~~-----------  277 (323)
                      ...++..|+|||++.+.    ..++.++||||||+++|+|++|..||........ ...+.........           
T Consensus       160 ~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (292)
T 3o0g_A          160 AEVVTLWYRPPDVLFGA----KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             SCCSCGGGCCHHHHTTC----SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             CCccccCCcChHHHcCC----CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence            66789999999998632    2356799999999999999999888754433222 2222221111100           


Q ss_pred             -------------CCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          278 -------------PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       278 -------------~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                                   ......++.++.+|+++||+.||++|||++++|+||||++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence                         112235789999999999999999999999999999999764

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.9e-52  Score=367.77  Aligned_cols=261  Identities=25%  Similarity=0.451  Sum_probs=220.8

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcC-CCCccceeceeEEcCCC
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKPSG  123 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~  123 (323)
                      .+..++|++.+.||+|+||.||+|++..+++.||+|++....  .......+..|..++..+ +||||+++++++.+ .+
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~-~~   91 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-KE   91 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-SS
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe-CC
Confidence            466789999999999999999999999999999999996431  012234567888888876 99999999999998 67


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          124 DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      .+++||||+++++|.+++.....+++..+..++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++.....
T Consensus        92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~  170 (345)
T 1xjd_A           92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG-HIKIADFGMCKENML  170 (345)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCC
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCC-CEEEeEChhhhhccc
Confidence            8999999999999999999888899999999999999999999999999999999999999998 899999999976543


Q ss_pred             CccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCC
Q 020657          204 SLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDG  283 (323)
Q Consensus       204 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (323)
                      ........+||+.|+|||++.+..     ++.++||||||+++|+|++|..||.+.+.    ..+...+... ...++..
T Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~ell~g~~Pf~~~~~----~~~~~~i~~~-~~~~p~~  240 (345)
T 1xjd_A          171 GDAKTNTFCGTPDYIAPEILLGQK-----YNHSVDWWSFGVLLYEMLIGQSPFHGQDE----EELFHSIRMD-NPFYPRW  240 (345)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHTTCC-----BCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHC-CCCCCTT
T ss_pred             CCCcccCCCCCcccCChhhhcCCC-----CCChhhhHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHHhC-CCCCCcc
Confidence            334455678999999999987443     45699999999999999999999965433    3333333333 3456778


Q ss_pred             CChhHHHHHHHhcccCcCCCCCHH-HHhcCcccccCC
Q 020657          284 ASPEFRSFIECCLQKEFSKRWTAS-QLLTHPFLCKNR  319 (323)
Q Consensus       284 ~~~~l~~ll~~~l~~~p~~Rpt~~-~~l~h~~f~~~~  319 (323)
                      ++.++.+|+++||+.||++||++. ++++||||+++.
T Consensus       241 ~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~  277 (345)
T 1xjd_A          241 LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN  277 (345)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             cCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence            999999999999999999999998 999999998764

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=7.1e-52  Score=363.92  Aligned_cols=270  Identities=21%  Similarity=0.358  Sum_probs=210.3

Q ss_pred             cchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcCCCCccceeceeEEcCC
Q 020657           44 TTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS  122 (323)
Q Consensus        44 ~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  122 (323)
                      .......++|++.+.||+|+||.||+|++..+++.||+|++..... ......+.+|+.+++.++||||+++++++.+ .
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~  105 (329)
T 3gbz_A           27 APSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH-N  105 (329)
T ss_dssp             -----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE-T
T ss_pred             CCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec-C
Confidence            3445667899999999999999999999999999999999975543 3345667899999999999999999999987 6


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC----CcEEEeecCcc
Q 020657          123 GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN----MQVKIADFGVS  198 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~----~~~kl~Dfg~~  198 (323)
                      ...++||||+.+ +|.+++...+.+++..++.++.||+.||.|||+.|++|+||||+||+++.++    ..+||+|||++
T Consensus       106 ~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          106 HRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             TEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             CEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            889999999985 9999999888899999999999999999999999999999999999995332    26999999999


Q ss_pred             hhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCC
Q 020657          199 KIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPP  278 (323)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~  278 (323)
                      ..............++..|+|||++.+.    ..++.++||||||+++|+|++|..||...........+..........
T Consensus       185 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  260 (329)
T 3gbz_A          185 RAFGIPIRQFTHEIITLWYRPPEILLGS----RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT  260 (329)
T ss_dssp             HHHC-----------CCTTCCHHHHTTC----CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             cccCCcccccCCCcCCccccCHHHhcCC----CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchh
Confidence            8776554445556789999999998632    335679999999999999999999997654444334443332221111


Q ss_pred             CC-------------------------CCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          279 SL-------------------------PDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       279 ~~-------------------------~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      ..                         +..+++++.+|+++||+.||++|||++++|+||||++..
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  326 (329)
T 3gbz_A          261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND  326 (329)
T ss_dssp             TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred             hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence            11                         012678999999999999999999999999999999864

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=7.3e-52  Score=361.97  Aligned_cols=263  Identities=26%  Similarity=0.418  Sum_probs=204.7

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      .++|++++.||+|+||.||+|.+..+++.||+|++...........+.+|+.+++.++||||+++++++.. ++..++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~   82 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT-ENKLTLVF   82 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC-TTEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE-CCeEEEEE
Confidence            47899999999999999999999989999999999766544445667899999999999999999999987 67899999


Q ss_pred             eccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          130 EYMDSGTLDTLLNKN------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       130 e~~~~~sL~~~l~~~------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      ||+++ +|.+++...      ..+++..+..++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++.....
T Consensus        83 e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~  160 (317)
T 2pmi_A           83 EFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRG-QLKLGDFGLARAFGI  160 (317)
T ss_dssp             ECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCSSCEETTS
T ss_pred             EecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCC-CEEECcCccceecCC
Confidence            99985 999988643      3589999999999999999999999999999999999999987 899999999987654


Q ss_pred             CccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCC------
Q 020657          204 SLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP------  277 (323)
Q Consensus       204 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~------  277 (323)
                      .........++..|+|||++.+    ...++.++||||||+++|+|++|..||.+.........+.........      
T Consensus       161 ~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (317)
T 2pmi_A          161 PVNTFSSEVVTLWYRAPDVLMG----SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV  236 (317)
T ss_dssp             CCCCCCCCCSCCTTCCHHHHTT----CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred             CcccCCCCcccccccCchHhhC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence            4444456678999999999863    234567999999999999999999999765544333333322211000      


Q ss_pred             -----------------------CCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          278 -----------------------PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       278 -----------------------~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                                             +.....++.++.+|+++||+.||++|||++++|+||||++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  301 (317)
T 2pmi_A          237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY  301 (317)
T ss_dssp             GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence                                   011235788999999999999999999999999999998754

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.8e-51  Score=367.08  Aligned_cols=268  Identities=27%  Similarity=0.514  Sum_probs=227.1

Q ss_pred             chhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC
Q 020657           45 TAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS  122 (323)
Q Consensus        45 ~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  122 (323)
                      ...+..++|++.+.||+|+||.||+|++..+++.||+|++....  .......+.+|+.+++.++||||+++++++.+ .
T Consensus         9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~   87 (384)
T 4fr4_A            9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD-E   87 (384)
T ss_dssp             CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-S
T ss_pred             CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-C
Confidence            34567899999999999999999999999999999999986331  11234677899999999999999999999997 6


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          123 GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      +..++||||+.+++|.+++.....+++..++.++.||+.||.|||+.||+||||||+||+++.++ .+||+|||++....
T Consensus        88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~vkL~DFG~a~~~~  166 (384)
T 4fr4_A           88 EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHG-HVHITDFNIAAMLP  166 (384)
T ss_dssp             SEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECC
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCC-CEEEeccceeeecc
Confidence            78999999999999999999888899999999999999999999999999999999999999998 89999999997654


Q ss_pred             cCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCC
Q 020657          203 RSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPD  282 (323)
Q Consensus       203 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (323)
                      .. .......+|+.|+|||++....  ...++.++||||||+++|+|++|..||........ ..+..... .....++.
T Consensus       167 ~~-~~~~~~~gt~~Y~aPE~~~~~~--~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~-~~~~~~~~-~~~~~~p~  241 (384)
T 4fr4_A          167 RE-TQITTMAGTKPYMAPEMFSSRK--GAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-KEIVHTFE-TTVVTYPS  241 (384)
T ss_dssp             TT-CCBCCCCSCGGGCCGGGTCCCS--SCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH-HHHHHHHH-HCCCCCCT
T ss_pred             CC-CceeccCCCccccCCeeeccCC--CCCCCccceeechHHHHHHHHhCCCCCCCCCCccH-HHHHHHHh-hcccCCCC
Confidence            32 3345678999999999986322  23456799999999999999999999976544433 23322222 23455677


Q ss_pred             CCChhHHHHHHHhcccCcCCCCC-HHHHhcCcccccCC
Q 020657          283 GASPEFRSFIECCLQKEFSKRWT-ASQLLTHPFLCKNR  319 (323)
Q Consensus       283 ~~~~~l~~ll~~~l~~~p~~Rpt-~~~~l~h~~f~~~~  319 (323)
                      .++.++.+||++||+.||++||+ ++++++||||+++.
T Consensus       242 ~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~  279 (384)
T 4fr4_A          242 AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN  279 (384)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred             cCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence            89999999999999999999998 89999999998763

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.7e-51  Score=361.11  Aligned_cols=263  Identities=29%  Similarity=0.469  Sum_probs=211.2

Q ss_pred             cchhccccccceeeeecccCCeEEEEEEec---ccCcEEEEEeecCCC---ChHHHHHHHHHHHHHHcCCCCccceecee
Q 020657           44 TTAAIAYSDLEKLQVLGHGNGGTVYKVQHR---CTHKIYALKVVHGDA---DPTVRRQVFREMEILRRTDSPFIVQCFGI  117 (323)
Q Consensus        44 ~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~---~~~~~v~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~  117 (323)
                      ....+..++|++.+.||+|+||.||+|++.   .+++.||+|++....   .......+.+|+.+++.++||||++++++
T Consensus        10 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   89 (327)
T 3a62_A           10 GPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYA   89 (327)
T ss_dssp             ---CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEE
T ss_pred             CCCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEE
Confidence            344567899999999999999999999985   589999999997542   22334567789999999999999999999


Q ss_pred             EEcCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCc
Q 020657          118 FEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGV  197 (323)
Q Consensus       118 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~  197 (323)
                      +.. .+..++||||+.+++|.+++...+.+++..++.++.||+.||.|||++|++||||||+||+++.++ .+||+|||+
T Consensus        90 ~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~  167 (327)
T 3a62_A           90 FQT-GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG-HVKLTDFGL  167 (327)
T ss_dssp             EEC-SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTS-CEEECCCSC
T ss_pred             EEc-CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCC-cEEEEeCCc
Confidence            987 678999999999999999998888899999999999999999999999999999999999999987 899999999


Q ss_pred             chhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCC
Q 020657          198 SKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP  277 (323)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~  277 (323)
                      +..............++..|+|||++...     .++.++||||||+++|+|++|..||......    .....+.. ..
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~i~~-~~  237 (327)
T 3a62_A          168 CKESIHDGTVTHTFCGTIEYMAPEILMRS-----GHNRAVDWWSLGALMYDMLTGAPPFTGENRK----KTIDKILK-CK  237 (327)
T ss_dssp             C----------CTTSSCCTTSCHHHHTTS-----CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHH-TC
T ss_pred             ccccccCCccccccCCCcCccCHhhCcCC-----CCCCcccchhHHHHHHHHHHCCCCCCCCCHH----HHHHHHHh-CC
Confidence            97654443444556789999999998643     3456999999999999999999999654332    22222222 23


Q ss_pred             CCCCCCCChhHHHHHHHhcccCcCCCC-----CHHHHhcCcccccC
Q 020657          278 PSLPDGASPEFRSFIECCLQKEFSKRW-----TASQLLTHPFLCKN  318 (323)
Q Consensus       278 ~~~~~~~~~~l~~ll~~~l~~~p~~Rp-----t~~~~l~h~~f~~~  318 (323)
                      ..++..++.++.+|+++||+.||++||     +++++++||||++.
T Consensus       238 ~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~  283 (327)
T 3a62_A          238 LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI  283 (327)
T ss_dssp             CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred             CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence            456678899999999999999999999     89999999999875

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.9e-51  Score=364.93  Aligned_cols=262  Identities=27%  Similarity=0.483  Sum_probs=215.3

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHH-HHcCCCCccceeceeEEcCC
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEI-LRRTDSPFIVQCFGIFEKPS  122 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~  122 (323)
                      ..+..++|++++.||+|+||.||+|++..+++.||+|++....  .......+.+|..+ ++.++||||+++++++.+ .
T Consensus        33 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~-~  111 (373)
T 2r5t_A           33 PHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-A  111 (373)
T ss_dssp             TTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC-S
T ss_pred             CCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe-C
Confidence            4567789999999999999999999999999999999996542  22334455667666 466899999999999998 6


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          123 GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      +.+++||||+.+++|.+++.+...+++..++.++.||+.||.|||++||+||||||+||+++.+| .+||+|||++....
T Consensus       112 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          112 DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG-HIVLTDFGLCKENI  190 (373)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCBCGGGB
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC-CEEEeeCccccccc
Confidence            88999999999999999999888899999999999999999999999999999999999999998 89999999998654


Q ss_pred             cCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCC
Q 020657          203 RSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPD  282 (323)
Q Consensus       203 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (323)
                      .........++|+.|+|||++....     ++.++||||||+++|||++|..||.....    ..+...+... ...++.
T Consensus       191 ~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~ell~G~~Pf~~~~~----~~~~~~i~~~-~~~~~~  260 (373)
T 2r5t_A          191 EHNSTTSTFCGTPEYLAPEVLHKQP-----YDRTVDWWCLGAVLYEMLYGLPPFYSRNT----AEMYDNILNK-PLQLKP  260 (373)
T ss_dssp             CCCCCCCSBSCCCCCCCHHHHTTCC-----CCTHHHHHHHHHHHHHHHHSSCTTCCSBH----HHHHHHHHHS-CCCCCS
T ss_pred             cCCCccccccCCccccCHHHhCCCC-----CCchhhhHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHhc-ccCCCC
Confidence            4444556678999999999987443     45699999999999999999999965433    3333333322 345667


Q ss_pred             CCChhHHHHHHHhcccCcCCCCCH----HHHhcCcccccCC
Q 020657          283 GASPEFRSFIECCLQKEFSKRWTA----SQLLTHPFLCKNR  319 (323)
Q Consensus       283 ~~~~~l~~ll~~~l~~~p~~Rpt~----~~~l~h~~f~~~~  319 (323)
                      .++.++.+|+++||+.||++||++    +++++||||+++.
T Consensus       261 ~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~  301 (373)
T 2r5t_A          261 NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN  301 (373)
T ss_dssp             SSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred             CCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence            899999999999999999999986    6999999998753

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=5.2e-51  Score=361.88  Aligned_cols=259  Identities=27%  Similarity=0.445  Sum_probs=219.4

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCCh-----HHHHHHHHHHHHHHcCCCCccceeceeEEcCCC
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADP-----TVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG  123 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  123 (323)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++......     .....+.+|+.+++.+.||||+++++++.+ ..
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~   88 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN-RT   88 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SS
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe-CC
Confidence            457899999999999999999999999999999999755322     134678899999999999999999999987 68


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCC---cEEEeecCcchh
Q 020657          124 DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNM---QVKIADFGVSKI  200 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~---~~kl~Dfg~~~~  200 (323)
                      .+++||||+.+++|.+++.....+++..+..++.||+.||.|||+.|++|+||||+||+++.++.   .+||+|||++..
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~  168 (361)
T 2yab_A           89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE  168 (361)
T ss_dssp             EEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence            89999999999999999988888999999999999999999999999999999999999987653   699999999976


Q ss_pred             hccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC---C
Q 020657          201 MCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD---P  277 (323)
Q Consensus       201 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~---~  277 (323)
                      .... .......+|+.|+|||++....     ++.++||||||+++|+|++|..||.+...    ..+...+....   +
T Consensus       169 ~~~~-~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslGvil~~ll~g~~Pf~~~~~----~~~~~~i~~~~~~~~  238 (361)
T 2yab_A          169 IEDG-VEFKNIFGTPEFVAPEIVNYEP-----LGLEADMWSIGVITYILLSGASPFLGDTK----QETLANITAVSYDFD  238 (361)
T ss_dssp             CCTT-CCCCCCCSCGGGCCHHHHTTCC-----CCTHHHHHHHHHHHHHHHHSCCSSCCSSH----HHHHHHHHTTCCCCC
T ss_pred             cCCC-CccccCCCCccEECchHHcCCC-----CCccccHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhcCCCCC
Confidence            6443 2234567999999999987443     45699999999999999999999965433    23333332222   1


Q ss_pred             CCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          278 PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       278 ~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      ...+..+++++.+||++||..||++|||++++|+||||++.
T Consensus       239 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  279 (361)
T 2yab_A          239 EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (361)
T ss_dssp             HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred             chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence            12235789999999999999999999999999999999864

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.3e-51  Score=373.28  Aligned_cols=261  Identities=27%  Similarity=0.401  Sum_probs=220.5

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEE
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIA  126 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  126 (323)
                      ...++|++.+.||+|+||.||+|.+..+++.+|+|++..... ......+.+|+.+++.++||||+++++++.+ ++..+
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~   86 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE-EGHHY   86 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC-SSEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE-CCEEE
Confidence            345789999999999999999999999999999999976543 3445678899999999999999999999987 78899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecC--CCcEEEeecCcchhhccC
Q 020657          127 ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNN--NMQVKIADFGVSKIMCRS  204 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~--~~~~kl~Dfg~~~~~~~~  204 (323)
                      +||||+.+++|.+.+.....+++..+..++.||+.||.|||+.|++||||||+||+++.+  +..+||+|||++......
T Consensus        87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~  166 (444)
T 3soa_A           87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE  166 (444)
T ss_dssp             EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred             EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence            999999999999999988889999999999999999999999999999999999999842  237999999999776655


Q ss_pred             ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC---CCCCC
Q 020657          205 LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD---PPSLP  281 (323)
Q Consensus       205 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~  281 (323)
                      ........+++.|+|||++....     ++.++||||||+++|+|++|..||.....    ..+...+..+.   +....
T Consensus       167 ~~~~~~~~gt~~Y~APE~l~~~~-----~~~~~DIwSlGvilyell~G~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~  237 (444)
T 3soa_A          167 QQAWFGFAGTPGYLSPEVLRKDP-----YGKPVDLWACGVILYILLVGYPPFWDEDQ----HRLYQQIKAGAYDFPSPEW  237 (444)
T ss_dssp             CCBCCCSCSCGGGCCHHHHTTCC-----BCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHTCCCCCTTTT
T ss_pred             CceeecccCCcccCCHHHhcCCC-----CCCccccHHHHHHHHHHHhCCCCCCCccH----HHHHHHHHhCCCCCCcccc
Confidence            55455678999999999987443     45699999999999999999999965433    33333333222   22333


Q ss_pred             CCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          282 DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       282 ~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      ..+++++.+|+++||+.||++|||++++|+||||++.
T Consensus       238 ~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          238 DTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence            5789999999999999999999999999999999653

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-51  Score=359.67  Aligned_cols=257  Identities=26%  Similarity=0.489  Sum_probs=219.8

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeE
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDI  125 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  125 (323)
                      +..++|++.+.||+|+||.||+|++..+++.||+|++....  .......+.+|..+++.++||||+++++++.+ ...+
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~   81 (318)
T 1fot_A            3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-AQQI   81 (318)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-SSEE
T ss_pred             CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe-CCEE
Confidence            45689999999999999999999999999999999986431  11224567789999999999999999999987 6789


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc
Q 020657          126 AILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL  205 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~  205 (323)
                      ++||||+.+++|.+++.....+++..++.++.||+.||.|||++|++||||||+||+++.++ .+||+|||++.....  
T Consensus        82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~Dfg~a~~~~~--  158 (318)
T 1fot_A           82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG-HIKITDFGFAKYVPD--  158 (318)
T ss_dssp             EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS-CEEECCCSSCEECSS--
T ss_pred             EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCC-CEEEeecCcceecCC--
Confidence            99999999999999999888899999999999999999999999999999999999999987 899999999976533  


Q ss_pred             cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCC
Q 020657          206 DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS  285 (323)
Q Consensus       206 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (323)
                       ......+|+.|+|||++....     ++.++||||||+++|+|++|..||.....    ......+... ...++..++
T Consensus       159 -~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~i~~~-~~~~p~~~~  227 (318)
T 1fot_A          159 -VTYTLCGTPDYIAPEVVSTKP-----YNKSIDWWSFGILIYEMLAGYTPFYDSNT----MKTYEKILNA-ELRFPPFFN  227 (318)
T ss_dssp             -CBCCCCSCTTTCCHHHHTTCC-----BCTTHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHHC-CCCCCTTSC
T ss_pred             -ccccccCCccccCHhHhcCCC-----CCcccchhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHHhC-CCCCCCCCC
Confidence             233567899999999987443     45699999999999999999999965433    2222333222 345677899


Q ss_pred             hhHHHHHHHhcccCcCCCC-----CHHHHhcCcccccCC
Q 020657          286 PEFRSFIECCLQKEFSKRW-----TASQLLTHPFLCKNR  319 (323)
Q Consensus       286 ~~l~~ll~~~l~~~p~~Rp-----t~~~~l~h~~f~~~~  319 (323)
                      .++.+|+++||+.||++||     +++++++||||+++.
T Consensus       228 ~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~  266 (318)
T 1fot_A          228 EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV  266 (318)
T ss_dssp             HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred             HHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence            9999999999999999999     999999999998753

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.7e-51  Score=353.69  Aligned_cols=260  Identities=25%  Similarity=0.413  Sum_probs=209.8

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      ++|++.+.||+|+||.||+|++ .+++.||+|++..... ......+.+|+.+++.++||||+++++++.+ .+..++||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~   79 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-KKRLVLVF   79 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-SSCEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc-CCeEEEEE
Confidence            6899999999999999999999 5789999999965532 2234567899999999999999999999987 67899999


Q ss_pred             eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          130 EYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       130 e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      ||+.+ +|.+++... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++ .+||+|||++..........
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~  157 (288)
T 1ob3_A           80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVRKY  157 (288)
T ss_dssp             ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCTTHHHHHCC-----
T ss_pred             EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEEeECccccccCcccccc
Confidence            99986 999888753 5799999999999999999999999999999999999999987 89999999998765444444


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCC-----------
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP-----------  277 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~-----------  277 (323)
                      ....++..|+|||++.+    ...++.++||||||+++|+|++|..||.+.........+.........           
T Consensus       158 ~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T 1ob3_A          158 THEIVTLWYRAPDVLMG----SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (288)
T ss_dssp             ----CCCTTCCHHHHTT----CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ccccccccccCchheeC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc
Confidence            45678999999999863    233567999999999999999999999765443333333322211100           


Q ss_pred             -------------CCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          278 -------------PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       278 -------------~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                                   ..+...+++++.+|+++||+.||++|||++++|+||||++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence                         01224678999999999999999999999999999999875

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.7e-51  Score=364.00  Aligned_cols=262  Identities=27%  Similarity=0.435  Sum_probs=220.2

Q ss_pred             chhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcC-CCCccceeceeEEcC
Q 020657           45 TAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKP  121 (323)
Q Consensus        45 ~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~  121 (323)
                      ...+..++|++.+.||+|+||.||+|++..+++.||+|++....  .......+..|..++..+ .||+|+++++++.+ 
T Consensus        14 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-   92 (353)
T 2i0e_A           14 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-   92 (353)
T ss_dssp             -----CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC-
T ss_pred             cCCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc-
Confidence            34466789999999999999999999999899999999986431  112245677899999887 79999999999997 


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhh
Q 020657          122 SGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM  201 (323)
Q Consensus       122 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~  201 (323)
                      .+.+++||||+++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+||+++.++ .+||+|||++...
T Consensus        93 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~vkL~DFG~a~~~  171 (353)
T 2i0e_A           93 MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKEN  171 (353)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCC-cEEEEeCCccccc
Confidence            678999999999999999999878899999999999999999999999999999999999999998 8999999999764


Q ss_pred             ccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCC
Q 020657          202 CRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLP  281 (323)
Q Consensus       202 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (323)
                      ..........+||+.|+|||++....     ++.++||||||+++|+|++|..||.....    ..+.+.+... ...++
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~ell~G~~Pf~~~~~----~~~~~~i~~~-~~~~p  241 (353)
T 2i0e_A          172 IWDGVTTKTFCGTPDYIAPEIIAYQP-----YGKSVDWWAFGVLLYEMLAGQAPFEGEDE----DELFQSIMEH-NVAYP  241 (353)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHTTCC-----BSTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHC-CCCCC
T ss_pred             ccCCcccccccCCccccChhhhcCCC-----cCCcccccchHHHHHHHHcCCCCCCCCCH----HHHHHHHHhC-CCCCC
Confidence            43344455678999999999987443     45699999999999999999999965433    3333333332 34567


Q ss_pred             CCCChhHHHHHHHhcccCcCCCCC-----HHHHhcCcccccC
Q 020657          282 DGASPEFRSFIECCLQKEFSKRWT-----ASQLLTHPFLCKN  318 (323)
Q Consensus       282 ~~~~~~l~~ll~~~l~~~p~~Rpt-----~~~~l~h~~f~~~  318 (323)
                      ..++.++.+|+++||+.||++||+     ++++++||||+++
T Consensus       242 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~  283 (353)
T 2i0e_A          242 KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  283 (353)
T ss_dssp             TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred             CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence            889999999999999999999994     6999999999875

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=4.3e-51  Score=363.10  Aligned_cols=263  Identities=29%  Similarity=0.433  Sum_probs=211.3

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEE
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++.....  ....+.+|+.+++.++||||+++++++.+ ....++
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~l   93 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA--IDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAI   93 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT--SCHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc--ccHHHHHHHHHHHhCCCCCCCcEEEEEee-CCEEEE
Confidence            456899999999999999999999999999999999975432  23557799999999999999999999987 678999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC-CcEEEeecCcchhhccCcc
Q 020657          128 LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN-MQVKIADFGVSKIMCRSLD  206 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~-~~~kl~Dfg~~~~~~~~~~  206 (323)
                      ||||+.+++|.+++...+.+++..++.++.||+.||.|||++|++||||||+||+++.++ ..+||+|||++...... .
T Consensus        94 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-~  172 (361)
T 3uc3_A           94 IMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S  172 (361)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred             EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-C
Confidence            999999999999998888899999999999999999999999999999999999998765 14999999998743222 2


Q ss_pred             ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC-CCCCCCCCC
Q 020657          207 ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD-PPSLPDGAS  285 (323)
Q Consensus       207 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  285 (323)
                      ......++..|+|||++.+..+.    +.++||||||+++|+|++|..||.............+.+.... .......++
T Consensus       173 ~~~~~~gt~~y~aPE~~~~~~~~----~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  248 (361)
T 3uc3_A          173 QPKSTVGTPAYIAPEVLLRQEYD----GKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRIS  248 (361)
T ss_dssp             --------CTTSCHHHHHCSSCC----HHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCC
T ss_pred             CCCCCcCCCCcCChhhhcCCCCC----CCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCC
Confidence            23445789999999998643322    2359999999999999999999987766666666555544332 222234689


Q ss_pred             hhHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          286 PEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       286 ~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      +++.+|+++||+.||++|||++++++||||.+.
T Consensus       249 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          249 PECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             HHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence            999999999999999999999999999999654

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.2e-51  Score=361.37  Aligned_cols=261  Identities=24%  Similarity=0.359  Sum_probs=216.5

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      .++|++.+.||+|+||.||+|++..+++.||+|++...........+.+|+.+++.++||||+++++++.+ .+..++||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~   84 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFL   84 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec-CCeEEEEE
Confidence            57899999999999999999999999999999999766554555678899999999999999999999987 68899999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC--ccc
Q 020657          130 EYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS--LDA  207 (323)
Q Consensus       130 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~--~~~  207 (323)
                      ||+++++|.+++.....+++..++.++.||+.||.|||+.|++|+||||+||+++.++ .+||+|||++......  ...
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~  163 (323)
T 3tki_A           85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERL  163 (323)
T ss_dssp             ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECEETTEECC
T ss_pred             EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCC-CEEEEEeeccceeccCCcccc
Confidence            9999999999998887899999999999999999999999999999999999999987 8999999999765432  222


Q ss_pred             cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChh
Q 020657          208 CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPE  287 (323)
Q Consensus       208 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (323)
                      .....++..|+|||++.+..    ..+.++||||||+++|+|++|..||.............  ............++.+
T Consensus       164 ~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  237 (323)
T 3tki_A          164 LNKMCGTLPYVAPELLKRRE----FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW--KEKKTYLNPWKKIDSA  237 (323)
T ss_dssp             BCSCCSCGGGSCHHHHHCSS----BCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHH--HTTCTTSTTGGGSCHH
T ss_pred             cCCCccCcCccCcHHhccCC----CCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH--hcccccCCccccCCHH
Confidence            34567899999999986332    23568999999999999999999997654433222211  1112222223568999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          288 FRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       288 l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      +.+|+++||+.||++|||++++++||||++.
T Consensus       238 ~~~li~~~L~~dP~~R~t~~eil~h~~~~~~  268 (323)
T 3tki_A          238 PLALLHKILVENPSARITIPDIKKDRWYNKP  268 (323)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             HHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence            9999999999999999999999999999764

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.2e-51  Score=354.91  Aligned_cols=264  Identities=28%  Similarity=0.463  Sum_probs=212.8

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCCh-------------------------HHHHHHHHHH
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADP-------------------------TVRRQVFREM  100 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~-------------------------~~~~~~~~e~  100 (323)
                      ..+..++|++.+.||+|+||.||+|.+..+++.||+|++......                         ...+.+.+|+
T Consensus         8 ~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~   87 (298)
T 2zv2_A            8 DCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEI   87 (298)
T ss_dssp             --CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHH
T ss_pred             CceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHH
Confidence            445678999999999999999999999999999999999754211                         1235688999


Q ss_pred             HHHHcCCCCccceeceeEEcC-CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 020657          101 EILRRTDSPFIVQCFGIFEKP-SGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPS  179 (323)
Q Consensus       101 ~~l~~l~h~~i~~~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~  179 (323)
                      .+++.++||||+++++++.+. ....++||||+++++|.+++. ...+++..++.++.||+.||.|||+.|++|+||||+
T Consensus        88 ~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~  166 (298)
T 2zv2_A           88 AILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS  166 (298)
T ss_dssp             HHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred             HHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence            999999999999999999863 567899999999999987654 347999999999999999999999999999999999


Q ss_pred             CeEEecCCCcEEEeecCcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 020657          180 NLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQP  259 (323)
Q Consensus       180 nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~  259 (323)
                      ||+++.++ .+||+|||++..............++..|+|||++.....  ...+.++||||||+++|+|++|..||...
T Consensus       167 Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~  243 (298)
T 2zv2_A          167 NLLVGEDG-HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRK--IFSGKALDVWAMGVTLYCFVFGQCPFMDE  243 (298)
T ss_dssp             GEEECTTS-CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCC--CEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             HEEECCCC-CEEEecCCCccccccccccccCCcCCccccChhhhccCCC--CCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence            99999987 8999999999876554444455679999999999863321  12356899999999999999999999543


Q ss_pred             CCCccHHHHHHHHhcCC-CCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          260 GQRPDWATLMCAICFGD-PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       260 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                      .    ...+...+.... .......+++++.+|+.+||+.||++|||++++++||||.+
T Consensus       244 ~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          244 R----IMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             S----HHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             c----HHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence            2    223322222222 22233578999999999999999999999999999999963

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.7e-51  Score=356.54  Aligned_cols=265  Identities=26%  Similarity=0.421  Sum_probs=214.1

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      .++|++.+.||+|++|.||+|.+..+++.||+|++..... ....+.+.+|+.+++.++||||+++++++.. .+..++|
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv   80 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR-KRRLHLV   80 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec-CCeEEEE
Confidence            4689999999999999999999998999999999876543 4456778899999999999999999999987 6889999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          129 MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      |||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++..........
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~  159 (311)
T 4agu_A           81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHS-VIKLCDFGFARLLTGPSDYY  159 (311)
T ss_dssp             EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECC------
T ss_pred             EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCC-CEEEeeCCCchhccCccccc
Confidence            99999999999998888899999999999999999999999999999999999999987 89999999997765444444


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcC-------------
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFG-------------  275 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~-------------  275 (323)
                      ....++..|+|||++.+    ...++.++||||||+++|+|++|..||.+.........+.......             
T Consensus       160 ~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (311)
T 4agu_A          160 DDEVATRWYRSPELLVG----DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY  235 (311)
T ss_dssp             ------GGGCCHHHHHT----CSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred             CCCcCCccccChHHHhc----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence            55678999999999853    2345679999999999999999999996654433333222211100             


Q ss_pred             ---CC----CC------CCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          276 ---DP----PS------LPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       276 ---~~----~~------~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                         ..    ..      ....++.++.+|+++||+.||++|||++++|+||||++.+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  293 (311)
T 4agu_A          236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE  293 (311)
T ss_dssp             GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred             cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence               00    00      01357889999999999999999999999999999998764

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=8.7e-51  Score=357.85  Aligned_cols=265  Identities=25%  Similarity=0.396  Sum_probs=225.9

Q ss_pred             cchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCC--CChHHHHHHHHHHHHHHcCCCCccceeceeEEcC
Q 020657           44 TTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP  121 (323)
Q Consensus        44 ~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  121 (323)
                      .......++|++.+.||+|+||.||+|.+..+++.+++|++...  ........+.+|+.+++.++|+||+++++++.+ 
T Consensus        34 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-  112 (335)
T 2owb_A           34 LVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-  112 (335)
T ss_dssp             EEETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred             ecCcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-
Confidence            33445678999999999999999999999999999999998654  244567788999999999999999999999987 


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhh
Q 020657          122 SGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM  201 (323)
Q Consensus       122 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~  201 (323)
                      .+..++||||+.+++|.+++.....+++..++.++.||+.||.|||++|++|+||||+||+++.++ .+||+|||++...
T Consensus       113 ~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~~  191 (335)
T 2owb_A          113 NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKV  191 (335)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             CCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCC-CEEEeeccCceec
Confidence            678999999999999999998888899999999999999999999999999999999999999987 8999999999776


Q ss_pred             ccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCC
Q 020657          202 CRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLP  281 (323)
Q Consensus       202 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (323)
                      ...........++..|+|||++...     .++.++||||||+++|+|++|..||......    .....+... ...++
T Consensus       192 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~-~~~~~  261 (335)
T 2owb_A          192 EYDGERKKVLCGTPNYIAPEVLSKK-----GHSFEVDVWSIGCIMYTLLVGKPPFETSCLK----ETYLRIKKN-EYSIP  261 (335)
T ss_dssp             CSTTCCBCCCCSCCSSCCHHHHHTS-----CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHHT-CCCCC
T ss_pred             ccCcccccccCCCccccCHHHhccC-----CCCchhhHHHHHHHHHHHHHCcCCCCCCCHH----HHHHHHhcC-CCCCC
Confidence            5444444556789999999998643     3456999999999999999999999554322    222222222 33466


Q ss_pred             CCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          282 DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       282 ~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                      ..++.++.+|+++||+.||++|||++++++|+||.+...
T Consensus       262 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~  300 (335)
T 2owb_A          262 KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI  300 (335)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence            788999999999999999999999999999999987543

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.7e-51  Score=375.91  Aligned_cols=262  Identities=26%  Similarity=0.507  Sum_probs=213.4

Q ss_pred             chhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCC--CChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC
Q 020657           45 TAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS  122 (323)
Q Consensus        45 ~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  122 (323)
                      ...+..++|++.+.||+|+||.||+|.+..+++.||+|++...  ........+.+|+.+++.++||||+++++++.. .
T Consensus       142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-~  220 (446)
T 4ejn_A          142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-H  220 (446)
T ss_dssp             --CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE-T
T ss_pred             ccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee-C
Confidence            3456678999999999999999999999999999999998643  223344567789999999999999999999987 6


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCCeEEecCCCcEEEeecCcchhh
Q 020657          123 GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG-HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM  201 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~  201 (323)
                      +.+++||||+++++|.+++.....+++..+..++.||+.||.|||+ .||+||||||+||+++.++ .+||+|||++...
T Consensus       221 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~-~~kl~DFG~a~~~  299 (446)
T 4ejn_A          221 DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEG  299 (446)
T ss_dssp             TEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS-CEEECCCCCCCTT
T ss_pred             CEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC-CEEEccCCCceec
Confidence            7899999999999999999888899999999999999999999998 9999999999999999987 8999999999765


Q ss_pred             ccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCC
Q 020657          202 CRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLP  281 (323)
Q Consensus       202 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (323)
                      ...........+|..|+|||++...     .++.++||||||+++|+|++|..||.....    ..+...+... ...++
T Consensus       300 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~ell~g~~Pf~~~~~----~~~~~~i~~~-~~~~p  369 (446)
T 4ejn_A          300 IKDGATMKTFCGTPEYLAPEVLEDN-----DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKLFELILME-EIRFP  369 (446)
T ss_dssp             CC-----CCSSSCGGGCCHHHHHTS-----CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHC-CCCCC
T ss_pred             cCCCcccccccCCccccCHhhcCCC-----CCCCccchhhhHHHHHHHhhCCCCCCCCCH----HHHHHHHHhC-CCCCC
Confidence            4444445567899999999998643     345699999999999999999999965433    3333333222 34567


Q ss_pred             CCCChhHHHHHHHhcccCcCCCC-----CHHHHhcCcccccC
Q 020657          282 DGASPEFRSFIECCLQKEFSKRW-----TASQLLTHPFLCKN  318 (323)
Q Consensus       282 ~~~~~~l~~ll~~~l~~~p~~Rp-----t~~~~l~h~~f~~~  318 (323)
                      ..+++++.+||.+||+.||++||     |++++++||||++.
T Consensus       370 ~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~  411 (446)
T 4ejn_A          370 RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI  411 (446)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence            78999999999999999999999     99999999999876

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=5.7e-52  Score=376.03  Aligned_cols=272  Identities=24%  Similarity=0.374  Sum_probs=223.2

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC--hHHHHHHHHHHHHHHcCCCCccceeceeEEcCCC
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD--PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG  123 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  123 (323)
                      ..+..++|++.+.||+|+||.||+|++..+++.||+|++.....  ......+.+|..++..+.||||+++++++.+ .+
T Consensus        69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~-~~  147 (437)
T 4aw2_A           69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD-DN  147 (437)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC-SS
T ss_pred             ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-CC
Confidence            34567899999999999999999999998999999999863210  0112236789999999999999999999998 68


Q ss_pred             eEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          124 DIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      .+++||||+.+++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++ .+||+|||++....
T Consensus       148 ~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g-~vkL~DFGla~~~~  226 (437)
T 4aw2_A          148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG-HIRLADFGSCLKLM  226 (437)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECC
T ss_pred             EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCC-CEEEcchhhhhhcc
Confidence            89999999999999999987 56899999999999999999999999999999999999999998 89999999997654


Q ss_pred             cCcc-ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCC
Q 020657          203 RSLD-ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLP  281 (323)
Q Consensus       203 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (323)
                      .... .....+||+.|+|||++.....+...++.++||||||+++|||++|..||.+.+.......+.........+...
T Consensus       227 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  306 (437)
T 4aw2_A          227 EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQV  306 (437)
T ss_dssp             TTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSC
T ss_pred             cCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCccc
Confidence            3322 233467999999999986221123345669999999999999999999997655444444444333223334444


Q ss_pred             CCCChhHHHHHHHhcccCcCC--CCCHHHHhcCcccccCC
Q 020657          282 DGASPEFRSFIECCLQKEFSK--RWTASQLLTHPFLCKNR  319 (323)
Q Consensus       282 ~~~~~~l~~ll~~~l~~~p~~--Rpt~~~~l~h~~f~~~~  319 (323)
                      ..+++++.+||++||+.+|++  |++++++++||||+++.
T Consensus       307 ~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~  346 (437)
T 4aw2_A          307 TDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGID  346 (437)
T ss_dssp             CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred             ccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCC
Confidence            568999999999999988888  99999999999998764

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=8.3e-51  Score=359.44  Aligned_cols=256  Identities=26%  Similarity=0.478  Sum_probs=220.5

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeE
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDI  125 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  125 (323)
                      ...++|++++.||+|+||.||+|++..+++.||+|++....  .......+.+|+.+++.++||||+++++++.+ ...+
T Consensus        38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~  116 (350)
T 1rdq_E           38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-NSNL  116 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEE
T ss_pred             CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-CCEE
Confidence            45689999999999999999999999999999999986431  11234567889999999999999999999997 6789


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc
Q 020657          126 AILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL  205 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~  205 (323)
                      ++||||+++++|.+++...+.+++..++.++.||+.||.|||++|++||||||+||+++.++ .+||+|||++...... 
T Consensus       117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~DFg~a~~~~~~-  194 (350)
T 1rdq_E          117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG-YIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECSSC-
T ss_pred             EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCC-CEEEcccccceeccCC-
Confidence            99999999999999999888899999999999999999999999999999999999999987 8999999999765432 


Q ss_pred             cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCC
Q 020657          206 DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS  285 (323)
Q Consensus       206 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (323)
                        .....+|+.|+|||++....     ++.++||||||+++|+|++|..||.....    ..+...+..+ ...++..++
T Consensus       195 --~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~ell~g~~Pf~~~~~----~~~~~~i~~~-~~~~p~~~~  262 (350)
T 1rdq_E          195 --TWTLCGTPEALAPEIILSKG-----YNKAVDWWALGVLIYEMAAGYPPFFADQP----IQIYEKIVSG-KVRFPSHFS  262 (350)
T ss_dssp             --BCCCEECGGGCCHHHHTTCC-----BCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHC-CCCCCTTCC
T ss_pred             --cccccCCccccCHHHhcCCC-----CCCcCCEecccHhHhHHhhCCCCCCCCCH----HHHHHHHHcC-CCCCCCCCC
Confidence              23567899999999987443     45699999999999999999999965432    3333333333 345677899


Q ss_pred             hhHHHHHHHhcccCcCCCCC-----HHHHhcCcccccC
Q 020657          286 PEFRSFIECCLQKEFSKRWT-----ASQLLTHPFLCKN  318 (323)
Q Consensus       286 ~~l~~ll~~~l~~~p~~Rpt-----~~~~l~h~~f~~~  318 (323)
                      .++.+|+++||+.||++||+     ++++++||||++.
T Consensus       263 ~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~  300 (350)
T 1rdq_E          263 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             HHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence            99999999999999999998     9999999999875

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=8.8e-52  Score=363.37  Aligned_cols=258  Identities=28%  Similarity=0.442  Sum_probs=216.8

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeE
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDI  125 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  125 (323)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++....  .......+.+|+.+++.++||||+++++++.+ ....
T Consensus         6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~   84 (336)
T 3h4j_B            6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT-PTDI   84 (336)
T ss_dssp             SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEE
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEE
Confidence            34688999999999999999999999999999999986331  11123467899999999999999999999998 6789


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc
Q 020657          126 AILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL  205 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~  205 (323)
                      ++||||+ +++|.+.+...+.+++..++.++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++...... 
T Consensus        85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kl~DFG~s~~~~~~-  161 (336)
T 3h4j_B           85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNL-NVKIADFGLSNIMTDG-  161 (336)
T ss_dssp             EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTC-CEEECCSSCTBTTTTS-
T ss_pred             EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCC-CEEEEEeccceeccCC-
Confidence            9999999 569999988888899999999999999999999999999999999999999987 8999999999765433 


Q ss_pred             cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCC
Q 020657          206 DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS  285 (323)
Q Consensus       206 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (323)
                      .......+++.|+|||++.+..+    .+.++||||||+++|+|++|..||...........+     ......++..++
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~----~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i-----~~~~~~~p~~~s  232 (336)
T 3h4j_B          162 NFLKTSCGSPNYAAPEVINGKLY----AGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV-----NSCVYVMPDFLS  232 (336)
T ss_dssp             BTTCCCTTSTTTSCGGGSCCSGG----GCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC-----CSSCCCCCTTSC
T ss_pred             cccccccCCcCcCCHHHHcCCCC----CCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH-----HcCCCCCcccCC
Confidence            23345679999999999864332    256999999999999999999999765433211111     112344567789


Q ss_pred             hhHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          286 PEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       286 ~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      +++.+|+++||+.||.+|||++++++||||+..
T Consensus       233 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          233 PGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence            999999999999999999999999999999754

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.1e-50  Score=358.95  Aligned_cols=261  Identities=30%  Similarity=0.435  Sum_probs=204.8

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeE
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDI  125 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  125 (323)
                      .....++|++.+.||+|+||.||+|.+..+++.||+|++....   ..+.+.+|+.++++++||||+++++++.. .+..
T Consensus        48 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~  123 (349)
T 2w4o_A           48 RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFET-PTEI  123 (349)
T ss_dssp             CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEEC-SSEE
T ss_pred             cccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEec-CCeE
Confidence            3455678999999999999999999999899999999997543   23567789999999999999999999987 6789


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEec---CCCcEEEeecCcchhhc
Q 020657          126 AILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNN---NNMQVKIADFGVSKIMC  202 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~---~~~~~kl~Dfg~~~~~~  202 (323)
                      ++||||+.+++|.+++...+.+++..++.++.||+.||.|||+.|++||||||+||+++.   ++ .+||+|||++....
T Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~-~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          124 SLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDA-PLKIADFGLSKIVE  202 (349)
T ss_dssp             EEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTC-CEEECCCC------
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCC-CEEEccCccccccC
Confidence            999999999999999988888999999999999999999999999999999999999975   55 89999999997654


Q ss_pred             cCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC---CCC
Q 020657          203 RSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD---PPS  279 (323)
Q Consensus       203 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~  279 (323)
                      .. .......++..|+|||++.+.     .++.++||||||+++|+|++|..||.......   .+...+....   ...
T Consensus       203 ~~-~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~~i~~~~~~~~~~  273 (349)
T 2w4o_A          203 HQ-VLMKTVCGTPGYCAPEILRGC-----AYGPEVDMWSVGIITYILLCGFEPFYDERGDQ---FMFRRILNCEYYFISP  273 (349)
T ss_dssp             -----------CGGGSCHHHHTTC-----CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH---HHHHHHHTTCCCCCTT
T ss_pred             cc-cccccccCCCCccCHHHhcCC-----CCCcccchHHHHHHHHHHHhCCCCCCCCcccH---HHHHHHHhCCCccCCc
Confidence            32 223345789999999998743     34669999999999999999999996554332   2222222222   223


Q ss_pred             CCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          280 LPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       280 ~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                      ....++.++.+|+++||+.||++|||++++|+||||.+...
T Consensus       274 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  314 (349)
T 2w4o_A          274 WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAA  314 (349)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred             hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCcc
Confidence            34678999999999999999999999999999999987653

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.8e-51  Score=360.65  Aligned_cols=262  Identities=24%  Similarity=0.369  Sum_probs=207.4

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEe
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILME  130 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e  130 (323)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+|+.+++.++||||+++++++.. .+..++|||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e   80 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-EKSLTLVFE   80 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEEC-SSCEEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEee-CCEEEEEec
Confidence            6899999999999999999999989999999999755433333345679999999999999999999987 678999999


Q ss_pred             ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccc
Q 020657          131 YMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN  209 (323)
Q Consensus       131 ~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~  209 (323)
                      |+++ +|.+++... ..+++..+..++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++...........
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~~~~~~~  158 (324)
T 3mtl_A           81 YLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERG-ELKLADFGLARAKSIPTKTYD  158 (324)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTC-CEEECSSSEEECC--------
T ss_pred             cccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCC-CEEEccCcccccccCCccccc
Confidence            9985 888888754 4699999999999999999999999999999999999999987 899999999976654444445


Q ss_pred             cccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCC----------
Q 020657          210 SYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPS----------  279 (323)
Q Consensus       210 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----------  279 (323)
                      ...++..|+|||++.+    ...++.++||||||+++|+|++|..||.+.........+...........          
T Consensus       159 ~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (324)
T 3mtl_A          159 NEVVTLWYRPPDILLG----STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  234 (324)
T ss_dssp             ----CGGGCCHHHHTT----CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred             cccCcccccChhhhcC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence            5678999999999863    23456799999999999999999999976554443333333222211111          


Q ss_pred             ---------------CCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          280 ---------------LPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       280 ---------------~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                                     ....+++++.+|+++||+.||++|||++++|+||||.+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  289 (324)
T 3mtl_A          235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG  289 (324)
T ss_dssp             HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence                           1135788999999999999999999999999999998764

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3e-50  Score=361.53  Aligned_cols=271  Identities=24%  Similarity=0.318  Sum_probs=218.3

Q ss_pred             chhccccccceeeeeccc--CCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcC
Q 020657           45 TAAIAYSDLEKLQVLGHG--NGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP  121 (323)
Q Consensus        45 ~~~~~~~~~~~~~~lg~G--~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  121 (323)
                      ......++|++.+.||+|  +||.||+|++..+++.||+|++.... .......+.+|+.+++.++||||+++++++.+ 
T Consensus        19 ~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-   97 (389)
T 3gni_B           19 SFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-   97 (389)
T ss_dssp             CCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-
T ss_pred             cccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE-
Confidence            344567899999999999  99999999999999999999997553 34566788899999999999999999999997 


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcch
Q 020657          122 SGDIAILMEYMDSGTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       122 ~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                      .+..++||||+.+++|.+++...  ..+++..+..++.||+.||.|||+.||+||||||+||+++.++ .+||+|||.+.
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~-~~kl~dfg~~~  176 (389)
T 3gni_B           98 DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG-KVYLSGLRSNL  176 (389)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCGGGCE
T ss_pred             CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEcccccce
Confidence            68899999999999999999765  6799999999999999999999999999999999999999987 89999999886


Q ss_pred             hhccCc-------cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHH
Q 020657          200 IMCRSL-------DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAI  272 (323)
Q Consensus       200 ~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~  272 (323)
                      ......       .......++..|+|||++...   ...++.++||||||+++|+|++|..||.+..............
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  253 (389)
T 3gni_B          177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQN---LQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT  253 (389)
T ss_dssp             ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTT---SSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----
T ss_pred             eeccccccccccccccccccccccccCHHHHhcc---CCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence            543211       112234788999999998742   1335669999999999999999999997655443322211100


Q ss_pred             hc-----------------------------------------CCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          273 CF-----------------------------------------GDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       273 ~~-----------------------------------------~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ..                                         .....++..+++++.+||++||+.||++|||++++|+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             ----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            00                                         0011234568899999999999999999999999999


Q ss_pred             CcccccCCC
Q 020657          312 HPFLCKNRR  320 (323)
Q Consensus       312 h~~f~~~~~  320 (323)
                      ||||++.+.
T Consensus       334 hp~f~~~~~  342 (389)
T 3gni_B          334 HSFFKQIKR  342 (389)
T ss_dssp             SGGGGGC--
T ss_pred             CHHHHHHhh
Confidence            999988654

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.8e-51  Score=362.26  Aligned_cols=261  Identities=27%  Similarity=0.393  Sum_probs=216.3

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCC----CChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD----ADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS  122 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  122 (323)
                      .+..++|++.+.||+|+||.||+|.+..+++.||+|++...    ......+.+.+|+.+++.++||||+++++++.+ .
T Consensus        20 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~   98 (351)
T 3c0i_A           20 VLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS-D   98 (351)
T ss_dssp             CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-T
T ss_pred             CccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe-C
Confidence            34567899999999999999999999999999999998532    111234678899999999999999999999987 6


Q ss_pred             CeEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC--CcEEEeecC
Q 020657          123 GDIAILMEYMDSGTLDTLLNK----NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN--MQVKIADFG  196 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~--~~~kl~Dfg  196 (323)
                      +.+++||||+++++|.+.+..    ...+++..+..++.||+.||.|||++|++||||||+||+++.++  ..+||+|||
T Consensus        99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A           99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence            889999999999999887753    23589999999999999999999999999999999999998654  249999999


Q ss_pred             cchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC
Q 020657          197 VSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD  276 (323)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~  276 (323)
                      ++..............+|+.|+|||++....     ++.++||||||+++|+|++|..||.+..     ..+...+....
T Consensus       179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~i~~~~  248 (351)
T 3c0i_A          179 VAIQLGESGLVAGGRVGTPHFMAPEVVKREP-----YGKPVDVWGCGVILFILLSGCLPFYGTK-----ERLFEGIIKGK  248 (351)
T ss_dssp             TCEECCTTSCBCCCCCSCGGGCCHHHHTTCC-----BCTHHHHHHHHHHHHHHHHSSCSSCSSH-----HHHHHHHHHTC
T ss_pred             ceeEecCCCeeecCCcCCcCccCHHHHcCCC-----CCchHhhHHHHHHHHHHHHCCCCCCCcH-----HHHHHHHHcCC
Confidence            9987655444445667999999999987443     4569999999999999999999996531     22333333222


Q ss_pred             CCC---CCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          277 PPS---LPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       277 ~~~---~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      ...   ....++.++.+|+++||+.||++|||+.++|+||||++.
T Consensus       249 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          249 YKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             CCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence            221   125789999999999999999999999999999999864

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.9e-50  Score=357.74  Aligned_cols=260  Identities=29%  Similarity=0.451  Sum_probs=219.7

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEE
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIA  126 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  126 (323)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.++||||+++++++.+ .+..+
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~  104 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ESFHY  104 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEE
Confidence            34578999999999999999999999999999999997553 34556778899999999999999999999987 68899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC--CcEEEeecCcchhhccC
Q 020657          127 ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN--MQVKIADFGVSKIMCRS  204 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~--~~~kl~Dfg~~~~~~~~  204 (323)
                      +||||+.+++|.+.+.....+++..+..++.||+.||.|||+.|++|+||||+||+++.++  ..+||+|||++......
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~  184 (362)
T 2bdw_A          105 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  184 (362)
T ss_dssp             EEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred             EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence            9999999999999998888899999999999999999999999999999999999998653  25999999999765433


Q ss_pred             ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC---CCCCC
Q 020657          205 LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD---PPSLP  281 (323)
Q Consensus       205 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~  281 (323)
                       .......+++.|+|||++...     .++.++||||||+++|+|++|..||.....    ..+...+..+.   +....
T Consensus       185 -~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~~ll~g~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~  254 (362)
T 2bdw_A          185 -EAWHGFAGTPGYLSPEVLKKD-----PYSKPVDIWACGVILYILLVGYPPFWDEDQ----HRLYAQIKAGAYDYPSPEW  254 (362)
T ss_dssp             -CSCCCSCSCTTTCCHHHHTTC-----CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHTCCCCCTTGG
T ss_pred             -cccccCCCCccccCHHHHccC-----CCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHhCCCCCCcccc
Confidence             223456799999999998743     345699999999999999999999965433    23333332222   12222


Q ss_pred             CCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          282 DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       282 ~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      ..+++++.+|+.+||+.||++|||++++|+||||.+.
T Consensus       255 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          255 DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence            4689999999999999999999999999999999753

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-50  Score=355.59  Aligned_cols=263  Identities=25%  Similarity=0.434  Sum_probs=218.2

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCCh-----HHHHHHHHHHHHHHcCCCCccceeceeEEcCCC
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADP-----TVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG  123 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  123 (323)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++......     .....+.+|+.+++.++||||+++++++.+ ..
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~   87 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN-KT   87 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SS
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CC
Confidence            457899999999999999999999999999999999755321     135678899999999999999999999987 67


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCC---cEEEeecCcchh
Q 020657          124 DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNM---QVKIADFGVSKI  200 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~---~~kl~Dfg~~~~  200 (323)
                      ..++||||+.+++|.+++.....+++..++.++.||+.||.|||+.|++|+||||+||+++.++.   .+||+|||++..
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~  167 (326)
T 2y0a_A           88 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK  167 (326)
T ss_dssp             EEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             EEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence            89999999999999999988888999999999999999999999999999999999999987652   699999999976


Q ss_pred             hccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCC
Q 020657          201 MCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSL  280 (323)
Q Consensus       201 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  280 (323)
                      .... .......+++.|+|||++...     .++.++||||||+++|+|++|..||.+.........+.. .....+...
T Consensus       168 ~~~~-~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~  240 (326)
T 2y0a_A          168 IDFG-NEFKNIFGTPEFVAPEIVNYE-----PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA-VNYEFEDEY  240 (326)
T ss_dssp             CCTT-SCCCCCCSCTTTCCHHHHTTC-----CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH-TCCCCCHHH
T ss_pred             CCCC-CccccccCCcCcCCceeecCC-----CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHh-cCCCcCccc
Confidence            6432 223456789999999998643     345699999999999999999999965433222222211 111111122


Q ss_pred             CCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          281 PDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       281 ~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      ...++..+.+|+++||+.||++|||++++|+||||++..
T Consensus       241 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred             cccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence            357899999999999999999999999999999998653

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-50  Score=353.60  Aligned_cols=255  Identities=26%  Similarity=0.382  Sum_probs=215.8

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      .++|++.+.||+|+||.||+|.+..+++.+++|++....  .....+.+|+.+++.++||||+++++++.+ .+..++||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~   80 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFES-MEELVMIF   80 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEec-CCEEEEEE
Confidence            578999999999999999999999999999999996443  445668899999999999999999999987 67899999


Q ss_pred             eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEec--CCCcEEEeecCcchhhccCcc
Q 020657          130 EYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNN--NNMQVKIADFGVSKIMCRSLD  206 (323)
Q Consensus       130 e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~--~~~~~kl~Dfg~~~~~~~~~~  206 (323)
                      ||+++++|.+.+... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.  ++ .+||+|||++...... .
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~-~~kl~Dfg~a~~~~~~-~  158 (321)
T 1tki_A           81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSS-TIKIIEFGQARQLKPG-D  158 (321)
T ss_dssp             CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCC-CEEECCCTTCEECCTT-C
T ss_pred             EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCC-CEEEEECCCCeECCCC-C
Confidence            999999999999765 47999999999999999999999999999999999999987  55 8999999999765433 2


Q ss_pred             ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCC---CCCC
Q 020657          207 ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPS---LPDG  283 (323)
Q Consensus       207 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~  283 (323)
                      ......+++.|+|||++...     .++.++||||||+++|+|++|..||.....    ..+...+.......   ....
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~  229 (321)
T 1tki_A          159 NFRLLFTAPEYYAPEVHQHD-----VVSTATDMWSLGTLVYVLLSGINPFLAETN----QQIIENIMNAEYTFDEEAFKE  229 (321)
T ss_dssp             EEEEEESCGGGSCHHHHTTC-----EECHHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHHTCCCCCHHHHTT
T ss_pred             ccccccCChhhcCcHHhcCC-----CCCchhhHHHHHHHHHHHHhCCCCCcCCCH----HHHHHHHHcCCCCCChhhhcc
Confidence            23445689999999998643     345699999999999999999999965433    23333333222211   1247


Q ss_pred             CChhHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          284 ASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       284 ~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      ++.++.+|+++||..||++|||++++|+||||++.
T Consensus       230 ~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          230 ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence            89999999999999999999999999999999765

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5.9e-50  Score=350.41  Aligned_cols=259  Identities=28%  Similarity=0.522  Sum_probs=218.4

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEec
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEY  131 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~  131 (323)
                      .|.....||+|+||.||+|++..+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.. .+..++||||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~  123 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHFNVVEMYKSYLV-GEELWVLMEF  123 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CSHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEECC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCcceEEEEEEE-CCEEEEEEec
Confidence            47888899999999999999988999999999975543 234667899999999999999999999987 6789999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccccc
Q 020657          132 MDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSY  211 (323)
Q Consensus       132 ~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  211 (323)
                      +++++|.+++.. ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++ .+||+|||++.............
T Consensus       124 ~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~  201 (321)
T 2c30_A          124 LQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKSL  201 (321)
T ss_dssp             CCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSSSCCBCCC
T ss_pred             CCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-cEEEeeeeeeeecccCccccccc
Confidence            999999999875 4699999999999999999999999999999999999999987 89999999997765544444566


Q ss_pred             cccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCC--CCCCChhHH
Q 020657          212 VGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSL--PDGASPEFR  289 (323)
Q Consensus       212 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~  289 (323)
                      .++..|+|||++...     .++.++||||||+++|+|++|..||.....    ......+.....+.+  ...+++++.
T Consensus       202 ~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~il~el~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~  272 (321)
T 2c30_A          202 VGTPYWMAPEVISRS-----LYATEVDIWSLGIMVIEMVDGEPPYFSDSP----VQAMKRLRDSPPPKLKNSHKVSPVLR  272 (321)
T ss_dssp             CSCGGGCCHHHHTTC-----CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHHSSCCCCTTGGGSCHHHH
T ss_pred             cCCccccCHhhhcCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhcCCCCCcCccccCCHHHH
Confidence            899999999998643     345699999999999999999999965432    222223333333222  346789999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCcccccCCCCCC
Q 020657          290 SFIECCLQKEFSKRWTASQLLTHPFLCKNRRSDC  323 (323)
Q Consensus       290 ~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~~~  323 (323)
                      +|+.+||+.||++|||++++++||||.+...+.|
T Consensus       273 ~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~~  306 (321)
T 2c30_A          273 DFLERMLVRDPQERATAQELLDHPFLLQTGLPEC  306 (321)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHTSGGGGGCCCGGG
T ss_pred             HHHHHHccCChhhCcCHHHHhcChhhccCCCccc
Confidence            9999999999999999999999999987765543

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=6.2e-50  Score=344.28  Aligned_cols=264  Identities=28%  Similarity=0.457  Sum_probs=220.7

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      ..++|++.+.||+|++|.||+|.+..+++.|++|++.... .......+.+|+.+++.++||||+++++++.. .+..++
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~   82 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ESFHYL   82 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc-CCEEEE
Confidence            3588999999999999999999999999999999997543 44556778899999999999999999999987 678999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC--CcEEEeecCcchhhccCc
Q 020657          128 LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN--MQVKIADFGVSKIMCRSL  205 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~--~~~kl~Dfg~~~~~~~~~  205 (323)
                      ||||+.+++|.+.+.....+++..+..++.||+.||.|||+.|++|+||||+||+++.++  ..+||+|||++...... 
T Consensus        83 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~-  161 (284)
T 3kk8_A           83 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-  161 (284)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS-
T ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC-
Confidence            999999999999998888899999999999999999999999999999999999998654  24999999999765433 


Q ss_pred             cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCC
Q 020657          206 DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS  285 (323)
Q Consensus       206 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (323)
                      .......++..|+|||++....     ++.++||||||+++|+|++|..||...........+... ....+......++
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  235 (284)
T 3kk8_A          162 EAWHGFAGTPGYLSPEVLKKDP-----YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG-AYDYPSPEWDTVT  235 (284)
T ss_dssp             CBCCCSCSCGGGCCHHHHTTCC-----BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-CCCCCTTTTTTSC
T ss_pred             ccccCCCCCcCCcCchhhcCCC-----CCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhc-cccCCchhhcccC
Confidence            2234567899999999987443     456999999999999999999999654332222222111 1112233335789


Q ss_pred             hhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          286 PEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       286 ~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                      +++.+|+++||+.||++|||++++++||||.+.++
T Consensus       236 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (284)
T 3kk8_A          236 PEAKSLIDSMLTVNPKKRITADQALKVPWICNRER  270 (284)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred             HHHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence            99999999999999999999999999999988765

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=6.4e-51  Score=358.15  Aligned_cols=270  Identities=26%  Similarity=0.388  Sum_probs=216.8

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcC
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP  121 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  121 (323)
                      ........++|++.+.||+|+||.||+|++..+++.||+|++.... .......+.+|+.+++.++||||+++++++.. 
T Consensus        17 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-   95 (331)
T 4aaa_A           17 ENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK-   95 (331)
T ss_dssp             --CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-
T ss_pred             chhhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec-
Confidence            4455567889999999999999999999999899999999986554 34456678899999999999999999999987 


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhh
Q 020657          122 SGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM  201 (323)
Q Consensus       122 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~  201 (323)
                      .+..++||||+++++|.+++.....+++..+..++.||+.||.|||+.|++|+||||+||+++.++ .+||+|||++...
T Consensus        96 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  174 (331)
T 4aaa_A           96 KKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG-VVKLCDFGFARTL  174 (331)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCTTC---
T ss_pred             CCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCC-cEEEEeCCCceee
Confidence            688999999999999999888777899999999999999999999999999999999999999987 8999999999776


Q ss_pred             ccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcC------
Q 020657          202 CRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFG------  275 (323)
Q Consensus       202 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~------  275 (323)
                      ...........++..|+|||++.+.    ..++.++||||||+++|+|++|..||...........+.......      
T Consensus       175 ~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  250 (331)
T 4aaa_A          175 AAPGEVYDDEVATRWYRAPELLVGD----VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQE  250 (331)
T ss_dssp             ---------CCCCCTTCCHHHHTTC----TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             cCCccccCCCcCCccccCcccccCC----CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Confidence            5544444566789999999998632    245679999999999999999999996654433332222111100      


Q ss_pred             -----------CCCC---------CCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          276 -----------DPPS---------LPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       276 -----------~~~~---------~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                                 ..+.         ....+++++.+|+.+||+.||++|||++++|+||||+..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             HHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             HhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence                       0000         113578999999999999999999999999999999764

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=5.2e-50  Score=345.12  Aligned_cols=257  Identities=26%  Similarity=0.454  Sum_probs=210.8

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEE
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      -..++|++.+.||+|+||.||+|.+..+++.+++|++...........+.+|+.+++.++||||+++++++.+ ....++
T Consensus        19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~l   97 (285)
T 3is5_A           19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED-YHNMYI   97 (285)
T ss_dssp             CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred             ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheec-CCeEEE
Confidence            3458899999999999999999999989999999999766544456778899999999999999999999987 678999


Q ss_pred             EEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEec---CCCcEEEeecCcchh
Q 020657          128 LMEYMDSGTLDTLLNK----NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNN---NNMQVKIADFGVSKI  200 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~---~~~~~kl~Dfg~~~~  200 (323)
                      ||||+++++|.+.+..    ...+++..++.++.||+.||.|||+.|++|+||||+||+++.   ++ .+||+|||++..
T Consensus        98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~-~~kl~Dfg~a~~  176 (285)
T 3is5_A           98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHS-PIKIIDFGLAEL  176 (285)
T ss_dssp             EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTC-CEEECCCCCCCC
T ss_pred             EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCC-CEEEEeeeccee
Confidence            9999999999998853    367999999999999999999999999999999999999953   44 799999999976


Q ss_pred             hccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCC--C
Q 020657          201 MCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP--P  278 (323)
Q Consensus       201 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~--~  278 (323)
                      .... .......++..|+|||++..      .++.++||||||+++|+|++|..||.+..    .............  .
T Consensus       177 ~~~~-~~~~~~~~t~~y~aPE~~~~------~~~~~~Di~slG~il~~ll~g~~pf~~~~----~~~~~~~~~~~~~~~~  245 (285)
T 3is5_A          177 FKSD-EHSTNAAGTALYMAPEVFKR------DVTFKCDIWSAGVVMYFLLTGCLPFTGTS----LEEVQQKATYKEPNYA  245 (285)
T ss_dssp             -----------CTTGGGCCHHHHTT------CCCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHCCCCCC
T ss_pred             cCCc-ccCcCcccccCcCChHHhcc------CCCcccCeehHHHHHHHHHhCCCCCCCCC----HHHHHhhhccCCcccc
Confidence            5433 22345578999999998752      34679999999999999999999995543    2333333322222  2


Q ss_pred             CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          279 SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       279 ~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                      .....+++++.+|+++||+.||++|||++++|+||||++
T Consensus       246 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          246 VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            222457899999999999999999999999999999985

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=8.2e-50  Score=345.34  Aligned_cols=262  Identities=26%  Similarity=0.408  Sum_probs=224.7

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCC--CChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCe
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGD  124 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  124 (323)
                      ....++|++.+.||+|+||.||+|.+..+++.+++|++...  ........+.+|+.+++.++||||+++++++.+ .+.
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~   89 (294)
T 2rku_A           11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-NDF   89 (294)
T ss_dssp             TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSE
T ss_pred             CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc-CCE
Confidence            34568999999999999999999999989999999998654  234566788899999999999999999999987 678


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC
Q 020657          125 IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS  204 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~  204 (323)
                      .++||||+++++|.+++.....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus        90 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           90 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYD  168 (294)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCST
T ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCC-CEEEEeccCceecccC
Confidence            999999999999999998888899999999999999999999999999999999999999987 8999999999776544


Q ss_pred             ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCC
Q 020657          205 LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA  284 (323)
Q Consensus       205 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (323)
                      ........++..|+|||.+...     ..+.++||||||+++|+|++|..||......    ....... .....++..+
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~-~~~~~~~~~~  238 (294)
T 2rku_A          169 GERKKVLCGTPNYIAPEVLSKK-----GHSFEVDVWSIGCIMYTLLVGKPPFETSCLK----ETYLRIK-KNEYSIPKHI  238 (294)
T ss_dssp             TCCBCCCCSCCSSCCHHHHTTS-----CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHH-TTCCCCCTTS
T ss_pred             ccccccccCCCCcCCcchhccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHh-hccCCCcccc
Confidence            4444556789999999998643     3456999999999999999999999554322    2222222 2234566788


Q ss_pred             ChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       285 ~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                      +..+.+|+++||+.||++|||++++++||||.+..-
T Consensus       239 ~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~  274 (294)
T 2rku_A          239 NPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI  274 (294)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred             CHHHHHHHHHHcccChhhCcCHHHHhhChheecCCc
Confidence            999999999999999999999999999999987644

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.7e-50  Score=350.63  Aligned_cols=267  Identities=26%  Similarity=0.396  Sum_probs=207.3

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC----hHHHHHHHHHHHHHHcC---CCCccceeceeE
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD----PTVRRQVFREMEILRRT---DSPFIVQCFGIF  118 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~  118 (323)
                      ..+..++|++.+.||+|+||.||+|++..+++.||+|++.....    ......+.+|+.+++.+   .||||+++++++
T Consensus         4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~   83 (308)
T 3g33_A            4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC   83 (308)
T ss_dssp             ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred             CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence            34567899999999999999999999998999999999863321    11123455666666665   599999999998


Q ss_pred             EcCCC----eEEEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEE
Q 020657          119 EKPSG----DIAILMEYMDSGTLDTLLNKNGT--FSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKI  192 (323)
Q Consensus       119 ~~~~~----~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl  192 (323)
                      .....    ..++||||+.+ +|.+++.....  +++..++.++.||+.||.|||+.|++|+||||+||+++.++ .+||
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~-~~kl  161 (308)
T 3g33_A           84 ATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG-TVKL  161 (308)
T ss_dssp             EECCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTS-CEEE
T ss_pred             eccCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-CEEE
Confidence            76433    58999999975 99999987544  99999999999999999999999999999999999999987 8999


Q ss_pred             eecCcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHH
Q 020657          193 ADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAI  272 (323)
Q Consensus       193 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~  272 (323)
                      +|||++...... .......+|..|+|||++....     ++.++||||||+++|+|++|..||...........+....
T Consensus       162 ~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~  235 (308)
T 3g33_A          162 ADFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQST-----YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI  235 (308)
T ss_dssp             CSCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSC-----CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHH
T ss_pred             eeCccccccCCC-cccCCccccccccCchHHcCCC-----CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            999999765432 2234567899999999986433     4569999999999999999999997655544444444333


Q ss_pred             hcCCCCC----------------------CCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          273 CFGDPPS----------------------LPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       273 ~~~~~~~----------------------~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                      .......                      ....+++++.+|+.+||+.||++|||++++|+||||++...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~  305 (308)
T 3g33_A          236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG  305 (308)
T ss_dssp             CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-----
T ss_pred             CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCC
Confidence            2221111                      11357899999999999999999999999999999998654

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.4e-51  Score=366.71  Aligned_cols=271  Identities=26%  Similarity=0.378  Sum_probs=219.9

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCC
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG  123 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  123 (323)
                      ..+..++|++.+.||+|+||.||+|++..+++.||+|++....  .......+.+|..++..+.||||+++++++.+ .+
T Consensus        56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~-~~  134 (412)
T 2vd5_A           56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD-EN  134 (412)
T ss_dssp             HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC-SS
T ss_pred             ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee-CC
Confidence            3466789999999999999999999999999999999986321  11122346789999999999999999999998 68


Q ss_pred             eEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          124 DIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      .+++||||+++++|.+++.+. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++ .+||+|||++....
T Consensus       135 ~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g-~vkL~DFGla~~~~  213 (412)
T 2vd5_A          135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG-HIRLADFGSCLKLR  213 (412)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECC
T ss_pred             EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCC-CEEEeechhheecc
Confidence            899999999999999999864 4799999999999999999999999999999999999999988 89999999997654


Q ss_pred             cCcc-ccccccccccccCCcccCCC--CCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCC
Q 020657          203 RSLD-ACNSYVGTCAYMSPERFDPD--AYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPS  279 (323)
Q Consensus       203 ~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  279 (323)
                      .... .....+||+.|+|||++...  ......++.++||||||+++|||++|..||...........+.........+.
T Consensus       214 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~  293 (412)
T 2vd5_A          214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPL  293 (412)
T ss_dssp             TTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC-
T ss_pred             CCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCc
Confidence            3322 23346799999999998621  11123456799999999999999999999976544444444433222233344


Q ss_pred             CCCCCChhHHHHHHHhcccCcCCC---CCHHHHhcCcccccCC
Q 020657          280 LPDGASPEFRSFIECCLQKEFSKR---WTASQLLTHPFLCKNR  319 (323)
Q Consensus       280 ~~~~~~~~l~~ll~~~l~~~p~~R---pt~~~~l~h~~f~~~~  319 (323)
                      ++..+++++.+||++||+ +|++|   ++++++++||||+++.
T Consensus       294 ~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~  335 (412)
T 2vd5_A          294 VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLD  335 (412)
T ss_dssp             ---CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCC
T ss_pred             cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCC
Confidence            456899999999999999 99998   5999999999998764

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=8.1e-50  Score=346.83  Aligned_cols=260  Identities=35%  Similarity=0.574  Sum_probs=224.9

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEE
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      -..+.|++.+.||+|++|.||+|.+..+++.|++|++...........+.+|+.+++.++||||+++++++.. ....++
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l   97 (303)
T 3a7i_A           19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-DTKLWI   97 (303)
T ss_dssp             CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEE
T ss_pred             ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-CCeEEE
Confidence            3457799999999999999999999989999999999866555556788999999999999999999999987 678999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccc
Q 020657          128 LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA  207 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~  207 (323)
                      ||||+++++|.+++.. ..+++..+..++.||+.||.+||+.|++|+||+|+||+++.++ .++|+|||++.........
T Consensus        98 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~  175 (303)
T 3a7i_A           98 IMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIK  175 (303)
T ss_dssp             EEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECBTTBCC
T ss_pred             EEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCC-CEEEeecccceecCccccc
Confidence            9999999999999875 4789999999999999999999999999999999999999987 8999999999776554444


Q ss_pred             cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChh
Q 020657          208 CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPE  287 (323)
Q Consensus       208 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (323)
                      .....++..|+|||++....     ++.++||||||+++|+|++|..||....    .......+.....+.++..++..
T Consensus       176 ~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~  246 (303)
T 3a7i_A          176 RNTFVGTPFWMAPEVIKQSA-----YDSKADIWSLGITAIELARGEPPHSELH----PMKVLFLIPKNNPPTLEGNYSKP  246 (303)
T ss_dssp             BCCCCSCGGGCCHHHHTTCC-----BCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHHHHHSCCCCCCSSCCHH
T ss_pred             cCccCCCcCccCHHHHhcCC-----CCchhhhHHHHHHHHHHccCCCCCCCcC----HHHHHHHhhcCCCCCCccccCHH
Confidence            45567899999999987443     4569999999999999999999995432    23333334445566677889999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          288 FRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       288 l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      +.+|+.+||+.||++|||++++++||||.+..
T Consensus       247 l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  278 (303)
T 3a7i_A          247 LKEFVEACLNKEPSFRPTAKELLKHKFILRNA  278 (303)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence            99999999999999999999999999996544

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=6.4e-50  Score=360.07  Aligned_cols=258  Identities=29%  Similarity=0.455  Sum_probs=202.3

Q ss_pred             ccccccee-eeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHc-CCCCccceeceeEEc---CCC
Q 020657           49 AYSDLEKL-QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRR-TDSPFIVQCFGIFEK---PSG  123 (323)
Q Consensus        49 ~~~~~~~~-~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~---~~~  123 (323)
                      ..++|.+. +.||+|+||.||+|.+..+++.||+|++...      ..+.+|+.++.+ .+||||+++++++..   ...
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~  132 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK  132 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence            45677777 6899999999999999999999999999632      345678887644 589999999998764   245


Q ss_pred             eEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEec---CCCcEEEeecCcc
Q 020657          124 DIAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNN---NNMQVKIADFGVS  198 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~---~~~~~kl~Dfg~~  198 (323)
                      .+++||||+.+++|.+++....  .+++..++.++.||+.||.|||+.||+||||||+||+++.   ++ .+||+|||++
T Consensus       133 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~-~~kl~DFG~a  211 (400)
T 1nxk_A          133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA-ILKLTDFGFA  211 (400)
T ss_dssp             EEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTC-CEEECCCTTC
T ss_pred             EEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCc-cEEEEecccc
Confidence            6899999999999999998643  5999999999999999999999999999999999999987   55 8999999999


Q ss_pred             hhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCcc---HHHHHHHHhcC
Q 020657          199 KIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPD---WATLMCAICFG  275 (323)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~---~~~~~~~~~~~  275 (323)
                      ...... .......+|..|+|||++...     .++.++||||||+++|+|++|..||........   ...........
T Consensus       212 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~  285 (400)
T 1nxk_A          212 KETTSH-NSLTTPCYTPYYVAPEVLGPE-----KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE  285 (400)
T ss_dssp             EECC------------CTTCCGGGSCCC-----CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCC
T ss_pred             cccCCC-CccccCCCCCCccCHhhcCCC-----CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCccc
Confidence            765332 223456789999999998643     345699999999999999999999976544322   11211111111


Q ss_pred             CCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          276 DPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       276 ~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      .+......++.++.+||++||+.||++|||++++++||||.+..
T Consensus       286 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  329 (400)
T 1nxk_A          286 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  329 (400)
T ss_dssp             CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred             CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence            22223357899999999999999999999999999999997654

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.8e-50  Score=354.97  Aligned_cols=257  Identities=25%  Similarity=0.390  Sum_probs=210.7

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC-------
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS-------  122 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------  122 (323)
                      .++|++.+.||+|+||.||+|++..+++.||+|++.........+.+.+|+.+++.++||||+++++++.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            4789999999999999999999998999999999986666667788999999999999999999999985432       


Q ss_pred             -------------------------------------------------CeEEEEEeccCCCCHHHHHHhcCC---CCHH
Q 020657          123 -------------------------------------------------GDIAILMEYMDSGTLDTLLNKNGT---FSEP  150 (323)
Q Consensus       123 -------------------------------------------------~~~~lv~e~~~~~sL~~~l~~~~~---~~~~  150 (323)
                                                                       ...++||||+++++|.+++.....   .++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                             238999999999999999986543   5666


Q ss_pred             HHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc------------ccccccccccccc
Q 020657          151 KLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL------------DACNSYVGTCAYM  218 (323)
Q Consensus       151 ~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~------------~~~~~~~~~~~y~  218 (323)
                      .++.++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++.......            .......++..|+
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  243 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM  243 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCC-CEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence            7999999999999999999999999999999999987 89999999997765432            1223457899999


Q ss_pred             CCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhccc
Q 020657          219 SPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQK  298 (323)
Q Consensus       219 aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~  298 (323)
                      |||++.+.     .++.++||||||+++|+|++|..|+.      ..............+......++++.+|+++||+.
T Consensus       244 aPE~~~~~-----~~~~~~Di~slG~il~el~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  312 (332)
T 3qd2_B          244 SPEQIHGN-----NYSHKVDIFSLGLILFELLYSFSTQM------ERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSP  312 (332)
T ss_dssp             CHHHHHCC-----CCCTHHHHHHHHHHHHHHHSCCCCHH------HHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCS
T ss_pred             ChHHhcCC-----CCcchhhHHHHHHHHHHHHHcCCChh------HHHHHHHHhhccCCCcccccCChhHHHHHHHHccC
Confidence            99998743     34669999999999999999876651      12223333333333333345678899999999999


Q ss_pred             CcCCCCCHHHHhcCcccccC
Q 020657          299 EFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       299 ~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      ||++|||++++|+||||++.
T Consensus       313 ~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          313 SPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             SGGGSCCHHHHHHSTTCCCC
T ss_pred             CCCcCCCHHHHhhchhhhcC
Confidence            99999999999999999874

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.3e-50  Score=357.24  Aligned_cols=258  Identities=24%  Similarity=0.383  Sum_probs=216.6

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceeceeEEcCCCeEEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++......     ..+|+.++.++ +||||+++++++.+ ....++
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~E~~~l~~~~~hp~iv~~~~~~~~-~~~~~l   93 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-----PTEEIEILLRYGQHPNIITLKDVYDD-GKYVYV   93 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-----CHHHHHHHHHHTTSTTBCCEEEEEEC-SSEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-----hHHHHHHHHHhcCCCCcCeEEEEEEc-CCEEEE
Confidence            467899999999999999999999999999999999755422     34677888887 79999999999987 688999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC---CcEEEeecCcchhhccC
Q 020657          128 LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN---MQVKIADFGVSKIMCRS  204 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~---~~~kl~Dfg~~~~~~~~  204 (323)
                      ||||+.+++|.+.+...+.+++..+..++.||+.||.|||+.|++||||||+||++..++   ..+||+|||++......
T Consensus        94 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~  173 (342)
T 2qr7_A           94 VTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE  173 (342)
T ss_dssp             EECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence            999999999999998888899999999999999999999999999999999999985432   25999999999876554


Q ss_pred             ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCC---CCCC
Q 020657          205 LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP---PSLP  281 (323)
Q Consensus       205 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~  281 (323)
                      ........++..|+|||++....     ++.++||||||+++|+|++|..||..... .....+...+..+..   ...+
T Consensus       174 ~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~~~~i~~~~~~~~~~~~  247 (342)
T 2qr7_A          174 NGLLMTPCYTANFVAPEVLERQG-----YDAACDIWSLGVLLYTMLTGYTPFANGPD-DTPEEILARIGSGKFSLSGGYW  247 (342)
T ss_dssp             TCCBCCSSCCSSCCCHHHHHHHH-----HHHHHHHHHHHHHHHHHHHSSCSSCSSTT-SCHHHHHHHHHHCCCCCCSTTT
T ss_pred             CCceeccCCCccccCHHHhcCCC-----CCCccCeeeHhHHHHHHhcCCCCCCCCCc-CCHHHHHHHHccCCcccCcccc
Confidence            44455677899999999986332     35699999999999999999999975432 333444444443332   2334


Q ss_pred             CCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          282 DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       282 ~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      ..+++++.+|+++||+.||++|||++++++||||.+.
T Consensus       248 ~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  284 (342)
T 2qr7_A          248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW  284 (342)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence            6789999999999999999999999999999999653

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.8e-50  Score=358.33  Aligned_cols=258  Identities=27%  Similarity=0.418  Sum_probs=206.7

Q ss_pred             cccce--eeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           51 SDLEK--LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        51 ~~~~~--~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      +.|.+  .+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.. .+..++|
T Consensus        87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv  164 (373)
T 2x4f_A           87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-MKDKEEVKNEISVMNQLDHANLIQLYDAFES-KNDIVLV  164 (373)
T ss_dssp             GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEE
Confidence            34444  678999999999999999899999999997543 3455678899999999999999999999987 6789999


Q ss_pred             EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEe--cCCCcEEEeecCcchhhccCc
Q 020657          129 MEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVN--NNNMQVKIADFGVSKIMCRSL  205 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~--~~~~~~kl~Dfg~~~~~~~~~  205 (323)
                      |||+++++|.+++... ..+++..++.++.||+.||.|||+.|++||||||+||+++  .++ .+||+|||++.......
T Consensus       165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~-~~kl~DFG~a~~~~~~~  243 (373)
T 2x4f_A          165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKPRE  243 (373)
T ss_dssp             EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTT-EEEECCCSSCEECCTTC
T ss_pred             EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCC-cEEEEeCCCceecCCcc
Confidence            9999999998888643 4699999999999999999999999999999999999994  344 89999999997664332


Q ss_pred             cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCC
Q 020657          206 DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS  285 (323)
Q Consensus       206 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (323)
                       ......++..|+|||++..     ..++.++||||||+++|+|++|..||.+.........+... ...........++
T Consensus       244 -~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~  316 (373)
T 2x4f_A          244 -KLKVNFGTPEFLAPEVVNY-----DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC-RWDLEDEEFQDIS  316 (373)
T ss_dssp             -BCCCCCSSCTTCCHHHHTT-----CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT-CCCSCSGGGTTSC
T ss_pred             -ccccccCCCcEeChhhccC-----CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-cCCCChhhhccCC
Confidence             2344578999999999863     34566999999999999999999999655433222222221 1111122235789


Q ss_pred             hhHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          286 PEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       286 ~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      +++.+|+.+||+.||++|||++++|+||||.+.
T Consensus       317 ~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          317 EEAKEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            999999999999999999999999999999865

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=5.2e-50  Score=356.35  Aligned_cols=265  Identities=40%  Similarity=0.725  Sum_probs=223.1

Q ss_pred             chhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCe
Q 020657           45 TAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGD  124 (323)
Q Consensus        45 ~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  124 (323)
                      ...+..++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+|+.+++.++||||+++++++.. .+.
T Consensus        27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~  105 (360)
T 3eqc_A           27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGE  105 (360)
T ss_dssp             CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-TTE
T ss_pred             ccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-CCE
Confidence            3456778999999999999999999999999999999999877777778889999999999999999999999987 688


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          125 IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH-KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      .++||||+++++|.+++...+.+++..+..++.+++.||.|||+. |++|+||||+||+++.++ .++|+|||++.....
T Consensus       106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLID  184 (360)
T ss_dssp             EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHHHHH
T ss_pred             EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCC-CEEEEECCCCccccc
Confidence            999999999999999999888899999999999999999999996 999999999999999987 899999999976543


Q ss_pred             CccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCcc-------------------
Q 020657          204 SLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPD-------------------  264 (323)
Q Consensus       204 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~-------------------  264 (323)
                      .  ......++..|+|||++.+.     .++.++||||||+++|+|++|..||........                   
T Consensus       185 ~--~~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (360)
T 3eqc_A          185 S--MANSFVGTRSYMSPERLQGT-----HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP  257 (360)
T ss_dssp             H--C----CCCCTTCCHHHHTTC-----CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------
T ss_pred             c--cccCCCCCCCeECHHHHcCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCc
Confidence            2  22345789999999998643     456799999999999999999999965432111                   


Q ss_pred             -------------------HHHHHHHHhcCCCCCCC-CCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          265 -------------------WATLMCAICFGDPPSLP-DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       265 -------------------~~~~~~~~~~~~~~~~~-~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                                         .............+..+ ..++.++.+|+++||+.||++|||++++|+||||++.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  331 (360)
T 3eqc_A          258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  331 (360)
T ss_dssp             ----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             ccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence                               11222222223333333 4578999999999999999999999999999999764

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=5.7e-50  Score=351.05  Aligned_cols=259  Identities=25%  Similarity=0.391  Sum_probs=197.4

Q ss_pred             ccccee---eeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCC-CCccceeceeEEcCCCeEE
Q 020657           51 SDLEKL---QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD-SPFIVQCFGIFEKPSGDIA  126 (323)
Q Consensus        51 ~~~~~~---~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~  126 (323)
                      ++|++.   +.||+|+||.||+|.+..+++.||+|++...    ....+.+|+.+++.+. ||||+++++++.+ ....+
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~-~~~~~   82 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHD-QLHTF   82 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc-CCEEE
Confidence            456664   7899999999999999999999999999633    3456778999999996 9999999999987 68899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC--CcEEEeecCcchhhccC
Q 020657          127 ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN--MQVKIADFGVSKIMCRS  204 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~--~~~kl~Dfg~~~~~~~~  204 (323)
                      +||||+++++|.+++...+.+++..+..++.||+.||.|||+.|++||||||+||+++.++  ..+||+|||++......
T Consensus        83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  162 (325)
T 3kn6_A           83 LVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD  162 (325)
T ss_dssp             EEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred             EEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence            9999999999999999888999999999999999999999999999999999999998653  27999999999765544


Q ss_pred             ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC---ccHHHHHHHHhcCCCCCC-
Q 020657          205 LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQR---PDWATLMCAICFGDPPSL-  280 (323)
Q Consensus       205 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~-  280 (323)
                      ........++..|+|||++...     .++.++||||||+++|+|++|..||......   .....+...+..+..... 
T Consensus       163 ~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~  237 (325)
T 3kn6_A          163 NQPLKTPCFTLHYAAPELLNQN-----GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG  237 (325)
T ss_dssp             ---------------------C-----CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCS
T ss_pred             CCcccccCCCcCccCHHHhcCC-----CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCc
Confidence            4444566789999999998643     3567999999999999999999999664332   223344444443332211 


Q ss_pred             --CCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          281 --PDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       281 --~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                        ...+++++.+|+++||+.||++|||++++++||||++..
T Consensus       238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~  278 (325)
T 3kn6_A          238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS  278 (325)
T ss_dssp             HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred             ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence              136899999999999999999999999999999998754

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.1e-50  Score=362.36  Aligned_cols=266  Identities=27%  Similarity=0.412  Sum_probs=207.4

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCC-CChHHHHHHHHHHHHHHcCC-CCccceeceeEEcC-CCe
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTD-SPFIVQCFGIFEKP-SGD  124 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~-~~~  124 (323)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++... ........+.+|+.+++.+. ||||+++++++... ...
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            4568999999999999999999999999999999998654 34455677889999999996 99999999999753 346


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC
Q 020657          125 IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS  204 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~  204 (323)
                      +++||||+.+ +|..++..+ .+++..+..++.||+.||.|||+.||+||||||+||+++.++ .+||+|||+++.....
T Consensus        86 ~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~  162 (388)
T 3oz6_A           86 VYLVFDYMET-DLHAVIRAN-ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAEC-HVKVADFGLSRSFVNI  162 (388)
T ss_dssp             EEEEEECCSE-EHHHHHHHT-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEESSSC
T ss_pred             EEEEecccCc-CHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCC-CEEecCCccccccccc
Confidence            8999999985 999988764 789999999999999999999999999999999999999997 8999999999764321


Q ss_pred             ---------------------ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCc
Q 020657          205 ---------------------LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRP  263 (323)
Q Consensus       205 ---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~  263 (323)
                                           .......++|..|+|||++.+    ...++.++||||||+++|+|++|..||.+.+...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  238 (388)
T 3oz6_A          163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG----STKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN  238 (388)
T ss_dssp             CCCCCCGGGCCC---------------CCCGGGGCCHHHHTT----CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccccccccccccccccccccccCCcccCCcCCHHHhcC----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                                 111234578999999999863    2345679999999999999999999997655443


Q ss_pred             cHHHHHHHHhcCCC-----------------------------C-------------CCCCCCChhHHHHHHHhcccCcC
Q 020657          264 DWATLMCAICFGDP-----------------------------P-------------SLPDGASPEFRSFIECCLQKEFS  301 (323)
Q Consensus       264 ~~~~~~~~~~~~~~-----------------------------~-------------~~~~~~~~~l~~ll~~~l~~~p~  301 (323)
                      ....+.........                             .             .....+++++.+||++||+.||+
T Consensus       239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~  318 (388)
T 3oz6_A          239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN  318 (388)
T ss_dssp             HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence            33333322111000                             0             01126789999999999999999


Q ss_pred             CCCCHHHHhcCcccccCCC
Q 020657          302 KRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       302 ~Rpt~~~~l~h~~f~~~~~  320 (323)
                      +|||++++|+||||+..+.
T Consensus       319 ~R~t~~e~l~Hp~~~~~~~  337 (388)
T 3oz6_A          319 KRISANDALKHPFVSIFHN  337 (388)
T ss_dssp             GSCCHHHHTTSTTTTTTCC
T ss_pred             cCCCHHHHhCCHHHHHhcC
Confidence            9999999999999987654

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.2e-50  Score=369.18  Aligned_cols=262  Identities=30%  Similarity=0.471  Sum_probs=222.7

Q ss_pred             chhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC
Q 020657           45 TAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS  122 (323)
Q Consensus        45 ~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  122 (323)
                      ...+..++|.+.+.||+|+||.||+|.+..+|+.||+|++....  .......+.+|+.+++.++||||+++++++.+ .
T Consensus        10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-~   88 (476)
T 2y94_A           10 DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST-P   88 (476)
T ss_dssp             CSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC-S
T ss_pred             CCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-C
Confidence            34566789999999999999999999999999999999986431  11234578899999999999999999999987 6


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          123 GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      +..++||||+++++|.+++...+.+++..++.++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++....
T Consensus        89 ~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~-~vkL~DFG~a~~~~  167 (476)
T 2y94_A           89 SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMS  167 (476)
T ss_dssp             SEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTC-CEEECCCSSCEECC
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCC-CeEEEeccchhhcc
Confidence            78999999999999999998888899999999999999999999999999999999999999987 89999999997654


Q ss_pred             cCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCC
Q 020657          203 RSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPD  282 (323)
Q Consensus       203 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (323)
                      .. .......+++.|+|||++.+..    ..+.++||||||+++|+|++|..||......    .+...+..+ ....+.
T Consensus       168 ~~-~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwSlGvil~elltG~~Pf~~~~~~----~~~~~i~~~-~~~~p~  237 (476)
T 2y94_A          168 DG-EFLRTSCGSPNYAAPEVISGRL----YAGPEVDIWSSGVILYALLCGTLPFDDDHVP----TLFKKICDG-IFYTPQ  237 (476)
T ss_dssp             TT-CCBCCCCSCSTTCCHHHHTTCC----BCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH----HHHHHHHTT-CCCCCT
T ss_pred             cc-ccccccCCCcCeEChhhccCCC----CCCCcceehhhHHHHHHHhhCCCCCCCCCHH----HHHHHHhcC-CcCCCc
Confidence            32 2234567999999999987433    2356999999999999999999999654433    233333222 334567


Q ss_pred             CCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          283 GASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       283 ~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      .+++++.+|+++||+.||++|||++++++||||++.
T Consensus       238 ~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          238 YLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             TCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             cCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence            789999999999999999999999999999999764

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.4e-50  Score=345.17  Aligned_cols=259  Identities=31%  Similarity=0.466  Sum_probs=216.2

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCe
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGD  124 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  124 (323)
                      ....++|++.+.||+|++|.||+|.+..+++.|++|++....  .......+.+|+.+++.++||||+++++++.+ ...
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   83 (279)
T 3fdn_A            5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-ATR   83 (279)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSE
T ss_pred             eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec-CCE
Confidence            345789999999999999999999999999999999985432  11224568899999999999999999999987 678


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC
Q 020657          125 IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS  204 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~  204 (323)
                      .++||||+++++|.+.+.....+++..++.++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus        84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~-~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSS  162 (279)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTS-CEEECSCCEESCC---
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCC-CEEEEeccccccCCcc
Confidence            999999999999999998888899999999999999999999999999999999999999987 8999999998554332


Q ss_pred             ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCC
Q 020657          205 LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA  284 (323)
Q Consensus       205 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (323)
                        ......++..|+|||.+.+.     ..+.++||||||+++|+|++|..||.....    ......+.. ....++..+
T Consensus       163 --~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~-~~~~~~~~~  230 (279)
T 3fdn_A          163 --RRTDLCGTLDYLPPEMIEGR-----MHDEKVDLWSLGVLCYEFLVGKPPFEANTY----QETYKRISR-VEFTFPDFV  230 (279)
T ss_dssp             -------CCCCTTCCHHHHTTC-----CCCTTHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHH-TCCCCCTTS
T ss_pred             --cccccCCCCCccCHhHhccC-----CCCccchhHhHHHHHHHHHHCCCCCCCCcH----HHHHHHHHh-CCCCCCCcC
Confidence              22345789999999998643     345699999999999999999999954332    222222222 234566778


Q ss_pred             ChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       285 ~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      +.++.+|+++||+.||++|||++++++||||++..
T Consensus       231 ~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~  265 (279)
T 3fdn_A          231 TEGARDLISRLLKHNPSQRPMLREVLEHPWITANS  265 (279)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred             CHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence            99999999999999999999999999999997644

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=6.9e-50  Score=370.06  Aligned_cols=263  Identities=29%  Similarity=0.448  Sum_probs=225.6

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC--hHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeE
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD--PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDI  125 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  125 (323)
                      +..++|++.+.||+|+||.||+|++..+|+.||+|++.....  ......+.+|+.+++.++||||+++++++.+ ...+
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~~l  260 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET-KTDL  260 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee-CCEE
Confidence            556899999999999999999999998999999999964321  1223567889999999999999999999987 6889


Q ss_pred             EEEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhh
Q 020657          126 AILMEYMDSGTLDTLLNKN----GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM  201 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~  201 (323)
                      ++||||++|++|.+++...    ..+++..++.++.||+.||.|||+.||+||||||+||+++.+| .+||+|||++...
T Consensus       261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g-~vkL~DFGla~~~  339 (543)
T 3c4z_A          261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG-NVRISDLGLAVEL  339 (543)
T ss_dssp             EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCC-CEEEeecceeeec
Confidence            9999999999999998753    4699999999999999999999999999999999999999998 8999999999876


Q ss_pred             ccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCC
Q 020657          202 CRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLP  281 (323)
Q Consensus       202 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (323)
                      ...........||+.|+|||++.+.     .++.++||||||+++|+|++|..||...........+.+.+... ...++
T Consensus       340 ~~~~~~~~~~~GT~~Y~APE~l~~~-----~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~-~~~~p  413 (543)
T 3c4z_A          340 KAGQTKTKGYAGTPGFMAPELLLGE-----EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ-AVTYP  413 (543)
T ss_dssp             CTTCCCBCCCCSCTTTSCHHHHTTC-----CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC-CCCCC
T ss_pred             cCCCcccccccCCccccChhhhcCC-----CCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc-ccCCC
Confidence            5544444556899999999999744     34569999999999999999999998766555555555554433 34567


Q ss_pred             CCCChhHHHHHHHhcccCcCCCCC-----HHHHhcCcccccC
Q 020657          282 DGASPEFRSFIECCLQKEFSKRWT-----ASQLLTHPFLCKN  318 (323)
Q Consensus       282 ~~~~~~l~~ll~~~l~~~p~~Rpt-----~~~~l~h~~f~~~  318 (323)
                      ..+++++.+|+++||+.||++||+     ++++++||||+++
T Consensus       414 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i  455 (543)
T 3c4z_A          414 DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI  455 (543)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred             cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence            889999999999999999999996     4899999999875

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.7e-50  Score=344.69  Aligned_cols=261  Identities=29%  Similarity=0.475  Sum_probs=196.9

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIA  126 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  126 (323)
                      ..++|++.+.||+|+||.||+|.+..+++.|++|++....  .......+.+|+.+++.++||||+++++++.+ .+..+
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   87 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED-SNYVY   87 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC-SSEEE
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc-CCeEE
Confidence            4578999999999999999999998899999999986331  11224678899999999999999999999987 67899


Q ss_pred             EEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc
Q 020657          127 ILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL  205 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~  205 (323)
                      +||||+++++|.+++... ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNM-NIKIADFGLATQLKMPH  166 (278)
T ss_dssp             EEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTC-CEEECCCTTCEECC---
T ss_pred             EEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEEEeecceeeccCCC
Confidence            999999999999999864 5799999999999999999999999999999999999999987 89999999997665433


Q ss_pred             cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCC
Q 020657          206 DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS  285 (323)
Q Consensus       206 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (323)
                      .......++..|+|||.+...     ..+.++||||||+++|+|++|..||............    . .....++..++
T Consensus       167 ~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~-~~~~~~~~~~~  236 (278)
T 3cok_A          167 EKHYTLCGTPNYISPEIATRS-----AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV----V-LADYEMPSFLS  236 (278)
T ss_dssp             ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C----C-SSCCCCCTTSC
T ss_pred             CcceeccCCCCcCCcchhcCC-----CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH----h-hcccCCccccC
Confidence            333456789999999998643     3456999999999999999999999765443222211    1 11234566789


Q ss_pred             hhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCCC
Q 020657          286 PEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS  321 (323)
Q Consensus       286 ~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~  321 (323)
                      .++.+|+.+||+.||++|||++++++||||.+....
T Consensus       237 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  272 (278)
T 3cok_A          237 IEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSST  272 (278)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC-----
T ss_pred             HHHHHHHHHHcccCHhhCCCHHHHhcCccccCCCCc
Confidence            999999999999999999999999999999876543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.3e-50  Score=365.24  Aligned_cols=266  Identities=27%  Similarity=0.380  Sum_probs=210.5

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-------ChHHHHHHHHHHHHHHcCCCCccceeceeEEc
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-------DPTVRRQVFREMEILRRTDSPFIVQCFGIFEK  120 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  120 (323)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++....       .......+.+|+.+++.++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            34678999999999999999999999999999999986431       11223357899999999999999999999864


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC--CcEEEeecCcc
Q 020657          121 PSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN--MQVKIADFGVS  198 (323)
Q Consensus       121 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~--~~~kl~Dfg~~  198 (323)
                        +..++||||+.+++|.+.+...+.+++..+..++.||+.||.|||+.|++||||||+||+++.++  ..+||+|||++
T Consensus       212 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a  289 (419)
T 3i6u_A          212 --EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  289 (419)
T ss_dssp             --SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred             --CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence              56899999999999999998888899999999999999999999999999999999999997543  25999999999


Q ss_pred             hhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCC
Q 020657          199 KIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPP  278 (323)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~  278 (323)
                      ...... .......++..|+|||++....  ...++.++||||||+++|+|++|..||.....................+
T Consensus       290 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~  366 (419)
T 3i6u_A          290 KILGET-SLMRTLCGTPTYLAPEVLVSVG--TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP  366 (419)
T ss_dssp             TSCC------------CTTCCTTTTC------CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCH
T ss_pred             eecCCC-ccccccCCCCCccCceeeecCC--CCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCc
Confidence            765432 2234567899999999985321  2345679999999999999999999997665554444433322222222


Q ss_pred             CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          279 SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       279 ~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      .....+++.+.+|+++||+.||++|||++++|+||||++.
T Consensus       367 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          367 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence            2335789999999999999999999999999999999864

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.1e-49  Score=341.32  Aligned_cols=263  Identities=24%  Similarity=0.356  Sum_probs=220.5

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      .++|++.+.||+|++|.||+|.+..+++.|++|++...........+.+|+.+++.++||||+++++++.+ .+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~   84 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFL   84 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc-CCEEEEEE
Confidence            57899999999999999999999989999999999765545566788999999999999999999999987 68899999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc--cc
Q 020657          130 EYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL--DA  207 (323)
Q Consensus       130 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~--~~  207 (323)
                      ||+++++|.+++.....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||.+.......  ..
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~  163 (276)
T 2yex_A           85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERL  163 (276)
T ss_dssp             ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECEETTEECC
T ss_pred             EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCC-CEEEeeCCCccccCCCcchhc
Confidence            9999999999998777899999999999999999999999999999999999999987 89999999997654322  22


Q ss_pred             cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChh
Q 020657          208 CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPE  287 (323)
Q Consensus       208 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (323)
                      .....++..|+|||++....    ..+.++||||||+++|+|++|..||.............  ............++..
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~----~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  237 (276)
T 2yex_A          164 LNKMCGTLPYVAPELLKRRE----FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW--KEKKTYLNPWKKIDSA  237 (276)
T ss_dssp             BCCCCSCGGGCCGGGGTCSS----BCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHH--HTTCTTSTTGGGSCHH
T ss_pred             ccCCccccCccChHHHhcCC----CCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHh--hhcccccCchhhcCHH
Confidence            34567899999999986332    23568999999999999999999997655433222111  1111112223568999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          288 FRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       288 l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                      +.+|+.+||+.||++|||++++++||||++...
T Consensus       238 ~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (276)
T 2yex_A          238 PLALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (276)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             HHHHHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence            999999999999999999999999999987643

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.3e-50  Score=364.53  Aligned_cols=269  Identities=27%  Similarity=0.448  Sum_probs=219.9

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCC
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG  123 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  123 (323)
                      ..+..++|++.+.||+|+||.||+|++..+++.||+|++....  .......+.+|+.+++.++||||+++++++.+ ..
T Consensus        64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~  142 (410)
T 3v8s_A           64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-DR  142 (410)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC-SS
T ss_pred             cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CC
Confidence            3456789999999999999999999999999999999985321  00112236789999999999999999999997 78


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          124 DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      .+++||||+++++|.+++... .+++..++.++.||+.||.|||+.||+||||||+||+++.++ .+||+|||++.....
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g-~ikL~DFG~a~~~~~  220 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMNK  220 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCT
T ss_pred             EEEEEEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCC-CEEEeccceeEeecc
Confidence            899999999999999999764 689999999999999999999999999999999999999998 899999999976543


Q ss_pred             Cc-cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCC
Q 020657          204 SL-DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPD  282 (323)
Q Consensus       204 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (323)
                      .. ......+||+.|+|||++..... ...++.++||||||+++|+|++|..||.+.+.......+....... ..+...
T Consensus       221 ~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~-~~p~~~  298 (410)
T 3v8s_A          221 EGMVRCDTAVGTPDYISPEVLKSQGG-DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL-TFPDDN  298 (410)
T ss_dssp             TSEEECCSCCSCGGGCCHHHHHTTTT-TCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC-CCCTTC
T ss_pred             CCcccccCCcCCccccCHHHhhccCC-CcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc-cCCCcc
Confidence            32 22346789999999999864331 1225669999999999999999999997654443344443322111 122234


Q ss_pred             CCChhHHHHHHHhcccCcCC--CCCHHHHhcCcccccCC
Q 020657          283 GASPEFRSFIECCLQKEFSK--RWTASQLLTHPFLCKNR  319 (323)
Q Consensus       283 ~~~~~l~~ll~~~l~~~p~~--Rpt~~~~l~h~~f~~~~  319 (323)
                      .++.++.+||++||+.+|.+  |+++++|++||||+++.
T Consensus       299 ~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~  337 (410)
T 3v8s_A          299 DISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  337 (410)
T ss_dssp             CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred             cccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence            78999999999999999988  99999999999998863

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=5.6e-50  Score=371.66  Aligned_cols=262  Identities=27%  Similarity=0.452  Sum_probs=224.0

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeE
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDI  125 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  125 (323)
                      +..++|++.+.||+|+||.||+|++..+|+.||+|++....  .......+.+|+.+++.++||||+++++++.+ .+.+
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~~l  259 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-KDAL  259 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee-CCEE
Confidence            56788999999999999999999999999999999986431  11223557889999999999999999999987 6789


Q ss_pred             EEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          126 AILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      ++||||++|++|.+++...+  .+++..++.++.||+.||.|||+.||+||||||+||+++.++ .+||+|||++.....
T Consensus       260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g-~vKL~DFGla~~~~~  338 (576)
T 2acx_A          260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG-HIRISDLGLAVHVPE  338 (576)
T ss_dssp             EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCEECCT
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCC-CeEEEecccceeccc
Confidence            99999999999999997644  499999999999999999999999999999999999999988 899999999976543


Q ss_pred             CccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCC
Q 020657          204 SLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDG  283 (323)
Q Consensus       204 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (323)
                      .. .....+||+.|+|||++....     ++.++||||||+++|+|++|..||...........+...+.. .+..++..
T Consensus       339 ~~-~~~~~~GT~~Y~APEvl~~~~-----~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~-~~~~~p~~  411 (576)
T 2acx_A          339 GQ-TIKGRVGTVGYMAPEVVKNER-----YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VPEEYSER  411 (576)
T ss_dssp             TC-CEECCCSCGGGCCHHHHTTCE-----ESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-CCCCCCTT
T ss_pred             Cc-cccccCCCccccCHHHHcCCC-----CCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-ccccCCcc
Confidence            32 223458999999999987443     456999999999999999999999876655555555444433 34566788


Q ss_pred             CChhHHHHHHHhcccCcCCCC-----CHHHHhcCcccccC
Q 020657          284 ASPEFRSFIECCLQKEFSKRW-----TASQLLTHPFLCKN  318 (323)
Q Consensus       284 ~~~~l~~ll~~~l~~~p~~Rp-----t~~~~l~h~~f~~~  318 (323)
                      +++++.+|+++||+.||++||     +++++++||||++.
T Consensus       412 ~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i  451 (576)
T 2acx_A          412 FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL  451 (576)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred             CCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence            999999999999999999999     89999999999875

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.5e-50  Score=353.80  Aligned_cols=266  Identities=26%  Similarity=0.413  Sum_probs=212.5

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCCh----HHHHHHHHHHHHHHcCCCCccceeceeEEcCCCe
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADP----TVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGD  124 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  124 (323)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++......    .....+.+|+.+++.++||||+++++++.. .+.
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~   86 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-KSN   86 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-TTC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee-CCc
Confidence            457899999999999999999999989999999999754321    123467799999999999999999999987 678


Q ss_pred             EEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          125 IAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      .++||||+.+ +|.+.+... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .+||+|||++.....
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~  164 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG-VLKLADFGLAKSFGS  164 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCCGGGSTTTS
T ss_pred             eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCC-CEEEEecccceeccC
Confidence            9999999986 888888754 4689999999999999999999999999999999999999987 899999999987755


Q ss_pred             CccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCC----
Q 020657          204 SLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPS----  279 (323)
Q Consensus       204 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----  279 (323)
                      .........++..|+|||++.+    ...++.++||||||+++|+|++|..||.+.........+...........    
T Consensus       165 ~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  240 (346)
T 1ua2_A          165 PNRAYTHQVVTRWYRAPELLFG----ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM  240 (346)
T ss_dssp             CCCCCCCSCCCCTTCCHHHHTT----CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred             CcccCCcccccccccCchHhhC----CCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhh
Confidence            5444556678999999999853    23356799999999999999999999966544433344433322211111    


Q ss_pred             -------------------CCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCCC
Q 020657          280 -------------------LPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS  321 (323)
Q Consensus       280 -------------------~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~  321 (323)
                                         +...++.++.+|+++||+.||++|||++++|+||||.+...+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~  301 (346)
T 1ua2_A          241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  301 (346)
T ss_dssp             TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence                               114567899999999999999999999999999999876543

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.9e-49  Score=359.52  Aligned_cols=267  Identities=27%  Similarity=0.355  Sum_probs=211.0

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC----C
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS----G  123 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~  123 (323)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.+++.++|+||+++++++....    .
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            4578999999999999999999999999999999997553 3455678899999999999999999999987643    5


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          124 DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      ..++||||+.+ +|.+++.....+++..++.++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++.....
T Consensus       104 ~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-~~kL~DFGla~~~~~  181 (432)
T 3n9x_A          104 ELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDC-SVKVCDFGLARTINS  181 (432)
T ss_dssp             CEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEEC--
T ss_pred             eEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCC-CEEEccCCCcccccc
Confidence            79999999975 9999999888899999999999999999999999999999999999999997 899999999976543


Q ss_pred             Ccc----------------------ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCC----
Q 020657          204 SLD----------------------ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFL----  257 (323)
Q Consensus       204 ~~~----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~----  257 (323)
                      ...                      .....++|..|+|||++..    ...++.++|||||||++|||++|..||.    
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~----~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~  257 (432)
T 3n9x_A          182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL----QENYTKSIDIWSTGCIFAELLNMLQSHINDPT  257 (432)
T ss_dssp             -----------------------------CCCCCTTCCHHHHTT----CSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGG
T ss_pred             cccccccccccccccccccccchhccccCCCCCccccCHHHHhc----CCCCCcccccchHHHHHHHHHhcccccccccc
Confidence            221                      1245678999999998642    3345679999999999999998544442    


Q ss_pred             -------CCCCC-----------------ccHHHHHHHH--------------------hc-CCCCC-----CCCCCChh
Q 020657          258 -------QPGQR-----------------PDWATLMCAI--------------------CF-GDPPS-----LPDGASPE  287 (323)
Q Consensus       258 -------~~~~~-----------------~~~~~~~~~~--------------------~~-~~~~~-----~~~~~~~~  287 (323)
                             +.+..                 .....+....                    .. .....     ....++++
T Consensus       258 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  337 (432)
T 3n9x_A          258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDD  337 (432)
T ss_dssp             GCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHH
T ss_pred             cccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHH
Confidence                   22110                 0000011000                    00 00001     11468999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCcccccCCCC
Q 020657          288 FRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS  321 (323)
Q Consensus       288 l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~  321 (323)
                      +.+||++||+.||++|||++++|+||||++.+.+
T Consensus       338 ~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  371 (432)
T 3n9x_A          338 GINLLESMLKFNPNKRITIDQALDHPYLKDVRKK  371 (432)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred             HHHHHHHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence            9999999999999999999999999999987654

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-49  Score=355.65  Aligned_cols=262  Identities=26%  Similarity=0.422  Sum_probs=216.9

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+ ....++|
T Consensus        49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~lv  126 (387)
T 1kob_A           49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFED-KYEMVLI  126 (387)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-SSEEEEE
T ss_pred             cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe-CCEEEEE
Confidence            3578999999999999999999999999999999997553 3345678899999999999999999999987 6889999


Q ss_pred             EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecC-CCcEEEeecCcchhhccCcc
Q 020657          129 MEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNN-NMQVKIADFGVSKIMCRSLD  206 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~-~~~~kl~Dfg~~~~~~~~~~  206 (323)
                      |||+.+++|.+++... ..+++..++.++.||+.||.|||+.|++||||||+||+++.+ ...+||+|||++....... 
T Consensus       127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~-  205 (387)
T 1kob_A          127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-  205 (387)
T ss_dssp             EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred             EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc-
Confidence            9999999999998754 379999999999999999999999999999999999999753 2379999999997654332 


Q ss_pred             ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCCh
Q 020657          207 ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP  286 (323)
Q Consensus       207 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (323)
                      ......+|..|+|||++...     .++.++||||||+++|+|++|..||.+.........+.. ............+++
T Consensus       206 ~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~s~  279 (387)
T 1kob_A          206 IVKVTTATAEFAAPEIVDRE-----PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR-CDWEFDEDAFSSVSP  279 (387)
T ss_dssp             CEEEECSSGGGCCHHHHTTC-----CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH-CCCCCCSSTTTTSCH
T ss_pred             ceeeeccCCCccCchhccCC-----CCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHh-CCCCCCccccccCCH
Confidence            22345789999999998743     345699999999999999999999965433222222211 111122334467899


Q ss_pred             hHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          287 EFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       287 ~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      ++.+||++||+.||++|||++++|+||||++..
T Consensus       280 ~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          280 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence            999999999999999999999999999998754

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-49  Score=354.31  Aligned_cols=262  Identities=27%  Similarity=0.392  Sum_probs=210.2

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC-----
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS-----  122 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----  122 (323)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++++....     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            3578999999999999999999999999999999996543 3455678899999999999999999999987632     


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          123 GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      ..+++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++....
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~  179 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQAD  179 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCC-CEEEEeeecccccc
Confidence            3469999999 6799999876 4789999999999999999999999999999999999999987 89999999997654


Q ss_pred             cCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhc--------
Q 020657          203 RSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICF--------  274 (323)
Q Consensus       203 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~--------  274 (323)
                      ..   .....+|..|+|||++.+    ...++.++||||||+++|+|++|..||.+.+.......+......        
T Consensus       180 ~~---~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  252 (367)
T 1cm8_A          180 SE---MTGYVVTRWYRAPEVILN----WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  252 (367)
T ss_dssp             SS---CCSSCSCGGGCCTHHHHT----TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             cc---cCcCcCCCCcCCHHHHhC----CCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            32   334578999999999863    234567999999999999999999999765443333322221110        


Q ss_pred             ------------------CCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          275 ------------------GDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       275 ------------------~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                                        .....+...+++++.+|+++||..||++|||++++|+||||++.+.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~  316 (367)
T 1cm8_A          253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  316 (367)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence                              0011233567999999999999999999999999999999987654

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-49  Score=347.14  Aligned_cols=270  Identities=32%  Similarity=0.521  Sum_probs=213.2

Q ss_pred             cchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceeceeEEcC-
Q 020657           44 TTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKP-  121 (323)
Q Consensus        44 ~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-  121 (323)
                      .......++|++.+.||+|+||.||+|.+..+++.|++|++.....  ....+.+|+.+++.+ .||||+++++++... 
T Consensus        17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   94 (326)
T 2x7f_A           17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFIKKN   94 (326)
T ss_dssp             CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred             hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc--cHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence            3344567899999999999999999999988999999999975532  235678999999998 799999999998763 


Q ss_pred             ----CCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeec
Q 020657          122 ----SGDIAILMEYMDSGTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADF  195 (323)
Q Consensus       122 ----~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Df  195 (323)
                          .+..++||||+++++|.+++...  ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++ .++|+||
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~-~~kl~Df  173 (326)
T 2x7f_A           95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA-EVKLVDF  173 (326)
T ss_dssp             --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC-CEEECCC
T ss_pred             CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCC-CEEEeeC
Confidence                46789999999999999999753  4799999999999999999999999999999999999999887 8999999


Q ss_pred             CcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcC
Q 020657          196 GVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFG  275 (323)
Q Consensus       196 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~  275 (323)
                      |++..............++..|+|||++.........++.++||||||+++|+|++|..||.....   ...+.......
T Consensus       174 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~  250 (326)
T 2x7f_A          174 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP---MRALFLIPRNP  250 (326)
T ss_dssp             TTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSC
T ss_pred             cCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH---HHHHHHhhcCc
Confidence            999776544333445678999999999874433345567799999999999999999999954432   22222222223


Q ss_pred             CCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          276 DPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       276 ~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      .+......++..+.+|+.+||..||++|||++++++||||++..
T Consensus       251 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  294 (326)
T 2x7f_A          251 APRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP  294 (326)
T ss_dssp             CCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred             cccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence            33344567899999999999999999999999999999998754

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-49  Score=364.65  Aligned_cols=265  Identities=23%  Similarity=0.319  Sum_probs=199.0

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcC----CCe
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP----SGD  124 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~~  124 (323)
                      .++|++.+.||+|+||.||+|++..+++.||+|++.... +....+.+.+|+.+++.++||||+++++++...    ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            478999999999999999999999999999999987543 345567889999999999999999999998542    256


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC
Q 020657          125 IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS  204 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~  204 (323)
                      +++||||+. ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++......
T Consensus       132 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~-~~kl~DFGla~~~~~~  209 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYP  209 (458)
T ss_dssp             EEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC-CEEECCCTTCBCTTSC
T ss_pred             EEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCC-CEeecccccchhccCc
Confidence            899999985 59999998888899999999999999999999999999999999999999997 8999999999765422


Q ss_pred             c---------------------------cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh------
Q 020657          205 L---------------------------DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL------  251 (323)
Q Consensus       205 ~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt------  251 (323)
                      .                           ......++|..|+|||++..    ...++.++|||||||++|||++      
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~----~~~~~~~~DiwSlG~il~elltg~~~~~  285 (458)
T 3rp9_A          210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL----QENYTEAIDVWSIGCIFAELLNMIKENV  285 (458)
T ss_dssp             TTCCCCCC---------------------------CCCTTCCHHHHTT----CCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred             cccccccccCccccccccccccccccccccccCCcccccccChHHhhC----CCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence            1                           11234577999999998642    3345679999999999999998      


Q ss_pred             -----CCCCCCCCCCC--------------------ccHHHHHHHHhc-------------------C----CC---CCC
Q 020657          252 -----GHFPFLQPGQR--------------------PDWATLMCAICF-------------------G----DP---PSL  280 (323)
Q Consensus       252 -----g~~p~~~~~~~--------------------~~~~~~~~~~~~-------------------~----~~---~~~  280 (323)
                           |..+|.+.+..                    .....+......                   .    ..   ...
T Consensus       286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (458)
T 3rp9_A          286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER  365 (458)
T ss_dssp             SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred             cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence                 56666443311                    000111110000                   0    00   011


Q ss_pred             CCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          281 PDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       281 ~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                      ...+++++.+||++||..||++|||++++|+||||++.+.
T Consensus       366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~  405 (458)
T 3rp9_A          366 FPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI  405 (458)
T ss_dssp             STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred             CCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence            2456899999999999999999999999999999998753

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.6e-49  Score=340.64  Aligned_cols=258  Identities=27%  Similarity=0.360  Sum_probs=216.7

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ..++|++.+.||+|+||.||+|.+..++..+++|++...... ....+.+|+.+++.++||||+++++++.+ ....++|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv   84 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE-DVDRFKQEIEIMKSLDHPNIIRLYETFED-NTDIYLV   84 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeEEEE
Confidence            357899999999999999999999999999999998754322 24678899999999999999999999987 6789999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEE---ecCCCcEEEeecCcchhhccCc
Q 020657          129 MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLV---NNNNMQVKIADFGVSKIMCRSL  205 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~---~~~~~~~kl~Dfg~~~~~~~~~  205 (323)
                      |||+++++|.+.+...+.+++..++.++.|++.||.|||+.|++|+||||+||++   +.++ .++|+|||++...... 
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~-~~~l~Dfg~~~~~~~~-  162 (277)
T 3f3z_A           85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDS-PLKLIDFGLAARFKPG-  162 (277)
T ss_dssp             EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTC-CEEECCCTTCEECCTT-
T ss_pred             EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCC-cEEEEecccceeccCc-
Confidence            9999999999999888889999999999999999999999999999999999999   6665 8999999999765433 


Q ss_pred             cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCC---CC
Q 020657          206 DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSL---PD  282 (323)
Q Consensus       206 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~  282 (323)
                      .......++..|+|||++.+.      ++.++||||||+++|+|++|..||.....    ......+........   ..
T Consensus       163 ~~~~~~~~t~~y~aPE~~~~~------~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~  232 (277)
T 3f3z_A          163 KMMRTKVGTPYYVSPQVLEGL------YGPECDEWSAGVMMYVLLCGYPPFSAPTD----SEVMLKIREGTFTFPEKDWL  232 (277)
T ss_dssp             SCBCCCCSCTTTCCHHHHTTC------BCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCCHHHHT
T ss_pred             cchhccCCCCCccChHHhccc------CCchhhehhHHHHHHHHHHCCCCCCCCCH----HHHHHHHHhCCCCCCchhhh
Confidence            233456789999999998532      56699999999999999999999965433    223223322222111   13


Q ss_pred             CCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          283 GASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       283 ~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                      .+++++.+|+++||+.||++|||+.++|+||||++...
T Consensus       233 ~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  270 (277)
T 3f3z_A          233 NVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLS  270 (277)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcccc
Confidence            68999999999999999999999999999999976543

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3.9e-49  Score=345.35  Aligned_cols=261  Identities=26%  Similarity=0.427  Sum_probs=219.1

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCCh-----HHHHHHHHHHHHHHcCCCCccceeceeEEcCC
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADP-----TVRRQVFREMEILRRTDSPFIVQCFGIFEKPS  122 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  122 (323)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++......     .....+.+|+.+++.+.||||+++++++.+ .
T Consensus         9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~   87 (321)
T 2a2a_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN-R   87 (321)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-S
T ss_pred             hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence            3467899999999999999999999989999999999755321     135678899999999999999999999987 6


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCC---cEEEeecCcch
Q 020657          123 GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNM---QVKIADFGVSK  199 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~---~~kl~Dfg~~~  199 (323)
                      ...++||||+.+++|.+++.....+++..++.++.||+.||.|||+.|++|+||||+||+++.++.   .++|+|||++.
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~  167 (321)
T 2a2a_A           88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (321)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence            789999999999999999998888999999999999999999999999999999999999988753   69999999997


Q ss_pred             hhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC---
Q 020657          200 IMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD---  276 (323)
Q Consensus       200 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~---  276 (323)
                      ...... ......++..|+|||++...     .++.++||||||+++|+|++|..||......    .....+....   
T Consensus       168 ~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~i~~~~~~~  237 (321)
T 2a2a_A          168 EIEDGV-EFKNIFGTPEFVAPEIVNYE-----PLGLEADMWSIGVITYILLSGASPFLGDTKQ----ETLANITSVSYDF  237 (321)
T ss_dssp             ECCTTC-CCCCCCSCGGGCCHHHHTTC-----CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH----HHHHHHHTTCCCC
T ss_pred             ecCccc-cccccCCCCCccCcccccCC-----CCCCccccHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHhccccc
Confidence            654432 23455689999999998643     3456999999999999999999999654332    2222222222   


Q ss_pred             CCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          277 PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       277 ~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      +..+...++..+.+|+++||+.||++|||++++++||||.+..
T Consensus       238 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~  280 (321)
T 2a2a_A          238 DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (321)
T ss_dssp             CHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred             ChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence            1122357899999999999999999999999999999998754

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1e-49  Score=348.20  Aligned_cols=268  Identities=26%  Similarity=0.393  Sum_probs=211.1

Q ss_pred             ccccccee-eeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceeceeEEcCCCeEE
Q 020657           49 AYSDLEKL-QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKPSGDIA  126 (323)
Q Consensus        49 ~~~~~~~~-~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~  126 (323)
                      ..++|++. +.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.++.++ +||||+++++++.+ .+..+
T Consensus        10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~-~~~~~   87 (316)
T 2ac3_A           10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG-HIRSRVFREVEMLYQCQGHRNVLELIEFFEE-EDRFY   87 (316)
T ss_dssp             TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS-CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEE
T ss_pred             cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc-hhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-CCEEE
Confidence            45789986 789999999999999998999999999975532 3356788999999885 79999999999987 68899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCC--cEEEeecCcchhhccC
Q 020657          127 ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNM--QVKIADFGVSKIMCRS  204 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~--~~kl~Dfg~~~~~~~~  204 (323)
                      +||||+.+++|.+++.....+++..+..++.||+.||.|||+.|++|+||||+||+++.++.  .+||+|||++......
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  167 (316)
T 2ac3_A           88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN  167 (316)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred             EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence            99999999999999988888999999999999999999999999999999999999987651  3999999998755321


Q ss_pred             c-------cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCc-----------cHH
Q 020657          205 L-------DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRP-----------DWA  266 (323)
Q Consensus       205 ~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~-----------~~~  266 (323)
                      .       .......++..|+|||++.........++.++||||||+++|+|++|..||.......           ...
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  247 (316)
T 2ac3_A          168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN  247 (316)
T ss_dssp             --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred             CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence            1       1122346899999999986321111234569999999999999999999997654322           012


Q ss_pred             HHHHHHhcCCCCCCC----CCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          267 TLMCAICFGDPPSLP----DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       267 ~~~~~~~~~~~~~~~----~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      .+...+.... ..++    ..++.++.+|+++||+.||++|||++++|+||||++..
T Consensus       248 ~~~~~i~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  303 (316)
T 2ac3_A          248 MLFESIQEGK-YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA  303 (316)
T ss_dssp             HHHHHHHHCC-CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred             HHHHHHhccC-cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence            2333333222 2222    46899999999999999999999999999999998754

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.9e-49  Score=365.51  Aligned_cols=261  Identities=28%  Similarity=0.462  Sum_probs=217.1

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCCh------------HHHHHHHHHHHHHHcCCCCcccee
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADP------------TVRRQVFREMEILRRTDSPFIVQC  114 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~i~~~  114 (323)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++......            .....+.+|+.+++.++||||+++
T Consensus        32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  111 (504)
T 3q5i_A           32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL  111 (504)
T ss_dssp             SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            34568899999999999999999999999999999999754311            235678899999999999999999


Q ss_pred             ceeEEcCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC--CcEEE
Q 020657          115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN--MQVKI  192 (323)
Q Consensus       115 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~--~~~kl  192 (323)
                      ++++.+ ....++||||+.+++|.+.+.....+++..+..++.||+.||.|||+.|++||||||+||+++.++  ..+||
T Consensus       112 ~~~~~~-~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl  190 (504)
T 3q5i_A          112 FDVFED-KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI  190 (504)
T ss_dssp             EEEEEC-SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred             EEEEEc-CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence            999997 788999999999999999998888899999999999999999999999999999999999998765  26999


Q ss_pred             eecCcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHH
Q 020657          193 ADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAI  272 (323)
Q Consensus       193 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~  272 (323)
                      +|||++...... .......+++.|+|||++..      .++.++||||||+++|+|++|..||.+...    ..+...+
T Consensus       191 ~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i  259 (504)
T 3q5i_A          191 VDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK------KYNEKCDVWSCGVIMYILLCGYPPFGGQND----QDIIKKV  259 (504)
T ss_dssp             CCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT------CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHH
T ss_pred             EECCCCEEcCCC-CccccccCCcCCCCHHHhcc------CCCchHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHH
Confidence            999999766443 23345679999999999852      346699999999999999999999965433    3333333


Q ss_pred             hcCCCC---CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          273 CFGDPP---SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       273 ~~~~~~---~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      ..+...   .....+++++.+|+++||+.||++|||++++|+||||++..
T Consensus       260 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          260 EKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             HHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred             HcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence            333221   11257899999999999999999999999999999997654

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.2e-49  Score=341.57  Aligned_cols=263  Identities=26%  Similarity=0.426  Sum_probs=223.1

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEc-CCCeEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEK-PSGDIAI  127 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~l  127 (323)
                      .++|++.+.||+|++|.||+|.+..+++.|++|++.... .......+.+|+.+++.++||||+++++++.. .....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            579999999999999999999999899999999997653 44567788999999999999999999998743 3568999


Q ss_pred             EEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC-----CeecCCCCCCeEEecCCCcEEEeecCcc
Q 020657          128 LMEYMDSGTLDTLLNKN----GTFSEPKLAHIASQILKGLSYLHGHK-----IIHRDIKPSNLLVNNNNMQVKIADFGVS  198 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~~i~~~l~~Lh~~g-----ivH~di~~~nil~~~~~~~~kl~Dfg~~  198 (323)
                      ||||+++++|.+++...    ..+++..++.++.||+.||.|||+.|     ++|+||+|+||+++.++ .+||+|||++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~-~~kl~dfg~~  163 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGLA  163 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSS-CEEECCCCHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCC-CEEEecCchh
Confidence            99999999999999753    34999999999999999999999999     99999999999999987 8999999999


Q ss_pred             hhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCC
Q 020657          199 KIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPP  278 (323)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~  278 (323)
                      ..............++..|+|||++...     .++.++||||||+++|+|++|..||....    ...+...+..+...
T Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~i~~~~~~  234 (279)
T 2w5a_A          164 RILNHDTSFAKTFVGTPYYMSPEQMNRM-----SYNEKSDIWSLGCLLYELCALMPPFTAFS----QKELAGKIREGKFR  234 (279)
T ss_dssp             HHC---CHHHHHHHSCCTTCCHHHHHCC------CCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHTCCC
T ss_pred             eeeccccccccccCCCccccChHHhccC-----CCCchhhHHHHHHHHHHHHHCCCCCcccC----HHHHHHHHhhcccc
Confidence            7765433333345688999999998643     34679999999999999999999996543    34444455555666


Q ss_pred             CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCCCC
Q 020657          279 SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSD  322 (323)
Q Consensus       279 ~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~~  322 (323)
                      .++..++.++.+++.+||+.||++|||++++++|+|+.+...++
T Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~  278 (279)
T 2w5a_A          235 RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHH  278 (279)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGSCC
T ss_pred             cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhcccC
Confidence            77788999999999999999999999999999999999887765

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=5e-49  Score=343.10  Aligned_cols=259  Identities=26%  Similarity=0.383  Sum_probs=208.1

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcC-CCCccceeceeEEc
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRT-DSPFIVQCFGIFEK  120 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~  120 (323)
                      .....+..++|++.+.||+|+||+||+|++..+++.||+|++.... ..........|+..+..+ +|+||+++++++.+
T Consensus        49 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~  128 (311)
T 3p1a_A           49 SRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE  128 (311)
T ss_dssp             TSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             CCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe
Confidence            3444566689999999999999999999999899999999986543 334444555666666554 89999999999987


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcch
Q 020657          121 PSGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       121 ~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                       .+..++||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||||+||+++.++ .+||+|||++.
T Consensus       129 -~~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kl~DFG~a~  205 (311)
T 3p1a_A          129 -GGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRG-RCKLGDFGLLV  205 (311)
T ss_dssp             -TTEEEEEEECCC-CBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGG-CEEECCCTTCE
T ss_pred             -CCEEEEEEeccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC-CEEEccceeee
Confidence             788999999994 588888765 44699999999999999999999999999999999999999987 89999999987


Q ss_pred             hhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCC
Q 020657          200 IMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPS  279 (323)
Q Consensus       200 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  279 (323)
                      ..... .......+|..|+|||++.+      .++.++||||||+++|+|++|..|+...   .....+   .....++.
T Consensus       206 ~~~~~-~~~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~el~~g~~~~~~~---~~~~~~---~~~~~~~~  272 (311)
T 3p1a_A          206 ELGTA-GAGEVQEGDPRYMAPELLQG------SYGTAADVFSLGLTILEVACNMELPHGG---EGWQQL---RQGYLPPE  272 (311)
T ss_dssp             ECC-------CCCCCGGGCCGGGGGT------CCSTHHHHHHHHHHHHHHHHTCCCCSSH---HHHHHH---TTTCCCHH
T ss_pred             ecccC-CCCcccCCCccccCHhHhcC------CCCchhhHHHHHHHHHHHHhCCCCCCCc---cHHHHH---hccCCCcc
Confidence            65432 22344568999999998863      3567999999999999999997766332   112222   11122233


Q ss_pred             CCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          280 LPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       280 ~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                      ++..+++++.+|+++||+.||++|||++++|+||||++
T Consensus       273 ~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          273 FTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             cccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            45678999999999999999999999999999999975

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.9e-49  Score=351.99  Aligned_cols=263  Identities=27%  Similarity=0.368  Sum_probs=218.8

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC----CeE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS----GDI  125 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~  125 (323)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++...........+.+|+.+++.++||||+++++++....    ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            4789999999999999999999999999999999987666667788999999999999999999999987532    468


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc
Q 020657          126 AILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL  205 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~  205 (323)
                      ++||||+.+ +|.+++... .+++..++.++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++.......
T Consensus       106 ~iv~e~~~~-~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          106 YIVQDLMET-DLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDH  182 (364)
T ss_dssp             EEEEECCSE-EHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCGGG
T ss_pred             EEEEcccCc-CHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCC-CEEEEeCcceEecCCCC
Confidence            999999975 999988764 699999999999999999999999999999999999999987 89999999997654332


Q ss_pred             cc---cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcC-------
Q 020657          206 DA---CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFG-------  275 (323)
Q Consensus       206 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~-------  275 (323)
                      ..   .....++..|+|||++..    ...++.++||||||+++|+|++|..||.+.........+.......       
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  258 (364)
T 3qyz_A          183 DHTGFLTEYVATRWYRAPEIMLN----SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  258 (364)
T ss_dssp             CBCCTTCCCCSCGGGCCHHHHHT----BCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred             CccccccccccccCCCCCHHhcC----CCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            21   234578999999998642    2334669999999999999999999997766555444443221110       


Q ss_pred             --------------CCC-----CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          276 --------------DPP-----SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       276 --------------~~~-----~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                                    ...     .+...++.++.+|+++||++||++|||++++|+||||++..
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  321 (364)
T 3qyz_A          259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY  321 (364)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred             hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence                          000     11246789999999999999999999999999999998764

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=9.2e-49  Score=338.08  Aligned_cols=259  Identities=28%  Similarity=0.443  Sum_probs=216.3

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcC---CC
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP---SG  123 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~  123 (323)
                      .....|++...||+|+||.||+|.+..++..|++|++.... .......+.+|+.+++.++||||+++++++...   ..
T Consensus        23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  102 (290)
T 1t4h_A           23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK  102 (290)
T ss_dssp             TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred             cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence            44567999999999999999999999999999999987543 455677889999999999999999999987642   45


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCCeEEe-cCCCcEEEeecCcchh
Q 020657          124 DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK--IIHRDIKPSNLLVN-NNNMQVKIADFGVSKI  200 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g--ivH~di~~~nil~~-~~~~~~kl~Dfg~~~~  200 (323)
                      .+++||||+++++|.+++.....+++..++.++.||+.||.|||+.|  ++|+||||+||+++ .++ .++|+|||++..
T Consensus       103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~-~~kl~Dfg~~~~  181 (290)
T 1t4h_A          103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG-SVKIGDLGLATL  181 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTS-CEEECCTTGGGG
T ss_pred             eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCC-CEEEeeCCCccc
Confidence            68999999999999999998888999999999999999999999999  99999999999998 555 899999999965


Q ss_pred             hccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcC-CCCC
Q 020657          201 MCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFG-DPPS  279 (323)
Q Consensus       201 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~  279 (323)
                      ....  ......++..|+|||++.+      .++.++||||||+++|+|++|..||......   ..+....... .+..
T Consensus       182 ~~~~--~~~~~~~t~~y~aPE~~~~------~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~  250 (290)
T 1t4h_A          182 KRAS--FAKAVIGTPEFMAPEMYEE------KYDESVDVYAFGMCMLEMATSEYPYSECQNA---AQIYRRVTSGVKPAS  250 (290)
T ss_dssp             CCTT--SBEESCSSCCCCCGGGGGT------CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH---HHHHHHHTTTCCCGG
T ss_pred             cccc--ccccccCCcCcCCHHHHhc------cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH---HHHHHHHhccCCccc
Confidence            4332  2234568999999998752      2567999999999999999999999654332   2333333222 2334


Q ss_pred             CCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          280 LPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       280 ~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      ++...++++.+|+.+||+.||++|||++++++||||++.
T Consensus       251 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          251 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             cCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence            556778999999999999999999999999999999864

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.2e-49  Score=339.41  Aligned_cols=265  Identities=27%  Similarity=0.421  Sum_probs=213.6

Q ss_pred             cchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcC
Q 020657           44 TTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP  121 (323)
Q Consensus        44 ~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  121 (323)
                      ....+..++|++.+.||+|++|.||+|.+..+++.|++|++....  .......+.+|+.+++.++||||+++++++.. 
T Consensus         4 ~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-   82 (276)
T 2h6d_A            4 HDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST-   82 (276)
T ss_dssp             ---CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred             ccCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec-
Confidence            345567899999999999999999999999899999999986431  11234578899999999999999999999987 


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhh
Q 020657          122 SGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM  201 (323)
Q Consensus       122 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~  201 (323)
                      .+..++||||+.+++|.+++.....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++...
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~  161 (276)
T 2h6d_A           83 PTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHM-NAKIADFGLSNMM  161 (276)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTS-CEEECCCCGGGCC
T ss_pred             CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCC-CEEEeeccccccc
Confidence            678999999999999999998888899999999999999999999999999999999999999987 8999999999765


Q ss_pred             ccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCC
Q 020657          202 CRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLP  281 (323)
Q Consensus       202 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (323)
                      ... .......++..|+|||.+....    ..+.++||||||+++|+|++|..||....    ...+...+... ...++
T Consensus       162 ~~~-~~~~~~~~~~~y~aPE~~~~~~----~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~~~~~~~~-~~~~~  231 (276)
T 2h6d_A          162 SDG-EFLRTSCGSPNYAAPEVISGRL----YAGPEVDIWSCGVILYALLCGTLPFDDEH----VPTLFKKIRGG-VFYIP  231 (276)
T ss_dssp             CC--------------CCTGGGTTSC----CCHHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHC-CCCCC
T ss_pred             CCC-cceecccCCccccCHHHHcCCC----CCCccchHHHHHHHHHHHHhCCCCCCCCc----HHHHHHHhhcC-cccCc
Confidence            432 2223456889999999986332    23569999999999999999999995432    23333333322 33456


Q ss_pred             CCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          282 DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       282 ~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                      ..++..+.+|+.+||+.||++|||++++++||||++.-.
T Consensus       232 ~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  270 (276)
T 2h6d_A          232 EYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLP  270 (276)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred             hhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCch
Confidence            778999999999999999999999999999999987543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.6e-49  Score=352.09  Aligned_cols=266  Identities=24%  Similarity=0.367  Sum_probs=213.1

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcCCCCccceeceeEEcC------
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-PTVRRQVFREMEILRRTDSPFIVQCFGIFEKP------  121 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------  121 (323)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++..... ......+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            35899999999999999999999998999999999865532 22345677899999999999999999998763      


Q ss_pred             -CCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcch
Q 020657          122 -SGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       122 -~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                       .+..++||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++.
T Consensus        95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a~  172 (351)
T 3mi9_A           95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG-VLKLADFGLAR  172 (351)
T ss_dssp             --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred             CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC-CEEEccchhcc
Confidence             3468999999986 77666654 45799999999999999999999999999999999999999987 89999999997


Q ss_pred             hhccC----ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcC
Q 020657          200 IMCRS----LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFG  275 (323)
Q Consensus       200 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~  275 (323)
                      .....    ........++..|+|||++.+    ...++.++||||||+++|+|+||..||.+.........+...... 
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-  247 (351)
T 3mi9_A          173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLG----ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS-  247 (351)
T ss_dssp             ECCCCSSSSCCCCCSSCSCGGGCCHHHHTT----CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC-
T ss_pred             cccccccccccccCCcccccCccCchhhcC----CCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC-
Confidence            65422    122334568999999998853    233567999999999999999999999765444333333332222 


Q ss_pred             CCCCCCCC----------------------------CChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCCC
Q 020657          276 DPPSLPDG----------------------------ASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS  321 (323)
Q Consensus       276 ~~~~~~~~----------------------------~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~  321 (323)
                      .++.....                            .++++.+|+++||+.||++|||++++|+||||.+...+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  321 (351)
T 3mi9_A          248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP  321 (351)
T ss_dssp             CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred             CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence            11111111                            26779999999999999999999999999999876544

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.3e-49  Score=345.27  Aligned_cols=266  Identities=32%  Similarity=0.547  Sum_probs=215.3

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEE
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      ...++|++.+.||+|+||.||+|.+..+++.|++|++..... .....+.+|+.+++.++||||+++++++.. .+..++
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l   93 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE-EELEDYIVEIEILATCDHPYIVKLLGAYYH-DGKLWI   93 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-C-CEEE
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH-HHHHHHHHHHHHHhcCCCCCEeeeeeeeee-CCeEEE
Confidence            456889999999999999999999998999999999875432 335678899999999999999999999987 678999


Q ss_pred             EEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc
Q 020657          128 LMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD  206 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~  206 (323)
                      ||||+++++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++........
T Consensus        94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~  172 (302)
T 2j7t_A           94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQ  172 (302)
T ss_dssp             EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTS-CEEECCCHHHHHHHHHHH
T ss_pred             EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCC-CEEEEECCCCcccccccc
Confidence            9999999999998875 55799999999999999999999999999999999999999887 899999999865433333


Q ss_pred             ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCC--CCCCCC
Q 020657          207 ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPP--SLPDGA  284 (323)
Q Consensus       207 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  284 (323)
                      ......++..|+|||++.........++.++||||||+++|+|++|..||.....    ............+  ..+..+
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~  248 (302)
T 2j7t_A          173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP----MRVLLKIAKSDPPTLLTPSKW  248 (302)
T ss_dssp             C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHHSCCCCCSSGGGS
T ss_pred             ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH----HHHHHHHhccCCcccCCcccc
Confidence            3345578999999999843222344556799999999999999999999965432    2222222222222  234578


Q ss_pred             ChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       285 ~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                      +.++.+|+.+||+.||++|||++++++||||++...
T Consensus       249 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  284 (302)
T 2j7t_A          249 SVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS  284 (302)
T ss_dssp             CHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred             CHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence            899999999999999999999999999999988654

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.6e-50  Score=356.14  Aligned_cols=277  Identities=25%  Similarity=0.383  Sum_probs=217.2

Q ss_pred             CCCCCCccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCC----CChHHHHHHHHHHHHHHcCCCCccc
Q 020657           37 TNNNTTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD----ADPTVRRQVFREMEILRRTDSPFIV  112 (323)
Q Consensus        37 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~  112 (323)
                      ...........-..++|++.+.||+|+||.||+|.+..+++.||+|++...    ........+.+|+.+++.++||||+
T Consensus        12 ~~~~~q~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv   91 (345)
T 3hko_A           12 ENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA   91 (345)
T ss_dssp             --CCCCCBCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBC
T ss_pred             ccccccCchhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcc
Confidence            333444445555678999999999999999999999999999999998643    1334567889999999999999999


Q ss_pred             eeceeEEcCCCeEEEEEeccCCCCHHHHHHh----------------------------------------cCCCCHHHH
Q 020657          113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNK----------------------------------------NGTFSEPKL  152 (323)
Q Consensus       113 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~----------------------------------------~~~~~~~~~  152 (323)
                      ++++++.+ .+..++||||+++++|.+++..                                        ...+++..+
T Consensus        92 ~~~~~~~~-~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (345)
T 3hko_A           92 RLYEVYED-EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLI  170 (345)
T ss_dssp             CEEEEEEC-SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHH
T ss_pred             eeehhhcc-CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHH
Confidence            99999987 6889999999999999998852                                        112367889


Q ss_pred             HHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC-CcEEEeecCcchhhccCcc----ccccccccccccCCcccCCCC
Q 020657          153 AHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN-MQVKIADFGVSKIMCRSLD----ACNSYVGTCAYMSPERFDPDA  227 (323)
Q Consensus       153 ~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~-~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~  227 (323)
                      +.++.||+.||.|||+.|++|+||||+||+++.++ ..+||+|||++........    ......++..|+|||++... 
T Consensus       171 ~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-  249 (345)
T 3hko_A          171 SNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT-  249 (345)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCS-
T ss_pred             HHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccC-
Confidence            99999999999999999999999999999998654 2799999999976533211    23456789999999998631 


Q ss_pred             CCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCC--CCCCCCChhHHHHHHHhcccCcCCCCC
Q 020657          228 YGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPP--SLPDGASPEFRSFIECCLQKEFSKRWT  305 (323)
Q Consensus       228 ~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~ll~~~l~~~p~~Rpt  305 (323)
                        ...++.++||||||+++|+|++|..||...........+..   .....  .....+++++.+|+.+||+.||.+|||
T Consensus       250 --~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  324 (345)
T 3hko_A          250 --NESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLN---KKLCFENPNYNVLSPLARDLLSNLLNRNVDERFD  324 (345)
T ss_dssp             --SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---CCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred             --CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHh---cccccCCcccccCCHHHHHHHHHHcCCChhHCCC
Confidence              23456799999999999999999999965543332222222   12111  122357999999999999999999999


Q ss_pred             HHHHhcCcccccCCC
Q 020657          306 ASQLLTHPFLCKNRR  320 (323)
Q Consensus       306 ~~~~l~h~~f~~~~~  320 (323)
                      +.++|+||||++...
T Consensus       325 ~~~~l~hp~~~~~~~  339 (345)
T 3hko_A          325 AMRALQHPWISQFSD  339 (345)
T ss_dssp             HHHHHHSHHHHTTSS
T ss_pred             HHHHhcChhhccChH
Confidence            999999999988653

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3.8e-49  Score=340.30  Aligned_cols=266  Identities=34%  Similarity=0.548  Sum_probs=206.2

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHH-HHHHHHHHHcCCCCccceeceeEEcCCCe
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQ-VFREMEILRRTDSPFIVQCFGIFEKPSGD  124 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~-~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  124 (323)
                      ..+..++|++.+.||+|+||.||+|.+..+++.||+|++........... +.++...++.++||||+++++++.+ .+.
T Consensus         2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-~~~   80 (290)
T 3fme_A            2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR-EGD   80 (290)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSS
T ss_pred             CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec-cCC
Confidence            35678999999999999999999999998999999999976654444344 4444455777899999999999987 678


Q ss_pred             EEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCCeEEecCCCcEEEeecCcch
Q 020657          125 IAILMEYMDSGTLDTLLN----KNGTFSEPKLAHIASQILKGLSYLHGH-KIIHRDIKPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~----~~~~~~~~~~~~i~~~i~~~l~~Lh~~-givH~di~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                      .++||||+++ +|.+++.    ....+++..++.++.||+.||.|||++ |++|+||||+||+++.++ .+||+|||++.
T Consensus        81 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~  158 (290)
T 3fme_A           81 VWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG-QVKMCDFGISG  158 (290)
T ss_dssp             EEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC-CEEBCCC----
T ss_pred             EEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEEEeecCCcc
Confidence            9999999985 8877765    356799999999999999999999998 999999999999999987 89999999997


Q ss_pred             hhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCC
Q 020657          200 IMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPS  279 (323)
Q Consensus       200 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  279 (323)
                      ...... ......++..|+|||++.... ....++.++||||||+++|+|+||..||...  ......+........+..
T Consensus       159 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~~  234 (290)
T 3fme_A          159 YLVDDV-AKDIDAGCKPYMAPERINPEL-NQKGYSVKSDIWSLGITMIELAILRFPYDSW--GTPFQQLKQVVEEPSPQL  234 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCT-TC--CCHHHHHHHHHHHHHHHHHTSCSSCCC--SCHHHHHHHHHHSCCCCC
T ss_pred             cccccc-cccccCCCccccChhhcChhh-cCcCCCcHHHHHHHHHHHHHHHHCCCCcccc--CchHHHHHHHhccCCCCc
Confidence            654432 223346899999999974221 2345677999999999999999999999543  223344444444444444


Q ss_pred             CCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          280 LPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       280 ~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      ....++.++.+|+.+||+.||++|||++++++||||+..
T Consensus       235 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          235 PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence            446789999999999999999999999999999999754

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=7.7e-49  Score=341.49  Aligned_cols=264  Identities=27%  Similarity=0.460  Sum_probs=209.2

Q ss_pred             CCccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEE
Q 020657           41 TTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFE  119 (323)
Q Consensus        41 ~~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  119 (323)
                      .......+..++|++.+.||+|+||.||+|++  +++.||+|++.... .......+.+|+.++++++||||+++++++.
T Consensus        27 ~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  104 (309)
T 3p86_A           27 MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT  104 (309)
T ss_dssp             -----CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCcccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            34666778899999999999999999999988  68899999997554 3455678899999999999999999999998


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCCeEEecCCCcEEEee
Q 020657          120 KPSGDIAILMEYMDSGTLDTLLNKNGT---FSEPKLAHIASQILKGLSYLHGHK--IIHRDIKPSNLLVNNNNMQVKIAD  194 (323)
Q Consensus       120 ~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~i~~~l~~Lh~~g--ivH~di~~~nil~~~~~~~~kl~D  194 (323)
                      + .+..++||||+.+++|.+++.....   +++..++.++.||+.||.|||+.|  ++||||||+||+++.++ .+||+|
T Consensus       105 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~-~~kL~D  182 (309)
T 3p86_A          105 Q-PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKY-TVKVCD  182 (309)
T ss_dssp             S-TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTC-CEEECC
T ss_pred             E-CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCC-cEEECC
Confidence            7 6779999999999999999986543   899999999999999999999999  99999999999999987 899999


Q ss_pred             cCcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhc
Q 020657          195 FGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICF  274 (323)
Q Consensus       195 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~  274 (323)
                      ||++..............++..|+|||++....     ++.++||||||+++|+|++|..||......   .........
T Consensus       183 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~elltg~~Pf~~~~~~---~~~~~~~~~  254 (309)
T 3p86_A          183 FGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP-----SNEKSDVYSFGVILWELATLQQPWGNLNPA---QVVAAVGFK  254 (309)
T ss_dssp             CC-----------------CCTTSCHHHHTTCC-----CCTTHHHHHHHHHHHHHHHCCCTTTTSCHH---HHHHHHHHS
T ss_pred             CCCCccccccccccccCCCCccccChhhhcCCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhc
Confidence            999976554444445667899999999987443     456999999999999999999999544322   222222223


Q ss_pred             CCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc--Ccccc
Q 020657          275 GDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT--HPFLC  316 (323)
Q Consensus       275 ~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~--h~~f~  316 (323)
                      .....++..+++++.+|+++||+.||++|||++++++  ++++.
T Consensus       255 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~  298 (309)
T 3p86_A          255 CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK  298 (309)
T ss_dssp             CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            4456677889999999999999999999999999987  34443

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.5e-49  Score=341.91  Aligned_cols=261  Identities=29%  Similarity=0.445  Sum_probs=219.8

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCC
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG  123 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  123 (323)
                      ..+..++|++.+.||+|++|.||+|.+..+++.|++|++....  .......+.+|+.+++.++||||+++++++.+ .+
T Consensus         9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   87 (284)
T 2vgo_A            9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD-RK   87 (284)
T ss_dssp             -CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SS
T ss_pred             cchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc-CC
Confidence            3456789999999999999999999999899999999985331  11224568899999999999999999999987 67


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          124 DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      ..++||||+++++|.+++.....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++.....
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           88 RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKG-ELKIADFGWSVHAPS  166 (284)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTC-CEEECCCTTCEECSS
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCC-CEEEecccccccCcc
Confidence            8999999999999999998888899999999999999999999999999999999999999987 899999999865433


Q ss_pred             CccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCC
Q 020657          204 SLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDG  283 (323)
Q Consensus       204 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (323)
                      .  ......++..|+|||++...     .++.++||||||+++|+|++|..||......    .....+. .....++..
T Consensus       167 ~--~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~-~~~~~~~~~  234 (284)
T 2vgo_A          167 L--RRRTMCGTLDYLPPEMIEGK-----THDEKVDLWCAGVLCYEFLVGMPPFDSPSHT----ETHRRIV-NVDLKFPPF  234 (284)
T ss_dssp             S--CBCCCCSCGGGCCHHHHTTC-----CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHH-TTCCCCCTT
T ss_pred             c--ccccccCCCCcCCHHHhccC-----CCCcccchhhHHHHHHHHHHCCCCCCCCCHh----HHHHHHh-ccccCCCCc
Confidence            2  22345789999999998743     3456999999999999999999999654332    2222222 223456678


Q ss_pred             CChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          284 ASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       284 ~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                      ++.++.+|+.+||+.||.+|||++++++||||+...+
T Consensus       235 ~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~  271 (284)
T 2vgo_A          235 LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR  271 (284)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred             CCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence            8999999999999999999999999999999976543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.1e-49  Score=379.57  Aligned_cols=263  Identities=27%  Similarity=0.436  Sum_probs=222.0

Q ss_pred             chhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcC-CCCccceeceeEEcC
Q 020657           45 TAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKP  121 (323)
Q Consensus        45 ~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~  121 (323)
                      ...+..++|++++.||+|+||.||+|++..+++.||+|++....  .......+..|..++..+ .||+|+++++++.+ 
T Consensus       335 ~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~-  413 (674)
T 3pfq_A          335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-  413 (674)
T ss_dssp             -----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC-
T ss_pred             cccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe-
Confidence            34566789999999999999999999999999999999986431  112235567888999887 79999999999987 


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhh
Q 020657          122 SGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM  201 (323)
Q Consensus       122 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~  201 (323)
                      .+.+++||||+++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++...
T Consensus       414 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g-~ikL~DFGla~~~  492 (674)
T 3pfq_A          414 MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKEN  492 (674)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSS-CEEECCCTTCEEC
T ss_pred             CCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCC-cEEEeecceeecc
Confidence            678999999999999999999888899999999999999999999999999999999999999998 8999999999765


Q ss_pred             ccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCC
Q 020657          202 CRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLP  281 (323)
Q Consensus       202 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (323)
                      ...........||+.|+|||++....     ++.++||||||+++|||++|..||.+.+.    ..+.+.+.. ....++
T Consensus       493 ~~~~~~~~~~~GT~~Y~APE~l~~~~-----~~~~~DvwSlGvilyelltG~~Pf~~~~~----~~~~~~i~~-~~~~~p  562 (674)
T 3pfq_A          493 IWDGVTTKTFCGTPDYIAPEIIAYQP-----YGKSVDWWAFGVLLYEMLAGQAPFEGEDE----DELFQSIME-HNVAYP  562 (674)
T ss_dssp             CCTTCCBCCCCSCSSSCCHHHHTCCC-----BSTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHS-SCCCCC
T ss_pred             ccCCcccccccCCCcccCHhhhcCCC-----CCccceEechHHHHHHHHcCCCCCCCCCH----HHHHHHHHh-CCCCCC
Confidence            44444456678999999999997444     45699999999999999999999965433    333333333 345677


Q ss_pred             CCCChhHHHHHHHhcccCcCCCCCH-----HHHhcCcccccCC
Q 020657          282 DGASPEFRSFIECCLQKEFSKRWTA-----SQLLTHPFLCKNR  319 (323)
Q Consensus       282 ~~~~~~l~~ll~~~l~~~p~~Rpt~-----~~~l~h~~f~~~~  319 (323)
                      ..++.++.+||++||+.||++||++     ++|++||||+++.
T Consensus       563 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~  605 (674)
T 3pfq_A          563 KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  605 (674)
T ss_dssp             TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred             ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence            8899999999999999999999997     9999999998763

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.2e-49  Score=364.42  Aligned_cols=260  Identities=24%  Similarity=0.399  Sum_probs=205.8

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC-----
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS-----  122 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----  122 (323)
                      ..++|++++.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.++||||+++++++....     
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            4588999999999999999999999999999999997542 3455678889999999999999999999996532     


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          123 GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      ...++||||+++ ++.+.+..  .+++..+..++.||+.||.|||+.||+||||||+||+++.++ .+||+|||++....
T Consensus       140 ~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~-~~kl~DFG~a~~~~  215 (464)
T 3ttj_A          140 QDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAG  215 (464)
T ss_dssp             CEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCCC----
T ss_pred             CeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCC-CEEEEEEEeeeecC
Confidence            467999999986 57666643  489999999999999999999999999999999999999987 89999999997664


Q ss_pred             cCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcC-------
Q 020657          203 RSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFG-------  275 (323)
Q Consensus       203 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~-------  275 (323)
                      .. ......++|..|+|||++.+.     .++.++||||||+++|+|++|..||.+.+....+..+.......       
T Consensus       216 ~~-~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~  289 (464)
T 3ttj_A          216 TS-FMMTPYVVTRYYRAPEVILGM-----GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  289 (464)
T ss_dssp             -C-CCC----CCCTTCCHHHHTTC-----CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             CC-cccCCCcccccccCHHHHcCC-----CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            33 223456789999999999744     34569999999999999999999997655433333333222110       


Q ss_pred             ----------CCCCC---------CCC-----------CChhHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          276 ----------DPPSL---------PDG-----------ASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       276 ----------~~~~~---------~~~-----------~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                                ..+.+         +..           .++++.+||++||..||++|||++|+|+||||+..
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~  362 (464)
T 3ttj_A          290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  362 (464)
T ss_dssp             SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence                      00000         000           14679999999999999999999999999999854

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=7e-49  Score=347.06  Aligned_cols=260  Identities=29%  Similarity=0.464  Sum_probs=216.6

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++....  .......+.+|+.+++.++||||+++++++.. .+..++
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~l  131 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAWL  131 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCeEEE
Confidence            466999999999999999999998899999999997553  23445678899999999999999999999987 678999


Q ss_pred             EEeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc
Q 020657          128 LMEYMDSGTLDTLLN-KNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD  206 (323)
Q Consensus       128 v~e~~~~~sL~~~l~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~  206 (323)
                      ||||+.| +|.+.+. ....+++..+..++.|++.||.|||+.|++||||||+||+++.++ .+||+|||++.....   
T Consensus       132 v~e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~---  206 (348)
T 1u5q_A          132 VMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAP---  206 (348)
T ss_dssp             EEECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-EEEECCCTTCBSSSS---
T ss_pred             EEecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEeeccCceecCC---
Confidence            9999975 7877775 456799999999999999999999999999999999999999987 999999999976532   


Q ss_pred             ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCCh
Q 020657          207 ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP  286 (323)
Q Consensus       207 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (323)
                       .....++..|+|||++...  ....++.++||||||+++|+|++|..||......   ..+........+...+..++.
T Consensus       207 -~~~~~gt~~y~aPE~~~~~--~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  280 (348)
T 1u5q_A          207 -ANSFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHIAQNESPALQSGHWSE  280 (348)
T ss_dssp             -BCCCCSCGGGCCHHHHHTT--SSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHSCCCCCCCTTSCH
T ss_pred             -CCcccCCcceeCHhhhccc--cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhcCCCCCCCCCCCH
Confidence             2345789999999998421  1234566999999999999999999999654322   222222233333444567899


Q ss_pred             hHHHHHHHhcccCcCCCCCHHHHhcCcccccCCCC
Q 020657          287 EFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS  321 (323)
Q Consensus       287 ~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~  321 (323)
                      .+.+|+.+||+.||++|||++++++||||.+.+.+
T Consensus       281 ~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~  315 (348)
T 1u5q_A          281 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP  315 (348)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred             HHHHHHHHHcccChhhCcCHHHHhhChhhhccCCc
Confidence            99999999999999999999999999999876543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=6e-49  Score=347.24  Aligned_cols=266  Identities=24%  Similarity=0.409  Sum_probs=216.0

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCC--CccceeceeEEcCCC
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDS--PFIVQCFGIFEKPSG  123 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~  123 (323)
                      .+..++|++.+.||+|+||.||+|.+. +++.||+|++.... .......+.+|+.+++.++|  +||+++++++.. ..
T Consensus         5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-~~   82 (343)
T 3dbq_A            5 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-DQ   82 (343)
T ss_dssp             ESSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SS
T ss_pred             eeecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee-CC
Confidence            456789999999999999999999985 68899999997553 44556788999999999986  999999999987 68


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          124 DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      ..++|||+ .+++|.+++...+.+++..+..++.||+.||.|||+.|++||||||+||++++ + .+||+|||++.....
T Consensus        83 ~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~-~-~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           83 YIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G-MLKLIDFGIANQMQP  159 (343)
T ss_dssp             EEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T-EEEECCCSSSCCC--
T ss_pred             EEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC-C-cEEEeecccccccCc
Confidence            89999995 56799999998889999999999999999999999999999999999999974 4 799999999976543


Q ss_pred             Ccc--ccccccccccccCCcccCCCCC------CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcC
Q 020657          204 SLD--ACNSYVGTCAYMSPERFDPDAY------GGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFG  275 (323)
Q Consensus       204 ~~~--~~~~~~~~~~y~aPE~~~~~~~------~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~  275 (323)
                      ...  ......++..|+|||++.....      ....++.++||||||+++|+|++|..||.....  ....+.......
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~~~~~~~  237 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLHAIIDPN  237 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHHHHCTT
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh--HHHHHHHHhcCC
Confidence            322  2235678999999999853211      124567899999999999999999999964322  233344444344


Q ss_pred             CCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          276 DPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       276 ~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      ....++...+.++.+|+.+||+.||++|||++++|+||||+...
T Consensus       238 ~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  281 (343)
T 3dbq_A          238 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  281 (343)
T ss_dssp             SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             cccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence            45566777889999999999999999999999999999997543

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.1e-48  Score=336.77  Aligned_cols=255  Identities=23%  Similarity=0.374  Sum_probs=212.1

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcC-CCCccceeceeEEcCCCeEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKPSGDIA  126 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~  126 (323)
                      ..++|++.+.||+|++|.||+|.+..+++.||+|++.... .......+.+|+..+..+ +||||+++++++.+ .+..+
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-~~~~~   87 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-DDHML   87 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-TTEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-CCeEE
Confidence            3578999999999999999999999899999999997653 334567788999999998 99999999999987 67899


Q ss_pred             EEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC---------------
Q 020657          127 ILMEYMDSGTLDTLLNKN----GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN---------------  187 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~---------------  187 (323)
                      +||||+++++|.+++...    ..+++..++.++.||+.||.|||++|++|+||||+||+++.++               
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~  167 (289)
T 1x8b_A           88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA  167 (289)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred             EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence            999999999999999754    6799999999999999999999999999999999999998432               


Q ss_pred             ---CcEEEeecCcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCcc
Q 020657          188 ---MQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPD  264 (323)
Q Consensus       188 ---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~  264 (323)
                         ..++|+|||.+......    ....++..|+|||++.+.    ...+.++||||||+++|+|++|..++...   ..
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~----~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~  236 (289)
T 1x8b_A          168 SNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQEN----YTHLPKADIFALALTVVCAAGAEPLPRNG---DQ  236 (289)
T ss_dssp             --CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTC----CTTHHHHHHHHHHHHHHHHTTCCCCCSSS---HH
T ss_pred             CCceEEEEcccccccccCCc----cccCCCccccChhHhcCC----CCCCchhhHHHHHHHHHHHhcCCCCCcch---hH
Confidence               37999999999765432    234589999999998632    23456999999999999999998776322   11


Q ss_pred             HHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          265 WATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                          .........+.++..+++++.+|+++||+.||++|||++++++||||.+..
T Consensus       237 ----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  287 (289)
T 1x8b_A          237 ----WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS  287 (289)
T ss_dssp             ----HHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred             ----HHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence                222333455667788999999999999999999999999999999998754

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1e-49  Score=350.82  Aligned_cols=252  Identities=27%  Similarity=0.429  Sum_probs=214.3

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-------hHHHHHHHHHHHHHHcCCCCccceeceeEEcC
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-------PTVRRQVFREMEILRRTDSPFIVQCFGIFEKP  121 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  121 (323)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++.....       ......+.+|+.+++.++||||+++++++.+ 
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-  100 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN-  100 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC-
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence            45789999999999999999999999999999999975531       1123456789999999999999999999987 


Q ss_pred             CCeEEEEEeccCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchh
Q 020657          122 SGDIAILMEYMDSG-TLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       122 ~~~~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                      .+..++||||+.++ +|.+++...+.+++..++.++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++..
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~a~~  179 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF-TIKLIDFGSAAY  179 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEE
T ss_pred             CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCC-cEEEeecccceE
Confidence            68899999999766 9999999888899999999999999999999999999999999999999987 899999999976


Q ss_pred             hccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCC
Q 020657          201 MCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSL  280 (323)
Q Consensus       201 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  280 (323)
                      .... .......++..|+|||++.+..+    .+.++||||||+++|+|++|..||.....           ........
T Consensus       180 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~----~~~~~DiwslG~il~el~~g~~pf~~~~~-----------~~~~~~~~  243 (335)
T 3dls_A          180 LERG-KLFYTFCGTIEYCAPEVLMGNPY----RGPELEMWSLGVTLYTLVFEENPFCELEE-----------TVEAAIHP  243 (335)
T ss_dssp             CCTT-CCBCEECSCGGGCCHHHHTTCCB----CSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----------GTTTCCCC
T ss_pred             CCCC-CceeccCCCccccChhhhcCCCC----CCCcccchhHHHHHHHHHhCCCchhhHHH-----------HHhhccCC
Confidence            5433 22344678999999999874332    35689999999999999999999954211           11122334


Q ss_pred             CCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          281 PDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       281 ~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      +..+++++.+|+++||+.||++|||++++++||||++.
T Consensus       244 ~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          244 PYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             CcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence            55689999999999999999999999999999999763

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=5.2e-49  Score=349.91  Aligned_cols=262  Identities=26%  Similarity=0.383  Sum_probs=213.1

Q ss_pred             CCccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCC-----CCccceec
Q 020657           41 TTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD-----SPFIVQCF  115 (323)
Q Consensus        41 ~~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~  115 (323)
                      .+.....+..++|++.+.||+|+||.||+|++..+++.||+|++...  .........|+.+++.+.     ||||++++
T Consensus        25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~  102 (360)
T 3llt_A           25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIVKYH  102 (360)
T ss_dssp             CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred             eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence            35566677889999999999999999999999989999999999633  355566778999999986     99999999


Q ss_pred             eeEEcCCCeEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEec--------
Q 020657          116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNN--------  185 (323)
Q Consensus       116 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~--------  185 (323)
                      +++.. .+..++||||+ +++|.+++....  .+++..++.++.||+.||.|||+.|++||||||+||+++.        
T Consensus       103 ~~~~~-~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~  180 (360)
T 3llt_A          103 GKFMY-YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLI  180 (360)
T ss_dssp             EEEEE-TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEE
T ss_pred             ceeeE-CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccccccc
Confidence            99987 67899999999 789999998654  5999999999999999999999999999999999999974        


Q ss_pred             -----------------CCCcEEEeecCcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHH
Q 020657          186 -----------------NNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLE  248 (323)
Q Consensus       186 -----------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~  248 (323)
                                       ++ .+||+|||++......   .....++..|+|||++.+..     ++.++||||||+++|+
T Consensus       181 ~~~~~~~~~~~~~~~~~~~-~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~e  251 (360)
T 3llt_A          181 TVRRVTDGKKIQIYRTKST-GIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLG-----WDVSSDMWSFGCVLAE  251 (360)
T ss_dssp             EEECTTTCCEEEEEEESCC-CEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCC-----CCTTHHHHHHHHHHHH
T ss_pred             chhcccccccccccccCCC-CEEEEeccCceecCCC---CcCccCcccccCcHHHcCCC-----CCCccchHHHHHHHHH
Confidence                             44 8999999999754332   23457899999999987443     4569999999999999


Q ss_pred             HHhCCCCCCCCCCCccHHHHHHHHhcCCC------------------------------------------CCCCCCCCh
Q 020657          249 LYLGHFPFLQPGQRPDWATLMCAICFGDP------------------------------------------PSLPDGASP  286 (323)
Q Consensus       249 lltg~~p~~~~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~  286 (323)
                      |++|..||...........+.... ...+                                          +.+....++
T Consensus       252 ll~g~~pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  330 (360)
T 3llt_A          252 LYTGSLLFRTHEHMEHLAMMESII-QPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHE  330 (360)
T ss_dssp             HHHSSCSCCCSSHHHHHHHHHHHT-CCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCH
T ss_pred             HHHCCCCCCCCcHHHHHHHHHHhc-CCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHH
Confidence            999999996644332222221111 0000                                          000112347


Q ss_pred             hHHHHHHHhcccCcCCCCCHHHHhcCcccc
Q 020657          287 EFRSFIECCLQKEFSKRWTASQLLTHPFLC  316 (323)
Q Consensus       287 ~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~  316 (323)
                      .+.+||++||+.||++|||++++|+||||+
T Consensus       331 ~l~~li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          331 LFCDFLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             HHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence            788999999999999999999999999996

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.4e-49  Score=351.81  Aligned_cols=264  Identities=26%  Similarity=0.390  Sum_probs=223.7

Q ss_pred             CCCccchhccccccceeeeecccCCeEEEEEE-----ecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccce
Q 020657           40 NTTATTAAIAYSDLEKLQVLGHGNGGTVYKVQ-----HRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQ  113 (323)
Q Consensus        40 ~~~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~-----~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~  113 (323)
                      ......+.+..++|++.+.||+|+||.||+|+     +..+++.||+|++.........+.+.+|+.+++++ .||||++
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            34567888999999999999999999999998     44567899999998776666778899999999999 7899999


Q ss_pred             eceeEEcCCCeEEEEEeccCCCCHHHHHHhcCC-----------------------------------------------
Q 020657          114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGT-----------------------------------------------  146 (323)
Q Consensus       114 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----------------------------------------------  146 (323)
                      +++++.......++||||+.+++|.+++.....                                               
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            999998866679999999999999999976432                                               


Q ss_pred             -------------------CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc--
Q 020657          147 -------------------FSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL--  205 (323)
Q Consensus       147 -------------------~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~--  205 (323)
                                         +++..++.++.||+.||.|||+.|++|+||||+||+++.++ .+||+|||++.......  
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~  249 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDY  249 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTSCTTC
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC-cEEEEeccceeeecccccc
Confidence                               89999999999999999999999999999999999999887 89999999997653322  


Q ss_pred             cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCC
Q 020657          206 DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA  284 (323)
Q Consensus       206 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (323)
                      .......++..|+|||++..     ..++.++||||||+++|+|+| |..||.+.....   .+............+..+
T Consensus       250 ~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~  321 (359)
T 3vhe_A          250 VRKGDARLPLKWMAPETIFD-----RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---EFCRRLKEGTRMRAPDYT  321 (359)
T ss_dssp             EEC--CEECGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH---HHHHHHHHTCCCCCCTTC
T ss_pred             hhccccCCCceeEChhhhcC-----CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH---HHHHHHHcCCCCCCCCCC
Confidence            22334567889999999863     335679999999999999998 999997655443   333344445566677889


Q ss_pred             ChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          285 SPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       285 ~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ++++.+++.+||+.||++|||++++++|
T Consensus       322 ~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          322 TPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            9999999999999999999999999986

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.4e-49  Score=348.27  Aligned_cols=266  Identities=27%  Similarity=0.385  Sum_probs=214.3

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-------ChHHHHHHHHHHHHHHcCCCCccceeceeEEc
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-------DPTVRRQVFREMEILRRTDSPFIVQCFGIFEK  120 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  120 (323)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++....       .......+.+|+.+++.++||||+++++++..
T Consensus         7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   86 (322)
T 2ycf_A            7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA   86 (322)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence            34578999999999999999999999899999999986442       11233457899999999999999999999876


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC--CcEEEeecCcc
Q 020657          121 PSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN--MQVKIADFGVS  198 (323)
Q Consensus       121 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~--~~~kl~Dfg~~  198 (323)
                        +..++||||+.+++|.+.+.....+++..++.++.||+.||.|||++|++|+||||+||+++.++  ..+||+|||++
T Consensus        87 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  164 (322)
T 2ycf_A           87 --EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  164 (322)
T ss_dssp             --SSEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred             --CceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence              34899999999999999998888899999999999999999999999999999999999998754  24999999999


Q ss_pred             hhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCC
Q 020657          199 KIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPP  278 (323)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~  278 (323)
                      ....... ......++..|+|||++...  ....++.++||||||+++|+|++|..||.....................+
T Consensus       165 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  241 (322)
T 2ycf_A          165 KILGETS-LMRTLCGTPTYLAPEVLVSV--GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP  241 (322)
T ss_dssp             EECCCCH-HHHHHHSCCTTCCHHHHHHT--TTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCH
T ss_pred             eeccccc-ccccccCCcCccCchhhccC--CCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCc
Confidence            7653321 12345689999999987421  12345679999999999999999999997665554444333322211122


Q ss_pred             CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          279 SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       279 ~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      .....++.++.+|+++||+.||++|||++++|+||||++.
T Consensus       242 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          242 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence            2235789999999999999999999999999999999763

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=7.5e-50  Score=346.77  Aligned_cols=272  Identities=28%  Similarity=0.450  Sum_probs=193.9

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS  122 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  122 (323)
                      ..++.+..++|++.+.||+|++|.||+|.+..+++.||+|++...........+.+|+.+++.++||||+++++++.. .
T Consensus         7 ~~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   85 (303)
T 2vwi_A            7 ALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV-K   85 (303)
T ss_dssp             ------CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEES-S
T ss_pred             ccccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee-c
Confidence            345678889999999999999999999999889999999998765444556778899999999999999999999987 6


Q ss_pred             CeEEEEEeccCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEee
Q 020657          123 GDIAILMEYMDSGTLDTLLNK--------NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIAD  194 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~--------~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~D  194 (323)
                      +..++||||+.+++|.+++..        ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~d  164 (303)
T 2vwi_A           86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG-SVQIAD  164 (303)
T ss_dssp             SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC-CEEECC
T ss_pred             CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCC-CEEEEe
Confidence            789999999999999999863        45689999999999999999999999999999999999999987 899999


Q ss_pred             cCcchhhccCc-----cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHH
Q 020657          195 FGVSKIMCRSL-----DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLM  269 (323)
Q Consensus       195 fg~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~  269 (323)
                      ||++.......     .......++..|+|||++...    ..++.++||||||+++|+|++|..||.............
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  240 (303)
T 2vwi_A          165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV----RGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL  240 (303)
T ss_dssp             CHHHHHCC---------------CCCTTCCHHHHHHH----HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH
T ss_pred             ccchheeccCCCccchhhhcccCCCccccCHHHhccc----cCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHh
Confidence            99997654321     112345689999999987521    224569999999999999999999996654332222211


Q ss_pred             HHHhcC-----CCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          270 CAICFG-----DPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       270 ~~~~~~-----~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                      ......     ........++.++.+|+.+||+.||.+|||++++++||||++.+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  296 (303)
T 2vwi_A          241 QNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN  296 (303)
T ss_dssp             TSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred             ccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence            111000     011233567899999999999999999999999999999987654

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.5e-48  Score=339.00  Aligned_cols=258  Identities=28%  Similarity=0.455  Sum_probs=215.2

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ..++|++.+.||+|+||.||+|++..+++.|++|++..... .....+.+|+.+++.++||||+++++++.+ .+..++|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv   84 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYES-TTHYYLV   84 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhccc-CCEEEEE
Confidence            45789999999999999999999998999999999975432 234567899999999999999999999987 6789999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEE---ecCCCcEEEeecCcchhhccCc
Q 020657          129 MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLV---NNNNMQVKIADFGVSKIMCRSL  205 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~---~~~~~~~kl~Dfg~~~~~~~~~  205 (323)
                      |||+++++|.+++...+.+++..+..++.||+.||.|||+.|++|+||+|+||++   +.++ .++|+|||++...... 
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~-~~kl~Dfg~~~~~~~~-  162 (304)
T 2jam_A           85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENS-KIMITDFGLSKMEQNG-  162 (304)
T ss_dssp             ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTC-CEEBCSCSTTCCCCCB-
T ss_pred             EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCC-CEEEccCCcceecCCC-
Confidence            9999999999999888889999999999999999999999999999999999999   5565 8999999998654322 


Q ss_pred             cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC---CCCCCC
Q 020657          206 DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD---PPSLPD  282 (323)
Q Consensus       206 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~  282 (323)
                       ......++..|+|||++...     .++.++||||||+++|+|++|..||.....    ..+...+..+.   ......
T Consensus       163 -~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~  232 (304)
T 2jam_A          163 -IMSTACGTPGYVAPEVLAQK-----PYSKAVDCWSIGVITYILLCGYPPFYEETE----SKLFEKIKEGYYEFESPFWD  232 (304)
T ss_dssp             -TTHHHHSCCCBCCTTTBSSC-----SCCHHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHHCCCCCCTTTTT
T ss_pred             -ccccccCCCCccChHHhccC-----CCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHcCCCCCCccccc
Confidence             22344688999999998643     356799999999999999999999965433    22322222222   234456


Q ss_pred             CCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          283 GASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       283 ~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                      .++.++.+|+.+||+.||++|||++++++||||++...
T Consensus       233 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (304)
T 2jam_A          233 DISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTA  270 (304)
T ss_dssp             TSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCS
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCCc
Confidence            78999999999999999999999999999999987643

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=9e-49  Score=349.29  Aligned_cols=258  Identities=24%  Similarity=0.350  Sum_probs=218.4

Q ss_pred             cchhccccccceeeeecccCCeEEEEEEec-------ccCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceec
Q 020657           44 TTAAIAYSDLEKLQVLGHGNGGTVYKVQHR-------CTHKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCF  115 (323)
Q Consensus        44 ~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~-------~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~  115 (323)
                      ..+.+..++|++.+.||+|+||.||+|++.       .++..||+|++...........+.+|+.+++.+ +||||++++
T Consensus        74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~  153 (370)
T 2psq_A           74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL  153 (370)
T ss_dssp             TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred             ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence            345677899999999999999999999874       245679999998776666778899999999999 899999999


Q ss_pred             eeEEcCCCeEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 020657          116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNG----------------TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPS  179 (323)
Q Consensus       116 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~  179 (323)
                      +++.. .+.+++||||+.+++|.+++....                .+++..++.++.||+.||.|||++|++||||||+
T Consensus       154 ~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~  232 (370)
T 2psq_A          154 GACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR  232 (370)
T ss_dssp             EEECS-SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred             EEEcc-CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchh
Confidence            99987 678999999999999999997643                4789999999999999999999999999999999


Q ss_pred             CeEEecCCCcEEEeecCcchhhccCcc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 020657          180 NLLVNNNNMQVKIADFGVSKIMCRSLD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPF  256 (323)
Q Consensus       180 nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~  256 (323)
                      ||+++.++ .+||+|||++........  ......++..|+|||++..     ..++.++||||||+++|||+| |..||
T Consensus       233 NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DvwslG~il~ellt~g~~p~  306 (370)
T 2psq_A          233 NVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-----RVYTHQSDVWSFGVLMWEIFTLGGSPY  306 (370)
T ss_dssp             GEEECTTC-CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-----CCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             hEEECCCC-CEEEccccCCcccCcccceecccCCCcccceECHhHhcC-----CCCCcHHHHHHHHHHHHHHHcCCCCCC
Confidence            99999987 899999999976543221  2233456788999999863     345679999999999999999 99999


Q ss_pred             CCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          257 LQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      .+....    .+...+..+.....+..++.++.+|+++||+.||++|||+++++++
T Consensus       307 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          307 PGIPVE----ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             TTCCGG----GHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHH----HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            665433    3333444455667778899999999999999999999999999875

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-49  Score=350.56  Aligned_cols=267  Identities=30%  Similarity=0.474  Sum_probs=223.0

Q ss_pred             hhccccccceeeeecccCCeEEEEEEec---ccCcEEEEEeecCCC---ChHHHHHHHHHHHHHHcC-CCCccceeceeE
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHR---CTHKIYALKVVHGDA---DPTVRRQVFREMEILRRT-DSPFIVQCFGIF  118 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~---~~~~~v~iK~~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~  118 (323)
                      ..+..++|++.+.||+|+||.||+|++.   .+++.||+|++....   .......+.+|+.+++.+ .||||+++++++
T Consensus        49 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  128 (355)
T 1vzo_A           49 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF  128 (355)
T ss_dssp             CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred             ccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence            3455689999999999999999999984   478999999986431   112234466789999998 699999999999


Q ss_pred             EcCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcc
Q 020657          119 EKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVS  198 (323)
Q Consensus       119 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~  198 (323)
                      .. ....++||||+.+++|.+++.....+++..+..++.||+.||.|||+.|++|+||||+||+++.++ .+||+|||++
T Consensus       129 ~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a  206 (355)
T 1vzo_A          129 QT-ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLS  206 (355)
T ss_dssp             EE-TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEESCSSEE
T ss_pred             ee-CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-cEEEeeCCCC
Confidence            87 678999999999999999998888899999999999999999999999999999999999999987 8999999999


Q ss_pred             hhhccC-ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCC
Q 020657          199 KIMCRS-LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP  277 (323)
Q Consensus       199 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~  277 (323)
                      ...... ........+|..|+|||++.+.   ...++.++||||||+++|+|++|..||...........+....... .
T Consensus       207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~  282 (355)
T 1vzo_A          207 KEFVADETERAYDFCGTIEYMAPDIVRGG---DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-E  282 (355)
T ss_dssp             EECCGGGGGGGCGGGSCCTTCCHHHHTTC---C---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-C
T ss_pred             eecccCCCCcccCcccCcCccChhhhcCC---CCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc-C
Confidence            765332 2223345789999999998632   2234569999999999999999999998766665555555544433 4


Q ss_pred             CCCCCCCChhHHHHHHHhcccCcCCCC-----CHHHHhcCcccccC
Q 020657          278 PSLPDGASPEFRSFIECCLQKEFSKRW-----TASQLLTHPFLCKN  318 (323)
Q Consensus       278 ~~~~~~~~~~l~~ll~~~l~~~p~~Rp-----t~~~~l~h~~f~~~  318 (323)
                      +.++..++..+.+|+.+||+.||++||     |++++++||||++.
T Consensus       283 ~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~  328 (355)
T 1vzo_A          283 PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  328 (355)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence            556788999999999999999999999     99999999999875

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.4e-49  Score=367.07  Aligned_cols=260  Identities=30%  Similarity=0.473  Sum_probs=215.8

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEE
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIA  126 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  126 (323)
                      -..++|++.+.||+|+||+||+|.+..+++.||+|++.... .......+.+|+.+++.++||||+++++++.+ ....+
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~   97 (486)
T 3mwu_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-SSSFY   97 (486)
T ss_dssp             HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEE
T ss_pred             ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc-CCEEE
Confidence            35689999999999999999999999999999999985321 11224668899999999999999999999987 68899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC--CcEEEeecCcchhhccC
Q 020657          127 ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN--MQVKIADFGVSKIMCRS  204 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~--~~~kl~Dfg~~~~~~~~  204 (323)
                      +||||+.+++|.+.+...+.+++..+..++.||+.||.|||+.||+||||||+||+++..+  ..+||+|||++......
T Consensus        98 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  177 (486)
T 3mwu_A           98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (486)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence            9999999999999998888899999999999999999999999999999999999996432  37999999999765433


Q ss_pred             ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCC---CCCC
Q 020657          205 LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP---PSLP  281 (323)
Q Consensus       205 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~  281 (323)
                       .......+++.|+|||++.+      .++.++||||||+++|+|++|..||.+....    .+...+..+..   .+..
T Consensus       178 -~~~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~  246 (486)
T 3mwu_A          178 -TKMKDRIGTAYYIAPEVLRG------TYDEKCDVWSAGVILYILLSGTPPFYGKNEY----DILKRVETGKYAFDLPQW  246 (486)
T ss_dssp             -----CCTTGGGGCCGGGGGS------CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHTCCCSCSGGG
T ss_pred             -CccCCCcCCCCCCCHHHhCC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCCCccc
Confidence             22345679999999999863      2567999999999999999999999654332    23233322221   1223


Q ss_pred             CCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          282 DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       282 ~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      ..+++++.+||++||+.||++|||+.++|+||||++..
T Consensus       247 ~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          247 RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence            56899999999999999999999999999999998654

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.2e-48  Score=350.82  Aligned_cols=268  Identities=24%  Similarity=0.404  Sum_probs=216.7

Q ss_pred             chhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCC--CCccceeceeEEcC
Q 020657           45 TAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTD--SPFIVQCFGIFEKP  121 (323)
Q Consensus        45 ~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~  121 (323)
                      ...+...+|++.+.||+|+||.||+|.+. +++.||+|++.... .......+.+|+.+++.+.  ||||+++++++.. 
T Consensus        50 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~-  127 (390)
T 2zmd_A           50 CISVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-  127 (390)
T ss_dssp             CEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-
T ss_pred             cccccCCceEEEEEEccCCCeEEEEEEcC-CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec-
Confidence            34455678999999999999999999987 48999999997553 4556778899999999996  5999999999987 


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhh
Q 020657          122 SGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM  201 (323)
Q Consensus       122 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~  201 (323)
                      .+.+++||| +.+++|.+++.....+++..+..++.||+.||.|||+.||+||||||+||++++ + .+||+|||++...
T Consensus       128 ~~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~-~-~~kl~DFG~a~~~  204 (390)
T 2zmd_A          128 DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G-MLKLIDFGIANQM  204 (390)
T ss_dssp             SSEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS-S-CEEECCCSSSCCC
T ss_pred             CCEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC-C-eEEEEecCccccc
Confidence            678999999 457799999998888999999999999999999999999999999999999964 4 7999999999766


Q ss_pred             ccCcc--ccccccccccccCCcccCCCCC------CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHh
Q 020657          202 CRSLD--ACNSYVGTCAYMSPERFDPDAY------GGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAIC  273 (323)
Q Consensus       202 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~------~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~  273 (323)
                      .....  ......+|+.|+|||++.....      ....++.++||||||+++|+|++|..||.....  ....+.....
T Consensus       205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--~~~~~~~~~~  282 (390)
T 2zmd_A          205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLHAIID  282 (390)
T ss_dssp             ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HHHHHHHHHC
T ss_pred             cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH--HHHHHHHHhC
Confidence            43221  2345679999999999864221      123567899999999999999999999965432  2233333333


Q ss_pred             cCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          274 FGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       274 ~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      ......++...+.++.+|+++||+.||++|||+.++|+||||+...
T Consensus       283 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  328 (390)
T 2zmd_A          283 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  328 (390)
T ss_dssp             TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             ccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence            3344556677789999999999999999999999999999997654

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=9.5e-49  Score=338.63  Aligned_cols=271  Identities=32%  Similarity=0.506  Sum_probs=219.4

Q ss_pred             CccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcC
Q 020657           42 TATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP  121 (323)
Q Consensus        42 ~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  121 (323)
                      .........++|.....||+|+||.||+|.+..+++.|++|.+.... ......+.+|+.+++.++||||+++++++.. 
T Consensus        13 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-   90 (295)
T 2clq_A           13 DLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-   90 (295)
T ss_dssp             -CCCEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEE-
T ss_pred             ccccccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-
Confidence            34455566777888889999999999999999899999999997553 3445678899999999999999999999987 


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEec-CCCcEEEeecCc
Q 020657          122 SGDIAILMEYMDSGTLDTLLNKN---GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNN-NNMQVKIADFGV  197 (323)
Q Consensus       122 ~~~~~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~-~~~~~kl~Dfg~  197 (323)
                      .+..++||||+++++|.+++...   ..+++..+..++.||+.||.|||+.|++|+||+|+||+++. ++ .++|+|||+
T Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~-~~kl~Dfg~  169 (295)
T 2clq_A           91 NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSG-VLKISDFGT  169 (295)
T ss_dssp             TTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTC-CEEECCTTT
T ss_pred             CCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCC-CEEEeeccc
Confidence            67899999999999999999764   24678999999999999999999999999999999999998 55 899999999


Q ss_pred             chhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCC
Q 020657          198 SKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP  277 (323)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~  277 (323)
                      +..............++..|+|||++....   ..++.++||||||+++|+|++|..||......  .............
T Consensus       170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~  244 (295)
T 2clq_A          170 SKRLAGINPCTETFTGTLQYMAPEIIDKGP---RGYGKAADIWSLGCTIIEMATGKPPFYELGEP--QAAMFKVGMFKVH  244 (295)
T ss_dssp             CEESCC-----CCCCCCGGGCCHHHHHHGG---GGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH--HHHHHHHHHHCCC
T ss_pred             ccccCCCCCcccccCCCccccChhhhcCCC---CCCCcHHHHHHHHHHHHHHHHCCCCccCCCch--hHHHHhhcccccc
Confidence            976654333344567899999999986322   12456999999999999999999999654322  1222223333455


Q ss_pred             CCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          278 PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       278 ~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                      +.++..++.++.+|+.+||+.||++|||++++++||||+...+
T Consensus       245 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  287 (295)
T 2clq_A          245 PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK  287 (295)
T ss_dssp             CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred             ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence            6677889999999999999999999999999999999987654

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.8e-48  Score=340.04  Aligned_cols=261  Identities=35%  Similarity=0.595  Sum_probs=212.2

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeE
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDI  125 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  125 (323)
                      .....++|++.+.||+|+||.||+|.+..+++.|++|.+.....   ...+.+|+.+++.++||||+++++++.. .+..
T Consensus        24 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   99 (314)
T 3com_A           24 TKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD---LQEIIKEISIMQQCDSPHVVKYYGSYFK-NTDL   99 (314)
T ss_dssp             ------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC---CHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEE
T ss_pred             hhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH---HHHHHHHHHHHHhCCCCCCccEEEEEEe-CCEE
Confidence            34567899999999999999999999998999999999975532   3567889999999999999999999987 6789


Q ss_pred             EEEEeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC
Q 020657          126 AILMEYMDSGTLDTLLN-KNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS  204 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~  204 (323)
                      ++||||+.+++|.+++. ....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus       100 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          100 WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEG-HAKLADFGVAGQLTDT  178 (314)
T ss_dssp             EEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECBTT
T ss_pred             EEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCC-CEEEeecccchhhhhh
Confidence            99999999999999997 456799999999999999999999999999999999999999987 8999999999776554


Q ss_pred             ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCC--CCCC
Q 020657          205 LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPP--SLPD  282 (323)
Q Consensus       205 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~  282 (323)
                      ........++..|+|||++....     ++.++||||||+++|+|++|..||......   .... ........  ..+.
T Consensus       179 ~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~-~~~~~~~~~~~~~~  249 (314)
T 3com_A          179 MAKRNTVIGTPFWMAPEVIQEIG-----YNCVADIWSLGITAIEMAEGKPPYADIHPM---RAIF-MIPTNPPPTFRKPE  249 (314)
T ss_dssp             BSCBCCCCSCGGGCCHHHHSSSC-----BCTTHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHH-HHHHSCCCCCSSGG
T ss_pred             ccccCccCCCCCccChhhcCCCC-----CCccccHHHHHHHHHHHHhCCCCCCCCChH---HHHH-HHhcCCCcccCCcc
Confidence            44445567899999999987443     456999999999999999999999644322   1111 12222222  2345


Q ss_pred             CCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          283 GASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       283 ~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                      .++.++.+|+.+||+.||++|||++++++||||++...
T Consensus       250 ~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~  287 (314)
T 3com_A          250 LWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKG  287 (314)
T ss_dssp             GSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCC
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCc
Confidence            67899999999999999999999999999999987653

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.7e-48  Score=345.68  Aligned_cols=261  Identities=30%  Similarity=0.468  Sum_probs=216.9

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-------hHHHHHHHHHHHHHHcC-CCCccceeceeEEcC
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-------PTVRRQVFREMEILRRT-DSPFIVQCFGIFEKP  121 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-------~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~  121 (323)
                      .++|++.+.||+|++|.||+|.+..+|+.||+|++.....       ......+.+|+.+++.+ +||||+++++++.. 
T Consensus        93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-  171 (365)
T 2y7j_A           93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-  171 (365)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB-
T ss_pred             hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee-
Confidence            4679999999999999999999988999999999875531       12356678999999998 79999999999987 


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhh
Q 020657          122 SGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM  201 (323)
Q Consensus       122 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~  201 (323)
                      .+..++||||+.+++|.+++.....+++..+..++.||+.||.|||+.|++|+||||+||+++.++ .++|+|||++...
T Consensus       172 ~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~-~ikl~DfG~~~~~  250 (365)
T 2y7j_A          172 SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNM-QIRLSDFGFSCHL  250 (365)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEEEecCccccc
Confidence            688999999999999999998888899999999999999999999999999999999999999987 8999999999766


Q ss_pred             ccCccccccccccccccCCcccCCCCC-CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCC-
Q 020657          202 CRSLDACNSYVGTCAYMSPERFDPDAY-GGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPS-  279 (323)
Q Consensus       202 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-  279 (323)
                      .... ......++..|+|||++..... ....++.++||||||+++|+|++|..||.....    ......+..+.... 
T Consensus       251 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~  325 (365)
T 2y7j_A          251 EPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ----ILMLRMIMEGQYQFS  325 (365)
T ss_dssp             CTTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHTCCCCC
T ss_pred             CCCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH----HHHHHHHHhCCCCCC
Confidence            4332 2345678999999998853321 123456799999999999999999999965432    22222222222111 


Q ss_pred             --CCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          280 --LPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       280 --~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                        ....++..+.+|+++||+.||++|||++++|+||||++
T Consensus       326 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          326 SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence              12467899999999999999999999999999999974

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.6e-49  Score=364.87  Aligned_cols=257  Identities=28%  Similarity=0.465  Sum_probs=212.5

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      ..++|++++.||+|+||.||+|++..++..||+|++.... .......+.+|+.+++.++||||+++++++.+ ....++
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~l  113 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED-KRNYYL  113 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEE
Confidence            4567999999999999999999999999999999997543 12235668899999999999999999999987 688999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC--CcEEEeecCcchhhccCc
Q 020657          128 LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN--MQVKIADFGVSKIMCRSL  205 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~--~~~kl~Dfg~~~~~~~~~  205 (323)
                      ||||+.+++|.+.+.....+++..+..++.||+.||.|||+.|++||||||+||+++..+  ..+||+|||++...... 
T Consensus       114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~-  192 (494)
T 3lij_A          114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-  192 (494)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT-
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC-
Confidence            999999999999998888899999999999999999999999999999999999997643  25999999999766443 


Q ss_pred             cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCC---CCCCC
Q 020657          206 DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP---PSLPD  282 (323)
Q Consensus       206 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~  282 (323)
                      .......+++.|+|||++..      .++.++||||||+++|+|++|..||.+...    ..+...+..+..   .....
T Consensus       193 ~~~~~~~gt~~y~aPE~l~~------~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~  262 (494)
T 3lij_A          193 KKMKERLGTAYYIAPEVLRK------KYDEKCDVWSIGVILFILLAGYPPFGGQTD----QEILRKVEKGKYTFDSPEWK  262 (494)
T ss_dssp             BCBCCCCSCTTTCCHHHHTT------CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHTCCCCCSGGGT
T ss_pred             ccccccCCCcCeeCHHHHcc------cCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCCCCCchhcc
Confidence            23345679999999999852      356699999999999999999999965433    333333332222   22235


Q ss_pred             CCChhHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          283 GASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       283 ~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                      .+++++.+|+++||+.||++|||++++|+||||++
T Consensus       263 ~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  297 (494)
T 3lij_A          263 NVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE  297 (494)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred             cCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence            78999999999999999999999999999999975

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-49  Score=346.11  Aligned_cols=266  Identities=24%  Similarity=0.406  Sum_probs=215.4

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC-CeE
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS-GDI  125 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~  125 (323)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+|+.+++.++||||+++++++.... ...
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (319)
T 4euu_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (319)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence            3456899999999999999999999998999999999975443344567789999999999999999999987643 378


Q ss_pred             EEEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEE----ecCCCcEEEeecCcc
Q 020657          126 AILMEYMDSGTLDTLLNKNG---TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLV----NNNNMQVKIADFGVS  198 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~----~~~~~~~kl~Dfg~~  198 (323)
                      ++||||+++++|.+++....   .+++..++.++.||+.||.|||+.|++|+||||+||++    +.++ .+||+|||++
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~-~~kL~Dfg~a  163 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS-VYKLTDFGAA  163 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCE-EEEECCCTTC
T ss_pred             EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCc-eEEEccCCCc
Confidence            99999999999999997543   39999999999999999999999999999999999998    5554 7999999999


Q ss_pred             hhhccCccccccccccccccCCcccCCC---CCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcC
Q 020657          199 KIMCRSLDACNSYVGTCAYMSPERFDPD---AYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFG  275 (323)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~  275 (323)
                      ....... ......++..|+|||++...   ......++.++||||||+++|+|+||..||...........+...+..+
T Consensus       164 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          164 RELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             EECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             eecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            7654432 23445789999999987521   1113456679999999999999999999997665544444444444333


Q ss_pred             CCC------------------------CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcc
Q 020657          276 DPP------------------------SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPF  314 (323)
Q Consensus       276 ~~~------------------------~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~  314 (323)
                      .+.                        .+...++..+.+|+++||+.||++|||++++|+||-
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            321                        122234568999999999999999999999999974

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.7e-48  Score=341.21  Aligned_cols=261  Identities=23%  Similarity=0.392  Sum_probs=211.1

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCC-CCccceeceeEEcC-CCeE
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD-SPFIVQCFGIFEKP-SGDI  125 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~-~~~~  125 (323)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++....    .+.+.+|+.+++.++ ||||+++++++... ....
T Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~  108 (330)
T 3nsz_A           33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  108 (330)
T ss_dssp             EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred             cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence            34688999999999999999999999899999999996443    356789999999997 99999999999863 4568


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc
Q 020657          126 AILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL  205 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~  205 (323)
                      ++||||+.+++|.+++.   .+++..++.++.||+.||.|||+.|++||||||+||+++.++..+||+|||++...... 
T Consensus       109 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-  184 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-  184 (330)
T ss_dssp             EEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT-
T ss_pred             EEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC-
Confidence            99999999999999875   48999999999999999999999999999999999999977658999999999765433 


Q ss_pred             cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccH-HHHHH---------HHhcC
Q 020657          206 DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDW-ATLMC---------AICFG  275 (323)
Q Consensus       206 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~-~~~~~---------~~~~~  275 (323)
                      .......++..|+|||++..    ...++.++||||||+++|+|++|..||......... ..+..         .....
T Consensus       185 ~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  260 (330)
T 3nsz_A          185 QEYNVRVASRYFKGPELLVD----YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  260 (330)
T ss_dssp             CCCCSCCSCGGGCCHHHHTT----CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             CccccccccccccChhhhcC----CCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHh
Confidence            23345678899999999863    234567999999999999999999999654332111 11000         00000


Q ss_pred             C-----------------------CCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          276 D-----------------------PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       276 ~-----------------------~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                      .                       .......+++++.+||++||++||++|||++++|+||||++..+
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  328 (330)
T 3nsz_A          261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  328 (330)
T ss_dssp             TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred             ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence            0                       00111237899999999999999999999999999999998754

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.3e-48  Score=342.40  Aligned_cols=259  Identities=25%  Similarity=0.410  Sum_probs=216.6

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEecccCc---EEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEE
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFE  119 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~---~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  119 (323)
                      .....+..++|++.+.||+|+||.||+|.+..+++   .||+|++...........+.+|+.+++.++||||+++++++.
T Consensus        41 ~~~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  120 (325)
T 3kul_A           41 SFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVT  120 (325)
T ss_dssp             --CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             hhccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            33456788999999999999999999999975554   599999987767777788999999999999999999999998


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcc
Q 020657          120 KPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVS  198 (323)
Q Consensus       120 ~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~  198 (323)
                      + .+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++
T Consensus       121 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a  198 (325)
T 3kul_A          121 R-GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL-VCKVSDFGLS  198 (325)
T ss_dssp             G-GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCSSC
T ss_pred             e-CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCC-CEEECCCCcc
Confidence            7 67789999999999999999654 5799999999999999999999999999999999999999987 8999999999


Q ss_pred             hhhccCcc---ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhc
Q 020657          199 KIMCRSLD---ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICF  274 (323)
Q Consensus       199 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~  274 (323)
                      ........   ......++..|+|||++...     .++.++||||||+++|+|++ |..||...    ....+...+..
T Consensus       199 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~Di~slG~il~ell~~g~~p~~~~----~~~~~~~~~~~  269 (325)
T 3kul_A          199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR-----TFSSASDVWSFGVVMWEVLAYGERPYWNM----TNRDVISSVEE  269 (325)
T ss_dssp             EECC----CCEECC---CCGGGSCHHHHHHC-----EECHHHHHHHHHHHHHHHHTTSCCTTTTS----CHHHHHHHHHT
T ss_pred             cccccCccceeeccCCCCcccccCHhHhcCC-----CCCcHHHHHHHHHHHHHHHcCCCCCcccC----CHHHHHHHHHc
Confidence            76643322   12233456789999998643     34569999999999999998 99999544    33444555555


Q ss_pred             CCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          275 GDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       275 ~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ......+..+++++.+|+..||+.||++|||++++++.
T Consensus       270 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  307 (325)
T 3kul_A          270 GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV  307 (325)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            55666778899999999999999999999999999853

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.6e-48  Score=336.43  Aligned_cols=265  Identities=28%  Similarity=0.444  Sum_probs=218.7

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC--------hHHHHHHHHHHHHHHcCC-CCccceeceeE
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD--------PTVRRQVFREMEILRRTD-SPFIVQCFGIF  118 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~--------~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~  118 (323)
                      ...++|++.+.||+|++|.||+|.+..+++.||+|++.....        ......+.+|+.+++++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            456899999999999999999999998999999999975431        234567789999999995 99999999999


Q ss_pred             EcCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcc
Q 020657          119 EKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVS  198 (323)
Q Consensus       119 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~  198 (323)
                      .. ....++||||+++++|.+++.....+++..++.++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++
T Consensus        94 ~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~  171 (298)
T 1phk_A           94 ET-NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFS  171 (298)
T ss_dssp             EC-SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTC
T ss_pred             cc-CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCC-cEEEecccch
Confidence            87 688999999999999999999888899999999999999999999999999999999999999987 8999999999


Q ss_pred             hhhccCccccccccccccccCCcccCCCCC-CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC-
Q 020657          199 KIMCRSLDACNSYVGTCAYMSPERFDPDAY-GGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD-  276 (323)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~-  276 (323)
                      ...... .......++..|+|||++..... ....++.++||||||+++|+|++|..||......    .....+.... 
T Consensus       172 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~  246 (298)
T 1phk_A          172 CQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM----LMLRMIMSGNY  246 (298)
T ss_dssp             EECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHTCC
T ss_pred             hhcCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH----HHHHHHhcCCc
Confidence            765432 22344578999999998742111 1234567999999999999999999999654322    2222222222 


Q ss_pred             --CCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          277 --PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       277 --~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                        .......++..+.+|+.+||+.||++|||++++++||||++..
T Consensus       247 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (298)
T 1phk_A          247 QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV  291 (298)
T ss_dssp             CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred             ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence              1122246889999999999999999999999999999998764

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=6.7e-49  Score=339.62  Aligned_cols=260  Identities=25%  Similarity=0.390  Sum_probs=210.2

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCC--CChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCC
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG  123 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  123 (323)
                      ..+..++|++.+.||+|+||.||+|.+..+++.||+|++...  ......+.+.+|+.+++.++||||+++++++.. .+
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~   84 (294)
T 4eqm_A            6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE-DD   84 (294)
T ss_dssp             SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC-SS
T ss_pred             hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee-CC
Confidence            445678999999999999999999999999999999998644  345567789999999999999999999999987 68


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          124 DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      ..++||||+++++|.+++...+++++..++.++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++.....
T Consensus        85 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           85 CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNK-TLKIFDFGIAKALSE  163 (294)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCSSSTTC--
T ss_pred             eEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEEeCCCcccccc
Confidence            8999999999999999999888899999999999999999999999999999999999999987 899999999976543


Q ss_pred             Cc-cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCC---CC
Q 020657          204 SL-DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP---PS  279 (323)
Q Consensus       204 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~  279 (323)
                      .. .......++..|+|||.+.+..     ++.++||||||+++|+|+||..||.+....   ...........+   ..
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~Di~slG~~l~~ll~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~  235 (294)
T 4eqm_A          164 TSLTQTNHVLGTVQYFSPEQAKGEA-----TDECTDIYSIGIVLYEMLVGEPPFNGETAV---SIAIKHIQDSVPNVTTD  235 (294)
T ss_dssp             -----------CCSSCCHHHHHTCC-----CCTTHHHHHHHHHHHHHHHSSCSSCSSCHH---HHHHHHHSSCCCCHHHH
T ss_pred             ccccccCccccCccccCHhHhcCCC-----CCchHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHhhccCCCcchh
Confidence            32 2233456899999999987433     456999999999999999999999654322   112222221111   12


Q ss_pred             CCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          280 LPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       280 ~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                      ....+++.+.+++.+||+.||++||+..+.+.+.|.
T Consensus       236 ~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~  271 (294)
T 4eqm_A          236 VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLS  271 (294)
T ss_dssp             SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred             cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence            456789999999999999999999965555555443

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.3e-48  Score=335.93  Aligned_cols=260  Identities=28%  Similarity=0.450  Sum_probs=214.1

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCCh-----HHHHHHHHHHHHHHcCCCCccceeceeEEcCCC
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADP-----TVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG  123 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  123 (323)
                      ..++|++.+.||+|+||.||+|.+..+++.|++|++......     ...+.+.+|+.+++.++||||+++++++.+ ..
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~   81 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN-KT   81 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SS
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC-CC
Confidence            357899999999999999999999989999999998754321     135678899999999999999999999987 67


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCC---cEEEeecCcchh
Q 020657          124 DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNM---QVKIADFGVSKI  200 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~---~~kl~Dfg~~~~  200 (323)
                      ..++||||+++++|.+++.....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.   .++|+|||++..
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~  161 (283)
T 3bhy_A           82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK  161 (283)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence            89999999999999999988888999999999999999999999999999999999999987642   699999999976


Q ss_pred             hccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC---C
Q 020657          201 MCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD---P  277 (323)
Q Consensus       201 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~---~  277 (323)
                      ..... ......++..|+|||++...     .++.++||||||+++|+|++|..||......    .....+....   +
T Consensus       162 ~~~~~-~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~  231 (283)
T 3bhy_A          162 IEAGN-EFKNIFGTPEFVAPEIVNYE-----PLGLEADMWSIGVITYILLSGASPFLGETKQ----ETLTNISAVNYDFD  231 (283)
T ss_dssp             CC---------CCCGGGCCHHHHTTC-----CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHTTCCCCC
T ss_pred             ccCCC-cccccCCCcCccCcceecCC-----CCCcchhhhhHHHHHHHHHHCCCCCCCcchH----HHHHHhHhcccCCc
Confidence            54322 22345689999999998643     3456999999999999999999999654332    2222222211   1


Q ss_pred             CCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          278 PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       278 ~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      ......++..+.+|+++||+.||++|||++++++||||++.+
T Consensus       232 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          232 EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence            122357889999999999999999999999999999998754

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.4e-49  Score=365.42  Aligned_cols=260  Identities=28%  Similarity=0.425  Sum_probs=219.4

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCe
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGD  124 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  124 (323)
                      .+..++|++.+.||+|+||.||+|.+..+++.||+|++....  .......+.+|+.+++.++||||+++++++.+ .+.
T Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~  100 (484)
T 3nyv_A           22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED-KGY  100 (484)
T ss_dssp             CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSE
T ss_pred             CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCE
Confidence            456789999999999999999999999999999999986542  12345678899999999999999999999997 788


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEe---cCCCcEEEeecCcchhh
Q 020657          125 IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVN---NNNMQVKIADFGVSKIM  201 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~---~~~~~~kl~Dfg~~~~~  201 (323)
                      .++||||+.+++|.+.+.....+++..+..++.||+.||.|||++|++||||||+||+++   .++ .+||+|||++...
T Consensus       101 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~-~~kl~Dfg~a~~~  179 (484)
T 3nyv_A          101 FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDA-NIRIIDFGLSTHF  179 (484)
T ss_dssp             EEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTC-CEEECCTTHHHHB
T ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCC-cEEEEeeeeeEEc
Confidence            999999999999999998888899999999999999999999999999999999999994   444 8999999999776


Q ss_pred             ccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCC---C
Q 020657          202 CRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP---P  278 (323)
Q Consensus       202 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~---~  278 (323)
                      .... ......+++.|+|||++.+      .++.++||||||+++|+|++|..||.+...    ..+...+..+..   .
T Consensus       180 ~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~~~  248 (484)
T 3nyv_A          180 EASK-KMKDKIGTAYYIAPEVLHG------TYDEKCDVWSTGVILYILLSGCPPFNGANE----YDILKKVEKGKYTFEL  248 (484)
T ss_dssp             CCCC-SHHHHTTGGGTCCHHHHHT------CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCCS
T ss_pred             cccc-ccccCCCCccccCceeecC------CCCCcceeHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHcCCCCCCC
Confidence            4432 2334578999999999853      356799999999999999999999965433    233333332221   1


Q ss_pred             CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          279 SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       279 ~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      +....+++++.+|+++||+.||++|||++++|+||||++..
T Consensus       249 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~  289 (484)
T 3nyv_A          249 PQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT  289 (484)
T ss_dssp             GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred             cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence            22256899999999999999999999999999999997643

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=4.9e-49  Score=350.40  Aligned_cols=262  Identities=26%  Similarity=0.393  Sum_probs=198.2

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcC-----C
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP-----S  122 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~  122 (323)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++++...     .
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            3488999999999999999999999999999999997553 345567788999999999999999999998652     2


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          123 GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      ...++|+|++ +++|.+++.. ..+++..+..++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++....
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kL~DFG~a~~~~  183 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTA  183 (367)
T ss_dssp             CCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECC--------
T ss_pred             CeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCC-CEEEeecccccccc
Confidence            5579999999 5699998876 5799999999999999999999999999999999999999987 89999999997654


Q ss_pred             cCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcC-------
Q 020657          203 RSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFG-------  275 (323)
Q Consensus       203 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~-------  275 (323)
                      ..   .....++..|+|||++.+    ...++.++||||||+++|+|++|..||.+.+.......+.......       
T Consensus       184 ~~---~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  256 (367)
T 2fst_X          184 DE---MTGYVATRWYRAPEIMLN----WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  256 (367)
T ss_dssp             ----------CCCTTCCHHHHTT----CCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             cc---CCCcCcCcCccChHHHcC----CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            32   234578999999999863    2345679999999999999999999997655433333332211100       


Q ss_pred             --------------CCC-----CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          276 --------------DPP-----SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       276 --------------~~~-----~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                                    ..+     .....+++++.+||++||..||++|||++++|+||||++.+.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~  320 (367)
T 2fst_X          257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  320 (367)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence                          000     012357889999999999999999999999999999987654

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-48  Score=348.26  Aligned_cols=264  Identities=24%  Similarity=0.362  Sum_probs=221.5

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEe-----cccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceecee
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQH-----RCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGI  117 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~-----~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~  117 (323)
                      .....+..++|++.+.||+|+||.||+|.+     ..+++.||+|++...........+.+|+.+++.++||||++++++
T Consensus        63 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~  142 (367)
T 3l9p_A           63 SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGV  142 (367)
T ss_dssp             GGSCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cchhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            345567889999999999999999999994     456779999999876666777788999999999999999999999


Q ss_pred             EEcCCCeEEEEEeccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC--C
Q 020657          118 FEKPSGDIAILMEYMDSGTLDTLLNKN-------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN--M  188 (323)
Q Consensus       118 ~~~~~~~~~lv~e~~~~~sL~~~l~~~-------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~--~  188 (323)
                      +.. ....++||||+.+++|.+++...       ..+++..++.++.||+.||.|||+.|++||||||+||+++.++  .
T Consensus       143 ~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~  221 (367)
T 3l9p_A          143 SLQ-SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR  221 (367)
T ss_dssp             ECS-SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTC
T ss_pred             Eec-CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCc
Confidence            987 67789999999999999999754       3489999999999999999999999999999999999998543  2


Q ss_pred             cEEEeecCcchhhccC--ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccH
Q 020657          189 QVKIADFGVSKIMCRS--LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDW  265 (323)
Q Consensus       189 ~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~  265 (323)
                      .+||+|||++......  ........++..|+|||++...     .++.++||||||+++|+|++ |..||...    ..
T Consensus       222 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~DvwslG~il~ellt~g~~pf~~~----~~  292 (367)
T 3l9p_A          222 VAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-----IFTSKTDTWSFGVLLWEIFSLGYMPYPSK----SN  292 (367)
T ss_dssp             CEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-----CCCHHHHHHHHHHHHHHHHTTSCCSSTTC----CH
T ss_pred             eEEECCCccccccccccccccCCCcCCcccEECHHHhcCC-----CCCcHHHHHHHHHHHHHHHhCCCCCCCCC----CH
Confidence            5999999999765332  2223345678899999998633     35669999999999999998 99999543    33


Q ss_pred             HHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccc
Q 020657          266 ATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLC  316 (323)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~  316 (323)
                      ..+...+..+.....+..++..+.+|+.+||+.||++|||+++++++.++.
T Consensus       293 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          293 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            455555555666667788999999999999999999999999999987653

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.1e-49  Score=351.44  Aligned_cols=261  Identities=26%  Similarity=0.368  Sum_probs=207.6

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcC-----
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP-----  121 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----  121 (323)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++......     ..+|+.+++.++||||+++++++...     
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-----HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            34568999999999999999999999999999999998755321     23799999999999999999998542     


Q ss_pred             --------------------------------CCeEEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHH
Q 020657          122 --------------------------------SGDIAILMEYMDSGTLDTLLN----KNGTFSEPKLAHIASQILKGLSY  165 (323)
Q Consensus       122 --------------------------------~~~~~lv~e~~~~~sL~~~l~----~~~~~~~~~~~~i~~~i~~~l~~  165 (323)
                                                      ....++||||+++ +|.+.+.    .+..+++..++.++.||+.||.|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                            2348899999985 8777664    45679999999999999999999


Q ss_pred             HHhCCCeecCCCCCCeEEec-CCCcEEEeecCcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHH
Q 020657          166 LHGHKIIHRDIKPSNLLVNN-NNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGL  244 (323)
Q Consensus       166 Lh~~givH~di~~~nil~~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~  244 (323)
                      ||+.|++||||||+||+++. ++ .+||+|||++....... ......++..|+|||++.+    ...++.++||||||+
T Consensus       157 LH~~gi~H~Dikp~Nil~~~~~~-~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~  230 (383)
T 3eb0_A          157 IHSLGICHRDIKPQNLLVNSKDN-TLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLG----ATEYTPSIDLWSIGC  230 (383)
T ss_dssp             HHTTTEECSCCCGGGEEEETTTT-EEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTT----CSSCCTHHHHHHHHH
T ss_pred             HHHCcCccCccCHHHEEEcCCCC-cEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcC----CCCCCcchhhhhHHH
Confidence            99999999999999999984 55 89999999997654332 2345578999999998863    233567999999999


Q ss_pred             HHHHHHhCCCCCCCCCCCccHHHHHHHHhcC---------------CC---------CCCCCCCChhHHHHHHHhcccCc
Q 020657          245 TLLELYLGHFPFLQPGQRPDWATLMCAICFG---------------DP---------PSLPDGASPEFRSFIECCLQKEF  300 (323)
Q Consensus       245 ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~---------------~~---------~~~~~~~~~~l~~ll~~~l~~~p  300 (323)
                      ++|+|++|..||.+.........+.......               ..         ..++..++.++.+|+.+||+.||
T Consensus       231 il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  310 (383)
T 3eb0_A          231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP  310 (383)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence            9999999999997654443333333221110               00         01345688999999999999999


Q ss_pred             CCCCCHHHHhcCcccccCC
Q 020657          301 SKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       301 ~~Rpt~~~~l~h~~f~~~~  319 (323)
                      ++|||++++|+||||++.+
T Consensus       311 ~~R~t~~e~l~hp~f~~~~  329 (383)
T 3eb0_A          311 DLRINPYEAMAHPFFDHLR  329 (383)
T ss_dssp             GGSCCHHHHHTSGGGHHHH
T ss_pred             hhCCCHHHHhcCHHHHHHH
Confidence            9999999999999997643

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4e-48  Score=343.19  Aligned_cols=266  Identities=29%  Similarity=0.417  Sum_probs=215.4

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcC----CC
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP----SG  123 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~  123 (323)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+|+.+++.++||||+++++++...    ..
T Consensus         8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   87 (353)
T 2b9h_A            8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN   87 (353)
T ss_dssp             CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred             ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence            34689999999999999999999999899999999997666666777888999999999999999999987653    26


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          124 DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      ..++||||+.+ +|.+++.. ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++ .+||+|||++.....
T Consensus        88 ~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~  164 (353)
T 2b9h_A           88 EVYIIQELMQT-DLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDE  164 (353)
T ss_dssp             CEEEEECCCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECC-
T ss_pred             eEEEEEeccCc-cHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCC-cEEEEeccccccccc
Confidence            78999999975 99998876 4789999999999999999999999999999999999999987 899999999976543


Q ss_pred             Ccc----------ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHh
Q 020657          204 SLD----------ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAIC  273 (323)
Q Consensus       204 ~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~  273 (323)
                      ...          ......++..|+|||++..    ...++.++||||||+++|+|++|..||.+.........+.....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  240 (353)
T 2b9h_A          165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLT----SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG  240 (353)
T ss_dssp             ---------------CCCCCCGGGCCHHHHHS----CCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ccccccCccccccchhhccccccccCCeeecc----CCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence            211          1123467999999998752    23456799999999999999999999976543322222221111


Q ss_pred             cCC----------------------CC-----CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          274 FGD----------------------PP-----SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       274 ~~~----------------------~~-----~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                      ...                      .+     .....+++++.+|+++||+.||++|||++++++||||++.+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (353)
T 2b9h_A          241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD  314 (353)
T ss_dssp             CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence            000                      00     012467899999999999999999999999999999987654

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-47  Score=344.16  Aligned_cols=261  Identities=25%  Similarity=0.362  Sum_probs=223.5

Q ss_pred             CCccchhccccccceeeeecccCCeEEEEEEecc-------cCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccc
Q 020657           41 TTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRC-------THKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIV  112 (323)
Q Consensus        41 ~~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~  112 (323)
                      +....+.+..++|++.+.||+|+||.||+|.+..       .+..||+|++...........+.+|+.+++.+ +||||+
T Consensus        59 ~~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv  138 (382)
T 3tt0_A           59 PEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNII  138 (382)
T ss_dssp             CCCTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             ccCcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhh
Confidence            3456678889999999999999999999999753       33579999998777777778899999999999 999999


Q ss_pred             eeceeEEcCCCeEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCC
Q 020657          113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNG----------------TFSEPKLAHIASQILKGLSYLHGHKIIHRDI  176 (323)
Q Consensus       113 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~~i~~~l~~Lh~~givH~di  176 (323)
                      ++++++.. .+..++||||+.+++|.+++....                .+++..++.++.||+.||.|||+.|++||||
T Consensus       139 ~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl  217 (382)
T 3tt0_A          139 NLLGACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDL  217 (382)
T ss_dssp             CEEEEECS-SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             hheeeecc-CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCC
Confidence            99999987 678999999999999999997643                4899999999999999999999999999999


Q ss_pred             CCCCeEEecCCCcEEEeecCcchhhccCc--cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CC
Q 020657          177 KPSNLLVNNNNMQVKIADFGVSKIMCRSL--DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GH  253 (323)
Q Consensus       177 ~~~nil~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~  253 (323)
                      ||+||+++.++ .+||+|||++.......  .......++..|+|||++.+     ..++.++||||||+++|+|++ |.
T Consensus       218 kp~NIll~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DiwslG~il~ellt~g~  291 (382)
T 3tt0_A          218 AARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-----RIYTHQSDVWSFGVLLWEIFTLGG  291 (382)
T ss_dssp             CGGGEEECTTC-CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-----CCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             CcceEEEcCCC-cEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-----CCCCchhHHHHHHHHHHHHHhCCC
Confidence            99999999987 89999999997654322  22334456788999999863     345679999999999999999 99


Q ss_pred             CCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          254 FPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       254 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      .||...    ....+...+........+..++.++.+|+++||+.||++|||+++++++
T Consensus       292 ~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          292 SPYPGV----PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             CSSTTC----CHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCC----CHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            999543    3445555566666677778899999999999999999999999999975

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.1e-48  Score=354.34  Aligned_cols=263  Identities=25%  Similarity=0.337  Sum_probs=208.7

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcC-----C
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP-----S  122 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~  122 (323)
                      ....+|++.+.||+|+||.||+|++..+++.||+|++.....     ...+|+++++.++||||+++++++...     .
T Consensus        51 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~  125 (420)
T 1j1b_A           51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE  125 (420)
T ss_dssp             CEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred             cccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence            345579999999999999999999998999999999865432     233799999999999999999987532     2


Q ss_pred             CeEEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcc
Q 020657          123 GDIAILMEYMDSGTLDTLLN----KNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVS  198 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~----~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~  198 (323)
                      ..+++||||+++ ++.+.+.    ....+++..++.++.||+.||.|||+.||+||||||+||+++.++..+||+|||++
T Consensus       126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence            246799999986 6766654    35679999999999999999999999999999999999999976547899999999


Q ss_pred             hhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcC---
Q 020657          199 KIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFG---  275 (323)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~---  275 (323)
                      ....... ......++..|+|||++.+.    ..++.++||||||+++|||++|+.||.+.........+.......   
T Consensus       205 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~  279 (420)
T 1j1b_A          205 KQLVRGE-PNVSYICSRYYRAPELIFGA----TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE  279 (420)
T ss_dssp             EECCTTC-CCCSCCSCTTSCCHHHHTTC----SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             hhcccCC-CceeeeeCCCcCCHHHHcCC----CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            7654332 22346789999999998632    245669999999999999999999997654433333333221100   


Q ss_pred             ------------CCCC---------CCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCCC
Q 020657          276 ------------DPPS---------LPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS  321 (323)
Q Consensus       276 ------------~~~~---------~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~  321 (323)
                                  ..+.         ++..+++++.+||++||..||++|||+.++++||||++.+.+
T Consensus       280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  346 (420)
T 1j1b_A          280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP  346 (420)
T ss_dssp             HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred             HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccc
Confidence                        0000         234678999999999999999999999999999999876543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=6.6e-49  Score=342.40  Aligned_cols=263  Identities=25%  Similarity=0.384  Sum_probs=210.9

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCC
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG  123 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  123 (323)
                      .....++|++.+.||+|+||.||+|++..+++.||+|++....  +......+.+|+.+++.++||||+++++++.....
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   86 (311)
T 3ork_A            7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP   86 (311)
T ss_dssp             CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET
T ss_pred             cceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC
Confidence            3455789999999999999999999999899999999997653  44556788999999999999999999999865322


Q ss_pred             ---eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchh
Q 020657          124 ---DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       124 ---~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                         ..++||||+++++|.+++...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++ .+||+|||++..
T Consensus        87 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~~  165 (311)
T 3ork_A           87 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN-AVKVMDFGIARA  165 (311)
T ss_dssp             TEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTS-CEEECCCSCC--
T ss_pred             CCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCC-CEEEeeccCccc
Confidence               3599999999999999999888899999999999999999999999999999999999999987 899999999976


Q ss_pred             hccCc---cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCC
Q 020657          201 MCRSL---DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP  277 (323)
Q Consensus       201 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~  277 (323)
                      .....   .......++..|+|||++.+.     .++.++||||||+++|+|+||..||......   ............
T Consensus       166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~---~~~~~~~~~~~~  237 (311)
T 3ork_A          166 IADSGNSVTQTAAVIGTAQYLSPEQARGD-----SVDARSDVYSLGCVLYEVLTGEPPFTGDSPV---SVAYQHVREDPI  237 (311)
T ss_dssp             ----------------CCTTCCHHHHHTC-----CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHCCCC
T ss_pred             ccccccccccccccCcCcccCCHHHhcCC-----CCCchHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHhcCCCC
Confidence            54322   122345689999999998643     4566999999999999999999999554322   222222221111


Q ss_pred             C--CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          278 P--SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       278 ~--~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                      +  .....++.++.+|+.+||+.||++||+..+++.|+|++-
T Consensus       238 ~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          238 PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            1  123568999999999999999999999999999999864

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.3e-48  Score=349.17  Aligned_cols=258  Identities=24%  Similarity=0.368  Sum_probs=219.7

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS  122 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  122 (323)
                      ...+.+..++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+|+.+++.++||||+++++++.. .
T Consensus       106 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~  184 (377)
T 3cbl_A          106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-K  184 (377)
T ss_dssp             CCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred             ccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec-C
Confidence            456788899999999999999999999999889999999999866666667788999999999999999999999987 6


Q ss_pred             CeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhh
Q 020657          123 GDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM  201 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~  201 (323)
                      +..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++...
T Consensus       185 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~-~~kl~DfG~s~~~  263 (377)
T 3cbl_A          185 QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN-VLKISDFGMSREE  263 (377)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCGGGCEEC
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCC-cEEECcCCCceec
Confidence            7899999999999999999754 4699999999999999999999999999999999999999987 8999999999754


Q ss_pred             ccCcccc--ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCC
Q 020657          202 CRSLDAC--NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPP  278 (323)
Q Consensus       202 ~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  278 (323)
                      .......  ....++..|+|||++....     ++.++||||||+++|||+| |..||....    .......+..+...
T Consensus       264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~DvwslG~il~el~t~g~~p~~~~~----~~~~~~~~~~~~~~  334 (377)
T 3cbl_A          264 ADGVYAASGGLRQVPVKWTAPEALNYGR-----YSSESDVWSFGILLWETFSLGASPYPNLS----NQQTREFVEKGGRL  334 (377)
T ss_dssp             TTSEEECCSSCCEEEGGGSCHHHHHHCE-----EEHHHHHHHHHHHHHHHHTTSCCSSTTSC----HHHHHHHHHTTCCC
T ss_pred             CCCceeecCCCCCCCcCcCCHhHhccCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHHHcCCCC
Confidence            3322111  1223567899999986433     4569999999999999998 999995543    23344444455566


Q ss_pred             CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          279 SLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       279 ~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ..+..+++++.+|+.+||+.||++|||++++++
T Consensus       335 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          335 PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            777889999999999999999999999999985

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-48  Score=342.04  Aligned_cols=258  Identities=24%  Similarity=0.398  Sum_probs=220.1

Q ss_pred             cchhccccccceeeeecccCCeEEEEEEec-----ccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeE
Q 020657           44 TTAAIAYSDLEKLQVLGHGNGGTVYKVQHR-----CTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIF  118 (323)
Q Consensus        44 ~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~  118 (323)
                      ....+..++|++.+.||+|+||.||+|++.     .+++.||+|++...........+.+|+.+++.++||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  119 (343)
T 1luf_A           40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC  119 (343)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            445778899999999999999999999986     345899999998776677778899999999999999999999999


Q ss_pred             EcCCCeEEEEEeccCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeec
Q 020657          119 EKPSGDIAILMEYMDSGTLDTLLNKN------------------------GTFSEPKLAHIASQILKGLSYLHGHKIIHR  174 (323)
Q Consensus       119 ~~~~~~~~lv~e~~~~~sL~~~l~~~------------------------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~  174 (323)
                      .+ .+..++||||+.+++|.+++...                        ..+++..++.++.||+.||.|||++|++|+
T Consensus       120 ~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~  198 (343)
T 1luf_A          120 AV-GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR  198 (343)
T ss_dssp             CS-SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             cc-CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            87 67899999999999999999763                        568999999999999999999999999999


Q ss_pred             CCCCCCeEEecCCCcEEEeecCcchhhccCc--cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-
Q 020657          175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSL--DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-  251 (323)
Q Consensus       175 di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-  251 (323)
                      ||||+||+++.++ .+||+|||++.......  .......++..|+|||++...     .++.++||||||+++|+|+| 
T Consensus       199 Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~Di~slG~il~el~t~  272 (343)
T 1luf_A          199 DLATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-----RYTTESDVWAYGVVLWEIFSY  272 (343)
T ss_dssp             CCSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-----CCCHHHHHHHHHHHHHHHHTT
T ss_pred             CCCcceEEECCCC-eEEEeecCCCcccccCccccccCCCcccceecChhhhccC-----CcCcccccHHHHHHHHHHHhc
Confidence            9999999999987 89999999997664322  222345678899999998633     35679999999999999999 


Q ss_pred             CCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          252 GHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       252 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      |..||...    ....+...+..+.....+..++.++.+|+++||+.||++|||+.+++++
T Consensus       273 g~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          273 GLQPYYGM----AHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             TCCTTTTS----CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCcCCCC----ChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            99999543    3344445555556667778899999999999999999999999999864

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=4.9e-48  Score=350.88  Aligned_cols=261  Identities=29%  Similarity=0.433  Sum_probs=210.1

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcC------CCCccceeceeEE
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT------DSPFIVQCFGIFE  119 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~  119 (323)
                      ......+|++.+.||+|+||.||+|.+..+++.||+|++...  ......+.+|+.+++.+      +|+||+.+++++.
T Consensus        92 ~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~  169 (429)
T 3kvw_A           92 HDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT  169 (429)
T ss_dssp             TCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred             CCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence            345567899999999999999999999999999999999643  34556677888888776      5779999999998


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCc--EEEeec
Q 020657          120 KPSGDIAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQ--VKIADF  195 (323)
Q Consensus       120 ~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~--~kl~Df  195 (323)
                      . ....++||||+. ++|.+++....  .+++..++.++.||+.||.|||+.||+||||||+||+++.++ .  +||+||
T Consensus       170 ~-~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~-~~~vkL~DF  246 (429)
T 3kvw_A          170 F-RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQG-RSGIKVIDF  246 (429)
T ss_dssp             E-TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTT-SCCEEECCC
T ss_pred             c-CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCC-CcceEEeec
Confidence            7 688999999997 59999887653  489999999999999999999999999999999999999886 4  999999


Q ss_pred             CcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcC
Q 020657          196 GVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFG  275 (323)
Q Consensus       196 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~  275 (323)
                      |++......   .....++..|+|||++.+..     ++.++||||||+++|+|+||..||.+.........+.......
T Consensus       247 G~a~~~~~~---~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p  318 (429)
T 3kvw_A          247 GSSCYEHQR---VYTYIQSRFYRAPEVILGAR-----YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMP  318 (429)
T ss_dssp             TTCEETTCC---CCSSCSCGGGCCHHHHHTBC-----CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             ccceecCCc---ccccCCCCCccChHHHhCCC-----CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            999654322   23457899999999987443     4569999999999999999999997665443333333221100


Q ss_pred             C------------------CC------------------------------------CCCCCCChhHHHHHHHhcccCcC
Q 020657          276 D------------------PP------------------------------------SLPDGASPEFRSFIECCLQKEFS  301 (323)
Q Consensus       276 ~------------------~~------------------------------------~~~~~~~~~l~~ll~~~l~~~p~  301 (323)
                      .                  .+                                    .+....++++.+||++||++||+
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~  398 (429)
T 3kvw_A          319 SQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPA  398 (429)
T ss_dssp             CHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTT
T ss_pred             CHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChh
Confidence            0                  00                                    01123478899999999999999


Q ss_pred             CCCCHHHHhcCcccccCC
Q 020657          302 KRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       302 ~Rpt~~~~l~h~~f~~~~  319 (323)
                      +|||++|+|+||||++..
T Consensus       399 ~Rpta~e~L~Hpw~~~~~  416 (429)
T 3kvw_A          399 VRMTPGQALRHPWLRRRL  416 (429)
T ss_dssp             TSCCHHHHHTSTTTC---
T ss_pred             hCCCHHHHhCChhhccCC
Confidence            999999999999998753

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.9e-48  Score=340.65  Aligned_cols=269  Identities=24%  Similarity=0.384  Sum_probs=217.4

Q ss_pred             Cccchhcccccccee-eeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcC-CCCccceeceeE
Q 020657           42 TATTAAIAYSDLEKL-QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRT-DSPFIVQCFGIF  118 (323)
Q Consensus        42 ~~~~~~~~~~~~~~~-~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~  118 (323)
                      .........++|.+. +.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.+ .||||+++++++
T Consensus        19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~   98 (327)
T 3lm5_A           19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY   98 (327)
T ss_dssp             CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            344555667788888 89999999999999999999999999987543 223456788999999998 569999999999


Q ss_pred             EcCCCeEEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEec---CCCcEEEe
Q 020657          119 EKPSGDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNN---NNMQVKIA  193 (323)
Q Consensus       119 ~~~~~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~---~~~~~kl~  193 (323)
                      .. .+..++||||+.+++|.+++..  ...+++..++.++.||+.||.|||+.|++||||||+||+++.   ++ .+||+
T Consensus        99 ~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~-~~kL~  176 (327)
T 3lm5_A           99 EN-TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLG-DIKIV  176 (327)
T ss_dssp             EC-SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBC-CEEEC
T ss_pred             Ee-CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCC-cEEEe
Confidence            87 6789999999999999998854  357999999999999999999999999999999999999987   55 89999


Q ss_pred             ecCcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHh
Q 020657          194 DFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAIC  273 (323)
Q Consensus       194 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~  273 (323)
                      |||++....... ......++..|+|||++...     .++.++||||||+++|+|++|..||...........+. ...
T Consensus       177 Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~-~~~  249 (327)
T 3lm5_A          177 DFGMSRKIGHAC-ELREIMGTPEYLAPEILNYD-----PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS-QVN  249 (327)
T ss_dssp             CGGGCEEC----------CCCGGGCCHHHHTTC-----CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-HTC
T ss_pred             eCccccccCCcc-ccccccCCcCccCCeeecCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH-hcc
Confidence            999997654332 23445789999999998643     34569999999999999999999996544332222222 222


Q ss_pred             cCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          274 FGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       274 ~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      ..........++..+.+|+.+||+.||++|||++++|+||||++..
T Consensus       250 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~  295 (327)
T 3lm5_A          250 VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD  295 (327)
T ss_dssp             CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred             cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence            2233444467899999999999999999999999999999998764

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=7.4e-48  Score=331.21  Aligned_cols=257  Identities=24%  Similarity=0.358  Sum_probs=214.3

Q ss_pred             CccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcC
Q 020657           42 TATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP  121 (323)
Q Consensus        42 ~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  121 (323)
                      ....+.+..++|++.+.||+|+||.||+|.+. ++..||+|++......  .+.+.+|+.+++.++||||+++++++.+ 
T Consensus        15 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~-   90 (283)
T 3gen_A           15 GYGSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTK-   90 (283)
T ss_dssp             -CCTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred             CCCCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC--HHHHHHHHHHHhcCCCCCEeeEEEEEec-
Confidence            45678899999999999999999999999886 6778999999755422  3568899999999999999999999987 


Q ss_pred             CCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchh
Q 020657          122 SGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       122 ~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                      .+..++||||+.+++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||||+||+++.++ .++|+|||++..
T Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~  169 (283)
T 3gen_A           91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRY  169 (283)
T ss_dssp             SSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTS-CEEECSTTGGGG
T ss_pred             CCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCC-CEEEcccccccc
Confidence            6789999999999999999976 45799999999999999999999999999999999999999987 899999999976


Q ss_pred             hccCc-cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCC
Q 020657          201 MCRSL-DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPP  278 (323)
Q Consensus       201 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  278 (323)
                      ..... .......++..|+|||++...     .++.++||||||+++|+|+| |..||....    .......+......
T Consensus       170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~----~~~~~~~~~~~~~~  240 (283)
T 3gen_A          170 VLDDEYTSSVGSKFPVRWSPPEVLMYS-----KFSSKSDIWAFGVLMWEIYSLGKMPYERFT----NSETAEHIAQGLRL  240 (283)
T ss_dssp             BCCHHHHSTTSTTSCGGGCCHHHHHHC-----CCSHHHHHHHHHHHHHHHHTTTCCTTTTSC----HHHHHHHHHTTCCC
T ss_pred             ccccccccccCCccCcccCCHHHhccC-----CCCchhhHHHHHHHHHHHHhCCCCCccccC----hhHHHHHHhcccCC
Confidence            54322 122334567789999998633     34669999999999999998 999995443    33444444455556


Q ss_pred             CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          279 SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       279 ~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ..+...++.+.+|+.+||+.||++|||++++++|
T Consensus       241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          241 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            6677889999999999999999999999999976

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=7.9e-48  Score=335.40  Aligned_cols=251  Identities=26%  Similarity=0.403  Sum_probs=211.1

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeE
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDI  125 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  125 (323)
                      ..+..++|++.+.||+|+||.||+|.+..+++.||+|++.. .+....+.+.+|+.+++.++||||+++++++.+ ++..
T Consensus         5 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~   82 (310)
T 3s95_A            5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR-FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-DKRL   82 (310)
T ss_dssp             EEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEE
T ss_pred             eeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-CCee
Confidence            34567899999999999999999999999999999999854 345667889999999999999999999999987 6889


Q ss_pred             EEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC
Q 020657          126 AILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS  204 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~  204 (323)
                      ++||||+.+++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||||+||+++.++ .+||+|||++......
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~  161 (310)
T 3s95_A           83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENK-NVVVADFGLARLMVDE  161 (310)
T ss_dssp             EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTS-CEEECCCTTCEECC--
T ss_pred             EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCC-CEEEeecccceecccc
Confidence            999999999999999987 56799999999999999999999999999999999999999987 8999999999765432


Q ss_pred             ccc--------------cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCc-----cH
Q 020657          205 LDA--------------CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRP-----DW  265 (323)
Q Consensus       205 ~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~-----~~  265 (323)
                      ...              .....+|..|+|||++...     .++.++||||||+++|+|++|..||.......     ..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~  236 (310)
T 3s95_A          162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR-----SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV  236 (310)
T ss_dssp             ------------------CCCCSCGGGCCHHHHTTC-----CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH
T ss_pred             cccccccccccccccccccccCCCcceeCHHHhcCC-----CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh
Confidence            211              1145789999999998743     44569999999999999999999986532221     11


Q ss_pred             HHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          266 ATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      .....       ...+..+++.+.+|+.+||+.||++|||++++++
T Consensus       237 ~~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          237 RGFLD-------RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             HHHHH-------HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hcccc-------ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            11111       1235678899999999999999999999999986

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.1e-47  Score=327.81  Aligned_cols=255  Identities=24%  Similarity=0.404  Sum_probs=214.7

Q ss_pred             cchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCC
Q 020657           44 TTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG  123 (323)
Q Consensus        44 ~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  123 (323)
                      ..+.+..++|++.+.||+|+||.||+|.+. +++.||+|++......  .+.+.+|+.++++++||||+++++++.+ .+
T Consensus         3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~   78 (269)
T 4hcu_A            3 GKWVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLE-QA   78 (269)
T ss_dssp             --CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECS-SS
T ss_pred             ccEEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC--HHHHHHHHHHHHhCCCCCEeeEEEEEec-CC
Confidence            456788899999999999999999999987 5778999999755422  3568899999999999999999999987 67


Q ss_pred             eEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          124 DIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      ..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++....
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~  157 (269)
T 4hcu_A           79 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVL  157 (269)
T ss_dssp             SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG-CEEECCTTGGGGBC
T ss_pred             ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCC-CEEecccccccccc
Confidence            89999999999999999965 34689999999999999999999999999999999999999887 89999999997654


Q ss_pred             cCc-cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCC
Q 020657          203 RSL-DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSL  280 (323)
Q Consensus       203 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  280 (323)
                      ... .......++..|+|||++...     .++.++||||||+++|+|++ |..||...    ........+........
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~ll~~g~~p~~~~----~~~~~~~~~~~~~~~~~  228 (269)
T 4hcu_A          158 DDQYTSSTGTKFPVKWASPEVFSFS-----RYSSKSDVWSFGVLMWEVFSEGKIPYENR----SNSEVVEDISTGFRLYK  228 (269)
T ss_dssp             CHHHHSTTSTTCCGGGCCHHHHHHC-----CCCHHHHHHHHHHHHHHHHTTSCCTTTTC----CHHHHHHHHHTTCCCCC
T ss_pred             ccccccccCcccccccCCHHHhcCC-----CCCchhhhHHHHHHHHHHhcCCCCCCCCC----CHHHHHHHHhcCccCCC
Confidence            322 122334567789999998633     35669999999999999999 99999543    33444555555556666


Q ss_pred             CCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          281 PDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       281 ~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      +...+.++.+++.+||+.||++|||++++++|
T Consensus       229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          229 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            77889999999999999999999999999976

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=4.2e-48  Score=345.31  Aligned_cols=261  Identities=27%  Similarity=0.414  Sum_probs=209.1

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCC----
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG----  123 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----  123 (323)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.++||||+++++++.....    
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            3479999999999999999999999999999999997653 34557788899999999999999999999986332    


Q ss_pred             -eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          124 -DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       124 -~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                       ..++||||+.+ +|.+.+.  ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++ .+||+|||++....
T Consensus       120 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~~~  195 (371)
T 4exu_A          120 YDFYLVMPFMQT-DLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLARHAD  195 (371)
T ss_dssp             CCCEEEEECCCE-EHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECSTTCC----
T ss_pred             eeEEEEEccccc-cHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCC-CEEEEecCcccccc
Confidence             23999999974 8888774  3589999999999999999999999999999999999999987 89999999997654


Q ss_pred             cCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcC-------
Q 020657          203 RSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFG-------  275 (323)
Q Consensus       203 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~-------  275 (323)
                      ..   .....++..|+|||++.+    ...++.++||||||+++|+|++|..||.+.........+.......       
T Consensus       196 ~~---~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  268 (371)
T 4exu_A          196 AE---MTGYVVTRWYRAPEVILS----WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  268 (371)
T ss_dssp             -------CTTCCCTTSCHHHHSC----CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             cC---cCCcccCccccCHHHhcC----CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence            32   234568999999999863    2345679999999999999999999997654333222222211100       


Q ss_pred             ----------------CC---CCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          276 ----------------DP---PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       276 ----------------~~---~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                                      ..   ..+...+++++.+|+++||+.||++|||++++|+||||++.+.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  332 (371)
T 4exu_A          269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD  332 (371)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCC
Confidence                            00   0122467899999999999999999999999999999987643

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3.9e-48  Score=335.77  Aligned_cols=258  Identities=28%  Similarity=0.462  Sum_probs=205.8

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcC--------
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP--------  121 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------  121 (323)
                      .++|++.+.||+|+||.||+|++..+++.|++|++...  ......+.+|+.+++.++||||+++++++.+.        
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            46899999999999999999999989999999999542  34567788999999999999999999987542        


Q ss_pred             ----CCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecC
Q 020657          122 ----SGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFG  196 (323)
Q Consensus       122 ----~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg  196 (323)
                          ....++||||+++++|.+++... ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~-~~kl~dfg  161 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR-NVKIGDFG  161 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCCC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCC-CEEEeeCc
Confidence                35689999999999999999854 3578899999999999999999999999999999999999987 89999999


Q ss_pred             cchhhccC--------------ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 020657          197 VSKIMCRS--------------LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQR  262 (323)
Q Consensus       197 ~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~  262 (323)
                      ++......              ........++..|+|||++.+.    ..++.++||||||+++|+|++   ||....  
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~Di~slG~il~~l~~---p~~~~~--  232 (303)
T 1zy4_A          162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT----GHYNEKIDMYSLGIIFFEMIY---PFSTGM--  232 (303)
T ss_dssp             CCSCTTC-------------------------CTTSCHHHHTSC----SCCCTHHHHHHHHHHHHHHHS---CCSSHH--
T ss_pred             chhhcccccchhccccccccccccccccCCCcccccCcccccCC----CCCcchhhHHHHHHHHHHHHh---ccCCch--
Confidence            99765422              1122345688999999998632    245679999999999999998   553211  


Q ss_pred             ccHHHHHHHH---hcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          263 PDWATLMCAI---CFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       263 ~~~~~~~~~~---~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                       .........   ....+..++...+..+.+|+++||+.||++|||++++++||||+....
T Consensus       233 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (303)
T 1zy4_A          233 -ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQ  292 (303)
T ss_dssp             -HHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCH
T ss_pred             -hHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCCh
Confidence             112222222   222344556677888999999999999999999999999999987653

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2e-47  Score=333.27  Aligned_cols=273  Identities=24%  Similarity=0.396  Sum_probs=218.1

Q ss_pred             CCccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCC--CCccceecee
Q 020657           41 TTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTD--SPFIVQCFGI  117 (323)
Q Consensus        41 ~~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~  117 (323)
                      ...+...+..++|++.+.||+|+||.||+|.+. +++.||+|++.... .......+.+|+.+++.++  |+||++++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~   96 (313)
T 3cek_A           18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY   96 (313)
T ss_dssp             --CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred             CCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence            346667788899999999999999999999986 58899999997543 4556778899999999997  5999999999


Q ss_pred             EEcCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCc
Q 020657          118 FEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGV  197 (323)
Q Consensus       118 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~  197 (323)
                      +.. .+..++|||+ .+++|.+++.....+++..++.++.||+.||.|||+.|++|+||||+||++++ + .+||+|||+
T Consensus        97 ~~~-~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~-~~kL~Dfg~  172 (313)
T 3cek_A           97 EIT-DQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G-MLKLIDFGI  172 (313)
T ss_dssp             EEC-SSEEEEEECC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T-EEEECCCSS
T ss_pred             eec-CCEEEEEEec-CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-C-eEEEeeccc
Confidence            987 6789999994 56799999998888999999999999999999999999999999999999975 4 899999999


Q ss_pred             chhhccCcc--ccccccccccccCCcccCCCCC------CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHH
Q 020657          198 SKIMCRSLD--ACNSYVGTCAYMSPERFDPDAY------GGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLM  269 (323)
Q Consensus       198 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~------~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~  269 (323)
                      +........  ......++..|+|||++.....      ....++.++||||||+++|+|++|..||.....  ....+.
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~~~~~  250 (313)
T 3cek_A          173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLH  250 (313)
T ss_dssp             SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHH
T ss_pred             cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH--HHHHHH
Confidence            976543221  1234568999999999864221      124567799999999999999999999965432  223333


Q ss_pred             HHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          270 CAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                      ..........++...+.++.+|+++||+.||++|||++++++||||+....
T Consensus       251 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  301 (313)
T 3cek_A          251 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  301 (313)
T ss_dssp             HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC--
T ss_pred             HHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCC
Confidence            333334445566778999999999999999999999999999999987654

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.2e-48  Score=344.68  Aligned_cols=270  Identities=23%  Similarity=0.294  Sum_probs=202.1

Q ss_pred             CccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcC
Q 020657           42 TATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP  121 (323)
Q Consensus        42 ~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  121 (323)
                      .........++|++.+.||+|+||.||+|.+..+++.||+|++.....  ......+++..++.++||||+++++++...
T Consensus        14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~   91 (360)
T 3e3p_A           14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR--FRNRELQIMQDLAVLHHPNIVQLQSYFYTL   91 (360)
T ss_dssp             SSHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT--CCCHHHHHHHHHHHHCCTTBCCEEEEEEEE
T ss_pred             hhhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc--ccHHHHHHHHHHHhcCCCCcccHHHhhhcc
Confidence            344556778899999999999999999999998999999999865432  223456778888889999999999998652


Q ss_pred             CC------eEEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH--hCCCeecCCCCCCeEEec-CCC
Q 020657          122 SG------DIAILMEYMDSGTLDTLLN----KNGTFSEPKLAHIASQILKGLSYLH--GHKIIHRDIKPSNLLVNN-NNM  188 (323)
Q Consensus       122 ~~------~~~lv~e~~~~~sL~~~l~----~~~~~~~~~~~~i~~~i~~~l~~Lh--~~givH~di~~~nil~~~-~~~  188 (323)
                      ..      ..++||||+.+ +|...+.    ....+++..+..++.||+.||.|||  +.|++|+||||+||+++. ++ 
T Consensus        92 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~-  169 (360)
T 3e3p_A           92 GERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG-  169 (360)
T ss_dssp             CSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTT-
T ss_pred             ccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCC-
Confidence            22      37899999987 5544433    4567899999999999999999999  999999999999999997 65 


Q ss_pred             cEEEeecCcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHH
Q 020657          189 QVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATL  268 (323)
Q Consensus       189 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~  268 (323)
                      .+||+|||++....... ......++..|+|||++.+    ...++.++||||||+++|+|++|..||...........+
T Consensus       170 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~  244 (360)
T 3e3p_A          170 TLKLCDFGSAKKLSPSE-PNVAYICSRYYRAPELIFG----NQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI  244 (360)
T ss_dssp             EEEECCCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTT----CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             cEEEeeCCCceecCCCC-CcccccCCcceeCHHHHcC----CCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHH
Confidence            99999999997664332 2334568999999999853    233567999999999999999999999765444333333


Q ss_pred             HHHHhcCC---------------------------CCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          269 MCAICFGD---------------------------PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       269 ~~~~~~~~---------------------------~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                      ........                           ........+.++.+|+.+||+.||++|||+.++|+||||++...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  323 (360)
T 3e3p_A          245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD  323 (360)
T ss_dssp             HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred             HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence            32211100                           01122335789999999999999999999999999999988754

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.9e-49  Score=354.80  Aligned_cols=257  Identities=16%  Similarity=0.171  Sum_probs=201.8

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCC--CChHHHHHHHHHHH---HHHcCCCCccceec-------
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREME---ILRRTDSPFIVQCF-------  115 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~e~~---~l~~l~h~~i~~~~-------  115 (323)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++...  ......+.+.+|+.   +++.++||||++++       
T Consensus        70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~  149 (377)
T 3byv_A           70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  149 (377)
T ss_dssp             CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred             CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence            3468899999999999999999999889999999999743  23345677889995   45556899999998       


Q ss_pred             eeEEcCCC----------------eEEEEEeccCCCCHHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhCCCe
Q 020657          116 GIFEKPSG----------------DIAILMEYMDSGTLDTLLNKNGTFSE-------PKLAHIASQILKGLSYLHGHKII  172 (323)
Q Consensus       116 ~~~~~~~~----------------~~~lv~e~~~~~sL~~~l~~~~~~~~-------~~~~~i~~~i~~~l~~Lh~~giv  172 (323)
                      +++.....                ..++||||+ +|+|.+++...+.+++       ..++.++.||+.||.|||++||+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv  228 (377)
T 3byv_A          150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV  228 (377)
T ss_dssp             EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence            66655321                378999999 5699999986544555       88889999999999999999999


Q ss_pred             ecCCCCCCeEEecCCCcEEEeecCcchhhccCccccccccccccccCCcccCCCC------CCCCCCCcchhHHHHHHHH
Q 020657          173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDA------YGGNYNGYAGDIWSLGLTL  246 (323)
Q Consensus       173 H~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~~~~~~Dv~slG~ll  246 (323)
                      ||||||+||+++.++ .+||+|||++.....   ......+ ..|+|||++....      .....++.++||||||+++
T Consensus       229 HrDikp~NIll~~~~-~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il  303 (377)
T 3byv_A          229 HTYLRPVDIVLDQRG-GVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI  303 (377)
T ss_dssp             CSCCCGGGEEECTTC-CEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred             cCCCCHHHEEEcCCC-CEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence            999999999999987 899999999975432   2234456 9999999987430      0011456799999999999


Q ss_pred             HHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          247 LELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       247 ~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      |+|++|..||...........+         ......+++++.+|+.+||+.||++|||+.++++||||++.+
T Consensus       304 ~elltg~~Pf~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  367 (377)
T 3byv_A          304 YWIWCADLPITKDAALGGSEWI---------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR  367 (377)
T ss_dssp             HHHHHSSCCC------CCSGGG---------GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred             HHHHHCCCCCcccccccchhhh---------hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence            9999999999654433221111         112357899999999999999999999999999999998653

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.5e-47  Score=333.87  Aligned_cols=263  Identities=22%  Similarity=0.348  Sum_probs=222.4

Q ss_pred             CCCCccchhccccccceeeeecccCCeEEEEEEec-----ccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccce
Q 020657           39 NNTTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHR-----CTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ  113 (323)
Q Consensus        39 ~~~~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~  113 (323)
                      .......+.+..++|++.+.||+|+||.||+|.+.     .+++.|++|.+...........+.+|+.+++.++||||++
T Consensus        13 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~   92 (322)
T 1p4o_A           13 DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR   92 (322)
T ss_dssp             SCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCC
T ss_pred             cccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEee
Confidence            33456778889999999999999999999999876     3578899999987766666778899999999999999999


Q ss_pred             eceeEEcCCCeEEEEEeccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEE
Q 020657          114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKN----------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLV  183 (323)
Q Consensus       114 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~  183 (323)
                      +++++.+ .+..++||||+.+++|.+++...          ..+++..++.++.||+.||.|||++|++||||||+||++
T Consensus        93 ~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli  171 (322)
T 1p4o_A           93 LLGVVSQ-GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV  171 (322)
T ss_dssp             EEEEECS-SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE
T ss_pred             eEEEEcc-CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE
Confidence            9999987 67889999999999999999642          357999999999999999999999999999999999999


Q ss_pred             ecCCCcEEEeecCcchhhccCcc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 020657          184 NNNNMQVKIADFGVSKIMCRSLD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPG  260 (323)
Q Consensus       184 ~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~  260 (323)
                      +.++ .+||+|||++........  ......++..|+|||++...     .++.++||||||+++|+|++ |..||... 
T Consensus       172 ~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~el~~~g~~p~~~~-  244 (322)
T 1p4o_A          172 AEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-----VFTTYSDVWSFGVVLWEIATLAEQPYQGL-  244 (322)
T ss_dssp             CTTC-CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-----CCCHHHHHHHHHHHHHHHHHTSCCTTTTS-
T ss_pred             cCCC-eEEECcCccccccccccccccccCCCCCCCccChhhhccC-----CCCchhhHHHHHHHHHHHHhcCCCccccC-
Confidence            9987 899999999976543321  22334567889999998633     34669999999999999999 89999543 


Q ss_pred             CCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          261 QRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                         ....+...+........+..++..+.+|+++||+.||++|||+.++++|
T Consensus       245 ---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          245 ---SNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             ---CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---CHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence               3344444444555566678899999999999999999999999999987

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=9e-48  Score=335.41  Aligned_cols=259  Identities=24%  Similarity=0.395  Sum_probs=219.6

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEec-----ccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceecee
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHR-----CTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGI  117 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~  117 (323)
                      ...+.+..++|++.+.||+|+||.||+|.+.     .+++.||+|++...........+.+|+.+++.++||||++++++
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   94 (314)
T 2ivs_A           15 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGA   94 (314)
T ss_dssp             CTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             CcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence            4566788999999999999999999999973     34588999999877667777889999999999999999999999


Q ss_pred             EEcCCCeEEEEEeccCCCCHHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCCee
Q 020657          118 FEKPSGDIAILMEYMDSGTLDTLLNKNGT------------------------FSEPKLAHIASQILKGLSYLHGHKIIH  173 (323)
Q Consensus       118 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------------------~~~~~~~~i~~~i~~~l~~Lh~~givH  173 (323)
                      +.. .+..++||||+.+++|.+++.....                        +++..++.++.||+.||.|||++|++|
T Consensus        95 ~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH  173 (314)
T 2ivs_A           95 CSQ-DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVH  173 (314)
T ss_dssp             ECS-SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             Eec-CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence            987 6789999999999999999986433                        899999999999999999999999999


Q ss_pred             cCCCCCCeEEecCCCcEEEeecCcchhhccCcc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh
Q 020657          174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL  251 (323)
Q Consensus       174 ~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt  251 (323)
                      +||||+||+++.++ .+||+|||++........  ......++..|+|||++...     .++.++||||||+++|+|+|
T Consensus       174 ~dikp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~el~t  247 (314)
T 2ivs_A          174 RDLAARNILVAEGR-KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-----IYTTQSDVWSFGVLLWEIVT  247 (314)
T ss_dssp             CCCSGGGEEEETTT-EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-----EECHHHHHHHHHHHHHHHHT
T ss_pred             cccchheEEEcCCC-CEEEccccccccccccccceeccCCCCcccccChhhhcCC-----CcCchhhHHHHHHHHHHHHh
Confidence            99999999999987 899999999976543222  22334567889999998643     34569999999999999999


Q ss_pred             -CCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          252 -GHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       252 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                       |..||.......    +............+..+++++.+|+.+||+.||++|||+++++++
T Consensus       248 ~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          248 LGGNPYPGIPPER----LFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             TSCCSSTTCCGGG----HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCCCHHH----HHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence             999996654433    333344445566778899999999999999999999999999876

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=8.2e-48  Score=337.17  Aligned_cols=267  Identities=19%  Similarity=0.324  Sum_probs=198.7

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEecccCc---EEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeE
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHK---IYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIF  118 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~---~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~  118 (323)
                      .....+..++|++.+.||+|+||.||+|.+..+++   .||+|++.... .....+.+.+|+.+++.++||||+++++++
T Consensus        15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   94 (323)
T 3qup_A           15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS   94 (323)
T ss_dssp             -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred             hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence            34556778899999999999999999999876665   89999997553 334567889999999999999999999998


Q ss_pred             EcCCCe-----EEEEEeccCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC
Q 020657          119 EKPSGD-----IAILMEYMDSGTLDTLLNKNG------TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN  187 (323)
Q Consensus       119 ~~~~~~-----~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~  187 (323)
                      ......     .++||||+.+++|.+++....      .+++..++.++.||+.||.|||+.|++|+||||+||+++.++
T Consensus        95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~  174 (323)
T 3qup_A           95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM  174 (323)
T ss_dssp             ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS
T ss_pred             eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC
Confidence            763221     389999999999999996432      589999999999999999999999999999999999999987


Q ss_pred             CcEEEeecCcchhhccCcc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCcc
Q 020657          188 MQVKIADFGVSKIMCRSLD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPD  264 (323)
Q Consensus       188 ~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~  264 (323)
                       .+||+|||++........  ......++..|+|||.+.+.     .++.++||||||+++|+|++ |..||........
T Consensus       175 -~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~  248 (323)
T 3qup_A          175 -TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN-----LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI  248 (323)
T ss_dssp             -CEEECCCCC-----------------CCGGGCCHHHHHHC-----CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred             -CEEEeeccccccccccccccccccccCcccccCchhhcCC-----CCCCccchhhHHHHHHHHHhCCCCCccccChHHH
Confidence             899999999976543321  22234467789999998643     35679999999999999999 9999976554433


Q ss_pred             HHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCC-------HHHHhcCcccccCC
Q 020657          265 WATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWT-------ASQLLTHPFLCKNR  319 (323)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt-------~~~~l~h~~f~~~~  319 (323)
                      ..    ..........+..+++++.+|+++||+.||++|||       ++++++|+|+.+..
T Consensus       249 ~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~  306 (323)
T 3qup_A          249 YN----YLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS  306 (323)
T ss_dssp             HH----HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred             HH----HHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence            33    33334455667789999999999999999999999       88889999997643

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.1e-47  Score=338.19  Aligned_cols=264  Identities=26%  Similarity=0.379  Sum_probs=211.7

Q ss_pred             cchhccccccceeeeecccCCeEEEEEEe-cccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCC------ccceece
Q 020657           44 TTAAIAYSDLEKLQVLGHGNGGTVYKVQH-RCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSP------FIVQCFG  116 (323)
Q Consensus        44 ~~~~~~~~~~~~~~~lg~G~~~~v~~~~~-~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~  116 (323)
                      ....+..++|++.+.||+|+||.||+|.+ ..+++.||+|++...  ......+.+|+.+++.++|+      +++++++
T Consensus         7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~   84 (339)
T 1z57_A            7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLE   84 (339)
T ss_dssp             STTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEE
T ss_pred             ecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeec
Confidence            44556778999999999999999999998 557899999999643  34566788899999887655      4899999


Q ss_pred             eEEcCCCeEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEec---------
Q 020657          117 IFEKPSGDIAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNN---------  185 (323)
Q Consensus       117 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~---------  185 (323)
                      ++.. .+..++||||+ +++|.+++....  .+++..+..++.||+.||.|||++|++|+||||+||+++.         
T Consensus        85 ~~~~-~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~  162 (339)
T 1z57_A           85 WFEH-HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP  162 (339)
T ss_dssp             EEEE-TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred             cccc-CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCC
Confidence            9987 67999999999 679999997654  6899999999999999999999999999999999999987         


Q ss_pred             ----------CCCcEEEeecCcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 020657          186 ----------NNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFP  255 (323)
Q Consensus       186 ----------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p  255 (323)
                                ++ .+||+|||++......   .....++..|+|||++...     .++.++||||||+++|+|++|..|
T Consensus       163 ~~~~~~~~~~~~-~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~slG~il~el~~g~~p  233 (339)
T 1z57_A          163 KIKRDERTLINP-DIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILAL-----GWSQPCDVWSIGCILIEYYLGFTV  233 (339)
T ss_dssp             ---CEEEEESCC-CEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTS-----CCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccccccccccCC-CceEeeCcccccCccc---cccccCCccccChHHhhCC-----CCCcchhhHHHHHHHHHHHhCCCC
Confidence                      43 7999999999764322   2345789999999998743     346699999999999999999999


Q ss_pred             CCCCCCCccHHHHHHHHhcCCC----------------------------------------CCCCCCCChhHHHHHHHh
Q 020657          256 FLQPGQRPDWATLMCAICFGDP----------------------------------------PSLPDGASPEFRSFIECC  295 (323)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~l~~ll~~~  295 (323)
                      |...+.......+.... ...+                                        .......++++.+|+++|
T Consensus       234 f~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  312 (339)
T 1z57_A          234 FPTHDSKEHLAMMERIL-GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKM  312 (339)
T ss_dssp             CCCSCHHHHHHHHHHHH-CSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHH
T ss_pred             CCCCChHHHHHHHHHHh-CCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHH
Confidence            96654333222222111 1000                                        001122356789999999


Q ss_pred             cccCcCCCCCHHHHhcCcccccCCCC
Q 020657          296 LQKEFSKRWTASQLLTHPFLCKNRRS  321 (323)
Q Consensus       296 l~~~p~~Rpt~~~~l~h~~f~~~~~~  321 (323)
                      |+.||++|||++++++||||++.+++
T Consensus       313 L~~dP~~Rpt~~ell~hp~f~~~~~~  338 (339)
T 1z57_A          313 LEYDPAKRITLREALKHPFFDLLKKS  338 (339)
T ss_dssp             TCSSTTTSCCHHHHTTSGGGGGGGC-
T ss_pred             hCcCcccccCHHHHhcCHHHHHHhcc
Confidence            99999999999999999999998764

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=7.3e-47  Score=329.25  Aligned_cols=262  Identities=26%  Similarity=0.434  Sum_probs=205.3

Q ss_pred             CccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCC--CChHHHHHHHHHHHHHHcCCCCccceeceeEE
Q 020657           42 TATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSPFIVQCFGIFE  119 (323)
Q Consensus        42 ~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  119 (323)
                      .........++|++.+.||+|+||.||+|.+..+++.||+|++...  ........+.+|+.+++.++||||+++++++.
T Consensus        23 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~  102 (310)
T 2wqm_A           23 RPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI  102 (310)
T ss_dssp             CGGGTTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             CCCcccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            3444556678999999999999999999999889999999999753  34556778899999999999999999999998


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeec
Q 020657          120 KPSGDIAILMEYMDSGTLDTLLNK----NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADF  195 (323)
Q Consensus       120 ~~~~~~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Df  195 (323)
                      . .+..++||||+.+++|.+++..    ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++ .++|+||
T Consensus       103 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~-~~kl~Df  180 (310)
T 2wqm_A          103 E-DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG-VVKLGDL  180 (310)
T ss_dssp             E-TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCC
T ss_pred             c-CCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCC-CEEEEec
Confidence            7 6789999999999999999864    45689999999999999999999999999999999999999987 8999999


Q ss_pred             CcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcC
Q 020657          196 GVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFG  275 (323)
Q Consensus       196 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~  275 (323)
                      |++..............++..|+|||++...     .++.++||||||+++|+|++|..||.+...  ....+.......
T Consensus       181 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~  253 (310)
T 2wqm_A          181 GLGRFFSSKTTAAHSLVGTPYYMSPERIHEN-----GYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLYSLCKKIEQC  253 (310)
T ss_dssp             ------------------CCSSCCHHHHTTC-----CCCHHHHHHHHHHHHHHHHHSSCTTC---C--CHHHHHHHHHTT
T ss_pred             cceeeecCCCccccccCCCeeEeChHHhCCC-----CCCchhhHHHHHHHHHHHHhCCCCCcccch--hHHHHHHHhhcc
Confidence            9997765444444456789999999998643     356799999999999999999999965432  223333334333


Q ss_pred             CCCCC-CCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          276 DPPSL-PDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       276 ~~~~~-~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ..+.. ...++.++.+|+.+||+.||++|||+++++++
T Consensus       254 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          254 DYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             CSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            33333 36789999999999999999999999999864

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.5e-48  Score=345.81  Aligned_cols=260  Identities=25%  Similarity=0.407  Sum_probs=201.2

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC-----
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS-----  122 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----  122 (323)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.++||||+++++++....     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            4579999999999999999999999999999999997543 3455677889999999999999999999997633     


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          123 GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      ...++||||+.+ +|.+.+.  ..+++..+..++.||+.||.|||++|++||||||+||+++.++ .+||+|||++....
T Consensus       103 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a~~~~  178 (371)
T 2xrw_A          103 QDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAG  178 (371)
T ss_dssp             CEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCCCC-----
T ss_pred             cceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC-CEEEEEeecccccc
Confidence            278999999976 7888875  3589999999999999999999999999999999999999987 89999999997654


Q ss_pred             cCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcC-------
Q 020657          203 RSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFG-------  275 (323)
Q Consensus       203 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~-------  275 (323)
                      ... ......++..|+|||++.+.     .++.++||||||+++|+|++|..||.+.+.......+.......       
T Consensus       179 ~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  252 (371)
T 2xrw_A          179 TSF-MMTPYVVTRYYRAPEVILGM-----GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  252 (371)
T ss_dssp             ------------CTTCCHHHHTTC-----CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred             ccc-ccCCceecCCccCHHHhcCC-----CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            322 23345789999999998743     34569999999999999999999997654332222222111000       


Q ss_pred             ----------CCCCC--------------CC------CCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          276 ----------DPPSL--------------PD------GASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       276 ----------~~~~~--------------~~------~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                                ..+.+              +.      ..+.++.+|+++||+.||++|||++++|+||||+..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  325 (371)
T 2xrw_A          253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  325 (371)
T ss_dssp             SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence                      00000              00      115679999999999999999999999999999754

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=8.3e-48  Score=331.65  Aligned_cols=264  Identities=30%  Similarity=0.457  Sum_probs=218.6

Q ss_pred             cchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC
Q 020657           44 TTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS  122 (323)
Q Consensus        44 ~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  122 (323)
                      ...+...++|++.+.||+|++|.||+|.+..+++.|++|++.... .......+.+|+.++++++||||+++++++.. .
T Consensus        15 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   93 (287)
T 2wei_A           15 YFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-S   93 (287)
T ss_dssp             HHTHHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-S
T ss_pred             hHHHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC-C
Confidence            344556789999999999999999999999899999999986442 22335678899999999999999999999987 6


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC--CcEEEeecCcchh
Q 020657          123 GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN--MQVKIADFGVSKI  200 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~--~~~kl~Dfg~~~~  200 (323)
                      +..++||||+.+++|.+.+.....+++..++.++.||+.||.+||+.|++|+||+|+||+++.++  ..+||+|||++..
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~  173 (287)
T 2wei_A           94 SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (287)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred             CeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence            78999999999999999998777899999999999999999999999999999999999997643  2699999999976


Q ss_pred             hccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCC-C-
Q 020657          201 MCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP-P-  278 (323)
Q Consensus       201 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~-~-  278 (323)
                      ..... ......++..|+|||.+.+      .++.++||||||+++|+|++|..||.....    ..+...+..+.. . 
T Consensus       174 ~~~~~-~~~~~~~~~~y~aPE~~~~------~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~  242 (287)
T 2wei_A          174 FQQNT-KMKDRIGTAYYIAPEVLRG------TYDEKCDVWSAGVILYILLSGTPPFYGKNE----YDILKRVETGKYAFD  242 (287)
T ss_dssp             BCCCS-SCSCHHHHHTTCCHHHHTT------CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCC
T ss_pred             ecCCC-ccccccCcccccChHHhcC------CCCCchhhHhHHHHHHHHHhCCCCCCCCCH----HHHHHHHHcCCCCCC
Confidence            54332 2234467889999998863      256799999999999999999999965432    222222222221 1 


Q ss_pred             -CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          279 -SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       279 -~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                       .....++.++.+|+++||+.||++|||++++++||||++..
T Consensus       243 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  284 (287)
T 2wei_A          243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (287)
T ss_dssp             SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred             chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence             22257899999999999999999999999999999998654

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1e-47  Score=330.07  Aligned_cols=258  Identities=25%  Similarity=0.376  Sum_probs=206.3

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEeccc---CcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEE
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCT---HKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFE  119 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  119 (323)
                      ...+.+..++|++.+.||+|+||.||+|.+..+   +..|++|++...........+.+|+.+++.++||||+++++++.
T Consensus         7 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   86 (281)
T 1mp8_A            7 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT   86 (281)
T ss_dssp             --CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             ccceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence            445678889999999999999999999998643   45799999987666677788999999999999999999999985


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcc
Q 020657          120 KPSGDIAILMEYMDSGTLDTLLNKNG-TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVS  198 (323)
Q Consensus       120 ~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~  198 (323)
                        ++..++||||+.+++|.+++.... .+++..++.++.|++.||.|||+.|++|+||||+||+++.++ .+||+|||++
T Consensus        87 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~  163 (281)
T 1mp8_A           87 --ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLS  163 (281)
T ss_dssp             --SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECC----
T ss_pred             --cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCC-CEEECccccc
Confidence              456899999999999999997654 699999999999999999999999999999999999999987 8999999999


Q ss_pred             hhhccCcc-ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCC
Q 020657          199 KIMCRSLD-ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGD  276 (323)
Q Consensus       199 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~  276 (323)
                      ........ ......++..|+|||++...     .++.++||||||+++|+|++ |..||.........    ..+....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~----~~i~~~~  234 (281)
T 1mp8_A          164 RYMEDSTYYKASKGKLPIKWMAPESINFR-----RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI----GRIENGE  234 (281)
T ss_dssp             ---------------CCGGGCCHHHHHHC-----CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH----HHHHTTC
T ss_pred             cccCcccccccccCCCcccccChhhcccC-----CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH----HHHHcCC
Confidence            76643321 22234466789999998633     34669999999999999996 99999765444332    3333445


Q ss_pred             CCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          277 PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       277 ~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ...++..+++++.+++.+||+.||++|||+.+++++
T Consensus       235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          235 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            566778899999999999999999999999999864

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.7e-48  Score=337.39  Aligned_cols=267  Identities=29%  Similarity=0.432  Sum_probs=207.9

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEc-------
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEK-------  120 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------  120 (323)
                      ...++|++.+.||+|++|.||+|.+..+++.||+|++... +....+.+.+|+.+++.++||||+++++++..       
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   86 (320)
T 2i6l_A            8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD   86 (320)
T ss_dssp             EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred             ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence            4568999999999999999999999989999999998754 34566788999999999999999999998743       


Q ss_pred             ------CCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEee
Q 020657          121 ------PSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIAD  194 (323)
Q Consensus       121 ------~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~D  194 (323)
                            .....++||||+. ++|.+++.. ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++..+||+|
T Consensus        87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D  164 (320)
T 2i6l_A           87 DVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD  164 (320)
T ss_dssp             ----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred             ccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence                  2467899999998 499999865 46899999999999999999999999999999999999985545899999


Q ss_pred             cCcchhhccCc---cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHH
Q 020657          195 FGVSKIMCRSL---DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCA  271 (323)
Q Consensus       195 fg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~  271 (323)
                      ||++.......   .......++..|+|||.+..    ...++.++||||||+++|+|++|..||...........+...
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  240 (320)
T 2i6l_A          165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS----PNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES  240 (320)
T ss_dssp             CTTCBCC--------CCCGGGSCCTTCCHHHHHC----TTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             CccccccCCCcccccccccccccccccCcHHhcC----cccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            99997654321   12234457889999998752    234567999999999999999999999665433222222211


Q ss_pred             Hhc--------------------CCCC-----CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCCC
Q 020657          272 ICF--------------------GDPP-----SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS  321 (323)
Q Consensus       272 ~~~--------------------~~~~-----~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~  321 (323)
                      ...                    ...+     .+...++.++.+|+++||+.||++|||++++|+||||+...-+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p  315 (320)
T 2i6l_A          241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP  315 (320)
T ss_dssp             SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred             cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence            100                    0000     1234689999999999999999999999999999999876543

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=9.9e-48  Score=345.36  Aligned_cols=264  Identities=26%  Similarity=0.341  Sum_probs=205.4

Q ss_pred             chhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC--
Q 020657           45 TAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS--  122 (323)
Q Consensus        45 ~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--  122 (323)
                      .......+|++.+.||+|+||.||+|++..+++ +++|++.....     ...+|+.+++.++||||+++++++....  
T Consensus        34 ~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-----~~~~E~~il~~l~h~niv~l~~~~~~~~~~  107 (394)
T 4e7w_A           34 TGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-----FKNRELQIMRIVKHPNVVDLKAFFYSNGDK  107 (394)
T ss_dssp             SCCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred             CCCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-----hHHHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence            344556789999999999999999999986665 77777754432     1236999999999999999999986422  


Q ss_pred             ---CeEEEEEeccCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEe-cCCCcEEEeec
Q 020657          123 ---GDIAILMEYMDSGTLDTLLN---KNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVN-NNNMQVKIADF  195 (323)
Q Consensus       123 ---~~~~lv~e~~~~~sL~~~l~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~-~~~~~~kl~Df  195 (323)
                         ..+++||||++++.+.....   ....+++..++.++.||+.||.|||+.|++||||||+||+++ .++ .+||+||
T Consensus       108 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~-~~kL~DF  186 (394)
T 4e7w_A          108 KDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG-VLKLIDF  186 (394)
T ss_dssp             SSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT-EEEECCC
T ss_pred             CCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCC-cEEEeeC
Confidence               23789999998743333322   356799999999999999999999999999999999999999 565 8999999


Q ss_pred             CcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcC
Q 020657          196 GVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFG  275 (323)
Q Consensus       196 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~  275 (323)
                      |++....... ......++..|+|||++.+    ...++.++||||||+++|+|++|+.||.+.........+.......
T Consensus       187 G~a~~~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p  261 (394)
T 4e7w_A          187 GSAKILIAGE-PNVSYICSRYYRAPELIFG----ATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP  261 (394)
T ss_dssp             TTCEECCTTC-CCCSSCSCGGGCCHHHHTT----CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             CCcccccCCC-CCcccccCcCccCHHHHcC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            9997654332 2335678999999999853    2335679999999999999999999997655443333333221100


Q ss_pred             ---------------CCC---------CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          276 ---------------DPP---------SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       276 ---------------~~~---------~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                                     ..+         .++..+++++.+|+.+||+.||++|||+.++++||||++.+.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (394)
T 4e7w_A          262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT  330 (394)
T ss_dssp             CHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred             CHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence                           000         123458899999999999999999999999999999998654

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.2e-47  Score=331.04  Aligned_cols=261  Identities=23%  Similarity=0.334  Sum_probs=220.2

Q ss_pred             CccchhccccccceeeeecccCCeEEEEEEe-----cccCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceec
Q 020657           42 TATTAAIAYSDLEKLQVLGHGNGGTVYKVQH-----RCTHKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCF  115 (323)
Q Consensus        42 ~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~-----~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~  115 (323)
                      ....+.+..++|++.+.||+|+||.||+|.+     ..+++.||+|++.........+.+.+|+.+++.+ +||||++++
T Consensus        14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~   93 (313)
T 1t46_A           14 YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLL   93 (313)
T ss_dssp             CCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEE
Confidence            4566788899999999999999999999985     3467899999998776666678899999999999 999999999


Q ss_pred             eeEEcCCCeEEEEEeccCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCC
Q 020657          116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNG------------------TFSEPKLAHIASQILKGLSYLHGHKIIHRDIK  177 (323)
Q Consensus       116 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------------~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~  177 (323)
                      +++.. .+..++||||+++++|.+++....                  .+++..++.++.||+.||.|||+.|++|+|||
T Consensus        94 ~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk  172 (313)
T 1t46_A           94 GACTI-GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA  172 (313)
T ss_dssp             EEECS-SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             EEEec-CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCc
Confidence            99987 678899999999999999997643                  48999999999999999999999999999999


Q ss_pred             CCCeEEecCCCcEEEeecCcchhhccCcc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCC
Q 020657          178 PSNLLVNNNNMQVKIADFGVSKIMCRSLD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHF  254 (323)
Q Consensus       178 ~~nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~  254 (323)
                      |+||+++.++ .+||+|||++........  ......++..|+|||++...     .++.++||||||+++|+|+| |..
T Consensus       173 p~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~ellt~g~~  246 (313)
T 1t46_A          173 ARNILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-----VYTFESDVWSYGIFLWELFSLGSS  246 (313)
T ss_dssp             GGGEEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-----CCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             cceEEEcCCC-CEEEccccccccccccccceeccCCCCcceeeChHHhcCC-----CCChHHHHHHHHHHHHHHHhCCCC
Confidence            9999999987 899999999976644322  12334567789999988633     45679999999999999998 999


Q ss_pred             CCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          255 PFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       255 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ||............   .........+..++.++.+|+.+||+.||.+|||+++++++
T Consensus       247 p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          247 PYPGMPVDSKFYKM---IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             SSTTCCSSHHHHHH---HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCcccchhHHHHH---hccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            99766544333332   33334455567889999999999999999999999999875

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2e-47  Score=332.01  Aligned_cols=261  Identities=27%  Similarity=0.458  Sum_probs=213.1

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC---ChHHHHHHHHHHHHHHcCCCCccceeceeEEc-CCCeE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA---DPTVRRQVFREMEILRRTDSPFIVQCFGIFEK-PSGDI  125 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~  125 (323)
                      .++|++.+.||+|+||.||+|.+..+++.|++|++....   .......+.+|+.+++.++||||+++++++.. .....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            578999999999999999999999899999999986432   12345678899999999999999999999853 24578


Q ss_pred             EEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          126 AILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      ++||||+.++ |.+++..  ...+++..+..++.||+.||.|||++|++|+||||+||+++.++ .++|+|||++.....
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~-~~kl~dfg~~~~~~~  161 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGG-TLKISALGVAEALHP  161 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECCT
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCC-cEEeeccccccccCc
Confidence            9999999875 7777764  45699999999999999999999999999999999999999987 899999999976542


Q ss_pred             C--ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCC
Q 020657          204 S--LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLP  281 (323)
Q Consensus       204 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (323)
                      .  ........++..|+|||++....   ...+.++||||||+++|+|++|..||....    ...+...+... ...++
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~i~~~-~~~~~  233 (305)
T 2wtk_C          162 FAADDTCRTSQGSPAFQPPEIANGLD---TFSGFKVDIWSAGVTLYNITTGLYPFEGDN----IYKLFENIGKG-SYAIP  233 (305)
T ss_dssp             TCSSCEECCCCSCGGGCCHHHHTCCS---CEESHHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHC-CCCCC
T ss_pred             cccccccccCCCCCCCcChhhccCcc---cCCcchhhHHHHHHHHHHHHhCCCCCCCch----HHHHHHHHhcC-CCCCC
Confidence            1  22233556899999999986322   223569999999999999999999996432    33333333333 34566


Q ss_pred             CCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          282 DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       282 ~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                      ..+++.+.+|+++||+.||++|||++++++||||++...
T Consensus       234 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          234 GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             CccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence            788999999999999999999999999999999987654

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.6e-47  Score=338.07  Aligned_cols=262  Identities=27%  Similarity=0.416  Sum_probs=210.6

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCC----
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG----  123 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----  123 (323)
                      ..++|.+.+.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++++.....    
T Consensus        22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  101 (353)
T 3coi_A           22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  101 (353)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence            3578999999999999999999999999999999997653 34456788899999999999999999999986332    


Q ss_pred             -eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          124 -DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       124 -~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                       ..++||||+.+ +|.+++..  .+++..+..++.||+.||.|||++|++|+||||+||+++.++ .+||+|||++....
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~  177 (353)
T 3coi_A          102 YDFYLVMPFMQT-DLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLARHAD  177 (353)
T ss_dssp             CCCEEEEECCSE-EGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTC-CEEECSTTCTTC--
T ss_pred             eeEEEEeccccC-CHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCC-cEEEeecccccCCC
Confidence             35999999974 88877643  589999999999999999999999999999999999999987 89999999997653


Q ss_pred             cCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHh---------
Q 020657          203 RSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAIC---------  273 (323)
Q Consensus       203 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~---------  273 (323)
                      ..   .....++..|+|||++..    ...++.++||||||+++|+|++|..||.+.........+.....         
T Consensus       178 ~~---~~~~~~t~~y~aPE~~~~----~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  250 (353)
T 3coi_A          178 AE---MTGYVVTRWYRAPEVILS----WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  250 (353)
T ss_dssp             ---------CCSBCCSCHHHHSC----CSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred             CC---ccccccCcCcCCHHHHhC----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            32   234568999999999863    23456699999999999999999999976543322222221110         


Q ss_pred             --------------c---CCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCCC
Q 020657          274 --------------F---GDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS  321 (323)
Q Consensus       274 --------------~---~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~  321 (323)
                                    .   .........+++++.+|+++||+.||++|||++++++||||+..+.+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~  315 (353)
T 3coi_A          251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP  315 (353)
T ss_dssp             CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCc
Confidence                          0   01122345789999999999999999999999999999999876543

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-47  Score=337.29  Aligned_cols=260  Identities=25%  Similarity=0.346  Sum_probs=214.8

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEec-----ccCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceece
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHR-----CTHKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFG  116 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~  116 (323)
                      ...+++..++|++.+.||+|+||.||+|.+.     .++..||+|++...........+.+|+.+++.+ +||||+++++
T Consensus        37 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  116 (344)
T 1rjb_A           37 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLG  116 (344)
T ss_dssp             CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CcCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            3467888999999999999999999999973     356789999998665555567889999999999 8999999999


Q ss_pred             eEEcCCCeEEEEEeccCCCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 020657          117 IFEKPSGDIAILMEYMDSGTLDTLLNKNG-----------------------TFSEPKLAHIASQILKGLSYLHGHKIIH  173 (323)
Q Consensus       117 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------------------~~~~~~~~~i~~~i~~~l~~Lh~~givH  173 (323)
                      ++.. .+..++||||+++++|.+++....                       .+++..++.++.||+.||.|||+.|++|
T Consensus       117 ~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH  195 (344)
T 1rjb_A          117 ACTL-SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH  195 (344)
T ss_dssp             EECS-SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred             EEee-CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            9987 678999999999999999997543                       3799999999999999999999999999


Q ss_pred             cCCCCCCeEEecCCCcEEEeecCcchhhccCcc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh
Q 020657          174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL  251 (323)
Q Consensus       174 ~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt  251 (323)
                      +||||+||+++.++ .+||+|||++........  ......++..|+|||++...     .++.++||||||+++|+|+|
T Consensus       196 ~Dikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~Di~slG~il~el~t  269 (344)
T 1rjb_A          196 RDLAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-----IYTIKSDVWSYGILLWEIFS  269 (344)
T ss_dssp             TTCSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-----CCCHHHHHHHHHHHHHHHTT
T ss_pred             CCCChhhEEEcCCC-cEEeCCCccCcccccCccceeccCccCccCccCHHHhccC-----CCChhHhHHHHHHHHHHHHc
Confidence            99999999999987 999999999976543322  22334567889999988633     35679999999999999998


Q ss_pred             -CCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          252 -GHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       252 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                       |..||............   .........+..+++++.+|+.+||+.||.+|||++++++|
T Consensus       270 ~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  328 (344)
T 1rjb_A          270 LGVNPYPGIPVDANFYKL---IQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  328 (344)
T ss_dssp             TSCCSSTTCCCSHHHHHH---HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCcccCCcHHHHHHH---HhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence             99999766544333332   33344556667889999999999999999999999999986

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3.5e-47  Score=329.99  Aligned_cols=263  Identities=25%  Similarity=0.347  Sum_probs=216.4

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEE----ecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeE
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQ----HRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIF  118 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~----~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~  118 (323)
                      .....+...+|++.+.||+|+||.||+|+    +..+++.||+|++...........+.+|+.+++.++||||+++++++
T Consensus        13 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   92 (302)
T 4e5w_A           13 VDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGIC   92 (302)
T ss_dssp             CCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEE
Confidence            44555667889999999999999999999    56689999999998665545567788999999999999999999998


Q ss_pred             EcCC-CeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecC
Q 020657          119 EKPS-GDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFG  196 (323)
Q Consensus       119 ~~~~-~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg  196 (323)
                      .... ...++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||||+||+++.++ .++|+|||
T Consensus        93 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg  171 (302)
T 4e5w_A           93 TEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH-QVKIGDFG  171 (302)
T ss_dssp             EC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCT
T ss_pred             ecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCC-CEEECccc
Confidence            8632 568999999999999999954 45799999999999999999999999999999999999999987 99999999


Q ss_pred             cchhhccCc---cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC-----------CCC
Q 020657          197 VSKIMCRSL---DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQP-----------GQR  262 (323)
Q Consensus       197 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~-----------~~~  262 (323)
                      ++.......   .......++..|+|||++....     ++.++||||||+++|+|+||..|+...           ...
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  246 (302)
T 4e5w_A          172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK-----FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQ  246 (302)
T ss_dssp             TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCE-----EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGG
T ss_pred             ccccccCCCcceeccCCCCCCccccCCeeecCCC-----CCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccc
Confidence            997664432   2233456778899999986433     346999999999999999999886321           122


Q ss_pred             ccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          263 PDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      .....+............+..+++++.+|+++||+.||++|||++++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          247 MTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             GHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             cCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            3344555566666677778899999999999999999999999999985

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=9.9e-48  Score=337.27  Aligned_cols=266  Identities=24%  Similarity=0.364  Sum_probs=217.9

Q ss_pred             CCccchhccccccceeeeecccCCeEEEEEE-----ecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceec
Q 020657           41 TTATTAAIAYSDLEKLQVLGHGNGGTVYKVQ-----HRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCF  115 (323)
Q Consensus        41 ~~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~-----~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~  115 (323)
                      +......+..++|++.+.||+|+||.||+|+     +..+++.||+|++...........+.+|+.+++.++||||++++
T Consensus        20 s~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   99 (327)
T 2yfx_A           20 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCI   99 (327)
T ss_dssp             CGGGSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             chhhcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEE
Confidence            3455667889999999999999999999999     44578899999998666666777899999999999999999999


Q ss_pred             eeEEcCCCeEEEEEeccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC-
Q 020657          116 GIFEKPSGDIAILMEYMDSGTLDTLLNKN-------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN-  187 (323)
Q Consensus       116 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~-  187 (323)
                      +++.. ....++||||+++++|.+++...       ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++ 
T Consensus       100 ~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~  178 (327)
T 2yfx_A          100 GVSLQ-SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGP  178 (327)
T ss_dssp             EEECS-SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSST
T ss_pred             EEEcC-CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCC
Confidence            99987 67789999999999999999864       3489999999999999999999999999999999999998432 


Q ss_pred             -CcEEEeecCcchhhccCc--cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 020657          188 -MQVKIADFGVSKIMCRSL--DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRP  263 (323)
Q Consensus       188 -~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~  263 (323)
                       ..++|+|||++.......  .......++..|+|||++...     .++.++||||||+++|+|+| |..||...    
T Consensus       179 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~ellt~g~~p~~~~----  249 (327)
T 2yfx_A          179 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-----IFTSKTDTWSFGVLLWEIFSLGYMPYPSK----  249 (327)
T ss_dssp             TCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC-----CCCHHHHHHHHHHHHHHHHTTSCCSSTTC----
T ss_pred             cceEEECccccccccccccccccCCCcCCCcceeCHhHhcCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCc----
Confidence             369999999997654332  122344678899999998633     34679999999999999998 99999543    


Q ss_pred             cHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccc
Q 020657          264 DWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLC  316 (323)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~  316 (323)
                      ....+...+........+..++..+.+|+.+||+.||++|||++++++|.|+.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          250 SNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            23444445555556667788999999999999999999999999999997764

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.3e-47  Score=334.92  Aligned_cols=269  Identities=35%  Similarity=0.603  Sum_probs=199.3

Q ss_pred             CccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHH-HHHcCCCCccceeceeEEc
Q 020657           42 TATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREME-ILRRTDSPFIVQCFGIFEK  120 (323)
Q Consensus        42 ~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~  120 (323)
                      +...+.+..++|++.+.||+|+||.||+|.+..+++.||+|++...........+..|+. +++.++||||+++++++..
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~   92 (327)
T 3aln_A           13 PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR   92 (327)
T ss_dssp             CCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred             hHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence            456778889999999999999999999999998999999999987766555666666766 6677899999999999987


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCCeEEecCCCcEEEee
Q 020657          121 PSGDIAILMEYMDSGTLDTLLNK-----NGTFSEPKLAHIASQILKGLSYLHGH-KIIHRDIKPSNLLVNNNNMQVKIAD  194 (323)
Q Consensus       121 ~~~~~~lv~e~~~~~sL~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~Lh~~-givH~di~~~nil~~~~~~~~kl~D  194 (323)
                       .+..++||||+.+ +|.+++..     ...+++..+..++.|++.||.|||+. |++|+||||+||+++.++ .+||+|
T Consensus        93 -~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~-~~kl~D  169 (327)
T 3aln_A           93 -EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG-NIKLCD  169 (327)
T ss_dssp             -SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTT-EEEECC
T ss_pred             -CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCC-CEEEcc
Confidence             6789999999986 88887763     56799999999999999999999999 999999999999999987 999999


Q ss_pred             cCcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhc
Q 020657          195 FGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICF  274 (323)
Q Consensus       195 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~  274 (323)
                      ||++....... ......++..|+|||++.... ....++.++||||||+++|+|++|..||......   .........
T Consensus       170 fg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~  244 (327)
T 3aln_A          170 FGISGQLVDSI-AKTRDAGCRPYMAPERIDPSA-SRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV---FDQLTQVVK  244 (327)
T ss_dssp             CSSSCC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------CCCCC
T ss_pred             CCCceeccccc-ccccCCCCccccCceeecccc-CcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH---HHHHHHHhc
Confidence            99997654332 223346889999999984221 1334567999999999999999999999653221   111112222


Q ss_pred             CCCCCC----CCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          275 GDPPSL----PDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       275 ~~~~~~----~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      +..+.+    ...++.++.+|+++||+.||++|||++++++||||.+.
T Consensus       245 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  292 (327)
T 3aln_A          245 GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY  292 (327)
T ss_dssp             SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence            222222    24689999999999999999999999999999999753

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.3e-47  Score=334.67  Aligned_cols=264  Identities=26%  Similarity=0.415  Sum_probs=209.9

Q ss_pred             cccccceeeeecccCCeEEEEEEec-ccCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcC---CCCccceeceeEEc---
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHR-CTHKIYALKVVHGDAD-PTVRRQVFREMEILRRT---DSPFIVQCFGIFEK---  120 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~---  120 (323)
                      ..++|++.+.||+|+||.||+|.+. .+++.||+|++..... ......+.+|+.+++.+   +||||+++++++..   
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            4588999999999999999999995 6788999999864321 11122344666666655   89999999999862   


Q ss_pred             -CCCeEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCc
Q 020657          121 -PSGDIAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGV  197 (323)
Q Consensus       121 -~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~  197 (323)
                       .....++||||+. ++|.+++....  .+++..++.++.||+.||.|||+.|++|+||||+||+++.++ .+||+|||+
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~-~~kl~Dfg~  166 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGL  166 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECSCCS
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCC-CEEEecCcc
Confidence             2567899999998 49999997643  489999999999999999999999999999999999999987 899999999


Q ss_pred             chhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC-
Q 020657          198 SKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD-  276 (323)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~-  276 (323)
                      +...... .......++..|+|||++...     .++.++||||||+++|+|++|..||.+.........+........ 
T Consensus       167 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  240 (326)
T 1blx_A          167 ARIYSFQ-MALTSVVVTLWYRAPEVLLQS-----SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE  240 (326)
T ss_dssp             CCCCCGG-GGGCCCCCCCTTCCHHHHTTC-----CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred             cccccCC-CCccccccccceeCHHHHhcC-----CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence            9765432 223456789999999998743     345699999999999999999999976544433333333221110 


Q ss_pred             ---------------------CCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          277 ---------------------PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       277 ---------------------~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                                           ...+...++..+.+|+.+||+.||++|||++++++||||++.+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  305 (326)
T 1blx_A          241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  305 (326)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence                                 01233568899999999999999999999999999999988764

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-48  Score=338.98  Aligned_cols=258  Identities=21%  Similarity=0.392  Sum_probs=203.5

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCCh-----HHHHHHHHHHHHHHcC----CCCccce
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADP-----TVRRQVFREMEILRRT----DSPFIVQ  113 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~-----~~~~~~~~e~~~l~~l----~h~~i~~  113 (323)
                      ........++|++.+.||+|+||.||+|.+..+++.||+|++......     .....+.+|+.+++++    +|+||++
T Consensus        23 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~  102 (312)
T 2iwi_A           23 GKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIR  102 (312)
T ss_dssp             ----------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCC
T ss_pred             ccchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeee
Confidence            445566778999999999999999999999989999999999654321     1223455788888888    8999999


Q ss_pred             eceeEEcCCCeEEEEEec-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEe-cCCCcEE
Q 020657          114 CFGIFEKPSGDIAILMEY-MDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVN-NNNMQVK  191 (323)
Q Consensus       114 ~~~~~~~~~~~~~lv~e~-~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~-~~~~~~k  191 (323)
                      +++++.. .+..++|+|+ +.+++|.+++.....+++..++.++.||+.||.|||+.|++|+||+|+||+++ .++ .++
T Consensus       103 ~~~~~~~-~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-~~k  180 (312)
T 2iwi_A          103 LLDWFET-QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG-CAK  180 (312)
T ss_dssp             EEEEC------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTT-EEE
T ss_pred             EEEEEec-CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCC-eEE
Confidence            9999887 5778999999 78899999999888899999999999999999999999999999999999999 565 899


Q ss_pred             EeecCcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHH
Q 020657          192 IADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCA  271 (323)
Q Consensus       192 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~  271 (323)
                      |+|||++......  ......++..|+|||++....    ..+.++||||||+++|+|++|..||...      ..... 
T Consensus       181 l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~----~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~~~-  247 (312)
T 2iwi_A          181 LIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQ----YHALPATVWSLGILLYDMVCGDIPFERD------QEILE-  247 (312)
T ss_dssp             ECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSC----BCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHH-
T ss_pred             EEEcchhhhcccC--cccccCCcccccCceeeecCC----CCCccchHHHHHHHHHHHHHCCCCCCCh------HHHhh-
Confidence            9999999765433  233456899999999886332    2235899999999999999999999432      11211 


Q ss_pred             HhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          272 ICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       272 ~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                          ....++..++.++.+|+.+||+.||++|||++++++||||++..
T Consensus       248 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~  291 (312)
T 2iwi_A          248 ----AELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA  291 (312)
T ss_dssp             ----TCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred             ----hccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence                23446678899999999999999999999999999999998754

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=4.1e-47  Score=334.33  Aligned_cols=261  Identities=24%  Similarity=0.346  Sum_probs=220.2

Q ss_pred             CCccchhccccccceeeeecccCCeEEEEEEec-------ccCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccc
Q 020657           41 TTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHR-------CTHKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIV  112 (323)
Q Consensus        41 ~~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~-------~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~  112 (323)
                      +....+.+..++|++.+.||+|+||.||+|.+.       .++..||+|++...........+.+|+.+++.+ +||||+
T Consensus        25 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv  104 (334)
T 2pvf_A           25 PEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII  104 (334)
T ss_dssp             CCCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEe
Confidence            345667888999999999999999999999975       356789999998776667778899999999999 899999


Q ss_pred             eeceeEEcCCCeEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCC
Q 020657          113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNG----------------TFSEPKLAHIASQILKGLSYLHGHKIIHRDI  176 (323)
Q Consensus       113 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~~i~~~l~~Lh~~givH~di  176 (323)
                      ++++++.. .+..++||||+.+++|.+++....                .+++..++.++.||+.||.|||+.|++|+||
T Consensus       105 ~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl  183 (334)
T 2pvf_A          105 NLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDL  183 (334)
T ss_dssp             CEEEEECS-SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             eEEEEEcc-CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCC
Confidence            99999987 678999999999999999997643                3899999999999999999999999999999


Q ss_pred             CCCCeEEecCCCcEEEeecCcchhhccCcc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CC
Q 020657          177 KPSNLLVNNNNMQVKIADFGVSKIMCRSLD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GH  253 (323)
Q Consensus       177 ~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~  253 (323)
                      ||+||+++.++ .+||+|||++........  ......++..|+|||++...     .++.++||||||+++|+|++ |.
T Consensus       184 kp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~ellt~g~  257 (334)
T 2pvf_A          184 AARNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-----VYTHQSDVWSFGVLMWEIFTLGG  257 (334)
T ss_dssp             SGGGEEECTTC-CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-----EECHHHHHHHHHHHHHHHHTTSC
T ss_pred             ccceEEEcCCC-CEEEccccccccccccccccccCCCCcccceeChHHhcCC-----CcChHHHHHHHHHHHHHHHhCCC
Confidence            99999999987 899999999976543321  22334567889999988633     34569999999999999999 99


Q ss_pred             CCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          254 FPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       254 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      .||.+.    ....+...+........+..++.++.+++++||+.||.+|||+++++++
T Consensus       258 ~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          258 SPYPGI----PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             CSSTTC----CHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCcCcC----CHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            999554    3344445555555667778899999999999999999999999999865

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.5e-47  Score=334.40  Aligned_cols=262  Identities=26%  Similarity=0.401  Sum_probs=221.3

Q ss_pred             CccchhccccccceeeeecccCCeEEEEEEec-----ccCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceec
Q 020657           42 TATTAAIAYSDLEKLQVLGHGNGGTVYKVQHR-----CTHKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCF  115 (323)
Q Consensus        42 ~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~  115 (323)
                      ....+.+..++|++.+.||+|+||.||+|.+.     .+++.||+|++...........+.+|+.+++.+ .||||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            45677888999999999999999999999853     467899999998776666777899999999999 789999999


Q ss_pred             eeEEcCCCeEEEEEeccCCCCHHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 020657          116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNGT----------------FSEPKLAHIASQILKGLSYLHGHKIIHRDIKPS  179 (323)
Q Consensus       116 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----------------~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~  179 (323)
                      +++.......++||||+.+++|.+++.....                +++..++.++.||+.||.|||+.|++|+||||+
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~  177 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR  177 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccc
Confidence            9998766679999999999999999986543                899999999999999999999999999999999


Q ss_pred             CeEEecCCCcEEEeecCcchhhccCcc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 020657          180 NLLVNNNNMQVKIADFGVSKIMCRSLD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPF  256 (323)
Q Consensus       180 nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~  256 (323)
                      ||+++.++ .+||+|||++........  ......++..|+|||++..     ..++.++||||||+++|+|+| |..||
T Consensus       178 Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~t~g~~p~  251 (316)
T 2xir_A          178 NILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-----RVYTIQSDVWSFGVLLWEIFSLGASPY  251 (316)
T ss_dssp             GEEECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             eEEECCCC-CEEECCCccccccccCccceeccCCCcceeecCchhhcc-----ccccchhHHHHHHHHHHHHHhCCCCCC
Confidence            99999887 899999999976543221  2234456789999999863     335679999999999999998 99999


Q ss_pred             CCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          257 LQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      .......   .+......+.....+..+++++.+++.+||+.||.+|||++++++|
T Consensus       252 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          252 PGVKIDE---EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             TTCCCSH---HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccchhH---HHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            7654433   2333344455566677889999999999999999999999999986

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.7e-47  Score=324.28  Aligned_cols=253  Identities=23%  Similarity=0.381  Sum_probs=213.2

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeE
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDI  125 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  125 (323)
                      +.+..++|++.+.||+|+||.||+|.+. ++..||+|++......  ...+.+|+.+++.++||||+++++++.. ....
T Consensus         3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   78 (268)
T 3sxs_A            3 MELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVCSK-EYPI   78 (268)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC--HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSE
T ss_pred             eEechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc--HHHHHHHHHHHHhCCCCCEeeEEEEEcc-CCce
Confidence            4677899999999999999999999886 6778999999755422  3568899999999999999999999987 6789


Q ss_pred             EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC
Q 020657          126 AILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS  204 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~  204 (323)
                      ++||||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++......
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A           79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDL-CVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTC-CEEECCTTCEEECCTT
T ss_pred             EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCC-CEEEccCccceecchh
Confidence            9999999999999999764 4599999999999999999999999999999999999999987 8999999999765433


Q ss_pred             cc-ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCCC
Q 020657          205 LD-ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLPD  282 (323)
Q Consensus       205 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (323)
                      .. ......++..|+|||++....     ++.++||||||+++|+|+| |..||....    ................+.
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~~l~~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~  228 (268)
T 3sxs_A          158 QYVSSVGTKFPVKWSAPEVFHYFK-----YSSKSDVWAFGILMWEVFSLGKMPYDLYT----NSEVVLKVSQGHRLYRPH  228 (268)
T ss_dssp             CEEECCSCCCCGGGCCHHHHHHSE-----EETTHHHHHHHHHHHHHHTTTCCTTTTSC----HHHHHHHHHTTCCCCCCT
T ss_pred             hhhcccCCCcCcccCCHHHHhccC-----CchhhhhHHHHHHHHHHHcCCCCCccccC----hHHHHHHHHcCCCCCCCC
Confidence            22 223344567899999986433     4559999999999999998 999995433    334444445555666677


Q ss_pred             CCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          283 GASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       283 ~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ..++.+.+++++||+.||++|||+++++++
T Consensus       229 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          229 LASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             TSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             cChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            889999999999999999999999999987

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=7.9e-48  Score=342.52  Aligned_cols=268  Identities=21%  Similarity=0.278  Sum_probs=206.2

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC----------ChHHHHHHHHHHHHHHcCCCCccceec
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA----------DPTVRRQVFREMEILRRTDSPFIVQCF  115 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~----------~~~~~~~~~~e~~~l~~l~h~~i~~~~  115 (323)
                      .....++|++.+.||+|+||.||+|.+. +++.||+|++....          +....+.+.+|+.+++.++||||++++
T Consensus        17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   95 (362)
T 3pg1_A           17 LHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLR   95 (362)
T ss_dssp             HHHTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred             HHHhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcccee
Confidence            3456789999999999999999999986 59999999986432          223457889999999999999999999


Q ss_pred             eeEEcC----CCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcE
Q 020657          116 GIFEKP----SGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQV  190 (323)
Q Consensus       116 ~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~  190 (323)
                      +++...    ....++||||+.+ +|.+.+... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++ .+
T Consensus        96 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~-~~  173 (362)
T 3pg1_A           96 DIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN-DI  173 (362)
T ss_dssp             EEEEECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CE
T ss_pred             eeEEeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCC-CE
Confidence            998542    3368999999985 777777643 4799999999999999999999999999999999999999887 89


Q ss_pred             EEeecCcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHH
Q 020657          191 KIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMC  270 (323)
Q Consensus       191 kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~  270 (323)
                      ||+|||++...... .......++..|+|||++.+    ...++.++||||||+++|+|++|..||.+.........+..
T Consensus       174 kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~  248 (362)
T 3pg1_A          174 TICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQ----FKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVE  248 (362)
T ss_dssp             EECCTTC----------------CGGGCCHHHHTT----CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             EEEecCcccccccc-cccceecccceecCcHHhcC----CCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            99999999754332 22334578899999998863    23356799999999999999999999976543333333222


Q ss_pred             HHhc-------------------CCCC--------CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCCC
Q 020657          271 AICF-------------------GDPP--------SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS  321 (323)
Q Consensus       271 ~~~~-------------------~~~~--------~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~  321 (323)
                      ....                   ....        .....+++.+.+|+.+||+.||++|||++++|+||||++...+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  326 (362)
T 3pg1_A          249 VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP  326 (362)
T ss_dssp             HHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred             HcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence            1110                   0000        1224568899999999999999999999999999999987543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.1e-48  Score=347.37  Aligned_cols=264  Identities=15%  Similarity=0.143  Sum_probs=193.5

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC--hHHHHHHHHHHHHHHcC--CCCccceec-------
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD--PTVRRQVFREMEILRRT--DSPFIVQCF-------  115 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~e~~~l~~l--~h~~i~~~~-------  115 (323)
                      .....+|++.+.||+|+||.||+|.+..+++.||+|++.....  ......+.+|+.+++.+  +||||++++       
T Consensus        58 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~  137 (371)
T 3q60_A           58 SQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPS  137 (371)
T ss_dssp             TCCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCC
T ss_pred             CCCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeee
Confidence            3445679999999999999999999998999999999987642  34456677775444444  699988755       


Q ss_pred             eeEEcCC----------------CeEEEEEeccCCCCHHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHhCCCe
Q 020657          116 GIFEKPS----------------GDIAILMEYMDSGTLDTLLNKN-GTFSEPKL------AHIASQILKGLSYLHGHKII  172 (323)
Q Consensus       116 ~~~~~~~----------------~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~------~~i~~~i~~~l~~Lh~~giv  172 (323)
                      +++....                ..+++||||++ ++|.+++... ..++...+      ..++.||+.||+|||++||+
T Consensus       138 d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~iv  216 (371)
T 3q60_A          138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLV  216 (371)
T ss_dssp             EEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCc
Confidence            4444321                34899999998 7999999753 34455555      67779999999999999999


Q ss_pred             ecCCCCCCeEEecCCCcEEEeecCcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhC
Q 020657          173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLG  252 (323)
Q Consensus       173 H~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg  252 (323)
                      ||||||+||+++.++ .+||+|||++.......   ....++..|+|||++...   ...++.++||||||+++|+|+||
T Consensus       217 HrDikp~NIll~~~~-~~kL~DFG~a~~~~~~~---~~~~~t~~y~aPE~~~~~---~~~~~~~~DiwSlG~il~elltg  289 (371)
T 3q60_A          217 HGHFTPDNLFIMPDG-RLMLGDVSALWKVGTRG---PASSVPVTYAPREFLNAS---TATFTHALNAWQLGLSIYRVWCL  289 (371)
T ss_dssp             ETTCSGGGEEECTTS-CEEECCGGGEEETTCEE---EGGGSCGGGCCHHHHTCS---EEECCHHHHHHHHHHHHHHHHHS
T ss_pred             cCcCCHHHEEECCCC-CEEEEecceeeecCCCc---cCccCCcCCcChhhccCC---CCCcCccccHHHHHHHHHHHHhC
Confidence            999999999999987 89999999997654322   134566999999998631   13456799999999999999999


Q ss_pred             CCCCCCCCCCcc--HHHHHHHHhc--CCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          253 HFPFLQPGQRPD--WATLMCAICF--GDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       253 ~~p~~~~~~~~~--~~~~~~~~~~--~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      ..||........  ..........  .........+++++.+||.+||+.||++|||++++|+||||++.
T Consensus       290 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  359 (371)
T 3q60_A          290 FLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL  359 (371)
T ss_dssp             SCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred             CCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence            999976532210  0000000000  11112235789999999999999999999999999999999864

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.6e-47  Score=328.88  Aligned_cols=260  Identities=28%  Similarity=0.399  Sum_probs=210.2

Q ss_pred             chhccccccceeeeecccCCeEEEEEE----ecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEc
Q 020657           45 TAAIAYSDLEKLQVLGHGNGGTVYKVQ----HRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEK  120 (323)
Q Consensus        45 ~~~~~~~~~~~~~~lg~G~~~~v~~~~----~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  120 (323)
                      ...+..++|++.+.||+|+||.||+|+    +..+++.||+|++... .....+.+.+|+.+++.++||||+++++++..
T Consensus         4 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   82 (295)
T 3ugc_A            4 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS   82 (295)
T ss_dssp             --CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred             cCcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            345778999999999999999999998    5668899999999754 34556788999999999999999999999854


Q ss_pred             C-CCeEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcc
Q 020657          121 P-SGDIAILMEYMDSGTLDTLLNKNG-TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVS  198 (323)
Q Consensus       121 ~-~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~  198 (323)
                      . ....++||||+++++|.+++...+ .+++..++.++.||+.||.|||+.|++|+||||+||+++.++ .+||+|||++
T Consensus        83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~~  161 (295)
T 3ugc_A           83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLT  161 (295)
T ss_dssp             HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCCSC
T ss_pred             CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCC-eEEEccCccc
Confidence            2 345899999999999999997644 599999999999999999999999999999999999999987 8999999999


Q ss_pred             hhhccCcc---ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC------------Cc
Q 020657          199 KIMCRSLD---ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQ------------RP  263 (323)
Q Consensus       199 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~------------~~  263 (323)
                      ........   ......++..|+|||++...     .++.++||||||+++|+|+||..||.....            ..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~  236 (295)
T 3ugc_A          162 KVLPQDKEFFKVKEPGESPIFWYAPESLTES-----KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM  236 (295)
T ss_dssp             C-------------CTTCGGGGCCHHHHHHC-----CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHH
T ss_pred             ccccCCcceeeeccCCCCccceeCcHHhcCC-----CCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccch
Confidence            76643321   12234567789999998643     346799999999999999999999843210            11


Q ss_pred             cHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          264 DWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ....+............+..+++++.+|+++||+.||++|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          237 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            112344444555566777889999999999999999999999999985

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=5.5e-48  Score=341.68  Aligned_cols=261  Identities=26%  Similarity=0.434  Sum_probs=215.3

Q ss_pred             chhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCCh----------------HHHHHHHHHHHHHHcCCC
Q 020657           45 TAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADP----------------TVRRQVFREMEILRRTDS  108 (323)
Q Consensus        45 ~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~----------------~~~~~~~~e~~~l~~l~h  108 (323)
                      ......++|++.+.||+|+||.||+|.+  +++.||+|++......                .....+.+|+.+++.++|
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h  102 (348)
T 2pml_X           25 EKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKN  102 (348)
T ss_dssp             SSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCC
T ss_pred             hcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCC
Confidence            3345678999999999999999999999  8999999998633110                112678899999999999


Q ss_pred             CccceeceeEEcCCCeEEEEEeccCCCCHHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCC
Q 020657          109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTL------LNK--NGTFSEPKLAHIASQILKGLSYLHG-HKIIHRDIKPS  179 (323)
Q Consensus       109 ~~i~~~~~~~~~~~~~~~lv~e~~~~~sL~~~------l~~--~~~~~~~~~~~i~~~i~~~l~~Lh~-~givH~di~~~  179 (323)
                      |||+++++++.+ .+..++||||+++++|.++      +..  ...+++..++.++.||+.||.|||+ .|++|+||+|+
T Consensus       103 ~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~  181 (348)
T 2pml_X          103 EYCLTCEGIITN-YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPS  181 (348)
T ss_dssp             TTBCCCSEEEES-SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGG
T ss_pred             CCcceEEEEEee-CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChH
Confidence            999999999988 6789999999999999998      655  5679999999999999999999999 99999999999


Q ss_pred             CeEEecCCCcEEEeecCcchhhccCccccccccccccccCCcccCCCCCCCCCCCc-chhHHHHHHHHHHHHhCCCCCCC
Q 020657          180 NLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGY-AGDIWSLGLTLLELYLGHFPFLQ  258 (323)
Q Consensus       180 nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~-~~Dv~slG~ll~~lltg~~p~~~  258 (323)
                      ||+++.++ .++|+|||.+......  ......++..|+|||++....    .++. ++||||||+++|+|++|..||..
T Consensus       182 Nil~~~~~-~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~----~~~~~~~Di~slG~il~~l~~g~~pf~~  254 (348)
T 2pml_X          182 NILMDKNG-RVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNES----SYNGAKVDIWSLGICLYVMFYNVVPFSL  254 (348)
T ss_dssp             GEEECTTS-CEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCC----CEEHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             hEEEcCCC-cEEEeccccccccccc--cccCCCCCcCccCchhhcCCC----CCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999987 8999999999765433  334567899999999986331    2333 89999999999999999999976


Q ss_pred             CCCCccHHHHHHHHhcCCCCCCC-------------------CCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          259 PGQRPDWATLMCAICFGDPPSLP-------------------DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      ....   ..+...+.... ..++                   ..++.++.+|+++||+.||.+|||++++++||||++..
T Consensus       255 ~~~~---~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~  330 (348)
T 2pml_X          255 KISL---VELFNNIRTKN-IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN  330 (348)
T ss_dssp             SSCS---HHHHHHHTSCC-CCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             CCcH---HHHHHHHhccC-cCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence            5442   22222222221 2222                   56899999999999999999999999999999998764

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.7e-47  Score=340.01  Aligned_cols=258  Identities=25%  Similarity=0.389  Sum_probs=205.7

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEec---ccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEE
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHR---CTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFE  119 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  119 (323)
                      .-...+..++|++.+.||+|+||.||+|++.   .++..||+|++...........+.+|+.++++++||||+++++++.
T Consensus        37 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  116 (373)
T 2qol_A           37 EFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT  116 (373)
T ss_dssp             TTSCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             HHHhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            3345677889999999999999999999976   4677899999987666677788999999999999999999999998


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcc
Q 020657          120 KPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVS  198 (323)
Q Consensus       120 ~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~  198 (323)
                      . .+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++
T Consensus       117 ~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a  194 (373)
T 2qol_A          117 K-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL-VCKVSDFGLG  194 (373)
T ss_dssp             S-SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC---
T ss_pred             e-CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCC-CEEECcCccc
Confidence            7 67899999999999999999764 3699999999999999999999999999999999999999987 8999999999


Q ss_pred             hhhccCccc---cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhc
Q 020657          199 KIMCRSLDA---CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICF  274 (323)
Q Consensus       199 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~  274 (323)
                      .........   .....++..|+|||++...     .++.++||||||+++|||++ |..||....    ...+...+..
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~SlG~il~ellt~g~~P~~~~~----~~~~~~~i~~  265 (373)
T 2qol_A          195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-----KFTSASDVWSYGIVLWEVMSYGERPYWEMS----NQDVIKAVDE  265 (373)
T ss_dssp             -------------------CTTSCHHHHHHC-----CCCHHHHHHHHHHHHHHHHTTC-CTTTTCC----HHHHHHHHHT
T ss_pred             cccccCCccceeccCCCcCCCccChhhhccC-----CcCchhcHHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHHHc
Confidence            776433211   1223346789999998643     34669999999999999997 999996543    3344444444


Q ss_pred             CCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          275 GDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       275 ~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ......+..++..+.+|+.+||+.||++|||++++++
T Consensus       266 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          266 GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             TEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            4445556788999999999999999999999999885

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=8.6e-47  Score=329.79  Aligned_cols=269  Identities=34%  Similarity=0.604  Sum_probs=201.3

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHH-HHHHHHHHcCCCCccceeceeEEcC
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQV-FREMEILRRTDSPFIVQCFGIFEKP  121 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~-~~e~~~l~~l~h~~i~~~~~~~~~~  121 (323)
                      ........++|++.+.||+|+||.||+|.+..+++.||+|++............ .++..+++.++||||+++++++.. 
T Consensus        17 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-   95 (318)
T 2dyl_A           17 GQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT-   95 (318)
T ss_dssp             SSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-
T ss_pred             chhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec-
Confidence            455667789999999999999999999999989999999999876554444444 444556778899999999999987 


Q ss_pred             CCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCCeEEecCCCcEEEeecCcch
Q 020657          122 SGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGH-KIIHRDIKPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       122 ~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~-givH~di~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                      .+..++||||+ ++.+..+... ...+++..+..++.||+.||.|||+. |++|+||+|+||+++.++ .+||+|||++.
T Consensus        96 ~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~  173 (318)
T 2dyl_A           96 NTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-QIKLCDFGISG  173 (318)
T ss_dssp             SSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTS-CEEECCCTTC-
T ss_pred             CCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCC-CEEEEECCCch
Confidence            67899999999 4566666653 56799999999999999999999995 999999999999999987 89999999997


Q ss_pred             hhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCC
Q 020657          200 IMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPS  279 (323)
Q Consensus       200 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  279 (323)
                      ...... ......++..|+|||++.........++.++||||||+++|+|++|..||......   ...........++.
T Consensus       174 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~  249 (318)
T 2dyl_A          174 RLVDDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD---FEVLTKVLQEEPPL  249 (318)
T ss_dssp             --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH---HHHHHHHHHSCCCC
T ss_pred             hccCCc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc---HHHHHHHhccCCCC
Confidence            654322 22345689999999998654434455678999999999999999999999653322   22333333344444


Q ss_pred             CC--CCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          280 LP--DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       280 ~~--~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      ++  ..++.++.+|+.+||+.||.+|||++++++||||++.
T Consensus       250 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (318)
T 2dyl_A          250 LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY  290 (318)
T ss_dssp             CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred             CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence            43  4689999999999999999999999999999999753

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.1e-47  Score=343.63  Aligned_cols=264  Identities=26%  Similarity=0.352  Sum_probs=208.0

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCC--------CCcccee
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD--------SPFIVQC  114 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~  114 (323)
                      .....+..++|++.+.||+|+||.||+|++..+++.||+|++...  ......+.+|+.+++.++        |+||+++
T Consensus        29 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~  106 (397)
T 1wak_A           29 VKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQL  106 (397)
T ss_dssp             SCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCE
T ss_pred             EehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeee
Confidence            445566678999999999999999999999999999999999643  455677889999999885        7889999


Q ss_pred             ceeEEc---CCCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCCeEEecCC-
Q 020657          115 FGIFEK---PSGDIAILMEYMDSGTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGH-KIIHRDIKPSNLLVNNNN-  187 (323)
Q Consensus       115 ~~~~~~---~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~-givH~di~~~nil~~~~~-  187 (323)
                      ++++..   .....++||||+.+ ++.+.+...  ..+++..++.++.||+.||.|||++ |++||||||+||+++.++ 
T Consensus       107 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~  185 (397)
T 1wak_A          107 LDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQ  185 (397)
T ss_dssp             EEEEEEEETTEEEEEEEECCCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHH
T ss_pred             ecceeecCCCCceEEEEEeccCc-cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccch
Confidence            999872   24578999999955 665555433  4699999999999999999999998 999999999999998664 


Q ss_pred             -----------------------------------------------CcEEEeecCcchhhccCccccccccccccccCC
Q 020657          188 -----------------------------------------------MQVKIADFGVSKIMCRSLDACNSYVGTCAYMSP  220 (323)
Q Consensus       188 -----------------------------------------------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aP  220 (323)
                                                                     ..+||+|||++......   .....+|..|+||
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aP  262 (397)
T 1wak_A          186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSL  262 (397)
T ss_dssp             HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCH
T ss_pred             hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCC
Confidence                                                           26999999999765432   2345789999999


Q ss_pred             cccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCcc---HHHHHH--HHhcCCC------------------
Q 020657          221 ERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPD---WATLMC--AICFGDP------------------  277 (323)
Q Consensus       221 E~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~---~~~~~~--~~~~~~~------------------  277 (323)
                      |++.+..     ++.++||||||+++|+|+||..||........   ...+..  ......+                  
T Consensus       263 E~~~~~~-----~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  337 (397)
T 1wak_A          263 EVLIGSG-----YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKG  337 (397)
T ss_dssp             HHHHTSC-----CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTS
T ss_pred             hhhcCCC-----CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcc
Confidence            9987443     45699999999999999999999976544321   111111  1000000                  


Q ss_pred             --------------------CCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          278 --------------------PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       278 --------------------~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                                          ...+...+..+.+||++||+.||++|||++++|+||||++
T Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          338 DLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             SBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             ccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                                0112233467899999999999999999999999999974

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=5.5e-47  Score=346.15  Aligned_cols=250  Identities=25%  Similarity=0.434  Sum_probs=211.7

Q ss_pred             cchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCC
Q 020657           44 TTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG  123 (323)
Q Consensus        44 ~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  123 (323)
                      ..+.+..++|++.+.||+|+||.||+|.+.  ++.||+|++....   ....+.+|+.+++.++||||+++++++....+
T Consensus       186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  260 (450)
T 1k9a_A          186 SGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG  260 (450)
T ss_dssp             TTCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTS
T ss_pred             cccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCC
Confidence            456788999999999999999999999984  7799999997553   34568899999999999999999999887566


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhh
Q 020657          124 DIAILMEYMDSGTLDTLLNKNGT--FSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM  201 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~  201 (323)
                      ..++||||+.+++|.+++...+.  +++..++.++.||+.||.|||++|++||||||+||+++.++ .+||+|||++...
T Consensus       261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~  339 (450)
T 1k9a_A          261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEA  339 (450)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCC-CEEEeeCCCcccc
Confidence            89999999999999999986543  79999999999999999999999999999999999999987 8999999999754


Q ss_pred             ccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCC
Q 020657          202 CRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSL  280 (323)
Q Consensus       202 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  280 (323)
                      ...   .....++..|+|||++...     .++.++||||||+++|||+| |..||..........    .+..+.....
T Consensus       340 ~~~---~~~~~~~~~y~aPE~~~~~-----~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~----~i~~~~~~~~  407 (450)
T 1k9a_A          340 SST---QDTGKLPVKWTAPEALREK-----KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP----RVEKGYKMDA  407 (450)
T ss_dssp             C---------CCCTTTSCHHHHHSS-----CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH----HHHTTCCCCC
T ss_pred             ccc---ccCCCCCcceeCHHHhcCC-----CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHHcCCCCCC
Confidence            322   1223567899999998643     35679999999999999998 999997665544333    3334556677


Q ss_pred             CCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          281 PDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       281 ~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      +..+++++.+||.+||+.||++|||++++++
T Consensus       408 p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          408 PDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            7889999999999999999999999999975

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.5e-47  Score=344.18  Aligned_cols=262  Identities=24%  Similarity=0.371  Sum_probs=192.0

Q ss_pred             cccccee-eeecccCCeEEEEEEec--ccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEc-CCCeE
Q 020657           50 YSDLEKL-QVLGHGNGGTVYKVQHR--CTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEK-PSGDI  125 (323)
Q Consensus        50 ~~~~~~~-~~lg~G~~~~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~  125 (323)
                      .+.|++. ++||+|+||.||+|++.  .+++.||+|++......   ..+.+|+.+++.++||||+++++++.. .....
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS---MSACREIALLRELKHPNVISLQKVFLSHADRKV   95 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC---HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC---HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence            3557774 47999999999999965  56889999999755322   356789999999999999999999853 35689


Q ss_pred             EEEEeccCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEE----ecCCCcEEE
Q 020657          126 AILMEYMDSGTLDTLLNKN---------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLV----NNNNMQVKI  192 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~~---------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~----~~~~~~~kl  192 (323)
                      ++||||+.+ +|.+++...         ..+++..++.++.||+.||.|||+.||+||||||+||++    +.++ .+||
T Consensus        96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~-~~kl  173 (405)
T 3rgf_A           96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG-RVKI  173 (405)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTT-CEEE
T ss_pred             EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCC-cEEE
Confidence            999999975 888777521         248999999999999999999999999999999999999    5555 8999


Q ss_pred             eecCcchhhccCc---cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC-------
Q 020657          193 ADFGVSKIMCRSL---DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQR-------  262 (323)
Q Consensus       193 ~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~-------  262 (323)
                      +|||++.......   .......+|..|+|||++.+    ...++.++||||||+++|+|++|..||......       
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~  249 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG----ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY  249 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTT----CCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcC----CCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence            9999998764322   22344678999999999863    233567999999999999999999999654432       


Q ss_pred             --ccHHHHHHHHhcCCCCC---------------------------------CCCCCChhHHHHHHHhcccCcCCCCCHH
Q 020657          263 --PDWATLMCAICFGDPPS---------------------------------LPDGASPEFRSFIECCLQKEFSKRWTAS  307 (323)
Q Consensus       263 --~~~~~~~~~~~~~~~~~---------------------------------~~~~~~~~l~~ll~~~l~~~p~~Rpt~~  307 (323)
                        .....+...........                                 .....+.++.+||++||++||++|||++
T Consensus       250 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~  329 (405)
T 3rgf_A          250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE  329 (405)
T ss_dssp             CHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred             hHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence              11122222111111000                                 0112378899999999999999999999


Q ss_pred             HHhcCcccccCCC
Q 020657          308 QLLTHPFLCKNRR  320 (323)
Q Consensus       308 ~~l~h~~f~~~~~  320 (323)
                      ++|+||||.+...
T Consensus       330 e~L~hp~f~~~~~  342 (405)
T 3rgf_A          330 QAMQDPYFLEDPL  342 (405)
T ss_dssp             HHHTSGGGTSSSC
T ss_pred             HHhcChhhccCCC
Confidence            9999999987643

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.1e-46  Score=326.23  Aligned_cols=255  Identities=26%  Similarity=0.431  Sum_probs=202.8

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCC
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG  123 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  123 (323)
                      .....++|++.+.||+|+||.||+|.+..+++.|++|++....  .......+.+|+.+++.++||||+++++++.. ++
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~  107 (309)
T 2h34_A           29 EGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-DG  107 (309)
T ss_dssp             -----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TT
T ss_pred             CCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-CC
Confidence            3345689999999999999999999999899999999987542  34456788999999999999999999999987 68


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          124 DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      ..++||||+++++|.+++.....+++..++.++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++.....
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADD-FAYLVDFGIASATTD  186 (309)
T ss_dssp             EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSCCC------
T ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCC-CEEEecCccCccccc
Confidence            8999999999999999999888899999999999999999999999999999999999999987 899999999976543


Q ss_pred             Cc-cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC--CCCC
Q 020657          204 SL-DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD--PPSL  280 (323)
Q Consensus       204 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~  280 (323)
                      .. .......++..|+|||++...     .++.++||||||+++|+|++|..||....    ...+........  ....
T Consensus       187 ~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~  257 (309)
T 2h34_A          187 EKLTQLGNTVGTLYYMAPERFSES-----HATYRADIYALTCVLYECLTGSPPYQGDQ----LSVMGAHINQAIPRPSTV  257 (309)
T ss_dssp             ----------CCGGGCCGGGTCC---------CCCHHHHHHHHHHHHHHSSCSSCSCH----HHHHHHHHHSCCCCGGGT
T ss_pred             cccccccccCCCcCccCHHHHcCC-----CCCchHhHHHHHHHHHHHHHCCCCCCCch----HHHHHHHhccCCCCcccc
Confidence            32 223345688999999998643     44569999999999999999999995432    222222222222  2235


Q ss_pred             CCCCChhHHHHHHHhcccCcCCCC-CHHHHhc
Q 020657          281 PDGASPEFRSFIECCLQKEFSKRW-TASQLLT  311 (323)
Q Consensus       281 ~~~~~~~l~~ll~~~l~~~p~~Rp-t~~~~l~  311 (323)
                      +..++.++.+++.+||+.||++|| |++++++
T Consensus       258 ~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          258 RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence            567899999999999999999999 8888775

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4.1e-47  Score=333.31  Aligned_cols=256  Identities=22%  Similarity=0.369  Sum_probs=205.9

Q ss_pred             chhccccccceeeeecccCCeEEEEEEecccCcE----EEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEc
Q 020657           45 TAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKI----YALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEK  120 (323)
Q Consensus        45 ~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~----v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  120 (323)
                      ...+..++|++.+.||+|+||.||+|++..+++.    |++|.+...........+.+|+.+++.++||||+++++++..
T Consensus         9 ~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   88 (327)
T 3poz_A            9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT   88 (327)
T ss_dssp             SEECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred             HhhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence            3446678999999999999999999998777665    577877655544556788999999999999999999999986


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcch
Q 020657          121 PSGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       121 ~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                        +..++|++++.+++|.+++.. ...+++..++.++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++.
T Consensus        89 --~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~  165 (327)
T 3poz_A           89 --STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAK  165 (327)
T ss_dssp             --SSEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCTTHHH
T ss_pred             --CCeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCC-CEEEccCccee
Confidence              347899999999999999976 45799999999999999999999999999999999999999987 89999999998


Q ss_pred             hhccCccc--cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCC
Q 020657          200 IMCRSLDA--CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGD  276 (323)
Q Consensus       200 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~  276 (323)
                      ........  .....++..|+|||++.+.     .++.++||||||+++|+|+| |..||.......    +...+....
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~~~~~~~~~  236 (327)
T 3poz_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHR-----IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSILEKGE  236 (327)
T ss_dssp             HHTTTCC-------CCCGGGSCHHHHHHC-----CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHHHHHTTC
T ss_pred             EccCCcccccccCCCccccccChHHhccC-----CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH----HHHHHHcCC
Confidence            76543322  2234567799999998743     45679999999999999999 999996654433    333333444


Q ss_pred             CCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          277 PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       277 ~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ....+..++.++.+++.+||+.||++|||+.+++++
T Consensus       237 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          237 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            556677889999999999999999999999999975

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.7e-47  Score=332.89  Aligned_cols=265  Identities=26%  Similarity=0.318  Sum_probs=210.3

Q ss_pred             CCccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEc
Q 020657           41 TTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEK  120 (323)
Q Consensus        41 ~~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  120 (323)
                      .......+..++|++.+.||+|+||.||+|++.  ++.||+|++....  .......+|+.+++.++||||+++++++..
T Consensus        14 ~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   89 (322)
T 3soc_A           14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKR   89 (322)
T ss_dssp             CCCCCEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred             cCccccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceecc
Confidence            345566788899999999999999999999984  7899999996442  334455678999999999999999999876


Q ss_pred             CC---CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CCeecCCCCCCeEEecCC
Q 020657          121 PS---GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH----------KIIHRDIKPSNLLVNNNN  187 (323)
Q Consensus       121 ~~---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~----------givH~di~~~nil~~~~~  187 (323)
                      ..   ..+++||||+++++|.+++... .+++..++.++.||+.||.|||+.          |++|+||||+||+++.++
T Consensus        90 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~  168 (322)
T 3soc_A           90 GTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL  168 (322)
T ss_dssp             ECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC
T ss_pred             CCCCCceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC
Confidence            42   2479999999999999999765 589999999999999999999999          999999999999999987


Q ss_pred             CcEEEeecCcchhhccCcc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC---
Q 020657          188 MQVKIADFGVSKIMCRSLD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQR---  262 (323)
Q Consensus       188 ~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~---  262 (323)
                       .+||+|||++........  ......++..|+|||++.+.......++.++||||||+++|+|+||..||.+....   
T Consensus       169 -~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~  247 (322)
T 3soc_A          169 -TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML  247 (322)
T ss_dssp             -CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred             -eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence             899999999976543322  23345789999999998754433344566899999999999999999999764332   


Q ss_pred             ---------ccHHHHHHHHhcCC-CCCCCC-----CCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          263 ---------PDWATLMCAICFGD-PPSLPD-----GASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       263 ---------~~~~~~~~~~~~~~-~~~~~~-----~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                               .....+........ .+.++.     ..+.++.+|+++||+.||++|||++++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             TTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             chhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                     12333333332222 222221     12345999999999999999999999986

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=8.9e-48  Score=336.53  Aligned_cols=259  Identities=23%  Similarity=0.390  Sum_probs=212.7

Q ss_pred             CccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCCh-----HHHHHHHHHHHHHHcCC--CCcccee
Q 020657           42 TATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADP-----TVRRQVFREMEILRRTD--SPFIVQC  114 (323)
Q Consensus        42 ~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~-----~~~~~~~~e~~~l~~l~--h~~i~~~  114 (323)
                      .........++|++.+.||+|+||.||+|.+..+++.||+|++......     .....+.+|+.+++.+.  |+||+++
T Consensus        34 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~  113 (320)
T 3a99_A           34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL  113 (320)
T ss_dssp             ------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred             cccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence            4555666789999999999999999999999989999999998644211     11234567899999986  5999999


Q ss_pred             ceeEEcCCCeEEEEEeccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEe-cCCCcEEE
Q 020657          115 FGIFEKPSGDIAILMEYMDS-GTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVN-NNNMQVKI  192 (323)
Q Consensus       115 ~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~-~~~~~~kl  192 (323)
                      ++++.. .+..++|+|++.+ ++|.+++.....+++..++.++.||+.||.|||+.|++|+||||+||+++ .++ .+||
T Consensus       114 ~~~~~~-~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~-~~kL  191 (320)
T 3a99_A          114 LDWFER-PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG-ELKL  191 (320)
T ss_dssp             EEEEEC-SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEE
T ss_pred             EEEEec-CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCC-CEEE
Confidence            999987 6789999999976 79999998888899999999999999999999999999999999999999 555 8999


Q ss_pred             eecCcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHH
Q 020657          193 ADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAI  272 (323)
Q Consensus       193 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~  272 (323)
                      +|||++......  ......++..|+|||++....    ..+.++||||||+++|+|++|..||...      ....   
T Consensus       192 ~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~----~~~~~~Di~slG~il~el~~g~~pf~~~------~~~~---  256 (320)
T 3a99_A          192 IDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHR----YHGRSAAVWSLGILLYDMVCGDIPFEHD------EEII---  256 (320)
T ss_dssp             CCCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSC----BCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHH---
T ss_pred             eeCccccccccc--cccCCCCCccCCChHHhccCC----CCCccchHHhHHHHHHHHHHCCCCCCCh------hhhh---
Confidence            999999765432  223456899999999886332    2346899999999999999999999432      1111   


Q ss_pred             hcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          273 CFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                        .....++..+++++.+|+++||+.||++|||++++++||||++..
T Consensus       257 --~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          257 --RGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             --HCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             --cccccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence              112345678899999999999999999999999999999998764

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=6.4e-47  Score=326.13  Aligned_cols=258  Identities=23%  Similarity=0.341  Sum_probs=218.8

Q ss_pred             CccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcC
Q 020657           42 TATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP  121 (323)
Q Consensus        42 ~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  121 (323)
                      ....+.+..++|++.+.||+|++|.||+|.+..++..|++|++....  ...+.+.+|+.+++.++||||+++++++.+ 
T Consensus         4 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-   80 (288)
T 3kfa_A            4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-   80 (288)
T ss_dssp             TCCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS--THHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             chhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-
Confidence            35678889999999999999999999999999899999999997543  345678899999999999999999999987 


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcch
Q 020657          122 SGDIAILMEYMDSGTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       122 ~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                      ....++||||+.+++|.+++...  ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++ .++|+|||++.
T Consensus        81 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~  159 (288)
T 3kfa_A           81 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSR  159 (288)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGG-CEEECCCCGGG
T ss_pred             CCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCC-CEEEccCccce
Confidence            67899999999999999999863  4589999999999999999999999999999999999999887 89999999997


Q ss_pred             hhccCcc-ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCC
Q 020657          200 IMCRSLD-ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDP  277 (323)
Q Consensus       200 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~  277 (323)
                      ....... ......++..|+|||++...     .++.++||||||+++|+|++ |..||........    .........
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~----~~~~~~~~~  230 (288)
T 3kfa_A          160 LMTGDTYTAHAGAKFPIKWTAPESLAYN-----KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV----YELLEKDYR  230 (288)
T ss_dssp             TSCSSSSEEETTEEECGGGCCHHHHHHC-----CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH----HHHHHTTCC
T ss_pred             eccCCccccccCCccccCcCChhhhccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH----HHHHhccCC
Confidence            6653322 22334567789999998643     34679999999999999999 9999966544332    233333445


Q ss_pred             CCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          278 PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       278 ~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ...+..+++.+.+|+++||+.||++|||++++++.
T Consensus       231 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~  265 (288)
T 3kfa_A          231 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA  265 (288)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHH
Confidence            56667899999999999999999999999999863

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.5e-47  Score=335.85  Aligned_cols=260  Identities=28%  Similarity=0.453  Sum_probs=184.7

Q ss_pred             hccccccceee-eecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEc---CC
Q 020657           47 AIAYSDLEKLQ-VLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEK---PS  122 (323)
Q Consensus        47 ~~~~~~~~~~~-~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~  122 (323)
                      ....++|++.+ .||+|+||.||+|.+..+++.||+|++...  ....   .+....++.++||||+++++++..   ..
T Consensus        24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~   98 (336)
T 3fhr_A           24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--PKAR---QEVDHHWQASGGPHIVCILDVYENMHHGK   98 (336)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--HHHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--HHHH---HHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence            34568899965 699999999999999999999999999643  2222   223334566799999999999864   23


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC--CcEEEeecCcc
Q 020657          123 GDIAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN--MQVKIADFGVS  198 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~--~~~kl~Dfg~~  198 (323)
                      ...++||||+.+++|.+++....  .+++..++.++.||+.||.|||+.|++|+||||+||+++.++  ..+||+|||++
T Consensus        99 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A           99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             ceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            45899999999999999998653  699999999999999999999999999999999999998642  25999999999


Q ss_pred             hhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHh---cC
Q 020657          199 KIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAIC---FG  275 (323)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~---~~  275 (323)
                      ......  ......++..|+|||++...     .++.++||||||+++|+|++|..||.................   ..
T Consensus       179 ~~~~~~--~~~~~~~t~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  251 (336)
T 3fhr_A          179 KETTQN--ALQTPCYTPYYVAPEVLGPE-----KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYG  251 (336)
T ss_dssp             EEC------------------------C-----HHHHHHHHHHHHHHHHHHHHSSCCC---------------------C
T ss_pred             eecccc--ccccCCCCcCccChhhhCCC-----CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccc
Confidence            765432  22345679999999998533     345699999999999999999999966544333222222111   12


Q ss_pred             CCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          276 DPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       276 ~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      .+......++.++.+|+++||+.||++|||++++|+||||++.
T Consensus       252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          252 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence            2233335789999999999999999999999999999999764

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.7e-46  Score=321.28  Aligned_cols=256  Identities=22%  Similarity=0.378  Sum_probs=211.2

Q ss_pred             chhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCCh---HHH---HHHHHHHHHHHcCCCCccceeceeE
Q 020657           45 TAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADP---TVR---RQVFREMEILRRTDSPFIVQCFGIF  118 (323)
Q Consensus        45 ~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~---~~~---~~~~~e~~~l~~l~h~~i~~~~~~~  118 (323)
                      ...+..++|++.+.||+|+||.||+|++..+++.||+|++......   ...   ..+.+|+.+++.++||||+++++++
T Consensus        13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   92 (287)
T 4f0f_A           13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM   92 (287)
T ss_dssp             CCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             hhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee
Confidence            4456679999999999999999999999989999999998654322   111   6788999999999999999999998


Q ss_pred             EcCCCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCCeEEecCCCc-----E
Q 020657          119 EKPSGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHK--IIHRDIKPSNLLVNNNNMQ-----V  190 (323)
Q Consensus       119 ~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~g--ivH~di~~~nil~~~~~~~-----~  190 (323)
                      .+. .  ++||||+.+++|.+.+.. ...+++..++.++.|++.||.|||+.|  ++|+||||+||+++.++ .     +
T Consensus        93 ~~~-~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~-~~~~~~~  168 (287)
T 4f0f_A           93 HNP-P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLD-ENAPVCA  168 (287)
T ss_dssp             TTT-T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCC-TTCSCCE
T ss_pred             cCC-C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccC-CCCceeE
Confidence            763 3  699999999999887764 447999999999999999999999999  99999999999998765 4     9


Q ss_pred             EEeecCcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHH
Q 020657          191 KIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMC  270 (323)
Q Consensus       191 kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~  270 (323)
                      ||+|||++.....   ......++..|+|||++...   ...++.++||||||+++|+|++|..||....... ......
T Consensus       169 kl~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~  241 (287)
T 4f0f_A          169 KVADFGLSQQSVH---SVSGLLGNFQWMAPETIGAE---EESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-IKFINM  241 (287)
T ss_dssp             EECCCTTCBCCSS---CEECCCCCCTTSCGGGSSCS---SCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH-HHHHHH
T ss_pred             EeCCCCccccccc---cccccCCCccccCchhhccC---CCCcCchhhHHHHHHHHHHHHcCCCCCccccccH-HHHHHH
Confidence            9999999965432   23345789999999998422   2334679999999999999999999996554332 222333


Q ss_pred             HHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          271 AICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      .......+.++..+++++.+|+++||+.||++|||++++++
T Consensus       242 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          242 IREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            33345566777889999999999999999999999999986

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=7.3e-47  Score=349.03  Aligned_cols=257  Identities=23%  Similarity=0.343  Sum_probs=218.0

Q ss_pred             CccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcC
Q 020657           42 TATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP  121 (323)
Q Consensus        42 ~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  121 (323)
                      ....+.+..++|++.+.||+|+||.||+|.+..++..||+|++.....  ..+.+.+|+.++++++||||+++++++.. 
T Consensus       211 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~-  287 (495)
T 1opk_A          211 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTR-  287 (495)
T ss_dssp             SSSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             cccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc--chHHHHHHHHHHHhcCCCCEeeEEEEEec-
Confidence            356688899999999999999999999999998899999999975532  35678899999999999999999999987 


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcch
Q 020657          122 SGDIAILMEYMDSGTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       122 ~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                      ...+++||||+.+++|.+++...  ..+++..++.++.||+.||.|||++|++||||||+||+++.++ .+||+|||++.
T Consensus       288 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~  366 (495)
T 1opk_A          288 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENH-LVKVADFGLSR  366 (495)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG-CEEECCTTCEE
T ss_pred             CCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCC-cEEEeecccce
Confidence            67899999999999999999753  4589999999999999999999999999999999999999887 89999999997


Q ss_pred             hhccCc-cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCC
Q 020657          200 IMCRSL-DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDP  277 (323)
Q Consensus       200 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~  277 (323)
                      ...... .......++..|+|||++....     ++.++||||||+++|||+| |..||.+......    ...+.....
T Consensus       367 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~----~~~~~~~~~  437 (495)
T 1opk_A          367 LMTGDTYTAHAGAKFPIKWTAPESLAYNK-----FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV----YELLEKDYR  437 (495)
T ss_dssp             CCTTCCEECCTTCCCCGGGCCHHHHHHCE-----ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH----HHHHHTTCC
T ss_pred             eccCCceeecCCCcCCcceeCHhHHhcCC-----CCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH----HHHHHcCCC
Confidence            654322 1223344567899999986433     4569999999999999999 9999976544332    233333455


Q ss_pred             CCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          278 PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       278 ~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ...+..+++++.+||.+||+.||++|||++++++
T Consensus       438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence            6677889999999999999999999999999986

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.5e-46  Score=330.55  Aligned_cols=260  Identities=24%  Similarity=0.360  Sum_probs=218.5

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEecccCc-----EEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceece
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHK-----IYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFG  116 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~-----~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~  116 (323)
                      ...+.+..++|++.+.||+|+||.||+|.+..+++     .|++|++...........+.+|+.+++.+ +||||+++++
T Consensus        38 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~  117 (333)
T 2i1m_A           38 NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLG  117 (333)
T ss_dssp             CGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            45678889999999999999999999999876554     79999998776667778899999999999 8999999999


Q ss_pred             eEEcCCCeEEEEEeccCCCCHHHHHHh--------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeE
Q 020657          117 IFEKPSGDIAILMEYMDSGTLDTLLNK--------------NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLL  182 (323)
Q Consensus       117 ~~~~~~~~~~lv~e~~~~~sL~~~l~~--------------~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil  182 (323)
                      ++.. .+..++||||+++++|.+++..              ...+++..++.++.||+.||.|||+.|++|+||||+||+
T Consensus       118 ~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl  196 (333)
T 2i1m_A          118 ACTH-GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL  196 (333)
T ss_dssp             EECS-SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCE
T ss_pred             EEec-CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEE
Confidence            9987 6789999999999999999964              235799999999999999999999999999999999999


Q ss_pred             EecCCCcEEEeecCcchhhccCcc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 020657          183 VNNNNMQVKIADFGVSKIMCRSLD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQP  259 (323)
Q Consensus       183 ~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~  259 (323)
                      ++.++ .+||+|||++........  ......++..|+|||++...     .++.++||||||+++|+|+| |..||...
T Consensus       197 ~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~el~t~g~~p~~~~  270 (333)
T 2i1m_A          197 LTNGH-VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-----VYTVQSDVWSYGILLWEIFSLGLNPYPGI  270 (333)
T ss_dssp             EEGGG-EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-----CCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             ECCCC-eEEECccccccccccccceeecCCCCCCccccCHHHhccC-----CCChHHHHHHHHHHHHHHHcCCCCCCccc
Confidence            99987 899999999976543322  12334567789999988633     35679999999999999998 99999765


Q ss_pred             CCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          260 GQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      .........   .........+..++..+.+|+.+||+.||.+|||+++++++
T Consensus       271 ~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          271 LVNSKFYKL---VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             CSSHHHHHH---HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             chhHHHHHH---HhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            544333333   23344455667789999999999999999999999999874

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.8e-46  Score=343.17  Aligned_cols=255  Identities=22%  Similarity=0.372  Sum_probs=215.3

Q ss_pred             CccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcC
Q 020657           42 TATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP  121 (323)
Q Consensus        42 ~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  121 (323)
                      ....+.+..++|++.+.||+|+||.||+|.+. ++..||+|++....  ...+.+.+|+.+++.++||||+++++++.  
T Consensus       179 ~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~--  253 (454)
T 1qcf_A          179 EKDAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT--  253 (454)
T ss_dssp             CTTCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC--
T ss_pred             cccceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe--
Confidence            35678899999999999999999999999986 57789999997543  23567889999999999999999999986  


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcch
Q 020657          122 SGDIAILMEYMDSGTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       122 ~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                      .+..++||||+.+++|.+++...  ..+++..++.++.||+.||.|||++|++||||||+||+++.++ .+||+|||++.
T Consensus       254 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DFG~a~  332 (454)
T 1qcf_A          254 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL-VCKIADFGLAR  332 (454)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTC-CEEECSTTGGG
T ss_pred             CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCC-cEEEeeCCCce
Confidence            45789999999999999999743  3689999999999999999999999999999999999999987 89999999997


Q ss_pred             hhccCc-cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCC
Q 020657          200 IMCRSL-DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDP  277 (323)
Q Consensus       200 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~  277 (323)
                      ...... .......++..|+|||++...     .++.++||||||+++|||+| |..||.+...    ..+...+..+..
T Consensus       333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslG~~l~el~t~g~~P~~~~~~----~~~~~~i~~~~~  403 (454)
T 1qcf_A          333 VIEDNEYTAREGAKFPIKWTAPEAINFG-----SFTIKSDVWSFGILLMEIVTYGRIPYPGMSN----PEVIRALERGYR  403 (454)
T ss_dssp             GBCCHHHHTTCSSSSCGGGSCHHHHHHC-----CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----HHHHHHHHHTCC
T ss_pred             EcCCCceeccCCCcccccccCHHHhccC-----CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHcCCC
Confidence            654322 112334467789999998633     35679999999999999999 9999965433    344444445556


Q ss_pred             CCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          278 PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       278 ~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ...+..+++++.+|+.+||+.||++|||++++++
T Consensus       404 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          404 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            6677889999999999999999999999999975

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1e-46  Score=323.81  Aligned_cols=257  Identities=26%  Similarity=0.364  Sum_probs=212.7

Q ss_pred             cchhccccccceeeeecccCCeEEEEEEecc---cCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEc
Q 020657           44 TTAAIAYSDLEKLQVLGHGNGGTVYKVQHRC---THKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEK  120 (323)
Q Consensus        44 ~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  120 (323)
                      ..+.+..++|++.+.||+|+||.||+|.+..   ++..|++|++...........+.+|+.+++.++||||+++++++.+
T Consensus         5 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   84 (281)
T 3cc6_A            5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE   84 (281)
T ss_dssp             CCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred             ccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence            3556788999999999999999999999653   3446999999877666777889999999999999999999999875


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcch
Q 020657          121 PSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       121 ~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                        +..++||||+.+++|.+++... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++ .+||+|||++.
T Consensus        85 --~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~  161 (281)
T 3cc6_A           85 --EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE-CVKLGDFGLSR  161 (281)
T ss_dssp             --SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETT-EEEECCCCGGG
T ss_pred             --CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCC-cEEeCccCCCc
Confidence              4568999999999999999764 4599999999999999999999999999999999999999987 89999999997


Q ss_pred             hhccCcc-ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCC
Q 020657          200 IMCRSLD-ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDP  277 (323)
Q Consensus       200 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~  277 (323)
                      ....... ......++..|+|||++...     .++.++||||||+++|+|+| |..||...........    ......
T Consensus       162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~----~~~~~~  232 (281)
T 3cc6_A          162 YIEDEDYYKASVTRLPIKWMSPESINFR-----RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV----LEKGDR  232 (281)
T ss_dssp             CC---------CCCCCGGGCCHHHHHHC-----CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH----HHHTCC
T ss_pred             ccccccccccccCCCCcceeCchhhccC-----CCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHH----HhcCCC
Confidence            6543221 22334567789999998633     34569999999999999998 9999976544433322    333445


Q ss_pred             CCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          278 PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       278 ~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ...+..+++.+.+|+++||+.||++|||+.+++++
T Consensus       233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          233 LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            56667889999999999999999999999999875

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=8.5e-47  Score=331.32  Aligned_cols=258  Identities=26%  Similarity=0.376  Sum_probs=212.8

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEecccCcEE--EEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceeceeEE
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIY--ALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFGIFE  119 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v--~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~  119 (323)
                      .....+..++|++.+.||+|+||.||+|++..++..+  ++|.+...........+.+|+.+++++ +||||+++++++.
T Consensus        17 ~~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~   96 (327)
T 1fvr_A           17 TIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE   96 (327)
T ss_dssp             CCSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred             cccccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeee
Confidence            3444577899999999999999999999998888755  999987655555667788999999999 8999999999998


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEE
Q 020657          120 KPSGDIAILMEYMDSGTLDTLLNKNG----------------TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLV  183 (323)
Q Consensus       120 ~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~  183 (323)
                      + .+..++||||+++++|.+++....                .+++..++.++.||+.||.|||+.|++|+||||+||++
T Consensus        97 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~  175 (327)
T 1fvr_A           97 H-RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV  175 (327)
T ss_dssp             E-TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             e-CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE
Confidence            7 688999999999999999997653                68999999999999999999999999999999999999


Q ss_pred             ecCCCcEEEeecCcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 020657          184 NNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQR  262 (323)
Q Consensus       184 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~  262 (323)
                      +.++ .+||+|||++...... .......++..|+|||++...     .++.++||||||+++|+|+| |..||...   
T Consensus       176 ~~~~-~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~ellt~g~~pf~~~---  245 (327)
T 1fvr_A          176 GENY-VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYS-----VYTTNSDVWSYGVLLWEIVSLGGTPYCGM---  245 (327)
T ss_dssp             CGGG-CEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHC-----EECHHHHHHHHHHHHHHHHTTSCCTTTTC---
T ss_pred             cCCC-eEEEcccCcCcccccc-ccccCCCCCccccChhhhccc-----cCCchhcchHHHHHHHHHHcCCCCCCCCC---
Confidence            9987 8999999998643221 122334567889999998633     34569999999999999998 99999544   


Q ss_pred             ccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          263 PDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                       ....+...+..+.....+..+++++.+|+.+||+.||++|||+++++++
T Consensus       246 -~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          246 -TCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             -CHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -cHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence             3344555555555566677899999999999999999999999999976

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-46  Score=328.56  Aligned_cols=257  Identities=26%  Similarity=0.401  Sum_probs=210.2

Q ss_pred             chhccccccceeeeecccCCeEEEEEEecccC----cEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEc
Q 020657           45 TAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTH----KIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEK  120 (323)
Q Consensus        45 ~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~----~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  120 (323)
                      ..++..++|++.+.||+|+||.||+|.+..++    ..|++|++...........+.+|+.+++.++||||+++++++..
T Consensus        38 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  117 (333)
T 1mqb_A           38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK  117 (333)
T ss_dssp             CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             cccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence            34677899999999999999999999986543    35999999877666677789999999999999999999999987


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcch
Q 020657          121 PSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       121 ~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                       .+..++||||+.+++|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++ .+||+|||++.
T Consensus       118 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~~~  195 (333)
T 1mqb_A          118 -YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL-VCKVSDFGLSR  195 (333)
T ss_dssp             -SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCCCC--
T ss_pred             -CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCC-cEEECCCCcch
Confidence             67899999999999999999764 5799999999999999999999999999999999999999987 89999999997


Q ss_pred             hhccCccc---cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcC
Q 020657          200 IMCRSLDA---CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFG  275 (323)
Q Consensus       200 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~  275 (323)
                      ........   .....++..|+|||++...     .++.++||||||+++|+|++ |..||....    ...+...+..+
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~ellt~g~~pf~~~~----~~~~~~~~~~~  266 (333)
T 1mqb_A          196 VLEDDPEATYTTSGGKIPIRWTAPEAISYR-----KFTSASDVWSFGIVMWEVMTYGERPYWELS----NHEVMKAINDG  266 (333)
T ss_dssp             ---------------CCCGGGSCHHHHHSC-----CCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHHHHHHHTT
T ss_pred             hhccccccccccCCCCccccccCchhcccC-----CCCchhhhHHHHHHHHHHHcCCCCCcccCC----HHHHHHHHHCC
Confidence            76433211   1223456789999998633     34669999999999999998 999995443    33444445555


Q ss_pred             CCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          276 DPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       276 ~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      .....+..++..+.+|+.+||+.||++|||+.+++++
T Consensus       267 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          267 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            5566677899999999999999999999999999864

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.8e-47  Score=335.28  Aligned_cols=254  Identities=23%  Similarity=0.332  Sum_probs=208.8

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcE----EEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKI----YALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS  122 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~----v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  122 (323)
                      .+..++|++.+.||+|+||.||+|.+..+++.    |++|.+...........+.+|+.+++.++||||+++++++..  
T Consensus         9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--   86 (325)
T 3kex_A            9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG--   86 (325)
T ss_dssp             BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB--
T ss_pred             hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--
Confidence            35678999999999999999999999877775    777877544433334556789999999999999999999864  


Q ss_pred             CeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhh
Q 020657          123 GDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM  201 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~  201 (323)
                      +..++||||+.+++|.+++... ..+++..++.++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++...
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~a~~~  165 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPS-QVQVADFGVADLL  165 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSS-CEEECSCSGGGGS
T ss_pred             CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCC-eEEECCCCccccc
Confidence            5689999999999999999764 5789999999999999999999999999999999999999987 8999999999876


Q ss_pred             ccCcc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCC
Q 020657          202 CRSLD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPP  278 (323)
Q Consensus       202 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  278 (323)
                      .....  ......++..|+|||++...     .++.++||||||+++|+|+| |..||.......    +...+......
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~~~~~~~~~  236 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHFG-----KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE----VPDLLEKGERL  236 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHHC-----CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH----HHHHHHTTCBC
T ss_pred             CcccccccccCCCCcccccChHHhccC-----CCChhhHhHHhHHHHHHHHhCCCCCccccCHHH----HHHHHHcCCCC
Confidence            44322  22345577799999998643     35679999999999999999 999997654432    33333344556


Q ss_pred             CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          279 SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       279 ~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ..+..++.++.+|+.+||+.||++|||+.+++++
T Consensus       237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          237 AQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            6667789999999999999999999999999876

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.1e-46  Score=319.34  Aligned_cols=254  Identities=24%  Similarity=0.405  Sum_probs=213.8

Q ss_pred             chhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCe
Q 020657           45 TAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGD  124 (323)
Q Consensus        45 ~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  124 (323)
                      .+.+..++|++.+.||+|++|.||+|.+. +++.|++|++......  .+.+.+|+.+++.++||||+++++++.+ .+.
T Consensus         2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   77 (267)
T 3t9t_A            2 KWVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLE-QAP   77 (267)
T ss_dssp             -CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC--HHHHHHHHHHHHTCCCTTBCCEEEEECS-SSS
T ss_pred             ceEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEcc-CCC
Confidence            35677899999999999999999999987 6788999999765432  3568899999999999999999999987 678


Q ss_pred             EEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          125 IAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      .++||||+++++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||++.....
T Consensus        78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~~  156 (267)
T 3t9t_A           78 ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLD  156 (267)
T ss_dssp             CEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGG-CEEECCTTGGGGBCC
T ss_pred             eEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCC-CEEEccccccccccc
Confidence            99999999999999999764 4689999999999999999999999999999999999999887 899999999976533


Q ss_pred             Cc-cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCC
Q 020657          204 SL-DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLP  281 (323)
Q Consensus       204 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (323)
                      .. .......++..|+|||++...     .++.++||||||+++|+|++ |..||...    ........+........+
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~~g~~p~~~~----~~~~~~~~i~~~~~~~~~  227 (267)
T 3t9t_A          157 DQYTSSTGTKFPVKWASPEVFSFS-----RYSSKSDVWSFGVLMWEVFSEGKIPYENR----SNSEVVEDISTGFRLYKP  227 (267)
T ss_dssp             HHHHSTTSTTCCGGGCCHHHHHHC-----CCCHHHHHHHHHHHHHHHHTTSCCTTTTC----CHHHHHHHHHTTCCCCCC
T ss_pred             ccccccccccccccccChhhhcCC-----CccchhchhhhHHHHHHHhccCCCCCCCC----CHHHHHHHHhcCCcCCCC
Confidence            21 122334567789999998633     34669999999999999999 89999543    334444455555556667


Q ss_pred             CCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          282 DGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       282 ~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ...+..+.+++.+||+.||++|||+++++++
T Consensus       228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          228 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            7889999999999999999999999999875

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.9e-46  Score=334.78  Aligned_cols=263  Identities=25%  Similarity=0.341  Sum_probs=207.0

Q ss_pred             cchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCC-CC-----ccceecee
Q 020657           44 TTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD-SP-----FIVQCFGI  117 (323)
Q Consensus        44 ~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~i~~~~~~  117 (323)
                      .......++|++.+.||+|+||.||+|.+..+++.||+|++...  ......+..|+.+++.++ |+     +|+.++++
T Consensus        47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~  124 (382)
T 2vx3_A           47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH  124 (382)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred             ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence            34455678999999999999999999999989999999999643  345566778888888774 44     48999999


Q ss_pred             EEcCCCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCCeecCCCCCCeEEec--CCCcEE
Q 020657          118 FEKPSGDIAILMEYMDSGTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLH--GHKIIHRDIKPSNLLVNN--NNMQVK  191 (323)
Q Consensus       118 ~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh--~~givH~di~~~nil~~~--~~~~~k  191 (323)
                      +.. .+..++||||+.+ +|.+++...  ..+++..+..++.||+.||.|||  +.||+||||||+||+++.  ++ .+|
T Consensus       125 ~~~-~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~-~~k  201 (382)
T 2vx3_A          125 FMF-RNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRS-AIK  201 (382)
T ss_dssp             EEE-TTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSC-CEE
T ss_pred             ecc-CCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCC-cEE
Confidence            987 6889999999975 999999764  46899999999999999999999  469999999999999954  44 799


Q ss_pred             EeecCcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHH
Q 020657          192 IADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCA  271 (323)
Q Consensus       192 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~  271 (323)
                      |+|||++......   .....++..|+|||++.+.     .++.++||||||+++|+|+||..||.+.........+...
T Consensus       202 L~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~-----~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~  273 (382)
T 2vx3_A          202 IVDFGSSCQLGQR---IYQYIQSRFYRSPEVLLGM-----PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV  273 (382)
T ss_dssp             ECCCTTCEETTCC---CCSSCSCGGGCCHHHHTTC-----CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             EEeccCceecccc---cccccCCccccChHHHcCC-----CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            9999999766432   2346789999999998744     3456999999999999999999999765443333333322


Q ss_pred             HhcCCC------C-------CCC------------------CC----------------------------CChhHHHHH
Q 020657          272 ICFGDP------P-------SLP------------------DG----------------------------ASPEFRSFI  292 (323)
Q Consensus       272 ~~~~~~------~-------~~~------------------~~----------------------------~~~~l~~ll  292 (323)
                      ......      +       .++                  ..                            .++++.+||
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli  353 (382)
T 2vx3_A          274 LGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLI  353 (382)
T ss_dssp             HCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHH
T ss_pred             hCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHH
Confidence            110000      0       000                  00                            013789999


Q ss_pred             HHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          293 ECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       293 ~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      ++||++||++|||++++|+||||++..
T Consensus       354 ~~mL~~dP~~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          354 LRMLDYDPKTRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             HHHTCSCTTTSCCHHHHTTSGGGCC--
T ss_pred             HHhcCCChhhCCCHHHHhcCcccccCC
Confidence            999999999999999999999998754

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3.1e-46  Score=322.48  Aligned_cols=256  Identities=23%  Similarity=0.402  Sum_probs=212.0

Q ss_pred             cchhccccccceee-eecccCCeEEEEEEe--cccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEE
Q 020657           44 TTAAIAYSDLEKLQ-VLGHGNGGTVYKVQH--RCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFE  119 (323)
Q Consensus        44 ~~~~~~~~~~~~~~-~lg~G~~~~v~~~~~--~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  119 (323)
                      ....+..++|++.+ .||+|+||.||+|.+  ..+++.|++|++.... +....+.+.+|+.+++.++||||+++++++.
T Consensus         9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   88 (291)
T 1xbb_A            9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE   88 (291)
T ss_dssp             --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC
Confidence            44566778999999 999999999999954  4567899999997553 2345678899999999999999999999995


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcch
Q 020657          120 KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       120 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                        .+..++||||+.+++|.+++...+.+++..++.++.||+.||.|||+.|++|+||||+||+++.++ .++|+|||++.
T Consensus        89 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~  165 (291)
T 1xbb_A           89 --AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSK  165 (291)
T ss_dssp             --SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTTCE
T ss_pred             --CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCC-cEEEccCCcce
Confidence              467899999999999999999888899999999999999999999999999999999999999987 89999999997


Q ss_pred             hhccCccc---cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcC
Q 020657          200 IMCRSLDA---CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFG  275 (323)
Q Consensus       200 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~  275 (323)
                      ........   .....++..|+|||.+....     ++.++||||||+++|+|++ |..||....    ...+...+...
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~~l~~~g~~p~~~~~----~~~~~~~~~~~  236 (291)
T 1xbb_A          166 ALRADENYYKAQTHGKWPVKWYAPECINYYK-----FSSKSDVWSFGVLMWEAFSYGQKPYRGMK----GSEVTAMLEKG  236 (291)
T ss_dssp             ECCTTCSEEEC----CCCGGGCCHHHHHHCE-----EEHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHHHHHHHHTT
T ss_pred             eeccCCCcccccccCCCCceeeChHHhccCC-----CChhhhHHHHHHHHHHHHhcCCCCCCCCC----HHHHHHHHHcC
Confidence            65433221   12234567899999986333     4569999999999999999 999995543    34444555556


Q ss_pred             CCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          276 DPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       276 ~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ....++..+++++.+++.+||+.||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          237 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            667777889999999999999999999999999985

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.2e-46  Score=322.03  Aligned_cols=263  Identities=26%  Similarity=0.427  Sum_probs=201.4

Q ss_pred             CCccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEE
Q 020657           41 TTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFE  119 (323)
Q Consensus        41 ~~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  119 (323)
                      .....+++..++|++.+.||+|+||.||+|.+..   .+++|++.... .......+.+|+.+++.++||||++++++..
T Consensus        14 ~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   90 (289)
T 3og7_A           14 DAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST   90 (289)
T ss_dssp             ----CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             CCCCCCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc
Confidence            3466778999999999999999999999998743   49999987554 4456678899999999999999999999654


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcc
Q 020657          120 KPSGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVS  198 (323)
Q Consensus       120 ~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~  198 (323)
                        ....++||||+.+++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||||+||+++.++ .++|+|||++
T Consensus        91 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~  167 (289)
T 3og7_A           91 --APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN-TVKIGDFGLA  167 (289)
T ss_dssp             --SSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT-EEEECCCC--
T ss_pred             --CCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC-CEEEccceec
Confidence              4568999999999999999964 45699999999999999999999999999999999999999987 9999999999


Q ss_pred             hhhccC--ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhc-C
Q 020657          199 KIMCRS--LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICF-G  275 (323)
Q Consensus       199 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~-~  275 (323)
                      ......  ........++..|+|||++....  ...++.++||||||+++|+|++|..||.................. .
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  245 (289)
T 3og7_A          168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQD--SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP  245 (289)
T ss_dssp             ----------------CCCTTCCHHHHC------CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC
T ss_pred             cccccccccccccccCCCccccCchhhcccC--CCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc
Confidence            755421  22233456899999999986221  334567999999999999999999999765544333333222111 1


Q ss_pred             CCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          276 DPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       276 ~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ........+++++.+|+.+||+.||++|||++++++
T Consensus       246 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          246 DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            223344678999999999999999999999999986

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.1e-46  Score=318.75  Aligned_cols=254  Identities=19%  Similarity=0.341  Sum_probs=213.2

Q ss_pred             chhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcC-C
Q 020657           45 TAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP-S  122 (323)
Q Consensus        45 ~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~  122 (323)
                      ...+..++|++.+.||+|+||.||+|.+  +++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+. .
T Consensus         4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   81 (271)
T 3kmu_A            4 HSGIDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA   81 (271)
T ss_dssp             CCCCCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred             cCCCCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence            4567789999999999999999999998  48899999997654 445667899999999999999999999999873 2


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCCeEEecCCCcEEEeecCcc
Q 020657          123 GDIAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHK--IIHRDIKPSNLLVNNNNMQVKIADFGVS  198 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~g--ivH~di~~~nil~~~~~~~~kl~Dfg~~  198 (323)
                      ...++||||+++++|.+++....  .+++..++.++.||+.||.|||+.|  ++|+||||+||+++.++ .++|+|||++
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~-~~~l~~~~~~  160 (271)
T 3kmu_A           82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM-TARISMADVK  160 (271)
T ss_dssp             SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTS-CEEEEGGGSC
T ss_pred             CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCc-ceeEEeccce
Confidence            67899999999999999998755  4899999999999999999999999  99999999999999987 8999988887


Q ss_pred             hhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCC
Q 020657          199 KIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPP  278 (323)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~  278 (323)
                      .....     ....++..|+|||++......  ..+.++||||||+++|+|++|..||.....   .............+
T Consensus       161 ~~~~~-----~~~~~t~~y~aPE~~~~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~~  230 (271)
T 3kmu_A          161 FSFQS-----PGRMYAPAWVAPEALQKKPED--TNRRSADMWSFAVLLWELVTREVPFADLSN---MEIGMKVALEGLRP  230 (271)
T ss_dssp             CTTSC-----TTCBSCGGGSCHHHHHSCGGG--SCHHHHHHHHHHHHHHHHHHCSCTTTTSCH---HHHHHHHHHSCCCC
T ss_pred             eeecc-----cCccCCccccChhhhccCCCC--CCCchhhHHHHHHHHHHHHhCCCCccccCh---HHHHHHHHhcCCCC
Confidence            54322     334678999999998744322  223479999999999999999999964432   22233334445566


Q ss_pred             CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          279 SLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       279 ~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      .++..+++++.+++.+||+.||++|||++++++
T Consensus       231 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          231 TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            778889999999999999999999999999985

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3.8e-46  Score=330.40  Aligned_cols=263  Identities=23%  Similarity=0.327  Sum_probs=207.3

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEecccC-cEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCc------cceec
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTH-KIYALKVVHGDADPTVRRQVFREMEILRRTDSPF------IVQCF  115 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~-~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~  115 (323)
                      ........++|++.+.||+|+||.||+|.+..++ +.||+|++...  ......+.+|+.+++.++|++      ++.++
T Consensus        11 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~   88 (355)
T 2eu9_A           11 CRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMS   88 (355)
T ss_dssp             CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEE
T ss_pred             cccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEee
Confidence            4455566789999999999999999999997766 68999999643  355667788999999887655      88888


Q ss_pred             eeEEcCCCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEE----------
Q 020657          116 GIFEKPSGDIAILMEYMDSGTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLV----------  183 (323)
Q Consensus       116 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~----------  183 (323)
                      +++.. .+..++||||+. +++.+.+...  ..+++..++.++.||+.||.|||++|++|+||||+||++          
T Consensus        89 ~~~~~-~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~  166 (355)
T 2eu9_A           89 DWFNF-HGHMCIAFELLG-KNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYN  166 (355)
T ss_dssp             EEEEE-TTEEEEEEECCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred             eeeee-CCeEEEEEeccC-CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccc
Confidence            88887 678999999995 5666666543  369999999999999999999999999999999999999          


Q ss_pred             ---------ecCCCcEEEeecCcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCC
Q 020657          184 ---------NNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHF  254 (323)
Q Consensus       184 ---------~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~  254 (323)
                               +.++ .+||+|||++......   .....++..|+|||++.+.     .++.++||||||+++|+|++|..
T Consensus       167 ~~~~~~~~~~~~~-~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~slG~il~el~~g~~  237 (355)
T 2eu9_A          167 EHKSCEEKSVKNT-SIRVADFGSATFDHEH---HTTIVATRHYRPPEVILEL-----GWAQPCDVWSIGCILFEYYRGFT  237 (355)
T ss_dssp             CC-CCCEEEESCC-CEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTC-----CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             ccccccccccCCC-cEEEeecCcccccccc---ccCCcCCCcccCCeeeecC-----CCCCccchHHHHHHHHHHHhCCC
Confidence                     4555 8999999999764332   2345789999999998743     34569999999999999999999


Q ss_pred             CCCCCCCCccHHHHHHHHhcCCCC----------------------------------------CCCCCCChhHHHHHHH
Q 020657          255 PFLQPGQRPDWATLMCAICFGDPP----------------------------------------SLPDGASPEFRSFIEC  294 (323)
Q Consensus       255 p~~~~~~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~l~~ll~~  294 (323)
                      ||...........+.... ...+.                                        ......+.++.+|+++
T Consensus       238 pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  316 (355)
T 2eu9_A          238 LFQTHENREHLVMMEKIL-GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRR  316 (355)
T ss_dssp             SCCCSSHHHHHHHHHHHH-CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHHc-CCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHH
Confidence            996654333222222211 10000                                        0011224578999999


Q ss_pred             hcccCcCCCCCHHHHhcCcccccCC
Q 020657          295 CLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       295 ~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      ||+.||++|||++++|+||||++..
T Consensus       317 ~L~~dP~~Rpt~~e~l~hp~f~~~~  341 (355)
T 2eu9_A          317 MLEFDPAQRITLAEALLHPFFAGLT  341 (355)
T ss_dssp             HTCSSTTTSCCHHHHTTSGGGGGCC
T ss_pred             HhcCChhhCcCHHHHhcChhhcCCC
Confidence            9999999999999999999998754

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.4e-46  Score=324.02  Aligned_cols=257  Identities=18%  Similarity=0.228  Sum_probs=210.5

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceeceeEEcCCCe
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKPSGD  124 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  124 (323)
                      ..+..++|++.+.||+|++|.||+|.+..+++.||+|++......   ..+.+|+.+++.+ .|+|++++++++.. ...
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~   80 (298)
T 1csn_A            5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQE-GLH   80 (298)
T ss_dssp             -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEE-TTE
T ss_pred             CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc---HHHHHHHHHHHHHhcCCCCCeEEeecCC-Cce
Confidence            456778999999999999999999999889999999998654322   3466899999998 79999999999987 788


Q ss_pred             EEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCC----cEEEeecCcch
Q 020657          125 IAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNM----QVKIADFGVSK  199 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~----~~kl~Dfg~~~  199 (323)
                      .++||||+ +++|.+++... ..+++..++.++.||+.||.|||+.|++||||||+||+++.++.    .+||+|||++.
T Consensus        81 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           81 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             eEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            99999999 88999999864 46999999999999999999999999999999999999987651    39999999997


Q ss_pred             hhccCcc-------ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHH---H
Q 020657          200 IMCRSLD-------ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATL---M  269 (323)
Q Consensus       200 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~---~  269 (323)
                      .......       ......++..|+|||++.+.     .++.++||||||+++|+|++|..||...........+   .
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  234 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-----EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG  234 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-----CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcCC-----CCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH
Confidence            6654322       23456789999999998643     3567999999999999999999999776544333322   2


Q ss_pred             HHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          270 CAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ..........+...+++++.+|+.+||+.||++|||++++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          235 EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             HHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             hhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            2222222233445789999999999999999999999998753

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-45  Score=318.91  Aligned_cols=253  Identities=21%  Similarity=0.302  Sum_probs=209.7

Q ss_pred             cccceeeeecccCCeEEEEEEecccCc---EEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~---~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      -.|++.+.||+|+||.||+|.+..+++   .+++|.+.........+.+.+|+.+++.++||||+++++++.+.+...++
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  100 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV  100 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence            346667999999999999999754444   79999998777767778899999999999999999999999875666699


Q ss_pred             EEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccC--
Q 020657          128 LMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS--  204 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~--  204 (323)
                      ||||+.+++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++ .+||+|||++......  
T Consensus       101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~~~  179 (298)
T 3pls_A          101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESF-TVKVADFGLARDILDREY  179 (298)
T ss_dssp             EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECCTTSSCTTTTGGG
T ss_pred             EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-cEEeCcCCCcccccCCcc
Confidence            9999999999999976 45689999999999999999999999999999999999999987 8999999999765432  


Q ss_pred             --ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCC
Q 020657          205 --LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPD  282 (323)
Q Consensus       205 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (323)
                        ........++..|+|||.+.+.     .++.++||||||+++|+|++|..|+.........   ............+.
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~  251 (298)
T 3pls_A          180 YSVQQHRHARLPVKWTALESLQTY-----RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL---THFLAQGRRLPQPE  251 (298)
T ss_dssp             GCSCCSSCTTCGGGGSCHHHHTTC-----CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGH---HHHHHTTCCCCCCT
T ss_pred             cccccCcCCCCCccccChhhhccC-----CCChhhchhhHHHHHHHHhhCCCCCCccCCHHHH---HHHhhcCCCCCCCc
Confidence              1223345678899999998643     3566999999999999999976666544443332   23333344556677


Q ss_pred             CCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          283 GASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       283 ~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      .++..+.+|+++||+.||.+|||++++++.
T Consensus       252 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  281 (298)
T 3pls_A          252 YCPDSLYQVMQQCWEADPAVRPTFRVLVGE  281 (298)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            889999999999999999999999999863

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-46  Score=321.77  Aligned_cols=256  Identities=24%  Similarity=0.377  Sum_probs=216.1

Q ss_pred             chhccccccceee-eecccCCeEEEEEEec--ccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcC
Q 020657           45 TAAIAYSDLEKLQ-VLGHGNGGTVYKVQHR--CTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP  121 (323)
Q Consensus        45 ~~~~~~~~~~~~~-~lg~G~~~~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  121 (323)
                      .+.+..++|.+.+ .||+|+||.||+|.+.  .++..|++|++...........+.+|+.+++.++||||+++++++.  
T Consensus         3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--   80 (287)
T 1u59_A            3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ--   80 (287)
T ss_dssp             CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--
T ss_pred             cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec--
Confidence            3456778899988 9999999999999864  4678899999987766777888999999999999999999999995  


Q ss_pred             CCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchh
Q 020657          122 SGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       122 ~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                      .+..++||||+.+++|.+++.. ...+++..++.++.||+.||.+||+.|++|+||+|+||+++.++ .++|+|||++..
T Consensus        81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~~  159 (287)
T 1u59_A           81 AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGLSKA  159 (287)
T ss_dssp             SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT-EEEECCCTTCEE
T ss_pred             CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCC-CEEECcccceee
Confidence            4568999999999999999964 34699999999999999999999999999999999999999987 899999999976


Q ss_pred             hccCcc---ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCC
Q 020657          201 MCRSLD---ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGD  276 (323)
Q Consensus       201 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~  276 (323)
                      ......   ......++..|+|||++...     .++.++||||||+++|+|+| |..||.....    ..+...+....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~~~~~i~~~~  230 (287)
T 1u59_A          160 LGADDSYYTARSAGKWPLKWYAPECINFR-----KFSSRSDVWSYGVTMWEALSYGQKPYKKMKG----PEVMAFIEQGK  230 (287)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHC-----EECHHHHHHHHHHHHHHHHTTSCCTTTTCCT----HHHHHHHHTTC
T ss_pred             eccCcceeeccccccccccccCHHHhccC-----CCCchhhHHHHHHHHHHHHcCCCCCcccCCH----HHHHHHHhcCC
Confidence            643222   12234467889999998633     34569999999999999998 9999965443    33344444455


Q ss_pred             CCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          277 PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       277 ~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ...++..+++++.+|+.+||+.||++|||+.+++++
T Consensus       231 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  266 (287)
T 1u59_A          231 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQR  266 (287)
T ss_dssp             CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            667778999999999999999999999999999987

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.3e-46  Score=318.83  Aligned_cols=251  Identities=27%  Similarity=0.451  Sum_probs=199.3

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCCh---HHHHHHHHHHHHHHcCCCCccceeceeEEcCCC
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADP---TVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG  123 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  123 (323)
                      ++..++|++.+.||+|+||.||+|.+  +++.||+|++......   ...+.+.+|+.+++.++||||+++++++.. .+
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   79 (271)
T 3dtc_A            3 EIDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK-EP   79 (271)
T ss_dssp             BCCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC-C-
T ss_pred             ccchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-CC
Confidence            46678999999999999999999998  4889999998754322   234678899999999999999999999987 67


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---CeecCCCCCCeEEec--------CCCcEEE
Q 020657          124 DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK---IIHRDIKPSNLLVNN--------NNMQVKI  192 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g---ivH~di~~~nil~~~--------~~~~~kl  192 (323)
                      ..++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.|   ++|+||||+||+++.        ++ .++|
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~-~~kl  157 (271)
T 3dtc_A           80 NLCLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNK-ILKI  157 (271)
T ss_dssp             -CEEEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSC-CEEE
T ss_pred             ceEEEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCc-ceEE
Confidence            78999999999999999864 47999999999999999999999999   899999999999986        44 7999


Q ss_pred             eecCcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHH
Q 020657          193 ADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAI  272 (323)
Q Consensus       193 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~  272 (323)
                      +|||++........  ....++..|+|||.+...     .++.++||||||+++|+|++|..||.....   ........
T Consensus       158 ~Dfg~~~~~~~~~~--~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~  227 (271)
T 3dtc_A          158 TDFGLAREWHRTTK--MSAAGAYAWMAPEVIRAS-----MFSKGSDVWSYGVLLWELLTGEVPFRGIDG---LAVAYGVA  227 (271)
T ss_dssp             CCCCC---------------CCGGGSCHHHHHHC-----CCSHHHHHHHHHHHHHHHHHCCCTTTTSCH---HHHHHHHH
T ss_pred             ccCCcccccccccc--cCCCCccceeCHHHhccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHhhh
Confidence            99999976543322  245689999999998633     346799999999999999999999965432   22233333


Q ss_pred             hcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          273 CFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      .......++..+++.+.+++.+||+.||++|||+.+++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          228 MNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            3344556778899999999999999999999999999875

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-46  Score=328.34  Aligned_cols=254  Identities=22%  Similarity=0.376  Sum_probs=206.0

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEE----EEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIY----ALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS  122 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v----~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  122 (323)
                      .+..++|++.+.||+|+||.||+|.+..+++.+    ++|.+...........+.+|+.+++.++||||+++++++..  
T Consensus        11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--   88 (327)
T 3lzb_A           11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--   88 (327)
T ss_dssp             ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES--
T ss_pred             ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec--
Confidence            456789999999999999999999998777754    77777655555566788999999999999999999999986  


Q ss_pred             CeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhh
Q 020657          123 GDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM  201 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~  201 (323)
                      +..++|++++.+++|.+++.. ...+++..++.++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++...
T Consensus        89 ~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kL~DfG~a~~~  167 (327)
T 3lzb_A           89 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLL  167 (327)
T ss_dssp             SSEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCTTC----
T ss_pred             CCceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCC-CEEEccCcceeEc
Confidence            348899999999999999976 45799999999999999999999999999999999999999987 8999999999776


Q ss_pred             ccCcc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCC
Q 020657          202 CRSLD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPP  278 (323)
Q Consensus       202 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  278 (323)
                      .....  ......++..|+|||++.+.     .++.++||||||+++|+|++ |..||.......    +...+......
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----~~~~~~~~~~~  238 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHR-----IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSILEKGERL  238 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHC-----CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHHHHHTTCCC
T ss_pred             cCccccccccCCCccccccCHHHHcCC-----CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----HHHHHHcCCCC
Confidence            43322  22234467789999998743     35669999999999999999 999996654433    33333344556


Q ss_pred             CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          279 SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       279 ~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ..+..++.++.+|+++||+.||++|||++++++.
T Consensus       239 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          239 PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            6677899999999999999999999999999863

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.1e-46  Score=331.04  Aligned_cols=252  Identities=19%  Similarity=0.241  Sum_probs=205.9

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceeceeEEcCCCeEE
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKPSGDIA  126 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~  126 (323)
                      +..++|++.+.||+|+||.||+|.+..+++.||+|++......   ..+.+|+.+++.+ +||||+++++++.. ....+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~h~~i~~~~~~~~~-~~~~~   81 (330)
T 2izr_A            6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA---PQLHLEYRFYKQLGSGDGIPQVYYFGPC-GKYNA   81 (330)
T ss_dssp             EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS---CCHHHHHHHHHHHCSCTTSCCEEEEEEE-TTEEE
T ss_pred             EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch---HHHHHHHHHHHHhhCCCCCCEEEEEEec-CCccE
Confidence            4568899999999999999999999889999999998755322   3467899999999 99999999999987 67899


Q ss_pred             EEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCc-----EEEeecCcchh
Q 020657          127 ILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQ-----VKIADFGVSKI  200 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~-----~kl~Dfg~~~~  200 (323)
                      +||||+ +++|.+++.. ...+++..++.++.||+.||.|||+.|++||||||+||+++.++ .     +||+|||++..
T Consensus        82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~-~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPG-NKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGG-GTCTTSEEECCCTTCEE
T ss_pred             EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCC-CCCCceEEEEEccccee
Confidence            999999 8899999986 46799999999999999999999999999999999999999876 5     99999999986


Q ss_pred             hccCcc-------ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHH--
Q 020657          201 MCRSLD-------ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCA--  271 (323)
Q Consensus       201 ~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~--  271 (323)
                      ......       ......+|..|+|||++.+.     .++.++||||||+++|+|++|..||.+.........+...  
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~  234 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGK-----EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD  234 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-----CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCC-----CCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh
Confidence            544322       12456799999999998743     3467999999999999999999999876544433222211  


Q ss_pred             -HhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          272 -ICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       272 -~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                       .............+ ++.+|+..||+.||.+||+++++++
T Consensus       235 ~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          235 TKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             hhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence             11111111223345 9999999999999999999998875

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.7e-46  Score=321.91  Aligned_cols=251  Identities=24%  Similarity=0.431  Sum_probs=203.4

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS  122 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  122 (323)
                      ...+.+..++|++.+.||+|++|.||+|.+  +++.|++|++....   ..+.+.+|+.+++.++||||+++++++....
T Consensus        13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (278)
T 1byg_A           13 RSGWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK   87 (278)
T ss_dssp             --CCBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred             hccccCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            445678889999999999999999999988  58899999987543   3467889999999999999999999987656


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchh
Q 020657          123 GDIAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                      +..++||||+++++|.+++....  .+++..+..++.|++.||.+||+.|++|+||||+||+++.++ .++|+|||++..
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~  166 (278)
T 1byg_A           88 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKE  166 (278)
T ss_dssp             -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEEECCCCC---
T ss_pred             CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCC-cEEEeecccccc
Confidence            67899999999999999997643  389999999999999999999999999999999999999887 899999999876


Q ss_pred             hccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCC
Q 020657          201 MCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPS  279 (323)
Q Consensus       201 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  279 (323)
                      .....   ....++..|+|||++...     .++.++||||||+++|+|+| |..||......    .+...+.......
T Consensus       167 ~~~~~---~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~----~~~~~~~~~~~~~  234 (278)
T 1byg_A          167 ASSTQ---DTGKLPVKWTAPEALREK-----KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----DVVPRVEKGYKMD  234 (278)
T ss_dssp             ------------CCTTTSCHHHHHHC-----CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG----GHHHHHTTTCCCC
T ss_pred             ccccc---cCCCccccccCHHHhCCC-----CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHhcCCCCC
Confidence            54322   233567889999998633     34669999999999999998 99999655433    2333344445566


Q ss_pred             CCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          280 LPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       280 ~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      .+..+++.+.+++++||+.||++|||++++++
T Consensus       235 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          235 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence            77889999999999999999999999999985

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=6e-46  Score=339.47  Aligned_cols=260  Identities=23%  Similarity=0.338  Sum_probs=212.6

Q ss_pred             CccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcC
Q 020657           42 TATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP  121 (323)
Q Consensus        42 ~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  121 (323)
                      ....+.+..++|++.+.||+|+||.||+|.+. .+..||+|++.....  ..+.+.+|+.+++.++||||+++++++.. 
T Consensus       175 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-  250 (452)
T 1fmk_A          175 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-  250 (452)
T ss_dssp             STTCSBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             CccccccChhHceeeeeecCCCCeEEEEEEEC-CCceEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-
Confidence            35678899999999999999999999999997 456799999975532  24578899999999999999999999875 


Q ss_pred             CCeEEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcch
Q 020657          122 SGDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       122 ~~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                       +..++||||+.+++|.+++..  +..+++..+..++.||+.||.|||++|++||||||+||+++.++ .+||+|||++.
T Consensus       251 -~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~  328 (452)
T 1fmk_A          251 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLAR  328 (452)
T ss_dssp             -SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCTTC
T ss_pred             -CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCC-CEEECCCccce
Confidence             568999999999999999974  35699999999999999999999999999999999999999887 89999999997


Q ss_pred             hhccCcc-ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCC
Q 020657          200 IMCRSLD-ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDP  277 (323)
Q Consensus       200 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~  277 (323)
                      ....... ......++..|+|||++...     .++.++||||||+++|+|+| |..||.+..    ...+...+..+..
T Consensus       329 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~sDvwslG~~l~el~t~g~~P~~~~~----~~~~~~~i~~~~~  399 (452)
T 1fmk_A          329 LIEDNEYTARQGAKFPIKWTAPEAALYG-----RFTIKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYR  399 (452)
T ss_dssp             --------------CCGGGSCHHHHHHC-----CCCHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHHHHHHHHTTCC
T ss_pred             ecCCCceecccCCcccccccCHhHHhcC-----CCCccccHHhHHHHHHHHHhCCCCCCCCCC----HHHHHHHHHcCCC
Confidence            6543221 22234567889999998633     35679999999999999999 999996543    2344444555556


Q ss_pred             CCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC--cccc
Q 020657          278 PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH--PFLC  316 (323)
Q Consensus       278 ~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h--~~f~  316 (323)
                      ...+..+++.+.+||.+||+.||++|||++++++.  .+|.
T Consensus       400 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          400 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence            67778899999999999999999999999999863  5554

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2e-46  Score=323.23  Aligned_cols=250  Identities=21%  Similarity=0.317  Sum_probs=205.8

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccC-------cEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEE
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTH-------KIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFE  119 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~-------~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  119 (323)
                      .+..++|++.+.||+|+||.||+|.+..++       ..|++|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   82 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCV   82 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence            466789999999999999999999998766       469999986443 344567889999999999999999999998


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCc--------E
Q 020657          120 KPSGDIAILMEYMDSGTLDTLLNKNGT-FSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQ--------V  190 (323)
Q Consensus       120 ~~~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~--------~  190 (323)
                      + .+..++||||+.+++|.+++...+. +++..++.++.||+.||.|||+.|++||||||+||+++.++ .        +
T Consensus        83 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~~~~~~~~~  160 (289)
T 4fvq_A           83 C-GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREE-DRKTGNPPFI  160 (289)
T ss_dssp             C-TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECC-BGGGTBCCEE
T ss_pred             e-CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCC-ccccccccee
Confidence            7 6778999999999999999986554 99999999999999999999999999999999999999886 5        9


Q ss_pred             EEeecCcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHH
Q 020657          191 KIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMC  270 (323)
Q Consensus       191 kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~  270 (323)
                      ||+|||++......    ....++..|+|||++..    ...++.++||||||+++|+|++|..|+............  
T Consensus       161 kl~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~--  230 (289)
T 4fvq_A          161 KLSDPGISITVLPK----DILQERIPWVPPECIEN----PKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF--  230 (289)
T ss_dssp             EECCCCSCTTTSCH----HHHHHTTTTSCHHHHHC----GGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH--
T ss_pred             eeccCcccccccCc----cccCCcCcccCHHHhCC----CCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH--
Confidence            99999998654322    23457888999999863    134567999999999999999965555433222211111  


Q ss_pred             HHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          271 AICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                       .  .....++...+.++.+|+++||+.||++|||++++++|
T Consensus       231 -~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          231 -Y--EDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             -H--HTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             -h--hccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence             1  12445566778999999999999999999999999976

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=8.3e-46  Score=325.03  Aligned_cols=258  Identities=27%  Similarity=0.429  Sum_probs=216.5

Q ss_pred             ccccccceeeeecccCCeEEEEEE----ecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEc-CC
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQ----HRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEK-PS  122 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~----~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~  122 (323)
                      +..++|++.+.||+|+||.||+|+    +..+++.|++|++... .....+.+.+|+.+++.++|+||+++++++.. ..
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   98 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR   98 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence            567899999999999999999999    5668899999999755 34556778999999999999999999999864 35


Q ss_pred             CeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhh
Q 020657          123 GDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM  201 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~  201 (323)
                      ...++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||||+||+++.++ .+||+|||++...
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~~~~~  177 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA-HVKIADFGLAKLL  177 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCGGGCEEC
T ss_pred             ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCC-CEEEcccccceec
Confidence            678999999999999999976 44699999999999999999999999999999999999999987 8999999999765


Q ss_pred             ccCcc---ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----------CCccHHH
Q 020657          202 CRSLD---ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPG-----------QRPDWAT  267 (323)
Q Consensus       202 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~-----------~~~~~~~  267 (323)
                      .....   ......++..|+|||++....     ++.++||||||+++|+|++|..||....           .......
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  252 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSDNI-----FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR  252 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHHCE-----EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHH
T ss_pred             ccCCccceeeccCCccccccCHHHhccCC-----CChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHH
Confidence            43322   223345778899999986433     4569999999999999999999985422           1223344


Q ss_pred             HHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          268 LMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      +............+..+++++.+|+++||+.||++|||+++++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          253 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            555556666677788999999999999999999999999999755

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=9.5e-46  Score=317.41  Aligned_cols=254  Identities=22%  Similarity=0.374  Sum_probs=213.1

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS  122 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  122 (323)
                      ...|.+..++|++.+.||+|++|.||+|.+. +++.|++|++.....  ..+.+.+|+.+++.++||||+++++++..  
T Consensus         5 ~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--   79 (279)
T 1qpc_A            5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVTQ--   79 (279)
T ss_dssp             TCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             hhhcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc--cHHHHHHHHHHHHhCCCcCcceEEEEEcC--
Confidence            4568888999999999999999999999986 677899999975532  24678899999999999999999999874  


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchh
Q 020657          123 GDIAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                      +..++||||+.+++|.+++....  .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++..
T Consensus        80 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~  158 (279)
T 1qpc_A           80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL-SCKIADFGLARL  158 (279)
T ss_dssp             SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEE
T ss_pred             CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCC-CEEECCCccccc
Confidence            46899999999999999997533  689999999999999999999999999999999999999887 899999999976


Q ss_pred             hccCcc-ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCC
Q 020657          201 MCRSLD-ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPP  278 (323)
Q Consensus       201 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  278 (323)
                      ...... ......++..|+|||++...     .++.++||||||+++|+|++ |..||....    ...+...+......
T Consensus       159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~el~~~g~~p~~~~~----~~~~~~~~~~~~~~  229 (279)
T 1qpc_A          159 IEDNEYTAREGAKFPIKWTAPEAINYG-----TFTIKSDVWSFGILLTEIVTHGRIPYPGMT----NPEVIQNLERGYRM  229 (279)
T ss_dssp             CSSSCEECCTTCCCCTTTSCHHHHHHC-----EECHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHHHHHHHHTTCCC
T ss_pred             ccCcccccccCCCCccCccChhhhccC-----CCCchhhhHHHHHHHHHHHhCCCCCCcccC----HHHHHHHHhcccCC
Confidence            643322 22334567789999998633     34569999999999999999 999995543    23444444445556


Q ss_pred             CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          279 SLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       279 ~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ..+..++.++.+|+++||+.||++|||++++++
T Consensus       230 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            667789999999999999999999999999986

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3e-47  Score=342.65  Aligned_cols=264  Identities=23%  Similarity=0.422  Sum_probs=211.1

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC-CeE
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS-GDI  125 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~  125 (323)
                      ....++|++.+.||+|+||.||+|++..+++.||+|++...........+.+|+.+++.++||||+++++++.... ...
T Consensus         5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~   84 (396)
T 4eut_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (396)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence            3456899999999999999999999998999999999975443344567789999999999999999999988643 368


Q ss_pred             EEEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEE----ecCCCcEEEeecCcc
Q 020657          126 AILMEYMDSGTLDTLLNKNG---TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLV----NNNNMQVKIADFGVS  198 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~----~~~~~~~kl~Dfg~~  198 (323)
                      ++||||+.+++|.+++....   .+++..++.++.||+.||.|||+.|++||||||+||++    +.++ .+||+|||++
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~-~~kL~DFG~a  163 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS-VYKLTDFGAA  163 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCE-EEEECCGGGC
T ss_pred             EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCce-eEEEecCCCc
Confidence            99999999999999997543   39999999999999999999999999999999999998    5554 7999999999


Q ss_pred             hhhccCccccccccccccccCCcccCCCCCC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcC
Q 020657          199 KIMCRSLDACNSYVGTCAYMSPERFDPDAYG---GNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFG  275 (323)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~---~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~  275 (323)
                      ...... .......++..|+|||++......   ...++.++||||||+++|+|++|..||...........+...+..+
T Consensus       164 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  242 (396)
T 4eut_A          164 RELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (396)
T ss_dssp             EECCCG-GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred             eEccCC-CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence            765433 223456789999999987532111   1234568999999999999999999997655444434444444433


Q ss_pred             CCCC------------------------CCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          276 DPPS------------------------LPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       276 ~~~~------------------------~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      .+..                        +...++..+.+++++||++||++|||+++++++
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            3321                        112345678999999999999999999998643

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.3e-45  Score=319.58  Aligned_cols=255  Identities=22%  Similarity=0.302  Sum_probs=207.6

Q ss_pred             ccccccceeeeecccCCeEEEEEEeccc---CcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCe
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCT---HKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGD  124 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  124 (323)
                      ....+|++.+.||+|+||.||+|.+..+   ...+++|.+...........+.+|+.++++++||||+++++++...++.
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (298)
T 3f66_A           22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  101 (298)
T ss_dssp             GGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred             ccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence            3456799999999999999999996533   3368999998777777778899999999999999999999997666778


Q ss_pred             EEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          125 IAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      .++||||+.+++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||||+||+++.++ .+||+|||++.....
T Consensus       102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYD  180 (298)
T ss_dssp             CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECSCGGGCCCSC
T ss_pred             eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCC-CEEECcccccccccc
Confidence            8999999999999999975 44689999999999999999999999999999999999999987 899999999976543


Q ss_pred             Cc----cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCC
Q 020657          204 SL----DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPP  278 (323)
Q Consensus       204 ~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  278 (323)
                      ..    .......++..|+|||.+...     .++.++||||||+++|+|++ |..||..........    ........
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~----~~~~~~~~  251 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQ-----KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV----YLLQGRRL  251 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHC-----CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHH----HHHTTCCC
T ss_pred             cchhccccccCCCCCccccChHHhcCC-----CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHH----HHhcCCCC
Confidence            22    122334567889999998633     34569999999999999999 555554443333222    22334455


Q ss_pred             CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          279 SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       279 ~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ..+..++..+.+++++||+.||++|||++++++.
T Consensus       252 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  285 (298)
T 3f66_A          252 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  285 (298)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            5667889999999999999999999999999863

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.6e-46  Score=326.99  Aligned_cols=257  Identities=28%  Similarity=0.416  Sum_probs=211.3

Q ss_pred             ccccccceeeeecccCCeEEEEEE----ecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcC-C
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQ----HRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP-S  122 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~----~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~  122 (323)
                      +..+.|++++.||+|+||.||++.    +..+++.||+|++...........+.+|+.+++.++||||+++++++.+. .
T Consensus        28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (318)
T 3lxp_A           28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA  107 (318)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred             ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence            334444999999999999998775    44578899999998777677788899999999999999999999999864 3


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          123 GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      ..+++||||+++++|.+++... .+++..++.++.||+.||.+||+.|++|+||||+||+++.++ .++|+|||++....
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          108 ASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDR-LVKIGDFGLAKAVP  185 (318)
T ss_dssp             TEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCGGGCEECC
T ss_pred             ceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCC-CEEECCcccccccc
Confidence            6789999999999999999765 589999999999999999999999999999999999999987 89999999997764


Q ss_pred             cCcc---ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-----------CccHHHH
Q 020657          203 RSLD---ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQ-----------RPDWATL  268 (323)
Q Consensus       203 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~-----------~~~~~~~  268 (323)
                      ....   ......++..|+|||++....     ++.++||||||+++|+|+||..||.....           ......+
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  260 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKEYK-----FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL  260 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHHCE-----EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHH
T ss_pred             ccccccccccCCCCCceeeChHHhcCCC-----CCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHH
Confidence            4321   223445778899999986433     45699999999999999999999954211           1112233


Q ss_pred             HHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          269 MCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ............+..++.++.+|+++||+.||++|||++++++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            4444555566777889999999999999999999999999985

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.6e-46  Score=335.23  Aligned_cols=263  Identities=26%  Similarity=0.386  Sum_probs=206.0

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCC-----------CCcccee
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD-----------SPFIVQC  114 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~  114 (323)
                      ..+..++|++.+.||+|+||.||+|.+..+++.||+|++...  ......+.+|+.+++++.           |+||+++
T Consensus        14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~   91 (373)
T 1q8y_A           14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   91 (373)
T ss_dssp             CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             CcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC--ccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence            345678999999999999999999999989999999999643  345567788999988875           8999999


Q ss_pred             ceeEEcCC---CeEEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCCeEEecCC-
Q 020657          115 FGIFEKPS---GDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHGH-KIIHRDIKPSNLLVNNNN-  187 (323)
Q Consensus       115 ~~~~~~~~---~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~-givH~di~~~nil~~~~~-  187 (323)
                      ++++....   ...++|||++ +++|.+++..  ...+++..+..++.||+.||.|||++ |++|+||||+||+++.++ 
T Consensus        92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred             HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence            99987522   2689999999 7799999976  34599999999999999999999998 999999999999995321 


Q ss_pred             ----CcEEEeecCcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCc
Q 020657          188 ----MQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRP  263 (323)
Q Consensus       188 ----~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~  263 (323)
                          ..+||+|||++......   .....++..|+|||++.+.     .++.++||||||+++|+|+||..||.......
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~-----~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  242 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGA-----PWGCGADIWSTACLIFELITGDFLFEPDEGHS  242 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTC-----CCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             CcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCC-----CCCchHhHHHHHHHHHHHHhCCCCCCCCcccc
Confidence                27999999999765432   2345789999999998743     34569999999999999999999997543221


Q ss_pred             ---c---HHHHHHHHhc-------------------------------------CCCCCCCCCCChhHHHHHHHhcccCc
Q 020657          264 ---D---WATLMCAICF-------------------------------------GDPPSLPDGASPEFRSFIECCLQKEF  300 (323)
Q Consensus       264 ---~---~~~~~~~~~~-------------------------------------~~~~~~~~~~~~~l~~ll~~~l~~~p  300 (323)
                         .   ...+......                                     .....++..++.++.+||++||+.||
T Consensus       243 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  322 (373)
T 1q8y_A          243 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP  322 (373)
T ss_dssp             --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred             cCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCc
Confidence               1   1111111000                                     00112233456789999999999999


Q ss_pred             CCCCCHHHHhcCcccccCC
Q 020657          301 SKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       301 ~~Rpt~~~~l~h~~f~~~~  319 (323)
                      ++|||++++|+||||++..
T Consensus       323 ~~Rpt~~ell~hp~f~~~~  341 (373)
T 1q8y_A          323 RKRADAGGLVNHPWLKDTL  341 (373)
T ss_dssp             TTCBCHHHHHTCGGGTTCT
T ss_pred             cccCCHHHHhhChhhhccc
Confidence            9999999999999998764

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.9e-45  Score=347.21  Aligned_cols=254  Identities=23%  Similarity=0.367  Sum_probs=208.3

Q ss_pred             hhccccccceee-eecccCCeEEEEEEec--ccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC
Q 020657           46 AAIAYSDLEKLQ-VLGHGNGGTVYKVQHR--CTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS  122 (323)
Q Consensus        46 ~~~~~~~~~~~~-~lg~G~~~~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  122 (323)
                      +.+..+++.+.+ .||+|+||.||+|.+.  .++..||+|++.........+.+.+|+.+++.++||||+++++++..  
T Consensus       330 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--  407 (613)
T 2ozo_A          330 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--  407 (613)
T ss_dssp             SBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES--
T ss_pred             eeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc--
Confidence            445556666666 8999999999999875  35667999999876555566789999999999999999999999975  


Q ss_pred             CeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhh
Q 020657          123 GDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM  201 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~  201 (323)
                      +.+++||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++...
T Consensus       408 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~-~vkL~DFGla~~~  486 (613)
T 2ozo_A          408 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH-YAKISDFGLSKAL  486 (613)
T ss_dssp             SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCSTTTTC
T ss_pred             CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCC-cEEEeeccCcccc
Confidence            4699999999999999999653 4699999999999999999999999999999999999999987 8999999999765


Q ss_pred             ccCccc---cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCC
Q 020657          202 CRSLDA---CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDP  277 (323)
Q Consensus       202 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~  277 (323)
                      ......   .....++..|+|||++...     .++.++||||||+++|||+| |..||......    .+...+..+..
T Consensus       487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~-----~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~----~~~~~i~~~~~  557 (613)
T 2ozo_A          487 GADDSYYTARSAGKWPLKWYAPECINFR-----KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----EVMAFIEQGKR  557 (613)
T ss_dssp             C--------------CCTTSCHHHHHHC-----CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH----HHHHHHHTTCC
T ss_pred             cCCCceeeeccCCCCccceeCHhhhcCC-----CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH----HHHHHHHcCCC
Confidence            432211   1223356789999998633     35669999999999999998 99999765443    34444555666


Q ss_pred             CCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          278 PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       278 ~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ...+..+++++.+||.+||+.||++|||++++++
T Consensus       558 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          558 MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            7778889999999999999999999999999853

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.8e-45  Score=318.22  Aligned_cols=254  Identities=22%  Similarity=0.290  Sum_probs=207.7

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ..++|++.+.||+|++|.||+|++..+++.||+|++......   ..+.+|+.+++.++|++++..+..+.......++|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC---CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch---hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence            457899999999999999999999889999999998755432   34778999999999988887777765557889999


Q ss_pred             EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEe---cCCCcEEEeecCcchhhccC
Q 020657          129 MEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVN---NNNMQVKIADFGVSKIMCRS  204 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~---~~~~~~kl~Dfg~~~~~~~~  204 (323)
                      |||+ +++|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+||+++   .++ .+||+|||++......
T Consensus        84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~-~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTT-CEEECCCTTCEECBCT
T ss_pred             EEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCC-eEEEeeCCCccccccc
Confidence            9999 7899999973 45799999999999999999999999999999999999994   565 8999999999766543


Q ss_pred             cc-------ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC---ccHHHHHHHHhc
Q 020657          205 LD-------ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQR---PDWATLMCAICF  274 (323)
Q Consensus       205 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~---~~~~~~~~~~~~  274 (323)
                      ..       ......++..|+|||++.+.     .++.++||||||+++|+|++|..||......   .....+......
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  236 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGI-----EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  236 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTC-----CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccCChhhhcCC-----CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC
Confidence            22       12456789999999998743     3567999999999999999999999764432   233333333222


Q ss_pred             CCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          275 GDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       275 ~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      .....++..+++++.+|+++||+.||++|||++++++.
T Consensus       237 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  274 (296)
T 3uzp_A          237 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL  274 (296)
T ss_dssp             SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred             CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence            22223446789999999999999999999999998853

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.4e-45  Score=321.66  Aligned_cols=261  Identities=20%  Similarity=0.293  Sum_probs=206.3

Q ss_pred             CccchhccccccceeeeecccCCeEEEEEEecc---cCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceecee
Q 020657           42 TATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRC---THKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGI  117 (323)
Q Consensus        42 ~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~---~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~  117 (323)
                      ......+..++|++.+.||+|+||.||+|.+..   ++..||+|++.... .......+.+|+.+++.++||||++++++
T Consensus        25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~  104 (313)
T 3brb_A           25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV  104 (313)
T ss_dssp             CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred             hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence            355666788999999999999999999998764   45689999997553 44556778999999999999999999999


Q ss_pred             EEcCCC----eEEEEEeccCCCCHHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC
Q 020657          118 FEKPSG----DIAILMEYMDSGTLDTLLN------KNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN  187 (323)
Q Consensus       118 ~~~~~~----~~~lv~e~~~~~sL~~~l~------~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~  187 (323)
                      +.....    ..++||||+.+++|.+++.      ....+++..++.++.||+.||.|||+.|++|+||||+||+++.++
T Consensus       105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~  184 (313)
T 3brb_A          105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM  184 (313)
T ss_dssp             EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS
T ss_pred             EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC
Confidence            876332    3599999999999999984      335699999999999999999999999999999999999999987


Q ss_pred             CcEEEeecCcchhhccCc--cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCcc
Q 020657          188 MQVKIADFGVSKIMCRSL--DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPD  264 (323)
Q Consensus       188 ~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~  264 (323)
                       .+||+|||++.......  .......++..|+|||.+..     ..++.++||||||+++|+|++ |..||........
T Consensus       185 -~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  258 (313)
T 3brb_A          185 -TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-----RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM  258 (313)
T ss_dssp             -CEEECSCSCC----------------CCGGGSCHHHHHS-----SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred             -cEEEeecCcceecccccccCcccccCCCccccCchhhcC-----CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH
Confidence             89999999997654332  12233456788999999863     345679999999999999999 8899966544333


Q ss_pred             HHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          265 WATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      .    .....+.....+..+++++.+|+.+||+.||++|||+.+++++
T Consensus       259 ~----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          259 Y----DYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             H----HHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             H----HHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3    3333344566678899999999999999999999999999875

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.9e-46  Score=326.40  Aligned_cols=267  Identities=21%  Similarity=0.280  Sum_probs=211.7

Q ss_pred             CCCCccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeE
Q 020657           39 NNTTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIF  118 (323)
Q Consensus        39 ~~~~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~  118 (323)
                      .........+..++|++.+.||+|+||.||+|.+..+++.||+|++... .......+.+|+.+++.++||||+++++++
T Consensus        17 ~~~~g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   95 (317)
T 2buj_A           17 LYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAYC   95 (317)
T ss_dssp             CSEEEEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             eeecccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-CHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            3345666777889999999999999999999999889999999998654 345567888999999999999999999998


Q ss_pred             Ec---CCCeEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEE
Q 020657          119 EK---PSGDIAILMEYMDSGTLDTLLNK----NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVK  191 (323)
Q Consensus       119 ~~---~~~~~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~k  191 (323)
                      ..   .....++||||+.+++|.+++..    ...+++..++.++.||+.||.|||+.|++|+||||+||+++.++ .++
T Consensus        96 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~-~~k  174 (317)
T 2buj_A           96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEG-QPV  174 (317)
T ss_dssp             EEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEE
T ss_pred             EeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC-CEE
Confidence            63   23478999999999999999875    46799999999999999999999999999999999999999987 899


Q ss_pred             EeecCcchhhccCcc---------ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-
Q 020657          192 IADFGVSKIMCRSLD---------ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQ-  261 (323)
Q Consensus       192 l~Dfg~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~-  261 (323)
                      |+|||++........         ......++..|+|||++.....  ..++.++||||||+++|+|++|..||..... 
T Consensus       175 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~  252 (317)
T 2buj_A          175 LMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSH--CVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK  252 (317)
T ss_dssp             ECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSE--EEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT
T ss_pred             EEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCC--cCCCchhhHHHHHHHHHHHHhCCCChhhhhcc
Confidence            999998865432111         0122346889999999863321  1245699999999999999999999943211 


Q ss_pred             CccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          262 RPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      .......   .........+..++.++.+|+.+||+.||++|||+++++++
T Consensus       253 ~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          253 GDSVALA---VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             TSCHHHH---HHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cchhhHH---hhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            1111111   11122333446789999999999999999999999999986

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3e-46  Score=332.58  Aligned_cols=262  Identities=20%  Similarity=0.277  Sum_probs=200.6

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEeccc-----CcEEEEEeecCCCChHH----------HHHHHHHHHHHHcCC
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCT-----HKIYALKVVHGDADPTV----------RRQVFREMEILRRTD  107 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~-----~~~v~iK~~~~~~~~~~----------~~~~~~e~~~l~~l~  107 (323)
                      ....++..++|++.+.||+|+||.||+|.+..+     ++.||+|++........          ...+..|+..++.++
T Consensus        27 ~~i~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~  106 (364)
T 3op5_A           27 EIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLK  106 (364)
T ss_dssp             CEEECTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCS
T ss_pred             cEeeccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhcc
Confidence            344456677999999999999999999998754     57899999875532110          112334555667788


Q ss_pred             CCccceeceeEEcC---CCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEE
Q 020657          108 SPFIVQCFGIFEKP---SGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLV  183 (323)
Q Consensus       108 h~~i~~~~~~~~~~---~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~  183 (323)
                      |+||+++++++...   ....++||||+ +++|.+++... ..+++..++.++.||+.||.|||+.|++||||||+||++
T Consensus       107 h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill  185 (364)
T 3op5_A          107 YLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLL  185 (364)
T ss_dssp             CCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             CCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEE
Confidence            99999999998653   24589999999 88999999765 679999999999999999999999999999999999999


Q ss_pred             e--cCCCcEEEeecCcchhhccCccc-------cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCC
Q 020657          184 N--NNNMQVKIADFGVSKIMCRSLDA-------CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHF  254 (323)
Q Consensus       184 ~--~~~~~~kl~Dfg~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~  254 (323)
                      +  .++ .+||+|||++.........       .....+|..|+|||++.+.     .++.++||||||+++|+|+||..
T Consensus       186 ~~~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~slG~~l~el~~g~~  259 (364)
T 3op5_A          186 NYKNPD-QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV-----APSRRGDLEILGYCMIQWLTGHL  259 (364)
T ss_dssp             ESSCTT-CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC-----CCCHHHHHHHHHHHHHHHHHSCC
T ss_pred             ecCCCC-eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC-----CCCchhhHHHHHHHHHHHHhCCC
Confidence            9  666 8999999999765432211       1334589999999998743     35679999999999999999999


Q ss_pred             CCCCCCCCccHHHHHHHHhcCCCC------CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          255 PFLQPGQRPDWATLMCAICFGDPP------SLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       255 p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ||.+....................      .....++.++.+|+..||+.||++|||++++++
T Consensus       260 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          260 PWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             TTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             CccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            997543333222111111000000      012567999999999999999999999999875

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.3e-45  Score=347.55  Aligned_cols=253  Identities=24%  Similarity=0.413  Sum_probs=207.7

Q ss_pred             hcccccccee-eeecccCCeEEEEEEe--cccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC
Q 020657           47 AIAYSDLEKL-QVLGHGNGGTVYKVQH--RCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS  122 (323)
Q Consensus        47 ~~~~~~~~~~-~~lg~G~~~~v~~~~~--~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  122 (323)
                      .+....+.+. +.||+|+||.||+|.+  ..+++.||+|++.... +....+.+.+|+.+++.++||||+++++++..  
T Consensus       364 ~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--  441 (635)
T 4fl3_A          364 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA--  441 (635)
T ss_dssp             BCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred             cccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--
Confidence            3344445444 3899999999999965  4567899999997542 33456789999999999999999999999874  


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          123 GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      +..++||||+.+++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+||+++.++ .+||+|||++....
T Consensus       442 ~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~-~~kL~DFGla~~~~  520 (635)
T 4fl3_A          442 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALR  520 (635)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCTTHHHHTT
T ss_pred             CCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCC-CEEEEEcCCccccc
Confidence            45899999999999999999888899999999999999999999999999999999999999987 89999999998764


Q ss_pred             cCcc---ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCC
Q 020657          203 RSLD---ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPP  278 (323)
Q Consensus       203 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  278 (323)
                      ....   ......++..|+|||++...     .++.++||||||+++|||++ |..||.+...    ..+...+..+...
T Consensus       521 ~~~~~~~~~~~~~~t~~y~APE~~~~~-----~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~----~~~~~~i~~~~~~  591 (635)
T 4fl3_A          521 ADENYYKAQTHGKWPVKWYAPECINYY-----KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----SEVTAMLEKGERM  591 (635)
T ss_dssp             C-------------CGGGSCHHHHHHC-----CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHHHHTTCCC
T ss_pred             cCccccccccCCCCceeeeChhhhcCC-----CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHcCCCC
Confidence            3321   12233456789999998633     34569999999999999998 9999955433    4455555556677


Q ss_pred             CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          279 SLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       279 ~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ..+..++.++.+||.+||+.||++|||++++++
T Consensus       592 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          592 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            778899999999999999999999999999985

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.8e-45  Score=317.36  Aligned_cols=248  Identities=28%  Similarity=0.468  Sum_probs=202.9

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEE
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIA  126 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  126 (323)
                      .+..++|++.+.||+|+||.||+|.+  .++.|++|.+...   ...+.+.+|+.++++++||||+++++++.+   ..+
T Consensus         4 ~i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~   75 (307)
T 2eva_A            4 MIDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACLN---PVC   75 (307)
T ss_dssp             BCCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCTT---TTE
T ss_pred             cCCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---CcE
Confidence            35678999999999999999999998  4788999998643   345678899999999999999999998764   378


Q ss_pred             EEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCCeecCCCCCCeEEecCCCcEEEeecCcchh
Q 020657          127 ILMEYMDSGTLDTLLNKNG---TFSEPKLAHIASQILKGLSYLHG---HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~~~---~~~~~~~~~i~~~i~~~l~~Lh~---~givH~di~~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                      +||||+++++|.+++....   .++...++.++.|+++||.|||+   +|++|+||||+||+++.++..+||+|||++..
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~  155 (307)
T 2eva_A           76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD  155 (307)
T ss_dssp             EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred             EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence            9999999999999998654   37899999999999999999999   89999999999999998874589999999976


Q ss_pred             hccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCC
Q 020657          201 MCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSL  280 (323)
Q Consensus       201 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  280 (323)
                      .....   ....++..|+|||++.+.     .++.++||||||+++|+|++|..||......  ...+.........+..
T Consensus       156 ~~~~~---~~~~gt~~y~aPE~~~~~-----~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~  225 (307)
T 2eva_A          156 IQTHM---TNNKGSAAWMAPEVFEGS-----NYSEKCDVFSWGIILWEVITRRKPFDEIGGP--AFRIMWAVHNGTRPPL  225 (307)
T ss_dssp             ------------CCTTSSCHHHHTCC-----CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS--HHHHHHHHHTTCCCCC
T ss_pred             ccccc---ccCCCCCceEChhhhCCC-----CCCcHHHHHHHHHHHHHHHHCCCCchhhCcc--HHHHHHHHhcCCCCCc
Confidence            54322   234689999999998743     3466999999999999999999999654332  2233334444556667


Q ss_pred             CCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          281 PDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       281 ~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      +..++..+.+|+.+||+.||++|||+++++++
T Consensus       226 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          226 IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            78899999999999999999999999999974

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.8e-46  Score=327.85  Aligned_cols=266  Identities=22%  Similarity=0.317  Sum_probs=210.3

Q ss_pred             CCccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEc
Q 020657           41 TTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEK  120 (323)
Q Consensus        41 ~~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  120 (323)
                      .+.....+..++|++.+.||+|+||.||+|.+. +++.||+|++...........+.+|+.+++.++||||+++++++..
T Consensus        20 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   98 (326)
T 3uim_A           20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT   98 (326)
T ss_dssp             CCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECC
T ss_pred             ecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEec
Confidence            356677788899999999999999999999865 6899999999765433333467899999999999999999999987


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CCeecCCCCCCeEEecCCCcEEEe
Q 020657          121 PSGDIAILMEYMDSGTLDTLLNKNG----TFSEPKLAHIASQILKGLSYLHGH---KIIHRDIKPSNLLVNNNNMQVKIA  193 (323)
Q Consensus       121 ~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~i~~~l~~Lh~~---givH~di~~~nil~~~~~~~~kl~  193 (323)
                       ....++||||+.+++|.+++....    .+++..+..++.|++.||.|||+.   |++|+||||+||+++.++ .+||+
T Consensus        99 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~-~~kl~  176 (326)
T 3uim_A           99 -PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVG  176 (326)
T ss_dssp             -SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC-CEEEC
T ss_pred             -CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC-CEEec
Confidence             677899999999999999997543    489999999999999999999999   999999999999999987 89999


Q ss_pred             ecCcchhhccCc-cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC----CCCCccHHHH
Q 020657          194 DFGVSKIMCRSL-DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQ----PGQRPDWATL  268 (323)
Q Consensus       194 Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~----~~~~~~~~~~  268 (323)
                      |||++....... .......++..|+|||++....     ++.++||||||+++|+|+||..||..    .........+
T Consensus       177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  251 (326)
T 3uim_A          177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-----SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW  251 (326)
T ss_dssp             CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSE-----ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred             cCccccccCcccccccccccCCcCccCHHHhccCC-----CCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence            999997654332 2233456899999999986433     45699999999999999999999942    2222222222


Q ss_pred             HHHHhcCCC----------CCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcc
Q 020657          269 MCAICFGDP----------PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPF  314 (323)
Q Consensus       269 ~~~~~~~~~----------~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~  314 (323)
                      .........          ..++...+..+.+++.+||+.||++|||+.++++|-.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             HTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             HHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence            222111110          1111223477999999999999999999999998743

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.3e-46  Score=331.45  Aligned_cols=252  Identities=21%  Similarity=0.300  Sum_probs=200.1

Q ss_pred             cccceeeeecccCCeEEEEEEeccc---CcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCT---HKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      ..|++.+.||+|+||.||+|.+..+   +..|++|.+...........+.+|+.+++.++||||+++++++...++..++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            4578889999999999999997533   3468999987666666778899999999999999999999997665678899


Q ss_pred             EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc
Q 020657          128 LMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD  206 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~  206 (323)
                      ||||+.+++|.+++... ..+++..+..++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++........
T Consensus       169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kL~DFG~a~~~~~~~~  247 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEF  247 (373)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC-----------
T ss_pred             EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCC-CEEEeecccccccccccc
Confidence            99999999999999754 4589999999999999999999999999999999999999987 899999999976533211


Q ss_pred             ----ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCC
Q 020657          207 ----ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLP  281 (323)
Q Consensus       207 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (323)
                          ......++..|+|||++...     .++.++||||||+++|+|+| |..||...........    ...+.....+
T Consensus       248 ~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~----~~~~~~~~~p  318 (373)
T 3c1x_A          248 DSVHNKTGAKLPVKWMALESLQTQ-----KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY----LLQGRRLLQP  318 (373)
T ss_dssp             ----------CCGGGSCHHHHHHC-----CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH----HHTTCCCCCC
T ss_pred             ccccccCCCCCcccccChHHhcCC-----CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH----HHcCCCCCCC
Confidence                12234567789999998633     34669999999999999999 6777765544433222    2334455566


Q ss_pred             CCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          282 DGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       282 ~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ..++..+.+++.+||+.||++|||+++++++
T Consensus       319 ~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          319 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            7899999999999999999999999999865

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.8e-45  Score=318.21  Aligned_cols=253  Identities=22%  Similarity=0.297  Sum_probs=203.1

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++.....   ...+.+|+.+++.++|++++..+..+.......++|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc---chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            45789999999999999999999988999999998764432   234678999999999988888887775557889999


Q ss_pred             EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEE---ecCCCcEEEeecCcchhhccC
Q 020657          129 MEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLV---NNNNMQVKIADFGVSKIMCRS  204 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~---~~~~~~~kl~Dfg~~~~~~~~  204 (323)
                      |||+ +++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||||+||++   +.++ .+||+|||++......
T Consensus        84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~-~~kL~Dfg~a~~~~~~  161 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTT-CEEECCCTTCEECBCT
T ss_pred             EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCC-eEEEecCccceeccCc
Confidence            9999 7899999974 4579999999999999999999999999999999999999   6666 8999999999766443


Q ss_pred             cc-------ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCc---cHHHHHHHHhc
Q 020657          205 LD-------ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRP---DWATLMCAICF  274 (323)
Q Consensus       205 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~---~~~~~~~~~~~  274 (323)
                      ..       ......++..|+|||++...     .++.++||||||+++|+|++|..||.......   ....+......
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  236 (296)
T 4hgt_A          162 RTHQHIPYRENKNLTGTARYASINTHLGI-----EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  236 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCGGGCCHHHHTTC-----CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred             ccCccCCCCcccccCCCccccchHHhcCC-----CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc
Confidence            22       22356789999999998743     35679999999999999999999997654432   22333222222


Q ss_pred             CCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          275 GDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       275 ~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      .........+++++.+|+.+||+.||++|||++++++
T Consensus       237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          237 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            2222334678999999999999999999999999985

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.7e-45  Score=341.51  Aligned_cols=260  Identities=23%  Similarity=0.342  Sum_probs=217.4

Q ss_pred             CccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcC
Q 020657           42 TATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP  121 (323)
Q Consensus        42 ~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  121 (323)
                      ....|.+..++|++.+.||+|+||.||+|.+. .+..||+|++.....  ..+.+.+|+.+++.++|+||+++++++.. 
T Consensus       258 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~-  333 (535)
T 2h8h_A          258 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-  333 (535)
T ss_dssp             STTCSBCCGGGEEEEEEEEECSSEEEEEEEET-TTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             CccceecchhhhhhheecccCCCeEEEEEEEC-CCceEEEEEeCCCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence            35678899999999999999999999999997 456799999975542  24578899999999999999999999875 


Q ss_pred             CCeEEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcch
Q 020657          122 SGDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       122 ~~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                       +..++||||+.+++|.+++..  ...+++..++.++.||+.||.|||++|++||||||+||+++.++ .+||+|||++.
T Consensus       334 -~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~  411 (535)
T 2h8h_A          334 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLAR  411 (535)
T ss_dssp             -SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCTTSTT
T ss_pred             -ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCC-cEEEcccccce
Confidence             568999999999999999974  35699999999999999999999999999999999999999887 89999999997


Q ss_pred             hhccCc-cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCC
Q 020657          200 IMCRSL-DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDP  277 (323)
Q Consensus       200 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~  277 (323)
                      ...... .......++..|+|||++...     .++.++||||||+++|||+| |..||.+..    ...+...+..+..
T Consensus       412 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~sDvwSlGv~l~el~t~g~~P~~~~~----~~~~~~~i~~~~~  482 (535)
T 2h8h_A          412 LIEDNEYTARQGAKFPIKWTAPEAALYG-----RFTIKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYR  482 (535)
T ss_dssp             TCCCHHHHTTCSTTSCGGGSCHHHHHHC-----CCCHHHHHHHHHHHHHHHTTTTCCSSTTCC----HHHHHHHHHTTCC
T ss_pred             ecCCCceecccCCcCcccccCHHHhccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHHHcCCC
Confidence            654321 112234467889999998633     35679999999999999999 999996543    2344445555556


Q ss_pred             CCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC--cccc
Q 020657          278 PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH--PFLC  316 (323)
Q Consensus       278 ~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h--~~f~  316 (323)
                      ...+..++.++.+||.+||+.||++|||+++|++.  .+|.
T Consensus       483 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          483 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence            66778899999999999999999999999999864  4544

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4.7e-46  Score=325.75  Aligned_cols=258  Identities=26%  Similarity=0.341  Sum_probs=206.8

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEE
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIA  126 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  126 (323)
                      ....++|++.+.||+|+||.||+|.+. +++.||+|++..... .....+.+|+.+++.++||||+++++++.. .+..+
T Consensus        35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~  111 (321)
T 2qkw_B           35 EEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESS-QGIEEFETEIETLSFCRHPHLVSLIGFCDE-RNEMI  111 (321)
T ss_dssp             CCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCS-SHHHHHHHHHHGGGSCCCTTBCCEEEECCC-TTCCE
T ss_pred             HHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CCeEE
Confidence            345689999999999999999999975 789999999875543 445678899999999999999999999887 67899


Q ss_pred             EEEeccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          127 ILMEYMDSGTLDTLLNKNG----TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      +||||+.+++|.+++....    .+++..++.++.||+.||.|||+.|++|+||||+||+++.++ .+||+|||++....
T Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~  190 (321)
T 2qkw_B          112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENF-VPKITDFGISKKGT  190 (321)
T ss_dssp             EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTC-CEEECCCTTCEECS
T ss_pred             EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCC-CEEEeecccccccc
Confidence            9999999999999886532    589999999999999999999999999999999999999987 89999999997643


Q ss_pred             cCc--cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccH--HHH-HHHHhcCC-
Q 020657          203 RSL--DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDW--ATL-MCAICFGD-  276 (323)
Q Consensus       203 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~--~~~-~~~~~~~~-  276 (323)
                      ...  .......++..|+|||++....     ++.++||||||+++|+|+||..||.........  ..+ ........ 
T Consensus       191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  265 (321)
T 2qkw_B          191 ELDQTHLSTVVKGTLGYIDPEYFIKGR-----LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL  265 (321)
T ss_dssp             SSSCCCCBCCCEEETTTCCHHHHHHCB-----CCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred             cccccccccccCCCccccCHHHhcCCC-----CCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence            221  1223445899999999986433     456999999999999999999999765433221  111 11111111 


Q ss_pred             --------CCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCc
Q 020657          277 --------PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHP  313 (323)
Q Consensus       277 --------~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~  313 (323)
                              ...++...+..+.+++.+||+.||++|||+++++++-
T Consensus       266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence                    1112233457799999999999999999999999763

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.7e-45  Score=316.97  Aligned_cols=257  Identities=26%  Similarity=0.391  Sum_probs=200.7

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHc--CCCCccceeceeEEcC---
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRR--TDSPFIVQCFGIFEKP---  121 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~---  121 (323)
                      .+..++|++.+.||+|+||.||+|.+  +++.||+|++...    ....+..|.+++..  ++||||+++++++...   
T Consensus         4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~   77 (301)
T 3q4u_A            4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHS   77 (301)
T ss_dssp             CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETT
T ss_pred             ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCC
Confidence            45678999999999999999999998  6899999998543    23445566666666  7999999999986432   


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCCeecCCCCCCeEEecCCCcEEEe
Q 020657          122 SGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH--------GHKIIHRDIKPSNLLVNNNNMQVKIA  193 (323)
Q Consensus       122 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh--------~~givH~di~~~nil~~~~~~~~kl~  193 (323)
                      ....++||||+++++|.++++. ..+++..++.++.||+.||.|||        +.|++||||||+||+++.++ .+||+
T Consensus        78 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~-~~kl~  155 (301)
T 3q4u_A           78 STQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG-QCCIA  155 (301)
T ss_dssp             EEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS-CEEEC
T ss_pred             CceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC-CEEEe
Confidence            3458999999999999999965 47899999999999999999999        99999999999999999987 89999


Q ss_pred             ecCcchhhccCccc----cccccccccccCCcccCCCCCCCC-CCCcchhHHHHHHHHHHHHhC----------CCCCCC
Q 020657          194 DFGVSKIMCRSLDA----CNSYVGTCAYMSPERFDPDAYGGN-YNGYAGDIWSLGLTLLELYLG----------HFPFLQ  258 (323)
Q Consensus       194 Dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~-~~~~~~Dv~slG~ll~~lltg----------~~p~~~  258 (323)
                      |||++.........    .....+|..|+|||++........ .++.++||||||+++|+|+||          ..||..
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            99999765433221    233478999999999874432111 334689999999999999999          888865


Q ss_pred             CCCC-ccHHHHHHHHhc-CCCCCCCC-----CCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          259 PGQR-PDWATLMCAICF-GDPPSLPD-----GASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       259 ~~~~-~~~~~~~~~~~~-~~~~~~~~-----~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      .... .....+...... ...+.++.     ..+.++.+|+++||+.||++|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          236 VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             cCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            4332 233333332222 22233322     24577999999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.4e-46  Score=352.47  Aligned_cols=265  Identities=26%  Similarity=0.406  Sum_probs=207.0

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEc-----CC
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEK-----PS  122 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~  122 (323)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+|+.+++.++||||+++++++..     ..
T Consensus        11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~   90 (676)
T 3qa8_A           11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN   90 (676)
T ss_dssp             ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred             CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence            3358999999999999999999999989999999999877677778889999999999999999999998653     24


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC--CcEEEeecCc
Q 020657          123 GDIAILMEYMDSGTLDTLLNKNG---TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN--MQVKIADFGV  197 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~--~~~kl~Dfg~  197 (323)
                      +..++||||+++++|.+++....   .+++..++.++.||+.||.|||+.|++|+||+|+||+++.++  ..++|+|||+
T Consensus        91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            56799999999999999998643   589999999999999999999999999999999999999765  2489999999


Q ss_pred             chhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccH------HHHHHH
Q 020657          198 SKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDW------ATLMCA  271 (323)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~------~~~~~~  271 (323)
                      +....... ......++..|+|||++.+     ..++.++||||||+++|+|++|..||........+      ......
T Consensus       171 a~~~~~~~-~~~~~~gt~~Y~APE~l~~-----~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~  244 (676)
T 3qa8_A          171 AKELDQGE-LCTEFVGTLQYLAPELLEQ-----KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI  244 (676)
T ss_dssp             CCBTTSCC-CCCCCCSCCTTCSSCSSCC-----SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------C
T ss_pred             cccccccc-ccccccCCcccCChHHhcc-----CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhh
Confidence            97764432 2345678999999999864     34566999999999999999999999653111000      000000


Q ss_pred             ---------Hhc----CCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          272 ---------ICF----GDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       272 ---------~~~----~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                               ...    ..+..+...++..+.+|++.||++||++|||++++++||||+..
T Consensus       245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l  304 (676)
T 3qa8_A          245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL  304 (676)
T ss_dssp             CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred             hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence                     000    00111223456889999999999999999999999999999753

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.2e-45  Score=315.67  Aligned_cols=250  Identities=28%  Similarity=0.418  Sum_probs=208.2

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEc------
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEK------  120 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------  120 (323)
                      .....+|++.+.||+|++|.||+|.+..+++.|++|++....     ..+.+|+.+++.++||||+++++++..      
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (284)
T 2a19_B            7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE   81 (284)
T ss_dssp             HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred             chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence            345678999999999999999999998899999999997553     245689999999999999999998753      


Q ss_pred             ---------CCCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCc
Q 020657          121 ---------PSGDIAILMEYMDSGTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQ  189 (323)
Q Consensus       121 ---------~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~  189 (323)
                               ....+++||||+++++|.+++...  ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++ .
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~  160 (284)
T 2a19_B           82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK-Q  160 (284)
T ss_dssp             -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-E
T ss_pred             cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCC-C
Confidence                     134579999999999999999753  5799999999999999999999999999999999999999987 8


Q ss_pred             EEEeecCcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHH
Q 020657          190 VKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLM  269 (323)
Q Consensus       190 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~  269 (323)
                      ++|+|||++....... ......++..|+|||++...     .++.++||||||+++|+|++|..|+...      ....
T Consensus       161 ~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~~~~~~~~~------~~~~  228 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQ-----DYGKEVDLYALGLILAELLHVCDTAFET------SKFF  228 (284)
T ss_dssp             EEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCS-----CCCTHHHHHHHHHHHHHHHSCCSSHHHH------HHHH
T ss_pred             EEECcchhheeccccc-cccccCCcccccChhhhccC-----CCcchhhhHHHHHHHHHHHhcCCcchhH------HHHH
Confidence            9999999987654432 23345689999999998643     3456999999999999999999887321      1222


Q ss_pred             HHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          270 CAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                      ....   ...++..++.++.+|+.+||+.||++|||+.++++|.+.-.
T Consensus       229 ~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          229 TDLR---DGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             HHHH---TTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             HHhh---cccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            2222   12345678999999999999999999999999999977643

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=8.6e-45  Score=319.49  Aligned_cols=261  Identities=26%  Similarity=0.342  Sum_probs=195.5

Q ss_pred             CCccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCC-CCccceeceeEE
Q 020657           41 TTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD-SPFIVQCFGIFE  119 (323)
Q Consensus        41 ~~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~  119 (323)
                      .......+...+|++.+.||+|+||.||+|++..+++.||+|++... .......+.+|+.+++.+. ||||+++++++.
T Consensus        18 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~   96 (337)
T 3ll6_A           18 FVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAAS   96 (337)
T ss_dssp             STTCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             hhcceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-chHHHHHHHHHHHHHHHhccCCChhhcccccc
Confidence            34566677788999999999999999999999989999999998644 3455677889999999995 999999999984


Q ss_pred             -------cCCCeEEEEEeccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCCeEEecCC
Q 020657          120 -------KPSGDIAILMEYMDSGTLDTLLNK---NGTFSEPKLAHIASQILKGLSYLHGHK--IIHRDIKPSNLLVNNNN  187 (323)
Q Consensus       120 -------~~~~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~g--ivH~di~~~nil~~~~~  187 (323)
                             .....+++||||+. ++|.+++..   ...+++..++.++.||+.||.|||+.|  ++|+||||+||+++.++
T Consensus        97 ~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~  175 (337)
T 3ll6_A           97 IGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG  175 (337)
T ss_dssp             ECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTS
T ss_pred             ccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCC
Confidence                   22445899999997 599888864   457999999999999999999999999  99999999999999987


Q ss_pred             CcEEEeecCcchhhccCccc------------cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 020657          188 MQVKIADFGVSKIMCRSLDA------------CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFP  255 (323)
Q Consensus       188 ~~~kl~Dfg~~~~~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p  255 (323)
                       .+||+|||++.........            .....++..|+|||++...  ....++.++||||||+++|+|++|..|
T Consensus       176 -~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~~~Dv~slG~il~el~~g~~p  252 (337)
T 3ll6_A          176 -TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLY--SNFPIGEKQDIWALGCILYLLCFRQHP  252 (337)
T ss_dssp             -CEEBCCCTTCBCCSSCC-------------------------------CC--TTSCSSHHHHHHHHHHHHHHHHHSSCC
T ss_pred             -CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhcc--ccCCCChHHhHHHHHHHHHHHHhCCCC
Confidence             8999999999765432211            1134588999999998421  234557799999999999999999999


Q ss_pred             CCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCc
Q 020657          256 FLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHP  313 (323)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~  313 (323)
                      |.......    +.   ............+..+.+|+++||+.||++|||++++++|-
T Consensus       253 ~~~~~~~~----~~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l  303 (337)
T 3ll6_A          253 FEDGAKLR----IV---NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL  303 (337)
T ss_dssp             C-------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             CcchhHHH----hh---cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            95432211    11   11122233456788999999999999999999999999873

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=325.24  Aligned_cols=263  Identities=21%  Similarity=0.264  Sum_probs=201.6

Q ss_pred             cchhccccccceeeeecccCCeEEEEEEecc---cCcEEEEEeecCCCChHH----------HHHHHHHHHHHHcCCCCc
Q 020657           44 TTAAIAYSDLEKLQVLGHGNGGTVYKVQHRC---THKIYALKVVHGDADPTV----------RRQVFREMEILRRTDSPF  110 (323)
Q Consensus        44 ~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~---~~~~v~iK~~~~~~~~~~----------~~~~~~e~~~l~~l~h~~  110 (323)
                      ....+..++|++.+.||+|+||.||+|.+..   ++..+++|++........          ...+.+|+..++.++|||
T Consensus        30 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~n  109 (345)
T 2v62_A           30 VLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLG  109 (345)
T ss_dssp             EEECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCC
T ss_pred             eeccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccC
Confidence            3345667899999999999999999999986   788999999976543211          123567888889999999


Q ss_pred             cceeceeEEcC---CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC
Q 020657          111 IVQCFGIFEKP---SGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN  187 (323)
Q Consensus       111 i~~~~~~~~~~---~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~  187 (323)
                      |+++++++...   ....++||||+ +++|.+++...+.+++..++.++.||+.||.|||+.|++||||||+||+++.++
T Consensus       110 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          110 IPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             CCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSS
T ss_pred             cceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCC
Confidence            99999998762   46789999999 889999998777899999999999999999999999999999999999998753


Q ss_pred             -CcEEEeecCcchhhccCcc-------ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 020657          188 -MQVKIADFGVSKIMCRSLD-------ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQP  259 (323)
Q Consensus       188 -~~~kl~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~  259 (323)
                       ..+||+|||++........       ......++..|+|||++.+.     .++.++||||||+++|+|++|..||...
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~slG~il~ell~g~~pf~~~  263 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-----ALSRRSDVEILGYCMLRWLCGKLPWEQN  263 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-----CCCHHHHHHHHHHHHHHHHHSSCTTGGG
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-----CCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence             2799999999976543211       11345789999999998743     4567999999999999999999999643


Q ss_pred             CCCcc-HHHHHHHHhcCCCCCC-----CCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          260 GQRPD-WATLMCAICFGDPPSL-----PDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       260 ~~~~~-~~~~~~~~~~~~~~~~-----~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ..... ............+..+     ...++.++.+|+.+||+.||++|||++++++.
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          264 LKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             TTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             ccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            22222 2222222222111110     12788999999999999999999999999853

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.1e-45  Score=333.52  Aligned_cols=263  Identities=24%  Similarity=0.326  Sum_probs=196.3

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceeceeEEcC
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKP  121 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~  121 (323)
                      .....+...+|++.+.||+|+||+||.. ...+++.||||++......    ...+|+.+++.+ +||||+++++++.+ 
T Consensus        16 ~~~~~i~~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~~----~~~~E~~~l~~l~~HpnIv~l~~~~~~-   89 (432)
T 3p23_A           16 TSVVIVGKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFS----FADREVQLLRESDEHPNVIRYFCTEKD-   89 (432)
T ss_dssp             --CEEETTEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTEE----ECHHHHHHHHHSCCCTTBCCEEEEEEE-
T ss_pred             CCcEEEccEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHHH----HHHHHHHHHHhccCCCCcCeEEEEEec-
Confidence            4455666778999999999999997643 3347899999998654322    245799999998 79999999999987 


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecC---C-CcEEEeecC
Q 020657          122 SGDIAILMEYMDSGTLDTLLNKNG-TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNN---N-MQVKIADFG  196 (323)
Q Consensus       122 ~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~---~-~~~kl~Dfg  196 (323)
                      ....++||||+.+ +|.+++.... ..++..++.++.||+.||.|||+.||+||||||+||+++.+   + ..+||+|||
T Consensus        90 ~~~~~lv~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG  168 (432)
T 3p23_A           90 RQFQYIAIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFG  168 (432)
T ss_dssp             TTEEEEEEECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTT
T ss_pred             CCEEEEEEECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEeccc
Confidence            6889999999975 9999997543 45666778999999999999999999999999999999532   1 358899999


Q ss_pred             cchhhccCc---cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHH
Q 020657          197 VSKIMCRSL---DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAI  272 (323)
Q Consensus       197 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~  272 (323)
                      ++.......   .......+|..|+|||++....  ....+.++||||||+++|+|+| |..||......    ......
T Consensus       169 ~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~----~~~~~~  242 (432)
T 3p23_A          169 LCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDC--KENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR----QANILL  242 (432)
T ss_dssp             EEECC------------CCSCTTSCCGGGTSCC-----CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH----HHHHHT
T ss_pred             ceeeccCCCcceeeccccCCCcCccChhhhhccc--ccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH----HHHHHh
Confidence            997654322   2234467899999999986332  2334569999999999999999 99998433221    111111


Q ss_pred             hcCCCCC--CCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          273 CFGDPPS--LPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       273 ~~~~~~~--~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      .......  .....+..+.+|+.+||+.||++|||++++++||||.+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~  290 (432)
T 3p23_A          243 GACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL  290 (432)
T ss_dssp             TCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred             ccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence            1111111  112345668999999999999999999999999999753

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.9e-45  Score=323.32  Aligned_cols=252  Identities=17%  Similarity=0.296  Sum_probs=202.2

Q ss_pred             ccccccceeeeecccCCeEEEEEEecc--------cCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccce------
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRC--------THKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ------  113 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~--------~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~------  113 (323)
                      ...++|++.+.||+|+||.||+|++..        +++.||+|++...      ..+.+|+.+++.++||||++      
T Consensus        39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~  112 (352)
T 2jii_A           39 KSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLY  112 (352)
T ss_dssp             TTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred             ccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhc
Confidence            346899999999999999999999986        4889999999744      35678999999999999987      


Q ss_pred             ---------eceeEEcCCCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeE
Q 020657          114 ---------CFGIFEKPSGDIAILMEYMDSGTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLL  182 (323)
Q Consensus       114 ---------~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil  182 (323)
                               +++++...+...++||||+ +++|.+++...  ..+++..++.++.||+.||.|||++|++||||||+||+
T Consensus       113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF  191 (352)
T ss_dssp             TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred             cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence                     5667665568899999999 88999999875  68999999999999999999999999999999999999


Q ss_pred             EecCC-CcEEEeecCcchhhccCcc-------ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCC
Q 020657          183 VNNNN-MQVKIADFGVSKIMCRSLD-------ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHF  254 (323)
Q Consensus       183 ~~~~~-~~~kl~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~  254 (323)
                      ++.++ ..+||+|||++........       ......++..|+|||++.+.     .++.++||||||+++|+|++|..
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~slG~il~el~~g~~  266 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-----GPSRRSDLQSLGYCMLKWLYGFL  266 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-----CCCHHHHHHHHHHHHHHHHHSCC
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-----CCCchhhHHHHHHHHHHHHhCCC
Confidence            99874 2799999999976543221       11334789999999998743     45679999999999999999999


Q ss_pred             CCCCCC-CCccHHHHHHHHhcCCCCCCC------CCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          255 PFLQPG-QRPDWATLMCAICFGDPPSLP------DGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       255 p~~~~~-~~~~~~~~~~~~~~~~~~~~~------~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ||.... ................ ..+.      ..++.++.+|+.+||+.||++|||++++++.
T Consensus       267 pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  330 (352)
T 2jii_A          267 PWTNCLPNTEDIMKQKQKFVDKP-GPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN  330 (352)
T ss_dssp             TTGGGTTCHHHHHHHHHHHHHSC-CCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             CcccCCcCHHHHHHHHHhccCCh-hhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence            997654 2222222222222222 2221      2578999999999999999999999999753

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.7e-45  Score=318.10  Aligned_cols=260  Identities=28%  Similarity=0.401  Sum_probs=210.9

Q ss_pred             chhccccccceeeeecccCCeEEEEEE----ecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEc
Q 020657           45 TAAIAYSDLEKLQVLGHGNGGTVYKVQ----HRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEK  120 (323)
Q Consensus        45 ~~~~~~~~~~~~~~lg~G~~~~v~~~~----~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  120 (323)
                      ...+..++|++.+.||+|++|.||+|+    +..+++.||+|++.... ......+.+|+.+++.++||||+++++++..
T Consensus        35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  113 (326)
T 2w1i_A           35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYS  113 (326)
T ss_dssp             --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred             ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence            345677899999999999999999998    45689999999997653 4556778999999999999999999999865


Q ss_pred             C-CCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcc
Q 020657          121 P-SGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVS  198 (323)
Q Consensus       121 ~-~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~  198 (323)
                      . ....++||||+++++|.+++... ..+++..++.++.||+.||.+||+.|++|+||||+||+++.++ .++|+|||++
T Consensus       114 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~-~~kL~Dfg~~  192 (326)
T 2w1i_A          114 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLT  192 (326)
T ss_dssp             ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCTTC
T ss_pred             cCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCC-cEEEecCcch
Confidence            3 23689999999999999999865 4599999999999999999999999999999999999999987 8999999999


Q ss_pred             hhhccCccc---cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--------C----Cc
Q 020657          199 KIMCRSLDA---CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPG--------Q----RP  263 (323)
Q Consensus       199 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~--------~----~~  263 (323)
                      .........   .....++..|+|||++....     ++.++||||||+++|+|+||..||....        .    ..
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~  267 (326)
T 2w1i_A          193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESK-----FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM  267 (326)
T ss_dssp             EECCSSCSEEECSSCCSCCGGGCCHHHHHHCE-----EEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHH
T ss_pred             hhccccccccccccCCCCceeEECchhhcCCC-----CCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhh
Confidence            766443221   22345677899999986433     4569999999999999999999985321        0    01


Q ss_pred             cHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          264 DWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ....+............+..++.++.+|+++||+.||++|||++++++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          268 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            112233444444455667889999999999999999999999999985

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=9.7e-45  Score=314.32  Aligned_cols=237  Identities=29%  Similarity=0.474  Sum_probs=188.4

Q ss_pred             cccccccee-eeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHH-HcCCCCccceeceeEEc---CC
Q 020657           48 IAYSDLEKL-QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEIL-RRTDSPFIVQCFGIFEK---PS  122 (323)
Q Consensus        48 ~~~~~~~~~-~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~---~~  122 (323)
                      ...++|.+. +.||+|+||.||+|.+..+++.||+|++...      ....+|+.++ +.++||||+++++++..   ..
T Consensus        14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~   87 (299)
T 3m2w_A           14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGR   87 (299)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence            345678887 7899999999999999989999999999632      3456788887 55699999999999864   24


Q ss_pred             CeEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEec---CCCcEEEeecCc
Q 020657          123 GDIAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNN---NNMQVKIADFGV  197 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~---~~~~~kl~Dfg~  197 (323)
                      ...++||||+++++|.+++....  .+++..++.++.||+.||.|||+.|++|+||||+||+++.   ++ .++|+|||+
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~-~~kl~Dfg~  166 (299)
T 3m2w_A           88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA-ILKLTDFGF  166 (299)
T ss_dssp             EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTC-CEEECCCTT
T ss_pred             ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCC-cEEEecccc
Confidence            56899999999999999998654  6999999999999999999999999999999999999997   55 899999999


Q ss_pred             chhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCC
Q 020657          198 SKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP  277 (323)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~  277 (323)
                      +.....                           ..++.++||||||+++|+|+||..||...........+..... ...
T Consensus       167 a~~~~~---------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~-~~~  218 (299)
T 3m2w_A          167 AKETTG---------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR-MGQ  218 (299)
T ss_dssp             CEECTT---------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSC-TTC
T ss_pred             cccccc---------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHh-hcc
Confidence            854321                           1234599999999999999999999965432211111111110 011


Q ss_pred             CCCC----CCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          278 PSLP----DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       278 ~~~~----~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      ..++    ..+++++.+|+.+||+.||++|||++++++||||++..
T Consensus       219 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          219 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence            1122    46899999999999999999999999999999997654

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=7.7e-45  Score=313.50  Aligned_cols=256  Identities=26%  Similarity=0.425  Sum_probs=200.1

Q ss_pred             chhccccccceeeeecccCCeEEEEEEecc-cCc--EEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEE
Q 020657           45 TAAIAYSDLEKLQVLGHGNGGTVYKVQHRC-THK--IYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFE  119 (323)
Q Consensus        45 ~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~-~~~--~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  119 (323)
                      ...+..++|++.+.||+|++|.||+|.+.. +++  .|++|++....  .....+.+.+|+.+++.++||||+++++++.
T Consensus        12 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   91 (291)
T 1u46_A           12 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL   91 (291)
T ss_dssp             CEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence            345667899999999999999999998643 333  68999987542  3456678899999999999999999999998


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcc
Q 020657          120 KPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVS  198 (323)
Q Consensus       120 ~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~  198 (323)
                      ..  ..++||||+.+++|.+++... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++ .+||+|||++
T Consensus        92 ~~--~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~  168 (291)
T 1u46_A           92 TP--PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD-LVKIGDFGLM  168 (291)
T ss_dssp             SS--SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCTTC
T ss_pred             cC--CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCC-CEEEcccccc
Confidence            63  488999999999999998753 5699999999999999999999999999999999999999987 8999999999


Q ss_pred             hhhccCcc---ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHH-h
Q 020657          199 KIMCRSLD---ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAI-C  273 (323)
Q Consensus       199 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~-~  273 (323)
                      ........   ......++..|+|||++...     .++.++||||||+++|+|++ |..||.....    ..+...+ .
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~~~~  239 (291)
T 1u46_A          169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTR-----TFSHASDTWMFGVTLWEMFTYGQEPWIGLNG----SQILHKIDK  239 (291)
T ss_dssp             EECCC-CCEEEC-----CCGGGCCHHHHHHC-----EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHHHT
T ss_pred             ccccccccchhhhccCCCCceeeCchhhcCC-----CCCchhhHHHHHHHHHHHHhCCCCCcccCCH----HHHHHHHHc
Confidence            76543322   12234567789999998633     34569999999999999999 9999965432    2222222 2


Q ss_pred             cCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          274 FGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       274 ~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      .......+..++.++.+++.+||+.||++|||+.+++++
T Consensus       240 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          240 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            333455667899999999999999999999999999873

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=7.6e-45  Score=319.99  Aligned_cols=269  Identities=25%  Similarity=0.366  Sum_probs=198.3

Q ss_pred             chhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHH--HHcCCCCccceeceeEEc--
Q 020657           45 TAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEI--LRRTDSPFIVQCFGIFEK--  120 (323)
Q Consensus        45 ~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~--l~~l~h~~i~~~~~~~~~--  120 (323)
                      ...+..++|++.+.||+|+||.||+|++  +++.||+|++....    ...+..|..+  +..++|+||+++++.+..  
T Consensus         7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~   80 (336)
T 3g2f_A            7 EPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVGDERVT   80 (336)
T ss_dssp             --CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred             CCCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCcchhhheecccccc
Confidence            3456789999999999999999999987  68999999996432    2233344444  445899999999975432  


Q ss_pred             --CCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CCeecCCCCCCeEEecCCCc
Q 020657          121 --PSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH---------KIIHRDIKPSNLLVNNNNMQ  189 (323)
Q Consensus       121 --~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---------givH~di~~~nil~~~~~~~  189 (323)
                        ....+++||||+++++|.+++... ..++..++.++.||+.||.|||+.         |++||||||+||+++.++ .
T Consensus        81 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~-~  158 (336)
T 3g2f_A           81 ADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG-T  158 (336)
T ss_dssp             TTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS-C
T ss_pred             cCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC-c
Confidence              233578999999999999999765 458999999999999999999999         999999999999999987 8


Q ss_pred             EEEeecCcchhhccCc--------cccccccccccccCCcccCCCCCCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 020657          190 VKIADFGVSKIMCRSL--------DACNSYVGTCAYMSPERFDPDAYGG--NYNGYAGDIWSLGLTLLELYLGHFPFLQP  259 (323)
Q Consensus       190 ~kl~Dfg~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~--~~~~~~~Dv~slG~ll~~lltg~~p~~~~  259 (323)
                      +||+|||++.......        .......+|..|+|||++.+.....  ..++.++||||||+++|+|++|..||...
T Consensus       159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~  238 (336)
T 3g2f_A          159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG  238 (336)
T ss_dssp             EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred             EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence            9999999997654321        1122456899999999987432111  23446899999999999999998877543


Q ss_pred             CCCc--------------cHHHHHHHH-hcCCCCCCCCC------CChhHHHHHHHhcccCcCCCCCHHHHh------cC
Q 020657          260 GQRP--------------DWATLMCAI-CFGDPPSLPDG------ASPEFRSFIECCLQKEFSKRWTASQLL------TH  312 (323)
Q Consensus       260 ~~~~--------------~~~~~~~~~-~~~~~~~~~~~------~~~~l~~ll~~~l~~~p~~Rpt~~~~l------~h  312 (323)
                      ....              ....+.... .....+.++..      +++++.+|+.+||+.||++|||+++++      -+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~  318 (336)
T 3g2f_A          239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM  318 (336)
T ss_dssp             SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence            3221              112221111 12223344433      334799999999999999999999994      56


Q ss_pred             cccccCCCC
Q 020657          313 PFLCKNRRS  321 (323)
Q Consensus       313 ~~f~~~~~~  321 (323)
                      +|-++..++
T Consensus       319 ~~~~~~~~~  327 (336)
T 3g2f_A          319 IWERNKSVS  327 (336)
T ss_dssp             CCCC-----
T ss_pred             HHHhcccCC
Confidence            888887765

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=6.4e-44  Score=338.91  Aligned_cols=258  Identities=25%  Similarity=0.385  Sum_probs=214.8

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEeccc---CcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEE
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCT---HKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFE  119 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  119 (323)
                      .....+..++|++.+.||+|+||.||+|.+..+   +..|++|.+...........+.+|+.+++.++||||+++++++.
T Consensus       382 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  461 (656)
T 2j0j_A          382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT  461 (656)
T ss_dssp             GGGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            455677788999999999999999999998643   45799999887666777788999999999999999999999985


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcc
Q 020657          120 KPSGDIAILMEYMDSGTLDTLLNKNG-TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVS  198 (323)
Q Consensus       120 ~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~  198 (323)
                      +  +..++||||+.+++|.+++...+ .+++..++.++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++
T Consensus       462 ~--~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~-~vkL~DFG~a  538 (656)
T 2j0j_A          462 E--NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLS  538 (656)
T ss_dssp             S--SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCCCC
T ss_pred             c--CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCC-CEEEEecCCC
Confidence            4  56899999999999999997543 689999999999999999999999999999999999999987 9999999999


Q ss_pred             hhhccCcc-ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCC
Q 020657          199 KIMCRSLD-ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGD  276 (323)
Q Consensus       199 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~  276 (323)
                      ........ ......++..|+|||++...     .++.++||||||+++|||++ |..||.+..    ...+...+..+.
T Consensus       539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~DiwSlG~il~ellt~g~~Pf~~~~----~~~~~~~i~~~~  609 (656)
T 2j0j_A          539 RYMEDSTYYKASKGKLPIKWMAPESINFR-----RFTSASDVWMFGVCMWEILMHGVKPFQGVK----NNDVIGRIENGE  609 (656)
T ss_dssp             CSCCC----------CCGGGCCHHHHHHC-----CCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHHHHHHHHTC
T ss_pred             eecCCCcceeccCCCCCcceeCHHHhcCC-----CCCchhhHHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHcCC
Confidence            76543321 12234566789999998633     34669999999999999997 999996543    334444555566


Q ss_pred             CCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          277 PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       277 ~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ...++..+++.+.+|+.+||+.||++|||+.++++.
T Consensus       610 ~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          610 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            677788999999999999999999999999999863

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=6.4e-45  Score=318.15  Aligned_cols=265  Identities=23%  Similarity=0.324  Sum_probs=209.7

Q ss_pred             CCCCCccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcCCCCccceece
Q 020657           38 NNNTTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-PTVRRQVFREMEILRRTDSPFIVQCFG  116 (323)
Q Consensus        38 ~~~~~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~  116 (323)
                      ........+.+..++|++.+.||+|+||.||+|.+..   .+++|++..... ....+.+.+|+.+++.++||||+++++
T Consensus        20 ~~~~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   96 (319)
T 2y4i_B           20 QTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG   96 (319)
T ss_dssp             --CCCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCE
T ss_pred             ccccccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEE
Confidence            3344578889999999999999999999999999853   489999865422 223345678999999999999999999


Q ss_pred             eEEcCCCeEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeec
Q 020657          117 IFEKPSGDIAILMEYMDSGTLDTLLNKNG-TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADF  195 (323)
Q Consensus       117 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Df  195 (323)
                      ++.+ ....++||||+.+++|.+++...+ .+++..++.++.||+.||.|||+.|++|+||||+||+++ ++ .++|+||
T Consensus        97 ~~~~-~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~-~~~l~Df  173 (319)
T 2y4i_B           97 ACMS-PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NG-KVVITDF  173 (319)
T ss_dssp             EEEC-SSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC----CCEECCC
T ss_pred             EEec-CCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CC-CEEEeec
Confidence            9987 677999999999999999998654 699999999999999999999999999999999999998 44 8999999


Q ss_pred             CcchhhccC-----ccccccccccccccCCcccCCCCC----CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHH
Q 020657          196 GVSKIMCRS-----LDACNSYVGTCAYMSPERFDPDAY----GGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWA  266 (323)
Q Consensus       196 g~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~----~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~  266 (323)
                      |++......     ........++..|+|||++.....    ....++.++||||||+++|+|++|..||....    ..
T Consensus       174 g~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~  249 (319)
T 2y4i_B          174 GLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP----AE  249 (319)
T ss_dssp             SCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC----HH
T ss_pred             CCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HH
Confidence            998654321     122234468899999999864221    13446789999999999999999999995433    23


Q ss_pred             HHHHHHhcCCCCCC-CCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          267 TLMCAICFGDPPSL-PDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       267 ~~~~~~~~~~~~~~-~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ...........+.. ...++.++.+|+.+||+.||++|||++++++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~  296 (319)
T 2y4i_B          250 AIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM  296 (319)
T ss_dssp             HHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred             HHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            33333333333333 34689999999999999999999999999864

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.2e-44  Score=312.12  Aligned_cols=250  Identities=24%  Similarity=0.319  Sum_probs=203.1

Q ss_pred             cceeeeecccCCeEEEEEEecccCcEEEEEeecCCC---ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           53 LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA---DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        53 ~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      |...+.||+|+||.||+|.+  +++.|++|++....   .......+.+|+.+++.++||||+++++++.+ .+..++||
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~  109 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD-GDDLCLVY  109 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec-CCceEEEE
Confidence            34448999999999999997  68899999986542   34556788999999999999999999999987 67899999


Q ss_pred             eccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc
Q 020657          130 EYMDSGTLDTLLNK---NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD  206 (323)
Q Consensus       130 e~~~~~sL~~~l~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~  206 (323)
                      ||+++++|.+++..   ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++........
T Consensus       110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~  188 (307)
T 2nru_A          110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAF-TAKISDFGLARASEKFAQ  188 (307)
T ss_dssp             ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECCSCSS
T ss_pred             EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC-cEEEeecccccccccccc
Confidence            99999999999863   34699999999999999999999999999999999999999987 899999999876543221


Q ss_pred             --ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC--------
Q 020657          207 --ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD--------  276 (323)
Q Consensus       207 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~--------  276 (323)
                        ......++..|+|||.+.+      .++.++||||||+++|+|++|..||...........+........        
T Consensus       189 ~~~~~~~~g~~~y~aPE~~~~------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (307)
T 2nru_A          189 TVMTSRIVGTTAYMAPEALRG------EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYID  262 (307)
T ss_dssp             CEECSSCCSCGGGCCHHHHTT------EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSC
T ss_pred             cccccccCCCcCcCChHHhcC------CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcc
Confidence              2234568999999998853      245699999999999999999999977655444333333222211        


Q ss_pred             --CCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          277 --PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       277 --~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                        ....+...+..+.+++.+||+.||++|||+++++++
T Consensus       263 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          263 KKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             SSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence              112223345779999999999999999999999864

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=4.4e-44  Score=328.10  Aligned_cols=254  Identities=22%  Similarity=0.281  Sum_probs=204.3

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEE
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      ...++|++.+.||+|+||.||+|.+..+++.||||++......   ..+.+|+.+++.+.|++.+..+..+.......++
T Consensus         4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l   80 (483)
T 3sv0_A            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL   80 (483)
T ss_dssp             EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred             CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence            3468999999999999999999999889999999998755332   2467899999999875555545444444788999


Q ss_pred             EEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEE---ecCCCcEEEeecCcchhhcc
Q 020657          128 LMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLV---NNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~---~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      ||||+ +++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||+   +.++ .+||+|||++.....
T Consensus        81 vme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~-~vkL~DFGla~~~~~  158 (483)
T 3sv0_A           81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYRD  158 (483)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTT-CEEECCCTTCEECBC
T ss_pred             EEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCC-eEEEEeCCcceeccC
Confidence            99999 7899999975 5579999999999999999999999999999999999999   4665 899999999977654


Q ss_pred             Ccc-------ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHH---HHHHh
Q 020657          204 SLD-------ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATL---MCAIC  273 (323)
Q Consensus       204 ~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~---~~~~~  273 (323)
                      ...       ......++..|+|||++...     .++.++||||||+++|+|++|..||...........+   .....
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~  233 (483)
T 3sv0_A          159 TSTHQHIPYRENKNLTGTARYASVNTHLGI-----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV  233 (483)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-----CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH
T ss_pred             CccccccccccccccCCCccccCHHHhcCC-----CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc
Confidence            322       22356789999999998744     3467999999999999999999999876554433322   22222


Q ss_pred             cCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          274 FGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       274 ~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ......++..++.++.+|+..||+.+|++||++++|++
T Consensus       234 ~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          234 ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            22222334678999999999999999999999998874

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.5e-44  Score=315.05  Aligned_cols=262  Identities=24%  Similarity=0.382  Sum_probs=201.4

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHc--CCCCccceeceeEEc
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRR--TDSPFIVQCFGIFEK  120 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~  120 (323)
                      ........++|++.+.||+|+||.||+|.+.  ++.||+|++....    .....+|.+++..  ++||||+++++++..
T Consensus        29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~  102 (337)
T 3mdy_A           29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFIAADIK  102 (337)
T ss_dssp             HHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred             cccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc----cchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence            4455566789999999999999999999984  8999999985432    2334455566555  489999999999876


Q ss_pred             CC---CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CCeecCCCCCCeEEecCCCc
Q 020657          121 PS---GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH--------KIIHRDIKPSNLLVNNNNMQ  189 (323)
Q Consensus       121 ~~---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~--------givH~di~~~nil~~~~~~~  189 (323)
                      ..   ...++||||+.+++|.+++... .+++..++.++.|++.||.|||+.        |++|+||||+||+++.++ .
T Consensus       103 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~-~  180 (337)
T 3mdy_A          103 GTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG-T  180 (337)
T ss_dssp             SCGGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS-C
T ss_pred             CCCCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC-C
Confidence            32   6789999999999999999765 689999999999999999999999        999999999999999987 8


Q ss_pred             EEEeecCcchhhccCccc----cccccccccccCCcccCCCCCCCC-CCCcchhHHHHHHHHHHHHhC----------CC
Q 020657          190 VKIADFGVSKIMCRSLDA----CNSYVGTCAYMSPERFDPDAYGGN-YNGYAGDIWSLGLTLLELYLG----------HF  254 (323)
Q Consensus       190 ~kl~Dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~-~~~~~~Dv~slG~ll~~lltg----------~~  254 (323)
                      +||+|||++.........    .....++..|+|||++........ ..+.++||||||+++|+|+||          +.
T Consensus       181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~  260 (337)
T 3mdy_A          181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL  260 (337)
T ss_dssp             EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence            999999999765432221    224578999999999875443321 111249999999999999999          77


Q ss_pred             CCCCCCCC-ccHHHHHHHHhc-CCCCCCCC-----CCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          255 PFLQPGQR-PDWATLMCAICF-GDPPSLPD-----GASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       255 p~~~~~~~-~~~~~~~~~~~~-~~~~~~~~-----~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ||...... .....+...... ...+.++.     .+++++.+|+++||+.||++|||+.++++|
T Consensus       261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          261 PYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             cHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            77554322 233333333322 22233332     456779999999999999999999999976

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.5e-44  Score=328.56  Aligned_cols=257  Identities=25%  Similarity=0.333  Sum_probs=192.1

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceeceeEEcCCCeEEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      .+.|.+.+.||+|+||+||.+.. .+|+.||+|++....    .+.+.+|+.+++.+ +||||+++++++.+ ....++|
T Consensus        14 ~~~~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-~~~~~lv   87 (434)
T 2rio_A           14 KNLVVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSETT-DRFLYIA   87 (434)
T ss_dssp             SSCEEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEEEC-SSEEEEE
T ss_pred             hheeeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEec-CCeEEEE
Confidence            45566778999999999987543 479999999986432    34567899999876 89999999999987 6889999


Q ss_pred             EeccCCCCHHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecC------------CCc
Q 020657          129 MEYMDSGTLDTLLNKNGTF-------SEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNN------------NMQ  189 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~~~-------~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~------------~~~  189 (323)
                      |||++ ++|.+++......       ++..++.++.||+.||.|||+.|++||||||+||+++.+            ...
T Consensus        88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~  166 (434)
T 2rio_A           88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR  166 (434)
T ss_dssp             ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred             EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence            99996 5999999765432       233457899999999999999999999999999999753            237


Q ss_pred             EEEeecCcchhhccCcc----ccccccccccccCCcccCCCCC--CCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 020657          190 VKIADFGVSKIMCRSLD----ACNSYVGTCAYMSPERFDPDAY--GGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQR  262 (323)
Q Consensus       190 ~kl~Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~  262 (323)
                      +||+|||++........    ......+|..|+|||++.+...  ....++.++||||||+++|+|+| |..||......
T Consensus       167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~  246 (434)
T 2rio_A          167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR  246 (434)
T ss_dssp             EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred             EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence            99999999977644322    1234578999999999874321  23456789999999999999998 99999543322


Q ss_pred             ccHHHHHHHHhcCCCCCC----CCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          263 PDWATLMCAICFGDPPSL----PDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~----~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                        ...+.....  .....    ...++.++.+|+.+||+.||++|||+.++++||||.+
T Consensus       247 --~~~i~~~~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          247 --ESNIIRGIF--SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             --HHHHHHTCC--CCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             --HHHHhcCCC--CcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence              122222111  11111    1134578999999999999999999999999999965

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=7.5e-44  Score=306.55  Aligned_cols=234  Identities=16%  Similarity=0.164  Sum_probs=190.0

Q ss_pred             Cccchh-ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC--hHHHHHHHHHHHHHHcCCCCccceeceeE
Q 020657           42 TATTAA-IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD--PTVRRQVFREMEILRRTDSPFIVQCFGIF  118 (323)
Q Consensus        42 ~~~~~~-~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~  118 (323)
                      ...... +..++|++.+.||+|+||.||+|.+..+++.||+|++.....  ......+.+|+.+++.++||||+++++++
T Consensus        21 ~~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~  100 (286)
T 3uqc_A           21 QLVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV  100 (286)
T ss_dssp             CCCTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cCCCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEE
Confidence            334444 667899999999999999999999998899999999976533  45667889999999999999999999999


Q ss_pred             EcCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcc
Q 020657          119 EKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVS  198 (323)
Q Consensus       119 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~  198 (323)
                      .. .+..++||||+++++|.+++..+  .....+..++.||+.||.|||++|++||||||+||+++.++ .+||++++..
T Consensus       101 ~~-~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g-~~kl~~~~~~  176 (286)
T 3uqc_A          101 HT-RAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDG-DVVLAYPATM  176 (286)
T ss_dssp             EE-TTEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTS-CEEECSCCCC
T ss_pred             EE-CCcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCC-CEEEEecccc
Confidence            87 68899999999999999999654  46677899999999999999999999999999999999987 8999855432


Q ss_pred             hhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCC-
Q 020657          199 KIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP-  277 (323)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~-  277 (323)
                                          +|            .+.++||||||+++|+|+||..||.+................... 
T Consensus       177 --------------------~~------------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  224 (286)
T 3uqc_A          177 --------------------PD------------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIE  224 (286)
T ss_dssp             --------------------TT------------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCC
T ss_pred             --------------------CC------------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCC
Confidence                                21            356999999999999999999999765443211000000000000 


Q ss_pred             -CCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          278 -PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       278 -~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                       ..+...+++++.+|+.+||+.||++| |++++++.
T Consensus       225 ~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          225 PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence             12335789999999999999999999 99999863

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.7e-43  Score=312.08  Aligned_cols=263  Identities=24%  Similarity=0.333  Sum_probs=208.8

Q ss_pred             CccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHc--CCCCccceeceeEE
Q 020657           42 TATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRR--TDSPFIVQCFGIFE  119 (323)
Q Consensus        42 ~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~  119 (323)
                      +........++|++.+.||+|+||.||+|.+  +++.||+|++...    ....+.+|.+++..  ++||||+++++++.
T Consensus        33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~  106 (342)
T 1b6c_B           33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADN  106 (342)
T ss_dssp             CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred             ceeecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence            3444556678999999999999999999998  5899999998533    23556788888887  78999999999998


Q ss_pred             cCC---CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCCeecCCCCCCeEEecCCC
Q 020657          120 KPS---GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH--------GHKIIHRDIKPSNLLVNNNNM  188 (323)
Q Consensus       120 ~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh--------~~givH~di~~~nil~~~~~~  188 (323)
                      ...   ...++||||+.+++|.+++... .+++..++.++.|++.||.|||        +.|++|+||||+||+++.++ 
T Consensus       107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~-  184 (342)
T 1b6c_B          107 KDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-  184 (342)
T ss_dssp             CCCSSCCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS-
T ss_pred             ccCCccceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC-
Confidence            743   2789999999999999999764 6899999999999999999999        89999999999999999987 


Q ss_pred             cEEEeecCcchhhccCcc----ccccccccccccCCcccCCCCCCC-CCCCcchhHHHHHHHHHHHHhC----------C
Q 020657          189 QVKIADFGVSKIMCRSLD----ACNSYVGTCAYMSPERFDPDAYGG-NYNGYAGDIWSLGLTLLELYLG----------H  253 (323)
Q Consensus       189 ~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~-~~~~~~~Dv~slG~ll~~lltg----------~  253 (323)
                      .+||+|||++........    ......++..|+|||++....... ...+.++||||||+++|+|+||          .
T Consensus       185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~  264 (342)
T 1b6c_B          185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ  264 (342)
T ss_dssp             CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence            899999999976644322    224457899999999987442211 1223589999999999999999          8


Q ss_pred             CCCCCCCCC-ccHHHHHHHHhcC-CCCCCCC-----CCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          254 FPFLQPGQR-PDWATLMCAICFG-DPPSLPD-----GASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       254 ~p~~~~~~~-~~~~~~~~~~~~~-~~~~~~~-----~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      .||...... .....+....... ..+.++.     .++..+.+|+.+||+.||++|||++++++|
T Consensus       265 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            888654332 2344444433322 2333332     234679999999999999999999999976

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2e-43  Score=314.45  Aligned_cols=249  Identities=17%  Similarity=0.197  Sum_probs=197.6

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEE-----ecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCC---CCcccee
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQ-----HRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD---SPFIVQC  114 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~-----~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~  114 (323)
                      .....+..++|++.+.||+|+||.||+|.     +..+++.||+|++....    ...+..|+.+++.+.   |+||+.+
T Consensus        57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~l~~~~~~~iv~~  132 (365)
T 3e7e_A           57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----PWEFYIGTQLMERLKPSMQHMFMKF  132 (365)
T ss_dssp             SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC----HHHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred             ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC----hhHHHHHHHHHHHhhhhhhhhhhhh
Confidence            45566778899999999999999999994     56689999999997543    234667777777776   8999999


Q ss_pred             ceeEEcCCCeEEEEEeccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEec----
Q 020657          115 FGIFEKPSGDIAILMEYMDSGTLDTLLNK-----NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNN----  185 (323)
Q Consensus       115 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~----  185 (323)
                      ++++.. .+..++||||+++++|.+++..     ...+++..++.++.||+.||.|||++||+||||||+||+++.    
T Consensus       133 ~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~  211 (365)
T 3e7e_A          133 YSAHLF-QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLE  211 (365)
T ss_dssp             EEEEEC-SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTC
T ss_pred             heeeec-CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccC
Confidence            999987 6788999999999999999973     457999999999999999999999999999999999999988    


Q ss_pred             -------CCCcEEEeecCcchhhcc--CccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 020657          186 -------NNMQVKIADFGVSKIMCR--SLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPF  256 (323)
Q Consensus       186 -------~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~  256 (323)
                             ++ .+||+|||++.....  .........+|..|+|||++.+..     ++.++||||||+++|+|+||..||
T Consensus       212 ~~~~~~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~il~elltg~~pf  285 (365)
T 3e7e_A          212 QDDEDDLSA-GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-----WNYQIDYFGVAATVYCMLFGTYMK  285 (365)
T ss_dssp             C------CT-TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-----BSTHHHHHHHHHHHHHHHHSSCCC
T ss_pred             ccccccccC-CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-----CCccccHHHHHHHHHHHHhCCCcc
Confidence                   66 899999999965432  222334567999999999987443     456999999999999999999999


Q ss_pred             CCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          257 LQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      .........       .......  ...++.+.+++..||+.+|.+|++..+.+.
T Consensus       286 ~~~~~~~~~-------~~~~~~~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~  331 (365)
T 3e7e_A          286 VKNEGGECK-------PEGLFRR--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLR  331 (365)
T ss_dssp             EEEETTEEE-------ECSCCTT--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred             ccCCCCcee-------echhccc--cCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence            543221100       0000011  134678999999999999999976544443

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.5e-43  Score=337.49  Aligned_cols=246  Identities=22%  Similarity=0.284  Sum_probs=203.0

Q ss_pred             chhccccccceeeeecccCCeEEEEEEecc-cCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCC
Q 020657           45 TAAIAYSDLEKLQVLGHGNGGTVYKVQHRC-THKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG  123 (323)
Q Consensus        45 ~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  123 (323)
                      ...+..++|++.+.||+|+||.||+|.+.. +++.|++|++...........+.+|+.+++.++||||+++++++...+.
T Consensus        74 ~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  153 (681)
T 2pzi_A           74 PGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR  153 (681)
T ss_dssp             TTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECT
T ss_pred             CCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCC
Confidence            345667899999999999999999999976 6899999999766666777788999999999999999999999886433


Q ss_pred             e----EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcch
Q 020657          124 D----IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       124 ~----~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                      .    .++||||+++++|.+++..  .+++..++.++.||+.||.|||++||+||||||+||+++.+  .+||+|||++.
T Consensus       154 ~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~--~~kl~DFG~a~  229 (681)
T 2pzi_A          154 HGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE--QLKLIDLGAVS  229 (681)
T ss_dssp             TSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS--CEEECCCTTCE
T ss_pred             CCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC--cEEEEecccch
Confidence            2    7999999999999988755  79999999999999999999999999999999999999875  79999999997


Q ss_pred             hhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCC
Q 020657          200 IMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPS  279 (323)
Q Consensus       200 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  279 (323)
                      .....    ....+|+.|+|||++...      .+.++||||||+++|+|++|..||.+......            +..
T Consensus       230 ~~~~~----~~~~gt~~y~aPE~~~~~------~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~------------~~~  287 (681)
T 2pzi_A          230 RINSF----GYLYGTPGFQAPEIVRTG------PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL------------PED  287 (681)
T ss_dssp             ETTCC----SCCCCCTTTSCTTHHHHC------SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC------------CTT
T ss_pred             hcccC----CccCCCccccCHHHHcCC------CCCceehhhhHHHHHHHHhCCCCCcccccccc------------ccc
Confidence            65432    345689999999998632      26799999999999999999988854221100            000


Q ss_pred             C-CCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccc
Q 020657          280 L-PDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLC  316 (323)
Q Consensus       280 ~-~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~  316 (323)
                      . ....++.+.+||.+||+.||++||+..+.+.|+|+.
T Consensus       288 ~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          288 DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence            0 012357899999999999999999999999988874

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-43  Score=320.47  Aligned_cols=256  Identities=17%  Similarity=0.162  Sum_probs=194.1

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCCh--HHHHHHHHHHHHHHcCCC-Cccce---------ec
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADP--TVRRQVFREMEILRRTDS-PFIVQ---------CF  115 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h-~~i~~---------~~  115 (323)
                      .....|...+.||+|+||.||+|.+..+|+.||||++......  ...+.+.+|+.+++.+.| .+...         ..
T Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~  154 (413)
T 3dzo_A           75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  154 (413)
T ss_dssp             SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred             CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence            4456688999999999999999999999999999998744322  235678899999999876 22111         11


Q ss_pred             ee------------EEcC----CCeEEEEEeccCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 020657          116 GI------------FEKP----SGDIAILMEYMDSGTLDTLLNK-------NGTFSEPKLAHIASQILKGLSYLHGHKII  172 (323)
Q Consensus       116 ~~------------~~~~----~~~~~lv~e~~~~~sL~~~l~~-------~~~~~~~~~~~i~~~i~~~l~~Lh~~giv  172 (323)
                      +.            +...    ...++++|+.+. ++|.++++.       ...+++..+..++.||+.||.|||++||+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ii  233 (413)
T 3dzo_A          155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV  233 (413)
T ss_dssp             EEEECCC---------------CCSEEEEEECCS-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hhcccCCCCccccccCCCccccccceEEEeehhc-CCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            11            1110    224677888774 699998841       23478889999999999999999999999


Q ss_pred             ecCCCCCCeEEecCCCcEEEeecCcchhhccCccccccccccccccCCcccCCCC-----CCCCCCCcchhHHHHHHHHH
Q 020657          173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDA-----YGGNYNGYAGDIWSLGLTLL  247 (323)
Q Consensus       173 H~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~~~~~~Dv~slG~ll~  247 (323)
                      ||||||+||+++.++ .+||+|||++......   .....+ ..|+|||++....     .....++.++||||||+++|
T Consensus       234 HrDiKp~NILl~~~~-~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~  308 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRG-GVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY  308 (413)
T ss_dssp             CSCCCGGGEEECTTC-CEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCC-eEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence            999999999999998 8999999998765433   334566 9999999983111     12334567999999999999


Q ss_pred             HHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          248 ELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       248 ~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      +|+||..||...........+         ......+++++.+||.+||+.||++|||+.++++||||++.
T Consensus       309 elltg~~Pf~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~  370 (413)
T 3dzo_A          309 WIWCADLPNTDDAALGGSEWI---------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  370 (413)
T ss_dssp             HHHHSSCCCCTTGGGSCSGGG---------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             HHHHCCCCCCCcchhhhHHHH---------HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence            999999999654332211111         11124678999999999999999999999999999999764

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2e-44  Score=317.35  Aligned_cols=248  Identities=18%  Similarity=0.254  Sum_probs=190.0

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-------ChHHHHHHHHHHHHHHcCC---------CC
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-------DPTVRRQVFREMEILRRTD---------SP  109 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-------~~~~~~~~~~e~~~l~~l~---------h~  109 (323)
                      ..+..++|++.+.||+|+||.||+|++  +++.||+|++....       .....+.+.+|+.+++.++         ||
T Consensus        15 ~~~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~   92 (336)
T 2vuw_A           15 HCLPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTE   92 (336)
T ss_dssp             HHSCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCC
T ss_pred             hhcccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCC
Confidence            346679999999999999999999998  68999999997553       2233466788999888875         55


Q ss_pred             ccceecee-----------------EEc------------CCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHH
Q 020657          110 FIVQCFGI-----------------FEK------------PSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQIL  160 (323)
Q Consensus       110 ~i~~~~~~-----------------~~~------------~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~  160 (323)
                      ||+++.++                 +.+            ..+..++||||+.+|++.+.+.+ ..+++..++.++.||+
T Consensus        93 niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~  171 (336)
T 2vuw_A           93 GFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLT  171 (336)
T ss_dssp             CBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHH
T ss_pred             chhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHH
Confidence            55555554                 332            25789999999999876555543 5689999999999999


Q ss_pred             HHHHHHH-hCCCeecCCCCCCeEEecCC-------------------CcEEEeecCcchhhccCccccccccccccccCC
Q 020657          161 KGLSYLH-GHKIIHRDIKPSNLLVNNNN-------------------MQVKIADFGVSKIMCRSLDACNSYVGTCAYMSP  220 (323)
Q Consensus       161 ~~l~~Lh-~~givH~di~~~nil~~~~~-------------------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aP  220 (323)
                      .||.||| +.||+||||||+|||++.++                   ..+||+|||+++.....     ...+|..|+||
T Consensus       172 ~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aP  246 (336)
T 2vuw_A          172 ASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDE  246 (336)
T ss_dssp             HHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCS
T ss_pred             HHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccCh
Confidence            9999999 99999999999999999874                   27999999999765432     34789999999


Q ss_pred             cccCCCCCCCCCCCcchhHHHHHHH-HHHHHhCCCCCCCCCCCccH-HHHHHHHh----cCCC--CCCCCCCChhHHHHH
Q 020657          221 ERFDPDAYGGNYNGYAGDIWSLGLT-LLELYLGHFPFLQPGQRPDW-ATLMCAIC----FGDP--PSLPDGASPEFRSFI  292 (323)
Q Consensus       221 E~~~~~~~~~~~~~~~~Dv~slG~l-l~~lltg~~p~~~~~~~~~~-~~~~~~~~----~~~~--~~~~~~~~~~l~~ll  292 (323)
                      |++.+..      +.++|||||+.+ .+++++|..||...    .+ ..+.....    ....  ...+..+++++.+||
T Consensus       247 E~~~g~~------~~~~Diwsl~~~~~~~~~~g~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli  316 (336)
T 2vuw_A          247 DLFTGDG------DYQFDIYRLMKKENNNRWGEYHPYSNV----LWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFH  316 (336)
T ss_dssp             GGGCCCS------SHHHHHHHHHHHHHTTCTTSCCTHHHH----HHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHH
T ss_pred             hhhcCCC------ccceehhhhhCCCCcccccccCCCcch----hhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHH
Confidence            9986332      569999998776 67788899998321    11 11111111    1111  111235788999999


Q ss_pred             HHhcccCcCCCCCHHHHh-cCcccc
Q 020657          293 ECCLQKEFSKRWTASQLL-THPFLC  316 (323)
Q Consensus       293 ~~~l~~~p~~Rpt~~~~l-~h~~f~  316 (323)
                      ++||+.|     |++++| +||||+
T Consensus       317 ~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          317 RTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             HHGGGSS-----SHHHHHHHCGGGC
T ss_pred             HHHhccC-----CHHHHHhcCCCcC
Confidence            9999977     999999 999995

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=7.2e-35  Score=272.16  Aligned_cols=187  Identities=16%  Similarity=0.165  Sum_probs=136.0

Q ss_pred             eecccCCeEEEEEEecccCcEEEEEeecCCC---------ChHHHHHHHHHHHHHHcC-CCCccceeceeEEcCCCeEEE
Q 020657           58 VLGHGNGGTVYKVQHRCTHKIYALKVVHGDA---------DPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        58 ~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~---------~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      ..+.|+.+....++....|+.+++|++....         .....+.+.+|+++|+++ .|+||+++++++++ ++..||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed-~~~~yL  319 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN-AQSGWL  319 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC-SSEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE-CCEEEE
Confidence            4566777777777776789999999997542         123456789999999999 69999999999998 789999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccc
Q 020657          128 LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA  207 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~  207 (323)
                      ||||++|++|.+.+...+++++.   .|+.||+.||+|+|++|||||||||+|||++.+| ++||+|||+|+........
T Consensus       320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg-~vKL~DFGlAr~~~~~~~~  395 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQ-HARLIDFGSIVTTPQDCSW  395 (569)
T ss_dssp             EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTS-CEEECCCTTEESCC---CC
T ss_pred             EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCC-CEEEeecccCeeCCCCCcc
Confidence            99999999999999988888865   4789999999999999999999999999999998 8999999999876555444


Q ss_pred             cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 020657          208 CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFP  255 (323)
Q Consensus       208 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p  255 (323)
                      ....+||+.|+|||++.+.      ...++|+|++|++++++.++..+
T Consensus       396 ~~t~vGTp~YmAPE~l~g~------~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          396 PTNLVQSFFVFVNELFAEN------KSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             SHHHHHHHHHHHHHHC-----------------------CCCCTTHHH
T ss_pred             ccCceechhhccHHHhCCC------CCCcccccccccchhhhccccch
Confidence            5567899999999998643      23489999999998877655433

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=9.2e-28  Score=222.99  Aligned_cols=185  Identities=18%  Similarity=0.174  Sum_probs=138.8

Q ss_pred             eeeeecccCCeEEEEEEecccCcEEEEEeecCCCC--hH-----HHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEE
Q 020657           55 KLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD--PT-----VRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        55 ~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      ..+.||+|+||.||+|..  .++.+++|.......  ..     ..+++.+|++++++++||||+++..++.. .+..++
T Consensus       340 ~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-~~~~~l  416 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD-LDNKRI  416 (540)
T ss_dssp             --------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE-TTTTEE
T ss_pred             CCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe-CCccEE
Confidence            356899999999999955  578888888654321  11     24557899999999999999955555444 456699


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccc
Q 020657          128 LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA  207 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~  207 (323)
                      ||||+++++|.+++..        +..++.||+++|.|||++||+||||||+||+++.   .+||+|||+++........
T Consensus       417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~---~~kL~DFGla~~~~~~~~~  485 (540)
T 3en9_A          417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK---DLYIIDFGLGKISNLDEDK  485 (540)
T ss_dssp             EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS---SEEECCCTTCEECCCHHHH
T ss_pred             EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC---eEEEEECccCEECCCcccc
Confidence            9999999999999865        6789999999999999999999999999999987   7999999999876543221


Q ss_pred             -------cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 020657          208 -------CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPF  256 (323)
Q Consensus       208 -------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~  256 (323)
                             .....+|+.|+|||++....   ..++..+|+|+...-..+-..+.-+|
T Consensus       486 ~~~~~~~~~~~~GT~~y~APEv~~~~~---~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          486 AVDLIVFKKAVLSTHHEKFDEIWERFL---EGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHCGGGHHHHHHHHH---HHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccchhhhhhhhcCCCCcCCHHHHHHHH---HHHHHHHhHHHHHHHHHHHHHhcccc
Confidence                   13567899999999986311   12234789999888777777666555

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=3.1e-24  Score=183.47  Aligned_cols=134  Identities=19%  Similarity=0.214  Sum_probs=110.0

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCCh-----------------HHHHHHHHHHHHHHcCCCCcccee
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADP-----------------TVRRQVFREMEILRRTDSPFIVQC  114 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~-----------------~~~~~~~~e~~~l~~l~h~~i~~~  114 (323)
                      .|++.+.||+|++|.||+|.+ .+|+.||+|++......                 .....+.+|+.+++.++  | +++
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v  166 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV  166 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred             EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence            344559999999999999999 78999999999643211                 23567889999999998  5 777


Q ss_pred             ceeEEcCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEee
Q 020657          115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIAD  194 (323)
Q Consensus       115 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~D  194 (323)
                      .+++..  +..++||||++|++|.+ +.      ......++.||+.||.+||+.|++||||||+||+++ ++ .++|+|
T Consensus       167 ~~~~~~--~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~-~vkl~D  235 (282)
T 1zar_A          167 PKVYAW--EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EE-GIWIID  235 (282)
T ss_dssp             CCEEEE--ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TT-EEEECC
T ss_pred             CeEEec--cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CC-cEEEEE
Confidence            776654  45699999999999987 42      123557999999999999999999999999999999 76 899999


Q ss_pred             cCcchh
Q 020657          195 FGVSKI  200 (323)
Q Consensus       195 fg~~~~  200 (323)
                      ||++..
T Consensus       236 FG~a~~  241 (282)
T 1zar_A          236 FPQSVE  241 (282)
T ss_dssp             CTTCEE
T ss_pred             CCCCeE
Confidence            999853

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.86  E-value=7.3e-22  Score=166.75  Aligned_cols=139  Identities=19%  Similarity=0.232  Sum_probs=108.4

Q ss_pred             ccceeeeecccCCeEEEEEEecccCcE--EEEEeecCCCCh-----------------------HHHHHHHHHHHHHHcC
Q 020657           52 DLEKLQVLGHGNGGTVYKVQHRCTHKI--YALKVVHGDADP-----------------------TVRRQVFREMEILRRT  106 (323)
Q Consensus        52 ~~~~~~~lg~G~~~~v~~~~~~~~~~~--v~iK~~~~~~~~-----------------------~~~~~~~~e~~~l~~l  106 (323)
                      -|++.+.||+|+||.||+|.+..+|+.  ||+|++......                       .....+.+|+.++..+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            367889999999999999999668888  999997543211                       1123678899999999


Q ss_pred             CCCcc--ceeceeEEcCCCeEEEEEeccCC-C----CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCCeecCCCC
Q 020657          107 DSPFI--VQCFGIFEKPSGDIAILMEYMDS-G----TLDTLLNKNGTFSEPKLAHIASQILKGLSYLH-GHKIIHRDIKP  178 (323)
Q Consensus       107 ~h~~i--~~~~~~~~~~~~~~~lv~e~~~~-~----sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh-~~givH~di~~  178 (323)
                      .|+++  +.+++.     ...++||||+.+ |    +|.++...   .++..+..++.|++.+|.+|| +.|++||||||
T Consensus       128 ~~~~i~~p~~~~~-----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp  199 (258)
T 1zth_A          128 KEAGVSVPQPYTY-----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSE  199 (258)
T ss_dssp             HHTTCCCCCEEEE-----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred             HhCCCCCCeEEEc-----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence            88764  333332     235899999942 3    67766432   245578899999999999999 99999999999


Q ss_pred             CCeEEecCCCcEEEeecCcchhh
Q 020657          179 SNLLVNNNNMQVKIADFGVSKIM  201 (323)
Q Consensus       179 ~nil~~~~~~~~kl~Dfg~~~~~  201 (323)
                      .||+++.   .++|+|||+|...
T Consensus       200 ~NILl~~---~~~liDFG~a~~~  219 (258)
T 1zth_A          200 YNIMYID---KVYFIDMGQAVTL  219 (258)
T ss_dssp             TSEEESS---SEEECCCTTCEET
T ss_pred             HHEEEcC---cEEEEECcccccC
Confidence            9999987   6999999999654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.79  E-value=3.4e-20  Score=162.87  Aligned_cols=140  Identities=17%  Similarity=0.155  Sum_probs=98.9

Q ss_pred             cceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-------------hHHHHH--------HHHHHHHHHcCCCCcc
Q 020657           53 LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-------------PTVRRQ--------VFREMEILRRTDSPFI  111 (323)
Q Consensus        53 ~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-------------~~~~~~--------~~~e~~~l~~l~h~~i  111 (323)
                      |++.+.||.|++|.||+|.+. +|+.||+|+++....             ......        ..+|...+.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            889999999999999999986 799999999753210             000111        1345555555533333


Q ss_pred             ceeceeEEcCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCC---
Q 020657          112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNM---  188 (323)
Q Consensus       112 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~---  188 (323)
                      .-..-+...   ..++||||++|.+|..+.      .......++.||+.+|.+||++|+|||||||.|||+++++.   
T Consensus       176 ~vp~p~~~~---~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d  246 (397)
T 4gyi_A          176 PVPEPIAQS---RHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAED  246 (397)
T ss_dssp             SCCCEEEEE---TTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSC
T ss_pred             CCCeeeecc---CceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccc
Confidence            211111111   237999999998886543      22345678899999999999999999999999999987651   


Q ss_pred             ------cEEEeecCcchhhc
Q 020657          189 ------QVKIADFGVSKIMC  202 (323)
Q Consensus       189 ------~~kl~Dfg~~~~~~  202 (323)
                            .+.||||+.+....
T Consensus       247 ~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          247 PSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             TTSEEEEEEECCCTTCEETT
T ss_pred             ccccccceEEEEeCCcccCC
Confidence                  38999999886543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.49  E-value=1.2e-13  Score=116.61  Aligned_cols=140  Identities=16%  Similarity=0.158  Sum_probs=109.2

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCC-CCccceeceeEEcCCCeEEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD-SPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ...|++...++.|+.+.||++..  .++.+++|+...... .....+.+|+.+++.+. +..+.++++++.. .+..++|
T Consensus        13 l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-~~~~~lv   88 (263)
T 3tm0_A           13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERH-DGWSNLL   88 (263)
T ss_dssp             HTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-TTEEEEE
T ss_pred             hccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEec-CCceEEE
Confidence            35688999999999999999986  367899999864211 11234778899998884 6678889988876 6789999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 020657          129 MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG----------------------------------------  168 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~----------------------------------------  168 (323)
                      ||+++|.+|.+...     +......++.+++++|..||+                                        
T Consensus        89 ~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T 3tm0_A           89 MSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             EECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred             EEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence            99999999887531     222345778899999999998                                        


Q ss_pred             -------------------CCCeecCCCCCCeEEecCCCcEEEeecCcch
Q 020657          169 -------------------HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       169 -------------------~givH~di~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                                         .+++|||+++.||++++++ .+.|+||+.+.
T Consensus       164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~lIDwe~a~  212 (263)
T 3tm0_A          164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK-VSGFIDLGRSG  212 (263)
T ss_dssp             SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE-EEEECCCTTCE
T ss_pred             CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc-EEEEEEchhcc
Confidence                               3489999999999998754 56799999874

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.36  E-value=3.5e-12  Score=107.19  Aligned_cols=134  Identities=15%  Similarity=0.128  Sum_probs=96.3

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCc--cceeceeEEcCCCeEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF--IVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~~lv  128 (323)
                      ..+.+....+.|..+.||++... +|+.+++|+.....    ...+.+|+.+++.+.+.+  +.+++++... .+..++|
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~-~g~~~vlK~~~~~~----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-~~~~~~v   93 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTE-AGRDWLL   93 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECT-TSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-SSCEEEE
T ss_pred             CCCceEecccCCCCceEEEEecC-CCCeEEEEeCCccc----chhhhHHHHHHHHHHhCCCCCCeEEEeccC-CCCCEEE
Confidence            34555444456667999999753 67789999986541    134568888888875434  4558887776 5678999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 020657          129 MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK--------------------------------------  170 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g--------------------------------------  170 (323)
                      |||++|.++.  ..   ..+   ...++.++++.|..||+..                                      
T Consensus        94 ~e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (264)
T 1nd4_A           94 LGEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL  165 (264)
T ss_dssp             EECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred             EEecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence            9999998884  21   122   2356677778888888643                                      


Q ss_pred             --------------------CeecCCCCCCeEEecCCCcEEEeecCcch
Q 020657          171 --------------------IIHRDIKPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       171 --------------------ivH~di~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                                          ++|+|++|.||++++++ .+.|+|||.+.
T Consensus       166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~liD~~~a~  213 (264)
T 1nd4_A          166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGR-FSGFIDCGRLG  213 (264)
T ss_dssp             CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTE-EEEECCCTTCE
T ss_pred             cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCc-EEEEEcchhcc
Confidence                                99999999999998764 56799999874

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.35  E-value=3.1e-12  Score=112.92  Aligned_cols=144  Identities=15%  Similarity=0.248  Sum_probs=105.9

Q ss_pred             cceeeeecccCCeEEEEEEecccCcEEEEEeec--CCCChHHHHHHHHHHHHHHcCC--CCccceeceeEEcCC--CeEE
Q 020657           53 LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH--GDADPTVRRQVFREMEILRRTD--SPFIVQCFGIFEKPS--GDIA  126 (323)
Q Consensus        53 ~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~--~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~--~~~~  126 (323)
                      ...++.|+.|.++.+|++...  +..+++|+..  ..........+.+|+.+++.+.  +..+++++.++.+..  +..+
T Consensus        40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~  117 (359)
T 3dxp_A           40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF  117 (359)
T ss_dssp             CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred             CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence            345678999999999999874  4678889876  3322223456778999999886  345778888776531  4578


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 020657          127 ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG--------------------------------------  168 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~--------------------------------------  168 (323)
                      +||||++|.++.+.  .-..++......++.+++++|..||+                                      
T Consensus       118 ~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          118 YIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             EEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            99999999777531  12346788889999999999999997                                      


Q ss_pred             --------------------CCCeecCCCCCCeEEecCCC-cEEEeecCcchh
Q 020657          169 --------------------HKIIHRDIKPSNLLVNNNNM-QVKIADFGVSKI  200 (323)
Q Consensus       169 --------------------~givH~di~~~nil~~~~~~-~~kl~Dfg~~~~  200 (323)
                                          .+++|||+++.||+++.++. .+.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                36899999999999997652 368999999864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.15  E-value=3.5e-11  Score=103.62  Aligned_cols=190  Identities=18%  Similarity=0.222  Sum_probs=120.2

Q ss_pred             eeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCC-CCc--cceeceeEEcCC--CeEEEEEe
Q 020657           56 LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD-SPF--IVQCFGIFEKPS--GDIAILME  130 (323)
Q Consensus        56 ~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~--i~~~~~~~~~~~--~~~~lv~e  130 (323)
                      ++.++.|..+.+|++.     ..+++|+...   ......+.+|+.+++.+. +..  +..++.......  ...++||+
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~---~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~   96 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKH---SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT   96 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESS---HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCC---cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence            4568999999999964     4588998642   244567889999998873 332  333443322211  13478999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 020657          131 YMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG------------------------------------------  168 (323)
Q Consensus       131 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~------------------------------------------  168 (323)
                      +++|.++.....  ..++......++.++++.+..||+                                          
T Consensus        97 ~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A           97 KIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             CCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             ccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            999988875433  246778888888888888888885                                          


Q ss_pred             ----------------CCCeecCCCCCCeEEecC-CCcEEEeecCcchhhccCccccccccccccccCCcccCC--CCCC
Q 020657          169 ----------------HKIIHRDIKPSNLLVNNN-NMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDP--DAYG  229 (323)
Q Consensus       169 ----------------~givH~di~~~nil~~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~  229 (323)
                                      ..++|+|+++.||+++.+ +..+.|+||+.+.......+........ .-..|+....  ..|+
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~-~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDD-EEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTT-TSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhc-cccCHHHHHHHHHHcC
Confidence                            136999999999999984 3368899999985432211110000000 0011111100  0000


Q ss_pred             CC-------CCCcchhHHHHHHHHHHHHhCCCCC
Q 020657          230 GN-------YNGYAGDIWSLGLTLLELYLGHFPF  256 (323)
Q Consensus       230 ~~-------~~~~~~Dv~slG~ll~~lltg~~p~  256 (323)
                      ..       ......+.|+++.++|.+.+|..+|
T Consensus       254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            00       0011368999999999999998776

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.95  E-value=1.9e-08  Score=86.52  Aligned_cols=136  Identities=18%  Similarity=0.219  Sum_probs=95.5

Q ss_pred             eeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCC---ccceeceeEEcCCCeEEEEEec
Q 020657           55 KLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSP---FIVQCFGIFEKPSGDIAILMEY  131 (323)
Q Consensus        55 ~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~~~~~~lv~e~  131 (323)
                      -+..++.|....+|+.     +..+++|+..   .......+.+|+.+++.+.+.   .+..++.+.....+..++||++
T Consensus        23 ~v~~l~~G~~n~v~~v-----g~~~VlR~~~---~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~   94 (306)
T 3tdw_A           23 SVESLGEGFRNYAILV-----NGDWVFRFPK---SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK   94 (306)
T ss_dssp             CEEEEEECSSEEEEEE-----TTTEEEEEES---SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred             eeeecCCCcceeEEEE-----CCEEEEEecC---CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence            3566888999999997     4567889853   234567788999999998642   3556666665445667899999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 020657          132 MDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH------------------------------------------  169 (323)
Q Consensus       132 ~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~------------------------------------------  169 (323)
                      ++|.++....-  ..++......++.++.+.|..||+.                                          
T Consensus        95 i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           95 VQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             CCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             cCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            99988876321  1234555555555555555555532                                          


Q ss_pred             ------------------CCeecCCCCCCeEEec---CCCcEEEeecCcchh
Q 020657          170 ------------------KIIHRDIKPSNLLVNN---NNMQVKIADFGVSKI  200 (323)
Q Consensus       170 ------------------givH~di~~~nil~~~---~~~~~kl~Dfg~~~~  200 (323)
                                        .++|+|+++.||+++.   ++..+.|+||+.+..
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                              3599999999999987   342458999998854

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.89  E-value=3.8e-08  Score=82.99  Aligned_cols=133  Identities=20%  Similarity=0.185  Sum_probs=94.3

Q ss_pred             eecccCCe-EEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCC-CCccceeceeEEcCCCeEEEEEeccCCC
Q 020657           58 VLGHGNGG-TVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD-SPFIVQCFGIFEKPSGDIAILMEYMDSG  135 (323)
Q Consensus        58 ~lg~G~~~-~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~lv~e~~~~~  135 (323)
                      .+..|..+ .||+......+..+++|+...    .....+.+|...++.+. +--+.+++.++.+ .+..++|||+++|.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~-~~~~~lvme~l~G~  105 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRT-PDDAWLLTTAIPGK  105 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEET----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE-TTEEEEEEECCCSE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCC----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEE-CCeEEEEEEeeCCc
Confidence            34445444 689988876777899998752    33456788999988874 3346778888776 57889999999998


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------------
Q 020657          136 TLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH----------------------------------------------  169 (323)
Q Consensus       136 sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~----------------------------------------------  169 (323)
                      ++.+.....    ......+..+++..|..||+.                                              
T Consensus       106 ~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          106 TAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             EHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             cccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            887765432    122334555566666666531                                              


Q ss_pred             ------------CCeecCCCCCCeEEecCCCcEEEeecCcchh
Q 020657          170 ------------KIIHRDIKPSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       170 ------------givH~di~~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                                  .++|||+++.||+++.++ .+-|+||+.+..
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~-~~~viDwe~a~~  223 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGK-LIGCIDVGRVGI  223 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTE-EEEECCCTTCEE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCe-EEEEEECccccc
Confidence                        278999999999999875 667999998843

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.51  E-value=3.1e-07  Score=81.88  Aligned_cols=78  Identities=19%  Similarity=0.213  Sum_probs=48.6

Q ss_pred             eeeeecccCCeEEEEEEecccCcEEEEEeecCCCC------hHHHHHHHHHHHHHHcCCC--Cc-cceeceeEEcCCCeE
Q 020657           55 KLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD------PTVRRQVFREMEILRRTDS--PF-IVQCFGIFEKPSGDI  125 (323)
Q Consensus        55 ~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~~~e~~~l~~l~h--~~-i~~~~~~~~~~~~~~  125 (323)
                      ..+.+|.|..+.||++.+..+++.+++|.......      .....++..|..+++.+..  +. +..++.+ .  ....
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-d--~~~~  110 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-D--TEMA  110 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-E--TTTT
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE-c--CCcc
Confidence            35689999999999998765678899998653211      0122345678888877632  33 4455543 2  2345


Q ss_pred             EEEEeccCCC
Q 020657          126 AILMEYMDSG  135 (323)
Q Consensus       126 ~lv~e~~~~~  135 (323)
                      ++|||++++.
T Consensus       111 ~lvmE~l~g~  120 (397)
T 2olc_A          111 VTVMEDLSHL  120 (397)
T ss_dssp             EEEECCCTTS
T ss_pred             EEEEEeCCCc
Confidence            7999999764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.48  E-value=4.4e-07  Score=79.65  Aligned_cols=86  Identities=13%  Similarity=0.096  Sum_probs=54.6

Q ss_pred             cceeeee-cccCCeEEEEEEec--c----cCcEEEEEeecCCCC--hHHHHHHHHHHHHHHcCC-C--CccceeceeEEc
Q 020657           53 LEKLQVL-GHGNGGTVYKVQHR--C----THKIYALKVVHGDAD--PTVRRQVFREMEILRRTD-S--PFIVQCFGIFEK  120 (323)
Q Consensus        53 ~~~~~~l-g~G~~~~v~~~~~~--~----~~~~v~iK~~~~~~~--~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~  120 (323)
                      ....+.| +.|..+.+|+....  .    +++.+++|+......  ......+.+|+.+++.+. +  -.+.+++.+..+
T Consensus        22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~  101 (357)
T 3ats_A           22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT  101 (357)
T ss_dssp             EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred             eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence            3445778 88888999998753  1    166788998753220  000134567888877763 2  346677777654


Q ss_pred             CC--CeEEEEEeccCCCCHH
Q 020657          121 PS--GDIAILMEYMDSGTLD  138 (323)
Q Consensus       121 ~~--~~~~lv~e~~~~~sL~  138 (323)
                      ..  +..++|||+++|.++.
T Consensus       102 ~~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          102 GDVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             STTTSSCEEEEECCCCBCCC
T ss_pred             CCccCCceEEEEecCCCChh
Confidence            22  3568999999886543

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.40  E-value=4.6e-06  Score=72.46  Aligned_cols=30  Identities=23%  Similarity=0.414  Sum_probs=26.6

Q ss_pred             CCCeecCCCCCCeEEecCCCcEEEeecCcch
Q 020657          169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       169 ~givH~di~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                      .+++|||+++.||+++.++ .+.|+||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~-~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENE-QIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGG-CEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCC-cEEEEehhhcc
Confidence            5899999999999998765 79999999874

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.24  E-value=2.7e-05  Score=62.12  Aligned_cols=136  Identities=15%  Similarity=0.097  Sum_probs=91.5

Q ss_pred             CCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccccc
Q 020657          134 SGTLDTLLN-KNGTFSEPKLAHIASQILKGLSYLHG-HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSY  211 (323)
Q Consensus       134 ~~sL~~~l~-~~~~~~~~~~~~i~~~i~~~l~~Lh~-~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  211 (323)
                      ..||.+++. .+.+++++++|.++.|.+.+|..+-. +.-...=+.|..|++..+| +|.+.+ ..+.            
T Consensus        32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG-~V~f~~-~~s~------------   97 (229)
T 2yle_A           32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDG-AVTLAP-AADD------------   97 (229)
T ss_dssp             EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTS-CEEECC-C---------------
T ss_pred             cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCC-ceeccc-cccc------------
Confidence            348999997 46689999999999999999888732 1111233456899999998 777653 1110            


Q ss_pred             cccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHH
Q 020657          212 VGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSF  291 (323)
Q Consensus       212 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  291 (323)
                      .....+.+||...      ...+.+.=||+||++||..+--.+|                      +..+..+|++|.+|
T Consensus        98 ~~~~~~~~pe~~~------~~~te~~~IysLG~tLY~ALDygL~----------------------e~eE~eLS~~LE~L  149 (229)
T 2yle_A           98 AGEPPPVAGKLGY------SQCMETEVIESLGIIIYKALDYGLK----------------------ENEERELSPPLEQL  149 (229)
T ss_dssp             ---------CCSS------SSSCHHHHHHHHHHHHHHHHTTTCC----------------------TTEEECCCHHHHHH
T ss_pred             ccccCCCChhhcc------ccchHHHHHHHHHHHHHHHhhcCCC----------------------cccchhhCHHHHHH
Confidence            1233566888752      3345689999999999998843322                      23346789999999


Q ss_pred             HHHhccc-------------------------CcCCCCCHHHHhc
Q 020657          292 IECCLQK-------------------------EFSKRWTASQLLT  311 (323)
Q Consensus       292 l~~~l~~-------------------------~p~~Rpt~~~~l~  311 (323)
                      |..|.+-                         .+..|.++++|++
T Consensus       150 L~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~  194 (229)
T 2yle_A          150 IDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK  194 (229)
T ss_dssp             HHHHTTCCC--------------------CCSCCCCCCSHHHHHH
T ss_pred             HHHHHhcccccccccccccccccccccccccccccCcCCHHHHHH
Confidence            9999765                         3468889998884

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.18  E-value=1.3e-05  Score=71.97  Aligned_cols=82  Identities=13%  Similarity=0.146  Sum_probs=47.0

Q ss_pred             HhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccccc-cccccccCCcccCCCCCCCCCCCcchhHHHHHHH
Q 020657          167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSY-VGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLT  245 (323)
Q Consensus       167 h~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~l  245 (323)
                      +...++|||+++.||+++.++  +.++||+.+.......+..... .....|.+|+......  ........++......
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~--~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  305 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS--TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQE--NDRKEYKQWILRTIEQ  305 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC--EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSS--CCSHHHHHHHHHHHHH
T ss_pred             CCCeEEecCCCCCcEEEeCCC--CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccc--cchHHHHHHHHHHHHH
Confidence            356899999999999998764  9999999885432211111100 0112345554432110  1111224556677777


Q ss_pred             HHHHHhC
Q 020657          246 LLELYLG  252 (323)
Q Consensus       246 l~~lltg  252 (323)
                      +|+.+++
T Consensus       306 ~~~~y~~  312 (420)
T 2pyw_A          306 TWNLFNK  312 (420)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            8877754

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=98.09  E-value=1.2e-05  Score=68.77  Aligned_cols=71  Identities=10%  Similarity=0.063  Sum_probs=43.6

Q ss_pred             eeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCcc-ceeceeEEcCCCeEEEEEecc-C
Q 020657           56 LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI-VQCFGIFEKPSGDIAILMEYM-D  133 (323)
Q Consensus        56 ~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~lv~e~~-~  133 (323)
                      ++.|+.|....+|++      +.+++|+.......  .....+|+.+++.+...++ .+++....   ..-++++||+ +
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~~~---~~~~~v~e~i~~   91 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHVDP---ATGVMVTRYIAG   91 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEECT---TTCCEEEECCTT
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEEEC---CCCEEEEeecCC
Confidence            788999999999998      45889998643211  1122457777766632223 45554432   2346899999 6


Q ss_pred             CCCH
Q 020657          134 SGTL  137 (323)
Q Consensus       134 ~~sL  137 (323)
                      |.++
T Consensus        92 g~~l   95 (301)
T 3dxq_A           92 AQTM   95 (301)
T ss_dssp             CEEC
T ss_pred             CccC
Confidence            6544

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.08  E-value=4.9e-05  Score=65.12  Aligned_cols=78  Identities=15%  Similarity=0.188  Sum_probs=59.6

Q ss_pred             cceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCC---CCccceeceeEEcCCCeEEEEE
Q 020657           53 LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD---SPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        53 ~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      ..-.+.|+.|....+|+...  ++..+++|+....    ....+..|+..++.|.   ...+++++.+... .+..++||
T Consensus        38 i~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-~g~~~lvm  110 (312)
T 3jr1_A           38 IKHKEKLYSGEMNEIWLIND--EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNS-QGHSFLLL  110 (312)
T ss_dssp             CCEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-SSEEEEEE
T ss_pred             eeeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-CCceEEEE
Confidence            34567899999999999986  4677889987532    2456778888888773   3567888887766 57899999


Q ss_pred             eccCCCCH
Q 020657          130 EYMDSGTL  137 (323)
Q Consensus       130 e~~~~~sL  137 (323)
                      ||+++..+
T Consensus       111 e~l~G~~~  118 (312)
T 3jr1_A          111 EALNKSKN  118 (312)
T ss_dssp             ECCCCCCC
T ss_pred             EeccCCCC
Confidence            99998754

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.99  E-value=4.5e-05  Score=64.62  Aligned_cols=83  Identities=17%  Similarity=0.160  Sum_probs=58.2

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCC---CccceeceeEEcCCC
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS---PFIVQCFGIFEKPSG  123 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~~~~  123 (323)
                      .+...+..-+..+|.|..+.||+.+.. +|+.+++|+...... .....+..|+..|+.|..   -.+++++++.   . 
T Consensus        11 ~l~G~~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~-~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---~-   84 (288)
T 3f7w_A           11 ELTGREVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAP-ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD---D-   84 (288)
T ss_dssp             HHHCCCEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCC-CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---T-
T ss_pred             HhcCCCeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCc-chhhHHHHHHHHHHHHHhhCCCCcceEEecc---C-
Confidence            455677788899999999999999875 788999998764422 222346688888888742   2344455432   2 


Q ss_pred             eEEEEEeccCCCC
Q 020657          124 DIAILMEYMDSGT  136 (323)
Q Consensus       124 ~~~lv~e~~~~~s  136 (323)
                       .++||||+.+..
T Consensus        85 -~~lv~e~l~~~~   96 (288)
T 3f7w_A           85 -RTLAMEWVDERP   96 (288)
T ss_dssp             -TEEEEECCCCCC
T ss_pred             -ceEEEEeecccC
Confidence             278999987654

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.88  E-value=7.3e-05  Score=64.30  Aligned_cols=139  Identities=14%  Similarity=0.158  Sum_probs=75.9

Q ss_pred             eeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCc--cceecee------EEcCCCeEE
Q 020657           55 KLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF--IVQCFGI------FEKPSGDIA  126 (323)
Q Consensus        55 ~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~------~~~~~~~~~  126 (323)
                      -++.|+.|....+|++...  +..+++|+......   ...+..|+.+++.|...+  +.+++..      ... .+..+
T Consensus        26 ~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~-~g~~~   99 (322)
T 2ppq_A           26 SYKGIAEGVENSNFLLHTT--KDPLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL-SGRPA   99 (322)
T ss_dssp             EEEEECC---EEEEEEEES--SCCEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE-TTEEE
T ss_pred             EeeccCCCcccceEEEEeC--CccEEEEEeCCCCC---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEE-CCEEE
Confidence            3567778888999998764  33688999865311   123445667666653212  3333321      111 35678


Q ss_pred             EEEeccCCCCHH-----H------HH---Hh-cCC--------CC---HHHHHH------------HHHHHHHHHHHHHh
Q 020657          127 ILMEYMDSGTLD-----T------LL---NK-NGT--------FS---EPKLAH------------IASQILKGLSYLHG  168 (323)
Q Consensus       127 lv~e~~~~~sL~-----~------~l---~~-~~~--------~~---~~~~~~------------i~~~i~~~l~~Lh~  168 (323)
                      +++++++|.++.     .      .+   +. ...        ..   +.....            +...+.+.+..+..
T Consensus       100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~  179 (322)
T 2ppq_A          100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA  179 (322)
T ss_dssp             EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred             EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence            999999876431     1      11   11 001        01   011000            00113344555542


Q ss_pred             -------CCCeecCCCCCCeEEecCCCcEEEeecCcchh
Q 020657          169 -------HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       169 -------~givH~di~~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                             .+++|+|+++.||+++.++ .+.++||+.+..
T Consensus       180 ~~~~~~~~~liHgDl~~~Nil~~~~~-~~~lIDf~~a~~  217 (322)
T 2ppq_A          180 HWPKDLPAGVIHADLFQDNVFFLGDE-LSGLIDFYFACN  217 (322)
T ss_dssp             HCCCSSCEEEECSCCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred             hCcccCCcccCCCCCCccCEEEeCCc-eEEEecchhccC
Confidence                   3799999999999998764 457999998853

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.83  E-value=3.5e-05  Score=67.84  Aligned_cols=141  Identities=16%  Similarity=0.201  Sum_probs=82.7

Q ss_pred             cccceeeeecccCCeEEEEEEecc-------cCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCc-cceeceeEEcCC
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRC-------THKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF-IVQCFGIFEKPS  122 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~  122 (323)
                      +.++ ++.|..|....+|++....       +++.+++|+.....  .....+.+|..+++.|..-+ ..++++.+.+  
T Consensus        51 ~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~--~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~--  125 (379)
T 3feg_A           51 EELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL--QGVDSLVLESVMFAILAERSLGPQLYGVFPE--  125 (379)
T ss_dssp             GGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT--
T ss_pred             CceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc--chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC--
Confidence            3444 4567788888999988642       35789999974321  12345568888888774222 3556665542  


Q ss_pred             CeEEEEEeccCCCCHHH--------------HHH---h-----cCCCC--HHHHHHHHHHHHH-----------------
Q 020657          123 GDIAILMEYMDSGTLDT--------------LLN---K-----NGTFS--EPKLAHIASQILK-----------------  161 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~--------------~l~---~-----~~~~~--~~~~~~i~~~i~~-----------------  161 (323)
                         .+||||++|.++..              .+.   .     .+...  ...+..|..++-.                 
T Consensus       126 ---g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l  202 (379)
T 3feg_A          126 ---GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSL  202 (379)
T ss_dssp             ---EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTH
T ss_pred             ---ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHH
Confidence               39999998765421              111   1     11112  3455556554422                 


Q ss_pred             --HHHHHH----hC----CCeecCCCCCCeEEecC----CCcEEEeecCcchh
Q 020657          162 --GLSYLH----GH----KIIHRDIKPSNLLVNNN----NMQVKIADFGVSKI  200 (323)
Q Consensus       162 --~l~~Lh----~~----givH~di~~~nil~~~~----~~~~kl~Dfg~~~~  200 (323)
                        .+..|.    ..    .++|+|+.+.||+++.+    + .+.++||..+..
T Consensus       203 ~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~-~~~~IDwE~a~~  254 (379)
T 3feg_A          203 KDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENAD-SLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---C-CEEECCCTTCEE
T ss_pred             HHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccC-cEEEEecccCCc
Confidence              223332    22    58999999999999876    4 799999999853

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.82  E-value=5.9e-05  Score=67.77  Aligned_cols=74  Identities=16%  Similarity=0.254  Sum_probs=49.3

Q ss_pred             eeeeecccCCeEEEEEEecc-------cCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCcc-ceeceeEEcCCCeEE
Q 020657           55 KLQVLGHGNGGTVYKVQHRC-------THKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI-VQCFGIFEKPSGDIA  126 (323)
Q Consensus        55 ~~~~lg~G~~~~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~  126 (323)
                      .+..|+.|....+|++....       +++.+++|+......   ...+.+|..+++.|...++ +++++.+.+     .
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~-----g  148 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFSG-----G  148 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT-----E
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC-----C
Confidence            45678889999999998642       257899999854221   1334478888887743333 556665432     3


Q ss_pred             EEEeccCCCC
Q 020657          127 ILMEYMDSGT  136 (323)
Q Consensus       127 lv~e~~~~~s  136 (323)
                      +|+||++|.+
T Consensus       149 ~v~e~l~G~~  158 (429)
T 1nw1_A          149 RLEEYIPSRP  158 (429)
T ss_dssp             EEECCCCEEE
T ss_pred             EEEEEeCCcc
Confidence            8999998643

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.78  E-value=9.5e-05  Score=63.97  Aligned_cols=137  Identities=13%  Similarity=0.154  Sum_probs=70.6

Q ss_pred             eeeecccCCeE-EEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCC--CccceeceeEEcCCCeEEEEEecc
Q 020657           56 LQVLGHGNGGT-VYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS--PFIVQCFGIFEKPSGDIAILMEYM  132 (323)
Q Consensus        56 ~~~lg~G~~~~-v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~~lv~e~~  132 (323)
                      ++.|+.|.... +|+.... +++.+++|.......    ..+..|+.+++.+..  -.+.+++.+... .+  +++||++
T Consensus        23 ~~~l~gg~s~~~~~r~~~~-~~~~~vlk~~~~~~~----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~-~g--~ll~e~l   94 (333)
T 3csv_A           23 RTPLAGDASSRRYQRLRSP-TGAKAVLMDWSPEEG----GDTQPFVDLAQYLRNLDISAPEIYAEEHA-RG--LLLIEDL   94 (333)
T ss_dssp             ECC--------CCEEEECT-TCCEEEEEECCTTTT----CCSHHHHHHHHHHHHTTCBCCCEEEEETT-TT--EEEECCC
T ss_pred             eeECCCCCCCceEEEEEcC-CCCeEEEEECCCCCC----ccccHHHHHHHHHHhCCCCCCceeeecCC-CC--EEEEeeC
Confidence            34566665554 5666542 356777877543321    223356666665532  234556655322 33  6899999


Q ss_pred             CCCCHHHHHHhc--------------------------CCCCHHHHH-------HHH-------------HHHHHHHHHH
Q 020657          133 DSGTLDTLLNKN--------------------------GTFSEPKLA-------HIA-------------SQILKGLSYL  166 (323)
Q Consensus       133 ~~~sL~~~l~~~--------------------------~~~~~~~~~-------~i~-------------~~i~~~l~~L  166 (323)
                      .+.++.+++...                          +.++.....       .+.             ..+...+..+
T Consensus        95 ~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l  174 (333)
T 3csv_A           95 GDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQI  174 (333)
T ss_dssp             CSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHH
T ss_pred             CCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence            876665443210                          112221111       000             1111222333


Q ss_pred             ------HhCCCeecCCCCCCeEEecC----CCcEEEeecCcchhh
Q 020657          167 ------HGHKIIHRDIKPSNLLVNNN----NMQVKIADFGVSKIM  201 (323)
Q Consensus       167 ------h~~givH~di~~~nil~~~~----~~~~kl~Dfg~~~~~  201 (323)
                            +...++|||+.+.||+++.+    + .+.|+||+.+...
T Consensus       175 ~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~-~~~lIDf~~a~~G  218 (333)
T 3csv_A          175 LSAQLEGDMVFVHRDFHAQNLLWLPEREGLA-RVGVIDFQDAKLG  218 (333)
T ss_dssp             HHHHCCSCCEEECSCCSGGGEEECTTSCGGG-GEEECCCTTCEEE
T ss_pred             HHhcccCCCeeEeCCcCcccEEeccCcCCCC-CeEEEeCCCcCcC
Confidence                  23479999999999999874    4 7899999998643

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.68  E-value=0.00031  Score=60.51  Aligned_cols=75  Identities=11%  Similarity=0.142  Sum_probs=46.3

Q ss_pred             eeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCC--ccceecee-----EEcCCCeEEEEE
Q 020657           57 QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSP--FIVQCFGI-----FEKPSGDIAILM  129 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~-----~~~~~~~~~lv~  129 (323)
                      ..++ |....+|++... +|+.+++|+......  ....+..|..+++.+...  .++.++..     ... .+..+++|
T Consensus        32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~-~g~~~~l~  106 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNH-QGFYFAVF  106 (328)
T ss_dssp             EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEE-TTEEEEEE
T ss_pred             Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEE-CCEEEEEE
Confidence            4566 788899988764 466789999864321  123455677777766321  23444432     112 45668899


Q ss_pred             eccCCCC
Q 020657          130 EYMDSGT  136 (323)
Q Consensus       130 e~~~~~s  136 (323)
                      ++++|.+
T Consensus       107 ~~i~G~~  113 (328)
T 1zyl_A          107 PSVGGRQ  113 (328)
T ss_dssp             ECCCCEE
T ss_pred             EecCCCC
Confidence            9998754

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.60  E-value=0.0001  Score=64.73  Aligned_cols=74  Identities=12%  Similarity=0.192  Sum_probs=43.5

Q ss_pred             eeeecccCCeEEEEEEeccc--------CcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCc-cceeceeEEcCCCeEE
Q 020657           56 LQVLGHGNGGTVYKVQHRCT--------HKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF-IVQCFGIFEKPSGDIA  126 (323)
Q Consensus        56 ~~~lg~G~~~~v~~~~~~~~--------~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~~  126 (323)
                      +..++.|....+|++.....        ++.+++|+......  .......|..+++.+...+ ..++++..   .+  +
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~~~~E~~~l~~L~~~g~~P~~~~~~---~~--~  110 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD--ELYNTISEFEVYKTMSKYKIAPQLLNTF---NG--G  110 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG--GTSCHHHHHHHHHHHHHTTSSCCEEEEE---TT--E
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc--ceecHHHHHHHHHHHHhcCCCCceEEec---CC--c
Confidence            56778888899999986531        26888998754321  1112356777777764333 44566543   22  6


Q ss_pred             EEEeccCCCC
Q 020657          127 ILMEYMDSGT  136 (323)
Q Consensus       127 lv~e~~~~~s  136 (323)
                      +||+|++|.+
T Consensus       111 ~v~e~i~G~~  120 (369)
T 3c5i_A          111 RIEEWLYGDP  120 (369)
T ss_dssp             EEEECCCSEE
T ss_pred             EEEEEecCCc
Confidence            8999998754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.59  E-value=0.00039  Score=62.84  Aligned_cols=76  Identities=20%  Similarity=0.249  Sum_probs=48.2

Q ss_pred             eeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCcc-ceeceeEEcCCCeEEEEEeccC
Q 020657           55 KLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI-VQCFGIFEKPSGDIAILMEYMD  133 (323)
Q Consensus        55 ~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~lv~e~~~  133 (323)
                      .+..|+.|....+|++.....+..+++|+........  -...+|..+++.|...++ .++++.+.  .   .+|+||++
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~--idR~~E~~vl~~L~~~gl~P~ll~~~~--~---G~v~e~I~  184 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI--INREREKKISCILYNKNIAKKIYVFFT--N---GRIEEFMD  184 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC--SCHHHHHHHHHHHTTSSSBCCEEEEET--T---EEEEECCC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh--cCHHHHHHHHHHHHhcCCCCCEEEEeC--C---eEEEEeeC
Confidence            3567888999999999875334788999985432111  112478888888865444 55666653  2   35999998


Q ss_pred             CCCH
Q 020657          134 SGTL  137 (323)
Q Consensus       134 ~~sL  137 (323)
                      |.++
T Consensus       185 G~~l  188 (458)
T 2qg7_A          185 GYAL  188 (458)
T ss_dssp             SEEC
T ss_pred             CccC
Confidence            7544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.50  E-value=0.0014  Score=56.71  Aligned_cols=31  Identities=29%  Similarity=0.488  Sum_probs=26.9

Q ss_pred             CCCeecCCCCCCeEEecCCCcEEEeecCcchh
Q 020657          169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       169 ~givH~di~~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                      .+++|+|+.+.||+++.++ .+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~-~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEE-SIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGG-CEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCC-eEEEEECCCCee
Confidence            3699999999999998765 799999988754

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=97.01  E-value=0.0011  Score=59.17  Aligned_cols=76  Identities=12%  Similarity=0.139  Sum_probs=47.9

Q ss_pred             eeeeecccCCeEEEEEEeccc-------CcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCc-cceeceeEEcCCCeEE
Q 020657           55 KLQVLGHGNGGTVYKVQHRCT-------HKIYALKVVHGDADPTVRRQVFREMEILRRTDSPF-IVQCFGIFEKPSGDIA  126 (323)
Q Consensus        55 ~~~~lg~G~~~~v~~~~~~~~-------~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~~  126 (323)
                      -+..+..|....+|+......       ++.+++|+.......  .-...+|..+++.+..-+ ..++++.+.   +  +
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~--~idR~~E~~~l~~L~~~gi~P~l~~~~~---~--~  146 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK--FYDSKVELDVFRYLSNINIAPNIIADFP---E--G  146 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C--CCCHHHHHHHHHHHHHTTSSCCEEEEET---T--E
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch--hcCHHHHHHHHHHHHhcCCCCCEEEEcC---C--C
Confidence            356777888899999987421       578999997543211  112346777777764222 345555332   2  6


Q ss_pred             EEEeccCCCCH
Q 020657          127 ILMEYMDSGTL  137 (323)
Q Consensus       127 lv~e~~~~~sL  137 (323)
                      +|++|++|.+|
T Consensus       147 ~I~efI~G~~l  157 (424)
T 3mes_A          147 RIEEFIDGEPL  157 (424)
T ss_dssp             EEEECCCSEEC
T ss_pred             EEEEEeCCccC
Confidence            89999998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=96.86  E-value=0.0039  Score=55.34  Aligned_cols=30  Identities=23%  Similarity=0.418  Sum_probs=24.4

Q ss_pred             CeecCCCCCCeEEec-----CCCcEEEeecCcchh
Q 020657          171 IIHRDIKPSNLLVNN-----NNMQVKIADFGVSKI  200 (323)
Q Consensus       171 ivH~di~~~nil~~~-----~~~~~kl~Dfg~~~~  200 (323)
                      ++|+|+.+.||++.+     ++..+.++||.+|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            689999999999943     223799999999954

>1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3

Probab=89.34  E-value=5.6  Score=33.81  Aligned_cols=147  Identities=13%  Similarity=0.185  Sum_probs=79.5

Q ss_pred             ccchhccccc---cceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceecee--
Q 020657           43 ATTAAIAYSD---LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGI--  117 (323)
Q Consensus        43 ~~~~~~~~~~---~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~--  117 (323)
                      .....+.++.   +..++....|..|.++...   ++..++||-..    ....+.+.-++...-.+.-|...-+.-.  
T Consensus        58 ~~i~~i~w~~l~~v~~I~~s~~Gstgvff~~t---d~~~~VVK~s~----~l~~E~l~s~LA~~LGlpiP~~Riv~~~~~  130 (342)
T 1cja_A           58 NDIGDINWKNLQQFKGIERSEKGTEGLFFVET---ESGVFIVKRST----NIESETFCSLLCMRLGLHAPKVRVVSSNSE  130 (342)
T ss_dssp             SCTTCCCTTCGGGEEEEEECCSTTSCEEEEEE---SSCEEEEECCT----THHHHHHHHHHHHHHTCCCCCEEEEESSSH
T ss_pred             CcccccccccccCeeEEEeccCCCCCeEEEEe---CCCEEEEeCcH----HHHHHHHHHHHHHHhCCCCCCeeEEeeCcH
Confidence            4557777777   6677777888766544444   46788899541    2233334444443333445542221110  


Q ss_pred             -----------EEc--------CCCeEEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHH--HHHHHHHHhCC----
Q 020657          118 -----------FEK--------PSGDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQI--LKGLSYLHGHK----  170 (323)
Q Consensus       118 -----------~~~--------~~~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i--~~~l~~Lh~~g----  170 (323)
                                 +..        ..+...++|+|.+|..|...-..  ...+..    ....++  +-+++.+...+    
T Consensus       131 E~~e~~~~L~~~~~~~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~~----~~~k~LG~Ii~FDi~InN~DR~P  206 (342)
T 1cja_A          131 EGTNMLECLAAIDKSFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTK----STMQQLGSLMALDVIVNNSDRLP  206 (342)
T ss_dssp             HHHHHHHHHHHHCSSSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCH----HHHHHHHHHHHHHHHHTCCSSSC
T ss_pred             HHHHHHHHHHHhhhhhHHHHHhhcccceehhhhcCCCccccchhhhhhhhcCH----HHHHhhchhheehhhhcCCccCc
Confidence                       000        12356799999987665532110  011222    223333  23455555542    


Q ss_pred             Ce-ecCCCCCCeEEecCCCcEEEeecCcchh
Q 020657          171 II-HRDIKPSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       171 iv-H~di~~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                      .+ +..-.+.||+++.++..+.++|-+.+..
T Consensus       207 l~W~n~GN~~NIL~~~~n~~~~~IDhn~af~  237 (342)
T 1cja_A          207 IAWTNEGNLDNIMLSERGATVVPIDSKIIPL  237 (342)
T ss_dssp             SSSCSCCCGGGEEEESBTTCEEECSCCCCCC
T ss_pred             ccccCCCChhheEEeCCCCeEEEEcCCcccc
Confidence            11 1235788999988765689999988844

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=82.25  E-value=0.11  Score=46.93  Aligned_cols=62  Identities=10%  Similarity=-0.001  Sum_probs=16.5

Q ss_pred             eeeeecccCCeEEEEEEecccCcEEEE------EeecCC-CChHHHHHHHHHHHHHHcCCCCccceeceeEE
Q 020657           55 KLQVLGHGNGGTVYKVQHRCTHKIYAL------KVVHGD-ADPTVRRQVFREMEILRRTDSPFIVQCFGIFE  119 (323)
Q Consensus        55 ~~~~lg~G~~~~v~~~~~~~~~~~v~i------K~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  119 (323)
                      +.+.||   ||.||.|.+......||+      |..... .+.+....+.+|..+++.++|+|+++.+++..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            345555   999999998655567777      655432 22333456778888888899999999887643

>2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A*

Probab=81.35  E-value=21  Score=33.67  Aligned_cols=44  Identities=25%  Similarity=0.296  Sum_probs=31.2

Q ss_pred             HHHHHHHHHH--HHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcch
Q 020657          151 KLAHIASQIL--KGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       151 ~~~~i~~~i~--~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                      ....++..+|  ..+.|+=..    ||=+++||+++.+| .+.=+|||.+.
T Consensus       530 ar~nF~~SlA~~Svv~YILGl----GDRH~~NILid~tG-~v~HIDFG~~f  575 (696)
T 2x6h_A          530 VMDTYIKSCAGYCVITYLLGV----GDRHLDNLLLTTNG-KLFHIDFGYIL  575 (696)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTC----CCCCTTTEEECTTS-CEEECCCCSCT
T ss_pred             HHHHHHHHHHHHHHHHHHccC----CCCCCcceEEeCCC-CEEEEeehhhh
Confidence            4445555544  345555433    48899999999887 89999999874

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	323
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-81
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-80
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	5e-77
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	9e-77
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-76
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-75
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-75
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-73
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-71
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-71
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	8e-71
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-69
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	6e-69
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-67
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-67
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	6e-67
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-66
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-65
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-64
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-63
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-63
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-63
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	8e-63
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-61
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-60
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-60
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-60
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	7e-60
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-59
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-59
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-59
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-58
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-58
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-58
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-58
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	7e-58
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	7e-58
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-57
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-57
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-57
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-57
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-56
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-56
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-56
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	8e-56
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-55
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-55
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-55
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	6e-55
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-55
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-54
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-54
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-53
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-53
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-52
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-52
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-52
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-50
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-49
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-48
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	9e-48
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-38
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-22

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  247 bits (631), Expect = 1e-81
 Identities = 87/268 (32%), Positives = 137/268 (51%), Gaps = 10/268 (3%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           E +  LG G  G VYK Q++ T  + A KV+              E++IL   D P IV+
Sbjct: 15  EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVK 73

Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKII 172
               F     ++ IL+E+   G +D ++ +     +E ++  +  Q L  L+YLH +KII
Sbjct: 74  LLDAFYYE-NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKII 132

Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNY 232
           HRD+K  N+L    +  +K+ADFGVS    R++   +S++GT  +M+PE    +      
Sbjct: 133 HRDLKAGNILF-TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 191

Query: 233 NGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSL--PDGASPEFRS 290
             Y  D+WSLG+TL+E+     P        +   ++  I   +PP+L  P   S  F+ 
Sbjct: 192 YDYKADVWSLGITLIEMAEIEPPH----HELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 247

Query: 291 FIECCLQKEFSKRWTASQLLTHPFLCKN 318
           F++ CL+K    RWT SQLL HPF+  +
Sbjct: 248 FLKKCLEKNVDARWTTSQLLQHPFVTVD 275

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  244 bits (624), Expect = 5e-80
 Identities = 111/315 (35%), Positives = 166/315 (52%), Gaps = 49/315 (15%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           +   D EK+  LG GNGG V+KV H+ +  + A K++H +  P +R Q+ RE+++L   +
Sbjct: 3   LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 62

Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
           SP+IV  +G F    G+I+I ME+MD G+LD +L K G   E  L  ++  ++KGL+YL 
Sbjct: 63  SPYIVGFYGAFYSD-GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121

Query: 168 -GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPD 226
             HKI+HRD+KPSN+LV N+  ++K+ DFGVS  +  S+   NS+VGT +YMSPER    
Sbjct: 122 EKHKIMHRDVKPSNILV-NSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERL--- 175

Query: 227 AYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMC---------------- 270
             G +Y     DIWS+GL+L+E+ +G +P   P  +       C                
Sbjct: 176 -QGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233

Query: 271 ----------------------AICFGDPPSLPDGA-SPEFRSFIECCLQKEFSKRWTAS 307
                                  I    PP LP G  S EF+ F+  CL K  ++R    
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293

Query: 308 QLLTHPFLCKNRRSD 322
           QL+ H F+ ++   +
Sbjct: 294 QLMVHAFIKRSDAEE 308

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  234 bits (599), Expect = 5e-77
 Identities = 73/275 (26%), Positives = 123/275 (44%), Gaps = 21/275 (7%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTDSPF 110
           D E L  +G G+ G   K++ +   KI   K +  G      ++ +  E+ +LR    P 
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 111 IVQCFGIF-EKPSGDIAILMEYMDSGTLDTLLNKN----GTFSEPKLAHIASQILKGLSY 165
           IV+ +    ++ +  + I+MEY + G L +++ K         E  +  + +Q+   L  
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 166 LH-----GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSP 220
            H     GH ++HRD+KP+N+ ++     VK+ DFG+++I+        ++VGT  YMSP
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183

Query: 221 ERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSL 280
           E+ +  +Y         DIWSLG  L EL     PF           L   I  G    +
Sbjct: 184 EQMNRMSYN-----EKSDIWSLGCLLYELCALMPPF----TAFSQKELAGKIREGKFRRI 234

Query: 281 PDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
           P   S E    I   L  +   R +  ++L +P +
Sbjct: 235 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  235 bits (601), Expect = 9e-77
 Identities = 82/269 (30%), Positives = 132/269 (49%), Gaps = 15/269 (5%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH--GDADPTVRRQVFREMEILRRTDSPFI 111
             L+ +GHG+ G VY  +     ++ A+K +   G       + + +E+  L++   P  
Sbjct: 18  SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 77

Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
           +Q  G + +      ++MEY      D L        E ++A +    L+GL+YLH H +
Sbjct: 78  IQYRGCYLRE-HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136

Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGN 231
           IHRD+K  N+L+ +    VK+ DFG + IM  +    NS+VGT  +M+PE       G  
Sbjct: 137 IHRDVKAGNILL-SEPGLVKLGDFGSASIMAPA----NSFVGTPYWMAPEVILAMDEGQ- 190

Query: 232 YNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA-SPEFRS 290
           Y+G   D+WSLG+T +EL     P        +  + +  I   + P+L  G  S  FR+
Sbjct: 191 YDGKV-DVWSLGITCIELAERKPPL----FNMNAMSALYHIAQNESPALQSGHWSEYFRN 245

Query: 291 FIECCLQKEFSKRWTASQLLTHPFLCKNR 319
           F++ CLQK    R T+  LL H F+ + R
Sbjct: 246 FVDSCLQKIPQDRPTSEVLLKHRFVLRER 274

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  233 bits (596), Expect = 1e-76
 Identities = 79/270 (29%), Positives = 121/270 (44%), Gaps = 16/270 (5%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDS 108
            D E  + LG G  G VY  + + +  I ALKV+         V  Q+ RE+EI      
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           P I++ +G F      + +++EY   GT+   L K   F E + A   +++   LSY H 
Sbjct: 66  PNILRLYGYFHDA-TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124

Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAY 228
            ++IHRDIKP NLL+ +   ++KIADFG S           +  GT  Y+ PE  +   +
Sbjct: 125 KRVIHRDIKPENLLLGSAG-ELKIADFGWSVHA--PSSRRTTLCGTLDYLPPEMIEGRMH 181

Query: 229 GGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEF 288
                    D+WSLG+   E  +G  PF    +   +      I   +    PD  +   
Sbjct: 182 -----DEKVDLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFT-FPDFVTEGA 231

Query: 289 RSFIECCLQKEFSKRWTASQLLTHPFLCKN 318
           R  I   L+   S+R    ++L HP++  N
Sbjct: 232 RDLISRLLKHNPSQRPMLREVLEHPWITAN 261

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  230 bits (588), Expect = 2e-75
 Identities = 61/269 (22%), Positives = 104/269 (38%), Gaps = 10/269 (3%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
           D + +Q LG G  G V    +R T +  A+K+V           + +E+ I +  +   +
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65

Query: 112 VQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKI 171
           V+ +G   +      + +EY   G L   +  +    EP       Q++ G+ YLHG  I
Sbjct: 66  VKFYGHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124

Query: 172 IHRDIKPSNLLVNNNNMQVKIADFGVSKIM--CRSLDACNSYVGTCAYMSPERFDPDAYG 229
            HRDIKP NLL+ +    +KI+DFG++ +          N   GT  Y++PE        
Sbjct: 125 THRDIKPENLLL-DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL----KR 179

Query: 230 GNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFR 289
             ++    D+WS G+ L  +  G  P+                      +          
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237

Query: 290 SFIECCLQKEFSKRWTASQLLTHPFLCKN 318
           + +   L +  S R T   +    +  K 
Sbjct: 238 ALLHKILVENPSARITIPDIKKDRWYNKP 266

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  229 bits (585), Expect = 6e-75
 Identities = 72/272 (26%), Positives = 119/272 (43%), Gaps = 18/272 (6%)

Query: 50  YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTDS 108
           +   +    +G G+  TVYK     T    A   +       + R++   E E+L+    
Sbjct: 10  FLKFDI--EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH 67

Query: 109 PFIVQCFGIFE---KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSY 165
           P IV+ +  +E   K    I ++ E M SGTL T L +        L     QILKGL +
Sbjct: 68  PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF 127

Query: 166 LH--GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF 223
           LH     IIHRD+K  N+ +      VKI D G++ +   S     + +GT  +M+PE +
Sbjct: 128 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFMAPEMY 185

Query: 224 DPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDG 283
           +       Y+  + D+++ G+ +LE+    +P+     +              P S    
Sbjct: 186 E-----EKYD-ESVDVYAFGMCMLEMATSEYPY--SECQNAAQIYRRVTSGVKPASFDKV 237

Query: 284 ASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
           A PE +  IE C+++   +R++   LL H F 
Sbjct: 238 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (576), Expect = 3e-73
 Identities = 74/266 (27%), Positives = 128/266 (48%), Gaps = 11/266 (4%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
            + + +G G  GTVY      T +  A++ ++    P  +  +  E+ ++R   +P IV 
Sbjct: 23  TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVN 81

Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
               +     ++ ++MEY+  G+L  ++ +     E ++A +  + L+ L +LH +++IH
Sbjct: 82  YLDSYLVG-DELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIH 139

Query: 174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYN 233
           RDIK  N+L+   +  VK+ DFG    +       ++ VGT  +M+PE     AY     
Sbjct: 140 RDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY----- 193

Query: 234 GYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIE 293
           G   DIWSLG+  +E+  G  P+    + P  A  + A         P+  S  FR F+ 
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPY--LNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251

Query: 294 CCLQKEFSKRWTASQLLTHPFLCKNR 319
            CL  +  KR +A +LL H FL   +
Sbjct: 252 RCLDMDVEKRGSAKELLQHQFLKIAK 277

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  221 bits (564), Expect = 2e-71
 Identities = 74/274 (27%), Positives = 124/274 (45%), Gaps = 16/274 (5%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +   VLG G    V   + + T K+ A+K +   A       +  E+ +L +   P IV 
Sbjct: 12  DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVA 71

Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
              I+E   G + ++M+ +  G L   + + G ++E   + +  Q+L  + YLH   I+H
Sbjct: 72  LDDIYESG-GHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVH 130

Query: 174 RDIKPSNLLVN--NNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGN 231
           RD+KP NLL    + + ++ I+DFG+SK+        ++  GT  Y++PE      Y   
Sbjct: 131 RDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SVLSTACGTPGYVAPEVLAQKPY--- 186

Query: 232 YNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD---PPSLPDGASPEF 288
               A D WS+G+    L  G+ PF       + A L   I   +        D  S   
Sbjct: 187 --SKAVDCWSIGVIAYILLCGYPPF----YDENDAKLFEQILKAEYEFDSPYWDDISDSA 240

Query: 289 RSFIECCLQKEFSKRWTASQLLTHPFLCKNRRSD 322
           + FI   ++K+  KR+T  Q L HP++  +   D
Sbjct: 241 KDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALD 274

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  221 bits (565), Expect = 6e-71
 Identities = 65/267 (24%), Positives = 117/267 (43%), Gaps = 17/267 (6%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +  + LG G  G V++V  R T   +A K V      + +  V +E++ +     P +V 
Sbjct: 29  DIHEELGTGAFGVVHRVTERATGNNFAAKFVM-TPHESDKETVRKEIQTMSVLRHPTLVN 87

Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
               FE    ++ ++ E+M  G L   + +++   SE +      Q+ KGL ++H +  +
Sbjct: 88  LHDAFEDD-NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 146

Query: 173 HRDIKPSNLLVNNN-NMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGN 231
           H D+KP N++     + ++K+ DFG++  +     +     GT  + +PE  +       
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHL-DPKQSVKVTTGTAEFAAPEVAEGKPV--- 202

Query: 232 YNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD---PPSLPDGASPEF 288
             GY  D+WS+G+    L  G  PF       +    +  +   D     S   G S + 
Sbjct: 203 --GYYTDMWSVGVLSYILLSGLSPF----GGENDDETLRNVKSCDWNMDDSAFSGISEDG 256

Query: 289 RSFIECCLQKEFSKRWTASQLLTHPFL 315
           + FI   L  + + R T  Q L HP+L
Sbjct: 257 KDFIRKLLLADPNTRMTIHQALEHPWL 283

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  221 bits (565), Expect = 8e-71
 Identities = 70/277 (25%), Positives = 124/277 (44%), Gaps = 17/277 (6%)

Query: 50  YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSP 109
           Y   + L+ LG G  G V++   + T +++  K ++    P  +  V  E+ I+ +   P
Sbjct: 28  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN-TPYPLDKYTVKNEISIMNQLHHP 86

Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
            ++     FE    ++ +++E++  G L D +  ++   SE ++ +   Q  +GL ++H 
Sbjct: 87  KLINLHDAFEDK-YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 145

Query: 169 HKIIHRDIKPSNLLV-NNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDA 227
           H I+H DIKP N++        VKI DFG++  +    +       T  + +PE  D + 
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDREP 204

Query: 228 YGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD---PPSLPDGA 284
                 G+  D+W++G+    L  G  PF       D    +  +   D           
Sbjct: 205 V-----GFYTDMWAIGVLGYVLLSGLSPF----AGEDDLETLQNVKRCDWEFDEDAFSSV 255

Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS 321
           SPE + FI+  LQKE  KR T    L HP+L  +  +
Sbjct: 256 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 292

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  216 bits (550), Expect = 1e-69
 Identities = 72/279 (25%), Positives = 124/279 (44%), Gaps = 20/279 (7%)

Query: 50  YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH--------GDADPTVRRQVFREME 101
           Y + E  ++LG G    V +  H+ T K YA+K++          +    +R    +E++
Sbjct: 2   YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61

Query: 102 ILRRTDS-PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQIL 160
           ILR+    P I+Q    +E  +    ++ + M  G L   L +  T SE +   I   +L
Sbjct: 62  ILRKVSGHPNIIQLKDTYETNT-FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL 120

Query: 161 KGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSP 220
           + +  LH   I+HRD+KP N+L++++   +K+ DFG S  +    +      GT +Y++P
Sbjct: 121 EVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSCQLDPG-EKLREVCGTPSYLAP 178

Query: 221 ERFDPDAYGGN-YNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD--- 276
           E  +      +   G   D+WS G+ +  L  G  PF           ++  I  G+   
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF----WHRKQMLMLRMIMSGNYQF 234

Query: 277 PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
                D  S   +  +   L  +  KR+TA + L HPF 
Sbjct: 235 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (547), Expect = 6e-69
 Identities = 77/274 (28%), Positives = 127/274 (46%), Gaps = 22/274 (8%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSP 109
           D +  ++LG G+  TV   +   T + YA+K++             V RE +++ R D P
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           F V+ +  F+     +   + Y  +G L   + K G+F E       ++I+  L YLHG 
Sbjct: 69  FFVKLYFTFQDD-EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127

Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR--SLDACNSYVGTCAYMSPERFDPDA 227
            IIHRD+KP N+L+ N +M ++I DFG +K++         NS+VGT  Y+SPE     +
Sbjct: 128 GIIHRDLKPENILL-NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 186

Query: 228 YGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPE 287
                   + D+W+LG  + +L  G  PF    +  +   +   I   +    P+   P+
Sbjct: 187 A-----CKSSDLWALGCIIYQLVAGLPPF----RAGNEYLIFQKIIKLEYD-FPEKFFPK 236

Query: 288 FRSFIECCLQKEFSKRWTASQ------LLTHPFL 315
            R  +E  L  + +KR    +      L  HPF 
Sbjct: 237 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 270

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (540), Expect = 1e-67
 Identities = 65/274 (23%), Positives = 110/274 (40%), Gaps = 18/274 (6%)

Query: 50  YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSP 109
           Y      + LG G  G V++     + K Y  K V      T +  V +E+ IL      
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK--VKGTDQVLVKKEISILNIARHR 61

Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNG-TFSEPKLAHIASQILKGLSYLHG 168
            I+     FE    ++ ++ E++    +   +N +    +E ++     Q+ + L +LH 
Sbjct: 62  NILHLHESFESM-EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120

Query: 169 HKIIHRDIKPSNLLV-NNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDA 227
           H I H DI+P N++     +  +KI +FG ++ +    D          Y +PE      
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPE-----V 174

Query: 228 YGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD---PPSLPDGA 284
           +  +    A D+WSLG  +  L  G  PF           ++  I   +           
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPF----LAETNQQIIENIMNAEYTFDEEAFKEI 230

Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN 318
           S E   F++  L KE   R TAS+ L HP+L + 
Sbjct: 231 SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (536), Expect = 2e-67
 Identities = 69/270 (25%), Positives = 118/270 (43%), Gaps = 13/270 (4%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRT 106
           I    +   Q +G G+ GTVYK +    H   A+K+++  A  P   +    E+ +LR+T
Sbjct: 5   IPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61

Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQILKGLSY 165
               I+   G    P   +AI+ ++ +  +L   L      F   KL  IA Q  +G+ Y
Sbjct: 62  RHVNILLFMGYSTAP--QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 119

Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA--CNSYVGTCAYMSPERF 223
           LH   IIHRD+K +N+ + + ++ VKI DFG++ +  R   +       G+  +M+PE  
Sbjct: 120 LHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

Query: 224 DPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPD-WATLMCAICFGDPPSLPD 282
                  N   +  D+++ G+ L EL  G  P+     R      +       D   +  
Sbjct: 179 --RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 236

Query: 283 GASPEFRSFIECCLQKEFSKRWTASQLLTH 312
                 +  +  CL+K+  +R    Q+L  
Sbjct: 237 NCPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (537), Expect = 6e-67
 Identities = 76/275 (27%), Positives = 129/275 (46%), Gaps = 23/275 (8%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRR-TDSPFIVQCF 115
           QVLG G  G V ++ ++ T + +ALK++          +  RE+E+  R +  P IV+  
Sbjct: 18  QVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIV 71

Query: 116 GIFEKPSGD---IAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSYLHGHK 170
            ++E        + I+ME +D G L + +   G   F+E + + I   I + + YLH   
Sbjct: 72  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 131

Query: 171 IIHRDIKPSNLLVN--NNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAY 228
           I HRD+KP NLL      N  +K+ DFG +K    S ++  +   T  Y++PE   P+ Y
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKY 190

Query: 229 GGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD---PPSLPDGAS 285
                  + D+WSLG+ +  L  G+ PF           +   I  G    P       S
Sbjct: 191 -----DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 245

Query: 286 PEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR 320
            E +  I   L+ E ++R T ++ + HP++ ++ +
Sbjct: 246 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (530), Expect = 5e-66
 Identities = 68/268 (25%), Positives = 117/268 (43%), Gaps = 16/268 (5%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRT-DS 108
           D    ++LG G+ G V+  + + T++ +A+K +  D             E  +L    + 
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PF+   F  F+    ++  +MEY++ G L   +     F   +    A++I+ GL +LH 
Sbjct: 63  PFLTHMFCTFQTK-ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121

Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAY 228
             I++RD+K  N+L++ +    KIADFG+ K         N++ GT  Y++PE      Y
Sbjct: 122 KGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY 180

Query: 229 GGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEF 288
                 ++ D WS G+ L E+ +G  PF       D   L  +I   +P   P     E 
Sbjct: 181 -----NHSVDWWSFGVLLYEMLIGQSPF----HGQDEEELFHSIRMDNPF-YPRWLEKEA 230

Query: 289 RSFIECCLQKEFSKRWTA-SQLLTHPFL 315
           +  +     +E  KR      +  HP  
Sbjct: 231 KDLLVKLFVREPEKRLGVRGDIRQHPLF 258

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (520), Expect = 2e-65
 Identities = 61/268 (22%), Positives = 109/268 (40%), Gaps = 19/268 (7%)

Query: 47  AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRT 106
           A+   +L+ LQ +G G  G V    +R      A+K +  DA     +    E  ++ + 
Sbjct: 3   ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT---AQAFLAEASVMTQL 57

Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLS 164
               +VQ  G+  +  G + I+ EYM  G+L   L   G        L   +  + + + 
Sbjct: 58  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117

Query: 165 YLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFD 224
           YL G+  +HRD+   N+LV + +   K++DFG++K    +    ++      + +PE   
Sbjct: 118 YLEGNNFVHRDLAARNVLV-SEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALR 173

Query: 225 PDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
              +         D+WS G+ L E+Y        P  R     ++  +  G     PDG 
Sbjct: 174 EKKF-----STKSDVWSFGILLWEIYSFGRV---PYPRIPLKDVVPRVEKGYKMDAPDGC 225

Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTH 312
            P     ++ C   + + R +  QL   
Sbjct: 226 PPAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (516), Expect = 3e-64
 Identities = 76/289 (26%), Positives = 124/289 (42%), Gaps = 33/289 (11%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH----GDADPTVRRQVFREMEILRRTDSP 109
           EKL  LG G   TVYK + + T++I A+K +      +A   + R   RE+++L+    P
Sbjct: 1   EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60

Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
            I+     F     +I+++ ++M++     + + +   +   +       L+GL YLH H
Sbjct: 61  NIIGLLDAFGHK-SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119

Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYG 229
            I+HRD+KP+NLL+ + N  +K+ADFG++K       A    V T  Y +PE      +G
Sbjct: 120 WILHRDLKPNNLLL-DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL----LFG 174

Query: 230 GNYNGYAGDIWSLGLTLLELYLGHFPF------------------LQPGQRPDWATLMCA 271
               G   D+W++G  L EL L                           Q PD  +L   
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234

Query: 272 ICFGDPPSLP-----DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
           + F   P +P       A  +    I+         R TA+Q L   + 
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 283

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  203 bits (516), Expect = 2e-63
 Identities = 75/274 (27%), Positives = 129/274 (47%), Gaps = 20/274 (7%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH-----GDADPTVRRQVFREMEILRRT 106
           D    +++G G  G VY  +   T K+YA+K +           T+       + ++   
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 107 DSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
           D PFIV     F  P   ++ +++ M+ G L   L+++G FSE  +   A++I+ GL ++
Sbjct: 65  DCPFIVCMSYAFHTP-DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123

Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPD 226
           H   +++RD+KP+N+L+ + +  V+I+D G++    +        VGT  YM+PE     
Sbjct: 124 HNRFVVYRDLKPANILL-DEHGHVRISDLGLACDFSKKKPHA--SVGTHGYMAPEVLQ-- 178

Query: 227 AYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP 286
              G     + D +SLG  L +L  GH PF     +      +  +       LPD  SP
Sbjct: 179 --KGVAYDSSADWFSLGCMLFKLLRGHSPF--RQHKTKDKHEIDRMTLTMAVELPDSFSP 234

Query: 287 EFRSFIECCLQKEFSKRWT-----ASQLLTHPFL 315
           E RS +E  LQ++ ++R       A ++   PF 
Sbjct: 235 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 3e-63
 Identities = 68/270 (25%), Positives = 121/270 (44%), Gaps = 16/270 (5%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH-----GDADPTVRRQVFREMEILRRTDS 108
           +  + LG G    V K + + T   YA K +             R  + RE+ IL+    
Sbjct: 13  DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 72

Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           P ++    ++E    D+ +++E +  G L   L +  + +E +      QIL G+ YLH 
Sbjct: 73  PNVITLHEVYENK-TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131

Query: 169 HKIIHRDIKPSNLLVNNNNM---QVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDP 225
            +I H D+KP N+++ + N+   ++KI DFG++  +    +   +  GT  +++PE  + 
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAPEIVNY 190

Query: 226 DAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS 285
           +       G   D+WS+G+    L  G  PFL   ++   A  + A+ +          S
Sbjct: 191 EPL-----GLEADMWSIGVITYILLSGASPFLGDTKQETLA-NVSAVNYEFEDEYFSNTS 244

Query: 286 PEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
              + FI   L K+  KR T    L HP++
Sbjct: 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (508), Expect = 3e-63
 Identities = 62/267 (23%), Positives = 114/267 (42%), Gaps = 22/267 (8%)

Query: 58  VLGHGNGGTVYKVQHRC--THKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQC 114
            LG GN GTV K  ++     K  A+K++  +A DP ++ ++  E  ++++ D+P+IV+ 
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 115 FGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHR 174
            GI E  S    ++ME  + G L+  L +N    +  +  +  Q+  G+ YL     +HR
Sbjct: 74  IGICEAES--WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 131

Query: 175 DIKPSNLLVNNNNMQVKIADFGVSKIM---CRSLDACNSYVGTCAYMSPERFDPDAYGGN 231
           D+   N+L+       KI+DFG+SK +        A         + +PE  +       
Sbjct: 132 DLAARNVLL-VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN-----YY 185

Query: 232 YNGYAGDIWSLGLTLLE-LYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRS 290
                 D+WS G+ + E    G  P+    +    + +   +  G+    P G   E   
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPY----RGMKGSEVTAMLEKGERMGCPAGCPREMYD 241

Query: 291 FIECCLQKEFSKRWTASQL---LTHPF 314
            +  C   +   R   + +   L + +
Sbjct: 242 LMNLCWTYDVENRPGFAAVELRLRNYY 268

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 8e-63
 Identities = 61/269 (22%), Positives = 107/269 (39%), Gaps = 24/269 (8%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH-----GDADPTVRRQVFREMEILRRTDS 108
           +   +LG G  G+VY       +   A+K V         +     +V  E+ +L++  S
Sbjct: 7   QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66

Query: 109 --PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYL 166
               +++    FE+P   + IL        L   + + G   E        Q+L+ + + 
Sbjct: 67  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126

Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPD 226
           H   ++HRDIK  N+L++ N  ++K+ DFG   ++  +      + GT  Y  PE     
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIR-- 182

Query: 227 AYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASP 286
                Y+G +  +WSLG+ L ++  G  PF    +                       S 
Sbjct: 183 --YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG-----------QVFFRQRVSS 229

Query: 287 EFRSFIECCLQKEFSKRWTASQLLTHPFL 315
           E +  I  CL    S R T  ++  HP++
Sbjct: 230 ECQHLIRWCLALRPSDRPTFEEIQNHPWM 258

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 2e-61
 Identities = 73/271 (26%), Positives = 124/271 (45%), Gaps = 19/271 (7%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSP 109
           D + L++LG G  G V  V+ + T + YA+K++  +             E  +L+ T  P
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           F+      F+     +  +MEY + G L   L++   F+E +     ++I+  L YLH  
Sbjct: 66  FLTALKYAFQTH-DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124

Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYG 229
            +++RDIK  NL+++ +   +KI DFG+ K          ++ GT  Y++PE  + + Y 
Sbjct: 125 DVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY- 182

Query: 230 GNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFR 289
               G A D W LG+ + E+  G  PF       D   L   I   +    P   SPE +
Sbjct: 183 ----GRAVDWWGLGVVMYEMMCGRLPF----YNQDHERLFELILMEEIR-FPRTLSPEAK 233

Query: 290 SFIECCLQKEFSKRW-----TASQLLTHPFL 315
           S +   L+K+  +R       A +++ H F 
Sbjct: 234 SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  193 bits (492), Expect = 2e-60
 Identities = 70/272 (25%), Positives = 123/272 (45%), Gaps = 22/272 (8%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDS 108
            D + L+ LG G+ G V+ ++ R   + YA+KV+  +             E  +L     
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 109 PFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           PFI++ +G F+     I ++M+Y++ G L +LL K+  F  P     A+++   L YLH 
Sbjct: 64  PFIIRMWGTFQDA-QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122

Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAY 228
             II+RD+KP N+L+ + N  +KI DFG +K +    D   +  GT  Y++PE      Y
Sbjct: 123 KDIIYRDLKPENILL-DKNGHIKITDFGFAKYVP---DVTYTLCGTPDYIAPEVVSTKPY 178

Query: 229 GGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEF 288
                  + D WS G+ + E+  G+ PF       +       I   +    P   + + 
Sbjct: 179 -----NKSIDWWSFGILIYEMLAGYTPF----YDSNTMKTYEKILNAELR-FPPFFNEDV 228

Query: 289 RSFIECCLQKEFSKRW-----TASQLLTHPFL 315
           +  +   + ++ S+R          +  HP+ 
Sbjct: 229 KDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 2e-60
 Identities = 64/268 (23%), Positives = 110/268 (41%), Gaps = 17/268 (6%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           I   DL  L+ LG G  G V   + R      A+K++          +   E +++    
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIK--EGSMSEDEFIEEAKVMMNLS 57

Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLN-KNGTFSEPKLAHIASQILKGLSYL 166
              +VQ +G+  K    I I+ EYM +G L   L      F   +L  +   + + + YL
Sbjct: 58  HEKLVQLYGVCTKQ-RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 116

Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS-LDACNSYVGTCAYMSPERFDP 225
              + +HRD+   N LV N+   VK++DFG+S+ +      +         +  PE    
Sbjct: 117 ESKQFLHRDLAARNCLV-NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175

Query: 226 DAYGGNYNGYAGDIWSLGLTLLELY-LGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
             +         DIW+ G+ + E+Y LG  P+    +R   +     I  G     P  A
Sbjct: 176 SKF-----SSKSDIWAFGVLMWEIYSLGKMPY----ERFTNSETAEHIAQGLRLYRPHLA 226

Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLTH 312
           S +  + +  C  ++  +R T   LL++
Sbjct: 227 SEKVYTIMYSCWHEKADERPTFKILLSN 254

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  191 bits (487), Expect = 4e-60
 Identities = 65/273 (23%), Positives = 122/273 (44%), Gaps = 21/273 (7%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFI 111
           E  ++LG G    V+  +    H+  A+KV+  D   DP+   +  RE +     + P I
Sbjct: 10  ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 69

Query: 112 VQCFGIFE---KPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           V  +   E          I+MEY+D  TL  +++  G  +  +   + +   + L++ H 
Sbjct: 70  VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ 129

Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA---CNSYVGTCAYMSPERFDP 225
           + IIHRD+KP+N+++ +    VK+ DFG+++ +  S ++     + +GT  Y+SPE+   
Sbjct: 130 NGIIHRDVKPANIMI-SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188

Query: 226 DAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD---PPSLPD 282
           D+          D++SLG  L E+  G  PF          ++       D   P +  +
Sbjct: 189 DSV-----DARSDVYSLGCVLYEVLTGEPPF----TGDSPVSVAYQHVREDPIPPSARHE 239

Query: 283 GASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
           G S +  + +   L K    R+  +  +    +
Sbjct: 240 GLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 7e-60
 Identities = 63/266 (23%), Positives = 113/266 (42%), Gaps = 22/266 (8%)

Query: 59  LGHGNGGTVYKVQHRCTHK--IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG 116
           LG GN G+V +  +R   K    A+KV+    +     ++ RE +I+ + D+P+IV+  G
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 117 IFEKPSGDIAILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRD 175
           + +  +  + ++ME    G L   L  K        +A +  Q+  G+ YL     +HRD
Sbjct: 77  VCQAEA--LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRD 134

Query: 176 IKPSNLLVNNNNMQVKIADFGVSKIMCRS---LDACNSYVGTCAYMSPERFDPDAYGGNY 232
           +   N+L+  N    KI+DFG+SK +        A ++      + +PE  +        
Sbjct: 135 LAARNVLL-VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN-----FRK 188

Query: 233 NGYAGDIWSLGLTLLE-LYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSF 291
                D+WS G+T+ E L  G  P+    ++     +M  I  G     P    PE  + 
Sbjct: 189 FSSRSDVWSYGVTMWEALSYGQKPY----KKMKGPEVMAFIEQGKRMECPPECPPELYAL 244

Query: 292 IECCLQKEFSKRWTASQL---LTHPF 314
           +  C   ++  R     +   +   +
Sbjct: 245 MSDCWIYKWEDRPDFLTVEQRMRACY 270

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 1e-59
 Identities = 67/296 (22%), Positives = 115/296 (38%), Gaps = 42/296 (14%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
                +V+G+G+ G VY+ +   + ++ A+K V  D     +R   RE++I+R+ D   I
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75

Query: 112 VQCFGIFEKPSGD-----IAILMEYMDSGTLDTLLN---KNGTFSEPKLAHIASQILKGL 163
           V+    F           + ++++Y+         +      T     +     Q+ + L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 164 SYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF 223
           +Y+H   I HRDIKP NLL++ +   +K+ DFG +K + R  +   SY+ +  Y +PE  
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELI 194

Query: 224 DPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPF---------------LQPGQRPDWATL 268
               +G      + D+WS G  L EL LG   F               L    R     +
Sbjct: 195 ----FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250

Query: 269 MCAICFGDPPSLP---------DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
                    P +              PE  +     L+   + R T  +   H F 
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 1e-59
 Identities = 57/273 (20%), Positives = 112/273 (41%), Gaps = 19/273 (6%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           +    L+ ++ LG G  G V+   +   H   A+K +              E  ++++  
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLK--QGSMSPDAFLAEANLMKQLQ 66

Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSY 165
              +V+ + +  +    I I+ EYM++G+L   L        +  KL  +A+QI +G+++
Sbjct: 67  HQRLVRLYAVVTQ--EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124

Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS-LDACNSYVGTCAYMSPERFD 224
           +     IHRD++ +N+LV ++ +  KIADFG+++++  +   A         + +PE  +
Sbjct: 125 IEERNYIHRDLRAANILV-SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183

Query: 225 PDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
                        D+WS G+ L E+         P        ++  +  G     PD  
Sbjct: 184 -----YGTFTIKSDVWSFGILLTEIVTHGRI---PYPGMTNPEVIQNLERGYRMVRPDNC 235

Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLT--HPFL 315
             E    +  C ++    R T   L +    F 
Sbjct: 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 2e-59
 Identities = 74/298 (24%), Positives = 108/298 (36%), Gaps = 38/298 (12%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
             L  +G G  G V            A+K +      T  ++  RE++IL R     I+ 
Sbjct: 11  TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG 70

Query: 114 CFGIFEKPS---GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK 170
              I   P+        L+ ++    L  LL K    S   + +   QIL+GL Y+H   
Sbjct: 71  INDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSAN 129

Query: 171 IIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA---CNSYVGTCAYMSPERFDPDA 227
           ++HRD+KPSNLL+ N    +KI DFG++++     D       YV T  Y +PE      
Sbjct: 130 VLHRDLKPSNLLL-NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM---- 184

Query: 228 YGGNYNGYAGDIWSLGLTLLELYLGHFPF------------LQPGQRPDWATLMCAICFG 275
                   + DIWS+G  L E+      F            L     P    L C I   
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244

Query: 276 DP--------------PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR 319
                             L   A  +    ++  L     KR    Q L HP+L +  
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 1e-58
 Identities = 61/267 (22%), Positives = 109/267 (40%), Gaps = 15/267 (5%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           I  S+L  +Q +G G  G V+           A+K +   A          E E++ +  
Sbjct: 2   IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA--MSEEDFIEEAEVMMKLS 58

Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTL-LNKNGTFSEPKLAHIASQILKGLSYL 166
            P +VQ +G+  +    I ++ E+M+ G L      + G F+   L  +   + +G++YL
Sbjct: 59  HPKLVQLYGVCLEQ-APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 117

Query: 167 HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS-LDACNSYVGTCAYMSPERFDP 225
               +IHRD+   N LV   N  +K++DFG+++ +      +         + SPE F  
Sbjct: 118 EEACVIHRDLAARNCLV-GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176

Query: 226 DAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS 285
             Y         D+WS G+ + E++        P +    + ++  I  G     P  AS
Sbjct: 177 SRY-----SSKSDVWSFGVLMWEVFSEGKI---PYENRSNSEVVEDISTGFRLYKPRLAS 228

Query: 286 PEFRSFIECCLQKEFSKRWTASQLLTH 312
                 +  C ++    R   S+LL  
Sbjct: 229 THVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 3e-58
 Identities = 64/270 (23%), Positives = 112/270 (41%), Gaps = 16/270 (5%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILR 104
           I    +E  + +G G  G V++  +          A+K        +VR +  +E   +R
Sbjct: 4   IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 63

Query: 105 RTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGL 163
           + D P IV+  G+  +    + I+ME    G L + L     +     L   A Q+   L
Sbjct: 64  QFDHPHIVKLIGVITE--NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 121

Query: 164 SYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD-ACNSYVGTCAYMSPER 222
           +YL   + +HRDI   N+LV ++N  VK+ DFG+S+ M  S     +       +M+PE 
Sbjct: 122 AYLESKRFVHRDIAARNVLV-SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 180

Query: 223 FDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPD 282
            +   +       A D+W  G+ + E+ +       P Q      ++  I  G+   +P 
Sbjct: 181 INFRRF-----TSASDVWMFGVCMWEILMHGVK---PFQGVKNNDVIGRIENGERLPMPP 232

Query: 283 GASPEFRSFIECCLQKEFSKRWTASQLLTH 312
              P   S +  C   + S+R   ++L   
Sbjct: 233 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  187 bits (476), Expect = 3e-58
 Identities = 63/270 (23%), Positives = 110/270 (40%), Gaps = 11/270 (4%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILR 104
           I  S ++  QV+G G  G V     +   K     A+K +        RR    E  I+ 
Sbjct: 23  IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMG 82

Query: 105 RTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTL-LNKNGTFSEPKLAHIASQILKGL 163
           + D P ++   G+  K    + I+ E+M++G+LD+     +G F+  +L  +   I  G+
Sbjct: 83  QFDHPNVIHLEGVVTKS-TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGM 141

Query: 164 SYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF 223
            YL     +HRD+   N+LV N+N+  K++DFG+S+ +                +     
Sbjct: 142 KYLADMNYVHRDLAARNILV-NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 200

Query: 224 DPDAYGGNYNGYAGDIWSLGLTLLELY-LGHFPFLQPGQRPDWATLMCAICFGDPPSLPD 282
            P+A        A D+WS G+ + E+   G  P+           ++ AI        P 
Sbjct: 201 APEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY----WDMTNQDVINAIEQDYRLPPPM 256

Query: 283 GASPEFRSFIECCLQKEFSKRWTASQLLTH 312
                    +  C QK+ + R    Q++  
Sbjct: 257 DCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 4e-58
 Identities = 70/290 (24%), Positives = 119/290 (41%), Gaps = 32/290 (11%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPF 110
           + +K++ +G G  G VYK +++ T ++ ALK +  D     V     RE+ +L+  + P 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 111 IVQCFGIFEKPSGDIAILMEYMDSGTLDTL-LNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           IV+   +       + ++ E++       +  +       P +     Q+L+GL++ H H
Sbjct: 63  IVKLLDVIHTE-NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121

Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYG 229
           +++HRD+KP NLL+ N    +K+ADFG+++     +      V T  Y +PE       G
Sbjct: 122 RVLHRDLKPQNLLI-NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL----LG 176

Query: 230 GNYNGYAGDIWSLGLTLLELYLGHFPF------------------------LQPGQRPDW 265
             Y   A DIWSLG    E+      F                              PD+
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236

Query: 266 ATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
                     D   +      + RS +   L  + +KR +A   L HPF 
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 7e-58
 Identities = 68/297 (22%), Positives = 107/297 (36%), Gaps = 42/297 (14%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKI-----YALKVVHGDADPTVRRQVFREMEI 102
               +LE  +VLG G  G V         K       A+K++   AD + R  +  E+++
Sbjct: 34  FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 93

Query: 103 LRR-TDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN----------------- 144
           + +      IV   G      G I ++ EY   G L   L                    
Sbjct: 94  MTQLGSHENIVNLLGACTLS-GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152

Query: 145 ------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVS 198
                    +   L   A Q+ KG+ +L     +HRD+   N+LV  +   VKI DFG++
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV-THGKVVKICDFGLA 211

Query: 199 KIM--CRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLE-LYLGHFP 255
           + +    +     +      +M+PE                D+WS G+ L E   LG  P
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLF-----EGIYTIKSDVWSYGILLWEIFSLGVNP 266

Query: 256 FLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH 312
           +  PG   D A     I  G     P  A+ E    ++ C   +  KR +   L + 
Sbjct: 267 Y--PGIPVD-ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 7e-58
 Identities = 58/273 (21%), Positives = 112/273 (41%), Gaps = 20/273 (7%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKV----VHGDADPTVRRQVFREMEIL 103
           +  ++ +K++VLG G  GTVYK       +   + V    +     P   +++  E  ++
Sbjct: 6   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65

Query: 104 RRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTL-DTLLNKNGTFSEPKLAHIASQILKG 162
              D+P + +  GI    +  + ++ + M  G L D +           L +   QI KG
Sbjct: 66  ASVDNPHVCRLLGICL--TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123

Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNS--YVGTCAYMSP 220
           ++YL   +++HRD+   N+LV      VKI DFG++K++       ++        +M+ 
Sbjct: 124 MNYLEDRRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182

Query: 221 ERFDPDAYGGNYNGYAGDIWSLGLTLLEL-YLGHFPFLQPGQRPDWATLMCAICFGDPPS 279
           E      Y      +  D+WS G+T+ EL   G  P+         + +   +  G+   
Sbjct: 183 ESILHRIY-----THQSDVWSYGVTVWELMTFGSKPY----DGIPASEISSILEKGERLP 233

Query: 280 LPDGASPEFRSFIECCLQKEFSKRWTASQLLTH 312
            P   + +    +  C   +   R    +L+  
Sbjct: 234 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  185 bits (470), Expect = 2e-57
 Identities = 60/265 (22%), Positives = 104/265 (39%), Gaps = 13/265 (4%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           +  +D+     LG G  G VY+   +      A+K +    D     +  +E  +++   
Sbjct: 14  MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIK 71

Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNG--TFSEPKLAHIASQILKGLSY 165
            P +VQ  G+  +      I+ E+M  G L   L +      S   L ++A+QI   + Y
Sbjct: 72  HPNLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 130

Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDP 225
           L     IHRD+   N LV   N  VK+ADFG+S++M              A    +   P
Sbjct: 131 LEKKNFIHRDLAARNCLV-GENHLVKVADFGLSRLMTGD----TYTAHAGAKFPIKWTAP 185

Query: 226 DAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS 285
           ++   N      D+W+ G+ L E+         P    D + +   +        P+G  
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMS---PYPGIDLSQVYELLEKDYRMERPEGCP 242

Query: 286 PEFRSFIECCLQKEFSKRWTASQLL 310
            +    +  C Q   S R + +++ 
Sbjct: 243 EKVYELMRACWQWNPSDRPSFAEIH 267

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (469), Expect = 4e-57
 Identities = 67/284 (23%), Positives = 110/284 (38%), Gaps = 30/284 (10%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIY--ALKVVHGDADPTVRRQVFREMEILRR 105
           + ++D++   V+G GN G V K + +        A+K +   A     R    E+E+L +
Sbjct: 7   LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 66

Query: 106 -TDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN----------------GTFS 148
               P I+   G  E   G + + +EY   G L   L K+                 T S
Sbjct: 67  LGHHPNIINLLGACEHR-GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125

Query: 149 EPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC 208
             +L H A+ + +G+ YL   + IHRD+   N+LV   N   KIADFG+S+         
Sbjct: 126 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV-GENYVAKIADFGLSRGQEVY-VKK 183

Query: 209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATL 268
                   +M+ E         +      D+WS G+ L E+         P      A L
Sbjct: 184 TMGRLPVRWMAIES-----LNYSVYTTNSDVWSYGVLLWEIVSLGGT---PYCGMTCAEL 235

Query: 269 MCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH 312
              +  G     P     E    +  C +++  +R + +Q+L  
Sbjct: 236 YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  184 bits (468), Expect = 4e-57
 Identities = 63/294 (21%), Positives = 116/294 (39%), Gaps = 41/294 (13%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRC-----THKIYALKVVHGDADPTVRRQVFREMEI 102
              +++E ++ +G G  G V++ +           + A+K++  +A   ++    RE  +
Sbjct: 10  YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 69

Query: 103 LRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNG----------------- 145
           +   D+P IV+  G+       + +L EYM  G L+  L                     
Sbjct: 70  MAEFDNPNIVKLLGVCAVG-KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128

Query: 146 -------TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVS 198
                    S  +   IA Q+  G++YL   K +HRD+   N LV   NM VKIADFG+S
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV-GENMVVKIADFGLS 187

Query: 199 KIMCRS--LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPF 256
           + +  +    A  +      +M PE    + Y         D+W+ G+ L E++      
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRY-----TTESDVWAYGVVLWEIFSYGLQ- 241

Query: 257 LQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLL 310
             P        ++  +  G+  + P+    E  + +  C  K  + R +   + 
Sbjct: 242 --PYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  185 bits (469), Expect = 6e-57
 Identities = 58/298 (19%), Positives = 118/298 (39%), Gaps = 47/298 (15%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRR-TDSPF 110
           D + ++ LG G    V++  +   ++   +K++     P  ++++ RE++IL      P 
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL----KPVKKKKIKREIKILENLRGGPN 91

Query: 111 IVQCFGIFEKPSGD-IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           I+    I + P     A++ E++++     L     T ++  +     +ILK L Y H  
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM 148

Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYG 229
            I+HRD+KP N+++++ + ++++ D+G+++         N  V +  +  PE        
Sbjct: 149 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELL----VD 203

Query: 230 GNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD------------- 276
                Y+ D+WSLG  L  +     PF       D    +  +   +             
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263

Query: 277 --------------------PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPF 314
                                       SPE   F++  L+ +   R TA + + HP+
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 2e-56
 Identities = 67/306 (21%), Positives = 114/306 (37%), Gaps = 48/306 (15%)

Query: 51  SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTDSP 109
           S  EKL  +G G  G V+K +HR T +  ALK V   +          RE++IL+     
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 110 FIVQCFGIFEKPS-------GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKG 162
            +V    I    +       G I ++ ++ +      L N    F+  ++  +   +L G
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129

Query: 163 LSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM----CRSLDACNSYVGTCAYM 218
           L Y+H +KI+HRD+K +N+L+  +   +K+ADFG+++          +   + V T  Y 
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188

Query: 219 SPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRP-DWATLMCAICFGDP 277
            PE       G    G   D+W  G  + E++         G        L+  +C    
Sbjct: 189 PPELL----LGERDYGPPIDLWGAGCIMAEMWTRSPIM--QGNTEQHQLALISQLCGSIT 242

Query: 278 PSLPDG----------------------------ASPEFRSFIECCLQKEFSKRWTASQL 309
           P +                                 P     I+  L  + ++R  +   
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

Query: 310 LTHPFL 315
           L H F 
Sbjct: 303 LNHDFF 308

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  183 bits (465), Expect = 4e-56
 Identities = 69/271 (25%), Positives = 123/271 (45%), Gaps = 22/271 (8%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD--ADPTVRRQVFREMEILRRTDSP 109
             ++++ LG G+ G V  V+H+ +   YA+K++                E  IL+  + P
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101

Query: 110 FIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH 169
           F+V+    F+  S ++ ++MEY+  G + + L + G FSEP     A+QI+    YLH  
Sbjct: 102 FLVKLEFSFKDNS-NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160

Query: 170 KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYG 229
            +I+RD+KP NLL++     +++ DFG +K +        +  GT   ++PE      Y 
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVK---GRTWTLCGTPEALAPEIILSKGY- 215

Query: 230 GNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFR 289
                 A D W+LG+ + E+  G+ PF           +   I  G     P   S + +
Sbjct: 216 ----NKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKIVSGKVR-FPSHFSSDLK 266

Query: 290 SFIECCLQKEFSKRW-----TASQLLTHPFL 315
             +   LQ + +KR+       + +  H + 
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  181 bits (460), Expect = 5e-56
 Identities = 65/287 (22%), Positives = 111/287 (38%), Gaps = 32/287 (11%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIV 112
             L+ +G G  G VYK Q+    + +ALK +  +  D  +     RE+ IL+      IV
Sbjct: 5   HGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63

Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
           + + +       + ++ E++D      L    G            Q+L G++Y H  +++
Sbjct: 64  KLYDVIHTKK-RLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVL 122

Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNY 232
           HRD+KP NLL+N    ++KIADFG+++     +      + T  Y +P+       G   
Sbjct: 123 HRDLKPQNLLINREG-ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL----MGSKK 177

Query: 233 NGYAGDIWSLGLTLLELYLGHFPF---------------LQPGQRPDWATLMCAICFG-- 275
                DIWS+G    E+  G   F               L      +W  +     +   
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237

Query: 276 -------DPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
                     S   G        +   L+ + ++R TA Q L H + 
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  181 bits (459), Expect = 8e-56
 Identities = 57/284 (20%), Positives = 96/284 (33%), Gaps = 23/284 (8%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
              + +G G+ G +Y        +  A+K+           Q+  E +I +       + 
Sbjct: 10  RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIP 66

Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
                        ++ME +     D     +  FS   +  +A Q++  + Y+H    IH
Sbjct: 67  TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIH 126

Query: 174 RDIKPSNLLVNNN--NMQVKIADFGVSKIM-------CRSLDACNSYVGTCAYMSPERFD 224
           RD+KP N L+        V I DFG++K                 +  GT  Y S     
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN--- 183

Query: 225 PDAYGGNYNGYAGDIWSLGLTLLELYLG--HFPFLQPGQRPDWATLMCAICFGDP-PSLP 281
              + G       D+ SLG  L+   LG   +  L+   +      +       P   L 
Sbjct: 184 --THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241

Query: 282 DGASPEFRSFIECCLQKEFSKRWTAS---QLLTHPFLCKNRRSD 322
            G   EF +++  C    F  +   S   QL  + F  +    D
Sbjct: 242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 285

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 1e-55
 Identities = 59/273 (21%), Positives = 105/273 (38%), Gaps = 19/273 (6%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD 107
           I    L     LG G  G V+      T +  A+K +             +E +++++  
Sbjct: 14  IPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM--SPEAFLQEAQVMKKLR 70

Query: 108 SPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTL--LNKNGTFSEPKLAHIASQILKGLSY 165
              +VQ + +  +    I I+ EYM  G+L              P+L  +A+QI  G++Y
Sbjct: 71  HEKLVQLYAVVSE--EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 128

Query: 166 LHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM-CRSLDACNSYVGTCAYMSPERFD 224
           +     +HRD++ +N+LV   N+  K+ADFG+++++      A         + +P    
Sbjct: 129 VERMNYVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP---- 183

Query: 225 PDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGA 284
             A  G +     D+WS G+ L EL         P        ++  +  G     P   
Sbjct: 184 EAALYGRFT-IKSDVWSFGILLTELTTKGRV---PYPGMVNREVLDQVERGYRMPCPPEC 239

Query: 285 SPEFRSFIECCLQKEFSKRWTASQLLT--HPFL 315
                  +  C +KE  +R T   L      + 
Sbjct: 240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 2e-55
 Identities = 70/288 (24%), Positives = 118/288 (40%), Gaps = 32/288 (11%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTDSPFIV 112
           EKL+ +G G  GTV+K ++R TH+I ALK V   D D  V     RE+ +L+      IV
Sbjct: 5   EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64

Query: 113 QCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKII 172
           +   +         ++ E+ D        + NG      +     Q+LKGL + H   ++
Sbjct: 65  RLHDVLHSDKKLT-LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVL 123

Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNY 232
           HRD+KP NLL+ N N ++K+A+FG+++     +   ++ V T  Y  P+      +G   
Sbjct: 124 HRDLKPQNLLI-NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL----FGAKL 178

Query: 233 NGYAGDIWSLGLTLLELYLGHFPFLQP-------------------------GQRPDWAT 267
              + D+WS G    EL     P                              + PD+  
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238

Query: 268 LMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
                      ++    +   R  ++  L+    +R +A + L HP+ 
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 3e-55
 Identities = 60/287 (20%), Positives = 103/287 (35%), Gaps = 31/287 (10%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRC-----THKIYALKVVHGDADPTVRRQVFREMEI 102
              + L   + LG G  G V +               A+K++   A  T R  +  E+++
Sbjct: 20  FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79

Query: 103 LRR-TDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNG---------------- 145
           L    +   IV   G      G   ++ EY   G L   L +                  
Sbjct: 80  LSYLGNHMNIVNLLGACTIG-GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138

Query: 146 --TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR 203
                   L   + Q+ KG+++L     IHRD+   N+L+  +    KI DFG+++ +  
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL-THGRITKICDFGLARDIK- 196

Query: 204 SLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRP 263
             +  N  V   A +  +   P++       +  D+WS G+ L EL+            P
Sbjct: 197 --NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP--YPGMP 252

Query: 264 DWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLL 310
             +     I  G     P+ A  E    ++ C   +  KR T  Q++
Sbjct: 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 6e-55
 Identities = 64/276 (23%), Positives = 109/276 (39%), Gaps = 21/276 (7%)

Query: 45  TAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHK---IYALKVVHGD--ADPTVRRQVFRE 99
           T  I   DL  L+ LG G+ G V + +           A+K +  D  + P       RE
Sbjct: 2   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61

Query: 100 MEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQ 158
           +  +   D   +++ +G+    +  + ++ E    G+L   L K+ G F    L+  A Q
Sbjct: 62  VNAMHSLDHRNLIRLYGVVL--TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119

Query: 159 ILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD---ACNSYVGTC 215
           + +G+ YL   + IHRD+   NLL+      VKI DFG+ + + ++ D            
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 178

Query: 216 AYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELY-LGHFPFLQPGQRPDWATLMCAICF 274
           A+ +PE             +A D W  G+TL E++  G  P+           L      
Sbjct: 179 AWCAPESL-----KTRTFSHASDTWMFGVTLWEMFTYGQEPW---IGLNGSQILHKIDKE 230

Query: 275 GDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLL 310
           G+    P+    +  + +  C   +   R T   L 
Sbjct: 231 GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 6e-55
 Identities = 80/291 (27%), Positives = 132/291 (45%), Gaps = 19/291 (6%)

Query: 38  NNNTTATTAAIAYSDLEKLQVLGHGNGGTVYKVQH---RCTHKIYALKVVHGD---ADPT 91
             N T     +   + E L+VLG G  G V+ V+      T K+YA+KV+          
Sbjct: 11  TANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAK 70

Query: 92  VRRQVFREMEILRR-TDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEP 150
                  E ++L     SPF+V     F+     + ++++Y++ G L T L++   F+E 
Sbjct: 71  TTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-TKLHLILDYINGGELFTHLSQRERFTEH 129

Query: 151 KLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVS-KIMCRSLDACN 209
           ++     +I+  L +LH   II+RDIK  N+L+++N   V + DFG+S + +    +   
Sbjct: 130 EVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKEFVADETERAY 188

Query: 210 SYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLM 269
            + GT  YM+P+           +  A D WSLG+ + EL  G  PF   G++   A + 
Sbjct: 189 DFCGTIEYMAPDIVRGGDS---GHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS 245

Query: 270 CAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRW-----TASQLLTHPFL 315
             I   +PP  P   S   +  I+  L K+  KR       A ++  H F 
Sbjct: 246 RRILKSEPP-YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 3e-54
 Identities = 57/282 (20%), Positives = 109/282 (38%), Gaps = 27/282 (9%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRC-----THKIYALKVVHGDADPTVRRQVFREMEI 102
           +A   +   + LG G+ G VY+   +           A+K V+  A    R +   E  +
Sbjct: 17  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 76

Query: 103 LRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTF----------SEPKL 152
           ++  +   +V+  G+  +      ++ME M  G L + L                S  K+
Sbjct: 77  MKEFNCHHVVRLLGVVSQG-QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135

Query: 153 AHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRS--LDACNS 210
             +A +I  G++YL+ +K +HRD+   N +V   +  VKI DFG+++ +  +        
Sbjct: 136 IQMAGEIADGMAYLNANKFVHRDLAARNCMV-AEDFTVKIGDFGMTRDIYETDYYRKGGK 194

Query: 211 YVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMC 270
            +    +MSPE      +    +     +WS G+ L E+         P Q      ++ 
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSD-----VWSFGVVLWEIATLAEQ---PYQGLSNEQVLR 246

Query: 271 AICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH 312
            +  G     PD         +  C Q     R +  ++++ 
Sbjct: 247 FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 5e-54
 Identities = 61/273 (22%), Positives = 107/273 (39%), Gaps = 16/273 (5%)

Query: 45  TAAIAYSDLEKLQVLGHGNGGTVYKVQHRCT----HKIYALKVVHGDADPTVRRQVFREM 100
           T  I  S + + +V+G G  G VYK   + +        A+K +        R     E 
Sbjct: 1   TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60

Query: 101 EILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQIL 160
            I+ +     I++  G+  K    + I     +      L  K+G FS  +L  +   I 
Sbjct: 61  GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120

Query: 161 KGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNS---YVGTCAY 217
            G+ YL     +HRD+   N+LV N+N+  K++DFG+S+++    +A  +         +
Sbjct: 121 AGMKYLANMNYVHRDLAARNILV-NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179

Query: 218 MSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP 277
            +PE              A D+WS G+ + E+         P        +M AI  G  
Sbjct: 180 TAPEAIS-----YRKFTSASDVWSFGIVMWEVMTYGER---PYWELSNHEVMKAINDGFR 231

Query: 278 PSLPDGASPEFRSFIECCLQKEFSKRWTASQLL 310
              P          +  C Q+E ++R   + ++
Sbjct: 232 LPTPMDCPSAIYQLMMQCWQQERARRPKFADIV 264

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 1e-53
 Identities = 55/264 (20%), Positives = 97/264 (36%), Gaps = 17/264 (6%)

Query: 57  QVLGHGNGGTVYKVQHRC---THKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +V+G G+ G VY              A+K ++   D     Q   E  I++    P ++ 
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92

Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLN-KNGTFSEPKLAHIASQILKGLSYLHGHKII 172
             GI  +  G   +++ YM  G L   +  +    +   L     Q+ KG+ +L   K +
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 152

Query: 173 HRDIKPSNLLVNNNNMQVKIADFGVSKIM----CRSLDACNSYVGTCAYMSPERFDPDAY 228
           HRD+   N ++ +    VK+ADFG+++ M      S+           +M+ E       
Sbjct: 153 HRDLAARNCML-DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ---- 207

Query: 229 GGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEF 288
                    D+WS G+ L EL     P        D       +  G     P+      
Sbjct: 208 -TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV---YLLQGRRLLQPEYCPDPL 263

Query: 289 RSFIECCLQKEFSKRWTASQLLTH 312
              +  C   +   R + S+L++ 
Sbjct: 264 YEVMLKCWHPKAEMRPSFSELVSR 287

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 1e-53
 Identities = 73/294 (24%), Positives = 119/294 (40%), Gaps = 42/294 (14%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIV 112
             LQ +G G  G V       T    A+K ++         ++ +RE+ +L+      ++
Sbjct: 21  RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVI 80

Query: 113 QCFGIFEKPS-----GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F          D  ++M +M  GT    L K+    E ++  +  Q+LKGL Y+H
Sbjct: 81  GLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH 138

Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDA 227
              IIHRD+KP NL V N + ++KI DFG+++     +     YV T  Y +PE      
Sbjct: 139 AAGIIHRDLKPGNLAV-NEDCELKILDFGLARQADSEM---TGYVVTRWYRAPEVI---- 190

Query: 228 YGGNYNGYAGDIWSLGLTLLELYLGHFPF--------------------------LQPGQ 261
                     DIWS+G  + E+  G   F                          LQ  +
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250

Query: 262 RPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
             ++   +  +   D  S+   ASP   + +E  L  +  +R TA + L HP+ 
Sbjct: 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 304

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 2e-52
 Identities = 65/289 (22%), Positives = 111/289 (38%), Gaps = 32/289 (11%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYK-----VQHRCTHKIYALKVVHGDADPTVRRQVFREMEI 102
                L+  + LG G  G V +     +    T +  A+K++   A  +  R +  E++I
Sbjct: 10  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 69

Query: 103 LRRTDSPF-IVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNG---------------- 145
           L        +V   G   KP G + +++E+   G L T L                    
Sbjct: 70  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129

Query: 146 TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL 205
             +   L   + Q+ KG+ +L   K IHRD+   N+L+ +    VKI DFG+++ + +  
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL-SEKNVVKICDFGLARDIYKDP 188

Query: 206 D--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRP 263
           D            +M+PE                D+WS G+ L E++          +  
Sbjct: 189 DYVRKGDARLPLKWMAPETIF-----DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243

Query: 264 DWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH 312
           +       +  G     PD  +PE    +  C   E S+R T S+L+ H
Sbjct: 244 EE--FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 3e-52
 Identities = 66/294 (22%), Positives = 116/294 (39%), Gaps = 39/294 (13%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCT-HKIYALKVVHGD-ADPTVRRQVFREMEILRR---TDS 108
           E +  +G G  G V+K +      +  ALK V     +  +     RE+ +LR     + 
Sbjct: 10  ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 69

Query: 109 PFIVQCFGIFEKPSGD----IAILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQILKGL 163
           P +V+ F +      D    + ++ E++D      L            +  +  Q+L+GL
Sbjct: 70  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 129

Query: 164 SYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERF 223
            +LH H+++HRD+KP N+LV  ++ Q+K+ADFG+++ +     A  S V T  Y +PE  
Sbjct: 130 DFLHSHRVVHRDLKPQNILV-TSSGQIKLADFGLAR-IYSFQMALTSVVVTLWYRAPEVL 187

Query: 224 DPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPF---------------LQPGQRPDW--- 265
                  +Y     D+WS+G    E++     F               +      DW   
Sbjct: 188 ----LQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242

Query: 266 ----ATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL 315
                    +                 +  +  CL    +KR +A   L+HP+ 
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 3e-52
 Identities = 69/290 (23%), Positives = 111/290 (38%), Gaps = 38/290 (13%)

Query: 48  IAYSDLEKLQVLGHGNGGTVYKVQHRCTHK-------IYALKVVHGDADPTVRRQVFREM 100
           +    L   + LG G  G V   +     K         A+K++  DA       +  EM
Sbjct: 10  LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 69

Query: 101 EILRR-TDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLL----------------NK 143
           E+++       I+   G   +  G + +++EY   G L   L                N 
Sbjct: 70  EMMKMIGKHKNIINLLGACTQD-GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128

Query: 144 NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR 203
               S   L   A Q+ +G+ YL   K IHRD+   N+LV   +  +KIADFG+++ +  
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV-TEDNVMKIADFGLARDIHH 187

Query: 204 SLDACNSYV--GTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELY-LGHFPFLQPG 260
                 +        +M+PE      Y      +  D+WS G+ L E++ LG  P+  PG
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIY-----THQSDVWSFGVLLWEIFTLGGSPY--PG 240

Query: 261 QRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLL 310
              +   L   +  G     P   + E    +  C     S+R T  QL+
Sbjct: 241 VPVEE--LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  167 bits (424), Expect = 1e-50
 Identities = 51/271 (18%), Positives = 91/271 (33%), Gaps = 24/271 (8%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQ 113
           +  + +G G+ G +++  +   ++  A+K     +D    R  +R  ++L        V 
Sbjct: 8   KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVY 67

Query: 114 CFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIH 173
            FG          ++++ +     D L      FS   +A  A Q+L  +  +H   +++
Sbjct: 68  YFGQEGLH---NVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 124

Query: 174 RDIKPSNLLVNNNNMQ----VKIADFGVSKI-------MCRSLDACNSYVGTCAYMSPER 222
           RDIKP N L+   N +    + + DFG+ K                 +  GT  YMS   
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184

Query: 223 FDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD----PP 278
                          D+ +LG   +    G  P+ Q  +          I          
Sbjct: 185 HLGREQ-----SRRDDLEALGHVFMYFLRGSLPW-QGLKAATNKQKYERIGEKKQSTPLR 238

Query: 279 SLPDGASPEFRSFIECCLQKEFSKRWTASQL 309
            L  G   EF  ++       F        L
Sbjct: 239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYL 269

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 2e-49
 Identities = 59/292 (20%), Positives = 107/292 (36%), Gaps = 39/292 (13%)

Query: 52  DLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI 111
            +   + +G G  G V++ +     +  A+K+     + +  R+   E+          I
Sbjct: 4   TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENI 59

Query: 112 VQCFGIFEKPSGD---IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
           +       K +G    + ++ +Y + G+L   LN+    +   +  +A     GL++LH 
Sbjct: 60  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHM 118

Query: 169 H--------KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD----ACNSYVGTCA 216
                     I HRD+K  N+LV   N    IAD G++     + D    A N  VGT  
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILV-KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177

Query: 217 YMSPERFDPDAYGGNYN-GYAGDIWSLGLTLLELYLGHFPF-----------LQPGQRPD 264
           YM+PE  D      ++      DI+++GL   E+                        P 
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237

Query: 265 WATLMCAICFGD-PPSLPDG-----ASPEFRSFIECCLQKEFSKRWTASQLL 310
              +   +C     P++P+      A       +  C     + R TA ++ 
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 2e-48
 Identities = 61/305 (20%), Positives = 114/305 (37%), Gaps = 53/305 (17%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIV 112
           + L+ +G G  G V         +  A+K +     + T  ++ +RE+ +++  +   I+
Sbjct: 20  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79

Query: 113 QCFGIFEKPS-----GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLH 167
               +F          D+ ++ME MD+     +  +       +++++  Q+L G+ +LH
Sbjct: 80  SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLH 136

Query: 168 GHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDA 227
              IIHRD+KPSN++V  ++  +KI DFG+++    S      YV T  Y +PE      
Sbjct: 137 SAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVIL--- 191

Query: 228 YGGNYNGYAGDIWSLGLTLLELYLGHFPF------------------------------- 256
             G       DIWS+G  + E+      F                               
Sbjct: 192 --GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249

Query: 257 ------LQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLL 310
                         +  L     F          + + R  +   L  + +KR +    L
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309

Query: 311 THPFL 315
            HP++
Sbjct: 310 QHPYI 314

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 9e-48
 Identities = 71/302 (23%), Positives = 115/302 (38%), Gaps = 44/302 (14%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVH-GDADPTVRRQVFREMEILRRTDSPFIV 112
           + L  +G G  G+V       T    A+K +          ++ +RE+ +L+      ++
Sbjct: 21  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 80

Query: 113 QCFGIFEKPS----GDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG 168
               +F         +   L+ ++    L+ +  K    ++  +  +  QIL+GL Y+H 
Sbjct: 81  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHS 139

Query: 169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAY 228
             IIHRD+KPSNL VN +    KI DFG+++           YV T  Y +PE       
Sbjct: 140 ADIIHRDLKPSNLAVNEDCEL-KILDFGLARHTDDE---MTGYVATRWYRAPEIM----L 191

Query: 229 GGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPP---------- 278
              +     DIWS+G  + EL  G   F  PG        +     G P           
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHIDQLKLILRLVGTPGAELLKKISSE 249

Query: 279 ------------------SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR 320
                             ++  GA+P     +E  L  +  KR TA+Q L H +  +   
Sbjct: 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309

Query: 321 SD 322
            D
Sbjct: 310 PD 311

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  136 bits (343), Expect = 5e-38
 Identities = 62/330 (18%), Positives = 108/330 (32%), Gaps = 68/330 (20%)

Query: 54  EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRR-------- 105
             ++ LG G+  TV+  +    +   A+K+V G  D         E+++L+R        
Sbjct: 16  ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG--DKVYTEAAEDEIKLLQRVNDADNTK 73

Query: 106 ---TDSPFIVQCFGIFEKPSGD---IAILMEYMDSGTLDTLL-NKNGTFSEPKLAHIASQ 158
                +  I++    F     +   + ++ E +    L  +   ++       +  I+ Q
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 159 ILKGLSYL-HGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM--CRSLDACNSYVGTC 215
           +L GL Y+     IIH DIKP N+L+   +    +    ++ +   C   +   + + T 
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193

Query: 216 AYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATL----MCA 271
            Y SPE      +     G   DIWS    + EL  G F F                   
Sbjct: 194 EYRSPEVLLGAPW-----GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248

Query: 272 ICFGDPPS---------------------------------------LPDGASPEFRSFI 292
              G+ PS                                            + E   F+
Sbjct: 249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 308

Query: 293 ECCLQKEFSKRWTASQLLTHPFLCKNRRSD 322
              LQ +  KR  A  L+ HP+L      +
Sbjct: 309 SPMLQLDPRKRADAGGLVNHPWLKDTLGME 338

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 91.0 bits (225), Expect = 1e-22
 Identities = 32/215 (14%), Positives = 60/215 (27%), Gaps = 52/215 (24%)

Query: 57  QVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-----------------DPTVRRQVFRE 99
           +++G G    V+            +K                            R    E
Sbjct: 6   KLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 100 MEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQI 159
              L++     + + +          A+LME +D+        +           +   I
Sbjct: 65  FRALQKLQGLAVPKVYAWEGN-----AVLMELIDAK-------ELYRVRVENPDEVLDMI 112

Query: 160 LKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACNSYVGTCAYMS 219
           L+ ++  +   I+H D+   N+LV  +   + I DF  S             V       
Sbjct: 113 LEEVAKFYHRGIVHGDLSQYNVLV--SEEGIWIIDFPQS-------------VEVGEEGW 157

Query: 220 PERFDPDA------YGGNYNGYAGDIWSLGLTLLE 248
            E  + D       +   Y     DI S    +L+
Sbjct: 158 REILERDVRNIITYFSRTY-RTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	323
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.74
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.49
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.39
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.81
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.69
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.53
d1cjaa_	342	Actin-fragmin kinase, catalytic domain {Physarum p	88.01

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-62  Score=415.48  Aligned_cols=261  Identities=24%  Similarity=0.358  Sum_probs=218.3

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      .++|++++.||+|+||+||+|++..+|+.||+|++......+..+.+.+|+.+++.++||||+++++++.+ ++.+++||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-~~~~~ivm   82 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFL   82 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CceeEEEE
Confidence            46899999999999999999999999999999999866555556778999999999999999999999998 68899999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc--cc
Q 020657          130 EYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL--DA  207 (323)
Q Consensus       130 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~--~~  207 (323)
                      ||+++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+|.......  ..
T Consensus        83 Ey~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~-~~KL~DFG~a~~~~~~~~~~~  161 (271)
T d1nvra_          83 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERL  161 (271)
T ss_dssp             ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECEETTEECC
T ss_pred             eccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCC-CEEEccchhheeeccCCcccc
Confidence            9999999999998888899999999999999999999999999999999999999987 89999999998664332  23


Q ss_pred             cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChh
Q 020657          208 CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPE  287 (323)
Q Consensus       208 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (323)
                      ....+||+.|+|||++.+..    ..+.++||||||+++|+|+||+.||.............  ............++++
T Consensus       162 ~~~~~GT~~Y~APE~~~~~~----~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~s~~  235 (271)
T d1nvra_         162 LNKMCGTLPYVAPELLKRRE----FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW--KEKKTYLNPWKKIDSA  235 (271)
T ss_dssp             BCCCCSCGGGSCTHHHHCSS----BCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH--HTTCTTSTTGGGSCHH
T ss_pred             ccceeeCcCccCHhHhcCCC----CCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHH--hcCCCCCCccccCCHH
Confidence            34568999999999986433    23468999999999999999999997655443322222  1222222333578999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          288 FRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       288 l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      +.+|+++||+.||++|||++|+|+||||++.
T Consensus       236 ~~~li~~~L~~dP~~R~t~~eil~hpwf~~~  266 (271)
T d1nvra_         236 PLALLHKILVENPSARITIPDIKKDRWYNKP  266 (271)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence            9999999999999999999999999999753

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-62  Score=410.51  Aligned_cols=255  Identities=31%  Similarity=0.482  Sum_probs=220.6

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      .++|++.+.||+|+||+||+|++..+++.||+|++....  +......+.+|+.+++.++||||+++++++.+ ++..++
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~i   83 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-ATRVYL   83 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE-CCEEEE
Confidence            578999999999999999999999999999999986331  12335678899999999999999999999997 688999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccc
Q 020657          128 LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA  207 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~  207 (323)
                      ||||+++|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||++......  .
T Consensus        84 vmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~-~~kl~DFG~a~~~~~~--~  160 (263)
T d2j4za1          84 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSS--R  160 (263)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCSCSCCCCC--C
T ss_pred             EEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCC-CEeecccceeeecCCC--c
Confidence            999999999999999888999999999999999999999999999999999999999987 8999999999765432  2


Q ss_pred             cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChh
Q 020657          208 CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPE  287 (323)
Q Consensus       208 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (323)
                      .....||+.|+|||++.+..     ++.++||||||+++|+|+||+.||.+.+    ...+...+.. ....++..++++
T Consensus       161 ~~~~~Gt~~Y~APE~~~~~~-----~~~~~DiwSlGvilyell~G~~Pf~~~~----~~~~~~~i~~-~~~~~p~~~s~~  230 (263)
T d2j4za1         161 RTTLCGTLDYLPPEMIEGRM-----HDEKVDLWSLGVLCYEFLVGKPPFEANT----YQETYKRISR-VEFTFPDFVTEG  230 (263)
T ss_dssp             CEETTEEGGGCCHHHHTTCC-----CCTTHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHHHHT-TCCCCCTTSCHH
T ss_pred             ccccCCCCcccCHHHHcCCC-----CCchhhhhhHhHHHHHHhcCCCCCCCCC----HHHHHHHHHc-CCCCCCccCCHH
Confidence            34567999999999997443     4569999999999999999999995543    2333333332 335577889999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          288 FRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       288 l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      +.+|+.+||+.||++|||++|+|+||||+++
T Consensus       231 ~~~li~~~L~~dp~~R~t~~eil~hp~~~~~  261 (263)
T d2j4za1         231 ARDLISRLLKHNPSQRPMLREVLEHPWITAN  261 (263)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             HHHHHHHHccCCHhHCcCHHHHHcCcCcCCc
Confidence            9999999999999999999999999999753

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-61  Score=412.71  Aligned_cols=262  Identities=32%  Similarity=0.555  Sum_probs=224.7

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      .+.|++++.||+|+||+||+|++..+++.||+|++..... ...+.+.+|++++++++||||+++++++.+ ++.+++||
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~lvm   88 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE-EELEDYMVEIDILASCDHPNIVKLLDAFYY-ENNLWILI   88 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS-GGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred             ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEee-CCeEEEEE
Confidence            3579999999999999999999999999999999975533 345678899999999999999999999998 68899999


Q ss_pred             eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          130 EYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       130 e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      ||+++|+|.+++.+ .+.+++..+..++.||+.||.|||++||+||||||+||+++.++ ++||+|||+|..........
T Consensus        89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~-~~Kl~DFG~a~~~~~~~~~~  167 (288)
T d2jfla1          89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRR  167 (288)
T ss_dssp             ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECHHHHHHH
T ss_pred             ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCC-CEEEEechhhhccCCCcccc
Confidence            99999999998764 55799999999999999999999999999999999999999987 89999999997654443344


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCC--CCCCCCCh
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPP--SLPDGASP  286 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  286 (323)
                      ....||+.|+|||++.........++.++|||||||++|+|+||..||.+.........+    ....++  ..+..+++
T Consensus       168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i----~~~~~~~~~~~~~~s~  243 (288)
T d2jfla1         168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI----AKSEPPTLAQPSRWSS  243 (288)
T ss_dssp             TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH----HHSCCCCCSSGGGSCH
T ss_pred             cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH----HcCCCCCCCccccCCH
Confidence            567899999999999766655667788999999999999999999999765444333322    223332  33467899


Q ss_pred             hHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          287 EFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       287 ~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                      ++.+||++||+.||++|||++|+|+||||+..
T Consensus       244 ~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~  275 (288)
T d2jfla1         244 NFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD  275 (288)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            99999999999999999999999999999753

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-61  Score=411.39  Aligned_cols=256  Identities=29%  Similarity=0.524  Sum_probs=220.0

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      .++|++++.||+|+||+||+|++..+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+ ++.+++||
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~ivm   96 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVM   96 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-HHHHHHHHHHHHHhCCCCCEeeEeEEEEE-CCEEEEEE
Confidence            35899999999999999999999999999999998754332 24678899999999999999999999998 67899999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccc
Q 020657          130 EYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN  209 (323)
Q Consensus       130 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~  209 (323)
                      ||+++++|.+++.++ .+++..++.++.||+.||.|||++||+||||||+||+++.++ ++||+|||++...........
T Consensus        97 Ey~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~-~vkl~DFG~a~~~~~~~~~~~  174 (293)
T d1yhwa1          97 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRS  174 (293)
T ss_dssp             ECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSTTCCBC
T ss_pred             EecCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCC-cEeeccchhheeecccccccc
Confidence            999999999988764 699999999999999999999999999999999999999987 899999999987765555556


Q ss_pred             cccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC-CCCCCCCCChhH
Q 020657          210 SYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD-PPSLPDGASPEF  288 (323)
Q Consensus       210 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l  288 (323)
                      ...||+.|+|||++.+..     ++.++||||||+++|+|+||..||.+....   ..+........ ....+..+++++
T Consensus       175 ~~~gt~~Y~aPE~~~~~~-----~~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~s~~~  246 (293)
T d1yhwa1         175 TMVGTPYWMAPEVVTRKA-----YGPKVDIWSLGIMAIEMIEGEPPYLNENPL---RALYLIATNGTPELQNPEKLSAIF  246 (293)
T ss_dssp             CCCSCGGGCCHHHHSSSC-----BCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHHCSCCCSSGGGSCHHH
T ss_pred             ccccCCCccChhhhcCCC-----CCchhceehHhHHHHHHhhCCCCCCCCCHH---HHHHHHHhCCCCCCCCcccCCHHH
Confidence            678999999999997544     456999999999999999999999654322   22222222222 234456789999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          289 RSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       289 ~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                      .+||.+||+.||++|||++|+|+||||+.
T Consensus       247 ~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         247 RDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence            99999999999999999999999999975

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-61  Score=405.10  Aligned_cols=256  Identities=27%  Similarity=0.433  Sum_probs=211.2

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcC-CCeEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP-SGDIAI  127 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~l  127 (323)
                      .++|++++.||+|+||+||+|++..+|+.||+|++.... +......+.+|++++++++||||+++++++.+. .+.+++
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            478999999999999999999999999999999997654 445567789999999999999999999998643 456899


Q ss_pred             EEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----CeecCCCCCCeEEecCCCcEEEeecCcc
Q 020657          128 LMEYMDSGTLDTLLNK----NGTFSEPKLAHIASQILKGLSYLHGHK-----IIHRDIKPSNLLVNNNNMQVKIADFGVS  198 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~g-----ivH~di~~~nil~~~~~~~~kl~Dfg~~  198 (323)
                      ||||+++|+|.+++.+    ...+++..++.++.||+.||.|||+.|     |+||||||+||+++.++ .+||+|||++
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~-~vkl~DFG~a  161 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGLA  161 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTS-CEEECCHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCC-cEEEeeccce
Confidence            9999999999999863    457999999999999999999999876     99999999999999987 8999999999


Q ss_pred             hhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCC
Q 020657          199 KIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPP  278 (323)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~  278 (323)
                      ..............+|+.|+|||++.+.     .++.++||||||+++|||+||+.||.+.    ....+...+..+...
T Consensus       162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~-----~~~~~~DIwSlGvilyel~tg~~Pf~~~----~~~~~~~~i~~~~~~  232 (269)
T d2java1         162 RILNHDTSFAKAFVGTPYYMSPEQMNRM-----SYNEKSDIWSLGCLLYELCALMPPFTAF----SQKELAGKIREGKFR  232 (269)
T ss_dssp             HHC-----------CCCSCCCHHHHTTC-----CCCHHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHTCCC
T ss_pred             eecccCCCccccCCCCcccCCHHHHcCC-----CCChHHHHHhhCHHHHHHhhCCCCCCCC----CHHHHHHHHHcCCCC
Confidence            8876554455567899999999998744     3466999999999999999999999543    334555556666667


Q ss_pred             CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 020657          279 SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFL  315 (323)
Q Consensus       279 ~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f  315 (323)
                      .++..+|+++.+|+++||+.||++|||++|+|+|||+
T Consensus       233 ~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         233 RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            7888999999999999999999999999999999995

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-61  Score=415.82  Aligned_cols=264  Identities=41%  Similarity=0.729  Sum_probs=222.9

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEE
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIA  126 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  126 (323)
                      ++..++|++++.||+|+||+||+|++..+|+.||+|++...........+.+|+.+++.++||||++++++|.+ .+.++
T Consensus         2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~   80 (322)
T d1s9ja_           2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEIS   80 (322)
T ss_dssp             CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC-SSEEE
T ss_pred             CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEE
Confidence            35678999999999999999999999999999999999877666777889999999999999999999999998 67899


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc
Q 020657          127 ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGH-KIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL  205 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~  205 (323)
                      +||||+.+++|.+++.+.+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+|.......
T Consensus        81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~~~~~~  159 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSM  159 (322)
T ss_dssp             EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHHHHHHT
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC-CEEEeeCCCccccCCCc
Confidence            9999999999999999888899999999999999999999974 999999999999999997 89999999998764432


Q ss_pred             cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccH--------------------
Q 020657          206 DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDW--------------------  265 (323)
Q Consensus       206 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~--------------------  265 (323)
                        ....+||..|+|||++.+..     ++.++||||+||++|||++|+.||.+.......                    
T Consensus       160 --~~~~~GT~~Y~APEvl~~~~-----y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (322)
T d1s9ja_         160 --ANSFVGTRSYMSPERLQGTH-----YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT  232 (322)
T ss_dssp             --C---CCSSCCCCHHHHHCSC-----CCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred             --cccccCCccccCchHHcCCC-----CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence              34568999999999997544     456999999999999999999999765432110                    


Q ss_pred             ------------------HHHHHHHhcCCCCCCC-CCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          266 ------------------ATLMCAICFGDPPSLP-DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       266 ------------------~~~~~~~~~~~~~~~~-~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                                        ...........++.++ ..+|.++.+||++||+.||++|||++|+|+||||++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~  305 (322)
T d1s9ja_         233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  305 (322)
T ss_dssp             -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             ccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence                              1111122222233333 34689999999999999999999999999999997643

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.7e-60  Score=406.12  Aligned_cols=259  Identities=29%  Similarity=0.458  Sum_probs=221.4

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ..|++++.||+|+||+||+|++..+++.||+|++....  .....+.+.+|+.++++++||||+++++++.+ ++..++|
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~iv   93 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAWLV   93 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-CCEEEEE
Confidence            45999999999999999999999999999999997653  33456778999999999999999999999987 6889999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          129 MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      ||||.+++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....    .
T Consensus        94 ~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~-~~Kl~DFG~a~~~~~----~  168 (309)
T d1u5ra_          94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAP----A  168 (309)
T ss_dssp             EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-EEEECCCTTCBSSSS----B
T ss_pred             EEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCC-CEEEeecccccccCC----C
Confidence            99999999988888788899999999999999999999999999999999999999987 999999999976433    2


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhH
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEF  288 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (323)
                      ....||+.|+|||++.+..  ...++.++||||||+++|||++|..||.+...   ...+........+...+..+|+++
T Consensus       169 ~~~~GT~~Y~APE~~~~~~--~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~s~~~  243 (309)
T d1u5ra_         169 NSFVGTPYWMAPEVILAMD--EGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNESPALQSGHWSEYF  243 (309)
T ss_dssp             CCCCSCGGGCCHHHHTTTT--SCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCCCCSCTTSCHHH
T ss_pred             CccccCccccCHHHHhccC--CCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhCCCCCCCCCCCCHHH
Confidence            3467999999999986332  23456799999999999999999999965432   233333333333444456789999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          289 RSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       289 ~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                      .+|+++||+.||++|||++++|+||||.+.+.
T Consensus       244 ~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~  275 (309)
T d1u5ra_         244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP  275 (309)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred             HHHHHHHCcCChhHCcCHHHHHhCHHhcCCCC
Confidence            99999999999999999999999999987554

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.1e-60  Score=408.37  Aligned_cols=258  Identities=28%  Similarity=0.445  Sum_probs=203.7

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      .++|++.+.||+|+||+||+|++..+++.||+|++...........+.+|+.+++.++||||+++++++.+ ++.+++||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lvm   86 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES-GGHLYLIM   86 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEE
Confidence            46799999999999999999999999999999999766544445678899999999999999999999997 78899999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEec---CCCcEEEeecCcchhhccCcc
Q 020657          130 EYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNN---NNMQVKIADFGVSKIMCRSLD  206 (323)
Q Consensus       130 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~---~~~~~kl~Dfg~~~~~~~~~~  206 (323)
                      ||++|++|.+++...+.+++..+..++.||+.||.|||+.|++||||||+||++..   ++ .+||+|||++...... .
T Consensus        87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~-~vkl~DFG~a~~~~~~-~  164 (307)
T d1a06a_          87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDS-KIMISDFGLSKMEDPG-S  164 (307)
T ss_dssp             CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTC-CEEECCC-----------
T ss_pred             eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCc-eEEEeccceeEEccCC-C
Confidence            99999999999998889999999999999999999999999999999999999953   45 8999999999765433 2


Q ss_pred             ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC---CCCCCCC
Q 020657          207 ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD---PPSLPDG  283 (323)
Q Consensus       207 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  283 (323)
                      .....+||+.|+|||++.+..     ++.++|||||||++|+|++|..||.+...    ..+...+....   +...+..
T Consensus       165 ~~~~~~GT~~y~APE~~~~~~-----~~~~~DiwSlGvilyell~g~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~  235 (307)
T d1a06a_         165 VLSTACGTPGYVAPEVLAQKP-----YSKAVDCWSIGVIAYILLCGYPPFYDEND----AKLFEQILKAEYEFDSPYWDD  235 (307)
T ss_dssp             --------CTTSCHHHHTTCC-----CCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHTTCCCCCTTTTTT
T ss_pred             eeeeeeeCccccCcHHHcCCC-----CCcHHHhhhhhHHHHHHHhCCCCCCCCCH----HHHHHHHhccCCCCCCccccC
Confidence            334567999999999997443     45699999999999999999999965433    22333332222   2344568


Q ss_pred             CChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          284 ASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       284 ~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      +|+++.+|+.+||+.||++|||++|+++||||++..
T Consensus       236 ~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  271 (307)
T d1a06a_         236 ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT  271 (307)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSC
T ss_pred             CCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence            999999999999999999999999999999998654

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-59  Score=407.36  Aligned_cols=259  Identities=28%  Similarity=0.527  Sum_probs=226.4

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeE
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDI  125 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  125 (323)
                      +..++|++++.||+|+||.||+|++..+|+.||+|++....  .....+.+.+|+.+++.++||||+++++++.+ ...+
T Consensus         2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~   80 (337)
T d1o6la_           2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-HDRL   80 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-SSEE
T ss_pred             CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc-cccc
Confidence            45689999999999999999999999999999999996431  12235667899999999999999999999998 7889


Q ss_pred             EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc
Q 020657          126 AILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL  205 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~  205 (323)
                      ++||||+++|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.+| .+||+|||+|.......
T Consensus        81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g-~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCSCCTT
T ss_pred             ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCC-CEEEeecccccccccCC
Confidence            99999999999999999988999999999999999999999999999999999999999998 89999999998765555


Q ss_pred             cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCC
Q 020657          206 DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS  285 (323)
Q Consensus       206 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (323)
                      ......+||+.|+|||++.+..+     +.++|||||||++|||++|+.||.+.+.    ..+.+.+... ...++..+|
T Consensus       160 ~~~~~~~GT~~Y~aPE~~~~~~y-----~~~~DiwSlGvilyeml~G~~pf~~~~~----~~~~~~i~~~-~~~~p~~~s  229 (337)
T d1o6la_         160 ATMKTFCGTPEYLAPEVLEDNDY-----GRAVDWWGLGVVMYEMMCGRLPFYNQDH----ERLFELILME-EIRFPRTLS  229 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSSSCB-----CTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHC-CCCCCTTSC
T ss_pred             cccccceeCHHHhhhhhccCCCC-----ChhhcccchhhHHHHHHHCCCCCCCcCH----HHHHHHHhcC-CCCCCccCC
Confidence            55566789999999999975544     5699999999999999999999965433    3343333333 356788999


Q ss_pred             hhHHHHHHHhcccCcCCCCC-----HHHHhcCcccccC
Q 020657          286 PEFRSFIECCLQKEFSKRWT-----ASQLLTHPFLCKN  318 (323)
Q Consensus       286 ~~l~~ll~~~l~~~p~~Rpt-----~~~~l~h~~f~~~  318 (323)
                      +++.+||++||+.||++|++     ++++++||||++.
T Consensus       230 ~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i  267 (337)
T d1o6la_         230 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence            99999999999999999994     9999999999875

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-60  Score=406.70  Aligned_cols=258  Identities=29%  Similarity=0.487  Sum_probs=218.7

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      .++|++.+.||+|+||+||+|++..+++.||+|++....  +......+.+|++++++++||||+++++++.+ ++.+++
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~i   85 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-DEKLYF   85 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC-SSEEEE
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE-CCEEEE
Confidence            378999999999999999999999999999999986431  12234678899999999999999999999997 688999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc--
Q 020657          128 LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL--  205 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~--  205 (323)
                      ||||+++|+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+||+++.++ .+||+|||+|.......  
T Consensus        86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~-~vkl~DFG~a~~~~~~~~~  164 (288)
T d1uu3a_          86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESKQ  164 (288)
T ss_dssp             EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECC-----
T ss_pred             EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCc-eEEecccccceecccCCcc
Confidence            999999999999999888999999999999999999999999999999999999999997 89999999998664322  


Q ss_pred             cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCC
Q 020657          206 DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS  285 (323)
Q Consensus       206 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (323)
                      .......||+.|+|||++.+.     .++.++|||||||++|+|+||..||.+.+    ...+...+... ...++..++
T Consensus       165 ~~~~~~~GT~~Y~APE~~~~~-----~~~~~~DiwSlGvilyell~g~~Pf~~~~----~~~~~~~i~~~-~~~~p~~~s  234 (288)
T d1uu3a_         165 ARANSFVGTAQYVSPELLTEK-----SACKSSDLWALGCIIYQLVAGLPPFRAGN----EYLIFQKIIKL-EYDFPEKFF  234 (288)
T ss_dssp             -----CCCCGGGCCHHHHHTC-----CCCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHTT-CCCCCTTCC
T ss_pred             cccccccCCccccCceeeccC-----CCCcccceehhhHHHHHHhhCCCCCCCcC----HHHHHHHHHcC-CCCCCccCC
Confidence            223456799999999998744     34669999999999999999999996543    23333333332 356778899


Q ss_pred             hhHHHHHHHhcccCcCCCCCHHH------HhcCcccccCC
Q 020657          286 PEFRSFIECCLQKEFSKRWTASQ------LLTHPFLCKNR  319 (323)
Q Consensus       286 ~~l~~ll~~~l~~~p~~Rpt~~~------~l~h~~f~~~~  319 (323)
                      +++.+||++||+.||++|||++|      +++||||+++.
T Consensus       235 ~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~  274 (288)
T d1uu3a_         235 PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT  274 (288)
T ss_dssp             HHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCC
Confidence            99999999999999999999988      58899998864

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-59  Score=395.11  Aligned_cols=252  Identities=29%  Similarity=0.463  Sum_probs=213.9

Q ss_pred             cceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcC---CCeEEEE
Q 020657           53 LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP---SGDIAIL  128 (323)
Q Consensus        53 ~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~~lv  128 (323)
                      |++...||+|+||+||+|++..+++.||+|++.... .....+.+.+|++++++++||||+++++++.+.   ...+++|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            477789999999999999999999999999987543 445567789999999999999999999998642   4568999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCCeEEec-CCCcEEEeecCcchhhccCc
Q 020657          129 MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHK--IIHRDIKPSNLLVNN-NNMQVKIADFGVSKIMCRSL  205 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~g--ivH~di~~~nil~~~-~~~~~kl~Dfg~~~~~~~~~  205 (323)
                      |||+++++|.+++.+...+++..++.++.||+.||.|||++|  |+||||||+|||++. ++ .+||+|||++...... 
T Consensus        91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~-~~Kl~DFGla~~~~~~-  168 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG-SVKIGDLGLATLKRAS-  168 (270)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTS-CEEECCTTGGGGCCTT-
T ss_pred             EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCC-CEEEeecCcceeccCC-
Confidence            999999999999998889999999999999999999999998  999999999999975 55 8999999999754332 


Q ss_pred             cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC-CCCCCCCC
Q 020657          206 DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD-PPSLPDGA  284 (323)
Q Consensus       206 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  284 (323)
                       ......||+.|+|||++.+      .++.++||||||+++|+|++|+.||....   ....+.+.+..+. +..++...
T Consensus       169 -~~~~~~GT~~Y~aPE~~~~------~~~~~~DIwSlGvilyel~~g~~Pf~~~~---~~~~~~~~i~~~~~~~~~~~~~  238 (270)
T d1t4ha_         169 -FAKAVIGTPEFMAPEMYEE------KYDESVDVYAFGMCMLEMATSEYPYSECQ---NAAQIYRRVTSGVKPASFDKVA  238 (270)
T ss_dssp             -SBEESCSSCCCCCGGGGGT------CCCTHHHHHHHHHHHHHHHHSSCTTTTCS---SHHHHHHHHTTTCCCGGGGGCC
T ss_pred             -ccCCcccCccccCHHHhCC------CCCCcCchhhHHHHHHHHHHCCCCCCCcc---cHHHHHHHHHcCCCCcccCccC
Confidence             2345679999999999853      25679999999999999999999996443   2333444443333 34456678


Q ss_pred             ChhHHHHHHHhcccCcCCCCCHHHHhcCcccc
Q 020657          285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLC  316 (323)
Q Consensus       285 ~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~  316 (323)
                      ++++.+|+.+||+.||++|||++|+|+||||+
T Consensus       239 ~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         239 IPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            99999999999999999999999999999996

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-58  Score=393.85  Aligned_cols=259  Identities=25%  Similarity=0.436  Sum_probs=218.6

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-----ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCe
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-----DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGD  124 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  124 (323)
                      .++|++.+.||+|+||+||+|++..+|+.||+|++....     .....+.+.+|+.++++++||||+++++++.+ .+.
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~   87 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN-KTD   87 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCE
Confidence            467999999999999999999999999999999986442     22246778999999999999999999999998 788


Q ss_pred             EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCC---cEEEeecCcchhh
Q 020657          125 IAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNM---QVKIADFGVSKIM  201 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~---~~kl~Dfg~~~~~  201 (323)
                      +++||||+++|+|.+++...+.+++..++.++.||+.||.|||+.|++||||||+||+++.++.   .+||+|||++...
T Consensus        88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~  167 (293)
T d1jksa_          88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  167 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence            9999999999999999988889999999999999999999999999999999999999987652   5999999999766


Q ss_pred             ccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC---CC
Q 020657          202 CRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD---PP  278 (323)
Q Consensus       202 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~---~~  278 (323)
                      ... .......+++.|+|||++...     .++.++||||||+++|+|+||+.||.+....    .....+....   +.
T Consensus       168 ~~~-~~~~~~~~t~~y~APE~~~~~-----~~~~~~DiwSlGvilyell~g~~Pf~~~~~~----~~~~~i~~~~~~~~~  237 (293)
T d1jksa_         168 DFG-NEFKNIFGTPEFVAPEIVNYE-----PLGLEADMWSIGVITYILLSGASPFLGDTKQ----ETLANVSAVNYEFED  237 (293)
T ss_dssp             TTS-CBCSCCCCCGGGCCHHHHTTC-----CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHTTCCCCCH
T ss_pred             CCC-ccccccCCCCcccCHHHHcCC-----CCCCcccchhhhHHHHHHHcCCCCCCCCCHH----HHHHHHHhcCCCCCc
Confidence            433 233456789999999999744     3456999999999999999999999654332    2222322222   12


Q ss_pred             CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          279 SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       279 ~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      ..+..+|.++.+||++||+.||++|||++++|+||||++..
T Consensus       238 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  278 (293)
T d1jksa_         238 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  278 (293)
T ss_dssp             HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred             hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            23367899999999999999999999999999999998643

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.7e-58  Score=397.64  Aligned_cols=254  Identities=27%  Similarity=0.491  Sum_probs=220.7

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++....  .....+.+.+|+.+++.++||||+++++++.+ .+.+++
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~i   81 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-AQQIFM   81 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-SSEEEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee-CCeeee
Confidence            578999999999999999999999999999999986431  12235678899999999999999999999998 789999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccc
Q 020657          128 LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA  207 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~  207 (323)
                      ||||+.|++|..++.....+++..++.++.||+.||.|||++||+||||||+||+++.+| .+||+|||+|......   
T Consensus        82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g-~vkL~DFG~a~~~~~~---  157 (316)
T d1fota_          82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG-HIKITDFGFAKYVPDV---  157 (316)
T ss_dssp             EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS-CEEECCCSSCEECSSC---
T ss_pred             EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCC-CEEEecCccceEeccc---
Confidence            999999999999999988999999999999999999999999999999999999999987 8999999999775433   


Q ss_pred             cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChh
Q 020657          208 CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPE  287 (323)
Q Consensus       208 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (323)
                      .....||+.|+|||++.+..     ++.++||||||+++|+|+||..||.+.+    ...+...+..+ ...++..++++
T Consensus       158 ~~~~~Gt~~Y~APE~l~~~~-----y~~~~DiwSlGvilyemltG~~Pf~~~~----~~~~~~~i~~~-~~~~p~~~s~~  227 (316)
T d1fota_         158 TYTLCGTPDYIAPEVVSTKP-----YNKSIDWWSFGILIYEMLAGYTPFYDSN----TMKTYEKILNA-ELRFPPFFNED  227 (316)
T ss_dssp             BCCCCSCTTTCCHHHHTTCC-----BCTTHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHHHHHC-CCCCCTTSCHH
T ss_pred             cccccCcccccCHHHHcCCC-----CCchhhccccchhHHHHHhCCCCCCCcC----HHHHHHHHHcC-CCCCCCCCCHH
Confidence            23567999999999987444     4569999999999999999999996543    23333333333 34567889999


Q ss_pred             HHHHHHHhcccCcCCCC-----CHHHHhcCcccccC
Q 020657          288 FRSFIECCLQKEFSKRW-----TASQLLTHPFLCKN  318 (323)
Q Consensus       288 l~~ll~~~l~~~p~~Rp-----t~~~~l~h~~f~~~  318 (323)
                      +.+++++||..||.+|+     |++++++||||+++
T Consensus       228 ~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i  263 (316)
T d1fota_         228 VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV  263 (316)
T ss_dssp             HHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             HHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence            99999999999999996     99999999999886

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=8.5e-58  Score=402.68  Aligned_cols=260  Identities=29%  Similarity=0.504  Sum_probs=219.5

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCC-----CChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCC
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD-----ADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG  123 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  123 (323)
                      ..++|++.+.||+|+||.||+|++..+|+.||+|++...     ..........+++.+++.+.||||+++++++.+ .+
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~-~~   80 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-PD   80 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-SS
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE-CC
Confidence            468999999999999999999999999999999998532     112222333455777888899999999999998 68


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          124 DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      .+++||||+++++|.+++.+...+++..++.++.||+.||.|||++|++||||||+|||++.+| .+||+|||+|.....
T Consensus        81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g-~iKl~DFGla~~~~~  159 (364)
T d1omwa3          81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSK  159 (364)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSS-CEEECCCTTCEECSS
T ss_pred             EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCC-cEEEeeeceeeecCC
Confidence            8999999999999999999888999999999999999999999999999999999999999987 899999999976543


Q ss_pred             CccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCC
Q 020657          204 SLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDG  283 (323)
Q Consensus       204 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (323)
                      .  ......||+.|+|||++..    ...++.++|||||||++|+|+||+.||........ ..+.. ........++..
T Consensus       160 ~--~~~~~~GT~~y~APE~~~~----~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~~~-~~~~~~~~~~~~  231 (364)
T d1omwa3         160 K--KPHASVGTHGYMAPEVLQK----GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDR-MTLTMAVELPDS  231 (364)
T ss_dssp             S--CCCSCCSCGGGCCHHHHST----TCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-HHHHH-HSSSCCCCCCSS
T ss_pred             C--cccccccccccchhHHhhc----CCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH-hcccCCCCCCCC
Confidence            3  2345679999999999863    23456699999999999999999999976544332 22222 233445667788


Q ss_pred             CChhHHHHHHHhcccCcCCCCC-----HHHHhcCcccccC
Q 020657          284 ASPEFRSFIECCLQKEFSKRWT-----ASQLLTHPFLCKN  318 (323)
Q Consensus       284 ~~~~l~~ll~~~l~~~p~~Rpt-----~~~~l~h~~f~~~  318 (323)
                      +++++.+||.+||+.||++|||     ++++++||||+++
T Consensus       232 ~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i  271 (364)
T d1omwa3         232 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  271 (364)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred             CCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence            9999999999999999999999     7999999999875

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.9e-58  Score=402.78  Aligned_cols=257  Identities=26%  Similarity=0.453  Sum_probs=218.1

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      .++|++++.||+|+||.||+|++..+|+.||+|++.... ......+.+|+.++++++||||+++++++.+ ++.+++||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~ivm  105 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFED-KYEMVLIL  105 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-SSEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEE
Confidence            478999999999999999999999999999999997554 3345678899999999999999999999997 78899999


Q ss_pred             eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEe--cCCCcEEEeecCcchhhccCcc
Q 020657          130 EYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVN--NNNMQVKIADFGVSKIMCRSLD  206 (323)
Q Consensus       130 e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~--~~~~~~kl~Dfg~~~~~~~~~~  206 (323)
                      ||++|++|.+.+... .++++..++.++.||+.||.|||++||+||||||+|||++  .++ .+||+|||+|...... .
T Consensus       106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~-~vkL~DFGla~~~~~~-~  183 (352)
T d1koba_         106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKAS-SVKIIDFGLATKLNPD-E  183 (352)
T ss_dssp             ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCC-CEEECCCTTCEECCTT-S
T ss_pred             EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCC-eEEEeecccceecCCC-C
Confidence            999999998877654 4699999999999999999999999999999999999998  345 8999999999776433 2


Q ss_pred             ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC---CCCCCCC
Q 020657          207 ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD---PPSLPDG  283 (323)
Q Consensus       207 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  283 (323)
                      ......+++.|+|||++.+..     ++.++|||||||++|+|+||..||.+....    .....+....   +......
T Consensus       184 ~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwSlGvilyelltG~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~  254 (352)
T d1koba_         184 IVKVTTATAEFAAPEIVDREP-----VGFYTDMWAIGVLGYVLLSGLSPFAGEDDL----ETLQNVKRCDWEFDEDAFSS  254 (352)
T ss_dssp             CEEEECSSGGGCCHHHHTTCC-----BCHHHHHHHHHHHHHHHHHSCCSSCCSSHH----HHHHHHHHCCCCCCSSTTTT
T ss_pred             ceeeccCcccccCHHHHcCCC-----CCCccchHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCCcccccC
Confidence            334567899999999997544     456999999999999999999999654332    2222222222   3344568


Q ss_pred             CChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          284 ASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       284 ~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      +++++.+||++||+.||.+|||++|+|+||||++..
T Consensus       255 ~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         255 VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence            999999999999999999999999999999998654

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.5e-58  Score=391.52  Aligned_cols=261  Identities=28%  Similarity=0.456  Sum_probs=221.0

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC--------hHHHHHHHHHHHHHHcCC-CCccceeceeEEc
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD--------PTVRRQVFREMEILRRTD-SPFIVQCFGIFEK  120 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~--------~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~  120 (323)
                      .++|++.+.||+|+||+||+|++..+++.||+|++.....        ....+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            4789999999999999999999999999999999975532        123456889999999996 9999999999998


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchh
Q 020657          121 PSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       121 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                       ++..++||||+++++|.+++...+.+++..++.++.||+.||+|||++|++||||||+||+++.++ .+||+|||++..
T Consensus        82 -~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~-~~kl~DFG~a~~  159 (277)
T d1phka_          82 -NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSCQ  159 (277)
T ss_dssp             -SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEE
T ss_pred             -CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCC-CeEEccchheeE
Confidence             789999999999999999999888999999999999999999999999999999999999999987 899999999987


Q ss_pred             hccCccccccccccccccCCcccCCCCC-CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC---
Q 020657          201 MCRSLDACNSYVGTCAYMSPERFDPDAY-GGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD---  276 (323)
Q Consensus       201 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~---  276 (323)
                      ..... ......||..|.|||.+.+... ....++.++||||+|+++|+|+||+.||.+....    ...+.+..+.   
T Consensus       160 ~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~----~~~~~i~~~~~~~  234 (277)
T d1phka_         160 LDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM----LMLRMIMSGNYQF  234 (277)
T ss_dssp             CCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHTCCCC
T ss_pred             ccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH----HHHHHHHhCCCCC
Confidence            65432 2345679999999999864322 2344577999999999999999999999654332    2222222222   


Q ss_pred             CCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          277 PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       277 ~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                      +......+|+++.+|+.+||+.||++|||++|+|+||||++
T Consensus       235 ~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         235 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence            22233579999999999999999999999999999999976

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=4.4e-58  Score=402.17  Aligned_cols=257  Identities=26%  Similarity=0.415  Sum_probs=218.0

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      .++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+ ++.+++||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~ivm  102 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFED-DNEMVMIY  102 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEE
Confidence            468999999999999999999999999999999997553 3445678899999999999999999999998 78999999


Q ss_pred             eccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEec--CCCcEEEeecCcchhhccCcc
Q 020657          130 EYMDSGTLDTLLN-KNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNN--NNMQVKIADFGVSKIMCRSLD  206 (323)
Q Consensus       130 e~~~~~sL~~~l~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~--~~~~~kl~Dfg~~~~~~~~~~  206 (323)
                      ||+++|+|.+++. ..+.+++..+..++.||+.||.|||++|++||||||+||+++.  ++ .+||+|||++...... .
T Consensus       103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~-~vkL~DFG~a~~~~~~-~  180 (350)
T d1koaa2         103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSN-ELKLIDFGLTAHLDPK-Q  180 (350)
T ss_dssp             CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSC-CEEECCCTTCEECCTT-S
T ss_pred             EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCC-eEEEeecchheecccc-c
Confidence            9999999999985 4457999999999999999999999999999999999999964  34 8999999999766433 2


Q ss_pred             ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC---CCCCCCC
Q 020657          207 ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD---PPSLPDG  283 (323)
Q Consensus       207 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  283 (323)
                      ......+|+.|+|||++.+..     ++.++|||||||++|+|+||..||.+.+.    ..+...+....   +......
T Consensus       181 ~~~~~~gT~~Y~aPEv~~~~~-----~~~~~DiwSlGvilyell~G~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~  251 (350)
T d1koaa2         181 SVKVTTGTAEFAAPEVAEGKP-----VGYYTDMWSVGVLSYILLSGLSPFGGEND----DETLRNVKSCDWNMDDSAFSG  251 (350)
T ss_dssp             CEEEECSCTTTCCHHHHHTCC-----BCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHTCCCSCCGGGGG
T ss_pred             ccceecCcccccCHHHHcCCC-----CChhHhhhhhhHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCCCCCcccccC
Confidence            334567899999999987443     45699999999999999999999965432    33333333222   2233357


Q ss_pred             CChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          284 ASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       284 ~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      +++++.+||++||+.||++|||++|+|+||||++..
T Consensus       252 ~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~  287 (350)
T d1koaa2         252 ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN  287 (350)
T ss_dssp             CCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            899999999999999999999999999999998654

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-58  Score=395.30  Aligned_cols=262  Identities=26%  Similarity=0.397  Sum_probs=214.3

Q ss_pred             ceeeeecccCCeEEEEEEecccCcEEEEEeecCCCCh----HHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           54 EKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADP----TVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        54 ~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      +.++.||+|+||+||+|++..+|+.||+|++......    .....+.+|+.+++.++||||+++++++.+ ++.+++||
T Consensus         1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~-~~~~~ivm   79 (299)
T d1ua2a_           1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-KSNISLVF   79 (299)
T ss_dssp             CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-TTCCEEEE
T ss_pred             CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCceeehh
Confidence            3578999999999999999999999999998654322    223568899999999999999999999998 67899999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccc
Q 020657          130 EYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN  209 (323)
Q Consensus       130 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~  209 (323)
                      ||+.++++..+...+..+++..+..++.||+.||+|||++|++||||||+||+++.++ .+||+|||++...........
T Consensus        80 E~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~-~~KL~DFG~a~~~~~~~~~~~  158 (299)
T d1ua2a_          80 DFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG-VLKLADFGLAKSFGSPNRAYT  158 (299)
T ss_dssp             ECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCCGGGSTTTSCCCCCC
T ss_pred             hhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCC-ccccccCccccccCCCccccc
Confidence            9999888777777777899999999999999999999999999999999999999987 899999999987766555556


Q ss_pred             cccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCC-----------
Q 020657          210 SYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPP-----------  278 (323)
Q Consensus       210 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----------  278 (323)
                      ..++|+.|+|||++..    ...++.++|||||||++|||+||..||.+....+....+.+........           
T Consensus       159 ~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~  234 (299)
T d1ua2a_         159 HQVVTRWYRAPELLFG----ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY  234 (299)
T ss_dssp             CSCCCCTTCCHHHHTT----CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred             ceecChhhccHHHHcc----CCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchh
Confidence            6789999999999862    3345679999999999999999999996654443333333322111110           


Q ss_pred             -------C-----CCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCCC
Q 020657          279 -------S-----LPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS  321 (323)
Q Consensus       279 -------~-----~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~  321 (323)
                             .     ....+++++.+||++||+.||++|||++|+|+||||++...|
T Consensus       235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p  289 (299)
T d1ua2a_         235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  289 (299)
T ss_dssp             CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCC
Confidence                   0     113568899999999999999999999999999999987543

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-57  Score=394.33  Aligned_cols=256  Identities=26%  Similarity=0.444  Sum_probs=219.1

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHH-HcCCCCccceeceeEEcCCCeEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEIL-RRTDSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++....  .......+..|..++ +.++||||+++++++.+ ++.+++
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~-~~~~yi   80 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-KENLFF   80 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-SSEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc-CCceeE
Confidence            68999999999999999999999999999999996431  111233455666655 46899999999999998 688999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccc
Q 020657          128 LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA  207 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~  207 (323)
                      ||||+++|+|.+++.....+++..++.++.||+.||.|||++|++||||||+|||++.++ ++||+|||++.........
T Consensus        81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~-~~kl~DFG~a~~~~~~~~~  159 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG-HIKIADFGMCKENMLGDAK  159 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCTTCC
T ss_pred             EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCC-ceeccccchhhhccccccc
Confidence            999999999999999888999999999999999999999999999999999999999987 8999999999876555555


Q ss_pred             cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChh
Q 020657          208 CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPE  287 (323)
Q Consensus       208 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (323)
                      .....||+.|+|||++.+..     ++.++|||||||++|+|+||+.||.+.+    ...+...+... .+.++..+|++
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwSlGvilyemltG~~PF~~~~----~~~~~~~i~~~-~~~~p~~~s~~  229 (320)
T d1xjda_         160 TNTFCGTPDYIAPEILLGQK-----YNHSVDWWSFGVLLYEMLIGQSPFHGQD----EEELFHSIRMD-NPFYPRWLEKE  229 (320)
T ss_dssp             BCCCCSCGGGCCHHHHTTCC-----BCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHC-CCCCCTTSCHH
T ss_pred             ccccCCCCCcCCHHHHcCCC-----CCchhhhhhhhHHHHHHHhCCCCCCCCC----HHHHHHHHHcC-CCCCCccCCHH
Confidence            56678999999999997443     4569999999999999999999996543    33344444433 45677889999


Q ss_pred             HHHHHHHhcccCcCCCCCHH-HHhcCcccccC
Q 020657          288 FRSFIECCLQKEFSKRWTAS-QLLTHPFLCKN  318 (323)
Q Consensus       288 l~~ll~~~l~~~p~~Rpt~~-~~l~h~~f~~~  318 (323)
                      +.+||++||+.||++|||++ ++++||||++.
T Consensus       230 ~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~  261 (320)
T d1xjda_         230 AKDLLVKLFVREPEKRLGVRGDIRQHPLFREI  261 (320)
T ss_dssp             HHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             HHHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence            99999999999999999995 89999999875

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1e-57  Score=400.09  Aligned_cols=255  Identities=26%  Similarity=0.474  Sum_probs=220.5

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      .++|++++.||+|+||.||+|+++.+|+.||+|++....  .......+.+|+.+++.++||||+++++++.+ ....++
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~~  118 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-NSNLYM  118 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc-cccccc
Confidence            479999999999999999999999999999999986331  12234568899999999999999999999998 688999


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccc
Q 020657          128 LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDA  207 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~  207 (323)
                      ||||+.+++|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.+| .+||+|||+|......   
T Consensus       119 v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g-~ikL~DFG~a~~~~~~---  194 (350)
T d1rdqe_         119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG-YIQVTDFGFAKRVKGR---  194 (350)
T ss_dssp             EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECSSC---
T ss_pred             ccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCC-CEEeeeceeeeecccc---
Confidence            999999999999999888999999999999999999999999999999999999999987 8999999999876433   


Q ss_pred             cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChh
Q 020657          208 CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPE  287 (323)
Q Consensus       208 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (323)
                      .....||+.|+|||++.+..     ++.++|||||||++|+|+||..||.+..    ...+...+... ...++..++++
T Consensus       195 ~~~~~Gt~~Y~APE~~~~~~-----~~~~~DiwSlGvilyemltG~~Pf~~~~----~~~~~~~i~~~-~~~~p~~~s~~  264 (350)
T d1rdqe_         195 TWTLCGTPEALAPEIILSKG-----YNKAVDWWALGVLIYEMAAGYPPFFADQ----PIQIYEKIVSG-KVRFPSHFSSD  264 (350)
T ss_dssp             BCCCEECGGGCCHHHHTTCC-----BCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHC-CCCCCTTCCHH
T ss_pred             cccccCccccCCHHHHcCCC-----CCccccccchhHHHHHHHhCCCCCCCcC----HHHHHHHHhcC-CCCCCccCCHH
Confidence            23567999999999997544     4569999999999999999999996542    33333333333 34567789999


Q ss_pred             HHHHHHHhcccCcCCCC-----CHHHHhcCcccccCC
Q 020657          288 FRSFIECCLQKEFSKRW-----TASQLLTHPFLCKNR  319 (323)
Q Consensus       288 l~~ll~~~l~~~p~~Rp-----t~~~~l~h~~f~~~~  319 (323)
                      +.+||++||+.||.+|+     |++++++||||++..
T Consensus       265 ~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~  301 (350)
T d1rdqe_         265 LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD  301 (350)
T ss_dssp             HHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred             HHHHHHHHhhhCHHhccccccccHHHHHcCccccCCC
Confidence            99999999999999995     999999999998753

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-57  Score=389.15  Aligned_cols=265  Identities=26%  Similarity=0.425  Sum_probs=216.3

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCCh-HHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADP-TVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      ++|++++.||+|+||+||+|++..+|+.||+|++...... .....+.+|++++++++||||+++++++.+ .+.+++||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-~~~~~iv~   80 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-ENKLYLVF   80 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc-ccceeEEE
Confidence            6899999999999999999999999999999999655322 235678899999999999999999999998 78899999


Q ss_pred             eccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcccc
Q 020657          130 EYMDSGTLDTLLN-KNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDAC  208 (323)
Q Consensus       130 e~~~~~sL~~~l~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (323)
                      ||+.++.+..... ....+++..+..++.||+.||.|||+.||+||||||+||+++.++ .+||+|||.|..........
T Consensus        81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~-~~kl~DFG~a~~~~~~~~~~  159 (298)
T d1gz8a_          81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTY  159 (298)
T ss_dssp             ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSTTHHHHHCCCSBCT
T ss_pred             eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccC-cceeccCCcceeccCCcccc
Confidence            9997644443333 345699999999999999999999999999999999999999987 89999999998876666666


Q ss_pred             ccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCC----------
Q 020657          209 NSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPP----------  278 (323)
Q Consensus       209 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------  278 (323)
                      ....+++.|+|||++....    ..+.++||||||+++|+|++|..||.+.........+..........          
T Consensus       160 ~~~~gt~~y~apE~~~~~~----~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         160 THEVVTLWYRAPEILLGCK----YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD  235 (298)
T ss_dssp             TCCBCCCTTCCHHHHTTCS----SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             eeecccceeeehhhhcccc----CCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence            6778999999999876333    34679999999999999999999997654333333332221111100          


Q ss_pred             ---C-----------CCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCCC
Q 020657          279 ---S-----------LPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS  321 (323)
Q Consensus       279 ---~-----------~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~  321 (323)
                         .           ....++.++.+|+++||..||++|||++|+|+||||++..+|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence               0           113567899999999999999999999999999999988765

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.5e-57  Score=385.12  Aligned_cols=258  Identities=22%  Similarity=0.320  Sum_probs=221.6

Q ss_pred             CccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcC
Q 020657           42 TATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP  121 (323)
Q Consensus        42 ~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  121 (323)
                      ....|++..++|++.+.||+|+||+||+|++..+++.||+|++.....  ..+.+.+|+.++++++||||+++++++.+ 
T Consensus         8 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~-   84 (287)
T d1opja_           8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTR-   84 (287)
T ss_dssp             TCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             CCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc--hHHHHHHHHHHHHhCCCCCEecCCccEee-
Confidence            456789999999999999999999999999998999999999875543  34678899999999999999999999987 


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcch
Q 020657          122 SGDIAILMEYMDSGTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       122 ~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                      .+.+++||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++ ++||+|||+++
T Consensus        85 ~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~-~~Kl~DFG~a~  163 (287)
T d1opja_          85 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSR  163 (287)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCCTT
T ss_pred             CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCC-cEEEcccccee
Confidence            67899999999999999998753  5689999999999999999999999999999999999999987 89999999998


Q ss_pred             hhccCcc-ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCC
Q 020657          200 IMCRSLD-ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPP  278 (323)
Q Consensus       200 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~  278 (323)
                      ....... ......++..|+|||++...     .++.++||||||+++|||++|..||.....   ...+.+.+..+..+
T Consensus       164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~---~~~~~~~i~~~~~~  235 (287)
T d1opja_         164 LMTGDTYTAHAGAKFPIKWTAPESLAYN-----KFSIKSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRM  235 (287)
T ss_dssp             TCCSSSSEEETTEEECGGGCCHHHHHHC-----CCSHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHHHHHHTTCCC
T ss_pred             ecCCCCceeeccccccccccChHHHcCC-----CCCchhhhhhHHHHHHHHHhCCCCCCCcch---HHHHHHHHhcCCCC
Confidence            7654322 23344578899999998744     346799999999999999998777754332   34444555556677


Q ss_pred             CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          279 SLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       279 ~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      .++..+++++.+|+.+||+.||++|||++++++
T Consensus       236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            788899999999999999999999999999976

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-56  Score=381.38  Aligned_cols=260  Identities=26%  Similarity=0.404  Sum_probs=210.0

Q ss_pred             chhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCC
Q 020657           45 TAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG  123 (323)
Q Consensus        45 ~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  123 (323)
                      .|+++.++|++.+.||+|+||+||+|++.   ..||||+++... +....+.+.+|+.++++++||||+++++++..  +
T Consensus         2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~--~   76 (276)
T d1uwha_           2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--P   76 (276)
T ss_dssp             CCBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS--S
T ss_pred             CcccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec--c
Confidence            47888999999999999999999999864   359999987543 44567789999999999999999999998754  5


Q ss_pred             eEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          124 DIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      .+++||||+++|+|.+++... ..+++..+..++.||++||+|||++||+||||||+|||++.++ .+||+|||+|....
T Consensus        77 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~-~~Kl~DFGla~~~~  155 (276)
T d1uwha_          77 QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKS  155 (276)
T ss_dssp             SCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTS-SEEECCCCCSCC--
T ss_pred             EEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCC-CEEEccccceeecc
Confidence            689999999999999999754 5699999999999999999999999999999999999999987 89999999997654


Q ss_pred             cCc--cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHH-HhcCCCCC
Q 020657          203 RSL--DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCA-ICFGDPPS  279 (323)
Q Consensus       203 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~  279 (323)
                      ...  .......+|+.|+|||++....  ...++.++||||||+++|||+||+.||.+............. ........
T Consensus       156 ~~~~~~~~~~~~gt~~y~APE~l~~~~--~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~  233 (276)
T d1uwha_         156 RWSGSHQFEQLSGSILWMAPEVIRMQD--KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK  233 (276)
T ss_dssp             ----------CCCCGGGCCHHHHTTCS--SCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGG
T ss_pred             ccCCcccccccccCcccCCHHHHhccc--CCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchh
Confidence            322  2334567899999999986432  234577999999999999999999999765443322222211 11112234


Q ss_pred             CCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          280 LPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       280 ~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ++..+++++.+|+.+||+.||++|||+++++++
T Consensus       234 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            567889999999999999999999999999987

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-56  Score=386.43  Aligned_cols=255  Identities=26%  Similarity=0.390  Sum_probs=215.6

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++....  .....+.+|+++++.++||||+++++++.+ ++.+++||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~lvm   80 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFES-MEELVMIF   80 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEE
Confidence            578999999999999999999999999999999997553  334567899999999999999999999998 68899999


Q ss_pred             eccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC-CcEEEeecCcchhhccCccc
Q 020657          130 EYMDSGTLDTLLNKNG-TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN-MQVKIADFGVSKIMCRSLDA  207 (323)
Q Consensus       130 e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~-~~~kl~Dfg~~~~~~~~~~~  207 (323)
                      |||+|++|.+.+...+ .+++..++.++.||+.||.|||++||+||||||+||+++.++ ..+||+|||++...... ..
T Consensus        81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-~~  159 (321)
T d1tkia_          81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DN  159 (321)
T ss_dssp             CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-CE
T ss_pred             ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC-Cc
Confidence            9999999999997654 799999999999999999999999999999999999998542 37999999999765432 22


Q ss_pred             cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCC---CCCCCCC
Q 020657          208 CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP---PSLPDGA  284 (323)
Q Consensus       208 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  284 (323)
                      .....+++.|+|||.+.+..     ++.++||||||+++|+|++|..||.....    ..+...+.....   ......+
T Consensus       160 ~~~~~~t~~y~ape~~~~~~-----~~~~~DiWSlGvily~ll~G~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~  230 (321)
T d1tkia_         160 FRLLFTAPEYYAPEVHQHDV-----VSTATDMWSLGTLVYVLLSGINPFLAETN----QQIIENIMNAEYTFDEEAFKEI  230 (321)
T ss_dssp             EEEEESCGGGSCHHHHTTCE-----ECHHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHHTCCCCCHHHHTTS
T ss_pred             ccccccccccccchhccCCC-----CCchhhcccHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCCCCChhhccCC
Confidence            34567899999999987444     45699999999999999999999965433    333333332222   1222478


Q ss_pred             ChhHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          285 SPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       285 ~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                      |+++.+||++||..||++|||++|+|+||||++
T Consensus       231 s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         231 SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence            999999999999999999999999999999965

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-56  Score=387.13  Aligned_cols=259  Identities=25%  Similarity=0.346  Sum_probs=215.7

Q ss_pred             cchhccccccceeeeecccCCeEEEEEEecccCc-----EEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceecee
Q 020657           44 TTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHK-----IYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFGI  117 (323)
Q Consensus        44 ~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~-----~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~  117 (323)
                      ..|+++.++|++.+.||+|+||+||+|++..+++     .||+|.+...........+.+|+.+++++ +||||++++++
T Consensus        30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~  109 (325)
T d1rjba_          30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGA  109 (325)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEE
Confidence            4577888999999999999999999999875543     69999987665555667788999999998 89999999999


Q ss_pred             EEcCCCeEEEEEeccCCCCHHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeec
Q 020657          118 FEKPSGDIAILMEYMDSGTLDTLLNKN-----------------------GTFSEPKLAHIASQILKGLSYLHGHKIIHR  174 (323)
Q Consensus       118 ~~~~~~~~~lv~e~~~~~sL~~~l~~~-----------------------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~  174 (323)
                      +.+ .+.+++||||+++|+|.+++...                       ..+++..++.++.||+.||.|||++||+||
T Consensus       110 ~~~-~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR  188 (325)
T d1rjba_         110 CTL-SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR  188 (325)
T ss_dssp             ECS-SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred             Eee-CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            987 67899999999999999999653                       248999999999999999999999999999


Q ss_pred             CCCCCCeEEecCCCcEEEeecCcchhhccCcc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-
Q 020657          175 DIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-  251 (323)
Q Consensus       175 di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-  251 (323)
                      ||||+||+++.++ .+||+|||+|+.......  ......+|+.|+|||++...     .++.++||||||+++|||+| 
T Consensus       189 DlKp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~~DiwS~Gvil~emlt~  262 (325)
T d1rjba_         189 DLAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-----IYTIKSDVWSYGILLWEIFSL  262 (325)
T ss_dssp             TCSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-----CCCHHHHHHHHHHHHHHHTTT
T ss_pred             cCchhccccccCC-eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-----CCCcceeccchhHHHHHHHhC
Confidence            9999999999987 999999999976544332  22345679999999998743     44679999999999999997 


Q ss_pred             CCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          252 GHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       252 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      |..||.+......   +...+..+.....+..+++++.+||.+||+.||++|||+++|++|
T Consensus       263 g~~Pf~~~~~~~~---~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         263 GVNPYPGIPVDAN---FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             SCCSSTTCCCSHH---HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCCHHHH---HHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            8999976555433   333344455677788999999999999999999999999999986

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.6e-56  Score=380.00  Aligned_cols=255  Identities=25%  Similarity=0.403  Sum_probs=207.5

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCc---EEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCC
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHK---IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG  123 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~---~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  123 (323)
                      ++..++|++.+.||+|+||+||+|++..+++   .||+|.+.........+.+.+|+.++++++||||++++|++.. .+
T Consensus        22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~  100 (299)
T d1jpaa_          22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK-ST  100 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred             hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee-CC
Confidence            4667889999999999999999999876654   5889998777777777889999999999999999999999987 67


Q ss_pred             eEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          124 DIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      ..++||||+++|+|.+++.. .+.+++..+..++.||++||.|||++|++||||||+|||++.++ .+||+|||+++...
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~-~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLE  179 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC-------
T ss_pred             EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCC-cEEECCcccceEcc
Confidence            89999999999999998876 45699999999999999999999999999999999999999987 89999999998764


Q ss_pred             cCccc-----cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCC
Q 020657          203 RSLDA-----CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGD  276 (323)
Q Consensus       203 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~  276 (323)
                      .....     .....+++.|+|||++...     .++.++||||||+++|||+| |..||.+..    ...+...+..+.
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~----~~~~~~~i~~~~  250 (299)
T d1jpaa_         180 DDTSDPTYTSALGGKIPIRWTAPEAIQYR-----KFTSASDVWSYGIVMWEVMSYGERPYWDMT----NQDVINAIEQDY  250 (299)
T ss_dssp             ----------------CGGGSCHHHHHSC-----CCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHHHHHHHTTC
T ss_pred             CCCCcceeeecccccCCccccCHHHHhcC-----CCCcccccccchHHHHHHHhCCCCCCCCCC----HHHHHHHHHcCC
Confidence            33221     1224578899999998643     45669999999999999998 899995543    344555556666


Q ss_pred             CCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          277 PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       277 ~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ..+.+..++.++.+|+.+||+.||++|||+++++++
T Consensus       251 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         251 RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            677788899999999999999999999999998865

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.5e-56  Score=380.82  Aligned_cols=260  Identities=23%  Similarity=0.386  Sum_probs=212.9

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-PTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      ++|++++.||+|+||+||+|++. +|+.||+|++..... ......+.+|+.++++++||||+++++++.. ++..+++|
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~i~~   79 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-KKRLVLVF   79 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-SSCEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc-CCceeEEE
Confidence            68999999999999999999996 889999999975532 2335678899999999999999999999998 67899999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccc
Q 020657          130 EYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN  209 (323)
Q Consensus       130 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~  209 (323)
                      |++.++.+..+....+.+++..+..++.||+.||+|||+.||+||||||+||+++.++ .+||+|||.+...........
T Consensus        80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~-~~kl~DfG~a~~~~~~~~~~~  158 (286)
T d1ob3a_          80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVRKYT  158 (286)
T ss_dssp             ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCTTHHHHHCC------
T ss_pred             EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCC-CEEecccccceecccCccccc
Confidence            9999877777777778899999999999999999999999999999999999999997 899999999988765555555


Q ss_pred             cccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCC------------
Q 020657          210 SYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP------------  277 (323)
Q Consensus       210 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~------------  277 (323)
                      ...+++.|+|||.+..    ..+++.++||||||+++|||++|+.||.+.........+.........            
T Consensus       159 ~~~~~~~y~~pE~~~~----~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (286)
T d1ob3a_         159 HEIVTLWYRAPDVLMG----SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY  234 (286)
T ss_dssp             ---CCCTTCCHHHHTT----CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             eecccchhhhHHHHhC----CCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence            6678999999999863    334567999999999999999999999765443333333222111000            


Q ss_pred             ------------CCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 020657          278 ------------PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCK  317 (323)
Q Consensus       278 ------------~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~  317 (323)
                                  ......+++++.+||++||+.||++|||++|+|+||||++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                        1123567889999999999999999999999999999985

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-56  Score=377.82  Aligned_cols=257  Identities=24%  Similarity=0.394  Sum_probs=218.1

Q ss_pred             hccccccceeee-ecccCCeEEEEEEecc--cCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCC
Q 020657           47 AIAYSDLEKLQV-LGHGNGGTVYKVQHRC--THKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG  123 (323)
Q Consensus        47 ~~~~~~~~~~~~-lg~G~~~~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  123 (323)
                      .+..++|.+.+. ||+|+||+||+|.+..  ++..||||++.........+.+.+|++++++++||||++++|++.+  +
T Consensus         4 ~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~   81 (285)
T d1u59a_           4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--E   81 (285)
T ss_dssp             BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES--S
T ss_pred             eecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc--C
Confidence            355678888885 9999999999998753  4457999999877777778889999999999999999999999875  4


Q ss_pred             eEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          124 DIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      .+++||||+++|+|.+++.. ...+++..+..++.||+.||.|||++|++||||||+||+++.++ .+||+|||+++...
T Consensus        82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~  160 (285)
T d1u59a_          82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGLSKALG  160 (285)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT-EEEECCCTTCEECT
T ss_pred             eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCC-ceeeccchhhhccc
Confidence            68999999999999998764 45799999999999999999999999999999999999999987 99999999998664


Q ss_pred             cCcc---ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCC
Q 020657          203 RSLD---ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPP  278 (323)
Q Consensus       203 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  278 (323)
                      ....   ......+|..|+|||++....     ++.++||||||+++|||+| |..||.+...    ..+...+..+.++
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~----~~~~~~i~~~~~~  231 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFRK-----FSSRSDVWSYGVTMWEALSYGQKPYKKMKG----PEVMAFIEQGKRM  231 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCE-----ECHHHHHHHHHHHHHHHHTTSCCTTTTCCT----HHHHHHHHTTCCC
T ss_pred             ccccccccccccccCccccChHHHhCCC-----CCccchhhcchHHHHHHHhCCCCCCCCCCH----HHHHHHHHcCCCC
Confidence            3321   223456789999999986443     4569999999999999998 9999966543    3344555566777


Q ss_pred             CCCCCCChhHHHHHHHhcccCcCCCCCHHHH---hcCccc
Q 020657          279 SLPDGASPEFRSFIECCLQKEFSKRWTASQL---LTHPFL  315 (323)
Q Consensus       279 ~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~---l~h~~f  315 (323)
                      .++..+++++.+|+.+||+.||++|||+.+|   |+|.|+
T Consensus       232 ~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         232 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            8889999999999999999999999999888   577877

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-56  Score=377.52  Aligned_cols=261  Identities=21%  Similarity=0.337  Sum_probs=220.8

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS  122 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  122 (323)
                      ...|+++.++|++.+.||+|+||.||+|.++ +++.||||++.....  ..+.+.+|+.++++++||||+++++++.+  
T Consensus         5 ~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~--   79 (272)
T d1qpca_           5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVTQ--   79 (272)
T ss_dssp             TCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             CCCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC--CHHHHHHHHHHHHhCCCCCEeEEEeeecc--
Confidence            5678899999999999999999999999986 678899999975432  24578999999999999999999998764  


Q ss_pred             CeEEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchh
Q 020657          123 GDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                      +..++||||+++|+|.+++..  ...+++..+..++.||++||.|||+.||+||||||+||+++.++ .+||+|||+|+.
T Consensus        80 ~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~-~~Kl~DFGla~~  158 (272)
T d1qpca_          80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL-SCKIADFGLARL  158 (272)
T ss_dssp             SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEE
T ss_pred             CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeeccc-ceeeccccceEE
Confidence            567999999999999987753  33699999999999999999999999999999999999999987 899999999987


Q ss_pred             hccCc-cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCC
Q 020657          201 MCRSL-DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPS  279 (323)
Q Consensus       201 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  279 (323)
                      ..... .......++..|+|||++....     ++.++||||||+++|||+||..|+...   .....+.+.+..+..+.
T Consensus       159 ~~~~~~~~~~~~~gt~~y~APE~~~~~~-----~~~~sDvwS~Gvvl~ellt~~~~~~~~---~~~~~~~~~i~~~~~~~  230 (272)
T d1qpca_         159 IEDNEYTAREGAKFPIKWTAPEAINYGT-----FTIKSDVWSFGILLTEIVTHGRIPYPG---MTNPEVIQNLERGYRMV  230 (272)
T ss_dssp             CSSSCEECCTTCCCCTTTSCHHHHHHCE-----ECHHHHHHHHHHHHHHHHTTTCCSSTT---CCHHHHHHHHHTTCCCC
T ss_pred             ccCCccccccccCCcccccChHHHhCCC-----CCchhhhhhhHHHHHHHHhCCCCCCCC---CCHHHHHHHHHhcCCCC
Confidence            65432 2234456889999999987433     456999999999999999976665433   23345555666667778


Q ss_pred             CCCCCChhHHHHHHHhcccCcCCCCCHHHHhc--Cccccc
Q 020657          280 LPDGASPEFRSFIECCLQKEFSKRWTASQLLT--HPFLCK  317 (323)
Q Consensus       280 ~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~--h~~f~~  317 (323)
                      .+..+++++.+|+++||+.||++|||++++++  |+||..
T Consensus       231 ~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            88899999999999999999999999999998  788853

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-56  Score=381.05  Aligned_cols=253  Identities=24%  Similarity=0.387  Sum_probs=212.3

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-----hHHHHHHHHHHHHHHcCC--CCccceeceeEEcCC
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-----PTVRRQVFREMEILRRTD--SPFIVQCFGIFEKPS  122 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~  122 (323)
                      .++|++.+.||+|+||+||+|++..+|+.||+|++.....     .....++.+|+.++++++  ||||+++++++.+ .
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~-~   81 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-P   81 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC-S
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee-C
Confidence            4689999999999999999999999999999999864311     011234568999999986  8999999999998 6


Q ss_pred             CeEEEEEeccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhh
Q 020657          123 GDIAILMEYMDS-GTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM  201 (323)
Q Consensus       123 ~~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~  201 (323)
                      +..++||||+.+ +++.+++.....+++..++.++.||+.||.|||+.|++||||||+||+++.++..+||+|||++...
T Consensus        82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~  161 (273)
T d1xwsa_          82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL  161 (273)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence            789999999975 5788888888899999999999999999999999999999999999999966448999999999765


Q ss_pred             ccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCC
Q 020657          202 CRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLP  281 (323)
Q Consensus       202 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (323)
                      ...  ......||..|+|||++.+..    .++.++||||||+++|+|+||..||...      ..+..     ....++
T Consensus       162 ~~~--~~~~~~GT~~y~aPE~~~~~~----~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~-----~~~~~~  224 (273)
T d1xwsa_         162 KDT--VYTDFDGTRVYSPPEWIRYHR----YHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIR-----GQVFFR  224 (273)
T ss_dssp             CSS--CBCCCCSCGGGSCHHHHHHSC----BCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHH-----CCCCCS
T ss_pred             ccc--cccccccCCCcCCHHHHcCCC----CCCcccccccceeeehhHhhCCCCCCCc------hHHhh-----cccCCC
Confidence            332  234567999999999986433    2345799999999999999999999532      12221     234566


Q ss_pred             CCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          282 DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       282 ~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                      ..+|+++.+|+++||+.||++|||++|+|+||||++...
T Consensus       225 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~  263 (273)
T d1xwsa_         225 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL  263 (273)
T ss_dssp             SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred             CCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCC
Confidence            789999999999999999999999999999999998653

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-55  Score=375.81  Aligned_cols=248  Identities=24%  Similarity=0.433  Sum_probs=207.7

Q ss_pred             eeecccCCeEEEEEEec--ccCcEEEEEeecCC-CChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEeccC
Q 020657           57 QVLGHGNGGTVYKVQHR--CTHKIYALKVVHGD-ADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYMD  133 (323)
Q Consensus        57 ~~lg~G~~~~v~~~~~~--~~~~~v~iK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~  133 (323)
                      +.||+|+||+||+|.+.  .+++.||+|++... .+....+.+.+|+.++++++||||+++++++..  +..++||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~--~~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA--ESWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES--SSEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc--CCEEEEEEcCC
Confidence            46999999999999864  35678999999754 334556789999999999999999999999875  45789999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc---cccc
Q 020657          134 SGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD---ACNS  210 (323)
Q Consensus       134 ~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~  210 (323)
                      +|+|.+++.....+++..+..++.||+.||.|||++|++||||||+||+++.++ .+||+|||+++.......   ....
T Consensus        91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~-~~kl~DFGla~~~~~~~~~~~~~~~  169 (277)
T d1xbba_          91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQTH  169 (277)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTTCEECCTTCSEEEC---
T ss_pred             CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccC-cccccchhhhhhccccccccccccc
Confidence            999999999888999999999999999999999999999999999999999987 999999999976543322   2234


Q ss_pred             ccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHH
Q 020657          211 YVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFR  289 (323)
Q Consensus       211 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  289 (323)
                      ..+|+.|+|||++....     ++.++||||||+++|||+| |+.||.+..    ...+...+..+.++.++..+|+++.
T Consensus       170 ~~gt~~y~APE~l~~~~-----~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~----~~~~~~~i~~~~~~~~p~~~~~~~~  240 (277)
T d1xbba_         170 GKWPVKWYAPECINYYK-----FSSKSDVWSFGVLMWEAFSYGQKPYRGMK----GSEVTAMLEKGERMGCPAGCPREMY  240 (277)
T ss_dssp             -CCCGGGCCHHHHHHCE-----EEHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             cCCCceecCchhhcCCC-----CCchhhhccchhhhhHHhhCCCCCCCCCC----HHHHHHHHHcCCCCCCCcccCHHHH
Confidence            56889999999987443     4569999999999999997 899996543    3445555556677888899999999


Q ss_pred             HHHHHhcccCcCCCCCHHHH---hcCcccc
Q 020657          290 SFIECCLQKEFSKRWTASQL---LTHPFLC  316 (323)
Q Consensus       290 ~ll~~~l~~~p~~Rpt~~~~---l~h~~f~  316 (323)
                      +|+.+||+.||++|||++++   |+|+|++
T Consensus       241 ~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         241 DLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence            99999999999999999998   5677764

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-55  Score=371.45  Aligned_cols=252  Identities=24%  Similarity=0.370  Sum_probs=204.3

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEE
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l  127 (323)
                      ++.++|++.+.||+|+||+||+|++. +++.||||++.....  ..+.+.+|++++++++||||++++|++.. .+..++
T Consensus         2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~~l   77 (263)
T d1sm2a_           2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLE-QAPICL   77 (263)
T ss_dssp             BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEE
T ss_pred             CChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC--cHHHHHHHHHHHHhcCCCCcccccceecc-CCceEE
Confidence            45578999999999999999999986 677899999975433  34678999999999999999999999987 678999


Q ss_pred             EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc
Q 020657          128 LMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD  206 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~  206 (323)
                      ||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+++||||||+||+++.++ ++||+|||++........
T Consensus        78 v~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~~~~~  156 (263)
T d1sm2a_          78 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQY  156 (263)
T ss_dssp             EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGG-CEEECSCC----------
T ss_pred             EEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCC-CeEecccchheeccCCCc
Confidence            99999999999988654 5689999999999999999999999999999999999999987 899999999977644322


Q ss_pred             -ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCC
Q 020657          207 -ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS  285 (323)
Q Consensus       207 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (323)
                       ......+|..|+|||++...     .++.++||||||+++|||+|+..|+...   .....+.+.+..+.....+..++
T Consensus       157 ~~~~~~~gt~~y~aPE~l~~~-----~~~~k~DVwS~Gvil~el~t~~~~~~~~---~~~~~~~~~i~~~~~~~~p~~~~  228 (263)
T d1sm2a_         157 TSSTGTKFPVKWASPEVFSFS-----RYSSKSDVWSFGVLMWEVFSEGKIPYEN---RSNSEVVEDISTGFRLYKPRLAS  228 (263)
T ss_dssp             --------CTTSCCHHHHTTC-----CCCHHHHHHHHHHHHHHHHTTSCCTTCS---CCHHHHHHHHHHTCCCCCCTTSC
T ss_pred             eeecceecCcccCChHHhcCC-----CCCchhhhcchHHHHHHHHHCCCCCCCC---CCHHHHHHHHHhcCCCCCccccC
Confidence             23345688999999998744     3567999999999999999954444322   23345555566667777888899


Q ss_pred             hhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          286 PEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       286 ~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      +++.+|+.+||+.||++|||++++++|
T Consensus       229 ~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         229 THVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            999999999999999999999999986

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-55  Score=385.16  Aligned_cols=257  Identities=28%  Similarity=0.473  Sum_probs=208.3

Q ss_pred             ccccceee-eecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHc-CCCCccceeceeEEc---CCCe
Q 020657           50 YSDLEKLQ-VLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRR-TDSPFIVQCFGIFEK---PSGD  124 (323)
Q Consensus        50 ~~~~~~~~-~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~---~~~~  124 (323)
                      .++|++++ .||+|+||.||+|++..+++.||+|++...      ..+.+|+.++.+ ++||||++++++|.+   .+..
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~   83 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   83 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence            57899986 599999999999999999999999999632      346688988665 589999999999864   2456


Q ss_pred             EEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC--CcEEEeecCcchh
Q 020657          125 IAILMEYMDSGTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN--MQVKIADFGVSKI  200 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~--~~~kl~Dfg~~~~  200 (323)
                      +++|||||+||+|.+++...  ..+++..++.++.||+.||.|||+.||+||||||+||+++..+  ..+||+|||++..
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~  163 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  163 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeee
Confidence            89999999999999999763  4699999999999999999999999999999999999998632  2699999999976


Q ss_pred             hccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCC
Q 020657          201 MCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSL  280 (323)
Q Consensus       201 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  280 (323)
                      .... .......||+.|+|||++.+..     ++.++|||||||++|+|+||..||.+.........+...+.... ..+
T Consensus       164 ~~~~-~~~~~~~gt~~y~aPE~~~~~~-----y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~-~~~  236 (335)
T d2ozaa1         164 TTSH-NSLTTPCYTPYYVAPEVLGPEK-----YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ-YEF  236 (335)
T ss_dssp             CCCC-CCCCCCSCCCSSCCCCCCCGGG-----GSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS-SSC
T ss_pred             ccCC-CccccccCCcccCCcHHHcCCC-----CCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCC-CCC
Confidence            5443 2335568999999999987444     45699999999999999999999977655544444443332222 122


Q ss_pred             C----CCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          281 P----DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       281 ~----~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                      +    ..+|+++.+||++||+.||++|||++++|+||||.+..
T Consensus       237 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  279 (335)
T d2ozaa1         237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  279 (335)
T ss_dssp             CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred             CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence            2    35899999999999999999999999999999997543

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-55  Score=367.00  Aligned_cols=250  Identities=24%  Similarity=0.368  Sum_probs=215.5

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      +.++|++.+.||+|+||+||+|+++ +++.||||+++.....  .+.+.+|+.++++++||||++++|++.+ ++.+++|
T Consensus         2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~Ev~~~~~l~HpnIv~~~g~~~~-~~~~~iv   77 (258)
T d1k2pa_           2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTK-QRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC--HHHHHHHHHHHHTCCCTTBCCEEEEECC-SSSEEEE
T ss_pred             ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC--HHHHHHHHHHHHhcCCCceeeEEEEEee-CCceEEE
Confidence            4578999999999999999999985 7889999999765432  3578999999999999999999999987 6789999


Q ss_pred             EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc-
Q 020657          129 MEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD-  206 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~-  206 (323)
                      |||+.+|+|.+++.. ...+++..+..++.||++||.|||+.|++||||||+||+++.++ .+||+|||++........ 
T Consensus        78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~-~~kl~DfG~a~~~~~~~~~  156 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYT  156 (258)
T ss_dssp             EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTC-CEEECCCSSCCBCSSSSCC
T ss_pred             EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCC-cEEECcchhheeccCCCce
Confidence            999999999988754 45789999999999999999999999999999999999999987 899999999976544322 


Q ss_pred             ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCC
Q 020657          207 ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLPDGAS  285 (323)
Q Consensus       207 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (323)
                      ......++..|+|||++...     .++.++||||||+++|||+| |..||....    ...+...+..+.+...+...+
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~-----~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~----~~~~~~~i~~~~~~~~p~~~~  227 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYS-----KFSSKSDIWAFGVLMWEIYSLGKMPYERFT----NSETAEHIAQGLRLYRPHLAS  227 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHC-----CCCHHHHHHHHHHHHHHHHTTSCCTTTTSC----HHHHHHHHHTTCCCCCCTTCC
T ss_pred             eecccCCCCCcCCcHHhcCC-----CCCcceeecccchhhHhHHhcCCCCCCCCC----HHHHHHHHHhCCCCCCccccc
Confidence            23346688999999998743     34679999999999999998 899995443    344555566667778888999


Q ss_pred             hhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          286 PEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       286 ~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      +++.+|+++||+.||++|||++++++|
T Consensus       228 ~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         228 EKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            999999999999999999999999987

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-54  Score=371.63  Aligned_cols=264  Identities=26%  Similarity=0.400  Sum_probs=221.6

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      ++|++++.||+|+||+||+|++..+++.||+|+++... ......++.+|+.+++.++||||+++++++.+ ....++|+
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-~~~~~iv~   80 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-DKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc-ccceeEEe
Confidence            68999999999999999999999999999999997553 34567888999999999999999999999998 67899999


Q ss_pred             eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCccccc
Q 020657          130 EYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLDACN  209 (323)
Q Consensus       130 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~  209 (323)
                      +++.++++..++...+.+++..++.++.|++.||+|||++||+||||||+||+++.++ .+||+|||.+...........
T Consensus        81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~-~~kl~DFG~a~~~~~~~~~~~  159 (292)
T d1unla_          81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG-ELKLANFGLARAFGIPVRCYS  159 (292)
T ss_dssp             ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSCCSCCC
T ss_pred             eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCC-ceeeeecchhhcccCCCccce
Confidence            9999999999988888999999999999999999999999999999999999999987 899999999987765555555


Q ss_pred             cccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccH-HHHHHHHhc--------------
Q 020657          210 SYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDW-ATLMCAICF--------------  274 (323)
Q Consensus       210 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~-~~~~~~~~~--------------  274 (323)
                      ...++..|.|||++...    ...+.++||||||+++|||++|..||......... ..+......              
T Consensus       160 ~~~~~~~~~~pe~~~~~----~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (292)
T d1unla_         160 AEVVTLWYRPPDVLFGA----KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             SCCSCGGGCCHHHHTTC----SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             eeccccchhhhhHhccC----CCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence            66788899999988633    33466999999999999999999998654333222 111111110              


Q ss_pred             ----------CCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          275 ----------GDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       275 ----------~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                                .........+++++.+||++||++||++|||++|+|+||||++..-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~  291 (292)
T d1unla_         236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred             ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence                      0111233467889999999999999999999999999999987653

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-55  Score=377.57  Aligned_cols=265  Identities=25%  Similarity=0.395  Sum_probs=209.3

Q ss_pred             ccccceeeeecccCCeEEEEEEeccc-CcEEEEEeecCCCC-hHHHHHHHHHHHHHHcC---CCCccceeceeEEc----
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCT-HKIYALKVVHGDAD-PTVRRQVFREMEILRRT---DSPFIVQCFGIFEK----  120 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~-~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~----  120 (323)
                      .++|++++.||+|+||+||+|++..+ ++.||+|++..... ......+.+|+.+++.|   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            47999999999999999999999655 66799999864321 11222345666666654   79999999999853    


Q ss_pred             CCCeEEEEEeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcch
Q 020657          121 PSGDIAILMEYMDSGTLDTLLN-KNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       121 ~~~~~~lv~e~~~~~sL~~~l~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                      ....++++||++.++++..... ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~-~~kl~dfg~~~  164 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGLAR  164 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECSCCSCC
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCC-Ceeecchhhhh
Confidence            2356899999999876655444 345689999999999999999999999999999999999999987 89999999987


Q ss_pred             hhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC---
Q 020657          200 IMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD---  276 (323)
Q Consensus       200 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~---  276 (323)
                      ..... .......||+.|+|||++.+..     ++.++||||+||++|||+||+.||.+.+.......+........   
T Consensus       165 ~~~~~-~~~~~~~gT~~Y~APE~~~~~~-----y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  238 (305)
T d1blxa_         165 IYSFQ-MALTSVVVTLWYRAPEVLLQSS-----YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  238 (305)
T ss_dssp             CCCGG-GGGCCCCCCCTTCCHHHHTTCC-----CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             hhccc-ccCCCcccChhhcCcchhcCCC-----CChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhc
Confidence            54332 3345678999999999987444     45699999999999999999999976544433343333221110   


Q ss_pred             -------------------CCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCCC
Q 020657          277 -------------------PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS  321 (323)
Q Consensus       277 -------------------~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~  321 (323)
                                         ...+...+++.+.+||++||+.||++|||++|+|+||||+++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~  302 (305)
T d1blxa_         239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC  302 (305)
T ss_dssp             SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhh
Confidence                               012345678999999999999999999999999999999998764

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-54  Score=367.97  Aligned_cols=265  Identities=22%  Similarity=0.301  Sum_probs=216.9

Q ss_pred             CCccchhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEc
Q 020657           41 TTATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEK  120 (323)
Q Consensus        41 ~~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  120 (323)
                      .....|+++.++|++.+.||+|+||+||+|++. +++.||||++......  .+.+.+|+.++++++||||+++++++.+
T Consensus         7 ~~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~-~~~~vAiK~l~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~g~~~~   83 (285)
T d1fmka3           7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSE   83 (285)
T ss_dssp             SSTTCSBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCCcceEcCHHHEEEeeEEeeCCCeEEEEEEEC-CCCEEEEEEECcccCC--HHHHHHHHHHHHhcccCCEeEEEEEEec
Confidence            346678899999999999999999999999997 4467999999755432  3678999999999999999999999864


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcc
Q 020657          121 PSGDIAILMEYMDSGTLDTLLNK--NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVS  198 (323)
Q Consensus       121 ~~~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~  198 (323)
                        +..++||||+++|+|...+..  .+.+++..++.++.||+.||+|||+.|++||||||+||+++.++ ++||+|||++
T Consensus        84 --~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~-~~kl~DfGla  160 (285)
T d1fmka3          84 --EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLA  160 (285)
T ss_dssp             --SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCTT
T ss_pred             --CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCC-cEEEcccchh
Confidence              457899999999999988853  45699999999999999999999999999999999999999987 8999999999


Q ss_pred             hhhccCc-cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCC
Q 020657          199 KIMCRSL-DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP  277 (323)
Q Consensus       199 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~  277 (323)
                      +...... .......++..|+|||++...     .++.++||||||+++|||+||..||.....   ...+...+..+..
T Consensus       161 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDI~S~Giil~el~t~~~p~~~~~~---~~~~~~~i~~~~~  232 (285)
T d1fmka3         161 RLIEDNEYTARQGAKFPIKWTAPEAALYG-----RFTIKSDVWSFGILLTELTTKGRVPYPGMV---NREVLDQVERGYR  232 (285)
T ss_dssp             C--------------CCGGGSCHHHHHHC-----CCCHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHHHHTTCC
T ss_pred             hhccCCCceeeccccccccccChHHHhCC-----CCCcHHhhhcchHHHHHHHhCCCCCCCCCC---HHHHHHHHHhcCC
Confidence            7664332 222345689999999998643     345699999999999999997767644332   3444455555666


Q ss_pred             CCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc--CcccccCC
Q 020657          278 PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT--HPFLCKNR  319 (323)
Q Consensus       278 ~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~--h~~f~~~~  319 (323)
                      ...+..+++++.+|+.+||+.||++|||+++|++  ++||....
T Consensus       233 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence            7788899999999999999999999999999998  88987654

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-54  Score=369.02  Aligned_cols=255  Identities=25%  Similarity=0.390  Sum_probs=208.0

Q ss_pred             hhccccccceeeeecccCCeEEEEEEeccc---CcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCT---HKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS  122 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  122 (323)
                      |+++.++|++.+.||+|+||.||+|++..+   +..||+|.+...........+.+|+.++++++||||+++++++.+  
T Consensus         2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--   79 (273)
T d1mp8a_           2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--   79 (273)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--
T ss_pred             CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--
Confidence            678889999999999999999999998644   346889998777777778889999999999999999999999864  


Q ss_pred             CeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhh
Q 020657          123 GDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM  201 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~  201 (323)
                      +.+++||||+++|+|.+++.. ...+++..++.++.||++||.|||+.|++||||||+||+++.++ .+||+|||++...
T Consensus        80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~-~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYM  158 (273)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECC-------
T ss_pred             CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCC-cEEEccchhheec
Confidence            578999999999999988764 45799999999999999999999999999999999999999987 9999999999765


Q ss_pred             ccCc-cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCC
Q 020657          202 CRSL-DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPS  279 (323)
Q Consensus       202 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  279 (323)
                      .... .......+|+.|+|||++...     .++.++||||||+++|||+| |..||.......    +...+..+...+
T Consensus       159 ~~~~~~~~~~~~gt~~y~apE~l~~~-----~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~----~~~~i~~~~~~~  229 (273)
T d1mp8a_         159 EDSTYYKASKGKLPIKWMAPESINFR-----RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----VIGRIENGERLP  229 (273)
T ss_dssp             ------------CCGGGCCHHHHHHC-----CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHHHHHTTCCCC
T ss_pred             cCCcceeccceecCcccchhhHhccC-----CCCCccccccchHHHHHHHhcCCCCCCCCCHHH----HHHHHHcCCCCC
Confidence            4322 223345678999999998743     44569999999999999997 899996654433    333444566677


Q ss_pred             CCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          280 LPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       280 ~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ++..+|+++.+||.+||+.||++|||+++|++|
T Consensus       230 ~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         230 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            888999999999999999999999999999976

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-54  Score=365.52  Aligned_cols=255  Identities=25%  Similarity=0.353  Sum_probs=210.2

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccC----cEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTH----KIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS  122 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~----~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  122 (323)
                      ++..+.|++.+.||+|+||.||+|.+..++    ..||||++...........+.+|+.++++++||||++++|++.+ .
T Consensus         3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~-~   81 (283)
T d1mqba_           3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-Y   81 (283)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-S
T ss_pred             cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec-C
Confidence            456688999999999999999999987544    46999999877777777789999999999999999999999987 6


Q ss_pred             CeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhh
Q 020657          123 GDIAILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM  201 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~  201 (323)
                      +..++||||+.++++.+.+... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|||+++..
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~-~~Kl~DFGla~~~  160 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL-VCKVSDFGLSRVL  160 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCCCC----
T ss_pred             CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCC-eEEEcccchhhcc
Confidence            7899999999999999887654 5799999999999999999999999999999999999999987 8999999999876


Q ss_pred             ccCcc---ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCC
Q 020657          202 CRSLD---ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPP  278 (323)
Q Consensus       202 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~  278 (323)
                      .....   ......+|..|+|||++...     .++.++||||||+++|||++|..|+....   ....+...+..+..+
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~-----~~~~~sDI~S~Gvil~el~t~~~~~~~~~---~~~~~~~~i~~~~~~  232 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYR-----KFTSASDVWSFGIVMWEVMTYGERPYWEL---SNHEVMKAINDGFRL  232 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSC-----CCCHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHHHHHHTTCCC
T ss_pred             cCCCccceEeccCCCCccccCHHHHccC-----CCCCcccccccHHHHHHHHhCCCCccccC---CHHHHHHHHhccCCC
Confidence            43322   22334678999999998644     45669999999999999999766664432   334555666667777


Q ss_pred             CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          279 SLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       279 ~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ..+..++.++.+|+.+||+.||++|||+.+|++
T Consensus       233 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         233 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            888899999999999999999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-54  Score=375.09  Aligned_cols=266  Identities=29%  Similarity=0.476  Sum_probs=226.3

Q ss_pred             ccccccceeeeecccCCeEEEEEEe---cccCcEEEEEeecCCC---ChHHHHHHHHHHHHHHcCCC-CccceeceeEEc
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQH---RCTHKIYALKVVHGDA---DPTVRRQVFREMEILRRTDS-PFIVQCFGIFEK  120 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~---~~~~~~v~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~  120 (323)
                      +..++|++++.||+|+||+||+|++   ..+|+.||+|++....   +....+.+.+|++++++++| |||+++++++.+
T Consensus        21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~  100 (322)
T d1vzoa_          21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  100 (322)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence            3468899999999999999999987   3468999999986432   22234567789999999977 899999999988


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchh
Q 020657          121 PSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       121 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                       ....+++|||+.+++|.+.+...+.+++..+..++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++..
T Consensus       101 -~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~-~vkL~DFG~a~~  178 (322)
T d1vzoa_         101 -ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKE  178 (322)
T ss_dssp             -TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEESCSSEEEE
T ss_pred             -CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCC-CEEEeeccchhh
Confidence             678999999999999999999888899999999999999999999999999999999999999997 899999999976


Q ss_pred             hccC-ccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCC
Q 020657          201 MCRS-LDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPS  279 (323)
Q Consensus       201 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  279 (323)
                      .... ........++..|++||.+....   ..++.++|||||||+||+|+||+.||...........+....... ...
T Consensus       179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~---~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~-~~~  254 (322)
T d1vzoa_         179 FVADETERAYDFCGTIEYMAPDIVRGGD---SGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-EPP  254 (322)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC------CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-CCC
T ss_pred             hcccccccccccccccccchhHHhhcCC---cCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC-CCC
Confidence            5432 33344567899999999986332   234669999999999999999999998887777777776655443 455


Q ss_pred             CCCCCChhHHHHHHHhcccCcCCCC-----CHHHHhcCcccccCC
Q 020657          280 LPDGASPEFRSFIECCLQKEFSKRW-----TASQLLTHPFLCKNR  319 (323)
Q Consensus       280 ~~~~~~~~l~~ll~~~l~~~p~~Rp-----t~~~~l~h~~f~~~~  319 (323)
                      ++..+++++.+|+++||++||++||     |++|+++||||+++.
T Consensus       255 ~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~  299 (322)
T d1vzoa_         255 YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  299 (322)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence            6778999999999999999999999     589999999998865

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-54  Score=372.39  Aligned_cols=267  Identities=24%  Similarity=0.353  Sum_probs=210.9

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-hHHHHHHHHHHHHHHcCCCCccceeceeEEcC-------
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-PTVRRQVFREMEILRRTDSPFIVQCFGIFEKP-------  121 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-------  121 (323)
                      .++|++++.||+|+||+||+|++..+|+.||||++..... ......+.+|+.+++.++||||+++++++...       
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            6999999999999999999999999999999999865532 23456678999999999999999999997542       


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhh
Q 020657          122 SGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM  201 (323)
Q Consensus       122 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~  201 (323)
                      .+..++||||+.++++.........+++..++.++.||+.||.|||+.||+||||||+||+++.++ .+||+|||++...
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~-~~kl~dfg~~~~~  167 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG-VLKLADFGLARAF  167 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCC-cEEeeecceeeec
Confidence            345899999998877776666667899999999999999999999999999999999999999997 8999999999765


Q ss_pred             ccCc----cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCC
Q 020657          202 CRSL----DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP  277 (323)
Q Consensus       202 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~  277 (323)
                      ....    ......++|..|+|||++..    ...++.++||||||+++|+|++|+.||.+.........+.+.......
T Consensus       168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~----~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         168 SLAKNSQPNRYTNRVVTLWYRPPELLLG----ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CC-----CCCCCSCCSCGGGCCHHHHTT----CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             ccccccccccccceecCHHHhhHHHHcC----CCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            4321    22334578999999999863    234567999999999999999999999765443333333332221111


Q ss_pred             CCCC---------------------------CCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCCC
Q 020657          278 PSLP---------------------------DGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRRS  321 (323)
Q Consensus       278 ~~~~---------------------------~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~~  321 (323)
                      ....                           ...++++.+||.+||++||++|||++|+|+||||++..-|
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p  314 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP  314 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCC
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCC
Confidence            1100                           0126778999999999999999999999999999876543

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-54  Score=377.00  Aligned_cols=260  Identities=27%  Similarity=0.395  Sum_probs=208.6

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC-----C
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS-----G  123 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~  123 (323)
                      .++|++++.||+|+||+||+|.+..+|+.||+|++.... +....+.+.+|+.+|+.++||||++++++|...+     .
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            679999999999999999999999999999999997553 4455678899999999999999999999997632     2


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          124 DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      .+++||||+ +.+|..+.+. ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++.....
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~-~~kl~Dfg~a~~~~~  173 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQADS  173 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCS
T ss_pred             eEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccc-ccccccccceeccCC
Confidence            579999999 4578877755 4799999999999999999999999999999999999999997 899999999976543


Q ss_pred             CccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhc---------
Q 020657          204 SLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICF---------  274 (323)
Q Consensus       204 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~---------  274 (323)
                      .   .....+++.|+|||++.+    ...++.++||||+||++|+|++|..||.+.+..............         
T Consensus       174 ~---~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (346)
T d1cm8a_         174 E---MTGYVVTRWYRAPEVILN----WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL  246 (346)
T ss_dssp             S---CCSSCSCGGGCCTHHHHT----TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred             c---cccccccccccCHHHHcC----CCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence            2   345678999999999853    234567999999999999999999999765433222222111100         


Q ss_pred             -----------------CCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCC
Q 020657          275 -----------------GDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNR  319 (323)
Q Consensus       275 -----------------~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~  319 (323)
                                       .........+++++.+||++||..||++|||++|+|+||||++.+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         247 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             cchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                             001123356899999999999999999999999999999998764

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-53  Score=375.18  Aligned_cols=264  Identities=26%  Similarity=0.338  Sum_probs=210.2

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCC---eEEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG---DIAI  127 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---~~~l  127 (323)
                      ++|++++.||+|+||+||+|++..+|+.||+|++.........+.+.+|+.+++.++||||+++++++.....   ..++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            5799999999999999999999999999999999876666777889999999999999999999999865321   2344


Q ss_pred             EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCc--
Q 020657          128 LMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL--  205 (323)
Q Consensus       128 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~--  205 (323)
                      +++++.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.......  
T Consensus        88 l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~-~~kl~DfG~a~~~~~~~~~  165 (345)
T d1pmea_          88 LVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDH  165 (345)
T ss_dssp             EEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCGGGCB
T ss_pred             EEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCC-CEEEcccCceeeccCCCcc
Confidence            44556688999999765 699999999999999999999999999999999999999987 89999999997654322  


Q ss_pred             -cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcC---------
Q 020657          206 -DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFG---------  275 (323)
Q Consensus       206 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~---------  275 (323)
                       ......++++.|+|||++...    ..++.++||||+|+++|+|++|..||...................         
T Consensus       166 ~~~~~~~~gt~~y~aPE~l~~~----~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (345)
T d1pmea_         166 TGFLTEYVATRWYRAPEIMLNS----KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII  241 (345)
T ss_dssp             CCTTCCCCSCGGGCCGGGTTTB----CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred             ceeeccccccceechHHHhhcC----CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence             223456789999999998532    334569999999999999999999996654322222211111000         


Q ss_pred             ----------CCC-------CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          276 ----------DPP-------SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       276 ----------~~~-------~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                                .+.       .....+++++.+|+.+||+.||++|||++++|+||||+....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~  303 (345)
T d1pmea_         242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  303 (345)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence                      000       122467889999999999999999999999999999987654

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-54  Score=368.70  Aligned_cols=262  Identities=26%  Similarity=0.381  Sum_probs=211.4

Q ss_pred             CccchhccccccceeeeecccCCeEEEEEEecc-----cCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceec
Q 020657           42 TATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRC-----THKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCF  115 (323)
Q Consensus        42 ~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~  115 (323)
                      ....|++..++|++.+.||+|+||.||+|.+..     +++.||+|++.........+.+.+|..++.++ .|+||+.++
T Consensus         4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~   83 (299)
T d1ywna1           4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   83 (299)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence            346678999999999999999999999999754     45689999998766666677788888888876 689999999


Q ss_pred             eeEEcCCCeEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 020657          116 GIFEKPSGDIAILMEYMDSGTLDTLLNKN----------------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPS  179 (323)
Q Consensus       116 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~  179 (323)
                      +++...+..+++||||+++|+|.+++...                ..+++..++.++.||+.||.|||++||+||||||+
T Consensus        84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~  163 (299)
T d1ywna1          84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR  163 (299)
T ss_dssp             EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcc
Confidence            99887677899999999999999999642                24899999999999999999999999999999999


Q ss_pred             CeEEecCCCcEEEeecCcchhhccCcc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhC-CCCC
Q 020657          180 NLLVNNNNMQVKIADFGVSKIMCRSLD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLG-HFPF  256 (323)
Q Consensus       180 nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg-~~p~  256 (323)
                      |||++.++ .+||+|||+|+.......  ......||+.|+|||++...     .++.++||||||+++|||+|| ..||
T Consensus       164 NILl~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~sDiwS~Gvil~ellt~~~~p~  237 (299)
T d1ywna1         164 NILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-----VYTIQSDVWSFGVLLWEIFSLGASPY  237 (299)
T ss_dssp             GEEECGGG-CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC-----CCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             ceeECCCC-cEEEccCcchhhccccccccccCceeeCccccchhHhhcC-----CCCcccceeehHHHHHHHHhCCCCCC
Confidence            99999987 899999999976543322  23346789999999998743     446799999999999999986 4567


Q ss_pred             CCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          257 LQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      ......   ..+...+..+..+.++..+++++.+|+.+||+.||++|||++++++|
T Consensus       238 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         238 PGVKID---EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             TTCCCS---HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHH---HHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            554433   33444445566777888999999999999999999999999999987

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.4e-53  Score=363.38  Aligned_cols=259  Identities=25%  Similarity=0.382  Sum_probs=206.6

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC--ChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC---C
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA--DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS---G  123 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~  123 (323)
                      ..++|++.+.||+|+||+||+|++..+++.||+|++....  +......+.+|+.+++.++||||+++++++....   .
T Consensus         5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~   84 (277)
T d1o6ya_           5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   84 (277)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred             ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence            3578999999999999999999999999999999997553  4556778999999999999999999999987532   2


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          124 DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      .+++||||++|++|.+.+...+.+++..++.++.||+.||+|||+.|++||||||+||+++.++ ..+++|||.+.....
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~-~~~l~d~~~~~~~~~  163 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN-AVKVMDFGIARAIAD  163 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTS-CEEECCCTTCEECC-
T ss_pred             eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccc-cceeehhhhhhhhcc
Confidence            4889999999999999998888999999999999999999999999999999999999999987 899999999865433


Q ss_pred             Cc---cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCC--C
Q 020657          204 SL---DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDP--P  278 (323)
Q Consensus       204 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~--~  278 (323)
                      ..   .......||+.|+|||++...     .++.++||||||+++|+|+||..||.+....   ..+.+.......  .
T Consensus       164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~-----~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~~~~~~~~~~~  235 (277)
T d1o6ya_         164 SGNSVTQTAAVIGTAQYLSPEQARGD-----SVDARSDVYSLGCVLYEVLTGEPPFTGDSPV---SVAYQHVREDPIPPS  235 (277)
T ss_dssp             ---------------TTCCHHHHTTC-----CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHCCCCCGG
T ss_pred             ccccccccccccCcccccCHHHHcCC-----CCCcceecccchHHHHHHHhCCCCCCCcCHH---HHHHHHHhcCCCCCc
Confidence            22   233456799999999998643     4567999999999999999999999643322   222222222221  2


Q ss_pred             CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccc
Q 020657          279 SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLC  316 (323)
Q Consensus       279 ~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~  316 (323)
                      .....+|+++.+||++||+.||++||+..+.+.|+|.+
T Consensus       236 ~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         236 ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            34467899999999999999999999554555566653

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.6e-53  Score=370.54  Aligned_cols=260  Identities=22%  Similarity=0.405  Sum_probs=210.7

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCC-CCccceeceeEEcC-CCeEE
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD-SPFIVQCFGIFEKP-SGDIA  126 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~-~~~~~  126 (323)
                      ..++|++++.||+|+||+||+|++..+++.||+|++....    .+++.+|+.+++.++ ||||+++++++... ...++
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~  108 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  108 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence            3478999999999999999999999999999999986443    356789999999995 99999999999753 45699


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc
Q 020657          127 ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD  206 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~  206 (323)
                      +||||+.+++|..+.   +.+++..++.++.||+.||.|||++||+||||||+|||++.++..+||+|||+|...... .
T Consensus       109 ~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~-~  184 (328)
T d3bqca1         109 LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-Q  184 (328)
T ss_dssp             EEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT-C
T ss_pred             EEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC-C
Confidence            999999999987653   469999999999999999999999999999999999999976657999999999765433 2


Q ss_pred             ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHh-------------
Q 020657          207 ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAIC-------------  273 (323)
Q Consensus       207 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~-------------  273 (323)
                      ......+|..|+|||.+...    ..++.++||||+|+++|+|++|..||.................             
T Consensus       185 ~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  260 (328)
T d3bqca1         185 EYNVRVASRYFKGPELLVDY----QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  260 (328)
T ss_dssp             CCCSCCSCGGGCCHHHHTTC----CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             cccccccCccccCcccccCC----CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence            34556789999999997632    3346799999999999999999999976543322111111000             


Q ss_pred             cCC--------------------CCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          274 FGD--------------------PPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       274 ~~~--------------------~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                      ...                    .......+++++.+||++||..||++|||++|+|+||||++..+
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  327 (328)
T ss_dssp             CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred             cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence            000                    00111347889999999999999999999999999999998753

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-53  Score=370.25  Aligned_cols=252  Identities=23%  Similarity=0.374  Sum_probs=207.0

Q ss_pred             cccccceeeeecccCCeEEEEEEecccCc----EEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCe
Q 020657           49 AYSDLEKLQVLGHGNGGTVYKVQHRCTHK----IYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGD  124 (323)
Q Consensus        49 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  124 (323)
                      ..++|++++.||+|+||+||+|.+..+|+    .||+|.+....+....+.+.+|+.++++++||||++++|++.+  +.
T Consensus         7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~~   84 (317)
T d1xkka_           7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--ST   84 (317)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES--SS
T ss_pred             CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CC
Confidence            34679999999999999999999887766    5888888766555567789999999999999999999999986  45


Q ss_pred             EEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          125 IAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       125 ~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      .+++++++.+++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++.....
T Consensus        85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~-~~kl~DFGla~~~~~  163 (317)
T d1xkka_          85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGA  163 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCCSHHHHTTT
T ss_pred             eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCC-CeEeeccccceeccc
Confidence            7888999999999887765 45799999999999999999999999999999999999999987 999999999987654


Q ss_pred             Cccc--cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCC
Q 020657          204 SLDA--CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSL  280 (323)
Q Consensus       204 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  280 (323)
                      ....  .....+|..|+|||++...     .++.++||||||+++|||+| |..||.+.....    +...+..+.+...
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~----~~~~i~~~~~~~~  234 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHR-----IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSILEKGERLPQ  234 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHC-----CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG----HHHHHHHTCCCCC
T ss_pred             ccccccccccccCccccChHHHhcC-----CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH----HHHHHHcCCCCCC
Confidence            3222  2344689999999998744     35679999999999999998 788886554333    3334444666778


Q ss_pred             CCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          281 PDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       281 ~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      +..+++++.+|+.+||+.||++|||+.++++|
T Consensus       235 p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         235 PPICTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence            88999999999999999999999999999987

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-54  Score=376.54  Aligned_cols=260  Identities=25%  Similarity=0.341  Sum_probs=207.5

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcC-----CCeE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP-----SGDI  125 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~  125 (323)
                      .+|+.++.||+|+||+||+|++..+|+.||+|++.....     ...+|+.++++++||||++++++|...     ..++
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~   94 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL   94 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence            479999999999999999999999999999999975532     223799999999999999999998542     3357


Q ss_pred             EEEEeccCCCCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhc
Q 020657          126 AILMEYMDSGTLDTLL---NKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMC  202 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l---~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~  202 (323)
                      ++||||++++++..+.   .....+++..++.++.||+.||+|||++||+||||||+|||++.++..+||+|||++....
T Consensus        95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~  174 (350)
T d1q5ka_          95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  174 (350)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred             EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence            8999999875444433   3455799999999999999999999999999999999999999876689999999997654


Q ss_pred             cCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhc--------
Q 020657          203 RSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICF--------  274 (323)
Q Consensus       203 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~--------  274 (323)
                      .. .......++..|+|||.+..    ...++.++||||+||++|||++|..||...........+......        
T Consensus       175 ~~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         175 RG-EPNVSYICSRYYRAPELIFG----ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             TT-SCCCSCCSCTTSCCHHHHTT----CSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             CC-cccccccccccccChHHhhc----ccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence            33 23345679999999998753    334567999999999999999999999665443333332221100        


Q ss_pred             -------CCCC---------CCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          275 -------GDPP---------SLPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       275 -------~~~~---------~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                             ...+         ......++++.+||++||+.||++|||++|+|+||||++.+.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence                   0000         112457899999999999999999999999999999987654

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.7e-53  Score=365.64  Aligned_cols=258  Identities=24%  Similarity=0.394  Sum_probs=219.1

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEecc-----cCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceecee
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRC-----THKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGI  117 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~  117 (323)
                      ...++++.++|++.+.||+|+||+||+|++..     +++.||||++.........+.+.+|+.++++++||||++++++
T Consensus         5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~   84 (301)
T d1lufa_           5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV   84 (301)
T ss_dssp             HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence            34567788999999999999999999999753     5678999999877777778889999999999999999999999


Q ss_pred             EEcCCCeEEEEEeccCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 020657          118 FEKPSGDIAILMEYMDSGTLDTLLNKN------------------------GTFSEPKLAHIASQILKGLSYLHGHKIIH  173 (323)
Q Consensus       118 ~~~~~~~~~lv~e~~~~~sL~~~l~~~------------------------~~~~~~~~~~i~~~i~~~l~~Lh~~givH  173 (323)
                      +.. .+..++||||+.+++|.+++...                        ..+++..+..++.||+.||+|||+.|++|
T Consensus        85 ~~~-~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivH  163 (301)
T d1lufa_          85 CAV-GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH  163 (301)
T ss_dssp             ECS-SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             ecc-CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEe
Confidence            987 67899999999999999998642                        23889999999999999999999999999


Q ss_pred             cCCCCCCeEEecCCCcEEEeecCcchhhccCc--cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh
Q 020657          174 RDIKPSNLLVNNNNMQVKIADFGVSKIMCRSL--DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL  251 (323)
Q Consensus       174 ~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt  251 (323)
                      |||||+||+++.++ .+||+|||++.......  .......+++.|+|||.+...     .+|.++||||||+++|||++
T Consensus       164 rDlKp~NILld~~~-~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~t~ksDVwS~Gvvl~ell~  237 (301)
T d1lufa_         164 RDLATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-----RYTTESDVWAYGVVLWEIFS  237 (301)
T ss_dssp             SCCSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-----CCCHHHHHHHHHHHHHHHHT
T ss_pred             eEEcccceEECCCC-cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC-----CCChhhhhccchhhHHHHHc
Confidence            99999999999987 89999999998664332  223346688999999998743     45679999999999999999


Q ss_pred             CCC-CCCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          252 GHF-PFLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       252 g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      |.. ||...    ....+...+..+..+.++..+++++.+|+.+||+.||++|||+.+|++
T Consensus       238 ~~~~p~~~~----~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         238 YGLQPYYGM----AHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             TTCCTTTTS----CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCCCCCCC----CHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            865 56333    334555566667777888899999999999999999999999999964

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-54  Score=361.03  Aligned_cols=249  Identities=24%  Similarity=0.427  Sum_probs=205.7

Q ss_pred             hhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeE
Q 020657           46 AAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDI  125 (323)
Q Consensus        46 ~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  125 (323)
                      |+++.++|++.+.||+|+||.||+|++  .|+.||+|+++.+.   ..+.+.+|++++++++||||++++|++.+..+.+
T Consensus         2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (262)
T d1byga_           2 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   76 (262)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             CccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence            788999999999999999999999998  47789999996543   3467889999999999999999999986645678


Q ss_pred             EEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          126 AILMEYMDSGTLDTLLNKN--GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       126 ~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      ++||||+++|+|.+++...  ..+++..++.++.||+.||.|||+.+++||||||+||+++.++ .+||+|||++.....
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~-~~kl~dfg~s~~~~~  155 (262)
T d1byga_          77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASS  155 (262)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEEECCCCC------
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCC-CEeecccccceecCC
Confidence            9999999999999999653  3589999999999999999999999999999999999999997 899999999976543


Q ss_pred             CccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCCCCCCC
Q 020657          204 SLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDPPSLPD  282 (323)
Q Consensus       204 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (323)
                      .   .....++..|+|||++...     .++.++||||||+++|||+| |..||......    .+...+..+..+.++.
T Consensus       156 ~---~~~~~~~~~y~aPE~l~~~-----~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~----~~~~~i~~~~~~~~~~  223 (262)
T d1byga_         156 T---QDTGKLPVKWTAPEALREK-----KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----DVVPRVEKGYKMDAPD  223 (262)
T ss_dssp             ---------CCTTTSCHHHHHHC-----CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG----GHHHHHTTTCCCCCCT
T ss_pred             C---CccccccccCCChHHHhCC-----CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH----HHHHHHHcCCCCCCCc
Confidence            2   2334678899999998643     35679999999999999998 68777554333    3344445566778888


Q ss_pred             CCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          283 GASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       283 ~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      .+++++.+|+.+||..||++|||+.+++++
T Consensus       224 ~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         224 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            999999999999999999999999999874

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-52  Score=359.36  Aligned_cols=257  Identities=25%  Similarity=0.364  Sum_probs=215.7

Q ss_pred             cchhccccccceeeeecccCCeEEEEEEecccC-------cEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceec
Q 020657           44 TTAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTH-------KIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCF  115 (323)
Q Consensus        44 ~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~-------~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~  115 (323)
                      +.|+++.++|++.+.||+|+||.||+|++..++       ..||+|+++..........+.+|...+.++ +||||++++
T Consensus         6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~   85 (299)
T d1fgka_           6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL   85 (299)
T ss_dssp             TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence            348899999999999999999999999976443       479999998877777778889999999888 799999999


Q ss_pred             eeEEcCCCeEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 020657          116 GIFEKPSGDIAILMEYMDSGTLDTLLNKN----------------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPS  179 (323)
Q Consensus       116 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~  179 (323)
                      +++.+ ++..++||||+.+|+|.+++...                ..+++..++.++.||+.||.|||+.|++||||||+
T Consensus        86 ~~~~~-~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~  164 (299)
T d1fgka_          86 GACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR  164 (299)
T ss_dssp             EEECS-SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             ccccc-CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccc
Confidence            99987 67899999999999999999643                34899999999999999999999999999999999


Q ss_pred             CeEEecCCCcEEEeecCcchhhccCcc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 020657          180 NLLVNNNNMQVKIADFGVSKIMCRSLD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPF  256 (323)
Q Consensus       180 nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~  256 (323)
                      |||++.++ .+||+|||++........  ......+++.|+|||.+...     .++.++||||||+++|||++ |..||
T Consensus       165 NiLl~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-----~y~~k~DiwS~Gvvl~ell~~g~~p~  238 (299)
T d1fgka_         165 NVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-----IYTHQSDVWSFGVLLWEIFTLGGSPY  238 (299)
T ss_dssp             GEEECTTC-CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-----CCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             ceeecCCC-CeEeccchhhccccccccccccccCCCChhhhhhhHhcCC-----CCCchhhhHHhHHHHHHhccCCCCCC
Confidence            99999997 899999999987654322  23445688999999998744     45679999999999999998 68888


Q ss_pred             CCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          257 LQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ...    ....+...+..+..+..+..+++++.+|+.+||+.||++|||+.++++
T Consensus       239 ~~~----~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         239 PGV----PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             TTC----CHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCC----CHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            433    234455556667778888899999999999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-52  Score=359.55  Aligned_cols=265  Identities=22%  Similarity=0.346  Sum_probs=224.3

Q ss_pred             CccchhccccccceeeeecccCCeEEEEEEecc-----cCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceece
Q 020657           42 TATTAAIAYSDLEKLQVLGHGNGGTVYKVQHRC-----THKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG  116 (323)
Q Consensus        42 ~~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~  116 (323)
                      .+..|+++.++|++.+.||+|+||+||+|.+..     +++.||||+++..........+.+|+.++++++||||+++++
T Consensus        11 ~~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~   90 (308)
T d1p4oa_          11 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG   90 (308)
T ss_dssp             CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             CccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeee
Confidence            345689999999999999999999999999753     457899999987666666778999999999999999999999


Q ss_pred             eEEcCCCeEEEEEeccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecC
Q 020657          117 IFEKPSGDIAILMEYMDSGTLDTLLNKN----------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNN  186 (323)
Q Consensus       117 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~----------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~  186 (323)
                      ++.. +...++||||+.+|+|.+++...          ..+++..+..++.|+++||.|||+++++||||||+|||++.+
T Consensus        91 ~~~~-~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~  169 (308)
T d1p4oa_          91 VVSQ-GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED  169 (308)
T ss_dssp             EECS-SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT
T ss_pred             EEec-CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCC
Confidence            9987 67899999999999999988632          247899999999999999999999999999999999999998


Q ss_pred             CCcEEEeecCcchhhccCcc--ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCCCc
Q 020657          187 NMQVKIADFGVSKIMCRSLD--ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGH-FPFLQPGQRP  263 (323)
Q Consensus       187 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~-~p~~~~~~~~  263 (323)
                      + ++||+|||++........  ......+++.|+|||.+...     .++.++||||||+++|||+||. .||.+    .
T Consensus       170 ~-~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~-----~~~~~~Dv~S~G~il~El~t~~~~p~~~----~  239 (308)
T d1p4oa_         170 F-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-----VFTTYSDVWSFGVVLWEIATLAEQPYQG----L  239 (308)
T ss_dssp             C-CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-----CCCHHHHHHHHHHHHHHHHHTSCCTTTT----S
T ss_pred             c-eEEEeecccceeccCCcceeeccceecccccCCHHHHccC-----CCCcccccccHHHHHHHHHhCCCCCCCC----C
Confidence            7 999999999986644322  23344688999999998643     4456999999999999999985 66633    3


Q ss_pred             cHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc------Cccccc
Q 020657          264 DWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT------HPFLCK  317 (323)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~------h~~f~~  317 (323)
                      ....+...+..+.....+..+++.+.+|+.+||+.||++|||++++++      +|+|++
T Consensus       240 ~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~  299 (308)
T d1p4oa_         240 SNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE  299 (308)
T ss_dssp             CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred             CHHHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence            334455555566677788899999999999999999999999999997      677754

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-52  Score=362.03  Aligned_cols=254  Identities=26%  Similarity=0.363  Sum_probs=211.5

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCc--EEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceeceeEEcCCC
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHK--IYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFGIFEKPSG  123 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~--~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~  123 (323)
                      .++.++|++.+.||+|+||+||+|++..++.  .|+||.+.........+.+.+|+++++++ +||||+++++++.+ .+
T Consensus         6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-~~   84 (309)
T d1fvra_           6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RG   84 (309)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-TT
T ss_pred             ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec-CC
Confidence            4678999999999999999999999987776  46778876555555667899999999998 79999999999997 78


Q ss_pred             eEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCC
Q 020657          124 DIAILMEYMDSGTLDTLLNKN----------------GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNN  187 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~  187 (323)
                      .+++||||+++|+|.+++...                ..+++..+..++.||+.||.|||+.|++||||||+|||++.++
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~  164 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  164 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence            899999999999999999643                5689999999999999999999999999999999999999987


Q ss_pred             CcEEEeecCcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCC-CCCCCCCCccHH
Q 020657          188 MQVKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHF-PFLQPGQRPDWA  266 (323)
Q Consensus       188 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~-p~~~~~~~~~~~  266 (323)
                       .+||+|||++...... .......+|..|+|||.+...     .++.++||||||+++|||++|.. ||..    ....
T Consensus       165 -~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~~-----~~~~~sDvwSfGvil~ell~~~~~p~~~----~~~~  233 (309)
T d1fvra_         165 -VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYS-----VYTTNSDVWSYGVLLWEIVSLGGTPYCG----MTCA  233 (309)
T ss_dssp             -CEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHC-----EECHHHHHHHHHHHHHHHHTTSCCTTTT----CCHH
T ss_pred             -ceEEcccccccccccc-ccccceecCCcccchHHhccC-----CCCccceeehhHHHHHHHHhcCCCCCCC----CCHH
Confidence             8999999999755332 222345688999999998643     34669999999999999999765 5633    3345


Q ss_pred             HHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          267 TLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      .+...+..+.++..+..+++++.+|+.+||+.||++|||++++++|
T Consensus       234 ~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         234 ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             HHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            5666666677778888999999999999999999999999999987

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-52  Score=367.86  Aligned_cols=266  Identities=25%  Similarity=0.359  Sum_probs=212.1

Q ss_pred             chhccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcC--
Q 020657           45 TAAIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP--  121 (323)
Q Consensus        45 ~~~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--  121 (323)
                      .+++ .++|++++.||+|+||+||+|++..+|+.||+|++.... +....+.+.+|+.+++.++||||+++++++...  
T Consensus        13 ~~~~-~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~   91 (348)
T d2gfsa1          13 IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS   91 (348)
T ss_dssp             EEEE-ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             cccC-CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccc
Confidence            4444 478999999999999999999999999999999997553 345567788999999999999999999998642  


Q ss_pred             --CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcch
Q 020657          122 --SGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSK  199 (323)
Q Consensus       122 --~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~  199 (323)
                        +...+++++++.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++ .+|++|||.+.
T Consensus        92 ~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~-~~kl~dfg~a~  169 (348)
T d2gfsa1          92 LEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR  169 (348)
T ss_dssp             TTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCC----
T ss_pred             cccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccc-cccccccchhc
Confidence              2334566777788999999865 4799999999999999999999999999999999999999997 89999999986


Q ss_pred             hhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCC---
Q 020657          200 IMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGD---  276 (323)
Q Consensus       200 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~---  276 (323)
                      ....   ......++..|+|||++..    ....+.++||||||+++|+|++|..||.+.+.......+........   
T Consensus       170 ~~~~---~~~~~~g~~~y~apE~~~~----~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~  242 (348)
T d2gfsa1         170 HTDD---EMTGYVATRWYRAPEIMLN----WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL  242 (348)
T ss_dssp             CCTG---GGSSSCHHHHTSCHHHHTT----CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             ccCc---ccccccccccccCchhhcC----CccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence            5432   2345678999999998753    23445699999999999999999999976544333333322211100   


Q ss_pred             ------------------CCC-----CCCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccCCC
Q 020657          277 ------------------PPS-----LPDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKNRR  320 (323)
Q Consensus       277 ------------------~~~-----~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~~~  320 (323)
                                        ...     ....+++++.+||++||+.||++|||++|+|+||||++.+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~  309 (348)
T d2gfsa1         243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  309 (348)
T ss_dssp             HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             hhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence                              000     12467899999999999999999999999999999987654

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-51  Score=356.30  Aligned_cols=259  Identities=23%  Similarity=0.312  Sum_probs=218.8

Q ss_pred             ccchhccccccceeeeecccCCeEEEEEEec-----ccCcEEEEEeecCCCChHHHHHHHHHHHHHHcC-CCCccceece
Q 020657           43 ATTAAIAYSDLEKLQVLGHGNGGTVYKVQHR-----CTHKIYALKVVHGDADPTVRRQVFREMEILRRT-DSPFIVQCFG  116 (323)
Q Consensus        43 ~~~~~~~~~~~~~~~~lg~G~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~  116 (323)
                      ...|+++.++|++.+.||+|+||.||+|.+.     .+++.||+|+++..........+.+|+.+++.+ +||||+++++
T Consensus        15 ~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g   94 (311)
T d1t46a_          15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLG   94 (311)
T ss_dssp             CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence            4468899999999999999999999999863     467799999998777777777899999999998 6999999999


Q ss_pred             eEEcCCCeEEEEEeccCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCC
Q 020657          117 IFEKPSGDIAILMEYMDSGTLDTLLNKNG------------------TFSEPKLAHIASQILKGLSYLHGHKIIHRDIKP  178 (323)
Q Consensus       117 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------------~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~  178 (323)
                      ++.+ ....++||||+++++|.+++....                  .+++..+..++.||+.||.|||++|++||||||
T Consensus        95 ~~~~-~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp  173 (311)
T d1t46a_          95 ACTI-GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA  173 (311)
T ss_dssp             EECS-SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             EEee-CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccc
Confidence            9987 677999999999999999987532                  589999999999999999999999999999999


Q ss_pred             CCeEEecCCCcEEEeecCcchhhccCc--cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhC-CCC
Q 020657          179 SNLLVNNNNMQVKIADFGVSKIMCRSL--DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLG-HFP  255 (323)
Q Consensus       179 ~nil~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg-~~p  255 (323)
                      +||+++.++ .++++|||.+.......  .......+++.|+|||++..     ..++.++||||||+++|||+|+ ..|
T Consensus       174 ~NIl~~~~~-~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DIwS~G~~l~ellt~g~p~  247 (311)
T d1t46a_         174 RNILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-----CVYTFESDVWSYGIFLWELFSLGSSP  247 (311)
T ss_dssp             GGEEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             ccccccccC-cccccccchheeccCCCcceEeeecccChHHcCHHHhcC-----CCCCCcccccchHHHHHHHHhCCCCC
Confidence            999999987 99999999998765432  22334678999999999863     3456799999999999999984 555


Q ss_pred             CCCCCCCccHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          256 FLQPGQRPDWATLMCAICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      |........   +...+..+.++..+..++.++.+|+.+||+.||++|||+++|++
T Consensus       248 ~~~~~~~~~---~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         248 YPGMPVDSK---FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             STTCCSSHH---HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHHH---HHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            544433333   33334446677777889999999999999999999999999985

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-52  Score=351.89  Aligned_cols=253  Identities=25%  Similarity=0.384  Sum_probs=199.1

Q ss_pred             ccccccceeeeecccCCeEEEEEEeccc-C--cEEEEEeecCC--CChHHHHHHHHHHHHHHcCCCCccceeceeEEcCC
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCT-H--KIYALKVVHGD--ADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPS  122 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~-~--~~v~iK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  122 (323)
                      +..++|++.+.||+|+||.||+|++..+ +  ..||+|++...  .+....+.+.+|+.+++.++||||++++|++.+  
T Consensus         5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~--   82 (273)
T d1u46a_           5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT--   82 (273)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--
Confidence            4568899999999999999999986532 2  36899998754  234556789999999999999999999999975  


Q ss_pred             CeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhh
Q 020657          123 GDIAILMEYMDSGTLDTLLNK-NGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIM  201 (323)
Q Consensus       123 ~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~  201 (323)
                      ...++||||++++++.+.+.. .+.+++..++.++.||+.||.|||++|++||||||+||+++.++ .+||+|||++...
T Consensus        83 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~-~vkl~DfGl~~~~  161 (273)
T d1u46a_          83 PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD-LVKIGDFGLMRAL  161 (273)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCTTCEEC
T ss_pred             cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccccc-ceeeccchhhhhc
Confidence            467899999999999887754 45799999999999999999999999999999999999999987 9999999999876


Q ss_pred             ccCcc---ccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhcCCC
Q 020657          202 CRSLD---ACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYL-GHFPFLQPGQRPDWATLMCAICFGDP  277 (323)
Q Consensus       202 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~  277 (323)
                      .....   ......++..|+|||++...     .++.++||||||+++|||+| |..||.+......   +......+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~---~~~i~~~~~~  233 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTR-----TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI---LHKIDKEGER  233 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHC-----EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHHHTSCCC
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCC-----CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH---HHHHHhCCCC
Confidence            44322   12334577899999999744     34569999999999999998 8999954433222   2222334456


Q ss_pred             CCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          278 PSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       278 ~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ++.+..++.++.+|+.+||+.||++|||+++|++
T Consensus       234 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         234 LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            6777889999999999999999999999999863

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-51  Score=351.93  Aligned_cols=248  Identities=21%  Similarity=0.307  Sum_probs=206.6

Q ss_pred             eeeecccCCeEEEEEEecccC---cEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEEecc
Q 020657           56 LQVLGHGNGGTVYKVQHRCTH---KIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILMEYM  132 (323)
Q Consensus        56 ~~~lg~G~~~~v~~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~  132 (323)
                      .++||+|+||+||+|.+..++   ..||||.+....+....+.+.+|++++++++||||++++|++...++..++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            578999999999999986443   36899999876677778889999999999999999999999876677899999999


Q ss_pred             CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhccCcc----c
Q 020657          133 DSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCRSLD----A  207 (323)
Q Consensus       133 ~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~~~~----~  207 (323)
                      ++++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+|||++.++ .+||+|||++........    .
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~-~~kL~DFG~~~~~~~~~~~~~~~  190 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHN  190 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECSSGGGCCTTTTTCCCTTC
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCC-CEEEecccchhhcccccccccee
Confidence            999999988754 4578889999999999999999999999999999999999886 899999999976543221    2


Q ss_pred             cccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhcCCCCCCCCCCChh
Q 020657          208 CNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICFGDPPSLPDGASPE  287 (323)
Q Consensus       208 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (323)
                      .....++..|+|||.+...     .++.++||||||+++|||+||..||......   ..+...+..+.++..+..++++
T Consensus       191 ~~~~~gt~~y~aPE~~~~~-----~~~~ksDI~SfGivl~El~t~~~p~~~~~~~---~~~~~~i~~g~~~~~p~~~~~~  262 (311)
T d1r0pa_         191 KTGAKLPVKWMALESLQTQ-----KFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITVYLLQGRRLLQPEYCPDP  262 (311)
T ss_dssp             TTCSSCCGGGSCHHHHHHC-----CCCHHHHHHHHHHHHHHHHTTSCCSCC---------CHHHHHTTCCCCCCTTCCHH
T ss_pred             cccccccccccChHHHhcC-----CCCChhHhhhhHHHHHHHHHCCCCCCCCCCH---HHHHHHHHcCCCCCCcccCcHH
Confidence            2335688999999998743     3467999999999999999988888654332   2233334445667778889999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          288 FRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       288 l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      +.+|+.+||+.||++|||+.|+++|
T Consensus       263 l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         263 LYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999999988

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-52  Score=364.34  Aligned_cols=259  Identities=24%  Similarity=0.380  Sum_probs=198.7

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCC-ChHHHHHHHHHHHHHHcCCCCccceeceeEEcC-----CC
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDA-DPTVRRQVFREMEILRRTDSPFIVQCFGIFEKP-----SG  123 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~  123 (323)
                      .++|++++.||+|+||+||+|++..+|+.||+|++.... +.....++.+|+.++++++||||++++++|...     ..
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            368999999999999999999999999999999997653 345566789999999999999999999999642     36


Q ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeecCcchhhcc
Q 020657          124 DIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADFGVSKIMCR  203 (323)
Q Consensus       124 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Dfg~~~~~~~  203 (323)
                      .+|+||||+.++ +.+.+.  ..+++..++.++.||+.||.|||+.||+||||||+||+++.++ .++++|||++.....
T Consensus        96 ~~~iv~Ey~~~~-l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~-~~kl~df~~~~~~~~  171 (355)
T d2b1pa1          96 DVYLVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGT  171 (355)
T ss_dssp             EEEEEEECCSEE-HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCCCC------
T ss_pred             eeEEEEeccchH-HHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccccccc-ceeeechhhhhcccc
Confidence            789999999774 444443  4689999999999999999999999999999999999999987 899999999876544


Q ss_pred             CccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHHHHHhc---------
Q 020657          204 SLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLMCAICF---------  274 (323)
Q Consensus       204 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~~~~~~---------  274 (323)
                      .. ......+|..|+|||++.+.     .++.++||||+||++|+|++|..||.+.+.......+......         
T Consensus       172 ~~-~~~~~~~t~~y~aPE~l~~~-----~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (355)
T d2b1pa1         172 SF-MMTPYVVTRYYRAPEVILGM-----GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_dssp             ----------CCTTCCHHHHTTC-----CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred             cc-ccccccccccccChhhhcCC-----CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence            32 33455789999999999743     4456999999999999999999999765433332222221111         


Q ss_pred             ---------CCCCC-------------C------CCCCChhHHHHHHHhcccCcCCCCCHHHHhcCcccccC
Q 020657          275 ---------GDPPS-------------L------PDGASPEFRSFIECCLQKEFSKRWTASQLLTHPFLCKN  318 (323)
Q Consensus       275 ---------~~~~~-------------~------~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h~~f~~~  318 (323)
                               .....             .      ....++++.+||++||..||++|||++|+|+||||+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~  317 (355)
T d2b1pa1         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  317 (355)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence                     00000             0      01235678999999999999999999999999999863

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.5e-49  Score=340.86  Aligned_cols=258  Identities=21%  Similarity=0.275  Sum_probs=200.6

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCCeEEEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSGDIAILM  129 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~  129 (323)
                      .++|++.+.||+|+||.||+|++..+|+.||+|++......   ..+..|+++++.++|++++..+..+.......++||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm   82 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   82 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS---CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC---HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence            36899999999999999999999989999999998755332   346789999999988876666655544478899999


Q ss_pred             eccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecC--CCcEEEeecCcchhhccCc-
Q 020657          130 EYMDSGTLDTLLN-KNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNN--NMQVKIADFGVSKIMCRSL-  205 (323)
Q Consensus       130 e~~~~~sL~~~l~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~--~~~~kl~Dfg~~~~~~~~~-  205 (323)
                      ||+++ ++...+. ....+++..+..++.|++.||+|||++||+||||||+||+++..  +..++|+|||+|....... 
T Consensus        83 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~  161 (299)
T d1ckia_          83 ELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  161 (299)
T ss_dssp             ECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred             EEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence            99965 6655554 56689999999999999999999999999999999999998642  2379999999998764322 


Q ss_pred             ------cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHHH---HHHhcCC
Q 020657          206 ------DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATLM---CAICFGD  276 (323)
Q Consensus       206 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~~---~~~~~~~  276 (323)
                            .......||+.|+|||++.+     ..++.++||||||+++|||+||..||.............   .......
T Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~  236 (299)
T d1ckia_         162 HQHIPYRENKNLTGTARYASINTHLG-----IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  236 (299)
T ss_dssp             CCBCCCCBCCSCCCCSSSCCHHHHTT-----BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred             ccceeccccCCcCCCccccCHHHHhC-----CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC
Confidence                  12345679999999999873     345679999999999999999999997655443333222   1111122


Q ss_pred             CCCCCCCCChhHHHHHHHhcccCcCCCCCHHH---HhcCcccc
Q 020657          277 PPSLPDGASPEFRSFIECCLQKEFSKRWTASQ---LLTHPFLC  316 (323)
Q Consensus       277 ~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~---~l~h~~f~  316 (323)
                      .+.....+|+++.+|+..||+.+|++||++++   +|+|+|.+
T Consensus       237 ~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence            23345678999999999999999999999874   46777654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=335.83  Aligned_cols=257  Identities=23%  Similarity=0.261  Sum_probs=195.4

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceeceeEEcCCC---eEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFGIFEKPSG---DIA  126 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---~~~  126 (323)
                      .++|.+.+.||+|+||+||+|++  +|+.||||++....  ........|+..+..++||||+++++++.+...   .++
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~--~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~   77 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc--hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence            36788999999999999999997  68899999986432  222222345555567899999999999876332   589


Q ss_pred             EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCCeecCCCCCCeEEecCCCcEEEeecCcc
Q 020657          127 ILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG--------HKIIHRDIKPSNLLVNNNNMQVKIADFGVS  198 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~--------~givH~di~~~nil~~~~~~~~kl~Dfg~~  198 (323)
                      +||||+++|+|.+++++. .+++..+..++.|++.||.|||+        .||+||||||+||+++.++ ++||+|||++
T Consensus        78 lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~-~~Kl~DFGl~  155 (303)
T d1vjya_          78 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLA  155 (303)
T ss_dssp             EEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC-CeEEEecCcc
Confidence            999999999999999875 68999999999999999999996        5999999999999999987 9999999999


Q ss_pred             hhhccCcc----ccccccccccccCCcccCCCCCC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-----------C
Q 020657          199 KIMCRSLD----ACNSYVGTCAYMSPERFDPDAYG-GNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQ-----------R  262 (323)
Q Consensus       199 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~-~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~-----------~  262 (323)
                      ........    ......||+.|+|||++...... ...++.++||||||+++|||+||..||.....           .
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~  235 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence            76644322    23356799999999998744322 12346689999999999999999887633221           1


Q ss_pred             ccHHHHHHHHhc-CCCCCCCCC-----CChhHHHHHHHhcccCcCCCCCHHHHhcC
Q 020657          263 PDWATLMCAICF-GDPPSLPDG-----ASPEFRSFIECCLQKEFSKRWTASQLLTH  312 (323)
Q Consensus       263 ~~~~~~~~~~~~-~~~~~~~~~-----~~~~l~~ll~~~l~~~p~~Rpt~~~~l~h  312 (323)
                      .....+...... ..++.++..     ....+.+|+.+||+.||++|||+.||+++
T Consensus       236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            223333333322 223333332     22458999999999999999999999863

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=9.4e-48  Score=329.53  Aligned_cols=254  Identities=18%  Similarity=0.228  Sum_probs=205.5

Q ss_pred             ccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCC-CccceeceeEEcCCCeEE
Q 020657           48 IAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS-PFIVQCFGIFEKPSGDIA  126 (323)
Q Consensus        48 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~  126 (323)
                      +...+|++.+.||+|+||+||+|++..+|+.||+|++......   ..+.+|++.++.++| +|++.+++++.. ....+
T Consensus         2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~   77 (293)
T d1csna_           2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQE-GLHNV   77 (293)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEE-TTEEE
T ss_pred             CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc---HHHHHHHHHHHHhcCCCCCCEEEEEeec-CCccE
Confidence            4468999999999999999999999999999999998655332   235678888888865 899999999887 78899


Q ss_pred             EEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecC----CCcEEEeecCcchhh
Q 020657          127 ILMEYMDSGTLDTLLNKN-GTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNN----NMQVKIADFGVSKIM  201 (323)
Q Consensus       127 lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~----~~~~kl~Dfg~~~~~  201 (323)
                      +||||+ +++|.+++... ..++...+..++.|++.||+|||+.|++||||||+||+++..    ...+||+|||+|+..
T Consensus        78 ~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          78 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             EEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            999999 56999888754 479999999999999999999999999999999999999742    237999999999876


Q ss_pred             ccCc-------cccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCccHHHH---HHH
Q 020657          202 CRSL-------DACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPDWATL---MCA  271 (323)
Q Consensus       202 ~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~~~~~---~~~  271 (323)
                      ....       .......||+.|+|||++.+     ..++.++||||||+++|||+||..||.+..........   ...
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~-----~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~  231 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLG-----REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK  231 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-----CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcC-----CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc
Confidence            4321       12334679999999999874     34567999999999999999999999876555443332   222


Q ss_pred             HhcCCCCCCCCCCChhHHHHHHHhcccCcCCCCCHHHHhc
Q 020657          272 ICFGDPPSLPDGASPEFRSFIECCLQKEFSKRWTASQLLT  311 (323)
Q Consensus       272 ~~~~~~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~~~~l~  311 (323)
                      ........++..+|+++.+++..|++.+|++||+++.+.+
T Consensus       232 ~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         232 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             cCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            2222223345678999999999999999999999877654

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.2e-45  Score=322.83  Aligned_cols=258  Identities=26%  Similarity=0.369  Sum_probs=193.2

Q ss_pred             cccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCC-----------CCccceeceeEE
Q 020657           51 SDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD-----------SPFIVQCFGIFE  119 (323)
Q Consensus        51 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~  119 (323)
                      .+|++++.||+|+||+||+|++..+|+.||||++...  ....+.+.+|+.+++.+.           |+||+++++++.
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~--~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~   90 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   90 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc--ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence            5799999999999999999999999999999999644  344567788888887764           578999998875


Q ss_pred             c-CCCeEEEEEeccCCCCHHHH-H--HhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCCeEEecCCC-----c
Q 020657          120 K-PSGDIAILMEYMDSGTLDTL-L--NKNGTFSEPKLAHIASQILKGLSYLHG-HKIIHRDIKPSNLLVNNNNM-----Q  189 (323)
Q Consensus       120 ~-~~~~~~lv~e~~~~~sL~~~-l--~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~givH~di~~~nil~~~~~~-----~  189 (323)
                      . .....+++++++........ .  .....+++..++.++.||+.||.|||+ .||+||||||+||+++.++.     .
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~  170 (362)
T d1q8ya_          91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ  170 (362)
T ss_dssp             EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccce
Confidence            4 23456677776655443222 2  234578999999999999999999998 89999999999999987642     4


Q ss_pred             EEEeecCcchhhccCccccccccccccccCCcccCCCCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCcc---HH
Q 020657          190 VKIADFGVSKIMCRSLDACNSYVGTCAYMSPERFDPDAYGGNYNGYAGDIWSLGLTLLELYLGHFPFLQPGQRPD---WA  266 (323)
Q Consensus       190 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ll~~lltg~~p~~~~~~~~~---~~  266 (323)
                      ++++|||.+.....   ......+++.|+|||++...     .++.++||||+|+++++|++|+.||........   ..
T Consensus       171 ~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~  242 (362)
T d1q8ya_         171 IKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGA-----PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  242 (362)
T ss_dssp             EEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTC-----CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             eeEeeccccccccc---ccccccccccccChhhcccc-----CCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence            99999999875433   23456799999999998743     345699999999999999999999965433211   11


Q ss_pred             HHHHHHhc-CC---------------------------------------CCCCCCCCChhHHHHHHHhcccCcCCCCCH
Q 020657          267 TLMCAICF-GD---------------------------------------PPSLPDGASPEFRSFIECCLQKEFSKRWTA  306 (323)
Q Consensus       267 ~~~~~~~~-~~---------------------------------------~~~~~~~~~~~l~~ll~~~l~~~p~~Rpt~  306 (323)
                      .+...... +.                                       ........++++.+||.+||.+||.+|||+
T Consensus       243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta  322 (362)
T d1q8ya_         243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  322 (362)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence            11100000 00                                       001122345789999999999999999999


Q ss_pred             HHHhcCcccccC
Q 020657          307 SQLLTHPFLCKN  318 (323)
Q Consensus       307 ~~~l~h~~f~~~  318 (323)
                      +|+|+||||++.
T Consensus       323 ~e~L~Hp~f~~~  334 (362)
T d1q8ya_         323 GGLVNHPWLKDT  334 (362)
T ss_dssp             HHHHTCGGGTTC
T ss_pred             HHHhcCcccCCC
Confidence            999999999854

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=4.7e-24  Score=170.08  Aligned_cols=135  Identities=19%  Similarity=0.221  Sum_probs=107.6

Q ss_pred             cceeeeecccCCeEEEEEEecccCcEEEEEeecCCCC-----------------hHHHHHHHHHHHHHHcCCCCccceec
Q 020657           53 LEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDAD-----------------PTVRRQVFREMEILRRTDSPFIVQCF  115 (323)
Q Consensus        53 ~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~-----------------~~~~~~~~~e~~~l~~l~h~~i~~~~  115 (323)
                      +.+.+.||+|+||+||+|++. +|+.||+|+++....                 ........+|...+.++.|.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            357889999999999999986 789999998753211                 11233455688889999999998887


Q ss_pred             eeEEcCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCeEEecCCCcEEEeec
Q 020657          116 GIFEKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHGHKIIHRDIKPSNLLVNNNNMQVKIADF  195 (323)
Q Consensus       116 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~~givH~di~~~nil~~~~~~~~kl~Df  195 (323)
                      ++..     .+++||++++..+.       .++...+..++.|++.++.+||++|++||||||+||+++++  .++|+||
T Consensus        81 ~~~~-----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~--~~~liDF  146 (191)
T d1zara2          81 AWEG-----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE--GIWIIDF  146 (191)
T ss_dssp             EEET-----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT--EEEECCC
T ss_pred             EecC-----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC--CEEEEEC
Confidence            6532     27999999885543       24556678899999999999999999999999999999975  5899999


Q ss_pred             Ccchhhc
Q 020657          196 GVSKIMC  202 (323)
Q Consensus       196 g~~~~~~  202 (323)
                      |+|....
T Consensus       147 G~a~~~~  153 (191)
T d1zara2         147 PQSVEVG  153 (191)
T ss_dssp             TTCEETT
T ss_pred             CCcccCC
Confidence            9986653

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.74  E-value=2.4e-08  Score=81.72  Aligned_cols=141  Identities=16%  Similarity=0.150  Sum_probs=90.0

Q ss_pred             ccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCC-CCccceeceeEEcCCCeEEEE
Q 020657           50 YSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTD-SPFIVQCFGIFEKPSGDIAIL  128 (323)
Q Consensus        50 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~lv  128 (323)
                      ...|+..+..+.++.+.||+...  +++.+++|........ ....+.+|..+++.+. +--+.+++.+... ++..++|
T Consensus        13 ~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~-~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~-~~~~~lv   88 (263)
T d1j7la_          13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERH-DGWSNLL   88 (263)
T ss_dssp             HTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEE-TTEEEEE
T ss_pred             hhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCccc-chhhHHHHHHHHHHHhccCCCCcEEEEEec-CCceEEE
Confidence            45677777665566678998865  5667788887544221 1224567788777663 3346677777665 6788999


Q ss_pred             EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 020657          129 MEYMDSGTLDTLLNKNGTFSEPKLAHIASQILKGLSYLHG----------------------------------------  168 (323)
Q Consensus       129 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~l~~Lh~----------------------------------------  168 (323)
                      |++++|.++.+.....     .....++.++++.+..||+                                        
T Consensus        89 ~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T d1j7la_          89 MSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             EECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred             EEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence            9999988775543211     0111222333333333331                                        


Q ss_pred             -------------C------CCeecCCCCCCeEEecCCCcEEEeecCcchh
Q 020657          169 -------------H------KIIHRDIKPSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       169 -------------~------givH~di~~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                                   .      .++|+|+.+.||++++++ .+.|+||+.+..
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~-~~~lIDwe~a~~  213 (263)
T d1j7la_         164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK-VSGFIDLGRSGR  213 (263)
T ss_dssp             CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTE-EEEECCCTTCEE
T ss_pred             chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCc-eEEEeechhccc
Confidence                         1      279999999999999764 556999998743

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.49  E-value=1.9e-07  Score=80.99  Aligned_cols=78  Identities=17%  Similarity=0.123  Sum_probs=47.9

Q ss_pred             eeeecccCCeEEEEEEecccCcEEEEEeecCC------CChHHHHHHHHHHHHHHcCC-C--CccceeceeEEcCCCeEE
Q 020657           56 LQVLGHGNGGTVYKVQHRCTHKIYALKVVHGD------ADPTVRRQVFREMEILRRTD-S--PFIVQCFGIFEKPSGDIA  126 (323)
Q Consensus        56 ~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~------~~~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~~~~~~  126 (323)
                      .+.||.|....||++.+..+++.+++|.....      ..+....+...|...++.+. +  ..+++++.+.   ....+
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d---~~~~~  107 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD---TEMAV  107 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE---TTTTE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc---CCCCE
Confidence            45789999999999998777888999975421      11122334556777777652 2  3455555542   23457


Q ss_pred             EEEeccCCCC
Q 020657          127 ILMEYMDSGT  136 (323)
Q Consensus       127 lv~e~~~~~s  136 (323)
                      +|||++.+..
T Consensus       108 lvmE~L~~~~  117 (392)
T d2pula1         108 TVMEDLSHLK  117 (392)
T ss_dssp             EEECCCTTSE
T ss_pred             EEEeccCCcc
Confidence            8999997654

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.39  E-value=1.2e-06  Score=70.99  Aligned_cols=74  Identities=12%  Similarity=0.114  Sum_probs=49.4

Q ss_pred             eecccCC-eEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCC--CccceeceeEEcCCCeEEEEEeccCC
Q 020657           58 VLGHGNG-GTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDS--PFIVQCFGIFEKPSGDIAILMEYMDS  134 (323)
Q Consensus        58 ~lg~G~~-~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~~lv~e~~~~  134 (323)
                      .+..|.. +.||+.... ++..+++|........    .+..|...++.+..  -.+.+++.+..+ .+..++||++++|
T Consensus        17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~~----~l~~E~~~l~~L~~~gvpvP~v~~~~~~-~~~~~~v~~~i~G   90 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGALN----ELQDEAARLSWLATTGVPCAAVLDVVTE-AGRDWLLLGEVPG   90 (255)
T ss_dssp             ECSCTTSSCEEEEEECT-TSCCEEEEEECSCTTS----CHHHHHHHHHHHHTTTCCBCCEEEEEEC-SSCEEEEEECCSS
T ss_pred             EcCCcccCCeEEEEEeC-CCCEEEEEeCCccCHh----HHHHHHHHHHHHHhcCCCCCceeeeccc-ccceEEEEEeeec
Confidence            3444443 678998875 5667888987655432    34567777766532  335667777666 5678999999987


Q ss_pred             CCH
Q 020657          135 GTL  137 (323)
Q Consensus       135 ~sL  137 (323)
                      .++
T Consensus        91 ~~~   93 (255)
T d1nd4a_          91 QDL   93 (255)
T ss_dssp             EET
T ss_pred             ccc
Confidence            655

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.81  E-value=2.3e-05  Score=65.70  Aligned_cols=70  Identities=10%  Similarity=0.141  Sum_probs=44.2

Q ss_pred             cCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCcc--ceec----e-eEEcCCCeEEEEEeccCC
Q 020657           62 GNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFI--VQCF----G-IFEKPSGDIAILMEYMDS  134 (323)
Q Consensus        62 G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i--~~~~----~-~~~~~~~~~~lv~e~~~~  134 (323)
                      +....||++... +|+.+++|+.+....  ..+.+..|...+..|...++  +..+    + .+.. .+..+.+++++.|
T Consensus        33 s~EN~vy~v~~~-dg~~~VlK~~rp~~~--s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~-~~~~~~l~~~~~G  108 (325)
T d1zyla1          33 SYENRVYQFQDE-DRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNH-QGFYFAVFPSVGG  108 (325)
T ss_dssp             CSSSEEEEECCT-TCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEE-TTEEEEEEECCCC
T ss_pred             cccceeEEEEcC-CCCEEEEEEeCCCCC--CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeee-eeEEEEEEeecCC
Confidence            334689999885 788899999876532  23556678888777642222  1111    1 1222 5678889999876


Q ss_pred             C
Q 020657          135 G  135 (323)
Q Consensus       135 ~  135 (323)
                      .
T Consensus       109 ~  109 (325)
T d1zyla1         109 R  109 (325)
T ss_dssp             E
T ss_pred             c
Confidence            4

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.69  E-value=0.00014  Score=62.51  Aligned_cols=74  Identities=18%  Similarity=0.244  Sum_probs=49.8

Q ss_pred             eeeecccCCeEEEEEEecc-------cCcEEEEEeecCCCChHHHHHHHHHHHHHHcCC-CCccceeceeEEcCCCeEEE
Q 020657           56 LQVLGHGNGGTVYKVQHRC-------THKIYALKVVHGDADPTVRRQVFREMEILRRTD-SPFIVQCFGIFEKPSGDIAI  127 (323)
Q Consensus        56 ~~~lg~G~~~~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~l  127 (323)
                      ++.|+.|-.-.+|++....       ..+.|+++++-.. ...  ....+|..+++.+. +.-..++++++..     .+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~~--idr~~E~~i~~~ls~~gl~Pkll~~~~~-----g~  118 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETE--SHLVAESVIFTLLSERHLGPKLYGIFSG-----GR  118 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCH--HHHHHHHHHHHHHHHTTSSSCEEEEETT-----EE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-chh--hHHHHHHHHHHHHHhCCCCCeEEEEcCC-----ce
Confidence            4678889999999998642       3456888887532 222  23557888888874 3334567777643     68


Q ss_pred             EEeccCCCCH
Q 020657          128 LMEYMDSGTL  137 (323)
Q Consensus       128 v~e~~~~~sL  137 (323)
                      |+||++|.++
T Consensus       119 I~efi~g~~l  128 (395)
T d1nw1a_         119 LEEYIPSRPL  128 (395)
T ss_dssp             EECCCCEEEC
T ss_pred             EEEEeccccC
Confidence            8999987543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.53  E-value=0.00032  Score=58.09  Aligned_cols=31  Identities=19%  Similarity=0.269  Sum_probs=26.7

Q ss_pred             CCCeecCCCCCCeEEecCCCcEEEeecCcchh
Q 020657          169 HKIIHRDIKPSNLLVNNNNMQVKIADFGVSKI  200 (323)
Q Consensus       169 ~givH~di~~~nil~~~~~~~~kl~Dfg~~~~  200 (323)
                      .|++|+|+.++||+++.++ ..-++||+.+..
T Consensus       183 ~giIHgDl~~dNvl~~~~~-v~gvIDF~~~~~  213 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDE-LSGLIDFYFACN  213 (316)
T ss_dssp             EEEECSCCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred             cccccCCcchhhhhccccc-ceeEeccccccc
Confidence            3799999999999999875 568999999853

>d1cjaa_ d.144.1.3 (A:) Actin-fragmin kinase, catalytic domain {Physarum polycephalum [TaxId: 5791]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Actin-fragmin kinase, catalytic domain
domain: Actin-fragmin kinase, catalytic domain
species: Physarum polycephalum [TaxId: 5791]

Probab=88.01  E-value=1.4  Score=34.93  Aligned_cols=143  Identities=12%  Similarity=0.108  Sum_probs=76.6

Q ss_pred             hccccccceeeeecccCCeEEEEEEecccCcEEEEEeecCCCChHHHHHHHHHHHHHHcCCCCccceece----------
Q 020657           47 AIAYSDLEKLQVLGHGNGGTVYKVQHRCTHKIYALKVVHGDADPTVRRQVFREMEILRRTDSPFIVQCFG----------  116 (323)
Q Consensus        47 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~----------  116 (323)
                      .+...+++-++.-..|+.|..|. ..  ++..+++|.-.    ....+.+..++...-.+.-|...-+..          
T Consensus        65 ~~~l~~~K~i~~s~~Gs~Gv~FV-~~--e~gaiVlK~s~----tta~E~y~~eLAr~LGvpvPqmRvI~~~~~E~~~~~~  137 (342)
T d1cjaa_          65 WKNLQQFKGIERSEKGTEGLFFV-ET--ESGVFIVKRST----NIESETFCSLLCMRLGLHAPKVRVVSSNSEEGTNMLE  137 (342)
T ss_dssp             TTCGGGEEEEEECCSTTSCEEEE-EE--SSCEEEEECCT----THHHHHHHHHHHHHHTCCCCCEEEEESSSHHHHHHHH
T ss_pred             hhhHHhhhceEEeecCCceEEEE-Ec--CCceEEEecCC----chHHHHHHHHHHHHhCCCCCceEEecCCCHHHHHHHH
Confidence            34445555555555666666555 33  45567788732    233455556665555566665544320          


Q ss_pred             -------eE----EcCCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHH---HHHHHHHHHhC---CCeecC-CCC
Q 020657          117 -------IF----EKPSGDIAILMEYMDSGTLDTLLNKNGTFSEPKLAHIASQ---ILKGLSYLHGH---KIIHRD-IKP  178 (323)
Q Consensus       117 -------~~----~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~---i~~~l~~Lh~~---givH~d-i~~  178 (323)
                             ..    ..-.....++|||.+|.++.+.-..  ..+.......+.+   |+..=.+++..   .+.+++ =.+
T Consensus       138 ~~l~~~e~d~~I~sel~~A~~liMeYvpG~~l~e~~~~--~a~~~fs~~~l~~LGkIiaFDifInN~DR~PL~Wrn~GN~  215 (342)
T d1cjaa_         138 CLAAIDKSFRVITTLANQANILLMELVRGITLNKLTTT--SAPEVLTKSTMQQLGSLMALDVIVNNSDRLPIAWTNEGNL  215 (342)
T ss_dssp             HHHHHCSSSCHHHHHTTCSEEEEEECCCEEESTTCCSS--SHHHHSCHHHHHHHHHHHHHHHHHTCCSSSCSSSCSCCCG
T ss_pred             HHhcCCChhHHHHHHHhcccceeeeccCCccccccccc--cchhhhcHHHHHHhhhHHHHHHHHcCCccccccccCCCCc
Confidence                   00    0112357899999998777543210  1111111222333   22222344443   345552 188


Q ss_pred             CCeEEecCCCcEEEeecCcc
Q 020657          179 SNLLVNNNNMQVKIADFGVS  198 (323)
Q Consensus       179 ~nil~~~~~~~~kl~Dfg~~  198 (323)
                      .||+++.++..+..+|=+..
T Consensus       216 ~Niml~~n~~~~~~IDs~i~  235 (342)
T d1cjaa_         216 DNIMLSERGATVVPIDSKII  235 (342)
T ss_dssp             GGEEEESBTTCEEECSCCCC
T ss_pred             cceEEecCCcEEEEecCCcc
Confidence            99999998878888885443